PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Winston, JS; Strange, BA; O'Doherty, J; Dolan, RJ				Winston, JS; Strange, BA; O'Doherty, J; Dolan, RJ			Automatic and intentional brain responses during evaluation of trustworthiness of faces	NATURE NEUROSCIENCE			English	Article							FACIAL EXPRESSIONS; HUMAN AMYGDALA; NEURAL RESPONSES; PERCEPTION; RECOGNITION; EMOTION; FEAR; MIND; ACTIVATION; MECHANISMS	Successful social interaction partly depends on appraisal of others from their facial appearance. A critical aspect of this appraisal relates to whether we consider others to be trustworthy. We determined the neural basis for such trustworthiness judgments using event-related functional magnetic resonance imaging. Subjects viewed faces and assessed either trustworthiness or age. In a parametric factorial design, trustworthiness ratings were correlated with BOLD signal change to reveal task-independent increased activity in bilateral amygdala and right insula in response to faces judged untrustworthy. Right superior temporal sulcus (STS) showed enhanced signal change during explicit trustworthiness judgments alone. The findings extend a proposed model of social cognition by highlighting a functional dissociation between automatic engagement of amygdala versus intentional engagement of STS in social judgment.	Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; Inst Cognit Neurosci, London WC1N 3AR, England; UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School	Winston, JS (corresponding author), Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.	j.winston@fil.ion.ucl.ac.uk	O'Doherty, John P/F-1204-2013; Winston, Joel/F-6180-2010; Strange, Bryan A/L-9466-2014; Strange, Bryan/AAF-3805-2019	Winston, Joel/0000-0002-3957-0612; Strange, Bryan A/0000-0001-6476-4091; Strange, Bryan/0000-0001-6476-4091; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 2000, J NEUROSCI, V20, P2683; Adolphs R, 1999, TRENDS COGN SCI, V3, P469, DOI 10.1016/S1364-6613(99)01399-6; Adolphs R, 2001, CURR OPIN NEUROBIOL, V11, P231, DOI 10.1016/S0959-4388(00)00202-6; Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Bonda E, 1996, J NEUROSCI, V16, P3737; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; Brunet E, 2000, NEUROIMAGE, V11, P157, DOI 10.1006/nimg.1999.0525; Buchel C, 1999, J NEUROSCI, V19, P10869; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Casey KL, 1999, P NATL ACAD SCI USA, V96, P7668, DOI 10.1073/pnas.96.14.7668; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Cohen DonaldJ., 2000, UNDERSTANDING OTHER, P334; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio A. R., 1999, FEELING WHAT HAPPENS; Dolan RJ, 1996, NEUROIMAGE, V4, P194, DOI 10.1006/nimg.1996.0070; Dolan RJ, 2001, P NATL ACAD SCI USA, V98, P10006, DOI 10.1073/pnas.171288598; Duvernoy HM, 1999, HUMAN BRAIN; Ekman P., 1975, PICTURES FACIAL AFFE; Elliott R, 1998, J NEUROSCI, V18, P4697; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Humphrey N, 1983, CONSCIOUSNESS REGAIN; Isenberg N, 1999, P NATL ACAD SCI USA, V96, P10456, DOI 10.1073/pnas.96.18.10456; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 2001, NEUROIMAGE, V13, P1044, DOI 10.1006/nimg.2000.0721; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Phillips ML, 1998, P ROY SOC B-BIOL SCI, V265, P1809, DOI 10.1098/rspb.1998.0506; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Strange BA, 2000, NEUROIMAGE, V12, P425, DOI 10.1006/nimg.2000.0637; Talairach J., 1988, COPLANAR STEREOTAXIC; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	50	745	753	6	129	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					277	283		10.1038/nn816	http://dx.doi.org/10.1038/nn816			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850635	Green Published			2022-12-24	WOS:000174146000020
J	Marques, G; Bao, H; Haerry, TE; Shimell, MJ; Duchek, P; Zhang, B; O'Connor, MB				Marques, G; Bao, H; Haerry, TE; Shimell, MJ; Duchek, P; Zhang, B; O'Connor, MB			The Drosophila BMP type II receptor wishful thinking regulates neuromuscular synapse morphology and function	NEURON			English	Article							PRIMARY PULMONARY-HYPERTENSION; GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; TGF-BETA; GENETIC DISSECTION; NERVOUS-SYSTEM; SYMPATHETIC NEURONS; GLUTAMATE RECEPTORS; GERMLINE MUTATIONS; DENDRITIC GROWTH	Proper synaptic development is critical for establishing all aspects of neural function including learning, memory, and locomotion. Here, we describe the phenotypic consequences of mutations in the wishful thinking (wit) gene, the Drosophila homolog of the vertebrate BMP type II receptor. Mutations in wit result in pharate lethality that can be rescued by expression of a wit transgene in motor neurons but not in muscles. Mutant larvae exhibit small synapses, severe defects in evoked junctional potentials, a lower frequency of spontaneous vesicle release, and an alteration in the ultrastructure of synaptic active zones. These results reveal a novel role for BMP signaling in regulating Drosophila neuromuscular junction synapse assembly and activity and may indicate that similar pathways could govern vertebrate synapse development.	Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; Univ Texas, Inst Mol & Cellular Biol, Neurobiol Sect, Patterson Labs 227, Austin, TX 78712 USA; Univ Texas, Inst Mol & Cellular Biol, Sect Mol Cellular & Dev Biol, Patterson Labs 227, Austin, TX 78712 USA	University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.		O'Connor, Michael B/C-9977-2014	O'Connor, Michael B/0000-0002-3067-5506				Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Augsburger A, 1999, NEURON, V24, P127, DOI 10.1016/S0896-6273(00)80827-2; BAARENDS WM, 1994, DEVELOPMENT, V120, P189; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE KS, 1995, J PHYSIOLOGY-PARIS, V89, P59, DOI 10.1016/0928-4257(96)80552-3; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; Brummel T, 1999, GENE DEV, V13, P98, DOI 10.1101/gad.13.1.98; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; BUDNIK V, 1999, INT REV NEUROBIOLOGY, V43; Cameron JS, 1998, NEURON, V21, P1045, DOI 10.1016/S0896-6273(00)80622-4; Cameron JS, 1999, DEVELOPMENT, V126, P4157; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Chin J, 1999, LEARN MEMORY, V6, P317; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Frisch A, 1998, DEVELOPMENT, V125, P431; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Hannan F, 1999, INT REV NEUROBIOL, V43, P119, DOI 10.1016/S0074-7742(08)60543-7; HARRISON SD, 1995, GENETICS, V139, P1701; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Jiang YY, 2000, J NEUROSCI RES, V62, P809, DOI 10.1002/1097-4547(20001215)62:6<809::AID-JNR7>3.3.CO;2-W; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KULKARNI SJ, 1994, MOL GEN GENET, V243, P555, DOI 10.1007/BF00284204; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Landgraf M, 1997, J NEUROSCI, V17, P9642; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIU F, 1995, MOL CELL BIOL, V15, P3479; Liu QR, 1997, J NEUROSCI, V17, P755; Lo PCH, 1999, MECH DEVELOP, V86, P171, DOI 10.1016/S0925-4773(99)00108-2; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Lorentzon M, 1996, EXP NEUROL, V142, P351, DOI 10.1006/exnr.1996.0204; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MCDONALD KL, 1994, METHOD CELL BIOL, V44, P411, DOI 10.1016/S0091-679X(08)60926-7; MCLENNAN IS, 1994, NEUROSCI LETT, V177, P151, DOI 10.1016/0304-3940(94)90889-3; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Newfeld SJ, 1999, GENETICS, V152, P783; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Schneider C, 1999, NEURON, V24, P861, DOI 10.1016/S0896-6273(00)81033-8; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Stewart BA, 1996, J NEUROSCI, V16, P3877; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	71	243	249	1	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					529	543		10.1016/S0896-6273(02)00595-0	http://dx.doi.org/10.1016/S0896-6273(02)00595-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856528	Bronze			2022-12-24	WOS:000173911100007
J	Taddese, A; Bean, BP				Taddese, A; Bean, BP			Subthreshold sodium current from rapidly inactivating sodium channels drives spontaneous firing of tuberomammillary neurons	NEURON			English	Article							RAT SUPRACHIASMATIC NUCLEUS; CEREBELLAR PURKINJE NEURONS; ACTIVATED CATION CURRENT; PERSISTENT NA+ CURRENT; NEOCORTICAL NEURONS; HIPPOCAMPAL-NEURONS; ELECTROPHYSIOLOGICAL PROPERTIES; SINGLE-CHANNEL; IONIC CURRENTS; MEMBRANE-PROPERTIES	A role for "persistent," subthreshold, TTX-sensitive sodium current in driving the pacemaking of many central neurons has been proposed, but this has been impossible to test pharmacologically. Using isolated tuberomammillary neurons, we assessed the role of subthreshold sodium current in pacemaking by performing voltage-clamp experiments using a cell's own pacemaking cycle as voltage command. TTX-sensitive sodium current flows throughout the pacemaking cycle, even at voltages as negative as -70 mV, and this current is sufficient to drive spontaneous firing. When sodium channels underlying transient current were driven into slow inactivation by rapid stimulation, persistent current decreased in parallel, suggesting that persistent sodium current originates from subthreshold gating of the same sodium channels that underlie the phasic sodium current. This behavior of sodium channels may endow all neurons with an intrinsic propensity for rhythmic, spontaneous firing.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Bean, BP (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.							Agrawal N, 2001, NEUROSCIENCE, V102, P53, DOI 10.1016/S0306-4522(00)00455-3; ALDRICH RW, 1983, NATURE, V306, P436, DOI 10.1038/306436a0; ALZHEIMER C, 1993, J NEUROSCI, V13, P660; ARMSTRONG CM, 1977, J GEN PHYSIOL, V70, P567, DOI 10.1085/jgp.70.5.567; Bennett BD, 2000, J NEUROSCI, V20, P8493, DOI 10.1523/JNEUROSCI.20-22-08493.2000; Bergles DE, 1996, J NEUROSCI, V16, P572; Bevan MD, 1999, J NEUROSCI, V19, P7617, DOI 10.1523/JNEUROSCI.19-17-07617.1999; BEZANILLA F, 1977, J GEN PHYSIOL, V70, P549, DOI 10.1085/jgp.70.5.549; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; BROWN AM, 1994, J NEUROPHYSIOL, V71, P2562, DOI 10.1152/jn.1994.71.6.2562; Brown RE, 2001, PROG NEUROBIOL, V63, P637, DOI 10.1016/S0301-0082(00)00039-3; Brumberg JC, 2000, J NEUROSCI, V20, P4829; Butera RJ, 1999, J NEUROPHYSIOL, V82, P382, DOI 10.1152/jn.1999.82.1.382; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; COHEN CJ, 1984, CIRC RES, V54, P636, DOI 10.1161/01.RES.54.6.636; Conti F, 1996, BIOPHYS J, V71, P1295, DOI 10.1016/S0006-3495(96)79330-X; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; CUMMINS TR, 1994, J NEUROPHYSIOL, V71, P1052, DOI 10.1152/jn.1994.71.3.1052; D'Angelo E, 1998, J NEUROPHYSIOL, V80, P493, DOI 10.1152/jn.1998.80.2.493; Dickson CT, 1997, NEUROSCIENCE, V81, P937, DOI 10.1016/S0306-4522(97)00263-7; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DOERR T, 1989, PFLUG ARCH EUR J PHY, V413, P599, DOI 10.1007/BF00581808; Eaholtz G, 1999, J GEN PHYSIOL, V113, P279, DOI 10.1085/jgp.113.2.279; Fleidervish IA, 1996, J NEUROPHYSIOL, V76, P2125, DOI 10.1152/jn.1996.76.3.2125; Fleidervish IA, 1996, J PHYSIOL-LONDON, V493, P83, DOI 10.1113/jphysiol.1996.sp021366; FRENCH CR, 1990, J GEN PHYSIOL, V95, P1139, DOI 10.1085/jgp.95.6.1139; FURUKAWA K, 1994, J NEUROPHYSIOL, V71, P868, DOI 10.1152/jn.1994.71.3.868; HAAS HL, 1988, J PHYSIOL-LONDON, V399, P633; Hammarstrom AKM, 1999, J PHYSIOL-LONDON, V520, P451, DOI 10.1111/j.1469-7793.1999.t01-1-00451.x; Hammarstrom AKM, 1998, J PHYSIOL-LONDON, V510, P735, DOI 10.1111/j.1469-7793.1998.735bj.x; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOTSON JR, 1979, J NEUROPHYSIOL, V42, P889, DOI 10.1152/jn.1979.42.3.889; HUANG RC, 1993, J NEUROPHYSIOL, V70, P1692, DOI 10.1152/jn.1993.70.4.1692; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P683, DOI 10.1152/jn.1996.76.2.683; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; KAMONDI A, 1991, J NEUROPHYSIOL, V66, P1902, DOI 10.1152/jn.1991.66.6.1902; Kay AR, 1998, J NEUROPHYSIOL, V80, P1167, DOI 10.1152/jn.1998.80.3.1167; KUO CC, 1994, NEURON, V12, P819, DOI 10.1016/0896-6273(94)90335-2; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS RR, 1992, J NEUROPHYSIOL, V68, P1307, DOI 10.1152/jn.1992.68.4.1307; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Madeja M, 2000, EUR J NEUROSCI, V12, P1, DOI 10.1046/j.1460-9568.2000.00871.x; Magistretti J, 1998, BIOPHYS J, V74, P831, DOI 10.1016/S0006-3495(98)74007-X; Magistretti J, 1999, J NEUROSCI, V19, P7334, DOI 10.1523/JNEUROSCI.19-17-07334.1999; Magistretti J, 1999, J GEN PHYSIOL, V114, P491, DOI 10.1085/jgp.114.4.491; Magistretti J, 1996, TRENDS NEUROSCI, V19, P530, DOI 10.1016/S0166-2236(96)40004-2; Maurice N, 2001, J NEUROSCI, V21, P2268, DOI 10.1523/JNEUROSCI.21-07-02268.2001; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Parri HR, 1998, J NEUROSCI, V18, P854; PATEL BT, 1986, NEUROSCI LETT, V63, P185, DOI 10.1016/0304-3940(86)90059-5; PATTON DE, 1991, NEURON, V7, P637, DOI 10.1016/0896-6273(91)90376-B; Pennartz CMA, 1997, J NEUROPHYSIOL, V78, P1811, DOI 10.1152/jn.1997.78.4.1811; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Raman IM, 1997, J NEUROSCI, V17, P4517, DOI 10.1523/jneurosci.17-12-04517.1997; Raman IM, 2001, BIOPHYS J, V80, P729, DOI 10.1016/S0006-3495(01)76052-3; Raman IM, 2000, J NEUROSCI, V20, P9004; Raman IM, 1999, J NEUROSCI, V19, P1663; REINER PB, 1987, NEUROSCI LETT, V73, P43, DOI 10.1016/0304-3940(87)90028-0; Schwarz C, 1997, J NEUROPHYSIOL, V78, P3323, DOI 10.1152/jn.1997.78.6.3323; Smith MR, 1998, J NEUROSCI, V18, P6093; STAFSTROM CE, 1982, BRAIN RES, V236, P221, DOI 10.1016/0006-8993(82)90050-6; Steriade M, 2001, J NEUROPHYSIOL, V86, P1, DOI 10.1152/jn.2001.86.1.1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Stevens DR, 1996, J PHYSIOL-LONDON, V493, P747, DOI 10.1113/jphysiol.1996.sp021419; Takakusaki K, 1997, NEUROSCIENCE, V78, P771, DOI 10.1016/S0306-4522(96)00540-4; UTESHEV V, 1995, NEUROSCIENCE, V66, P143, DOI 10.1016/0306-4522(94)00593-T; WADA H, 1991, TRENDS NEUROSCI, V14, P415, DOI 10.1016/0166-2236(91)90034-R; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Wu NP, 2001, J NEUROSCI, V21, P3729, DOI 10.1523/JNEUROSCI.21-11-03729.2001; Zaza A, 1997, J PHYSIOL-LONDON, V505, P677, DOI 10.1111/j.1469-7793.1997.677ba.x	76	232	240	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					587	600		10.1016/S0896-6273(02)00574-3	http://dx.doi.org/10.1016/S0896-6273(02)00574-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856532	Bronze			2022-12-24	WOS:000173911100011
J	Simon, O; Mangin, JF; Cohen, L; Le Bihan, D; Dehaene, S				Simon, O; Mangin, JF; Cohen, L; Le Bihan, D; Dehaene, S			Topographical layout of hand, eye, calculation, and language-related areas in the human parietal lobe	NEURON			English	Article							FUNCTIONAL-ANATOMY; INTRAPARIETAL AREA; VISUAL GUIDANCE; HUMAN-BRAIN; CORTEX; MONKEY; ATTENTION; REPRESENTATIONS; NEURONS; MOTOR	To identify subdivisions of the human parietal cortex, we collected fMRI data while ten subjects performed six tasks: grasping, pointing, saccades, attention, calculation, and phoneme detection. Examination of task intersections revealed a systematic anterior-to-posterior organization of activations associated with grasping only, grasping and pointing, all visuomotor tasks, attention and saccades, and saccades only. Calculation yielded two distinct activations: one unique to calculation in the bilateral anterior IPS mesial to the supramarginal gyrus and the other shared with phoneme detection in the left IPS mesial to the angular gyrus. These results suggest human homologs of the monkey areas AIP, MIP, V6A, and LIP and imply a large cortical expansion of the inferior parietal lobule correlated with the development of human language and calculation abilities.	CEA DSV, Serv Hosp Frederic Joliot, INSERM, U334, Orsay, France; CEA DSV, Serv Hosp Frederic Joliot, IFR 49, Unite Neuroact Fonct, Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), CEA DSV, Serv Hosp Frederic Joliot, INSERM, U334, Orsay, France.		Mangin, Jean-Francois/AAI-8983-2020	cohen, laurent/0000-0002-5010-9085				Battaglia-Mayer A, 2001, CEREB CORTEX, V11, P528, DOI 10.1093/cercor/11.6.528; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Chochon F, 1999, J COGNITIVE NEUROSCI, V11, P617, DOI 10.1162/089892999563689; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Colby CL, 1998, NEURON, V20, P15, DOI 10.1016/S0896-6273(00)80429-8; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Culham JC, 2001, CURR OPIN NEUROBIOL, V11, P157, DOI 10.1016/S0959-4388(00)00191-4; DECETY J, 1994, NATURE, V371, P600, DOI 10.1038/371600a0; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 1995, MATH COGNITION, V1, P83, DOI DOI 10.1155/2014/461647; Disbrow E, 2000, J COMP NEUROL, V418, P1, DOI 10.1002/(SICI)1096-9861(20000228)418:1<1::AID-CNE1>3.0.CO;2-P; EIDELBERG D, 1984, ARCH NEUROL-CHICAGO, V41, P843, DOI 10.1001/archneur.1984.04050190049013; Faillenot I, 1997, CEREB CORTEX, V7, P77, DOI 10.1093/cercor/7.1.77; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; GALLESE V, 1994, NEUROREPORT, V5, P1525, DOI 10.1097/00001756-199407000-00029; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; Galletti C, 1999, EUR J NEUROSCI, V11, P3922, DOI 10.1046/j.1460-9568.1999.00817.x; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Grafton ST, 1996, CEREB CORTEX, V6, P226, DOI 10.1093/cercor/6.2.226; Grosbras MH, 1999, CEREB CORTEX, V9, P705, DOI 10.1093/cercor/9.7.705; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iriki A, 1996, NEUROREPORT, V7, P2325; Jonides J, 1998, J NEUROSCI, V18, P5026; Kawashima R, 1996, NEUROREPORT, V7, P1253, DOI 10.1097/00001756-199605170-00006; Lee KM, 2000, ANN NEUROL, V48, P657, DOI 10.1002/1531-8249(200010)48:4<657::AID-ANA13>3.3.CO;2-B; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MOUNTCASTLE VB, 1975, J NEUROPHYSIOL, V38, P871, DOI 10.1152/jn.1975.38.4.871; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; Muri RM, 1996, J NEUROL NEUROSUR PS, V60, P445, DOI 10.1136/jnnp.60.4.445; Nobre AC, 2000, NEUROIMAGE, V11, P210, DOI 10.1006/nimg.2000.0539; Pallier C, 1997, BEHAV RES METH INS C, V29, P322, DOI 10.3758/BF03200583; Pesenti M, 2000, J COGNITIVE NEUROSCI, V12, P461, DOI 10.1162/089892900562273; Pinel P, 2001, NEUROIMAGE, V14, P1013, DOI 10.1006/nimg.2001.0913; Portin K, 1999, P ROY SOC B-BIOL SCI, V266, P981, DOI 10.1098/rspb.1999.0733; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1987, NEUROPSYCHOLOGIA, V25, P31, DOI 10.1016/0028-3932(87)90041-8; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Sereno MI, 2001, SCIENCE, V294, P1350, DOI 10.1126/science.1063695; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Zago L, 2001, NEUROIMAGE, V13, P314, DOI 10.1006/nimg.2000.0697	49	589	602	2	49	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					475	487		10.1016/S0896-6273(02)00575-5	http://dx.doi.org/10.1016/S0896-6273(02)00575-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832233	Bronze			2022-12-24	WOS:000173643200016
J	Price, MP; McIlwrath, SL; Xie, JH; Cheng, C; Qiao, J; Tarr, DE; Sluka, KA; Brennan, TJ; Lewin, GR; Welsh, MJ				Price, MP; McIlwrath, SL; Xie, JH; Cheng, C; Qiao, J; Tarr, DE; Sluka, KA; Brennan, TJ; Lewin, GR; Welsh, MJ			The DRASIC cation channel contributes to the detection of cutaneous touch and acid stimuli in mice	NEURON			English	Article							EPITHELIAL NA+ CHANNEL; ROOT GANGLION NEURONS; SENSORY NEURONS; TISSUE ACIDOSIS; ION CHANNELS; HAIRY SKIN; MECHANOSENSORY NEURONS; CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; FINE-STRUCTURE	Cation channels in the DEG/ENaC family are proposed to detect cutaneous stimuli in mammals. We localized one such channel, DRASIC, in several different specialized sensory nerve endings of skin, suggesting it might participate in mechanosensation and/or acid-evoked nociception. Disrupting the mouse DRASIC gene altered sensory transduction in specific and distinct ways. Loss of DRASIC increased the sensitivity of mechanoreceptors detecting light touch, but it reduced the sensitivity of a mechanoreceptor responding to noxious pinch and decreased the response of acid- and noxious heat-sensitive nociceptors. The data suggest that DRASIC subunits participate in heteromultimeric channel complexes in sensory neurons. Moreover, in different cellular contexts, DRASIC may respond to mechanical stimuli or to low pH to mediate normal touch and pain sensation.	Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Grad Program Phys Therapy, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Anesthesia, Iowa City, IA 52242 USA; Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA; Max Delbruck Ctr Mol Med, Dept Neurosci, Growth Factors & Regenerat Grp, D-13092 Berlin, Germany	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Welsh, MJ (corresponding author), Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA.	glewin@mdc.berlin.de; mjwelsh@blue.weeg.ulowa.edu	Lewin, Gary R/B-8028-2011	Lewin, Gary/0000-0002-2890-6352; Sluka, Kathleen/0000-0003-0207-8728; Welsh, Michael/0000-0002-1646-6206; Brennan, Timothy/0000-0002-0150-5145; Tarr, Ellen/0000-0003-1604-4545	NIDDK NIH HHS [DK25295] Funding Source: Medline; NINDS NIH HHS [NS39734] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK025295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039734] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams CM, 1998, J CELL BIOL, V140, P143, DOI 10.1083/jcb.140.1.143; Airaksinen MS, 1996, NEURON, V16, P287, DOI 10.1016/S0896-6273(00)80047-1; Babinski K, 1999, J NEUROCHEM, V72, P51, DOI 10.1046/j.1471-4159.1999.0720051.x; Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1991, J PHYSIOL-LONDON, V433, P145, DOI 10.1113/jphysiol.1991.sp018419; Burgess PR, 1973, HDB SENSORY PHYSIOLO, VII, P29; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Cervero F, 1996, PAIN, V68, P13, DOI 10.1016/S0304-3959(96)03165-X; Cesare P, 1997, CURR OPIN NEUROBIOL, V7, P493, DOI 10.1016/S0959-4388(97)80028-1; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; Darian-Smith I., 1984, HDB PHYSL 2 1, VIII, P739; Diamond J, 1988, Prog Brain Res, V74, P51; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Drummond HA, 2000, BRAIN RES, V884, P1, DOI 10.1016/S0006-8993(00)02831-6; FRENCH AS, 1992, ANNU REV PHYSIOL, V54, P135, DOI 10.1146/annurev.physiol.54.1.135; Fricke B, 2000, CELL TISSUE RES, V299, P327; Garcia-Anoveros J, 2001, J NEUROSCI, V21, P2678, DOI 10.1523/JNEUROSCI.21-08-02678.2001; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; GORMAN C, 1983, SCIENCE, V221, P551, DOI 10.1126/science.6306768; HALATA Z, 1993, J INVEST DERMATOL, V101, pS75, DOI 10.1111/1523-1747.ep12362877; Hamill OP, 1996, TRENDS NEUROSCI, V19, P258, DOI 10.1016/S0166-2236(96)30009-X; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; IDE C, 1976, AM J ANAT, V147, P329, DOI 10.1002/aja.1001470307; IKEDA I, 1994, J PHYSIOL-LONDON, V479, P247, DOI 10.1113/jphysiol.1994.sp020292; Issberner U, 1996, NEUROSCI LETT, V208, P191, DOI 10.1016/0304-3940(96)12576-3; JOHNSON KO, 1992, ANNU REV NEUROSCI, V15, P227, DOI 10.1146/annurev.ne.15.030192.001303; Kinkelin I, 1999, EUR J NEUROSCI, V11, P3963, DOI 10.1046/j.1460-9568.1999.00822.x; KOCHER L, 1987, PAIN, V29, P363, DOI 10.1016/0304-3959(87)90051-0; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; KRUGER L, 1981, J COMP NEUROL, V198, P137, DOI 10.1002/cne.901980112; Lawson SN, 1997, J PHYSIOL-LONDON, V505, P177, DOI 10.1111/j.1469-7793.1997.00177.x; Lawson SN., 1992, SENSORY NEURONS DIVE, P27; LeMaster AM, 1999, J NEUROSCI, V19, P5919, DOI 10.1523/JNEUROSCI.19-14-05919.1999; Lewin G.R., 2000, MOL BASIS PAIN INDUC, P129; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu JD, 1996, SCIENCE, V273, P361, DOI 10.1126/science.273.5273.361; Maingret F, 1999, J BIOL CHEM, V274, P26691, DOI 10.1074/jbc.274.38.26691; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; Mansikka H, 1999, ANESTHESIOLOGY, V90, P1643, DOI 10.1097/00000542-199906000-00021; Martin J. H., 1991, PRINCIPLES NEURAL SC, V3, P341; MCCARTHY PW, 1989, NEUROSCIENCE, V28, P745, DOI 10.1016/0306-4522(89)90019-5; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; McDonald FJ, 1999, P NATL ACAD SCI USA, V96, P1727, DOI 10.1073/pnas.96.4.1727; MCDONALD FJ, 1995, AM J PHYSIOL-CELL PH, V268, pC1157, DOI 10.1152/ajpcell.1995.268.5.C1157; Mogil JS, 1999, PAIN, V80, P67, DOI 10.1016/S0304-3959(98)00197-3; MUNGER BL, 1988, ARCH HISTOL CYTOL, V51, P1, DOI 10.1679/aohc.51.1; Perl ER, 1992, SENSORY NEURONS DIVE, P3; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 1996, J BIOL CHEM, V271, P7879, DOI 10.1074/jbc.271.14.7879; Reeh PW, 1996, PROG BRAIN RES, V113, P143, DOI 10.1016/S0079-6123(08)61085-7; Sinclair D., 1981, MECH CUTANEOUS SENSA; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; STEEN KH, 1993, NEUROSCI LETT, V154, P113, DOI 10.1016/0304-3940(93)90184-M; STEEN KH, 1992, J NEUROSCI, V12, P86; Stucky CL, 1999, J NEUROSCI, V19, P6497; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; SZOLCSANYI J, 1988, BRAIN RES, V446, P262, DOI 10.1016/0006-8993(88)90885-2; Tavernarakis N, 1997, NEURON, V18, P107, DOI 10.1016/S0896-6273(01)80050-7; TREEDE RD, 1992, PROG NEUROBIOL, V38, P397, DOI 10.1016/0301-0082(92)90027-C; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1996, J BIOL CHEM, V271, P10433, DOI 10.1074/jbc.271.18.10433; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WHEELERACETO H, 1990, PAIN, V40, P229, DOI 10.1016/0304-3959(90)90073-M; Woolf Clifford J., 1994, Current Opinion in Neurobiology, V4, P525, DOI 10.1016/0959-4388(94)90053-1; Yeomans DC, 1996, PAIN, V68, P141, DOI 10.1016/S0304-3959(96)03177-6	73	462	486	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1071	1083		10.1016/S0896-6273(01)00547-5	http://dx.doi.org/10.1016/S0896-6273(01)00547-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754838	Bronze			2022-12-24	WOS:000172886800013
J	Dahanukar, A; Foster, K; van Naters, WMVDG; Carlson, JR				Dahanukar, A; Foster, K; van Naters, WMVDG; Carlson, JR			A Gr receptor is required for response to the sugar trehalose in taste neurons of Drosophila	NATURE NEUROSCIENCE			English	Article							SWEET TASTE; GENE; FAMILY; MELANOGASTER; SENSITIVITY; IDENTIFICATION; PROJECTIONS; MOUTHPARTS; EXPRESSION	We recently identified from the Drosophila genome database a large family of G protein-coupled receptor genes, the Gr genes, and predicted that they encode taste receptors on the basis of their structure and specificity of expression. The expression of Gr genes in gustatory neurons has subsequently been confirmed and 56 family members have been reported. Here we provide functional evidence that one Gr gene, Gr5a, encodes a taste receptor required for response to the sugar trehalose. In two different mutants that carry deletions in Gr5a, electrophysiological and behavioral responses to trehalose were diminished but the response to sucrose was unaffected. Transgenic rescue experiments showed that Gr5a confers response to trehalose. The results correlate a particular taste ligand with a Gr receptor and indicate a role for G protein-mediated signaling in the transduction of sweet taste in Drosophila.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.	john.carlson@yale.edu	van der Goes van Naters, Wynand/A-5868-2010	Dahanukar, Anupama/0000-0003-0534-7700				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; AMAKAWA T, 1990, J INSECT PHYSIOL, V36, P281, DOI 10.1016/0022-1910(90)90112-S; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; Dethier VG, 1976, HUNGRY FLY; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; GLENDINNING JI, 2000, NEUROBIOLOGY TASTE S, V2, P315; HODGSON ES, 1955, SCIENCE, V122, P417, DOI 10.1126/science.122.3166.417-a; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Max M, 2001, NAT GENET, V28, P58, DOI 10.1038/88270; Montmayeur JP, 2001, NAT NEUROSCI, V4, P492, DOI 10.1038/87440; Murakami M, 2000, J GEN PHYSIOL, V115, P455, DOI 10.1085/jgp.115.4.455; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; Nelson G, 2001, CELL, V106, P381, DOI 10.1016/S0092-8674(01)00451-2; RAY K, 1993, DEV BIOL, V155, P26, DOI 10.1006/dbio.1993.1003; RODRIGUES V, 1981, MOL GEN GENET, V181, P406, DOI 10.1007/BF00425621; Sainz E, 2001, J NEUROCHEM, V77, P896, DOI 10.1046/j.1471-4159.2001.00292.x; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; SHANBHAG SR, 1992, CELL TISSUE RES, V267, P273, DOI 10.1007/BF00302965; Singh RN, 1997, MICROSC RES TECHNIQ, V39, P547, DOI 10.1002/(SICI)1097-0029(19971215)39:6<547::AID-JEMT7>3.0.CO;2-A; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; STOCKER RF, 1981, CELL TISSUE RES, V216, P513; TANIMURA T, 1988, GENETICS, V119, P399; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; TANIMURA T, 1981, J COMP PHYSIOL, V141, P265, DOI 10.1007/BF01342672; Ueno K, 2001, CURR BIOL, V11, P1451, DOI 10.1016/S0960-9822(01)00450-X; WIECZOREK H, 1989, J COMP PHYSIOL A, V164, P825, DOI 10.1007/BF00616754	31	199	201	4	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1182	1186		10.1038/nn765	http://dx.doi.org/10.1038/nn765			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704765				2022-12-24	WOS:000172525000013
J	Haarmeier, T; Bunjes, F; Lindner, A; Berret, E; Thier, P				Haarmeier, T; Bunjes, F; Lindner, A; Berret, E; Thier, P			Optimizing visual motion perception during eye movements	NEURON			English	Article							OPTIC FLOW STIMULI; FILEHNE ILLUSION; SELF-MOTION; RESPONSE SELECTIVITY; PATH PERCEPTION; FIELD STIMULI; MST NEURONS; SENSITIVITY; MECHANISMS; JUDGMENTS	We usually perceive a stationary, stable world and we are able to correctly estimate the direction of heading from optic flow despite coherent visual motion induced by eye movements. This astonishing example of perceptual invariance results from a comparison of visual information with internal reference signals predicting the visual consequences of an eye movement. Here we demonstrate that the reference signal predicting the consequences of smooth-pursuit eye movements is continuously calibrated on the basis of direction-selective interactions between the pursuit motor command and the rotational flow induced by the eye movement, thereby minimizing imperfections of the reference signal and guaranteeing an ecologically optimal interpretation of visual motion.	Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany; Univ Tubingen, Dept Gen Neurol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Thier, P (corresponding author), Univ Tubingen, Dept Cognit Neurol, D-72076 Tubingen, Germany.			Lindner, Axel/0000-0002-8201-788X; Thier, Peter/0000-0001-5909-4222				BANKS MS, 1996, VISION RES, V36, P413; Bradley DC, 1996, SCIENCE, V273, P1544, DOI 10.1126/science.273.5281.1544; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1346, DOI 10.1152/jn.1991.65.6.1346; DUFFY CJ, 1991, J NEUROPHYSIOL, V65, P1329, DOI 10.1152/jn.1991.65.6.1329; Freeman TCA, 2000, PERCEPT PSYCHOPHYS, V62, P900, DOI 10.3758/BF03212076; Freeman TCA, 1999, VISION RES, V39, P2659, DOI 10.1016/S0042-6989(98)00293-4; Gibson JJ, 1950, PERCEPTION VISUAL WO; Haarmeier T, 1998, J COGNITIVE NEUROSCI, V10, P464, DOI 10.1162/089892998562870; Haarmeier T, 1997, NATURE, V389, P849, DOI 10.1038/39872; Haarmeier T, 1996, VISION RES, V36, P741, DOI 10.1016/0042-6989(95)00154-9; KOENDERINK JJ, 1976, J OPT SOC AM, V66, P717, DOI 10.1364/JOSA.66.000717; KOMATSU H, 1988, J NEUROPHYSIOL, V60, P580, DOI 10.1152/jn.1988.60.2.580; Lappe M, 1999, TRENDS COGN SCI, V3, P329, DOI 10.1016/S1364-6613(99)01364-9; LIEBERMAN HR, 1982, BEHAV RES METH INSTR, V14, P21, DOI 10.3758/BF03202110; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MACK A, 1973, Q J EXP PSYCHOL, V25, P71, DOI 10.1080/14640747308400324; MCKEE SP, 1985, PERCEPT PSYCHOPHYS, V37, P286, DOI 10.3758/BF03211350; RIEGER JH, 1985, J OPT SOC AM A, V2, P354, DOI 10.1364/JOSAA.2.000354; ROYDEN CS, 1994, VISION RES, V34, P3197, DOI 10.1016/0042-6989(94)90084-1; ROYDEN CS, 1992, NATURE, V360, P583, DOI 10.1038/360583a0; Shenoy KV, 1999, J NEUROPHYSIOL, V81, P2764, DOI 10.1152/jn.1999.81.6.2764; SMITH AT, 1990, VISION RES, V30, P1467, DOI 10.1016/0042-6989(90)90027-I; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; THIER P, 1992, EUR J NEUROSCI, V4, P539, DOI 10.1111/j.1460-9568.1992.tb00904.x; THOMPSON P, 1982, VISION RES, V22, P377, DOI 10.1016/0042-6989(82)90153-5; VANDENBERG AV, 1994, NATURE, V371, P700, DOI 10.1038/371700a0; VANDENBERG AV, 1992, VISION RES, V32, P1285, DOI 10.1016/0042-6989(92)90223-6; VANDENBERG AV, 1993, NATURE, V365, P497, DOI 10.1038/365497a0; vandenBerg AV, 1996, VISION RES, V36, P2337, DOI 10.1016/0042-6989(95)00247-2; von Helmholtz H, 1962, PHYSL OPTICS, VIII; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; WERTHEIM AH, 1987, PERCEPTION, V16, P299, DOI 10.1068/p160299; WERTHEIM AH, 1994, BEHAV BRAIN SCI, V17, P293, DOI 10.1017/S0140525X00034646	34	61	61	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					527	535		10.1016/S0896-6273(01)00486-X	http://dx.doi.org/10.1016/S0896-6273(01)00486-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709162	Bronze			2022-12-24	WOS:000172119100017
J	Maurel-Zaffran, C; Suzuki, T; Gahmon, G; Treisman, JE; Dickson, BJ				Maurel-Zaffran, C; Suzuki, T; Gahmon, G; Treisman, JE; Dickson, BJ			Cell-autonomous and nonautonomous functions of LAR in R7 photoreceptor axon targeting	NEURON			English	Article							ABL TYROSINE KINASE; PHOSPHATASE CRYP-ALPHA; DROSOPHILA EMBRYO; IN-VIVO; GUIDANCE; PROTEIN; DOMAIN; GROWTH; DELTA; MORPHOGENESIS	During Drosophila visual system development, photoreceptors R7 and R8 project axons to targets in distinct layers of the optic lobe. We show here that the LAR receptor tyrosine phosphatase is required in the eye for correct targeting of R7 axons. In LAR mutants, R7 axons initially project to their correct target layer, but then retract to the R8 target layer. This targeting defect can be fully rescued by transgenic expression of LAR in R7, and partially rescued by expression of LAR in R8. The phosphatase domains of LAR are required for its activity in R7, but not in R8. These data suggest that LAR can act both as a receptor in R7, and as a ligand provided by R8. Genetic interactions implicate both Enabled and Trio in LAR signal transduction.	NYU, Sch Med, Skirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; Res Inst Mol Pathol, A-1030 Vienna, Austria	New York University; New York University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Treisman, JE (corresponding author), NYU, Sch Med, Skirball Inst Biomol Med, 540 1st Ave, New York, NY 10016 USA.		Suzuki, Takashi/D-3651-2019; Dickson, Barry/AAE-7632-2019	Suzuki, Takashi/0000-0001-9093-2562; Dickson, Barry/0000-0003-0715-892X; Treisman, Jessica/0000-0002-7453-107X				Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; BASLER K, 1989, DEVELOPMENT, V107, P723; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; Clandinin TR, 2001, NEURON, V32, P237, DOI 10.1016/S0896-6273(01)00474-3; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Fogerty FJ, 1999, ONCOGENE, V18, P219, DOI 10.1038/sj.onc.1202239; Frydman HM, 2001, DEVELOPMENT, V128, P3209; GERTLER FB, 1989, CELL, V58, P103, DOI 10.1016/0092-8674(89)90407-8; GERTLER FB, 1995, GENE DEV, V9, P521, DOI 10.1101/gad.9.5.521; Haj F, 1999, MOL CELL NEUROSCI, V14, P225, DOI 10.1006/mcne.1999.0785; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kullander K, 2001, GENE DEV, V15, P877, DOI 10.1101/gad.868901; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; Ledig MM, 1999, J CELL BIOL, V147, P375, DOI 10.1083/jcb.147.2.375; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Maurel-Zaffran C, 2000, DEVELOPMENT, V127, P1007; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; RICHARDSON H, 1995, DEVELOPMENT, V121, P3371; Sommer L, 1997, DEV DYNAM, V208, P48, DOI 10.1002/(SICI)1097-0177(199701)208:1<48::AID-AJA5>3.0.CO;2-1; Stoker AW, 1995, DEV BRAIN RES, V90, P129, DOI 10.1016/0165-3806(96)83493-6; Sun Q, 2000, DEVELOPMENT, V127, P801; Sun Q, 2001, MOL CELL NEUROSCI, V17, P274, DOI 10.1006/mcne.2000.0939; Sun QL, 2000, MOL CELL NEUROSCI, V16, P686, DOI 10.1006/mcne.2000.0893; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wang J, 1999, MOL CELL NEUROSCI, V14, P370, DOI 10.1006/mcne.1999.0789; White NM, 2000, DEVELOPMENT, V127, P1681; Wilkinson DG, 2000, INT REV CYTOL, V196, P177; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; WOLFF T, 1997, MOL CELLULAR APPROAC, P474; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9	40	107	108	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					225	235		10.1016/S0896-6273(01)00471-8	http://dx.doi.org/10.1016/S0896-6273(01)00471-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683993	Bronze			2022-12-24	WOS:000171893700008
J	Morgan, JR; Prasad, K; Jin, SP; Augustine, GJ; Lafer, EM				Morgan, JR; Prasad, K; Jin, SP; Augustine, GJ; Lafer, EM			Uncoating of clathrin-coated vesicles in presynaptic terminals: Roles for Hsc70 and auxilin	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; PEPTIDE BINDING-PROTEIN; G-ASSOCIATED KINASE; J-DOMAIN; IN-VIVO; MOLECULAR CHAPERONE; ATPASE ACTIVITY; ANTIGEN PRESENTATION; ALPHA-ADAPTIN; ENDOCYTOSIS	We have examined the roles of Hsc70 and auxilin in the uncoating of clathrin-coated vesicles (CCVs) during neuronal endocytosis. We identified two peptides that inhibit the ability of Hsc70 and auxilin to uncoat CCVs in vitro. When injected into nerve terminals, these peptides inhibited both synaptic transmission and CCV uncoating. Mutation of a conserved HPD motif within the J domain of auxilin prevented binding to Hsc70 in vitro and injecting this mutant protein inhibited CCV uncoating in vivo, demonstrating that the interaction of auxilin with Hsc70 is critical for CCV uncoating. These studies establish that auxilin and Hsc70 participate in synaptic vesicle recycling in neurons and that an interaction between these proteins is required for CCV uncoating.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; Univ Texas, Hlth Sci Ctr, Dept Biochem, San Antonio, TX 78245 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Duke University; University of Texas System; University of Texas Health San Antonio; Marine Biological Laboratory - Woods Hole	Augustine, GJ (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	georgea@neuro.duke.edu	Augustine, George James/J-9228-2013	Lafer, Eileen/0000-0002-0493-6522	NINDS NIH HHS [NS21624, NS29051, R01 NS029051] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029051, R56NS029051, R01NS021624] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHLE S, 1990, J CELL BIOL, V111, P19, DOI 10.1083/jcb.111.1.19; BAROUCH W, 1994, J BIOL CHEM, V269, P28563; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; BRAELL WA, 1984, J CELL BIOL, V99, P734, DOI 10.1083/jcb.99.2.734; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Burns ME, 1998, J GEN PHYSIOL, V111, P243, DOI 10.1085/jgp.111.2.243; Chamberlain LH, 1997, J BIOL CHEM, V272, P31420, DOI 10.1074/jbc.272.50.31420; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; De Camilli P, 2001, SYNAPSES, P217; Gall WE, 2000, CURR BIOL, V10, P1349, DOI 10.1016/S0960-9822(00)00771-5; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; GREENE LE, 1995, J BIOL CHEM, V270, P2967, DOI 10.1074/jbc.270.7.2967; GREENE LE, 1990, J BIOL CHEM, V265, P6682; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; Han CJ, 2000, J BIOMOL NMR, V17, P281, DOI 10.1023/A:1008353226591; Hannan LA, 1998, MOL BIOL CELL, V9, P2217, DOI 10.1091/mbc.9.8.2217; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; HESS SD, 1993, SCIENCE, V259, P1169, DOI 10.1126/science.8438167; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Holstein SEH, 1996, J CELL BIOL, V135, P925, DOI 10.1083/jcb.135.4.925; Jiang RF, 1997, J BIOL CHEM, V272, P6141, DOI 10.1074/jbc.272.10.6141; Kanaoka Y, 1997, FEBS LETT, V402, P73, DOI 10.1016/S0014-5793(96)01484-6; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kimura SH, 1997, GENOMICS, V44, P179, DOI 10.1006/geno.1997.4873; LAKEY EK, 1987, P NATL ACAD SCI USA, V84, P1659, DOI 10.1073/pnas.84.6.1659; Lemmon SK, 2001, CURR BIOL, V11, pR49, DOI 10.1016/S0960-9822(01)00010-0; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; Mayer MP, 1998, BIOL CHEM, V379, P261; Morgan JR, 2000, J NEUROSCI, V20, P8667; Morgan JR, 1999, J NEUROSCI, V19, P10201; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Pishvaee B, 1998, CELL, V95, P443, DOI 10.1016/S0092-8674(00)81611-6; Pishvaee B, 2000, NAT CELL BIOL, V2, P958, DOI 10.1038/35046619; PRASAD K, 1993, J BIOL CHEM, V268, P23758; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; SANCHEZ ME, 1990, J EXP BIOL, V152, P369; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Suh WC, 1998, P NATL ACAD SCI USA, V95, P15223, DOI 10.1073/pnas.95.26.15223; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; Tebar F, 1999, MOL BIOL CELL, V10, P2687, DOI 10.1091/mbc.10.8.2687; Tsai J, 1996, J BIOL CHEM, V271, P9347, DOI 10.1074/jbc.271.16.9347; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; WALL D, 1994, J BIOL CHEM, V269, P5446; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Zhang B, 1998, NEURON, V21, P1465, DOI 10.1016/S0896-6273(00)80664-9; Zhang H, 1999, J CELL SCI, V112, P1345; Zhao XH, 2001, J CELL SCI, V114, P353	55	91	93	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					289	300		10.1016/S0896-6273(01)00467-6	http://dx.doi.org/10.1016/S0896-6273(01)00467-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683998	Bronze			2022-12-24	WOS:000171893700013
J	Isaacson, JS; Murphy, GJ				Isaacson, JS; Murphy, GJ			Glutamate-mediated extrasynaptic inhibition: Direct coupling of NMDA receptors to Ca2+-activated K+ channels	NEURON			English	Article							ACTIVATED POTASSIUM CHANNEL; RAT HIPPOCAMPAL-NEURONS; CA2+ CHANNELS; OLFACTORY-BULB; ION CHANNELS; CALCIUM; CONDUCTANCE; MODULATION; HYPERPOLARIZATIONS; SPILLOVER	NMDA receptors (NMDARs) typically contribute to excitatory synaptic transmission in the CNS. While Ca2+ influx through NMDARs plays a critical role in synaptic plasticity, direct actions of NMDAR-mediated Ca2+ influx on neuronal excitability have not been well established. Here we show that Ca2+ influx through NMDARs is directly coupled to activation of BK-type Ca2+-activated K+ channels in outside-out membrane patches from rat olfactory bulb granule cells. Repetitive stimulation of glutamatergic synapses in olfactory bulb slices evokes a slow inhibitory postsynaptic current (IPSC) in granule cells that requires both NMDARs and BK channels. The slow IPSO is enhanced by glutamate uptake blockers, suggesting that extrasynaptic NMDARs underlie the response. These findings reveal a novel inhibitory action of extrasynaptic NMDARs in the brain.	Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Grad Program Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Isaacson, JS (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA.			Murphy, Gabe/0000-0002-9321-8556	NIGMS NIH HHS [GM 08107] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADLER EM, 1991, J NEUROSCI, V11, P1496; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Chavis P, 1998, EUR J NEUROSCI, V10, P2322, DOI 10.1046/j.1460-9568.1998.00243.x; Dutar P, 2000, J NEUROPHYSIOL, V84, P2284, DOI 10.1152/jn.2000.84.5.2284; EGAN TM, 1993, J NEUROPHYSIOL, V69, P1433, DOI 10.1152/jn.1993.69.5.1433; Fagni L, 2000, TRENDS NEUROSCI, V23, P80, DOI 10.1016/S0166-2236(99)01492-7; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; GALVEZ A, 1990, J BIOL CHEM, V265, P11083; GOLA M, 1993, NEURON, V10, P689, DOI 10.1016/0896-6273(93)90170-V; Grillner S, 2001, J PHYSIOL-LONDON, V533, P23, DOI 10.1111/j.1469-7793.2001.0023b.x; HILL RH, 1989, BRAIN RES, V499, P388, DOI 10.1016/0006-8993(89)90790-7; Hille B., 1992, IONIC CHANNELS EXCIT; Holmes KH, 1996, J NEUROPHYSIOL, V76, P3059, DOI 10.1152/jn.1996.76.5.3059; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Knaus HG, 1996, J NEUROSCI, V16, P955; Knoflach F, 1998, J PHYSIOL-LONDON, V509, P347, DOI 10.1111/j.1469-7793.1998.347bn.x; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, J NEUROSCI, V7, P3230; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MCMANUS OB, 1991, J BIOENERG BIOMEMBR, V23, P537, DOI 10.1007/BF00785810; Naraghi M, 1997, J NEUROSCI, V17, P6961; NICOLL RA, 1981, SCIENCE, V212, P957, DOI 10.1126/science.6262912; PETRALIA RS, 1994, J NEUROSCI, V14, P6102; RANDALL A, 1995, J NEUROSCI, V15, P2995; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; WALLEN P, 1987, J NEUROSCI, V7, P2745; ZORUMSKI CF, 1989, NEUROSCI LETT, V99, P293, DOI 10.1016/0304-3940(89)90462-X; [No title captured]	34	115	121	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					1027	1034		10.1016/S0896-6273(01)00428-7	http://dx.doi.org/10.1016/S0896-6273(01)00428-7			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580901	Bronze			2022-12-24	WOS:000171281300016
J	Brockie, PJ; Mellem, JE; Hills, T; Madsen, DM; Maricq, AV				Brockie, PJ; Mellem, JE; Hills, T; Madsen, DM; Maricq, AV			The C-elegans glutamate receptor subunit NMR-1 is required for slow NMDA-activated currents that regulate reversal frequency during locomotion	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; ACID-BINDING PROTEINS; MOLECULAR DESIGN; CORTICAL-NEURONS; AMPA RECEPTORS; ION CHANNELS; SPINAL-CORD; SITE; CELLS; LOCALIZATION	The N-methyl-D-aspartate (NMDA) subtype of glutamate receptor is important for synaptic plasticity and nervous system development and function. We have used genetic and electrophysiological methods to demonstrate that NMR-1, a Caenorhabditis elegans NMDA-type ionotropic glutamate receptor subunit, plays a role in the control of movement and foraging behavior. nmr-1 mutants show a lower probability of switching from forward to backward movement and a reduced ability to navigate a complex environment. Electrical recordings from the interneuron AVA show that NMDA-dependent currents are selectively disrupted in nmr-1 mutants. We also show that a slowly desensitizing variant of a non-NMDA receptor can rescue the nmr-1 mutant phenotype. We propose that NMDA receptors in C. elegans provide long-lived currents that modulate the frequency of movement reversals during foraging behavior.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Maricq, AV (corresponding author), Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA.	maricq@biology.utah.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035812] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35812] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anson LC, 1998, J NEUROSCI, V18, P581; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BERG HC, 1975, NATURE, V254, P389, DOI 10.1038/254389a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; Brockie PJ, 2001, J NEUROSCI, V21, P1510, DOI 10.1523/JNEUROSCI.21-05-01510.2001; BUMASHEV N, 1992, SCIENCE, V257, P1415; CHALFIE M, 1985, J NEUROSCI, V5, P956; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CROLL NA, 1975, J ZOOL, V176, P159, DOI 10.1111/j.1469-7998.1975.tb03191.x; CULOTTI JG, 1978, GENETICS, V90, P243; Dingledine R, 1999, PHARMACOL REV, V51, P7; DIPRISCO GV, 1995, BRAIN RES, V695, P76, DOI 10.1016/0006-8993(95)00936-K; FERRERMONTIEL AV, 1995, P NATL ACAD SCI USA, V92, P8021, DOI 10.1073/pnas.92.17.8021; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harsch A, 2000, J NEUROSCI, V20, P6181, DOI 10.1523/JNEUROSCI.20-16-06181.2000; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HOM R, 1988, J GEN PHYSIOL, V92, P145; KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; KRISTAN WB, 1995, J NEUROBIOL, V27, P380, DOI 10.1002/neu.480270310; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Matsui K, 1998, J NEUROSCI, V18, P4500; Mori H, 1998, NEURON, V21, P571, DOI 10.1016/S0896-6273(00)80567-X; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Schmidt BJ, 1998, ANN NY ACAD SCI, V860, P189, DOI 10.1111/j.1749-6632.1998.tb09049.x; SEEBURG PH, 1995, RECENT PROG HORM RES, V50, P19; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIGVARDT KA, 1985, BRAIN RES, V336, P390, DOI 10.1016/0006-8993(85)90676-6; SILLAR KT, 1994, P ROY SOC B-BIOL SCI, V255, P139, DOI 10.1098/rspb.1994.0020; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WILSON R, 1994, NATURE, V368, P32, DOI 10.1038/368032a0; Zheng Y, 1999, NEURON, V24, P347, DOI 10.1016/S0896-6273(00)80849-1; ZWAAL RR, 1993, P NATL ACAD SCI USA, V90, P7431, DOI 10.1073/pnas.90.16.7431	49	153	158	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 30	2001	31	4					617	630		10.1016/S0896-6273(01)00394-4	http://dx.doi.org/10.1016/S0896-6273(01)00394-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545720	Bronze			2022-12-24	WOS:000170759200015
J	Bezzi, P; Domercq, M; Brambilla, L; Galli, R; Schols, D; De Clercq, E; Vescovi, A; Bagetta, G; Kollias, G; Meldolesi, J; Volterra, A				Bezzi, P; Domercq, M; Brambilla, L; Galli, R; Schols, D; De Clercq, E; Vescovi, A; Bagetta, G; Kollias, G; Meldolesi, J; Volterra, A			CXCR4-activated astrocyte glutamate release via TNFa: amplification by microglia triggers neurotoxicity	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; COAT PROTEIN GP120; GLIAL-CELLS; SYNAPTIC TRANSMISSION; SIGNAL-TRANSDUCTION; CHEMOKINE RECEPTORS; IN-SITU; CXCR4; MODULATION; ALPHA	Astrocytes actively participate in synaptic integration by releasing transmitter (glutamate) via a calcium-regulated, exocytosis-like process. Here we show that this process follows activation of the receptor CXCR4 by the chemokine stromal cell-derived factor 1 (SDF-1). An extraordinary feature of the ensuing signaling cascade is the rapid extracellular release of tumor necrosis factor-alpha (TNF alpha). Autocrine/paracrine TNF alpha -dependent signaling leading to prostaglandin (PG) formation not only controls glutamate release and astrocyte communication, but also causes their derangement when activated microglia cooperate to dramatically enhance release of the cytokine in response to CXCR4 stimulation. We demonstrate that altered glial communication has direct neuropathological consequences and that agents interfering with CXCR4-dependent astrocyte-microglia signaling prevent neuronal apoptosis induced by the HIV-1 coat glycoprotein, gp120(IIIB) Our results identify a new pathway for glia-glia and glia-neuron communication that is relevant to both normal brain function and neurodegenerative diseases.	Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, I-20133 Milan, Italy; San Raffaele Sci Inst, Dept Neurosci, DIBIT, I-20132 Milan, Italy; Vita Salute Univ, I-20132 Milan, Italy; Hosp San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; Katholieke Univ Leuven, Rega Inst Med Res, B-3000 Louvain, Belgium; Univ Calabria, Dept Pharmacobiol, I-87036 Cosenza, Italy; Biomed Sci Res Ctr Al Fleming, Inst Immunol, Vari 16672, Greece	University of Milan; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; KU Leuven; University of Calabria; Alexander Fleming Biomedical Sciences Research Center	Volterra, A (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.		Brambilla, Liliana/AAA-3303-2021; Bagetta, Giacinto/N-9716-2018; Schols, Dominique/AAC-1309-2021; Bezzi, Paola/AAP-2440-2020; Kollias, George/A-7079-2012; Bagetta, Giacinto/E-8402-2012; Schols, Dominique/S-9057-2017; Galli, Rossella/AAI-8028-2020; Vescovi, Angelo Luigi/A-4919-2015; Domercq, Maria/Z-2274-2019	Brambilla, Liliana/0000-0001-5714-3625; Bagetta, Giacinto/0000-0001-8540-6218; Schols, Dominique/0000-0003-3256-5850; Kollias, George/0000-0003-1867-3150; Bagetta, Giacinto/0000-0001-8540-6218; Schols, Dominique/0000-0003-3256-5850; Galli, Rossella/0000-0001-9023-7033; Vescovi, Angelo Luigi/0000-0002-1742-4112; Domercq, Maria/0000-0002-4918-9276; Volterra, Andrea/0000-0003-1069-1602; De Clercq, Erik/0000-0002-2985-8890	Telethon [GGP02052, 754] Funding Source: Medline	Telethon(Fondazione Telethon)		ABELE AE, 1990, NEURON, V4, P413, DOI 10.1016/0896-6273(90)90053-I; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Asensio VC, 1999, TRENDS NEUROSCI, V22, P504, DOI 10.1016/S0166-2236(99)01453-8; Bagetta G, 1999, NEUROSCIENCE, V89, P1051, DOI 10.1016/S0306-4522(98)00363-7; Benveniste EN, 1995, FASEB J, V9, P1577, DOI 10.1096/fasebj.9.15.8529837; Bezzi P, 2001, CURR OPIN NEUROBIOL, V11, P387, DOI 10.1016/S0959-4388(00)00223-3; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Braun JS, 1999, NAT MED, V5, P298, DOI 10.1038/6514; Davis CB, 1997, J EXP MED, V186, P1793, DOI 10.1084/jem.186.10.1793; Donzella GA, 1998, NAT MED, V4, P72, DOI 10.1038/nm0198-072; Dreyer EB, 1995, EUR J NEUROSCI, V7, P2502, DOI 10.1111/j.1460-9568.1995.tb01048.x; Endres MJ, 1996, CELL, V87, P745, DOI 10.1016/S0092-8674(00)81393-8; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; FUTAKI N, 1994, PROSTAGLANDINS, V47, P55, DOI 10.1016/0090-6980(94)90074-4; GEARING AJH, 1994, NATURE, V370, P555, DOI 10.1038/370555a0; GENIS P, 1992, J EXP MED, V176, P1703, DOI 10.1084/jem.176.6.1703; GIULIAN D, 1986, J NEUROSCI, V6, P2163; Grosche J, 1999, NAT NEUROSCI, V2, P139, DOI 10.1038/5692; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528; Hesselgesser J, 1997, CURR BIOL, V7, P112, DOI 10.1016/S0960-9822(06)00055-8; Innocenti B, 2000, J NEUROSCI, V20, P1800; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; KRIEGLER M, 1988, CELL, V53, P45, DOI 10.1016/0092-8674(88)90486-2; Limatola C, 2000, EUR J NEUROSCI, V12, P2497, DOI 10.1046/j.1460-9568.2000.00139.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Miller RJ, 1999, TRENDS NEUROSCI, V22, P471, DOI 10.1016/S0166-2236(99)01408-3; Nagasawa T, 1999, Adv Immunol, V71, P211; Newman EA, 1998, J NEUROSCI, V18, P4022; Noda M, 2000, J NEUROSCI, V20, P251, DOI 10.1523/JNEUROSCI.20-01-00251.2000; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Pasti L, 2001, J NEUROSCI, V21, P477, DOI 10.1523/JNEUROSCI.21-02-00477.2001; Pasti L, 1997, J NEUROSCI, V17, P7817; Porter JT, 1996, J NEUROSCI, V16, P5073; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Streit Wolfgang J., 1995, P85; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; TOGGAS SM, 1994, NATURE, V367, P188, DOI 10.1038/367188a0; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; Zheng JL, 1999, J VIROL, V73, P8256, DOI 10.1128/JVI.73.10.8256-8267.1999; Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	50	817	853	0	66	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					702	710		10.1038/89490	http://dx.doi.org/10.1038/89490			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426226				2022-12-24	WOS:000169621300015
J	Rushworth, MFS; Ellison, A; Walsh, V				Rushworth, MFS; Ellison, A; Walsh, V			Complementary localization and lateralization of orienting and motor attention	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; EYE-MOVEMENTS; SPATIAL REPRESENTATION; VISUOSPATIAL ATTENTION; RECEPTIVE-FIELDS; VISUAL-ATTENTION; RHESUS-MONKEY; NEURONS	It is widely agreed that the right posterior parietal cortex has a preeminent role in visuospatial and orienting attention. A number of lines of evidence suggest that although orienting and the preparation of oculomotor responses are dissociable from each other, the two are intimately related. If this is true, then it should be possible to identify other attentional mechanisms tied to other response modalities. We used repetitive transcranial magnetic stimulation (rTMS) to demonstrate the existence of a distinct anterior parietal mechanism of motor attention. The critical area for motor attention is anterior to the one concerned with orienting, and it is lateralized to the left hemisphere in humans.	Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Rushworth, MFS (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	matthew.rushworth@psy.ox.ac.uk		Rushworth, Matthew/0000-0002-5578-9884				Ashbridge E, 1997, NEUROPSYCHOLOGIA, V35, P1121, DOI 10.1016/S0028-3932(97)00003-1; CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; COLBY CL, 1995, CEREB CORTEX, V5, P470, DOI 10.1093/cercor/5.5.470; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; CORBETTA M, 1993, J NEUROSCI, V13, P1202; Cracco RQ, 1999, J NEUROSCI METH, V86, P209, DOI 10.1016/S0165-0270(98)00167-8; Deiber MP, 1996, J NEUROPHYSIOL, V75, P233, DOI 10.1152/jn.1996.75.1.233; Desmurget M, 1999, NAT NEUROSCI, V2, P563, DOI 10.1038/9219; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; DUHAMEL JR, 1992, BRAIN, V115, P1387, DOI 10.1093/brain/115.5.1387; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Edgley SA, 1997, BRAIN, V120, P839, DOI 10.1093/brain/120.5.839; EIDELBERG D, 1984, ARCH NEUROL-CHICAGO, V41, P843, DOI 10.1001/archneur.1984.04050190049013; Evans A. C., 1996, P343; Ferraina S, 1997, J NEUROPHYSIOL, V77, P1034, DOI 10.1152/jn.1997.77.2.1034; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Marzi CA, 1998, EXP BRAIN RES, V118, P435, DOI 10.1007/s002210050299; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; PASCUALLEONE A, 1994, NEUROLOGY, V44, P494, DOI 10.1212/WNL.44.3_Part_1.494; Passingham RE, 1998, COMP NEUROPSYCHOLOGY, P271; Paus T, 1997, J NEUROSCI, V17, P3178; Paus T, 1998, J NEUROPHYSIOL, V79, P1102, DOI 10.1152/jn.1998.79.2.1102; Pisella L, 2000, NAT NEUROSCI, V3, P729, DOI 10.1038/76694; POSNER MI, 1984, J NEUROSCI, V4, P1863; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; ROBINSON CJ, 1980, J COMP NEUROL, V192, P69, DOI 10.1002/cne.901920105; Ruohonen J, 1999, EEG CL N SU, P30; Rushworth MFS, 1997, NEUROPSYCHOLOGIA, V35, P1261, DOI 10.1016/S0028-3932(97)00050-X; Rushworth MFS, 1998, J NEUROPHYSIOL, V79, P478, DOI 10.1152/jn.1998.79.1.478; Rushworth MFS, 1997, EXP BRAIN RES, V117, P311, DOI 10.1007/s002210050225; RUSHWORTH MFS, IN PRESS J COGN NEUR; Sakata H, 1999, EXP BRAIN RES, V128, P160, DOI 10.1007/s002210050831; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; SHELIGA BM, 1995, EXP BRAIN RES, V105, P261; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; STEINMETZ MA, 1995, CEREB CORTEX, V5, P448, DOI 10.1093/cercor/5.5.448; Talairach J., 1988, COPLANAR STEREOTAXIC; VONBONIN G, 1947, NEOCORTEX MACACCA MU; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P245; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 1998, TRENDS COGN SCI, V2, P103, DOI 10.1016/S1364-6613(98)01134-6; Walsh V, 1999, NEUROPSYCHOLOGIA, V37, P125; WASSERMANN EM, 1998, ELECTROENCEPHALOGR C, V198, P1; WITELSON SF, 1992, J COMP NEUROL, V323, P326, DOI 10.1002/cne.903230303	50	316	318	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					656	661		10.1038/88492	http://dx.doi.org/10.1038/88492			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369949				2022-12-24	WOS:000169061800021
J	Bermingham, NA; Hassan, BA; Wang, VY; Fernandez, M; Banfi, S; Bellen, HJ; Fritzsch, B; Zoghbi, HY				Bermingham, NA; Hassan, BA; Wang, VY; Fernandez, M; Banfi, S; Bellen, HJ; Fritzsch, B; Zoghbi, HY			Proprioceptor pathway development is dependent on MATH1	NEURON			English	Article							LIM HOMEOBOX GENE; SPINAL-CORD; COMMISSURAL INTERNEURONS; NERVOUS-SYSTEM; ROOF PLATE; BOX GENES; EXPRESSION; NEURONS; CELLS; DROSOPHILA	The proprioceptive system provides continuous positional information on the limbs and body to the thalamus, cortex, pontine nucleus, and cerebellum. We showed previously that the basic helix-loop-helix transcription factor Math1 is essential for the development of certain components of the proprioceptive pathway, Including inner-ear hair cells, cerebellar granule neurons, and the pontine nuclei. Here, we demonstrate that Math1 null embryos lack the D1 interneurons and that these interneurons give rise to a subset of proprioceptor interneurons and the spinocerebellar and cuneocerebellar tracts. We also identify three downstream genes of Math1 (Lh2A, Lh2B, and Barhl1) and establish that Math1 governs the development of multiple components of the proprioceptive pathway.	Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Telethon Inst Genet & Med, I-20132 Milan, Italy; Creighton Univ, Dept Biomed Sci, Omaha, NE 68178 USA	Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Creighton University	Zoghbi, HY (corresponding author), Baylor Coll Med, Howard Hughes Med Inst, 1 Baylor Plaza, Houston, TX 77030 USA.		Banfi, Sandro/K-3963-2018; Hassan, Bassem A/D-5221-2012	Banfi, Sandro/0000-0002-6541-8833; Hassan, Bassem A/0000-0001-9533-4908; Bellen, Hugo/0000-0001-5992-5989; Zoghbi, Huda/0000-0002-0700-3349; Fritzsch, Bernd/0000-0002-4882-8398	Telethon [TGM00Z02, TGM06S01] Funding Source: Medline	Telethon(Fondazione Telethon)		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; ALBRECHT U, 1997, VISUALIZATION GENE E; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bertuzzi S, 1996, GENOMICS, V36, P234, DOI 10.1006/geno.1996.0458; Birk OS, 2000, NATURE, V403, P909, DOI 10.1038/35002622; Brodal A., 1981, NEUROLOGICAL ANATOMY, V3rd; Brodal P., 1998, CENTRAL NERVOUS SYST; Bulfone A, 2000, HUM MOL GENET, V9, P1443, DOI 10.1093/hmg/9.9.1443; Casarosa S, 1999, DEVELOPMENT, V126, P525; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; ECHELARD Y, 1994, DEVELOPMENT, V120, P2213; FEDTSOVA NG, 1995, MECH DEVELOP, V53, P291, DOI 10.1016/0925-4773(95)00435-1; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; Helms AW, 1998, DEVELOPMENT, V125, P919; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KOJIMA T, 1991, P NATL ACAD SCI USA, V88, P4343, DOI 10.1073/pnas.88.10.4343; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; MARTIN JH, 1996, NEUROANATOMY TEXT AT; Matsumoto K, 1996, NEUROSCI LETT, V211, P147, DOI 10.1016/0304-3940(96)12749-X; Porter FD, 1997, DEVELOPMENT, V124, P2935; Retaux S, 1999, J NEUROSCI, V19, P783; Saito T, 1998, DEV BIOL, V199, P216, DOI 10.1006/dbio.1998.8889; Sasai Y, 1998, NEURON, V21, P455, DOI 10.1016/S0896-6273(00)80554-1; Tracey David J., 1995, P67; Turner EE, 1997, SCHIZOPHR RES, V27, P169, DOI 10.1016/S0920-9964(97)00067-4; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227	41	220	227	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					411	422		10.1016/S0896-6273(01)00305-1	http://dx.doi.org/10.1016/S0896-6273(01)00305-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395003	Bronze			2022-12-24	WOS:000168962000014
J	Bokde, ALW; Tagamets, MA; Friedman, RB; Horwitz, B				Bokde, ALW; Tagamets, MA; Friedman, RB; Horwitz, B			Functional interactions of the inferior frontal cortex during the processing of words and word-like stimuli	NEURON			English	Article							PREFRONTAL CORTEX; HUMAN BRAIN; WORKING-MEMORY; SPEECH; PET; ACTIVATION; RETRIEVAL; RECOGNITION; PERCEPTION; SEMANTICS	The hypothesis that ventral/anterior left inferior frontal gyrus (LIFG) subserves semantic processing and dorsal/posterior LIFG subserves phonological processing was tested by determining the pattern of functional connectivity of these regions with regions in left occipital and temporal cortex during the processing of words and word-like stimuli. In accordance with the hypothesis, we found strong functional connectivity between activity in ventral LIFG and activity in occipital and temporal cortex only for words, and strong functional connectivity between activity in dorsal LIFG and activity in occipital and temporal cortex for words, pseudowords, and letter strings, but not for false font strings. These results demonstrate a task-dependent functional fractionation of the LIFG in terms of its functional links with posterior brain areas.	Natl Inst Deafness & Other Commun Disorders, Language Sect, NIH, Bethesda, MD 21228 USA; NIMH, Geriatr Psychiat Branch, NIH, Bethesda, MD 20892 USA; Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Funct Neuroimaging Lab, Baltimore, MD 21201 USA; Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA; NRH Res Ctr, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Maryland; University of Maryland Baltimore; Georgetown University	Horwitz, B (corresponding author), Natl Inst Deafness & Other Commun Disorders, Language Sect, NIH, Bethesda, MD 21228 USA.	horwitz@helix.nih.gov	anand, amit/A-7222-2009	Bokde, Arun/0000-0003-0114-4914	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000057, ZIADC000057] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD36019] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BACHMAN DL, 1988, HDB NEUROPSYCHOLOGY, P281; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beason-Held LL, 1998, VISUAL NEUROSCI, V15, P503; Benson D.F., 1985, PRINCIPLES BEHAV NEU; Binder JR, 2000, CEREB CORTEX, V10, P512, DOI 10.1093/cercor/10.5.512; Binder JR, 1997, J NEUROSCI, V17, P353, DOI 10.1523/JNEUROSCI.17-01-00353.1997; BUCKNER RL, 1995, J NEUROPHYSIOL, V74, P2163, DOI 10.1152/jn.1995.74.5.2163; Caplan D, 1998, J COGNITIVE NEUROSCI, V10, P541, DOI 10.1162/089892998562843; Caplan D., 1992, LANGUAGE STRUCTURE P; DAMASIO AR, 1992, NEW ENGL J MED, V326, P531, DOI 10.1056/NEJM199202203260806; Dapretto M, 1999, NEURON, V24, P427, DOI 10.1016/S0896-6273(00)80855-7; DEMB JB, 1995, J NEUROSCI, V15, P5870; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Furey ML, 2000, BRAIN RES BULL, V51, P213, DOI 10.1016/S0361-9230(99)00219-1; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GOODGLASS H, 1988, HDB NEUROPSYCHOLOGY, P249; Hagoort P, 1999, J COGNITIVE NEUROSCI, V11, P383, DOI 10.1162/089892999563490; Hagoort Peter, 1999, NEUROCOGNITION LANGU; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; HORWITZ B, 1992, J COGNITIVE NEUROSCI, V4, P311, DOI 10.1162/jocn.1992.4.4.311; Horwitz B, 1999, TRENDS COGN SCI, V3, P91, DOI 10.1016/S1364-6613(99)01282-6; Horwitz B, 2000, NEURAL NETWORKS, V13, P829, DOI 10.1016/S0893-6080(00)00062-9; HORWITZ B, 1999, NEUROIMAGE, V9, pS392; Just MA, 1996, SCIENCE, V274, P114, DOI 10.1126/science.274.5284.114; KLEIN D, 1995, P NATL ACAD SCI USA, V92, P2899, DOI 10.1073/pnas.92.7.2899; Levelt WJM, 1999, TRENDS COGN SCI, V3, P223, DOI 10.1016/S1364-6613(99)01319-4; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; NOBRE AC, 1994, NATURE, V372, P260, DOI 10.1038/372260a0; Passingham RE, 1998, COMP NEUROPSYCHOLOGY, P271; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Paulesu E, 1997, NEUROREPORT, V8, P2011, DOI 10.1097/00001756-199705260-00042; Petersen S E, 1989, J Cogn Neurosci, V1, P153, DOI 10.1162/jocn.1989.1.2.153; PETERSEN SE, 1993, ANNU REV NEUROSCI, V16, P509, DOI 10.1146/annurev.ne.16.030193.002453; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; PRICE C, 1999, NEUROCOGNITION LANGU, P211; Price CJ, 1996, CEREB CORTEX, V6, P62, DOI 10.1093/cercor/6.1.62; Pugh KR, 1996, BRAIN, V119, P1221, DOI 10.1093/brain/119.4.1221; Rumsey JM, 1997, BRAIN, V120, P739, DOI 10.1093/brain/120.5.739; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Tagamets MA, 1998, CEREB CORTEX, V8, P310, DOI 10.1093/cercor/8.4.310; Tagamets MA, 2000, J COGNITIVE NEUROSCI, V12, P281, DOI 10.1162/089892900562101; Talairach J., 1988, COPLANAR STEREOTAXIC; Tarkiainen A, 1999, BRAIN, V122, P2119, DOI 10.1093/brain/122.11.2119; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Tranel D, 1997, NEUROPSYCHOLOGIA, V35, P1319, DOI 10.1016/S0028-3932(97)00085-7; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; Zatorre RJ, 1996, CEREB CORTEX, V6, P21, DOI 10.1093/cercor/6.1.21; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767	53	168	169	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					609	617		10.1016/S0896-6273(01)00288-4	http://dx.doi.org/10.1016/S0896-6273(01)00288-4			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	436XW	11395018	Bronze			2022-12-24	WOS:000168962000029
J	Kawai, F; Horiguchi, M; Suzuki, H; Miyachi, E				Kawai, F; Horiguchi, M; Suzuki, H; Miyachi, E			Na+ action potentials in human photoreceptors	NEURON			English	Article							NUCLEOTIDE-GATED CHANNELS; ROD PHOTORECEPTORS; BIPOLAR CELLS; CONE PHOTORECEPTORS; MAMMALIAN RETINA; GANGLION-CELLS; VISUAL TRANSDUCTION; SALAMANDER RETINA; INNER SEGMENTS; PRIMATE RETINA	Mammalian photoreceptors are hyperpolarized by a light stimulus and are commonly thought to be nonspiking neurons. We used the whole-cell patch-clamp technique on surgically excised human retina to examine whether human photoreceptors can elicit action potentials. We discovered that human rod photoreceptors express voltage-gated Na+ channels, and generate Na+ action potentials, in response to membrane depolarization from membrane potentials of -60 or -70 mV. Na+ spikes in human rods were elicited at the termination of a light response that hyperpolarized the potential well below -50 mV. This served to amplify the release of a neurotransmitter when a bright light is turned off, and thus selectively amplify the off response to the light signal.	Fujita Hlth Univ, Sch Med, Dept Physiol, Aichi 4701192, Japan; Fujita Hlth Univ, Sch Med, Dept Ophthalmol, Aichi 4701192, Japan	Fujita Health University; Fujita Health University	Kawai, F (corresponding author), Fujita Hlth Univ, Sch Med, Dept Physiol, Aichi 4701192, Japan.			KAWAI, Fusao/0000-0001-8847-9906				BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; Berry MJ, 1999, NATURE, V398, P334, DOI 10.1038/18678; Broillet MC, 1999, ANN NY ACAD SCI, V868, P730, DOI 10.1111/j.1749-6632.1999.tb11352.x; Calkins DJ, 1999, NEURON, V24, P313, DOI 10.1016/S0896-6273(00)80846-6; CALKINS DJ, 1994, NATURE, V371, P70, DOI 10.1038/371070a0; Cook PB, 1998, NAT NEUROSCI, V1, P714, DOI 10.1038/3714; COPENHAGEN DR, 1989, NATURE, V341, P536, DOI 10.1038/341536a0; Dacey DM, 2000, ANNU REV NEUROSCI, V23, P743, DOI 10.1146/annurev.neuro.23.1.743; Dacey DM, 1999, PROG RETIN EYE RES, V18, P737, DOI 10.1016/S1350-9462(98)00013-5; DAVSON H, 1972, PHYSL EYE, P147; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; FAIN GL, 1980, J PHYSIOL-LONDON, V303, P495, DOI 10.1113/jphysiol.1980.sp013300; GERSCHENFELD HM, 1980, J EXP BIOL, V89, P177; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HIDAKA S, 1998, PFLUGERS ARCH, V436, P436; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; KANEKO A, 1985, J PHYSIOL-LONDON, V358, P131, DOI 10.1113/jphysiol.1985.sp015544; Kawai F, 1999, J NEUROSCI, V19, P2954; Kawai F, 1999, NAT NEUROSCI, V2, P133, DOI 10.1038/5686; Kawai F, 1996, J GEN PHYSIOL, V108, P525, DOI 10.1085/jgp.108.6.525; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; KRAFT TW, 1993, J PHYSIOL-LONDON, V464, P747, DOI 10.1113/jphysiol.1993.sp019661; LIPTON SA, 1977, J GEN PHYSIOL, V70, P747, DOI 10.1085/jgp.70.6.747; MARICQ AV, 1990, J NEUROPHYSIOL, V64, P1917, DOI 10.1152/jn.1990.64.6.1917; MARICQ AV, 1988, NEURON, V1, P503, DOI 10.1016/0896-6273(88)90181-X; Masland RH, 1996, CURR OPIN NEUROBIOL, V6, P467, DOI 10.1016/S0959-4388(96)80051-1; MATTHEWS G, 1987, J PHYSIOL-LONDON, V389, P691, DOI 10.1113/jphysiol.1987.sp016678; McDougall W, 1904, BRIT J PSYCHOL, V1, P78, DOI 10.1111/j.2044-8295.1904.tb00150.x; Michels R.G., 1990, RETINAL DETACHMENT, P761; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; OHJI M, 2000, MACULAR SURG, P221; Pan ZH, 2000, J NEUROPHYSIOL, V84, P2564, DOI 10.1152/jn.2000.84.5.2564; PICCOLINO M, 1980, PROC R SOC SER B-BIO, V206, P439, DOI 10.1098/rspb.1980.0007; Protti DA, 2000, NEURON, V25, P215, DOI 10.1016/S0896-6273(00)80884-3; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; SCHEIN SJ, 1988, J COMP NEUROL, V269, P479, DOI 10.1002/cne.902690403; SCHNAPF JL, 1990, J PHYSIOL-LONDON, V427, P681, DOI 10.1113/jphysiol.1990.sp018193; SCHNEEWEIS DM, 1995, SCIENCE, V268, P1053, DOI 10.1126/science.7754386; Schneeweis DM, 1999, J NEUROSCI, V19, P1203; Schneeweis DM, 2000, VISUAL NEUROSCI, V17, P659, DOI 10.1017/S0952523800175017; Torre V, 1995, J NEUROSCI, V15, P7757; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; Wassle H, 1999, NATURE, V397, P473, DOI 10.1038/17216; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; WEN R, 1994, J PHYSIOL-LONDON, V476, P187, DOI 10.1113/jphysiol.1994.sp020122; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; WILSON M, 1991, VISUAL NEUROSCI, V6, P19, DOI 10.1017/S0952523800000870; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zenisek D, 1998, VISUAL NEUROSCI, V15, P69, DOI 10.1017/S0952523898151064	56	41	41	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					451	458		10.1016/S0896-6273(01)00299-9	http://dx.doi.org/10.1016/S0896-6273(01)00299-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395006	Bronze			2022-12-24	WOS:000168962000017
J	Segawa, H; Miyashita, T; Hirate, Y; Higashijima, S; Chino, N; Uyemura, K; Kikuchi, Y; Okamoto, H				Segawa, H; Miyashita, T; Hirate, Y; Higashijima, S; Chino, N; Uyemura, K; Kikuchi, Y; Okamoto, H			Functional repression of islet-2 by disruption of complex with Ldb impairs peripheral axonal outgrowth in embryonic zebrafish	NEURON			English	Article							LIM-HOMEODOMAIN PROTEINS; MESSENGER-RNA EXPRESSION; PATHWAY SELECTION; SPINAL NEURONS; MOTOR-NEURONS; DROSOPHILA; DOMAIN; GENE; MOTONEURON; CHIP	Islet-2 is a LIM/homeodomain-type transcription factor of the Islet-1 family expressed in embryonic zebrafish. Two lslet-2 molecules bind to the LIM domain binding protein (Ldb) dimers. Overexpression of the LIM domains of Islet-2 or the LIM-interacting domain of Ldb proteins prevented binding of Islet-2 to Ldb proteins in vitro and caused similar in vivo defects in positioning, peripheral axonal outgrowth, and neurotransmitter expression by the Islet-2-positive primary sensory and motor neurons as the defects induced by injection of Islet-2-specific antisense morpholino oligonucleotide. These and other experiments, i.e., mosaic analysis, coexpression of full-length Islet-2, and overexpression of the chimeric LIM domains derived from two different Islet-1 family members, demonstrated that Islet-2 regulates neuronal differentiation by forming a complex with Ldb dimers and possibly with some other Islet-2-specific cofactors.	RIKEN, Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama 3510198, Japan; Core Res Evolut Sci & Technol, Japan Sci & Technol Corp, Kawaguchi, Saitama, Japan; Precursory Res Embryon Sci & Technol, JST, Inheritance & Variat Grp, Kawaguchi, Saitama 3320012, Japan; Keio Univ, Sch Med, Dept Rehabil Med, Shinjuku Ku, Tokyo 1600016, Japan; Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1600016, Japan; Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan; Saitama Univ, Fac Sci, Dept Regulat Biol, Saitama 3388570, Japan	RIKEN; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); Keio University; Keio University; Nara Institute of Science & Technology; Saitama University	Okamoto, H (corresponding author), RIKEN, Brain Sci Inst, Lab Dev Gene Regulat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Okamoto, Hitoshi/P-9767-2015	Okamoto, Hitoshi/0000-0002-7512-8549; Kikuchi, Yutaka/0000-0001-5688-7358; Higashijima, Shin-ichi/0000-0001-6350-4992				Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; Appel B, 1995, DEVELOPMENT, V121, P4117; Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Bach I, 1997, GENE DEV, V11, P1370, DOI 10.1101/gad.11.11.1370; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; Dawid IB, 1998, TRENDS GENET, V14, P156, DOI 10.1016/S0168-9525(98)01424-3; EISEN JS, 1990, J NEUROSCI, V10, P34; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fernandez-Funez P, 1998, EMBO J, V17, P6846, DOI 10.1093/emboj/17.23.6846; Higashijima S, 2000, J NEUROSCI, V20, P206, DOI 10.1523/JNEUROSCI.20-01-00206.2000; Howard PW, 2000, J BIOL CHEM, V275, P13336, DOI 10.1074/jbc.275.18.13336; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Johnson JD, 1997, MOL CELL BIOL, V17, P3488, DOI 10.1128/MCB.17.7.3488; Jurata LW, 1996, P NATL ACAD SCI USA, V93, P11693, DOI 10.1073/pnas.93.21.11693; Kikuchi Y, 1997, NEURON, V18, P369, DOI 10.1016/S0896-6273(00)81239-8; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; LUNDGREN SE, 1995, DEVELOPMENT, V121, P1769; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; Patel TD, 2000, NEURON, V25, P345, DOI 10.1016/S0896-6273(00)80899-5; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; SANES JR, 1986, EMBO J, V5, P3133, DOI 10.1002/j.1460-2075.1986.tb04620.x; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TOKUMOTO M, 1995, DEV BIOL, V171, P578, DOI 10.1006/dbio.1995.1306; Toyama R, 1998, MECH DEVELOP, V71, P197, DOI 10.1016/S0925-4773(97)00202-5; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; TUTTLE R, 1995, DEVELOPMENT, V121, P1301; van Meyel DJ, 2000, DEVELOPMENT, V127, P1823; van Meyel DJ, 1999, MOL CELL, V4, P259, DOI 10.1016/S1097-2765(00)80373-1; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE	40	79	81	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					423	436		10.1016/S0896-6273(01)00283-5	http://dx.doi.org/10.1016/S0896-6273(01)00283-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395004	Bronze			2022-12-24	WOS:000168962000015
J	Sun, JY; Wu, LG				Sun, JY; Wu, LG			Fast kinetics of exocytosis revealed by simultaneous measurements of presynaptic capacitance and postsynaptic currents at a central synapse	NEURON			English	Article							RETINAL BIPOLAR NEURONS; MULTIPLE RELEASE SITES; RAT MEDIAL NUCLEUS; TRANSMITTER RELEASE; TRAPEZOID BODY; HIPPOCAMPAL SYNAPSES; BRAIN-STEM; RECEPTOR DESENSITIZATION; EXCITATORY SYNAPSES; CALCIUM-DEPENDENCE	The rate of release from nerve terminals depends on both the number of release sites and the rate of release at each site. The latter remains largely unknown at central synapses. We addressed this issue by simultaneously measuring the nerve terminal membrane capacitance and the postsynaptic current at single calyceal synapses in rat brainstem. We found that a 10 ms presynaptic step depolarization depleted a releasable pool containing 3300-5200 vesicles. Released vesicles were endocytosed with a time constant of a few seconds to tens of seconds. Release of only one third of this pool saturated both postsynaptic AMPA and NMDA receptors. A release site can release more than three vesicles in 10 ms (>300 vesicles per second). We conclude that both a large number of release sites and a fast release rate at each site enable synapses to release at a high rate.	Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Dept Anat, St Louis, MO 63110 USA; Washington Univ, Dept Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Wu, LG (corresponding author), Washington Univ, Dept Anesthesiol, St Louis, MO 63110 USA.							Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Angleson JK, 1997, TRENDS NEUROSCI, V20, P281, DOI 10.1016/S0166-2236(97)01083-7; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; Borst JGG, 1998, J PHYSIOL-LONDON, V506, P143, DOI 10.1111/j.1469-7793.1998.143bx.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; CASEY MA, 1985, J COMP NEUROL, V232, P401, DOI 10.1002/cne.902320311; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Chuhma N, 1998, J NEUROSCI, V18, P512; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dobrunz LE, 1997, P NATL ACAD SCI USA, V94, P14843, DOI 10.1073/pnas.94.26.14843; FERNANDEZ JM, 1982, J GEN PHYSIOL, V79, P41, DOI 10.1085/jgp.79.1.41; FETTIPLACE R, 1971, J MEMBRANE BIOL, V5, P277, DOI 10.1007/BF01870555; FORSYTHE ID, 1993, P ROY SOC B-BIOL SCI, V251, P151, DOI 10.1098/rspb.1993.0022; Gillis Kevin D., 1995, P155; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; LENN NJ, 1966, AM J ANAT, V118, P375, DOI 10.1002/aja.1001180205; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Mennerick S, 1997, J NEUROPHYSIOL, V78, P51, DOI 10.1152/jn.1997.78.1.51; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Otis T, 1996, J NEUROSCI, V16, P7496; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PATNEAU DK, 1993, J NEUROSCI, V13, P3496; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Ryugo DK, 1996, J COMP NEUROL, V365, P141, DOI 10.1002/(SICI)1096-9861(19960129)365:1<141::AID-CNE11>3.0.CO;2-T; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; Schikorski T, 1997, J NEUROSCI, V17, P5858; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Taschenberger H, 2000, J NEUROSCI, V20, P9162; TATSUOKA H, 1989, J COMP NEUROL, V290, P343, DOI 10.1002/cne.902900304; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Wang LY, 2000, J NEUROSCI, V20; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; YAMADA KA, 1993, J NEUROSCI, V13, P3904	62	188	192	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					171	182		10.1016/S0896-6273(01)00271-9	http://dx.doi.org/10.1016/S0896-6273(01)00271-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343653	Bronze			2022-12-24	WOS:000168412900019
J	Whitfield, J; Neame, SJ; Paquet, L; Bernard, O; Ham, J				Whitfield, J; Neame, SJ; Paquet, L; Bernard, O; Ham, J			Dominant-negative c-Jun promotes neuronal survival by reducing BIM expression and inhibiting mitochondrial cytochrome c release	NEURON			English	Article							PROGRAMMED CELL-DEATH; NERVE GROWTH-FACTOR; TROPHIC FACTOR DEPRIVATION; SYMPATHETIC NEURONS; BCL-2 FAMILY; FAS LIGAND; CASPASE ACTIVATION; APOPTOSIS; BAX; PROTEIN	Sympathetic neurons require nerve growth factor for survival and die by apoptosis in its absence. Key steps in the death pathway include c-Jun activation, mitochondrial cytochrome c release, and caspase activation. Here, we show that neurons rescued from NGF withdrawal-induced apoptosis by expression of dominant-negative c-Jun do not release cytochrome c from their mitochondria. Furthermore, we find that the mRNA for BIMEL, a proapoptotic BCL-2 family member, increases in level after NGF withdrawal and that this is reduced by dominant-negative c-Jun. Finally, overexpression of BIMEL in neurons induces cytochrome c redistribution and apoptosis in the presence of NGF, and neurons injected with sim antisense oligonucleotides or isolated from Bim(-/-) knockout mice die more slowly after NGF withdrawal.	UCL, Eisai London Res Labs, London WC1E 6BT, England; McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ H3A 2B4, Canada; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Eisai Co Ltd; University of London; University College London; McGill University; Walter & Eliza Hall Institute	Whitfield, J (corresponding author), UCL, Eisai London Res Labs, Bernard Katz Bldg,Gower St, London WC1E 6BT, England.	jonathan_whitfield@eisai.net; j.ham@ich.ucl.ac.uk	Ham, Jonathan/C-5164-2008; Whitfield, Jonathan/N-6690-2014	Neame, Stephen/0000-0002-6951-032X; Whitfield, Jonathan/0000-0002-4925-7283				Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Eilers A, 1998, J NEUROSCI, V18, P1713; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Faris M, 1998, MOL CELL BIOL, V18, P5414, DOI 10.1128/MCB.18.9.5414; FARLIE PG, 1995, P NATL ACAD SCI USA, V92, P4397, DOI 10.1073/pnas.92.10.4397; GARCIA I, 1992, SCIENCE, V258, P302, DOI 10.1126/science.1411528; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; GREENLUND LJS, 1995, NEURON, V15, P649, DOI 10.1016/0896-6273(95)90153-1; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Ham J, 2000, BIOCHEM PHARMACOL, V60, P1015, DOI 10.1016/S0006-2952(00)00372-5; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1432, DOI 10.1210/me.12.9.1432; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Juin P, 1999, GENE DEV, V13, P1367, DOI 10.1101/gad.13.11.1367; Jurgensmeier JM, 1998, P NATL ACAD SCI USA, V95, P4997, DOI 10.1073/pnas.95.9.4997; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LLOYD A, 1991, NATURE, V352, P632, DOI 10.1038/352635a0; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Narita M, 1998, P NATL ACAD SCI USA, V95, P14681, DOI 10.1073/pnas.95.25.14681; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Precious B., 1985, VIROLOGY PRACTICAL A, P193; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHLINGENSIEPEN KH, 1994, CELL MOL NEUROBIOL, V14, P487, DOI 10.1007/BF02088833; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Stefanis L, 1997, CURR OPIN NEUROL, V10, P299, DOI 10.1097/00019052-199708000-00004; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Vekrellis K, 1997, DEVELOPMENT, V124, P1239; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; WANG LY, 1996, J POLYM RES, V3, P1; Watson A, 1998, J NEUROSCI, V18, P751; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739	60	486	501	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					629	643		10.1016/S0896-6273(01)00239-2	http://dx.doi.org/10.1016/S0896-6273(01)00239-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301023	Bronze			2022-12-24	WOS:000167868900013
J	Chung, YD; Zhu, JC; Han, YG; Kernan, MJ				Chung, YD; Zhu, JC; Han, YG; Kernan, MJ			nompA encodes a PNS-specific, ZP domain protein required to connect mechanosensory dendrites to sensory structures	NEURON			English	Article							MUSSEL DREISSENA-POLYMORPHA; SIBLING CELL FATE; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; SECONDARY STRUCTURE; MOLECULAR-CLONING; NEURAL NETWORKS; ZONA-PELLUCIDA; ORGAN LINEAGE; GLIAL-CELL	Mutations in the no-mechanoreceptor-potential A (nompA) gene, which eliminate transduction in Drosophila mechanosensory organs, disrupt contacts between neuronal sensory endings and cuticular structures, nompA encodes a transmembrane protein with a large, modular extracellular segment that includes a zona pellucida (ZP) domain and several plasminogen N-terminal (PAN) modules. It is specifically expressed in type 1 sense organs of the peripheral nervous system by the support cells that ensheath the neuronal sensory process. A green fluorescent protein (GFP)NompA fusion protein is localized to the dendritic cap, an extracellular matrix that covers the ciliary outer segment of the sensory process and that shows organizational defects in nompA mutants. The structure and location of NompA suggest that it forms part of a mechanical linkage required to transmit mechanical stimuli to the transduction apparatus.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kernan, MJ (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.		Han, Young-Goo/N-2664-2018	Han, Young-Goo/0000-0002-4008-294X; Kernan, Maurice/0000-0002-1546-6159	NIDCD NIH HHS [R01 DC002780] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002780] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alloisio N, 1999, EUR J HUM GENET, V7, P255, DOI 10.1038/sj.ejhg.5200273; Anderson KE, 1998, BIOL BULL, V194, P150, DOI 10.2307/1543045; Anderson KE, 2000, J EXP BIOL, V203, P3065; BODMER R, 1987, CELL, V51, P293, DOI 10.1016/0092-8674(87)90156-5; BORK P, 1992, FEBS LETT, V300, P237, DOI 10.1016/0014-5793(92)80853-9; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; Carlson SD, 1997, GLIA, V19, P269; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Chen B, 1998, GENETICS, V149, P157; CHENG JH, 1993, BIOCHEM J, V294, P589, DOI 10.1042/bj2940589; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; Du HP, 1996, NEURON, V16, P183, DOI 10.1016/S0896-6273(00)80035-5; Eberl DF, 2000, J NEUROSCI, V20, P5981, DOI 10.1523/JNEUROSCI.20-16-05981.2000; FUKUOKA SI, 1991, P NATL ACAD SCI USA, V88, P2898, DOI 10.1073/pnas.88.7.2898; GARCIAANOVEROS J, 1995, CURR BIOL, V5, P441, DOI 10.1016/S0960-9822(95)00085-6; Gho M, 1999, DEVELOPMENT, V126, P3573; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gosline JM, 1999, J EXP BIOL, V202, P3295; GREVE JM, 1985, J MOL BIOL, V181, P253, DOI 10.1016/0022-2836(85)90089-0; HARTENSTEIN V, 1988, DEVELOPMENT, V102, P869; HARTENSTEIN V, 1990, DEV BIOL, V138, P147, DOI 10.1016/0012-1606(90)90184-K; HARTENSTEIN V, 1989, DEVELOPMENT, V107, P389; HESSION C, 1987, SCIENCE, V237, P1479, DOI 10.1126/science.3498215; Ho DH, 1998, J BIOL CHEM, V273, P16382, DOI 10.1074/jbc.273.26.16382; HOSAKA M, 1991, J BIOL CHEM, V266, P12127; Hudspeth AJ, 1997, NEURON, V19, P947, DOI 10.1016/S0896-6273(00)80385-2; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; JONES SJM, 1995, MOL GEN GENET, V248, P719, DOI 10.1007/BF02191712; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KILLICK R, 1995, J CELL BIOL, V129, P535, DOI 10.1083/jcb.129.2.535; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Legan PK, 1997, J BIOL CHEM, V272, P8791, DOI 10.1074/jbc.272.13.8791; LI XJ, 1995, J BIOL CHEM, V270, P17674, DOI 10.1074/jbc.270.30.17674; Manning L, 1999, DEVELOPMENT, V126, P2063; Merritt DJ, 1997, MICROSC RES TECHNIQ, V39, P492, DOI 10.1002/(SICI)1097-0029(19971215)39:6<492::AID-JEMT4>3.0.CO;2-G; Moulins M., 1976, STRUCTURE FUNCTION P; Mustapha M, 1999, HUM MOL GENET, V8, P409, DOI 10.1093/hmg/8.3.409; POLLACK JA, 1985, 203 CALTECH BIOL; Reddy GV, 1999, DEVELOPMENT, V126, P2083; ROST B, 1994, PROTEINS, V19, P55, DOI 10.1002/prot.340190108; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Rost B, 1996, METHOD ENZYMOL, V266, P525; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sakata H, 1997, J BIOL CHEM, V272, P9457; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SEBASTIANO M, 1991, DEV BIOL, V146, P519, DOI 10.1016/0012-1606(91)90253-Y; SHANBHAG SR, 1992, INT J INSECT MORPHOL, V21, P311, DOI 10.1016/0020-7322(92)90026-J; Simmler MC, 2000, NAT GENET, V24, P139, DOI 10.1038/72793; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thummel CS, 1992, DROS INF SERV, V71, P150; THURM U, 1964, SCIENCE, V145, P1063, DOI 10.1126/science.145.3636.1063; Thurm U., 1980, P735; Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7; Uga S., 1965, J ELECTRON MICROSC, V14, P173; Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; WASSARMAN PM, 1988, ANNU REV BIOCHEM, V57, P415, DOI 10.1146/annurev.bi.57.070188.002215; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6; YUREWICZ EC, 1993, BIOCHIM BIOPHYS ACTA, V1174, P211, DOI 10.1016/0167-4781(93)90119-X; Zhou HJ, 1998, STRUCTURE, V6, P109, DOI 10.1016/S0969-2126(98)00012-4; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	65	129	137	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					415	428		10.1016/S0896-6273(01)00215-X	http://dx.doi.org/10.1016/S0896-6273(01)00215-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239432	Bronze			2022-12-24	WOS:000167141700015
J	Aberle, H; Haghighi, AP; Fetter, RD; McCabe, BD; Magalhaes, TR; Goodman, CS				Aberle, H; Haghighi, AP; Fetter, RD; McCabe, BD; Magalhaes, TR; Goodman, CS			wishful thinking encodes a BMP type II receptor that regulates synaptic growth in Drosophila	NEURON			English	Article							BONE MORPHOGENETIC PROTEINS; RAT SYMPATHETIC NEURONS; DENDRITIC GROWTH; NEUROMUSCULAR-JUNCTIONS; FUNCTIONAL COMPONENTS; OSTEOGENIC PROTEIN-1; SIGNAL-TRANSDUCTION; TRANSMITTER RELEASE; GENETIC DISSECTION; PLASTICITY	We conducted a large-scale screen for Drosophila mutants that have structural abnormalities of the larval neuromuscular junction (NMJ). We recovered mutations in wishful thinking (wit), a gene that positively regulates synaptic growth. wit encodes a BMP type II receptor. In wit mutant larvae, the size of the NMJs is greatly reduced relative to the size of the muscles. wit NMJs have reduced evoked excitatory junctional potentials, decreased levels of the synaptic cell adhesion molecule Fasciclin II, and synaptic membrane detachment at active zones. Wit is expressed by a subset of neurons, including motoneurons. The NMJ phenotype is specifically rescued by transgenic expression of Wit only in motoneurons. Thus, Wit appears to function as a presynaptic receptor that regulates synaptic size at the Drosophila NMJ.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.		Aberle, Hermann/L-8461-2017	Aberle, Hermann/0000-0002-4864-6105; R Magalhaes, Tiago/0000-0002-5528-2119; McCabe, Brian/0000-0003-1620-0501				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Beppu H, 2000, DEV BIOL, V221, P249, DOI 10.1006/dbio.2000.9670; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Guo X, 1998, NEUROSCI LETT, V245, P131, DOI 10.1016/S0304-3940(98)00192-X; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Jiang Y, 2000, NEUROSCIENCE, V97, P735, DOI 10.1016/S0306-4522(00)00084-1; Kawabata M, 1998, CYTOKINE GROWTH F R, V9, P49, DOI 10.1016/S1359-6101(97)00036-1; KAWABATA M, 1995, J BIOL CHEM, V270, P5625, DOI 10.1074/jbc.270.10.5625; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; LEIN P, 1995, NEURON, V15, P597, DOI 10.1016/0896-6273(95)90148-5; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LIU F, 1995, MOL CELL BIOL, V15, P3479; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114, DOI 10.1113/jphysiol.1955.sp005397; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Parnas D, 2001, NEURON, V32, P415, DOI 10.1016/S0896-6273(01)00485-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Raftery LA, 1999, DEV BIOL, V210, P251, DOI 10.1006/dbio.1999.9282; ROBERTSON HM, 1988, GENETICS, V118, P461; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Stewart BA, 1996, J NEUROSCI, V16, P3877; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Withers GS, 2000, EUR J NEUROSCI, V12, P106, DOI 10.1046/j.1460-9568.2000.00889.x; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; ZHONG Y, 1992, J NEUROSCI, V12, P644; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	43	392	401	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					545	558		10.1016/S0896-6273(02)00589-5	http://dx.doi.org/10.1016/S0896-6273(02)00589-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856529	Bronze			2022-12-24	WOS:000173911100008
J	Sobolevsky, AI; Beck, C; Wollmuth, LP				Sobolevsky, AI; Beck, C; Wollmuth, LP			Molecular Rearrangements of the extracellular vestibule in NMDAR channels during gating	NEURON			English	Article							RAT HIPPOCAMPAL-NEURONS; GLUTAMATE-RECEPTOR; SUBSTITUTED CYSTEINES; ION CHANNELS; M2 SEGMENT; K+ CHANNEL; BLOCK; ACCESSIBILITY; MEMANTINE; BINDING	Many N-methyl-D-aspartate receptor (NMDAR) channel blockers that have therapeutic potential can be trapped in the closed state. Using a combination of the substituted cysteine accessibility method and open channel blockers, we found that the M3 segment forms the core of the extracellular vestibule, including a deep site for trapping blockers. The M3 segment, as well as more superficial parts of the extracellular vestibule, undergo extensive remodeling during channel closure, but do not define the activation gate, which is located deeper in the pore. Rather, the pore walls lining the extracellular vestibule constrict during channel closure. This movement is essential for coupling ligand binding to activation gate opening and accounts for the different mechanisms of open channel block, including trapping.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; Max Planck Inst Med Res, Abt Mol Neurobiol, D-69120 Heidelberg, Germany	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Max Planck Society	Sobolevsky, AI (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.			Wollmuth, Lonnie/0000-0002-8179-1259	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039102] Funding Source: NIH RePORTER; NINDS NIH HHS [R01 NS39102] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonov SM, 1998, NAT NEUROSCI, V1, P451, DOI 10.1038/2167; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Beck C, 1999, NEURON, V22, P559, DOI 10.1016/S0896-6273(00)80710-2; BENVENISTE M, 1995, J PHYSIOL-LONDON, V483, P367, DOI 10.1113/jphysiol.1995.sp020591; Blanpied TA, 1997, J NEUROPHYSIOL, V77, P309, DOI 10.1152/jn.1997.77.1.309; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Chen HSV, 1997, J PHYSIOL-LONDON, V499, P27, DOI 10.1113/jphysiol.1997.sp021909; COSTA ACS, 1994, J PHARMACOL EXP THER, V268, P503; Dingledine R, 1999, PHARMACOL REV, V51, P7; HUETTNER JE, 1988, P NATL ACAD SCI USA, V85, P1307, DOI 10.1073/pnas.85.4.1307; Karlin A, 1998, METHOD ENZYMOL, V293, P123; Kohda K, 2000, NAT NEUROSCI, V3, P315, DOI 10.1038/73877; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; Kuner T, 1996, NEURON, V17, P343, DOI 10.1016/S0896-6273(00)80165-8; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; MACDONALD JF, 1991, J PHYSIOL-LONDON, V432, P483, DOI 10.1113/jphysiol.1991.sp018396; Parsons CG, 1998, DRUG NEWS PERSPECT, V11, P523, DOI 10.1358/dnp.1998.11.9.863689; Pascual JM, 1998, J GEN PHYSIOL, V111, P717, DOI 10.1085/jgp.111.6.717; Sobolevsky A, 1998, BIOPHYS J, V74, P1305, DOI 10.1016/S0006-3495(98)77844-0; Sobolevsky AI, 2000, J PHYSIOL-LONDON, V526, P493, DOI 10.1111/j.1469-7793.2000.t01-2-00493.x; Sobolevsky AI, 1999, BBA-BIOMEMBRANES, V1416, P69, DOI 10.1016/S0005-2736(98)00211-9; Sobolevsky AI, 1998, J PHYSIOL-LONDON, V512, P47, DOI 10.1111/j.1469-7793.1998.047bf.x; Sobolevsky AI, 1999, J NEUROSCI, V19, P10611, DOI 10.1523/JNEUROSCI.19-24-10611.1999; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; WO ZG, 1994, P NATL ACAD SCI USA, V91, P7154, DOI 10.1073/pnas.91.15.7154; Wollmuth LP, 1996, J PHYSIOL-LONDON, V491, P779, DOI 10.1113/jphysiol.1996.sp021257; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448	32	97	98	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					75	85		10.1016/S0896-6273(01)00560-8	http://dx.doi.org/10.1016/S0896-6273(01)00560-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779481	Bronze			2022-12-24	WOS:000173106200011
J	Wang, ZW; Saifee, O; Nonet, ML; Salkoff, L				Wang, ZW; Saifee, O; Nonet, ML; Salkoff, L			SLO-1 potassium channels control quantal content of neurotransmitter release at the C-. elegans neuromuscular junction	NEURON			English	Article							CA2+-ACTIVATED K+ CHANNELS; PRESYNAPTIC ACTIVE ZONES; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; LARGE-CONDUCTANCE; BETA-SUBUNIT; ION CHANNELS; ACETYLCHOLINE-RELEASE; CALCIUM SENSITIVITY; NERVE-TERMINALS	Six mutants of SLO-1, a large-conductance, Ca2+-activated K+ channel of C. elegans, were obtained in a genetic screen for regulators of neurotransmitter release. Mutants were isolated by their ability to suppress lethargy of an unc-64 syntaxin mutant that restricts neurotransmitter release. We measured evoked postsynaptic currents at the neuromuscular junction in both wild-type and mutants and observed that the removal of SLO-1 greatly increased quanta[ content primarily by increasing duration of release. The selective isolation of slo-1 as the only ion channel mutant derived from a whole genomic screen to detect regulators of neurotransmitter release suggests that SLO-1 plays an important, if not unique, role in regulating neurotransmitter release.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Salkoff, L (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, Campus Box 8108,660 S Euclid Ave, St Louis, MO 63110 USA.	salkoffl@thalamus.wustl.edu						ADELMAN JP, 1992, NEURON, V9, P209, DOI 10.1016/0896-6273(92)90160-F; ALFONSO A, 1993, SCIENCE, V261, P617, DOI 10.1126/science.8342028; ANDERSON AJ, 1988, BRIT J PHARMACOL, V95, P1329, DOI 10.1111/j.1476-5381.1988.tb11772.x; Avery L, 1995, METHOD CELL BIOL, V48, P251; AVERY L, 1993, J EXP BIOL, V175, P283; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BUTLER A, 1993, SCIENCE, V261, P221, DOI 10.1126/science.7687074; CHAPMAN PF, 1995, NEURON, V14, P591, DOI 10.1016/0896-6273(95)90315-1; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; DiChiara TJ, 1997, J NEUROSCI, V17, P4942; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; ESGUERRA M, 1994, NATURE, V369, P563, DOI 10.1038/369563a0; Fischer HS, 1999, NEUROSCI LETT, V263, P208, DOI 10.1016/S0304-3940(99)00116-0; GARCIA ML, 1991, J BIOENERG BIOMEMBR, V23, P615, DOI 10.1007/BF00785814; GENGYOANDO K, 1993, NEURON, V11, P703, DOI 10.1016/0896-6273(93)90080-B; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HERMAN RK, 1980, NEMATODES BIOL MODEL, V1, P227; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; ISSA NP, 1994, P NATL ACAD SCI USA, V91, P7578, DOI 10.1073/pnas.91.16.7578; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; KATZ E, 1995, J PHYSIOL-LONDON, V486, P695, DOI 10.1113/jphysiol.1995.sp020845; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1995, J BIOL CHEM, V270, P22434, DOI 10.1074/jbc.270.38.22434; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LINDGREN CA, 1989, J PHYSIOL-LONDON, V414, P201, DOI 10.1113/jphysiol.1989.sp017684; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674; MARSHALL DL, 1994, TOXICON, V32, P1433, DOI 10.1016/0041-0101(94)90415-4; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; Maryon EB, 1998, J CELL SCI, V111, P2885; Mathie A, 1998, GEN PHARMACOL-VASC S, V30, P13, DOI 10.1016/S0306-3623(97)00034-7; MCCOBB DP, 1995, AM J PHYSIOL-HEART C, V269, pH767, DOI 10.1152/ajpheart.1995.269.3.H767; Meera P, 2000, P NATL ACAD SCI USA, V97, P5562, DOI 10.1073/pnas.100118597; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; MORITA K, 1990, J NEUROSCI, V10, P2614; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OKKEMA PG, 1993, GENETICS, V135, P385; PALLANCK L, 1994, HUM MOL GENET, V3, P1239, DOI 10.1093/hmg/3.8.1239; Pattillo JM, 2001, NEUROSCIENCE, V102, P229, DOI 10.1016/S0306-4522(00)00453-X; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; RAND JB, 1985, PSYCHOPHARMACOL BULL, V21, P623; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; Richards D, 1999, BRIT DENT J, V1, P3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; ROBERTSON BE, 1993, AM J PHYSIOL, V265, pC299; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; ROBITAILLE R, 1992, J NEUROSCI, V12, P297; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Salkoff L, 1999, CURR TOP MEMBR, V46, P9; SALKOFF L, 1985, J PHYSIOL-PARIS, V80, P275; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; SIVARAMAKRISHNAN S, 1991, J GEN PHYSIOL, V98, P1161, DOI 10.1085/jgp.98.6.1161; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sun XP, 1999, J PHYSIOL-LONDON, V518, P639, DOI 10.1111/j.1469-7793.1999.0639p.x; TABTI N, 1989, PFLUG ARCH EUR J PHY, V413, P395, DOI 10.1007/BF00584489; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Tucker T, 1995, NEURON, V15, P1323, DOI 10.1016/0896-6273(95)90011-X; VATANPOUR H, 1995, BRIT J PHARMACOL, V114, P1502, DOI 10.1111/j.1476-5381.1995.tb13377.x; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; WANG G, 1992, J PHYSIOL-LONDON, V457, P47, DOI 10.1113/jphysiol.1992.sp019364; Wang ZW, 1997, J GEN PHYSIOL, V110, P35, DOI 10.1085/jgp.110.1.35; Wang ZW, 1996, AM J PHYSIOL-LUNG C, V271, pL100, DOI 10.1152/ajplung.1996.271.1.L100; WANGEMANN P, 1993, HEARING RES, V66, P123, DOI 10.1016/0378-5955(93)90133-L; Warbington L, 1996, INVERTEBR NEUROSCI, V2, P51, DOI 10.1007/BF02336660; Waterston R., 1988, NEMATODE C ELEGANS, P281; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; WILLIAMS BD, 1992, GENETICS, V131, P609; Xia XM, 1998, J NEUROSCI, V18, P2360; Xia XM, 2000, J NEUROSCI, V20, P4890; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; Yazejian B, 1997, J NEUROSCI, V17, P2990; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	85	173	181	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					867	881		10.1016/S0896-6273(01)00522-0	http://dx.doi.org/10.1016/S0896-6273(01)00522-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738032	Bronze			2022-12-24	WOS:000172700700013
J	Gorea, A; Sagi, D				Gorea, A; Sagi, D			Disentangling signal from noise in visual contrast discrimination	NATURE NEUROSCIENCE			English	Article							HUMAN-VISION; NEURONS; MODEL; MECHANISMS; MASKING; CORTEX; CAT	Human ability to detect stimulus changes (DeltaC) decreases with increasing reference level (C). Because detection performance reflects the signal-to-noise ratio within the relevant sensory brain module, this behavior can be accounted for in two extreme ways: first, the internal response change DeltaR evoked by a constant DeltaC decreases with C (that is, the transducer R = f(C) displays a compressive nonlinearity), whereas the internal noise is independent of R; second, DeltaR is constant with C but the noise level increases with R. A newly discovered constraint on human decision-making helps solve this century-old problem: in a detection task where multiple changes occur with equal probabilities, observers use a unique response criterion to decide whether a change has occurred. For contrast discrimination, our results supported the first account above: human performance was limited by the contrast transducer nonlinearity and an almost constant noise.	Expt Psychol Lab, CNRS, F-92774 Boulogne, France; Univ Paris 05, F-92774 Boulogne, France; Weizmann Inst Sci, Dept Neurobiol Brain Res, IL-76100 Rehovot, Israel	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Weizmann Institute of Science	Gorea, A (corresponding author), Expt Psychol Lab, CNRS, 71 Ave Edouard Vaillant, F-92774 Boulogne, France.		Sagi, Dov/A-5454-2008; Gorea, Andrei/A-7092-2012	Sagi, Dov/0000-0002-8446-9230; Gorea, Andrei/0000-0002-8569-0658				AHUMADA AJ, 1985, J OPT SOC AM A, V2, P1133, DOI 10.1364/JOSAA.2.001133; BARLOW HB, 1956, J OPT SOC AM, V46, P634, DOI 10.1364/JOSA.46.000634; BARLOW HB, 1957, J PHYSIOL-LONDON, V136, P469, DOI 10.1113/jphysiol.1957.sp005774; BARLOW HB, 1987, J OPT SOC AM A, V4, P2366, DOI 10.1364/JOSAA.4.002366; Barlow HB, 1977, VERTEBRATE PHOTORECP; De Vries H, 1943, PHYSICA, V10, P553, DOI 10.1016/S0031-8914(43)90575-0; ESKEW RT, 1991, J OPT SOC AM A, V8, P394, DOI 10.1364/JOSAA.8.000394; Falmagne J.-C., 1985, ELEMENTS PSYCHOPHYSI; Fechner G. T., 1860, ELEMENTE PSYCHOPHYSI; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Gorea A, 2000, P NATL ACAD SCI USA, V97, P12380, DOI 10.1073/pnas.97.22.12380; GREEN DM, 1966, SIGNAL DETECTION THE; Itti L, 2000, J OPT SOC AM A, V17, P1899, DOI 10.1364/JOSAA.17.001899; KONTSEVICH LL, IN PRESS VISION RES; KRAUSKOPF J, 1980, VISION RES, V20, P193, DOI 10.1016/0042-6989(80)90101-7; LAMMING D, 1997, MEASUREMENT SENSATIO; LEGGE GE, 1987, J OPT SOC AM A, V4, P391, DOI 10.1364/JOSAA.4.000391; LEGGE GE, 1980, J OPT SOC AM, V70, P1458, DOI 10.1364/JOSA.70.001458; LEGGE GE, 1981, VISION RES, V21, P457, DOI 10.1016/0042-6989(81)90092-4; Lu ZL, 1999, J OPT SOC AM A, V16, P764, DOI 10.1364/JOSAA.16.000764; Lu ZL, 1998, VISION RES, V38, P1183, DOI 10.1016/S0042-6989(97)00273-3; NACHMIAS J, 1974, VISION RES, V14, P1039, DOI 10.1016/0042-6989(74)90175-8; NACHMIAS J, 1970, J OPT SOC AM, V60, P382, DOI 10.1364/JOSA.60.000382; Pelli D. G., 1990, VISION CODING EFFICI; PELLI DG, 1981, PSYCHOLOGY; ROSE A, 1948, J OPT SOC AM, V38, P196, DOI 10.1364/JOSA.38.000196; Rose A., 1942, PROC I RADIO ENG NEW, V30, P293, DOI [10.1109/jrproc.1942.230998, DOI 10.1109/JRPROC.1942.230998]; SAGI D, 1983, VISION RES, V23, P1595, DOI 10.1016/0042-6989(83)90173-6; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY WR, 1993, J NEUROSCI, V13, P334; STEVENS SS, 1957, PSYCHOL REV, V64, P153, DOI 10.1037/h0046162; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; WILSON HR, 1980, BIOL CYBERN, V38, P171, DOI 10.1007/BF00337406	35	53	54	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1146	1150		10.1038/nn741	http://dx.doi.org/10.1038/nn741			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687818				2022-12-24	WOS:000171970900019
J	Hendricks, JC; Williams, JA; Panckeri, K; Kirk, D; Tello, M; Yin, JCP; Sehgal, A				Hendricks, JC; Williams, JA; Panckeri, K; Kirk, D; Tello, M; Yin, JCP; Sehgal, A			A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis	NATURE NEUROSCIENCE			English	Article							LONG-TERM-MEMORY; GENE-EXPRESSION; SLEEP; ANTIDEPRESSANT; INDUCTION; INCREASES; ACTIVATOR; WAKING; CLOCK; STATE	In the fruit fly, Drosophila melanogaster, rest shares features with mammalian sleep, including prolonged immobility, decreased sensory responsiveness and a homeostatic rebound after deprivation. To understand the molecular regulation of sleep-like rest, we investigated the involvement of a candidate gene, cAMP response-element binding protein (CREB). The duration of rest was inversely related to cAMP signaling and CREB activity. Acutely blocking CREB activity in transgenic flies did not affect the clock, but increased rest rebound. CREB mutants also had a prolonged and increased homeostatic rebound. In wild types, in vivo CREB activity increased after rest deprivation and remained elevated for a 72-hour recovery period. These data indicate that cAMP signaling has a non-circadian role in waking and rest homeostasis in Drosophila.	Univ Penn, Ctr Sleep & Resp Neurobiol, Philadelphia, PA 19104 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Univ Penn, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; University of Pennsylvania	Hendricks, JC (corresponding author), Univ Penn, Ctr Sleep & Resp Neurobiol, 991 Maloney Bldg,3600 Spruce St, Philadelphia, PA 19104 USA.				NCI NIH HHS [SCOR-HL-60287] Funding Source: Medline; NHLBI NIH HHS [R01-HL-59649] Funding Source: Medline; NIMH NIH HHS [R01 MH067774] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA015753] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Belvin MP, 1999, NEURON, V22, P777, DOI 10.1016/S0896-6273(00)80736-9; Capece ML, 1997, AM J PHYSIOL-REG I, V273, pR1430, DOI 10.1152/ajpregu.1997.273.4.R1430; Cirelli C, 1996, SCIENCE, V274, P1211, DOI 10.1126/science.274.5290.1211; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DUDAI Y, 1983, NEUROSCI LETT, V42, P207, DOI 10.1016/0304-3940(83)90408-1; Duman RS, 1998, J ECT, V14, P181; Eresh S, 1997, EMBO J, V16, P2014, DOI 10.1093/emboj/16.8.2014; Everson CA, 2000, AM J PHYSIOL-REG I, V278, pR905, DOI 10.1152/ajpregu.2000.278.4.R905; Freeland K, 2000, BIOCHEM J, V345, P233, DOI 10.1042/0264-6021:3450233; HABENER JF, 1995, VITAM HORM, V91, P1; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Jewett ME, 1999, SLEEP, V22, P171, DOI 10.1093/sleep/22.2.171; Kilduff TS, 2000, NEURON, V26, P295, DOI 10.1016/S0896-6273(00)81163-0; Lelkes Z, 1998, PHARMACOL BIOCHEM BE, V60, P835, DOI 10.1016/S0091-3057(98)00038-0; LEVINE JD, 1994, NEURON, V13, P967, DOI 10.1016/0896-6273(94)90262-3; Naylor E, 2000, J NEUROSCI, V20, P8138; Nibuya M, 1996, J NEUROSCI, V16, P2365; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Park SK, 2000, J BIOL CHEM, V275, P20588, DOI 10.1074/jbc.M002460200; Plautz JD, 1997, J BIOL RHYTHM, V12, P204, DOI 10.1177/074873049701200302; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Walton MR, 2000, TRENDS NEUROSCI, V23, P48, DOI 10.1016/S0166-2236(99)01500-3; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; YIN JCP, 1995, MOL CELL BIOL, V15, P5123; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9; Zamboni G, 1999, ARCH ITAL BIOL, V137, P249	32	170	173	1	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1108	1115		10.1038/nn743	http://dx.doi.org/10.1038/nn743			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687816				2022-12-24	WOS:000171970900014
J	Vallstedt, A; Muhr, J; Pattyn, A; Pierani, A; Mendelsohn, M; Sander, M; Jessell, TM; Ericson, J				Vallstedt, A; Muhr, J; Pattyn, A; Pierani, A; Mendelsohn, M; Sander, M; Jessell, TM; Ericson, J			Different levels of repressor activity assign redundant and specific roles to Nkx6 genes in motor neuron and interneuron specification	NEURON			English	Article							PROGENITOR-CELL IDENTITY; SONIC HEDGEHOG; SPINAL-CORD; HOMEODOMAIN PROTEIN; DROSOPHILA EMBRYO; HOMEOBOX GENES; EXPRESSION; FAMILY; PATTERN; MOUSE	Specification of neuronal fate in the vertebrate central nervous system depends on the profile of transcription factor expression by neural progenitor cells, but the precise roles of such factors in neurogenesis remain poorly characterized. Two closely related transcriptional repressors, Nkx6.2 and Nkx6.1, are expressed by progenitors in overlapping domains of the ventral spinal cord. We provide genetic evidence that differences in the level of repressor activity of these homeodomain proteins underlies the diversification of interneuron subtypes, and provides a fail-safe mechanism during motor neuron generation. A reduction in Nkx6 activity further permits VO neurons to be generated from progenitors that lack homeodomain proteins normally required for their generation, providing direct evidence for a model in which progenitor homeodomain proteins direct specific cell fates by actively suppressing the expression of transcription factors that direct alternative fates.	Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10032 USA; Univ Hamburg, Ctr Mol Neurobiol, D-20251 Hamburg, Germany	Karolinska Institutet; Columbia University; Howard Hughes Medical Institute; University of Hamburg	Ericson, J (corresponding author), Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.		Pierani, Alessandra/O-6136-2017; Alexandre, Pattyn/ABF-1346-2020; Sander, Maike/N-6615-2016	Pierani, Alessandra/0000-0002-4872-4791; Pattyn, Alexandre/0000-0003-1215-1482; Ericson, Johan/0000-0002-8019-7127; Sander, Maike/0000-0001-5308-7785				Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BASLER K, 1993, CELL, V73, P687, DOI 10.1016/0092-8674(93)90249-P; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Briscoe J, 2001, MOL CELL, V7, P1279, DOI 10.1016/S1097-2765(01)00271-4; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Cai J, 1999, DEV DYNAM, V216, P459, DOI 10.1002/(SICI)1097-0177(199912)216:4/5<459::AID-DVDY14>3.3.CO;2-Z; Cai J, 2001, MOL CELL BIOL, V21, P4399, DOI 10.1128/MCB.21.13.4399-4403.2001; DAVIS CA, 1991, DEVELOPMENT, V111, P287; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Hamburger H., 1953, J MORPHOL, V88, P49; Hoshiyama D, 1998, J MOL EVOL, V47, P640, DOI 10.1007/PL00006421; Jorgensen MC, 1999, FEBS LETT, V461, P287, DOI 10.1016/S0014-5793(99)01436-2; KOMURO I, 1993, EMBO J, V12, P1387, DOI 10.1002/j.1460-2075.1993.tb05783.x; KRAUT R, 1991, DEVELOPMENT, V111, P611; Lee SH, 2001, MAMM GENOME, V12, P157, DOI 10.1007/s003350010247; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; Peters T, 2000, GENOME RES, V10, P1453, DOI 10.1101/gr.144100; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Tanaka M, 2000, MOL CELL BIOL, V20, P2874, DOI 10.1128/MCB.20.8.2874-2879.2000; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Toresson H, 2000, DEVELOPMENT, V127, P4361; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wang CC, 2000, MAMM GENOME, V11, P466, DOI 10.1007/s003350010089; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Yun K, 2001, DEVELOPMENT, V128, P193	43	212	217	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					743	755		10.1016/S0896-6273(01)00412-3	http://dx.doi.org/10.1016/S0896-6273(01)00412-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567614	Bronze			2022-12-24	WOS:000171013300009
J	Fremeau, RT; Troyer, MD; Pahner, I; Nygaard, GO; Tran, CH; Reimer, RJ; Bellocchio, EE; Fortin, D; Storm-Mathisen, J; Edwards, RH				Fremeau, RT; Troyer, MD; Pahner, I; Nygaard, GO; Tran, CH; Reimer, RJ; Bellocchio, EE; Fortin, D; Storm-Mathisen, J; Edwards, RH			The expression of vesicular glutamate transporters defines two classes of excitatory synapse	NEURON			English	Article							INORGANIC-PHOSPHATE COTRANSPORTER; RETROGRADE LECTIN TRANSPORT; CAENORHABDITIS-ELEGANS; RAT-BRAIN; ACETYLCHOLINE TRANSPORTER; AFFERENT-PROJECTIONS; TRANSMITTER RELEASE; REGIONAL EXPRESSION; MOLECULAR-CLONING; XENOPUS OOCYTES	The quantal release of glutamate depends on its transport into synaptic vesicles. Recent work has shown that a protein previously implicated in the uptake of inorganic phosphate across the plasma membrane catalyzes glutamate uptake by synaptic vesicles. However, only a subset of glutamate neurons expresses this vesicular glutamate transporter (VGLUT1). We now report that excitatory neurons lacking VGLUT1 express a closely related protein that has also been implicated in phosphate transport. Like VGLUT1, this protein localizes to synaptic vesicles and functions as a vesicular glutamate transporter (VGLUT2). The complementary expression of VGLUT1 and 2 defines two distinct classes of excitatory synapse.	Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, Grad Program Biomed Sci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, Grad Program Cell Biol, San Francisco, CA 94143 USA; Univ Oslo, IMBA, Dept Anat, N-0317 Oslo, Norway	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Oslo	Edwards, RH (corresponding author), Univ Calif San Francisco, Sch Med, Dept Neurol, Grad Program Neurosci, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Fortin, Doris/0000-0002-2729-7890; Storm-Mathisen, Jon/0000-0002-2930-3262				Aihara Y, 2000, J NEUROCHEM, V74, P2622, DOI 10.1046/j.1471-4159.2000.0742622.x; Amaral David G., 1995, P443; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; AVERY L, 1993, GENETICS, V133, P897; BAJJALIEH SM, 1993, P NATL ACAD SCI USA, V90, P2150, DOI 10.1073/pnas.90.6.2150; Bellocchio EE, 1998, J NEUROSCI, V18, P8648; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Broer S, 1998, J MEMBRANE BIOL, V164, P71, DOI 10.1007/s002329900394; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; CARLSON MD, 1989, J BIOL CHEM, V264, P7369; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; CLIFTOGRADY L, 1990, J CELL BIOL, V110, P1693, DOI 10.1083/jcb.110.5.1693; CORNWALL J, 1988, NEUROSCIENCE, V24, P1035, DOI 10.1016/0306-4522(88)90085-1; CORNWALL J, 1988, BRAIN RES BULL, V21, P147, DOI 10.1016/0361-9230(88)90227-4; DAN Y, 1994, NEURON, V13, P909, DOI 10.1016/0896-6273(94)90256-9; Dent JA, 1997, EMBO J, V16, P5867, DOI 10.1093/emboj/16.19.5867; DISBROW JK, 1982, BIOCHEM BIOPH RES CO, V108, P1221, DOI 10.1016/0006-291X(82)92130-1; Dittman JS, 1998, J NEUROSCI, V18, P6147; FREMEAU RT, 1992, NEURON, V8, P915, DOI 10.1016/0896-6273(92)90206-S; FYKSE EM, 1993, J NEUROSCI, V13, P4997; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Glinn M, 1998, J NEUROCHEM, V70, P1850; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Hisano S, 2000, MOL BRAIN RES, V83, P34, DOI 10.1016/S0169-328X(00)00194-7; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Krantz DE, 2000, J CELL BIOL, V149, P379, DOI 10.1083/jcb.149.2.379; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; MANCINI GMS, 1989, J BIOL CHEM, V264, P15247; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; NAITO S, 1983, J BIOL CHEM, V258, P696; Newman EA, 1998, J NEUROSCI, V18, P4022; NI BH, 1995, J NEUROSCI, V15, P5789; NI BH, 1994, P NATL ACAD SCI USA, V91, P5607, DOI 10.1073/pnas.91.12.5607; Otis TS, 2001, NEURON, V29, P11, DOI 10.1016/S0896-6273(01)00176-3; RAIZEN DM, 1994, NEURON, V12, P483, DOI 10.1016/0896-6273(94)90207-0; Reimer RJ, 1998, CURR OPIN NEUROBIOL, V8, P405, DOI 10.1016/S0959-4388(98)80068-8; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; STANFIELD BB, 1984, BRAIN RES, V309, P299; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; Sulzer D, 1998, J NEUROSCI, V18, P4588, DOI 10.1523/jneurosci.18-12-04588.1998; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; VANGROEN T, 1990, BRAIN RES, V518, P227, DOI 10.1016/0006-8993(90)90976-I; VAROQUI H, 1994, FEBS LETT, V342, P97, DOI 10.1016/0014-5793(94)80592-X; Verheijen FW, 1999, NAT GENET, V23, P462, DOI 10.1038/70585; Wolosker H, 1996, J BIOL CHEM, V271, P11726, DOI 10.1074/jbc.271.20.11726; WOUTERLOOD FG, 1990, J COMP NEUROL, V296, P179, DOI 10.1002/cne.902960202; WYSS JM, 1979, ANAT EMBRYOL, V156, P165, DOI 10.1007/BF00300012	53	953	973	2	40	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 2	2001	31	2					247	260		10.1016/S0896-6273(01)00344-0	http://dx.doi.org/10.1016/S0896-6273(01)00344-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502256	Bronze			2022-12-24	WOS:000170277700010
J	Flynn, GE; Zagotta, WN				Flynn, GE; Zagotta, WN			Conformational changes in S6 coupled to the opening of cyclic nucleotide-gated channels	NEURON			English	Review							ION CHANNELS; K+-CHANNEL; ACTIVATED CHANNELS; SUBUNIT STOICHIOMETRY; ROD PHOTORECEPTORS; CATION CHANNEL; RETINAL RODS; TOPOLOGY; PORE; MECHANISM	In cyclic nucleotide-gated channels (CNG), direct binding of cyclic nucleotides in the carboxy-terminal region is allosterically coupled to opening of the pore. A CNG1 channel pore was probed using site-directed cysteine substitution to elucidate conformational changes associated with channel opening. The effects of cysteine modification on permeation suggest a structural homology between CNG and KcsA pores. We found that intersubunit disulfide bonds form spontaneously between S399C residues in the helix bundle when channels are in the closed but not in the open state. While MTSET modification of pore-lining residues was state dependent, Ag+ modification of V391C, in the inner vestibule, occurred at the same diffusion-limited rate in both open and closed states. Our results suggest that the helix bundle undergoes a conformational change associated with gating but is not the activation Elate for CNG channels.	Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zagotta, WN (corresponding author), Univ Washington, Howard Hughes Med Inst, Dept Physiol & Biophys, Seattle, WA 98195 USA.				NEI NIH HHS [R01 EY010329-08, R01 EY010329, T32 EY07031] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY010329, T32EY007031] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Becchetti A, 1999, J GEN PHYSIOL, V114, P377, DOI 10.1085/jgp.114.3.377; Becchetti A, 2000, PFLUG ARCH EUR J PHY, V440, P556, DOI 10.1007/s004240050006; CAREAGA CL, 1992, BIOPHYS J, V62, P209, DOI 10.1016/S0006-3495(92)81806-4; del Camino D, 2001, BIOPHYS J, V80, p16A; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fodor AA, 1997, J GEN PHYSIOL, V109, P3, DOI 10.1085/jgp.109.1.3; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P857, DOI 10.1016/0896-6273(95)90229-5; GORDON SE, 1995, NEURON, V14, P177; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HEGINBOTHAM L, 1992, SCIENCE, V258, P1152, DOI 10.1126/science.1279807; HENN DK, 1995, P NATL ACAD SCI USA, V92, P7425, DOI 10.1073/pnas.92.16.7425; Hille B., 1992, IONIC CHANNELS EXCIT; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; ILDEFONSE M, 1992, J MEMBRANE BIOL, V130, P91; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; KARPEN JW, 1988, P NATL ACAD SCI USA, V85, P1287, DOI 10.1073/pnas.85.4.1287; KARPEN JW, 1993, J GEN PHYSIOL, V101, P1, DOI 10.1085/jgp.101.1.1; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Liu DT, 1996, NEURON, V16, P983, DOI 10.1016/S0896-6273(00)80121-X; Liu J, 2000, NEURON, V28, P899, DOI 10.1016/S0896-6273(00)00162-8; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; MOLDAY RS, 1991, J BIOL CHEM, V266, P21917; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Ruiz M, 1997, NATURE, V389, P389, DOI 10.1038/38744; SHABB JB, 1992, J BIOL CHEM, V267, P5723; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; Stotz SC, 1996, BIOPHYS J, V71, P3136, DOI 10.1016/S0006-3495(96)79507-3; Sun ZP, 1996, NEURON, V16, P141, DOI 10.1016/S0896-6273(00)80031-8; Sunderman ER, 1999, J GEN PHYSIOL, V113, P601, DOI 10.1085/jgp.113.5.601; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Varnum MD, 1996, BIOPHYS J, V70, P2667, DOI 10.1016/S0006-3495(96)79836-3; VARNUM MD, 1995, NEURON, V15, P619, DOI 10.1016/0896-6273(95)90150-7; WOHLFART P, 1992, J BIOL CHEM, V267, P644; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZAGOTTA WN, 1989, NEURON, V3, P773, DOI 10.1016/0896-6273(89)90246-8; ZUFALL F, 1994, ANNU REV BIOPH BIOM, V23, P577, DOI 10.1146/annurev.bb.23.060194.003045	45	138	142	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					689	698		10.1016/S0896-6273(01)00324-5	http://dx.doi.org/10.1016/S0896-6273(01)00324-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430803	Bronze			2022-12-24	WOS:000169508900010
J	Korkotian, E; Segal, M				Korkotian, E; Segal, M			Spike-associated fast contraction of dendritic spines in cultured hippocampal neurons	NEURON			English	Article							GLUTAMATE RECEPTORS; NMDA RECEPTORS; ACTIN; CALCIUM; TRANSMISSION; MECHANISMS	Dendritic spines have long been known to contain contractile elements and have recently been shown to express apparent spontaneous motility. Using high-resolution imaging of dendritic spines of green-fluorescent protein (GFP)-expressing, patch-clamped hippocampal neurons in dissociated culture, we find that bursts of action potentials, evoked by depolarizing current pulses, cause momentary contractions of dendritic spines. Blocking calcium currents with cobalt prevented these twitches. In additional experiments with neurons loaded via a micropipette with calcium-sensitive and insensitive dyes, spontaneous calcium transients were associated with a rapid contraction of the spine head. The spine twitch was prolonged by tetraethylammonium or bicuculline, which enhance calcium transients, and was blocked by the actin polymerization antagonist latrunculin-B. The spine twitch may be instrumental in modulating reactivity of the NMDA receptor to afferent stimulation, following back-propagating action potentials.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Segal, M (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.		SEGAL, MENAHEM/K-1577-2012; Korkotian, Eduard/K-1744-2012; Korkotian, Eduard/P-4559-2019	Korkotian, Eduard/0000-0001-5515-3387; 				Allison DW, 1998, J NEUROSCI, V18, P2423; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; FIFKOVA E, 1985, BRAIN RES REV, V9, P187, DOI 10.1016/0165-0173(85)90012-8; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Goldin M, 2001, J NEUROSCI, V21, P186, DOI 10.1523/JNEUROSCI.21-01-00186.2001; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Halpain S, 1998, J NEUROSCI, V18, P9835; Kim CH, 1999, J NEUROSCI, V19, P4314; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; KORKOTIAN E, 2001, IN PRESS J NEUROSCI; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; PAOLETTI P, 1994, NEURON, V13, P645, DOI 10.1016/0896-6273(94)90032-9; PAPA M, 1995, J NEUROSCI, V15, P1; SEGAL M, 1995, J NEUROPHYSIOL, V74, P484, DOI 10.1152/jn.1995.74.1.484; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; STELZER EHK, 2000, IMAGING NEURONS; VANDERVOORT HTM, 1989, J MICROSC-OXFORD, V153, P123; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	26	67	68	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					751	758		10.1016/S0896-6273(01)00314-2	http://dx.doi.org/10.1016/S0896-6273(01)00314-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430808	Bronze			2022-12-24	WOS:000169508900015
J	Bhat, MA; Rios, JC; Lu, Y; Garcia-Fresco, GP; Ching, W; St Martin, M; Li, JJ; Einheber, S; Chesler, M; Rosenbluth, J; Salzer, JL; Bellen, HJ				Bhat, MA; Rios, JC; Lu, Y; Garcia-Fresco, GP; Ching, W; St Martin, M; Li, JJ; Einheber, S; Chesler, M; Rosenbluth, J; Salzer, JL; Bellen, HJ			Axon-glia interactions and the domain organization of myelinated axons requires Neurexin IV/Caspr/Paranodin	NEURON			English	Article							PROTEIN-COUPLED RECEPTOR-2; SEPTATE JUNCTION; CUTTING EDGE; IDENTIFICATION; EXPRESSION; LOCALIZATION; RANVIER; BINDING; CASPR; CCR10	Myelinated fibers are organized into distinct domains that are necessary for saltatory conduction. These domains include the nodes of Ranvier and the flanking paranodal regions where glial cells closely appose and form specialized septate-like junctions with axons. These junctions contain a Drosophila Neurexin IV-related protein, Caspr/Paranodin (NCP1). Mice that lack NCP1 exhibit tremor, ataxia, and significant motor paresis. In the absence of NCP1, normal paranodal junctions fail to form, and the organization of the paranodal loops is disrupted. Contactin is undetectable in the paranodes, and K+ channels are displaced from the juxtaparanodal into the paranodal domains. Loss of NCP1 also results in a severe decrease in peripheral nerve conduction velocity. These results show a critical role for NCP1 in the delineation of specific axonal domains and the axon-glia interactions required for normal saltatory conduction.	CUNY Mt Sinai Sch Med, Dept Med, Cardiovasc Res Inst, Dept Biochem & Mol Biol, New York, NY 10029 USA; NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; NYU, Sch Med, Dept Physiol & Neurosci, New York, NY 10016 USA; NYU, Sch Med, Rusk Inst, New York, NY 10016 USA; Baylor Coll Med, Howard Hughes Med Inst, Dept Mol & Human Genet, Program Dev Biol, Houston, TX 77030 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; New York University; New York University; New York University; Baylor College of Medicine; Howard Hughes Medical Institute	Bhat, MA (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, Cardiovasc Res Inst, Dept Biochem & Mol Biol, New York, NY 10029 USA.	bhatm01@doc.mssm.edu	BHAT, MANZOOR/S-9273-2018	BHAT, MANZOOR/0000-0003-0989-1498; Salzer, James/0000-0001-9126-7197; Chesler, Mitchell/0000-0002-3189-8234; Bellen, Hugo/0000-0001-5992-5989	NCI NIH HHS [KO1-CA 78437] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07308] Funding Source: Medline; NINDS NIH HHS [NS38208, NS37475] Funding Source: Medline; CSR NIH HHS [RG2539] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K01CA078437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038208, R01NS037475] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); CSR NIH HHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRES KH, 1965, Z ZELLFORSCH MIK ANA, V65, P701, DOI 10.1007/BF00342591; BARGMANN W, 1964, Z ZELLFORSCH MIK ANA, V64, P868, DOI 10.1007/BF00323315; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellen HJ, 1998, TRENDS NEUROSCI, V21, P444, DOI 10.1016/S0166-2236(98)01267-3; Bennett V, 1999, J NEUROCYTOL, V28, P303, DOI 10.1023/A:1007005528505; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; Bonini JA, 1997, DNA CELL BIOL, V16, P1023, DOI 10.1089/dna.1997.16.1023; Bosio A, 1998, CELL TISSUE RES, V292, P199, DOI 10.1007/s004410051051; BUNGE RP, 1989, J CELL BIOL, V109, P273, DOI 10.1083/jcb.109.1.273; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Collinson JM, 1998, GLIA, V23, P11, DOI 10.1002/(SICI)1098-1136(199805)23:1<11::AID-GLIA2>3.0.CO;2-7; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; Dupree JL, 1999, J NEUROCYTOL, V28, P271, DOI 10.1023/A:1007049310758; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dupree JL, 1998, J NEUROSCI, V18, P1642; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; FaivreSarrailh C, 1997, MOL CELL NEUROSCI, V9, P109, DOI 10.1006/mcne.1997.0609; Homey B, 2000, J IMMUNOL, V164, P3465, DOI 10.4049/jimmunol.164.7.3465; Jarmin DI, 2000, J IMMUNOL, V164, P3460, DOI 10.4049/jimmunol.164.7.3460; Koch T, 1997, GLIA, V19, P199, DOI 10.1002/(SICI)1098-1136(199703)19:3<199::AID-GLIA3>3.0.CO;2-V; Melendez-Vasquez CV, 2001, P NATL ACAD SCI USA, V98, P1235, DOI 10.1073/pnas.98.3.1235; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Poliak S, 1999, NEURON, V24, P1037, DOI 10.1016/S0896-6273(00)81049-1; RAINE CS, 1982, J NEUROCYTOL, V11, P935, DOI 10.1007/BF01148309; RLOS JC, 2000, J NEUROSCI, V20, P8354; ROBERTSON JD, 1957, J PHYSIOL-LONDON, V137, pP8; Rosenbluth Jack, 1995, P613; Rudenko G, 1999, CELL, V99, P93, DOI 10.1016/S0092-8674(00)80065-3; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; TALT S, 2000, J CELL BIOL, V150, P657; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; Thullier F, 1999, PHARMACOL BIOCHEM BE, V63, P213, DOI 10.1016/S0091-3057(98)00228-7; Wang W, 2000, J BIOL CHEM, V275, P22313, DOI 10.1074/jbc.M001461200; Ward RE, 1998, J CELL BIOL, V140, P1463, DOI 10.1083/jcb.140.6.1463	40	433	440	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					369	383		10.1016/S0896-6273(01)00294-X	http://dx.doi.org/10.1016/S0896-6273(01)00294-X			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395000	Bronze			2022-12-24	WOS:000168962000011
J	Hardie, RC; Raghu, P; Moore, S; Juusola, M; Baines, RA; Sweeney, ST				Hardie, RC; Raghu, P; Moore, S; Juusola, M; Baines, RA; Sweeney, ST			Calcium influx via TRP channels is required to maintain PIP2 levels in Drosophila photoreceptors	NEURON			English	Article							LIGHT-SENSITIVE CHANNELS; RETINAL-DEGENERATION-B; PHOSPHOLIPASE-C; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE; INSP(3) RECEPTOR; IN-VIVO; PROTEIN; CA2+; PHOTOTRANSDUCTION	The trp (transient receptor potential) gene encodes a Ca2+ channel responsible for the major component of the phospholipase C (PLC) mediated light response in Drosophila. In trp mutants, maintained light leads to response decay and temporary total loss of sensitivity (inactivation). Using genetically targeted PIP2-sensitive inward rectifier channels (Kir2.1) as biosensors, we provide evidence that trp decay reflects depletion of PIP2 Two independent mutations in the PIP2 recycling pathway (rdgB and cds) prevented recovery from inactivation. Abolishing Ca2+ influx in wild-type photoreceptors mimicked inactivation, while raising Ca2+ by blocking Na+/Ca2+ exchange prevented inactivation in trp. The results suggest that Ca2+ influx prevents PIP, depletion by inhibiting PLC activity and facilitating PIP2 recycling. Without this feedback one photon appears sufficient to deplete the phosphoinositide pool of similar to4 microvilli.	Univ Cambridge, Dept Anat, Cambridge, England; Univ Cambridge, Dept Physiol, Cambridge, England; Univ Cambridge, Dept Zool, Cambridge, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England	University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge	Hardie, RC (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge, England.	rchl4@hermes.cam.ac.uk	Juusola, Mikko/E-6948-2011; Padinjat, Raghu/Z-5578-2019	Hardie, Roger/0000-0001-5531-3264; Sweeney, Sean/0000-0003-2673-9578; Baines, Richard/0000-0001-8571-4376; Juusola, Mikko/0000-0002-4428-5330				Acharya JK, 1997, NEURON, V18, P881, DOI 10.1016/S0896-6273(00)80328-1; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Batty IH, 1998, BIOCHEM J, V330, P1069; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; Cook B, 1999, CELL CALCIUM, V25, P161, DOI 10.1054/ceca.1998.0018; COSENS DJ, 1969, NATURE, V224, P285, DOI 10.1038/224285a0; Dabdoub A, 1999, J NEUROSCI, V19, P10262; DEER JLR, 1995, J BIOL CHEM, V270, P12623, DOI 10.1074/jbc.270.21.12623; FRANCESCHINI N, 1971, KYBERNETIK, V9, P159, DOI 10.1007/BF02215177; Hardie RC, 1996, J NEUROSCI, V16, P2924; HARDIE RC, 1995, CELL CALCIUM, V18, P256, DOI 10.1016/0143-4160(95)90023-3; HARDIE RC, 1994, J GEN PHYSIOL, V103, P409, DOI 10.1085/jgp.103.3.409; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; HOCHSTRATE P, 1989, J COMP PHYSIOL A, V166, P179, DOI 10.1007/BF00193462; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; HOWARD J, 1987, PROC R SOC SER B-BIO, V231, P415, DOI 10.1098/rspb.1987.0053; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Juusola M, 2001, J GEN PHYSIOL, V117, P3, DOI 10.1085/jgp.117.1.3; Kobrinsky E, 2000, NAT CELL BIOL, V2, P507, DOI 10.1038/35019544; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Milligan SC, 1997, J CELL BIOL, V139, P351, DOI 10.1083/jcb.139.2.351; MINKE B, 1975, NATURE, V258, P84, DOI 10.1038/258084a0; MINKE B, 1991, PROG RETIN RES, V11, P99, DOI 10.1016/0278-4327(91)90026-X; MINKE B, 1982, J GEN PHYSIOL, V79, P361, DOI 10.1085/jgp.79.3.361; Minke B, 2000, HDB BIOL PHYSICS, V3; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Niemeyer BA, 1996, CELL, V85, P651, DOI 10.1016/S0092-8674(00)81232-5; Oberwinkler J, 2000, J NEUROSCI, V20, P1701; PERETZ A, 1994, NEURON, V12, P1257, DOI 10.1016/0896-6273(94)90442-1; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Postma M, 1999, BIOPHYS J, V77, P1811, DOI 10.1016/S0006-3495(99)77026-8; Raghu P, 2000, MOL CELL NEUROSCI, V15, P429, DOI 10.1006/mcne.2000.0846; RANGANATHAN R, 1994, NEURON, V13, P837, DOI 10.1016/0896-6273(94)90250-X; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Richard EA, 1997, INVEST OPHTH VIS SCI, V38, P2775; Rohacs T, 1999, J BIOL CHEM, V274, P36065, DOI 10.1074/jbc.274.51.36065; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sullivan KMC, 2000, P NATL ACAD SCI USA, V97, P5942, DOI 10.1073/pnas.110145997; SUZUKI E, 1993, J ELECTRON MICROSC, V42, P178; SZUTS EZ, 1993, VISUAL NEUROSCI, V10, P921, DOI 10.1017/S0952523800006131; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; VIHTELIC TS, 1993, J CELL BIOL, V122, P1013, DOI 10.1083/jcb.122.5.1013; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0; Zhang HD, 1999, J BIOMED OPT, V4, P183, DOI 10.1117/1.429905; Zinkler D., 1985, Verhandlungen der Deutschen Zoologischen Gesellschaft, V78, P303	57	162	166	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					149	159		10.1016/S0896-6273(01)00269-0	http://dx.doi.org/10.1016/S0896-6273(01)00269-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343651	Bronze			2022-12-24	WOS:000168412900017
J	Helfrich-Forster, C; Winter, C; Hofbauer, A; Hall, JC; Stanewsky, R				Helfrich-Forster, C; Winter, C; Hofbauer, A; Hall, JC; Stanewsky, R			The circadian clock of fruit flies is blind after elimination of all known photoreceptors	NEURON			English	Article							PERIOD GENE-EXPRESSION; DROSOPHILA CLOCK; ELECTROPHYSIOLOGICAL CHARACTERIZATION; BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; TIMELESS GENES; LIGHT; CRYPTOCHROME; NEURONS; NEUROPEPTIDE	Circadian rhythms are entrained by light to follow the daily solar cycle. We show that Drosophila uses at least three light input pathways for this entrainment: (1) cryptochrome, acting in the pacemaker cells themselves, (2) the compound eyes, and (3) extraocular photoreception, possibly involving an internal structure known as the Hofbauer-Buchner eyelet, which is located underneath the compound eye and projects to the pacemaker center in the brain. Although influencing the circadian system in different ways, each input pathway appears capable of entraining circadian rhythms at the molecular and behavioral level. This entrainment is completely abolished in glass(60J) cry(b) double mutants, which lack all known external and internal eye structures in addition to being devoid of cryptochrome.	Univ Regensburg, Zool Inst Entwicklungsbiol, D-93040 Regensburg, Germany; Univ Tubingen, Zool Inst Tierphysiol, D-72076 Tubingen, Germany; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; NSF Ctr Biol Timing, Waltham, MA 02454 USA	University of Regensburg; Eberhard Karls University of Tubingen; Brandeis University; National Science Foundation (NSF)	Stanewsky, R (corresponding author), Univ Regensburg, Zool Inst Entwicklungsbiol, D-93040 Regensburg, Germany.	ralf.stanewsky@biologie.uni-regensburg.de	Stanewsky, Ralf/ABB-9193-2021	Stanewsky, Ralf/0000-0001-8238-6864; Helfrich-Forster, Charlotte/0000-0002-0859-9092	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH051573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM-33205] Funding Source: Medline; NIMH NIH HHS [MH-51573] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BLASCHKE I, 1996, BRAIN EVOLUTION, V1, P30; DOWSE HB, 1989, PHYSIOL ZOOL, V62, P785, DOI 10.1086/physzool.62.3.30157927; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Edery I, 1999, CHRONOBIOL INT, V16, P377, DOI 10.3109/07420529908998716; Egan ES, 1999, J NEUROSCI, V19, P3665; Emery IF, 1997, P NATL ACAD SCI USA, V94, P4092, DOI 10.1073/pnas.94.8.4092; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; ERKERT HG, 1986, FOLIA PRIMATOL, V47, P171, DOI 10.1159/000156276; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; Giebultowicz JM, 2000, CURR BIOL, V10, P107, DOI 10.1016/S0960-9822(00)00299-2; Giebultowicz JM, 1997, NATURE, V386, P664, DOI 10.1038/386664a0; Hall JC, 2000, CURR OPIN NEUROBIOL, V10, P456, DOI 10.1016/S0959-4388(00)00117-3; Hardin PE, 1999, SCIENCE, V286, P2460, DOI 10.1126/science.286.5449.2460; HARDIN PE, 1992, EMBO J, V11, P1; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Helfrich-Forster C, 1998, J COMP PHYSIOL A, V182, P435, DOI 10.1007/s003590050192; HELFRICHFORSTER C, 1995, P NATL ACAD SCI USA, V92, P612, DOI 10.1073/pnas.92.2.612; HOFBAUER A, 1989, NATURWISSENSCHAFTEN, V76, P335, DOI 10.1007/BF00368438; HU KG, 1978, J COMP PHYSIOL, V126, P15, DOI 10.1007/BF01342646; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Kaneko M, 1997, J NEUROSCI, V17, P6745; Kaneko M, 1998, CURR OPIN NEUROBIOL, V8, P652, DOI 10.1016/S0959-4388(98)80095-0; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; LINDSLEY DL, 1992, GENETIC VARIATIONS D; Marrus SB, 1996, EMBO J, V15, P6877, DOI 10.1002/j.1460-2075.1996.tb01080.x; MOOREEDE MC, 1982, CLOCK THAT TIMES USJ; MOSES K, 1989, NATURE, V340, P531, DOI 10.1038/340531a0; Mrosovsky N, 1999, CHRONOBIOL INT, V16, P415, DOI 10.3109/07420529908998717; Ohata K, 1998, INT CONGR SER, V1152, P167; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Pearn MT, 1996, J BIOL CHEM, V271, P4937; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Sancar A, 2000, ANNU REV BIOCHEM, V69, P31, DOI 10.1146/annurev.biochem.69.1.31; Schibler U, 2000, NATURE, V404, P25, DOI 10.1038/35003674; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; SHORTRIDGE RD, 1991, J BIOL CHEM, V266, P12474; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; Stanewsky R, 1997, J NEUROSCI, V17, P676; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Yasuyama K, 1999, J COMP NEUROL, V412, P193, DOI 10.1002/(SICI)1096-9861(19990920)412:2<193::AID-CNE1>3.0.CO;2-0; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; ZERR DM, 1990, J NEUROSCI, V10, P2749; ZIPURSKY SL, 1984, CELL, V36, P15, DOI 10.1016/0092-8674(84)90069-2	52	279	282	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					249	261		10.1016/S0896-6273(01)00277-X	http://dx.doi.org/10.1016/S0896-6273(01)00277-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343659	Bronze			2022-12-24	WOS:000168412900025
J	Sadja, R; Smadja, K; Alagem, N; Reuveny, E				Sadja, R; Smadja, K; Alagem, N; Reuveny, E			Coupling G beta gamma-dependent activation to channel opening via pore elements in inwardly rectifying potassium channels	NEURON			English	Article							MUSCARINIC K+ CHANNEL; FUNCTIONAL EXPRESSION; G-PROTEINS; SUBUNITS; IDENTIFICATION; BINDING; NA+; DETERMINANTS; INHIBITION; GEOMETRY	G protein-coupled inwardly rectifying potassium channels, GIRK/Kir3.x, are gated by the G beta gamma subunits of the G protein. The molecular mechanism of gating was investigated by employing a novel yeast-based random mutagenesis approach that selected for channel mutants that are active in the absence of G beta gamma. Mutations in TM2 were found that mimicked the G beta gamma -activated state. The activity of these channel mutants was independent of receptor stimulation and of the availability of heterologously expressed G beta gamma subunits but depended on PtdIns(4,5)P-2. The results suggest that the TM2 region plays a key role in channel gating following G beta gamma binding in a phospholipid-dependent manner. This mechanism of gating in inwardly rectifying K+ channels may be similar to the involvement of the homologous region in prokaryotic KcsA potassium channel and, thus, suggests evolutionary conservation of the gating structure.	Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Reuveny, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	e.reuveny@weizmann.ac.il						BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; DASCAL N, 1993, P NATL ACAD SCI USA, V90, P10235, DOI 10.1073/pnas.90.21.10235; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUPRAT F, 1995, BIOCHEM BIOPH RES CO, V212, P657, DOI 10.1006/bbrc.1995.2019; Guo L, 1998, RECEPTOR CHANNEL, V5, P273; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; HURLEY JH, 1992, BIOPOLYMERS, V32, P1443, DOI 10.1002/bip.360321104; INANOBE A, 1995, BIOCHEM BIOPH RES CO, V212, P1022, DOI 10.1006/bbrc.1995.2072; Ivanova-Nikolova TT, 1998, J GEN PHYSIOL, V112, P199, DOI 10.1085/jgp.112.2.199; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; Kumar S, 1996, BIOPHYS J, V71, P1574, DOI 10.1016/S0006-3495(96)79360-8; KUNKEL MT, 1995, CELL, V83, P443, DOI 10.1016/0092-8674(95)90122-1; Leung DW, 1989, TECHNIQUE, V1, P11; LI SC, 1992, INT J PEPT PROT RES, V40, P243; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; Loussouarn G, 2000, J BIOL CHEM, V275, P1137, DOI 10.1074/jbc.275.2.1137; Lu T, 1999, NEURON, V22, P571, DOI 10.1016/S0896-6273(00)80711-4; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Oprea TI, 1997, P NATL ACAD SCI USA, V94, P2133, DOI 10.1073/pnas.94.6.2133; Peng LY, 2000, BIOPHYS J, V78, p465A; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; SENTENAC H, 1992, SCIENCE, V256, P663, DOI 10.1126/science.1585180; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; SLESINGER PA, 1995, NEURON, V15, P1145, DOI 10.1016/0896-6273(95)90102-7; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sui JL, 1996, J GEN PHYSIOL, V108, P381, DOI 10.1085/jgp.108.5.381; Sui JL, 1999, ADV SEC MESS PHOSPH, V33, P179; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Velimirovic BM, 1996, FEBS LETT, V379, P31, DOI 10.1016/0014-5793(95)01465-9; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; WILLIAMS KA, 1991, BIOCHEMISTRY-US, V30, P8919, DOI 10.1021/bi00101a001; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; YANG XC, 1989, SCIENCE, V243, P1068, DOI 10.1126/science.2466333; Zhang HD, 1999, J BIOMED OPT, V4, P183, DOI 10.1117/1.429905; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457	53	76	76	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					669	680		10.1016/S0896-6273(01)00242-2	http://dx.doi.org/10.1016/S0896-6273(01)00242-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301026	Bronze			2022-12-24	WOS:000167868900016
J	Constantinidis, C; Williams, GV; Goldman-Rakic, PS				Constantinidis, C; Williams, GV; Goldman-Rakic, PS			A role for inhibition in shaping the temporal flow of information in prefrontal cortex	NATURE NEUROSCIENCE			English	Article							WORKING-MEMORY; VISUAL-CORTEX; ORIENTATION SELECTIVITY; NEURONAL-ACTIVITY; NETWORK MODEL; DYNAMICS; MONKEY; SYNCHRONIZATION; CONNECTIVITY; ASSOCIATION	The prefrontal cortex is important in guiding or inhibiting future responses, which requires the temporal integration of events and which provides continuity to the thought process. No cellular mechanism has been proposed to explain how the mental representation of a response or idea is linked to the next. Using simultaneous recordings in monkeys, we revealed inhibitory interactions between neurons active at different time points relative to the cue presentation, delay interval and response period of a working memory task. These findings suggest an important role of inhibition in the cerebral cortex-controlling the timing of neuronal activities during cognitive operations and thereby shaping the temporal flow of information.	Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06520 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, POB 208001,333 Cedar St,SHM B404, New Haven, CT 06520 USA.	patricia.goldman-rakic@yale.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038546, R01MH038546] Funding Source: NIH RePORTER; NIMH NIH HHS [MH38546] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Changeux JP, 2000, INT J PSYCHOPHYSIOL, V35, P179, DOI 10.1016/S0167-8760(99)00052-5; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; Dehaene S, 1997, P NATL ACAD SCI USA, V94, P13293, DOI 10.1073/pnas.94.24.13293; ELHANANY E, 1990, J COMP NEUROL, V291, P43, DOI 10.1002/cne.902910105; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FETZ E, 1991, CEREB CORTEX, V9, P1; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; FUSTER JM, 1990, ANN NY ACAD SCI, V608, P318, DOI 10.1111/j.1749-6632.1990.tb48901.x; FUSTER JM, 1991, PROG BRAIN RES, V87, P201; FUSTER JM, 1985, HUM NEUROBIOL, V4, P169; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; GUIGON E, 1995, CEREB CORTEX, V5, P135, DOI 10.1093/cercor/5.2.135; Krimer LS, 2001, J NEUROSCI, V21, P3788, DOI 10.1523/JNEUROSCI.21-11-03788.2001; Lisman JE, 1998, NAT NEUROSCI, V1, P273, DOI 10.1038/1086; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; Melchitzky DS, 1998, J COMP NEUROL, V390, P211, DOI 10.1002/(SICI)1096-9861(19980112)390:2<211::AID-CNE4>3.0.CO;2-4; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; Oram MW, 2001, J NEUROPHYSIOL, V86, P1700, DOI 10.1152/jn.2001.86.4.1700; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Rao SG, 2000, J NEUROSCI, V20, P485, DOI 10.1523/JNEUROSCI.20-01-00485.2000; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Troyer TW, 1998, J NEUROSCI, V18, P5908; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	42	264	271	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					175	180		10.1038/nn799	http://dx.doi.org/10.1038/nn799			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802172				2022-12-24	WOS:000173558400021
J	Bunge, SA; Dudukovic, NM; Thomason, ME; Vaidya, CJ; Gabrieli, JDE				Bunge, SA; Dudukovic, NM; Thomason, ME; Vaidya, CJ; Gabrieli, JDE			Immature frontal lobe contributions to cognitive control in children: Evidence from fMRI	NEURON			English	Article							DEVELOPMENTAL-CHANGES; INHIBITORY MECHANISM; CORTEX; ACTIVATION; AGE; GO; INTERFERENCE; INFORMATION; MATURATION; CHILDHOOD	Event-related fMRI was employed to characterize differences in brain activation between children ages 8-12 and adults related to two forms of cognitive control: interference suppression and response inhibition. Children were more susceptible to interference and less able to inhibit inappropriate responses than were adults. Effective interference suppression in children was associated with prefrontal activation in the opposite hemisphere relative to adults. In contrast, effective response inhibition in children was associated with activation of posterior, but not prefrontal, regions activated by adults. Children failed to activate a region in right ventrolateral prefrontal cortex that was recruited for both types of cognitive control by adults. Thus, children exhibited immature prefrontal activation that varied according to the type of cognitive control required.	Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; Georgetown Univ, Dept Psychol, Washington, DC 20057 USA	Stanford University; Stanford University; Georgetown University	Bunge, SA (corresponding author), MIT, Dept Brain & Cognit Sci, NE20-351, Cambridge, MA 02139 USA.	sbunge@mit.edu	Gabrieli, John/AAJ-2869-2020; Thomason, Moriah E/AAW-9511-2021		NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061426] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH061426] Funding Source: Medline; PHS HHS [61426] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Bunge SA, 2001, BRAIN, V124, P2074, DOI 10.1093/brain/124.10.2074; Bunge SA, 2000, P NATL ACAD SCI USA, V97, P3573, DOI 10.1073/pnas.050583797; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Casey BJ, 1997, J COGNITIVE NEUROSCI, V9, P835, DOI 10.1162/jocn.1997.9.6.835; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; COMALLI PE, 1962, J GENET PSYCHOL, V100, P47, DOI 10.1080/00221325.1962.10533572; COSTANTINI AF, 1973, J GENET PSYCHOL, V123, P309, DOI 10.1080/00221325.1973.10532690; DEMPSTER FN, 1992, DEV REV, V12, P45, DOI 10.1016/0273-2297(92)90003-K; DIAMOND A, 1988, CHILD DEV, V59, P523, DOI 10.1111/j.1467-8624.1988.tb01486.x; DIAMOND A, 2002, IN PRESS FRONTAL LOB; Dove A, 2000, COGNITIVE BRAIN RES, V9, P103, DOI 10.1016/S0926-6410(99)00029-4; Dronkers NF, 1996, NATURE, V384, P159, DOI 10.1038/384159a0; DRONKERS NF, 2000, NEW COGNITIVE NEUROS, P949; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Friston K.J., 1994, HUM BRAIN MAPP, V1, P153, DOI DOI 10.1002/HBM.460010207; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Gaillard WD, 2001, NEUROIMAGE, V13, P239, DOI 10.1006/nimg.2000.0681; Garavan H, 1999, P NATL ACAD SCI USA, V96, P8301, DOI 10.1073/pnas.96.14.8301; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Harnishfeger K.K., 1993, EMERGING THEMES COGN, P28, DOI DOI 10.1007/978-1-4613-9220-0_; Hazeltine E, 2000, J COGNITIVE NEUROSCI, V12, P118, DOI 10.1162/089892900563984; HOLMES AP, 1998, 4 INT C FUNCT MAPP H, V7, pS754; HUTTENLOCHER PR, 1979, BRAIN RES, V163, P195; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P55, DOI 10.1016/0006-3223(91)90210-D; Konishi S, 1999, BRAIN, V122, P981, DOI 10.1093/brain/122.5.981; Konishi S, 1998, EUR J NEUROSCI, V10, P1209, DOI 10.1046/j.1460-9568.1998.00167.x; Lorsbach TC, 1997, J EXP CHILD PSYCHOL, V64, P317, DOI 10.1006/jecp.1996.2350; Luna B, 2001, NEUROIMAGE, V13, P786, DOI 10.1006/nimg.2000.0743; LURLA AR, 1966, HIGHER CORTICAL FUNC; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Muzik O, 2000, NEUROIMAGE, V12, P538, DOI 10.1006/nimg.2000.0651; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PFEFFERBAUM A, 1994, ARCH NEUROL-CHICAGO, V51, P874, DOI 10.1001/archneur.1994.00540210046012; Ridderinkhof KR, 1997, J EXP CHILD PSYCHOL, V65, P315, DOI 10.1006/jecp.1997.2367; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2001, NEUROIMAGE, V13, P250, DOI 10.1006/nimg.2000.0685; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spreen O, 1998, COMPENDIUM NEUROPSYC; Stuss D.T., 1986, FRONTAL LOBES; TIPPER SP, 1989, J EXP CHILD PSYCHOL, V48, P353, DOI 10.1016/0022-0965(89)90047-7; Vaidya CJ, 1998, P NATL ACAD SCI USA, V95, P14494, DOI 10.1073/pnas.95.24.14494; Wechsler D., 1991, WISC 3 WECHSLER INTE; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; WOODCOCK RW, 1998, WOODCOCK READING MYS; Yakovlev P. I., 1967, REGIONAL DEV BRAIN E, P3	51	954	971	1	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					301	311		10.1016/S0896-6273(01)00583-9	http://dx.doi.org/10.1016/S0896-6273(01)00583-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	513PU	11804576	Green Accepted, Bronze			2022-12-24	WOS:000173387700016
J	Coffey, PJ; Girman, S; Wang, SM; Hetherington, L; Keegan, DJ; Adamson, P; Greenwood, J; Lund, RD				Coffey, PJ; Girman, S; Wang, SM; Hetherington, L; Keegan, DJ; Adamson, P; Greenwood, J; Lund, RD			Long-term preservation of cortically dependent visual function in RCS rats by transplantation	NATURE NEUROSCIENCE			English	Article							PUPILLARY LIGHT REFLEX; DISCRIMINATION	Cell transplantation is one way of limiting the progress of retinal degeneration in animal models of blinding diseases such as retinitis pigmentosa (RP) and age-related macular degeneration (AMD). Here we transplanted a human retinal pigment epithelia] (RPE) cell line into the subretinal space of one such model, the Royal College of Surgeons (RCS) rat, and showed, using head tracking to moving stripes and pattern discrimination in conjunction with single-unit cortical physiology, that cortically mediated vision can be preserved with this treatment.	Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA; Univ Sheffield, Dept Psychol, Sheffield S10 2TP, S Yorkshire, England; Univ Coll, Inst Ophthalmol, London EC1V 9EL, England	Utah System of Higher Education; University of Utah; University of Sheffield; University of London; University College London	Lund, RD (corresponding author), Univ Utah, Moran Eye Ctr, Dept Ophthalmol, Salt Lake City, UT 84132 USA.			Coffey, Peter/0000-0002-5427-2939; Greenwood, John/0000-0003-4496-2984				BOK D, 1971, J CELL BIOL, V49, P664, DOI 10.1083/jcb.49.3.664; COWEY A, 1979, EXP BRAIN RES, V35, P443; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; DELCERRO M, 1991, NEUROREPORT, V2, P529, DOI 10.1097/00001756-199109000-00008; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; KANUGA N, IN PRESS INVEST OPHT; LAVAIL MM, 1974, VISION RES, V14, P693, DOI 10.1016/0042-6989(74)90066-2; LI LX, 1988, EXP EYE RES, V47, P911, DOI 10.1016/0014-4835(88)90073-5; Lund RD, 2001, P NATL ACAD SCI USA, V98, P9942, DOI 10.1073/pnas.171266298; Sauve Y, 2001, NEUROSCIENCE, V103, P51, DOI 10.1016/S0306-4522(00)00557-1; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; Whiteley SJO, 1996, EXP NEUROL, V140, P100, DOI 10.1006/exnr.1996.0120	13	168	179	1	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					53	56		10.1038/nn782	http://dx.doi.org/10.1038/nn782			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753416				2022-12-24	WOS:000173031800015
J	Ohno, M; Frankland, PW; Chen, AP; Costa, RM; Silva, AJ				Ohno, M; Frankland, PW; Chen, AP; Costa, RM; Silva, AJ			Inducible, pharmacogenetic approaches to the study of learning and memory	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; MAP KINASE; CONTEXTUAL FEAR; MOUSE GENOME; RAS; HIPPOCAMPUS; ACTIVATION; CASCADE; PHOSPHORYLATION	Here we introduce a strategy in which pharmacology is used to induce the effects of recessive mutations. For example, mice heterozygous for a null mutation of the K-ras gene (K-ras(+/-)) show normal hippocampal mitogen-activated protein kinase (MAPK) activation, long-term potentiation (LTP) and contextual conditioning. However, a dose of a mitogen-activated/extracellular-signal-regulated kinase (MEK) inhibitor, ineffective in wild-type controls, blocks MAPK activation, LTP and contextual learning in K-ras(+/-) mutants. These indicate that K-Ras/MEK/MAPK signaling is critical in synaptic and behavioral plasticity. A subthreshold dose of NMDA receptor antagonists triggered a contextual learning deficit in mice heterozygous for a point mutation (T286A) in the alpha CaMKII gene, but not in K-ras(+/-) mutants, demonstrating the specificity of the synergistic interaction between the MEK inhibitor and the K-ras(+/-) mutation. This pharmacogenetic approach combines the high temporal specificity that pharmacological manipulations offer, with the molecular specificity of genetic disruptions.	Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Brain Res Inst, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Silva, AJ (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Dept Neurobiol, Los Angeles, CA 90095 USA.		Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Costa, Rui M./0000-0003-0495-8374; Silva, Alcino/0000-0001-5525-0494	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD033098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013622, U01AG013622, R37AG013622] Funding Source: NIH RePORTER; NIA NIH HHS [AG13622] Funding Source: Medline; NICHD NIH HHS [P01HD33098] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Anagnostaras SG, 2000, LEARN MEMORY, V7, P58, DOI 10.1101/lm.7.1.58; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berman DE, 2001, SCIENCE, V291, P2417, DOI 10.1126/science.1058165; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; BRANDON EP, 1995, CURR BIOL, V5, P625, DOI 10.1016/S0960-9822(95)00127-8; BRANDON EP, 1995, CURR BIOL, V5, P758, DOI 10.1016/S0960-9822(95)00152-7; Cammarota M, 1998, EUR J NEUROSCI, V10, P2669, DOI 10.1046/j.1460-9568.1998.t01-1-00254.x; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Derkinderen P, 1999, NEUROREPORT, V10, pR24; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FANSELOW MS, 1990, ANIM LEARN BEHAV, V18, P264, DOI 10.3758/BF03205285; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Frankland PW, 1998, BEHAV NEUROSCI, V112, P863, DOI 10.1037/0735-7044.112.4.863; Fukunaga K, 1998, MOL NEUROBIOL, V16, P79, DOI 10.1007/BF02740604; FUKUNAGA K, 1992, J BIOL CHEM, V267, P22527; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Giese KP, 1998, SCIENCE, V279, P870, DOI 10.1126/science.279.5352.870; Giese KP, 2001, NEUROPHARMACOLOGY, V41, P791, DOI 10.1016/S0028-3908(01)00096-X; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Johnson L, 1997, GENE DEV, V11, P3277; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Koera K, 1997, ONCOGENE, V15, P1151, DOI 10.1038/sj.onc.1201284; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LISMAN J, 1994, TRENDS NEUROSCI, V17, P406, DOI 10.1016/0166-2236(94)90014-0; Manabe T, 2000, J NEUROSCI, V20, P2504; McLeod HL, 2001, ANNU REV PHARMACOL, V41, P101, DOI 10.1146/annurev.pharmtox.41.1.101; Ouyang Y, 1997, J NEUROSCI, V17, P5416; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Ray P, 1997, J CLIN INVEST, V100, P2501, DOI 10.1172/JCI119792; Roberson ED, 1999, J NEUROSCI, V19, P4337; Schafe GE, 1999, LEARN MEMORY, V6, P97; Selcher JC, 1999, LEARN MEMORY, V6, P478, DOI 10.1101/lm.6.5.478; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Silva AJ, 1997, ANNU REV GENET, V31, P527, DOI 10.1146/annurev.genet.31.1.527; SILVA AJ, 1998, NEUROBIOLOGY LEARNIN, P89; Steimer W, 2001, CLIN CHIM ACTA, V308, P33, DOI 10.1016/S0009-8981(01)00423-5; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; Tan SE, 1996, BRAIN RES, V711, P234, DOI 10.1016/0006-8993(95)01411-X; Tognon CE, 1998, MOL CELL BIOL, V18, P6995, DOI 10.1128/MCB.18.12.6995	47	83	83	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1238	1243		10.1038/nn771	http://dx.doi.org/10.1038/nn771			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713472				2022-12-24	WOS:000172525000021
J	Lu, HC; Gonzalez, E; Crair, MC				Lu, HC; Gonzalez, E; Crair, MC			Barrel cortex critical period plasticity is independent of changes in NMDA receptor subunit composition	NEURON			English	Article							DEPENDENT SYNAPTIC PLASTICITY; LONG-TERM POTENTIATION; OCULAR DOMINANCE PLASTICITY; D-ASPARTATE RECEPTOR; MICE LACKING; FUNCTIONAL-PROPERTIES; VISUAL-CORTEX; DEVELOPMENTAL REGULATION; SOMATOSENSORY CORTEX; NEURONAL PATTERNS	The regulation of NMDA receptor (NMDAR) subunit composition and expression during development is thought to control the process of thalamocortical afferent innervation, segregation, and plasticity. Thalamocortical synaptic plasticity in the mouse is dependent on NMDARs containing the NR2B subunit, which are the dominant form during the "critical period" window for plasticity. Near the end of the critical period there is a gradual increase in the contribution of NR2A subunits that happens in parallel to changes in NMDAR-mediated current kinetics. However, no extension of the critical period occurs in NR2A knockout mice, despite the fact that NMDA subunit composition and current kinetics remain immature past the end of the critical period. These data suggest that regulation of NMDAR subunit composition is not essential for closing the critical period plasticity window in mouse somatosensory barrel cortex.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Crair, MC (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza,S-603, Houston, TX 77030 USA.	mcrair@bcm.tmc.edu			NIMH NIH HHS [MH62639] Funding Source: Medline; NINDS NIH HHS [F32 NS011034, NS11034] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS011034] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1992, J NEUROPHYSIOL, V68, P345, DOI 10.1152/jn.1992.68.1.345; Agmon A, 1996, J NEUROSCI, V16, P4684; AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Barth AL, 2001, NAT NEUROSCI, V4, P235, DOI 10.1038/85070; BEAR MF, 1990, J NEUROSCI, V10, P909; Bear MF, 1996, J PHYSIOL-PARIS, V90, P223, DOI 10.1016/S0928-4257(97)81428-3; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blitzer RD, 1998, SCIENCE, V280, P1940, DOI 10.1126/science.280.5371.1940; Cao ZP, 2000, BRAIN RES, V859, P26, DOI 10.1016/S0006-8993(99)02450-6; Cao ZP, 2000, BRAIN RES, V868, P296, DOI 10.1016/S0006-8993(00)02343-X; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Catalano SM, 1997, J NEUROSCI, V17, P8376; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; Flint AC, 1997, J NEUROSCI, V17, P2469; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FOX K, 1994, J NEUROSCI, V14, P7665; FOX K, 1989, J NEUROSCI, V9, P2443; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; Gil Z, 1999, NEURON, V23, P385, DOI 10.1016/S0896-6273(00)80788-6; Glazewski S, 1999, CEREB CORTEX, V9, P249, DOI 10.1093/cercor/9.3.249; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hannan AJ, 2001, NAT NEUROSCI, V4, P282, DOI 10.1038/85132; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoffmann H, 2000, J NEUROCHEM, V75, P1590, DOI 10.1046/j.1471-4159.2000.0751590.x; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Iwasato T, 1997, NEURON, V19, P1201, DOI 10.1016/S0896-6273(00)80412-2; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kirson ED, 1996, J PHYSIOL-LONDON, V497, P437, DOI 10.1113/jphysiol.1996.sp021779; Kiyama Y, 1998, J NEUROSCI, V18, P6704; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LI YQ, 1994, CELL, V76, P427, DOI 10.1016/0092-8674(94)90108-2; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nase G, 1999, EUR J NEUROSCI, V11, P4320, DOI 10.1046/j.1460-9568.1999.00859.x; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Quinlan EM, 1999, P NATL ACAD SCI USA, V96, P12876, DOI 10.1073/pnas.96.22.12876; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Ramoa AS, 1997, DEV BRAIN RES, V101, P165, DOI 10.1016/S0165-3806(97)00061-8; Rema V, 1998, J NEUROSCI, V18, P10196; Roberts EB, 1999, J NEUROPHYSIOL, V81, P2587, DOI 10.1152/jn.1999.81.5.2587; Roberts EB, 1998, J NEUROPHYSIOL, V80, P1021, DOI 10.1152/jn.1998.80.3.1021; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SAUDOU F, 1994, SCIENCE, V265, P1875, DOI 10.1126/science.8091214; SCHEETZ AJ, 1994, FASEB J, V8, P745, DOI 10.1096/fasebj.8.10.8050674; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SCHOEPFER R, 1994, PROG NEUROBIOL, V42, P353, DOI 10.1016/0301-0082(94)90076-0; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Shi J, 2000, NEURON, V28, P103, DOI 10.1016/S0896-6273(00)00089-1; SINGER W, 1995, SCIENCE, V270, P758, DOI 10.1126/science.270.5237.758; Steigerwald F, 2000, J NEUROSCI, V20, P4573, DOI 10.1523/JNEUROSCI.20-12-04573.2000; Stern EA, 2001, NEURON, V31, P305, DOI 10.1016/S0896-6273(01)00360-9; STROMINGER RN, 1987, J NEUROSCI METH, V22, P113, DOI 10.1016/0165-0270(87)90004-5; Sun LX, 2000, SYNAPSE, V35, P212, DOI 10.1002/(SICI)1098-2396(20000301)35:3<212::AID-SYN6>3.0.CO;2-O; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tovar KR, 2000, J NEUROPHYSIOL, V83, P616, DOI 10.1152/jn.2000.83.1.616; Umemiya M, 2001, J NEUROSCI, V21, P1, DOI 10.1523/JNEUROSCI.21-01-00001.2001; Vallano ML, 1996, J NEUROSCI, V16, P631; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wallace H, 2001, J NEUROSCI, V21, P3881, DOI 10.1523/JNEUROSCI.21-11-03881.2001; WANG YH, 1995, J NEUROCHEM, V65, P176; WATANABE M, 1992, NEUROREPORT, V3, P1138, DOI 10.1097/00001756-199212000-00027; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WILLIAMS K, 1993, MOL PHARMACOL, V44, P851; WONGRILEY MTT, 1980, P NATL ACAD SCI-BIOL, V77, P2333, DOI 10.1073/pnas.77.4.2333; Woolsey T.A., 1990, P461; ZHONG J, 1995, J NEUROCHEM, V64, P531	86	146	150	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					619	634		10.1016/S0896-6273(01)00501-3	http://dx.doi.org/10.1016/S0896-6273(01)00501-3			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719203	Bronze			2022-12-24	WOS:000172363900009
J	Martinez, LM; Alonso, JM				Martinez, LM; Alonso, JM			Construction of complex receptive fields in cat primary visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CROSS-CORRELATION ANALYSIS; CORTICAL SIMPLE CELLS; STRIATE CORTEX; SPATIAL STRUCTURE; FUNCTIONAL CONNECTIVITY; ORIENTATION SELECTIVITY; PYRAMIDAL NEURONS; THALAMIC CONTROL; RAT NEOCORTEX	In primary visual cortex, neurons are classified into simple cells and complex cells based on their response properties. Although the role of these two cell types in vision is still unknown, an attractive hypothesis is that simple cells are necessary to construct complex receptive fields. This hierarchical model puts forward two main predictions. First, simple cells should connect monosynaptically to complex cells. Second, complex cells should become silent when simple cells are inactivated. We have recently provided evidence for the first prediction, and here we do the same for the second. In summary, our results suggest that the receptive fields of most layer 2+3 complex cells are generated by a mechanism that requires simple cell inputs.	Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA; Univ A Coruna, Neurosci & Motor Control Grp Neurocom, La Coruna 15006, Spain; Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA	Rockefeller University; Universidade da Coruna; University of Connecticut	Alonso, JM (corresponding author), Rockefeller Univ, Neurobiol Lab, New York, NY 10021 USA.							ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; AKAOKA H, 1992, J NEUROSCI METH, V42, P119, DOI 10.1016/0165-0270(92)90142-Z; Alonso JM, 1998, NAT NEUROSCI, V1, P395, DOI 10.1038/1609; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Boyd JD, 1996, J COMP NEUROL, V365, P659; Brody CD, 1998, J NEUROPHYSIOL, V80, P3345, DOI 10.1152/jn.1998.80.6.3345; BULLIER J, 1979, J NEUROPHYSIOL, V42, P1251, DOI 10.1152/jn.1979.42.5.1251; BURKE W, 1992, VISUAL NEUROSCI, V9, P47, DOI 10.1017/S0952523800006362; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Crick F, 1998, NATURE, V391, P245, DOI 10.1038/34584; Debanne D, 1998, J PHYSIOL-LONDON, V508, P523, DOI 10.1111/j.1469-7793.1998.00523.x; DENO RL, 1955, PHYSL NERVOUS SYSTEM; DEUCHARS J, 1994, J PHYSIOL-LONDON, V478, P423, DOI 10.1113/jphysiol.1994.sp020262; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; FERSTER D, 1990, VISUAL NEUROSCI, V4, P115, DOI 10.1017/S0952523800002285; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FERSTER D, 1978, J COMP NEUROL, V182, P923, DOI 10.1002/cne.901820510; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; Fregnac Y, 1996, J PHYSIOL-PARIS, V90, P113, DOI 10.1016/S0928-4257(97)81412-X; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; GILBERT CD, 1977, J PHYSIOL-LONDON, V268, P391, DOI 10.1113/jphysiol.1977.sp011863; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HOFFMANN KP, 1971, BRAIN RES, V32, P460, DOI 10.1016/0006-8993(71)90340-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P159, DOI 10.1002/cne.902330203; Hupe JM, 1999, J NEUROSCI METH, V86, P129, DOI 10.1016/S0165-0270(98)00162-9; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Lee C, 1998, VISUAL NEUROSCI, V15, P27, DOI 10.1017/S0952523898146151; LEVAY S, 1979, BRAIN RES, V164, P304, DOI 10.1016/0006-8993(79)90026-X; LEVAY S, 1977, J COMP NEUROL, V172, P563, DOI 10.1002/cne.901720402; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; MALPELI JG, 1983, J NEUROPHYSIOL, V49, P595, DOI 10.1152/jn.1983.49.3.595; MALPELI JG, 1986, J NEUROPHYSIOL, V56, P1062, DOI 10.1152/jn.1986.56.4.1062; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MASON A, 1991, J NEUROSCI, V11, P72; Mel BW, 1998, J NEUROSCI, V18, P4325; MIGNARD M, 1991, SCIENCE, V251, P1249, DOI 10.1126/science.1848727; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; MULLIKIN WH, 1984, J NEUROPHYSIOL, V52, P350, DOI 10.1152/jn.1984.52.2.350; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; ORBAN GA, 1984, NEURONAL OPERATIONSV; PERKEL DH, 1967, BIOPHYS J, V7, P391, DOI 10.1016/S0006-3495(67)86596-2; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Sakai K, 2000, VISION RES, V40, P855, DOI 10.1016/S0042-6989(99)00230-8; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; SCHILLER PH, 1976, J NEUROPHYSIOL, V39, P1288, DOI 10.1152/jn.1976.39.6.1288; Sherman SM, 1998, P NATL ACAD SCI USA, V95, P7121, DOI 10.1073/pnas.95.12.7121; SHERMAN SM, 1985, FUNCTIONAL ORG W X Y; SINGER W, 1975, J NEUROPHYSIOL, V38, P1080, DOI 10.1152/jn.1975.38.5.1080; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SPITZER H, 1988, PROG NEUROBIOL, V31, P285, DOI 10.1016/0301-0082(88)90016-0; STONE J, 1979, BRAIN RES REV, V1, P345, DOI 10.1016/0165-0173(79)90010-9; Stratford KJ, 1996, NATURE, V382, P258, DOI 10.1038/382258a0; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; Ziburkus J, 2000, VISUAL NEUROSCI, V17, P187, DOI 10.1017/S0952523800172013	70	62	62	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					515	525		10.1016/S0896-6273(01)00489-5	http://dx.doi.org/10.1016/S0896-6273(01)00489-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709161	Bronze			2022-12-24	WOS:000172119100016
J	Lin, CH; Yeh, SH; Lin, CH; Lu, KT; Leu, TH; Chang, WC; Gean, PW				Lin, CH; Yeh, SH; Lin, CH; Lu, KT; Leu, TH; Chang, WC; Gean, PW			A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; LONG-TERM POTENTIATION; ELEMENT-BINDING PROTEIN; NERVE GROWTH-FACTOR; PHOSPHATIDYLINOSITOL 3-KINASE; MEMORY CONSOLIDATION; DENTATE GYRUS; LATE-PHASE; IN-VITRO; AREA CA1	Western blot analysis of neuronal tissues taken from fear-conditioned rats showed a selective activation of phosphatidylinositol 3-kinase (PI-3 kinase) in the amygdala. PI-3 kinase was also activated in response to long-term potentiation (LTP)-inducing tetanic stimulation. PI-3 kinase inhibitors blocked tetanus-induced LTP as well as PI-3 kinase activation. In parallel, these inhibitors interfered with long-term fear memory while leaving short-term memory intact. Tetanus and forskolin-induced activation of mitogen-activated protein kinase (MAPK) was blocked by PI-3 kinase inhibitors, which also inhibited cAMP response element binding protein (CREB) phosphorylation. These results provide novel evidence of a requirement of PI-3 kinase activation in the amygdala for synaptic plasticity and memory consolidation, and this activation may occur at a point upstream of MAPK activation.	Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan	National Cheng Kung University	Gean, PW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan.		Yeh, Shiu-Hwa/D-2088-2010					Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Berman DE, 1998, J NEUROSCI, V18, P10037; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Blum S, 1999, J NEUROSCI, V19, P3535; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; CAMPEAU S, 1995, J NEUROSCI, V15, P2312, DOI 10.1523/JNEUROSCI.15-03-02312.1995; CASSELLA JV, 1986, PHYSIOL BEHAV, V36, P377, DOI 10.1016/0031-9384(86)90032-6; Coogan AN, 1999, J NEUROPHYSIOL, V81, P103, DOI 10.1152/jn.1999.81.1.103; Crowder RJ, 1998, J NEUROSCI, V18, P2933; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Filippa N, 1999, MOL CELL BIOL, V19, P4989; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Hawes BE, 1996, J BIOL CHEM, V271, P12133, DOI 10.1074/jbc.271.21.12133; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Jun KS, 1998, LEARN MEMORY, V5, P317; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kanterewicz BI, 2000, J NEUROSCI, V20, P3057, DOI 10.1523/JNEUROSCI.20-09-03057.2000; Kelly A, 2000, NEUROPHARMACOLOGY, V39, P643, DOI 10.1016/S0028-3908(99)00169-0; LeDoux J.E., 1994, SEMIN NEUROSCI, V6, P231, DOI 10.1006/smns.1994.1030; LEDOUX JE, 1990, J NEUROSCI, V10, P1062; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Miller TM, 1997, J BIOL CHEM, V272, P9847; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; Perkinton MS, 1999, J NEUROSCI, V19, P5861, DOI 10.1523/JNEUROSCI.19-14-05861.1999; Roberson ED, 1999, J NEUROSCI, V19, P4337; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Soler RM, 1999, J NEUROSCI, V19, P9160; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Wu SP, 1999, J BIOMED SCI, V6, P409, DOI 10.1007/BF02253672; Wymann MP, 1998, BBA-MOL CELL BIOL L, V1436, P127, DOI 10.1016/S0005-2760(98)00139-8; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	49	282	290	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					841	851		10.1016/S0896-6273(01)00433-0	http://dx.doi.org/10.1016/S0896-6273(01)00433-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567621	Bronze			2022-12-24	WOS:000171013300016
J	Schmitz, D; Schuchmann, S; Fisahn, A; Draguhn, A; Buhl, EH; Petrasch-Parwez, E; Dermietzel, R; Heinemann, U; Traub, RD				Schmitz, D; Schuchmann, S; Fisahn, A; Draguhn, A; Buhl, EH; Petrasch-Parwez, E; Dermietzel, R; Heinemann, U; Traub, RD			Axo-axonal coupling: A novel mechanism for ultrafast neuronal communication	NEURON			English	Article							RAT HIPPOCAMPAL SLICES; ACTION-POTENTIAL PROPAGATION; HIGH-FREQUENCY OSCILLATIONS; CA1 PYRAMIDAL NEURONS; FIELD BURST ACTIVITY; GAP-JUNCTIONS; SYNAPTIC-INTERACTIONS; CHEMICAL SYNAPSES; INITIAL SEGMENT; BRAIN NEURONS	We provide physiological, pharmacological, and structural evidence that axons of hippocampal principal cells are electrically coupled, with prepotentials or spikelets forming the physiological substrate of electrical coupling as observed in cell somata. Antidromic activation of neighboring axons induced somatic spikelet potentials in neurons of CA3, CA1, and dentate gyrus areas of rat hippocampal slices. Somatic invasion by these spikelets was dependent on the activation of fast Na+ channels in the postjunctional neuron. Antidromically elicited spikelets; were suppressed by gap junction blockers and low intracellular pH. Paired axo-somatic and somato-dendritic recordings revealed that the coupling potentials appeared in the axon before invading the soma and the dendrite. Using confocal laser scanning microscopy we found that putative axons of principal cells were dye coupled. Our data thus suggest that hippocampal neurons are coupled by axo-axonal junctions, providing a novel mechanism for very fast electrical communication.	Humboldt Univ, Charite, Inst Physiol, D-10117 Berlin, Germany; NICHHD, LCMN, NIH, Bethesda, MD 20892 USA; Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England; Ruhr Univ Bochum, Dept Neuroanat, D-4630 Bochum, Germany; Univ Birmingham, Sch Med, Div Neurosci, Birmingham B15 2TT, W Midlands, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Leeds; Ruhr University Bochum; University of Birmingham	Schmitz, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 513 Parnassus Ave, San Francisco, CA 94143 USA.			Schmitz, Dietmar/0000-0003-2741-5241				ANDREW RD, 1982, BRAIN RES BULL, V8, P211, DOI 10.1016/0361-9230(82)90048-X; ATHANASSIOS GS, 1998, NEURON, V21, P1123; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; CHURCH J, 1991, J NEUROSCI, V11, P3289; Colbert CM, 1996, J NEUROSCI, V16, P6676; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; DERMIETZEL R, 1973, NATURWISSENSCHAFTEN, V60, P208, DOI 10.1007/BF00599446; Deuchars J, 1996, NEUROSCIENCE, V74, P1009, DOI 10.1016/S0306-4522(96)00251-5; Dodt HU, 1999, SCIENCE, V286, P110, DOI 10.1126/science.286.5437.110; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Geiger JRP, 2000, NEURON, V28, P927, DOI 10.1016/S0896-6273(00)00164-1; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gladwell SJ, 2001, NEUROSCI LETT, V300, P1, DOI 10.1016/S0304-3940(01)01530-0; GUTNICK MJ, 1985, NEUROSCIENCE, V15, P659, DOI 10.1016/0306-4522(85)90067-3; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; KNOWLES WD, 1981, J NEUROSCI, V1, P318; KONNERTH A, 1984, NATURE, V307, P69, DOI 10.1038/307069a0; Kopysova IL, 1998, J NEUROSCI, V18, P7436; KOSAKA T, 1983, BRAIN RES, V271, P157, DOI 10.1016/0006-8993(83)91377-X; KOSAKA T, 1980, J NEUROCYTOL, V9, P861, DOI 10.1007/BF01205024; LAZRAK A, 1993, BIOPHYS J, V65, P2002, DOI 10.1016/S0006-3495(93)81242-6; MACVICAR BA, 1980, BRAIN RES, V196, P494, DOI 10.1016/0006-8993(80)90413-8; MACVICAR BA, 1982, J NEUROPHYSIOL, V47, P579, DOI 10.1152/jn.1982.47.4.579; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Rash JE, 1997, J COMP NEUROL, V388, P265, DOI 10.1002/(SICI)1096-9861(19971117)388:2<265::AID-CNE6>3.0.CO;2-#; Rorig B, 1996, EUR J NEUROSCI, V8, P1685, DOI 10.1111/j.1460-9568.1996.tb01312.x; RORIG B, 1995, J NEUROSCI, V15, P7386; RORIG B, 1995, NEUROREPORT, V6, P1811; SCHMIDT CG, 1981, RES MECH, V3, P175; SCHMIDT R, 1995, MICROPOROUS MATER, V5, P1, DOI 10.1016/0927-6513(95)00030-D; Simburger E, 1997, HISTOCHEM CELL BIOL, V107, P127, DOI 10.1007/s004180050097; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; SPRAY DC, 1981, SCIENCE, V211, P712, DOI 10.1126/science.6779379; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; Teubner B, 2001, J NEUROSCI, V21, P1117; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; Traub RD, 2001, EPILEPSIA, V42, P153, DOI 10.1046/j.1528-1157.2001.26900.x; Traub RD, 2000, J NEUROSCI, V20, P2086; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YASARGIL GM, 1990, J NEUROCYTOL, V19, P111, DOI 10.1007/BF01188443; YLINEN A, 1995, J NEUROSCI, V15, P30	55	324	330	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					831	840		10.1016/S0896-6273(01)00410-X	http://dx.doi.org/10.1016/S0896-6273(01)00410-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567620	Bronze			2022-12-24	WOS:000171013300015
J	Bedford, FK; Kittler, JT; Muller, E; Thomas, P; Uren, JM; Merlo, D; Wisden, W; Triller, A; Smart, TG; Moss, SJ				Bedford, FK; Kittler, JT; Muller, E; Thomas, P; Uren, JM; Merlo, D; Wisden, W; Triller, A; Smart, TG; Moss, SJ			GABA(A) receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1	NATURE NEUROSCIENCE			English	Article							GAMMA-2 SUBUNIT; HIPPOCAMPAL-NEURONS; IDENTIFICATION; SYNAPSES; GLYCINE; LOCALIZATION; ENDOCYTOSIS; EXPRESSION; GEPHYRIN; RESIDUES	Controlling the number of functional gamma -aminobutyric acid A (GABA(A)) receptors in neuronal membranes is a crucial factor for the efficacy of inhibitory neurotransmission. Here we describe the direct interaction of GABA(A) receptors with the ubiquitin-like protein Plic-1. Furthermore, Plic-1 is enriched at inhibitory synapses and is associated with subsynaptic membranes. Functionally, Plic-1 facilitates GABA(A) receptor cell surface expression without affecting the rate of receptor internalization. Plic-1 also enhances the stability of intracellular GABA(A) receptor subunits, increasing the number of receptors available for insertion into the plasma membrane. Our study identifies a previously unknown role for Plic-1, a modulation of GABA(A) receptor cell surface number, which suggests that Plic-1 facilitates accumulation of these receptors in dendritic membranes.	UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England; UCL, Dept Pharmacol, London WC1E 6BT, England; INSERM, U497, Dept Biol, Lab Biol Cellulaire Synapse, F-75005 Paris, France; Univ London Sch Pharm, Dept Pharmacol, London WC1E 1AX, England; MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of London; University College London; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); University of London; University College London; University of London School of Pharmacy; MRC Laboratory Molecular Biology	Moss, SJ (corresponding author), UCL, MRC, Mol Cell Biol Lab, Gower St, London WC1E 6BT, England.	steve.moss@ucl.ac.uk	Wisden, William/A-4071-2011; Kittler, Josef T/E-9113-2010; Merlo, Daniela/K-7986-2016; Kittler, Josef/N-7589-2019	Wisden, William/0000-0003-4743-0334; Kittler, Josef T/0000-0002-3437-9456; Merlo, Daniela/0000-0003-4240-5762; Kittler, Josef/0000-0002-3437-9456; TRILLER, Antoine/0000-0002-7530-1233				BENKE D, 1994, J BIOL CHEM, V269, P27100; Bonnert TP, 1999, P NATL ACAD SCI USA, V96, P9891, DOI 10.1073/pnas.96.17.9891; Colin I, 1998, J COMP NEUROL, V398, P359; Connolly CN, 1999, MOL CELL NEUROSCI, V13, P259, DOI 10.1006/mcne.1999.0746; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Davies PA, 1997, NATURE, V385, P820, DOI 10.1038/385820a0; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Funakoshi M, 1999, EMBO J, V18, P5009, DOI 10.1093/emboj/18.18.5009; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gorrie GH, 1997, J NEUROSCI, V17, P6587; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Jentsch S, 2000, TRENDS CELL BIOL, V10, P335, DOI 10.1016/S0962-8924(00)01785-2; Kittler JT, 2000, MOL CELL NEUROSCI, V16, P440, DOI 10.1006/mcne.2000.0882; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Kittler JT, 2000, J NEUROSCI, V20, P7972; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Mah AL, 2000, J CELL BIOL, V151, P847, DOI 10.1083/jcb.151.4.847; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Nusser Z, 1997, NEURON, V19, P697, DOI 10.1016/S0896-6273(00)80382-7; Nusser Z, 1998, NATURE, V395, P172, DOI 10.1038/25999; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Taylor PM, 2000, J NEUROSCI, V20, P1297; Taylor PM, 1999, J NEUROSCI, V19, P6360; Todd AJ, 1996, J NEUROSCI, V16, P974; TRILLER A, 1986, P101; TRILLER A, 1985, J CELL BIOL, V101, P683, DOI 10.1083/jcb.101.2.683; UNWIN N, 1993, CELL, V72, P31, DOI 10.1016/S0092-8674(05)80026-1; Wan Q, 1997, NATURE, V388, P686, DOI 10.1038/41792; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; Williams EJ, 1997, J BIOL CHEM, V272, P22349, DOI 10.1074/jbc.272.35.22349; Wooltorton JRA, 1997, EUR J NEUROSCI, V9, P2225, DOI 10.1111/j.1460-9568.1997.tb01641.x; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9	43	186	205	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					908	916		10.1038/nn0901-908	http://dx.doi.org/10.1038/nn0901-908			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528422				2022-12-24	WOS:000170698600017
J	Li, ZY; Murthy, VN				Li, ZY; Murthy, VN			Visualizing postendocytic traffic of synaptic vesicles at hippocampal synapses	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; CLATHRIN-MEDIATED ENDOCYTOSIS; GREEN FLUORESCENT PROTEINS; NEUROTRANSMITTER RELEASE; ACTIVE ZONES; TRANSMITTER RELEASE; DEPENDENT MECHANISM; MEMBRANE RETRIEVAL; NERVE-TERMINALS; MOTOR PROTEIN	We have investigated mechanisms in postendocytic, processing of synaptic vesicles at hippocampal synapses, using synaptobrevin/vesicle-associated membrane protein (VAMP) tagged with variants of the green fluorescent protein. Following exocytosis, VAMP is retrieved at synaptic and adjoining axonal regions. Retrieved VAMP-containing vesicles return to synaptic vesicle clusters at a rate slower than endocytosis. Vesicles containing a different protein, synaptophysin, recluster at a similar rate, suggesting common vesicular intermediates for the two proteins. Activity prolongs the time taken by endocytosed vesicles to return to synapses. Exogenous calcium buffers slow endocytosis but have no additional effect on the time course of reclustering. In contrast, the protein kinase inhibitor staurosporine does not affect endocytosis but slows reclustering. Finally, since VAMP can move freely on surface membranes, sustained synaptic activity leads to mixing of this vesicular component between adjacent synapses.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	vnmurthy@fas.harvard.edu		Murthy, Venkatesh/0000-0003-2443-4252				Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; Becherer U, 2001, J NEUROSCI, V21, P782, DOI 10.1523/JNEUROSCI.21-03-00782.2001; BELLEN H, 1999, NEUROTRANSMITTER REL, V23; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; Calakos N, 1996, PHYSIOL REV, V76, P1; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Cummings DD, 1996, J NEUROSCI, V16, P5312; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DREYER F, 1983, BRAIN RES, V270, P373, DOI 10.1016/0006-8993(83)90617-0; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Han WP, 1999, J NEUROSCI, V19, P900; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Katz B., 1969, RELEASE NEURAL TRANS; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; KOENIG JH, 1989, J NEUROSCI, V9, P3844; Kraszewski K, 1996, J NEUROSCI, V16, P5905; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Murthy VN, 1999, CURR OPIN NEUROBIOL, V9, P314, DOI 10.1016/S0959-4388(99)80046-4; Murthy VN, 1997, CURR BIOL, V7, pR512, DOI 10.1016/S0960-9822(06)00251-X; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neale EA, 1999, J CELL BIOL, V147, P1249, DOI 10.1083/jcb.147.6.1249; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Sankaranarayanan S, 2001, NAT NEUROSCI, V4, P129, DOI 10.1038/83949; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; Teng HB, 2000, J NEUROSCI, V20, P7986; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; Waters J, 2000, J NEUROSCI, V20, P7863; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500	54	106	109	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 30	2001	31	4					593	605		10.1016/S0896-6273(01)00398-1	http://dx.doi.org/10.1016/S0896-6273(01)00398-1			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545718	Bronze			2022-12-24	WOS:000170759200013
J	Griffiths, TD; Uppenkamp, S; Johnsrude, I; Josephs, O; Patterson, RD				Griffiths, TD; Uppenkamp, S; Johnsrude, I; Josephs, O; Patterson, RD			Encoding of the temporal regularity of sound in the human brainstem	NATURE NEUROSCIENCE			English	Article							LOW-FREQUENCY TONES; STRENGTH; NOISE	We measured the neural activity associated with the temporal structure of sound in the human auditory pathway from cochlear nucleus to cortex. The temporal structure includes regularities at the millisecond level and pitch sequences at the hundreds-of-milliseconds level. Functional magnetic resonance imaging (fMRI) of the whole brain with cardiac triggering allowed simultaneous observation of activity in the brainstem, thalamus and cerebrum. This work shows that the process of recoding temporal patterns into a more stable form begins as early as the cochlear nucleus and continues up to auditory cortex.	Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Cambridge CB2 3EG, England; Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Newcastle Univ, Sch Med, Dept Physiol Sci, Auditory Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; MRC, Cognit & Brain Sci Unit, Cambridge CB2 2EF, England	University of Cambridge; University of London; University College London; Newcastle University - UK	Griffiths, TD (corresponding author), Univ Cambridge, Dept Physiol, Ctr Neural Basis Hearing, Downing St, Cambridge CB2 3EG, England.	t.d.griffiths@ncl.ac.uk	Johnsrude, Ingrid S/G-4694-2011	Johnsrude, Ingrid S/0000-0002-7810-1333; Griffiths, Timothy/0000-0001-8066-4381				Chawla D, 1999, NEURAL COMPUT, V11, P1389, DOI 10.1162/089976699300016287; Duvernoy HM, 1999, HUMAN BRAIN; Griffiths TD, 1999, NEUROREPORT, V10, P3825, DOI 10.1097/00001756-199912160-00019; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799, DOI 10.1152/jn.1988.60.6.1799; MOORE WE, 1994, SPORT PSYCHOL, V8, P1; Nobili R, 1998, TRENDS NEUROSCI, V21, P159, DOI 10.1016/S0166-2236(97)01192-2; Patterson RD, 1996, J ACOUST SOC AM, V100, P3286, DOI 10.1121/1.417212; Patterson RD, 2000, J ACOUST SOC AM, V107, P1578, DOI 10.1121/1.428442; PATTERSON RD, 1995, J ACOUST SOC AM, V98, P1890, DOI 10.1121/1.414456; PATTERSON RD, 1994, P 3 ICSLP YOK JAP, P1395; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; ROSE JE, 1967, J NEUROPHYSIOL, V30, P769, DOI 10.1152/jn.1967.30.4.769; ROUILLER E, 1979, HEARING RES, V1, P213, DOI 10.1016/0378-5955(79)90015-7; Wiegrebe L, 2001, J NEUROPHYSIOL, V85, P1206, DOI 10.1152/jn.2001.85.3.1206; Yost WA, 1996, J ACOUST SOC AM, V99, P1066, DOI 10.1121/1.414593; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994	21	160	162	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					633	637		10.1038/88459	http://dx.doi.org/10.1038/88459			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369945				2022-12-24	WOS:000169061800017
J	Sherman, DL; Fabrizi, C; Gillespie, CS; Brophy, PJ				Sherman, DL; Fabrizi, C; Gillespie, CS; Brophy, PJ			Specific disruption of a Schwann cell dystrophin-related protein complex in a demyelinating neuropathy	NEURON			English	Article							PDZ-DOMAIN PROTEIN; PERIPHERAL-NERVE; MUSCULAR-DYSTROPHY; BASAL LAMINA; EXTRACELLULAR-MATRIX; GLYCOPROTEIN-COMPLEX; AXONAL ENSHEATHMENT; BINDING DOMAIN; ANIMAL-MODELS; CHAIN GENE	Dystroglycan-dystrophin complexes are believed to have structural and signaling functions by linking extracellular matrix proteins to the cytoskeleton and cortical signaling molecules. Here we characterize a dystroglycan-dystrophin-related protein 2 (DRP2) complex at the surface of myelin-forming Schwann cells. The complex is clustered by the interaction of DRP2 with L-periaxin, a homodimeric PDZ domain-containing protein. In the absence of L-periaxin, DRP2 is mislocalized and depleted, although other dystrophin family proteins are unaffected. Disruption of the DRP2-dystroglycan complex is followed by hypermyelination and destabilization of the Schwann cell-axon unit in Prx(-/-) mice. Hence, the DRP2-dystroglycan complex likely has a distinct function in the terminal stages of PNS myelinogenesis, possibly in the regulation of myelin thickness.	Univ Edinburgh, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh	Brophy, PJ (corresponding author), Univ Edinburgh, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland.		fabrizi, cinzia/G-2379-2012					Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1993, NAT GENET, V3, P283, DOI 10.1038/ng0493-283; ARAHATA K, 1993, P JPN ACAD B-PHYS, V69, P259, DOI 10.2183/pjab.69.259; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; BUNGE MB, 1990, ANN NY ACAD SCI, V580, P281, DOI 10.1111/j.1749-6632.1990.tb17937.x; BUNGE RP, 1986, ANNU REV NEUROSCI, V9, P305; BUNGE RP, 1978, J CELL BIOL, V78, P943, DOI 10.1083/jcb.78.3.943; CAREY DJ, 1986, J CELL BIOL, V102, P2254, DOI 10.1083/jcb.102.6.2254; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; COMI GP, 1995, HUM MOL GENET, V4, P2171, DOI 10.1093/hmg/4.11.2171; Cuppen E, 1998, MOL BIOL CELL, V9, P671, DOI 10.1091/mbc.9.3.671; di Vignano AT, 2000, FEBS LETT, V471, P229, DOI 10.1016/S0014-5793(00)01400-9; Dixon AK, 1997, J MOL BIOL, V270, P551, DOI 10.1006/jmbi.1997.1138; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; DOYU M, 1993, J NEUROCHEM, V60, P543, DOI 10.1111/j.1471-4159.1993.tb03183.x; Drubin DG, 1996, CELL, V84, P335, DOI 10.1016/S0092-8674(00)81278-7; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Dyck P, 1993, PERIPHERAL NEUROPATH; Dytrych L, 1998, J BIOL CHEM, V273, P5794, DOI 10.1074/jbc.273.10.5794; EINHEBER S, 1993, J CELL BIOL, V123, P1223, DOI 10.1083/jcb.123.5.1223; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; Froehner SC, 1997, SOC GEN PHY, V52, P197; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; GEE SH, 1993, J BIOL CHEM, V268, P14972; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Greenberg DS, 1996, HUM MOL GENET, V5, P1299, DOI 10.1093/hmg/5.9.1299; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Imamura M, 2000, HUM MOL GENET, V9, P3091, DOI 10.1093/hmg/9.20.3091; JUNG D, 1995, J BIOL CHEM, V270, P27305, DOI 10.1074/jbc.270.45.27305; Kachinsky AM, 1999, J CELL BIOL, V145, P391, DOI 10.1083/jcb.145.2.391; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; LEMKE G, 1988, DEVELOPMENT, V102, P499; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; Matsumura K, 1997, NEUROMUSCULAR DISORD, V7, P7, DOI 10.1016/S0960-8966(96)00402-6; Matsumura K, 1997, J BIOL CHEM, V272, P13904, DOI 10.1074/jbc.272.21.13904; MATSUMURA K, 1993, FEBS LETT, V334, P281, DOI 10.1016/0014-5793(93)80695-Q; Matsumura K, 1997, HISTOL HISTOPATHOL, V12, P195; Morris GE, 1998, BIOCHEMISTRY-US, V37, P11117, DOI 10.1021/bi9805137; Muller HW, 1997, NEUROBIOL DIS, V4, P215, DOI 10.1006/nbdi.1997.0148; PASTERNAK C, 1995, J CELL BIOL, V128, P355, DOI 10.1083/jcb.128.3.355; PETROF BJ, 1993, P NATL ACAD SCI USA, V90, P3710, DOI 10.1073/pnas.90.8.3710; Roberts RG, 2000, MOL CELL NEUROSCI, V16, P674, DOI 10.1006/mcne.2000.0895; Roberts RG, 1996, NAT GENET, V13, P223, DOI 10.1038/ng0696-223; Saito F, 1999, J BIOL CHEM, V274, P8240, DOI 10.1074/jbc.274.12.8240; Scherer SS, 1995, DEVELOPMENT, V121, P4265; Sherman DL, 2000, J BIOL CHEM, V275, P4537, DOI 10.1074/jbc.275.7.4537; Stevenson S, 1997, CIRC RES, V80, P269, DOI 10.1161/01.RES.80.2.269; Straub V, 1997, CURR OPIN NEUROL, V10, P168, DOI 10.1097/00019052-199704000-00016; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; SUZUKI A, 1994, EUR J BIOCHEM, V220, P283, DOI 10.1111/j.1432-1033.1994.tb18624.x; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; Uziyel Y, 2000, GLIA, V32, P109, DOI 10.1002/1098-1136(200011)32:2<109::AID-GLIA10>3.0.CO;2-1; Warner LE, 1999, ANNU REV MED, V50, P263, DOI 10.1146/annurev.med.50.1.263; Winder SJ, 1997, J MUSCLE RES CELL M, V18, P617, DOI 10.1023/A:1018627705273; XU H, 1994, NAT GENET, V8, P297, DOI 10.1038/ng1194-297; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Yamada H, 1996, J NEUROCHEM, V66, P1518; YAMADA H, 1994, FEBS LETT, V352, P49, DOI 10.1016/0014-5793(94)00917-1; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	66	145	160	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					677	687		10.1016/S0896-6273(01)00327-0	http://dx.doi.org/10.1016/S0896-6273(01)00327-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430802	Bronze			2022-12-24	WOS:000169508900009
J	Johnson, EN; Hawken, MJ; Shapley, R				Johnson, EN; Hawken, MJ; Shapley, R			The spatial transformation of color in the primary visual cortex of the macaque monkey	NATURE NEUROSCIENCE			English	Article							STRIATE CORTEX; CONTRAST SENSITIVITY; RECEPTIVE-FIELDS; CELLS; NEURONS; ORGANIZATION; MECHANISMS; LUMINANCE; V1; ORIENTATION	Perceptually, color is used to discriminate objects by hue and to identify color boundaries. The primate retina and the lateral geniculate nucleus (LGN) have cell populations sensitive to color modulation, but the role of the primary visual cortex (V1) in color signal processing is uncertain. We reevaluated color processing in V1 by studying single-neuron responses to luminance and to equiluminant color patterns equated for cone contrast. Many neurons respond robustly to both equiluminant color and luminance modulation (color-luminance cells). Also, there are neurons that prefer luminance (luminance cells), and a few neurons that prefer color (color cells). Surprisingly, most color-luminance cells are spatial-frequency tuned, with approximately equal selectivity for chromatic and achromatic patterns. Therefore, V1 retains the color sensitivity provided by the LGN, and adds spatial selectivity for color boundaries.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Johnson, EN (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.	zab@cns.nyu.edu			NATIONAL EYE INSTITUTE [R01EY008300, P30EY013079, R01EY001472] Funding Source: NIH RePORTER; NEI NIH HHS [P30-EY13079, EY01472, EY8300] Funding Source: Medline; NIMH NIH HHS [MH12430-01] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Batschelet E, 1981, CIRCULAR STAT BIOL; Boyd JD, 1999, J COMP NEUROL, V409, P573, DOI 10.1002/(SICI)1096-9861(19990712)409:4<573::AID-CNE5>3.0.CO;2-R; BRADLEY A, 1988, VISION RES, V28, P841, DOI 10.1016/0042-6989(88)90031-4; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; COLE GR, 1990, J OPT SOC AM A, V7, P128, DOI 10.1364/JOSAA.7.000128; DEVALOIS KK, 1983, J OPT SOC AM, V73, P11, DOI 10.1364/JOSA.73.000011; DEVALOIS RL, 1988, SPATIAL VISION, P218; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; DOW BM, 1974, J NEUROPHYSIOL, V37, P927, DOI 10.1152/jn.1974.37.5.927; Engel S, 1997, NATURE, V388, P68, DOI 10.1038/40398; ESTEVEZ O, 1982, VISION RES, V22, P681, DOI 10.1016/0042-6989(82)90104-3; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; GOURAS P, 1974, J PHYSIOL-LONDON, V238, P583, DOI 10.1113/jphysiol.1974.sp010545; HAWKEN MJ, 1988, J NEUROSCI, V8, P3541; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; JAMESON D, 1959, J OPT SOC AM, V49, P890, DOI 10.1364/JOSA.49.000890; KAPLAN E, 1988, NEUROSCI RES, pS151, DOI 10.1016/0921-8696(88)90014-X; Kiper DC, 1997, VISUAL NEUROSCI, V14, P1061, DOI 10.1017/S0952523800011779; KRAUSKOPF J, 1963, J OPT SOC AM, V53, P741, DOI 10.1364/JOSA.53.000741; KRAUSKOPF J, 1986, VISION RES, V26, P23, DOI 10.1016/0042-6989(86)90068-4; LENNIE P, 1990, J NEUROSCI, V10, P649; Lennie P., 1999, COLOR VISION GENES P, P235; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVICK WR, 1982, J PHYSIOL-LONDON, V329, P243, DOI 10.1113/jphysiol.1982.sp014301; Levitt JB, 1996, BEHAV BRAIN RES, V76, P5, DOI 10.1016/0166-4328(95)00188-3; LIVINGSTONE MS, 1984, J NEUROSCI, V4, P309; LUND JS, 1981, J COMP NEUROL, V202, P19, DOI 10.1002/cne.902020104; LUTKENHONER B, 1991, ACTA OTO-LARYNGOL, P52; MICHAEL CR, 1978, J NEUROPHYSIOL, V41, P572, DOI 10.1152/jn.1978.41.3.572; MULLEN KT, 1985, J PHYSIOL-LONDON, V359, P381, DOI 10.1113/jphysiol.1985.sp015591; REID RC, 1992, NATURE, V356, P716, DOI 10.1038/356716a0; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; SHAPLEY RM, 1999, COLOR VISION GENES P, P221; Shevell SK, 1998, VISION RES, V38, P1561, DOI 10.1016/S0042-6989(98)00006-6; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; SWITKES E, 1988, J OPT SOC AM A, V5, P1149, DOI 10.1364/JOSAA.5.001149; THORELL LG, 1984, VISION RES, V24, P751, DOI 10.1016/0042-6989(84)90216-5; TSO DY, 1988, J NEUROSCI, V8, P1712; VANDERHORST GJ, 1969, J OPT SOC AM, V59, P1482, DOI 10.1364/JOSA.59.001482; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; Wallach H, 1935, PSYCHOL FORSCH, V20, P325, DOI 10.1007/BF02409790; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zeki S., 1993, VISION BRAIN	44	283	286	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					409	416		10.1038/86061	http://dx.doi.org/10.1038/86061			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276232				2022-12-24	WOS:000168762200022
J	Cossart, R; Tyzio, R; Dinocourt, C; Esclapez, M; Hirsch, JC; Ben-Ari, Y; Bernard, C				Cossart, R; Tyzio, R; Dinocourt, C; Esclapez, M; Hirsch, JC; Ben-Ari, Y; Bernard, C			Presynaptic kainate receptors that enhance the release of GABA on CA1 hippocampal interneurons	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPUS; SYNAPTIC ACTIVATION; IN-VITRO; GABAERGIC INTERNEURONS; TRANSMITTER RELEASE; PYRAMIDAL NEURONS; AMPA RECEPTORS; INHIBITION; MECHANISMS	We report that kainate receptors are present on presynaptic GABAergic terminals contacting interneurons and that their activation increases GABA release. Application of kainate increased the frequency of miniature inhibitory postsynaptic currents recorded in CA1 interneurons. Local applications of glutamate but not of AMPA or NMDA also increased GABA quantal release. Application of kainate as well as synaptically released glutamate reduced the number of failures of GABAergic neurotransmission between interneurons. Thus, activation of presynaptic kainate receptors increases the probability of GABA release at interneuron-interneuron synapses. Glutamate may selectively control the communication between interneurons by increasing their mutual inhibition.	INSERM, INMED, U29, F-13273 Marseille, France; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Baylor College of Medicine	Ben-Ari, Y (corresponding author), INSERM, INMED, U29, Parc Sci Luminy,BP 13, F-13273 Marseille, France.		Esclapez, Monique/O-6509-2016; bernard, christophe/A-4929-2012; Cossart, Rosa/E-7674-2014; bernard, christophe/S-5937-2016; Cossart, Rosa/AAT-7934-2020	Esclapez, Monique/0000-0002-8558-1363; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; bernard, christophe/0000-0003-3014-1966; Cossart, Rosa/0000-0003-2111-6638; Ben-Ari, Yehezkel/0000-0001-6208-8480				BAHN S, 1994, J NEUROSCI, V14, P5525; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Bureau I, 1999, J NEUROSCI, V19, P653; Burnashev N, 1996, J PHYSIOL-LONDON, V496, P165, DOI 10.1113/jphysiol.1996.sp021674; Buzsaki G, 1997, CAN J PHYSIOL PHARM, V75, P508, DOI 10.1139/cjpp-75-5-508; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Cunha RA, 2000, FEBS LETT, V469, P159; Deisz RA, 1997, SYNAPSE, V25, P62, DOI 10.1002/(SICI)1098-2396(199701)25:1<62::AID-SYN8>3.0.CO;2-D; Esclapez M, 1997, P NATL ACAD SCI USA, V94, P12151, DOI 10.1073/pnas.94.22.12151; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fukuda T, 2000, J NEUROSCI, V20, P1519; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Glitsch M, 1999, J NEUROSCI, V19, P511; Gulyas AI, 1999, J NEUROSCI, V19, P10082; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; Hirsch JC, 1999, NAT NEUROSCI, V2, P499, DOI 10.1038/9142; Jiang L, 2000, J PHYSIOL-LONDON, V523, P425, DOI 10.1111/j.1469-7793.2000.t01-1-00425.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Liu QS, 1999, J NEUROPHYSIOL, V82, P1059, DOI 10.1152/jn.1999.82.2.1059; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; PETRALIA RS, 1994, J COMP NEUROL, V349, P85, DOI 10.1002/cne.903490107; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Prince DA, 1998, EPILEPSY RES, V32, P83, DOI 10.1016/S0920-1211(98)00042-4; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; SIEGEL SJ, 1995, J NEUROSCI, V15, P2707; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Vida I, 2000, P NATL ACAD SCI USA, V97, P1275, DOI 10.1073/pnas.97.3.1275; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0; WISDEN W, 1993, J NEUROSCI, V13, P3582; Yamada K, 1999, J NEUROPHYSIOL, V81, P2875, DOI 10.1152/jn.1999.81.6.2875	48	136	140	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					497	508		10.1016/S0896-6273(01)00221-5	http://dx.doi.org/10.1016/S0896-6273(01)00221-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239438	Bronze			2022-12-24	WOS:000167141700021
J	Hevner, RF; Shi, LM; Justice, N; Hsueh, YP; Sheng, M; Smiga, S; Bulfone, A; Goffinet, AM; Campagnoni, AT; Rubenstein, JLR				Hevner, RF; Shi, LM; Justice, N; Hsueh, YP; Sheng, M; Smiga, S; Bulfone, A; Goffinet, AM; Campagnoni, AT; Rubenstein, JLR			Tbr1 regulates differentiation of the preplate and layer 6	NEURON			English	Article							DEVELOPING CEREBRAL-CORTEX; NEURONAL MIGRATION; SUBPLATE NEURONS; THALAMOCORTICAL AXONS; EXTRACELLULAR-MATRIX; MUTANT MICE; CONNECTIONS; EXPRESSION; REELIN; MOUSE	During corticogenesis, early-born neurons of the pre-plate and layer 6 are important for guiding subsequent neuronal migrations and axonal projections. Tbr1 is a putative transcription factor that is highly expressed in glutamatergic early-born cortical neurons. In Tbr1-deficient mice, these early-born neurons had molecular and functional defects. Cajal-Retzius cells expressed decreased levels of Reelin, resulting in a reeler-like cortical migration disorder. Impaired subplate differentiation was associated with ectopic projection of thalamocortical fibers into the basal telencephalon. Layer 6 defects contributed to errors in the thalamocortical, corticothalamic, and callosal projections. These results show that Tbr1 is a common genetic determinant for the differentiation of early-born glutamatergic neocortical neurons and provide insights into the functions of these neurons as regulators of cortical development.	Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Calif Los Angeles, Sch Med, Inst Neuropsychiat, Los Angeles, CA 90024 USA; Fac Univ Notre Dame Paix, Sch Med, Neurobiol Unit, B-5000 Namur, Belgium	University of California System; University of California San Francisco; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Namur	Rubenstein, JLR (corresponding author), Univ Calif San Francisco, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA.	jlrr@cgl.ucsf.edu	Hsueh, Yi-Ping/ABH-5052-2020	Hsueh, Yi-Ping/0000-0002-0866-6275; Sheng, Morgan/0000-0002-8703-5366	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034661, K08NS001973] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH01046] Funding Source: Medline; NINDS NIH HHS [R01 NS34661, NS01973] Funding Source: Medline; Telethon [F.2] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon)		Alcantara S, 1998, J NEUROSCI, V18, P7779; ALLENDOERFER KL, 1994, ANNU REV NEUROSCI, V17, P185, DOI 10.1146/annurev.neuro.17.1.185; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BICKNESE AR, 1994, J NEUROSCI, V14, P3500; BLACKSTAD TW, 1956, J COMP NEUROL, V105, P417, DOI 10.1002/cne.901050305; Briata P, 1996, MECH DEVELOP, V57, P169, DOI 10.1016/0925-4773(96)00544-8; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Bulfone A, 1998, NEURON, V21, P1273, DOI 10.1016/S0896-6273(00)80647-9; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; Cecchi C, 2000, TRENDS NEUROSCI, V23, P347, DOI 10.1016/S0166-2236(00)01608-8; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FONSECA M, 1995, J COMP NEUROL, V361, P177, DOI 10.1002/cne.903610114; Fukuda T, 1997, J COMP NEUROL, V382, P141; GHOSH A, 1990, NATURE, V347, P179, DOI 10.1038/347179a0; GHOSH A, 1993, DEVELOPMENT, V117, P1031; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; KOESTER SE, 1994, J NEUROSCI, V14, P6608; Landry CF, 1998, J NEUROSCI, V18, P7315; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Liu XB, 1996, P NATL ACAD SCI USA, V93, P7332, DOI 10.1073/pnas.93.14.7332; Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000; MCCONNELL SK, 1994, J NEUROSCI, V14, P1892; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Meyer G, 1999, CEREB CORTEX, V9, P765, DOI 10.1093/cercor/9.8.765; Meyer G, 1998, J COMP NEUROL, V397, P493; MILLER B, 1995, J COMP NEUROL, V355, P615, DOI 10.1002/cne.903550410; Molnar Z, 1999, EXP NEUROL, V156, P363, DOI 10.1006/exnr.1999.7032; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Molnar Z, 1998, J NEUROSCI, V18, P5746; Polleux F, 1998, J NEUROSCI, V18, P9910; Probst M, 1901, ARCH PSYCHIAT NERVEN, V34, P709, DOI 10.1007/BF02680175; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; SILVER J, 1993, J COMP NEUROL, V328, P415, DOI 10.1002/cne.903280308; SMART IHM, 1977, J ANAT, V123, P515; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Weimann JM, 1999, NEURON, V24, P819, DOI 10.1016/S0896-6273(00)81030-2; WOLFER DP, 1994, J COMP NEUROL, V345, P1, DOI 10.1002/cne.903450102; WOOD JG, 1992, DEV BRAIN RES, V66, P137, DOI 10.1016/0165-3806(92)90150-U; Zhou C, 1999, NEURON, V24, P847, DOI 10.1016/S0896-6273(00)81032-6	51	659	672	2	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					353	366		10.1016/S0896-6273(01)00211-2	http://dx.doi.org/10.1016/S0896-6273(01)00211-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239428	Bronze			2022-12-24	WOS:000167141700011
J	Levenson, J; Weeber, E; Selcher, JC; Kategaya, LS; Sweatt, JD; Eskin, A				Levenson, J; Weeber, E; Selcher, JC; Kategaya, LS; Sweatt, JD; Eskin, A			Long-term potentiation and contextual fear conditioning increase neuronal glutamate uptake	NATURE NEUROSCIENCE			English	Article							RAT HIPPOCAMPUS; SYNAPTIC LOCALIZATION; TRANSPORTER CURRENTS; PROTEIN-SYNTHESIS; PYRAMIDAL CELLS; D-ASPARTATE; C6 GLIOMA; SYNAPSES; RELEASE; ACTIVATION	Induction and expression of long-term potentiation (LTP) in area CA1 of the hippocampus require the coordinated regulation of several cellular processes. We found that LTP in area CA1 was associated with an N-methyl-D-aspartate (NMDA) receptor-dependent increase in glutamate uptake. The increase in glutamate uptake was inhibited by either removal of Na+ or addition of D, L-threo-beta-hydroxyaspartate. Dihydrokainate (DHK), a specific inhibitor of the glial glutamate transporter GLT-1, did not block the increase in glutamate uptake. LTP was also associated with a translocation of the EAAC1 glutamate transporter from the cytosol to the plasma membrane. Contextual fear conditioning increased the maximum rate (V-max) of glutamate uptake and membrane expression of EAAC1 in area CA1. These results indicate that regulation of glutamate uptake may be important for maintaining the level of synaptic strength during long-term changes in synaptic efficacy.	Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	University of Houston System; University of Houston; Baylor College of Medicine	Eskin, A (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.		Weeber, Edwin J/A-5396-2012	Sweatt, J. David/0000-0003-3567-485X	NIMH NIH HHS [MH48147] Funding Source: Medline; NINDS NIH HHS [NS42156, NS28462] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042156, R01NS028462] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AbdulGhani AS, 1997, BRAIN RES, V755, P202, DOI 10.1016/S0006-8993(97)00098-X; Aggleton JP, 2000, HIPPOCAMPUS, V10, P466, DOI 10.1002/1098-1063(2000)10:4<466::AID-HIPO13>3.3.CO;2-P; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Bergles DE, 1998, J NEUROSCI, V18, P7709; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; CASADO M, 1993, J BIOL CHEM, V268, P27313; Cochilla AJ, 1998, NEURON, V20, P1007, DOI 10.1016/S0896-6273(00)80481-X; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Dube GR, 2000, J NEUROPHYSIOL, V83, P1141, DOI 10.1152/jn.2000.83.3.1141; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Grewer C, 2000, P NATL ACAD SCI USA, V97, P9706, DOI 10.1073/pnas.160170397; GUNDERSEN V, 1993, NEUROSCIENCE, V57, P97, DOI 10.1016/0306-4522(93)90114-U; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; He Y, 2000, J COMP NEUROL, V418, P255; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; Levenson J, 2000, P NATL ACAD SCI USA, V97, P12858, DOI 10.1073/pnas.220256497; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; MALENKA RC, 1987, BRAIN RES, V403, P198, DOI 10.1016/0006-8993(87)90145-4; Maleszka R, 2000, BEHAV BRAIN RES, V115, P49, DOI 10.1016/S0166-4328(00)00235-7; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Ng KT, 1997, NEUROSCI BIOBEHAV R, V21, P45, DOI 10.1016/0149-7634(95)00079-8; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Overstreet LS, 1999, J NEUROSCI, V19, P9663; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SORRA KE, 1993, J NEUROSCI, V13, P3736; Tanaka K, 1997, SCIENCE, V276, P1699, DOI 10.1126/science.276.5319.1699; TONG G, 1994, NEURON, V13, P1195, DOI 10.1016/0896-6273(94)90057-4; Torp R, 1997, ANAT EMBRYOL, V195, P317, DOI 10.1007/s004290050051; Turecek R, 2000, J NEUROSCI, V20, P2054	48	117	122	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					155	161		10.1038/nn791	http://dx.doi.org/10.1038/nn791			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788834				2022-12-24	WOS:000173558400018
J	Burrone, J; Neves, G; Gomis, A; Cooke, A; Lagnado, L				Burrone, J; Neves, G; Gomis, A; Cooke, A; Lagnado, L			Endogenous calcium buffers regulate fast exocytosis in the synaptic terminal of retinal bipolar cells	NEURON			English	Article							SACCULAR HAIR-CELLS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC TERMINALS; CA2+ MICRODOMAINS; GOLDFISH; CALRETININ; KINETICS; DYNAMICS; LOCALIZATION; SYNAPSES	Calcium-triggered exocytosis at the synapse is suppressed by addition of calcium chelators, but the effects of endogenous Ca2+ buffers have not been tested. We find that 80% of Ca2+ binding sites in the synaptic terminal of retinal bipolar cells were associated with mobile molecules that suppressed activation of Ca2+, sensitive K+ channels with an efficiency equivalent to similar to1.2 mM BAPTA. Removing these buffers caused a 30-fold increase In the number of vesicles released by Ca2+ tail currents lasting similar to0.5 ms and a 2-fold increase in the rapidly releasable pool of vesicles (RRP). The effects of BAPTA and EGTA indicate that vesicles comprising the RRP were docked at variable distances from Ca2+ channels. We propose that endogenous Ca2+ buffers regulate the size of the RRP by suppressing the release of vesicles toward the periphery of the active zone.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Lagnado, L (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Burrone, Juan/C-5654-2009; Gomis, Ana/S-1854-2017; Cooke, Anne/E-8709-2012; Neves, Guilherme/G-8957-2011	Gomis, Ana/0000-0003-4651-7673; Neves, Guilherme/0000-0001-6463-6997; Cooke, Anne/0000-0001-5562-6869; Burrone, Juan/0000-0003-1233-668X				ADLER EM, 1991, J NEUROSCI, V11, P1496; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; Bertram R, 1999, BIOPHYS J, V76, P735, DOI 10.1016/S0006-3495(99)77240-1; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; Burrone J, 1997, J PHYSIOL-LONDON, V505, P571, DOI 10.1111/j.1469-7793.1997.571ba.x; Burrone J, 2000, J NEUROSCI, V20, P568, DOI 10.1523/JNEUROSCI.20-02-00568.2000; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; Goda Y, 1997, CURR OPIN CELL BIOL, V9, P513, DOI 10.1016/S0955-0674(97)80027-0; Gomis A, 1999, J NEUROSCI, V19, P6309; Hack NJ, 2000, J NEUROSCI, V20; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; KATZ B, 1967, PROC R SOC SER B-BIO, V167, P23, DOI 10.1098/rspb.1967.0011; LAGNADO L, 1992, J PHYSIOL-LONDON, V455, P111, DOI 10.1113/jphysiol.1992.sp019293; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Naraghi M, 1997, J NEUROSCI, V17, P6961; NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neves G, 2001, P NATL ACAD SCI USA, V98, P15282, DOI 10.1073/pnas.261311698; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Neves G, 2001, J PHYSIOL-LONDON, V535, P809, DOI 10.1111/j.1469-7793.2001.t01-1-00809.x; OKADA T, 1995, NEUROSCI RES, V23, P297, DOI 10.1016/0168-0102(95)00955-8; ROBERTS WM, 1993, NATURE, V363, P74, DOI 10.1038/363074a0; ROBERTS WM, 1994, J NEUROSCI, V14, P3246; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Sabatini BL, 1997, J NEUROSCI, V17, P3425; Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0; Sakaba T, 1997, NEUROSCI RES, V27, P219, DOI 10.1016/S0168-0102(97)01155-3; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Schwaller B, 1997, J BIOL CHEM, V272, P29663, DOI 10.1074/jbc.272.47.29663; Tank DW, 1995, J NEUROSCI, V15, P7940; Tucker TR, 1996, J PHYSIOL-LONDON, V494, P613, DOI 10.1113/jphysiol.1996.sp021519; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Weruaga E, 2000, J CHEM NEUROANAT, V19, P1, DOI 10.1016/S0891-0618(00)00046-6; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	42	75	75	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					101	112		10.1016/S0896-6273(01)00565-7	http://dx.doi.org/10.1016/S0896-6273(01)00565-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779483	Bronze			2022-12-24	WOS:000173106200013
J	Sakaba, T; Neher, E				Sakaba, T; Neher, E			Calmodulin mediates rapid recruitment of fast-releasing synaptic vesicles at a calyx-type synapse	NEURON			English	Article							PRESYNAPTIC CALCIUM CURRENT; READILY RELEASABLE POOL; LONG-TERM POTENTIATION; LIGHT-CHAIN KINASE; TRANSMITTER RELEASE; RECEPTOR DESENSITIZATION; DEVELOPMENTAL-CHANGES; GLUTAMATE RELEASE; RESIDUAL CALCIUM; AUDITORY SYNAPSE	In many synapses, depletion and recruitment of releasable synaptic vesicles contribute to use-dependent synaptic depression and recovery. Recently it has been shown that high-frequency presynaptic stimulation enhances recovery from depression, which may be mediated by Ca2+. We addressed this issue by measuring quantal release rates at the calyx of Held synapse and found that transmission is mediated by a heterogeneous population of vesicles, with one subset releasing rapidly and recovering slowly and another one releasing reluctantly and recovering rapidly. Ca2+ promotes refilling of the rapidly releasing synaptic vesicle pool and calmodulin inhibitors block this effect. We propose that calmodulin-dependent refilling supports recovery from synaptic depression during high-frequency trains in concert with rapid recovery of the slowly releasing vesicles.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany	Max Planck Society	Neher, E (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany.	eneher@gwdg.de	Neher, Erwin/A-2109-2013	Sakaba, Takeshi/0000-0003-0688-7717				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; ADLER EM, 1991, J NEUROSCI, V11, P1496; AUGUSTINE GJ, 1994, ADV SEC MESS PHOSPH, V29, P139; Bellingham MC, 1999, NEURON, V23, P159, DOI 10.1016/S0896-6273(00)80762-X; BETZ WJ, 1970, J PHYSIOL-LONDON, V206, P629, DOI 10.1113/jphysiol.1970.sp009034; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Chuhma N, 1998, J NEUROSCI, V18, P512; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 2000, J NEUROSCI, V20, P1374; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gomis A, 1999, J NEUROSCI, V19, P6309; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Huang EP, 1997, J NEUROPHYSIOL, V78, P2870, DOI 10.1152/jn.1997.78.6.2870; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Isaacson JS, 1997, NEURON, V18, P143, DOI 10.1016/S0896-6273(01)80053-2; Ishikawa T, 2001, J PHYSIOL-LONDON, V533, P423, DOI 10.1111/j.1469-7793.2001.0423a.x; Iwasaki S, 1998, J PHYSIOL-LONDON, V509, P419, DOI 10.1111/j.1469-7793.1998.419bn.x; Iwasaki S, 2001, J PHYSIOL-LONDON, V534, P861, DOI 10.1111/j.1469-7793.2001.00861.x; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; KUSANO K, 1975, J PHYSIOL-LONDON, V245, P13, DOI 10.1113/jphysiol.1975.sp010832; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LILEY AW, 1953, J NEUROPHYSIOL, V16, P509, DOI 10.1152/jn.1953.16.5.509; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Neher E, 2001, J NEUROSCI, V21, P444, DOI 10.1523/JNEUROSCI.21-02-00444.2001; Ohana O, 1998, J PHYSIOL-LONDON, V513, P135, DOI 10.1111/j.1469-7793.1998.135by.x; Otis T, 1996, J NEUROSCI, V16, P7496; Park JB, 1997, J BIOL CHEM, V272, P20857, DOI 10.1074/jbc.272.33.20857; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Peters C, 1998, NATURE, V396, P575, DOI 10.1038/25133; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Quetglas S, 2000, P NATL ACAD SCI USA, V97, P9695, DOI 10.1073/pnas.97.17.9695; RAMAN IM, 1995, BIOPHYS J, V68, P137, DOI 10.1016/S0006-3495(95)80168-2; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Rozov A, 2001, J PHYSIOL-LONDON, V531, P807, DOI 10.1111/j.1469-7793.2001.0807h.x; Ryan TA, 1999, J NEUROSCI, V19, P1317; Sakaba T, 2001, J NEUROSCI, V21, P462, DOI 10.1523/JNEUROSCI.21-02-00462.2001; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Stevens CF, 1998, NEURON, V21, P415, DOI 10.1016/S0896-6273(00)80550-4; Sun JY, 2001, NEURON, V30, P171, DOI 10.1016/S0896-6273(01)00271-9; SWANDULLA D, 1991, NEURON, V7, P915, DOI 10.1016/0896-6273(91)90337-Y; Taschenberger H, 2000, J NEUROSCI, V20, P9162; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Tsodyks M, 2000, J NEUROSCI, V20; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; VONGERSDORFF H, 1997, J NEUROSCI, V17, P115; WALMSLEY B, 1988, J NEUROPHYSIOL, V60, P889, DOI 10.1152/jn.1988.60.3.889; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; Weis S, 1999, BIOPHYS J, V77, P2418, DOI 10.1016/S0006-3495(99)77079-7; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; Wu LG, 1999, J NEUROSCI, V19, P726; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Wu LG, 1999, NEURON, V23, P821, DOI 10.1016/S0896-6273(01)80039-8; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Xu XZS, 1998, J BIOL CHEM, V273, P31297, DOI 10.1074/jbc.273.47.31297; YAZAWA M, 1992, BIOCHEMISTRY-US, V31, P3171, DOI 10.1021/bi00127a018; ZUCKER RS, 1973, J PHYSIOL-LONDON, V229, P787, DOI 10.1113/jphysiol.1973.sp010167; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	79	271	273	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1119	1131		10.1016/S0896-6273(01)00543-8	http://dx.doi.org/10.1016/S0896-6273(01)00543-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754842	Bronze, Green Published			2022-12-24	WOS:000172886800017
J	Demb, JB; Zaghloul, K; Sterling, P				Demb, JB; Zaghloul, K; Sterling, P			Cellular basis for the response to second-order motion cues in Y retinal ganglion cells	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CAT VISUAL-CORTEX; 2ND-ORDER MOTION; MACAQUE MONKEY; AREA MT; CONTRAST ENHANCEMENT; SALAMANDER RETINA; SPATIAL SUMMATION; ORIENTATION BIAS; PERCEIVED SPEED	We perceive motion when presented with spatiotemporal changes in contrast (second-order cue). This requires linear signals to be rectified and then summed in temporal order to compute direction. Although both operations have been attributed to cortex, rectification might occur in retina, prior to the ganglion cell. Here we show that the Y ganglion cell does indeed respond to spatiotemporal contrast modulations of a second-order motion stimulus. Responses in an OFF ganglion cell are caused by an EPSP/IPSP sequence evoked from within the dendritic field; in ON cells inhibition is indirect. Inhibitory effects, which are blocked by tetrodotoxin, clamp the response near resting potential thus preventing saturation. Apparently the computation for second-order motion can be initiated by Y cells and completed by cortical cells that sum outputs of multiple Y cells in a directionally selective manner.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Demb, JB (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.			Demb, Jonathan/0000-0003-2227-9041	NATIONAL EYE INSTITUTE [T32EY007035, R01EY000828, F32EY006850] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY00828, F32-EY06850, T32-EY07035] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; Baker CL, 1999, CURR OPIN NEUROBIOL, V9, P461, DOI 10.1016/S0959-4388(99)80069-5; BILOTTA J, 1989, VISUAL NEUROSCI, V2, P3, DOI 10.1017/S0952523800004260; Blakemore MR, 2000, VISION RES, V40, P629, DOI 10.1016/S0042-6989(99)00214-X; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burkhardt DA, 1998, J NEUROPHYSIOL, V80, P1070, DOI 10.1152/jn.1998.80.3.1070; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Calkins DJ, 1998, J NEUROSCI, V18, P3373; CAVANAGH P, 1989, Spatial Vision, V4, P103, DOI 10.1163/156856889X00077; CHILCHILNISKY EJ, 1999, NAT NEUROSCI, V2, P889; CHUBB C, 1988, J OPT SOC AM A, V5, P1986, DOI 10.1364/JOSAA.5.001986; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; COHEN E, 1992, EUR J NEUROSCI, V4, P506, DOI 10.1111/j.1460-9568.1992.tb00901.x; COOK PB, 1994, J NEUROSCI, V14, P3852; DACEY DM, 1994, NATURE, V367, P731, DOI 10.1038/367731a0; Demb JB, 2001, J NEUROSCI, V21, P7447, DOI 10.1523/JNEUROSCI.21-19-07447.2001; Demb JB, 1999, J NEUROSCI, V19, P9756; DEMONASTERIO FM, 1978, J NEUROPHYSIOL, V41, P1394, DOI 10.1152/jn.1978.41.6.1394; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; Dougherty RF, 1999, NEURON, V24, P893, DOI 10.1016/S0896-6273(00)81036-3; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; FERSTER D, 1990, VISUAL NEUROSCI, V4, P115, DOI 10.1017/S0952523800002285; FERSTER D, 1991, J NEUROPHYSIOL, V66, P1667, DOI 10.1152/jn.1991.66.5.1667; FERSTER D, 1990, VISUAL NEUROSCI, V4, P135, DOI 10.1017/S0952523800002297; Freed MA, 2000, J NEUROPHYSIOL, V83, P2956, DOI 10.1152/jn.2000.83.5.2956; GRAHAM N, 1992, VISION RES, V32, P719, DOI 10.1016/0042-6989(92)90188-O; He S, 1998, VISION RES, V38, P985, DOI 10.1016/S0042-6989(97)00290-3; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; KAPLAN E, 1982, J PHYSIOL-LONDON, V330, P125, DOI 10.1113/jphysiol.1982.sp014333; LANKHEET MJM, 1989, VISION RES, V29, P505, DOI 10.1016/0042-6989(89)90037-0; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; LEVICK WR, 1980, NATURE, V286, P389, DOI 10.1038/286389a0; MACLEOD DIA, 1992, VISION RES, V32, P347, DOI 10.1016/0042-6989(92)90144-8; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Mareschal I, 1999, VISUAL NEUROSCI, V16, P527, DOI 10.1017/S0952523899163132; Mareschal I, 1998, NAT NEUROSCI, V1, P150, DOI 10.1038/401; MARROCCO RT, 1982, J NEUROSCI, V2, P1275; Movshon JA, 1996, J NEUROSCI, V16, P7733; O'Keefe LP, 1998, VISUAL NEUROSCI, V15, P305, DOI 10.1017/S0952523898152094; Orger MB, 2000, NAT NEUROSCI, V3, P1128, DOI 10.1038/80649; PEICHL L, 1987, PROC R SOC SER B-BIO, V231, P169, DOI 10.1098/rspb.1987.0040; Roska B, 2001, NATURE, V410, P583, DOI 10.1038/35069068; SAJOVIC P, 1982, NEUROSCIENCE, V7, P2427, DOI 10.1016/0306-4522(82)90205-6; Scott-Samuel NE, 1999, VISION RES, V39, P2853, DOI 10.1016/S0042-6989(98)00316-2; Seidemann E, 1999, NEURON, V24, P911, DOI 10.1016/S0896-6273(00)81038-7; Smith AT, 1997, VISION RES, V37, P45, DOI 10.1016/S0042-6989(96)00147-2; Smith AT, 1998, J NEUROSCI, V18, P3816; SOODAK RE, 1987, J NEUROPHYSIOL, V58, P267, DOI 10.1152/jn.1987.58.2.267; Stafford DK, 1997, VISUAL NEUROSCI, V14, P507, DOI 10.1017/S0952523800012165; STEVENS JK, 1980, SCIENCE, V207, P317, DOI 10.1126/science.7350663; STONE C, 1993, VISUAL NEUROSCI, V10, P31, DOI 10.1017/S0952523800003205; THIBOS LN, 1985, EXP BRAIN RES, V58, P1; Wandell BA, 1999, NEURON, V24, P901, DOI 10.1016/S0896-6273(00)81037-5; WILSON HR, 1992, VISUAL NEUROSCI, V9, P79, DOI 10.1017/S0952523800006386; Wolfe J, 1998, VISUAL NEUROSCI, V15, P653, DOI 10.1017/S0952523898154068; Yabuta NH, 1998, J NEUROSCI, V18, P9489; Zhou YX, 1996, J NEUROPHYSIOL, V75, P1038, DOI 10.1152/jn.1996.75.3.1038; ZHOU YX, 1994, J NEUROPHYSIOL, V72, P2134, DOI 10.1152/jn.1994.72.5.2134	61	60	61	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					711	721		10.1016/S0896-6273(01)00484-6	http://dx.doi.org/10.1016/S0896-6273(01)00484-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719210	Bronze			2022-12-24	WOS:000172363900016
J	Frankfort, BJ; Nolo, R; Zhang, ZH; Bellen, H; Mardon, G				Frankfort, BJ; Nolo, R; Zhang, ZH; Bellen, H; Mardon, G			senseless repression of rough is required for R8 photoreceptor differentiation in the developing Drosophila eye	NEURON			English	Article							EGF RECEPTOR; PRONEURAL GENE; CELL-FATE; OMMATIDIA DEVELOPMENT; PATTERN-FORMATION; ORGAN DEVELOPMENT; DEVELOPING RETINA; EXPRESSION; NOTCH; HOMOLOG	An outstanding model to study how neurons differentiate from among a field of equipotent undifferentiated cells is the process of R8 photoreceptor differentiation during Drosophila eye development. We show that in senseless mutant tissue, R8 differentiation fails and the presumptive R8 cell adopts the R2/R5 fate. We identify senseless repression of rough in R8 as an essential mechanism of R8 cell fate determination and demonstrate that misexpression of senseless in non-R8 photoreceptors results in repression of rough and induction of the R8 fate. Surprisingly, there is no loss of ommatidial clusters in senseless mutant tissue and all outer photoreceptor subtypes can be recruited, suggesting that other photoreceptors can substitute for R8 to initiate recruitment and that R8-specific signaling is not required for outer photoreceptor subtype assignment. A genetic model of R8 differentiation is presented.	Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Mardon, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gmardon@bcm.tmc.edu		Bellen, Hugo/0000-0001-5992-5989	NEI NIH HHS [R01 EY11232-01, P30 EY002520, R01 EY011232, R01 EY011232-10, EY02520] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY002520, R01EY011232] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker NE, 1996, CURR BIOL, V6, P1290, DOI 10.1016/S0960-9822(02)70715-X; BAKER NE, 1995, MECH DEVELOP, V49, P173, DOI 10.1016/0925-4773(94)00314-D; BAKER NE, 1990, SCIENCE, V250, P1370, DOI 10.1126/science.2175046; BAKER NE, 1992, DEV BIOL, V150, P381, DOI 10.1016/0012-1606(92)90250-K; CAGAN R, 1993, DEVELOPMENT, P19; CAGAN RL, 1989, GENE DEV, V3, P1099, DOI 10.1101/gad.3.8.1099; Chen KC, 1999, P NATL ACAD SCI USA, V96, P5055, DOI 10.1073/pnas.96.9.5055; CUBAS P, 1991, GENE DEV, V5, P996, DOI 10.1101/gad.5.6.996; Culi J, 1998, GENE DEV, V12, P2036, DOI 10.1101/gad.12.13.2036; DAVIS I, 1995, DEV BIOL, V170, P726, DOI 10.1006/dbio.1995.1251; DICKSON B, 1992, GENE DEV, V6, P2327, DOI 10.1101/gad.6.12a.2327; Dokucu ME, 1996, DEVELOPMENT, V122, P4139; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1998, CURR BIOL, V8, P1039, DOI 10.1016/S0960-9822(98)70441-5; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; FREEMAN M, 1994, MECH DEVELOP, V48, P25, DOI 10.1016/0925-4773(94)90003-5; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Grimes HL, 1996, P NATL ACAD SCI USA, V93, P14569, DOI 10.1073/pnas.93.25.14569; HART AC, 1990, GENE DEV, V4, P1835, DOI 10.1101/gad.4.11.1835; HEBERLEIN U, 1991, DEVELOPMENT, V112, P703; Huang YZ, 1996, DEVELOPMENT, V122, P3207; JARMAN AP, 1995, DEVELOPMENT, V121, P2019; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; Jia YW, 1997, DEVELOPMENT, V124, P2063; KIMMEL BE, 1990, GENE DEV, V4, P712, DOI 10.1101/gad.4.5.712; Kumar JP, 1998, DEVELOPMENT, V125, P3875; LAWRENCE PA, 1979, DEV BIOL, V71, P142, DOI 10.1016/0012-1606(79)90088-5; Lee EC, 2000, CURR BIOL, V10, P931, DOI 10.1016/S0960-9822(00)00622-9; Lee EC, 1996, MOL CELL BIOL, V16, P1179; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lesokhin AM, 1999, DEV BIOL, V205, P129, DOI 10.1006/dbio.1998.9121; MLODZIK M, 1990, GENE DEV, V4, P1848, DOI 10.1101/gad.4.11.1848; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Newsome TP, 2000, DEVELOPMENT, V127, P851; Nolo R, 2000, CELL, V102, P349, DOI 10.1016/S0092-8674(00)00040-4; Powell PA, 2001, NATURE, V409, P626, DOI 10.1038/35054566; Raabe T, 2000, BBA-MOL CELL RES, V1496, P151, DOI 10.1016/S0167-4889(00)00020-3; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; SKEATH JB, 1991, GENE DEV, V5, P984, DOI 10.1101/gad.5.6.984; Spencer SA, 1998, DEVELOPMENT, V125, P4777; Sun Y, 2000, P NATL ACAD SCI USA, V97, P6815, DOI 10.1073/pnas.110154497; Tio M, 1997, DEVELOPMENT, V124, P343; TIO M, 1994, MECH DEVELOP, V48, P13, DOI 10.1016/0925-4773(94)90002-7; TOMLINSON A, 1988, CELL, V55, P771, DOI 10.1016/0092-8674(88)90133-X; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VANDOREN M, 1992, GENE DEV, V6, P2592, DOI 10.1101/gad.6.12b.2592; VINCENT JP, 1994, DEV BIOL, V164, P328, DOI 10.1006/dbio.1994.1203; Wasserman JD, 2000, GENE DEV, V14, P1651; Wolff Tanya, 1993, P1277; Xu CY, 2000, CELL, V103, P87, DOI 10.1016/S0092-8674(00)00107-0; XU T, 1993, DEVELOPMENT, V117, P1223; Yang LH, 2001, DEVELOPMENT, V128, P1183; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	57	99	101	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					403	414		10.1016/S0896-6273(01)00480-9	http://dx.doi.org/10.1016/S0896-6273(01)00480-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709152	Green Accepted, Bronze			2022-12-24	WOS:000172119100007
J	Koushika, SP; Richmond, JE; Hadwiger, G; Weimer, RM; Jorgensen, EM; Nonet, ML				Koushika, SP; Richmond, JE; Hadwiger, G; Weimer, RM; Jorgensen, EM; Nonet, ML			A post-docking role for active zone protein Rim	NATURE NEUROSCIENCE			English	Article							SYNAPTIC VESICLES; FUSION-COMPETENCE; MUTANTS; UNC-13; SYNTAXIN; RAB3; SYNAPTOTAGMIN; ORGANIZATION; EXOCYTOSIS; EFFECTOR	Rim1 was previously identified as a Rab3 effector localized to the presynaptic active zone in vertebrates. Here we demonstrate that C. elegans unc-10 mutants lacking Rim are viable, but exhibit behavioral and physiological defects that are more severe than those of Rab3 mutants. Rim is localized to synaptic sites in C. elegans, but the ultrastructure of the presynaptic densities is normal in Rim mutants. Moreover, normal levels of docked synaptic vesicles were observed in mutants, suggesting that Rim is not involved in the docking process. The level of fusion competent vesicles at release sites was reduced fivefold in Rim mutants, but calcium sensitivity of release events was unchanged. Furthermore, expression of a constitutively open form of syntaxin suppressed the physiological defects of Rim mutants, suggesting Rim normally acts to regulate conformational changes in syntaxin. These data suggest Rim acts after vesicle docking likely via regulating priming.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Washington University (WUSTL); Utah System of Higher Education; University of Utah	Nonet, ML (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	nonetm@thalamus.wustl.edu		Koushika, Sandhya/0000-0002-1742-7356	NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059820] Funding Source: NIH RePORTER; NIMH NIH HHS [R03 MH059820-02, R03 MH059820-01] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; BRENNER S, 1974, GENETICS, V77, P71; BURNS ME, 1995, CELL, V83, P187, DOI 10.1016/0092-8674(95)90160-4; Chen YA, 2001, NEURON, V30, P161, DOI 10.1016/S0896-6273(01)00270-7; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; DIXON D, 1989, J NEUROSCI, V9, P4246; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; GEPPERT M, 1994, NATURE, V369, P493, DOI 10.1038/369493a0; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; HEUSER JE, 1973, HDB PHYSL, V1, P261; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; Klenchin VA, 2000, BIOCHIMIE, V82, P399, DOI 10.1016/S0300-9084(00)00208-X; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; NGUYEN M, 1995, GENETICS, V140, P527; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Rand James B., 1997, Cold Spring Harbor Monograph Series, V33, P611; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SHIRATAKI H, 1993, MOL CELL BIOL, V13, P2061, DOI 10.1128/MCB.13.4.2061; STAUNTON J, IN PRESS J NEUROSCI; Sulston J., 1988, NEMATODE CAENORHABDI, P587; VONMOLLARD GF, 1990, P NATL ACAD SCI USA, V87, P1988, DOI 10.1073/pnas.87.5.1988; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	42	237	249	0	17	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					997	1005		10.1038/nn732	http://dx.doi.org/10.1038/nn732			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11559854	Green Accepted			2022-12-24	WOS:000171325800013
J	Ethell, IM; Irie, F; Kalo, MS; Couchman, JR; Pasquale, EB; Yamaguchi, Y				Ethell, IM; Irie, F; Kalo, MS; Couchman, JR; Pasquale, EB; Yamaguchi, Y			EphB/syndecan-2 signaling in dendritic spine morphogenesis	NEURON			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; FRAGILE-X-SYNDROME; HIPPOCAMPAL-NEURONS; CYTOPLASMIC DOMAIN; EPHB RECEPTORS; COMMISSURAL AXONS; PDZ PROTEIN; PHOSPHORYLATION; PLASTICITY; SYNAPSES	We previously reported that the cell surface proteoglycan syndecan-2 can induce dendritic spine formation in hippocampal neurons. We demonstrate here that the EphB2 receptor tyrosine kinase phosphorylates syndecan-2 and that this phosphorylation event is crucial for syndecan-2 clustering and spine formation. Syndecan-2 is tyrosine phosphorylated and forms a complex with EphB2 in mouse brain. Dominant-negative inhibition of endogenous EphB receptor activities blocks clustering of endogenous syndecan-2 and normal spine formation in cultured hippocampal neurons. This is the first evidence that Eph receptors play a physiological role in dendritic spine morphogenesis. Our observations suggest that spine morphogenesis is triggered by the activation of Eph receptors, which causes tyrosine phosphorylation of target molecules, such as syndecan-2, in presumptive spines.	Burnham Inst, La Jolla, CA 92037 USA; Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Sanford Burnham Prebys Medical Discovery Institute; University of Alabama System; University of Alabama Birmingham	Yamaguchi, Y (corresponding author), Burnham Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Ethell, Iryna/0000-0002-1324-6611	NICHD NIH HHS [HD25938] Funding Source: Medline; NIGMS NIH HHS [GM50194] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Andersen P, 1999, NATURE, V399, P19, DOI 10.1038/19857; Asundi VK, 1997, BIOCHEM BIOPH RES CO, V240, P502, DOI 10.1006/bbrc.1997.7684; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Boxer AL, 1999, J NEUROPHYSIOL, V82, P3367, DOI 10.1152/jn.1999.82.6.3367; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Carey DJ, 1996, J BIOL CHEM, V271, P15253, DOI 10.1074/jbc.271.25.15253; COUCHMAN JR, 2000, PROTEOGLYCANS STRUCT, P147; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Drescher U, 2000, CELL, V103, P1005, DOI 10.1016/S0092-8674(00)00204-X; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Ethell IM, 1999, J CELL BIOL, V144, P575, DOI 10.1083/jcb.144.3.575; Ethell IM, 2000, J CELL BIOL, V151, P53, DOI 10.1083/jcb.151.1.53; Fiala JC, 1998, J NEUROSCI, V18, P8900; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gao YH, 2000, J CELL PHYSIOL, V184, P373, DOI 10.1002/1097-4652(200009)184:3<373::AID-JCP12>3.0.CO;2-I; Grootjans JJ, 1997, P NATL ACAD SCI USA, V94, P13683, DOI 10.1073/pnas.94.25.13683; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; HISAJIMA H, 1992, J NEUROSCI RES, V31, P549, DOI 10.1002/jnr.490310319; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hsueh YP, 1998, NEURON, V21, P1227, DOI 10.1016/S0896-6273(00)80641-8; Iba K, 2000, J CELL BIOL, V149, P1143, DOI 10.1083/jcb.149.5.1143; Jo K, 1999, J NEUROSCI, V19, P4189, DOI 10.1523/jneurosci.19-11-04189.1999; Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; Murphy DD, 1997, P NATL ACAD SCI USA, V94, P1482, DOI 10.1073/pnas.94.4.1482; Oh ES, 1997, ARCH BIOCHEM BIOPHYS, V344, P67, DOI 10.1006/abbi.1997.0180; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; PAPA M, 1995, J NEUROSCI, V15, P1; Pasquale EB, 1997, CURR OPIN CELL BIOL, V9, P608, DOI 10.1016/S0955-0674(97)80113-5; Rapraeger AC, 1998, CURR OPIN CELL BIOL, V10, P620, DOI 10.1016/S0955-0674(98)80038-0; RUDELLI RD, 1985, ACTA NEUROPATHOL, V67, P289, DOI 10.1007/BF00687814; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; SHAO HN, 1994, J BIOL CHEM, V269, P26606; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; WOODS A, 1994, MOL BIOL CELL, V5, P183, DOI 10.1091/mbc.5.2.183; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; Zisch AH, 2000, ONCOGENE, V19, P177, DOI 10.1038/sj.onc.1203304; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	45	251	260	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					1001	1013		10.1016/S0896-6273(01)00440-8	http://dx.doi.org/10.1016/S0896-6273(01)00440-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580899	Bronze			2022-12-24	WOS:000171281300014
J	Zhou, Q; Choi, G; Anderson, DJ				Zhou, Q; Choi, G; Anderson, DJ			The bHLH transcription factor Olig2 promotes oligodendrocyte differentiation in collaboration with Nkx2.2	NEURON			English	Article							SPINAL-CORD OLIGODENDROCYTES; PROGENITOR-CELL IDENTITY; MAMMALIAN NEURAL CREST; PRIMARY NEUROGENESIS; NERVOUS-SYSTEM; NEURONAL FATE; IN-VIVO; LINEAGE; SPECIFICATION; TUBE	Olig2, a basic helix-loop-helix (bHLH) transcription factor, is expressed in a restricted domain of the spinal cord ventricular zone that sequentially generates motoneurons and oligodendrocytes. Just prior to oligodendrocyte precursor formation, the domains of Olig2 and Nkx2.2 expression switch from being mutually exclusive to overlapping, and Neurogenins1 and 2 are extinguished within this region. Coexpression of Olig2 with Nkx2.2 in the spinal cord promotes ectopic and precocious oligodendrocyte differentiation. Both proteins function as transcriptional repressors in this assay. This effect is blocked by forced expression of Neurogenin1. By contrast, misexpression of Olig2 alone derepresses Neurogenins and promotes motoneuron differentiation. Olig2 therefore functions sequentially in motoneuron and oligodendrocyte, fate specification. This dual action is enabled by spatio-temporal changes in the expression domains of other transcription factors with which Olig2 functionally interacts.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, 1201 E Calif Blvd, Pasadena, CA 91125 USA.	mancusog@caltech.edu	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763; Zhou, Qiao/0000-0002-0099-3909	NINDS NIH HHS [R01-NS23476] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023476] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; CHRIST B, 1995, ANAT EMBRYOL, V191, P381, DOI 10.1007/BF00304424; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Desai AR, 2000, DEVELOPMENT, V127, P2863; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; GARD AL, 1990, NEURON, V5, P615, DOI 10.1016/0896-6273(90)90216-3; Hall A, 1996, DEVELOPMENT, V122, P4085; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Miller RH, 1996, TRENDS NEUROSCI, V19, P92, DOI 10.1016/S0166-2236(96)80036-1; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; ONO K, 1995, DEVELOPMENT, V121, P1743; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Pfeiffer Steve E., 1993, Trends in Cell Biology, V3, P191, DOI 10.1016/0962-8924(93)90213-K; PHILIPPE E, 1986, DEV BRAIN RES, V27, P275, DOI 10.1016/0165-3806(86)90255-5; PRINGLE NP, 1993, DEVELOPMENT, V117, P525; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Richardson WD, 1997, DEV NEUROSCI-BASEL, V19, P58, DOI 10.1159/000111186; Soula C, 2001, DEVELOPMENT, V128, P1369; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; STRUHL G, 1993, CELL, V74, P331, DOI 10.1016/0092-8674(93)90424-O; Sun T, 1998, MOL CELL NEUROSCI, V12, P228, DOI 10.1006/mcne.1998.0711; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Villegas EMP, 1999, DEV BIOL, V216, P98, DOI 10.1006/dbio.1999.9438; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; Wettstein DA, 1997, DEVELOPMENT, V124, P693; White PM, 1999, DEVELOPMENT, V126, P4351; Xu XH, 2000, MOL CELL NEUROSCI, V16, P740, DOI 10.1006/mcne.2000.0916; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	49	440	457	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					791	807		10.1016/S0896-6273(01)00414-7	http://dx.doi.org/10.1016/S0896-6273(01)00414-7			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567617	Bronze			2022-12-24	WOS:000171013300012
J	Ballas, N; Battaglioli, E; Atouf, F; Andres, ME; Chenoweth, J; Anderson, ME; Burger, C; Moniwa, M; Davie, JR; Bowers, WJ; Federoff, HJ; Rose, DW; Rosenfeld, MG; Brehm, P; Mandel, G				Ballas, N; Battaglioli, E; Atouf, F; Andres, ME; Chenoweth, J; Anderson, ME; Burger, C; Moniwa, M; Davie, JR; Bowers, WJ; Federoff, HJ; Rose, DW; Rosenfeld, MG; Brehm, P; Mandel, G			Regulation of neuronal traits by a novel transcriptional complex	NEURON			English	Article							RESTRICTIVE SILENCER FACTOR; NEURAL-SPECIFIC EXPRESSION; SODIUM-CHANNEL GENE; ACETYLCHOLINE-RECEPTOR GENE; SYNAPSIN-I GENE; HISTONE DEACETYLASE; TARGET GENES; TRANSGENIC MICE; FACTOR REST; SCG10 GENE	The transcriptional repressor, REST, helps restrict neuronal traits to neurons by blocking their expression In nonneuronal cells. To examine the repercussions of REST expression in neurons, we generated a neuronal cell line that expresses REST conditionally. REST expression inhibited differentiation by nerve growth factor, suppressing both sodium current and neurite growth. A novel corepressor complex, CoREST/HDAC2, was shown to be required for REST repression. In the presence of REST, the CoREST/HDAC2 complex occupied the native Nav1.2 sodium channel gene In chromatin. In neuronal cells that lack REST and express sodium channels, the corepressor complex was not present on the gene. Collectively, these studies define a novel HDAC complex that is recruited by the C-terminal repressor domain of REST to actively repress genes essential to the neuronal phenotype.	SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada; Univ Calif San Diego, Div Endocrinol & Metab, La Jolla, CA 92093 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Univ Rochester, Sch Med, Dept Neurol, Rochester, NY 14642 USA; Univ Rochester, Sch Med, Ctr Aging & Dev Biol, Rochester, NY 14642 USA	Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Rochester; University of Rochester	Mandel, G (corresponding author), SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA.		battaglioli, elena/H-9350-2017	Battaglioli, Elena/0000-0001-9168-7212; Davie, James/0000-0002-0420-6888; Burger, Corinna/0000-0002-9432-0114	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022518] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG018254] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG18254] Funding Source: Medline; NIDDK NIH HHS [DK54802] Funding Source: Medline; NIGMS NIH HHS [GM 50224-S1] Funding Source: Medline; NINDS NIH HHS [NS22518] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson D, 1997, MOL CELLULAR APPROAC, P26; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Avisar N, 1999, J BIOL CHEM, V274, P11399, DOI 10.1074/jbc.274.16.11399; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bessis A, 1997, P NATL ACAD SCI USA, V94, P5906, DOI 10.1073/pnas.94.11.5906; BESSIS A, 1995, NEUROSCIENCE, V69, P807, DOI 10.1016/0306-4522(95)00303-Z; Bowers WJ, 2000, MOL THER, V1, P294, DOI 10.1006/mthe.2000.0039; BOWERS WJ, 2001, IN PRESS GENE THER; Brene S, 2000, EUR J NEUROSCI, V12, P1525, DOI 10.1046/j.1460-9568.2000.00040.x; CATHALA G, 1983, DNA-J MOLEC CELL BIO, V2, P329, DOI 10.1089/dna.1983.2.329; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; COOPERMAN SS, 1987, P NATL ACAD SCI USA, V84, P8721, DOI 10.1073/pnas.84.23.8721; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Gottlieb DI, 1999, CELLS TISSUES ORGANS, V165, P165, DOI 10.1159/000016696; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Halterman MW, 1999, J NEUROSCI, V19, P6818, DOI 10.1523/JNEUROSCI.19-16-06818.1999; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; HENDZEL MJ, 1991, J BIOL CHEM, V266, P21936; HOWLAND DS, 1991, MOL BRAIN RES, V11, P345, DOI 10.1016/0169-328X(91)90044-X; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Humphrey GW, 2001, J BIOL CHEM, V276, P6817, DOI 10.1074/jbc.M007372200; Jones PL, 2001, J BIOL CHEM, V276, P8807, DOI 10.1074/jbc.C000879200; Kallunki P, 1998, P NATL ACAD SCI USA, V95, P3233, DOI 10.1073/pnas.95.6.3233; Knoepfler PS, 1999, CELL, V99, P447, DOI 10.1016/S0092-8674(00)81531-7; KRANER SD, 1992, NEURON, V9, P37, DOI 10.1016/0896-6273(92)90218-3; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; LI LA, 1993, P NATL ACAD SCI USA, V90, P1460, DOI 10.1073/pnas.90.4.1460; MANDEL G, 1988, P NATL ACAD SCI USA, V85, P924, DOI 10.1073/pnas.85.3.924; MAUE RA, 1990, NEURON, V4, P223, DOI 10.1016/0896-6273(90)90097-Y; Mieda M, 1997, J BIOL CHEM, V272, P5854, DOI 10.1074/jbc.272.9.5854; MORI N, 1990, NEURON, V4, P583, DOI 10.1016/0896-6273(90)90116-W; Myers SJ, 1998, J NEUROSCI, V18, P6723; Naruse Y, 1999, P NATL ACAD SCI USA, V96, P13691, DOI 10.1073/pnas.96.24.13691; Paquette AJ, 2000, P NATL ACAD SCI USA, V97, P12318, DOI 10.1073/pnas.97.22.12318; Park H, 1998, CHROMOSOMA, V107, P211, DOI 10.1007/s004120050299; Pazin MJ, 1997, CELL, V89, P325, DOI 10.1016/S0092-8674(00)80211-1; Roopra A, 2000, MOL CELL BIOL, V20, P2147, DOI 10.1128/MCB.20.6.2147-2157.2000; Schoch S, 1996, J BIOL CHEM, V271, P3317, DOI 10.1074/jbc.271.6.3317; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; TapiaRamirez J, 1997, P NATL ACAD SCI USA, V94, P1177, DOI 10.1073/pnas.94.4.1177; Thiel G, 1998, J BIOL CHEM, V273, P26891, DOI 10.1074/jbc.273.41.26891; Tyler JK, 1999, CELL, V99, P443, DOI 10.1016/S0092-8674(00)81530-5; Vignali M, 2000, MOL CELL BIOL, V20, P1899, DOI 10.1128/MCB.20.6.1899-1910.2000; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wolffe AP, 2000, J STRUCT BIOL, V129, P102, DOI 10.1006/jsbi.2000.4217; Wood IC, 1996, J BIOL CHEM, V271, P14221, DOI 10.1074/jbc.271.24.14221; WUENSCHELL CW, 1990, NEURON, V4, P595, DOI 10.1016/0896-6273(90)90117-X; Yang WM, 1996, P NATL ACAD SCI USA, V93, P12845, DOI 10.1073/pnas.93.23.12845; You A, 2001, P NATL ACAD SCI USA, V98, P1454, DOI 10.1073/pnas.98.4.1454	52	346	359	1	25	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					353	365		10.1016/S0896-6273(01)00371-3	http://dx.doi.org/10.1016/S0896-6273(01)00371-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516394	Bronze			2022-12-24	WOS:000170601000006
J	Zingman, LV; Alekseev, AE; Bienengraeber, M; Hodgson, D; Karger, AB; Dzeja, PP; Terzic, A				Zingman, LV; Alekseev, AE; Bienengraeber, M; Hodgson, D; Karger, AB; Dzeja, PP; Terzic, A			Signaling in channel/enzyme multimers: ATPase transitions in SUR module gate ATP-sensitive K+ conductance	NEURON			English	Article							NUCLEOTIDE-BINDING FOLDS; KINASE-CATALYZED PHOSPHOTRANSFER; SULFONYLUREA RECEPTOR; POTASSIUM CHANNELS; P-GLYCOPROTEIN; INSULIN-SECRETION; PHYSICAL ASSOCIATION; BETA-SUBUNIT; ION CHANNELS; HYDROLYSIS	ATP-sensitive potassium (K-ATP) channels are bifunctional multimers assembled by an ion conductor and a sulfonylurea receptor (SUR) ATPase. Sensitive to ATP/ADP, K-ATP channels are vital metabolic sensors. However, channel regulation by competitive ATP/ADP binding would require oscillations in intracellular nucleotides incompatible with cell survival. We found that channel behavior is determined by the ATPase-driven engagement of SUR into discrete conformations. Capture of the SUR catalytic cycle in prehydrolytic states facilitated pore closure, while recruitment of posthydrolytic intermediates translated in pore opening. In the cell, channel openers stabilized posthydrolytic states promoting K-ATP channel activation. Nucleotide exchange between intrinsic ATPase and ATP/ADP-scavenging systems defined the lifetimes of specific SUR conformations gating K-ATP channels. Signal transduction through the catalytic module provides a paradigm for channel/enzyme operation and integrates membrane excitability with metabolic cascades.	Mayo Clin & Mayo Fdn, Dept Med, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Mol Pharmacol, Div Cardiovasc Dis, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Dept Expt Therapeut, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Terzic, A (corresponding author), Mayo Clin & Mayo Fdn, Dept Med, Div Cardiovasc Dis, Mayo Fdn Guggenheim 7, Rochester, MN 55905 USA.	terzic.andre@mayo.edu	Alekseev, Alexey/I-5346-2013; Zingman, Leonid V/GXG-0136-2022	Zingman, Leonid V/0000-0002-7566-4616; Karger, Amy/0000-0002-2781-3824	NHLBI NIH HHS [HL-64822, HL-07111] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064822] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Ajtai K, 1999, BIOCHEMISTRY-US, V38, P6428, DOI 10.1021/bi990149r; Ajtai K, 1998, BIOPHYS CHEM, V71, P205, DOI 10.1016/S0301-4622(98)00097-0; Aleksandrov AA, 2000, J PHYSIOL-LONDON, V528, P259, DOI 10.1111/j.1469-7793.2000.00259.x; Alekseev AE, 1998, J GEN PHYSIOL, V111, P381, DOI 10.1085/jgp.111.2.381; Alekseev AE, 1997, J MEMBRANE BIOL, V159, P161, DOI 10.1007/s002329900279; Ashcroft FM, 2000, TRENDS PHARMACOL SCI, V21, P439; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1984, NATURE, V312, P446, DOI 10.1038/312446a0; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; BAUKROWITZ T, 1994, NEURON, V12, P473, DOI 10.1016/0896-6273(94)90206-2; Bienengraeber M, 2000, FASEB J, V14, P1943, DOI 10.1096/fj.00-0027com; Bryan J, 1999, BBA-BIOMEMBRANES, V1461, P285, DOI 10.1016/S0005-2736(99)00164-9; Carrasco AJ, 2001, P NATL ACAD SCI USA, V98, P7623, DOI 10.1073/pnas.121038198; CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T; Clapham DE, 1999, NAT STRUCT BIOL, V6, P807, DOI 10.1038/12261; D'hahan N, 1999, P NATL ACAD SCI USA, V96, P12162, DOI 10.1073/pnas.96.21.12162; Dzeja PP, 1999, CIRC RES, V84, P1137, DOI 10.1161/01.RES.84.10.1137; Dzeja PP, 1998, FASEB J, V12, P523, DOI 10.1096/fasebj.12.7.523; ElvirMairena JR, 1996, J BIOL CHEM, V271, P31903, DOI 10.1074/jbc.271.50.31903; Gadsby D. C., 1999, PHYSIOL REV, V79, pS77; GOLDSTEIN G, 1964, ANAL CHEM, V36, P243, DOI 10.1021/ac60207a074; GOODNO CC, 1979, P NATL ACAD SCI USA, V76, P2620, DOI 10.1073/pnas.76.6.2620; Gribble FM, 1998, P NATL ACAD SCI USA, V95, P7185, DOI 10.1073/pnas.95.12.7185; Gulbis JM, 2000, SCIENCE, V289, P123, DOI 10.1126/science.289.5476.123; GUTIERREZ JA, 1995, J BACTERIOL, V177, P390, DOI 10.1128/jb.177.2.390-400.1995; Hambrock A, 1999, MOL PHARMACOL, V55, P832; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Hille B, 1999, NAT MED, V5, P1105, DOI 10.1038/13415; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Ikuma M, 2000, P NATL ACAD SCI USA, V97, P8675, DOI 10.1073/pnas.140220597; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jovanovic A, 1998, CIRCULATION, V98, P1548, DOI 10.1161/01.CIR.98.15.1548; Jovanovic A, 1996, N-S ARCH PHARMACOL, V353, P241; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Koster JC, 2000, CELL, V100, P645, DOI 10.1016/S0092-8674(00)80701-1; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Li LH, 2000, BIOPHYS J, V79, P841, DOI 10.1016/S0006-3495(00)76340-5; Lorenz E, 1998, MOL CELL BIOL, V18, P1652, DOI 10.1128/MCB.18.3.1652; Lorenz E, 1999, J MOL CELL CARDIOL, V31, P425, DOI 10.1006/jmcc.1998.0876; Matsuo M, 2000, J BIOL CHEM, V275, P28757, DOI 10.1074/jbc.M004818200; Matsuo M, 1999, J BIOL CHEM, V274, P37479, DOI 10.1074/jbc.274.52.37479; MILLER C, 1992, SCIENCE, V258, P240, DOI 10.1126/science.1384128; Moreau C, 2000, EMBO J, V19, P6644, DOI 10.1093/emboj/19.24.6644; Nagata K, 2000, J BIOL CHEM, V275, P17626, DOI 10.1074/jbc.M000792200; NAKASHIMA H, 1993, EUR J PHARMACOL, V233, P219, DOI 10.1016/0014-2999(93)90053-K; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Olson LK, 1996, J BIOL CHEM, V271, P16544, DOI 10.1074/jbc.271.28.16544; OROURKE B, 1994, SCIENCE, V265, P962, DOI 10.1126/science.8052856; Petsko CA, 2000, P NATL ACAD SCI USA, V97, P538, DOI 10.1073/pnas.97.2.538; Peyser YM, 1996, BIOCHEMISTRY-US, V35, P4409, DOI 10.1021/bi952565r; Proks P, 1999, J BIOL CHEM, V274, P25393, DOI 10.1074/jbc.274.36.25393; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; Satoh E, 1998, J PHYSIOL-LONDON, V511, P663, DOI 10.1111/j.1469-7793.1998.663bg.x; Sauna ZE, 2000, P NATL ACAD SCI USA, V97, P2515, DOI 10.1073/pnas.97.6.2515; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Senior AE, 1997, SEMIN CANCER BIOL, V8, P143, DOI 10.1006/scbi.1997.0065; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; STANKIEWICZ PJ, 1995, MET IONS BIOL SYST, V31, P287; Takeda Y, 1998, BBA-BIOMEMBRANES, V1373, P131, DOI 10.1016/S0005-2736(98)00099-6; TERZIC A, 1994, NEURON, V12, P1049, DOI 10.1016/0896-6273(94)90313-1; TERZIC A, 1994, NEURON, V12, P885, DOI 10.1016/0896-6273(94)90340-9; TERZIC A, 1994, CARDIOVASC RES, V28, P746, DOI 10.1093/cvr/28.6.746; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Tesmer JJG, 1999, SCIENCE, V285, P756, DOI 10.1126/science.285.5428.756; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ueda K, 1999, BBA-BIOMEMBRANES, V1461, P305, DOI 10.1016/S0005-2736(99)00157-1; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verkhovsky MI, 1999, NATURE, V400, P480, DOI 10.1038/22813; WEISS JN, 1993, CARDIOVASC DRUG THER, V7, P499, DOI 10.1007/BF00877614; WEISS JN, 1987, SCIENCE, V238, P67, DOI 10.1126/science.2443972; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614	82	158	161	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2001	31	2					233	245		10.1016/S0896-6273(01)00356-7	http://dx.doi.org/10.1016/S0896-6273(01)00356-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502255	Bronze			2022-12-24	WOS:000170277700009
J	Kloss, B; Rothenfluh, A; Young, MW; Saez, L				Kloss, B; Rothenfluh, A; Young, MW; Saez, L			Phosphorylation of PERIOD is influenced by cycling physical associations of DOUBLE-TIME, PERIOD, and TIMELESS in the Drosophila clock	NEURON			English	Review							NUCLEAR ENTRY; CIRCADIAN-RHYTHMS; PROTEIN; MUTATION; GENE; ENTRAINMENT; MECHANISM; ABUNDANCE; SUGGESTS	The clock gene double-time (dbt) encodes an ortholog of casein kinase le that promotes phosphorylation and turnover of the PERIOD protein. Whereas the period (per), timeless (tim), and dClock (dClk) genes of Drosophila each contribute cycling mRNA and protein to a circadian clock, dbt RNA and DBT protein are constitutively expressed. Robust circadian changes in DBT subcellular localization are nevertheless observed in clock-containing cells of the fly head. These localization rhythms accompany formation of protein complexes that include PER, TIM, and DBT, and reflect periodic redistribution between the nucleus and the cytoplasm. Nuclear phosphorylation of PER is strongly enhanced when TIM is removed from PER/TIM/DBT complexes. The varying associations of PER, DBT and TIM appear to determine the onset and duration of nuclear PER function within the Drosophila clock.	Rockefeller Univ, Ctr Biol Timing, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn Sci & Technol, New York, NY 10021 USA	Rockefeller University; National Science Foundation (NSF); Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Ctr Biol Timing, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@rockvax.rockefeller.edu	, 机智的马小跳和机智的羊不愁/ABC-5169-2020	Kloss, Brian/0000-0003-0130-8739; Rothenfluh, Adrian/0000-0002-3813-5723	NIGMS NIH HHS [GM 54339] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; CURTIN KD, 1995, NEURON, V14, P365, DOI 10.1016/0896-6273(95)90292-9; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KOLODZIEJ PA, 1991, METHOD ENZYMOL, V194, P508; Lee CG, 1996, SCIENCE, V271, P1740, DOI 10.1126/science.271.5256.1740; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; MARTINEK S, 2001, IN PRESS CELL; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Rothenfluh A, 2000, GENETICS, V156, P665; Rothenfluh A, 2000, CURR BIOL, V10, P1399, DOI 10.1016/S0960-9822(00)00786-7; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; RUTILA JE, 1992, J NEUROGENET, V8, P101, DOI 10.3109/01677069209084155; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; Suri V, 2000, J NEUROSCI, V20, P7547; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Young MW, 2000, TRENDS BIOCHEM SCI, V25, P601, DOI 10.1016/S0968-0004(00)01695-9; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZERR DM, 1990, J NEUROSCI, V10, P2749; Zilian O, 1999, DEVELOPMENT, V126, P5409	31	144	147	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					699	706		10.1016/S0896-6273(01)00320-8	http://dx.doi.org/10.1016/S0896-6273(01)00320-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430804	Bronze			2022-12-24	WOS:000169508900011
J	Putcha, GV; Moulder, KL; Golden, JP; Bouillet, P; Adams, JA; Strasser, A; Johnson, EM				Putcha, GV; Moulder, KL; Golden, JP; Bouillet, P; Adams, JA; Strasser, A; Johnson, EM			Induction of BIM, a proapoptotic BH3-only BCL-2 family member, is critical for neuronal apoptosis	NEURON			English	Article							NERVE GROWTH-FACTOR; PROGRAMMED CELL-DEATH; TROPHIC-FACTOR DEPRIVATION; CEREBELLAR GRANULE CELLS; DEPENDENT SYMPATHETIC NEURONS; BAX-DEFICIENT MICE; CYTOCHROME-C; PHOSPHATIDYLINOSITOL 3-KINASE; PROTEIN-KINASE; TRANSCRIPTION FACTOR	Sympathetic neuronal death induced by nerve growth factor (NGF) deprivation requires the macromolecular synthesis-dependent translocation of BAX from the cytosol to mitochondria and its subsequent integration into the mitochondrial outer membrane, followed by BAX-mediated cytochrome c (cyt c) release. The gene products triggering this process remain unknown. Here, we report that BIM, a member of the BH3-only proapoptotic subfamily of the BCL-2 protein family, is one such molecule. NGF withdrawal induced expression of BIMEL, an integral mitochondrial membrane protein that functions upstream of (or in parallel with) the BAX/BCL-2 and caspase checkpoints. aim deletion conferred protection against developmental and induced neuronal apoptosis in both central and peripheral populations, but only transiently, suggesting that BIM-and perhaps other BH3-only proteins-serve partially redundant functions upstream of BAX-mediated cyt c release.	Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Washington University (WUSTL); Washington University (WUSTL); Walter & Eliza Hall Institute	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.		Adams, Jerry M/E-1199-2013; Strasser, Andreas/C-7581-2013; Bouillet, Philippe/E-1241-2013	Strasser, Andreas/0000-0002-5020-4891; Bouillet, Philippe/0000-0002-9012-6058; Adams, Jerry/0000-0002-4360-8628; Golden, Judith/0000-0002-5168-8525	NIA NIH HHS [R37AG-12947] Funding Source: Medline; NINDS NIH HHS [R01NS38651] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen FL, 2000, SCIENCE, V287, P1485, DOI 10.1126/science.287.5457.1485; Conradt B, 1998, CELL, V93, P519, DOI 10.1016/S0092-8674(00)81182-4; Crowder RJ, 1998, J NEUROSCI, V18, P2933; D'Mello SR, 1997, J NEUROSCI, V17, P1548; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Deckwerth TL, 1998, EXP NEUROL, V152, P150, DOI 10.1006/exnr.1998.6846; DECKWERTH TL, 1993, J CELL BIOL, V123, P1207, DOI 10.1083/jcb.123.5.1207; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; DEL PL, 1997, SCIENCE, V278, P687; Deshmukh M, 2000, CELL DEATH DIFFER, V7, P250, DOI 10.1038/sj.cdd.4400641; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Deshmukh M, 1996, J CELL BIOL, V135, P1341, DOI 10.1083/jcb.135.5.1341; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Easton RM, 1997, J NEUROSCI, V17, P9656; EDWARDS SN, 1991, J NEUROCHEM, V57, P2140, DOI 10.1111/j.1471-4159.1991.tb06434.x; Eilers A, 1998, J NEUROSCI, V18, P1713; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; FRANKLIN JL, 1995, J NEUROSCI, V15, P643; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Imaizumi K, 1997, J BIOL CHEM, V272, P18842, DOI 10.1074/jbc.272.30.18842; Inohara N, 1997, EMBO J, V16, P1686, DOI 10.1093/emboj/16.7.1686; JOHNSON EM, 1989, NEUROBIOL AGING, V10, P549, DOI 10.1016/0197-4580(89)90127-9; JOHNSON MI, 1983, METHOD ENZYMOL, V103, P334; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lipscomb EA, 1999, J NEUROCHEM, V73, P429, DOI 10.1046/j.1471-4159.1999.0730429.x; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Maroney AC, 1998, J NEUROSCI, V18, P104; MARTIN DP, 1988, J CELL BIOL, V106, P829, DOI 10.1083/jcb.106.3.829; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Mazzoni IE, 1999, J NEUROSCI, V19, P9716; McCarthy MJ, 1997, J CELL SCI, V110, P2165; Miller TM, 1996, J NEUROSCI, V16, P7487; Miller TM, 1997, J BIOL CHEM, V272, P9847; Miller TM, 1997, J CELL BIOL, V139, P205, DOI 10.1083/jcb.139.1.205; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; O'Connor L, 1998, EMBO J, V17, P384, DOI 10.1093/emboj/17.2.384; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; O'Reilly LA, 2000, AM J PATHOL, V157, P449, DOI 10.1016/S0002-9440(10)64557-9; OPPENHEIM RW, 1990, DEV BIOL, V138, P104, DOI 10.1016/0012-1606(90)90180-Q; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Philpott KL, 1997, J CELL BIOL, V139, P809, DOI 10.1083/jcb.139.3.809; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Putcha GV, 1999, J NEUROSCI, V19, P7476, DOI 10.1523/JNEUROSCI.19-17-07476.1999; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; RUIT KG, 1990, J NEUROSCI, V10, P2412; RYDEL RE, 1988, P NATL ACAD SCI USA, V85, P1257, DOI 10.1073/pnas.85.4.1257; Shindler KS, 1998, CELL DEATH DIFFER, V5, P901, DOI 10.1038/sj.cdd.4400421; Shindler KS, 1997, J NEUROSCI, V17, P3112; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; Stennicke HR, 2000, BBA-PROTEIN STRUCT M, V1477, P299, DOI 10.1016/S0167-4838(99)00281-2; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Tsui-Pierchala BA, 2000, J NEUROSCI, V20, P7228; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Virdee K, 1997, J NEUROCHEM, V69, P550; White FA, 1998, J NEUROSCI, V18, P1428; YIP HK, 1984, J NEUROSCI, V4, P2986; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	75	405	428	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					615	628		10.1016/S0896-6273(01)00238-0	http://dx.doi.org/10.1016/S0896-6273(01)00238-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301022	Bronze			2022-12-24	WOS:000167868900012
J	Huang, YQ; Lu, WY; Ali, DW; Pelkey, KA; Pitcher, GM; Lu, YM; Aoto, H; Roder, JC; Sasaki, T; Salter, MW; MacDonald, JF				Huang, YQ; Lu, WY; Ali, DW; Pelkey, KA; Pitcher, GM; Lu, YM; Aoto, H; Roder, JC; Sasaki, T; Salter, MW; MacDonald, JF			CAK beta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus	NEURON			English	Article							PROTEIN-COUPLED RECEPTORS; FOCAL ADHESION KINASE; TYROSINE KINASE; NMDA RECEPTORS; GLUTAMATE-RECEPTOR; C-SRC; REGULATORY PHOSPHORYLATION; ION CHANNELS; ACTIVATION; NEURONS	Long-term potentiation (LTP) is an activity-dependent enhancement of synaptic efficacy, considered a model of learning and memory. The biochemical cascade producing LTP requires activation of Src, which upregulates the function of NMDA receptors (NMDARs), but how Src becomes activated is unknown. Here, we show that the focal adhesion kinase CAK beta /Pyk2 upregulated NMDAR function by activating Src in CA1 hippocampal neurons. Induction of LTP was prevented by blocking CAK beta /Pyk2, and administering CAK beta /Pyk2 intracellularly mimicked and occluded LTP. Tyrosine phosphorylation of CAK beta /Pyk2 and its association with Src was increased by stimulation that produced LTP. Finally, CAK beta /Pyk2-stimulated enhancement of synaptic AMPA responses was prevented by blocking NMDARS, chelating intracellular Ca2+, or blocking Src. Thus, activating CAK beta /Pyk2 is required for inducing LTP and may depend upon downstream activation of Src to upregulate NMDA receptors.	Hosp Sick Children, Programme Brain & Behav, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Cell Biol Programme, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Sapporo Med Univ, Canc Res Inst, Dept Biochem, Sapporo, Hokkaido 0608556, Japan	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Sapporo Medical University	Salter, MW (corresponding author), Hosp Sick Children, Programme Brain & Behav, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.		Lu, Wei-Yang/K-4404-2013; Ali, Declan W/A-2611-2014; Roder, John/G-6468-2013; Ali, Declan/A-2611-2014	Ali, Declan W/0000-0002-8461-4864; Ali, Declan/0000-0001-7614-2484				ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; Atkins CM, 1998, NAT NEUROSCI, V1, P602, DOI 10.1038/2836; Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Biscardi JS, 1999, ADV CANCER RES, V76, P61; BLANTON MG, 1989, J NEUROSCI METH, V30, P203, DOI 10.1016/0165-0270(89)90131-3; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Della Rocca GJ, 1999, J BIOL CHEM, V274, P13978, DOI 10.1074/jbc.274.20.13978; DellaRocca GJ, 1997, J BIOL CHEM, V272, P19125, DOI 10.1074/jbc.272.31.19125; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; Dingledine R, 1999, PHARMACOL REV, V51, P7; EDMONDS B, 1995, ANNU REV PHYSIOL, V57, P495; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Girault JA, 1999, TRENDS NEUROSCI, V22, P257, DOI 10.1016/S0166-2236(98)01358-7; Gutkind JS, 1998, ONCOGENE, V17, P1331, DOI 10.1038/sj.onc.1202186; Herzog H, 1996, GENOMICS, V32, P484, DOI 10.1006/geno.1996.0149; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Huang YQ, 1997, J CELL BIOL, V138, P143, DOI 10.1083/jcb.138.1.143; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Lauri SE, 2000, NEUROREPORT, V11, P997, DOI 10.1097/00001756-200004070-00020; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Lin JW, 1998, J NEUROSCI, V18, P2017; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; MACDONALD JF, 1989, J PHYSIOL-LONDON, V414, P17, DOI 10.1113/jphysiol.1989.sp017674; MACDONALD JF, 1982, BRAIN RES, V237, P248, DOI 10.1016/0006-8993(82)90575-3; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARTINEZ R, 1987, SCIENCE, V237, P411, DOI 10.1126/science.2440106; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; RAYMOND LA, 1994, J PHYSIOLOGY-PARIS, V88, P181, DOI 10.1016/0928-4257(94)90004-3; Roche KW, 1996, NEURON, V16, P1179, DOI 10.1016/S0896-6273(00)80144-0; Salter MW, 1998, BIOCHEM PHARMACOL, V56, P789, DOI 10.1016/S0006-2952(98)00124-5; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Siciliano JC, 1996, J BIOL CHEM, V271, P28942, DOI 10.1074/jbc.271.46.28942; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; WANG JH, 1992, P NATL ACAD SCI USA, V89, P2576, DOI 10.1073/pnas.89.7.2576; WANG LY, 1995, J PHYSIOL-LONDON, V486, P83, DOI 10.1113/jphysiol.1995.sp020792; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yu H, 1996, J BIOL CHEM, V271, P29993, DOI 10.1074/jbc.271.47.29993; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674	52	226	237	0	11	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					485	496		10.1016/S0896-6273(01)00220-3	http://dx.doi.org/10.1016/S0896-6273(01)00220-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239437	Bronze			2022-12-24	WOS:000167141700020
J	Semendeferi, K; Lu, A; Schenker, N; Damasio, H				Semendeferi, K; Lu, A; Schenker, N; Damasio, H			Humans and great apes share a large frontal cortex	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; VOLUMETRIC-ANALYSIS; CEREBRAL-CORTEX; BRAIN; EVOLUTION; HOMINOIDS; LOBES	Some of the outstanding cognitive capabilities of humans are commonly attributed to a disproportionate enlargement of the human frontal lobe during evolution. This claim is based primarily on comparisons between the brains of humans and of other primates, to the exclusion of most great apes. We compared the relative size of the frontal cortices in living specimens of several primate species, including all extant hominoids, using magnetic resonance imaging. Human frontal cortices were not disproportionately large in comparison to those of the great apes. We suggest that the special cognitive abilities attributed to a frontal advantage may be due to differences in individual cortical areas and to a richer interconnectivity, none of which required an increase in the overall relative size of the frontal lobe during hominid evolution.	Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA	University of California System; University of California San Diego; University of Iowa	Semendeferi, K (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA.	ksemende@ucsd.edu	Schenker-Ahmed, Natalie M/B-7470-2011	Schenker-Ahmed, Natalie M/0000-0002-2651-1576; Semendeferi, Katerina/0000-0002-9867-9554				AIELLO LC, 1992, J HUM EVOL, V22, P127, DOI 10.1016/0047-2484(92)90034-7; BARBAS H, 1989, J COMP NEUROL, V286, P353, DOI 10.1002/cne.902860306; Blinkov SM, 1968, ZENTRALNERVENSYSTEM; Brodmann Karl, 1912, Anatomischer Anzeiger, V41; Buxhoeveden DP, 2001, AM J PHYS ANTHROPOL, V115, P361, DOI 10.1002/ajpa.1092; Clark DA, 2001, NATURE, V411, P189, DOI 10.1038/35075564; DAMASIO AR, 1994, DESCARTES ERROR; DAMASIO H, 1992, ARCH NEUROL-CHICAGO, V49, P137, DOI 10.1001/archneur.1992.00530260037016; de Winter W, 2001, NATURE, V409, P710, DOI 10.1038/35055547; Deacon T., 1997, SYMBOLIC SPECIES; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Frank RJ, 1997, NEUROIMAGE, V5, P13, DOI 10.1006/nimg.1996.0250; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; GOLDMANRAKIC PS, 1984, TRENDS NEUROSCI, V7, P425, DOI 10.1016/S0166-2236(84)80147-2; HOLLOWAY RALPH L., 1968, BRAIN RES, V7, P121, DOI 10.1016/0006-8993(68)90094-2; Jerison HJ, 1997, DEV PREFRONTAL CORTE, P9; McBride T, 1999, BRAIN BEHAV EVOLUT, V54, P159, DOI 10.1159/000006620; Nimchinsky EA, 1999, P NATL ACAD SCI USA, V96, P5268, DOI 10.1073/pnas.96.9.5268; Preuss TM, 1999, P NATL ACAD SCI USA, V96, P11601, DOI 10.1073/pnas.96.20.11601; RADINSKY L, 1974, AM J PHYS ANTHROPOL, V41, P15, DOI 10.1002/ajpa.1330410104; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Semendeferi K, 2000, J HUM EVOL, V38, P317, DOI 10.1006/jhev.1999.0381; Semendeferi K, 1997, J HUM EVOL, V32, P375, DOI 10.1006/jhev.1996.0099; Semendeferi K, 2001, AM J PHYS ANTHROPOL, V114, P224, DOI 10.1002/1096-8644(200103)114:3<224::AID-AJPA1022>3.0.CO;2-I; Semendeferi K, 1998, AM J PHYS ANTHROPOL, V106, P129, DOI 10.1002/(SICI)1096-8644(199806)106:2<129::AID-AJPA3>3.0.CO;2-L; SMITH RJ, 1994, J HUM EVOL, V26, P239, DOI 10.1006/jhev.1994.1013; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Zhang K, 2000, P NATL ACAD SCI USA, V97, P5621, DOI 10.1073/pnas.090504197; ZILLES K, 1988, ANAT EMBRYOL, V179, P173, DOI 10.1007/BF00304699	29	313	320	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					272	276		10.1038/nn814	http://dx.doi.org/10.1038/nn814			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850633				2022-12-24	WOS:000174146000019
J	Tsuda, H; Sasai, N; Matsuo-Takasaki, M; Sakuragi, M; Murakami, Y; Sasai, Y				Tsuda, H; Sasai, N; Matsuo-Takasaki, M; Sakuragi, M; Murakami, Y; Sasai, Y			Dorsalization of the neural tube by Xenopus Tiarin, a novel patterning factor secreted by the flanking nonneural head ectoderm	NEURON			English	Article							BONE MORPHOGENETIC PROTEIN-4; SONIC HEDGEHOG; HOMEOBOX GENE; MOTOR-NEURON; FLOOR PLATE; SPINAL-CORD; CELL PATTERN; ROOF PLATE; TRANSCRIPTION FACTOR; DISTINCT EXPRESSION	We have isolated a novel secreted dorsalizing factor of the neural tube, Xenopus Tiarin, which belongs to the olfactomedin-related family. Tiarin expression starts at the late gastrula stage in the nonneural ectoderm adjacent to the anterior neural plate. Overexpression of Tiarin in the embryo causes expansion of dorsal neural markers and suppression of ventral markers. In the eye-forming field, Tiarin overexpression induces the retinal markers and represses optic stalk markers. Tiarin directly dorsalizes neural tissues in the absence of mesodermal tissues and antagonizes the ventralizing activity of Sonic hedghog (Shh). Unlike BMP4, another dorsalizing factor, Tiarin does not display antineuralizing activity on the ectoderm or mesoderm-ventralizing activity. These findings show that Tiarin is a novel patterning signal candidate acting in the specification of the dorsal neural tube.	Kyoto Univ, Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Inst Frontier Med Sci, Dept Reparat Mat, Sakyo Ku, Kyoto 6068507, Japan; RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; RIKEN	Sasai, Y (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Dept Med Embryol & Neurobiol, Sakyo Ku, Kyoto 6068507, Japan.			Sasai, Noriaki/0000-0003-0360-1138				Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; ALTABA ARI, 1993, P NATL ACAD SCI USA, V90, P8268, DOI 10.1073/pnas.90.17.8268; Bang AG, 1997, DEVELOPMENT, V124, P2075; Barbieri AM, 1999, P NATL ACAD SCI USA, V96, P10729, DOI 10.1073/pnas.96.19.10729; Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Barth KA, 1999, DEVELOPMENT, V126, P4977; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; DALE L, 1992, DEVELOPMENT, V115, P573; Deardorff MA, 2001, DEVELOPMENT, V128, P3655; DICKINSON ME, 1995, DEVELOPMENT, V121, P2099; Dosch R, 1997, DEVELOPMENT, V124, P2325; EKKER SC, 1995, DEVELOPMENT, V121, P2337; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FAINSOD A, 1994, EMBO J, V13, P5015, DOI 10.1002/j.1460-2075.1994.tb06830.x; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Gowan K, 2001, NEURON, V31, P219, DOI 10.1016/S0896-6273(01)00367-1; GRUSS P, 1992, CELL, V69, P719, DOI 10.1016/0092-8674(92)90281-G; GURDON JB, 1976, J EMBRYOL EXP MORPH, V36, P523; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; HARRIS WA, 1991, NEURON, V6, P499, DOI 10.1016/0896-6273(91)90053-3; Heller N, 1997, MECH DEVELOP, V69, P83, DOI 10.1016/S0925-4773(97)00158-5; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hynes M, 1997, NEURON, V19, P15, DOI 10.1016/S0896-6273(00)80344-X; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES CM, 1992, DEVELOPMENT, V115, P639; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; KU M, 1993, DEVELOPMENT, V119, P1161; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; Lee J, 1997, DEVELOPMENT, V124, P2537; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li HS, 1997, DEVELOPMENT, V124, P603; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; MARTI E, 1995, NATURE, V375, P322, DOI 10.1038/375322a0; Mathers PH, 1997, NATURE, V387, P603, DOI 10.1038/42475; Matsui M, 2000, P NATL ACAD SCI USA, V97, P5291, DOI 10.1073/pnas.090020497; MAYOR R, 1995, DEVELOPMENT, V121, P767; Meyer D, 1997, INT J DEV BIOL, V41, P607; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Nagano T, 1998, MOL BRAIN RES, V53, P13, DOI 10.1016/S0169-328X(97)00271-4; Nguyen VH, 2000, DEVELOPMENT, V127, P1209; Panchision DM, 2001, GENE DEV, V15, P2094, DOI 10.1101/gad.894701; Pera EM, 2000, MECH DEVELOP, V96, P183, DOI 10.1016/S0925-4773(00)00394-4; Perea-Gomez A, 2001, INT J DEV BIOL, V45, P311; Pfaff SL, 1996, CELL, V84, P309, DOI 10.1016/S0092-8674(00)80985-X; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Placzek M, 2000, CURR OPIN NEUROBIOL, V10, P15, DOI 10.1016/S0959-4388(99)00060-4; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; ROELINK H, 1995, CELL, V81, P445, DOI 10.1016/0092-8674(95)90397-6; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; SAHA MS, 1993, DEVELOPMENT, V118, P193; Saha MS, 1997, DEV BIOL, V187, P209, DOI 10.1006/dbio.1997.8625; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Sasai N, 2001, DEVELOPMENT, V128, P2525; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; SIVE HL, 2000, EARLY DEV XENOPUS LA, P166; Small EM, 2000, MECH DEVELOP, V96, P259, DOI 10.1016/S0925-4773(00)00400-7; SNYDER DA, 1991, BIOCHEMISTRY-US, V30, P9143, DOI 10.1021/bi00102a004; SOKOL S, 1991, CELL, V67, P741, DOI 10.1016/0092-8674(91)90069-B; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Sussel L, 1999, DEVELOPMENT, V126, P3359; Suzuki A, 1997, DEVELOPMENT, V124, P3037; Takabatake T, 2000, MECH DEVELOP, V98, P99, DOI 10.1016/S0925-4773(00)00436-6; Tashiro K, 1999, METHOD ENZYMOL, V303, P479; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; WOLDA SL, 1993, DEV BIOL, V155, P46, DOI 10.1006/dbio.1993.1005; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; YAMADA T, 1991, CELL, V64, P635, DOI 10.1016/0092-8674(91)90247-V; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; YOKOE H, 1993, P NATL ACAD SCI USA, V90, P4655, DOI 10.1073/pnas.90.10.4655	92	48	48	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					515	528		10.1016/S0896-6273(02)00590-1	http://dx.doi.org/10.1016/S0896-6273(02)00590-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856527	Bronze			2022-12-24	WOS:000173911100006
J	Lauwereyns, J; Takikawa, Y; Kawagoe, R; Kobayashi, S; Koizumi, M; Coe, B; Sakagami, M; Hikosaka, O				Lauwereyns, J; Takikawa, Y; Kawagoe, R; Kobayashi, S; Koizumi, M; Coe, B; Sakagami, M; Hikosaka, O			Feature-based anticipation of cues that predict reward in monkey caudate nucleus	NEURON			English	Article							SACCADIC EYE-MOVEMENTS; PRIMATE PREFRONTAL NEURONS; MACAQUE VISUAL-CORTEX; BASAL GANGLIA; FUNCTIONAL-PROPERTIES; ORBITOFRONTAL CORTEX; BEHAVING MONKEY; AREA V4; ATTENTION; RESPONSES	A subset of caudate neurons fires before cues that instruct the monkey what he should do. To test the hypothesis that the anticipatory activity of such neurons depends on the context of stimulus-reward mapping, we examined their activity while the monkeys performed a memory-guided saccade task in which either the position or the color of a cue indicated presence or absence of reward. Some neurons showed anticipatory activity only when a particular position was associated with reward, while others fired selectively for color-reward associations. The functional segregation suggests that caudate neurons participate in feature-based anticipation of visual information that predicts reward. This neuronal code influences the general activity level in response to visual features without improving the quality of visual discrimination.	Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Dept Neurol, Bunkyo Ku, Tokyo 1138655, Japan; Tamagawa Univ, Brain Sci Res Ctr, Tokyo 1948610, Japan	Juntendo University; University of Tokyo	Hikosaka, O (corresponding author), Juntendo Univ, Sch Med, Dept Physiol, Bunkyo Ku, Hongo 2-1-1, Tokyo 1130033, Japan.	hikosaka@med.juntendo.ac.jp	Kobayashi, Shunsuke/C-2551-2008	Kobayashi, Shunsuke/0000-0002-6868-9313; Lauwereyns, Jan/0000-0003-0551-2550; Coe, Brian/0000-0002-3985-0163	NATIONAL EYE INSTITUTE [Z01EY000415, ZIAEY000415] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amador N, 2000, J NEUROPHYSIOL, V84, P2166, DOI 10.1152/jn.2000.84.4.2166; AOSAKI T, 1994, J NEUROSCI, V14, P3969; APICELLA P, 1992, J NEUROPHYSIOL, V68, P945, DOI 10.1152/jn.1992.68.3.945; Basso MA, 1997, NATURE, V389, P66, DOI 10.1038/37975; BINDRA D, 1968, PSYCHOL REV, V75, P1, DOI 10.1037/h0025306; Bowman EM, 1996, J NEUROPHYSIOL, V75, P1061, DOI 10.1152/jn.1996.75.3.1061; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; DIVAC I, 1967, J COMP PHYSIOL PSYCH, V63, P184, DOI 10.1037/h0024348; Dorris MC, 1998, J NEUROSCI, V18, P7015; DOWNING CJ, 1988, J EXP PSYCHOL HUMAN, V14, P188, DOI 10.1037/0096-1523.14.2.188; FISHER RS, 1986, BRAIN RES, V398, P148, DOI 10.1016/0006-8993(86)91260-6; Gold JI, 2001, TRENDS COGN SCI, V5, P10, DOI 10.1016/S1364-6613(00)01567-9; GROVES PM, 1994, NEUROSCIENCE, V58, P593, DOI 10.1016/0306-4522(94)90084-1; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HAWKINS HL, 1990, J EXP PSYCHOL HUMAN, V16, P802, DOI 10.1037/0096-1523.16.4.802; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1230; HIKOSAKA O, 1993, EXP BRAIN RES, V95, P457; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P799, DOI 10.1152/jn.1989.61.4.799; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P780, DOI 10.1152/jn.1989.61.4.780; HIKOSAKA O, 1989, J NEUROPHYSIOL, V61, P814, DOI 10.1152/jn.1989.61.4.814; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; KATO M, 1995, J NEUROSCI, V15, P912; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; KOBAYASHI S, 2002, IN PRESS J NEUROPHYS; Kusama T., 1970, STEREOTAXIC ATLAS BR; Lauwereyns J, 2000, J EXP PSYCHOL ANIM B, V26, P352, DOI 10.1037/0097-7403.26.3.352; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Levy R, 1997, J NEUROSCI, V17, P3870; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; McAdams CJ, 1999, NEURON, V23, P765, DOI 10.1016/S0896-6273(01)80034-9; McAdams CJ, 2000, J NEUROPHYSIOL, V83, P1751, DOI 10.1152/jn.2000.83.3.1751; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rainer G, 1999, J NEUROSCI, V19, P5493; Reynolds JH, 2000, NEURON, V26, P703, DOI 10.1016/S0896-6273(00)81206-4; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; ROLLS ET, 1983, BEHAV BRAIN RES, V7, P179, DOI 10.1016/0166-4328(83)90191-2; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; ROLLS ET, 1999, BRAIN EMOTION; SAKAGAMI M, 1994, EXP BRAIN RES, V97, P423; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SMITH AD, 1990, TRENDS NEUROSCI, V13, P259; Takikawa Y, 2002, J NEUROPHYSIOL, V87, P508, DOI 10.1152/jn.00288.2001; THORPE SJ, 1983, EXP BRAIN RES, V49, P93; Tinklepaugh OL, 1928, J COMP PSYCHOL, V8, P197, DOI 10.1037/h0075798; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0	57	97	100	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					463	473		10.1016/S0896-6273(02)00571-8	http://dx.doi.org/10.1016/S0896-6273(02)00571-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	518AG	11832232	Bronze			2022-12-24	WOS:000173643200015
J	Lee, SJ; Montell, C				Lee, SJ; Montell, C			Regulation of the rhodopsin protein phosphatase, RDGC, through interaction with calmodulin	NEURON			English	Article							DEGENERATION-C RDGC; RETINAL-DEGENERATION; PHOTORECEPTOR CELL; BINDING PROTEIN; DROSOPHILA PHOTORECEPTORS; CALCIUM CHANNELS; VISUAL ARRESTIN; SCALLOP MYOSIN; CA2+ CHANNEL; TRP	Hundreds of G protein-coupled receptors (GPCRs) and at least six GPCR kinases have been identified, but the only GPCR phosphatase that has been definitively demonstrated is the rhodopsin phosphatase encoded by the rdgC locus of Drosophila. Mutations in rdgC result in defects in termination of the light response and cause severe retinal degeneration. In the current work, we demonstrate that RDGC binds to calmodulin, and a mutation in an IQ motif that eliminates the calmodulin/RDGC interaction prevents dephosphorylation of rhodopsin in vivo and disrupts termination of the photoresponse. Our data indicate that RDGC is a novel calmodulin-dependent protein phosphatase and raise the possibility that regulation of other GPCRs through dephosphorylation may be controlled by calmodulin-dependent protein phosphatases related to RDGC.	Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Montell, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.		Lee, Seung Jae V/E-2468-2019; Montell, Craig/AAH-3357-2021	Montell, Craig/0000-0001-5637-1482	NATIONAL EYE INSTITUTE [R01EY008117, R01EY010852] Funding Source: NIH RePORTER; NEI NIH HHS [EY10852, EY08117] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Alloway PG, 2000, NEURON, V28, P129, DOI 10.1016/S0896-6273(00)00091-X; Alloway PG, 1999, P NATL ACAD SCI USA, V96, P6072, DOI 10.1073/pnas.96.11.6072; Andreeva AV, 1999, CELL SIGNAL, V11, P555, DOI 10.1016/S0898-6568(99)00032-7; ANTONIW JF, 1976, EUR J BIOCHEM, V68, P45, DOI 10.1111/j.1432-1033.1976.tb10763.x; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CHAPMAN ER, 1991, J BIOL CHEM, V266, P207; CHENEY R E, 1992, Current Opinion in Cell Biology, V4, P27, DOI 10.1016/0955-0674(92)90055-H; Chevesich J, 1997, NEURON, V18, P95, DOI 10.1016/S0896-6273(01)80049-0; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; DOLPH PJ, 1993, SCIENCE, V260, P1910, DOI 10.1126/science.8316831; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; HARDIE RC, 1995, J NEUROSCI, V15, P889; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; HOUDUSSE A, 1995, P NATL ACAD SCI USA, V92, P10644, DOI 10.1073/pnas.92.23.10644; Huang XZ, 1998, J BIOL CHEM, V273, P1462, DOI 10.1074/jbc.273.3.1462; Kahn ES, 1997, J NEUROCHEM, V68, P169; Kiselev A, 2000, NEURON, V28, P139, DOI 10.1016/S0896-6273(00)00092-1; KLEE CB, 1979, P NATL ACAD SCI USA, V76, P6270, DOI 10.1073/pnas.76.12.6270; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; LEONARD DS, 1992, J NEUROBIOL, V23, P605, DOI 10.1002/neu.480230602; Li HS, 2000, J CELL BIOL, V150, P1411, DOI 10.1083/jcb.150.6.1411; Li HS, 1998, J NEUROSCI, V18, P9601; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; MATSUMOTO H, 1984, SCIENCE, V223, P184, DOI 10.1126/science.6419348; Means AR, 2000, MOL ENDOCRINOL, V14, P4, DOI 10.1210/me.14.1.4; MINKE B, 2000, MOL MECH VISUAL TRAN, P449; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1988, CELL, V52, P757, DOI 10.1016/0092-8674(88)90413-8; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Montini E, 1997, HUM MOL GENET, V6, P1137, DOI 10.1093/hmg/6.7.1137; Munshi HG, 1996, BIOCHEMISTRY-US, V35, P15883, DOI 10.1021/bi962107y; PAK WL, 1995, INVEST OPHTH VIS SCI, V36, P2340; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; PORTER JA, 1992, J CELL BIOL, V116, P683, DOI 10.1083/jcb.116.3.683; PORTER JA, 1995, EMBO J, V14, P4450, DOI 10.1002/j.1460-2075.1995.tb00124.x; PORTER JA, 1993, SCIENCE, V262, P1038, DOI 10.1126/science.8235618; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rusnak F, 2000, PHYSIOL REV, V80, P1483, DOI 10.1152/physrev.2000.80.4.1483; Scott K, 1997, CELL, V91, P375, DOI 10.1016/S0092-8674(00)80421-3; Sherman PM, 1997, P NATL ACAD SCI USA, V94, P11639, DOI 10.1073/pnas.94.21.11639; Soderling TR, 2000, CURR OPIN NEUROBIOL, V10, P375, DOI 10.1016/S0959-4388(00)00090-8; STEELE F, 1990, NEURON, V4, P883, DOI 10.1016/0896-6273(90)90141-2; STEELE FR, 1992, CELL, V69, P669, DOI 10.1016/0092-8674(92)90230-A; STEWART AA, 1982, FEBS LETT, V137, P80, DOI 10.1016/0014-5793(82)80319-0; Vinos J, 1997, SCIENCE, V277, P687, DOI 10.1126/science.277.5326.687; WALLACE RW, 1980, BIOCHEMISTRY-US, V19, P1831, DOI 10.1021/bi00550a016; Warr CG, 1996, BIOCHEM J, V314, P497, DOI 10.1042/bj3140497; Wes PD, 1996, EMBO J, V15, P5839, DOI 10.1002/j.1460-2075.1996.tb00971.x; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; Xu XZS, 2000, NEURON, V26, P647, DOI 10.1016/S0896-6273(00)81201-5; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	60	38	38	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1097	1106		10.1016/S0896-6273(01)00538-4	http://dx.doi.org/10.1016/S0896-6273(01)00538-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754840	Bronze			2022-12-24	WOS:000172886800015
J	Liu, JP; Laufer, E; Jessell, TM				Liu, JP; Laufer, E; Jessell, TM			Assigning the positional identity of spinal motor neurons: Rostrocaudal patterning of Hox-c expression by FGFs, Gdf11, and retinoids	NEURON			English	Article							FIBROBLAST-GROWTH-FACTOR; SUBTYPE IDENTITY; SONIC HEDGEHOG; NEURAL-TUBE; TARGETED DISRUPTION; INDUCTIVE SIGNALS; ACID SYNTHESIS; SPECIFICATION; CORD; HINDBRAIN	Subclasses of motor neurons are generated at different positions along the rostrocaudal axis of the spinal cord. One feature of the rostrocaudal organization of spinal motor neurons is a position-dependent expression of Hox genes, but little is known about how this aspect of motor neuron subtype identity is assigned. We have used the expression profile of Hox-c proteins to define the source and identity of patterning signals that impose motor neuron positional identity along the rostrocaudal axis of the spinal cord. We provide evidence that the convergent activities of FGFs, Gdf11, and retinoid signals originating from Hensen's node and paraxial mesoderm establish and refine the Hox-c positional identity of motor neurons in the developing spinal cord.	Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA; Univ Virginia, Sch Med, Dept Neurosci, Charlottesville, VA 22908 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; University of Virginia	Jessell, TM (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu		Laufer, Edward/0000-0002-4933-1017				Bell E, 1999, SCIENCE, V284, P2168, DOI 10.1126/science.284.5423.2168; Belting HG, 1998, J EXP ZOOL, V282, P196, DOI 10.1002/(SICI)1097-010X(199809/10)282:1/2&lt;196::AID-JEZ22&gt;3.0.CO;2-R; Berggren K, 1999, DEV BIOL, V210, P288, DOI 10.1006/dbio.1999.9286; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Carpenter EM, 1997, DEVELOPMENT, V124, P4505; Constam DB, 1999, J CELL BIOL, V144, P139, DOI 10.1083/jcb.144.1.139; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; Ensini M, 1998, DEVELOPMENT, V125, P969; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; FOREHAND CJ, 1994, J NEUROSCI, V14, P231; Gamer LW, 1999, DEV BIOL, V208, P222, DOI 10.1006/dbio.1998.9191; Gavalas A, 1997, DEVELOPMENT, V124, P3693; Gavalas A, 2000, CURR OPIN GENET DEV, V10, P380, DOI 10.1016/S0959-437X(00)00100-3; Gould A, 1998, NEURON, V21, P39, DOI 10.1016/S0896-6273(00)80513-9; GrapinBotton A, 1997, DEVELOPMENT, V124, P849; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Hart KC, 2000, ONCOGENE, V19, P3309, DOI 10.1038/sj.onc.1203650; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; HOLLYDAY M, 1980, J COMP NEUROL, V194, P143, DOI 10.1002/cne.901940108; Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181; Isaacs HV, 1998, EMBO J, V17, P3413, DOI 10.1093/emboj/17.12.3413; Itasaki N, 1996, NEURON, V16, P487, DOI 10.1016/S0896-6273(00)80069-0; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jungbluth S, 1999, DEVELOPMENT, V126, P2751; Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KINTNER CR, 1991, DEVELOPMENT, V113, P1495; Lance-Jones C, 2001, DEVELOPMENT, V128, P2255; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545; LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546; Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3; LASKOWSKI MB, 1987, J NEUROSCI, V7, P252; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Liem KF, 2000, DEVELOPMENT, V127, P4855; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Liu JP, 1998, DEVELOPMENT, V125, P5055; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; Maden M, 1998, DEVELOPMENT, V125, P4133; MAHMOOD R, 1995, CURR BIOL, V5, P797, DOI 10.1016/S0960-9822(95)00157-6; MAHMOOD R, 1995, DEVELOPMENT, V121, P1399; Marom K, 1997, MECH DEVELOP, V64, P41, DOI 10.1016/S0925-4773(97)00043-9; Mathis L, 2001, NAT CELL BIOL, V3, P559, DOI 10.1038/35078535; Matise MP, 1996, DEVELOPMENT, V122, P659; McMahon JA, 1998, GENE DEV, V12, P1438, DOI 10.1101/gad.12.10.1438; McPherron AC, 1999, NAT GENET, V22, P260, DOI 10.1038/10320; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Muhr J, 1999, NEURON, V23, P689, DOI 10.1016/S0896-6273(01)80028-3; Nakashima M, 1999, MECH DEVELOP, V80, P185, DOI 10.1016/S0925-4773(98)00205-6; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Pownall ME, 1996, DEVELOPMENT, V122, P3881; RIESE J, 1995, MECH DEVELOP, V49, P13, DOI 10.1016/0925-4773(94)00296-Y; ROGHANI M, 1994, J BIOL CHEM, V269, P3976; SCHOENWOLF GC, 1992, ANAT REC, V233, P281, DOI 10.1002/ar.1092330211; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Storey KG, 1998, DEVELOPMENT, V125, P473; STOREY KG, 1992, DEVELOPMENT, V114, P729; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Studer M, 1996, NATURE, V384, P630, DOI 10.1038/384630a0; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Tiret L, 1998, DEVELOPMENT, V125, P279; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wilson SI, 2000, CURR BIOL, V10, P421, DOI 10.1016/S0960-9822(00)00431-0	68	231	243	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					997	1012		10.1016/S0896-6273(01)00544-X	http://dx.doi.org/10.1016/S0896-6273(01)00544-X			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754833	Bronze			2022-12-24	WOS:000172886800008
J	Annaert, WG; Esselens, C; Baert, V; Boeve, C; Snellings, G; Cupers, P; Craessaerts, K; De Strooper, B				Annaert, WG; Esselens, C; Baert, V; Boeve, C; Snellings, G; Cupers, P; Craessaerts, K; De Strooper, B			Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins	NEURON			English	Article							FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; CAENORHABDITIS-ELEGANS; HIPPOCAMPAL-NEURONS; BETA-PROTEIN; INTRAMEMBRANE PROTEOLYSIS; SUBCELLULAR-LOCALIZATION; SIGNAL-TRANSDUCTION; MISSENSE MUTATIONS; TRANSFECTED CELLS	The carboxyl terminus of presenilin 1 and 2 (PS1 and PS2) binds to the neuron-specific cell adhesion molecule telencephalin (TLN) in the brain. PS1 deficiency results in the abnormal accumulation of TLN in a yet unidentified intracellular compartment. The first transmembrane domain and carboxyl terminus of PS1 form a binding pocket with the transmembrane domain of TLN. Remarkably, APP binds to the same regions via part of its transmembrane domain encompassing the critical residues mutated in familial Alzheimer's disease. Our data surprisingly indicate a spatial dissociation between the binding site and the proposed catalytic site near the critical aspartates in PSs. They provide important experimental evidence to support a ring structure model for PS.	Katholieke Univ Leuven VIB, Gasthuisberg, Dept Human Genet, Lab Neuronal Cell Biol, B-3000 Louvain, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven	Annaert, WG (corresponding author), Katholieke Univ Leuven VIB, Gasthuisberg, Dept Human Genet, Lab Neuronal Cell Biol, B-3000 Louvain, Belgium.	ad@med.kuleuven.ac.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819; Esselens, Cary/0000-0001-8876-634X				Annaert W, 1999, TRENDS NEUROSCI, V22, P439, DOI 10.1016/S0166-2236(99)01455-1; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Arduengo PM, 1998, J CELL SCI, V111, P3645; Benson DL, 1998, J NEUROSCI RES, V52, P43, DOI 10.1002/(SICI)1097-4547(19980401)52:1<43::AID-JNR5>3.3.CO;2-A; Berezovska O, 1999, NEUROSCIENCE, V93, P433, DOI 10.1016/S0306-4522(99)00157-8; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; Cruts M, 1998, HUM MUTAT, V11, P183, DOI 10.1002/(SICI)1098-1004(1998)11:3<183::AID-HUMU1>3.3.CO;2-M; Culvenor JG, 1997, J NEUROSCI RES, V49, P719, DOI 10.1002/(SICI)1097-4547(19970915)49:6<719::AID-JNR6>3.0.CO;2-A; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; De Strooper B, 2000, J CELL SCI, V113, P1857; De Strooper B, 2001, J CELL BIOL, V152, pF17, DOI 10.1083/jcb.152.4.F17; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; DeBose-Boyd RA, 1999, CELL, V99, P703, DOI 10.1016/S0092-8674(00)81668-2; DeStrooper B, 1997, J BIOL CHEM, V272, P3590, DOI 10.1074/jbc.272.6.3590; Doan A, 1996, NEURON, V17, P1023, DOI 10.1016/S0896-6273(00)80232-9; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Esler WP, 2001, SCIENCE, V293, P1449, DOI 10.1126/science.1064638; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; Gahmberg CG, 1997, CURR OPIN CELL BIOL, V9, P643, DOI 10.1016/S0955-0674(97)80117-2; Georgakopoulos A, 1999, MOL CELL, V4, P893, DOI 10.1016/S1097-2765(00)80219-1; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hartmann D, 1999, CURR BIOL, V9, P719, DOI 10.1016/S0960-9822(99)80331-5; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Kim SH, 2000, NEUROBIOL DIS, V7, P99, DOI 10.1006/nbdi.1999.0280; Kim TW, 1997, J BIOL CHEM, V272, P11006; LEVITAN D, 1995, NATURE, V377, P351, DOI 10.1038/377351a0; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li XJ, 1998, P NATL ACAD SCI USA, V95, P7109, DOI 10.1073/pnas.95.12.7109; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Lukinova NI, 1999, GENETICS, V153, P1789; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; OKOCHI M, 2000, J BIOL CHEM, V275, P6365; Pradier L, 1999, NEUROBIOL DIS, V6, P43, DOI 10.1006/nbdi.1998.0212; Ray WJ, 1999, P NATL ACAD SCI USA, V96, P3263, DOI 10.1073/pnas.96.6.3263; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Saura CA, 2000, J BIOL CHEM, V275, P17136, DOI 10.1074/jbc.M909624199; Saura CA, 1999, J BIOL CHEM, V274, P13818, DOI 10.1074/jbc.274.20.13818; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; SISODIA S, 2001, TRENDS NEUROSCI, V24, P52; Soriano S, 2001, J CELL BIOL, V152, P785, DOI 10.1083/jcb.152.4.785; Steiner H, 2000, NAT REV MOL CELL BIO, V1, P217, DOI 10.1038/35043065; Steiner H, 1999, BIOCHEMISTRY-US, V38, P14600, DOI 10.1021/bi9914210; Steiner H, 1999, J BIOL CHEM, V274, P7615, DOI 10.1074/jbc.274.12.7615; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tian L, 2000, EUR J IMMUNOL, V30, P810, DOI 10.1002/1521-4141(200003)30:3<810::AID-IMMU810>3.3.CO;2-O; Tian L, 2000, J CELL BIOL, V150, P243, DOI 10.1083/jcb.150.1.243; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 2001, J BIOL CHEM, V276, P33273, DOI 10.1074/jbc.M011152200; Verdile G, 2000, J BIOL CHEM, V275, P20794, DOI 10.1074/jbc.C000208200; Weidemann A, 1997, NAT MED, V3, P328, DOI 10.1038/nm0397-328; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 2000, P NATL ACAD SCI USA, V97, P9299, DOI 10.1073/pnas.97.16.9299; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; YOSHIHARA Y, 1994, NEURON, V12, P541, DOI 10.1016/0896-6273(94)90211-9; YOSHIHARA Y, 1994, NEUROSCI RES, V21, P119, DOI 10.1016/0168-0102(94)90153-8; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	72	174	177	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					579	589		10.1016/S0896-6273(01)00512-8	http://dx.doi.org/10.1016/S0896-6273(01)00512-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719200	Bronze			2022-12-24	WOS:000172363900006
J	del Camino, D; Yellen, G				del Camino, D; Yellen, G			Tight steric closure at the intracellular activation gate of a voltage-gated K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNELS; ION CHANNELS; PORE; INACTIVATION; RECEPTOR; REGION; SITE; SELECTIVITY; PERMEATION; OCCUPANCY	In voltage-gated K+ channels (Kv), an intracellular gate regulates access from the cytoplasm to the pore by organic channel blockers and by chemical modifiers. But is ion flow itself controlled instead by constriction of the narrow selectivity filter near the extracellular surface? We find that the intracellular gate of Kv channels is capable of regulating access even by the small cations Cd2+ and Ag+. It can also exclude small neutral or negatively charged molecules, indicating that the gate operates by steric exclusion rather than electrostatically. Just intracellular to the gated region, channel closure does not restrict access even to very large reagents. Either these Kv channels have a broader inner entrance than seen in the KcsA crystal, even in the closed state, or the region is highly flexible (but nevertheless remains very securely closed nearby).	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Yellen, G (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.			Yellen, Gary/0000-0003-4228-7866	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029693] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 29693, R01 NS029693] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ARMSTRONG CM, 1966, J GEN PHYSIOL, V50, P491, DOI 10.1085/jgp.50.2.491; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; ARMSTRONG CM, 1975, QUART REV BIOPH, V7, P179; CHANDLER WK, 1965, J PHYSIOL-LONDON, V180, P788, DOI 10.1113/jphysiol.1965.sp007732; Chapman ML, 1997, BIOPHYS J, V72, P708, DOI 10.1016/S0006-3495(97)78707-1; CHOI KL, 1993, NEURON, V10, P533, DOI 10.1016/0896-6273(93)90340-W; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 1992, IONIC CHANNELS EXCIT; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Holmgren M, 1997, J GEN PHYSIOL, V109, P527, DOI 10.1085/jgp.109.5.527; Holmgren M, 1996, J GEN PHYSIOL, V108, P195, DOI 10.1085/jgp.108.3.195; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Marcus Y., 1997, ION PROPERTIES; NEYTON J, 1988, J GEN PHYSIOL, V92, P549, DOI 10.1085/jgp.92.5.549; NEYTON J, 1991, J GEN PHYSIOL, V97, P641, DOI 10.1085/jgp.97.4.641; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; STAUFFER DA, 1994, BIOCHEMISTRY-US, V33, P6840, DOI 10.1021/bi00188a013; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Townsend C, 1997, J GEN PHYSIOL, V110, P11, DOI 10.1085/jgp.110.1.11; VanDongen AM, 2001, BIOPHYS J, V80, p175A; Webster SM, 2001, BIOPHYS J, V80, p16A; YEH JZ, 1978, NATURE, V273, P387, DOI 10.1038/273387a0; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zheng J, 1997, J GEN PHYSIOL, V110, P101, DOI 10.1085/jgp.110.2.101; Zheng J, 1998, J GEN PHYSIOL, V112, P457, DOI 10.1085/jgp.112.4.457; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500	37	221	225	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					649	656		10.1016/S0896-6273(01)00487-1	http://dx.doi.org/10.1016/S0896-6273(01)00487-1			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719205	Bronze			2022-12-24	WOS:000172363900011
J	Ma, JX; Znoiko, S; Othersen, KL; Ryan, JC; Das, J; Isayama, T; Kono, M; Oprian, DD; Corson, DW; Cornwall, MC; Cameron, DA; Harosi, FI; Makino, CL; Crouch, RK				Ma, JX; Znoiko, S; Othersen, KL; Ryan, JC; Das, J; Isayama, T; Kono, M; Oprian, DD; Corson, DW; Cornwall, MC; Cameron, DA; Harosi, FI; Makino, CL; Crouch, RK			A visual pigment expressed in both rod and cone photoreceptors	NEURON			English	Article							TIGER SALAMANDER RETINA; PROTEIN BETA-SUBUNIT; MOLECULAR-CLONING; LINEAR DICHROISM; BOVINE RHODOPSIN; GAMMA-SUBUNIT; DARK NOISE; CELLS; GREEN; IDENTIFICATION	Rods and cones contain closely related but distinct G protein-coupled receptors, opsins, which have diverged to meet the differing requirements of night and day vision. Here, we provide evidence for an exception to that rule. Results from immunohistochemistry, spectrophotometry, and single-cell RT-PCR demonstrate that, in the tiger salamander, the green rods and blue-sensitive cones contain the same opsin. In contrast, the two cells express distinct G protein transducin a subunits: rod a transducin in green rods and cone a transducin in blue-sensitive cones. The different transducins do not appear to markedly affect photon sensitivity or response kinetics in the green rod and blue-sensitive cone. This suggests that neither the cell topology or the transducin is sufficient to differentiate the rod and the cone response.	Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA; Med Univ S Carolina, Dept Pathol, Charleston, SC 29425 USA; Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Ophthalmol, Boston, MA 02114 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA; Boston Univ, Sch Med, Dept Physiol, Boston, MA 02118 USA; Marine Biol Lab, Lab Sensory Physiol, Woods Hole, MA 02543 USA	Medical University of South Carolina; Medical University of South Carolina; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School; Brandeis University; Brandeis University; Boston University; Marine Biological Laboratory - Woods Hole	Ma, JX (corresponding author), Med Univ S Carolina, Dept Ophthalmol, 171 Ashley Ave, Charleston, SC 29425 USA.		Ryan, James/W-2269-2019; Kono, Masahiro/AAT-2265-2021; Makino, Clint Lawrence/H-8428-2019; Znoyko, Sergey/E-1294-2013	Kono, Masahiro/0000-0001-7377-1664; Makino, Clint Lawrence/0000-0002-6005-9069; Znoyko, Sergey/0000-0003-1265-328X; Lockman, Kashelle/0000-0001-8017-8084; Ryan, James/0000-0002-1101-3785; Cornwall, M./0000-0002-0847-939X	NEI NIH HHS [EY04939, EY11358, EY04876, EY12600, P30 EY12196, EY01157, R01 EY011358, EY12231, EY07543, R01 EY012231, R01 EY004939] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY007543, R29EY011358, R01EY009514, R01EY004939, R01EY011358, P30EY012196, R01EY012231, R01EY001157, R01EY004876, R01EY012600] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ABRAHAMSON EW, 1974, EXP EYE RES, V18, P51, DOI 10.1016/0014-4835(74)90043-8; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BOLL F, 1877, ARCH ANAT PHYSIOL  P, P4; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Chen N, 1996, INVEST OPHTH VIS SCI, V37, P1907; CRAFT CM, 1994, J BIOL CHEM, V269, P4613; Dartnall H. J. A., 1965, Vision Research, V5, P81, DOI 10.1016/0042-6989(65)90057-X; DARTNALL HJA, 1972, VISION RES, V8, P339; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fung K.Y., 1992, COMPUT GRAPH FORUM, V3, P267; Govardovski VI, 1987, SENS SYST, V1, P28; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; HAROSI FI, 1974, J OPT SOC AM, V64, P903, DOI 10.1364/JOSA.64.000903; HAROSI FI, 1982, COLOR RES APPL, V7, P135, DOI 10.1002/col.5080070216; HAROSI FI, 1975, J GEN PHYSIOL, V66, P357, DOI 10.1085/jgp.66.3.357; HAROSI FI, 1987, J GEN PHYSIOL, V89, P717, DOI 10.1085/jgp.89.5.717; Heath LA, 1997, GENE, V204, P121, DOI 10.1016/S0378-1119(97)00531-3; HENBEST HB, 1955, J CHEM SOC, P2765, DOI 10.1039/jr9550002765; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; HURWITZ RL, 1985, J BIOL CHEM, V260, P568; Imai H, 1997, P NATL ACAD SCI USA, V94, P2322, DOI 10.1073/pnas.94.6.2322; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; Kawamura S, 1999, GENETICS, V153, P1839; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; LEE RH, 1992, J BIOL CHEM, V267, P24776; LEREA CL, 1986, SCIENCE, V234, P77, DOI 10.1126/science.3529395; LEREA CL, 1989, NEURON, V3, P367, DOI 10.1016/0896-6273(89)90261-4; Liebman P.A., 1972, PHOTOCHEMISTRY VISIO, P481; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Ma JX, 1998, BBA-GENE STRUCT EXPR, V1443, P255, DOI 10.1016/S0167-4781(98)00221-8; Ma JX, 2001, VISUAL NEUROSCI, V18, P393, DOI 10.1017/S0952523801183057; MacNichol E. F.  Jr., 1978, Frontiers in Visual Science, P194; Makino CL, 1999, BIOPHYS J, V77, P1024, DOI 10.1016/S0006-3495(99)76953-5; Makino CL, 1996, J GEN PHYSIOL, V108, P27, DOI 10.1085/jgp.108.1.27; MARIANI AP, 1986, PROC R SOC SER B-BIO, V227, P483, DOI 10.1098/rspb.1986.0035; MATTHEWS G, 1983, J PHYSIOL-LONDON, V342, P347, DOI 10.1113/jphysiol.1983.sp014855; MUNTZ WRA, 1963, J EXP BIOL, V40, P371; MUNTZ WRA, 1962, J NEUROPHYSIOL, V25, P712, DOI 10.1152/jn.1962.25.6.712; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Nikonov S, 2000, J GEN PHYSIOL, V116, P795, DOI 10.1085/jgp.116.6.795; NILSSON SEG, 1964, J ULTRA MOL STRUCT R, V10, P390, DOI 10.1016/S0022-5320(64)80018-6; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; ONG OC, 1995, J BIOL CHEM, V270, P8495, DOI 10.1074/jbc.270.15.8495; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; OPRIAN DD, 1993, METH NEUROSCI, V15, P301; PENG YW, 1992, P NATL ACAD SCI USA, V89, P10882, DOI 10.1073/pnas.89.22.10882; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; REUTER T, 1966, VISION RES, V6, P15, DOI 10.1016/0042-6989(66)90011-3; Rieke F, 1996, BIOPHYS J, V71, P2553, DOI 10.1016/S0006-3495(96)79448-1; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; Ryan JC, 2000, VISUAL NEUROSCI, V17, P847, DOI 10.1017/S0952523800176047; Sherry DM, 1998, VISUAL NEUROSCI, V15, P1175, DOI 10.1017/S0952523898156201; SILLMAN AJ, 1991, P ROY SOC B-BIOL SCI, V243, P93, DOI 10.1098/rspb.1991.0016; TSUKIDA K, 1977, J CHROMATOGR, V134, P331; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; WANG SZ, 1992, BIOCHEMISTRY-US, V31, P3309, DOI 10.1021/bi00128a002; WITKOVSKY P, 1981, VISION RES, V21, P875, DOI 10.1016/0042-6989(81)90188-7; Xu L, 1998, Mol Vis, V4, P10; YEN L, 1984, VISION RES, V24, P1555, DOI 10.1016/S0042-6989(84)80005-X	62	84	86	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					451	461		10.1016/S0896-6273(01)00482-2	http://dx.doi.org/10.1016/S0896-6273(01)00482-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709156	Bronze			2022-12-24	WOS:000172119100011
J	Arnett, HA; Mason, J; Marino, M; Suzuki, K; Matsushima, GK; Ting, JPY				Arnett, HA; Mason, J; Marino, M; Suzuki, K; Matsushima, GK; Ting, JPY			TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CUPRIZONE-INDUCED DEMYELINATION; GLUTATHIONE-S-TRANSFERASE; NECROSIS-FACTOR RECEPTORS; MULTIPLE-SCLEROSIS; GERMINAL-CENTERS; GENE-EXPRESSION; DEFICIENT MICE; APOPTOSIS	Here we used mice lacking tumor necrosis factor-alpha (TNF alpha) and its associated receptors to study a model of demyelination and remyelination in which these events could be carefully controlled using a toxin, cuprizone. Unexpectedly, the lack of TNF alpha led to a significant delay in remyelination as assessed by histology, immunohistochemistry for myelin proteins and electron microscopy coupled with morphometric analysis. Failure of repair correlated with a reduction in the pool of proliferating oligodendrocyte progenitors (bromodeoxyuridine-labeled NG2(+) cells) followed by a reduction in the number of mature oligodendrocytes. Analysis of mice lacking TNF receptor 1 (TNFR1) or TNFR2 indicated that TNFR2, not TNFR1, is critical to oligodendrocyte regeneration. This unexpected reparative role for TNF alpha in the CNS is important for understanding oligodendrocyte regeneration/proliferation, nerve remyelination and the design of new therapeutics for demyelinating diseases.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med CB7295, Chapel Hill, NC 27599 USA; Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC 27599 USA; Mem Sloan Kettering Canc Ctr, Ludwig Inst, New York, NY 10017 USA; Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ting, JPY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med CB7295, Chapel Hill, NC 27599 USA.		Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763	NINDS NIH HHS [NS34190] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034190] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akassoglou K, 1998, AM J PATHOL, V153, P801, DOI 10.1016/S0002-9440(10)65622-2; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; BARRES BA, 1994, NATURE, V367, P371, DOI 10.1038/367371a0; Chaplin DD, 1998, CURR OPIN IMMUNOL, V10, P289, DOI 10.1016/S0952-7915(98)80167-2; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Croxford JL, 2000, J IMMUNOL, V164, P2776, DOI 10.4049/jimmunol.164.5.2776; Declercq W, 1998, J IMMUNOL, V161, P390; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Genain CP, 1999, NAT MED, V5, P170, DOI 10.1038/5532; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; Hajihosseini M, 1996, J NEUROSCI, V16, P7981; Haridas V, 1998, J IMMUNOL, V160, P3152; Hinks GL, 2000, MOL CELL NEUROSCI, V16, P542, DOI 10.1006/mcne.2000.0897; Hiremath MM, 1998, J NEUROIMMUNOL, V92, P38, DOI 10.1016/S0165-5728(98)00168-4; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; Keirstead HS, 1999, ADV EXP MED BIOL, V468, P183; Korner H, 1997, J EXP MED, V186, P1585, DOI 10.1084/jem.186.9.1585; Liu JL, 1998, NAT MED, V4, P78, DOI 10.1038/nm0198-078; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; LUDWIN SK, 1978, LAB INVEST, V39, P597; LUDWIN SK, 1984, NATURE, V308, P274, DOI 10.1038/308274a0; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Mason JL, 2000, J NEUROSCI RES, V61, P251, DOI 10.1002/1097-4547(20000801)61:3<251::AID-JNR3>3.0.CO;2-W; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; Matsumoto M, 1996, SCIENCE, V271, P1289, DOI 10.1126/science.271.5253.1289; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; MILLER DJ, 1994, J NEUROSCI, V14, P6230; Morell P, 1998, MOL CELL NEUROSCI, V12, P220, DOI 10.1006/mcne.1998.0715; Nait-Oumesmar B, 1999, EUR J NEUROSCI, V11, P4357, DOI 10.1046/j.1460-9568.1999.00873.x; Nishiyama A, 1996, J NEUROSCI RES, V43, P315, DOI 10.1002/(SICI)1097-4547(19960201)43:3<315::AID-JNR6>3.3.CO;2-3; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Raine CS, 1998, REV NEUROL-FRANCE, V154, P577; RUDDLE NH, 1990, J EXP MED, V172, P1193, DOI 10.1084/jem.172.4.1193; Schiffenbauer J, 2000, CLIN IMMUNOL, V95, P117, DOI 10.1006/clim.2000.4851; Shohami E, 1999, CYTOKINE GROWTH F R, V10, P119, DOI 10.1016/S1359-6101(99)00008-8; Sidman Richard L., 1971, ATLAS MOUSE BRAIN SP; SMALL RK, 1987, NATURE, V328, P155, DOI 10.1038/328155a0; TANSEY FA, 1991, J NEUROCHEM, V57, P95, DOI 10.1111/j.1471-4159.1991.tb02104.x; Tansey FA, 1997, MOL CHEM NEUROPATHOL, V31, P161, DOI 10.1007/BF02815240; TCHELINGERIAN JL, 1995, J NEUROCHEM, V65, P2377; vanOosten BW, 1996, NEUROLOGY, V47, P1531, DOI 10.1212/WNL.47.6.1531; Weiss T, 1998, J IMMUNOL, V161, P3136; Wu JP, 2000, NEUROSCI LETT, V292, P203, DOI 10.1016/S0304-3940(00)01472-5; YAJIMA K, 1979, LAB INVEST, V41, P385; YU WP, 1994, NEURON, V12, P1353, DOI 10.1016/0896-6273(94)90450-2	46	747	764	1	40	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1116	1122		10.1038/nn738	http://dx.doi.org/10.1038/nn738			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11600888				2022-12-24	WOS:000171970900015
J	Berke, JD; Sgambato, V; Zhu, PP; Lavoie, B; Vincent, M; Krause, M; Hyman, SE				Berke, JD; Sgambato, V; Zhu, PP; Lavoie, B; Vincent, M; Krause, M; Hyman, SE			Dopamine and glutamate induce distinct striatal splice forms of ania-6, an RNA polymerase II-associated cyclin	NEURON			English	Article							DEPENDENT PROTEIN-KINASE; C-TERMINAL DOMAIN; REGULATORY SUBUNIT; TRANSCRIPTION; EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; ACTIVATION; ISOFORMS; ADHESION	Control of neuronal gene expression by drugs or neurotransmitters is a critical step in long-term neural plasticity. Here, we show that a gene induced in the striatum by cocaine or direct dopamine stimulation, ania-6, is a member of a novel family of cyclins with homology to cyclins K/T/H/C. Further, different types of neurotransmitter stimulation cause selective induction of distinct ania-6 isoforms, through alternative splicing. The longer Ania-6 protein colocalizes with nuclear speckles and is associated with key elements of the RNA elongation/processing complex, including the hyperphosphorylated form of RNA polymerase II, the splicing factor SC-35, and the p110 PITSLRE cyclin-dependent kinase. Distinct types of neuronal stimulation may therefore differentially modulate nuclear RNA processing, through altered transcription and splicing of ania-6.	NINCDS, Mol Plast Sect, Bethesda, MD 20892 USA; NIDDKD, Mol Biol Lab, Bethesda, MD 20892 USA; NIMH, Bethesda, MD 20892 USA; Harvard Univ, Neurosci Program, Boston, MA 02115 USA; Univ Laval, CREFSIP, Quebec City, PQ G1K 7P4, Canada; Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Harvard University; Laval University; Laval University	Hyman, SE (corresponding author), NINCDS, Mol Plast Sect, Bethesda, MD 20892 USA.	shyman@helix.nih.gov	Sgambato, Véronique/G-9062-2017	Sgambato, Véronique/0000-0002-8792-8586; Krause, Michael/0000-0001-6127-3940	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK036117] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Berke JD, 1998, J NEUROSCI, V18, P5301, DOI 10.1523/JNEUROSCI.18-14-05301.1998; Bibb JA, 1999, NATURE, V402, P669, DOI 10.1038/45251; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Black DL, 1998, NEURON, V20, P165, DOI 10.1016/S0896-6273(00)80444-4; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; BREGMAN DB, 1995, J CELL BIOL, V129, P287, DOI 10.1083/jcb.129.2.287; Bregman DB, 2000, FRONT BIOSCI, V5, pD244, DOI 10.2741/Bregman; Busser J, 1998, J NEUROSCI, V18, P2801; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; COLE AJ, 1992, J NEUROCHEM, V58, P1420, DOI 10.1111/j.1471-4159.1992.tb11358.x; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Daoud R, 1999, EUR J NEUROSCI, V11, P788, DOI 10.1046/j.1460-9568.1999.00486.x; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; FROHMAN MA, 1994, PCR METH APPL, V4, pS40; Fu TJ, 1999, J BIOL CHEM, V274, P34527, DOI 10.1074/jbc.274.49.34527; Gao CY, 1997, BIOESSAYS, V19, P307, DOI 10.1002/bies.950190408; Gomi H, 1999, J NEUROSCI, V19, P9530; Hazzalin CA, 1998, MOL CELL BIOL, V18, P1844, DOI 10.1128/MCB.18.4.1844; Herrmann CH, 2001, J CELL SCI, V114, P1491; Holmberg J, 2000, NATURE, V408, P203, DOI 10.1038/35041577; Illenberger S, 1998, MOL BIOL CELL, V9, P1495, DOI 10.1091/mbc.9.6.1495; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KERYER G, 1993, P NATL ACAD SCI USA, V90, P5418, DOI 10.1073/pnas.90.12.5418; Kim E, 1997, J CELL BIOL, V136, P19, DOI 10.1083/jcb.136.1.19; Koushika SP, 1996, CURR BIOL, V6, P1634, DOI 10.1016/S0960-9822(02)70787-2; Loyer P, 1998, J CELL SCI, V111, P1495; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Mayeda A, 1999, EMBO J, V18, P4560, DOI 10.1093/emboj/18.16.4560; McCracken S, 1997, NATURE, V385, P357, DOI 10.1038/385357a0; Misteli T, 2000, J CELL SCI, V113, P1841; NAKANISHI N, 1992, P NATL ACAD SCI USA, V89, P8552, DOI 10.1073/pnas.89.18.8552; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Neugebauer KM, 1997, GENE DEV, V11, P3279, DOI 10.1101/gad.11.24.3279; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Okabe S, 1999, J NEUROSCI, V19, P7781; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Peng JM, 1998, J BIOL CHEM, V273, P13855, DOI 10.1074/jbc.273.22.13855; PowellCoffman JA, 1996, DEV BIOL, V178, P472, DOI 10.1006/dbio.1996.0232; Ramanathan K, 1999, SCIENCE, V283, P215, DOI 10.1126/science.283.5399.215; Rodger J, 1998, J NEUROCHEM, V71, P666; ROSS ME, 1994, J NEUROSCI, V14, P6384; Schacher S, 2000, J NEUROBIOL, V45, P152, DOI 10.1002/1097-4695(20001115)45:3<152::AID-NEU3>3.0.CO;2-0; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; SCHIAVI SC, 1992, BIOCHIM BIOPHYS ACTA, V1114, P95, DOI 10.1016/0304-419X(92)90009-N; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shippenberg TS, 1997, PHARMACOL BIOCHEM BE, V57, P449, DOI 10.1016/S0091-3057(96)00450-9; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; van Oordt WV, 2000, J CELL BIOL, V149, P307, DOI 10.1083/jcb.149.2.307; Vincent M, 1996, NUCLEIC ACIDS RES, V24, P4649, DOI 10.1093/nar/24.23.4649; Vogelezang MG, 1999, J NEUROSCI RES, V56, P323, DOI 10.1002/(SICI)1097-4547(19990515)56:4<323::AID-JNR1>3.0.CO;2-6; Vreugdenhil E, 1999, J NEUROBIOL, V39, P41, DOI 10.1002/(SICI)1097-4695(199904)39:1<41::AID-NEU4>3.0.CO;2-X; Wang X, 1999, EMBO J, V18, P4549, DOI 10.1093/emboj/18.16.4549; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; White NM, 1997, CURR OPIN NEUROBIOL, V7, P164, DOI 10.1016/S0959-4388(97)80004-9; XIANG JL, 1994, J BIOL CHEM, V269, P15786; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Zacharias DA, 1996, CURR BIOL, V6, P1642, DOI 10.1016/S0960-9822(02)70788-4	61	80	96	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					277	287		10.1016/S0896-6273(01)00465-2	http://dx.doi.org/10.1016/S0896-6273(01)00465-2			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683997	Bronze			2022-12-24	WOS:000171893700012
J	von Schack, D; Casademunt, E; Schweigreiter, R; Meyer, M; Bibel, M; Dechant, G				von Schack, D; Casademunt, E; Schweigreiter, R; Meyer, M; Bibel, M; Dechant, G			Complete ablation of the neurotrophin receptor p75(NTR) causes defects both in the nervous and the vascular system	NATURE NEUROSCIENCE			English	Article							GROWTH-FACTOR RECEPTOR; NGF; EXPRESSION; GENE; P75; RAT		Max Planck Inst Neurobiol, Dept Neurobiochem, D-82152 Martinsried, Germany; Friedrich Miescher Inst Biomed Res, Basel, Switzerland	Max Planck Society; Friedrich Miescher Institute for Biomedical Research	Dechant, G (corresponding author), AGY Therapeut, 290 Utah Ave, S San Francisco, CA 94080 USA.							CHAPMAN BS, 1995, PROTEIN SCI, V4, P1696, DOI 10.1002/pro.5560040905; Donovan MJ, 1996, NAT GENET, V14, P210, DOI 10.1038/ng1096-210; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; LARGE TH, 1989, NEURON, V2, P1123, DOI 10.1016/0896-6273(89)90179-7; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lin MI, 2000, DEV BIOL, V226, P180, DOI 10.1006/dbio.2000.9850; SCARISBRICK IA, 1993, J NEUROSCI, V13, P875; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; Silver L., 1998, MOUSE GENETICS CONCE; Wheeler EF, 1998, J COMP NEUROL, V391, P407	11	196	198	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					977	978		10.1038/nn730	http://dx.doi.org/10.1038/nn730			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11559852				2022-12-24	WOS:000171325800009
J	Hilgetag, CC; Theoret, H; Pascual-Leone, A				Hilgetag, CC; Theoret, H; Pascual-Leone, A			Enhanced visual spatial attention ipsilateral to rTMS-induced 'virtual lesions' of human parietal cortex	NATURE NEUROSCIENCE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; INTERHEMISPHERIC INHIBITION; UNILATERAL NEGLECT; EXCITABILITY; EXTINCTION; LOCALIZATION; HEMINEGLECT; REDUCTION; INDUCTION	The breakdown of attentional mechanisms after brain damage can have drastic behavioral consequences, as in patients suffering from spatial neglect. While much research has concentrated on impaired attention to targets contralateral to sites of brain damage, here we report the ipsilateral enhancement of visual attention after repetitive transcranial magnetic stimulation (rTMS) of parietal cortex at parameters known to reduce cortical excitability. Normal healthy subjects received rTMS (1 Hz, 10 mins) over right or left parietal cortex. Subsequently, detection of visual stimuli contralateral to the stimulated hemisphere was consistently impaired when stimuli were also present in the opposite hemifield, mirroring the extinction phenomenon commonly observed in neglect patients. Additionally, subjects' attention to ipsilateral targets improved significantly over normal levels. These results underline the potential of focal brain dysfunction to produce behavioral improvement and give experimental support to models of interhemispheric competition in the distributed brain network for spatial attention.	Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Neurol, Lab Magnet Brain Stimulat, Boston, MA 02215 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Hilgetag, CC (corresponding author), Int Jacobs Univ Bremen, Campus Ring 1, D-28759 Bremen, Germany.	claush@bu.edu	Pascual-Leone, Alvaro/AAC-5101-2019; Pascual-Leone, Alvaro/G-6566-2011; Hilgetag, Claus C/L-7282-2013; Hilgetag, Claus C/AAH-1760-2020	Pascual-Leone, Alvaro/0000-0001-8975-0382; Hilgetag, Claus C/0000-0003-2129-8910; Hilgetag, Claus C/0000-0003-2129-8910; Theoret, Hugo/0000-0002-7458-8797	NATIONAL EYE INSTITUTE [R01EY012091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH057980, R01MH060734] Funding Source: NIH RePORTER; NEI NIH HHS [R01EY12091] Funding Source: Medline; NIMH NIH HHS [R01MH60734, R01MH57980] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boroojerdi B, 2000, NEUROLOGY, V54, P1529, DOI 10.1212/WNL.54.7.1529; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Di Lazzaro V, 1999, EXP BRAIN RES, V124, P520, DOI 10.1007/s002210050648; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Fierro B, 2000, NEUROREPORT, V11, P1519, DOI 10.1097/00001756-200005150-00030; Fink GR, 2000, ANN NEUROL, V47, P440; Hilgetag C C, 1999, Prog Brain Res, V121, P121; Hilgetag CC, 2000, NEUROCOMPUTING, V32, P793, DOI 10.1016/S0925-2312(00)00246-0; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Kapur N, 1996, BRAIN, V119, P1775, DOI 10.1093/brain/119.5.1775; Karnath HO, 1998, BRAIN, V121, P2357, DOI 10.1093/brain/121.12.2357; Kinsbourne M, 1977, Adv Neurol, V18, P41; Kinsbourne M., 1993, UNILATERAL NEGLECT C, DOI DOI 10.4324/9780203765258; Kinsbourne M., 1987, NEUROPHYSIOLOGICAL N, P69, DOI DOI 10.1016/S0166-4115(08)61709-4; Kosslyn SM, 1999, SCIENCE, V284, P167, DOI 10.1126/science.284.5411.167; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Maeda F, 2000, CLIN NEUROPHYSIOL, V111, P800, DOI 10.1016/S1388-2457(99)00323-5; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; MOTTAGHY F, IN PRESS CEREB CORTE; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Pascual-Leone A, 1999, PHILOS T R SOC B, V354, P1229, DOI 10.1098/rstb.1999.0476; PASCUALLEONE A, 1994, NEUROLOGY, V44, P494, DOI 10.1212/WNL.44.3_Part_1.494; Pouget A, 2000, CURR OPIN NEUROBIOL, V10, P242, DOI 10.1016/S0959-4388(00)00077-5; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; SEYAL M, 1995, ANN NEUROL, V38, P264, DOI 10.1002/ana.410380221; Smania N, 1998, BRAIN, V121, P1759, DOI 10.1093/brain/121.9.1759; THEORET H, IN PRESS NEUROSCI LE; TOGA AW, 2001, NEUROIMAGE, V14, P1; Vallar G, 1998, TRENDS COGN SCI, V2, P87, DOI 10.1016/S1364-6613(98)01145-0; Vuilleumier P, 1996, NEUROLOGY, V46, P184, DOI 10.1212/WNL.46.1.184; Walsh V, 1998, P ROY SOC B-BIOL SCI, V265, P537, DOI 10.1098/rspb.1998.0328; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wassermann EM, 1998, NEUROSCI LETT, V250, P141, DOI 10.1016/S0304-3940(98)00437-6; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621, DOI 10.1001/archneur.1987.00520180043014	36	461	470	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					953	957		10.1038/nn0901-953	http://dx.doi.org/10.1038/nn0901-953			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528429				2022-12-24	WOS:000170698600024
J	Foa, L; Rajan, I; Haas, K; Wu, GY; Brakeman, P; Worley, P; Cline, H				Foa, L; Rajan, I; Haas, K; Wu, GY; Brakeman, P; Worley, P; Cline, H			The scaffold protein, Homer1b/c, regulates axon pathfinding in the central nervous system in vivo	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SMALL GTPASES; GROWTH; CALCIUM; FAMILY; GUIDANCE; CYTOSKELETON; COMPLEXES; MOLECULES; BINDS	Homer proteins are a family of multidomain cytosolic proteins that have been postulated to serve as scaffold proteins that affect responses to extracellular signals by regulating protein-protein interactions. We tested whether Homer proteins are involved in axon pathfinding in vivo, by expressing both wild-type and mutant isoforms of Homer in Xenopus optic tectal neurons. Time-lapse imaging demonstrated that interfering with the ability of endogenous Homer to form protein-protein interactions resulted in axon pathfinding errors at stereotypical choice points. These data demonstrate a function for scaffold proteins such as Homer in axon guidance. Homer may facilitate signal transduction from cell-surface receptors to intracellular proteins that govern the establishment of axon trajectories.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Cold Spring Harbor Laboratory; Johns Hopkins University	Cline, H (corresponding author), Cold Spring Harbor Lab, Beckman Bldg,1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	cline@cshi.org	Foa, Lisa/J-7781-2014; Haas, Kurt/B-3812-2009	Foa, Lisa/0000-0003-4131-8341; Haas, Kurt/0000-0003-4754-1560				Beneken J, 2000, NEURON, V26, P143, DOI 10.1016/S0896-6273(00)81145-9; Bentley David, 1994, Current Opinion in Neurobiology, V4, P43, DOI 10.1016/0959-4388(94)90030-2; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Ciruela F, 2000, MOL CELL NEUROSCI, V15, P36, DOI 10.1006/mcne.1999.0808; Ciruela F, 1999, BIOCHEM J, V341, P795, DOI 10.1042/0264-6021:3410795; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; CLINE HT, 1999, IMAGING LAB MANUAL; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Gao FB, 2000, NEURON, V28, P91, DOI 10.1016/S0896-6273(00)00088-X; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Goodman CS, 1996, ANNU REV NEUROSCI, V19, P341, DOI 10.1146/annurev.ne.19.030196.002013; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu S, 1999, NEURON, V22, P419, DOI 10.1016/S0896-6273(00)80696-0; Kammermeier PJ, 2000, J NEUROSCI, V20, P7238; Karlstrom RO, 1997, TRENDS NEUROSCI, V20, P3, DOI 10.1016/S0166-2236(96)40005-4; KATER SB, 1991, J NEUROSCI, V11, P891; Kato A, 1997, FEBS LETT, V412, P183, DOI 10.1016/S0014-5793(97)00775-8; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Klauck TM, 1996, SCIENCE, V271, P1589, DOI 10.1126/science.271.5255.1589; KRASNOW RE, 1994, DEVELOPMENT, V120, P1883; Krasnow RE, 1995, DEVELOPMENT, V121, P4095; Lin Chi-Hung, 1994, Current Opinion in Neurobiology, V4, P640, DOI 10.1016/0959-4388(94)90004-3; Luo LQ, 1996, PERSPECT DEV NEUROBI, V4, P199; Mackett M., 1985, DNA CLONING PRACTICA, P191; Nedivi E, 1996, P NATL ACAD SCI USA, V93, P2048, DOI 10.1073/pnas.93.5.2048; Rajan I, 1996, ROUX ARCH DEV BIOL, V205, P476, DOI 10.1007/BF00377229; Roche KW, 1999, J BIOL CHEM, V274, P25953, DOI 10.1074/jbc.274.36.25953; Sheng M, 1999, ANN NY ACAD SCI, V868, P483, DOI 10.1111/j.1749-6632.1999.tb11317.x; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Tadokoro S, 1999, P NATL ACAD SCI USA, V96, P13801, DOI 10.1073/pnas.96.24.13801; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wu GY, 1999, J NEUROSCI, V19, P4472; WU GY, 1995, NEURON, V14, P681, DOI 10.1016/0896-6273(95)90211-2; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Zhang Q, 1998, DEV BIOL, V195, P75, DOI 10.1006/dbio.1997.8837; Zheng JQ, 1996, PERSPECT DEV NEUROBI, V4, P205; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	43	59	61	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					499	506		10.1038/87447	http://dx.doi.org/10.1038/87447			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319558				2022-12-24	WOS:000168412600013
J	Kaplan, MR; Cho, MH; Ullian, EM; Isom, LL; Levinson, SR; Barres, BA				Kaplan, MR; Cho, MH; Ullian, EM; Isom, LL; Levinson, SR; Barres, BA			Differential control of clustering of the sodium channels Na(v)1.2 and Na(v)1.6 at developing CNS nodes of ranvier	NEURON			English	Article							RETINAL GANGLION-CELLS; CENTRAL-NERVOUS-SYSTEM; TYROSINE-PHOSPHATASE-BETA; WHITE MATTER GLIA; NEURONS IN-VITRO; ADHESION MOLECULE; RAT-BRAIN; HIPPOCAMPAL-NEURONS; MYELINATED AXONS; INITIAL SEGMENTS	Na(v)1.6 is the main sodium channel isoform at adult nodes of Ranvier. Here, we show that Na(v)1.2 and its beta2 subunit, but not Na(v)1.6 or beta1, are clustered in developing central nervous system nodes and that clustering of Na(v)1.2 and Na(v)1.6 is differentially controlled. Oligodendrocyte-conditioned medium is sufficient to induce clustering of Na(v)1.2 alpha and beta2 subunits along central nervous system axons in vitro. This clustering is regulated by electrical activity and requires an intact actin cytoskeleton and synthesis of a non-sodium channel protein. Neither soluble- or contact-mediated glial signals induce clustering of Na(v)1.6 or beta1 in a nonmyelinating culture system. These data reveal that the sequential clustering of Na(v)1.2 and Na(v)1.6 channels is differentially controlled and suggest that myelination induces Na(v)1.6 clustering.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA	Stanford University; University of Michigan System; University of Michigan; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.			Isom, Lori/0000-0002-9479-6729	NINDS NIH HHS [NS07280] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allison DW, 1998, J NEUROSCI, V18, P2423; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARRES BA, 1990, ANNU REV NEUROSCI, V13, P441, DOI 10.1146/annurev.neuro.13.1.441; BARRES BA, 1990, NEURON, V4, P507, DOI 10.1016/0896-6273(90)90109-S; BARRES BA, 1988, GLIA, V1, P10, DOI 10.1002/glia.440010104; BARTSCH U, 1993, GLIA, V9, P57, DOI 10.1002/glia.440090108; BECKH S, 1989, EMBO J, V8, P3611, DOI 10.1002/j.1460-2075.1989.tb08534.x; BENNETT V, 1992, J BIOL CHEM, V267, P8703; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; Caldwell JH, 2000, P NATL ACAD SCI USA, V97, P5616, DOI 10.1073/pnas.090034797; CATTERALL W, 1992, PHYSIOL REV, V72, pS14; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Ching W, 1999, J NEUROCYTOL, V28, P295, DOI 10.1023/A:1007053411667; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; DARGENT B, 1990, P NATL ACAD SCI USA, V87, P5907, DOI 10.1073/pnas.87.15.5907; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Fjell J, 1997, MOL BRAIN RES, V50, P197, DOI 10.1016/S0169-328X(97)00187-3; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; GORDON D, 1987, P NATL ACAD SCI USA, V84, P8682, DOI 10.1073/pnas.84.23.8682; Hanson MG, 1998, J NEUROSCI, V18, P7361; HARTSHORNE RP, 1982, J BIOL CHEM, V257, P3888; HESS A, 1952, PROC R SOC SER B-BIO, V140, P301, DOI 10.1098/rspb.1952.0063; Hinson AW, 1997, GLIA, V21, P339, DOI 10.1002/(SICI)1098-1136(199712)21:4<339::AID-GLIA1>3.0.CO;2-Z; Isom LL, 2000, AM J PHYSIOL-GASTR L, V278, pG349, DOI 10.1152/ajpgi.2000.278.3.G349; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Jareb M, 1997, J NEUROSCI, V17, P8955; JUNG M, 1993, GLIA, V9, P163, DOI 10.1002/glia.440090302; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kazen-Gillespie KA, 2000, J BIOL CHEM, V275, P1079, DOI 10.1074/jbc.275.2.1079; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; KIRSCH J, 1995, J NEUROSCI, V15, P4148; KORDELI E, 1990, J CELL BIOL, V110, P1341, DOI 10.1083/jcb.110.4.1341; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Meyer-Franke A, 1999, MOL CELL NEUROSCI, V14, P385, DOI 10.1006/mcne.1999.0788; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Ratcliffe CF, 2000, NAT NEUROSCI, V3, P437, DOI 10.1038/74805; Rios JC, 2000, J NEUROSCI, V20, P8354, DOI 10.1523/JNEUROSCI.20-22-08354.2000; SCHMIDT J, 1985, P NATL ACAD SCI USA, V82, P4847, DOI 10.1073/pnas.82.14.4847; SCHMIDT JW, 1986, CELL, V46, P437, DOI 10.1016/0092-8674(86)90664-1; Sharp AA, 1996, J NEUROSCI, V16, P6775; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shoop RD, 2000, J NEUROSCI, V20, P4021; Smith MR, 1998, J NEUROSCI, V18, P6093; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Tobler AR, 1999, J NEUROSCI, V19, P2027; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9; WOLLNER DA, 1986, P NATL ACAD SCI USA, V83, P8424, DOI 10.1073/pnas.83.21.8424; WOLLNER DA, 1988, NEURON, V1, P727, DOI 10.1016/0896-6273(88)90171-7; Xiao ZC, 1999, J BIOL CHEM, V274, P26511, DOI 10.1074/jbc.274.37.26511; Zhou DX, 1998, J CELL BIOL, V143, P1295, DOI 10.1083/jcb.143.5.1295; ZUBER C, 1992, J BIOL CHEM, V267, P9965	69	226	229	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					105	119		10.1016/S0896-6273(01)00266-5	http://dx.doi.org/10.1016/S0896-6273(01)00266-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343648	Bronze			2022-12-24	WOS:000168412900014
J	Wong, WT; Wong, ROL				Wong, WT; Wong, ROL			Changing specificity of neurotransmitter regulation of rapid dendritic remodeling during synaptogenesis	NATURE NEUROSCIENCE			English	Article							DEVELOPING CHICK RETINA; RHO-FAMILY; SPINE; RAC		Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Wong, ROL (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, 660 S Euclid, St Louis, MO 63110 USA.		Wong, Wai/B-6118-2017	Wong, Wai/0000-0003-0681-4016				Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Hering H, 1996, J COMP NEUROL, V375, P393, DOI 10.1002/(SICI)1096-9861(19961118)375:3<393::AID-CNE4>3.0.CO;2-Y; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Malosio ML, 1997, J NEUROSCI, V17, P6717; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; STERLING P, 1983, ANNU REV NEUROSCI, V6, P149, DOI 10.1146/annurev.ne.06.030183.001053; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wong WT, 2000, J NEUROSCI, V20, P5024; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Wong WT, 1998, J NEUROSCI, V18, P8839	15	82	84	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					351	352		10.1038/85987	http://dx.doi.org/10.1038/85987			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276221				2022-12-24	WOS:000168762200011
J	Hamann, M; Rossi, DJ; Attwell, D				Hamann, M; Rossi, DJ; Attwell, D			Tonic and spillover inhibition of granule cells control information flow through cerebellar cortex	NEURON			English	Article							GAMMA-AMINOBUTYRIC-ACID; SUBUNIT MESSENGER-RNAS; GABA(A) RECEPTORS; A RECEPTOR; RAT CEREBELLUM; NEUROSTEROID MODULATION; ALPHA-6 SUBUNIT; NMDA RECEPTORS; OLFACTORY-BULB; CURRENTS	We show that information flow through the adult cerebellar cortex, from the mossy fiber input to the Purkinje cell output, is controlled by furosemide-sensitive, diazepam- and neurosteroid-insensitive GABA(A) receptors on granule cells, which are activated both tonically and by GABA spillover from synaptic release sites. Tonic activation of these receptors contributes a 3-fold larger mean inhibitory conductance than GABA released synaptically by high-frequency stimulation. Tonic and spillover inhibition reduce the fraction of granule cells activated by mossy fiber input, generating an increase of coding sparseness, which is predicted to improve the information storage capacity of the cerebellum.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Attwell, D (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	d.attwell@ucl.ac.uk	Attwell, David/ABE-6750-2020; Hamann, Martine/P-8054-2014	Hamann, Martine/0000-0002-9142-6773				ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Brickley SG, 2001, NATURE, V409, P88, DOI 10.1038/35051086; DANGELO E, 1995, J PHYSIOL-LONDON, V484, P397, DOI 10.1113/jphysiol.1995.sp020673; Fancsik A, 2000, J NEUROSCI, V20, P3067, DOI 10.1523/JNEUROSCI.20-09-03067.2000; GABBIANI F, 1994, J NEUROPHYSIOL, V72, P999, DOI 10.1152/jn.1994.72.2.999; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Jechlinger M, 1998, J NEUROSCI, V18, P2449; KANEDA M, 1995, J PHYSIOL-LONDON, V485, P419, DOI 10.1113/jphysiol.1995.sp020739; KORPI ER, 1995, MOL PHARMACOL, V47, P283; Korpi ER, 1997, BRIT J PHARMACOL, V120, P741, DOI 10.1038/sj.bjp.0700922; LAURIE DJ, 1992, J NEUROSCI, V12, P4151; LAURIE DJ, 1992, J NEUROSCI, V12, P1063; Maex R, 1998, J NEUROPHYSIOL, V80, P2521, DOI 10.1152/jn.1998.80.5.2521; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Mihalek RM, 1999, P NATL ACAD SCI USA, V96, P12905, DOI 10.1073/pnas.96.22.12905; Nusser Z, 1999, EUR J NEUROSCI, V11, P1685, DOI 10.1046/j.1460-9568.1999.00581.x; Nusser Z, 1998, J NEUROSCI, V18, P1693; OTIS TS, 1992, NEUROSCIENCE, V49, P13, DOI 10.1016/0306-4522(92)90073-B; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Pirker S, 2000, NEUROSCIENCE, V101, P815, DOI 10.1016/S0306-4522(00)00442-5; QUIRK K, 1994, J BIOL CHEM, V269, P16020; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; ROSSI DJ, 1993, NEUROPHARMACOLOGY, V32, P1239, DOI 10.1016/0028-3908(93)90018-X; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; Saxena NC, 1996, MOL PHARMACOL, V49, P567; Sigel E, 2000, J NEUROCHEM, V74, P2590, DOI 10.1046/j.1471-4159.2000.0742590.x; Thompson SA, 1999, MOL PHARMACOL, V55, P993, DOI 10.1124/mol.55.6.993; Tia S, 1996, J NEUROSCI, V16, P3630; Tia S, 1996, NEUROPHARMACOLOGY, V35, P1375, DOI 10.1016/S0028-3908(96)00018-4; TYRRELL T, 1992, PHILOS T ROY SOC B, V336, P239, DOI 10.1098/rstb.1992.0059; Uusi-Oukari M, 2000, MOL CELL NEUROSCI, V16, P34, DOI 10.1006/mcne.2000.0856; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x; Wisden W, 1996, NEUROPHARMACOLOGY, V35, P1139, DOI 10.1016/S0028-3908(96)00076-7; WOHLFARTH KM, 2002, IN PRESS J NEUROSCI; Zhu WJ, 1996, J NEUROSCI, V16, P6648; Zhu WJ, 1997, J NEUROSCI, V17, P4022	38	275	281	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					625	633		10.1016/S0896-6273(02)00593-7	http://dx.doi.org/10.1016/S0896-6273(02)00593-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856535	Bronze			2022-12-24	WOS:000173911100014
J	Chen, XC; Tomchick, DR; Kovrigin, E; Arac, D; Machius, M; Sudhof, TC; Rizo, J				Chen, XC; Tomchick, DR; Kovrigin, E; Arac, D; Machius, M; Sudhof, TC; Rizo, J			Three-dimensional structure of the complexin/SNARE complex	NEURON			English	Article							N-TERMINAL DOMAIN; MEMBRANE-FUSION; SNARE COMPLEX; HYDROGEN-EXCHANGE; PROTEIN; EXOCYTOSIS; CRYSTALLOGRAPHY; SYNTAXIN; PROGRAM; PATHWAY	During neurotransmitter release, the neuronal SNARE proteins synaptobrevin/VAMP, syntaxin, and SNAP-25 form a four-helix bundle, the SNARE complex, that pulls the synaptic vesicle and plasma membranes together possibly causing membrane fusion. Complexin binds tightly to the SNARE complex and is essential for efficient Ca2+-evoked neurotransmitter release. A combined X-ray and TROSY-based NMR study now reveals the atomic structure of the complexin/SNARE complex. Complexin binds in an antiparallel alpha-helical conformation to the groove between the synaptobrevin and syntaxin helices. This interaction stabilizes the interface between these two helices, which bears the repulsive forces between the apposed membranes. These results suggest that complexin stabilizes the fully assembled SNARE complex as a key step that enables the exquisitely high speed of Ca2+-evoked neurotransmitter release.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rizo, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Tomchick, Diana/HGV-2018-2022	Tomchick, Diana/0000-0002-7529-4643	NINDS NIH HHS [NS37200] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037200] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; *CCP4, 1994, ACTA CRYSTALLOGR D, V50, P70; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Eastwood SL, 2000, MOL PSYCHIATR, V5, P425, DOI 10.1038/sj.mp.4000741; Englander SW, 2001, METHOD ENZYMOL, V334, P342; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; FASSHAUER D, 1999, INT M TRANSP PROT ME; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; HAKES DJ, 1992, ANAL BIOCHEM, V202, P293, DOI 10.1016/0003-2697(92)90108-J; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; ISHIZUKA T, 1995, BIOCHEM BIOPH RES CO, V213, P1107, DOI 10.1006/bbrc.1995.2241; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KIM KS, 1993, BIOCHEMISTRY-US, V32, P9600, DOI 10.1021/bi00088a012; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Misura KMS, 2001, J BIOL CHEM, V276, P41301, DOI 10.1074/jbc.M106853200; Morton AJ, 2001, J NEUROCHEM, V76, P166, DOI 10.1046/j.1471-4159.2001.00059.x; Naday I, 1998, OPT ENG, V37, P1235, DOI 10.1117/1.601789; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pabst S, 2000, J BIOL CHEM, V275, P19808, DOI 10.1074/jbc.M002571200; Pelham HRB, 1999, EXP CELL RES, V247, P1, DOI 10.1006/excr.1998.4356; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TAKAHASHI S, 1995, FEBS LETT, V368, P455, DOI 10.1016/0014-5793(95)00713-J; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xiao WZ, 2001, NAT STRUCT BIOL, V8, P308, DOI 10.1038/86174; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang DW, 1999, J AM CHEM SOC, V121, P2571, DOI 10.1021/ja984056t; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	49	312	327	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					397	409		10.1016/S0896-6273(02)00583-4	http://dx.doi.org/10.1016/S0896-6273(02)00583-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832227	Green Published, Bronze			2022-12-24	WOS:000173643200010
J	Barg, S; Olofsson, CS; Schriever-Abeln, J; Wendt, A; Gebre-Medhin, S; Renstrom, E; Rorsman, P				Barg, S; Olofsson, CS; Schriever-Abeln, J; Wendt, A; Gebre-Medhin, S; Renstrom, E; Rorsman, P			Delay between fusion pore opening and peptide release from large dense-core vesicles in neuroendocrine cells	NEURON			English	Article							GREEN FLUORESCENT PROTEIN; INSULIN SECRETORY GRANULE; ADRENAL CHROMAFFIN CELLS; PANCREATIC B-CELLS; EXOCYTOTIC EVENT; CALCIUM; DOCKING; CA2+; ESTABLISHMENT; MICROSCOPY	Peptidergic neurotransmission is slow compared to that mediated by classical neurotransmitters. We have studied exocytotic membrane fusion and cargo release by simultaneous capacitance measurements and confocal imaging of single secretory vesicles in neuroendocrine cells. Depletion of the readily releasable pool (RRP) correlated with exocytosis of 10%-20% of the docked vesicles. Some remaining vesicles became releasable after recovery of RRP. Expansion of the fusion pore, seen as an increase in luminal pH, occurred after similar to0.3 s, and peptide release was delayed by another 1-10 s. We conclude that (1) RRP refilling involves chemical modification of vesicles already in place, (2) the release of large neuropeptides via the fusion pore is negligible and only proceeds after complete fusion, and (3) sluggish peptidergic transmission reflects the time course of vesicle emptying.	Lund Univ, Biomed Ctr F11, Inst Physiol Sci, Dept Cellular & Mol Physiol, SE-22184 Lund, Sweden	Lund University	Barg, S (corresponding author), Lund Univ, Biomed Ctr F11, Inst Physiol Sci, Dept Cellular & Mol Physiol, SE-22184 Lund, Sweden.		Tuluc, Petronel/C-2527-2011; Barg, Sebastian/F-9523-2010; Rorsman, Patrik/A-4331-2016	Barg, Sebastian/0000-0003-4661-5724; Rorsman, Patrik/0000-0001-7578-0767; Vikman, Jenny/0000-0001-5082-8867; Olofsson, Charlotta/0000-0001-8824-3151; Wendt, Anna/0000-0001-8807-5979				Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; AMMALA C, 1993, J PHYSIOL-LONDON, V472, P665, DOI 10.1113/jphysiol.1993.sp019966; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Augustine GJ, 1996, ANNU REV PHARMACOL, V36, P659, DOI 10.1146/annurev.pa.36.040196.003303; Barg S, 2001, BIOPHYS J, V81, P3308, DOI 10.1016/S0006-3495(01)75964-4; BITTNER MA, 1992, J BIOL CHEM, V267, P16226; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; Calakos N, 1996, PHYSIOL REV, V76, P1; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Eliasson L, 1997, J PHYSIOL-LONDON, V503, P399, DOI 10.1111/j.1469-7793.1997.399bh.x; FERNANDEZCHACON R, 1995, FEBS LETT, V363, P221, DOI 10.1016/0014-5793(95)00319-5; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Han WP, 1999, P NATL ACAD SCI USA, V96, P14577, DOI 10.1073/pnas.96.25.14577; Han WP, 1999, J NEUROSCI, V19, P900; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; HOLZ RW, 1989, J BIOL CHEM, V264, P5412; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; KATZ B, 1966, NERVE MUSCLE SYNAPSE, P139; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; LEVITAN IB, 1991, NEURON CELL MOL BIOL, P167; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Lollike K, 1998, BIOPHYS J, V75, P53, DOI 10.1016/S0006-3495(98)77494-6; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Ninomiya Y, 1997, EMBO J, V16, P929, DOI 10.1093/emboj/16.5.929; Oheim M, 1998, EUR BIOPHYS J BIOPHY, V27, P83, DOI 10.1007/s002490050114; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Oheim M, 1999, EUR BIOPHYS J BIOPHY, V28, P91, DOI 10.1007/s002490050188; Ohnuma K, 2001, J PHYSIOL-LONDON, V535, P647, DOI 10.1111/j.1469-7793.2001.00647.x; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Patterson GH, 1997, BIOPHYS J, V73, P2782, DOI 10.1016/S0006-3495(97)78307-3; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Pouli AE, 1998, BIOCHEM J, V333, P193, DOI 10.1042/bj3330193; SALAMA G, 1980, J GEN PHYSIOL, V75, P109, DOI 10.1085/jgp.75.2.109; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; SCHELLER RH, 1962, INTRO MOL NEUROBIOLO, P119; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsuboi T, 2000, CURR BIOL, V10, P1307, DOI 10.1016/S0960-9822(00)00756-9; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; Wasmeier C, 1996, J BIOL CHEM, V271, P18161, DOI 10.1074/jbc.271.30.18161; Williams RM, 2000, J CELL SCI, V113, P3839; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	51	155	159	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					287	299		10.1016/S0896-6273(02)00563-9	http://dx.doi.org/10.1016/S0896-6273(02)00563-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804575	Bronze			2022-12-24	WOS:000173387700015
J	Rosenbluth, D; Allman, JM				Rosenbluth, D; Allman, JM			The effect of gaze angle and fixation distance on the responses of neurons in V1, V2, and V4	NEURON			English	Article							PRIMARY VISUAL-CORTEX; EYE POSITION; MONKEY; PROJECTIONS; MACAQUE; CONNECTIONS; MODULATION; MEMORY; FIELDS; AREAS	What we see depends on where we look. This paper characterizes the modulatory effects of point of regard in three-dimensional space on responsiveness of visual cortical neurons in areas V1, V2, and V4. Such modulatory effects are both common, affecting 85% of cells, and strong, frequently producing changes of mean firing rate by a factor of 10. The prevalence of neurons in area V4 showing a preference for near distances may be indicative of the involvement of this area in close scrutiny during object recognition. We propose that eye-position signals can be exploited by visual cortex as classical conditioning stimuli, enabling the perceptual learning of systematic relationships between point of regard and the structure of the visual environment.	Telcordia Technol, Adv Network Syst Res Lab, Morristown, NJ 07960 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA	Ericsson; Telcordia Technologies; California Institute of Technology	Rosenbluth, D (corresponding author), Telcordia Technol, Adv Network Syst Res Lab, 445 South St,Room 1A-732-B, Morristown, NJ 07960 USA.				NATIONAL EYE INSTITUTE [R01EY011759] Funding Source: NIH RePORTER; NEI NIH HHS [EY11759] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; Allman J. M., 1998, EVOLVING BRAINS; Altmann S.A., 1998, FORAGING SURVIVAL, DOI University of Chicago Press; AMARAL DG, 1984, J COMP NEUROL, V230, P465, DOI 10.1002/cne.902300402; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1988, CAN J PHYSIOL PHARM, V66, P488, DOI 10.1139/y88-078; Andersen Richard A., 1995, P519; BUISSERET P, 1977, EXP BRAIN RES, V28, P421; Bullier J, 1996, BEHAV BRAIN RES, V76, P89, DOI 10.1016/0166-4328(95)00182-4; Chun MM, 1999, NAT NEUROSCI, V2, P844, DOI 10.1038/12222; Dobbins AC, 1998, SCIENCE, V281, P552, DOI 10.1126/science.281.5376.552; EVARTS EV, 1976, J NEUROPHYSIOL, V39, P1069, DOI 10.1152/jn.1976.39.5.1069; Gamlin PDR, 1996, EYE, V10, P167, DOI 10.1038/eye.1996.42; GROSS C, 1973, HDV SENSORY PHYSL, V7; Hering E., 1942, SPATIAL SENSE MOVEME; Hinkle DA, 2001, NEUROREPORT, V12, P365, DOI 10.1097/00001756-200102120-00036; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; HUMPHREY N, 1969, Q J EXP PSYCHOL, V2, P225; JAMPEL RS, 1960, J COMP NEUROL, V115, P371, DOI 10.1002/cne.901150306; Kohler I, 1964, FORMATION TRANSFORMA; LAL R, 1990, J NEUROPHYSIOL, V63, P502, DOI 10.1152/jn.1990.63.3.502; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231, DOI 10.1098/rstb.1997.0105; LeDoux J. E., 1996, EMOTIONAL BRAIN; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; MAUNSELL JHR, 1995, SCIENCE, V270, P764, DOI 10.1126/science.270.5237.764; MILNER AD, 1996, VISUAL BRAIN ACTION; MORRISON J, 1998, HDB CHEM NEUROANAT 2, V14; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Sejnowski TJ, 1999, NEURON, V24, P773, DOI 10.1016/S0896-6273(00)81025-9; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; UNGERLEIDER LG, 1977, EXP BRAIN RES, V27, P251; WEYAND TG, 1993, J NEUROPHYSIOL, V69, P2258, DOI 10.1152/jn.1993.69.6.2258; ZEIGLER HP, 1957, AM J PSYCHOL, V70, P106, DOI 10.2307/1419238	36	73	74	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					143	149		10.1016/S0896-6273(01)00559-1	http://dx.doi.org/10.1016/S0896-6273(01)00559-1			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779487	Bronze			2022-12-24	WOS:000173106200017
J	Claridge-Chang, A; Wijnen, H; Naef, F; Boothroyd, C; Rajewsky, N; Young, MW				Claridge-Chang, A; Wijnen, H; Naef, F; Boothroyd, C; Rajewsky, N; Young, MW			Circadian regulation of gene expression systems in the Drosophila head	NEURON			English	Article							MESSENGER-RNA; BEHAVIORAL RHYTHMS; MUTANT DROSOPHILA; CLOCK GENE; MEDIATED ENDOCYTOSIS; ECTOPIC EXPRESSION; MOLECULAR ANALYSIS; NEUROPEPTIDE GENE; PROTEIN; PERIOD	Mechanisms composing Drosophila's clock are conserved within the animal kingdom. To learn how such clocks influence behavioral and physiological rhythms, we determined the complement of circadian transcripts in adult Drosophila heads. High-density oligonucleotide arrays were used to collect data in the form of three 12-point time course experiments spanning a total of 6 days. Analyses of 24 hr Fourier components of the expression patterns revealed significant oscillations for similar to 400 transcripts. Based on secondary filters and experimental verifications, a subset of 158 genes showed particularly robust cycling and many oscillatory phases. Circadian expression was associated with genes involved in diverse biological processes, including learning and memory/synapse function, vision, olfaction, locomotion, detoxification, and areas of metabolism. Data collected from three different clock mutants (per(o), tim(o1), and Clk(Jrk)), are consistent with both known and novel regulatory mechanisms controlling circadian transcription.	Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Phys Math Lab, New York, NY 10021 USA; Rockefeller Univ, Lab Theoret Condensed Matter Phys, New York, NY 10021 USA	Rockefeller University; Rockefeller University; Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, 1230 York Ave, New York, NY 10021 USA.	young@mail.rookefeller.edu	Wijnen, Herman/N-8391-2019; Naef, Felix/C-9527-2011; , 机智的马小跳和机智的羊不愁/ABC-5169-2020; Wijnen, Herman/B-8860-2013	Wijnen, Herman/0000-0002-8710-5176; Wijnen, Herman/0000-0002-8710-5176; Naef, Felix/0000-0001-9786-3037; Rajewsky, Nikolaus/0000-0002-4785-4332; Claridge-Chang, Adam/0000-0002-4583-3650	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054339, R37GM054339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH063579] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM54339] Funding Source: Medline; NIMH NIH HHS [F32 MH063579-01, F32 MH063579, MH63579] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Andretic R, 2000, P NATL ACAD SCI USA, V97, P1873, DOI 10.1073/pnas.97.4.1873; Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; BECKER MN, 1995, J NEUROSCI, V15, P6250; Benveniste RJ, 1998, DEVELOPMENT, V125, P4757; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; Broadie K, 1997, NEURON, V19, P391, DOI 10.1016/S0896-6273(00)80948-4; Brunel CA, 1998, DEV GENES EVOL, V208, P327, DOI 10.1007/s004270050188; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Cermakian N, 2000, NAT REV MOL CELL BIO, V1, P59, DOI 10.1038/35036078; CHEN DM, 1992, VISUAL NEUROSCI, V9, P125, DOI 10.1017/S0952523800009585; Chen X, 2000, GENETICS, V156, P1829; Chou WH, 1996, NEURON, V17, P1101, DOI 10.1016/S0896-6273(00)80243-3; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Crosby MA, 1999, MOL CELL BIOL, V19, P1159; DUDAI Y, 1976, P NATL ACAD SCI USA, V73, P1684, DOI 10.1073/pnas.73.5.1684; Edery I, 2000, PHYSIOL GENOMICS, V3, P59, DOI 10.1152/physiolgenomics.2000.3.2.59; Ehlen JC, 2001, J NEUROSCI, V21, P5351, DOI 10.1523/JNEUROSCI.21-14-05351.2001; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Gutteridge JMC, 2000, ANN NY ACAD SCI, V899, P136, DOI 10.1111/j.1749-6632.2000.tb06182.x; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hartman SJ, 2001, MOL VIS, V7, P95; Heintzen C, 2001, CELL, V104, P453, DOI 10.1016/S0092-8674(01)00232-X; Helfrich-Forster C, 2000, J NEUROSCI, V20, P3339, DOI 10.1523/JNEUROSCI.20-09-03339.2000; Helfrich-Forster C, 2001, NEURON, V30, P249, DOI 10.1016/S0896-6273(01)00277-X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hendricks JC, 2000, PROG NEUROBIOL, V61, P339, DOI 10.1016/S0301-0082(99)00048-9; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Hovemann BT, 1998, GENE, V221, P1, DOI 10.1016/S0378-1119(98)00440-5; HUANG YZ, 1995, SCIENCE, V270, P1828, DOI 10.1126/science.270.5243.1828; INOUE S, 1995, BEHAV BRAIN RES, V69, P91, DOI 10.1016/0166-4328(95)00014-K; Isaac RE, 2000, BIOCHEM SOC T, V28, P460, DOI 10.1042/0300-5127:0280460; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kandel E., 2000, PRINCIPLES NEURAL SC; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KORENBROT JI, 1989, NATURE, V337, P454, DOI 10.1038/337454a0; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Lynch G, 1998, NEUROBIOL LEARN MEM, V70, P82, DOI 10.1006/nlme.1998.3840; MYERS MP, 1995, SCIENCE, V270, P805, DOI 10.1126/science.270.5237.805; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; NEWBY LM, 1991, J NEUROGENET, V7, P85, DOI 10.3109/01677069109066213; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Park JH, 1998, J BIOL RHYTHM, V13, P219, DOI 10.1177/074873098129000066; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; Qualmann B, 2000, J CELL BIOL, V148, P1047, DOI 10.1083/jcb.148.5.1047; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Reuss H, 1997, NEURON, V19, P1249, DOI 10.1016/S0896-6273(00)80416-X; Ripperger JA, 2001, CURR OPIN CELL BIOL, V13, P357, DOI 10.1016/S0955-0674(00)00220-9; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Salinas AE, 1999, CURR MED CHEM, V6, P279; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Schibler U, 2001, SCIENCE, V293, P437, DOI 10.1126/science.1063296; Schopperle WM, 1998, NEURON, V20, P565, DOI 10.1016/S0896-6273(00)80995-2; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Stryer L., 1988, BIOCHEMISTRY-US; Takei K, 2001, TRENDS CELL BIOL, V11, P385, DOI 10.1016/S0962-8924(01)02082-7; Tierney AJ, 2001, COMP BIOCHEM PHYS A, V128, P791, DOI 10.1016/S1095-6433(00)00320-2; Truman James W., 1993, P1245; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Voet D VJ, 1990, BIOCHEMISTRY; Walter MF, 1996, ARCH INSECT BIOCHEM, V31, P219, DOI 10.1002/(SICI)1520-6327(1996)31:2&lt;219::AID-ARCH9&gt;3.0.CO;2-U; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Williams JA, 2001, ANNU REV PHYSIOL, V63, P729, DOI 10.1146/annurev.physiol.63.1.729; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Yang ZH, 2001, NEURON, V29, P453, DOI 10.1016/S0896-6273(01)00218-5; Yin D, 2000, MED HYPOTHESES, V54, P519, DOI 10.1054/mehy.1999.0889; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4	85	365	375	2	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					657	671		10.1016/S0896-6273(01)00515-3	http://dx.doi.org/10.1016/S0896-6273(01)00515-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719206	Bronze			2022-12-24	WOS:000172363900012
J	Snyder, EM; Philpot, BD; Huber, KM; Dong, X; Fallon, JR; Bear, MF				Snyder, EM; Philpot, BD; Huber, KM; Dong, X; Fallon, JR; Bear, MF			Internalization of ionotropic glutamate receptors in response to mGluR activation	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; PROTEIN-SYNTHESIS; SYNAPTIC TRANSMISSION; AMPA RECEPTORS; EXPRESSION; INDUCTION; LTD; CA1; POTENTIATION; ENDOCYTOSIS	Activation of group 1 metabotropic glutamate receptors (mGIuRs) stimulates dendritic protein synthesis and long-term synaptic depression (LTD), but it remains unclear how these effects are related. Here we provide evidence that a consequence of mGluR activation in the hippocampus is the rapid loss of both AMPA and NMDA receptors from synapses. Like mGluR-LTD, the stable expression of this change requires protein synthesis. These data suggest that expression of mGluR-LTD is at least partly postsynaptic, and that a functional consequence of dendritic protein synthesis is the regulation of glutamate receptor trafficking.	Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Brown Univ, Howard Hughes Med Inst, Providence, RI 02912 USA; Univ Texas, SW Med Ctr, Dept Physiol, Dallas, TX 75390 USA	Brown University; Brown University; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Bear, MF (corresponding author), Brown Univ, Dept Neurosci, Providence, RI 02912 USA.		Huber, Kimberly/X-5534-2019	Bear, Mark/0000-0002-9903-2541	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039321] Funding Source: NIH RePORTER; NCRR NIH HHS [P20 RR015578-020002, P20 RR015578] Funding Source: Medline; NINDS NIH HHS [P01 NS039321-03, P01 NS039321, NS39321] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; Bear MF, 1999, J NEUROBIOL, V41, P83, DOI 10.1002/(SICI)1097-4695(199910)41:1<83::AID-NEU11>3.0.CO;2-Z; Bear MF, 2001, SYNAPSES, P455; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BENKE TA, 1993, P NATL ACAD SCI USA, V90, P7819, DOI 10.1073/pnas.90.16.7819; BOLSHAKOV VY, 1994, SCIENCE, V264, P1148, DOI 10.1126/science.7909958; Camodeca N, 1999, NEUROPHARMACOLOGY, V38, P1597, DOI 10.1016/S0028-3908(99)00093-3; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chung HJ, 2000, J NEUROSCI, V20, P7258; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; Doherty AJ, 2000, BRIT J PHARMACOL, V131, P239, DOI 10.1038/sj.bjp.0703574; DUDEK SM, 1989, SCIENCE, V246, P673, DOI 10.1126/science.2573152; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	34	426	444	0	26	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1079	1085		10.1038/nn746	http://dx.doi.org/10.1038/nn746			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687813				2022-12-24	WOS:000171970900010
J	Cheng, HJ; Bagri, A; Yaron, A; Stein, E; Pleasure, SJ; Tessier-Lavigne, M				Cheng, HJ; Bagri, A; Yaron, A; Stein, E; Pleasure, SJ; Tessier-Lavigne, M			Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections	NEURON			English	Article							PERIPHERAL-NERVE PROJECTION; CAJAL-RETZIUS CELLS; GUIDANCE; NEUROPILIN-2; RECEPTORS; MICE; CONNECTIONS; RESPONSES; GROWTH; TRANSMEMBRANE	Plexins are receptors implicated in mediating signaling by semaphorins, a family of axonal chemorepellents. The role of specific plexins in mediating semaphorin function in vivo has not, however, yet been examined in vertebrates. Here, we show that plexin-A3 is the most ubiquitously expressed plexin family member within regions of the developing mammalian nervous system known to contain semaphorin-responsive neurons. Using a chimeric receptor construct, we provide evidence that plexin-A3 can transduce a repulsive signal in growth cones in vitro. Analysis of plexin-A3 knockout mice shows that plexin-A3 contributes to Sema3F and Sema3A signaling and that plexin-A3 regulates the development of hippocampal axonal projections in vivo.	Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, Neurodev Disorders Lab, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA.		Stein, Elke/E-8107-2013; Cheng, Hwai-Jong/AAY-5067-2021	Stein, Elke/0000-0001-8965-5692; Cheng, Hwai-Jong/0000-0003-0647-0567	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS002208] Funding Source: NIH RePORTER; NINDS NIH HHS [5 K08 NS02208] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barallobre MJ, 2000, DEVELOPMENT, V127, P4797; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Borrell V, 1999, EXP NEUROL, V156, P268, DOI 10.1006/exnr.1999.7022; Chedotal A, 1998, DEVELOPMENT, V125, P4313; Chen EY, 1996, HUM MOL GENET, V5, P659, DOI 10.1093/hmg/5.5.659; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; Murakami Y, 2001, DEV DYNAM, V220, P246, DOI 10.1002/1097-0177(20010301)220:3<246::AID-DVDY1112>3.0.CO;2-2; Nakamura F, 2000, J NEUROBIOL, V44, P219, DOI 10.1002/1097-4695(200008)44:2<219::AID-NEU11>3.0.CO;2-W; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Pleasure SJ, 2000, J NEUROSCI, V20, P6095, DOI 10.1523/JNEUROSCI.20-16-06095.2000; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; SCHWEGLER H, 1990, NEUROSCIENCE, V34, P293, DOI 10.1016/0306-4522(90)90139-U; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; SUPER H, 1994, J COMP NEUROL, V344, P101, DOI 10.1002/cne.903440108; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; White FA, 2000, DEV BIOL, V225, P79, DOI 10.1006/dbio.2000.9822; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; ZIMMER J, 1978, J COMP NEUROL, V179, P581, DOI 10.1002/cne.901790309	32	167	172	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					249	263		10.1016/S0896-6273(01)00478-0	http://dx.doi.org/10.1016/S0896-6273(01)00478-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683995	Bronze			2022-12-24	WOS:000171893700010
J	Quirk, JC; Reinhart, PH				Quirk, JC; Reinhart, PH			Identification of a novel tetramerization domain in large conductance K-Ca channels	NEURON			English	Article							ACTIVATED POTASSIUM CHANNELS; BETA-SUBUNIT; CALCIUM SENSITIVITY; TERMINAL DOMAIN; ION CHANNELS; RAT-BRAIN; VOLTAGE; PROTEINS; SHAKER; STOICHIOMETRY	More than 50 genes are known to encode K+ channel monomers and can coassemble to form hetero-tetrameric K+ channels. However, only a subset of possible monomer combinations come together to form functional ion channels. The assembly and tetramerization of appropriate channel monomers is mediated by association domains (ADs). To identify such domains in human large-conductance Ca2(+)-activated K+ channels (hSlo1), we screened hSlo1 domains for self-association using yeast two-hybrid assays. Putative ADs were subjected to functional assays in Xenopus oocytes and further characterized by co precipitation, native gel electrophoresis, and sucrose density gradient centrifugation assays. This led to the identification of a single intracellular association domain localized near the channel pore and required for channel function. We conclude that this novel tetramerization domain, referred to as BK-T1, promotes the assembly of hSlo1 monomers into functional Kc channels.	Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Reinhart, PH (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, POB 3209, Durham, NC 27710 USA.				NIMH NIH HHS [MH011753] Funding Source: Medline; NINDS NIH HHS [NS031253, NS041866] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031253, R01NS041866, R29NS031253] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott GW, 1997, BBA-PROTEIN STRUCT M, V1341, P71, DOI 10.1016/S0167-4838(97)00062-9; BIELEFELDT K, 1994, BIOPHYS J, V66, P1904, DOI 10.1016/S0006-3495(94)80984-1; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Bond CT, 1999, ANN NY ACAD SCI, V868, P370, DOI 10.1111/j.1749-6632.1999.tb11298.x; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P141; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Coetzee WA, 1999, ANN NY ACAD SCI, V868, P233, DOI 10.1111/j.1749-6632.1999.tb11293.x; COVARRUBIAS M, 1991, NEURON, V7, P763, DOI 10.1016/0896-6273(91)90279-9; Cui JM, 2000, BIOCHEMISTRY-US, V39, P15612, DOI 10.1021/bi001509+; Favre I, 2000, BIOCHEMISTRY-US, V39, P2001, DOI 10.1021/bi992140v; Fettiplace R, 1999, ANNU REV PHYSIOL, V61, P809, DOI 10.1146/annurev.physiol.61.1.809; GLOWATZKI E, 1995, P ROY SOC B-BIOL SCI, V261, P251, DOI 10.1098/rspb.1995.0145; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Joiner WJ, 1998, NAT NEUROSCI, V1, P462, DOI 10.1038/2176; Kaczorowski GJ, 1999, CURR OPIN CHEM BIOL, V3, P448, DOI 10.1016/S1367-5931(99)80066-0; Keskin O, 2000, BIOPHYS J, V78, P2093, DOI 10.1016/S0006-3495(00)76756-7; Knaus HG, 1996, J NEUROSCI, V16, P955; KNAUS HG, 1994, J BIOL CHEM, V269, P17274; Koster JC, 1998, BIOPHYS J, V74, P1821, DOI 10.1016/S0006-3495(98)77892-0; Kreusch A, 1998, NATURE, V392, P945, DOI 10.1038/31978; KUHSE J, 1993, NEURON, V11, P1049, DOI 10.1016/0896-6273(93)90218-G; LI M, 1992, SCIENCE, V257, P1225, DOI 10.1126/science.1519059; Lim HH, 1999, GENE, V240, P35, DOI 10.1016/S0378-1119(99)00398-4; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; MILEDI R, 1984, J PHYSIOL-LONDON, V357, P173, DOI 10.1113/jphysiol.1984.sp015495; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Nagase T, 2000, DNA RES, V7, P65, DOI 10.1093/dnares/7.1.65; North RA, 2000, TRENDS NEUROSCI, V23, P234, DOI 10.1016/S0166-2236(00)01592-7; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; PEROZO E, 1993, NEURON, V11, P353, DOI 10.1016/0896-6273(93)90190-3; REINHART PH, 1995, J NEUROSCI, V15, P4572; REINHART PH, 1989, NEURON, V2, P1031, DOI 10.1016/0896-6273(89)90227-4; ROBITAILLE R, 1993, NEURON, V11, P645, DOI 10.1016/0896-6273(93)90076-4; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Rothberg BS, 2000, J GEN PHYSIOL, V116, P75, DOI 10.1085/jgp.116.1.75; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Schreiber M, 1999, NAT NEUROSCI, V2, P416, DOI 10.1038/8077; Schreiber M, 1998, J BIOL CHEM, V273, P3509, DOI 10.1074/jbc.273.6.3509; SHEN NV, 1995, NEURON, V14, P625, DOI 10.1016/0896-6273(95)90319-4; Sheng ZF, 1998, METHOD ENZYMOL, V293, P17; Sheng ZF, 1997, BIOCHEMISTRY-US, V36, P15501; Taylor PM, 1999, J NEUROSCI, V19, P6360; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Wallner M, 1999, P NATL ACAD SCI USA, V96, P4137, DOI 10.1073/pnas.96.7.4137; Wallner M, 1996, P NATL ACAD SCI USA, V93, P14922, DOI 10.1073/pnas.93.25.14922; Wallner M, 1999, CURR TOP MEMBR, V46, P117; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Wei A, 1996, NEUROPHARMACOLOGY, V35, P805, DOI 10.1016/0028-3908(96)00126-8; Weiger TM, 2000, J NEUROSCI, V20, P3563, DOI 10.1523/JNEUROSCI.20-10-03563.2000; Yang J, 1995, NEURON, V15, P1441, DOI 10.1016/0896-6273(95)90021-7; YU XM, 1991, NATURE, V352, P64, DOI 10.1038/352064a0; Yuan A, 2000, NAT NEUROSCI, V3, P771, DOI 10.1038/77670; Zagotta WN, 2001, NEURON, V29, P547, DOI 10.1016/S0896-6273(01)00227-6	61	57	60	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					13	23		10.1016/S0896-6273(01)00444-5	http://dx.doi.org/10.1016/S0896-6273(01)00444-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604135	Bronze			2022-12-24	WOS:000171525200005
J	Nilsberth, C; Westlind-Danielsson, A; Eckman, CB; Condron, MM; Axelman, K; Forsell, C; Stenh, C; Luthman, J; Teplow, DB; Younkin, SG; Naslund, J; Lannfelt, L				Nilsberth, C; Westlind-Danielsson, A; Eckman, CB; Condron, MM; Axelman, K; Forsell, C; Stenh, C; Luthman, J; Teplow, DB; Younkin, SG; Naslund, J; Lannfelt, L			The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced A beta protofibril formation	NATURE NEUROSCIENCE			English	Article							AMYLOID PRECURSOR PROTEIN; FIBRIL FORMATION; IN-VITRO; CEREBRAL-HEMORRHAGE; GENE; FIBRILLOGENESIS; A-BETA(1-42); PRESENILINS; PEPTIDES; PLASMA	Several pathogenic Alzheimer's disease (AD) mutations have been described, all of which cause increased amyloid beta -protein (A beta) levels. Here we present studies of a pathogenic amyloid precursor protein (APP) mutation, located within the A beta sequence at codon 693 (E693G), that causes AD in a Swedish family. Carriers of this 'Arctic' mutation showed decreased A beta 42 and A beta 40 levels in plasma. Additionally, low levels of A beta 42 were detected in conditioned media from cells transfected with APP(E693G). Fibrillization studies demonstrated no difference in fibrillization rate, but A beta with the Arctic mutation formed protofibrils at a much higher rate and in larger quantities than wild-type (wt) A beta. The finding of increased protofibril formation and decreased A beta plasma levels in the Arctic AD may reflect an alternative pathogenic mechanism for AD involving rapid A beta protofibril formation leading to accelerated buildup of insoluble A beta intra- and/or extracellularly.	AstraZeneca, Discovery Res Area CNS & Pain Control, S-15185 Sodertalje, Sweden; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA	AstraZeneca; Mayo Clinic; Harvard University; Brigham & Women's Hospital	Lannfelt, L (corresponding author), Karolinska Inst, Novum KFC, Dept Neurotec, S-14186 Huddinge, Sweden.	lars.lannfelt@neurotec.ki.se			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038328] Funding Source: NIH RePORTER; NIA NIH HHS [AG14366] Funding Source: Medline; NINDS NIH HHS [NS38328] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CITRON M, 1994, P NATL ACAD SCI USA, V91, P11993, DOI 10.1073/pnas.91.25.11993; Citron M, 1997, NAT MED, V3, P67, DOI 10.1038/nm0197-67; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; De Jonghe C, 1998, NEUROBIOL DIS, V5, P281, DOI 10.1006/nbdi.1998.0202; FORSELL C, 1995, NEUROSCI LETT, V184, P90, DOI 10.1016/0304-3940(94)11176-J; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Harper JD, 1999, BIOCHEMISTRY-US, V38, P8972, DOI 10.1021/bi9904149; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Harper JD, 1997, CHEM BIOL, V4, P951, DOI 10.1016/S1074-5521(97)90303-3; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; He WL, 1999, BIOCHEMISTRY-US, V38, P10871, DOI 10.1021/bi990563r; HENDRIKS L, 1992, NAT GENET, V1, P218, DOI 10.1038/ng0692-218; Iwatsubo T, 1998, NEUROBIOL AGING, V19, P161, DOI 10.1016/S0197-4580(98)00015-3; JOHNSTON JA, 1994, FEBS LETT, V354, P274, DOI 10.1016/0014-5793(94)01137-0; KAMINO K, 1992, AM J HUM GENET, V51, P998; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Mayeux R, 1999, ANN NEUROL, V46, P412, DOI 10.1002/1531-8249(199909)46:3<412::AID-ANA19>3.0.CO;2-A; MULLAN M, 1992, NAT GENET, V1, P345, DOI 10.1038/ng0892-345; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; Selkoe DJ, 1999, NATURE, V399, pA23, DOI 10.1038/399a023; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Tagliavini F., 1999, ALZHEIMERS REP, V2, pS28; Tamaoka A, 1996, J NEUROL SCI, V141, P65, DOI 10.1016/0022-510X(96)00143-8; Teplow DB, 1998, AMYLOID, V5, P121, DOI 10.3109/13506129808995290; Tjernberg LO, 1996, J BIOL CHEM, V271, P8545, DOI 10.1074/jbc.271.15.8545; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Walsh DM, 1999, J BIOL CHEM, V274, P25945, DOI 10.1074/jbc.274.36.25945; Walsh DM, 2001, BIOCHEM J, V355, P869, DOI 10.1042/bj3550869; Watson DJ, 1999, BIOCHEM J, V340, P703, DOI 10.1042/0264-6021:3400703; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001	40	870	904	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					887	893		10.1038/nn0901-887	http://dx.doi.org/10.1038/nn0901-887			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528419				2022-12-24	WOS:000170698600014
J	Chen, ZF; Rebelo, S; White, F; Malmberg, AB; Baba, H; Lima, D; Woolf, CJ; Basbaum, AI; Anderson, DJ				Chen, ZF; Rebelo, S; White, F; Malmberg, AB; Baba, H; Lima, D; Woolf, CJ; Basbaum, AI; Anderson, DJ			The paired homeodomain protein DRG11 is required for the projection of cutaneous sensory afferent fibers to the dorsal spinal cord	NEURON			English	Article							SUBSTANTIA-GELATINOSA NEURONS; NERVOUS-SYSTEM; DIFFERENTIAL EXPRESSION; ODORANT RECEPTORS; GENE-EXPRESSION; SEMAPHORIN-III; MOTOR-NEURONS; MUTANT MICE; IN-VIVO; NF-L	Cutaneous sensory neurons that detect noxious stimuli project to the dorsal horn of the spinal cord, while those innervating muscle stretch receptors project to the ventral horn. DRG11, a paired homeodomain transcription factor, is expressed in both the developing dorsal horn and in sensory neurons, but not in the ventral spinal cord. Mouse embryos deficient in DRG11 display abnormalities in the spatio-temporal patterning of cutaneous sensory afferent fiber projections to the dorsal, but not the ventral spinal cord, as well as defects in dorsal horn morphogenesis. These early developmental abnormalities lead, in adults, to significantly attenuated sensitivity to noxious stimuli. In contrast, locomotion and sensori-motor functions appear normal. Drg11 is thus required for the formation of spatio-temporally appropriate projections from nociceptive sensory neurons to their central targets in the dorsal horn of the spinal cord.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Porto, Inst Histol & Embriol, P-4100 Porto, Portugal; Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, PVA EPVA Neurosci Res Ctr, New Haven, CT 06510 USA; Vet Adm Med Ctr, Rehabil Res Ctr, W Haven, CT 06516 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia & Crit Care, Boston, MA 02129 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Universidade do Porto; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Harvard University; Harvard Medical School; Massachusetts General Hospital	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.		White, Fletcher/F-3203-2015; Rebelo, Sandra/B-5587-2008; White, Fletcher A/F-2895-2012; Woolf, Clifford/A-9784-2010; Cruz e Silva, Odete/AAH-5595-2020	White, Fletcher/0000-0002-8408-9262; Lima, Deolinda/0000-0002-5723-0777; Rebelo, Sandra/0000-0002-5358-5204	NINDS NIH HHS [NS 14627, NS38253-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038253, R37NS014627, R01NS014627] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baba H, 1999, J NEUROSCI, V19, P859; Bennett DLH, 1998, J NEUROSCI, V18, P3059; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; BROWN AG, 1977, J PHYSIOL-LONDON, V272, P779, DOI 10.1113/jphysiol.1977.sp012073; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DICKENSON AH, 1987, NEUROSCI LETT, V83, P207, DOI 10.1016/0304-3940(87)90242-4; EMFORS P, 1994, CELL, V77, P503; ESCURAT M, 1990, J NEUROSCI, V10, P764; FARINAS I, 1994, NATURE, V369, P658, DOI 10.1038/369658a0; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; GOLDSTEIN ME, 1991, J NEUROSCI RES, V30, P92, DOI 10.1002/jnr.490300111; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HOGAN B, 1986, MANIPULATING MOUSE E; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Huang EJ, 1999, DEVELOPMENT, V126, P2869; HUNT SP, 1992, SENSORY NEURONS DIVE, P60; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; KNYIHARCSILLIK E, 1986, J HISTOCHEM CYTOCHEM, V34, P363, DOI 10.1177/34.3.3005391; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Leonardo ED, 1997, COLD SPRING HARB SYM, V62, P467; Lewin GR, 1996, PHILOS T ROY SOC B, V351, P405, DOI 10.1098/rstb.1996.0035; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Logan C, 1998, J NEUROSCI, V18, P5389, DOI 10.1523/JNEUROSCI.18-14-05389.1998; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; MIMICS K, 1995, J COMP NEUROL, V355, P601; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Morin X, 1997, NEURON, V18, P411, DOI 10.1016/S0896-6273(00)81242-8; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; RALSTON HJ, 1984, J NEUROPHYSIOL, V51, P777, DOI 10.1152/jn.1984.51.4.777; REN K, 1993, BRAIN RES BULL, V31, P13, DOI 10.1016/0361-9230(93)90004-U; SAITO T, 1995, MOL CELL NEUROSCI, V6, P280, DOI 10.1006/mcne.1995.1022; Scott SA, 1992, SENSORY NEURONS DIVE; SHORTLAND P, 1989, J COMP NEUROL, V289, P416, DOI 10.1002/cne.902890307; SILOSSANTIAGO I, 1995, NEUROREPORT, V6, P861, DOI 10.1097/00001756-199504190-00009; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Snider WD, 1996, NEURON, V16, P229, DOI 10.1016/S0896-6273(00)80039-2; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; THOMAS DA, 1994, NEUROSCI LETT, V171, P101, DOI 10.1016/0304-3940(94)90615-7; Tiveron MC, 1996, J NEUROSCI, V16, P7649; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wang SS, 1997, J NEUROSCI, V17, P4149; White FA, 2000, DEV BIOL, V225, P79, DOI 10.1006/dbio.2000.9822; Willis Jr W. D., 1991, SENSORY MECH SPINAL; Wilson P, 1996, PROG NEUROBIOL, V48, P105, DOI 10.1016/0301-0082(95)00040-2; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P11950, DOI 10.1073/pnas.93.21.11950; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497; YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3; YOSHIMURA M, 1989, J NEUROPHYSIOL, V62, P96, DOI 10.1152/jn.1989.62.1.96	71	110	117	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					59	73		10.1016/S0896-6273(01)00341-5	http://dx.doi.org/10.1016/S0896-6273(01)00341-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498051	Bronze			2022-12-24	WOS:000170101100011
J	Semyanov, A; Kullmann, DM				Semyanov, A; Kullmann, DM			Kainate receptor-dependent axonal depolarization and action potential initiation in interneurons	NATURE NEUROSCIENCE			English	Article							MOSSY FIBER SYNAPSES; HIPPOCAMPAL INTERNEURONS; SYNAPTIC ACTIVATION; GLUR6-DEFICIENT MICE; RAT HIPPOCAMPUS; INHIBITION; RELEASE; GLUR5; MECHANISMS; SEIZURES	Kainate receptor agonists are powerful chemoconvulsants and excitotoxins. These properties are in part explained by depolarization of hippocampal principal neurons. However, kainate also depresses evoked inhibitory signals in pyramidal neurons, and promotes spontaneous GABA release from interneurons. The mechanisms underlying these phenomena are not fully understood, nor are the consequences for the inhibitory traffic among interneurons. We report that both the amplitude and the frequency of spontaneous IPSCs recorded in interneurons were enhanced by low concentrations of kainate, but action potential-independent IPSCs were unaffected. In the presence of GABA(A) receptor antagonists, kainate lowered the threshold for antidromic action potential generation, suggesting that interneuron axons are directly depolarized; this effect was mimicked by synaptically released glutamate. Kainate application also induced spontaneous antidromic action potentials. Axonal receptors are thus important in initiating the intense interneuronal activity triggered by kainate, which in turn influences inhibitory signaling to principal cells.	UCL, Inst Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Semyanov, Alexey/A-7654-2010; Kullmann, Dimitri M/A-3162-2009	Semyanov, Alexey/0000-0002-6800-0942; Kullmann, Dimitri M/0000-0001-6696-3545				AGRAWAL SG, 1986, BRIT J PHARMACOL, V87, P345, DOI 10.1111/j.1476-5381.1986.tb10823.x; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bureau I, 1999, J NEUROSCI, V19, P653; Castillo PR, 1999, REV ECUAT NEUROL, V8, P18; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; FISHER RS, 1984, J NEUROSCI, V4, P1312; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Gulyas AI, 1996, J NEUROSCI, V16, P3397; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Lerma J, 1997, NEURON, V19, P1155, DOI 10.1016/S0896-6273(00)80407-9; Martina M, 2000, SCIENCE, V287, P295, DOI 10.1126/science.287.5451.295; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Mody I, 1998, NAT NEUROSCI, V1, P434, DOI 10.1038/2151; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; PINAULT D, 1995, BRAIN RES REV, V21, P42, DOI 10.1016/0165-0173(95)00004-M; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639	27	103	107	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					718	723		10.1038/89506	http://dx.doi.org/10.1038/89506			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426228				2022-12-24	WOS:000169621300017
J	Moon, LDF; Asher, RA; Rhodes, KE; Fawcett, JW				Moon, LDF; Asher, RA; Rhodes, KE; Fawcett, JW			Regeneration of CNS axons back to their target following treatment of adult rat brain with chondroitinase ABC	NATURE NEUROSCIENCE			English	Article							SULFATE PROTEOGLYCAN; NEURITE OUTGROWTH; ASTROCYTES; NEUROCAN; INHIBIT; GROWTH; INJURY		Univ Cambridge, Physiol Lab, Cambridge CB2 3EG, England	University of Cambridge	Fawcett, JW (corresponding author), Univ Cambridge, Physiol Lab, Downing St,Tennis Court Rd, Cambridge CB2 3EG, England.		Moon, Lawrence/C-4906-2008	Moon, Lawrence/0000-0001-9622-0312; Fawcett, James/0000-0002-7990-4568				Asher RA, 2000, J NEUROSCI, V20, P2427; Brecknell JE, 1996, NEUROSCIENCE, V71, P913, DOI 10.1016/0306-4522(95)00509-9; BRECKNELL JE, 1995, NEUROSCIENCE, V64, P219, DOI 10.1016/0306-4522(94)00370-K; Davies SJA, 1999, J NEUROSCI, V19, P5810, DOI 10.1523/JNEUROSCI.19-14-05810.1999; DOU CL, 1994, J NEUROSCI, V14, P7616; GRUMET M, 1993, J CELL BIOL, V120, P815, DOI 10.1083/jcb.120.3.815; LEVINE JM, 1994, J NEUROSCI, V14, P4716; McKeon RJ, 1999, J NEUROSCI, V19, P10778, DOI 10.1523/JNEUROSCI.19-24-10778.1999; MCKEON RJ, 1995, EXP NEUROL, V136, P32, DOI 10.1006/exnr.1995.1081; SMITHTHOMAS LC, 1995, J CELL SCI, V108, P1307; SNOW DM, 1990, EXP NEUROL, V109, P111, DOI 10.1016/S0014-4886(05)80013-5; Yamada H, 1997, J NEUROSCI, V17, P7784	12	463	498	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					465	466		10.1038/87415	http://dx.doi.org/10.1038/87415			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319553				2022-12-24	WOS:000168412600008
J	Frank, MG; Issa, NP; Stryker, MP				Frank, MG; Issa, NP; Stryker, MP			Sleep enhances plasticity in the developing visual cortex	NEURON			English	Article							CEREBRAL PROTEIN-SYNTHESIS; SLOW-WAVE SLEEP; REM-SLEEP; OCULAR DOMINANCE; MONOCULAR DEPRIVATION; GENICULATE-NUCLEUS; BEHAVIORAL STATE; CORTICAL-CELLS; BRIEF PERIODS; MEMORY	During a critical period of brain development, occluding the vision of one eye causes a rapid remodeling of the visual cortex and its inputs. Sleep has been linked to other processes thought to depend on synaptic remodeling, but a role for sleep in this form of cortical plasticity has not been demonstrated. We found that sleep enhanced the effects of a preceding period of monocular deprivation on Visual cortical responses, but wakefulness in complete darkness did not do so. The enhancement of plasticity by sleep was at least as great as that produced by an equal amount of additional deprivation. These findings demonstrate that sleep and sleep loss modify experience-dependent cortical plasticity in vivo. They suggest that sleep in early life may play a crucial role in brain development.	Univ Calif San Francisco, Dept Physiol, WM Keck Fdn, Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, Dept Physiol, WM Keck Fdn, Ctr Integrat Neurosci, Box 0444, San Francisco, CA 94143 USA.	stryker@phy.ucsf.edu		Stryker, Michael/0000-0003-1546-5831; Issa, Naoum Pierre/0000-0001-9247-1341	NEI NIH HHS [EY60831, R37 EY002874-22, R01 EY002874, EY06880, EY02874] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874, R01EY002874] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		AMBROSINI MV, 1992, PHYSIOL BEHAV, V51, P217, DOI 10.1016/0031-9384(92)90134-N; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BENINGTON JH, 1994, NEUROSCI LETT, V180, P76, DOI 10.1016/0304-3940(94)90917-2; BLOCK V, 1979, BRAINMECH MEMORY LEA, P120; BRAMHAM CR, 1994, NEUROSCIENCE, V59, P501, DOI 10.1016/0306-4522(94)90172-4; Buzsaki G, 1998, J SLEEP RES, V7, P17, DOI 10.1046/j.1365-2869.7.s1.3.x; Carrier J, 1999, LUNG BIOL HEALTH DIS, V133, P527; CAUTER EV, 1999, REGULATION SLEEP CIR, V133, P397; Cirelli C, 1999, J SLEEP RES, V8, P44; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; Dave AS, 1998, SCIENCE, V282, P2250, DOI 10.1126/science.282.5397.2250; Davis FC, 1999, LUNG BIOL HEALTH DIS, V133, P19; DAW NW, 1991, J NEUROBIOL, V22, P158, DOI 10.1002/neu.480220206; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; Dijk DJ, 1999, LUNG BIOL HEALTH DIS, V133, P111; Ekstrand BR, 1977, NEUROBIOLOGY SLEEP M, P419; Ficca G, 2000, BEHAV BRAIN RES, V112, P159, DOI 10.1016/S0166-4328(00)00177-7; FISHBEIN W, 1977, BEHAV BIOL, V19, P425, DOI 10.1016/S0091-6773(77)91903-4; Frank MG, 1998, AM J PHYSIOL-REG I, V275, pR148, DOI 10.1152/ajpregu.1998.275.1.R148; Frank MG, 1997, AM J PHYSIOL-REG I, V272, pR1792, DOI 10.1152/ajpregu.1997.272.6.R1792; FREEMAN RD, 1979, T OPHTHAL SOC UK, V99, P382; FREEMAN RD, 1979, NATURE, V282, P404, DOI 10.1038/282404a0; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; GIUDITTA A, 1995, BEHAV BRAIN RES, V69, P157, DOI 10.1016/0166-4328(95)00012-I; HENNEVIN E, 1993, BEHAV NEUROSCI, V107, P1018, DOI 10.1037/0735-7044.107.6.1018; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; IMBERT M, 1975, EXP BRAIN RES, V22, P25; Irwin M, 1999, J CLIN ENDOCR METAB, V84, P1979, DOI 10.1210/jc.84.6.1979; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; JONES BE, 1994, PRINCIPLES PRACTICE, P145; Jouvet-Mounier D, 1970, Dev Psychobiol, V2, P216; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; KASAMATSU T, 1979, J COMP NEUROL, V185, P163, DOI 10.1002/cne.901850110; Kudrimoti HS, 1999, J NEUROSCI, V19, P4090; LAGUZZI RF, 1979, BRAIN RES, V160, P445, DOI 10.1016/0006-8993(79)91072-2; LANCEL M, 1991, BRAIN RES, V548, P206, DOI 10.1016/0006-8993(91)91123-I; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; MALACH R, 1984, J NEUROPHYSIOL, V51, P538, DOI 10.1152/jn.1984.51.3.538; Maquet P, 2000, NAT NEUROSCI, V3, P831, DOI 10.1038/77744; MARKS GA, 1995, BEHAV BRAIN RES, V69, P1, DOI 10.1016/0166-4328(95)00018-O; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MCGRATH MJ, 1978, PSYCHOL BULL, V85, P24, DOI 10.1037/0033-2909.85.1.24; MIOCHE L, 1989, J NEUROPHYSIOL, V62, P185, DOI 10.1152/jn.1989.62.1.185; MIRMIRAN M, 1995, BEHAV BRAIN RES, V69, P13, DOI 10.1016/0166-4328(95)00019-P; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; NeunerJehle M, 1996, J NEUROSCI RES, V46, P138, DOI 10.1002/(SICI)1097-4547(19961015)46:2<138::AID-JNR2>3.0.CO;2-I; NEUNERJEHLE M, 1995, BRAIN RES, V685, P143, DOI 10.1016/0006-8993(95)00416-N; Oksenberg A, 1996, DEV BRAIN RES, V97, P51, DOI 10.1016/S0165-3806(96)00131-9; OLSON CR, 1980, EXP BRAIN RES, V38, P53; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; PAVLIDES C, 1989, J NEUROSCI, V9, P2907; PECK CK, 1975, EXP BRAIN RES, V22, P57; PETTIGREW JD, 1974, BRAIN RES, V66, P160, DOI 10.1016/0006-8993(74)90085-7; Plihal W, 1999, PSYCHOPHYSIOLOGY, V36, P571, DOI 10.1111/1469-8986.3650571; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; RAMACHANDRAN VS, 1982, BEHAV NEURAL BIOL, V35, P211, DOI 10.1016/S0163-1047(82)90641-0; RAMM P, 1990, PHYSIOL BEHAV, V48, P749, DOI 10.1016/0031-9384(90)90220-X; RAUSCHECKER JP, 1987, NATURE, V326, P183, DOI 10.1038/326183a0; REITER HO, 1986, EXP BRAIN RES, V65, P182; Ribeiro S, 1999, LEARN MEMORY, V6, P500, DOI 10.1101/lm.6.5.500; ROFFWARG HP, 1966, SCIENCE, V152, P604, DOI 10.1126/science.152.3722.604; ROTENBERG VS, 1992, NEUROSCI BIOBEHAV R, V16, P503, DOI 10.1016/S0149-7634(05)80191-5; Shaffery JP, 1999, DEV BRAIN RES, V114, P109, DOI 10.1016/S0165-3806(99)00027-9; Singer W, 1982, Hum Neurobiol, V1, P41; SINGER W, 1979, DEV CHEM SENSITIVITY, V31, P457; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; SMITH C, 1995, BEHAV BRAIN RES, V69, P137, DOI 10.1016/0166-4328(95)00024-N; SMITH C, 1986, PHYSIOL BEHAV, V36, P1053, DOI 10.1016/0031-9384(86)90479-8; SMITH C, 1985, NEUROSCI BIOBEHAV R, V9, P157, DOI 10.1016/0149-7634(85)90042-9; Steriade M, 1998, Sleep Res Online, V1, P1; Steriade M, 1999, TRENDS NEUROSCI, V22, P337, DOI 10.1016/S0166-2236(99)01407-1; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; TOBLER I, 1990, BEHAV BRAIN RES, V37, P109, DOI 10.1016/0166-4328(90)90086-T; TOBLER I, 1983, NEUROSCI LETT, V35, P297, DOI 10.1016/0304-3940(83)90333-6; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YINON U, 1984, DEV BRAIN RES, V16, P135, DOI 10.1016/0165-3806(84)90068-3	83	303	305	1	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					275	287		10.1016/S0896-6273(01)00279-3	http://dx.doi.org/10.1016/S0896-6273(01)00279-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	427NR	11343661	Bronze, Green Published			2022-12-24	WOS:000168412900027
J	Super, H; Spekreijse, H; Lamme, VAF				Super, H; Spekreijse, H; Lamme, VAF			Two distinct modes of sensory processing observed in monkey primary visual cortex (V1)	NATURE NEUROSCIENCE			English	Article							MACAQUE MONKEY; NEURONAL RESPONSES; DYNAMICS; DECISION; STIMULI; FIGURE; NEUROPHYSIOLOGY; ORIENTATION; SENSITIVITY; MECHANISMS	Even salient sensory stimuli are sometimes not detected. What goes wrong in the brain in that case? Here we show that a late (> 100-ms) component of the neural activity in the primary visual cortex of the monkey is selectively suppressed when stimuli are not seen. As there is evidence that this activity depends on feedback from extrastriate areas, these findings suggest a specific role for recurrent processing when stimuli are reaching a perceptual level. Further results show that this perceptual level is situated between purely sensory and decision or motor stages of processing.	Univ Amsterdam, Acad Med Ctr, Dept Visual Syst Anal, Grad Sch Neurosci, NL-1100 AA Amsterdam, Netherlands; Netherlands Ophthalm Res Inst, NL-1105 BA Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW)	Lamme, VAF (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Visual Syst Anal, Grad Sch Neurosci, POB 12011, NL-1100 AA Amsterdam, Netherlands.			Super, Hans/0000-0001-9328-0096				ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Block N, 1996, TRENDS NEUROSCI, V19, P456, DOI 10.1016/S0166-2236(96)20049-9; BOUR LJ, 1984, IEEE T BIO-MED ENG, V31, P419, DOI 10.1109/TBME.1984.325281; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; GILBERT CD, 1993, CEREB CORTEX, V3, P373, DOI 10.1093/cercor/3.5.373; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GREEN DM, 1966, SIGNAL DETECTION THE; Hupe JM, 1998, NATURE, V394, P784, DOI 10.1038/29537; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Lamme VAF, 1999, CEREB CORTEX, V9, P406, DOI 10.1093/cercor/9.4.406; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Lamme VAF, 1998, P NATL ACAD SCI USA, V95, P3263, DOI 10.1073/pnas.95.6.3263; Lamme VAF, 1998, CURR OPIN NEUROBIOL, V8, P529, DOI 10.1016/S0959-4388(98)80042-1; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; MOORE T, 1995, P NATL ACAD SCI USA, V92, P8215, DOI 10.1073/pnas.92.18.8215; Nothdurft HC, 1999, VISUAL NEUROSCI, V16, P15, DOI 10.1017/S0952523899156189; NOTHDURFT HC, 1985, VISION RES, V25, P551, DOI 10.1016/0042-6989(85)90159-2; Payne BR, 1996, TRENDS NEUROSCI, V19, P535, DOI 10.1016/S0166-2236(96)10061-8; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Pollen DA, 1999, CEREB CORTEX, V9, P4, DOI 10.1093/cercor/9.1.4; ROCK I, 1992, COGNITIVE PSYCHOL, V24, P501; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Rossi AF, 1996, SCIENCE, V273, P1104, DOI 10.1126/science.273.5278.1104; SALIN PA, 1995, PHYSIOL REV, V75, P107, DOI 10.1152/physrev.1995.75.1.107; Schall JD, 1998, CURR OPIN NEUROBIOL, V8, P211, DOI 10.1016/S0959-4388(98)80142-6; SCHILLER PH, 1979, J NEUROPHYSIOL, V42, P1124, DOI 10.1152/jn.1979.42.4.1124; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; THOMPSON P, 1983, DISASTERS, V7, P2; Vidyasagar TR, 1998, NEUROREPORT, V9, P1947, DOI 10.1097/00001756-199806220-00006; Zipser K, 1996, J NEUROSCI, V16, P7376	36	331	335	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					304	310		10.1038/85170	http://dx.doi.org/10.1038/85170			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224548				2022-12-24	WOS:000167178300019
J	Nieto, M; Schuurmans, C; Britz, O; Guillemot, F				Nieto, M; Schuurmans, C; Britz, O; Guillemot, F			Neural bHLH genes control the neuronal versus glial fate decision in cortical progenitors	NEURON			English	Article							FIBRILLARY ACIDIC PROTEIN; LIPID-BINDING PROTEIN; CREST STEM-CELLS; RADIAL GLIA; RESTRICTED PRECURSORS; TRANSCRIPTION FACTORS; CEREBRAL-CORTEX; EXPRESSION; ADULT; RAT	We have addressed the role of the proneural bHLH genes Neurogenin2 (Ngn2) and Mash1 in the selection of neuronal and glial fates by neural stem cells. We show that mice mutant for both genes present severe defects in development of the cerebral cortex, including a reduction of neurogenesis and a premature and excessive generation of astrocytic precursors. An analysis of wild-type and mutant cortical progenitors in culture showed that a large fraction of Ngn2; Mash1 double-mutant progenitors failed to adopt a neuronal fate, instead remaining pluripotent or entering an astrocytic differentiation pathway. Together, these results demonstrate that proneural genes are involved in lineage restriction of cortical progenitors, promoting the acquisition of the neuronal fate and inhibiting the astrocytic fate.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Guillemot, F (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, Boite Postale 163, F-67404 Illkirch Graffenstaden, France.	francois@igbmc.u-strasbg.fr	Nieto, Marta/F-1434-2013; Guillemot, Francois/AAV-1482-2021	Nieto, Marta/0000-0002-8349-8435; Schuurmans, Carol/0000-0003-3567-0058				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; ALTMAN J, 1966, EXP NEUROL, V16, P263, DOI 10.1016/0014-4886(66)90063-X; Anderson D, 1997, MOL CELLULAR APPROAC, P26; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BARTSCH S, 1992, J NEUROSCI, V12, P736; Bayer S.A., 1991, NEOCORTICAL DEV; BEDDINGTON RSP, 1989, DEVELOPMENT, V106, P37; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Casarosa S, 1999, DEVELOPMENT, V126, P525; Cau E, 2000, DEVELOPMENT, V127, P2323; Cau E, 1997, DEVELOPMENT, V124, P1611; CHOI BH, 1978, BRAIN RES, V148, P295, DOI 10.1016/0006-8993(78)90721-7; DAHL D, 1973, BRAIN RES, V61, P279, DOI 10.1016/0006-8993(73)90533-7; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gao FB, 1997, J CELL BIOL, V138, P1367, DOI 10.1083/jcb.138.6.1367; Ghosh MM, 1995, BIOREMED SER, V3, P15; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; GUILLEMOT F, 1993, MECH DEVELOP, V42, P171, DOI 10.1016/0925-4773(93)90006-J; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HUNTER KE, 1995, P NATL ACAD SCI USA, V92, P2061, DOI 10.1073/pnas.92.6.2061; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kondo T, 2000, DEVELOPMENT, V127, P2989; LAGENAUR C, 1981, J SUPRAMOL STR CELL, V15, P335, DOI 10.1002/jsscb.1981.380150404; Lee JE, 1997, CURR OPIN NEUROBIOL, V7, P13, DOI 10.1016/S0959-4388(97)80115-8; LEE MK, 1990, CELL MOTIL CYTOSKEL, V17, P118, DOI 10.1002/cm.970170207; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; Lo LC, 1998, DEVELOPMENT, V125, P609; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; LUND RD, 1985, NEUROSCI LETT, V61, P221, DOI 10.1016/0304-3940(85)90428-8; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; McKay R, 2000, J NEUROSCI RES, V59, P298, DOI 10.1002/(SICI)1097-4547(20000201)59:3<298::AID-JNR2>3.0.CO;2-U; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; MITROVIC N, 1994, J NEUROCYTOL, V23, P364, DOI 10.1007/BF01666526; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; NOLAN GP, 1988, P NATL ACAD SCI USA, V85, P2603, DOI 10.1073/pnas.85.8.2603; Park JK, 1999, J NEUROSCI, V19, P10383; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; PRICE J, 1988, DEVELOPMENT, V104, P473; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAKIC P, 1971, BRAIN RES, V33, P471, DOI 10.1016/0006-8993(71)90119-3; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; REH TA, 1992, J NEUROBIOL, V23, P1067, DOI 10.1002/neu.480230811; Rousselot P, 1997, J COMP NEUROL, V385, P415; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; Shah NM, 1997, P NATL ACAD SCI USA, V94, P11369, DOI 10.1073/pnas.94.21.11369; SHAH NM, 1994, CELL, V77, P349, DOI 10.1016/0092-8674(94)90150-3; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sommer L, 1995, NEURON, V15, P1245, DOI 10.1016/0896-6273(95)90005-5; Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6; SUN Y, 2001, IN PRESS CELL; Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602; Torii MA, 1999, DEVELOPMENT, V126, P443; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Wakamatsu Y, 2000, DEVELOPMENT, V127, P2811	74	409	432	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					401	413		10.1016/S0896-6273(01)00214-8	http://dx.doi.org/10.1016/S0896-6273(01)00214-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239431	Bronze			2022-12-24	WOS:000167141700014
J	Viana, F; de la Pena, E; Belmonte, C				Viana, F; de la Pena, E; Belmonte, C			Specificity of cold thermotransduction is determined by differential ionic channel expression	NATURE NEUROSCIENCE			English	Article							ACTIVATED CATION CURRENT; NEURONS; HEAT; RECEPTORS; MENTHOL; RAT; CAPSAICIN; CORNEA; FIBERS	Sensations of cold are mediated by specific thermoreceptor nerve endings excited by low temperature and menthol. Here we identify a population of cold-sensitive cultured mouse trigeminal ganglion neurons with a unique set of biophysical properties. Their impulse activity during cooling and menthol application was similar to that of cold thermoreceptor fibers in vivo. We show that cooling closes a background K+ channel, causing depolarization and firing that is limited by the slower reduction of a cationic inward current (I-h). In cold-insensitive neurons, firing is prevented by a slow, transient, 4-AP-sensitive K+ current (IKD) that acts as an excitability brake. In addition, pharmacological blockade of IKD induced thermosensitivity in cold-insensitive neurons, a finding that may explain cold allodynia in neuropathic pain. These results suggest that cold sensitivity is not associated to a specific transduction molecule but instead results from a favorable blend of ionic channels expressed in a small subset of sensory neurons.	Univ Miguel Hernandez, Inst Neurociencias, CSIC, San Juan De Alicante 03550, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN)	Viana, F (corresponding author), Univ Miguel Hernandez, Inst Neurociencias, CSIC, Apartado 18, San Juan De Alicante 03550, Spain.		Viana, Felix/U-8533-2017; Elvira, De la Pena/O-7380-2015	Viana, Felix/0000-0003-1439-949X; Elvira, De la Pena/0000-0001-5961-5067				BEVAN S, 1990, TRENDS PHARMACOL SCI, V11, P330; BRAUN HA, 1980, PFLUG ARCH EUR J PHY, V386, P1, DOI 10.1007/BF00584180; Brock JA, 2001, J PHYSIOL-LONDON, V533, P493, DOI 10.1111/j.1469-7793.2001.0493a.x; Brock JA, 1998, J PHYSIOL-LONDON, V512, P211, DOI 10.1111/j.1469-7793.1998.211bf.x; CARPENTER DO, 1981, FED PROC, V40, P2808; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Craig AD, 2001, J NEUROPHYSIOL, V86, P1459, DOI 10.1152/jn.2001.86.3.1459; Craig AD, 2000, NAT NEUROSCI, V3, P184, DOI 10.1038/72131; ECCLES R, 1994, J PHARM PHARMACOL, V46, P618, DOI 10.1111/j.2042-7158.1994.tb03871.x; GALLAR J, 1993, J PHYSIOL-LONDON, V468, P609, DOI 10.1113/jphysiol.1993.sp019791; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Grafe P, 1997, J NEUROPHYSIOL, V77, P421, DOI 10.1152/jn.1997.77.1.421; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; Hamill OP, 2001, PHYSIOL REV, V81, P685, DOI 10.1152/physrev.2001.81.2.685; Han ZS, 1998, NAT NEUROSCI, V1, P218, DOI 10.1038/665; HENSEL H, 1951, ACTA PHYSIOL SCAND, V22, P96, DOI 10.1111/j.1748-1716.1951.tb00758.x; HENSEL H, 1960, J PHYSIOL-LONDON, V153, P113, DOI 10.1113/jphysiol.1960.sp006522; Hensel H, 1976, Prog Brain Res, V43, P105; HENSEL H, 1974, PFLUG ARCH EUR J PHY, V352, P1, DOI 10.1007/BF01061945; HENSEL H, 1971, PFLUG ARCH EUR J PHY, V329, P1, DOI 10.1007/BF00586896; Hervieu GJ, 2001, NEUROSCIENCE, V103, P899, DOI 10.1016/S0306-4522(01)00030-6; IGGO A, 1975, SOMATOSENSORY SYSTEM, P5; KENSHALO DR, 1967, SCIENCE, V158, P1064, DOI 10.1126/science.158.3804.1064; Koerber HR, 1992, SENSORY NEURONS DIVE, P77; LAMOTTE RH, 1982, BRAIN RES, V244, P279, DOI 10.1016/0006-8993(82)90086-5; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; McCleskey EW, 1997, CURR BIOL, V7, pR679, DOI 10.1016/S0960-9822(06)00354-X; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PIERAU FK, 1975, PFLUG ARCH EUR J PHY, V359, P349, DOI 10.1007/BF00581445; Rasband MN, 2001, P NATL ACAD SCI USA, V98, P13373, DOI 10.1073/pnas.231376298; Reid G, 2001, NATURE, V413, P480, DOI 10.1038/35097164; Reid G, 2001, NEUROSCI LETT, V297, P171, DOI 10.1016/S0304-3940(00)01694-3; SCHAFER K, 1986, J GEN PHYSIOL, V88, P757, DOI 10.1085/jgp.88.6.757; SCHAFER K, 1988, PFLUG ARCH EUR J PHY, V412, P188, DOI 10.1007/BF00583749; SCROGGS RS, 1994, J NEUROPHYSIOL, V71, P271, DOI 10.1152/jn.1994.71.1.271; SPRAY DC, 1986, ANNU REV PHYSIOL, V48, P625; SPRAY DC, 1974, BRAIN RES, V72, P354, DOI 10.1016/0006-8993(74)90881-6; STANSFELD CE, 1986, NEUROSCI LETT, V64, P299, DOI 10.1016/0304-3940(86)90345-9; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; Takigawa T, 1998, NEUROSCIENCE, V82, P631; Viana F, 2001, EUR J NEUROSCI, V13, P722, DOI 10.1046/j.0953-816x.2000.01441.x; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; YARNITSKY D, 1991, BRAIN, V114, P1819, DOI 10.1093/brain/114.4.1819	47	258	271	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					254	260		10.1038/nn809	http://dx.doi.org/10.1038/nn809			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836533				2022-12-24	WOS:000174146000016
J	Dragoi, V; Turcu, CM; Sur, M				Dragoi, V; Turcu, CM; Sur, M			Stability of cortical responses and the statistics of natural scenes	NEURON			English	Article							PRIMARY VISUAL-CORTEX; CROSS-CORRELATION ANALYSIS; RETINAL GANGLION-CELLS; MONKEY STRIATE CORTEX; FUNCTIONAL ARCHITECTURE; ORIENTATION SENSITIVITY; HORIZONTAL INTERACTIONS; PATTERN ADAPTATION; ORIENTED CONTOURS; OCULAR DOMINANCE	The primary visual cortex (V1) of higher mammals contains maps of stimulus features; how these maps influence vision remains unknown. We have examined the functional significance of an asymmetry in the orientation map in cat V1, i.e., the fact that a larger area of V1 is preferentially activated by vertical and horizontal contours than by contours at oblique orientations. Despite the fact that neurons tuned to cardinal and oblique orientations have indistinguishable tuning characteristics, cardinal neurons remain more stable in their response properties after selective perturbation induced by adaptation. Similarly, human observers report different adaptation-induced changes in orientation tuning between cardinal and oblique axes. We suggest that the larger cortical area devoted to cardinal orientations imposes stability on the processing of cardinal contours during visual perception, by retaining invariant cortical responses along cardinal axes.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Dragoi, V (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.				NEI NIH HHS [EY07023] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1975, EXP BRAIN RES, V24, P181, DOI 10.1007/BF00234062; ANDREWS DP, 1967, VISION RES, V7, P975, DOI 10.1016/0042-6989(67)90014-4; Arakawa K, 2000, EXP BRAIN RES, V131, P121, DOI 10.1007/s002219900274; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BAUER JA, 1979, PERCEPTION, V8, P247, DOI 10.1068/p080247; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; BLAKEMORE C, 1969, J PHYSIOL-LONDON, V200, pP11; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; Blakemore C., 2010, VISION CODING EFFICI, P363, DOI 10.1017/cbo9780511626197.034; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; BOLTZ RL, 1979, SCIENCE, V205, P511, DOI 10.1126/science.109923; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; CAMPBELL FW, 1968, J PHYSIOL-LONDON, V198, P237, DOI 10.1113/jphysiol.1968.sp008604; Carandini M, 1998, NEUROPHARMACOLOGY, V37, P501, DOI 10.1016/S0028-3908(98)00069-0; Chapman B, 1998, P NATL ACAD SCI USA, V95, P2609, DOI 10.1073/pnas.95.5.2609; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P2621, DOI 10.1073/pnas.95.5.2621; Coppola DM, 1998, P NATL ACAD SCI USA, V95, P4002, DOI 10.1073/pnas.95.7.4002; COPPOLA DM, 2000, ABSTR SOC NEUR, V26; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DEBRUYN EJ, 1980, VISION RES, V20, P315, DOI 10.1016/0042-6989(80)90018-8; DEVALOIS RL, 1982, VISION RES, V22, P531, DOI 10.1016/0042-6989(82)90112-2; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; DRAGOI V, 1999, ABSTR SOC NEUROSCI, V25, P1548; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Furmanski CS, 2000, NAT NEUROSCI, V3, P535, DOI 10.1038/75702; GANZ L, 1966, PSYCHOL REV, V73, P128, DOI 10.1037/h0022952; Gibson JJ, 1937, J EXP PSYCHOL, V20, P453, DOI 10.1037/h0059826; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GREENLEE MW, 1987, VISION RES, V27, P1041, DOI 10.1016/0042-6989(87)90017-4; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HATA Y, 1991, J PHYSIOL-LONDON, V441, P593, DOI 10.1113/jphysiol.1991.sp018769; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; HUBENER M, 1997, J NEUROSCI, V17, P1270; Hughes A., 1977, VISUAL SYSTEM VERTEB, P613; KENNEDY H, 1979, J PHYSIOL-LONDON, V296, pP61; Kisvarday ZF, 1997, CEREB CORTEX, V7, P605, DOI 10.1093/cercor/7.7.605; Koulakov AA, 2001, NEURON, V29, P519, DOI 10.1016/S0896-6273(01)00223-9; LEVENTHAL AG, 1983, J COMP NEUROL, V220, P465, DOI 10.1002/cne.902200408; LEVENTHAL AG, 1977, P NATL ACAD SCI USA, V74, P1272, DOI 10.1073/pnas.74.3.1272; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MITCHELL DE, 1976, VISION RES, V16, P609, DOI 10.1016/0042-6989(76)90007-9; MOVSHON JA, 1979, NATURE, V278, P850, DOI 10.1038/278850a0; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; Muller T, 2000, NEURAL COMPUT, V12, P2573, DOI 10.1162/089976600300014854; NELSON SB, 1991, J NEUROSCI, V11, P344; OHZAWA I, 1982, NATURE, V298, P266, DOI 10.1038/298266a0; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P373; Rao SC, 1997, J COMP NEUROL, V387, P358; ROSE D, 1974, EXP BRAIN RES, V20, P1; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; SIMONCELLI EP, 1999, ADV NEURAL INFORMATI, V11; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; Swindale NV, 2000, NAT NEUROSCI, V3, P822, DOI 10.1038/77731; SWITKES E, 1978, VISION RES, V18, P1393, DOI 10.1016/0042-6989(78)90232-8; TSO DY, 1986, J NEUROSCI, V6, P1160; VANDENBUSSCHE E, 1980, ARCH INT PHYSIOL BIO, V88, pP11; WASSLE H, 1975, J COMP NEUROL, V159, P419, DOI 10.1002/cne.901590308; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WOLFE JM, 1986, INVEST OPHTH VIS SCI, V27, P538; WORGOTTER F, 1991, EXP BRAIN RES, V83, P665; Yarbus A.L., 1967, EYE MOVEMENT VISION	66	46	49	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1181	1192		10.1016/S0896-6273(01)00540-2	http://dx.doi.org/10.1016/S0896-6273(01)00540-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754846	Bronze			2022-12-24	WOS:000172886800021
J	Grunwald, IC; Korte, M; Wolfer, D; Wilkinson, GA; Unsicker, K; Lipp, HP; Bonhoeffer, T; Klein, D				Grunwald, IC; Korte, M; Wolfer, D; Wilkinson, GA; Unsicker, K; Lipp, HP; Bonhoeffer, T; Klein, D			Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; COMMISSURAL AXONS; EPHRIN LIGANDS; PROTEIN-KINASE; MUTANT MICE; MEMORY; LTP; DEPOTENTIATION; STIMULATION; ACTIVATION	During development, Eph receptors mediate the repulsive axon guidance function of ephrins, a family of membrane attached ligands with their own receptorlike signaling potential. In cultured glutamatergic neurons, EphB2 receptors were recently shown to associate with NMDA receptors at synaptic sites and were suggested to play a role in synaptogenesis. Here we show that Eph receptor stimulation in cultured neurons modulates signaling pathways implicated in synaptic plasticity, suggesting cross-talk with NMDA receptor-activated pathways. Mice lacking EphB2 have normal hippocampal synapse morphology, but display defects in synaptic plasticity. In EphB2(-/-) hippocampal slices, protein synthesis-dependent long-term potentiation (LTP) was impaired, and two forms of synaptic depression were completely extinguished. Interestingly, targeted expression of a carboxy-terminally truncated form of EphB2 rescued the EphB2 null phenotype, indicating that EphB2 kinase signaling is not required for these EphB2-mediated functions.	Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Martinsried, Germany; Max Planck Inst Neurobiol, Dept Cellular & Syst Neurobiol, D-82152 Martinsried, Germany; Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; Univ Zurich, Ctr Neurosci, CH-8057 Zurich, Switzerland; Univ Heidelberg, Dept Anat & Cell Biol 3, D-69120 Heidelberg, Germany	Max Planck Society; Max Planck Society; University of Zurich; University of Zurich; Ruprecht Karls University Heidelberg	Klein, D (corresponding author), Max Planck Inst Neurobiol, Dept Mol Neurobiol, Klopferspitz 18A, D-82152 Martinsried, Germany.		Bonhoeffer, Tobias/B-9481-2009; Wolfer, David P/B-3293-2016; Klein, Ruediger/C-6147-2008	Bonhoeffer, Tobias/0000-0001-7897-6634; Wolfer, David P/0000-0002-5957-1401; Klein, Ruediger/0000-0002-3109-0163; Grunwald Kadow, Ilona/0000-0002-9085-4274				Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Ali DW, 2001, CURR OPIN NEUROBIOL, V11, P336, DOI 10.1016/S0959-4388(00)00216-6; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bjorge JD, 2000, ONCOGENE, V19, P5620, DOI 10.1038/sj.onc.1203923; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Drescher U, 2000, CELL, V103, P1005, DOI 10.1016/S0092-8674(00)00204-X; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gao WQ, 1998, MOL CELL NEUROSCI, V11, P247, DOI 10.1006/mcne.1998.0696; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Gerlai R, 1999, J NEUROSCI, V19, P9538; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Kang HJ, 2001, CELL, V106, P771, DOI 10.1016/S0092-8674(01)00497-4; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kawasaki H, 1999, J BIOL CHEM, V274, P13498, DOI 10.1074/jbc.274.19.13498; Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Meyer BU, 1998, J NEUROL, V245, P106, DOI 10.1007/s004150050187; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; O'Dell T J, 1994, Learn Mem, V1, P129; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Qi M, 1996, P NATL ACAD SCI USA, V93, P1571, DOI 10.1073/pnas.93.4.1571; Shin D, 2001, DEV BIOL, V230, P139, DOI 10.1006/dbio.2000.9957; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; TAKASU MA, 2002, IN PRESS SCIENCE; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wagner JJ, 1996, HIPPOCAMPUS, V6, P24, DOI 10.1002/(SICI)1098-1063(1996)6:1<24::AID-HIPO5>3.0.CO;2-7; Wilkinson DG, 2000, CURR BIOL, V10, pR447, DOI 10.1016/S0960-9822(00)00530-3; Yu XM, 1999, P NATL ACAD SCI USA, V96, P7697, DOI 10.1073/pnas.96.14.7697; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhuo M, 1999, P NATL ACAD SCI USA, V96, P4650, DOI 10.1073/pnas.96.8.4650	48	234	247	1	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1027	1040		10.1016/S0896-6273(01)00550-5	http://dx.doi.org/10.1016/S0896-6273(01)00550-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754835	Bronze			2022-12-24	WOS:000172886800010
J	Sjostrom, PJ; Turrigiano, GG; Nelson, SB				Sjostrom, PJ; Turrigiano, GG; Nelson, SB			Rate, timing, and cooperativity jointly determine cortical synaptic plasticity	NEURON			English	Article							LONG-TERM POTENTIATION; NEOCORTICAL PYRAMIDAL NEURONS; AREA CA1; COINCIDENCE DETECTION; DENDRITIC SPINES; NMDA RECEPTORS; DEPRESSION; HIPPOCAMPUS; INDUCTION; SYNAPSES	Cortical long-term plasticity depends on firing rate, spike timing, and cooperativity among inputs, but how these factors interact during realistic patterns of activity is unknown. Here we monitored plasticity while systematically varying the rate, spike timing, and number of coincident afferents. These experiments demonstrate a novel form of cooperativity operating even when postsynaptic firing is evoked by current injection, and reveal a complex dependence of LTP and LTD on rate and timing. Based on these data, we constructed and tested three quantitative models of cortical plasticity. One of these models, in which spike-timing relationships causing LTP "win" out over those favoring LTD, closely fits the data and accurately predicts the build-up of plasticity during random firing. This provides a quantitative framework for predicting the impact of in vivo firing patterns on synaptic strength.	Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University	Nelson, SB (corresponding author), Brandeis Univ, Dept Biol, Volen Ctr Complex Syst, Mailstop 008 415 South St, Waltham, MA 02454 USA.	nelson@brandeis.edu	Sjöström, Per Jesper/B-9696-2019	Sjöström, Per Jesper/0000-0001-7085-2223; Nelson, Sacha/0000-0002-0108-8599	NEI NIH HHS [EY11116] Funding Source: Medline; NIMH NIH HHS [MH58754] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY011116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BARRIONUEVO G, 1983, P NATL ACAD SCI-BIOL, V80, P7347, DOI 10.1073/pnas.80.23.7347; Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P593, DOI 10.1111/j.1469-7793.2000.t01-1-00593.x; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Christie BR, 2000, HIPPOCAMPUS, V10, P673, DOI 10.1002/1098-1063(2000)10:6<673::AID-HIPO1005>3.0.CO;2-O; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DOUGLAS RM, 1982, BRAIN RES, V240, P259, DOI 10.1016/0006-8993(82)90221-9; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gray CM, 1999, NEURON, V24, P31, DOI 10.1016/S0896-6273(00)80820-X; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; KIRKWOOD A, 1994, J NEUROSCI, V14, P1634, DOI 10.1523/JNEUROSCI.14-03-01634.1994; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; LINSKER R, 1988, COMPUTER, V21, P105, DOI 10.1109/2.36; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; Migliore M, 1999, J COMPUT NEUROSCI, V7, P5, DOI 10.1023/A:1008906225285; Miller KD, 1996, NEURON, V17, P371, DOI 10.1016/S0896-6273(00)80169-5; Montgomery JM, 2001, NEURON, V29, P691, DOI 10.1016/S0896-6273(01)00244-6; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Perez Y, 2001, P NATL ACAD SCI USA, V98, P9401, DOI 10.1073/pnas.161493498; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Senn W, 2001, NEURAL COMPUT, V13, P35, DOI 10.1162/089976601300014628; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stuart GJ, 2001, NAT NEUROSCI, V4, P63, DOI 10.1038/82910; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Vetter P, 2001, J NEUROPHYSIOL, V85, P926, DOI 10.1152/jn.2001.85.2.926; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; ZALUTSKY RA, 1992, NEUROSCI LETT, V138, P193, DOI 10.1016/0304-3940(92)90503-Y; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	67	730	742	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1149	1164		10.1016/S0896-6273(01)00542-6	http://dx.doi.org/10.1016/S0896-6273(01)00542-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754844	Bronze			2022-12-24	WOS:000172886800019
J	Gunawardena, S; Goldstein, LSB				Gunawardena, S; Goldstein, LSB			Disruption of axonal transport and neuronal viability by amyloid precursor protein mutations in Drosophila	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; FAMILIAL ALZHEIMERS-DISEASE; A-BETA PEPTIDE; TRANSGENIC MICE; BIOLOGICAL FUNCTIONS; SIGNAL-TRANSDUCTION; KINESIN; GENE; DEFICITS; RECEPTOR	We tested the hypothesis that amyloid precursor protein (APP) and its relatives function as vesicular receptor proteins for kinesin-I. Deletion of the Drosophila APP-like gene (Appl) or overexpression of human APP695 or APPL constructs caused axonal transport phenotypes similar to kinesin and dynein mutants. Genetic reduction of kinesin-I expression enhanced while genetic reduction of dynein expression suppressed these phenotypes. Deletion of the C terminus of APP695 or APPL, including the kinesin binding region, disrupted axonal transport of APP695 and APPL and abolished the organelle accumulation phenotype. Neuronal apoptosis was induced only by overexpression of constructs containing both the C-terminal and A beta regions of APP695. We discuss the possibility that axonal transport disruption may play a role in the neurodegenerative pathology of Alzheimer's disease.	Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego	Goldstein, LSB (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.			gunawardena, shermali/0000-0001-8776-9397	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035252] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35252] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; Bowman AB, 1999, J CELL BIOL, V146, P165; BRAND A, 1995, TRENDS GENET, V11, P324, DOI 10.1016/S0168-9525(00)89091-5; BUXBAUM JD, 1993, BIOCHEM BIOPH RES CO, V197, P639, DOI 10.1006/bbrc.1993.2527; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; DAIGLE I, 1993, P NATL ACAD SCI USA, V90, P12045, DOI 10.1073/pnas.90.24.12045; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; De Strooper B, 2000, J CELL SCI, V113, P1857; Ebneth A, 1998, J CELL BIOL, V143, P777, DOI 10.1083/jcb.143.3.777; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; FERREIRA A, 1992, J CELL BIOL, V117, P595, DOI 10.1083/jcb.117.3.595; Fossgreen A, 1998, P NATL ACAD SCI USA, V95, P13703, DOI 10.1073/pnas.95.23.13703; Galvin JE, 2000, EXP NEUROL, V165, P77, DOI 10.1006/exnr.2000.7461; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Goldstein LSB, 2001, SCIENCE, V291, P2102, DOI 10.1126/science.1059766; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Heber S, 2000, J NEUROSCI, V20, P7951; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hurd DD, 1996, GENETICS, V144, P1075; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kaether C, 2000, MOL BIOL CELL, V11, P1213, DOI 10.1091/mbc.11.4.1213; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kang DE, 1997, NEUROLOGY, V49, P56, DOI 10.1212/WNL.49.1.56; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; LUO LQ, 1992, NEURON, V9, P595, DOI 10.1016/0896-6273(92)90024-8; Magara F, 1999, P NATL ACAD SCI USA, V96, P4656, DOI 10.1073/pnas.96.8.4656; Martin M, 1999, MOL BIOL CELL, V10, P3717, DOI 10.1091/mbc.10.11.3717; Masliah E, 1996, J NEUROSCI, V16, P5795; Moechars D, 1999, NEUROSCIENCE, V91, P819, DOI 10.1016/S0306-4522(98)00599-5; Price DL, 1998, ANNU REV GENET, V32, P461, DOI 10.1146/annurev.genet.32.1.461; Reese EL, 2000, J CELL BIOL, V151, P155, DOI 10.1083/jcb.151.1.155; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; Storey E, 1999, NEUROPATH APPL NEURO, V25, P81; SWANSON JA, 1992, J CELL SCI, V103, P201; Takahashi M, 2000, NEURON, V28, P461, DOI 10.1016/S0896-6273(00)00125-2; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Tesseur I, 2000, AM J PATHOL, V157, P1495, DOI 10.1016/S0002-9440(10)64788-8; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Torroja L, 1999, J NEUROSCI, V19, P7793; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; WASCO W, 1993, ANN NY ACAD SCI, V695, P203, DOI 10.1111/j.1749-6632.1993.tb23053.x; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	55	330	345	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					389	401		10.1016/S0896-6273(01)00496-2	http://dx.doi.org/10.1016/S0896-6273(01)00496-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709151	Bronze			2022-12-24	WOS:000172119100006
J	Haist, F; Gore, JB; Mao, H				Haist, F; Gore, JB; Mao, H			Consolidation of human memory over decades revealed by functional magnetic resonance imaging	NATURE NEUROSCIENCE			English	Article							GRADED RETROGRADE-AMNESIA; MEDIAL TEMPORAL-LOBE; HIPPOCAMPAL-FORMATION; CONTEXTUAL FEAR; BRAIN; REGISTRATION; RECOGNITION; ACTIVATION; IMPAIRMENT; VALIDATION	Medial temporal lobe (MTL) lesions typically produce retrograde amnesia characterized by the disproportionate loss of recently acquired memories. Temporally graded memory loss is interpreted traditionally as evidence for a consolidation process guided by the MTL. Here, using functional magnetic resonance imaging (fMRI), we show temporally graded changes in MTL activity in healthy older adults taking a famous faces remote memory test. Evidence for temporally graded change in the hippocampal formation was mixed, suggesting it may participate only in consolidation processes lasting a few years. Entorhinal cortex was associated with temporally graded changes extending up to 20 years. These findings support the basic tenets of consolidation theory and suggest that the entorhinal cortex, rather than the hippocampal formation, participates in memory consolidation over decades.	Childrens Hosp, Res Ctr, Lab Res Neursci Autism, La Jolla, CA 92037 USA; Georgia State Univ, Dept Psychol, Atlanta, GA 30303 USA; Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92037 USA; Emory Univ, Sch Med, Dept Radiol, Atlanta, GA 30322 USA	Children's Hospital Los Angeles; University System of Georgia; Georgia State University; University of California System; University of California San Diego; Emory University	Haist, F (corresponding author), Childrens Hosp, Res Ctr, Lab Res Neursci Autism, 8110 La Jolla Shores Dr,Suite 201, La Jolla, CA 92037 USA.		Haist, Frank/C-3177-2013	Haist, Frank/0000-0002-7254-6083				ALBERT MS, 1981, ARCH NEUROL-CHICAGO, V38, P495, DOI 10.1001/archneur.1981.00510080057008; ALBERT MS, 1979, ARCH NEUROL-CHICAGO, V36, P211, DOI 10.1001/archneur.1979.00500400065010; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; Cox RW, 1997, NMR BIOMED, V10, P171, DOI 10.1002/(SICI)1099-1492(199706/08)10:4/5<171::AID-NBM453>3.0.CO;2-L; Eichenbaum H, 1999, CURR BIOL, V9, pR482, DOI 10.1016/S0960-9822(99)80301-7; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Fanselow MS, 2000, BEHAV BRAIN RES, V110, P73, DOI 10.1016/S0166-4328(99)00186-2; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Ivanco TL, 2000, HIPPOCAMPUS, V10, P143, DOI 10.1002/(SICI)1098-1063(2000)10:2<143::AID-HIPO3>3.0.CO;2-G; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Kapur N, 1999, PSYCHOL BULL, V125, P800, DOI 10.1037/0033-2909.125.6.800; Kapur N, 1999, HIPPOCAMPUS, V9, P247, DOI 10.1002/(SICI)1098-1063(1999)9:3<247::AID-HIPO5>3.0.CO;2-W; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Knowlton BJ, 1998, CURR OPIN NEUROBIOL, V8, P293, DOI 10.1016/S0959-4388(98)80154-2; KRITCHEVSKY M, 1989, NEUROLOGY, V39, P213, DOI 10.1212/WNL.39.2.213; Leveroni CL, 2000, J NEUROSCI, V20, P878, DOI 10.1523/JNEUROSCI.20-02-00878.2000; Lynch G, 1998, NEUROBIOL LEARN MEM, V70, P82, DOI 10.1006/nlme.1998.3840; Maguire EA, 2001, NEUROREPORT, V12, P441, DOI 10.1097/00001756-200103050-00004; Markowitsch HJ, 2000, PRINCIPLES BEHAV COG, P257; MARSLENWILSON WD, 1975, NEUROPSYCHOLOGIA, V13, P353, DOI 10.1016/0028-3932(75)90013-5; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P215, DOI 10.1016/0028-3932(68)90021-3; MILNER PM, 1989, NEUROPSYCHOLOGIA, V27, P23, DOI 10.1016/0028-3932(89)90087-0; Moscovitch M, 1998, CURR OPIN NEUROBIOL, V8, P297, DOI 10.1016/S0959-4388(98)80155-4; Nadel L, 2000, HIPPOCAMPUS, V10, P352, DOI 10.1002/1098-1063(2000)10:4<352::AID-HIPO2>3.3.CO;2-4; Nadel L, 1997, CURR OPIN NEUROBIOL, V7, P217, DOI 10.1016/S0959-4388(97)80010-4; Parkin AJ, 1997, CURR BIOL, V7, pR768, DOI 10.1016/S0960-9822(06)00400-3; Petersen SE, 1998, P NATL ACAD SCI USA, V95, P853, DOI 10.1073/pnas.95.3.853; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Scoville WB, 2000, J NEUROPSYCH CLIN N, V12, P103; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; SQUIRE LR, 1989, J NEUROSCI, V9, P828; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1992, PSYCHOL REV, V99, P582; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Talairach J., 1988, COPLANAR STEREOTAXIC; Thornton JA, 1997, J NEUROSCI, V17, P8536; Witter MP, 2000, ANN NY ACAD SCI, V911, P1; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YONEDA Y, 1994, EUR NEUROL, V34, P243, DOI 10.1159/000117051; ZOLAMORGAN S, 1986, J NEUROSCI, V6, P2950; ZOLAMORGAN SM, 1990, SCIENCE, V250, P288, DOI 10.1126/science.2218534	50	165	168	0	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1139	1145		10.1038/nn739	http://dx.doi.org/10.1038/nn739			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	489AY	11600889				2022-12-24	WOS:000171970900018
J	Hu, HL; Marton, TF; Goodman, CS				Hu, HL; Marton, TF; Goodman, CS			Plexin B mediates axon guidance in Drosophila by simultaneously inhibiting active rac and enhancing RhoA signaling	NEURON			English	Article							GROWTH-CONE COLLAPSE; SEMAPHORIN RECEPTOR; SMALL GTPASES; TRANSMEMBRANE; NEUROPILIN; FAMILY; OUTGROWTH; MOTOR; CHEMOREPELLENT; MORPHOGENESIS	Plexins are neuronal receptors for the repulsive axon guidance molecule Semaphorins. Previous studies showed that Plexin B (PlexB) binds directly to the active, GTP-bound form of the Rac GTPase. Here, we define a seven amino acid sequence in PlexB required for Rac ITP binding. The interaction of PlexB with Rac(GTP) is necessary for Plexin-mediated axon guidance in vivo. A different region of PlexB binds to RhoA. Dosage-sensitive genetic interactions suggest that PlexB suppresses Rac activity and enhances RhoA activity. Biochemical evidence indicates that PlexB sequesters RacGTP from its downstream effector PAK. These results suggest a model whereby PlexB mediates repulsion by coordinately regulating two small GTPases in opposite directions: PlexB binds to Rac(GTP) and downregulates its output by blocking its access to PAK and, at the same time, binds to and increases the output of RhoA.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.	goodman@uclink4.berkeley.edu		Hu, Hailan/0000-0002-0425-5057	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Awasaki T, 2000, NEURON, V26, P119, DOI 10.1016/S0896-6273(00)81143-5; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bateman J, 2000, NEURON, V26, P93, DOI 10.1016/S0896-6273(00)81141-1; BILLUART P, 2001, IN PRESS CELL; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Dickson BJ, 2001, CURR OPIN NEUROBIOL, V11, P103, DOI 10.1016/S0959-4388(00)00180-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Feiner L, 1997, NEURON, V19, P539, DOI 10.1016/S0896-6273(00)80370-0; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Jin Z, 1997, J NEUROSCI, V17, P6256; Kaufmann N, 1998, DEVELOPMENT, V125, P453; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KOLODKIN AL, 1992, NEURON, V9, P831, DOI 10.1016/0896-6273(92)90237-8; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kuhn TB, 1999, J NEUROSCI, V19, P1965; Lei M, 2000, CELL, V102, P387, DOI 10.1016/S0092-8674(00)00043-X; Liebl EC, 2000, NEURON, V26, P107, DOI 10.1016/S0896-6273(00)81142-3; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Magie CR, 1999, DEVELOPMENT, V126, P5353; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; PUSCHEL AW, 1995, NEURON, V14, P941, DOI 10.1016/0896-6273(95)90332-1; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; SELF AJ, 1995, METHOD ENZYMOL, V256, P3; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Steven R, 1998, CELL, V92, P785, DOI 10.1016/S0092-8674(00)81406-3; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Wong JTW, 1997, DEVELOPMENT, V124, P3597; Yamashita T, 1999, NEURON, V24, P585, DOI 10.1016/S0896-6273(00)81114-9; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; Zou JX, 1999, P NATL ACAD SCI USA, V96, P13813, DOI 10.1073/pnas.96.24.13813	53	162	168	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					39	51		10.1016/S0896-6273(01)00453-6	http://dx.doi.org/10.1016/S0896-6273(01)00453-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604137	Bronze			2022-12-24	WOS:000171525200007
J	Huk, AC; Ress, D; Heeger, DJ				Huk, AC; Ress, D; Heeger, DJ			Neuronal basis of the motion aftereffect reconsidered	NEURON			English	Article							HUMAN VISUAL-CORTEX; CAT STRIATE CORTEX; DIRECTION-SELECTIVE ADAPTATION; POSITRON EMISSION TOMOGRAPHY; AREA MT; ATTENTIONAL MODULATION; FUNCTIONAL MRI; CORTICAL AREAS; SPEED SENSITIVITY; ORTHOGONAL MOTION	Several fMRI studies have reported MT+ response increases correlated with perception of the motion aftereffect (MAE). However, attention can strongly affect MT+ responses, and subjects may naturally attend more to the MAE than control trials without MAE. We found that requiring subjects to attend to motion on both MAE and control trials produced equal levels of MT+ response, suggesting that attention may have confounded the interpretation of previous experiments; in our data, attention accounts for the entire effect. After eliminating this confound, we observed that direction-selective motion adaptation produced a direction-selective imbalance in MT+ responses (and earlier visual areas), and yielded a corresponding asymmetry in speed discrimination thresholds. These findings provide physiological evidence that population level response imbalances underlie the MAE, and quantify the relative proportions of direction-selective neurons across human visual areas.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Huk, AC (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290, Seattle, WA 98195 USA.		Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935	NATIONAL EYE INSTITUTE [R01EY012741, F32EY006952] Funding Source: NIH RePORTER; NEI NIH HHS [F32-EY06952, R01-EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALBRIGHT TD, 1993, VISUAL MOTION ITS RO, P177; BARLOW HB, 1963, NATURE, V200, P1345, DOI 10.1038/2001345a0; Beauchamp MS, 1997, J NEUROPHYSIOL, V78, P516, DOI 10.1152/jn.1997.78.1.516; BECKERS G, 1995, BRAIN, V118, P49, DOI 10.1093/brain/118.1.49; Bex PJ, 1999, J OPT SOC AM A, V16, P2817, DOI 10.1364/JOSAA.16.002817; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Buchel C, 1998, BRAIN, V121, P1281, DOI 10.1093/brain/121.7.1281; CHAUDHURI A, 1990, NATURE, V344, P60, DOI 10.1038/344060a0; Chawla D, 1999, NAT NEUROSCI, V2, P671, DOI 10.1038/10230; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; Chawla D, 1999, NEUROIMAGE, V9, P508, DOI 10.1006/nimg.1999.0432; Clifford CWG, 1999, VISION RES, V39, P4324, DOI 10.1016/S0042-6989(99)00151-0; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Culham JC, 1999, J NEUROPHYSIOL, V81, P388, DOI 10.1152/jn.1999.81.1.388; Demb JB, 1998, J NEUROSCI, V18, P6939; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Efron B., 1994, INTRO BOOTSTRAP; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; GIASCHI D, 1993, J NEUROPHYSIOL, V70, P2024, DOI 10.1152/jn.1993.70.5.2024; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Glover GH, 1999, NEUROIMAGE, V9, P416, DOI 10.1006/nimg.1998.0419; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grunewald A, 1996, NATURE, V384, P358, DOI 10.1038/384358a0; HAMMOND P, 1985, EXP BRAIN RES, V60, P411; HAMMOND P, 1986, VISION RES, V26, P1055, DOI 10.1016/0042-6989(86)90039-8; HAMMOND P, 1988, EXP BRAIN RES, V72, P1, DOI 10.1007/BF00248495; Hautzel H, 2001, BRAIN RES, V892, P281, DOI 10.1016/S0006-8993(00)03224-8; He S, 1998, CURR BIOL, V8, P1215, DOI 10.1016/S0960-9822(07)00512-X; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Heeger DJ, 2000, NAT NEUROSCI, V3, P631, DOI 10.1038/76572; HOTSON J, 1994, VISION RES, V34, P2115, DOI 10.1016/0042-6989(94)90321-2; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MARLIN SG, 1988, J NEUROPHYSIOL, V59, P1314, DOI 10.1152/jn.1988.59.4.1314; MATHER G, 1980, PERCEPTION, V9, P379, DOI 10.1068/p090379; Mather G, 1998, MOTION AFTEREFFECT, P157; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; PANTIE A, 1974, VISION RES, V11, P943; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; PETERSEN SE, 1985, BRAIN RES, V346, P146, DOI 10.1016/0006-8993(85)91105-9; Rees G, 2000, NAT NEUROSCI, V3, P716, DOI 10.1038/76673; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; SAUL AB, 1989, VISUAL NEUROSCI, V2, P593, DOI 10.1017/S0952523800003527; SAWYERGLOVER AM, 1998, P SMRT 7 ANN M SYDN, P69; Scannell JW, 1999, P ROY SOC B-BIOL SCI, V266, P875, DOI 10.1098/rspb.1999.0718; SCHNEIDER W, 1993, NATURE, V365, P150, DOI 10.1038/365150a0; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHULMAN GL, 1993, PERCEPTION, V22, P947, DOI 10.1068/p220947; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Smith AT, 1998, J NEUROSCI, V18, P3816; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; SUTHERLAND NS, 1961, Q J EXP PSYCHOL, V13, P222, DOI 10.1080/17470216108416498; Taylor JG, 2000, NEUROIMAGE, V11, P257, DOI 10.1006/nimg.1999.0529; TEUE S, 2000, NAT NEUROSCI, V3, P270; THOMPSON P, 1994, PERCEPTION, V23, P1233, DOI 10.1068/p231233; TOOTELL RBH, 1995, NATURE, V375, P139, DOI 10.1038/375139a0; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; Vaina LM, 1999, HUM BRAIN MAPP, V7, P67, DOI 10.1002/(SICI)1097-0193(1999)7:1<67::AID-HBM6>3.0.CO;2-K; VANWEZEL RJA, 2001, IN PRESS NEUROSCI; VAUTIN RG, 1977, J NEUROPHYSIOL, V40, P1051, DOI 10.1152/jn.1977.40.5.1051; VERSTRATEN FAJ, 1994, VISION RES, V34, P1149, DOI 10.1016/0042-6989(94)90297-6; VONDERHEYDT R, 1978, ARCH ITAL BIOL, V116, P248; Wandell BA, 1999, ANNU REV NEUROSCI, V22, P145, DOI 10.1146/annurev.neuro.22.1.145; WATSON AB, 1979, VISION RES, V19, P515, DOI 10.1016/0042-6989(79)90136-6; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WENDEROTH P, 1988, PERCEPTION, V17, P81, DOI 10.1068/p170081; WRIGHT MJ, 1985, VISION RES, V25, P1947, DOI 10.1016/0042-6989(85)90019-7; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI S, 1993, P ROY SOC B-BIOL SCI, V252, P215, DOI 10.1098/rspb.1993.0068; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313	88	224	228	0	18	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					161	172		10.1016/S0896-6273(01)00452-4	http://dx.doi.org/10.1016/S0896-6273(01)00452-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604147	Bronze			2022-12-24	WOS:000171525200017
J	Akutagawa, E; Konishi, M				Akutagawa, E; Konishi, M			A monoclonal antibody specific to a song system nuclear antigen in estrildine finches	NEURON			English	Article							FEMALE ZEBRA FINCHES; MEMBRANE-PROTEIN LAMP; EARLY ESTROGEN-TREATMENT; SEXUAL-DIFFERENTIATION; GENE-EXPRESSION; MESSENGER-RNAS; IMMUNOCYTOCHEMICAL LOCALIZATION; ELECTROPHORETIC TRANSFER; POLYACRYLAMIDE GELS; NEURONAL GROWTH	This paper describes a monoclonal antibody that recognizes a molecule whose expression is mostly restricted to some of the forebrain areas that control singing behavior in adult estrildine species studied, including the zebra, Bengalese, and spice finches. When the song system displays extreme sexual dimorphism, as in these species, antibody staining occurs only in the male's song nuclei. However, protein expression is identical in both sexes of estrildine finches, in which females also have a well-developed song system. Canaries appear to lack the protein, but it can be induced in female zebra finches by early estrogen treatment. Antibody staining patterns in the zebra finch show that the protein's expression is developmentally regulated to coincide with the abrupt increase in the volume and cell size of the male's or the estrogen-treated female's song system.	CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology	Konishi, M (corresponding author), CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA.	konishim@starbasel.caltech.edu						ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; ADKINSREGAN E, 1987, ANIM BEHAV, V35, P1100, DOI 10.1016/S0003-3472(87)80167-7; ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R; AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; Akutagawa E, 1998, P NATL ACAD SCI USA, V95, P11429, DOI 10.1073/pnas.95.19.11429; ARNOLD AP, 1979, SCIENCE, V205, P702, DOI 10.1126/science.205.4407.702; ARNOLD AP, 1975, J EXP ZOOL, V191, P261, DOI 10.1002/jez.1401910212; ARNOLD AP, 1974, THESIS ROCKEFELLER U; BALTHAZART J, 1992, J COMP NEUROL, V317, P407, DOI 10.1002/cne.903170407; Bottjer SW, 1997, BRAIN BEHAV EVOLUT, V50, P284, DOI 10.1159/000113342; BOTTJER SW, 1992, J NEUROBIOL, V23, P1172, DOI 10.1002/neu.480230909; BRANKS PL, 1986, MOL BRAIN RES, V1, P1, DOI 10.1016/0169-328X(86)90015-X; BRENOWITZ EA, 1986, J NEUROSCI, V6, P2875; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; CLAYTON DF, 1988, NEURON, V1, P249, DOI 10.1016/0896-6273(88)90146-8; DEVOOGD TJ, 1988, J NEUROBIOL, V19, P199, DOI 10.1002/neu.480190303; Faisst AM, 1998, DEV DYNAM, V212, P293, DOI 10.1002/(SICI)1097-0177(199806)212:2<293::AID-AJA14>3.0.CO;2-5; GAHR M, 1988, P NATL ACAD SCI USA, V85, P7380, DOI 10.1073/pnas.85.19.7380; GAHR M, 1987, BRAIN RES, V402, P173, DOI 10.1016/0006-8993(87)91063-8; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Gil OD, 1998, J NEUROSCI, V18, P9312; GOLDMAN D, 1986, P NATL ACAD SCI USA, V83, P4076, DOI 10.1073/pnas.83.11.4076; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GORSKI RA, 1978, BRAIN RES, V148, P333, DOI 10.1016/0006-8993(78)90723-0; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; GURNEY ME, 1981, J NEUROSCI, V1, P658; Holloway CC, 2001, NAT NEUROSCI, V4, P170, DOI 10.1038/84001; Inoue T, 1998, DEV DYNAM, V211, P338, DOI 10.1002/(SICI)1097-0177(199804)211:4<338::AID-AJA5>3.3.CO;2-R; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; KIRN JR, 1989, J NEUROSCI, V9, P3176; KONISHI M, 1987, CIBA F SYMP, V126, P173; KONISHI M, 1982, TRENDS NEUROSCI, V5, P20, DOI 10.1016/0166-2236(82)90011-X; KONISHI M, 1985, NATURE, V315, P145, DOI 10.1038/315145a0; KONISHI M, 1988, P NATL ACAD SCI USA, V85, P7006, DOI 10.1073/pnas.85.18.7006; LEVITT P, 1984, SCIENCE, V223, P299, DOI 10.1126/science.6199842; Lumsden A, 1996, SCIENCE, V274, P1109, DOI 10.1126/science.274.5290.1109; MATTHEW WD, 1987, J IMMUNOL METHODS, V100, P73, DOI 10.1016/0022-1759(87)90174-8; MOONEY R, 1994, J NEUROSCI, V14, P6532; NORDEEN EJ, 1992, J NEUROBIOL, V23, P671, DOI 10.1002/neu.480230606; NORDEEN KW, 1987, J NEUROBIOL, V18, P569, DOI 10.1002/neu.480180607; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; OU SK, 1991, J IMMUNOL METHODS, V145, P111, DOI 10.1016/0022-1759(91)90316-8; PIMENTA AF, 1995, NEURON, V15, P287, DOI 10.1016/0896-6273(95)90034-9; POHLAPEL G, 1984, Z TIERPSYCHOL, V64, P330; POHLAPEL G, 1985, BRAIN RES, V336, P381, DOI 10.1016/0006-8993(85)90673-0; Reinoso BA, 1996, J COMP NEUROL, V375, P274, DOI 10.1002/(SICI)1096-9861(19961111)375:2<274::AID-CNE7>3.0.CO;2-#; Saez FJ, 2000, HISTOCHEM J, V32, P717; Sakaguchi H, 1999, J NEUROSCI, V19, P3973; Sambrook J., 1989, MOL CLONING LAB MANU, V2nd, ed.; SCHLINGER BA, 1991, P NATL ACAD SCI USA, V88, P4191, DOI 10.1073/pnas.88.10.4191; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; SIMPSON HB, 1991, J NEUROBIOL, V22, P777, DOI 10.1002/neu.480220711; STERNBERGER LA, 1983, P NATL ACAD SCI-BIOL, V80, P6126, DOI 10.1073/pnas.80.19.6126; STRUYK AF, 1995, J NEUROSCI, V15, P2141, DOI 10.1523/JNEUROSCI.15-03-02141.1995; SUTCLIFFE JG, 1983, CELL, V33, P671, DOI 10.1016/0092-8674(83)90010-7; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHL GR, 1986, J NEUROSCI, V6, P3258; Wade J, 1997, J EXP ZOOL, V278, P405, DOI 10.1002/(SICI)1097-010X(19970815)278:6<405::AID-JEZ8>3.0.CO;2-S; ZACCO A, 1990, J NEUROSCI, V10, P73; ZHUKAREVA V, 1995, DEVELOPMENT, V121, P1161; ZIPSER B, 1981, NATURE, V289, P549, DOI 10.1038/289549a0	67	15	15	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 30	2001	31	4					545	556		10.1016/S0896-6273(01)00388-9	http://dx.doi.org/10.1016/S0896-6273(01)00388-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545714	Bronze			2022-12-24	WOS:000170759200009
J	Tsivilis, D; Otten, LJ; Rugg, MD				Tsivilis, D; Otten, LJ; Rugg, MD			Context effects on the neural correlates of recognition memory: An electrophysiological study	NEURON			English	Article							RECOLLECTIVE EXPERIENCE; BRAIN POTENTIALS; ASSOCIATIONS; FAMILIARITY; REPETITION; DISSOCIATION; JUDGMENT; IMPLICIT; AMNESIA	Event-related potentials (ERPs) were recorded during a recognition memory test for previously studied visual objects. Some studied objects were paired with the same context (landscape scenes) as at study, some were superimposed on a different studied context, and some were paired with new contexts. Unstudied objects were paired with either a studied or a new context. Three ERP memory effects were observed: an early effect elicited by all stimuli containing at least one studied component; a second effect elicited only by stimuli in which both object and context had been studied; and a third effect elicited by stimuli containing a studied object. Thus, test stimuli engaged three distinct kinds of memory-related neural activity which differed in their specificity for task-relevant features.	UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Dept Psychol, London WC1N 3AR, England	University of London; University College London; University of London; University College London	Rugg, MD (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	m.rugg@uci.ac.uk	Otten, Leun/C-6036-2008					Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; [Anonymous], NEUROPSYCHOLOGY CONS; Brown MW, 1998, PROG NEUROBIOL, V55, P149, DOI 10.1016/S0301-0082(98)00002-1; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; Curran T, 2000, MEM COGNITION, V28, P923, DOI 10.3758/BF03209340; Donaldson DI, 1998, NEUROPSYCHOLOGIA, V36, P377, DOI 10.1016/S0028-3932(97)00143-7; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; GARDINER JM, 1988, MEM COGNITION, V16, P309, DOI 10.3758/BF03197041; GARDINER JM, 1991, MEM COGNITION, V19, P617, DOI 10.3758/BF03197157; Gardiner John M., 1993, P163; Goshen-Gottstein Y, 2000, NEUROPSYCHOLOGY, V14, P570, DOI 10.1037/0894-4105.14.4.570; GOSHENGOTTSTEIN Y, 1995, J EXP PSYCHOL LEARN, V21, P1249, DOI 10.1037/0278-7393.21.5.1249; Hamann SB, 1997, BEHAV NEUROSCI, V111, P850, DOI 10.1037/0735-7044.111.4.850; MANDLER G, 1980, PSYCHOL REV, V87, P252, DOI 10.1037/0033-295X.87.3.252; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; Mecklinger A, 2000, PSYCHOPHYSIOLOGY, V37, P565, DOI 10.1111/1469-8986.3750565; Rempel-Clower NL, 2000, CEREB CORTEX, V10, P851, DOI 10.1093/cercor/10.9.851; RUGG MD, 1994, PSYCHOPHYSIOLOGY, V31, P447, DOI 10.1111/j.1469-8986.1994.tb01048.x; Rugg MD, 1997, PSYCHOPHYSIOLOGY, V34, P572, DOI 10.1111/j.1469-8986.1997.tb01744.x; Rugg MD, 1998, NATURE, V392, P595, DOI 10.1038/33396; RUGG MD, IN PRESS NEUROPSYCHO; Tendolkar I, 1999, NEUROSCI LETT, V263, P45, DOI 10.1016/S0304-3940(99)00106-8; TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017; Tulving E., 1973, PSYCHOL REV, V80, P353; Wilding EL, 1996, BRAIN, V119, P889, DOI 10.1093/brain/119.3.889; Winer BJ, 1971, STAT PRINCIPLES EXPT; Xiang JZ, 1998, NEUROPHARMACOLOGY, V37, P657, DOI 10.1016/S0028-3908(98)00030-6; Yonelinas AP, 1998, NEUROPSYCHOLOGY, V12, P323, DOI 10.1037/0894-4105.12.3.323; YONELINAS AP, 1995, J MEM LANG, V34, P622, DOI 10.1006/jmla.1995.1028	29	175	178	2	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					497	505		10.1016/S0896-6273(01)00376-2	http://dx.doi.org/10.1016/S0896-6273(01)00376-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	465QG	11516405	Bronze			2022-12-24	WOS:000170601000017
J	Perrin, FE; Rathjen, FG; Stoeckli, ET				Perrin, FE; Rathjen, FG; Stoeckli, ET			Distinct subpopulations of sensory afferents require F11 or axonin-1 for growth to their target layers within the spinal cord of the chick	NEURON			English	Article							CELL-ADHESION MOLECULE; ROOT GANGLION NEURONS; NG-CAM; NEURITE OUTGROWTH; NERVOUS-SYSTEM; SEMAPHORIN-III; NR-CAM; PROJECTIONS; RECEPTOR; AXONS	Dorsal root ganglion neurons project axons to specific target layers in the gray matter of the spinal cord, according to their sensory modality. Using an in vivo approach, we demonstrate an involvement of the two immunoglobulin superfamily cell adhesion molecules axonin-1/TAG-1 and F11/F3/contactin in subpopulation-specific sensory axon guidance. Proprioceptive neurons, which establish connections with motoneurons in the ventral horn, depend on F11 interactions. Nociceptive fibers, which target to layers in the dorsal horn, require axonin-1 for pathfinding. In vitro NgCAM and NrCAM were shown to bind to both axonin-1 and F11. However, despite this fact and despite their ubiquitous expression in the spinal cord, NgCAM and NrCAM are selective binding partners for axonin-1 and F11 in sensory axon guidance. Whereas nociceptive pathfinding depends on NgCAM and axonin-1, proprioceptive fibers require NrCAM and F11.	Univ Basel, Pharmactr, CH-4056 Basel, Switzerland; Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	University of Basel; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Stoeckli, ET (corresponding author), Univ Basel, Pharmactr, CH-4056 Basel, Switzerland.	esther.stoeckli@unibas.ch	PERRIN, Florence/AAY-6815-2021	PERRIN, Florence/0000-0002-7630-0515; Stoeckli, Esther/0000-0002-8485-0648				Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; Baba H, 1999, J NEUROSCI, V19, P859; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; BRUMMENDORF T, 1993, NEURON, V10, P711; Brummendorf T, 1996, CURR OPIN NEUROBIOL, V6, P584, DOI 10.1016/S0959-4388(96)80089-4; BRUMMENDORF T, 1998, CELL ADHES COMMUN S, V6, P23; Burstyn-Cohen T, 1999, NEURON, V23, P233, DOI 10.1016/S0896-6273(00)80776-X; Buttiglione M, 1996, MOL CELL NEUROSCI, V8, P53, DOI 10.1006/mcne.1996.0043; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; Chong MS, 1999, J COMP NEUROL, V410, P42; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405; EIDE AL, 1995, J COMP NEUROL, V353, P247, DOI 10.1002/cne.903530207; Eide AL, 1997, ANAT EMBRYOL, V195, P237, DOI 10.1007/s004290050043; ERNFORS P, 1994, CELL, V77, P503, DOI 10.1016/0092-8674(94)90213-5; Fitzli D, 2000, J CELL BIOL, V149, P951, DOI 10.1083/jcb.149.4.951; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Friedel RH, 1997, P NATL ACAD SCI USA, V94, P12670, DOI 10.1073/pnas.94.23.12670; Fu SY, 2000, J NEUROBIOL, V45, P227, DOI 10.1002/1097-4695(200012)45:4<227::AID-NEU4>3.0.CO;2-N; Fyffe RE, 1992, SENSORY NEURONS DIVE, P131; HALFTER W, 1994, DEV BRAIN RES, V78, P87, DOI 10.1016/0165-3806(94)90013-2; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; KLEIN R, 1994, NATURE, V368, P249, DOI 10.1038/368249a0; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; KUHN TB, 1991, J CELL BIOL, V115, P1113, DOI 10.1083/jcb.115.4.1113; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; LEE MT, 1988, J NEUROSCI, V8, P2530; Lefcort F, 1996, J NEUROSCI, V16, P3704; Lewin GR, 1996, PHILOS T ROY SOC B, V351, P405, DOI 10.1098/rstb.1996.0035; Lustig M, 1999, DEV BIOL, V209, P340, DOI 10.1006/dbio.1999.9250; MENDELSON B, 1992, NEUROSCI LETT, V138, P72, DOI 10.1016/0304-3940(92)90475-M; MESSERSMITH EK, 1995, NEURON, V14, P949, DOI 10.1016/0896-6273(95)90333-X; Milev P, 1996, J BIOL CHEM, V271, P15716, DOI 10.1074/jbc.271.26.15716; MORALES G, 1993, NEURON, V11, P1113, DOI 10.1016/0896-6273(93)90224-F; OAKLEY RA, 1995, DEVELOPMENT, V121, P1341; Oakley RA, 1997, J NEUROSCI, V17, P4262; Ozaki S, 1997, J COMP NEUROL, V380, P215; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; Perrin FE, 2000, MICROSC RES TECHNIQ, V48, P25, DOI 10.1002/(SICI)1097-0029(20000101)48:1<25::AID-JEMT4>3.0.CO;2-F; Puschel AW, 1996, MOL CELL NEUROSCI, V7, P419, DOI 10.1006/mcne.1996.0030; RADER C, 1993, EUR J BIOCHEM, V215, P133, DOI 10.1111/j.1432-1033.1993.tb18015.x; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; Reichardt L. F., 1997, MOL CELLULAR APPROAC, P220; RUIT KG, 1992, NEURON, V8, P573, DOI 10.1016/0896-6273(92)90284-K; Scott SA, 1992, SENSORY NEURONS DIVE; Sharma K, 1998, DEVELOPMENT, V125, P635; Shepherd IT, 1997, DEVELOPMENT, V124, P1377; Shiga T, 1997, DEV BIOL, V192, P136, DOI 10.1006/dbio.1997.8742; SILOSSANTIAGO I, 1995, NEUROREPORT, V6, P861, DOI 10.1097/00001756-199504190-00009; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Snider WD, 1996, PHILOS T ROY SOC B, V351, P395, DOI 10.1098/rstb.1996.0034; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Stoeckli ET, 1996, DEV BIOL, V177, P15, DOI 10.1006/dbio.1996.0141; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; STOECKLI ET, 1995, NEURON, V14, P1165, DOI 10.1016/0896-6273(95)90264-3; Stoeckli ET, 1997, NEURON, V18, P209, DOI 10.1016/S0896-6273(00)80262-7; SUTER DM, 1995, J CELL BIOL, V131, P1067, DOI 10.1083/jcb.131.4.1067; TESSAROLLO L, 1994, P NATL ACAD SCI USA, V91, P11844, DOI 10.1073/pnas.91.25.11844; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; WOOLF CJ, 1992, NATURE, V355, P75, DOI 10.1038/355075a0; Xue Y, 1999, J COMP NEUROL, V408, P299, DOI 10.1002/(SICI)1096-9861(19990607)408:3<299::AID-CNE1>3.0.CO;2-N; ZUELLIG RA, 1992, EUR J BIOCHEM, V204, P453, DOI 10.1111/j.1432-1033.1992.tb16655.x	63	81	84	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					707	723		10.1016/S0896-6273(01)00315-4	http://dx.doi.org/10.1016/S0896-6273(01)00315-4			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430805	Bronze			2022-12-24	WOS:000169508900012
J	Rohr, KB; Barth, KA; Varga, ZM; Wilson, SW				Rohr, KB; Barth, KA; Varga, ZM; Wilson, SW			The nodal pathway acts upstream of hedgehog signaling to specify ventral telencephalic identity	NEURON			English	Article							ONE-EYED-PINHEAD; PROSENCEPHALIC NEURAL PLATE; SONIC-HEDGEHOG; NEURONAL DIFFERENTIATION; MAMMALIAN TELENCEPHALON; EMBRYONIC ZEBRAFISH; NERVOUS-SYSTEM; GENE-FUNCTION; FLOOR PLATE; EXPRESSION	The Nodal and Hedgehog signaling pathways influence dorsoventral patterning at all axial levels of the CNS, but it remains largely unclear how these pathways interact to mediate patterning. Here we show that, in zebrafish, Nodal signaling is required for induction of the homeobox genes nk2. 1a in the ventral diencephalon and nk2.1b in the ventral telencephalon. Hedgehog signaling is also required for telencephalic nk2. 1b expression but may not be essential to establish diencephalic nk2. la expression. Furthermore, Shh does not restore ventral diencephalic development in embryos lacking Nodal activity. In contrast, Shh does restore telencephalic nk2.1b expression in the absence of Nodal activity, suggesting that Hedgehog signaling acts downstream of Nodal activity to pattern the ventral telencephalon. Thus, the Nodal pathway regulates ventral forebrain patterning through both Hedgehog signaling-dependent and -independent mechanisms.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Freiburg, Inst Biol Zool 1, Dept Dev Biol, D-79104 Freiburg, Germany	University of London; University College London; University of Freiburg	Wilson, SW (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	s.wilson@ucl.ac.uk	Zebrafish, UCL/A-3125-2009; Wilson, Stephen W/B-9404-2008	Wilson, Stephen W/0000-0002-8557-5940				Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Barth KA, 1999, DEVELOPMENT, V126, P4977; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Concordet JP, 1996, DEVELOPMENT, V122, P2835; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Dale JK, 1997, CELL, V90, P257, DOI 10.1016/S0092-8674(00)80334-7; EKKER SC, 1995, CURR BIOL, V5, P944, DOI 10.1016/S0960-9822(95)00185-0; ERICSON J, 1995, CELL, V81, P747, DOI 10.1016/0092-8674(95)90536-7; Feldman B, 1998, NATURE, V395, P181, DOI 10.1038/26013; Fernandez AS, 1998, DEVELOPMENT, V125, P2099; Fishell G, 1997, CURR OPIN NEUROBIOL, V7, P62, DOI 10.1016/S0959-4388(97)80121-3; Force A, 1999, GENETICS, V151, P1531; Gaiano N, 1999, NAT NEUROSCI, V2, P812, DOI 10.1038/12186; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; Gunhaga L, 2000, DEVELOPMENT, V127, P3283; HATTA K, 1994, P NATL ACAD SCI USA, V91, P2061, DOI 10.1073/pnas.91.6.2061; Heisenberg CP, 1997, DEV BIOL, V184, P85, DOI 10.1006/dbio.1997.8511; Huh SO, 1999, DEV BIOL, V211, P53, DOI 10.1006/dbio.1999.9303; INOUE A, 1994, DEV DYNAM, V199, P1, DOI 10.1002/aja.1001990102; Inoue T, 2000, DEV BIOL, V219, P373, DOI 10.1006/dbio.2000.9616; Kalderon D, 2000, CELL, V103, P371, DOI 10.1016/S0092-8674(00)00129-X; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Kohtz JD, 1998, DEVELOPMENT, V125, P5079; KRAUSS S, 1993, CELL, V75, P1431, DOI 10.1016/0092-8674(93)90628-4; MACDONALD R, 1995, DEVELOPMENT, V121, P3267; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Meno C, 1999, MOL CELL, V4, P287, DOI 10.1016/S1097-2765(00)80331-7; Mione M, 2001, MECH DEVELOP, V100, P93, DOI 10.1016/S0925-4773(00)00501-3; Muller F, 2000, DEVELOPMENT, V127, P3889; Murone M, 1999, CURR BIOL, V9, P76, DOI 10.1016/S0960-9822(99)80018-9; Nomura M, 1998, NATURE, V393, P786, DOI 10.1038/31693; Odenthal J, 2000, DEV BIOL, V219, P350, DOI 10.1006/dbio.1999.9589; Pera EM, 1997, DEVELOPMENT, V124, P4153; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Rebagliati MR, 1998, DEV BIOL, V199, P261, DOI 10.1006/dbio.1998.8935; Rohr KB, 2000, MECH DEVELOP, V95, P267, DOI 10.1016/S0925-4773(00)00345-2; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Sampath K, 1998, NATURE, V395, P185, DOI 10.1038/26020; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Schier AF, 1996, DEVELOPMENT, V123, P165; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmid B, 2000, DEVELOPMENT, V127, P957; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Sirotkin HI, 2000, CURR BIOL, V10, P1051, DOI 10.1016/S0960-9822(00)00679-5; Sirotkin HI, 2000, DEVELOPMENT, V127, P2583; Song JW, 1999, DEV BIOL, V213, P157, DOI 10.1006/dbio.1999.9370; Strahle U, 1997, Genes Funct, V1, P131; Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664; Sussel L, 1999, DEVELOPMENT, V126, P3359; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Thisse C, 1999, DEVELOPMENT, V126, P229; Toresson H, 1998, DEV GENES EVOL, V208, P431, DOI 10.1007/s004270050200; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Varga ZM, 1999, DEVELOPMENT, V126, P5533; Varlet I, 1997, DEVELOPMENT, V124, P1033; Watanabe M, 1999, DEVELOPMENT, V126, P5621; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6	71	133	134	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					341	351		10.1016/S0896-6273(01)00210-0	http://dx.doi.org/10.1016/S0896-6273(01)00210-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239427	Bronze			2022-12-24	WOS:000167141700010
J	Busciglio, J; Pelsman, A; Wong, C; Pigino, G; Yuan, ML; Mori, H; Yankner, BA				Busciglio, J; Pelsman, A; Wong, C; Pigino, G; Yuan, ML; Mori, H; Yankner, BA			Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome	NEURON			English	Article							HUMAN PRIMARY NEURON; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; INTRACELLULAR ACCUMULATION; SECRETED FORMS; CELL-DEATH; A-BETA; HIPPOCAMPAL-NEURONS; TRANSFECTED CELLS; DECREASED LEVELS	Most Down's syndrome (DS) patients develop Alzheimer's disease (AD) neuropathology. Astrocyte and neuronal cultures derived from fetal DS brain show alterations in the processing of amyloid beta precursor protein (AbetaPP), including increased levels of APPP and C99, reduced levels of secreted AbetaPP (AbetaPPs) and C83, and intracellular accumulation of insoluble Abeta42. This pattern of AbetaPP processing is recapitulated in normal astrocytes by inhibition of mitochondrial metabolism, consistent with impaired mitochondrial function in DS astrocytes. Intracellular Abeta42 and reduced AbetaPPs are also detected in DS and AD brains. The survival of DS neurons is markedly increased by recombinant or astrocyte-produced AbetaPPs, suggesting that AbetaPPs may be a neuronal survival factor. Thus, mitochondrial dysfunction in DS may lead to intracellular deposition of Abeta42, reduced levels of AbetaPPs, and a chronic state of increased neuronal vulnerability.	Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT 06030 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Osaka City Univ, Sch Med, Dept Neurosci, Abeno Ku, Osaka 5458585, Japan	University of Connecticut; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Osaka Metropolitan University	Busciglio, J (corresponding author), Univ Connecticut, Ctr Hlth, Dept Neurosci, 263 Farmington Ave, Farmington, CT 06030 USA.	busciglio@nso1.uchc.edu	Pigino, Gustavo/L-7002-2019		NICHD NIH HHS [HD38466] Funding Source: Medline; NINDS NIH HHS [NS30352, NS33325] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030352, R01NS033325] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barger SW, 1996, MOL BRAIN RES, V40, P116; BEAL MF, 1995, ANN NEUROL, V38, P357, DOI 10.1002/ana.410380304; BLASS JP, 1991, REV NEUROL, V147, P513; BOWES MP, 1994, EXP NEUROL, V129, P112, DOI 10.1006/exnr.1994.1152; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Busciglio J, 1997, J NEUROSCI, V17, P5101, DOI 10.1523/jneurosci.17-13-05101.1997; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; BUSCIGLIO J, 1995, NATURE, V378, P776, DOI 10.1038/378776a0; BUSCIGLIO J, 1993, J NEUROCHEM, V61, P1565, DOI 10.1111/j.1471-4159.1993.tb13658.x; BUSH ML, 1995, P NATL ACAD SCI USA, V92, P1861, DOI 10.1073/pnas.92.6.1861; Clarke G, 2000, NATURE, V406, P195, DOI 10.1038/35018098; COYLE JT, 1986, BRAIN RES BULL, V16, P773, DOI 10.1016/0361-9230(86)90074-2; Druzhyna N, 1998, MUTAT RES-DNA REPAIR, V409, P81, DOI 10.1016/S0921-8777(98)00042-1; Frederikse PH, 1996, J BIOL CHEM, V271, P10169, DOI 10.1074/jbc.271.17.10169; FRIES E, 1980, P NATL ACAD SCI-BIOL, V77, P3870, DOI 10.1073/pnas.77.7.3870; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Gasparini L, 1997, NEUROSCI LETT, V231, P113, DOI 10.1016/S0304-3940(97)00536-3; Geula C, 1998, NAT MED, V4, P827, DOI 10.1038/nm0798-827; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Kim SH, 2000, CELL MOL LIFE SCI, V57, P1810, DOI 10.1007/PL00000661; Krapfenbauer K, 1999, J NEURAL TRANSM-SUPP, P211; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc AC, 1997, J NEUROCHEM, V68, P1183; Lemere CA, 1996, NEUROBIOL DIS, V3, P16, DOI 10.1006/nbdi.1996.0003; Lippiello L, 1999, ARTHRITIS RHEUM, V42, pS256; Lorenzo A, 2000, NAT NEUROSCI, V3, P460, DOI 10.1038/74833; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; MANN DMA, 1988, MECH AGEING DEV, V43, P99, DOI 10.1016/0047-6374(88)90041-3; MARTIN BL, 1995, J BIOL CHEM, V270, P26727, DOI 10.1074/jbc.270.45.26727; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McConlogue L, 1996, J BIOL CHEM, V271, P1343, DOI 10.1074/jbc.271.3.1343; Misonou H, 2000, BIOCHEMISTRY-US, V39, P6951, DOI 10.1021/bi000169p; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Murphy AN, 1999, J CEREBR BLOOD F MET, V19, P231, DOI 10.1097/00004647-199903000-00001; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nunomura A, 2000, J NEUROPATH EXP NEUR, V59, P1011, DOI 10.1093/jnen/59.11.1011; Odetti P, 1998, BIOCHEM BIOPH RES CO, V243, P849, DOI 10.1006/bbrc.1998.8186; Ohyagi Y, 2000, NEUROREPORT, V11, P167, DOI 10.1097/00001756-200001170-00033; Perez RG, 1997, J NEUROSCI, V17, P9407; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pigino G, 2001, J NEUROSCI, V21, P834, DOI 10.1523/JNEUROSCI.21-03-00834.2001; Prasher VP, 1998, ANN NEUROL, V43, P380, DOI 10.1002/ana.410430316; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; ROCH JM, 1992, J BIOL CHEM, V267, P2214; Schuchmann S, 2000, J NEUROCHEM, V74, P1205; Schuchmann S, 1998, J NEUROSCI, V18, P7216; Schupf N, 2001, NEUROSCI LETT, V301, P199, DOI 10.1016/S0304-3940(01)01657-3; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Shi B, 1996, J CLIN INVEST, V98, P1979, DOI 10.1172/JCI119002; Skovronsky DM, 1998, J CELL BIOL, V141, P1031, DOI 10.1083/jcb.141.4.1031; Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93; Valla J, 2001, J NEUROSCI, V21, P4923, DOI 10.1523/JNEUROSCI.21-13-04923.2001; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; WildBode C, 1997, J BIOL CHEM, V272, P16085, DOI 10.1074/jbc.272.26.16085; Wiltfang J, 1997, ELECTROPHORESIS, V18, P527, DOI 10.1002/elps.1150180332; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; YAMAMOTO K, 1994, J NEUROBIOL, V25, P585, DOI 10.1002/neu.480250510; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; YANG AJ, 1995, J BIOL CHEM, V270, P14786, DOI 10.1074/jbc.270.24.14786; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367	69	289	296	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					677	688		10.1016/S0896-6273(02)00604-9	http://dx.doi.org/10.1016/S0896-6273(02)00604-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879646	Bronze			2022-12-24	WOS:000174286200005
J	Arikawa-Hirasawa, E; Rossi, SG; Rotundo, RL; Yamada, Y				Arikawa-Hirasawa, E; Rossi, SG; Rotundo, RL; Yamada, Y			Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice	NATURE NEUROSCIENCE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; COLLAGEN-TAILED ACETYLCHOLINESTERASE; EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANES; SKELETAL-MUSCLE; ALPHA-DYSTROGLYCAN; BASAL LAMINA; CHOLINESTERASE; CARTILAGE; DIAPHRAGM	The collagen-tailed form of acetylcholinesterase (AChE) is concentrated at the vertebrate neuromuscular junction (NMJ), where it is responsible for rapidly terminating neurotransmission. This unique oligomeric form of AChE, consisting of three tetramers covalently attached to a collagen-like tail, is more highly expressed in innervated regions of skeletal muscle fibers, where it is externalized and attached to the synaptic basal lamina interposed between the nerve terminal and the receptor-rich postsynaptic membrane. Although it is clear that the enzyme is preferentially synthesized in regions of muscle contacted by the motoneuron, the molecular events underlying its localization to the NMJ are not known. Here we show that perlecan, a multifunctional heparan sulfate proteoglycan concentrated at the NMJ, is the unique acceptor molecule for collagen-tailed AChE at sites of nerve-muscle contact and is the principal mechanism for localizing AChE to the synaptic basal lamina.	Univ Miami, Sch Med, Dept Cell Biol & Anat, Miami, FL 33136 USA; Univ Miami, Sch Med, Neurosci Program, Miami, FL 33136 USA; Natl Inst Dent & Craniofacial Res, Craniofacial Dev Biol & Regenerat Branch, NIH, Bethesda, MD 20892 USA	University of Miami; University of Miami; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Rotundo, RL (corresponding author), Univ Miami, Sch Med, Dept Cell Biol & Anat, 1600 NW 10th Ave, Miami, FL 33136 USA.				NIA NIH HHS [R01 AG005917] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG005917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ANDERSON MJ, 1983, J CELL BIOL, V97, P1396, DOI 10.1083/jcb.97.5.1396; Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; BAYNE EK, 1984, J CELL BIOL, V99, P1486, DOI 10.1083/jcb.99.4.1486; BON S, 1978, EUR J BIOCHEM, V85, P1, DOI 10.1111/j.1432-1033.1978.tb12207.x; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; BRANDAN E, 1987, FEBS LETT, V213, P159, DOI 10.1016/0014-5793(87)81483-7; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; HALL ZW, 1973, J NEUROBIOL, V4, P343, DOI 10.1002/neu.480040404; IOZZO RV, 1994, BIOCHEM J, V302, P625, DOI 10.1042/bj3020625; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; JASMIN BJ, 1993, NEURON, V11, P467, DOI 10.1016/0896-6273(93)90151-G; JOHNSON CD, 1975, ANAL BIOCHEM, V64, P229, DOI 10.1016/0003-2697(75)90423-6; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LEIVO I, 1988, P NATL ACAD SCI USA, V85, P1544, DOI 10.1073/pnas.85.5.1544; LWEBUGAMUKASA JS, 1976, BIOCHEMISTRY-US, V15, P1425, DOI 10.1021/bi00652a012; MARNA A, 1938, J PHYSIOL-LONDON, V92, P34; MASSOULIE J, 1969, EUR J BIOCHEM, V11, P441, DOI 10.1111/j.1432-1033.1969.tb00794.x; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MCMAHAN UJ, 1978, NATURE, V271, P172, DOI 10.1038/271172a0; MICHEL RN, 1994, J CELL BIOL, V127, P1061, DOI 10.1083/jcb.127.4.1061; Nicole S, 2000, NAT GENET, V26, P480, DOI 10.1038/82638; Ohno K, 1998, P NATL ACAD SCI USA, V95, P9654, DOI 10.1073/pnas.95.16.9654; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; PEREZTUR J, 1991, FEBS LETT, V286, P25, DOI 10.1016/0014-5793(91)80932-S; ROSSI SG, 1992, J CELL BIOL, V119, P1657, DOI 10.1083/jcb.119.6.1657; Rossi SG, 1996, J BIOL CHEM, V271, P1979, DOI 10.1074/jbc.271.4.1979; ROSSI SG, 1993, J BIOL CHEM, V268, P19152; Rotundo RL, 1997, J CELL BIOL, V136, P367, DOI 10.1083/jcb.136.2.367; Rotundo RL, 1994, MYOLOGY, P607; SANES JR, 1986, J CELL BIOL, V102, P420, DOI 10.1083/jcb.102.2.420; SANES JR, 1994, MYOLOGY, P242; Talts JF, 1999, EMBO J, V18, P863, DOI 10.1093/emboj/18.4.863; TORRES JC, 1985, CELL MOL NEUROBIOL, V5, P303, DOI 10.1007/BF00711015; VIGNY M, 1983, J BIOL CHEM, V258, P8794	39	128	135	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					119	123		10.1038/nn801	http://dx.doi.org/10.1038/nn801			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802174				2022-12-24	WOS:000173558400013
J	Lee, I; Kesner, RP				Lee, I; Kesner, RP			Differential contribution of NMDA receptors in hippocampal subregions to spatial working memory	NATURE NEUROSCIENCE			English	Article							ANTAGONIST; BLOCKADE; ENVIRONMENT; IMPAIRMENT; INDUCTION; SYNAPSES; INFUSION; NEURONS; CONTEXT; RATS	N-methyl-D-aspartate (NMDA) receptor-dependent synaptic plasticity in the mammalian hippocampus is essential for learning and memory. Although computational models and anatomical studies have emphasized functional differences among hippocampal subregions, subregional specificity of NMDA receptor function is largely unknown. Here we present evidence that NMDA receptors in CA3 are required in a situation in which spatial representation needs to be reorganized, whereas the NMDA receptors in CA1 and/or the dentate gyrus are more involved in acquiring memory that needs to be retrieved after a delay period exceeding a short-term range. Our data, with data from CA1-specific knockout mice, suggest the possibility of heterogeneous mnemonic function of NMDA receptors in different subregions of the hippocampus.	Univ Utah, Med Ctr, Program Neurosci, Salt Lake City, UT 84132 USA; Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kesner, RP (corresponding author), Univ Utah, Med Ctr, Program Neurosci, 50 N Med Dr, Salt Lake City, UT 84132 USA.	rpkesner@behsci.utah.edu						Adams MM, 2001, J COMP NEUROL, V432, P230, DOI 10.1002/cne.1099; Bains JS, 1999, NAT NEUROSCI, V2, P720, DOI 10.1038/11184; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BAWIN SM, 1993, EPILEPSY RES, V15, P7, DOI 10.1016/0920-1211(93)90003-P; BOLHUIS JJ, 1992, BEHAV BRAIN RES, V47, P151, DOI 10.1016/S0166-4328(05)80121-4; Borroni AM, 2000, J NEUROSCI, V20, P9272; CARAMANOS Z, 1994, BEHAV NEUROSCI, V108, P30, DOI 10.1037/0735-7044.108.1.30; Cassel JC, 1998, NEUROBIOL LEARN MEM, V69, P22, DOI 10.1006/nlme.1997.3807; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; Gilbert PE, 2001, HIPPOCAMPUS, V11, P626, DOI 10.1002/hipo.1077; Granger R, 1996, HIPPOCAMPUS, V6, P567, DOI 10.1002/(SICI)1098-1063(1996)6:6<567::AID-HIPO2>3.0.CO;2-E; Hampson RE, 1999, NATURE, V402, P610, DOI 10.1038/45154; Hetherington PA, 1997, BEHAV NEUROSCI, V111, P20, DOI 10.1037/0735-7044.111.1.20; Huerta PT, 2000, NEURON, V25, P473, DOI 10.1016/S0896-6273(00)80909-5; Kawabe K, 1998, BRAIN RES, V781, P300, DOI 10.1016/S0006-8993(97)01256-0; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; Kesner RP, 2000, CURR OPIN NEUROBIOL, V10, P260, DOI 10.1016/S0959-4388(00)00067-2; Kesner RP, 2001, HIPPOCAMPUS, V11, P240, DOI 10.1002/hipo.1040; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Mizumori SJY, 1999, HIPPOCAMPUS, V9, P444, DOI 10.1002/(SICI)1098-1063(1999)9:4<444::AID-HIPO10>3.0.CO;2-Z; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Moser MB, 1998, J NEUROSCI, V18, P7535; MULLER D, 1988, SCIENCE, V242, P1694, DOI 10.1126/science.2904701; MULLER RU, 1987, J NEUROSCI, V7, P1951; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Paxinos G., 1998, RAT BRAIN STEROTAXIC; PEINADOMANZANO MA, 1990, BEHAV BRAIN RES, V38, P117, DOI 10.1016/0166-4328(90)90010-C; RAWLINS JNP, 1983, BEHAV BRAIN RES, V10, P233, DOI 10.1016/0166-4328(83)90033-5; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steele RJ, 1999, HIPPOCAMPUS, V9, P118, DOI 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8; TREVES A, 1992, HIPPOCAMPUS, V2, P189, DOI 10.1002/hipo.450020209; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wallenstein GV, 1998, TRENDS NEUROSCI, V21, P317, DOI 10.1016/S0166-2236(97)01220-4; Wiebe SP, 1997, HIPPOCAMPUS, V7, P656, DOI 10.1002/(SICI)1098-1063(1997)7:6<656::AID-HIPO7>3.0.CO;2-C; YOUNG SL, 1994, BEHAV NEUROSCI, V108, P19, DOI 10.1037/0735-7044.108.1.19	38	192	204	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					162	168		10.1038/nn790	http://dx.doi.org/10.1038/nn790			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11780144				2022-12-24	WOS:000173558400019
J	Usachev, YM; DeMarco, SJ; Campbell, C; Strehler, EE; Thayer, SA				Usachev, YM; DeMarco, SJ; Campbell, C; Strehler, EE; Thayer, SA			Bradykinin and ATP accelerate Ca2+ efflux from rat sensory neurons via protein kinase C and the plasma membrane Ca2+ pump isoform 4	NEURON			English	Article							CALMODULIN-BINDING DOMAIN; ROOT GANGLION NEURONS; CALCIUM-PUMP; CELLS; CA2+-ATPASE; RECEPTORS; CULTURE; MECHANISMS; ANTIBODIES; STORES	Modulation of Ca2+, channels by neurotransmitters; provides critical control of neuronal excitability and synaptic strength. Little is known about regulation of the Ca2+ efflux pathways that counterbalance Call influx in neurons. We demonstrate that bradykinin and ATP significantly facilitate removal of action potential-induced Ca2+ loads by stimulating plasma membrane Ca2+-ATPases (PMCAs) in rat sensory neurons. This effect was mimicked in the soma and axonal varicosities by phorbol esters and was blocked by antagonists of protein kinase C (PKC). Reduced expression of PMCA isoform 4 abolished, and overexpression of isoform 4b enhanced, PKC-dependent facilitation of Ca2+ efflux. This acceleration of PMCA4 underlies the shortening of the action potential afterhyperpolarization produced by activation of bradykinin and purinergic receptors. Thus, isoform-specific modulation of PMCA-mediated Ca2+ efflux represents a novel mechanism to control excitability in sensory neurons.	Univ Minnesota, Dept Pharmacol, Minneapolis, MN 55455 USA; Mayo Clin & Mayo Grad Sch Med, Dept Biochem & Mol Biol, Mayo Clin, Rochester, MN 55905 USA	University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic	Thayer, SA (corresponding author), Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.			Usachev, Yuriy/0000-0002-6948-4627	NIA NIH HHS [AG16678] Funding Source: Medline; NIDA NIH HHS [DA09293, DA07304] Funding Source: Medline; NIDCD NIH HHS [DC04200] Funding Source: Medline; NIGMS NIH HHS [GM58710] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009293, R37DA007304, R01DA007304] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Abrahams LG, 1999, J NEUROCHEM, V73, P50, DOI 10.1046/j.1471-4159.1999.0730050.x; BALASUBRAMANYAM M, 1995, CELL CALCIUM, V18, P526, DOI 10.1016/0143-4160(95)90015-2; BENHAM CD, 1992, J PHYSIOL-LONDON, V455, P567, DOI 10.1113/jphysiol.1992.sp019316; Boyer JL, 1996, MOL PHARMACOL, V50, P1323; Brandt PC, 1996, P NATL ACAD SCI USA, V93, P13843, DOI 10.1073/pnas.93.24.13843; BURGESS GM, 1989, J NEUROSCI, V9, P3314; CARAFOLI E, 1994, FASEB J, V8, P993, DOI 10.1096/fasebj.8.13.7926378; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Cesare P, 1999, NEURON, V23, P617, DOI 10.1016/S0896-6273(00)80813-2; Cook SP, 1997, NATURE, V387, P505, DOI 10.1038/387505a0; Cordoba-Rodriguez R, 1999, P NATL ACAD SCI USA, V96, P7650, DOI 10.1073/pnas.96.14.7650; DRAY A, 1993, TRENDS NEUROSCI, V16, P99, DOI 10.1016/0166-2236(93)90133-7; Elwess NL, 1997, J BIOL CHEM, V272, P17981, DOI 10.1074/jbc.272.29.17981; Enyedi A, 1997, J BIOL CHEM, V272, P27525, DOI 10.1074/jbc.272.44.27525; Enyedi A, 1996, J BIOL CHEM, V271, P32461, DOI 10.1074/jbc.271.50.32461; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Garcia ML, 2001, J NEUROSCI RES, V64, P661, DOI 10.1002/jnr.1120; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Hille B., 1992, IONIC CHANNELS EXCIT; Hillman DE, 1996, NEUROSCIENCE, V72, P315, DOI 10.1016/0306-4522(95)00518-8; JIN WZ, 1994, J NEUROSCI, V14, P1920; Juhaszova M, 2000, EUR J NEUROSCI, V12, P839, DOI 10.1046/j.1460-9568.2000.00974.x; Kessler F, 1999, PAIN, V83, P289, DOI 10.1016/S0304-3959(99)00108-6; Kim CC, 1998, MET MATER INT, V4, P95, DOI 10.1007/BF03026025; KoskKosicka D, 1997, MOL CELL BIOCHEM, V173, P79, DOI 10.1023/A:1006832603134; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Krizaj D, 1998, NEURON, V21, P249, DOI 10.1016/S0896-6273(00)80531-0; MILLER RJ, 1991, PROG NEUROBIOL, V37, P255, DOI 10.1016/0301-0082(91)90028-Y; Nakamura F, 1996, P NATL ACAD SCI USA, V93, P10465, DOI 10.1073/pnas.93.19.10465; Ralevic V, 1998, PHARMACOL REV, V50, P413; Sah P, 1996, TRENDS NEUROSCI, V19, P150, DOI 10.1016/S0166-2236(96)80026-9; SCHWIENING CJ, 1993, P ROY SOC B-BIOL SCI, V253, P285, DOI 10.1098/rspb.1993.0115; STAUFFER TP, 1995, J BIOL CHEM, V270, P12184, DOI 10.1074/jbc.270.20.12184; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; STUCKY CL, 1996, NEUROSCIENCE, V74, P111; Svichar N, 1997, NEUROREPORT, V8, P1555, DOI 10.1097/00001756-199705060-00002; THAYER SA, 1988, J NEUROSCI, V8, P4089; THOMAS D, 1994, METHOD CELL BIOL, V40, P65; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Usachev YM, 2000, PFLUG ARCH EUR J PHY, V439, P730, DOI 10.1007/s004249900240; Usachev YM, 2001, J NEUROCHEM, V76, P1756, DOI 10.1046/j.1471-4159.2001.00169.x; Usachev YM, 1999, J PHYSIOL-LONDON, V519, P115, DOI 10.1111/j.1469-7793.1999.0115o.x; Verma AK, 1999, J BIOL CHEM, V274, P527, DOI 10.1074/jbc.274.1.527; Wang GJ, 1998, MOL PHARMACOL, V53, P88, DOI 10.1124/mol.53.1.88; Wang K K, 1992, Trends Cell Biol, V2, P46, DOI 10.1016/0962-8924(92)90162-G; WANG KKW, 1991, ARCH BIOCHEM BIOPHYS, V289, P103, DOI 10.1016/0003-9861(91)90448-R; WERTH JL, 1994, J NEUROSCI, V14, P348; Werth JL, 1996, J NEUROSCI, V16, P1008; Yamoah EN, 1998, J NEUROSCI, V18, P610; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5	51	84	84	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					113	122		10.1016/S0896-6273(01)00557-8	http://dx.doi.org/10.1016/S0896-6273(01)00557-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779484	Bronze			2022-12-24	WOS:000173106200014
J	Huk, AC; Heeger, DJ				Huk, AC; Heeger, DJ			Pattern-motion responses in human visual cortex	NATURE NEUROSCIENCE			English	Article							AREA MT; COHERENCE; FMRI; PERCEPTION; NEURONS; MACAQUE; SIGNAL; BRAIN; MRI; V5	Physiological models of visual motion processing posit that 'pattern-motion cells' represent the direction of moving objects independent of their particular spatial pattern. We performed fMRI experiments to identify neuronal activity in the human brain selective for pattern motion. A protocol using adaptation to moving 'plaid' stimuli allowed us to separate pattern-motion responses from other types of motion-related activity within the same brain structures, and revealed strong pattern-motion selectivity in human visual area MT+. Reducing the perceptual coherence of the plaids yielded a corresponding decrease in pattern-motion responsivity, providing evidence that percepts of coherent motion are closely linked to the activity of pattern-motion cells in human MT+.	Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Huk, AC (corresponding author), Univ Washington, Dept Physiol & Biophys, Box 357290,Hlth Sci Bldg,Room G-424, Seattle, WA 98195 USA.		Huk, Alexander/A-8031-2016	Huk, Alexander/0000-0003-1430-6935	NATIONAL EYE INSTITUTE [R01EY012741] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY12741] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Chawla D, 1998, NEUROIMAGE, V7, P86, DOI 10.1006/nimg.1997.0319; Chawla D, 1999, NEUROIMAGE, V9, P508, DOI 10.1006/nimg.1999.0432; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Engel SA, 2001, J NEUROSCI, V21, P3949, DOI 10.1523/JNEUROSCI.21-11-03949.2001; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Heeger DJ, 1999, J NEUROSCI, V19, P7162, DOI 10.1523/JNEUROSCI.19-16-07162.1999; Huk AC, 2001, NEURON, V32, P161, DOI 10.1016/S0896-6273(01)00452-4; Huk AC, 2000, J NEUROPHYSIOL, V83, P3525, DOI 10.1152/jn.2000.83.6.3525; KOOI FL, 1992, PERCEPT PSYCHOPHYS, V52, P415, DOI 10.3758/BF03206701; Kourtzi Z, 2001, SCIENCE, V293, P1506, DOI 10.1126/science.1061133; Li B, 2001, EUR J NEUROSCI, V14, P690, DOI 10.1046/j.0953-816x.2001.01689.x; Movshon J. A., 1985, EXPT BRAIN RES S, V11, P117, DOI DOI 10.1007/978-3-662-09224-8_7.; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; RODMAN HR, 1989, EXP BRAIN RES, V75, P53; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; SMITH AT, 1992, VISION RES, V32, P393, DOI 10.1016/0042-6989(92)90148-C; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; STONER GR, 1990, NATURE, V344, P153, DOI 10.1038/344153a0; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; WELCH L, 1989, NATURE, V337, P734, DOI 10.1038/337734a0; WELCH L, 1990, PERCEPTION, V19, P425, DOI 10.1068/p190425; ZEKI S, 1991, J NEUROSCI, V11, P641	30	141	141	1	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					72	75		10.1038/nn774	http://dx.doi.org/10.1038/nn774			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11731801				2022-12-24	WOS:000173031800018
J	Henderson, JT; Georgiou, J; Jia, ZP; Robertson, J; Elowe, S; Roder, JC; Pawson, T				Henderson, JT; Georgiou, J; Jia, ZP; Robertson, J; Elowe, S; Roder, JC; Pawson, T			The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function	NEURON			English	Article							LONG-TERM POTENTIATION; NEURAL DEVELOPMENT; EPHRIN LIGANDS; RAT; PROTEIN; PHOSPHORYLATION; NEUROSCIENCE; MECHANISMS; EXPRESSION; SYNAPSES	Members of the Eph family of receptor tyrosine kinases control many aspects of cellular interactions during development, including axon guidance. Here, we demonstrate that EphB2 also regulates postnatal synaptic function in the mammalian CNS. Mice lacking the EphB2 intracellular kinase domain showed wildtype levels of LTP, whereas mice lacking the entire EphB2 receptor had reduced LTP at hippocampal CA1 and dentate gyrus synapses. Synaptic NMDA-mediated current was reduced in dentate granule neurons in EphB2 null mice, as was synaptically localized NR1 as revealed by immunogold localization. Finally, we show that EphB2 is upregulated in hippocampal pyramidal neurons in vitro and in vivo by stimuli known to induce changes in synaptic structure. Together, these data demonstrate that EphB2 plays an important role in regulating synaptic function.	Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	Henderson, JT (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Program Mol Biol & Canc, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.		Pawson, Tony J/E-4578-2013; Jia, zhengping/AAZ-4190-2021; Georgiou, John/E-9873-2013; Roder, John/G-6468-2013; Georgiou, John/ABA-1687-2020	Georgiou, John/0000-0003-4503-6384; Georgiou, John/0000-0003-4503-6384				Ausubel FM., 2006, ENZYMATIC MANIPULATI; Bergemann AD, 1998, ONCOGENE, V16, P471, DOI 10.1038/sj.onc.1201557; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Brownlee H, 2000, J COMP NEUROL, V425, P315, DOI 10.1002/1096-9861(20000918)425:2<315::AID-CNE12>3.0.CO;2-#; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; Buchert M, 1999, J CELL BIOL, V144, P361, DOI 10.1083/jcb.144.2.361; Cao ZP, 2000, BRAIN RES, V859, P26, DOI 10.1016/S0006-8993(99)02450-6; CARPENTER MK, 1995, J NEUROSCI RES, V42, P199, DOI 10.1002/jnr.490420207; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; DOUCETTE R, 1987, J COMP NEUROL, V261, P592, DOI 10.1002/cne.902610410; DRESCHER U, 1997, CURR BIOL, V7, P799; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Finney EM, 1998, J NEUROSCI, V18, P8826; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Gerlai R, 1999, J NEUROSCI, V19, P9538; Gomperts SN, 2000, J NEUROSCI, V20, P2229; Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Hollander E, 1997, CNS SPECTRUMS, V2, P16, DOI DOI 10.1017/S1092852900011068; Jia ZP, 1998, LEARN MEMORY, V5, P331; Lee S, 1997, MET MATER-KOREA, V3, P183, DOI 10.1007/BF03025960; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Matsunaga T, 2000, EUR J NEUROSCI, V12, P1599, DOI 10.1046/j.1460-9568.2000.00051.x; Meima L, 1997, EUR J NEUROSCI, V9, P177, DOI 10.1111/j.1460-9568.1997.tb01365.x; Milner TA, 2001, BRAIN RES BULL, V54, P131, DOI 10.1016/S0361-9230(00)00415-9; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; Rudge JS, 1998, EXP NEUROL, V149, P398, DOI 10.1006/exnr.1997.6737; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SLOVITER RS, 1982, BRAIN RES BULL, V8, P771, DOI 10.1016/0361-9230(82)90104-6; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Wang S, 1997, NEUROSCIENCE, V79, P117, DOI 10.1016/S0306-4522(96)00638-0; Wang XM, 1999, MOL CELL, V4, P903, DOI 10.1016/S1097-2765(00)80220-8; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452	46	251	262	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1041	1056		10.1016/S0896-6273(01)00553-0	http://dx.doi.org/10.1016/S0896-6273(01)00553-0			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754836	Bronze			2022-12-24	WOS:000172886800011
J	Alsina, B; Vu, T; Cohen-Cory, S				Alsina, B; Vu, T; Cohen-Cory, S			Visualizing synapse formation in arborizing optic axons in vivo: dynamics and modulation by BDNF	NATURE NEUROSCIENCE			English	Article							IN-VIVO; NEUROMUSCULAR-JUNCTIONS; HIPPOCAMPAL-NEURONS; EXCITATORY SYNAPSES; NEUROTROPHIC FACTOR; DENDRITIC GROWTH; C-ELEGANS; SYNAPTOGENESIS; PROTEIN; ARBORS	Dynamic developmental changes in axon arbor morphology may directly reflect the formation, stabilization and elimination of synapses. We used dual-color imaging to study, in the live, developing animal, the relationship between axon arborization and synapse formation at the single cell level, and to examine the participation of brain-derived neurotrophic factor (BDNF) in synaptogenesis. Green fluorescent protein (GFP)-tagged synaptobrevin II served as a marker to visualize synaptic sites in individual fluorescently labeled Xenopus optic axons. Time-lapse confocal microscopy revealed that although most synapses remain stable, synapses are also formed and eliminated as axons branch and increase their complexity. Most new branches originated at GFP-labeled synaptic sites. Increasing BDNF levels significantly increased both axon arborization and synapse number, with BDNF increasing synapse number per axon terminal. The ability to visualize central synapses in real time provides insights about the dynamic mechanisms underlying synaptogenesis, and reveals BDNF as a modulator of synaptogenesis in vivo.	Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Cohen-Cory, S (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Mental Retardat Res Ctr, 760 Westwood Plaza,NPI 58-258, Los Angeles, CA 90095 USA.		Alsina, Berta/A-2632-2010	Alsina, Berta/0000-0002-6997-1249	NATIONAL EYE INSTITUTE [R01EY011912] Funding Source: NIH RePORTER; NEI NIH HHS [EY11912, R01 EY011912] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; ALDER J, 1995, J NEUROSCI, V15, P511; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; CAMPBELL G, 1992, J NEUROSCI, V12, P1847; Causing CG, 1997, NEURON, V18, P257, DOI 10.1016/S0896-6273(00)80266-4; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; CONSTANTINEPATON M, 1990, COLD SPRING HARB SYM, V55, P431; Dingwell KS, 2000, J NEUROBIOL, V44, P246; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lom B, 1999, J NEUROSCI, V19, P9928; Martinez A, 1998, J NEUROSCI, V18, P7336; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; NORDEN JJ, 1994, J COMP NEUROL, V348, P461, DOI 10.1002/cne.903480310; Pinches EM, 1998, J NEUROBIOL, V35, P426, DOI 10.1002/(SICI)1097-4695(19980615)35:4<426::AID-NEU8>3.0.CO;2-0; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; RAMOA AS, 1988, J NEUROSCI, V8, P4239; ROURKE NA, 1990, NEURON, V5, P159; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Silver MA, 1999, J NEUROSCI, V19, P10829, DOI 10.1523/JNEUROSCI.19-24-10829.1999; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; SOLLNER T, 1994, TRENDS NEUROSCI, V17, P344, DOI 10.1016/0166-2236(94)90178-3; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; TRIMBLE WS, 1988, P NATL ACAD SCI USA, V85, P4538, DOI 10.1073/pnas.85.12.4538; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; YEN LS, 1995, J NEUROSCI, V15, P4712; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	50	284	298	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1093	1101		10.1038/nn735	http://dx.doi.org/10.1038/nn735			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11593233				2022-12-24	WOS:000171970900012
J	Gillespie, DC; Lampl, I; Anderson, JS; Ferster, D				Gillespie, DC; Lampl, I; Anderson, JS; Ferster, D			Dynamics of the orientation-tuned membrane potential response in cat primary visual cortex	NATURE NEUROSCIENCE			English	Article							STRIATE CORTEX; POSTSYNAPTIC POTENTIALS; SIMPLE CELLS; SELECTIVITY; INHIBITION; GABA; INACTIVATION; CONNECTIONS; NEURONS	Neurons in the primary visual cortex are highly selective for stimulus orientation, whereas their thalamic inputs are not. Much controversy has been focused on the mechanism by which cortical orientation selectivity arises. Although an increasing amount of evidence supports a linear model in which orientation selectivity is conferred upon visual cortical cells by the alignment of the receptive fields of their thalamic inputs, the controversy has recently been rekindled with the suggestion that late cortical input-delayed by multiple synapses-could lead to sharpening of orientation selectivity over time. Here we used intracellular recordings in vivo to examine temporal properties of the orientation-selective response to flashed gratings. Bayesian parameter estimation demonstrated that both preferred orientation and tuning width were stable throughout the response to a single stimulus.	Northwestern Univ, Inst Neurosci, Evanston, IL 60208 USA; Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University	Gillespie, DC (corresponding author), Northwestern Univ, Inst Neurosci, 2153 N Campus Dr, Evanston, IL 60208 USA.			Lampl, Ilan/0000-0002-9380-0730; Gillespie, Deda/0000-0002-3736-9886; Anderson, Jeffrey/0000-0002-9669-3846	NEI NIH HHS [R01EYO4726] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; CELEBRINI S, 1993, VISUAL NEUROSCI, V10, P811, DOI 10.1017/S0952523800006052; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; CROOK JM, 1992, J NEUROSCI, V12, P1816; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; EYSEL UT, 1990, EXP BRAIN RES, V80, P626; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1983, J PHYSIOL-LONDON, V342, P181, DOI 10.1113/jphysiol.1983.sp014846; FREEMAN TCB, IN PRESS INVEST OPHT; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KRNJEVIC K, 1966, J PHYSIOL-LONDON, V184, P16, DOI 10.1113/jphysiol.1966.sp007902; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Sivia D. S, 2006, DATA ANAL BAYESIAN T; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Swindale NV, 1998, BIOL CYBERN, V78, P45, DOI 10.1007/s004220050411; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; VOLGUSHEV M, 1995, VISUAL NEUROSCI, V12, P621, DOI 10.1017/S0952523800008919	28	48	48	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1014	1019		10.1038/nn731	http://dx.doi.org/10.1038/nn731			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11559853				2022-12-24	WOS:000171325800015
J	Moschovakis, AK; Gregoriou, GG; Savaki, HE				Moschovakis, AK; Gregoriou, GG; Savaki, HE			Functional imaging of the primate superior colliculus during saccades to visual targets	NATURE NEUROSCIENCE			English	Article							NEURAL-NETWORK SIMULATIONS; GUIDED REACHING TASK; EYE-MOVEMENTS; METABOLIC-ACTIVITY; OCULOMOTOR SYSTEM; BEHAVING MONKEY; BURST GENERATOR; ALERT MONKEY; ONE FORELIMB; GAZE SHIFTS	The primate superior colliculus (SC) is a midbrain nucleus crucial for the control of rapid eye movements (saccades). Its neurons are topographically arranged over the rostrocaudal and mediolateral extent of its deeper layers so that saccade metrics (amplitude and direction) are coded in terms of the location of active neurons. We used the quantitative [C-14]-deoxyglucose method to obtain a map of the two-dimensional pattern of activity throughout the SC of rhesus monkeys repeatedly executing visually guided saccades of the same amplitude and direction for the duration of the experiment. Increased metabolic activity was confined to a circumscribed region of the two-dimensional reconstructed map of the SC contralateral to the direction of the movement. The precise rostrocaudal and mediolateral location of the area activated depended on saccade metrics. Our data support the notion that the population of active SC cells remains stationary in collicular space during saccades.	Univ Crete, FORTH, Inst Appl & Computat Math, Iraklion 71110, Crete, Greece; Univ Crete, Sch Hlth Sci, Fac Med, Dept Basic Sci, Iraklion 71110, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete; University of Crete	Moschovakis, AK (corresponding author), Univ Crete, FORTH, Inst Appl & Computat Math, POB 1393, Iraklion 71110, Crete, Greece.		Gregoriou, Georgia/AAD-3925-2019; Gregoriou, Georgia/F-7759-2011	Gregoriou, Georgia/0000-0002-4002-6657; Gregoriou, Georgia/0000-0002-4002-6657; Moschovakis, Adonis/0000-0002-9966-3327				Aizawa H, 1998, J NEUROPHYSIOL, V79, P2082, DOI 10.1152/jn.1998.79.4.2082; Anderson RW, 1998, J NEUROPHYSIOL, V80, P798, DOI 10.1152/jn.1998.80.2.798; Bozis A, 1998, BIOL CYBERN, V79, P215, DOI 10.1007/s004220050472; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; Dalezios Y, 1996, NEUROSCIENCE, V72, P325, DOI 10.1016/0306-4522(95)00516-1; DROULEZ J, 1991, P NATL ACAD SCI USA, V88, P9653, DOI 10.1073/pnas.88.21.9653; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; GOLDBERG ME, 1972, J NEUROPHYSIOL, V35, P560, DOI 10.1152/jn.1972.35.4.560; Gregoriou GG, 2001, J CEREBR BLOOD F MET, V21, P671, DOI 10.1097/00004647-200106000-00005; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KADOYA S, 1971, J COMP NEUROL, V142, P495, DOI 10.1002/cne.901420407; KELLER EL, 1994, J NEUROPHYSIOL, V72, P2754, DOI 10.1152/jn.1994.72.6.2754; Krauzlis RJ, 2000, J NEUROPHYSIOL, V84, P876, DOI 10.1152/jn.2000.84.2.876; MOSCHOVAKIS AK, 1988, J NEUROPHYSIOL, V60, P263, DOI 10.1152/jn.1988.60.1.263; MOSCHOVAKIS AK, 1994, BIOL CYBERN, V70, P291, DOI 10.1007/BF00197610; Moschovakis AK, 1996, CURR OPIN NEUROBIOL, V6, P811, DOI 10.1016/S0959-4388(96)80032-8; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2334, DOI 10.1152/jn.1995.73.6.2334; MUNOZ DP, 1995, J NEUROPHYSIOL, V73, P2313, DOI 10.1152/jn.1995.73.6.2313; MUNOZ DP, 1991, SCIENCE, V251, P1358, DOI 10.1126/science.2003221; MUNOZ DP, 1993, J NEUROPHYSIOL, V70, P559, DOI 10.1152/jn.1993.70.2.559; Munoz DP, 1996, J NEUROPHYSIOL, V75, P2562, DOI 10.1152/jn.1996.75.6.2562; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1642, DOI 10.1152/jn.1991.66.5.1642; OPTICAN LM, 1995, VISION RES, V35, P3313, DOI 10.1016/0042-6989(95)00129-3; OTTES FP, 1986, VISION RES, V26, P857, DOI 10.1016/0042-6989(86)90144-6; Port NL, 2000, J NEUROPHYSIOL, V84, P344, DOI 10.1152/jn.2000.84.1.344; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Savaki HE, 1997, NEUROSCIENCE, V76, P1007, DOI 10.1016/S0306-4522(96)00439-3; SAVAKI HE, 1993, J NEUROSCI, V13, P2772; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; SCUDDER CA, 1988, J NEUROPHYSIOL, V59, P1455, DOI 10.1152/jn.1988.59.5.1455; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; SPARKS DL, 1978, BRAIN RES, V156, P1, DOI 10.1016/0006-8993(78)90075-6; SPARKS DL, 1980, BRAIN RES, V190, P39, DOI 10.1016/0006-8993(80)91158-0; SPARKS DL, 1976, BRAIN RES, V113, P21, DOI 10.1016/0006-8993(76)90003-2; UPDIKE BV, 1974, J NEUROPHYSIOL, V37, P896; VANGISBERGEN JAM, 1981, J NEUROPHYSIOL, V45, P417, DOI 10.1152/jn.1981.45.3.417; VANOPSTAL AJ, 1990, EXP BRAIN RES, V79, P299, DOI 10.1007/BF00608239; WAITZMAN DM, 1991, J NEUROPHYSIOL, V66, P1716, DOI 10.1152/jn.1991.66.5.1716; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575	41	28	28	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1026	1031		10.1038/nn727	http://dx.doi.org/10.1038/nn727			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11559850				2022-12-24	WOS:000171325800017
J	Zheng, F; Erreger, K; Low, CM; Banke, T; Lee, CJ; Conn, PJ; Traynelis, SF				Zheng, F; Erreger, K; Low, CM; Banke, T; Lee, CJ; Conn, PJ; Traynelis, SF			Allosteric interaction between the amino terminal domain and the ligand binding domain of NR2A	NATURE NEUROSCIENCE			English	Article							D-ASPARTATE RECEPTORS; CALCIUM-DEPENDENT INACTIVATION; GLYCINE-INSENSITIVE DESENSITIZATION; CULTURED HIPPOCAMPAL-NEURONS; OUTSIDE-OUT PATCHES; NMDA RECEPTOR; ZINC INHIBITION; NR1 SUBUNIT; CHANNELS; AFFINITY	Fast desensitization is an important regulatory mechanism of neuronal NMDA receptor function. Only recombinant NMDA receptors composed of NR1/NR2A exhibit a fast component of desensitization similar to neuronal NMDA receptors. Here we report that the fast desensitization of NR1/NR2A receptors is caused by ambient zinc, and that a positive allosteric interaction occurs between the extracellular zinc-binding site located in the amino terminal domain and the glutamate-binding domain of NR2A. The relaxation of macroscopic currents reflects a shift to a new equilibrium due to increased zinc affinity after binding of glutamate. We also show a similar interaction between the ifenprodil binding site and the glutamate binding site of NR1/NR2B receptors. These data raise the possibility that there is an allosteric interaction between the amino terminal domain and the ligand-binding domain of other glutamate receptors. Our findings may provide insight into how zinc and other extracellular modulators regulate NMDA receptor function.	Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA	Emory University	Zheng, F (corresponding author), Emory Univ, Sch Med, Dept Pharmacol, 1510 Clifton Rd, Atlanta, GA 30322 USA.		Low, Chian-Ming/V-9271-2017; Zheng, Fang/J-1400-2016; Conn, Peter/D-7848-2012	Low, Chian-Ming/0000-0002-1154-4842; Zheng, Fang/0000-0002-6626-1938; Banke, Tue/0000-0001-8417-4400; Lee, C Justin/0000-0002-3555-0980	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036654, R01NS034876, R01NS031373, R01NS036654, R01NS039418] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 34876, NS 39418, NS 31373, NS 36654] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; BERS DM, 1994, METHOD CELL BIOL, V40, P3; Brimecombe JC, 1998, J PHARMACOL EXP THER, V286, P627; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen NS, 1997, MOL PHARMACOL, V51, P1015, DOI 10.1124/mol.51.6.1015; Choi YB, 1999, NEURON, V23, P171, DOI 10.1016/S0896-6273(00)80763-1; CLARK GD, 1990, NEUROSCIENCE, V39, P787, DOI 10.1016/0306-4522(90)90261-2; Dingledine R, 1999, PHARMACOL REV, V51, P7; Fayyazuddin A, 2000, NEURON, V25, P683, DOI 10.1016/S0896-6273(00)81070-3; Gallagher MJ, 1997, J BIOL CHEM, V272, P24971, DOI 10.1074/jbc.272.40.24971; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LESTER RAJ, 1992, J NEUROSCI, V12, P635; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mott DD, 1998, NAT NEUROSCI, V1, P659, DOI 10.1038/3661; Paoletti P, 2000, NEURON, V28, P911, DOI 10.1016/S0896-6273(00)00163-X; Paoletti P, 1997, J NEUROSCI, V17, P5711; ROSENMUND C, 1993, J PHYSIOL-LONDON, V470, P705, DOI 10.1113/jphysiol.1993.sp019884; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; TONG G, 1995, SCIENCE, V267, P1510, DOI 10.1126/science.7878472; Traynelis SF, 1998, J NEUROSCI METH, V86, P25, DOI 10.1016/S0165-0270(98)00140-X; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; Traynelis SF, 1998, J NEUROSCI, V18, P6163; Traynelis SF, 1997, J PHYSIOL-LONDON, V503, P513, DOI 10.1111/j.1469-7793.1997.513bg.x; Vallano ML, 1996, J NEUROSCI, V16, P631; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; ZAR JH, 1999, BIOSTAT ANAL, P584; Zhang S, 1998, NEURON, V21, P443, DOI 10.1016/S0896-6273(00)80553-X; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634	42	98	102	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					894	901		10.1038/nn0901-894	http://dx.doi.org/10.1038/nn0901-894			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528420				2022-12-24	WOS:000170698600015
J	Schoppa, NE; Westbrook, GL				Schoppa, NE; Westbrook, GL			Glomerulus-specific synchronization of mitral cells in the olfactory bulb	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; NETWORK OSCILLATIONS; GLUTAMATE RECEPTORS; IN-VITRO; ODOR; NEURONS; INFORMATION; SYNAPSES; RATS; ORGANIZATION	Odor elicits a well-organized pattern of glomerular activation in the olfactory bulb. However, the mechanisms by which this spatial map is transformed into an odor code remain unclear. We examined this question in rat olfactory bulb slices in recordings from output mitral cells. Electrical stimulation of incoming afferents elicited slow (similar to2 Hz) oscillations that originated in glomeruli and were highly synchronized for mitral cells projecting to the same glomerulus. Cyclical depolarizations were generated by glutamate activation of dendritic autoreceptors, while the slow frequency was determined primarily by the duration of regenerative glutamate release. Patterned stimuli elicited stimulus-entrained oscillations that amplified weak and variable inputs. We suggest that these oscillations maintain the fidelity of the spatial map by ensuring that all mitral cells within a glomerulus-specific, network respond to odor as a functional unit.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Schoppa, NE (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.	schoppan@ohsu.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS026494, R01NS026494] Funding Source: NIH RePORTER; NINDS NIH HHS [NS26494] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Aroniadou-Anderjaska V, 1999, J NEUROPHYSIOL, V82, P489, DOI 10.1152/jn.1999.82.1.489; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carlson GC, 2000, J NEUROSCI, V20, P2011; Chao TI, 1997, J COMP NEUROL, V388, P191; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; CHAPUT MA, 1985, PHYSIOL BEHAV, V34, P249, DOI 10.1016/0031-9384(85)90113-1; Chen WR, 1997, BRAIN RES, V745, P189, DOI 10.1016/S0006-8993(96)01150-X; Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; Delaney KR, 1996, J NEUROSCI METH, V68, P193, DOI 10.1016/0165-0270(96)00069-6; Desmaisons D, 1999, J NEUROSCI, V19, P10727, DOI 10.1523/JNEUROSCI.19-24-10727.1999; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Duchamp-Viret P, 1999, SCIENCE, V284, P2171, DOI 10.1126/science.284.5423.2171; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; FIRESTEIN S, 1991, NEURON, V6, P825, DOI 10.1016/0896-6273(91)90178-3; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Friedman D, 2000, J NEUROPHYSIOL, V84, P39, DOI 10.1152/jn.2000.84.1.39; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Giustetto M, 1997, NEUROSCIENCE, V76, P787; Isaacson JS, 1999, NEURON, V23, P377, DOI 10.1016/S0896-6273(00)80787-4; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; JEFFERYS JGR, 1995, PHYSIOL REV, V75, P689, DOI 10.1152/physrev.1995.75.4.689; Kasowski HJ, 1999, J COMP NEUROL, V407, P261, DOI 10.1002/(SICI)1096-9861(19990503)407:2<261::AID-CNE7>3.0.CO;2-G; Kay LM, 1999, NAT NEUROSCI, V2, P1003, DOI 10.1038/14801; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; LEVETEAU J, 1966, SCIENCE, V153, P175, DOI 10.1126/science.153.3732.175; MACRIDES F, 1972, SCIENCE, V175, P84, DOI 10.1126/science.175.4017.84; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MARTINEZ DP, 1984, BRAIN RES, V308, P223, DOI 10.1016/0006-8993(84)91061-8; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mitchell SJ, 2000, NATURE, V404, P498, DOI 10.1038/35006649; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Montague AA, 1999, J COMP NEUROL, V405, P233, DOI 10.1002/(SICI)1096-9861(19990308)405:2<233::AID-CNE7>3.0.CO;2-A; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; MORI K, 1978, J PHYSIOL-LONDON, V279, P569, DOI 10.1113/jphysiol.1978.sp012362; NICOLL RA, 1982, NATURE, V296, P441, DOI 10.1038/296441a0; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; ONODA N, 1980, J NEUROPHYSIOL, V44, P29, DOI 10.1152/jn.1980.44.1.29; PATERNOSTRO MA, 1995, DEV BRAIN RES, V84, P1; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RESSLER KJ, 1994, CELL, V79, P1245, DOI 10.1016/0092-8674(94)90015-9; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Salin PA, 2001, J NEUROPHYSIOL, V85, P1275, DOI 10.1152/jn.2001.85.3.1275; Schoppa NE, 1998, J NEUROSCI, V18, P6790; Shepherd G. M., 1990, SYNAPTIC ORG BRAIN, P133; SOBEL EC, 1993, J NEUROPHYSIOL, V69, P1331, DOI 10.1152/jn.1993.69.4.1331; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; VANDENPOL AN, 1995, J COMP NEUROL, V359, P253, DOI 10.1002/cne.903590206; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; YOUNGENTOB SL, 1987, PHYSIOL BEHAV, V41, P59, DOI 10.1016/0031-9384(87)90131-4	58	183	186	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 30	2001	31	4					639	651		10.1016/S0896-6273(01)00389-0	http://dx.doi.org/10.1016/S0896-6273(01)00389-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545722	Bronze			2022-12-24	WOS:000170759200017
J	Maejima, T; Hashimoto, K; Yoshida, T; Aiba, A; Kano, M				Maejima, T; Hashimoto, K; Yoshida, T; Aiba, A; Kano, M			Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors	NEURON			English	Article							CEREBELLAR PURKINJE-CELLS; LONG-TERM DEPRESSION; CLIMBING FIBER INNERVATION; MICE LACKING MGLUR1; SYNAPTIC TRANSMISSION; MUTANT MICE; RAT-BRAIN; MOLECULAR CHARACTERIZATION; NEUROTRANSMITTER RELEASE; MOTOR COORDINATION	We report a type of synaptic modulation that involves retrograde signaling from postsynaptic metabotropic glutamate receptors (mGluRs) to presynaptic cannabinoid receptors. Activation of mGluR subtype 1 (mGluR1) expressed in cerebellar Purkinje cells (PCs) reduced neurotransmitter release from excitatory climbing fibers. This required activation of G proteins but not Ca2+ elevation in postsynaptic PCs. This effect was occluded by a cannabinoid agonist and totally abolished by cannabinoid antagonists. Depolarization-induced Ca2+ transients in PCs also caused cannabinoid receptor-mediated presynaptic inhibition. Thus, endocannabinoid production in PCs can be initiated by two distinct stimuli. Activation of mGIuR1 by repetitive stimulation of parallel fibers, the other excitatory input to PCs, caused transient cannabinoid receptor-mediated depression of climbing fiber input. Our data highlight a signaling mechanism whereby activation of postsynaptic mGluR retrogradely influences presynaptic functions via endocannabinoid system.	Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan; Kobe Univ, Fac Med, Div Cell Biol, Kobe, Hyogo 6500017, Japan	Kanazawa University; Kobe University	Kano, M (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan.		Yoshida, Takayuki/A-4243-2012	Aiba, Atsu/0000-0002-8192-0778; Kano, Masanobu/0000-0002-0725-3292; Hashimoto, Kouichi/0000-0002-3884-8213				ABE T, 1992, J BIOL CHEM, V267, P13361; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Altman J, 1997, DEV CEREBELLAR SYSTE; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; BATSHELOR AM, 1997, NATURE, V385, P74; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Cadas H, 1997, J NEUROSCI, V17, P1226; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; GEREAU RW, 1995, J NEUROSCI, V15, P6879; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Hansel C, 2000, NEURON, V26, P473, DOI 10.1016/S0896-6273(00)81179-4; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; KANO M, 1987, NATURE, V325, P276, DOI 10.1038/325276a0; Kano M, 1997, NEURON, V18, P71, DOI 10.1016/S0896-6273(01)80047-7; Kano M, 1998, P NATL ACAD SCI USA, V95, P15724, DOI 10.1073/pnas.95.26.15724; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Levenes C, 1998, J PHYSIOL-LONDON, V510, P867, DOI 10.1111/j.1469-7793.1998.867bj.x; Levenes C, 1997, NEUROREPORT, V8, P571, DOI 10.1097/00001756-199701200-00038; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; LUJAN R, 1996, EUR J NEUROSCI, V17, P5196; Maejima T, 2001, NEUROSCI RES, V40, P205, DOI 10.1016/S0168-0102(01)00241-3; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Montgomery JM, 2001, NEURON, V29, P567, DOI 10.1016/S0896-6273(01)00233-1; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; OBERDICK J, 1990, SCIENCE, V248, P223, DOI 10.1126/science.2109351; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Smitt PS, 2000, NEW ENGL J MED, V342, P21, DOI 10.1056/NEJM200001063420104; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Watase K, 1998, EUR J NEUROSCI, V10, P976, DOI 10.1046/j.1460-9568.1998.00108.x; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	60	418	422	1	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					463	475		10.1016/S0896-6273(01)00375-0	http://dx.doi.org/10.1016/S0896-6273(01)00375-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516402	Green Submitted, Bronze			2022-12-24	WOS:000170601000014
J	Kim, D; Song, I; Keum, S; Lee, T; Jeong, MJ; Kim, SS; McEnery, MW; Shin, HS				Kim, D; Song, I; Keum, S; Lee, T; Jeong, MJ; Kim, SS; McEnery, MW; Shin, HS			Lack of the burst firing of thalamocortical relay neurons and resistance to absence seizures in mice lacking alpha(1G) T-type Ca2+ channels	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; SYNCHRONOUS EPILEPTIC DISCHARGES; GENERALIZED PENICILLIN EPILEPSY; THALAMIC NEURONS; CALCIUM-CHANNEL; GABA(B) RECEPTORS; WAVE DISCHARGES; RESPONSE-MODES; LOW-THRESHOLD; RAT	T-type Ca2+ currents have been proposed to be involved in the genesis of spike-and-wave discharges, a sign of absence seizures, but direct evidence in vivo to support this hypothesis has been lacking. To address this question, we generated a null mutation of the alpha (1G) subunit of T-type Ca2+ channels. The thalamocortical relay neurons of the alpha (1G)-deficient mice lacked the burst mode firing of action potentials, whereas they showed the normal pattern of tonic mode firing. The alpha (1G)-deficient thalamus was specifically resistant to the generation of spike-and-wave discharges in response to GABA(B) receptor activation. Thus, the modulation of the intrinsic firing pattern mediated by alpha (1G) T-type Ca2+ channels plays a critical role in the genesis of absence seizures in the thalamocortical pathway.	Pohang Univ Sci & Technol, Dept Life Sci, Natl Creat Res Initiat Ctr Calcium & Learning, Pohang 790784, South Korea; Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Pohang University of Science & Technology (POSTECH); Case Western Reserve University	Shin, HS (corresponding author), Korea Inst Sci & Technol, POB 131, Seoul 136791, South Korea.	shin@kist.re.kr	Kim, Daesoo/C-1625-2011	Kim, Daesoo/0000-0001-9915-1463				Aizawa M, 1997, BIOL PHARM BULL, V20, P1066; AVOLI M, 1981, EPILEPSIA, V22, P443, DOI 10.1111/j.1528-1157.1981.tb06155.x; Avoli M, 1996, EPILEPSIA, V37, P1035, DOI 10.1111/j.1528-1157.1996.tb01022.x; Avoli M, 1990, GEN EPILEPSY NEUROBI; Caddick SJ, 1999, J NEUROPHYSIOL, V81, P2066, DOI 10.1152/jn.1999.81.5.2066; COULTER DA, 1989, ANN NEUROL, V25, P582, DOI 10.1002/ana.410250610; CRUNELLI V, 1991, TRENDS NEUROSCI, V14, P16, DOI 10.1016/0166-2236(91)90178-W; DESCHENES M, 1984, J NEUROPHYSIOL, V51, P1196, DOI 10.1152/jn.1984.51.6.1196; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Gibbs JW, 1996, J NEUROPHYSIOL, V76, P2568, DOI 10.1152/jn.1996.76.4.2568; GLOOR P, 1988, TRENDS NEUROSCI, V11, P63, DOI 10.1016/0166-2236(88)90166-X; GUIDO W, 1995, VISUAL NEUROSCI, V12, P723, DOI 10.1017/S0952523800008993; HOSFORD DA, 1992, SCIENCE, V257, P398, DOI 10.1126/science.1321503; HUGUENARD JR, 1994, J NEUROSCI, V14, P5485; HUGUENARD JR, 1994, J NEUROPHYSIOL, V71, P2576, DOI 10.1152/jn.1994.71.6.2576; Huntsman MM, 1999, SCIENCE, V283, P541, DOI 10.1126/science.283.5401.541; INOUE M, 1993, BRAIN RES, V612, P35, DOI 10.1016/0006-8993(93)91641-5; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KOSTYUK PG, 1992, NEUROSCIENCE, V51, P755, DOI 10.1016/0306-4522(92)90515-4; Leresche N, 1998, J NEUROSCI, V18, P4842; LIN FH, 1993, BRAIN RES, V608, P101, DOI 10.1016/0006-8993(93)90779-M; LO FS, 1991, EXP BRAIN RES, V83, P317; MCCARLEY RW, 1983, J NEUROPHYSIOL, V50, P798, DOI 10.1152/jn.1983.50.4.798; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; McCormick David A., 1994, Current Opinion in Neurobiology, V4, P550, DOI 10.1016/0959-4388(94)90056-6; McEnery MW, 1997, FEBS LETT, V420, P74, DOI 10.1016/S0014-5793(97)01490-7; NELSON JP, 1983, J NEUROPHYSIOL, V50, P784, DOI 10.1152/jn.1983.50.4.784; Niedermeyer E, 1996, CLIN ELECTROENCEPHAL, V27, P1, DOI 10.1177/155005949602700103; PELLEGRINI A, 1979, EXP NEUROL, V64, P155, DOI 10.1016/0014-4886(79)90012-8; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Pinault D, 1998, J PHYSIOL-LONDON, V509, P449, DOI 10.1111/j.1469-7793.1998.449bn.x; Raman IM, 1999, J NEUROSCI, V19, P1663; Sherman SM, 1996, VISUAL NEUROSCI, V13, P205, DOI 10.1017/S0952523800007446; Smith KA, 1996, BRAIN RES, V729, P147, DOI 10.1016/0006-8993(96)00174-6; SNEAD OC, 1992, EUR J PHARMACOL, V213, P343, DOI 10.1016/0014-2999(92)90623-C; SNEAD OC, 1988, EPILEPSIA, V29, P361; Snead OC, 2000, J NEUROSCI, V20, P6218, DOI 10.1523/JNEUROSCI.20-16-06218.2000; STERIADE M, 1995, J NEUROSCI, V15, P623; Steriade M, 1998, J NEUROPHYSIOL, V80, P1439, DOI 10.1152/jn.1998.80.3.1439; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Talley EM, 1999, J NEUROSCI, V19, P1895; Talley EM, 2000, MOL BRAIN RES, V75, P159, DOI 10.1016/S0169-328X(99)00307-1; TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995; Vance CL, 1998, J BIOL CHEM, V273, P14495, DOI 10.1074/jbc.273.23.14495; WILLIAMS DS, 1950, BRAIN, V67, P50	46	367	383	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2001	31	1					35	45		10.1016/S0896-6273(01)00343-9	http://dx.doi.org/10.1016/S0896-6273(01)00343-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498049	Bronze			2022-12-24	WOS:000170101100009
J	Klier, EM; Wang, HY; Crawford, JD				Klier, EM; Wang, HY; Crawford, JD			The superior colliculus encodes gaze commands in retinal coordinates	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; ALERT RHESUS-MONKEY; HEAD-FREE CAT; VISUAL SPACE; PARIETAL CORTEX; MOTOR MAP; STIMULATION; SHIFTS; NEURONS; PRIMATE	The superior colliculus (SC) has a topographic map of visual space, but the spatial nature of its output command for orienting gaze shifts remains unclear. Here we show that the SC codes neither desired gaze displacement nor gaze direction in space (as debated previously), but rather, desired gaze direction in retinal coordinates. Electrical micro-stimulation of the SC in two head-free (nonimmobilized) monkeys evoked natural-looking, eye-head gaze shifts, with anterior sites producing small, fixed-vector movements and posterior sites producing larger, strongly converging movements. However, when correctly calculated in retinal coordinates, all of these trajectories became 'fixed-vector.' Moreover, our data show that this eye-centered SC command is then further transformed, as a function of eye and head position, by downstream mechanisms into the head- and body-centered commands for coordinated eye-head gaze shifts.	York Univ, CIHR Grp Act & Percept, Toronto, ON M3J 1P3, Canada; York Univ, York Ctr Vis Res, Toronto, ON M3J 1P3, Canada; York Univ, Dept Psychol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Biol, Toronto, ON M3J 1P3, Canada; York Univ, Dept Kinesiol & Hlth Sci, Toronto, ON M3J 1P3, Canada	York University - Canada; York University - Canada; York University - Canada; York University - Canada; York University - Canada	Crawford, JD (corresponding author), York Univ, CIHR Grp Act & Percept, 4700 Keele St, Toronto, ON M3J 1P3, Canada.	jdc@yorku.ca		Crawford, Doug/0000-0003-2288-1286				ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; APTER JT, 1945, J NEUROPHYSIOL, V8, P123, DOI 10.1152/jn.1945.8.2.123; Batista AP, 1999, SCIENCE, V285, P257, DOI 10.1126/science.285.5425.257; Colby CL, 1999, ANNU REV NEUROSCI, V22, P319, DOI 10.1146/annurev.neuro.22.1.319; Crawford JD, 1999, J NEUROPHYSIOL, V81, P1760, DOI 10.1152/jn.1999.81.4.1760; Crawford JD, 2000, J NEUROSCI, V20, P2360; Crawford JD, 1997, J NEUROPHYSIOL, V78, P1447, DOI 10.1152/jn.1997.78.3.1447; CYNADER M, 1972, J NEUROPHYSIOL, V35, P187, DOI 10.1152/jn.1972.35.2.187; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Freedman EG, 1996, J NEUROPHYSIOL, V76, P927, DOI 10.1152/jn.1996.76.2.927; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Freedman EG, 1997, J NEUROPHYSIOL, V78, P1669, DOI 10.1152/jn.1997.78.3.1669; GOLDBERG ME, 1990, J NEUROPHYSIOL, V64, P489, DOI 10.1152/jn.1990.64.2.489; GUITTON D, 1980, EXP BRAIN RES, V39, P63; HARRIS LR, 1980, J PHYSIOL-LONDON, V300, P367, DOI 10.1113/jphysiol.1980.sp013167; Henriques DYP, 1998, J NEUROSCI, V18, P1583; HENRIQUES DYP, IN PRESS NEUROCOMPUT; HEPP K, 1993, J NEUROPHYSIOL, V69, P965, DOI 10.1152/jn.1993.69.3.965; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; Klier EM, 1998, J NEUROPHYSIOL, V80, P2274, DOI 10.1152/jn.1998.80.5.2274; MCILWAIN JT, 1986, J NEUROPHYSIOL, V55, P97, DOI 10.1152/jn.1986.55.1.97; Moschovakis AK, 1998, J NEUROPHYSIOL, V80, P3373, DOI 10.1152/jn.1998.80.6.3373; MUNOZ DP, 1991, J NEUROPHYSIOL, V66, P1624, DOI 10.1152/jn.1991.66.5.1624; PARE M, 1994, EXP BRAIN RES, V101, P123; ROBINSON DA, 1972, VISION RES, V12, P1795, DOI 10.1016/0042-6989(72)90070-3; ROUCOUX A, 1980, EXP BRAIN RES, V39, P75; Russo GS, 1996, J NEUROPHYSIOL, V76, P825, DOI 10.1152/jn.1996.76.2.825; SCHILLER PH, 1971, J NEUROPHYSIOL, V34, P920, DOI 10.1152/jn.1971.34.5.920; SCHILLER PH, 1972, J NEUROPHYSIOL, V35, P915, DOI 10.1152/jn.1972.35.6.915; SEGRAVES MA, 1992, HEAD NECK SENSORY MO, P292; Smith MA, 2001, J COMPUT NEUROSCI, V10, P127, DOI 10.1023/A:1011264913465; Snyder LH, 1998, NATURE, V394, P887, DOI 10.1038/29777; STEIN BE, 1976, BRAIN RES, V118, P469, DOI 10.1016/0006-8993(76)90314-0; STRASCHILL M, 1973, BRAIN RES, V59, P211, DOI 10.1016/0006-8993(73)90262-X; UEMURA T, 1980, ACTA OTO-LARYNGOL, V90, P191, DOI 10.3109/00016488009131715; VANOPSTAL AJ, 1991, SCIENCE, V252, P1313, DOI 10.1126/science.1925545; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; Wallace MT, 1996, J NEUROPHYSIOL, V76, P1246, DOI 10.1152/jn.1996.76.2.1246; WHITE JM, 1994, VISION RES, V34, P79, DOI 10.1016/0042-6989(94)90259-3; WURTZ RH, 1971, SCIENCE, V171, P82, DOI 10.1126/science.171.3966.82	40	128	130	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					627	632		10.1038/88450	http://dx.doi.org/10.1038/88450			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369944				2022-12-24	WOS:000169061800016
J	Bazhenov, M; Stopfer, M; Rabinovich, M; Huerta, R; Abarbanel, HDI; Sejnowski, TJ; Laurent, G				Bazhenov, M; Stopfer, M; Rabinovich, M; Huerta, R; Abarbanel, HDI; Sejnowski, TJ; Laurent, G			Model of transient oscillatory synchronization in the locust antennal lobe	NEURON			English	Article							THALAMIC RETICULAR NUCLEUS; ENCODING NEURAL ASSEMBLIES; OLFACTORY-BULB; ODOR; INTERNEURONS; PATTERNS; NETWORK; STIMULATION; INFORMATION; MECHANISMS	Transient pairwise synchronization of locust antennal lobe (AL) projection neurons (PNs) occurs during odor responses. In a Hodgkin-Huxley-type model of the AL, interactions between excitatory PNs and inhibitory local neurons (LNs) created coherent network oscillations during odor stimulation. GABAergic interconnections between LNs led to competition among them such that different groups of LNs oscillated with periodic Ca2+ spikes during different 50-250 ms temporal epochs, similar to those recorded in vivo. During these epochs, LN-evoked IPSPs caused phase-locked, population oscillations in sets of postsynaptic PNs. The model shows how alternations of the inhibitory drive can temporally encode sensory information in networks of neurons without precisely tuned intrinsic oscillatory properties.	Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Scripps Inst Oceanog, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; California Institute of Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Bazhenov, M (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.		Laurent, Gilles/A-4583-2012; Abarbanel, Henry Don Isaac/AAX-3192-2021; Huerta, Ramon/C-9296-2013; Sejnowski, Terrence/AAV-5558-2021; Huerta, Ramon/J-4316-2012	Laurent, Gilles/0000-0002-2296-114X; Huerta, Ramon/0000-0003-3925-5169; Huerta, Ramon/0000-0003-3925-5169; Stopfer, Mark/0000-0001-9200-1884; Rabinovich, Mikhail I./0000-0003-4499-5348	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Adrian ED, 1942, J PHYSIOL-LONDON, V100, P459, DOI 10.1113/jphysiol.1942.sp003955; ADRIAN ED, 1950, ELECTROEN CLIN NEURO, V2, P377, DOI 10.1016/0013-4694(50)90075-7; Bazhenov M, 1998, J NEUROPHYSIOL, V79, P2730, DOI 10.1152/jn.1998.79.5.2730; Bazhenov M, 2001, NEURON, V30, P569, DOI 10.1016/S0896-6273(01)00286-0; BURROWS M, 1982, J COMP PHYSIOL, V145, P447, DOI 10.1007/BF00612810; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; COBB SR, 1995, NATURE, V378, P75, DOI 10.1038/378075a0; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Enright W. H., 1995, SURVEY EXPLICIT RUNG; Ermentrout B, 1998, J NEUROPHYSIOL, V79, P2677, DOI 10.1152/jn.1998.79.5.2677; FREEMAN WJ, 1979, BIOL CYBERN, V35, P221, DOI 10.1007/BF00344205; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gauck V, 2000, J NEUROSCI, V20, P3006; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; GOLOMB D, 1994, J NEUROPHYSIOL, V72, P1109, DOI 10.1152/jn.1994.72.3.1109; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1305; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; KAUER JS, 1977, J PHYSIOL-LONDON, V272, P495, DOI 10.1113/jphysiol.1977.sp012056; Korn G.A., 1968, MATH HDB; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; Leitch B, 1996, J COMP NEUROL, V372, P487; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MEREDITH M, 1992, BRAIN RES BULL, V29, P111, DOI 10.1016/0361-9230(92)90014-O; RALL W, 1968, J NEUROPHYSIOL, V31, P884, DOI 10.1152/jn.1968.31.6.884; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; Shepherd G.M., 1998, SYNAPTIC ORG BRAIN, P159; Sloper J., 1978, PHILOS T R SOC LON B, V285, P124; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M., 1990, THALAMIC OSCILLATION; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer Mark, 1999, P163; Traub R.D., 1991, NEURONAL NETWORKS HI; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	47	161	165	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					553	567		10.1016/S0896-6273(01)00284-7	http://dx.doi.org/10.1016/S0896-6273(01)00284-7			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395014	Green Accepted, Green Published, Bronze			2022-12-24	WOS:000168962000025
J	de Bruyne, M; Foster, K; Carlson, JR				de Bruyne, M; Foster, K; Carlson, JR			Odor coding in the Drosophila antenna	NEURON			English	Article							OLFACTORY RECEPTOR NEURONS; 7-TRANSMEMBRANE PROTEINS; CHEMOSENSORY RECEPTORS; SENSORY MAP; WILD-TYPE; MELANOGASTER; ORGANIZATION; EXPRESSION; RESPONSES; PHEROMONE	Odor coding in the Drosophila antenna is examined by a functional analysis of individual olfactory receptor neurons (ORNs) in vivo. Sixteen distinct classes of ORNs, each with a unique response spectrum to a panel of 47 diverse odors, are identified by extracellular recordings. ORNs exhibit multiple modes of response dynamics: an individual neuron can show either excitatory or inhibitory responses, and can exhibit different modes of termination kinetics, when stimulated with different odors. The 16 ORN classes are combined in stereotyped configurations within seven functional types of basiconic sensilla. One sensillum type contains four ORNs and the others contain two neurons, combined according to a strict pairing rule. We provide a functional map of ORNs, showing that each ORN class is restricted to a particular spatial domain on the antennal surface.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Boeckh J., 1981, P86; BOEKHOFF I, 1994, J NEUROSCI, V14, P3304; BORST A, 1984, J INSECT PHYSIOL, V30, P507, DOI 10.1016/0022-1910(84)90032-5; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; Clyne Peter, 1997, Invertebrate Neuroscience, V3, P127, DOI 10.1007/BF02480367; Clyne PJ, 1999, NEURON, V22, P339, DOI 10.1016/S0896-6273(00)81094-6; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; de Bruyne M, 1999, J NEUROSCI, V19, P4520; DENOTTER CJ, 1992, PHYSIOL ENTOMOL, V17, P33, DOI 10.1111/j.1365-3032.1992.tb00987.x; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Grant AJ, 1998, J COMP PHYSIOL A, V183, P433, DOI 10.1007/s003590050269; Hansson BS, 1999, PHYSIOL ENTOMOL, V24, P121, DOI 10.1046/j.1365-3032.1999.00121.x; HATT H, 1994, P NATL ACAD SCI USA, V91, P6264, DOI 10.1073/pnas.91.14.6264; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Hing ALY, 1996, J NEUROBIOL, V30, P454; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Laissue PP, 1999, J COMP NEUROL, V405, P543; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; MURLIS J, 1992, ANNU REV ENTOMOL, V37, P505, DOI 10.1146/annurev.en.37.010192.002445; POSTLETHWAIT JH, 1971, DEV BIOL, V24, P477, DOI 10.1016/0012-1606(71)90061-3; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; RIESGOESCOVAR J, 1995, P NATL ACAD SCI USA, V92, P2864, DOI 10.1073/pnas.92.7.2864; RiesgoEscovar JR, 1997, J COMP PHYSIOL A, V180, P151, DOI 10.1007/s003590050036; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; SICARD G, 1984, BRAIN RES, V292, P283, DOI 10.1016/0006-8993(84)90764-9; Siddiqi O., 1991, CHEM SENSES, P79; STOCKER RF, 1983, CELL TISSUE RES, V232, P237, DOI 10.1007/BF00213783; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; VENKATESH S, 1984, INT J INSECT MORPHOL, V13, P51, DOI 10.1016/0020-7322(84)90032-1; Vickers NJ, 1996, J COMP PHYSIOL A, V178, P831, DOI 10.1007/BF00225831; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2; Wojtasek H, 1998, BIOCHEM BIOPH RES CO, V250, P217, DOI 10.1006/bbrc.1998.9278	46	530	542	2	60	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					537	552		10.1016/S0896-6273(01)00289-6	http://dx.doi.org/10.1016/S0896-6273(01)00289-6			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395013	Bronze			2022-12-24	WOS:000168962000024
J	Nagarajan, R; Svaren, J; Le, N; Araki, T; Watson, M; Milbrandt, J				Nagarajan, R; Svaren, J; Le, N; Araki, T; Watson, M; Milbrandt, J			EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; CELL-ADHESION MOLECULE; MARIE-TOOTH-DISEASE; SCHWANN-CELLS; NGFI-A; TRANSCRIPTIONAL ACTIVITY; OLIGONUCLEOTIDE ARRAYS; MICE DEFICIENT; GROWTH ARREST; PROTEIN ZERO	The identification of EGR2 mutations in patients with neuropathies and the phenotype Egr2/Krox20(-/-) have demonstrated that the Egr2 transcription factor is critical for peripheral nerve myelination. However, the mechanism by which these mutations cause disease remains unclear, as most patients present with disease in the heterozygous state, whereas Egr2(+/-) mice are phenotypically normal. To understand the effect of aberrant Egr2 activity on Schwann cell gene expression, we performed microarray expression profiling to identify genes regulated by Egr2 in Schwann cells. These include genes encoding myelin proteins and enzymes required for synthesis of normal myelin lipids. Using these newly identified targets, we have shown that neuropathy-associated EGR2 mutants dominant-negatively inhibit wild-type Egr2-mediated expression of essential myelin genes to levels sufficiently low to result in the abnormal myelination observed in these patients.	Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Univ Wisconsin, Sch Vet Med, Dept Comparat Biosci, Madison, WI 53706 USA	Washington University (WUSTL); Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Milbrandt, J (corresponding author), Washington Univ, Sch Med, Dept Pathol, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.		Svaren, John/A-1605-2010; Araki, Toshiyuki/H-4289-2019	Svaren, John/0000-0003-2963-7921; Araki, Toshiyuki/0000-0003-3625-2042; Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NCI NIH HHS [5 P01 CA49712-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adlkofer K, 1997, J NEUROSCI, V17, P4662; ADLKOFER K, 1995, NAT GENET, V11, P274, DOI 10.1038/ng1195-274; Anzini P, 1997, J NEUROSCI, V17, P4545; Aurelio ON, 2000, MOL CELL BIOL, V20, P770, DOI 10.1128/MCB.20.3.770-778.2000; Baumgartner S, 1996, CELL, V87, P1059, DOI 10.1016/S0092-8674(00)81800-0; Bellone E, 1999, Hum Mutat, V14, P353, DOI 10.1002/(SICI)1098-1004(199910)14:4<353::AID-HUMU17>3.3.CO;2-W; Boerkoel CF, 2001, AM J HUM GENET, V68, P325, DOI 10.1086/318208; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Bottomley SS., 1998, AM J HUM GENET, V63, pA352; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Carenini S, 1998, GLIA, V22, P213, DOI 10.1002/(SICI)1098-1136(199803)22:3<213::AID-GLIA1>3.0.CO;2-6; Carenini S, 1999, GLIA, V27, P203, DOI 10.1002/(SICI)1098-1136(199909)27:3<203::AID-GLIA2>3.3.CO;2-Z; Carenini S, 1997, CELL TISSUE RES, V287, P3; DEJONGHE P, 1997, J PERIPHER NERV SYST, V2, P370; Ehrengruber MU, 1998, METHOD ENZYMOL, V293, P483; FRESSINAUD C, 1986, J NEUROCHEM, V46, P1549, DOI 10.1111/j.1471-4159.1986.tb01775.x; Fruttiger M, 1999, DEVELOPMENT, V126, P457; Fu Q, 1998, J NEUROCHEM, V71, P549; Garbay B, 1998, J NEUROCHEM, V71, P1719; GIESE KP, 1992, CELL, V71, P565, DOI 10.1016/0092-8674(92)90591-Y; GILLEN C, 1995, J NEUROSCI RES, V42, P159, DOI 10.1002/jnr.490420203; Gillespie CS, 2000, NEURON, V26, P523, DOI 10.1016/S0896-6273(00)81184-8; Guilbot A, 2001, HUM MOL GENET, V10, P415, DOI 10.1093/hmg/10.4.415; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kubbutat MHG, 1999, CELL GROWTH DIFFER, V10, P87; Lee SL, 1996, MOL CELL BIOL, V16, P4566; Leiserson WM, 2000, NEURON, V28, P793, DOI 10.1016/S0896-6273(00)00154-9; LI CM, 1994, NATURE, V369, P747, DOI 10.1038/369747a0; Lipshutz RJ, 1999, NAT GENET, V21, P20, DOI 10.1038/4447; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lupski JR, 1997, HOSP PRACT, V32, P83, DOI 10.1080/21548331.1997.11443485; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; MARTINI R, 1995, NAT GENET, V11, P281, DOI 10.1038/ng1195-281; MARTINI R, 1995, J NEUROSCI, V15, P4488; Mechta-Grigoriou F, 2000, DEVELOPMENT, V127, P119; MONTAG D, 1994, NEURON, V13, P229, DOI 10.1016/0896-6273(94)90472-3; Morrison TB, 1998, BIOTECHNIQUES, V24, P954; Murphy P, 1996, DEVELOPMENT, V122, P2847; Neuberg DHH, 1998, J NEUROSCI RES, V53, P542, DOI 10.1002/(SICI)1097-4547(19980901)53:5<542::AID-JNR4>3.0.CO;2-9; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Notterpek L, 1999, GLIA, V25, P358, DOI 10.1002/(SICI)1098-1136(19990215)25:4<358::AID-GLIA5>3.0.CO;2-K; PAULSEN RE, 1992, J BIOL CHEM, V267, P16491; Raeymaekers P, 1991, Neuromuscul Disord, V1, P93, DOI 10.1016/0960-8966(91)90055-W; REDDY JC, 1995, J BIOL CHEM, V270, P10878, DOI 10.1074/jbc.270.18.10878; Rushton JA, 1999, J NEUROCHEM, V73, P1816; RUSSO MW, 1993, MOL CELL BIOL, V13, P6858, DOI 10.1128/MCB.13.11.6858; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; SALFUDEEN Z, 2000, J BIOL CHEM, V275, P15557; Schratzberger P, 2000, NAT MED, V6, P405, DOI 10.1038/74664; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Silverman ES, 1997, AM J PHYSIOL-HEART C, V273, pH1415, DOI 10.1152/ajpheart.1997.273.3.H1415; Sock E, 1997, J NEUROCHEM, V68, P1911; Sondell M, 1999, BRAIN RES, V846, P219, DOI 10.1016/S0006-8993(99)02056-9; SPRECA A, 1992, J CELL PHYSIOL, V152, P587, DOI 10.1002/jcp.1041520319; Svaren J, 2000, J BIOL CHEM, V275, P38524, DOI 10.1074/jbc.M005220200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Timmerman V, 1999, NEUROLOGY, V52, P1827, DOI 10.1212/WNL.52.9.1827; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Warner LE, 1999, HUM MOL GENET, V8, P1245, DOI 10.1093/hmg/8.7.1245; Warner LE, 1998, NAT GENET, V18, P382, DOI 10.1038/ng0498-382; Yoshida H, 1996, CANCER RES, V56, P2945; Zorick TS, 1999, DEVELOPMENT, V126, P1397; Zorick TS, 1996, MOL CELL NEUROSCI, V8, P129, DOI 10.1006/mcne.1996.0052	68	166	170	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					355	368		10.1016/S0896-6273(01)00282-3	http://dx.doi.org/10.1016/S0896-6273(01)00282-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11394999	Bronze			2022-12-24	WOS:000168962000010
J	Nguyen, MD; Lariviere, RC; Julien, JP				Nguyen, MD; Lariviere, RC; Julien, JP			Deregulation of Cdk5 in a mouse model of ALS: Toxicity alleviated by perikaryal neurofilament inclusions	NEURON			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CYCLIN-DEPENDENT KINASE-5; GLYCOGEN-SYNTHASE KINASE-3; CU/ZN-SUPEROXIDE-DISMUTASE; MOTOR-NEURONS; TRANSGENIC MICE; LINKED SOD1; ALZHEIMERS-DISEASE; TAU-PROTEIN; PHOSPHORYLATION	Recent studies suggest that increased activity of cyclin-dependent kinase 5 (Cdk5) may contribute to neuronal death and cytoskeletal abnormalities in Alzheimer's disease. We report here such deregulation of Cdk5 activity associated with the hyperphosphorylation of tau and neurofilament (NF) proteins in mice expressing a mutant superoxide dismutase (SOD1(G37R)) linked to amyotrophic lateral sclerosis (ALS). A Cdk5 involvement in motor neuron degeneration is supported by our analysis of three SOD1(G37R) mouse lines exhibiting perikaryal inclusions of NF proteins. Our results suggest that perikaryal accumulations of NF proteins in motor neurons may alleviate ALS pathogenesis by acting as a phosphorylation sink for Cdk5 activity, thereby reducing the detrimental hyperphosphorylation of tau and other neuronal substrates.	McGill Univ, Ctr Hlth, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada	McGill University	Julien, JP (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Ctr Res Neurosci, Montreal, PQ H3G 1A4, Canada.	mdju@musica.mcgill.ca						Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Bajaj NPS, 1998, NEUROSCI LETT, V245, P45, DOI 10.1016/S0304-3940(98)00176-1; Bajaj NPS, 1999, PROG NEURO-PSYCHOPH, V23, P833, DOI 10.1016/S0278-5846(99)00044-5; Bajaj NPS, 1997, J NEUROCHEM, V69, P737; BAUMANN K, 1993, FEBS LETT, V336, P417, DOI 10.1016/0014-5793(93)80849-P; Beaulieu JM, 1999, J CELL BIOL, V147, P531, DOI 10.1083/jcb.147.3.531; Beaulieu JM, 2000, J NEUROSCI, V20, P5321, DOI 10.1523/JNEUROSCI.20-14-05321.2000; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; BRION JP, 1995, AM J PATHOL, V147, P1465; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; CARPENTER S, 1968, NEUROLOGY, V18, P841, DOI 10.1212/WNL.18.9.841; Cleveland DW, 1999, NEURON, V24, P515, DOI 10.1016/S0896-6273(00)81108-3; Corson LB, 1998, P NATL ACAD SCI USA, V95, P6361, DOI 10.1073/pnas.95.11.6361; COTE F, 1993, CELL, V73, P35, DOI 10.1016/0092-8674(93)90158-M; Couillard-Despres S, 1998, P NATL ACAD SCI USA, V95, P9626, DOI 10.1073/pnas.95.16.9626; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; ELLIOTT JL, 1995, NEUROREPORT, V6, P449, DOI 10.1097/00001756-199502000-00011; Estevez AG, 1999, SCIENCE, V286, P2498, DOI 10.1126/science.286.5449.2498; Eyer J, 1998, NATURE, V391, P584, DOI 10.1038/35378; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; Ghadge GD, 1997, J NEUROSCI, V17, P8756; Giasson BI, 1996, J BIOL CHEM, V271, P30404, DOI 10.1074/jbc.271.48.30404; Green SL, 1998, J NEUROPATH EXP NEUR, V57, P1070, DOI 10.1097/00005072-199811000-00010; Guidato S, 1996, J NEUROCHEM, V66, P1698; HIRANO A, 1984, J NEUROPATH EXP NEUR, V43, P471, DOI 10.1097/00005072-198409000-00002; INCE P, 1993, NEUROPATH APPL NEURO, V19, P291, DOI 10.1111/j.1365-2990.1993.tb00443.x; IQBAL K, 1995, NEUROBIOL AGING, V16, P375, DOI 10.1016/0197-4580(95)00033-B; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Julien JP, 1999, CURR OPIN NEUROBIOL, V9, P554, DOI 10.1016/S0959-4388(99)00004-5; Julien JP, 2001, CELL, V104, P581, DOI 10.1016/S0092-8674(01)00244-6; Kong JM, 1998, J NEUROSCI, V18, P3241; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; LEW J, 1995, NEUROBIOL AGING, V16, P263, DOI 10.1016/0197-4580(95)00014-6; Li MW, 2000, SCIENCE, V288, P335, DOI 10.1126/science.288.5464.335; Mandelkow E, 1999, NATURE, V402, P588, DOI 10.1038/45095; Morrison BM, 1996, J COMP NEUROL, V373, P619, DOI 10.1002/(SICI)1096-9861(19960930)373:4<619::AID-CNE9>3.0.CO;2-4; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rouleau GA, 1996, ANN NEUROL, V39, P128, DOI 10.1002/ana.410390119; Roy J, 1998, J NEUROSCI, V18, P9673; SCHMIDT ML, 1987, LAB INVEST, V56, P282; Trotti D, 1999, NAT NEUROSCI, V2, P427, DOI 10.1038/8091; TSAI LH, 1993, DEVELOPMENT, V119, P1029; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Veeranna, 1998, J NEUROSCI, V18, P4008; Veeranna GJ, 2000, MOL BRAIN RES, V76, P229, DOI 10.1016/S0169-328X(00)00003-6; WiedauPazos M, 1996, SCIENCE, V271, P515, DOI 10.1126/science.271.5248.515; Williamson TL, 1998, P NATL ACAD SCI USA, V95, P9631, DOI 10.1073/pnas.95.16.9631; Williamson TL, 1999, NAT NEUROSCI, V2, P50, DOI 10.1038/4553; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yamaguchi H, 1996, ACTA NEUROPATHOL, V92, P232, DOI 10.1007/s004010050513; Zhang B, 1997, J CELL BIOL, V139, P1307, DOI 10.1083/jcb.139.5.1307; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654; Zhu QZ, 1998, J CELL BIOL, V143, P183, DOI 10.1083/jcb.143.1.183	63	273	286	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					135	147		10.1016/S0896-6273(01)00268-9	http://dx.doi.org/10.1016/S0896-6273(01)00268-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343650	Bronze			2022-12-24	WOS:000168412900016
J	Panzeri, S; Petersen, RS; Schultz, SR; Lebedev, M; Diamond, ME				Panzeri, S; Petersen, RS; Schultz, SR; Lebedev, M; Diamond, ME			The role of spike timing in the coding of stimulus location in rat somatosensory cortex	NEURON			English	Article							BARREL CORTEX; RECEPTIVE-FIELDS; SINGLE NEURONS; INFORMATION; RESPONSES; VARIABILITY; AFFERENTS; PATTERNS; RECOVERY; MOTION	Although the timing of single spikes is known to code for time-varying features of a sensory stimulus, it remains unclear whether time is also exploited in the neuronal coding of the spatial structure of the environment, where nontemporal stimulus features are fundamental. This report demonstrates that, in the whisker representation of rat cortex, precise spike timing of single neurons increases the information transmitted about stimulus location by 44%, compared to that transmitted only by the total number of spikes. Crucial to this code is the timing of the first spike after whisker movement. Complex, single neuron spike patterns play a smaller, synergistic role. Timing permits very few spikes to transmit high quantities of information about a behaviorally significant, spatial stimulus.	Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, I-34014 Trieste, Italy; Newcastle Univ, Dept Psychol, Neural Syst Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA; Natl Inst Hlth Anim Ctr, Lab Syst Neurosci, Poolesville, MD 20837 USA	International School for Advanced Studies (SISSA); Newcastle University - UK; Howard Hughes Medical Institute; New York University; National Institutes of Health (NIH) - USA	Diamond, ME (corresponding author), Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Via Beirut 2-4, I-34014 Trieste, Italy.	diamond@sissa.it	Schultz, Simon/C-9707-2009; Panzeri, Stefano/L-5977-2013; Lebedev, Mikhail A/H-5066-2016	Schultz, Simon/0000-0002-6794-5813; Panzeri, Stefano/0000-0003-1700-8909; Lebedev, Mikhail A/0000-0003-0355-8723; Petersen, Rasmus/0000-0002-5607-977X; DIAMOND, Mathew Ernest/0000-0003-2286-4566	NINDS NIH HHS [NS32647] Funding Source: Medline; Telethon [984] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032647] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Adrian ED, 1926, J PHYSIOL-LONDON, V61, P49, DOI 10.1113/jphysiol.1926.sp002273; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; ARMSTRONGJAMES M, 1992, J NEUROPHYSIOL, V68, P1345, DOI 10.1152/jn.1992.68.4.1345; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; BARNEOUD P, 1991, BEHAV BRAIN RES, V44, P87, DOI 10.1016/S0166-4328(05)80242-6; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Brecht M, 1997, BEHAV BRAIN RES, V84, P81, DOI 10.1016/S0166-4328(97)83328-1; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; DeWeese MR, 1999, NETWORK-COMP NEURAL, V10, P325, DOI 10.1088/0954-898X/10/4/303; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; Harris JA, 1999, P NATL ACAD SCI USA, V96, P7587, DOI 10.1073/pnas.96.13.7587; HELLER J, 1995, J COMPUT NEUROSCI, V2, P175, DOI 10.1007/BF00961433; HURWITZ BE, 1990, BRAIN RES, V512, P210, DOI 10.1016/0006-8993(90)90628-O; HUTSON KA, 1986, J NEUROPHYSIOL, V56, P1196, DOI 10.1152/jn.1986.56.4.1196; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; PANCERI S, 2001, IN PRESS NEURAL COMP, P1; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; PAZOS AJ, 1995, BRAIN RES, V689, P224, DOI 10.1016/0006-8993(95)00579-F; Petersen RS, 2000, J NEUROSCI, V20, P6135, DOI 10.1523/JNEUROSCI.20-16-06135.2000; Reich DS, 2000, J NEUROSCI, V20, P1964; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TOLHURST DJ, 1989, VISUAL NEUROSCI, V2, P409, DOI 10.1017/S0952523800002212; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; VALTSCHANOFF JG, 1993, NEUROSCI LETT, V157, P157, DOI 10.1016/0304-3940(93)90726-2; vanSteveninck RRD, 1997, SCIENCE, V275, P1805, DOI 10.1126/science.275.5307.1805; Victor JD, 1998, J NEUROPHYSIOL, V80, P554, DOI 10.1152/jn.1998.80.2.554; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WERNER G, 1965, J NEUROPHYSIOL, V28, P359, DOI 10.1152/jn.1965.28.2.359	44	312	311	1	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					769	777		10.1016/S0896-6273(01)00251-3	http://dx.doi.org/10.1016/S0896-6273(01)00251-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301035	Bronze			2022-12-24	WOS:000167868900025
J	Rao, SM; Mayer, AR; Harrington, DL				Rao, SM; Mayer, AR; Harrington, DL			The evolution of brain activation during temporal processing	NATURE NEUROSCIENCE			English	Article							TIME-ESTIMATION; WORKING-MEMORY; MOTOR; CEREBELLUM; ATTENTION; MOVEMENT; DISCRIMINATION; REPRESENTATION; INFORMATION; PERCEPTION	Timing is crucial to many aspects of human performance. To better understand its neural underpinnings, we used event-related fMRI to examine the time course of activation associated with different components of a time perception task. We distinguished systems associated with encoding time intervals from those related to comparing intervals and implementing a response. Activation in the basal ganglia occurred early, and was uniquely associated with encoding time intervals, whereas cerebellar activation unfolded late, suggesting an involvement in processes other than explicit timing. Early cortical activation associated with encoding of time intervals was observed in the right inferior parietal cortex and bilateral premotor cortex, implicating these systems in attention and temporary maintenance of intervals. Late activation in the right dorsolateral prefrontal cortex emerged during comparison of time intervals. Our results illustrate a dynamic network of cortical-subcortical activation associated with different components of temporal information processing.	Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; Dept Vet Affairs, Albuquerque, NM 87108 USA; Univ New Mexico, Dept Neurol, Albuquerque, NM 87113 USA	Medical College of Wisconsin; University of New Mexico	Harrington, DL (corresponding author), Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA.	dharring@unm.edu	Rao, Stephen M/A-2460-2010	Rao, Stephen M/0000-0002-6463-7460; Harrington, Deborah/0000-0001-9658-9080	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH051358, R01MH057836] Funding Source: NIH RePORTER; NCRR NIH HHS [M01 RR00058] Funding Source: Medline; NIMH NIH HHS [P01 MH51358, R01 MH57836] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; ARTIEDA J, 1992, BRAIN, V115, P199, DOI 10.1093/brain/115.1.199; Awh E, 1995, ANN NY ACAD SCI, V769, P97, DOI 10.1111/j.1749-6632.1995.tb38134.x; Baddeley A., 2007, WORKING MEMORY THOUG; Bower JM, 1997, PROG BRAIN RES, V114, P463; BRODAL P, 1979, NEUROSCIENCE, V4, P193, DOI 10.1016/0306-4522(79)90082-4; BROWN SW, 1985, PERCEPT PSYCHOPHYS, V38, P115, DOI 10.3758/BF03198848; BRUNIA CHM, 1988, ELECTROEN CLIN NEURO, V69, P234, DOI 10.1016/0013-4694(88)90132-0; Casini L, 1997, MEM COGNITION, V25, P812, DOI 10.3758/BF03211325; Casini L, 1999, NEUROPSYCHOLOGY, V13, P10, DOI 10.1037/0894-4105.13.1.10; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Desmond JE, 1997, J NEUROSCI, V17, P9675; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; GIBBON J, 1984, ANN NY ACAD SCI, V423, P52, DOI 10.1111/j.1749-6632.1984.tb23417.x; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13473, DOI 10.1073/pnas.93.24.13473; HALSBAND U, 1993, BRAIN, V116, P243, DOI 10.1093/brain/116.1.243; Harrington DL, 1998, NEUROPSYCHOLOGY, V12, P3, DOI 10.1037/0894-4105.12.1.3; Harrington DL, 1998, J NEUROSCI, V18, P1085; Harrington DL, 1999, REV NEUROSCIENCE, V10, P91, DOI 10.1515/REVNEURO.1999.10.2.91; Ivry R B, 1989, J Cogn Neurosci, V1, P136, DOI 10.1162/jocn.1989.1.2.136; Ivry RB, 1996, CURR OPIN NEUROBIOL, V6, P851, DOI 10.1016/S0959-4388(96)80037-7; IVRY RB, 1988, EXP BRAIN RES, V73, P167, DOI 10.1007/BF00279670; JUEPTNER M, 1995, NEUROLOGY, V45, P1540, DOI 10.1212/WNL.45.8.1540; Larsson J, 1996, NEUROREPORT, V7, P463, DOI 10.1097/00001756-199601310-00021; Lejeune H, 1997, NEUROSCI LETT, V235, P21, DOI 10.1016/S0304-3940(97)00698-8; Malapani C, 1998, J COGNITIVE NEUROSCI, V10, P316, DOI 10.1162/089892998562762; Malapani C, 1998, NEUROREPORT, V9, P3907, DOI 10.1097/00001756-199812010-00026; Mangels JA, 1998, COGNITIVE BRAIN RES, V7, P15, DOI 10.1016/S0926-6410(98)00005-6; Manto M, 1996, EUR NEUROL, V36, P333, DOI 10.1159/000117289; Maquet P, 1996, NEUROIMAGE, V3, P119, DOI 10.1006/nimg.1996.0014; MARICQ AV, 1983, PSYCHOPHARMACOLOGY, V79, P10, DOI 10.1007/BF00433008; Matell MS, 2000, BIOESSAYS, V22, P94, DOI 10.1002/(SICI)1521-1878(200001)22:1<94::AID-BIES14>3.0.CO;2-E; MECK WH, 1987, J NEUROSCI, V7, P3505; MECK WH, 1986, PHARMACOL BIOCHEM BE, V25, P1185, DOI 10.1016/0091-3057(86)90109-7; MOHL W, 1991, NEUROREPORT, V2, P309, DOI 10.1097/00001756-199106000-00002; NARABAYASHI H, 1985, CLIN NEUROPHYSIOL, P45; OBoyle DJ, 1996, BRAIN, V119, P51, DOI 10.1093/brain/119.1.51; PASTOR MA, 1992, BRAIN, V115, P875, DOI 10.1093/brain/115.3.875; Penhune VB, 1998, J COGNITIVE NEUROSCI, V10, P752, DOI 10.1162/089892998563149; POSNER MI, 1984, J NEUROSCI, V4, P1863; Prabhakaran V, 2000, NAT NEUROSCI, V3, P85, DOI 10.1038/71156; Rao SM, 1997, J NEUROSCI, V17, P5528; Schmahmann J. D., 1997, CEREBELLUM COGNITION; Smith EE, 1999, SCIENCE, V283, P1657, DOI 10.1126/science.283.5408.1657; Talairach J., 1988, COPLANAR STEREOTAXIC; Wearden JH, 1999, BEHAV PROCESS, V45, P3, DOI 10.1016/S0376-6357(99)00006-6; Zakay D., 1996, ADV PSYCHOL, V115, P143, DOI [10.1016/S0166-4115(96)80057-4, DOI 10.1016/S0166-4115(96)80057-4]	50	642	647	2	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					317	323		10.1038/85191	http://dx.doi.org/10.1038/85191			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405UE	11224550	Green Published			2022-12-24	WOS:000167178300021
J	Sereno, ME; Trinath, T; Augath, M; Logothetis, NK				Sereno, ME; Trinath, T; Augath, M; Logothetis, NK			Three-dimensional shape representation in monkey cortex	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; STRUCTURE-FROM-MOTION; VISUAL AREA MT; CORTICAL CONNECTIONS; RHESUS-MONKEY; INFEROTEMPORAL CORTEX; SURFACE ORIENTATION; POLYSENSORY AREA; MACAQUE; NEURONS	Using fMRI in anesthetized monkeys, this study investigates how the primate visual system constructs representations of three-dimensional (3D) shape from a variety of cues. Computer-generated 3D objects defined by shading, random dots, texture elements, or silhouettes were presented either statically or dynamically (rotating). Results suggest that 3D shape representations are highly localized, although widely distributed, in occipital, temporal, parietal, and frontal cortices and may involve common brain regions regardless of shape cue. This distributed network of areas cuts across both "what" and "where" processing streams, reflecting multiple uses for 3D shape representation in perception, recognition, and action.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany	University of Oregon; Max Planck Society	Sereno, ME (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.	margaret.sereno@tuebingen.mpg.de	Logothetis, Nikos/U-9282-2019					ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; BAYLIS GC, 1987, J NEUROSCI, V7, P330; BOUSSAOUD D, 1990, J COMP NEUROL, V296, P462, DOI 10.1002/cne.902960311; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; BRUCE C, 1981, J NEUROPHYSIOL, V46, P369, DOI 10.1152/jn.1981.46.2.369; BURKE DS, 1986, ARBOVIRUSES EPIDEMIO, V3, P63; CUTTING JE, 1984, J EXP PSYCHOL GEN, V113, P198, DOI 10.1037/0096-3445.113.2.198; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DISTLER C, 1993, J COMP NEUROL, V334, P125, DOI 10.1002/cne.903340111; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Gibson JJ, 1950, PERCEPTION VISUAL WO; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Janssen P, 2000, SCIENCE, V288, P2054, DOI 10.1126/science.288.5473.2054; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; Kourtzi Z, 2002, NAT NEUROSCI, V5, P17, DOI 10.1038/nn780; Lewis JW, 2000, J COMP NEUROL, V428, P79, DOI 10.1002/1096-9861(20001204)428:1<79::AID-CNE7>3.0.CO;2-Q; LOGOTHETIS NK, 1995, CEREB CORTEX, V5, P270, DOI 10.1093/cercor/5.3.270; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Lyon DC, 2001, J NEUROSCI, V21, P249, DOI 10.1523/JNEUROSCI.21-01-00249.2001; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MISTLIN AJ, 1990, EXP BRAIN RES, V82, P437; Moore C, 2001, NEURON, V29, P277, DOI 10.1016/S0896-6273(01)00197-0; MOREL A, 1990, VISUAL NEUROSCI, V4, P555, DOI 10.1017/S0952523800005769; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; O Scalaidhe SP, 1999, CEREB CORTEX, V9, P459, DOI 10.1093/cercor/9.5.459; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Oram MW, 1996, J NEUROPHYSIOL, V76, P109, DOI 10.1152/jn.1996.76.1.109; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PETRIDES M, 1984, J COMP NEUROL, V228, P105, DOI 10.1002/cne.902280110; Ringach DL, 1996, VISION RES, V36, P1479, DOI 10.1016/0042-6989(95)00285-5; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; Saleem KS, 2000, J NEUROSCI, V20, P5083; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SCHALL JD, 1995, J NEUROSCI, V15, P4464; SELEMON LD, 1988, J NEUROSCI, V8, P4049; SELTZER B, 1989, J COMP NEUROL, V290, P451, DOI 10.1002/cne.902900402; Seltzer B, 1996, J COMP NEUROL, V370, P173, DOI 10.1002/(SICI)1096-9861(19960624)370:2<173::AID-CNE4>3.0.CO;2-#; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; SELTZER B, 1989, J COMP NEUROL, V281, P97, DOI 10.1002/cne.902810108; SELTZER B, 1978, BRAIN RES, V149, P1, DOI 10.1016/0006-8993(78)90584-X; Sereno AB, 1998, NATURE, V395, P500, DOI 10.1038/26752; Sereno M. E., 1993, NEURAL COMPUTATION P; Sereno ME, 1999, J EXP PSYCHOL HUMAN, V25, P1834; Taira M, 2000, J NEUROPHYSIOL, V83, P3140, DOI 10.1152/jn.2000.83.5.3140; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tehovnik EJ, 2000, BRAIN RES REV, V32, P413, DOI 10.1016/S0165-0173(99)00092-2; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Van Essen DC, 2001, VISION RES, V41, P1359, DOI 10.1016/S0042-6989(01)00045-1; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; WEBSTER MJ, 1994, CEREB CORTEX, V4, P470, DOI 10.1093/cercor/4.5.470; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452	65	133	135	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					635	652		10.1016/S0896-6273(02)00598-6	http://dx.doi.org/10.1016/S0896-6273(02)00598-6			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856536	Bronze			2022-12-24	WOS:000173911100015
J	Gisselmann, G; Pusch, H; Hovemann, BT; Hatt, H				Gisselmann, G; Pusch, H; Hovemann, BT; Hatt, H			Two cDNAs coding for histamine-gated ion channels in D-melanogaster	NATURE NEUROSCIENCE			English	Article							CHLORIDE CHANNEL; DROSOPHILA; RECEPTORS; CELLS		Ruhr Univ Bochum, Lehrstuhl Zellphysiol, D-44780 Bochum, Germany; Ruhr Univ Bochum, AG Mol Zellbiochem, D-44780 Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Univ Str 150, D-44780 Bochum, Germany.							Cully DF, 1996, J BIOL CHEM, V271, P20187, DOI 10.1074/jbc.271.33.20187; FFRENCHCONSTANT RH, 1991, P NATL ACAD SCI USA, V88, P7209, DOI 10.1073/pnas.88.16.7209; HARDIE RC, 1988, J EXP BIOL, V138, P221; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HASHEMZADEHGARGARI H, 1992, J NEUROPHYSIOL, V68, P9, DOI 10.1152/jn.1992.68.1.9; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; Melzig J, 1998, J NEUROSCI, V18, P7160; ORTELLS MO, 1995, TRENDS NEUROSCI, V18, P121, DOI 10.1016/0166-2236(95)93887-4; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; SCHWARTZ JC, 1991, PHYSIOL REV, V71, P1, DOI 10.1152/physrev.1991.71.1.1; SKINGSLEY DR, 1995, J COMP PHYSIOL A, V176, P611, DOI 10.1007/BF01021581; Stuart AE, 1999, NEURON, V22, P431, DOI 10.1016/S0896-6273(00)80699-6; van der Goot H, 2000, EUR J MED CHEM, V35, P5, DOI 10.1016/S0223-5234(00)00101-X; Wetzel CH, 1999, J NEUROSCI, V19, P7426, DOI 10.1523/JNEUROSCI.19-17-07426.1999	15	107	112	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					11	12		10.1038/nn787	http://dx.doi.org/10.1038/nn787			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753412				2022-12-24	WOS:000173031800006
J	Xiao, ZJ; Suga, N				Xiao, ZJ; Suga, N			Modulation of cochlear hair cells by the auditory cortex in the mustached bat	NATURE NEUROSCIENCE			English	Article							CROSSED OLIVOCOCHLEAR BUNDLE; MIDBRAIN FREQUENCY MAP; PTERONOTUS-P-PARNELLII; MOUSTACHED BAT; INFERIOR COLLICULUS; CORTICOFUGAL MODULATION; ELECTRICAL-STIMULATION; NERVE RESPONSE; SYSTEM; MECHANICS	The corticofugal (descending) auditory system forms multiple feedback loops, and adjusts and improves auditory signal processing in the subcortical auditory nuclei. However, the mechanism by which the corticofugal system modulates cochlear hair cells has been unexplored. We found that electric stimulation of cortical neurons via the corticofugal system modulates cochlear hair cells in a highly specific way according to the relationship in terms of best frequency between cortical neurons and hair cells. Such frequency-specific effects can be explained by selective corticofugal modulation of individual olivocochlear efferent fibers.	Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Suga, N (corresponding author), Washington Univ, Dept Biol, 1 Brookings Dr, St Louis, MO 63130 USA.				NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000175] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-00175] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BISHOP AL, 1987, HEARING RES, V31, P175, DOI 10.1016/0378-5955(87)90124-9; DESMEDT JE, 1961, NATURE, V193, P1263; DEWSON JH, 1968, J NEUROPHYSIOL, V31, P122, DOI 10.1152/jn.1968.31.1.122; DOLAN DF, 1988, J ACOUST SOC AM, V83, P1081, DOI 10.1121/1.396052; GAIONI SJ, 1990, J NEUROPHYSIOL, V64, P1801, DOI 10.1152/jn.1990.64.6.1801; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; GEISLER CD, 1974, J ACOUST SOC AM, V56, P1908, DOI 10.1121/1.1903532; Goldberg RL, 1998, HEARING RES, V122, P71, DOI 10.1016/S0378-5955(98)00078-1; GOLDMAN LJ, 1977, BEHAV ECOL SOCIOBIOL, V2, P411, DOI 10.1007/BF00299509; HENSON OW, 1972, PHYSIOL BEHAV, V8, P1185, DOI 10.1016/0031-9384(72)90220-X; HENSON OW, 1982, HEARING RES, V7, P127, DOI 10.1016/0378-5955(82)90010-7; Henson OW., 1980, ANIMAL SONAR SYSTEMS, P913, DOI [10.1007/978-1-4684-7254-7_56, DOI 10.1007/978-1-4684-7254-7_56]; HUFFMAN RF, 1990, BRAIN RES REV, V15, P295, DOI 10.1016/0165-0173(90)90005-9; HUFFMAN RF, 1991, HEARING RES, V56, P79, DOI 10.1016/0378-5955(91)90156-4; HUFFMAN RF, 1993, J COMP PHYSIOL A, V171, P725, DOI 10.1007/BF00213069; KAWASE T, 1993, J NEUROPHYSIOL, V70, P2533, DOI 10.1152/jn.1993.70.6.2533; Khalfa S, 2001, NEUROSCIENCE, V104, P347, DOI 10.1016/S0306-4522(01)00072-0; Liu W, 1997, J COMP PHYSIOL A, V181, P599, DOI 10.1007/s003590050143; Ma XF, 2001, J NEUROPHYSIOL, V85, P1078, DOI 10.1152/jn.2001.85.3.1078; Maison S, 2001, PSYCHOPHYSIOLOGY, V38, P35, DOI 10.1017/S0048577201990109; MANABE T, 1978, SCIENCE, V200, P339, DOI 10.1126/science.635594; MOUNTAIN DC, 1980, SCIENCE, V210, P71, DOI 10.1126/science.7414321; Mulders WHA, 2000, HEARING RES, V149, P11, DOI 10.1016/S0378-5955(00)00157-X; NIEDER P, 1970, NATURE, V227, P184, DOI 10.1038/227184a0; OATMAN LC, 1977, EXP NEUROL, V57, P200, DOI 10.1016/0014-4886(77)90057-7; OLSEN JF, 1991, J NEUROPHYSIOL, V65, P1275, DOI 10.1152/jn.1991.65.6.1275; POLLAK G, 1972, SCIENCE, V176, P66, DOI 10.1126/science.176.4030.66; PUEL JL, 1988, BRAIN RES, V447, P380, DOI 10.1016/0006-8993(88)91144-4; RAJAN R, 1990, BRAIN RES, V506, P192, DOI 10.1016/0006-8993(90)91251-B; RIQUIMAROUX H, 1991, SCIENCE, V251, P565, DOI 10.1126/science.1990432; SCHNITZLER HU, 1970, Z VERGL PHYSIOL, V68, P25, DOI 10.1007/BF00297809; SIEGEL JH, 1982, HEARING RES, V6, P171, DOI 10.1016/0378-5955(82)90052-1; SUGA N, 1987, J NEUROPHYSIOL, V58, P643, DOI 10.1152/jn.1987.58.4.643; SUGA N, 1975, J EXP BIOL, V62, P277; SUGA N, 1982, J NEUROPHYSIOL, V47, P225, DOI 10.1152/jn.1982.47.2.225; SUGA N, 1985, J NEUROPHYSIOL, V53, P1109, DOI 10.1152/jn.1985.53.4.1109; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; SUGA N, 1977, J EXP BIOL, V69, P207; Warr WB, 1992, MAMMALIAN AUDITORY P, P410; WIEDERHOLD ML, 1970, J ACOUST SOC AM, V48, P966, DOI 10.1121/1.1912235; Xie DH, 1998, HEARING RES, V124, P60, DOI 10.1016/S0378-5955(98)00122-1; Yan J, 1996, SCIENCE, V273, P1100, DOI 10.1126/science.273.5278.1100; Yan W, 1998, NAT NEUROSCI, V1, P54, DOI 10.1038/255; Zhang YF, 1997, NATURE, V387, P900, DOI 10.1038/43180; Zhang YF, 2000, J NEUROPHYSIOL, V84, P325, DOI 10.1152/jn.2000.84.1.325; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489	47	128	130	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					57	63		10.1038/nn786	http://dx.doi.org/10.1038/nn786			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753417				2022-12-24	WOS:000173031800016
J	Op de Beeck, H; Wagemans, J; Vogels, R				Op de Beeck, H; Wagemans, J; Vogels, R			Inferotemporal neurons represent low-dimensional configurations of parameterized shapes	NATURE NEUROSCIENCE			English	Article							INFERIOR TEMPORAL NEURONS; SIMILARITY; RECOGNITION; SENSITIVITY; COMPONENTS; NETWORK; CORTEX; CELLS	Behavioral studies with parameterized shapes have shown that the similarities among these complex stimuli can be represented using a low number of dimensions. Using psychophysical measurements and single-cell recordings in macaque inferotemporal (IT) cortex, we found an agreement between low-dimensional parametric configurations of shapes and the representation of shape similarity at the behavioral and neuronal level. The shape configurations, computed from both the perceived and neuron-based similarities, revealed a low number of dimensions and contained the same stimulus order as the parametric configurations. However, at a metric level, the behavioral and neural representations deviated consistently from the parametric configurations. These findings suggest an ordinally faithful but metrically biased representation of shape similarity in IT.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, B-3000 Louvain, Belgium; Katholieke Univ Leuven, Expt Psychol Lab, B-3000 Louvain, Belgium	KU Leuven; KU Leuven	Vogels, R (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, B-3000 Louvain, Belgium.	rufin.vogels@med.kuleuven.ac.be	Rohlf, F J/A-8710-2008; Wagemans, Johan/M-3878-2019	Wagemans, Johan/0000-0002-7970-1541; Op de Beeck, Hans/0000-0002-2250-212X				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; ASHBY FG, 1988, PSYCHOL REV, V95, P124, DOI 10.1037/0033-295X.95.1.124; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BORG I, 1985, MULTIVAR BEHAV RES, V20, P325, DOI 10.1207/s15327906mbr2003_6; Cortese JM, 1996, J EXP PSYCHOL HUMAN, V22, P133, DOI 10.1037/0096-1523.22.1.133; CORTESE JM, 1992, PERCEPTUAL SIMILARIT; Cutzu F, 1998, VISION RES, V38, P2229, DOI 10.1016/S0042-6989(97)00186-7; DEAN P, 1976, PSYCHOL BULL, V83, P41, DOI 10.1037/0033-2909.83.1.41; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Edelman GM, 1987, NEURAL DARWINISM THE; Edelman S, 1998, BEHAV BRAIN SCI, V21, P449, DOI 10.1017/S0140525X98001253; Edelman S., 1999, REPRESENTATION RECOG; Freedman DJ, 2001, SCIENCE, V291, P312, DOI 10.1126/science.291.5502.312; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Gross CG, 1990, P INT C FUZZ LOG NEU, P375; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Marr D., 1982, VISION COMPUTATIONAL; Murray EA, 2000, EXP BRAIN RES, V133, P114, DOI 10.1007/s002210000406; NOSOFSKY RM, 1984, J EXP PSYCHOL LEARN, V10, P104, DOI 10.1037/0278-7393.10.1.104; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POGGIO T, 1990, SCIENCE, V247, P978, DOI 10.1126/science.247.4945.978; POGGIO T, 1990, NATURE, V343, P263, DOI 10.1038/343263a0; Rieke F., 1997, SPIKES EXPLORING NEU; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; SANDS SF, 1982, J EXP PSYCHOL GEN, V111, P369, DOI 10.1037/0096-3445.111.4.369; SHEPARD RN, 1980, SCIENCE, V210, P390, DOI 10.1126/science.210.4468.390; SHEPARD RN, 1973, COGNITIVE PSYCHOL, V4, P351, DOI 10.1016/0010-0285(73)90018-2; SHEPARD RN, 1987, SCIENCE, V237, P1317, DOI 10.1126/science.3629243; Smith EE, 1981, CATEGORIES CONCEPTS; Sugihara T, 1998, BIOL CYBERN, V78, P1, DOI 10.1007/s004220050407; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; Vogels R, 1999, EUR J NEUROSCI, V11, P1239, DOI 10.1046/j.1460-9568.1999.00531.x; Vogels R, 2001, J COGNITIVE NEUROSCI, V13, P444, DOI 10.1162/08989290152001871; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wilkinson F, 1998, VISION RES, V38, P3555, DOI 10.1016/S0042-6989(98)00039-X; Wise SP, 1999, HIPPOCAMPUS, V9, P101, DOI 10.1002/(SICI)1098-1063(1999)9:2<101::AID-HIPO3>3.0.CO;2-L; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; ZAHN CT, 1972, IEEE T COMPUT, VC 21, P269, DOI 10.1109/TC.1972.5008949	46	190	191	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1244	1252		10.1038/nn767	http://dx.doi.org/10.1038/nn767			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11713468	Green Published			2022-12-24	WOS:000172525000022
J	Zhou, FM; Liang, Y; Dani, JA				Zhou, FM; Liang, Y; Dani, JA			Endogenous nicotinic cholinergic activity regulates dopamine release in the striatum	NATURE NEUROSCIENCE			English	Article							ACETYLCHOLINE-RECEPTORS; NUCLEUS-ACCUMBENS; CIGARETTE-SMOKING; BRAIN; SCHIZOPHRENIA; MICRODIALYSIS; DIVERSITY; NEURONS; REWARD; PHARMACOLOGY	Dopamine is vital for coordinated motion and for association learning linked to behavioral reinforcement. Here we show that the precise overlap of striatal dopaminergic and cholinergic fibers underlies potent control of dopamine release by ongoing nicotinic receptor activity. In mouse striatal slices, nicotinic antagonists or depletion of endogenous acetylcholine decreased evoked dopamine release by 90%. Nicotine at the concentration experienced by smokers also regulated dopamine release. In mutant mice lacking the beta2 nicotinic subunit, evoked dopamine release was dramatically suppressed, and those mice did not show cholinergic regulation of dopamine release. The results offer new perspectives when considering nicotine addiction and the high prevalence of smoking in schizophrenics.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS021229, R01NS021229, R23NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA012661, R01DA009411] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12661, DA09411] Funding Source: Medline; NINDS NIH HHS [NS21229] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; Adler LE, 1998, SCHIZOPHRENIA BULL, V24, P189, DOI 10.1093/oxfordjournals.schbul.a033320; ADLER LE, 1993, AM J PSYCHIAT, V150, P1856; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; ANDEN NE, 1966, ACTA PHYSIOL SCAND, V67, P306, DOI 10.1111/j.1748-1716.1966.tb03317.x; AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; Balfour DJK, 2000, BEHAV BRAIN RES, V113, P73, DOI 10.1016/S0166-4328(00)00202-3; Bennett BD, 1999, J NEUROSCI, V19, P5586; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; BJORKLUND A, 1984, CLASSICAL TRANSMIT 1, P55; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; BUTCHER LL, 1984, CLASSICAL TRANSMITTE, P1; CHANG HT, 1988, BRAIN RES BULL, V21, P295, DOI 10.1016/0361-9230(88)90244-4; Colquhoun L M, 1997, Adv Pharmacol, V39, P191, DOI 10.1016/S1054-3589(08)60072-1; Dalack GW, 1998, AM J PSYCHIAT, V155, P1490, DOI 10.1176/ajp.155.11.1490; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Dani JA, 2001, NEURON, V31, P349, DOI 10.1016/S0896-6273(01)00379-8; Descarries L, 1997, PROG NEUROBIOL, V53, P603, DOI 10.1016/S0301-0082(97)00050-6; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Fenster CP, 1997, J NEUROSCI, V17, P5747; Garris PA, 1999, NATURE, V398, P67, DOI 10.1038/18019; Grace AA, 2000, BRAIN RES REV, V31, P330, DOI 10.1016/S0165-0173(99)00049-1; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; HENNINGFIELD JE, 1993, DRUG ALCOHOL DEPEN, V33, P23, DOI 10.1016/0376-8716(93)90030-T; HILL JA, 1993, J NEUROSCI, V13, P1551; HODGE AS, 1992, MOL PHARMACOL, V41, P937; Johnson JH, 2000, BRAIN RES BULL, V51, P249, DOI 10.1016/S0361-9230(99)00226-9; Jones IW, 2001, J COMP NEUROL, V439, P235, DOI 10.1002/cne.1345; Kalivas PW, 1999, CURR OPIN NEUROBIOL, V9, P223, DOI 10.1016/S0959-4388(99)80031-2; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617; Lang AE, 1998, NEW ENGL J MED, V339, P1130, DOI 10.1056/NEJM199810153391607; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Marshall DL, 1997, J NEUROCHEM, V68, P1511; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; PARSONS LH, 1992, J NEUROCHEM, V58, P212, DOI 10.1111/j.1471-4159.1992.tb09298.x; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; PRIOR C, 1992, GEN PHARMACOL, V23, P1017, DOI 10.1016/0306-3623(92)90280-W; Rezvani AH, 2001, BIOL PSYCHIAT, V49, P258, DOI 10.1016/S0006-3223(00)01094-5; SACAAN AI, 1995, J PHARMACOL EXP THER, V274, P224; SCHENK JO, 1982, BRAIN RES, V277, P1; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHWARTZ ML, 1993, J COMP NEUROL, V327, P48, DOI 10.1002/cne.903270105; SCHWARTZ RD, 1984, J NEUROCHEM, V42, P1495, DOI 10.1111/j.1471-4159.1984.tb02818.x; Vinson PN, 1997, J NEUROSCI METH, V73, P61, DOI 10.1016/S0165-0270(96)02213-3; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M; Wu Y, 2000, NEUROSCIENCE, V96, P65, DOI 10.1016/S0306-4522(99)00539-4; Xu W, 1999, J NEUROSCI, V19, P9298	48	411	416	1	18	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1224	1229		10.1038/nn769	http://dx.doi.org/10.1038/nn769			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713470				2022-12-24	WOS:000172525000019
J	Culham, JC; Cavanagh, P; Kanwisher, NG				Culham, JC; Cavanagh, P; Kanwisher, NG			Attention response functions: Characterizing brain areas using fMRI activation during parametric variations of attentional load	NEURON			English	Article							FRONTAL EYE-FIELD; POSITRON EMISSION TOMOGRAPHY; HUMAN VISUAL-CORTEX; SPATIAL ATTENTION; WORKING-MEMORY; CEREBRAL-CORTEX; SINGLE NEURONS; SACCADES; MOVEMENTS; MODULATION	We derived attention response functions for different cortical areas by plotting neural activity (measured by fMRI) as a function of attentional load in a visual tracking task. In many parietal and frontal cortical areas, activation increased with load over the entire range of loads tested, suggesting that these areas are directly involved in attentional processes. However, in other areas (FEF and parietal area 7), strong activation was observed even at the lowest attentional load (compared to a passive baseline using identical stimuli), but little or no additional activation was seen with increasing load. These latter areas appear to play a different role, perhaps supporting task-relevant functions that do not vary with load, such as the suppression of eye movements.	Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	Western University (University of Western Ontario); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Culham, JC (corresponding author), Univ Western Ontario, Dept Psychol, London, ON N6A 5C2, Canada.		Culham, Jody C./A-9863-2013	Culham, Jody C./0000-0003-0754-2999	NIMH NIH HHS [MH56037] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056037] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1989, NEUROBIOLOGY SACCADI; BIZZI E, 1968, EXP BRAIN RES, V6, P69; Broadbent D.E., 1958, PERCEPTION COMMUNICA; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Buchel C, 1996, NEUROIMAGE, V4, P60, DOI 10.1006/nimg.1996.0029; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; BUSH G, 1996, NEUROIMAGE, V3, pS55; Caminiti R, 1996, CEREB CORTEX, V6, P319, DOI 10.1093/cercor/6.3.319; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; CULHAM JC, 1997, SOC NEUR NEW ORL LA; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1976, VISION RES, V16, P99, DOI 10.1016/0042-6989(76)90083-3; INTRILIGATOR JM, 2001, IN PRESS COGNIT PSYC; INTRILIGATOR JM, 1997, SPATIAL RESOLUTION V; Klein R. M., 1980, ATTENTION PERFORM, P259, DOI DOI 10.1037/E665402011-424; KLEIN RM, 1994, ATTENTION PERFORM, V15, P333; Konishi S, 1998, NAT NEUROSCI, V1, P80, DOI 10.1038/283; LANG W, 1994, NEUROREPORT, V5, P921, DOI 10.1097/00001756-199404000-00017; McPeek RM, 2000, VISION RES, V40, P2499, DOI 10.1016/S0042-6989(00)00102-4; Olson C, 1993, NEUROBIOLOGY CINGULA, P366; Olson CR, 1996, J NEUROPHYSIOL, V76, P3285, DOI 10.1152/jn.1996.76.5.3285; Ono M, 1990, ATLAS CEREBRAL SULCI; PAUS T, 1995, J NEUROPHYSIOL, V74, P2179, DOI 10.1152/jn.1995.74.5.2179; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; PETIT L, 1995, EUR J NEUROSCI, V7, P169, DOI 10.1111/j.1460-9568.1995.tb01031.x; PRIORI A, 1993, BRAIN, V116, P355, DOI 10.1093/brain/116.2.355; PYLYSHYN Z, 1994, COGNITION, V50, P363, DOI 10.1016/0010-0277(94)90036-1; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; RIZZOLATTI G, 1994, ATTENTION PERFORM, V15, P231; SAKATA H, 1980, J NEUROPHYSIOL, V43, P1654, DOI 10.1152/jn.1980.43.6.1654; Schlaug G, 1996, NEUROREPORT, V7, P879, DOI 10.1097/00001756-199603220-00009; SEGRAVES MA, 1987, J NEUROPHYSIOL, V58, P1387, DOI 10.1152/jn.1987.58.6.1387; SHEPHERD M, 1986, Q J EXP PSYCHOL-A, V38, P475, DOI 10.1080/14640748608401609; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Somers DC, 1999, P NATL ACAD SCI USA, V96, P1663, DOI 10.1073/pnas.96.4.1663; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Talairach J., 1988, COPLANAR STEREOTAXIC; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treisman A., 1993, ATTENTION SELECTION, P5; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wojciulik E, 1999, NEURON, V23, P747, DOI 10.1016/S0896-6273(01)80033-7; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; YANTIS S, 1992, COGNITIVE PSYCHOL, V24, P295, DOI 10.1016/0010-0285(92)90010-Y	53	243	248	2	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					737	745		10.1016/S0896-6273(01)00499-8	http://dx.doi.org/10.1016/S0896-6273(01)00499-8			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	495WT	11719212	Bronze			2022-12-24	WOS:000172363900018
J	Murthy, VN; Schikorski, T; Stevens, CF; Zhu, YL				Murthy, VN; Schikorski, T; Stevens, CF; Zhu, YL			Inactivity produces increases in neurotransmitter release and synapse size	NEURON			English	Article							BARREL FIELD CORTEX; HIPPOCAMPAL SYNAPSES; DENDRITIC SPINES; QUANTAL ANALYSIS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS; NEURONS; RECEPTOR; AMPA; EXPRESSION	When hippocampal synapses in culture are pharmacologically silenced for several days, synaptic strength increases. The structural correlate of this change in strength is an increase in the size of the synapses, with all synaptic components-active zone, postsynaptic density, and bouton-becoming larger. Further, the number of docked vesicles and the total number of vesicles per synapse increases, although the number of docked vesicles per area of active zone is unchanged. In parallel with these anatomical changes, the physiologically measured size of the readily releasable pool (RRP) and the release probability are increased. Ultrastructural analysis of individual synapses in which the RRP was previously measured reveals that, within measurement error, the same number of vesicles are docked as are estimated to be in the RRP.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Harvard University; Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Schikorski, Thomas/0000-0003-3902-2461; Murthy, Venkatesh/0000-0003-2443-4252				ALLEN C, 1994, P NATL ACAD SCI USA, V91, P10380, DOI 10.1073/pnas.91.22.10380; Bacci A, 2001, J NEUROSCI, V21, P6588, DOI 10.1523/JNEUROSCI.21-17-06588.2001; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Benson DL, 1996, J NEUROSCI, V16, P6424; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Cannon WB, 1939, AM J MED SCI, V198, P737, DOI 10.1097/00000441-193912000-00001; Casey DE, 2000, J CLIN PSYCHIAT, V61, P5; CLARK CV, 1989, EYE, V3, P349, DOI 10.1038/eye.1989.50; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Craig AM, 1998, NEURON, V21, P459, DOI 10.1016/S0896-6273(00)80555-3; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; DUCLERT A, 1995, PHYSIOL REV, V75, P339, DOI 10.1152/physrev.1995.75.2.339; FAMBROUGH DM, 1970, SCIENCE, V168, P372, DOI 10.1126/science.168.3929.372; GRAMPP W, 1972, J PHYSIOL-LONDON, V221, P743, DOI 10.1113/jphysiol.1972.sp009780; GULYAS AI, 1993, NATURE, V366, P683, DOI 10.1038/366683a0; Hanse E, 2001, J PHYSIOL-LONDON, V531, P467, DOI 10.1111/j.1469-7793.2001.0467i.x; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; Kirov SA, 1999, NAT NEUROSCI, V2, P878, DOI 10.1038/13178; KORN H, 1991, TRENDS NEUROSCI, V14, P439, DOI 10.1016/0166-2236(91)90042-S; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mackinnon P, 2000, AUSTRALAS J AGEING, V19, P3; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MICHEVA KD, 1995, P NATL ACAD SCI USA, V92, P11834, DOI 10.1073/pnas.92.25.11834; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nusser Z, 1998, J NEUROSCI, V18, P1693; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1997, NATURE, V388, P478, DOI 10.1038/41335; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Schikorski T, 1997, J NEUROSCI, V17, P5858; SHARPLESS SK, 1964, ANNU REV PHYSIOL, V26, P357, DOI 10.1146/annurev.ph.26.030164.002041; SHARPLESS SK, 1975, DEV NEUROPSYCHOL, P125; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7	52	451	457	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					673	682		10.1016/S0896-6273(01)00500-1	http://dx.doi.org/10.1016/S0896-6273(01)00500-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719207	Bronze			2022-12-24	WOS:000172363900013
J	Rotshtein, P; Malach, R; Hadar, U; Graif, M; Hendler, T				Rotshtein, P; Malach, R; Hadar, U; Graif, M; Hendler, T			Feeling or features: Different sensitivity to emotion in high-order visual cortex and amygdala	NEURON			English	Article							OBJECT-PROCESSING STAGES; FACIAL EXPRESSIONS; NEURAL MECHANISMS; AVERSIVE STIMULI; RECOGNITION; AREAS; ACTIVATION; PROSOPAGNOSIA; PERCEPTION; NEURONS	Emotionally loaded visual stimuli have shown increased activation in visual and cortex limbic areas. However, differences in visual features of such images could confound these findings. In order to manipulate valence of stimuli while keeping visual features largely unchanged, we took advantage of an "expressional transfiguration" (ET) effect of faces. In addition, we used repetition effects, which enabled us to test more incisively the impact of the ET effect. Using the ET manipulation, we have shown that the activation in lateral occipital complex (LOC) was unaffected by valence attributes, but produced significant modulation of fMR adaptation. Contrary to LOC, amygdala activation was increased by ET manipulation unrelated to the adaptation. A correlation between amygdala and LOC adaptation points to a possible modulatory role of the amygdala upon visual cortex short-term plasticity.	Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel; Tel Aviv Univ, Fac Med, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Tel Aviv University; Weizmann Institute of Science	Hendler, T (corresponding author), Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel.	talma@tasmc.health.gov.il	hendler, talma/C-7677-2012	Rotshtein, Pia/0000-0002-0301-9511				ADOLPHS R, 1995, J NEUROSCI, V15, P5879; ADOLPHS R, 1994, NATURE, V372, P669, DOI 10.1038/372669a0; Aggleton J.P., 2000, SER AFFECTIVE SCI, P106; AMARAL D G, 1992, P1; Anderson AK, 2001, NATURE, V411, P305, DOI 10.1038/35077083; [Anonymous], 2000, SER AFFECTIVE SCI; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; BARTLETT JC, 1993, COGNITIVE PSYCHOL, V25, P281, DOI 10.1006/cogp.1993.1007; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; Bechara A, 1999, J NEUROSCI, V19, P5473; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; BORDI F, 1992, J NEUROSCI, V12, P2493; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; BROADBEN.DE, 1967, NATURE, V215, P581, DOI 10.1038/215581a0; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burt DM, 1997, NEUROPSYCHOLOGIA, V35, P685, DOI 10.1016/S0028-3932(96)00111-X; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Carmon A., 1978, ASYMMETRICAL FUNCTIO, P86; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Critchley H, 2000, HUM BRAIN MAPP, V9, P93, DOI 10.1002/(SICI)1097-0193(200002)9:2<93::AID-HBM4>3.3.CO;2-Q; Critchley HD, 2000, J NEUROSCI, V20, P3033; DAVIS M, 1992, ANNU REV NEUROSCI, V15, P353, DOI 10.1146/annurev.neuro.15.1.353; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Gelder B, 2000, BRAIN COGNITION, V44, P425, DOI 10.1006/brcg.1999.1203; Derryberry D, 1994, HEARTS EYE EMOTIONAL, P166; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DOLAN RJ, 2000, SER AFFECTIVE SCI, P225; Fischer H, 2000, NEUROREPORT, V11, P123, DOI 10.1097/00001756-200001170-00024; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 2000, P NATL ACAD SCI USA, V97, P7591, DOI 10.1073/pnas.97.13.7591; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Goebel R, 1998, NEUROREPORT, V9, P713, DOI 10.1097/00001756-199803090-00028; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2001, ACTA PSYCHOL, V107, P293, DOI 10.1016/S0001-6918(01)00019-1; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; ISHAI A, 1997, NEUROIMAGE, V5, pS149; Jiang Y, 2000, SCIENCE, V287, P643, DOI 10.1126/science.287.5453.643; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kosslyn SM, 1996, NEUROREPORT, V7, P1569, DOI 10.1097/00001756-199607080-00007; LABAR KS, 1995, J NEUROSCI, V15, P6846; Lane R., 1997, NEUROIMAGE, V5, pS115; Lane R.D., 2000, COGNITIVE NEUROSCIEN; Lane RD, 1997, NEUROPSYCHOLOGIA, V35, P1437, DOI 10.1016/S0028-3932(97)00070-5; Lane RD, 1999, NEUROPSYCHOLOGIA, V37, P989, DOI 10.1016/S0028-3932(99)00017-2; LANG PJ, 1995, AM PSYCHOL, V50, P372, DOI 10.1037/0003-066X.50.5.372; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; LANG PJ, 1996, NEUROIMAGE, V3, pS231; LEDOUX J, 2000, SER AFFECTIVE SCI, P129; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Levy I, 2001, NAT NEUROSCI, V4, P533, DOI 10.1038/87490; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MILLER EK, 1993, J NEUROSCI, V13, P1460; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Morris JS, 1998, BRAIN, V121, P47, DOI 10.1093/brain/121.1.47; Moscovitch M, 2000, COGNITIVE NEUROPSYCH, V17, P201, DOI 10.1080/026432900380571; NEBES RD, 1978, ASYMMETRICAL FUNCTIO, P99; Ohman A, 1974, Biol Psychol, V2, P85, DOI 10.1016/0301-0511(74)90017-9; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; Pizzagalli D, 1998, NEUROPSYCHOLOGIA, V36, P323, DOI 10.1016/S0028-3932(97)00117-6; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; ROLLS ET, 1977, BRAIN RES, V130, P229, DOI 10.1016/0006-8993(77)90272-4; Rolls ET, 2000, NEURON, V27, P205, DOI 10.1016/S0896-6273(00)00030-1; ROLLS ET, 1999, BRAIN EMOTION; Royet JP, 2000, J NEUROSCI, V20, P7752; SERGENT J, 1989, BRAIN, V112, P975, DOI 10.1093/brain/112.4.975; Sergent J., 1994, VIS COGN, V1, P349, DOI [10.1080/13506289408402305, DOI 10.1080/13506289408402305]; SILBERMAN EK, 1986, BRAIN COGNITION, V5, P322, DOI 10.1016/0278-2626(86)90035-7; Sugase Y, 1999, NATURE, V400, P869, DOI 10.1038/23703; Talairach J., 1988, COPLANAR STEREOTAXIC; Taylor SF, 1998, NEUROIMAGE, V8, P188, DOI 10.1006/nimg.1998.0356; Taylor SF, 2000, NEUROPSYCHOLOGIA, V38, P1415, DOI 10.1016/S0028-3932(00)00032-4; THOMPSON P, 1980, PERCEPTION, V9, P483, DOI 10.1068/p090483; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9; TRANEL D, 1988, BEHAV BRAIN RES, V30, P235, DOI 10.1016/0166-4328(88)90166-0; WATT CA, 1995, PERS INDIV DIFFER, V19, P635, DOI 10.1016/0191-8869(95)00102-C; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; YOUNG AW, 1993, BRAIN, V116, P941, DOI 10.1093/brain/116.4.941; Young AW, 1996, NEUROPSYCHOLOGIA, V34, P31, DOI 10.1016/0028-3932(95)00062-3; YOUNG AW, 1995, BRAIN, V118, P15, DOI 10.1093/brain/118.1.15	87	120	124	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					747	757		10.1016/S0896-6273(01)00513-X	http://dx.doi.org/10.1016/S0896-6273(01)00513-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	495WT	11719213	Bronze			2022-12-24	WOS:000172363900019
J	Wachowiak, M; Cohen, LB				Wachowiak, M; Cohen, LB			Representation of odorants by receptor neuron input to the mouse olfactory bulb	NEURON			English	Article							PRESYNAPTIC INHIBITION; RESPONSE PROPERTIES; GLOMERULAR LAYER; RAT; DISCRIMINATION; COMBINATORIAL; ORGANIZATION; TOPOGRAPHY; EXPRESSION; STIMULUS	To visualize odorant representations by receptor neuron input to the mouse olfactory bulb, we loaded receptor neurons with calcium-sensitive dye and imaged odorant-evoked responses from their axon terminals. Fluorescence increases reflected activation of receptor neuron populations converging onto individual glomeruli. We report several findings. First, five glomeruli were identifiable across animals based on their location and odorant responsiveness; all five showed complex response specificities. Second, maps of input were chemotopically organized at near-threshold concentrations but, at moderate concentrations, involved many widely distributed glomeruli. Third, the dynamic range of input to a glomerulus was greater than that reported for individual receptor neurons. Finally, odorant activation slopes could differ across glomeruli, and for different odorants activating the same glomerulus. These results imply a high degree of complexity in odorant representations at the level of olfactory bulb input.	Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; Marine Biol Lab, Woods Hole, MA 02543 USA	Yale University; Marine Biological Laboratory - Woods Hole	Wachowiak, M (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, 333 Cedar St, New Haven, CT 06520 USA.	matt.wachowiak@yale.edu			NIDCD NIH HHS [DC00378-03, DC05259] Funding Source: Medline; NINDS NIH HHS [NS08437] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS008437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005259, R56DC005259] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ADAMEK GD, 1984, BRAIN RES, V310, P87, DOI 10.1016/0006-8993(84)90012-X; ADRIAN ED, 1953, ACTA PHYSIOL SCAND, V29, P5, DOI 10.1111/j.1748-1716.1953.tb00990.x; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; Aroniadou-Anderjaska V, 2000, J NEUROPHYSIOL, V84, P1194, DOI 10.1152/jn.2000.84.3.1194; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; Bodyak N, 1999, CHEM SENSES, V24, P637, DOI 10.1093/chemse/24.6.637; Bozza TC, 1998, J NEUROSCI, V18, P4560; Cleland TA, 1999, NEURAL COMPUT, V11, P1673, DOI 10.1162/089976699300016188; Duchamp-Viret P, 2000, J NEUROSCI, V20, P2383; FIRESTEIN S, 1993, J PHYSIOL-LONDON, V468, P1; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; GUTHRIE KM, 1993, P NATL ACAD SCI USA, V90, P3329, DOI 10.1073/pnas.90.8.3329; Hsia AY, 1999, J NEUROPHYSIOL, V82, P1082, DOI 10.1152/jn.1999.82.2.1082; JASPER JR, 1992, BIOCHEM PHARMACOL, V43, P119, DOI 10.1016/0006-2952(92)90268-N; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; KAUER JS, 1991, TRENDS NEUROSCI, V14, P79, DOI 10.1016/0166-2236(91)90025-P; Kent PF, 1996, J NEUROSCI, V16, P345; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Lam YW, 2000, J NEUROSCI, V20, P749, DOI 10.1523/JNEUROSCI.20-02-00749.2000; LAMANTIA AS, 1992, J NEUROSCI, V12, P976; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Meister M, 2001, J NEUROSCI, V21, P1351; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; ODONOVAN MJ, 1993, J NEUROSCI METH, V46, P91, DOI 10.1016/0165-0270(93)90145-H; Rawson NE, 2000, J NEUROCHEM, V75, P185, DOI 10.1046/j.1471-4159.2000.0750185.x; Reisert J, 2001, J PHYSIOL-LONDON, V530, P113, DOI 10.1111/j.1469-7793.2001.0113m.x; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Schaefer ML, 2001, J NEUROSCI, V21, P2481, DOI 10.1523/JNEUROSCI.21-07-02481.2001; SHEPHERD GM, 1994, NEURON, V13, P771, DOI 10.1016/0896-6273(94)90245-3; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Strotmann J, 2000, J NEUROSCI, V20, P6927, DOI 10.1523/JNEUROSCI.20-18-06927.2000; Trotier Didier, 1994, Seminars in Cell Biology, V5, P47, DOI 10.1006/scel.1994.1007; Tsau Y, 1996, J NEUROSCI METH, V70, P121, DOI 10.1016/S0165-0270(96)00109-4; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; Wachowiak M, 1999, J NEUROSCI, V19, P8808, DOI 10.1523/JNEUROSCI.19-20-08808.1999; WACHOWIAK M, 2000, CHEM SENSES, V25, P675; Xu FQ, 2000, P NATL ACAD SCI USA, V97, P10601, DOI 10.1073/pnas.180321397; YAWS C, 1994, HDB VAPOR PRESSURES; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; YOUNGENTOB SL, 1990, PHYSIOL BEHAV, V47, P1053, DOI 10.1016/0031-9384(90)90352-5	45	360	366	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 20	2001	32	4					723	735		10.1016/S0896-6273(01)00506-2	http://dx.doi.org/10.1016/S0896-6273(01)00506-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719211	Bronze, Green Submitted			2022-12-24	WOS:000172363900017
J	Hashimoto, M; Rockenstein, E; Mante, M; Mallory, M; Masliah, E				Hashimoto, M; Rockenstein, E; Mante, M; Mallory, M; Masliah, E			beta-synuclein inhibits alpha-synuclein aggregation: A possible role as an anti-parkinsonian factor	NEURON			English	Article							ABNORMAL PROTEIN AGGREGATION; ALZHEIMERS-DISEASE; LEWY-BODY; NACP/ALPHA-SYNUCLEIN; OXIDATIVE STRESS; IN-VITRO; A-BETA; SELF-OLIGOMERIZATION; PRESYNAPTIC PROTEIN; PRECURSOR PROTEIN	We characterized beta -synuclein, the non-amyloidogenic homolog of alpha -synuclein, as an inhibitor of aggregation of alpha -synuclein, a molecule implicated in Parkinson's disease. For this, doubly transgenic mice expressing human (h)alpha- and beta -synuclein were generated. In doubly transgenic mice, beta -synuclein ameliorated motor deficits, neurodegenerative alterations, and neuronal alpha -synuclein accumulation seen in h alpha -synuclein transgenic mice. Similarly, cell lines transfected with beta -synuclein were resistant to alpha -synuclein accumulation. h alpha -synuclein was coimmunoprecipitated with h beta -synuclein in the brains of doubly transgenic mice and in the double-transfected cell lines. Our results raise the possibility that beta -synuclein might be a natural negative regulator of alpha -synuclein aggregation and that a similar class of endogenous factors might regulate the aggregation state of other molecules involved in neurodegeneration. Such an anti-amyloidogenic property of beta -synuclein might also provide a novel strategy for the treatment of neurodegenerative disorders.	Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Masliah, E (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	emasliah@ucsd.edu			NATIONAL INSTITUTE ON AGING [R37AG018440, P50AG005131, R01AG010689, R01AG018440] Funding Source: NIH RePORTER; NIA NIH HHS [AG5131, AG10689, AG18440] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; El-Agnaf OMA, 2000, J STRUCT BIOL, V130, P300, DOI 10.1006/jsbi.2000.4262; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; Forloni G, 2000, ANN NEUROL, V47, P632, DOI 10.1002/1531-8249(200005)47:5<632::AID-ANA11>3.3.CO;2-E; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hashimoto M, 1999, BRAIN PATHOL, V9, P707; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; IWAI A, 1995, BIOCHEMISTRY-US, V34, P10139, DOI 10.1021/bi00032a006; Iwai A, 2000, BBA-MOL BASIS DIS, V1502, P95, DOI 10.1016/S0925-4439(00)00036-3; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jenner P, 1996, PATHOL BIOL, V44, P57; Jensen PH, 1997, BIOCHEM J, V323, P539, DOI 10.1042/bj3230539; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Jia TL, 1999, CANCER RES, V59, P742; Jo EJ, 2000, J BIOL CHEM, V275, P34328, DOI 10.1074/jbc.M004345200; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Masliah E, 1996, AM J PATHOL, V148, P201; Masliah E, 2001, P NATL ACAD SCI USA, V98, P12245, DOI 10.1073/pnas.211412398; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MASLIAH E, 1998, NEUROSCI NEWS, V1, P14; Masliah E., 2001, J ALZHEIMERS DIS, V3, P1; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; NAKAJO S, 1993, EUR J BIOCHEM, V217, P1057, DOI 10.1111/j.1432-1033.1993.tb18337.x; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; NOGUCHI CT, 1989, ANN NY ACAD SCI, V565, P75, DOI 10.1111/j.1749-6632.1989.tb24152.x; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Ostrerova-Golts N, 2000, J NEUROSCI, V20, P6048, DOI 10.1523/JNEUROSCI.20-16-06048.2000; Paik SR, 1999, BIOCHEM J, V340, P821, DOI 10.1042/0264-6021:3400821; Paik SR, 1998, FEBS LETT, V421, P73, DOI 10.1016/S0014-5793(97)01537-8; Perrin RJ, 2000, J BIOL CHEM, V275, P34393, DOI 10.1074/jbc.M004851200; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ramassamy C, 1999, FREE RADICAL BIO MED, V27, P544, DOI 10.1016/S0891-5849(99)00102-1; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; Rockenstein E, 2001, BRAIN RES, V914, P48, DOI 10.1016/S0006-8993(01)02772-X; ROCKENSTEIN EM, 1995, J BIOL CHEM, V270, P28257; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Surguchov A, 1999, MOL CELL NEUROSCI, V13, P95, DOI 10.1006/mcne.1999.0735; Tabrizi SJ, 2000, HUM MOL GENET, V9, P2683, DOI 10.1093/hmg/9.18.2683; Takeda A, 1998, AM J PATHOL, V152, P367; Takenouchi T, 2001, MOL CELL NEUROSCI, V17, P141, DOI 10.1006/mcne.2000.0923; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; YOSHIMOTO M, 1995, P NATL ACAD SCI USA, V92, P9141, DOI 10.1073/pnas.92.20.9141; Zhou WB, 2000, BRAIN RES, V866, P33, DOI 10.1016/S0006-8993(00)02215-0	60	333	352	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					213	223		10.1016/S0896-6273(01)00462-7	http://dx.doi.org/10.1016/S0896-6273(01)00462-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683992	Bronze			2022-12-24	WOS:000171893700007
J	Song, S; Abbott, LF				Song, S; Abbott, LF			Cortical development and remapping through spike timing-dependent plasticity	NEURON			English	Article							OCULAR DOMINANCE; SYNAPTIC PLASTICITY; PYRAMIDAL CELLS; BARREL CORTEX; EXPERIENCE; MAPS; REORGANIZATION; POTENTIATION; DEPRESSION; COINCIDENCE	Long-term modification of synaptic efficacy can depend on the timing of pre- and postsynaptic action potentials. In model studies, such spike timing-dependent plasticity (STDP) introduces the desirable features of competition among synapses and regulation of postsynaptic firing characteristics. STDP strengthens synapses that receive correlated input, which can lead to the formation of stimulus-selective columns and the development, refinement, and maintenance of selectivity maps in network models. The temporal asymmetry of STDP suppresses strong destabilizing self-excitatory loops and allows a group of neurons that become selective early in development to direct other neurons to become similarly selective. STDP, acting alone without further hypothetical global constraints or additional forms of plasticity, can also reproduce the remapping seen in adult cortex following afferent lesions.	Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Abbott, LF (corresponding author), Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA.	abbott@bradeis.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058754] Funding Source: NIH RePORTER; NIMH NIH HHS [MH58754] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; ARMSTRONGJAMES M, 1994, J NEUROSCI, V14, P6978; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; BENUSKOVA L, 1994, P NATL ACAD SCI USA, V91, P4791, DOI 10.1073/pnas.91.11.4791; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLENENSTOCK EL, 1982, J NEUROSCI, V2, P32; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Gilbert CD, 1996, CURR OPIN NEUROBIOL, V6, P269, DOI 10.1016/S0959-4388(96)80083-3; Glazewski S, 1996, J NEUROPHYSIOL, V75, P1714, DOI 10.1152/jn.1996.75.4.1714; Grajski KA, 1990, NEURAL COMPUT, V2, P71, DOI 10.1162/neco.1990.2.1.71; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hubener M, 1999, NAT NEUROSCI, V2, P1043, DOI 10.1038/15964; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kempter R, 1999, PHYS REV E, V59, P4498, DOI 10.1103/PhysRevE.59.4498; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MERZENICH MM, 1984, J COMP NEUROL, V224, P591, DOI 10.1002/cne.902240408; MERZENICH MM, 1983, NEUROSCIENCE, V8, P33, DOI 10.1016/0306-4522(83)90024-6; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Purves, 1985, PRINCIPLES NEURAL DE; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STRYKER MP, 1986, BIOL CHANGE OTOLARYN, P211; SUTTON GG, 1994, NEURAL COMPUT, V6, P1, DOI 10.1162/neco.1994.6.1.1; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Troyer TW, 1997, NEURAL COMPUT, V9, P971, DOI 10.1162/neco.1997.9.5.971; WALL JT, 1988, TRENDS NEUROSCI, V11, P549, DOI 10.1016/0166-2236(88)90184-1; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Yuste R, 1999, J NEUROBIOL, V41, P1, DOI 10.1002/(SICI)1097-4695(199910)41:1<1::AID-NEU1>3.0.CO;2-2; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	45	363	368	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					339	350		10.1016/S0896-6273(01)00451-2	http://dx.doi.org/10.1016/S0896-6273(01)00451-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684002	Bronze			2022-12-24	WOS:000171893700017
J	Kristjansson, A; Chen, Y; Nakayama, K				Kristjansson, A; Chen, Y; Nakayama, K			Less attention is more in the preparation of antisaccades, but not prosaccades	NATURE NEUROSCIENCE			English	Article							SACCADIC EYE-MOVEMENTS; NEURONAL-ACTIVITY; SUPERIOR COLLICULUS; VISUAL-ATTENTION; CONTROL SETTINGS; RHESUS-MONKEYS; NEURAL CONTROL; ANTI-SACCADES; PRO-SACCADES; TASK	To make a saccadic eye movement to a target we must first attend to it. It is therefore not surprising that diverting attention increases saccade latency, but is latency increased in all cases? We show that attending to a peripheral discrimination task has a paradoxical effect. If the stimulus to be attended appears shortly (100 to 300 ms) before an eye movement is made in a direction opposite to that of a presented stimulus (an antisaccade), its latency is reduced to well below baseline performance. In contrast, latencies for saccades toward the stimulus (prosaccades) are increased under similar conditions. This paradoxical effect may arise from competition between the processes mediating prosaccades and antisaccades. When the discrimination task is presented at the critical moment, it interferes with a reflexive prosaccade, allowing faster antisaccades. The results suggest that the suppression of sensorimotor reflexes can facilitate volitional motor acts.	Harvard Univ, Vis Sci Lab, Cambridge, MA 02138 USA	Harvard University	Kristjansson, A (corresponding author), Harvard Univ, Vis Sci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.	kristjan@wjh.harvard.edu						Amador N, 1998, J NEUROPHYSIOL, V80, P1775, DOI 10.1152/jn.1998.80.4.1775; BACON WF, 1994, PERCEPT PSYCHOPHYS, V55, P485, DOI 10.3758/BF03205306; BROADBENT DE, 1956, Q J EXP PSYCHOL, V8, P145, DOI 10.1080/17470215608416814; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Dorris MC, 1997, J NEUROSCI, V17, P8566; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; Duncan J, 1997, CURR OPIN NEUROBIOL, V7, P255, DOI 10.1016/S0959-4388(97)80014-1; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V80, P1584, DOI 10.1152/jn.1998.80.3.1584; FISCHER B, 1993, BEHAV BRAIN SCI, V16, P553, DOI 10.1017/S0140525X00031575; Folk CL, 1999, PERCEPT PSYCHOPHYS, V61, P727, DOI 10.3758/BF03205541; Forbes K, 1996, J COGNITIVE NEUROSCI, V8, P344, DOI 10.1162/jocn.1996.8.4.344; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; Goldberg M. E, 2000, PRINCIPLES NEURAL SC, P782; GOLDBERG ME, 1981, J NEUROPHYSIOL, V46, P773, DOI 10.1152/jn.1981.46.4.773; GREENWALD AG, 1973, J EXP PSYCHOL, V101, P70, DOI 10.1037/h0035451; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1980, VISION RES, V20, P329, DOI 10.1016/0042-6989(80)90019-X; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Hoffman JE, 1998, ATTENTION, P119; Joseph JS, 1997, NATURE, V387, P805, DOI 10.1038/42940; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; KRISTJANSSON A, IN PRESS PERCEPTION; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; Neisser U., 1967, COGNITIVE PSYCHOL; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; PASHLER H, 1993, Q J EXP PSYCHOL-A, V46, P51, DOI 10.1080/14640749308401067; Pashler H, 1998, ATTENTION, P155, DOI DOI 10.1016/J.TICS.2005.01.008; POSNER MI, 1971, PSYCHOL REV, V78, P391, DOI 10.1037/h0031333; ROSS LE, 1980, PERCEPT PSYCHOPHYS, V27, P251, DOI 10.3758/BF03204262; SCHALL JD, 1991, J NEUROPHYSIOL, V66, P559, DOI 10.1152/jn.1991.66.2.559; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Sparks D L, 1993, Curr Opin Neurobiol, V3, P966, DOI 10.1016/0959-4388(93)90169-Y; Stuyven E, 2000, ACTA PSYCHOL, V104, P69, DOI 10.1016/S0001-6918(99)00054-2; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; YANTIS S, 1993, J EXP PSYCHOL HUMAN, V19, P676, DOI 10.1037/0096-1523.19.3.676	42	63	64	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1037	1042		10.1038/nn723	http://dx.doi.org/10.1038/nn723			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	478CR	11547337				2022-12-24	WOS:000171325800019
J	Chang, S; De Camilli, P				Chang, S; De Camilli, P			Glutamate regulates actin-based motility in axonal filopodia	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC KAINATE RECEPTORS; HIPPOCAMPAL PYRAMIDAL NEURONS; DENDRITIC SPINES; SYNAPTIC VESICLES; CALCIUM DYNAMICS; SYNAPTOGENESIS; SYNAPSES; CHANNELS; RECRUITMENT; PLASTICITY	The dynamics of axonal arbors during synaptogenesis and their plasticity in the adult nervous system remain poorly understood. Axonal filopodia, which emerge from the shaft of axonal branches and contain small synaptic vesicle clusters, initiate synaptic formation. We found that the movement of axonal filopodia is strongly inhibited by the neurotransmitter glutamate. This inhibitory effect is local, requires extracellular Ca2+, and can be blocked by CNQX treatment but not by NMDA, implicating axonal AMPA/kainate glutamate receptors. Transport and exo-endocytic recycling of synaptic vesicle packages in filopodia are not affected. These results reveal that the effect of glutamate on axonal filopodia is similar to its previously described effect on dendritic spines. Our results raise the possibility that axonal ionotropic glutamate receptors are also involved in synaptic plasticity in the adult nervous system.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06515 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cell Biol, New Haven, CT 06515 USA	Howard Hughes Medical Institute; Yale University; Yale University	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 295 Congress Ave,POB 9812, New Haven, CT 06515 USA.	pietro.decamilli@yale.edu	Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NINDS NIH HHS [NS36251] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; BENTLEY D, 1986, NATURE, V323, P712, DOI 10.1038/323712a0; Bolshakov VY, 1997, NEURON, V19, P635, DOI 10.1016/S0896-6273(00)80377-3; Boudin H, 2000, NEURON, V28, P485, DOI 10.1016/S0896-6273(00)00127-6; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; BRORSON JR, 1992, MOL PHARMACOL, V41, P603; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chang SH, 1999, NAT CELL BIOL, V1, P399, DOI 10.1038/15629; Chang SH, 1999, P NATL ACAD SCI USA, V96, P4095, DOI 10.1073/pnas.96.7.4095; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CHOI DW, 1994, PROG BRAIN RES, V100, P47; CRAIG A, 2000, SYNAPSES, V1, P571; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; DAVENPORT RW, 1993, NATURE, V361, P721, DOI 10.1038/361721a0; DECAMILLI P, 2000, SYNAPSES, V1, P89; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Dingledine R, 1999, PHARMACOL REV, V51, P7; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Halpain S, 1998, J NEUROSCI, V18, P9835; IINO M, 1990, J PHYSIOL-LONDON, V424, P151, DOI 10.1113/jphysiol.1990.sp018060; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRASZEWSKI K, 1995, J NEUROSCI, V15, P4328; MacDermott AB, 1999, ANNU REV NEUROSCI, V22, P443, DOI 10.1146/annurev.neuro.22.1.443; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MATTSON MP, 1988, J NEUROSCI, V8, P2087; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; POPOV S, 1992, J NEUROSCI, V12, P77; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; SHEETZ MP, 1992, CELL MOTIL CYTOSKEL, V22, P160, DOI 10.1002/cm.970220303; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; SUDHOF T, 2000, SYNAPSES, V1, P275; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Turetsky D M, 1994, Neurobiol Dis, V1, P101, DOI 10.1006/nbdi.1994.0013; VERDERIO C, 1994, J CELL BIOL, V126, P1527, DOI 10.1083/jcb.126.6.1527; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yin HZ, 1999, J COMP NEUROL, V409, P250; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	49	122	123	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					787	793		10.1038/90489	http://dx.doi.org/10.1038/90489			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477424				2022-12-24	WOS:000170137300011
J	Salmon, AM; Damaj, MI; Marubio, LM; Epping-Jordan, MP; Merlo-Pich, E; Changeux, JP				Salmon, AM; Damaj, MI; Marubio, LM; Epping-Jordan, MP; Merlo-Pich, E; Changeux, JP			Altered neuroadaptation in opiate dependence and neurogenic inflammatory nociception in alpha CGRP-deficient mice	NATURE NEUROSCIENCE			English	Article							GENE-RELATED PEPTIDE; SUBSTANCE-P; RECEPTOR; ANTINOCICEPTION; CAPSAICIN; MORPHINE; RELEASE; LACKING; NEURONS		Inst Pasteur, CNRS, URA 2182, F-75724 Paris 15, France; Univ Lausanne, Inst Biol Cellulaire & Morphol, Glaxo Wellcome Expt Res, CH-1005 Lausanne, Switzerland; Glaxo Wellcome Med Res Ctr, I-37100 Verona, Italy	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; GlaxoSmithKline; University of Lausanne; GlaxoSmithKline	Changeux, JP (corresponding author), Inst Pasteur, CNRS, URA 2182, 25 Rue Docteur Roux, F-75724 Paris 15, France.	changeux@pasteur.fr						Damasio A, 1995, DESCARTES ERROR EMOT; FRANCOCERECEDA A, 1987, PEPTIDES, V8, P399, DOI 10.1016/0196-9781(87)90117-3; Friese N, 1997, REGUL PEPTIDES, V70, P1, DOI 10.1016/S0167-0115(97)02141-1; GIBBINS IL, 1987, CELL TISSUE RES, V248, P417; HOKFELT T, 1992, ANN NY ACAD SCI, V657, P119; Huang YH, 2000, BRAIN RES, V873, P54, DOI 10.1016/S0006-8993(00)02473-2; HUGHES SR, 1991, BRIT J PHARMACOL, V104, P738, DOI 10.1111/j.1476-5381.1991.tb12497.x; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; MENARD DP, 1995, CAN J PHYSIOL PHARM, V73, P1089, DOI 10.1139/y95-156; MORTON CR, 1989, NEUROSCIENCE, V31, P807; Murtra P, 2000, NATURE, V405, P180, DOI 10.1038/35012069; ROSENFELD MG, 1984, SCIENCE, V225, P1315, DOI 10.1126/science.6089345; Salmon AM, 1999, NEUROREPORT, V10, P849, DOI 10.1097/00001756-199903170-00033; SCHULTEIS G, 1994, J PHARMACOL EXP THER, V271, P1391; WELCH SP, 1989, J PHARMACOL EXP THER, V251, P1	15	88	97	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					357	358		10.1038/86001	http://dx.doi.org/10.1038/86001			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276224	Green Published			2022-12-24	WOS:000168762200014
J	Torres, GE; Yao, WD; Mohn, AR; Quan, H; Kim, KM; Levey, AI; Staudinger, J; Caron, MG				Torres, GE; Yao, WD; Mohn, AR; Quan, H; Kim, KM; Levey, AI; Staudinger, J; Caron, MG			Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1	NEURON			English	Article							HUMAN DOPAMINE TRANSPORTER; SEROTONIN TRANSPORTERS; MOLECULAR MECHANISMS; MICE LACKING; NEUROTRANSMITTER TRANSPORTERS; STRIATAL SYNAPTOSOMES; SURFACE EXPRESSION; COCAINE; CLONING; LOCALIZATION	PDZ domain-containing proteins play an important role in the targeting and localization of synaptic membrane proteins. Here, we report an interaction between the PDZ domain-containing protein PICK1 and monoamine neurotransmitter transporters in vitro and in vivo. In dopaminergic neurons, PICK1 colocalizes with the dopamine transporter (DAT) and forms a stable protein complex. Coexpression of PICK1 with DAT in mammalian cells and neurons in culture results in colocalization of the two proteins in a cluster pattern and an enhancement of DAT uptake activity through an increase in the number of plasma membrane DAT. Deletion of the PDZ binding site at the carboxyl terminus of DAT abolishes its association with PICK1 and impairs the localization of the transporter in neurons. These findings indicate a role for PDZ-mediated protein interactions in the localization, expression, and function of monoamine transporters.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Cell Biol, Durham, NC 27710 USA; Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA	Duke University; Howard Hughes Medical Institute; Emory University; University of Kansas; University of Kansas Medical Center	Caron, MG (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Cell Biol, Durham, NC 27710 USA.		Levey, Allan/F-2104-2011	Levey, Allan/0000-0002-3153-502X; Ramsey, Amy/0000-0002-2717-5279	NINDS NIH HHS [NS-19576] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019576] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P744; Barker Eric L., 1995, P321; Bengel D, 1998, MOL PHARMACOL, V53, P649, DOI 10.1124/mol.53.4.649; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Clarkson ED, 1999, P SOC EXP BIOL MED, V222, P157, DOI 10.1046/j.1525-1373.1999.d01-126.x; Clarkson ED, 1998, P NATL ACAD SCI USA, V95, P1265, DOI 10.1073/pnas.95.3.1265; Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527; Daniels GM, 1999, J BIOL CHEM, V274, P35794, DOI 10.1074/jbc.274.50.35794; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Fanning AS, 1999, J CLIN INVEST, V103, P767, DOI 10.1172/JCI6509; Ferguson SSG, 1998, LIFE SCI, V62, P1561, DOI 10.1016/S0024-3205(98)00107-6; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; GIROS B, 1991, FEBS LETT, V295, P149, DOI 10.1016/0014-5793(91)81406-X; GIROS B, 1993, TRENDS PHARMACOL SCI, V14, P43, DOI 10.1016/0165-6147(93)90029-J; GIROS B, 1992, MOL PHARMACOL, V42, P383; Hall RA, 1998, NATURE, V392, P626, DOI 10.1038/33458; Hersch SM, 1997, J COMP NEUROL, V388, P211; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Jones SR, 1998, J NEUROSCI, V18, P1979; KILTY JE, 1991, SCIENCE, V254, P578, DOI 10.1126/science.1948035; Kornau HC, 1997, CURR OPIN NEUROBIOL, V7, P368, DOI 10.1016/S0959-4388(97)80064-5; Manivet P, 2000, J BIOL CHEM, V275, P9324, DOI 10.1074/jbc.275.13.9324; Melikian HE, 1999, J NEUROSCI, V19, P7699; Nirenberg MJ, 1996, J NEUROSCI, V16, P436; Nirenberg MJ, 1997, J NEUROSCI, V17, P6899; Nirenberg MJ, 1997, SYNAPSE, V26, P194; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; PACHOLCZYK T, 1991, NATURE, V350, P350, DOI 10.1038/350350a0; Pickel VM, 1999, J NEUROSCI, V19, P7356, DOI 10.1523/JNEUROSCI.19-17-07356.1999; Qian Y, 1997, J NEUROSCI, V17, P45, DOI 10.1523/JNEUROSCI.17-01-00045.1997; Ramamoorthy S, 1998, J BIOL CHEM, V273, P2458, DOI 10.1074/jbc.273.4.2458; RITZ MC, 1987, SCIENCE, V237, P1219, DOI 10.1126/science.2820058; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; SHIMADA S, 1991, SCIENCE, V254, P576, DOI 10.1126/science.1948034; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; STAUDINGER J, 1995, J CELL BIOL, V128, P263, DOI 10.1083/jcb.128.3.263; Staudinger J, 1997, J BIOL CHEM, V272, P32019, DOI 10.1074/jbc.272.51.32019; Tao-Cheng JH, 1999, NEUROSCIENCE, V94, P821, DOI 10.1016/S0306-4522(99)00373-5; Torres R, 1998, NEURON, V21, P1453, DOI 10.1016/S0896-6273(00)80663-7; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; USDIN TB, 1991, P NATL ACAD SCI USA, V88, P11168, DOI 10.1073/pnas.88.24.11168; VANDENBERGH DJ, 1992, MOL BRAIN RES, V15, P161, DOI 10.1016/0169-328X(92)90165-8; Vaughan RA, 1997, J BIOL CHEM, V272, P15541, DOI 10.1074/jbc.272.24.15541; Xia J, 1999, NEURON, V22, P179, DOI 10.1016/S0896-6273(00)80689-3; Xu F, 2000, NAT NEUROSCI, V3, P465, DOI 10.1038/74839; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X	50	252	269	1	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					121	134		10.1016/S0896-6273(01)00267-7	http://dx.doi.org/10.1016/S0896-6273(01)00267-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343649	Bronze			2022-12-24	WOS:000168412900015
J	Paladini, CA; Fiorillo, CD; Morikawa, H; Williams, JT				Paladini, CA; Fiorillo, CD; Morikawa, H; Williams, JT			Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons	NATURE NEUROSCIENCE			English	Article							VENTRAL TEGMENTAL AREA; EXCITATORY SYNAPTIC TRANSMISSION; RAT NUCLEUS-ACCUMBENS; SUBSTANTIA-NIGRA; RECEPTORS; COCAINE; LOCOMOTOR; MODULATION; PRAZOSIN; RELEASE	Amphetamine is a highly addictive psychostimulant that promotes the release of the catecholamines dopamine and norepinephrine. Amphetamine-induced release of dopamine in the midbrain inhibits the activity of dopamine neurons through activation of D-2 dopamine autoreceptors. Here we show that amphetamine may also excite dopamine neurons through modulation of glutamate neurotransmission. Amphetamine potently inhibits metabotropic glutamate receptor (mGluR)-mediated IPSPs in dopamine neurons, but has no effect on ionotropic glutamate receptor-mediated EPSCs. Amphetamine desensitizes the mGluR-mediated hyperpolarization through release of dopamine, activation of postsynaptic alpha (1) adrenergic receptors, and suppression of InsP(3)-induced calcium release from internal stores. By selectively suppressing the inhibitory component of glutamate-mediated transmission, amphetamine may promote burst firing of dopamine neurons. Through this mechanism, amphetamine may enhance phasic release of dopamine, which is important in the neural processing of reward.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Williams, JT (corresponding author), Oregon Hlth & Sci Univ, Vollum Inst, L474,3818 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.	williamj@ohsu.edu	Morikawa, Hitoshi/D-2411-2011; Fiorillo, Christopher Dante/C-1718-2011; Paladini, Carlos A/F-5464-2010	Fiorillo, Christopher/0000-0002-7232-9505	NIDA NIH HHS [DA05793, DA04523, DA07262] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004523] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Amara SG, 1998, DRUG ALCOHOL DEPEN, V51, P87, DOI 10.1016/S0376-8716(98)00068-4; BLANC G, 1994, EUR J NEUROSCI, V6, P293, DOI 10.1111/j.1460-9568.1994.tb00272.x; CLAUSING P, 1995, J PHARMACOL EXP THER, V274, P614; Darracq L, 1998, J NEUROSCI, V18, P2729; DICKINSON SL, 1988, PSYCHOPHARMACOLOGY, V96, P521, DOI 10.1007/BF02180034; Fiorillo CD, 2000, J NEUROSCI, V20, P7855; Fiorillo CD, 1998, NATURE, V394, P78, DOI 10.1038/27919; Fiorillo CD, 2000, J NEUROPHYSIOL, V83, P1307, DOI 10.1152/jn.2000.83.3.1307; Fon EA, 1997, NEURON, V19, P1271, DOI 10.1016/S0896-6273(00)80418-3; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRENHOFF J, 1995, EUR J NEUROSCI, V7, P1707, DOI 10.1111/j.1460-9568.1995.tb00692.x; GRENHOFF J, 1993, EUR J PHARMACOL, V233, P79, DOI 10.1016/0014-2999(93)90351-H; GRENHOFF J, 1993, J NEURAL TRANSM-GEN, V93, P11, DOI 10.1007/BF01244934; GROVES PM, 1975, SCIENCE, V190, P522, DOI 10.1126/science.242074; Guatteo E, 1999, J NEUROPHYSIOL, V82, P1974, DOI 10.1152/jn.1999.82.4.1974; HAJNOCZKY G, 1994, NATURE, V370, P474, DOI 10.1038/370474a0; Harvey J, 1996, J PHYSIOL-LONDON, V492, P143, DOI 10.1113/jphysiol.1996.sp021296; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Jones S, 1999, J NEUROSCI, V19, P9780; Jones SR, 1998, J NEUROSCI, V18, P1979; Marinelli M, 2000, J NEUROSCI, V20, P8876; MAVROTHALASSITIS GJ, 1991, CELL GROWTH DIFFER, V2, P215; MERCURI NB, 1989, BRIT J PHARMACOL, V98, P127, DOI 10.1111/j.1476-5381.1989.tb16872.x; Morikawa H, 2000, J NEUROSCI, V20, part. no.; Nicola SM, 1996, J NEUROSCI, V16, P1591; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Pan Q, 1996, IEEE PHOTONIC TECH L, V8, P278, DOI 10.1109/68.484266; Pierce RC, 1997, J NEUROSCI, V17, P3254; PONCELET M, 1983, PSYCHOPHARMACOLOGY, V80, P184, DOI 10.1007/BF00427967; READER TA, 1987, J NEURAL TRANSM, V68, P79, DOI 10.1007/BF01244641; RUFFOLO RR, 1984, J PHARMACOL EXP THER, V230, P595; Scarponi M, 1999, EUR J NEUROSCI, V11, P593, DOI 10.1046/j.1460-9568.1999.00482.x; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shi WX, 2000, J NEUROSCI, V20, P3504, DOI 10.1523/JNEUROSCI.20-09-03504.2000; SNODDY AM, 1985, EUR J PHARMACOL, V116, P221, DOI 10.1016/0014-2999(85)90156-6; SUAUDCHAGNY MF, 1992, NEUROSCIENCE, V49, P63, DOI 10.1016/0306-4522(92)90076-E; TESSEL RE, 1986, PSYCHOPHARMACOLOGY, V90, P436; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Travagli RA, 1996, J PHYSIOL-LONDON, V491, P177, DOI 10.1113/jphysiol.1996.sp021205; WILLIAMS JT, 1984, NEUROSCIENCE, V13, P137, DOI 10.1016/0306-4522(84)90265-3; YOKEL RA, 1974, PSYCHOPHARMACOLOGIA, V34, P255, DOI 10.1007/BF00421966	44	96	98	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					275	281		10.1038/85124	http://dx.doi.org/10.1038/85124			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224544				2022-12-24	WOS:000167178300015
J	Fisahn, A; Yamada, M; Duttaroy, A; Gan, JW; Deng, CX; McBain, CJ; Wess, J				Fisahn, A; Yamada, M; Duttaroy, A; Gan, JW; Deng, CX; McBain, CJ; Wess, J			Muscarinic induction of hippocampal gamma oscillations requires coupling of the M1 receptor to two mixed cation currents	NEURON			English	Article							CURRENT I-H; HYPERPOLARIZATION-ACTIVATED CURRENTS; VOLTAGE-CLAMP ANALYSIS; ACETYLCHOLINE-RECEPTOR; FREQUENCY OSCILLATIONS; NETWORK OSCILLATIONS; RAT HIPPOCAMPUS; MODULATION; PACEMAKER; MEMORY	Oscillatory network activity at gamma frequencies is assumed to be of major importance in cortical information processing. Whereas the synaptic mechanisms of gamma oscillations have been studied in detail, the ionic currents involved at the cellular level remain to be elucidated. Here we show that in vitro gamma oscillations induced by muscarine require activation of M1 receptors on hippocampal CA3 pyramidal neurons and are absent in M1 receptor-deficient mice. M1 receptor activation depolarizes pyramidal neurons by increasing the mixed Na+/K+ current I-h and the Ca2+-dependent nonspecific cation current I-cat, but not by modulation of I-M. Our data provide important insight into the molecular basis of gamma oscillations by unequivocally establishing a novel role for muscarinic modulation Of I-h and I-cat in rhythmic network activity.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; NIDDKD, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; NIDDKD, Biochem & Metab Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	McBain, CJ (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.	chrismcb@codon.nih.gov	Duttaroy, Asim K./J-9499-2016; deng, chuxia/N-6713-2016	Duttaroy, Asim K./0000-0003-1619-3778; 	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001205] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK056001, Z01DK056001, Z01DK032003] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BOSMITH RE, 1993, BRIT J PHARMACOL, V110, P343, DOI 10.1111/j.1476-5381.1993.tb13815.x; BRAGIN A, 1995, J NEUROSCI, V15, P47; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Buhl EH, 1998, J PHYSIOL-LONDON, V513, P117, DOI 10.1111/j.1469-7793.1998.117by.x; CAULFIELD MP, 1993, PHARMACOL THERAPEUT, V58, P319, DOI 10.1016/0163-7258(93)90027-B; COLINO A, 1993, EUR J NEUROSCI, V5, P1198, DOI 10.1111/j.1460-9568.1993.tb00974.x; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; Cuttle MF, 2001, J PHYSIOL-LONDON, V534, P733, DOI 10.1111/j.1469-7793.2001.00733.x; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; FISAHN A, 1999, THESIS OXFORD U OXFO; Gasparini S, 1999, EUR J NEUROSCI, V11, P3093, DOI 10.1046/j.1460-9568.1999.00728.x; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P1692, DOI 10.1073/pnas.96.4.1692; Gomeza J, 1999, P NATL ACAD SCI USA, V96, P10483, DOI 10.1073/pnas.96.18.10483; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; GRIFFITHS PD, 1994, NEUROSCI LETT, V169, P68, DOI 10.1016/0304-3940(94)90358-1; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; Hamilton SE, 1997, P NATL ACAD SCI USA, V94, P13311, DOI 10.1073/pnas.94.24.13311; HAROUTUNIAN V, 1994, SCHIZOPHR RES, V12, P137, DOI 10.1016/0920-9964(94)90071-X; HASSELMO ME, 1992, J NEUROPHYSIOL, V67, P1230, DOI 10.1152/jn.1992.67.5.1230; Hormuzdi SG, 2001, NEURON, V31, P487, DOI 10.1016/S0896-6273(01)00387-7; LANCASTER B, 1986, J NEUROPHYSIOL, V55, P1268, DOI 10.1152/jn.1986.55.6.1268; LEVEY AI, 1995, J NEUROSCI, V15, P4077; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; MACCAFERRI G, 1993, J NEUROPHYSIOL, V69, P2129, DOI 10.1152/jn.1993.69.6.2129; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MADISON DV, 1987, J NEUROSCI, V7, P733; Magee JC, 1999, NAT NEUROSCI, V2, P508, DOI 10.1038/9158; Magee JC, 1998, J NEUROSCI, V18, P7613; MCCORMICK DA, 1990, J PHYSIOL-LONDON, V431, P291, DOI 10.1113/jphysiol.1990.sp018331; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Rouse ST, 2000, NEUROSCI LETT, V278, P61, DOI 10.1016/S0304-3940(99)00914-3; Santoro B, 2000, J NEUROSCI, V20, P5264, DOI 10.1523/JNEUROSCI.20-14-05264.2000; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; SOLTESZ I, 1991, J PHYSIOL-LONDON, V441, P175, DOI 10.1113/jphysiol.1991.sp018745; Southan AP, 2000, J PHYSIOL-LONDON, V526, P91, DOI 10.1111/j.1469-7793.2000.t01-1-00091.x; STERIADE M, 1991, P NATL ACAD SCI USA, V88, P4396, DOI 10.1073/pnas.88.10.4396; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yamada M, 2001, P NATL ACAD SCI USA, V98, P14096, DOI 10.1073/pnas.251542998	47	186	191	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					615	624		10.1016/S0896-6273(02)00587-1	http://dx.doi.org/10.1016/S0896-6273(02)00587-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856534	Bronze			2022-12-24	WOS:000173911100013
J	Tong, JY; Hannan, F; Zhu, YH; Bernards, A; Zhong, Y				Tong, JY; Hannan, F; Zhu, YH; Bernards, A; Zhong, Y			Neurofibromin regulates G protein-stimulated adenylyl cyclase activity	NATURE NEUROSCIENCE			English	Article							DROSOPHILA NF1; GENE; DEFICITS; MODEL		Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11790 USA; Massachusetts Gen Hosp, Ctr Canc, Charlestown, MA 02129 USA	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Harvard University; Massachusetts General Hospital	Zhong, Y (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	zhongyi@cshl.org		Zhong, Yi/0000-0002-7927-5976; Zhong, Yi/0000-0001-7810-9899; Hannan, Frances/0000-0002-9958-3706	NINDS NIH HHS [NS34779] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034779] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Costa RM, 2001, NAT GENET, V27, P399, DOI 10.1038/86898; Defer N, 2000, AM J PHYSIOL-RENAL, V279, pF400, DOI 10.1152/ajprenal.2000.279.3.F400; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Hsueh YP, 2001, J NEUROSCI, V21, P3764, DOI 10.1523/JNEUROSCI.21-11-03764.2001; Kim HA, 1997, MOL CELL BIOL, V17, P862, DOI 10.1128/MCB.17.2.862; LEVIN LR, 1992, CELL, V68, P479, DOI 10.1016/0092-8674(92)90185-F; Silva AJ, 1997, NAT GENET, V15, P281, DOI 10.1038/ng0397-281; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097	14	153	160	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					95	96		10.1038/nn792	http://dx.doi.org/10.1038/nn792			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788835				2022-12-24	WOS:000173558400007
J	Sabatini, BL; Oertner, TG; Svoboda, K				Sabatini, BL; Oertner, TG; Svoboda, K			The life cycle of Ca2+ ions in dendritic spines	NEURON			English	Article							LONG-TERM POTENTIATION; BOVINE CHROMAFFIN CELLS; HIPPOCAMPAL-NEURONS; CALCIUM DYNAMICS; SINGLE SPINES; SYNAPTIC TRANSMISSION; PYRAMIDAL NEURONS; PURKINJE NEURONS; NMDA RECEPTORS; AREA CA1	Spine Ca2+ is critical for the induction of synaptic plasticity, but the factors that control Ca2+ handling in dendritic spines under physiological conditions are largely unknown. We studied [Ca2+] signaling in dendritic spines of CA1 pyramidal neurons and find that spines are specialized structures with low endogenous Ca2+ buffer capacity that allows large and extremely rapid [Ca2+] changes. Under physiological conditions, Ca2+ diffusion across the spine neck is negligible, and the spine head functions as a separate compartment on long time scales, allowing localized Ca2+ buildup during trains of synaptic stimuli. Furthermore, the kinetics of Ca2+ sources governs the time course of [Ca2+] signals and may explain the selective activation of long-term synaptic potentiation (LTP) and long-term depression (LTD) by NMDA-R-mediated synaptic Ca2+.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute	Svoboda, K (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	svoboda@cshl.org	Oertner, Thomas/F-2214-2010	Oertner, Thomas/0000-0002-2312-7528				ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; ANDERSEN P, 1980, J PHYSIOL-LONDON, V302, P463; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Gabso M, 1997, NEURON, V18, P473, DOI 10.1016/S0896-6273(00)81247-7; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hollingworth S, 1996, J GEN PHYSIOL, V108, P455, DOI 10.1085/jgp.108.5.455; Holmes WR, 2000, J COMPUT NEUROSCI, V8, P65, DOI 10.1023/A:1008969032563; HOLMES WR, 1990, BRAIN RES, V519, P338, DOI 10.1016/0006-8993(90)90098-V; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1999, BIOPHYS J, V77, P2226, DOI 10.1016/S0006-3495(99)77063-3; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; KULLMANN DM, 1992, NEURON, V9, P1175, DOI 10.1016/0896-6273(92)90075-O; Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1992, NEURON, V9, P121, DOI 10.1016/0896-6273(92)90227-5; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Maravall M, 2000, BIOPHYS J, V78, P2655, DOI 10.1016/S0006-3495(00)76809-3; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; PHILIPSON K, 1999, CALCIUM CELLULAR REG, P249; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Sabatini BL, 2001, CURR OPIN NEUROBIOL, V11, P349, DOI 10.1016/S0959-4388(00)00218-X; SIMON SM, 1985, BIOPHYS J, V48, P485, DOI 10.1016/S0006-3495(85)83804-2; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; STORM JF, 1990, PROG BRAIN RES, V83, P161; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Tank DW, 1995, J NEUROSCI, V15, P7940; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	57	514	518	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					439	452		10.1016/S0896-6273(02)00573-1	http://dx.doi.org/10.1016/S0896-6273(02)00573-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832230	Green Submitted, Bronze			2022-12-24	WOS:000173643200013
J	Craig, NJ; Alonso, MBD; Hawker, KL; Shiels, P; Glencorse, TA; Campbell, JM; Bennett, NK; Canham, M; Donald, D; Gardiner, M; Gilmore, DP; MacDonald, RJ; Maitland, K; McCallion, AS; Russell, D; Payne, AP; Sutcliffe, RG; Davies, RW				Craig, NJ; Alonso, MBD; Hawker, KL; Shiels, P; Glencorse, TA; Campbell, JM; Bennett, NK; Canham, M; Donald, D; Gardiner, M; Gilmore, DP; MacDonald, RJ; Maitland, K; McCallion, AS; Russell, D; Payne, AP; Sutcliffe, RG; Davies, RW			A candidate gene for human neurodegenerative disorders: a rat PKC gamma mutation causes a Parkinsonian syndrome	NATURE NEUROSCIENCE			English	Article							PROTEIN-KINASE-C; NEURONS; BRAIN		Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland; Neuropa, Glasgow G11 6NU, Lanark, Scotland; Univ Texas, SW Med Ctr, Dallas, TX 75390 USA	University of Glasgow; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Davies, RW (corresponding author), Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland.		MacDonald, Ray/AAA-1290-2022; Alonso, M. Beatriz Durán/L-5858-2017	Alonso, M. Beatriz Durán/0000-0001-7784-0591; Davies, Wayne/0000-0001-9555-2737; Canham, Maurice/0000-0003-1620-8044; Shiels, Paul/0000-0002-7577-9843; Payne, Philip/0000-0002-9532-2998				HASHIMOTO T, 1988, J NEUROSCI, V8, P1678; HUG H, 1993, BIOCHEM J, V291, P329, DOI 10.1042/bj2910329; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Payne AP, 2000, J ANAT, V196, P629, DOI 10.1046/j.1469-7580.2000.19640629.x; Polymeropoulos MH, 2000, ANN NY ACAD SCI, V920, P28; SAITO N, 1988, J NEUROSCI, V8, P369; SERIKAWA T, 1992, GENETICS, V131, P701; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; TANAKA C, 1994, ANNU REV NEUROSCI, V17, P551, DOI 10.1146/annurev.ne.17.030194.003003; Zirpel L, 1998, J NEUROPHYSIOL, V79, P2288, DOI 10.1152/jn.1998.79.5.2288	11	24	26	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1061	1062		10.1038/nn740	http://dx.doi.org/10.1038/nn740			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11600890				2022-12-24	WOS:000171970900006
J	Roelfsema, PR; Spekreijse, H				Roelfsema, PR; Spekreijse, H			The representation of erroneously perceived stimuli in the primary visual cortex	NEURON			English	Article							OBJECT-BASED ATTENTION; DECISION; RESPONSES; NEURONS; SIGNALS; NEUROPHYSIOLOGY; SENSITIVITY; INTEGRATION; PERCEPTION; VISION	In order to attain a correct interpretation of an ambiguous visual stimulus, the brain may have to elaborate on the sensory evidence. Are the neurons that carry the sensory evidence also involved in generating an interpretation? To address this question, we studied the activity of neurons in the primary visual cortex of macaque monkeys involved in a task in which they have to trace a curve mentally, without moving their eyes. On a percentage of trials, the monkeys made errors and traced the wrong curve. Here, we show that these errors are predicted by activity in area V1. Thus, neurons in the primary visual cortex do not only represent sensory events, but also the way in which they are interpreted by the monkey.	Univ Amsterdam, Grad Sch Neurosci Amsterdam, Acad Med Ctr, Dept Visual Syst Anal, NL-1100 AA Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Roelfsema, PR (corresponding author), Univ Amsterdam, Grad Sch Neurosci Amsterdam, Acad Med Ctr, Dept Visual Syst Anal, POB 12011, NL-1100 AA Amsterdam, Netherlands.	p.roelfsema@ioi.knaw.nl	Roelfsema, Pieter/J-6903-2013	Roelfsema, Pieter/0000-0002-1625-0034				Bosking WH, 1997, J NEUROSCI, V17, P2112; BOUR LJ, 1984, IEEE T BIO-MED ENG, V31, P419, DOI 10.1109/TBME.1984.325281; Britten KH, 1996, VISUAL NEUROSCI, V13, P87, DOI 10.1017/S095252380000715X; CELEBRINI S, 1994, J NEUROSCI, V14, P4109; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Groh JM, 1996, CURR BIOL, V6, P1406, DOI 10.1016/S0960-9822(96)00743-9; Grossberg S, 2000, VISION RES, V40, P1413, DOI 10.1016/S0042-6989(99)00229-1; JOLICOEUR P, 1986, MEM COGNITION, V14, P129, DOI 10.3758/BF03198373; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KATO H, 1978, J NEUROPHYSIOL, V41, P1071, DOI 10.1152/jn.1978.41.5.1071; KELLMAN PJ, 1991, COGNITIVE PSYCHOL, V23, P141, DOI 10.1016/0010-0285(91)90009-D; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; LEGATT AD, 1980, J NEUROSCI METH, V2, P203, DOI 10.1016/0165-0270(80)90061-8; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; MCCORMICK PA, 1992, J EXP PSYCHOL HUMAN, V18, P72, DOI 10.1037/0096-1523.18.1.72; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; ORAM MW, 1992, J NEUROPHYSIOL, V68, P70, DOI 10.1152/jn.1992.68.1.70; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; POLAT U, 1994, P NATL ACAD SCI USA, V91, P1206, DOI 10.1073/pnas.91.4.1206; Roelfsema PR, 2000, VISION RES, V40, P1385, DOI 10.1016/S0042-6989(00)00004-3; Roelfsema PR, 1998, NATURE, V395, P376, DOI 10.1038/26475; Roelfsema PR, 1998, CEREB CORTEX, V8, P385, DOI 10.1093/cercor/8.5.385; Salinas E, 1998, J NEUROSCI, V18, P499; Schall JD, 2000, CURR BIOL, V10, pR404, DOI 10.1016/S0960-9822(00)00504-2; Schmidt KE, 1997, EUR J NEUROSCI, V9, P1083, DOI 10.1111/j.1460-9568.1997.tb01459.x; Scholte HS, 2001, VISION RES, V41, P2569, DOI 10.1016/S0042-6989(01)00148-1; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, J NEUROSCI, V19, P7591, DOI 10.1523/JNEUROSCI.19-17-07591.1999; VOGELS R, 1990, BIOL CYBERN, V64, P25, DOI 10.1007/BF00203627	38	43	46	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					853	863		10.1016/S0896-6273(01)00408-1	http://dx.doi.org/10.1016/S0896-6273(01)00408-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	472YV	11567622	Bronze			2022-12-24	WOS:000171013300017
J	Yu, HK; Saura, CA; Choi, SY; Sun, LD; Yang, XD; Handler, M; Kawarabayashi, T; Younkin, L; Fedeles, B; Wilson, MA; Younkin, S; Kandel, ER; Kirkwood, A; Shen, J				Yu, HK; Saura, CA; Choi, SY; Sun, LD; Yang, XD; Handler, M; Kawarabayashi, T; Younkin, L; Fedeles, B; Wilson, MA; Younkin, S; Kandel, ER; Kirkwood, A; Shen, J			APP processing and synaptic plasticity in presenilin-1 conditional knockout mice	NEURON			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL ALZHEIMERS-DISEASE; GAMMA-SECRETASE ACTIVITY; LONG-TERM POTENTIATION; TRANSGENIC MICE; CULTURED-CELLS; NEURONAL DIFFERENTIATION; VESICLE EXOCYTOSIS; C-TERMINUS; IN-VIVO	We have developed a presenilin-1 (PS1) conditional knockout mouse (cKO), in which PS1 inactivation is restricted to the postnatal forebrain. The PS1 cKO mouse is viable and exhibits no gross abnormalities. The carboxy-terminal fragments of the amyloid precursor protein differentially accumulate in the cerebral cortex of cKO mice, while generation of beta -amyloid peptides is reduced. Expression of Notch downstream effector genes, Hes1, Hes5, and DII1, is unaffected in the cKO cortex. Although basal synaptic transmission, long-term potentiation, and long-term depression at hippocampal area CA1 synapses are normal, the PS1 cKO mice exhibit subtle but significant deficits in long-term spatial memory. These results demonstrate that inactivation of PS1 function in the adult cerebral cortex leads to reduced A beta generation and subtle cognitive deficits without affecting expression of Notch downstream genes.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; Johns Hopkins Univ, Mind Brain Inst, Baltimore, MD 21218 USA; MIT, Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02138 USA; Mayo Clin Jacksonville, Jacksonville, FL 32224 USA; Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Mayo Clinic; Columbia University; Howard Hughes Medical Institute	Shen, J (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA.		Shen, Jie/GXH-9449-2022; Saura, Carlos A/D-2727-2011; Saura, Carlos A/AFM-9239-2022	Saura, Carlos A/0000-0003-3692-5657; Fedeles, Bogdan/0000-0001-5252-826X; Choi, Se-Young/0000-0001-7534-5167				Ando K, 1999, J NEUROSCI, V19, P4421; Bailey CH, 2000, NAT REV NEUROSCI, V1, P11, DOI 10.1038/35036191; Baranes D, 1998, NEURON, V21, P813, DOI 10.1016/S0896-6273(00)80597-8; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1999, J NEUROSCI, V19, P1307; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; BUXBAUM JD, 1993, P NATL ACAD SCI USA, V90, P9195, DOI 10.1073/pnas.90.19.9195; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Esler WP, 2000, NAT CELL BIOL, V2, P428, DOI 10.1038/35017062; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; Handler M, 2000, DEVELOPMENT, V127, P2593; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Iijima K, 2000, J NEUROCHEM, V75, P1085, DOI 10.1046/j.1471-4159.2000.0751085.x; JARRETT JT, 1993, BIOCHEMISTRY-US, V32, P4693, DOI 10.1021/bi00069a001; Johnson D, 1997, EDN, V42, P94; Kawarabayashi T, 1996, NEUROBIOL AGING, V17, P215, DOI 10.1016/0197-4580(95)02061-6; Kirkwood A, 1999, J NEUROSCI, V19, P1599; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; KREZEL W, 1999, ABSTR SOC NEUROSCI, V25, P987; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oishi M, 1997, MOL MED, V3, P111, DOI 10.1007/BF03401803; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Parent A, 1999, NEUROBIOL DIS, V6, P56, DOI 10.1006/nbdi.1998.0207; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Simons M, 1996, J NEUROSCI, V16, P899; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; SUZUKI N, 1994, AM J PATHOL, V145, P452; TAKEBAYASHI K, 1995, J BIOL CHEM, V270, P1342, DOI 10.1074/jbc.270.3.1342; Thinakaran G, 1997, J BIOL CHEM, V272, P28415, DOI 10.1074/jbc.272.45.28415; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 1998, J BIOL CHEM, V273, P21153, DOI 10.1074/jbc.273.33.21153; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wittenburg N, 2000, NATURE, V406, P306, DOI 10.1038/35018575; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Xu XM, 1999, J BIOL CHEM, V274, P32543, DOI 10.1074/jbc.274.46.32543; Yu HK, 2000, GENESIS, V26, P5, DOI 10.1002/(SICI)1526-968X(200001)26:1<5::AID-GENE3>3.0.CO;2-8; Zaman SH, 2000, NEUROBIOL DIS, V7, P54, DOI 10.1006/nbdi.1999.0271; Zhang ZH, 2000, NAT CELL BIOL, V2, P463, DOI 10.1038/35017108; Zhang ZT, 1997, EMBO J, V16, P6141, DOI 10.1093/emboj/16.20.6141	59	203	209	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					713	726		10.1016/S0896-6273(01)00417-2	http://dx.doi.org/10.1016/S0896-6273(01)00417-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567612	Bronze			2022-12-24	WOS:000171013300007
J	Stern, EA; Maravall, M; Svoboda, K				Stern, EA; Maravall, M; Svoboda, K			Rapid development and plasticity of layer 2/3 maps in rat barrel cortex in vivo	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; NEOCORTICAL PYRAMIDAL NEURONS; CAT VISUAL-CORTEX; SOMATOSENSORY CORTEX; IN-VIVO; CRITICAL PERIOD; SYNAPTIC ACTIVITY; THALAMOCORTICAL SYNAPSES; COLUMNAR ORGANIZATION; POSTNATAL-DEVELOPMENT	Cortical synaptic circuitry develops rapidly in the second postnatal week, simultaneous with experience-dependent turnover of dendritic spines. To relate the emergence of sensory maps to synaptogenesis, we recorded synaptic potentials evoked by whisker deflection in layer 2/3 neurons from postnatal day (P) 12 to 20. At P12, synaptic responses were undetectable. Only 2 days later in life (P14), receptive fields had mature organization. Sensory deprivation, if initiated before P14, disrupted receptive field structure. In layer 4, responses and maps were already mature by P12 and insensitive to deprivation, implying that barrel cortex develops from layer 4 to layer 2/3. Thus, P12-14 is a critical period shared by layer 2/3 synapses and their spines, suggesting that spine plasticity is involved in the refinement of maps.	Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Howard Hughes Medical Institute; Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Howard Hughes Med Inst, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.		Maravall, Miguel/AAW-4328-2021	Maravall, Miguel/0000-0002-8869-7206				AGMON A, 1993, J NEUROSCI, V13, P5365, DOI 10.1523/JNEUROSCI.13-12-05365.1993; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1993, P NATL ACAD SCI USA, V90, P2082, DOI 10.1073/pnas.90.5.2082; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Feldman DE, 1998, NEURON, V21, P347, DOI 10.1016/S0896-6273(00)80544-9; FOX K, 1992, J NEUROSCI, V12, P1826; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27, DOI 10.1113/jphysiol.1978.sp012290; Hand PJ, 1982, CHANGING CONCEPTS NE, P49; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1963, J NEUROPHYSIOL, V26, P994, DOI 10.1152/jn.1963.26.6.994; HUBEL DH, 1959, J PHYSIOL-LONDON, V148, P574, DOI 10.1113/jphysiol.1959.sp006308; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; JHAVERI S, 1991, P NATL ACAD SCI USA, V88, P4489, DOI 10.1073/pnas.88.10.4489; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KILLACKEY HP, 1995, TRENDS NEUROSCI, V18, P402, DOI 10.1016/0166-2236(95)93937-S; KILLACKEY HP, 1994, J NEUROSCI, V14, P1496, DOI 10.1523/JNEUROSCI.14-03-01496.1994; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LORENZON NM, 1993, DEV BRAIN RES, V73, P213, DOI 10.1016/0165-3806(93)90141-V; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; Macknik SL, 2000, P NATL ACAD SCI USA, V97, P7556, DOI 10.1073/pnas.110142097; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; Pare D, 1998, J NEUROPHYSIOL, V79, P1450, DOI 10.1152/jn.1998.79.3.1450; Polley DB, 1999, NEURON, V24, P623, DOI 10.1016/S0896-6273(00)81117-4; Reyes A, 1999, J NEUROSCI, V19, P3827; RICE FL, 1977, J COMP NEUROL, V171, P545, DOI 10.1002/cne.901710408; Rosenberger J.L., 1983, UNDERSTANDING ROBUST, P297; SCHLAGGAR BL, 1994, J COMP NEUROL, V346, P80, DOI 10.1002/cne.903460106; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SIEGEL S, 1956, NONPARAMETRIC STAT; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; SIMONS DJ, 1983, BRAIN RES, V276, P178, DOI 10.1016/0006-8993(83)90561-9; SIMONS DJ, 1978, J NEUROPHYSIOL, V41, P798, DOI 10.1152/jn.1978.41.3.798; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stern EA, 1997, J NEUROPHYSIOL, V77, P1697, DOI 10.1152/jn.1997.77.4.1697; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Vees AM, 1998, J COMP NEUROL, V400, P110; WAITE PME, 1978, NATURE, V274, P600, DOI 10.1038/274600a0; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WIESEL TN, 1982, NATURE, V299, P583, DOI 10.1038/299583a0; WINFIELD DA, 1981, BRAIN RES, V206, P166, DOI 10.1016/0006-8993(81)90110-4; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	57	212	217	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 2	2001	31	2					305	315		10.1016/S0896-6273(01)00360-9	http://dx.doi.org/10.1016/S0896-6273(01)00360-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502260	Bronze			2022-12-24	WOS:000170277700014
J	Schuler, V; Luscher, C; Blanchet, C; Klix, N; Sansig, G; Klebs, K; Schmutz, M; Heid, J; Gentry, C; Urban, L; Fox, A; Spooren, W; Jaton, AL; Vigouret, JM; Pozza, M; Kelly, PH; Mosbacher, J; Froestl, W; Kaslin, E; Korn, R; Bischoff, S; Kaupmann, K; van der Putten, H; Bettler, B				Schuler, V; Luscher, C; Blanchet, C; Klix, N; Sansig, G; Klebs, K; Schmutz, M; Heid, J; Gentry, C; Urban, L; Fox, A; Spooren, W; Jaton, AL; Vigouret, JM; Pozza, M; Kelly, PH; Mosbacher, J; Froestl, W; Kaslin, E; Korn, R; Bischoff, S; Kaupmann, K; van der Putten, H; Bettler, B			Epilepsy, hyperalgesia, impaired memory, and loss of pre- and postsynaptic GABA(B) responses in mice lacking GABA(B(1))	NEURON			English	Article							RECEPTOR ANTAGONISTS; PRESYNAPTIC INHIBITION; RAT HIPPOCAMPUS; HETEROMERIC COMPLEXES; IN-VITRO; ADENOSINE; RELEASE; HETERODIMERIZATION; RETENTION; SUBTYPES	GABA(B) (gamma -aminobutyric acid type B) receptors are important for keeping neuronal excitability under control. Cloned GABA(B) receptors do not show the expected pharmacological diversity of native receptors and it is unknown whether they contribute to pre- as well as postsynaptic functions. Here, we demonstrate that Balb/c mice lacking the GABA(B(1)) subunit are viable, exhibit spontaneous seizures, hyperalgesia, hyperlocomotor activity, and memory impairment. Upon GABA(B) agonist application, null mutant mice show neither the typical muscle relaxation, hypothermia, or delta EEG waves. These behavioral findings are paralleled by a loss of all biochemical and electrophysiological GABA(B) responses in null mutant mice. This demonstrates that GABA(B(1)) is an essential component of pre- and postsynaptic GABA(B) receptors and casts doubt on the existence of proposed receptor subtypes.	Novartis Pharma AG, TA Nervous Syst, CH-4002 Basel, Switzerland; Novartis Inst Med Sci, London WC1E 6B9, England; Univ Geneva, Dept Pharmacol APSIC, CH-1211 Geneva, Switzerland; Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland; Univ Geneva, Dept Neurol, CH-1211 Geneva 4, Switzerland	Novartis; Novartis; University of Geneva; University of Geneva; University of Geneva	Bettler, B (corresponding author), Novartis Pharma AG, TA Nervous Syst, CH-4002 Basel, Switzerland.		bettler, bernhard/AAO-8018-2020; Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Bettler, Bernhard/0000-0003-0842-8207; Kaupmann, Klemens/0000-0001-8903-2508				AbdAlla S, 2000, NATURE, V407, P94, DOI 10.1038/35024095; BABBINI M, 1972, BRIT J PHARMACOL, V46, P213, DOI 10.1111/j.1476-5381.1972.tb06866.x; Badran S, 1997, EUR J PHARMACOL, V333, P135, DOI 10.1016/S0014-2999(97)01111-4; Benke D, 1999, J BIOL CHEM, V274, P27323, DOI 10.1074/jbc.274.38.27323; Bischoff S, 1999, J COMP NEUROL, V412, P1; BITTIGER H, 1993, TRENDS PHARMACOL SCI, V14, P391, DOI 10.1016/0165-6147(93)90056-P; BONANNO G, 1993, TRENDS PHARMACOL SCI, V14, P259, DOI 10.1016/0165-6147(93)90124-3; Brucato FH, 1996, NEUROSCIENCE, V74, P331, DOI 10.1016/0306-4522(96)00131-5; Calver AR, 2001, J NEUROSCI, V21, P1203; CAPOGNA M, 1993, J PHYSIOL-LONDON, V470, P539, DOI 10.1113/jphysiol.1993.sp019874; CASTELLANO C, 1993, PSYCHOPHARMACOLOGY, V111, P134, DOI 10.1007/BF02245514; Clark JA, 2000, BRAIN RES, V860, P41, DOI 10.1016/S0006-8993(00)01958-2; COHEN GA, 1992, NEURON, V9, P325, DOI 10.1016/0896-6273(92)90171-9; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; D'amour FE, 1941, J PHARMACOL EXP THER, V72, P74; Dinkel A, 1999, J IMMUNOL METHODS, V223, P255, DOI 10.1016/S0022-1759(99)00005-8; EDDY NB, 1953, J PHARMACOL EXP THER, V107, P385; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Getova D, 1997, EUR J PHARMACOL, V320, P9, DOI 10.1016/S0014-2999(96)00877-1; Gines S, 2000, P NATL ACAD SCI USA, V97, P8606, DOI 10.1073/pnas.150241097; JONESGOTMAN M, 1994, EPILEPSIA, V35, P61, DOI 10.1111/j.1528-1157.1994.tb02913.x; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Lin Q, 1996, J NEUROPHYSIOL, V75, P109, DOI 10.1152/jn.1996.75.1.109; Lingenhoehl K, 1999, NEUROPHARMACOLOGY, V38, P1667, DOI 10.1016/S0028-3908(99)00131-8; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698; MARESCAUX C, 1992, J NEURAL TRANSM-GEN, P179; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Mohler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; Mondadori C, 1996, BEHAV BRAIN RES, V77, P227, DOI 10.1016/0166-4328(95)00226-X; MOTT DD, 1994, INT REV NEUROBIOL, V36, P97, DOI 10.1016/S0074-7742(08)60304-9; Ng TKY, 2001, J COMP NEUROL, V433, P458, DOI 10.1002/cne.1153; OLPE HR, 1980, BRAIN RES BULL, V5, P507, DOI 10.1016/0361-9230(80)90082-9; Pagano A, 2001, J NEUROSCI, V21, P1189; Patel S, 2001, PAIN, V90, P217, DOI 10.1016/S0304-3959(00)00404-8; PROCTOR WR, 1987, BRAIN RES, V426, P187, DOI 10.1016/0006-8993(87)90441-0; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; SAHA N, 1993, PHARMACOL TOXICOL, V72, P159, DOI 10.1111/j.1600-0773.1993.tb00309.x; SANDYK R, 1985, CLIN NEUROPHARMACOL, V8, P294, DOI 10.1097/00002826-198509000-00011; SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1; Schwartz RH, 2000, SOUTH MED J, V93, P558; Slesinger PA, 1997, P NATL ACAD SCI USA, V94, P12210, DOI 10.1073/pnas.94.22.12210; THOMPSON SM, 1992, J PHYSIOL-LONDON, V451, P347, DOI 10.1113/jphysiol.1992.sp019168; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Tozawa R, 2001, J BIOL CHEM, V276, P12624, DOI 10.1074/jbc.M011063200; VENABLE N, 1990, PSYCHOPHARMACOLOGY, V100, P215, DOI 10.1007/BF02244409; WALDMEIER PC, 1994, BRIT J PHARMACOL, V113, P1515, DOI 10.1111/j.1476-5381.1994.tb17168.x; Walker K, 1999, MOL MED TODAY, V5, P319, DOI 10.1016/S1357-4310(99)01493-8; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6	54	420	445	2	58	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					47	58		10.1016/S0896-6273(01)00345-2	http://dx.doi.org/10.1016/S0896-6273(01)00345-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498050	Bronze			2022-12-24	WOS:000170101100010
J	Chino, Y; Smith, EL; Zhang, B; Matsuura, K; Mori, T; Kaas, JH				Chino, Y; Smith, EL; Zhang, B; Matsuura, K; Mori, T; Kaas, JH			Recovery of binocular responses by cortical neurons after early monocular lesions	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; ADULT CAT; STRIATE CORTEX; REORGANIZATION; PLASTICITY; RETINA; MONKEY; MAPS		Univ Houston, Coll Optometry, Houston, TX 77204 USA; Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA	University of Houston System; University of Houston; Vanderbilt University	Chino, Y (corresponding author), Univ Houston, Coll Optometry, 505 J Davis Armistead Bldg, Houston, TX 77204 USA.				NATIONAL EYE INSTITUTE [R01EY002686, P30EY007551, R01EY003611, R01EY008128] Funding Source: NIH RePORTER; NEI NIH HHS [EY-07551, EY-03611, EY-08128, EY-02686] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Calford MB, 1999, P ROY SOC B-BIOL SCI, V266, P499, DOI 10.1098/rspb.1999.0665; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; CHINO YM, 1995, J NEUROSCI, V15, P2417, DOI 10.1523/JNEUROSCI.15-03-02417.1995; CHINO YM, 1997, SEMIN NEUROSCI, V9, P24; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; DARIANSMITH C, 1994, NATURE, V368, P737, DOI 10.1038/368737a0; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DAW N, 1995, VISUAL DEV; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; KAAS JH, 1973, BRAIN RES, V59, P61, DOI 10.1016/0006-8993(73)90253-9; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Murakami I, 1997, VISUAL NEUROSCI, V14, P89, DOI 10.1017/S0952523800008798; Tripathy SP, 1999, VISION RES, V39, P1917, DOI 10.1016/S0042-6989(98)00230-2	15	11	11	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					689	690		10.1038/89469	http://dx.doi.org/10.1038/89469			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426222				2022-12-24	WOS:000169621300011
J	Paradis, S; Sweeney, ST; Davis, GW				Paradis, S; Sweeney, ST; Davis, GW			Homeostatic control of presynaptic release is triggered by postsynaptic membrane depolarization	NEURON			English	Article							RECTIFIER POTASSIUM CHANNEL; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; FASCICLIN-II; FUNCTIONAL COMPONENTS; SYNAPTIC PLASTICITY; GENETIC DISSECTION; RETROGRADE SIGNAL; QUANTAL SIZE; DROSOPHILA	Homeostatic mechanisms regulate synaptic function to maintain nerve and muscle excitation within reasonable physiological limits. The mechanisms that initiate homeostasic changes to synaptic function are not known. We specifically impaired cellular depolarization by expressing the Kir2.1 potassium channel in Drosophila muscle. In Kir2.1-expressing muscle there is a persistent outward potassium current (similar to 10 nA), decreased muscle input resistance (50-fold), and a hyperpolarized resting potential. Despite impaired muscle excitability, synaptic depolarization of muscle achieves wild-type levels. A quantal analysis demonstrates that increased presynaptic release (quantal content), without a change in quantal size (mEPSC amplitude), compensates for altered muscle excitation. Because morphological synaptic growth is normal, we conclude that a homeostatic increase in presynaptic release compensates for impaired muscle excitability. These data demonstrate that a monitor of muscle membrane depolarization is sufficient to initiate synaptic homeostatic compensation.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Davis, GW (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.	gdavis@biochem.ucsf.edu		Sweeney, Sean/0000-0003-2673-9578	PHS HHS [44908-32374] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P894; BALICEGORDON RJ, 1990, J NEUROSCI, V10, P2660; BEKKERS JM, 1995, J NEUROPHYSIOL, V73, P1145, DOI 10.1152/jn.1995.73.3.1145; Bradley KK, 1999, J PHYSIOL-LONDON, V515, P639, DOI 10.1111/j.1469-7793.1999.639ab.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1990, J NEUROSCI, V10, P3754; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; CHAVEZNORIEGA LE, 1994, J NEUROSCI, V14, P310; Davis GW, 1998, CURR OPIN NEUROBIOL, V8, P149, DOI 10.1016/S0959-4388(98)80018-4; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; Davis GW, 2001, ANNU REV PHYSIOL, V63, P847, DOI 10.1146/annurev.physiol.63.1.847; Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Desai NS, 1999, NAT NEUROSCI, V2, P515, DOI 10.1038/9165; DiAntonio A, 1999, J NEUROSCI, V19, P3023; FALK G, 1963, P R SOC B, V160, P69; Ganetzky B, 1983, J NEUROGENET, V1, P17, DOI 10.3109/01677068309107069; Golowasch J, 1999, J NEUROSCI, V19, part. no., DOI 10.1523/JNEUROSCI.19-20-j0004.1999; Jarecki J, 1995, J NEUROSCI, V15, P8177; Johns DC, 1999, J NEUROSCI, V19, P1691; KATZ B, 1957, J PHYSIOL-LONDON, V137, P267, DOI 10.1113/jphysiol.1957.sp005811; KATZ E, 1995, J PHYSIOL-LONDON, V486, P695, DOI 10.1113/jphysiol.1995.sp020845; KUBO Y, 1993, NATURE, V362, P127, DOI 10.1038/362127a0; KUNO M, 1971, J PHYSIOL-LONDON, V213, P545, DOI 10.1113/jphysiol.1971.sp009399; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Liu Z, 1998, J NEUROSCI, V18, P2309; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; LNENICKA GA, 1983, J PHYSIOL-LONDON, V345, P261, DOI 10.1113/jphysiol.1983.sp014977; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; RAHAMIMOFF R, 1973, J PHYSIOL-LONDON, V228, P241, DOI 10.1113/jphysiol.1973.sp010084; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Silinsky EM, 2000, BRIT J PHARMACOL, V129, P360, DOI 10.1038/sj.bjp.0703036; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; TURRIGIANO G, 1995, J NEUROSCI, V15, P3640; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; ZHONG Y, 1991, SCIENCE, V252, P1562, DOI 10.1126/science.2047864; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1	46	185	186	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					737	749		10.1016/S0896-6273(01)00326-9	http://dx.doi.org/10.1016/S0896-6273(01)00326-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430807				2022-12-24	WOS:000169508900014
J	Zacks, JM; Braver, TS; Sheridan, MA; Donaldson, DI; Snyder, AZ; Ollinger, JM; Buckner, RL; Raichle, ME				Zacks, JM; Braver, TS; Sheridan, MA; Donaldson, DI; Snyder, AZ; Ollinger, JM; Buckner, RL; Raichle, ME			Human brain activity time-locked to perceptual event boundaries	NATURE NEUROSCIENCE			English	Article							HUMAN CEREBRAL-CORTEX; EYE; ATTENTION; BEHAVIOR; SYSTEMS; RIVALRY; AREAS	Temporal structure has a major role in human understanding of everyday events. Observers are able to segment ongoing activity into temporal parts and sub-parts that are reliable, meaningful and correlated with ecologically relevant features of the action. Here we present evidence that a network of brain regions is tuned to perceptually salient event boundaries, both during intentional event segmentation and during naive passive viewing of events. Activity within this network may provide a basis for parsing the temporally evolving environment into meaningful units.	Washington Univ, Dept Psychol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63130 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zacks, JM (corresponding author), Washington Univ, Dept Psychol, 1 Brookings Dr, St Louis, MO 63130 USA.		Zacks, Jeffrey M/E-9099-2011; Donaldson, David I/A-5249-2009	Zacks, Jeffrey M/0000-0003-1171-3690; Donaldson, David I/0000-0002-8036-3455; Sheridan, Margaret/0000-0002-8909-7501; Braver, Todd/0000-0002-2631-3393				AVRAHAMI J, 1994, COGNITION, V53, P239, DOI 10.1016/0010-0277(94)90050-7; Bonda E, 1996, J NEUROSCI, V16, P3737; Corbetta M, 1998, NEURON, V21, P761, DOI 10.1016/S0896-6273(00)80593-0; Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831; Decety J, 1999, TRENDS COGN SCI, V3, P172, DOI 10.1016/S1364-6613(99)01312-1; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Grafman J, 1995, ANN NY ACAD SCI, V769, P337, DOI 10.1111/j.1749-6632.1995.tb38149.x; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Nelson K., 1986, EVENT KNOWLEDGE STRU, P21; NEWTSON D, 1976, J EXP SOC PSYCHOL, V12, P436, DOI 10.1016/0022-1031(76)90076-7; NEWTSON D, 1977, J PERS SOC PSYCHOL, V35, P847, DOI 10.1037/0022-3514.35.12.847; OLLINGER JM, 2000, FUNCTIONAL MAPPING H; Paus T, 1996, NEUROPSYCHOLOGIA, V34, P475, DOI 10.1016/0028-3932(95)00134-4; Talairach J., 1988, COPLANAR STEREOTAXIC; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; TOOTELL RBH, 1995, CEREB CORTEX, V5, P39, DOI 10.1093/cercor/5.1.39; Van Essen DC, 1998, P NATL ACAD SCI USA, V95, P788, DOI 10.1073/pnas.95.3.788; VanEssen DC, 1997, J NEUROSCI, V17, P7079; WATSON JDG, 1993, CEREB CORTEX, V3, P79, DOI 10.1093/cercor/3.2.79; Wynn K, 1996, PSYCHOL SCI, V7, P164, DOI 10.1111/j.1467-9280.1996.tb00350.x; Zacks JM, 2001, PSYCHOL BULL, V127, P3, DOI 10.1037//0033-2909.127.1.3; Zacks JM, 2001, J EXP PSYCHOL GEN, V130, P29, DOI 10.1037//0096-3445.130.1.29	26	308	311	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					651	655		10.1038/88486	http://dx.doi.org/10.1038/88486			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438PG	11369948				2022-12-24	WOS:000169061800020
J	Bronk, P; Wenniger, JJ; Dawson-Scully, K; Guo, XF; Hong, S; Atwood, HL; Zinsmaier, KE				Bronk, P; Wenniger, JJ; Dawson-Scully, K; Guo, XF; Hong, S; Atwood, HL; Zinsmaier, KE			Drosophila Hsc70-4 is critical for neurotransmitter exocytosis in vivo	NEURON			English	Article							CYSTEINE-STRING PROTEIN; TRANSMITTER RELEASE; HEAT-SHOCK; SYNAPTIC-TRANSMISSION; CALCIUM SENSITIVITY; CLATHRIN; OVEREXPRESSION; FACILITATION; EXPRESSION; MUTATIONS	Previous in vitro studies of cysteine-string protein (CSP) imply a potential role for the clathrin-uncoating ATPase Hsc70 in exocytosis. We show that hypomorphic mutations in Drosophila Hsc70-4 (Hsc4) impair nerve-evoked neurotransmitter release, but not synaptic vesicle recycling in vivo. The loss of release can be restored by increasing external or internal Ca2+ and is caused by a reduced Ca2+ sensitivity of exocytosis downstream of Ca2+ entry. Hsc4 and CSP are likely to act in common pathways, as indicated by their in vitro protein interaction, the similar loss of evoked release in individual and double mutants, and genetic interactions causing a loss of release in trans-heterozygous hsc4-csp double mutants. We suggest that Hsc4 and CSP cooperatively augment the probability of release by increasing the Ca2+ sensitivity of vesicle fusion.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA; Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada	University of Pennsylvania; University of Toronto	Zinsmaier, KE (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 234D Stemmler Hall, Philadelphia, PA 19104 USA.	zinsmaie@mail.med.upenn.edu	Dawson-Scully, Ken/B-6438-2008		NIMH NIH HHS [MH12611F31] Funding Source: Medline; NINDS NIH HHS [R01NS38274] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH012611] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038274] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Benfenati F, 1999, PHILOS T R SOC B, V354, P243, DOI 10.1098/rstb.1999.0376; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Capogna M, 1998, PHARMACOL THERAPEUT, V77, P203, DOI 10.1016/S0163-7258(97)00162-9; CECCARELLI B, 1973, J CELL BIOL, V57, P499, DOI 10.1083/jcb.57.2.499; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 2000, J NEUROCHEM, V74, P1781, DOI 10.1046/j.1471-4159.2000.0741781.x; CHANG HG, 1994, J PHYSIOL-LONDON, V476, P1; CRAIG EA, 1983, DEV BIOL, V99, P418, DOI 10.1016/0012-1606(83)90291-9; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Graham ME, 2000, J NEUROSCI, V20, P1281; Greener T, 2001, NAT CELL BIOL, V3, P215, DOI 10.1038/35055137; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; Hing HK, 1999, EUR J CELL BIOL, V78, P690, DOI 10.1016/S0171-9335(99)80037-5; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Jiang RF, 2000, J BIOL CHEM, V275, P8439, DOI 10.1074/jbc.275.12.8439; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; Newmyer SL, 2001, J CELL BIOL, V152, P607, DOI 10.1083/jcb.152.3.607; Nie ZP, 1999, J NEUROSCI, V19, P10270; PALTER KB, 1986, MOL CELL BIOL, V6, P1187, DOI 10.1128/MCB.6.4.1187; PERKINS LA, 1990, MOL CELL BIOL, V10, P3232, DOI 10.1128/MCB.10.6.3232; Ranjan R, 1998, J NEUROSCI, V18, P956; Rorth P, 1998, DEVELOPMENT, V125, P1049; ROTHMAN JE, 1986, CELL, V46, P5, DOI 10.1016/0092-8674(86)90852-4; RUBIN DM, 1993, GENE, V128, P155, DOI 10.1016/0378-1119(93)90558-K; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SPRADLING AC, 1995, P NATL ACAD SCI USA, V92, P10824, DOI 10.1073/pnas.92.24.10824; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Takahashi T, 2000, SCIENCE, V289, P460, DOI 10.1126/science.289.5478.460; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; Umbach JA, 1997, J NEUROSCI, V17, P7203; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Yuan LL, 1999, SCIENCE, V283, P1343, DOI 10.1126/science.283.5406.1343; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	46	100	103	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					475	488		10.1016/S0896-6273(01)00292-6	http://dx.doi.org/10.1016/S0896-6273(01)00292-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395008	Bronze			2022-12-24	WOS:000168962000019
J	Betz, A; Thakur, P; Junge, HJ; Ashery, U; Rhee, JS; Scheuss, V; Rosenmund, C; Rettig, J; Brose, N				Betz, A; Thakur, P; Junge, HJ; Ashery, U; Rhee, JS; Scheuss, V; Rosenmund, C; Rettig, J; Brose, N			Functional interaction of the active zone proteins Munc13-1 and RIM1 in synaptic vesicle priming	NEURON			English	Article							NEUROTRANSMITTER RELEASE; CRYSTAL-STRUCTURE; CHROMAFFIN CELLS; COMPLEX; UNC-13; EXPRESSION; EXOCYTOSIS; SYNTAXIN; SYSTEM; FUSION	Synaptic neurotransmitter release is restricted to active zones, where the processes of synaptic vesicle tethering, priming to fusion competence, and Ca2+-triggered fusion are taking place in a highly coordinated manner, We show that the active zone components Munc13-1, an essential vesicle priming protein, and RIM1, a Rab3 effector with a putative role in vesicle tethering, interact functionally. Disruption of this interaction causes a loss of fusion-competent synaptic vesicles, creating a phenocopy of Munc13-1-deficient neurons. RIM1 binding and Vesicle priming are mediated by two distinct structural modules of Munc13-1. The Munc13-1/RIM1 interaction may create a functional link between synaptic vesicle tethering and priming, or it may regulate the priming reaction itself, thereby determining the number of fusion-competent vesicles.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, Abt Neurogenet, D-37075 Gottingen, Germany; Univ Saarland, Inst Physiol, D-66421 Homburg, Germany	Max Planck Society; Max Planck Society; Saarland University	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.	crosenm@gwdg.de; jrettig@med-rz.uni-sb.de; brose@em.mpg.de	Rosenmund, Christian/AAC-3596-2020; Rettig, Jens/K-5103-2013; Volker, Scheuss/G-7846-2015	Rosenmund, Christian/0000-0002-3905-2444; Rettig, Jens/0000-0001-6160-3954; Ashery, Uri/0000-0001-6338-7888; JUNGE, HARALD/0000-0003-2458-6010; Scheuss, Volker/0000-0002-0659-3228				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 1997, J BIOL CHEM, V272, P2520; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; BROSE N, 1995, J BIOL CHEM, V270, P25273, DOI 10.1074/jbc.270.42.25273; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fenster SD, 2000, NEURON, V25, P203, DOI 10.1016/S0896-6273(00)80883-1; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GARCIA EP, 1995, J CELL BIOL, V129, P105, DOI 10.1083/jcb.129.1.105; Gonzalez L, 1999, CELL, V96, P755, DOI 10.1016/S0092-8674(00)80585-1; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Kohn RE, 2000, MOL BIOL CELL, V11, P3441, DOI 10.1091/mbc.11.10.3441; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; OLKKONEN VM, 1993, J NEUROSCI RES, V35, P445, DOI 10.1002/jnr.490350412; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Ozaki N, 2000, NAT CELL BIOL, V2, P805, DOI 10.1038/35041046; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Sassa T, 1999, J NEUROSCI, V19, P4772; Song Y, 1998, KIDNEY INT, V53, P1689, DOI 10.1046/j.1523-1755.1998.00942.x; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wang Y, 1997, NATURE, V388, P593, DOI 10.1038/41580; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	35	292	304	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					183	196		10.1016/S0896-6273(01)00272-0	http://dx.doi.org/10.1016/S0896-6273(01)00272-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343654	Bronze, Green Published			2022-12-24	WOS:000168412900020
J	Swadlow, HA; Gusev, AG				Swadlow, HA; Gusev, AG			The impact of 'bursting' thalamic impulses at a neocortical synapse	NATURE NEUROSCIENCE			English	Article							LATERAL GENICULATE NEURONS; FUNCTIONAL-ORGANIZATION; INHIBITORY INTERNEURONS; CAT; CELLS; NUCLEUS; RABBIT; ELECTROPHYSIOLOGY; TRANSMISSION; INFORMATION	Considerable effort has gone into understanding the mechanisms underlying high-frequency 'bursting' of thalamocortical impulses, their sensory information content and their involvement in perception. However, little is known about the influence of such impulses on their cortical targets. Here we follow bursting thalamic impulses to their terminus at the thalamocortical synapse of the awake rabbit, and examine their influence on a class of somatosensory cortical neurons. We show that thalamic bursts potently activate cortical circuits. Initial impulses of each burst have a greatly enhanced ability to elicit cortical action potentials, and later impulses in the burst further raise the probability of eliciting spikes. In some cases, multiple cortical spikes result from a single burst. Moreover, we show that the interval preceding each burst is crucial for generating the enhanced cortical response. The powerful activation of neocortex by thalamocortical bursts is fully consistent with an involvement of these impulses in perceptual/attentional processes.	Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; Russian Acad Med Sci, Moscow Brain Res Inst, Moscow 103064, Russia	University of Connecticut; Russian Academy of Medical Sciences	Swadlow, HA (corresponding author), Univ Connecticut, Dept Psychol, 406 Babbidge Rd, Storrs, CT 06269 USA.	swadlow@psych.psy.uconn.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH059322] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-59322] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AGMON A, 1992, J NEUROSCI, V12, P319; Biesold, 1990, BRAIN CHOLINERGIC SY, P3; COENEN AML, 1972, EXP BRAIN RES, V14, P227, DOI 10.1007/BF00816160; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; ECKHORN R, 1993, J NEUROSCI METH, V49, P175, DOI 10.1016/0165-0270(93)90121-7; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gil Z, 1997, NEURON, V19, P679, DOI 10.1016/S0896-6273(00)80380-3; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Guido W, 1998, VISUAL NEUROSCI, V15, P231, DOI 10.1017/S0952523898152033; GUIDO W, 1995, J NEUROPHYSIOL, V74, P1782, DOI 10.1152/jn.1995.74.4.1782; KRAMIS R, 1975, EXP NEUROL, V49, P58, DOI 10.1016/0014-4886(75)90195-8; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; LU SM, 1992, J NEUROPHYSIOL, V68, P2185, DOI 10.1152/jn.1992.68.6.2185; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MCCORMICK DA, 1990, NEUROSCIENCE, V39, P103, DOI 10.1016/0306-4522(90)90225-S; METHERATE R, 1993, SYNAPSE, V14, P132, DOI 10.1002/syn.890140206; MUKHERJEE P, 1995, J NEUROPHYSIOL, V74, P1222, DOI 10.1152/jn.1995.74.3.1222; Ramcharan EJ, 2000, J NEUROPHYSIOL, V84, P1982, DOI 10.1152/jn.2000.84.4.1982; Ramcharan EJ, 2000, VISUAL NEUROSCI, V17, P55, DOI 10.1017/S0952523800171056; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; REITBOECK HJ, 1983, J NEUROSCI METH, V8, P249, DOI 10.1016/0165-0270(83)90038-9; Sherman SM, 1996, J NEUROPHYSIOL, V76, P1367, DOI 10.1152/jn.1996.76.3.1367; SHERMAN SM, 1986, EXP BRAIN RES, V63, P1; SILLITO AM, 1983, BRAIN RES, V289, P143, DOI 10.1016/0006-8993(83)90015-X; SIMONS LH, 1989, CONSERV BIOL, V3, P11, DOI 10.1111/j.1523-1739.1989.tb00218.x; STERIADE M, 1988, PHYSIOL REV, V68, P649, DOI 10.1152/physrev.1988.68.3.649; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; Usrey WM, 2000, J NEUROSCI, V20, P5461, DOI 10.1523/JNEUROSCI.20-14-05461.2000; WEYAND TG, IN PRESS J NEUROPHYS	34	331	339	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					402	408		10.1038/86054	http://dx.doi.org/10.1038/86054			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276231				2022-12-24	WOS:000168762200021
J	Soto-Trevino, C; Thoroughman, KA; Marder, E; Abbott, LF				Soto-Trevino, C; Thoroughman, KA; Marder, E; Abbott, LF			Activity-dependent modification of inhibitory synapses in models of rhythmic neural networks	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; LOBSTER STOMATOGASTRIC GANGLION; GRADED SYNAPTIC TRANSMISSION; HEARTBEAT ELEMENTAL OSCILLATOR; TRANSIENT POTASSIUM CURRENT; MOTOR PATTERN GENERATION; PHASE-SHIFTS; RECIPROCAL INHIBITION; DOPAMINE MODULATION; SPIKING NEURONS	The faithful production of rhythms by many neural circuits depends critically on the strengths of inhibitory synaptic connections. We propose a model in which the strengths of inhibitory synapses in a central pattern-generating circuit are subject to activity-dependent plasticity. The strength of each synapse is modified as a function of the global activity of the postsynaptic neuron and by correlated activity of the pre- and postsynaptic neurons. This allows the self-assembly, from random initial synaptic strengths, of two cells into reciprocal oscillation and three cells into a rhythmic triphasic motor pattern. This self-assembly illustrates that complex oscillatory circuits that depend on multiple inhibitory synaptic connections can be tuned via simple activity-dependent rules.	Brandeis Univ, Volen Ctr, Waltham, MA 02454 USA; Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Thoroughman, KA (corresponding author), Brandeis Univ, Volen Ctr, Mail Stop 013,415 South St, Waltham, MA 02454 USA.				NIMH NIH HHS [MH 46742] Funding Source: Medline; NINDS NIH HHS [NS 07292] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046742, R37MH046742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007292] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X; ANGSTADT JD, 1991, J NEUROSCI, V11, P746; ARBAS EA, 1987, J NEUROSCI, V7, P3953; Brown TG, 1914, J PHYSIOL-LONDON, V48, P18; CASASNOVAS B, 1995, J NEUROSCI, V15, P5703; EISEN JS, 1984, J NEUROPHYSIOL, V51, P1375, DOI 10.1152/jn.1984.51.6.1375; FRIESEN WO, 1994, NEUROSCI BIOBEHAV R, V18, P547; Golowasch J, 1999, NEURAL COMPUT, V11, P1079, DOI 10.1162/089976699300016359; GRAUBARD K, 1980, P NATL ACAD SCI-BIOL, V77, P3733, DOI 10.1073/pnas.77.6.3733; GRAUBARD K, 1983, J NEUROPHYSIOL, V50, P508, DOI 10.1152/jn.1983.50.2.508; Grillner S, 1998, ANN NY ACAD SCI, V860, P1, DOI 10.1111/j.1749-6632.1998.tb09035.x; Harris -Warrick R.M., 1992, DYNAMIC BIOL NETWORK; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; HARRISWARRICK RM, 1995, J NEUROPHYSIOL, V74, P1404, DOI 10.1152/jn.1995.74.4.1404; HARTLINE DK, 1979, BIOL CYBERN, V33, P209, DOI 10.1007/BF00337410; HARTLINE DK, 1988, COMP BIOCHEM PHYS C, V91, P115, DOI 10.1016/0742-8413(88)90177-6; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; KORN H, 1992, P NATL ACAD SCI USA, V89, P440, DOI 10.1073/pnas.89.1.440; LEMASSON G, 1993, SCIENCE, V259, P1915, DOI 10.1126/science.8456317; Liu Z, 1998, J NEUROSCI, V18, P2309; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; MARTY A, 1995, CURR OPIN NEUROBIOL, V5, P335, DOI 10.1016/0959-4388(95)80046-8; MILLER JP, 1982, J NEUROPHYSIOL, V48, P1416, DOI 10.1152/jn.1982.48.6.1416; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; NADIM F, 1995, J COMPUT NEUROSCI, V2, P215, DOI 10.1007/BF00961435; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; Oda Y, 1998, NATURE, V394, P182, DOI 10.1038/28172; ODA Y, 1995, J NEUROPHYSIOL, V74, P1056, DOI 10.1152/jn.1995.74.3.1056; Olsen OH, 1996, J NEUROSCI, V16, P4958; OLSEN OH, 1995, J COMPUT NEUROSCI, V2, P237, DOI 10.1007/BF00961436; Richards KS, 1999, J NEUROPHYSIOL, V82, P2006, DOI 10.1152/jn.1999.82.4.2006; SATTERLIE RA, 1985, SCIENCE, V229, P402, DOI 10.1126/science.229.4711.402; SIEGEL M, 1994, P NATL ACAD SCI USA, V91, P11308, DOI 10.1073/pnas.91.24.11308; Sillar KT, 1998, ANN NY ACAD SCI, V860, P318, DOI 10.1111/j.1749-6632.1998.tb09059.x; Skinner F K, 1994, J Comput Neurosci, V1, P69, DOI 10.1007/BF00962719; TIERNEY AJ, 1992, J NEUROPHYSIOL, V67, P599, DOI 10.1152/jn.1992.67.3.599; WANG XJ, 1992, NEURAL COMPUT, V4, P84, DOI 10.1162/neco.1992.4.1.84	38	67	67	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					297	303		10.1038/85147	http://dx.doi.org/10.1038/85147			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224547				2022-12-24	WOS:000167178300018
J	Pierani, A; Moran-Rivard, L; Sunshine, MJ; Littman, DR; Goulding, M; Jessell, TM				Pierani, A; Moran-Rivard, L; Sunshine, MJ; Littman, DR; Goulding, M; Jessell, TM			Control of interneuron fate in the developing spinal cord by the progenitor homeodomain protein Dbx1	NEURON			English	Article							VENTRAL NEURAL-TUBE; LIM HOMEOBOX GENES; MOTOR-NEURON; COMMISSURAL NEURONS; CELL IDENTITY; EXPRESSION; SPECIFICATION; ENGRAILED-1; MOUSE; MOTONEURONES	Spinal interneurons help to coordinate motor behavior. During spinal cord development, distinct classes of interneurons are generated from progenitor cells located at different positions within the ventral neural tube. V0 and V1 interneurons derive from adjacent progenitor domains that are distinguished by expression of the homeodomain proteins Dbx1 and Dbx2. The spatially restricted expression of Dbx1 has a critical role in establishing the distinction in V0 and V1 neuronal fate. In Dbx1 mutant mice, neural progenitors fail to generate V0 neurons and instead give rise to interneurons that express many characteristics of V1 neurons-their transcription factor profile, neurotransmitter phenotype, migratory pattern, and aspects of their axonal trajectory. Thus, a single progenitor homeodomain transcription factor coordinates many of the differentiated properties of one class of interneurons generated in the ventral spinal cord.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA; NYU Med Ctr, Howard Hughes Med Inst, Skirball Inst Biomol Med, New York, NY 10016 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Columbia University; Howard Hughes Medical Institute; Howard Hughes Medical Institute; New York University; Salk Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA.	tmj1@columbia.edu	Pierani, Alessandra/O-6136-2017	Pierani, Alessandra/0000-0002-4872-4791; Sunshine, Mary Jean/0000-0002-2188-7881				Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brown AG, 1981, ORG SPINAL CORD; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Clarac F, 2000, TRENDS NEUROSCI, V23, P199, DOI 10.1016/S0166-2236(99)01535-0; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Ericson J, 1997, COLD SPRING HARB SYM, V62, P451; Gershon AA, 2000, DEVELOPMENT, V127, P2945; Herault Y, 1996, EMBO J, V15, P6727, DOI 10.1002/j.1460-2075.1996.tb01062.x; HUGHES SH, 1987, J VIROL, V61, P3004, DOI 10.1128/JVI.61.10.3004-3012.1987; HULTBORN H, 1971, J PHYSIOL-LONDON, V215, P591, DOI 10.1113/jphysiol.1971.sp009487; JANKOWSKA E, 1972, J PHYSIOL-LONDON, V222, P623, DOI 10.1113/jphysiol.1972.sp009818; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; LU SW, 1994, MECH DEVELOP, V47, P187, DOI 10.1016/0925-4773(94)90089-2; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Matise MP, 1997, J NEUROSCI, V17, P7805; McMahon AP, 2000, GENE DEV, V14, P2261, DOI 10.1101/gad.840800; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morgan BA, 1996, METHOD CELL BIOL, V51, P185, DOI 10.1016/S0091-679X(08)60629-9; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muramatsu T, 1998, INT J MOL MED, V1, P55; Phelps PE, 1996, DEVELOPMENT, V122, P2013; PHELPS PE, 1995, J COMP NEUROL, V355, P38, DOI 10.1002/cne.903550107; PHELPS PE, 1993, J COMP NEUROL, V330, P1, DOI 10.1002/cne.903300102; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Saueressig H, 1999, DEVELOPMENT, V126, P4201; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Shoji H, 1996, MECH DEVELOP, V56, P25, DOI 10.1016/0925-4773(96)00509-6; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; SILOSSANTIAGO I, 1994, J COMP NEUROL, V342, P221, DOI 10.1002/cne.903420206; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; Wenner P, 1998, ANN NY ACAD SCI, V860, P425, DOI 10.1111/j.1749-6632.1998.tb09066.x; Wenner P, 2000, J NEUROPHYSIOL, V84, P2651, DOI 10.1152/jn.2000.84.5.2651; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; Zhou YH, 2000, DEVELOPMENT, V127, P3829; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	45	278	282	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					367	384		10.1016/S0896-6273(01)00212-4	http://dx.doi.org/10.1016/S0896-6273(01)00212-4			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239429	Bronze			2022-12-24	WOS:000167141700012
J	Zella, JC; Brugge, JF; Schnupp, JWH				Zella, JC; Brugge, JF; Schnupp, JWH			Passive eye displacement alters auditory spatial receptive fields of cat superior colliculus neurons	NATURE NEUROSCIENCE			English	Article							SENSORIMOTOR INTEGRATION; POSITION; SPACE		Univ Wisconsin, Dept Physiol, Madison, WI 53705 USA; Univ Wisconsin, Waisman Ctr 627, Madison, WI 53705 USA; Univ Oxford, Physiol Lab, Oxford OX1 3PT, England	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Oxford	Schnupp, JWH (corresponding author), Univ Wisconsin, Dept Physiol, Madison, WI 53705 USA.		schnupp, jan/A-3006-2012	schnupp, jan w h/0000-0002-2604-0057	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NICHD NIH HHS [HD03352] Funding Source: Medline; NIDCD NIH HHS [DC00116] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Abrahams V C, 1979, Prog Brain Res, V50, P325; Brugge JF, 1996, J NEUROSCI, V16, P4420; Groh JM, 2001, NEURON, V29, P509, DOI 10.1016/S0896-6273(01)00222-7; GUTHRIE BL, 1983, SCIENCE, V221, P1193, DOI 10.1126/science.6612334; HARTLINE PH, 1995, EXP BRAIN RES, V104, P402; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; NELSON JS, 1989, J NEUROPHYSIOL, V62, P1360, DOI 10.1152/jn.1989.62.6.1360; PECK CK, 1995, EXP BRAIN RES, V103, P227; Quaia C, 1999, J NEUROPHYSIOL, V82, P999, DOI 10.1152/jn.1999.82.2.999	13	15	15	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1167	1169		10.1038/nn773	http://dx.doi.org/10.1038/nn773			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713474				2022-12-24	WOS:000172525000009
J	Krichevsky, AM; Kosik, KS				Krichevsky, AM; Kosik, KS			Neuronal RNA granules: A link between RNA localization and stimulation-dependent translation	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; LOCAL PROTEIN-SYNTHESIS; LONG-TERM FACILITATION; HEAT-SHOCK RESPONSE; MESSENGER-RNA; TARGETING ELEMENT; STRESS GRANULES; LIVING NEURONS; KINASE-II; BC1 RNA	RNA granules are a macromolecular structure observed in neurons, where they serve as motile units that translocate mRNAs. Isolated RNA granules are highly enriched in Staufen protein and ultrastructurally contain densely packed clusters of ribosomes. With depolarization, many mRNAs, including those involved in plasticity, rapidly shift from the RNA granule fraction to polysomes. Depolarization reorganizes granules and induces a less compact organization of their ribosomes. RNA granules are not translationally competent, as indicated by the failure to incorporate radioactive amino acids and the absence of eIF4E, 4G, and tRNAs. We concluded that RNA granules are a local storage compartment for mRNAs under translational arrest but are poised for release to actively translated pools. Local release of mRNAs and ribosomes from granules may serve as a macromolecular mechanism linking RNA localization to translation and synaptic plasticity.	Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Kosik, KS (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.			Krichevsky, Anna/0000-0002-5080-5507	NIA NIH HHS [AG06601] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG006601] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bagni C, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-10-j0004.2000; BARBARESE E, 1995, J CELL SCI, V108, P2781; Benson DL, 1997, NEUROREPORT, V8, P823, DOI 10.1097/00001756-199703030-00004; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; ESCOBAR MI, 1986, NEUROSCIENCE, V17, P975, DOI 10.1016/0306-4522(86)90074-6; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; FORRISTALL C, 1995, DEVELOPMENT, V121, P201; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kashikawa M, 1999, DEV GROWTH DIFFER, V41, P495; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KLOC M, 1995, DEVELOPMENT, V121, P287; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kobayashi S, 1998, BIOCHEM BIOPH RES CO, V253, P448, DOI 10.1006/bbrc.1998.9704; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Lipshitz HD, 2000, CURR OPIN GENET DEV, V10, P476, DOI 10.1016/S0959-437X(00)00116-7; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Muslimov IA, 1997, J NEUROSCI, V17, P4722; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; NOVER L, 1991, NEW BIOL, V3, P855; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Racca C, 1997, J NEUROSCI, V17, P1691; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; SIERRA JM, 1994, MOL BIOL REP, V19, P211, DOI 10.1007/BF00986963; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; SUNDELL CL, 1990, J CELL BIOL, V111, P2397, DOI 10.1083/jcb.111.6.2397; Tiedge H, 1996, J NEUROSCI, V16, P7171; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; Tujebajeva RM, 2000, J BIOL CHEM, V275, P6288, DOI 10.1074/jbc.275.9.6288; van der Velden AW, 1999, INT J BIOCHEM CELL B, V31, P87, DOI 10.1016/S1357-2725(98)00134-4; Wallace CS, 1998, J NEUROSCI, V18, P26; Walsh DM, 1997, J BIOL CHEM, V272, P22364, DOI 10.1074/jbc.272.35.22364; Wanner I, 1997, HISTOCHEM CELL BIOL, V108, P345, DOI 10.1007/s004180050175; Wilhelm JE, 2000, J CELL BIOL, V148, P427, DOI 10.1083/jcb.148.3.427; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; ZIMMERMAN JL, 1989, PLANT CELL, V1, P1137, DOI 10.1105/tpc.1.12.1137	52	396	408	0	21	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					683	696		10.1016/S0896-6273(01)00508-6	http://dx.doi.org/10.1016/S0896-6273(01)00508-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719208	Bronze			2022-12-24	WOS:000172363900014
J	Liu, DX; Greene, LA				Liu, DX; Greene, LA			Regulation of neuronal survival and death by E2F-dependent gene repression and derepression	NEURON			English	Article							CYCLIN-DEPENDENT KINASES; TRANSCRIPTION FACTOR E2F-1; DIFFERENTIATED PC12 CELLS; NERVE GROWTH-FACTOR; S-PHASE ENTRY; SYMPATHETIC NEURONS; RETINOBLASTOMA PROTEIN; APOPTOTIC RESPONSE; PROMOTE SURVIVAL; JNK ACTIVATION	Neuronal death induced by a variety of means requires participation of the E2F family of transcription factors. Here, we show that E2F acts as a gene silencer in neurons and that repression of E2F-responsive genes is required for neuronal survival. Moreover, neuronal death evoked by DNA damaging agents or trophic factor withdrawal is characterized by derepression of E2F-responsive genes. Such derepression, rather than direct E2F-promoted gene activation, is required for death. Among the genes that are derepressed in neurons subjected to DNA damage or trophic factor withdrawal are the transcription factors B- and C-myb. Overexpression of B- and C-myb is sufficient to evoke neuronal death. These findings support a model in which E2F-dependent gene repression and derepression play pivotal roles in neuronal survival and death, respectively.	Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Ctr Alzheimers Dis Res, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Columbia University	Liu, DX (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pathol, Taub Ctr Alzheimers Dis Res, 630 W 168th St, New York, NY 10032 USA.				NIA NIH HHS [AG00189-12] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aloyz RS, 1998, J CELL BIOL, V143, P1691, DOI 10.1083/jcb.143.6.1691; Athanasiou M, 1996, ONCOGENE, V12, P337; Athanasiou MC, 1998, MOL CELL NEUROSCI, V12, P16, DOI 10.1006/mcne.1998.0699; BIES J, 1995, CANCER RES, V55, P501; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cheng HK, 1999, DECIS SUPPORT SYST, V25, P19, DOI 10.1016/S0167-9236(98)00089-X; Chow KNB, 1996, MOL CELL BIOL, V16, P4862; Courtney MJ, 1999, EUR J NEUROSCI, V11, P1073, DOI 10.1046/j.1460-9568.1999.00520.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; ESTUS S, 1994, J CELL BIOL, V127, P1717, DOI 10.1083/jcb.127.6.1717; Farinelli SE, 1996, J NEUROSCI, V16, P1150, DOI 10.1523/jneurosci.16-03-01150.1996; FREEMAN RS, 1994, NEURON, V12, P343, DOI 10.1016/0896-6273(94)90276-3; Giovanni A, 1999, J BIOL CHEM, V274, P19011, DOI 10.1074/jbc.274.27.19011; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guegan C, 1997, NEUROREPORT, V8, P1003, DOI 10.1097/00001756-199703030-00037; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; He S, 2000, MOL CELL BIOL, V20, P363, DOI 10.1128/MCB.20.1.363-371.2000; Hou ST, 2000, J NEUROCHEM, V75, P91, DOI 10.1046/j.1471-4159.2000.0750091.x; Hsieh JK, 1997, GENE DEV, V11, P1840, DOI 10.1101/gad.11.14.1840; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; JOHNSON AF, 1993, ECOSYSTEMS WORLD, V2, P365; Kranenburg O, 1996, EMBO J, V15, P46, DOI 10.1002/j.1460-2075.1996.tb00332.x; LAM EWF, 1993, EMBO J, V12, P2705, DOI 10.1002/j.1460-2075.1993.tb05932.x; Liu DX, 2001, CELL TISSUE RES, V305, P217, DOI 10.1007/s004410100396; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Macleod KF, 1996, EMBO J, V15, P6178, DOI 10.1002/j.1460-2075.1996.tb01006.x; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Mattson MP, 2000, NAT REV MOL CELL BIO, V1, P120, DOI 10.1038/35040009; McShea A, 1997, AM J PATHOL, V150, P1933; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Morris EJ, 1996, J CELL BIOL, V134, P757, DOI 10.1083/jcb.134.3.757; Morris EJ, 2001, J NEUROSCI, V21, P5017, DOI 10.1523/JNEUROSCI.21-14-05017.2001; Muller H, 2001, GENE DEV, V15, P267, DOI 10.1101/gad.864201; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Osuga H, 2000, P NATL ACAD SCI USA, V97, P10254, DOI 10.1073/pnas.170144197; Padmanabhan J, 1999, J NEUROSCI, V19, P8747, DOI 10.1523/JNEUROSCI.19-20-08747.1999; Park DS, 1998, J CELL BIOL, V143, P457, DOI 10.1083/jcb.143.2.457; Park DS, 2000, J NEUROSCI, V20, P3104, DOI 10.1523/JNEUROSCI.20-09-03104.2000; Park DS, 1997, J NEUROSCI, V17, P8975; Park DS, 1996, J BIOL CHEM, V271, P8161, DOI 10.1074/jbc.271.14.8161; Park DS, 1997, J NEUROSCI, V17, P1256, DOI 10.1523/jneurosci.17-04-01256.1997; Park DS, 1996, J BIOL CHEM, V271, P21898, DOI 10.1074/jbc.271.36.21898; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; QIN XQ, 1994, P NATL ACAD SCI USA, V91, P10918, DOI 10.1073/pnas.91.23.10918; Raina A K, 2000, Prog Cell Cycle Res, V4, P235; Sala A, 1996, CANCER RES, V56, P1991; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Shin DH, 2001, BRAIN RES, V892, P203, DOI 10.1016/S0006-8993(00)03300-X; SLANSKY JE, 1993, MOL CELL BIOL, V13, P1610, DOI 10.1128/MCB.13.3.1610; Stiewe T, 2000, NAT GENET, V26, P464, DOI 10.1038/82617; Troy CM, 2001, J NEUROSCI, V21, P5007, DOI 10.1523/JNEUROSCI.21-14-05007.2001; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhu XW, 1999, AM J PATHOL, V155, P327, DOI 10.1016/S0002-9440(10)65127-9	56	107	112	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					425	438		10.1016/S0896-6273(01)00495-0	http://dx.doi.org/10.1016/S0896-6273(01)00495-0			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709154	Bronze			2022-12-24	WOS:000172119100009
J	Schuett, S; Bonhoeffer, T; Hubener, M				Schuett, S; Bonhoeffer, T; Hubener, M			Pairing-induced changes of orientation maps in cat visual cortex	NEURON			English	Article							LONG-TERM DEPRESSION; STRIATE CORTEX; MONOCULAR DEPRIVATION; SYNAPTIC PLASTICITY; OCULAR DOMINANCE; RECEPTIVE-FIELD; INTRACORTICAL INHIBITION; CORTICAL-NEURONS; RAT HIPPOCAMPUS; PYRAMIDAL CELLS	We have studied the precise temporal requirements for plasticity of orientation preference maps in kitten visual cortex. Pairing a brief visual stimulus with electrical stimulation in the cortex, we found that the relative timing determines the direction of plasticity: a shift in orientation preference toward the paired orientation occurs if the cortex is activated first visually and then electrically; the cortical response to the paired orientation is diminished if the sequence of visual and electrical activation is reversed. We furthermore show that pinwheel centers are less affected by the pairing than the pinwheel surround. Thus, plasticity is not uniformly distributed across the cortex, and, most importantly, the same spike time-dependent learning rules that have been found in single-cell in vitro studies are also valid on the level of cortical maps.	Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Max Planck Society	Hubener, M (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.		Bonhoeffer, Tobias/B-9481-2009	Bonhoeffer, Tobias/0000-0001-7897-6634				ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; ANTONINI A, 1993, SCIENCE, V260, P1819, DOI 10.1126/science.8511592; BERMAN N, 1982, J NEUROPHYSIOL, V48, P1362, DOI 10.1152/jn.1982.48.6.1362; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLAKEMORE C, 1970, NATURE, V228, P477, DOI 10.1038/228477a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 2000, J NEUROSCI, V20, P1922; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; DEBANNE D, 1994, P NATL ACAD SCI USA, V91, P1148, DOI 10.1073/pnas.91.3.1148; Dragoi V, 2001, NATURE, V411, P80, DOI 10.1038/35075070; Eysel UT, 1998, NEUROSCIENCE, V84, P25, DOI 10.1016/S0306-4522(97)00378-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; FERRER JMR, 1988, PROC R SOC SER B-BIO, V233, P77, DOI 10.1098/rspb.1988.0013; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FREEMAN RD, 1973, NATURE, V246, P359, DOI 10.1038/246359a0; Fregnac Y, 1999, J NEUROBIOL, V41, P69; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; Grinvald A., 1999, IN VIVO OPTICAL IMAG, P893; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; HIRSCH HVB, 1970, SCIENCE, V168, P869, DOI 10.1126/science.168.3933.869; Hubener M, 1997, J NEUROSCI, V17, P9270; IKEDA H, 1975, J PHYSL, V245, P114; Kirkwood A, 1997, P NATL ACAD SCI USA, V94, P3380, DOI 10.1073/pnas.94.7.3380; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kojic L, 2000, P NATL ACAD SCI USA, V97, P1841, DOI 10.1073/pnas.97.4.1841; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; KOSSUT M, 1983, ACTA NEUROBIOL EXP, V43, P273; KOSSUT M, 1991, EXP BRAIN RES, V85, P519; MAFFEI L, 1976, SCIENCE, V191, P579, DOI 10.1126/science.1251195; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McLean HA, 1996, J PHYSIOL-LONDON, V496, P471, DOI 10.1113/jphysiol.1996.sp021699; Miller KD, 1999, J NEUROBIOL, V41, P44, DOI 10.1002/(SICI)1097-4695(199910)41:1<44::AID-NEU7>3.0.CO;2-V; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; MURPHY PC, 1986, J PHYSIOL-LONDON, V381, P95, DOI 10.1113/jphysiol.1986.sp016315; MUSTARI M, 1981, BRAIN RES, V211, P165, DOI 10.1016/0006-8993(81)90077-9; Rattay F, 1999, NEUROSCIENCE, V89, P335, DOI 10.1016/S0306-4522(98)00330-3; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Schuett S, 2000, EUR J NEUROSCI, V12, P74; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Sermasi E, 1999, DEV BRAIN RES, V113, P61, DOI 10.1016/S0165-3806(98)00190-4; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Shevelev IA, 1998, NEUROSCIENCE, V84, P11, DOI 10.1016/S0306-4522(97)00363-1; Shouval HZ, 2000, J NEUROSCI, V20, P1119, DOI 10.1523/JNEUROSCI.20-03-01119.2000; Shulz DE, 2000, NATURE, V403, P549, DOI 10.1038/35000586; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P287, DOI 10.1113/jphysiol.1975.sp011055; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; Trepel C, 1998, J NEUROSCI, V18, P3404; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yousef T, 2001, NEUROREPORT, V12, P1693, DOI 10.1097/00001756-200106130-00035; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	65	110	113	1	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					325	337		10.1016/S0896-6273(01)00472-X	http://dx.doi.org/10.1016/S0896-6273(01)00472-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684001	Bronze			2022-12-24	WOS:000171893700016
J	Erickson, MG; Alseikhan, BA; Peterson, BZ; Yue, DT				Erickson, MG; Alseikhan, BA; Peterson, BZ; Yue, DT			Preassociation of calmodulin with voltage-gated Ca2+ channels revealed by FRET in single living cells	NEURON			English	Article							RESONANCE ENERGY-TRANSFER; GREEN FLUORESCENT PROTEIN; CALCIUM CHANNELS; CA2+-SENSITIVE INACTIVATION; CA2+-DEPENDENT INACTIVATION; ALPHA(1C) SUBUNIT; BETA-SUBUNIT; INHIBITION; DEPENDS; MOTIF	Among the most intriguing forms of Ca2+ channel modulation is the regulation of L-type and P/Q-type channels by intracellular Ca2+, acting via unconventional channel-calmodulin (CaM) interactions. In particular, overexpressing Ca2+-insensitive mutant CaM abolishes Ca2+-dependent modulation, hinting that Ca2+-free CaM may "preassociate" with these channels to enhance detection of local Ca2+. Despite the far-reaching consequences of this proposal, in vitro experiments testing for preassociation provide conflicting results. Here, we develop a three filter-cube fluorescence resonance energy transfer method (three-cube FRET) to directly probe for constitutive associations between channel subunits and CaM in single living cells. This FRET assay detects Ca2+-independent associations between CaM and the pore-forming a, subunit of L-type, P/Q-type, and, surprisingly, R-type channels. These results now definitively demonstrate channel-CaM preassociation in resting cells and underscore the potential of three-cube FRET for probing protein-protein interactions.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Calcium Signals Lab, Baltimore, MD 21205 USA; Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.							Bichet D, 2000, NEURON, V25, P177, DOI 10.1016/S0896-6273(00)80881-8; BREHM P, 1978, SCIENCE, V202, P1203, DOI 10.1126/science.103199; CAMPBELL KP, 1988, TRENDS NEUROSCI, V11, P425, DOI 10.1016/0166-2236(88)90193-2; CHAO SH, 1984, MOL PHARMACOL, V26, P75; CHIEN AJ, 1995, J BIOL CHEM, V270, P30036; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; DELEON M, 1995, SCIENCE, V270, P1502, DOI 10.1126/science.270.5241.1502; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; EPE B, 1983, P NATL ACAD SCI-BIOL, V80, P2579, DOI 10.1073/pnas.80.9.2579; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Harpur AG, 2001, NAT BIOTECHNOL, V19, P167, DOI 10.1038/84443; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Moon DL, 2001, BIOPHYS J, V80, p362A; Mouton J, 2001, J BIOL CHEM, V276, P22359, DOI 10.1074/jbc.M100755200; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Patterson G, 2001, J CELL SCI, V114, P837; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Pitt GS, 2001, J BIOL CHEM, V276, P30794, DOI 10.1074/jbc.M104959200; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Romanin C, 2000, FEBS LETT, V487, P301, DOI 10.1016/S0014-5793(00)02361-9; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; SELVIN PR, 1995, METHOD ENZYMOL, V246, P300; Siegel RM, 2000, SCIENCE, V288, P2354, DOI 10.1126/science.288.5475.2354; Soldatov NM, 1997, J BIOL CHEM, V272, P3560, DOI 10.1074/jbc.272.6.3560; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRON L, 1984, BIOPHYS J, V45, P939, DOI 10.1016/S0006-3495(84)84240-X; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; Van Der Meer B. W., 1994, RESONANCE ENERGY TRA; Vanderklish PW, 2000, P NATL ACAD SCI USA, V97, P2253, DOI 10.1073/pnas.040565597; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zhou JM, 1997, P NATL ACAD SCI USA, V94, P2301, DOI 10.1073/pnas.94.6.2301; Zuhlke RD, 1998, P NATL ACAD SCI USA, V95, P3287, DOI 10.1073/pnas.95.6.3287; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	46	367	371	2	29	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					973	985		10.1016/S0896-6273(01)00438-X	http://dx.doi.org/10.1016/S0896-6273(01)00438-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580897	Bronze			2022-12-24	WOS:000171281300012
J	Skradski, SL; Clark, AM; Jiang, HM; White, HS; Fu, YH; Ptacek, LJ				Skradski, SL; Clark, AM; Jiang, HM; White, HS; Fu, YH; Ptacek, LJ			A novel gene causing a mendelian audiogenic mouse epilepsy	NEURON			English	Article							CARDIAC NA+-CA2+ EXCHANGER; POTASSIUM CHANNEL GENE; GENERALIZED EPILEPSY; MULTICOPPER OXIDASE; FEBRILE SEIZURES; MUTANT MICE; MUTATION; SUSCEPTIBILITY; SUBUNIT; RECEPTOR	Frings mice are a model of generalized epilepsy and have seizures in response to loud noises. This phenotype is due to the autosomal recessive inheritance of a single gene on mouse chromosome 13. Here we report the fine genetic and physical mapping of the locus. Sequencing of the region led to identification of a novel gene; mutant mice are homozygous for a single base pair deletion that leads to premature termination of the encoded protein. Interestingly, the mRNA levels of this gene in various tissues are so low that the cDNA has eluded detection by standard library screening approaches. Study of the MASS1 protein will lead to new insights into regulation of neuronal excitability and a new pathway through which dysfunction can lead to epilepsy.	Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Pharmacol & Toxicol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Univ Utah, Anticonvulsant Screening Project, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; Univ Utah, Program Neurosci, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Ptacek, LJ (corresponding author), Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.			White, H. Steve/0000-0003-4550-4408	NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS032711] Funding Source: NIH RePORTER; NCRR NIH HHS [M01-RR000064] Funding Source: Medline; NINDS NIH HHS [NS32711] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Biervert C, 1998, SCIENCE, V279, P403, DOI 10.1126/science.279.5349.403; Brennan TJ, 1997, NAT GENET, V16, P387, DOI 10.1038/ng0897-387; Brouwers GJ, 1999, APPL ENVIRON MICROB, V65, P1762; Burgess DL, 1997, CELL, V88, P385, DOI 10.1016/S0092-8674(00)81877-2; Charlier C, 1998, NAT GENET, V18, P53, DOI 10.1038/ng0198-53; COLLINS RL, 1970, BEHAV GENET, V1, P99, DOI 10.1007/BF01071825; Escayg A, 2000, NAT GENET, V24, P343, DOI 10.1038/74159; Escayg A, 2000, AM J HUM GENET, V66, P1531, DOI 10.1086/302909; Fletcher CF, 1996, CELL, V87, P607, DOI 10.1016/S0092-8674(00)81381-1; Fouad GT, 1996, AM J HUM GENET, V59, P135; FRINGS H, 1951, J MAMMAL, V32, P60, DOI 10.2307/1375413; HARRIS ZL, 1995, P NATL ACAD SCI USA, V92, P2539, DOI 10.1073/pnas.92.7.2539; HENRY KR, 1967, SCIENCE, V158, P938, DOI 10.1126/science.158.3803.938-a; JEN J, 2000, METABOLIC MOL BASES, P5223; Johnson KR, 2000, GENOMICS, V70, P171, DOI 10.1006/geno.2000.6377; Letts VA, 1998, NAT GENET, V19, P340, DOI 10.1038/1228; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; Nakayama J, 2000, HUM MOL GENET, V9, P87, DOI 10.1093/hmg/9.1.87; NEUMANN PE, 1991, P NATL ACAD SCI USA, V88, P5408, DOI 10.1073/pnas.88.12.5408; Nicoll DA, 1996, ANN NY ACAD SCI, V779, P86, DOI 10.1111/j.1749-6632.1996.tb44772.x; Nikkila H, 2000, MOL ENDOCRINOL, V14, P1351, DOI 10.1210/me.14.9.1351; NOEBELS JL, 2000, METABOLIC MOL BASES, P5807; Plaster NM, 1999, NEUROLOGY, V53, P1180, DOI 10.1212/WNL.53.6.1180; PTACEK LJ, 1991, CELL, V67, P1021; Ptacek LJ, 1999, SEMIN NEUROL, V19, P363, DOI 10.1055/s-2008-1040851; PTACEK LJ, 1998, GENETICS FOCAL EPILE, P203; RIBAK CE, 1988, EPILEPSY RES, V2, P345, DOI 10.1016/0920-1211(88)90046-0; SCHREIBER RA, 1980, BEHAV GENET, V10, P537, DOI 10.1007/BF01066222; SEYFRIED TN, 1981, GENETICS, V99, P117; Signorini S, 1997, P NATL ACAD SCI USA, V94, P923, DOI 10.1073/pnas.94.3.923; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Skradski SL, 1998, GENOMICS, V49, P188, DOI 10.1006/geno.1998.5229; STEINLEIN OK, 1995, NAT GENET, V11, P201, DOI 10.1038/ng1095-201; Swoboda KJ, 2000, NEUROLOGY, V55, P224, DOI 10.1212/WNL.55.2.224; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Vulpe CD, 1999, NAT GENET, V21, P195, DOI 10.1038/5979; Wallace RH, 1998, NAT GENET, V19, P366, DOI 10.1038/1252; Zaitsev VN, 1999, J BIOL INORG CHEM, V4, P579, DOI 10.1007/s007750050380; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	41	152	159	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 30	2001	31	4					537	544		10.1016/S0896-6273(01)00397-X	http://dx.doi.org/10.1016/S0896-6273(01)00397-X			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545713	Bronze			2022-12-24	WOS:000170759200008
J	Gowan, K; Helms, AW; Hunsaker, TL; Collisson, T; Ebert, PJ; Odom, R; Johnson, JE				Gowan, K; Helms, AW; Hunsaker, TL; Collisson, T; Ebert, PJ; Odom, R; Johnson, JE			Crossinhibitory activities of Ngn1 and Math1 allow specification of distinct dorsal interneurons	NEURON			English	Article							CEREBELLAR GRANULE NEURONS; PERIPHERAL NERVOUS-SYSTEM; PROGENITOR-CELL IDENTITY; ACHAETE-SCUTE HOMOLOG-1; SPINAL-CORD; COMMISSURAL INTERNEURONS; DETERMINATION GENES; PRONEURAL GENES; BHLH GENES; ROOF PLATE	Distinct classes of neurons are generated from progenitor cells distributed in characteristic dorsoventral patterns in the developing spinal neural tube. We define restricted neural progenitor populations by the discrete, nonoverlapping expression of Ngn1, Math1, and Mash1. Crossinhibition between these bHLH factors is demonstrated and provides a mechanism for the generation of discrete bHLH expression domains. This precise control of bHLH factor expression is essential for proper neural development since as demonstrated in both loss- and gain-of-function experiments, expression of Math1 or Ngn1 in dorsal progenitor cells determines whether LH2A/B- or dorsal Lim1/2-expressing interneurons will develop. Together, the data suggest that although Math1 and Ngn1 appear to be redundant with respect to neurogenesis, they have distinct functions in specifying neuronal subtype in the dorsal neural tube.	Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Johnson, JE (corresponding author), Univ Texas, SW Med Ctr, Ctr Basic Neurosci, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.		Johnson, Jane/F-8881-2010	Ebert, Philip/0000-0002-8945-2948; /0000-0002-8605-2746	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [N01HD073263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007062] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032817] Funding Source: NIH RePORTER; NICHD NIH HHS [HD 37832, N01-HD-7-3263] Funding Source: Medline; NIGMS NIH HHS [T32GM07062] Funding Source: Medline; NINDS NIH HHS [NS32817] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Alder J, 1999, NAT NEUROSCI, V2, P535, DOI 10.1038/9189; ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; BIRREN SJ, 1993, DEVELOPMENT, V119, P597; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Cai L, 2000, DEVELOPMENT, V127, P3021; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Farah MH, 2000, DEVELOPMENT, V127, P693; Fedtsova N, 1997, DEV BIOL, V190, P18, DOI 10.1006/dbio.1997.8691; Fode C, 2000, GENE DEV, V14, P67; Fode C, 1998, NEURON, V20, P483, DOI 10.1016/S0896-6273(00)80989-7; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Hassan BA, 2000, GENE DEV, V14, P1852; Helms AW, 1998, DEVELOPMENT, V125, P919; Helms AW, 2000, DEVELOPMENT, V127, P1185; Helms AW, 2001, MOL CELL NEUROSCI, V17, P671, DOI 10.1006/mcne.2000.0969; Hirsch MR, 1998, DEVELOPMENT, V125, P599; HOGAN B, 1986, MANIPULATING MOUSE E; Horton S, 1999, MOL CELL NEUROSCI, V14, P355, DOI 10.1006/mcne.1999.0791; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Kandel E., 2000, PRINCIPLES NEURAL SC; Kim P, 1997, DEV BIOL, V187, P1, DOI 10.1006/dbio.1997.8572; Lee JS, 1999, FEBS LETT, V455, P276, DOI 10.1016/S0014-5793(99)00901-1; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1998, DEVELOPMENT, V125, P609; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Ma QF, 1999, GENE DEV, V13, P1717, DOI 10.1101/gad.13.13.1717; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Meredith A, 2000, DEV BIOL, V222, P336, DOI 10.1006/dbio.2000.9697; Muramatsu T, 1997, BIOCHEM BIOPH RES CO, V230, P376, DOI 10.1006/bbrc.1996.5882; Murray RC, 2000, DEV DYNAM, V218, P189, DOI 10.1002/(SICI)1097-0177(200005)218:1<189::AID-DVDY16>3.0.CO;2-4; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Perez SE, 1999, DEVELOPMENT, V126, P1715; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Simmons AD, 2001, DEV BIOL, V229, P327, DOI 10.1006/dbio.2000.9984; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Timmer J, 2001, GENESIS, V29, P123, DOI 10.1002/gene.1015; TOMITA K, 2000, IN PRESS EMBO J; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VermaKurvari S, 1996, DEV BIOL, V180, P605, DOI 10.1006/dbio.1996.0332; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277	60	240	246	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 2	2001	31	2					219	232		10.1016/S0896-6273(01)00367-1	http://dx.doi.org/10.1016/S0896-6273(01)00367-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502254	Bronze			2022-12-24	WOS:000170277700008
J	Inagaki, N; Chihara, K; Arimura, N; Menager, C; Kawano, Y; Matsuo, N; Nishimura, T; Amano, M; Kaibuchi, K				Inagaki, N; Chihara, K; Arimura, N; Menager, C; Kawano, Y; Matsuo, N; Nishimura, T; Amano, M; Kaibuchi, K			CRMP-2 induces axons in cultured hippocampal neurons	NATURE NEUROSCIENCE			English	Article							GROWTH CONE COLLAPSE; POLARITY; RHO; UNC-33		Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300101, Japan; JST, PRESTO, Recognit & Format, Kumamoto 8600012, Japan; Nagoya Univ, Grad Sch Med, Dept Cell Pharmacol, Nagoya, Aichi 4668550, Japan	Nara Institute of Science & Technology; Japan Science & Technology Agency (JST); Nagoya University	Kaibuchi, K (corresponding author), Nara Inst Sci & Technol, Div Signal Transduct, Nara 6300101, Japan.		Kawano, Yoji/C-7484-2011; Nishimura, Takashi/AAQ-9299-2020; Amano, Mutsuki/M-4820-2014; Nishimura, Takashi/D-7672-2017	Kawano, Yoji/0000-0003-0687-2777; Nishimura, Takashi/0000-0002-6773-0302; Amano, Mutsuki/0000-0002-0662-1524; Nishimura, Takashi/0000-0002-6773-0302; Inagaki, Naoyuki/0000-0002-2664-9196				Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Bradke F, 2000, CURR BIOL, V10, P1467, DOI 10.1016/S0960-9822(00)00807-1; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Byk T, 1998, EUR J BIOCHEM, V254, P14, DOI 10.1046/j.1432-1327.1998.2540014.x; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; DOTTI CG, 1987, NATURE, V330, P254, DOI 10.1038/330254a0; Esch T, 1999, J NEUROSCI, V19, P6417; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; LINDA H, 1985, BRAIN RES, V358, P329, DOI 10.1016/0006-8993(85)90978-3; MINTURN JE, 1995, J NEUROSCI, V15, P6757; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	15	445	458	0	17	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					781	782		10.1038/90476	http://dx.doi.org/10.1038/90476			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477421				2022-12-24	WOS:000170137300008
J	Schwartz, O; Simoncelli, EP				Schwartz, O; Simoncelli, EP			Natural signal statistics and sensory gain control	NATURE NEUROSCIENCE			English	Article							PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SIMPLE CELLS; ORIENTATION SELECTIVITY; SPATIAL SUMMATION; RECEPTIVE-FIELDS; CORTICAL-NEURONS; AUDITORY-NERVE; PATTERN-VISION; V1 NEURONS	We describe a form of nonlinear decomposition that is well-suited for efficient encoding of natural signals. Signals are initially decomposed using a bank of linear filters. Each filter response is then rectified and divided by a weighted sum of rectified responses of neighboring filters. We show that this decomposition, with parameters optimized for the statistics of a generic ensemble of natural images or sounds, provides a good characterization of the nonlinear response properties of typical neurons in primary visual cortex or auditory nerve, respectively. These results suggest that nonlinear response properties of sensory neurons are not an accident of biological implementation, but have an important functional role.	NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA; NYU, Courant Inst Math Sci, New York, NY 10003 USA	Howard Hughes Medical Institute; New York University; New York University	Simoncelli, EP (corresponding author), NYU, Ctr Neural Sci, Howard Hughes Med Inst, New York, NY 10003 USA.	eero.simoncelli@nyu.edu						Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; BARLOW H, 1989, COMP NEUR S, P54; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Borg-Graham LJ, 1998, NATURE, V393, P369, DOI 10.1038/30735; Carandini M, 1997, J NEUROSCI, V17, P8621; CAVANAUGH JR, 2000, THESIS NEW YORK U; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; Delgutte B., 1996, AUDITORY COMPUTATION, P157, DOI DOI 10.1007/978-1-4612-4070-9_5; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; FOLEY JM, 1994, J OPT SOC AM A, V11, P1710, DOI 10.1364/JOSAA.11.001710; GEISLER DC, 1998, SOUND SYNAPSE PHYSL; Geisler WS, 2001, VISION RES, V41, P711, DOI 10.1016/S0042-6989(00)00277-7; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; Graham N, 2000, VISION RES, V40, P2737, DOI 10.1016/S0042-6989(00)00123-1; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; JAVEL E, 1978, J ACOUST SOC AM, V63, P1093, DOI 10.1121/1.381817; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; LYON RF, 1990, LECT NOTES BIOMATH, V87, P395; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; ROSE JE, 1971, J NEUROPHYSIOL, V34, P685, DOI 10.1152/jn.1971.34.4.685; RUDERMAN DL, 1994, PHYS REV LETT, V73, P814, DOI 10.1103/PhysRevLett.73.814; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Shapley R, 1984, PROG RETIN RES, V3, P263, DOI DOI 10.1016/0278-4327(84)90011-7; Sigman M, 2001, P NATL ACAD SCI USA, V98, P1935, DOI 10.1073/pnas.031571498; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; SIMONCELLI EP, 1992, IEEE T INFORM THEORY, V38, P587, DOI 10.1109/18.119725; Simoncelli EP, 1999, ADV NEUR IN, V11, P153; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SLANEY M, 1993, 35 PATT HOLDW AUD FI; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; WAINWRIGHT MJ, IN PRESS APPL COMPUT; WAINWRIGHT MJ, 2001, IN PRESS PROBABILIST; Wang KS, 1994, IEEE T SPEECH AUDI P, V2, P421, DOI 10.1109/89.294356; Zhao HB, 1999, NATURE, V399, P359, DOI 10.1038/20686	50	547	550	0	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					819	825		10.1038/90526	http://dx.doi.org/10.1038/90526			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477428				2022-12-24	WOS:000170137300015
J	Kennedy, MJ; Lee, KA; Niemi, GA; Craven, KB; Garwin, GG; Saari, JC; Hurley, JB				Kennedy, MJ; Lee, KA; Niemi, GA; Craven, KB; Garwin, GG; Saari, JC; Hurley, JB			Multiple phosphorylation of rhodopsin and the in vivo chemistry underlying rod photoreceptor dark adaptation	NEURON			English	Article							PROTEIN-COUPLED RECEPTOR; VISUAL CYCLE; A-WAVE; TERMINAL DOMAIN; SITES; IDENTIFICATION; ARRESTIN; GENE; PHOTOTRANSDUCTION; DEPHOSPHORYLATION	Dark adaptation requires timely deactivation of phototransduction and efficient regeneration of visual pigment. No previous study has directly compared the kinetics of dark adaptation with rates of the various chemical reactions that influence it. To accomplish this, we developed a novel rapid-quench/mass spectrometry-based method to establish the initial kinetics and site specificity of light-stimulated rhodopsin phosphorylation in mouse retinas. We also measured phosphorylation and dephosphorylation, regeneration of rhodopsin, and reduction of all-trans retinal all under identical in vivo conditions. Dark adaptation was monitored by electroretinography. We found that rhodopsin is multiply phosphorylated and then dephosphorylated in an ordered fashion following exposure to light. Initially during dark adaptation, transduction activity wanes as multiple phosphates accumulate. Thereafter, full recovery of photosensitivity coincides with regeneration and dephosphorylation of rhodopsin.	Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hurley, JB (corresponding author), Univ Washington, Dept Biochem, Box 357350, Seattle, WA 98195 USA.	jbhhh@u.washington.edu			NEI NIH HHS [EY02317, EY06641, R01 EY006641] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07270] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY006641] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMUS G, 1988, HYBRIDOMA, V7, P237, DOI 10.1089/hyb.1988.7.237; Bayer AU, 1999, DOC OPHTHALMOL, V98, P233, DOI 10.1023/A:1002416918247; BRETON ME, 1994, INVEST OPHTH VIS SCI, V35, P295; CATT M, 1982, BIOCHEM SOC T, V10, P343, DOI 10.1042/bst0100343; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; CORNWALL MC, 1994, J PHYSIOL-LONDON, V480, P261, DOI 10.1113/jphysiol.1994.sp020358; Deng HB, 2000, BIOCHEMISTRY-US, V39, P5492, DOI 10.1021/bi991938b; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; Fain GL, 2001, PHYSIOL REV, V81, P117, DOI 10.1152/physrev.2001.81.1.117; Fredericks ZL, 1996, J BIOL CHEM, V271, P13796, DOI 10.1074/jbc.271.23.13796; FUCHS S, 1995, NAT GENET, V10, P360, DOI 10.1038/ng0795-360; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Greene NM, 1997, J BIOL CHEM, V272, P10341; Guo J, 2000, MOL PHARMACOL, V58, P1050, DOI 10.1124/mol.58.5.1050; GUREVICH VV, 1993, J BIOL CHEM, V268, P11628; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hurley JB, 1998, VISION RES, V38, P1341, DOI 10.1016/S0042-6989(97)00459-8; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Jones GJ, 1996, J GEN PHYSIOL, V108, P333, DOI 10.1085/jgp.108.4.333; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Langen R, 1999, BIOCHEMISTRY-US, V38, P7918, DOI 10.1021/bi990010g; Langlois G, 1996, P NATL ACAD SCI USA, V93, P4677, DOI 10.1073/pnas.93.10.4677; Leibrock CS, 1998, EYE, V12, P511, DOI 10.1038/eye.1998.139; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; MCDOWELL JH, 1993, BIOCHEMISTRY-US, V32, P4968, DOI 10.1021/bi00069a036; Mendez A, 2000, NEURON, V28, P153, DOI 10.1016/S0896-6273(00)00093-3; OHGURO H, 1993, BIOCHEMISTRY-US, V32, P5718, DOI 10.1021/bi00072a030; OHGURO H, 1995, J BIOL CHEM, V270, P14259, DOI 10.1074/jbc.270.24.14259; PALCZEWSKI K, 1989, J BIOL CHEM, V264, P15770; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PAPAC DI, 1993, BIOCHEMISTRY-US, V32, P5930, DOI 10.1021/bi00074a002; Saari JC, 2001, NEURON, V29, P739, DOI 10.1016/S0896-6273(01)00248-3; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Stiles W.S., 1932, EQUIVALENT ADAPTATIO, P194; Thomas MM, 1999, J PHYSIOL-LONDON, V518, P479, DOI 10.1111/j.1469-7793.1999.0479p.x; Van Hooser JP, 2000, METHOD ENZYMOL, V316, P565; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; YEAGLE PL, 1995, NAT STRUCT BIOL, V2, P832, DOI 10.1038/nsb1095-832	45	117	119	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2001	31	1					87	101		10.1016/S0896-6273(01)00340-3	http://dx.doi.org/10.1016/S0896-6273(01)00340-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498053	Bronze			2022-12-24	WOS:000170101100013
J	Yoshida, K; Watanabe, D; Ishikane, H; Tachibana, M; Pastan, I; Nakanishi, S				Yoshida, K; Watanabe, D; Ishikane, H; Tachibana, M; Pastan, I; Nakanishi, S			A key role of starburst amacrine cells in originating retinal directional selectivity and optokinetic eye movement	NEURON			English	Article							GANGLION-CELLS; RABBIT RETINA; MAMMALIAN RETINA; RAT RETINA; GABA; IMMUNOREACTIVITY; ACETYLCHOLINE; ORGANIZATION; EXPRESSION; DETECTORS	The directional selectivity of retinal ganglion cell responses represents a primitive pattern recognition that operates within a retinal neural circuit. The cellular origin and mechanism of directional selectivity were investigated by selectively eliminating retinal starburst amacrine cells, using immunotoxin-mediated cell targeting techniques. Starburst cell ablation in the adult retina abolished not only directional selectivity of ganglion cell responses but also an optokinetic eye reflex derived by stimulus movement. Starburst cells therefore serve as the key element that discriminates the direction of stimulus movement through integrative synaptic transmission and play a pivotal role in information processing that stabilizes image motion.	Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Mol & Syst Biol, Kyoto 6068501, Japan; Univ Tokyo, Grad Sch Humanities & Sociol, Dept Psychol, Tokyo 1130033, Japan; NCI, Mol Biol Lab, Div Basic Sci, NIH, Bethesda, MD 20892 USA	Kyoto University; Kyoto University; University of Tokyo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Nakanishi, S (corresponding author), Kyoto Univ, Fac Med, Dept Biol Sci, Kyoto 6068501, Japan.		pastan, ira/P-9319-2019	pastan, ira/0000-0002-9223-0270; Ishikane, Hiroshi/0000-0003-1316-2255				ARIEL M, 1982, J PHYSIOL-LONDON, V324, P161, DOI 10.1113/jphysiol.1982.sp014105; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Borg-Graham L.J., 1992, SINGLE NEURON COMPUT, P347; BRECHA N, 1988, P NATL ACAD SCI USA, V85, P6187, DOI 10.1073/pnas.85.16.6187; CLARKE RJ, 1985, EXP BRAIN RES, V57, P224; COHEN ED, 1995, P NATL ACAD SCI USA, V92, P1127, DOI 10.1073/pnas.92.4.1127; FAMIGLIETTI EV, 1991, J COMP NEUROL, V309, P40, DOI 10.1002/cne.903090105; FAMIGLIETTI EV, 1992, J COMP NEUROL, V324, P322, DOI 10.1002/cne.903240303; Gabriel R, 1998, NEUROSCI LETT, V247, P179, DOI 10.1016/S0304-3940(98)00323-1; GRZYWACZ NM, 1993, J NEUROPHYSIOL, V69, P2188, DOI 10.1152/jn.1993.69.6.2188; HAMASSAKIBRITTO DE, 1993, J NEUROSCI, V13, P1888; He SG, 1997, NATURE, V389, P378, DOI 10.1038/38723; Ishikane H, 1999, VISUAL NEUROSCI, V16, P1001, DOI 10.1017/S0952523899166033; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; IWASHITA M, 2001, IN PRESS NEUROSCI RE; Kaneko S, 2000, SCIENCE, V289, P633, DOI 10.1126/science.289.5479.633; Kittila CA, 1997, J NEUROPHYSIOL, V77, P675, DOI 10.1152/jn.1997.77.2.675; KOBAYASHI K, 1995, P NATL ACAD SCI USA, V92, P1132, DOI 10.1073/pnas.92.4.1132; Koulen P, 1996, EUR J NEUROSCI, V8, P2177, DOI 10.1111/j.1460-9568.1996.tb00739.x; LEVICK WR, 1967, J PHYSIOL-LONDON, V188, P285, DOI 10.1113/jphysiol.1967.sp008140; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASLAND RH, 1986, TRENDS NEUROSCI, V9, P218, DOI 10.1016/0166-2236(86)90062-7; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; NIRENBERG SA, 1994, INVEST OPHTH VIS SCI, V35, P2056; OMALLEY DM, 1992, J NEUROSCI, V12, P1394; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; OYSTER CW, 1972, VISION RES, V12, P183, DOI 10.1016/0042-6989(72)90110-1; Tagawa Y, 1999, J NEUROSCI, V19, P2568; Taylor WR, 2000, SCIENCE, V289, P2347, DOI 10.1126/science.289.5488.2347; TORRE V, 1978, PROC R SOC SER B-BIO, V202, P409, DOI 10.1098/rspb.1978.0075; Vaney D.I., 1990, PROGR RETINAL RES, V9, P49, DOI [10.1016/0278-4327(90)90004-2, DOI 10.1016/0278-4327(90)90004-2]; VANEY DI, 1988, BRAIN RES, V438, P369, DOI 10.1016/0006-8993(88)91366-2; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1	35	259	265	0	17	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					771	780		10.1016/S0896-6273(01)00316-6	http://dx.doi.org/10.1016/S0896-6273(01)00316-6			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430810	Bronze, Green Submitted			2022-12-24	WOS:000169508900017
J	Hara, J; Beuckmann, CT; Nambu, T; Willie, JT; Chemelli, RM; Sinton, CM; Sugiyama, F; Yagami, K; Goto, K; Yanagisawa, M; Sakurai, T				Hara, J; Beuckmann, CT; Nambu, T; Willie, JT; Chemelli, RM; Sinton, CM; Sugiyama, F; Yagami, K; Goto, K; Yanagisawa, M; Sakurai, T			Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity	NEURON			English	Article							TRANSGENIC MICE; IN-VITRO; SLEEP; HYPOTHALAMUS; SYSTEMS; RATS; HYPOCRETINS; DEFICIENCY; PEPTIDES; LOCUS	Orexins (hypocretins) are a pair of neuropeptides implicated in energy homeostasis and arousal, Recent reports suggest that loss of orexin-containing neurons occurs in human patients with narcolepsy. We generated transgenic mice in which orexin-containing neurons are ablated by orexinergic-specific expression of a truncated Machado-Joseph disease gene product (ataxin-3) with an expanded polyglutamine stretch. These mice showed a phenotype strikingly similar to human narcolepsy, including behavioral arrests, premature entry into rapid eye movement (REM) sleep, poorly consolidated sleep patterns, and a late-onset obesity, despite eating less than nontransgenic littermates. These results provide evidence that orexin-containing neurons play important roles in regulating vigilance states and energy homeostasis. Orexin/ataxin-3 mice provide a valuable model for studying the pathophysiology and treatment of narcolepsy.	Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Lab Anim Res Ctr, Tsukuba, Ibaraki 3058575, Japan; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pediat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75390 USA	University of Tsukuba; University of Tsukuba; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sakurai, T (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Pharmacol, Tsukuba, Ibaraki 3058575, Japan.							Bassetti C, 1996, NEUROL CLIN, V14, P545, DOI 10.1016/S0733-8619(05)70273-5; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen CT, 2000, AM J PHYSIOL-REG I, V278, pR692, DOI 10.1152/ajpregu.2000.278.3.R692; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Elias CF, 1998, J COMP NEUROL, V402, P442, DOI 10.1002/(SICI)1096-9861(19981228)402:4<442::AID-CNE2>3.0.CO;2-R; Gallopin T, 2000, NATURE, V404, P992, DOI 10.1038/35010109; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; Hakansson ML, 1999, J NEUROENDOCRINOL, V11, P653; HEYMAN RA, 1989, P NATL ACAD SCI USA, V86, P2698, DOI 10.1073/pnas.86.8.2698; HONDA Y, 1986, SLEEP, V9, P254, DOI 10.1093/sleep/9.1.254; Kadotani H, 1998, GENOME RES, V8, P427, DOI 10.1101/gr.8.5.427; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lubkin M, 1998, BIOCHEM BIOPH RES CO, V253, P241, DOI 10.1006/bbrc.1998.9750; Masuo Y, 1997, BRAIN RES PROTOC, V1, P321, DOI 10.1016/S1385-299X(97)00005-6; MIGNOT E, 1993, J NEUROSCI, V13, P1057; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Nakamura T, 2000, BRAIN RES, V873, P181, DOI 10.1016/S0006-8993(00)02555-5; Nambu T, 1999, BRAIN RES, V827, P243, DOI 10.1016/S0006-8993(99)01336-0; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Peyron C, 1998, J NEUROSCI, V18, P9996; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; RADULOVACKI M, 1984, J PHARMACOL EXP THER, V228, P268; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Samson WK, 1999, BRAIN RES, V831, P248, DOI 10.1016/S0006-8993(99)01457-2; Saper C.B., 2011, HDB PHYSL NERVOUS SY, DOI 10.1002/cphy.cp010506; Schuld A, 2000, LANCET, V355, P1274, DOI 10.1016/S0140-6736(05)74704-8; Shirasaka T, 1999, AM J PHYSIOL-REG I, V277, pR1780, DOI 10.1152/ajpregu.1999.277.6.R1780; Thannickal TC, 2000, NEURON, V27, P469, DOI 10.1016/S0896-6273(00)00058-1; WALKER JM, 1980, PEPTIDES, V1, P341, DOI 10.1016/0196-9781(80)90012-1; Willie JT, 2001, ANNU REV NEUROSCI, V24, P429, DOI 10.1146/annurev.neuro.24.1.429; Yoshizawa T, 2000, HUM MOL GENET, V9, P69, DOI 10.1093/hmg/9.1.69	33	1041	1077	2	54	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					345	354		10.1016/S0896-6273(01)00293-8	http://dx.doi.org/10.1016/S0896-6273(01)00293-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11394998	Bronze			2022-12-24	WOS:000168962000009
J	McAlpine, D; Jiang, D; Palmer, AR				McAlpine, D; Jiang, D; Palmer, AR			A neural code for low-frequency sound localization in mammals	NATURE NEUROSCIENCE			English	Article							MEDIAL SUPERIOR OLIVE; ANTEROVENTRAL COCHLEAR NUCLEUS; INFERIOR COLLICULUS NEURONS; INTERAURAL PHASE DISPARITY; OWL TYTO-ALBA; BARN OWL; BINAURAL INTERACTION; DIRECTIONAL HEARING; RESPONSE PROPERTIES; CHANGING FREQUENCY	We report a systematic relationship between sound-frequency tuning and sensitivity to interaural time delays for neurons in the midbrain nucleus of the inferior colliculus; neurons with relatively low best frequencies (BFs) showed response peaks at long delays, whereas neurons with relatively high BFs showed response peaks at short delays. The consequence of this relationship is that the steepest region of the function relating discharge rate to interaural time delay (ITD) fell close to midline for all neurons irrespective of BF. These data provide support for a processing of the output of coincidence detectors subserving low-frequency sound localization in which the location of a sound source is determined by the activity in two broad, hemispheric spatial channels, rather than numerous channels tuned to discrete spatial positions.	Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; UCL, Dept Physiol, London WC1E 6BT, England	University of Nottingham; University of London; University College London	McAlpine, D (corresponding author), Univ Nottingham, MRC, Inst Hearing Res, Sci Rd, Nottingham NG7 2RD, England.	d.mcalpine@ucl.ac.uk		McAlpine, David/0000-0001-5467-6725; Palmer, Alan/0000-0001-5893-4525				Batra R, 1997, J NEUROPHYSIOL, V78, P1222, DOI 10.1152/jn.1997.78.3.1222; Beckius GE, 1999, J NEUROSCI, V19, P3146; CARR CE, 1990, J NEUROSCI, V10, P3227; COLBURN HS, 1978, J ACOUST SOC AM, V64, P95, DOI 10.1121/1.381960; COLES RB, 1988, J COMP PHYSIOL A, V163, P117, DOI 10.1007/BF00612002; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; DOMINTZ RH, 1977, J ACOUST SOC AM, V61, P1586; ELVERLAND HH, 1978, EXP BRAIN RES, V32, P117; Fitzpatrick DC, 1997, NATURE, V388, P871, DOI 10.1038/42246; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; JENKINS WM, 1982, J NEUROPHYSIOL, V47, P987, DOI 10.1152/jn.1982.47.6.987; Jiang D, 1997, J NEUROSCI, V17, P9331; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; KNUDSEN EI, 1979, J COMP PHYSIOL, V133, P13, DOI 10.1007/BF00663106; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; KUWADA S, 1997, BINAURAL SPATIAL HEA, P399; McAlpine D, 1998, J NEUROSCI, V18, P6026; McAlpine D, 1996, HEARING RES, V97, P136, DOI 10.1016/0378-5955(96)00068-8; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; OLSEN JF, 1989, J NEUROSCI, V9, P2591; PALMER AR, 1992, PROCESSING COMPLEX S, P415; PHILLIPS DP, 1985, ANNU REV PSYCHOL, V36, P245; Shackleton TM, 2000, HEARING RES, V149, P199, DOI 10.1016/S0378-5955(00)00187-8; SHAMMA SA, 1989, J ACOUST SOC AM, V86, P989, DOI 10.1121/1.398734; SMITH PH, 1993, J COMP NEUROL, V331, P245, DOI 10.1002/cne.903310208; Spitzer MW, 1998, J NEUROPHYSIOL, V80, P3062, DOI 10.1152/jn.1998.80.6.3062; SPITZER MW, 1995, J NEUROPHYSIOL, V73, P1668, DOI 10.1152/jn.1995.73.4.1668; Stern R. M., 1996, BINAURAL SPATIAL HEA, P499; Stevens SS, 1936, AM J PSYCHOL, V48, P297, DOI 10.2307/1415748; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; Strutt J., 1907, PHILOS MAG, V13, P214, DOI [DOI 10.1080/14786440709463595, 10.1080/14786440709463595]; TAKAHASHI T, 1984, J NEUROSCI, V4, P1781; TAKAHASHI T, 1986, J NEUROSCI, V6, P3413; van BERGEIJK WILLEM A., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1431, DOI 10.1121/1.1918364; von Bekesy G, 1930, PHYS Z, V31, P824; WAGNER H, 1987, J NEUROSCI, V7, P3105; WENSTRUP JJ, 1986, J NEUROSCI, V6, P964; WIGHTMAN FL, 1989, J ACOUST SOC AM, V85, P868, DOI 10.1121/1.397558; YIN TCT, 1987, J NEUROPHYSIOL, V58, P562, DOI 10.1152/jn.1987.58.3.562; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; YIN TCT, 1986, J NEUROPHYSIOL, V55, P280, DOI 10.1152/jn.1986.55.2.280; YIN TCT, 1983, J NEUROPHYSIOL, V50, P1020, DOI 10.1152/jn.1983.50.4.1020; ZWISLOCKI J, 1956, J ACOUST SOC AM, V28, P866	44	327	332	2	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					396	401		10.1038/86049	http://dx.doi.org/10.1038/86049			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276230				2022-12-24	WOS:000168762200020
J	Moran-Rivard, L; Kagawa, T; Saueressig, H; Gross, MK; Burill, J; Goulding, M				Moran-Rivard, L; Kagawa, T; Saueressig, H; Gross, MK; Burill, J; Goulding, M			Evx1 is a postmitotic determinant of V0 interneuron identity in the spinal cord	NEURON			English	Article							PROGENITOR-CELL IDENTITY; MOTOR-NEURON; HOMEODOMAIN PROTEIN; TRANSCRIPTIONAL REPRESSION; COMMISSURAL INTERNEURONS; FLOOR PLATE; GENE; EXPRESSION; MOUSE; SPECIFICATION	Interneurons in the ventral spinal cord are essential for coordinated locomotion in vertebrates. During embryogenesis, the V0 and V1 classes of ventral interneurons are defined by expression of the homeodomain transcription factors Evx1/2 and En1, respectively. In this study, we show that Evx1 V0 interneurons are locally projecting intersegmental commissural neurons. In Evx1 mutant embryos, the majority of V0 interneurons fail to extend commissural axons. Instead, they adopt an En1-like ipsilateral axonal projection and ectopically express En1, indicating that V0 interneurons are transfated to a V1 identity. Conversely, misexpression of Evx1 represses En1, suggesting that Evx1 may suppress the V1 interneuron differentiation program. Our findings demonstrate that Evx1 is a postmitotic determinant of V0 interneuron identity and reveal a critical postmitotic phase for neuronal determination in the developing spinal cord.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Biol Grad Program, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego	Goulding, M (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	goulding@salk.edu						ALLUM JHJ, 1989, PROG BRAIN RES, V80, P399; BASTIAN H, 1991, EMBO J, V10, P3978; BASTIAN H, 1990, EMBO J, V9, P1839, DOI 10.1002/j.1460-2075.1990.tb08309.x; Briata P, 1997, FEBS LETT, V402, P131, DOI 10.1016/S0014-5793(96)01512-8; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; DAVIS CA, 1991, DEVELOPMENT, V111, P287; DELCOMYN F, 1980, SCIENCE, V210, P492, DOI 10.1126/science.7423199; DODD J, 1988, NEURON, V1, P105, DOI 10.1016/0896-6273(88)90194-8; DOLLE P, 1994, DEVELOPMENT, P143; Eide AL, 1999, J COMP NEUROL, V403, P332; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; GRILLNER S, 1975, PHYSIOL REV, V55, P247, DOI 10.1104/pp.55.2.247; Gross MK, 2000, DEVELOPMENT, V127, P413; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; HAN KY, 1993, GENE DEV, V7, P491, DOI 10.1101/gad.7.3.491; HARRISON PJ, 1986, J PHYSIOL-LONDON, V371, P147, DOI 10.1113/jphysiol.1986.sp015965; JAGLA K, 1995, MECH DEVELOP, V53, P345, DOI 10.1016/0925-4773(95)00450-5; JANKOWSKA E, 1990, BRAIN RES, V535, P327, DOI 10.1016/0006-8993(90)91618-Q; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KISSINGER CR, 1990, CELL, V63, P579, DOI 10.1016/0092-8674(90)90453-L; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kjaerulff O, 1997, J NEUROSCI, V17, P9433; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; LEBER SM, 1995, J NEUROSCI, V15, P1236; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; LITINGTUNG Y, 2000, NAT NEUROSCI, V10, P979; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; MARTI E, 1995, DEVELOPMENT, V121, P2537; Matise MP, 1997, J NEUROSCI, V17, P7805; NOMES HO, 1990, DEVELOPMENT, V109, P797; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Rekling JC, 2000, PHYSIOL REV, V80, P767, DOI 10.1152/physrev.2000.80.2.767; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Saueressig H, 1999, DEVELOPMENT, V126, P4201; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SILOSSANTIAGO I, 1992, J COMP NEUROL, V325, P514, DOI 10.1002/cne.903250405; SILOSSANTIAGO I, 1994, J COMP NEUROL, V342, P221, DOI 10.1002/cne.903420206; SPYROPOULOS DD, 1994, GENE DEV, V8, P1949, DOI 10.1101/gad.8.16.1949; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Wenner P, 1998, ANN NY ACAD SCI, V860, P425, DOI 10.1111/j.1749-6632.1998.tb09066.x; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; ZHADANOV AB, 1995, DEV DYNAM, V202, P354, DOI 10.1002/aja.1002020405; Zhou YH, 2000, DEVELOPMENT, V127, P3829	52	187	188	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					385	399		10.1016/S0896-6273(01)00213-6	http://dx.doi.org/10.1016/S0896-6273(01)00213-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239430	Bronze			2022-12-24	WOS:000167141700013
J	Star, EN; Kwiatkowski, DJ; Murthy, VN				Star, EN; Kwiatkowski, DJ; Murthy, VN			Rapid turnover of actin in dendritic spines and its regulation by activity	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; GEL-SOL TRANSFORMATION; F-ACTIN; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; SMALL GTPASES; GELSOLIN; PLASTICITY; FILAMENT; PROTEIN	Dendritic spines are motile structures that contain high concentrations of filamentous actin. Using hippocampal neurons expressing fluorescent actin and the method of fluorescence recovery after photobleaching, we found that 85+/-2% of actin in the spine was dynamic, with a turnover time of 44.2+/-4.0 s. The rapid turnover is not compatible with current models invoking a large population of stable filaments and static coupling of filaments to postsynaptic components. Low-frequency stimulation known to induce long-term depression in these neurons stabilized nearly half the dynamic actin in the spine. This effect depended on the activation of N-methyl-D-aspartate (NMDA) receptors and the influx of calcium. In neurons from mice lacking gelsolin, a calcium-dependent actin-binding protein, activity-dependent stabilization of actin was impaired. Our studies provide new information on the kinetics of actin turnover in spines, its regulation by neural activity and the mechanisms involved in this regulation.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Brigham & Womens Hosp, Div Hematol, Genet Lab, Boston, MA 02115 USA	Harvard University; Harvard University; Brigham & Women's Hospital	Murthy, VN (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.			Murthy, Venkatesh/0000-0003-2443-4252				Allison DW, 1998, J NEUROSCI, V18, P2423; Arcaro A, 1998, J BIOL CHEM, V273, P805, DOI 10.1074/jbc.273.2.805; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Azuma T, 1998, EMBO J, V17, P1362, DOI 10.1093/emboj/17.5.1362; BUBB MR, 1994, J BIOL CHEM, V269, P14869; CAJAL SRY, 1891, CELLULE, V7, P125; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Condeelis J, 2001, TRENDS CELL BIOL, V11, P288, DOI 10.1016/S0962-8924(01)02008-6; COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Furukawa K, 1997, J NEUROSCI, V17, P8178, DOI 10.1523/jneurosci.17-21-08178.1997; Goda Y, 1996, NEURON, V16, P103, DOI 10.1016/S0896-6273(00)80027-6; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; JANMEY PA, 1985, BIOCHEMISTRY-US, V24, P3714, DOI 10.1021/bi00335a046; Kim CH, 1999, J NEUROSCI, V19, P4314; Kinosian HJ, 1998, BIOPHYS J, V75, P3101, DOI 10.1016/S0006-3495(98)77751-3; Korkotian E, 2001, NEURON, V30, P751, DOI 10.1016/S0896-6273(01)00314-2; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; Matus A, 1999, CURR OPIN NEUROBIOL, V9, P561, DOI 10.1016/S0959-4388(99)00018-5; McGrath JL, 1998, BIOPHYS J, V75, P2070, DOI 10.1016/S0006-3495(98)77649-0; McGrath JL, 2000, P NATL ACAD SCI USA, V97, P6532, DOI 10.1073/pnas.100023397; Murthy VN, 2001, NEURON, V32, P673, DOI 10.1016/S0896-6273(01)00500-1; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Segal M, 2001, PROG NEUROBIOL, V63, P61, DOI 10.1016/S0301-0082(00)00021-6; Sund SE, 2000, BIOPHYS J, V79, P1655, DOI 10.1016/S0006-3495(00)76415-0; Tashiro A, 2000, CEREB CORTEX, V10, P927, DOI 10.1093/cercor/10.10.927; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; WEGNER A, 1976, J MOL BIOL, V108, P139, DOI 10.1016/S0022-2836(76)80100-3; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Xia ZG, 1996, J NEUROSCI, V16, P5425; YIN HL, 1979, NATURE, V281, P583, DOI 10.1038/281583a0; YIN HL, 1981, J CELL BIOL, V91, P901, DOI 10.1083/jcb.91.3.901; Zhang WD, 2001, J NEUROSCI, V21, P5169, DOI 10.1523/JNEUROSCI.21-14-05169.2001; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798	50	362	371	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					239	246		10.1038/nn811	http://dx.doi.org/10.1038/nn811			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850630				2022-12-24	WOS:000174146000014
J	Lanjuin, A; Sengupta, P				Lanjuin, A; Sengupta, P			Regulation of chemosensory receptor expression and sensory signaling by the KIN-29 Ser/Thr kinase	NEURON			English	Review							CONTROLLING DAUER FORMATION; ACTIVATED PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; CHEMORECEPTOR GENES; LARVAL DEVELOPMENT; NERVOUS-SYSTEM; NEURON FATES; YEAST SNF1; BODY-SIZE	Sensory signals regulate multiple developmental and behavioral circuits in C. elegans, providing a genetically tractable system in which to investigate the mechanisms underlying the acquisition and integration of sensory information. kin-29 mutants are defective in the expression of a set of chemoreceptor genes, and exhibit characteristics associated with altered sensory signaling, including increased lifespan, decreased body size, and deregulated entry into the dauer developmental stage. kin-29 encodes a Ser/Thr kinase with similarity to the MARK and AMPK/SNF1 family of kinases. We show that KIN-29 acts cell-autonomously and non-cell-autonomously in sensory neurons to regulate chemoreceptor expression, body size, and the dauer decision, suggesting that kin-29 function is essential for the correct acquisition and transduction of sensory information.	Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Volen Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Sengupta, P (corresponding author), Brandeis Univ, Dept Biol, MS 008,415 South St, Waltham, MA 02454 USA.	sengupta@brandeis.edu						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ailion M, 2000, GENETICS, V156, P1047; Ailion M, 1999, P NATL ACAD SCI USA, V96, P7394, DOI 10.1073/pnas.96.13.7394; ALBERT PS, 1981, J COMP NEUROL, V198, P435, DOI 10.1002/cne.901980305; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Ashrafi K, 2000, GENE DEV, V14, P1872; AVERY L, 1990, J EXP ZOOL, V253, P263, DOI 10.1002/jez.1402530305; Avery Leon, 1993, Genetics, V134, P455; Bargmann C. I., 1997, C ELEGANS, P717; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; Bessone S, 1999, DEV BIOL, V214, P87, DOI 10.1006/dbio.1999.9379; BRENNER S, 1974, GENETICS, V77, P71; Britton JS, 1998, DEVELOPMENT, V125, P2149; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; COLBERT HA, 1995, NEURON, V14, P803, DOI 10.1016/0896-6273(95)90224-4; Collet J, 1998, GENETICS, V148, P187; CORTON JM, 1994, CURR BIOL, V4, P315, DOI 10.1016/S0960-9822(00)00070-1; Daniels SA, 2000, GENETICS, V156, P123; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Dettman RW, 2001, GENETICS, V158, P253; DORMAN JB, 1995, GENETICS, V141, P1399; DREWES G, 1995, J BIOL CHEM, V270, P7679, DOI 10.1074/jbc.270.13.7679; Drewes G, 1997, CELL, V89, P297, DOI 10.1016/S0092-8674(00)80208-1; Dwyer ND, 2001, NEURON, V31, P277, DOI 10.1016/S0896-6273(01)00361-0; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fukushige T, 1999, J CELL SCI, V112, P395; GOLDEN JW, 1984, P NATL ACAD SCI-BIOL, V81, P819, DOI 10.1073/pnas.81.3.819; GOLDEN JW, 1984, J CHEM ECOL, V10, P1265, DOI 10.1007/BF00988553; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gottesmann B., 1994, HALLESCHES JB GEOWIS, V16, P23; GOTTLIEB S, 1994, GENETICS, V137, P107; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hardie DG, 1998, ANNU REV BIOCHEM, V67, P821, DOI 10.1146/annurev.biochem.67.1.821; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; HORVITZ HR, 1982, SCIENCE, V216, P1012, DOI 10.1126/science.6805073; Inoue T, 2000, DEV BIOL, V217, P192, DOI 10.1006/dbio.1999.9545; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LARSEN PL, 1995, GENETICS, V139, P1567; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; LIU DWC, 1994, J NEUROSCI, V14, P1953; LIVINGSTONE D, 1991, THESIS U CAMBRIDGE C; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; MENDEL JE, 1995, SCIENCE, V267, P1652, DOI 10.1126/science.7886455; Nagase T, 1999, DNA Res, V6, P337, DOI 10.1093/dnares/6.5.337; NGUYEN M, 1995, GENETICS, V140, P527; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Ogura K, 1997, GENE DEV, V11, P1801, DOI 10.1101/gad.11.14.1801; Ostling J, 1998, EUR J BIOCHEM, V252, P162, DOI 10.1046/j.1432-1327.1998.2520162.x; Patterson GI, 1997, GENE DEV, V11, P2679, DOI 10.1101/gad.11.20.2679; Patterson GI, 2000, TRENDS GENET, V16, P27, DOI 10.1016/S0168-9525(99)01916-2; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; POPHAM JD, 1979, CAN J ZOOL, V57, P794, DOI 10.1139/z79-098; Prasad BC, 1998, DEVELOPMENT, V125, P1561; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Riddle DL, 1997, C ELEGANS, P739; ROBERTSON FW, 1963, GENET RES, V4, P74, DOI 10.1017/S001667230000344X; Robertson HM, 2000, GENOME RES, V10, P192, DOI 10.1101/gr.10.2.192; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Sagasti A, 1999, GENE DEV, V13, P1794, DOI 10.1101/gad.13.14.1794; Sarafi-Reinach TR, 2001, DEVELOPMENT, V128, P3269; Satterlee JS, 2001, NEURON, V31, P943, DOI 10.1016/S0896-6273(01)00431-7; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; Savage C, 1996, P NATL ACAD SCI USA, V93, P790, DOI 10.1073/pnas.93.2.790; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; SEGALAT L, 1995, SCIENCE, V267, P1648, DOI 10.1126/science.7886454; Sengupta P, 1996, CELL, V84, P899, DOI 10.1016/S0092-8674(00)81068-5; Shen P, 2001, J NEUROBIOL, V47, P16, DOI 10.1002/neu.1012; Stern DL, 1999, DEVELOPMENT, V126, P1091; STONE J, 1982, TRENDS NEUROSCI, V5, P441, DOI 10.1016/0166-2236(82)90237-5; Suzuki Y, 1999, DEVELOPMENT, V126, P241; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; THOMAS JH, 1993, GENETICS, V134, P1105; THOMAS JH, 1990, GENETICS, V124, P855; THOMPSONJAEGER S, 1991, GENETICS, V129, P697; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Treitel MA, 1998, MOL CELL BIOL, V18, P6273, DOI 10.1128/MCB.18.11.6273; TRENT C, 1983, GENETICS, V104, P619; Troemel ER, 1999, CELL, V99, P387, DOI 10.1016/S0092-8674(00)81525-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; TROEMEL ER, 1999, THESIS U CALIFORNIA; Vincent O, 2001, GENE DEV, V15, P1104, DOI 10.1101/gad.879301; VOWELS JJ, 1994, GENETICS, V138, P303; VOWELS JJ, 1992, GENETICS, V130, P105; Waggoner LF, 2000, GENETICS, V154, P1181; WEINSHENKER D, 1995, J NEUROSCI, V15, P6975; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Wolkow CA, 2000, SCIENCE, V290, P147, DOI 10.1126/science.290.5489.147; WOODS A, 1994, J BIOL CHEM, V269, P19509	101	45	50	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					369	381		10.1016/S0896-6273(02)00572-X	http://dx.doi.org/10.1016/S0896-6273(02)00572-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832225	Bronze			2022-12-24	WOS:000173643200008
J	Perrier, AL; Massoulie, J; Krejci, E				Perrier, AL; Massoulie, J; Krejci, E			PRiMA: The membrane anchor of acetylcholinesterase in the brain	NEURON			English	Article							COLLAGEN-TAILED FORMS; C-TERMINAL DOMAINS; MOLECULAR-FORMS; HUMAN BUTYRYLCHOLINESTERASE; RAT ACETYLCHOLINESTERASE; QUATERNARY ASSOCIATIONS; NEUROMUSCULAR-JUNCTION; ATTACHMENT DOMAIN; CAUDATE-NUCLEUS; SUBUNIT	As a tetramer, acetylcholinesterase (AChE) is anchored to the basal lamina of the neuromuscular junction and to the membrane of neuronal synapses. We have previously shown that collagen Q (CoIQ) anchors AChE at the neuromuscular junction. We have now cloned the gene PRiMA (proline-rich membrane anchor) encoding the AChE anchor in mammalian brain. We show that PRiMA is able to organize AChE into tetramers and to anchor them at the surface of transfected cells. Furthermore, we demonstrate that AChE is actually anchored in neural cell membranes through its interaction with PRiMA. Finally, we propose that only PRiMA anchors AChE in mammalian brain and muscle cell membranes.	Ecole Normale Super, CNRS, UMR 8544, Neurobiol Cellulaire & Mol Lab, F-75230 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Krejci, E (corresponding author), Ecole Normale Super, CNRS, UMR 8544, Neurobiol Cellulaire & Mol Lab, 46 Rue Ulm, F-75230 Paris 05, France.	krejci@wotan.ens.fr	Perrier, Anselme L/B-2272-2019; Perrier, Anselme/E-3764-2010	Perrier, Anselme L/0000-0001-7915-1968; 				Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bon S, 1997, J BIOL CHEM, V272, P3007, DOI 10.1074/jbc.272.5.3007; Bon S, 1997, J BIOL CHEM, V272, P3016, DOI 10.1074/jbc.272.5.3016; Boschetti N, 1996, FEBS LETT, V380, P133, DOI 10.1016/0014-5793(96)00041-5; Botti SA, 1998, PROTEIN ENG, V11, P415, DOI 10.1093/protein/11.6.415; Bourne Y, 1999, J BIOL CHEM, V274, P30370, DOI 10.1074/jbc.274.43.30370; DUVAL N, 1992, EMBO J, V11, P3255, DOI 10.1002/j.1460-2075.1992.tb05403.x; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; Feyereisen R, 1995, TOXICOL LETT, V82-3, P83, DOI 10.1016/0378-4274(95)03470-6; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; FUENTES ME, 1988, BIOCHEM J, V256, P1047, DOI 10.1042/bj2561047; GENNARI K, 1987, J NEUROCHEM, V49, P12, DOI 10.1111/j.1471-4159.1987.tb03386.x; Giacobini E., 2000, CHOLINESTERASES CHOL, V3rd ed.; Gupta R, 1999, NUCLEIC ACIDS RES, V27, P370, DOI 10.1093/nar/27.1.370; Harder T, 1999, EUR J IMMUNOL, V29, P556, DOI 10.1002/(SICI)1521-4141(199902)29:02<556::AID-IMMU556>3.0.CO;2-2; INESTROSA NC, 1987, J BIOL CHEM, V262, P4441; KARLSSON E, 1984, J PHYSIOLOGY PARIS, V79, P232; Kaufer D, 1998, NATURE, V393, P373, DOI 10.1038/30741; Krejci E, 1997, J BIOL CHEM, V272, P22840, DOI 10.1074/jbc.272.36.22840; Krejci E, 1999, J NEUROSCI, V19, P10672, DOI 10.1523/JNEUROSCI.19-24-10672.1999; Kronman C, 2000, J BIOL CHEM, V275, P29488, DOI 10.1074/jbc.M004298200; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAZAR M, 1980, J NEUROCHEM, V35, P1067, DOI 10.1111/j.1471-4159.1980.tb07860.x; LEGAY C, 1993, J NEUROCHEM, V60, P337, DOI 10.1111/j.1471-4159.1993.tb05856.x; LEGAY C, 1995, EUR J NEUROSCI, V7, P1803, DOI 10.1111/j.1460-9568.1995.tb00699.x; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; LI Y, 1991, J BIOL CHEM, V266, P23083; LIAO J, 1993, EUR J BIOCHEM, V215, P333, DOI 10.1111/j.1432-1033.1993.tb18039.x; LIAO J, 1993, J NEUROCHEM, V61, P1127, DOI 10.1111/j.1471-4159.1993.tb03629.x; MARSH D, 1984, J NEUROCHEM, V43, P204, DOI 10.1111/j.1471-4159.1984.tb06698.x; MASSON P, 1993, J BIOL CHEM, V268, P14329; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MESULAM M, 2000, CHOLINESTERASES CHOL, P121; Navaratnam DS, 2000, J NEUROCHEM, V74, P2146, DOI 10.1046/j.1471-4159.2000.0742146.x; Peng HB, 1999, J CELL BIOL, V145, P911, DOI 10.1083/jcb.145.4.911; Perrier AL, 2000, J BIOL CHEM, V275, P34260, DOI 10.1074/jbc.M004289200; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; ROBERTS WL, 1991, J BIOL CHEM, V266, P7481; Simon S, 1998, EMBO J, V17, P6178, DOI 10.1093/emboj/17.21.6178; Tsigelny I, 2000, PROTEIN SCI, V9, P180	42	207	218	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					275	285		10.1016/S0896-6273(01)00584-0	http://dx.doi.org/10.1016/S0896-6273(01)00584-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804574	Bronze			2022-12-24	WOS:000173387700014
J	Kourtzi, Z; Bulthoff, HH; Erb, M; Grodd, W				Kourtzi, Z; Bulthoff, HH; Erb, M; Grodd, W			Object-selective responses in the human motion area MT/MST	NATURE NEUROSCIENCE			English	Article							HUMAN VISUAL-CORTEX; CORTICAL AREA; PERCEPTION; NEURONS; DEPTH; MT; DISPARITY		Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Univ Clin, D-72076 Tubingen, Germany	Max Planck Society; Massachusetts Institute of Technology (MIT); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Kourtzi, Z (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, D-72076 Tubingen, Germany.		Bülthoff, Heinrich H/J-6579-2012; Bülthoff, Heinrich/AAC-8818-2019	Bülthoff, Heinrich H/0000-0003-2568-0607; Erb, Michael/0000-0002-9311-4693; Kourtzi, Zoe/0000-0001-9441-7832				BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; Kanwisher N, 1996, COGNITIVE BRAIN RES, V5, P55, DOI 10.1016/S0926-6410(96)00041-9; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1148, DOI 10.1152/jn.1983.49.5.1148; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; ORBAN GA, 1995, P NATL ACAD SCI USA, V92, P993, DOI 10.1073/pnas.92.4.993; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Paradis AL, 2000, CEREB CORTEX, V10, P772, DOI 10.1093/cercor/10.8.772; QIAN N, 1994, J NEUROSCI, V14, P7367; Tootell RBH, 2001, CEREB CORTEX, V11, P298, DOI 10.1093/cercor/11.4.298; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Xiao DK, 1997, EUR J NEUROSCI, V9, P956, DOI 10.1111/j.1460-9568.1997.tb01446.x; ZEKI S, 1991, J NEUROSCI, V11, P641	15	100	100	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					17	18		10.1038/nn780	http://dx.doi.org/10.1038/nn780			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740503				2022-12-24	WOS:000173031800009
J	Eisen, JS; Melancon, E				Eisen, JS; Melancon, E			Interactions with identified muscle cells break motoneuron equivalence in embryonic zebrafish	NATURE NEUROSCIENCE			English	Article							SELECT APPROPRIATE PATHWAYS; GROWTH CONES; FATE; ABSENCE; SUBPOPULATIONS; SPECIFICATION; MUTATIONS; INDUCTION; SURVIVAL; HEDGEHOG	Two zebrafish motoneurons, CaP and VaP, are initially developmentally equivalent; later, CaP innervates ventral muscle, whereas VaP dies. Current models suggest that vertebrate motoneuron death results from failure to compete for limited, target-derived trophic support. In contrast, we provide evidence that zebrafish ventral muscle can support both CaP and VaP survival. However, VaP's growth cone is prevented from extending into ventral muscle by CaP-dependent interactions with identified muscle fibers, the muscle pioneers; this interaction breaks the initial equivalence of CaP and VaP. Thus, the processes mediating VaP death are more complex than failure to compete for trophic support, and may be important for correct spatial patterning.	Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Eisen, JS (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	eisen@uoneuro.uoregon.edu			NCRR NIH HHS [RR11724] Funding Source: Medline; NICHD NIH HHS [HD22486] Funding Source: Medline; NINDS NIH HHS [NS23915] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR011724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023915, R56NS023915] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Appel B, 1995, DEVELOPMENT, V121, P4117; Beattie CE, 1999, METHODS CELL BIOL, V60, P71; Beattie CE, 2000, DEVELOPMENT, V127, P2653; Currie PD, 1996, NATURE, V382, P452, DOI 10.1038/382452a0; DECHIARA TM, 1995, CELL, V83, P313, DOI 10.1016/0092-8674(95)90172-8; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; EISEN JS, 1991, NEURON, V6, P767, DOI 10.1016/0896-6273(91)90173-W; EISEN JS, 1990, J NEUROSCI, V10, P34; Eisen JS, 1999, TRENDS NEUROSCI, V22, P321, DOI 10.1016/S0166-2236(98)01370-8; EISEN JS, 1992, NEURON, V8, P231, DOI 10.1016/0896-6273(92)90290-T; EISEN JS, 1989, NEURON, V2, P1097, DOI 10.1016/0896-6273(89)90234-1; EISEN JS, 1991, SCIENCE, V252, P569, DOI 10.1126/science.1708527; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; Eisen JS, 1996, CELL, V87, P969, DOI 10.1016/S0092-8674(00)81792-4; FELSENFELD AL, 1991, DEV BIOL, V148, P23, DOI 10.1016/0012-1606(91)90314-S; Garces A, 2000, J NEUROSCI, V20, P4992; GATCHALIAN CL, 1992, NEURON, V9, P105, DOI 10.1016/0896-6273(92)90225-3; Granato M, 1996, DEVELOPMENT, V123, P399; Greensmith L, 1996, TRENDS NEUROSCI, V19, P450, DOI 10.1016/S0166-2236(96)20034-7; Grieshammer U, 1998, DEV BIOL, V197, P234, DOI 10.1006/dbio.1997.8859; HALPERN ME, 1993, CELL, V75, P99, DOI 10.1016/0092-8674(93)90682-G; HAMBURGER V, 1982, NEUROSCI COMMENT, V1, P39; Heinrich G, 2000, INT J DEV NEUROSCI, V18, P1, DOI 10.1016/S0736-5748(99)00071-4; Henion PD, 1996, DEV GENET, V18, P11; HORVITZ HR, 1994, COLD SPRING HARB SYM, V59, P377, DOI 10.1101/SQB.1994.059.01.042; Huang FZ, 1996, DEVELOPMENT, V122, P1839; KELEHER GP, 1990, P NATL ACAD SCI USA, V87, P8457, DOI 10.1073/pnas.87.21.8457; Kimble J., 1979, Cell lineage, stem cells and cell determination. (Proc. Internat. Workshop on cell lineage, stem cells and cell determination, Seillac, France, 20-24 May 1979. - Inserm Symposium No.10), P59; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; LANDMESSER LT, 1988, MESSAGE MIND, P121; LIU DWC, 1990, J NEUROSCI, V10, P3947, DOI 10.1523/JNEUROSCI.10-12-03947.1990; Melancon E, 1997, J NEUROSCI, V17, P7796; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; OPPENHEIM RW, 1989, TRENDS NEUROSCI, V12, P252, DOI 10.1016/0166-2236(89)90021-0; Pettmann B, 1998, NEURON, V20, P633, DOI 10.1016/S0896-6273(00)81004-1; Pfaff S, 1998, CURR OPIN NEUROBIOL, V8, P27, DOI 10.1016/S0959-4388(98)80005-6; PIKE SH, 1990, J NEUROSCI, V10, P44; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; RAIBLE DW, 1992, DEV DYNAM, V195, P29, DOI 10.1002/aja.1001950104; RAIBLE DW, 1995, CURR OPIN GENET DEV, V5, P444, DOI 10.1016/0959-437X(95)90047-K; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; STEWART WW, 1978, CELL, V14, P741, DOI 10.1016/0092-8674(78)90256-8; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; WEISBLAT DA, 1985, PHILOS T ROY SOC B, V312, P39, DOI 10.1098/rstb.1985.0176; WESTERFIELD M, 1986, J NEUROSCI, V6, P2267	48	24	25	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1065	1070		10.1038/nn742	http://dx.doi.org/10.1038/nn742			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11600891				2022-12-24	WOS:000171970900008
J	Okubo, Y; Kakizawa, S; Hirose, K; Iino, M				Okubo, Y; Kakizawa, S; Hirose, K; Iino, M			Visualization of IP3 dynamics reveals a novel AMPA receptor-triggered IP3 production pathway mediated by voltage-dependent Ca2+ influx in Purkinje cells	NEURON			English	Article							LONG-TERM DEPRESSION; INOSITOL 1,4,5-TRISPHOSPHATE 5-PHOSPHATASE; PHOSPHOLIPASE-C ISOZYMES; MGLUR1 MUTANT MICE; IMMUNOHISTOCHEMICAL LOCALIZATION; POLYMORPHONUCLEAR NEUTROPHILS; PHOSPHOINOSITIDE HYDROLYSIS; SYNAPTIC DEPRESSION; GLUTAMATE RECEPTORS; DENDRITIC SPINES	IP3 signaling in Purkinje cells is involved in the regulation of cell functions including LTD. We have used a GFP-tagged pleckstrin homology domain to visualize IP3 dynamics in Purkinje cells. Surprisingly, IP3 production was observed in response not only to mGIuR activation, but also to AMPA receptor activation in Purkinje cells in culture. AMPA-induced IP3 production was mediated by depolarization-induced Call influx because it was mimicked by depolarization and was blocked by inhibition of the P-type Ca2+ channel. Furthermore, trains of complex spikes, elicited by climbing fiber stimulation (1 Hz), induced IP3 production in Purkinje cells in cerebellar slices. These results revealed a novel IP3 signaling pathway in Purkinje cells that can be elicited by synaptic inputs from climbing fibers.	Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Tokyo 1130033, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Iino, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Pharmacol, Tokyo 1130033, Japan.	iino@m.u-tokyo.ac.jp						AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; Allen V, 1997, BIOCHEM J, V327, P545, DOI 10.1042/bj3270545; BANNO Y, 1994, J BIOL CHEM, V269, P15846; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BEZPROZVANNY I, 1991, NATURE, V351, P751, DOI 10.1038/351751a0; BIDEN TJ, 1987, J BIOL CHEM, V262, P3567; BLANK JL, 1992, J BIOL CHEM, V267, P23069; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Broad LM, 2001, J BIOL CHEM, V276, P15945, DOI 10.1074/jbc.M011571200; Capozzi I, 1999, BIOCHEM J, V344, P545, DOI 10.1042/0264-6021:3440545; CHESLER M, 1992, TRENDS NEUROSCI, V15, P396, DOI 10.1016/0166-2236(92)90191-A; CHOI WC, 1989, BRAIN RES, V499, P193, DOI 10.1016/0006-8993(89)91153-0; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Communi D, 1996, J BIOL CHEM, V271, P11676, DOI 10.1074/jbc.271.20.11676; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; DeSmedt F, 1996, J BIOL CHEM, V271, P10419, DOI 10.1074/jbc.271.17.10419; DESMEDT F, 1994, FEBS LETT, V347, P69, DOI 10.1016/0014-5793(94)00509-5; DOMINO SE, 1988, J BIOL CHEM, V263, P690; EBERHARD DA, 1987, J NEUROCHEM, V49, P1634, DOI 10.1111/j.1471-4159.1987.tb01037.x; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Ehrengruber MU, 1999, P NATL ACAD SCI USA, V96, P7041, DOI 10.1073/pnas.96.12.7041; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Gruol DL, 1996, J NEUROPHYSIOL, V76, P3325, DOI 10.1152/jn.1996.76.5.3325; Gwag BJ, 1998, MOL BRAIN RES, V63, P53, DOI 10.1016/S0169-328X(98)00251-4; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; IINO M, 1990, J GEN PHYSIOL, V95, P1103, DOI 10.1085/jgp.95.6.1103; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Ito M, 1984, CEREBELLUM NEURAL CO; KASONO K, 1995, NEUROREPORT, V6, P569, DOI 10.1097/00001756-199502000-00040; KENDALL DA, 1984, J NEUROCHEM, V42, P1388, DOI 10.1111/j.1471-4159.1984.tb02799.x; KHODAKHAH K, 1995, J PHYSIOL-LONDON, V487, P343, DOI 10.1113/jphysiol.1995.sp020884; KHODAKHAH K, 1993, P NATL ACAD SCI USA, V90, P4976, DOI 10.1073/pnas.90.11.4976; Khodakhah K, 1997, P NATL ACAD SCI USA, V94, P14009, DOI 10.1073/pnas.94.25.14009; Kim YH, 1999, J BIOL CHEM, V274, P26127, DOI 10.1074/jbc.274.37.26127; Kneen M, 1998, BIOPHYS J, V74, P1591, DOI 10.1016/S0006-3495(98)77870-1; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LAXMINARAYAN KM, 1994, J BIOL CHEM, V269, P17305; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; Lu YM, 1997, J NEUROSCI, V17, P5196; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Martelli AM, 1996, ACTA HISTOCHEM, V98, P131, DOI 10.1016/S0065-1281(96)80031-6; MELDRUM E, 1991, EUR J BIOCHEM, V196, P159, DOI 10.1111/j.1432-1033.1991.tb15799.x; MINTZ IM, 1992, NATURE, V355, P827, DOI 10.1038/355827a0; MIZUGUCHI M, 1991, BRAIN RES, V548, P35, DOI 10.1016/0006-8993(91)91103-8; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Reyes M, 1996, J NEUROSCI, V16, P5951; Rhee SG, 1997, J BIOL CHEM, V272, P15045, DOI 10.1074/jbc.272.24.15045; RYU SH, 1987, P NATL ACAD SCI USA, V84, P6649, DOI 10.1073/pnas.84.19.6649; SAKURAI M, 1990, P NATL ACAD SCI USA, V87, P3383, DOI 10.1073/pnas.87.9.3383; SHARP AH, 1993, J NEUROSCI, V13, P3051; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; SIMPSON PB, 1995, TRENDS NEUROSCI, V18, P299, DOI 10.1016/0166-2236(95)93919-O; SMART D, 1995, BIOCHEM J, V305, P577, DOI 10.1042/bj3050577; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TAYLOR SJ, 1991, NATURE, V350, P516, DOI 10.1038/350516a0; Tempia F, 1996, J NEUROSCI, V16, P456; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wang Y, 1997, J NEUROPHYSIOL, V77, P812, DOI 10.1152/jn.1997.77.2.812; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Watanabe M, 1998, EUR J NEUROSCI, V10, P2016, DOI 10.1046/j.1460-9568.1998.00213.x; Wilsch VW, 1998, J NEUROSCI, V18, P6071; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	76	88	92	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					113	122		10.1016/S0896-6273(01)00464-0	http://dx.doi.org/10.1016/S0896-6273(01)00464-0			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604143	Bronze			2022-12-24	WOS:000171525200013
J	Lu, QR; Cai, L; Rowitch, D; Cepko, CL; Stiles, CD				Lu, QR; Cai, L; Rowitch, D; Cepko, CL; Stiles, CD			Ectopic expression of Olig1 promotes oligodendrocyte formation and reduces neuronal survival in developing mouse cortex	NATURE NEUROSCIENCE			English	Article							DIFFERENTIATION; PROTEINS; GENES		Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Cepko, CL (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.			Rowitch, David/0000-0002-0079-0060; Cai, Li/0000-0003-3344-337X				BARRES BA, 1997, MOL CELLULAR APPROAC, P64; Cai L, 2000, DEVELOPMENT, V127, P3021; Calver AR, 1998, NEURON, V20, P869, DOI 10.1016/S0896-6273(00)80469-9; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Hattori M, 2000, NATURE, V405, P311, DOI 10.1038/35012518; Hojo M, 2000, DEVELOPMENT, V127, P2515; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kondo T, 2000, DEVELOPMENT, V127, P2989; KORENBERG JR, 1991, PROG CLIN BIOL RES, V373, P43; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Wang SL, 2001, NEURON, V29, P603, DOI 10.1016/S0896-6273(01)00237-9; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	15	101	106	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					973	974		10.1038/nn718	http://dx.doi.org/10.1038/nn718			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11574831				2022-12-24	WOS:000171325800007
J	Mizuguchi, R; Sugimori, M; Takebayashi, H; Kosako, H; Nagao, M; Yoshida, S; Nabeshima, Y; Shimamura, K; Nakafuku, M				Mizuguchi, R; Sugimori, M; Takebayashi, H; Kosako, H; Nagao, M; Yoshida, S; Nabeshima, Y; Shimamura, K; Nakafuku, M			Combinatorial roles of Olig2 and Neurogenin2 in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons	NEURON			English	Article							PROGENITOR-CELL IDENTITY; NEURAL CREST CELLS; MOTOR-NEURON; OLIGODENDROCYTE LINEAGE; SPINAL-CORD; SONIC HEDGEHOG; NERVOUS-SYSTEM; HOMEOBOX GENES; TRANSCRIPTION FACTORS; HOMEODOMAIN PROTEIN	Distinct classes of neurons are generated at defined times and positions during development of the nervous system. It remains elusive how specification of neuronal identity coordinates with acquisition of pan-neuronal properties. Here we show that basic helix-loop-helix (bHLH) transcription factors Olig2 and Neurogenin2 (Ngn2) play vital roles in the coordinated induction of pan-neuronal and subtype-specific properties of motoneurons. Olig2 and Ngn2 are specifically coexpressed in motoneuron progenitors. Misexpression studies in chick demonstrate the specific, combinatorial actions of Olig2 and Ngn2 in motoneuron generation. Our results further revealed crossregulatory interactions between bHLH and homeodomain transcription factors in the specification of motoneurons. We suggest that distinct classes of transcription factors collaborate to generate motoneurons in the ventral neural tube.	Univ Tokyo, Grad Sch Med, Dept Neurobiol, Bunkyo Ku, Tokyo 1130033, Japan; Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Sakyo Ku, Kyoto 6068501, Japan; Japan Sci & Technol Cooperat, CREST, Minato Ku, Tokyo 1050011, Japan	University of Tokyo; Kyoto University; Japan Science & Technology Agency (JST)	Nakafuku, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurobiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Nakafuku, Masato/J-3068-2013; Takebayashi, Hirohide/AAO-1693-2020	Nakafuku, Masato/0000-0001-7783-9005; Yoshida, Shosei/0000-0001-8861-1866				Anderson D, 1997, MOL CELLULAR APPROAC, P26; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Blader P, 1997, DEVELOPMENT, V124, P4557; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; Fode C, 2000, GENE DEV, V14, P67; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Hassan BA, 2000, GENE DEV, V14, P1852; Hatakeyama J, 2001, DEVELOPMENT, V128, P1313; Helms AW, 1998, DEVELOPMENT, V125, P919; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; LEBER SM, 1995, J NEUROSCI, V15, P1236; Ledent V, 2001, GENOME RES, V11, P754, DOI 10.1101/gr.177001; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lo LC, 1997, CURR BIOL, V7, P440, DOI 10.1016/S0960-9822(06)00191-6; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Mansouri A, 1998, MECH DEVELOP, V78, P171, DOI 10.1016/S0925-4773(98)00168-3; Matsunaga E, 2000, DEVELOPMENT, V127, P2357; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Osumi N, 1997, DEVELOPMENT, V124, P2961; Pattyn A, 2000, DEVELOPMENT, V127, P1349; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Perez SE, 1999, DEVELOPMENT, V126, P1715; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Pringle NP, 1996, DEV BIOL, V177, P30, DOI 10.1006/dbio.1996.0142; Qiu MS, 1998, MECH DEVELOP, V72, P77, DOI 10.1016/S0925-4773(98)00018-5; Richardson WD, 2000, GLIA, V29, P136, DOI 10.1002/(SICI)1098-1136(20000115)29:2<136::AID-GLIA6>3.0.CO;2-G; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Simmons AD, 2001, DEV BIOL, V229, P327, DOI 10.1006/dbio.2000.9984; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Stanke M, 1999, DEVELOPMENT, V126, P4087; Stoykova A, 2000, J NEUROSCI, V20, P8042; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TANAKA H, 1984, DEV BIOL, V106, P26, DOI 10.1016/0012-1606(84)90057-5; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; Torii MA, 1999, DEVELOPMENT, V126, P443; Tremblay P, 1996, DEVELOPMENT, V122, P2555; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; White NM, 2000, DEVELOPMENT, V127, P1681; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	58	350	366	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					757	771		10.1016/S0896-6273(01)00413-5	http://dx.doi.org/10.1016/S0896-6273(01)00413-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567615	Bronze			2022-12-24	WOS:000171013300010
J	Passafaro, M; Piech, V; Sheng, M				Passafaro, M; Piech, V; Sheng, M			Subunit-specific temporal and spatial patterns of AMPA receptor exocytosis in hippocampal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM DEPRESSION; DOMAIN-CONTAINING PROTEINS; GLUTAMATE RECEPTORS; SYNAPTIC PLASTICITY; BREFELDIN-A; MEMBRANE; SYNAPSES; GLUR2; LTP; REDISTRIBUTION	Using a thrombin cleavage assay in cultured hippocampal neurons, we studied the kinetics, regulation and site of AMPA receptor surface delivery. Surface insertion of the GluR1 subunit occurs slowly in basal conditions and is stimulated by NMDA receptor activation and insulin, whereas GluR2 exocytosis is constitutively rapid. Although both subunits ultimately concentrate in synapses, GluR1 and GluR2 show different spatial patterns of surface accumulation, consistent with GluR1 being inserted initially at extrasynaptic sites and GluR2 being inserted more directly at synapses. The spatiotemporal pattern of surface accumulation is determined by the cytoplasmic tails of GluR subunits, and in heteromeric receptors, GluR1 acts dominantly over GluR2. We propose that GluR1 controls the exocytosis and GluR2/3, the recycling and endocytosis of AMPA receptors.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Sheng, M (corresponding author), MIT, Ctr Learning & Memory, E18-215,77 Massachusetts Ave, Cambridge, MA 02139 USA.			Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [NS 35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; Chardin P, 1999, CELL, V97, P153, DOI 10.1016/S0092-8674(00)80724-2; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Chung HJ, 2000, J NEUROSCI, V20, P7258; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; HEIN L, 1994, J BIOL CHEM, V269, P27719; Jia ZP, 1996, NEURON, V17, P945, DOI 10.1016/S0896-6273(00)80225-1; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; MATSUSHIMA Y, 1965, OSAKA J MATH, V2, P1; Nakagawa T, 2000, SCIENCE, V290, P2270; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Scannevin RH, 2000, NAT REV NEUROSCI, V1, P133, DOI 10.1038/35039075; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Srivastava S, 1998, NEURON, V21, P581, DOI 10.1016/S0896-6273(00)80568-1; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wyszynski M, 1999, J NEUROSCI, V19, P6528; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zhou Q, 2001, P NATL ACAD SCI USA, V98, P1261, DOI 10.1073/pnas.031573798; Zhu JJ, 2000, NAT NEUROSCI, V3, P1098, DOI 10.1038/80614	43	501	521	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					917	926		10.1038/nn0901-917	http://dx.doi.org/10.1038/nn0901-917			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528423				2022-12-24	WOS:000170698600018
J	Dwyer, ND; Adler, CE; Crump, JG; L'Etoile, ND; Bargmann, CI				Dwyer, ND; Adler, CE; Crump, JG; L'Etoile, ND; Bargmann, CI			Polarized dendritic transport and the AP-1 mu 1 clathrin adaptor UNC-101 localize odorant receptors to olfactory cilia	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; POLYMERIC IMMUNOGLOBULIN RECEPTOR; GLR-1 GLUTAMATE-RECEPTOR; C-ELEGANS; CYTOPLASMIC DOMAIN; SYNAPTIC VESICLES; EPITHELIAL-CELLS; MDCK CELLS; HIPPOCAMPAL-NEURONS; SENSORY NEURONS	Odorant receptors and signaling proteins are localized to sensory cilia on olfactory dendrites. Using a GFP-tagged odorant receptor protein, Caenorhabditis elegans ODR-10, we characterized protein sorting and transport in olfactory neurons in vivo. ODR-10 is transported in rapidly moving dendritic vesicles that shuttle between the cell body and the cilia. Anterograde and retrograde vesicles move at different speeds, suggesting that dendrites have polarized transport mechanisms. Residues immediately after the seventh membrane-spanning domain of ODR-10 are required for localization; these residues are conserved in many G protein-coupled receptors. UNC-101 encodes a mu1 subunit of the AP-1 clathrin adaptor complex. In unc-101 mutants, dendritic vesicles are absent, ODR-10 receptor is evenly distributed over the plasma membrane, and other cilia membrane proteins are also mislocalized, implicating AP-1 in protein sorting to olfactory cilia.	Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Program Neurosci, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Genet Program, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Program Dev Biol, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu		Dwyer, Noelle/0000-0002-1995-7203; Crump, Gage/0000-0002-3209-0026; Bargmann, Cornelia/0000-0002-8484-0618				BAAS PW, 1988, P NATL ACAD SCI USA, V85, P8335, DOI 10.1073/pnas.85.21.8335; BRENNER S, 1974, GENETICS, V77, P71; BURTON PR, 1985, J COMP NEUROL, V242, P147, DOI 10.1002/cne.902420202; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colbert HA, 1997, J NEUROSCI, V17, P8259; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; Collet J, 1998, GENETICS, V148, P187; DERETIC D, 1991, J CELL BIOL, V113, P1281, DOI 10.1083/jcb.113.6.1281; Deretic D, 1998, EYE, V12, P526, DOI 10.1038/eye.1998.141; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Folsch H, 1999, CELL, V99, P189, DOI 10.1016/S0092-8674(00)81650-5; Futter CE, 1998, J CELL BIOL, V141, P611, DOI 10.1083/jcb.141.3.611; Grant B, 1999, MOL BIOL CELL, V10, P4311, DOI 10.1091/mbc.10.12.4311; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; HUNZIKER W, 1991, CELL, V66, P907, DOI 10.1016/0092-8674(91)90437-4; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; L'Etoile ND, 2000, NEURON, V25, P575, DOI 10.1016/S0896-6273(00)81061-2; LEE JH, 1994, GENE DEV, V8, P60, DOI 10.1101/gad.8.1.60; LI W, 1992, GENETICS, V132, P675; Liu XR, 1999, J NEUROSCI, V19, P6267; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; MATTER K, 1992, CELL, V71, P741, DOI 10.1016/0092-8674(92)90551-M; MOSTOV KE, 1995, BIOESSAYS, V17, P129, DOI 10.1002/bies.950170208; Nakagawa T, 2000, CELL, V103, P569, DOI 10.1016/S0092-8674(00)00161-6; Nonet ML, 1999, MOL BIOL CELL, V10, P2343, DOI 10.1091/mbc.10.7.2343; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Orzech E, 1999, J BIOL CHEM, V274, P2201, DOI 10.1074/jbc.274.4.2201; OTSUKA AJ, 1995, J CELL BIOL, V129, P1081, DOI 10.1083/jcb.129.4.1081; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PATEL N, 1993, P NATL ACAD SCI USA, V90, P9181, DOI 10.1073/pnas.90.19.9181; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; Robinson MS, 1997, TRENDS CELL BIOL, V7, P99, DOI 10.1016/S0962-8924(96)10048-9; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Saifee O, 1998, MOL BIOL CELL, V9, P1235, DOI 10.1091/mbc.9.6.1235; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Shim J, 2000, MOL BIOL CELL, V11, P2743, DOI 10.1091/mbc.11.8.2743; Simske JS, 1996, CELL, V85, P195, DOI 10.1016/S0092-8674(00)81096-X; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; TRAUB LM, 1993, J CELL BIOL, V123, P561, DOI 10.1083/jcb.123.3.561; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whitfield CW, 1999, MOL BIOL CELL, V10, P2087, DOI 10.1091/mbc.10.6.2087; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686	59	129	132	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2001	31	2					277	287		10.1016/S0896-6273(01)00361-0	http://dx.doi.org/10.1016/S0896-6273(01)00361-0			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502258	Bronze			2022-12-24	WOS:000170277700012
J	Deneve, S; Latham, PE; Pouget, A				Deneve, S; Latham, PE; Pouget, A			Efficient computation and cue integration with noisy population codes	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELDS; CORTEX; INFORMATION; GAZE	The brain represents sensory and motor variables through the activity of large populations of neurons. It is not understood how the nervous system computes with these population codes, given that individual neurons are noisy and thus unreliable. We focus here on two general types of computation, function approximation and cue integration, as these are powerful enough to handle a range of tasks, including sensorimotor transformations, feature extraction in sensory systems and multisensory integration. We demonstrate that a particular class of neural networks, basis function networks with multidimensional attractors, can perform both types of computation optimally with noisy neurons. Moreover, neurons in the intermediate layers of our model show response properties similar to those observed in several multimodal cortical areas. Thus, basis function networks with multidimensional attractors may be used by the brain to compute efficiently with population codes.	Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA	University of Rochester; University of California System; University of California Los Angeles	Pouget, A (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, 601 Elmwood Ave, Rochester, NY 14627 USA.	alex@bcs.rochester.edu		Pouget, Alexandre/0000-0003-3054-6365	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447, R29MH057823] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; BOUSSAOUD D, 1993, EXP BRAIN RES, V93, P423; Braitenberg V, 1991, ANATOMY CORTEX; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; GRAZIANO MSA, 1994, SCIENCE, V266, P1054, DOI 10.1126/science.7973661; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JAY MF, 1987, J NEUROPHYSIOL, V57, P22, DOI 10.1152/jn.1987.57.1.22; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Papoulis A., 1991, PROBABILITY RANDOM V; PARADISO MA, 1988, BIOL CYBERN, V58, P35, DOI 10.1007/BF00363954; POGGIO T, 1990, COLD SPRING HARB SYM, V55, P899; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2000, NAT NEUROSCI, V3, P1192, DOI 10.1038/81469; SALINAS E, 1995, J NEUROSCI, V15, P6461; SEUNG HS, 1993, P NATL ACAD SCI USA, V90, P10749, DOI 10.1073/pnas.90.22.10749; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; WESTHEIMER G, 1956, J OPT SOC AM, V46, P116, DOI 10.1364/JOSA.46.000116; Yuille AL, 1996, PERCEPTION BAYESIAN, P123, DOI DOI 10.1017/CBO9780511984037.006	22	249	252	0	21	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					826	831		10.1038/90541	http://dx.doi.org/10.1038/90541			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477429				2022-12-24	WOS:000170137300016
J	Bauer, EP; LeDoux, JE; Nader, K				Bauer, EP; LeDoux, JE; Nader, K			Fear conditioning and LTP in the lateral amygdala ave sensitive to the same stimulus contingencies	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; SYNAPSES; MEMORY		NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	Bauer, EP (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA.	bauer@cns.nyu.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH011902, K02MH000956, R01MH046516] Funding Source: NIH RePORTER; NIMH NIH HHS [KO2 MH00956, MH 11902-01A1, R37 MH 39774, R01 MH 46516] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; HUANG YY, 1992, SCIENCE, V255, P730, DOI 10.1126/science.1346729; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; KELSO SR, 1986, P NATL ACAD SCI USA, V83, P5326, DOI 10.1073/pnas.83.14.5326; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; RESCORLA RA, 1968, J COMP PHYSIOL PSYCH, V66, P1, DOI 10.1037/h0025984; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Weisskopf MG, 1999, J NEUROSCI, V19, P10512	15	88	89	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					687	688		10.1038/89465	http://dx.doi.org/10.1038/89465			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426221				2022-12-24	WOS:000169621300010
J	Cherny, RA; Atwood, CS; Xilinas, ME; Gray, DN; Jones, WD; McLean, CA; Barnham, KJ; Volitakis, I; Fraser, FW; Kim, YS; Huang, XD; Goldstein, LE; Moir, RD; Lim, JT; Beyreuther, K; Zheng, H; Tanzi, RE; Masters, CL; Bush, AI				Cherny, RA; Atwood, CS; Xilinas, ME; Gray, DN; Jones, WD; McLean, CA; Barnham, KJ; Volitakis, I; Fraser, FW; Kim, YS; Huang, XD; Goldstein, LE; Moir, RD; Lim, JT; Beyreuther, K; Zheng, H; Tanzi, RE; Masters, CL; Bush, AI			Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer's disease transgenic mice	NEURON			English	Article							A-BETA; MOUSE MODEL; FREE-RADICALS; PEPTIDE; PLAQUES; PROTEIN; AGGREGATION; CLIOQUINOL; PATHOLOGY; BRAINS	Inhibition of neocortical beta -amyloid (A beta) accumulation may be essential in an effective therapeutic intervention for Alzheimer's disease (AD). Cu and Zn are enriched in A beta deposits in AD, which are solubilized by Cu/Zn-selective chelators in vitro. Here we report a 49% decrease in brain A beta deposition (-375 mug/g wet weight, p = 0.0001) in a blinded study of APP2576 transgenic mice treated orally for 9 weeks with clioquinol, an antibiotic and bioavailable Cu/Zn chelator. This was accompanied by a modest increase in soluble A beta (1.45% of total cerebral A beta); APP, synaptophysin, and GFAP levels were unaffected. General health and body weight parameters were significantly more stable in the treated animals. These results support targeting the interactions of Cu and Zn with A beta as a novel therapy for the prevention and treatment of AD.	Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; Mental Hlth Res Inst Victoria, Parkville, Vic 3052, Australia; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Lab Oxidat Biol Genet, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Aging Unit, Charlestown, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Psychiat, Charlestown, MA 02129 USA; Univ Gothenburg, Sahlgrenska Univ Sjukhuset, Psychiat Sect, Inst Clin Neurosci, Molndal, Sweden; Biomol Res Inst, Parkville, Vic 3052, Australia; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol & Genet, Charlestown, MA 02129 USA; Heidelberg Univ, ZMBH, D-69120 Heidelberg, Germany; Baylor Coll Med, Huffington Ctr Aging, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Melbourne; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Sahlgrenska University Hospital; University of Gothenburg; Harvard University; Massachusetts General Hospital; Ruprecht Karls University Heidelberg; Baylor College of Medicine	Bush, AI (corresponding author), Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia.	bush@helix.mgh.harvard.edu	Jones, Walton/A-2417-2011; Tanzi, Rudolph/AAE-9622-2019; , Craig/AAB-3963-2022; Bush, Ashley/Y-2457-2019; Bush, Ashley I/A-1186-2007; Moir, Robert D./M-7612-2017	Jones, Walton/0000-0001-8642-627X; Tanzi, Rudolph/0000-0002-7032-1454; Bush, Ashley/0000-0001-8259-9069; Bush, Ashley I/0000-0001-8259-9069; Moir, Robert D./0000-0001-5431-3553; Goldstein, Lee/0000-0001-8419-9800; McLean, Catriona/0000-0002-0302-5727				Atwood CS, 1998, J BIOL CHEM, V273, P12817, DOI 10.1074/jbc.273.21.12817; Atwood CS, 2000, J NEUROCHEM, V75, P1219, DOI 10.1046/j.1471-4159.2000.0751219.x; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; BAUMGARTNER G, 1979, J NEUROL NEUROSUR PS, V42, P1073, DOI 10.1136/jnnp.42.12.1073; Bush AI, 1999, NEUROBIOL AGING, V20, P335; BUSH AI, 1994, J BIOL CHEM, V269, P12152; BUSH AI, 1994, SCIENCE, V265, P1464, DOI 10.1126/science.8073293; Cherny RA, 1999, J BIOL CHEM, V274, P23223, DOI 10.1074/jbc.274.33.23223; Cuajungco MP, 2000, J BIOL CHEM, V275, P19439, DOI 10.1074/jbc.C000165200; HARIGAYA Y, 1995, BIOCHEM BIOPH RES CO, V211, P1015, DOI 10.1006/bbrc.1995.1912; Haugabook SJ, 2001, FASEB J, V15, P16; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Huang XD, 1999, BIOCHEMISTRY-US, V38, P7609, DOI 10.1021/bi990438f; Huang XD, 1997, J BIOL CHEM, V272, P26464, DOI 10.1074/jbc.272.42.26464; Huang XD, 1999, J BIOL CHEM, V274, P37111, DOI 10.1074/jbc.274.52.37111; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; KIDANI Y, 1974, JPN ANALYST, V23, P1375; KOTAKI H, 1983, J PHARMACOBIO-DYNAM, V6, P881; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Kuo YM, 2001, J BIOL CHEM, V276, P12991, DOI 10.1074/jbc.M007859200; Lee JY, 1999, J NEUROSCI, V19, DOI 10.1523/jneurosci.19-11-j0002.1999; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Lovell MA, 1998, J NEUROL SCI, V158, P47, DOI 10.1016/S0022-510X(98)00092-6; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MCLACHLAN DRC, 1991, LANCET, V337, P1304, DOI 10.1016/0140-6736(91)92978-B; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MEADE TW, 1975, BRIT J PREV SOC MED, V29, P157; Moir RD, 1999, BIOCHEMISTRY-US, V38, P4595, DOI 10.1021/bi982437d; NAKAE K, 1973, LANCET, V1, P171; Padmanabhan G., 1989, ANAL PROFILES DRUG S, P57; RICHARDS DA, 1971, LANCET, V1, P44; ROSE FC, 1984, ACTA NEUROL SCAND, V70, P137; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; SHIRAKI H, 1979, HDB CLIN NEUROLOGY, V37; Smith MA, 1997, P NATL ACAD SCI USA, V94, P9866, DOI 10.1073/pnas.94.18.9866; Soto C, 1996, BIOCHEM BIOPH RES CO, V226, P672, DOI 10.1006/bbrc.1996.1413; Suh SW, 2000, BRAIN RES, V852, P274, DOI 10.1016/S0006-8993(99)02096-X; TAMAOKA A, 1994, BIOCHEM BIOPH RES CO, V205, P834, DOI 10.1006/bbrc.1994.2740; TATEISHI J, 1975, JPN J MED SCI BIOL, V28, P165; TOYOKURA Y, 1975, JPN J MED SCI BIOL, V28, P79; TSUBAKI T, 1971, LANCET, V1, P696, DOI 10.1016/S0140-6736(71)92699-7; Wang J, 1999, EXP NEUROL, V158, P328, DOI 10.1006/exnr.1999.7085; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; White AR, 1999, BRAIN RES, V842, P439, DOI 10.1016/S0006-8993(99)01861-2; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Yassin MS, 2000, J NEUROL SCI, V173, P40, DOI 10.1016/S0022-510X(99)00297-X	49	1213	1274	3	162	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					665	676		10.1016/S0896-6273(01)00317-8	http://dx.doi.org/10.1016/S0896-6273(01)00317-8			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430801	Bronze			2022-12-24	WOS:000169508900008
J	Rosay, P; Armstrong, JD; Wang, ZS; Kaiser, K				Rosay, P; Armstrong, JD; Wang, ZS; Kaiser, K			Synchronized neural activity in the Drosophila memory centers and its modulation by amnesiac	NEURON			English	Article							RECTIFIER POTASSIUM CURRENT; MUSHROOM BODIES; PHARMACOLOGICAL ANALYSIS; CORPORA PEDUNCULATA; IONIC CURRENTS; BINDING-SITES; NEURONS; BRAIN; BODY; CHANNELS	The mushroom bodies are key features of the brain circuitry for insect associative learning, especially when evoked by olfactory cues. Mushroom bodies are also notable for the close-packed parallel architecture of their many intrinsic neuronal elements, known as Kenyon cells. Here, we report that Kenyon cells of adult Drosophila exhibit synchronous oscillation of intracellular calcium concentration, with a mean period of approximately 4 min. Robust oscillation within a dissected brain persists for hours in insect saline and is strongly modulated in amplitude by the product(s) of the memory consolidation gene, amnesiac. It is also sensitive to pharmacological agents specific for several classes of ion channel and for acetylcholine and GABA receptors. A role in memory consolidation involving transcriptionally mediated synaptic strengthening is proposed.	Univ Glasgow, IBLS Div Mol Genet, Glasgow G12 8QQ, Lanark, Scotland; Neuropa Ltd, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	Kaiser, K (corresponding author), Univ Glasgow, IBLS Div Mol Genet, Anderson Coll Complex, Glasgow G12 8QQ, Lanark, Scotland.	k.kaiser@bio.gla.ac.uk		Armstrong, Douglas/0000-0002-5397-3864				Armstrong JD, 1998, LEARN MEMORY, V5, P102; BERTRAND D, 1994, EUR J NEUROSCI, V6, P869, DOI 10.1111/j.1460-9568.1994.tb00997.x; Bicker G, 1996, J NEUROSCI METH, V69, P33, DOI 10.1016/S0165-0270(96)00018-0; BICKER G, 1994, J NEUROPHYSIOL, V71, P808, DOI 10.1152/jn.1994.71.2.808; BICKER G, 1985, BRAIN RES, V360, P394, DOI 10.1016/0006-8993(85)91262-4; BRAND AH, 1993, DEVELOPMENT, V118, P401; Buckingham SD, 1997, J EXP BIOL, V200, P2685; BYERLY L, 1988, J NEUROSCI, V8, P4379; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; ELKINS T, 1986, P NATL ACAD SCI USA, V83, P8415, DOI 10.1073/pnas.83.21.8415; FEANY MB, 1995, SCIENCE, V268, P869, DOI 10.1126/science.7754370; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Gerber B, 1998, NEUROBIOL LEARN MEM, V69, P71, DOI 10.1006/nlme.1997.3801; GHO M, 1986, PFLUG ARCH EUR J PHY, V407, P526, DOI 10.1007/BF00657511; GIELOW ML, 1995, J NEUROSCI, V15, P6085; GREENBERG RM, 1989, INSECT BIOCHEM, V19, P309, DOI 10.1016/0020-1790(89)90077-2; GU GG, 1995, J NEUROBIOL, V28, P269, DOI 10.1002/neu.480280302; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1997, TRENDS NEUROSCI, V20, P245, DOI 10.1016/S0166-2236(96)01019-3; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Ito K, 1998, LEARN MEMORY, V5, P52; KNIGHT MR, 1991, NATURE, V352, P524, DOI 10.1038/352524a0; Kraliz D, 1997, J NEUROBIOL, V32, P1; Kraliz D, 1998, J NEUROGENET, V12, P25, DOI 10.3109/01677069809108553; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Leitch B, 1996, J COMP NEUROL, V372, P487; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; MURPHY TH, 1992, J NEUROSCI, V12, P4834; Nunez L, 1996, EUR J NEUROSCI, V8, P192, DOI 10.1111/j.1460-9568.1996.tb01180.x; O'Donnell MJ, 1998, AM J PHYSIOL-REG I, V274, pR1039, DOI 10.1152/ajpregu.1998.274.4.R1039; ODELL KMC, 1995, NEURON, V15, P55, DOI 10.1016/0896-6273(95)90064-0; ODOWD DK, 1988, J NEUROSCI, V8, P3633; PAURON D, 1987, BIOCHEMISTRY-US, V26, P6311, DOI 10.1021/bi00394a003; PELZER S, 1989, EMBO J, V8, P2365, DOI 10.1002/j.1460-2075.1989.tb08365.x; PRASHER D, 1985, BIOCHEM BIOPH RES CO, V126, P1259, DOI 10.1016/0006-291X(85)90321-3; PROKOP A, 1991, DEVELOPMENT, V111, P79; QUINN WG, 1979, NATURE, V277, P212, DOI 10.1038/277212a0; Rosay P, 1997, J CELL SCI, V110, P1683; SCHAFER S, 1994, J NEUROSCI, V14, P4600; SCHILDBERGER K, 1983, CELL TISSUE RES, V230, P573, DOI 10.1007/BF00216202; SCHURMANN FW, 1974, EXP BRAIN RES, V19, P406, DOI 10.1007/BF00234464; SHMIGOL A, 1995, NEUROSCIENCE, V65, P1109, DOI 10.1016/0306-4522(94)00553-H; SINGH S, 1989, NEURON, V2, P1325, DOI 10.1016/0896-6273(89)90070-6; SOLC CK, 1988, J NEUROSCI, V8, P2556; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang XS, 1997, BRAIN RES, V767, P239, DOI 10.1016/S0006-8993(97)00585-4; WRIGHT NJD, 1995, J NEUROSCI, V15, P1025; Wu C F, 1992, Ion Channels, V3, P261; Yamazaki Y, 1998, BRAIN RES, V788, P80, DOI 10.1016/S0006-8993(97)01515-1; YANG MY, 1995, NEURON, V15, P45; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	66	58	59	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					759	770		10.1016/S0896-6273(01)00323-3	http://dx.doi.org/10.1016/S0896-6273(01)00323-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430809	Bronze			2022-12-24	WOS:000169508900016
J	Boiko, T; Rasband, MN; Levinson, SR; Caldwell, JH; Mandel, G; Trimmer, JS; Matthews, G				Boiko, T; Rasband, MN; Levinson, SR; Caldwell, JH; Mandel, G; Trimmer, JS; Matthews, G			Compact myelin dictates the differential targeting of two sodium channel isoforms in the same axon	NEURON			English	Article							RAT OPTIC-NERVE; CELL-ADHESION MOLECULES; MOUSE MUTANT SHIVERER; SUBUNIT POLYPEPTIDES; HYPOMYELINATED AXONS; RANVIER FORMATION; ALPHA-SUBUNIT; NA+ CHANNELS; K+ CHANNELS; SYSTEM	Voltage-dependent sodium channels are uniformly distributed along unmyelinated axons, but are highly concentrated at nodes of Ranvier in myelinated axons. Here, we show that this pattern is associated with differential localization of distinct sodium channel a subunits to the unmyelinated and myelinated zones of the same retinal ganglion cell axons. In adult axons, Na(v)1.2 is localized to the unmyelinated tone, whereas Na(v)1.6 is specifically targeted to nodes. During development, Na(v)1.2 is expressed first and becomes clustered at immature nodes of Ranvier, but as myelination proceeds, Na(v)1.6 replaces Na(v)1.2 at nodes. In Shiverer mice, which lack compact myelin, Na(v)1.2 is found throughout adult axons, whereas little Na(v)1.6 is detected. Together, these data show that sodium channel isoforms are differentially targeted to distinct domains of the same axon in a process associated with formation of compact myelin.	SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA; SUNY Stony Brook, Howard Hughes Med Inst, Stony Brook, NY 11794 USA; SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; Univ Colorado, Hlth Sci Ctr, Dept Physiol & Biophys, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Dept Cellular & Struct Biol, Denver, CO 80262 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Howard Hughes Medical Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Matthews, G (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Stony Brook, NY 11794 USA.			Rasband, Matthew/0000-0001-8184-2477	NATIONAL EYE INSTITUTE [R01EY003821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022518, P01NS034375, R01NS026505, R37NS034383, R01NS034383] Funding Source: NIH RePORTER; NEI NIH HHS [EY03821, R01 EY003821] Funding Source: Medline; NINDS NIH HHS [NS34383, NS22518, NS34375, NS10906, NS26505] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baba H, 1999, J NEUROSCI RES, V58, P752, DOI 10.1002/(SICI)1097-4547(19991215)58:6<752::AID-JNR3>3.0.CO;2-D; BARTSCH U, 1989, J COMP NEUROL, V284, P451, DOI 10.1002/cne.902840310; BekeleArcuri Z, 1996, NEUROPHARMACOLOGY, V35, P851, DOI 10.1016/0028-3908(96)00128-1; Berghs S, 2000, J CELL BIOL, V151, P985, DOI 10.1083/jcb.151.5.985; BLACK JA, 1982, BRAIN RES, V250, P1, DOI 10.1016/0006-8993(82)90948-9; Brady ST, 1999, J NEUROSCI, V19, P7278, DOI 10.1523/JNEUROSCI.19-17-07278.1999; CALDWELL JH, 2000, P NATL ACAD SCI USA, V10, P1073; Ching W, 1999, J NEUROCYTOL, V28, P295, DOI 10.1023/A:1007053411667; Davis JQ, 1996, J CELL BIOL, V135, P1355, DOI 10.1083/jcb.135.5.1355; DUGANDZIJANOVAKOVIC S, 1995, J NEUROSCI, V15, P492; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dupree JL, 1998, J NEUROSCI, V18, P1642; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; Goldin AL, 1999, ANN NY ACAD SCI, V868, P38, DOI 10.1111/j.1749-6632.1999.tb11272.x; Gong B, 1999, J COMP NEUROL, V412, P342; HILDEBRAND C, 1984, J COMP NEUROL, V224, P25, DOI 10.1002/cne.902240103; INOUE Y, 1981, BRAIN RES, V219, P85, DOI 10.1016/0006-8993(81)90269-9; ISOM LL, 1995, CELL, V83, P433, DOI 10.1016/0092-8674(95)90121-3; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Kaplan MR, 2001, NEURON, V30, P105, DOI 10.1016/S0896-6273(01)00266-5; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Krzemien DM, 2000, J COMP NEUROL, V420, P70; Lambert S, 1997, J NEUROSCI, V17, P7025; Malhotra JD, 2000, J BIOL CHEM, V275, P11383, DOI 10.1074/jbc.275.15.11383; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; NOEBELS JL, 1991, NATURE, V352, P431, DOI 10.1038/352431a0; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; POLTORAK M, 1987, J CELL BIOL, V105, P1893, DOI 10.1083/jcb.105.4.1893; Raman IM, 1997, NEURON, V19, P881, DOI 10.1016/S0896-6273(00)80969-1; Rasband MN, 2001, J COMP NEUROL, V429, P166, DOI 10.1002/1096-9861(20000101)429:1<166::AID-CNE13>3.0.CO;2-Y; Rasband MN, 1999, J NEUROCYTOL, V28, P319, DOI 10.1023/A:1007057512576; Rasband MN, 2000, J PHYSIOL-LONDON, V525, P63, DOI 10.1111/j.1469-7793.2000.00063.x; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; ROSENBLUTH J, 1980, J COMP NEUROL, V194, P639, DOI 10.1002/cne.901940310; ROSENBLUTH J, 1981, BRAIN RES, V208, P283, DOI 10.1016/0006-8993(81)90558-8; Schaller KL, 2000, J COMP NEUROL, V420, P84; Scotland P, 1998, J CELL BIOL, V143, P1305, DOI 10.1083/jcb.143.5.1305; SHRAGER P, 1989, BRAIN RES, V483, P149, DOI 10.1016/0006-8993(89)90046-2; Smith MR, 1998, J NEUROSCI, V18, P6093; SRINIVASAN Y, 1988, NATURE, V333, P177, DOI 10.1038/333177a0; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Trapp BD, 2000, J CELL BIOL, V150, pF97, DOI 10.1083/jcb.150.3.F97; Tzoumaka E, 2000, J NEUROSCI RES, V60, P37, DOI 10.1002/(SICI)1097-4547(20000401)60:1<37::AID-JNR4>3.0.CO;2-W; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vabnick I, 1998, J NEUROBIOL, V37, P80, DOI 10.1002/(SICI)1097-4695(199810)37:1<80::AID-NEU7>3.0.CO;2-4; Wang GY, 1997, J NEUROPHYSIOL, V78, P2895, DOI 10.1152/jn.1997.78.6.2895; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WAXMAN SG, 1989, P NATL ACAD SCI USA, V86, P1406, DOI 10.1073/pnas.86.4.1406; WESTENBROEK RE, 1992, J NEUROSCI, V12, P2259, DOI 10.1523/jneurosci.12-06-02259.1992; WESTENBROEK RE, 1989, NEURON, V3, P695, DOI 10.1016/0896-6273(89)90238-9	51	313	321	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					91	104		10.1016/S0896-6273(01)00265-3	http://dx.doi.org/10.1016/S0896-6273(01)00265-3			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343647	Bronze			2022-12-24	WOS:000168412900013
J	Rubin, BD; Katz, LC				Rubin, BD; Katz, LC			Spatial coding of enantiomers in the rat olfactory bulb	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; ORGANIZATION		Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute	Rubin, BD (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Neurobiol, Durham, NC 27710 USA.							BELLUSCIO L, IN PRESS J NEUROSCI; DOTY RL, 1986, EXPERIENTIA, V42, P257, DOI 10.1007/BF01942506; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Laska M, 1999, CHEM SENSES, V24, P161, DOI 10.1093/chemse/24.2.161; Laska M, 1999, AM J PHYSIOL-REG I, V277, pR1098, DOI 10.1152/ajpregu.1999.277.4.R1098; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Slotnick B.M., 1990, COMP PERCEPT, V1, P155; STEWART WB, 1979, J COMP NEUROL, V185, P715, DOI 10.1002/cne.901850407; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857	15	70	74	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					355	356		10.1038/85997	http://dx.doi.org/10.1038/85997			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276223				2022-12-24	WOS:000168762200013
J	Oviedo, H; Reyes, AD				Oviedo, H; Reyes, AD			Boosting of neuronal firing evoked with asynchronous and synchronous inputs to the dendrite	NATURE NEUROSCIENCE			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; ACTION-POTENTIALS; APICAL DENDRITES; CORTICAL-NEURONS; CHANNELS; RAT; EPSPS; AMPLIFICATION; SOMA; INACTIVATION	Dendritic conductances have previously been shown to boost excitatory postsynaptic potentials (EPSPs). To determine whether this boosting translates to an increase in the efficacy for evoking action potentials, we injected barrages of EPSPs that simulate the inputs generated by a population of presynaptic cells into either the dendrite or the soma of pyramidal neurons in vitro. Although the individual dendritic and somatic EPSPs were identical, barrages delivered to the dendrite generated much higher firing rates. Boosting occurred when the simulated cells fired asynchronously and synchronously. This Na+-mediated boosting, which was manifested during repetitive firing, may compensate functionally for electrotonic attenuation of EPSPs.	NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University	Reyes, AD (corresponding author), NYU, Ctr Neural Sci, 4 Washington Pl, New York, NY 10003 USA.							Bekkers JM, 2000, J PHYSIOL-LONDON, V525, P611, DOI 10.1111/j.1469-7793.2000.t01-2-00611.x; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Colbert CM, 1996, J NEUROSCI, V16, P6676; Colbert CM, 1997, J NEUROSCI, V17, P6512; FERSTER D, 1995, SCIENCE, V270, P756, DOI 10.1126/science.270.5237.756; Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639, DOI 10.1152/jn.1997.77.3.1639; GRANIT R, 1966, J PHYSIOL-LONDON, V187, P379, DOI 10.1113/jphysiol.1966.sp008097; Kang J, 1996, J NEUROPHYSIOL, V76, P188, DOI 10.1152/jn.1996.76.1.188; Korngreen A, 2000, J PHYSIOL-LONDON, V525, P621, DOI 10.1111/j.1469-7793.2000.00621.x; Lipowsky R, 1996, J NEUROPHYSIOL, V76, P2181, DOI 10.1152/jn.1996.76.4.2181; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Mickus T, 1999, BIOPHYS J, V76, P846, DOI 10.1016/S0006-3495(99)77248-6; Poolos NP, 1999, J NEUROSCI, V19, P5205; Rall W, 1964, NEURAL THEORY MODELI, P73; Reyes A, 2001, ANNU REV NEUROSCI, V24, P653, DOI 10.1146/annurev.neuro.24.1.653; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes AD, 1996, J NEUROSCI, V16, P993; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Schwindt P, 1996, J NEUROPHYSIOL, V76, P3731, DOI 10.1152/jn.1996.76.6.3731; SCHWINDT PC, 1995, J NEUROPHYSIOL, V74, P2220, DOI 10.1152/jn.1995.74.5.2220; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Stevens CF, 1998, NAT NEUROSCI, V1, P210, DOI 10.1038/659; STUART G, 1995, NEURON, V15, P1065, DOI 10.1016/0896-6273(95)90095-0; Stuart G, 1998, J NEUROSCI, V18, P3501; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Zhu JJ, 2000, J PHYSIOL-LONDON, V526, P571, DOI 10.1111/j.1469-7793.2000.00571.x	30	41	42	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					261	266		10.1038/nn807	http://dx.doi.org/10.1038/nn807			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836531				2022-12-24	WOS:000174146000017
J	Featherstone, DE; Rushton, E; Broadie, K				Featherstone, DE; Rushton, E; Broadie, K			Developmental regulation of glutamate receptor field size by nonvesicular glutamate release	NATURE NEUROSCIENCE			English	Article							DROSOPHILA-MELANOGASTER; SYNAPTIC TRANSMISSION; NEUROMUSCULAR-JUNCTIONS; TRANSMITTER RELEASE; GENETIC-ANALYSIS; SYNTHETASE; NEUROTRANSMITTER; EXPRESSION; SYNTAXIN; CURRENTS	We hypothesized that presynaptic glutamate regulates postsynaptic ionotropic glutamate receptor number during synaptogenesis. To test this idea, we genetically manipulated presynaptic glutamate levels at the glutamatergic Drosophila neuromuscular junction (NMJ), then microscopically and electrophysiologically measured postsynaptic glutamate receptor field size and function. Our data show that presynaptic glutamate is a strong negative regulator of postsynaptic receptor field size and function during development. Glutamate-triggered receptor downregulation was not affected by block of synaptic vesicle fusion, demonstrating that receptors are regulated by nonvesicular glutamate release. Our results reveal an elegant mechanism for receptor field regulation during synaptogenesis and reveal a nonpathological role for nonvesicular glutamate release at the synapse.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Featherstone, DE (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.				NIGMS NIH HHS [GM54544] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; ATTWELL D, 1993, NEURON, V11, P401, DOI 10.1016/0896-6273(93)90145-H; Besson MT, 2000, CURR BIOL, V10, P207, DOI 10.1016/S0960-9822(00)00339-0; Besson MT, 1999, FEBS LETT, V449, P293; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE K, 1993, NEURON, V11, P607, DOI 10.1016/0896-6273(93)90073-Z; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; CAGGESE C, 1988, BIOCHEM GENET, V26, P571, DOI 10.1007/BF02399602; CAGGESE C, 1994, GENETICA, V94, P275, DOI 10.1007/BF01443441; CAGGESE C, 1992, DEV GENET, V13, P359, DOI 10.1002/dvg.1020130506; CAIZZI R, 1990, J MOL BIOL, V212, P17, DOI 10.1016/0022-2836(90)90301-2; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHASE BA, 1987, J NEUROBIOL, V18, P15, DOI 10.1002/neu.480180104; DAVIS GW, 1994, J NEUROBIOL, V25, P740, DOI 10.1002/neu.480250612; DEPINTO V, 1987, BIOCHEM GENET, V25, P821, DOI 10.1007/BF00502602; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Featherstone DE, 2001, J NEUROSCI, V21, P4215, DOI 10.1523/JNEUROSCI.21-12-04215.2001; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Featherstone DE, 2000, BRAIN RES BULL, V53, P501, DOI 10.1016/S0361-9230(00)00383-X; Heckmann M, 1998, NEUROSCI LETT, V256, P77, DOI 10.1016/S0304-3940(98)00756-3; IKEDA K, 1976, NATURE, V259, P489, DOI 10.1038/259489a0; Jabaudon D, 1999, P NATL ACAD SCI USA, V96, P8733, DOI 10.1073/pnas.96.15.8733; Jonas Peter, 1994, Current Opinion in Neurobiology, V4, P366, DOI 10.1016/0959-4388(94)90098-1; KOENIG JH, 1983, J CELL BIOL, V96, P1517, DOI 10.1083/jcb.96.6.1517; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; LANGLEY CH, 1981, GENETICS, V99, P151; Lissin DV, 1999, J NEUROSCI, V19, P3275; Nishikawa K, 1995, J NEUROSCI, V15, P7905; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Saitoe M, 1998, J NEUROSCI METH, V80, P163, DOI 10.1016/S0165-0270(97)00203-3; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Saitoe M, 2001, SCIENCE, V293, P514, DOI 10.1126/science.1061270; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Sheng M, 2001, CELL, V105, P825, DOI 10.1016/S0092-8674(01)00406-8; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Warr O, 1999, J PHYSIOL-LONDON, V514, P783, DOI 10.1111/j.1469-7793.1999.783ad.x; WHITE RAH, 1998, DROSOPHILA PRACTICAL, P215; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9	42	82	85	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					141	146		10.1038/nn789	http://dx.doi.org/10.1038/nn789			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11753421				2022-12-24	WOS:000173558400016
J	Doi, M; Iwasaki, K				Doi, M; Iwasaki, K			Regulation of retrograde signaling at neuromuscular junctions by the novel C2 domain protein AEX-1	NEURON			English	Article							ELEGANS NERVOUS-SYSTEM; CAENORHABDITIS-ELEGANS; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; GENETIC-ANALYSIS; MUTANTS; G(Q)ALPHA; RECEPTOR; ENCODES; IDENTIFICATION	Retrograde signaling from postsynaptic cells to presynaptic neurons Is essential for regulation of synaptic development, maintenance, and plasticity. Here we report that the novel protein AEX-1 controls retrograde signaling at neuromuscular junctions in C. elegans. aex-1 mutants show neural defects including reduced presynaptic activity and abnormal localization of the synaptic vesicle fusion protein UNC-13. Muscle-specific AEX-1 expression rescues these defects but neuron-specific expression does not. AEX-1 has an UNC-13 homologous domain and appears to regulate exocytosis in muscles. This retrograde signaling requires prohormone-convertase function in muscles, suggesting that a peptide is the retrograde signal. This signal regulates synaptic vesicle release via the EGL-30 Gqalpha protein at presynaptic terminals.	AIST, Neurosci Res Inst, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Iwasaki, K (corresponding author), AIST, Neurosci Res Inst, Mol Neurobiol Lab, Tsukuba, Ibaraki 3058566, Japan.		Doi, Motomichi/L-7438-2018	Doi, Motomichi/0000-0002-7837-3056				Bamber BA, 1999, J NEUROSCI, V19, P5348; Bargmann CI, 1998, ANNU REV NEUROSCI, V21, P279, DOI 10.1146/annurev.neuro.21.1.279; Brundage L, 1996, NEURON, V16, P999, DOI 10.1016/S0896-6273(00)80123-3; CULLCANDY SG, 1978, NATURE, V271, P74, DOI 10.1038/271074a0; Dal Santo P, 1999, CELL, V98, P757, DOI 10.1016/S0092-8674(00)81510-X; Epstein HF, 1995, METHODS CELL BIOL, V48; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Fleming JT, 1997, J NEUROSCI, V17, P5843; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; ITO Y, 1976, PROC R SOC SER B-BIO, V192, P475, DOI 10.1098/rspb.1976.0025; Iwasaki K, 1997, NEURON, V18, P613, DOI 10.1016/S0896-6273(00)80302-5; Iwasaki K, 2000, EMBO J, V19, P4806, DOI 10.1093/emboj/19.17.4806; Koch H, 2000, BIOCHEM J, V349, P247, DOI 10.1042/0264-6021:3490247; Lackner MR, 1999, NEURON, V24, P335, DOI 10.1016/S0896-6273(00)80848-X; LIU DWC, 1994, J NEUROSCI, V14, P1953; MADURO M, 1995, GENETICS, V141, P977; MCINTIRE SL, 1993, NATURE, V364, P337, DOI 10.1038/364337a0; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mendel J, 1999, NEURON, V24, P287, DOI 10.1016/S0896-6273(00)80840-5; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Miller KG, 1999, NEURON, V24, P323, DOI 10.1016/S0896-6273(00)80847-8; MITANI S, 1995, DEV GROWTH DIFFER, V37, P551; MOLENAAR PC, 1981, J NEUROCHEM, V37, P1081, DOI 10.1111/j.1471-4159.1981.tb04657.x; Nakayama K, 1997, BIOCHEM J, V327, P625, DOI 10.1042/bj3270625; NGUYEN M, 1995, GENETICS, V140, P527; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKKEMA PG, 1993, GENETICS, V135, P385; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Richards D, 1999, BRIT DENT J, V1, P3; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Shiratsuchi T, 1998, BIOCHEM BIOPH RES CO, V251, P158, DOI 10.1006/bbrc.1998.9408; Thacker C, 2000, BIOESSAYS, V22, P545, DOI 10.1002/(SICI)1521-1878(200006)22:6&lt;545::AID-BIES7&gt;3.0.CO;2-F; THOMAS JH, 1990, GENETICS, V124, P855; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Zhao HJ, 2000, DEVELOPMENT, V127, P1253; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886	42	66	76	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					249	259		10.1016/S0896-6273(01)00587-6	http://dx.doi.org/10.1016/S0896-6273(01)00587-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804572	Bronze			2022-12-24	WOS:000173387700012
J	Mack, TGA; Reiner, M; Beirowski, B; Mi, WQ; Emanuelli, M; Wagner, D; Thomson, D; Gillingwater, T; Court, F; Conforti, L; Fernando, FS; Tarlton, A; Andressen, C; Addicks, K; Magni, G; Ribchester, RR; Perry, VH; Coleman, MP				Mack, TGA; Reiner, M; Beirowski, B; Mi, WQ; Emanuelli, M; Wagner, D; Thomson, D; Gillingwater, T; Court, F; Conforti, L; Fernando, FS; Tarlton, A; Andressen, C; Addicks, K; Magni, G; Ribchester, RR; Perry, VH; Coleman, MP			Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene	NATURE NEUROSCIENCE			English	Article							SPINAL-CORD INJURY; NEUROMUSCULAR-JUNCTIONS; C57BL/OLA MICE; POLY(ADP-RIBOSE) POLYMERASE; BCL-2 OVEREXPRESSION; CELLULAR REACTIONS; MUTATION WLD(S); WILD-TYPE; MOUSE; NERVE	Axons and their synapses distal to an injury undergo rapid Wallerian degeneration, but axons in the C57BL/Wld(S) mouse are protected. The degenerative and protective mechanisms are unknown. We identified the protective gene, which encodes an N-terminal fragment of ubiquitination factor E4B (Ube4b) fused to nicotinamide mononucleotide adenylyltransferase (Nmnat), and showed that it confers a dose-dependent block of Wallerian degeneration. Transected distal axons survived for two weeks, and neuromuscular junctions were also protected. Surprisingly, the Wld protein was located predominantly in the nucleus, indicating an indirect protective mechanism. Nmnat enzyme activity, but not NAD(+) content, was increased fourfold in Wld(S) tissues. Thus, axon protection is likely to be mediated by altered ubiquitination or pyridine nucleotide metabolism.	Univ Cologne, Ctr Mol Med, D-50674 Cologne, Germany; Univ Cologne, Inst Genet, D-50674 Cologne, Germany; Univ Cologne, Dept Anat 1, D-50931 Cologne, Germany; Univ Ancona, Inst Biochem, I-60131 Ancona, Italy; Univ Edinburgh, Dept Neurosci, Edinburgh EH8 9JZ, Midlothian, Scotland; Mario Negri Inst Pharmacol Res, Mol Neurobiol Lab, I-20157 Milan, Italy; Univ Oxford, Dept Pharmacol, Oxford OX1 3QT, England; Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Cologne; University of Cologne; University of Cologne; Marche Polytechnic University; University of Edinburgh; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Oxford; University of Oxford; University of Southampton	Coleman, MP (corresponding author), Univ Cologne, Ctr Mol Med, Zuelpicher Str 47, D-50674 Cologne, Germany.	michael.coleman@uni-koeln.de	Perry, V. Hugh/Y-2935-2019	Ribchester, Richard/0000-0003-2670-6995; Court, Felipe/0000-0002-9394-7601; Gillingwater, Thomas/0000-0002-0306-5577				BALDUCCI E, 1995, ANAL BIOCHEM, V228, P64, DOI 10.1006/abio.1995.1315; BROWN MC, 1991, NEUROSCIENCE, V43, P279, DOI 10.1016/0306-4522(91)90435-Q; BUCKMASTER EA, 1995, EUR J NEUROSCI, V7, P1596, DOI 10.1111/j.1460-9568.1995.tb01155.x; Burne JF, 1996, J NEUROSCI, V16, P2064; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 1999, MAMM GENOME, V10, P617, DOI 10.1007/s003359901056; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; Costanzo EM, 1999, J PHYSIOL-LONDON, V521, P365, DOI 10.1111/j.1469-7793.1999.00365.x; DALCANTO MC, 1995, BRAIN RES, V676, P25, DOI 10.1016/0006-8993(95)00063-V; DECKWERTH TL, 1994, DEV BIOL, V165, P63, DOI 10.1006/dbio.1994.1234; Di Lisa F, 2001, FEBS LETT, V492, P4, DOI 10.1016/S0014-5793(01)02198-6; Emanuelli M, 2001, J BIOL CHEM, V276, P406, DOI 10.1074/jbc.M008700200; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Finn JT, 2000, J NEUROSCI, V20, P1333; Frei R, 1999, J NEUROSCI, V19, P6058, DOI 10.1523/JNEUROSCI.19-14-06058.1999; Fujiki M, 1996, J COMP NEUROL, V371, P469; Gillingwater TH, 2000, J PHYSIOL-LONDON, V523, p53P; Gillingwater TH, 2001, J PHYSIOL-LONDON, V534, P627, DOI 10.1111/j.1469-7793.2001.00627.x; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; GUNNING P, 1987, P NATL ACAD SCI USA, V84, P4831, DOI 10.1073/pnas.84.14.4831; Ha HC, 1999, P NATL ACAD SCI USA, V96, P13978, DOI 10.1073/pnas.96.24.13978; Hamilton MH, 2001, J BIOL CHEM, V276, P26324, DOI 10.1074/jbc.M101205200; Houseweart MK, 1999, J NEUROSCI, V19, P6446; KARNOVSKY MJ, 1965, J CELL BIOL, V27, pA137; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; Magni G, 1999, ADV ENZYMOL RAMB, V73, P135, DOI 10.1002/9780470123195.ch5; MI W, IN PRESS J NEUROSCI; Nagayama T, 2000, J NEUROCHEM, V74, P1636, DOI 10.1046/j.1471-4159.2000.0741636.x; PERRY VH, 1991, EUR J NEUROSCI, V3, P102, DOI 10.1111/j.1460-9568.1991.tb00815.x; Perry VH, 1999, PHILOS T ROY SOC B, V354, P1641, DOI 10.1098/rstb.1999.0509; PERRY VH, 1990, EUR J NEUROSCI, V2, P408, DOI 10.1111/j.1460-9568.1990.tb00433.x; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; RIBCHESTER RR, 1995, EUR J NEUROSCI, V7, P1641, DOI 10.1111/j.1460-9568.1995.tb01159.x; RIBCHESTER RR, 1994, P ROY SOC B-BIOL SCI, V255, P61, DOI 10.1098/rspb.1994.0009; Sagot Y, 1996, J NEUROSCI, V16, P2335; SAGOT Y, 1995, J NEUROSCI, V15, P7727; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Smith KJ, 2001, ANN NEUROL, V49, P470; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Valente EM, 2001, AM J HUM GENET, V68, P895, DOI 10.1086/319522; Waller A, 1850, PHIL T R SOC, V140, P423, DOI DOI 10.1098/RSTL.1850.0021; Wang NS, 2001, NEUROBIOL DIS, V8, P155; Zhang ZY, 1996, J COMP NEUROL, V371, P485; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	48	467	481	1	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1199	1206		10.1038/nn770	http://dx.doi.org/10.1038/nn770			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11770485	Green Published			2022-12-24	WOS:000172525000016
J	Keleman, K; Dickson, BJ				Keleman, K; Dickson, BJ			Short- and long-range repulsion by the Drosophila Unc5 netrin receptor	NEURON			English	Article							CONTROLLING TARGET SELECTION; PIONEER AXON MIGRATIONS; GROWTH CONE GUIDANCE; C-ELEGANS; COLORECTAL-CANCER; GENETIC-ANALYSIS; CNS MIDLINE; COMMISSURAL AXONS; TNF RECEPTOR; MOTOR AXONS	Netrins are bifunctional guidance molecules, attracting some axons and repelling others. They act through receptors of the DCC and UNCS families. DCC receptors have been implicated in both attraction and repulsion by Netrins. UNC5 receptors are required only for repulsion. In Drosophila, Netrins are expressed by midline cells of the CNS and by specific muscles in the periphery. They attract commissural and motor axons expressing the DCC family receptor Frazzled. Here we report the identification of the Drosophila Unc5 receptor, and show that it is a repulsive Netrin receptor likely to contribute to motor axon guidance. Ectopic expression of Unc5 on CNS axons can elicit either short- or long-range repulsion from the midline. Both short- and long-range repulsion require Netrin function, but only long-range repulsion requires Frazzled.	Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.		Dickson, Barry/AAE-7632-2019	Dickson, Barry/0000-0003-0715-892X				Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; BOLDIN MP, 1995, J BIOL CHEM, V270, P387, DOI 10.1074/jbc.270.1.387; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Colavita A, 1998, DEV BIOL, V194, P72, DOI 10.1006/dbio.1997.8790; Davis GW, 1997, NEURON, V19, P561, DOI 10.1016/S0896-6273(00)80372-4; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Fazeli A, 1997, NATURE, V386, P796, DOI 10.1038/386796a0; Gong QZ, 1999, DEVELOPMENT, V126, P1451; HAMELIN M, 1993, NATURE, V364, P327, DOI 10.1038/364327a0; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hiramoto M, 2000, NATURE, V406, P886, DOI 10.1038/35022571; HOFMANN K, 1995, FEBS LETT, V371, P321, DOI 10.1016/0014-5793(95)00931-X; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; ISHII N, 1992, NEURON, V9, P873, DOI 10.1016/0896-6273(92)90240-E; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Shirasaki R, 1996, NEURON, V17, P1079, DOI 10.1016/S0896-6273(00)80241-X; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; SONNENFELD MJ, 1994, MECH DEVELOP, V46, P3, DOI 10.1016/0925-4773(94)90033-7; Stein E, 2001, SCIENCE, V291, P1976, DOI 10.1126/science.1059391; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TARTAGLIA LA, 1992, IMMUNOL TODAY, V13, P151, DOI 10.1016/0167-5699(92)90116-O; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3	48	228	244	0	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					605	617		10.1016/S0896-6273(01)00505-0	http://dx.doi.org/10.1016/S0896-6273(01)00505-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719202	Bronze			2022-12-24	WOS:000172363900008
J	Harel, M; Kasher, R; Nicolas, A; Guss, JM; Balass, M; Fridkin, M; Smit, AB; Brejc, K; Sixma, TK; Katchalski-Katzir, E; Sussman, JL; Fuchs, S				Harel, M; Kasher, R; Nicolas, A; Guss, JM; Balass, M; Fridkin, M; Smit, AB; Brejc, K; Sixma, TK; Katchalski-Katzir, E; Sussman, JL; Fuchs, S			The binding site of acetylcholine receptor as visualized in the X-ray structure of a complex between alpha-bungarotoxin and a mimotope peptide	NEURON			English	Article							SYNTHETIC PEPTIDES; GAMMA-SUBUNIT; DELTA-SUBUNIT; MOLECULAR REPLACEMENT; NICOTINIC RECEPTOR; TORPEDO-MARMORATA; CRYSTAL-STRUCTURE; RESIDUES 173-204; EPSILON-SUBUNIT; SNAKE	We have determined the crystal structure at 1.8 Angstrom resolution of a complex of alpha -bungarotoxin with a high affinity 13-residue peptide that is homologous to the binding region of the alpha subunit of acetylcholine receptor. The peptide fits snugly to the toxin and adopts a beta hairpin conformation. The structures of the bound peptide and the homologous loop of acetylcholine binding protein, a soluble analog of the extracellular domain of acetylcholine receptor, are remarkably similar. Their superposition indicates that the toxin wraps around the receptor binding site loop, and in addition, binds tightly at the interface of two of the receptor subunits where it inserts a finger into the ligand binding site, thus blocking access to the acetylcholine binding site and explaining its strong antagonistic activity.	Weizmann Inst Sci, Dept Struct Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Organ Chem, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Vrije Univ Amsterdam, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Carcinogenesis, NL-1066 CX Amsterdam, Netherlands	Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Weizmann Institute of Science; Vrije Universiteit Amsterdam; Netherlands Cancer Institute	Fuchs, S (corresponding author), Weizmann Inst Sci, Dept Struct Chem, IL-76100 Rehovot, Israel.	sara.fuchs@weizmann.ac.il	Guss, Jules Mitchell/N-1387-2019; Smit, August B/E-8410-2011; Guss, Jules M/B-1283-2009	Guss, Jules Mitchell/0000-0003-4259-6079; Brejc, Katjusa/0000-0002-4562-6109; Sussman, Joel/0000-0003-0306-3878; Sixma, Titia K/0000-0001-6180-0632				Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; ARONHEIM A, 1988, J BIOL CHEM, V263, P9933; Atherton E., 1990, SOLID PHASE PEPTIDE; Balass M, 1997, P NATL ACAD SCI USA, V94, P6054, DOI 10.1073/pnas.94.12.6054; BARCHAN D, 1995, BIOCHEMISTRY-US, V34, P9172, DOI 10.1021/bi00028a029; BARCHAN D, 1992, P NATL ACAD SCI USA, V89, P7717, DOI 10.1073/pnas.89.16.7717; BASUS VJ, 1993, BIOCHEMISTRY-US, V32, P12290, DOI 10.1021/bi00097a004; BETZEL C, 1991, J BIOL CHEM, V266, P21530; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Changeux JP, 1998, NEURON, V21, P959, DOI 10.1016/S0896-6273(00)80616-9; CHANGEUX JP, 1970, P NATL ACAD SCI USA, V67, P1241, DOI 10.1073/pnas.67.3.1241; CONTITRONCONI BM, 1990, BIOCHEMISTRY-US, V29, P6221, DOI 10.1021/bi00478a016; Dauter Z, 2000, ACTA CRYSTALLOGR D, V56, P232, DOI 10.1107/S0907444999016352; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KACHALSKY SG, 1995, P NATL ACAD SCI USA, V92, P10801, DOI 10.1073/pnas.92.23.10801; KAO PN, 1984, J BIOL CHEM, V259, P1662; Karlin A, 1979, Adv Cytopharmacol, V3, P183; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Kasher R, 2001, CHEM BIOL, V8, P147, DOI 10.1016/S1074-5521(00)90063-2; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee C Y, 1966, Mem Inst Butantan, V33, P555; LENTZ TL, 1995, BIOCHEMISTRY-US, V34, P1316, DOI 10.1021/bi00004a026; LOVE RA, 1986, PROTEIN ENG, V1, P37, DOI 10.1093/protein/1.1.37; Malany S, 2000, BIOCHEMISTRY-US, V39, P15388, DOI 10.1021/bi001825o; Martin M, 1996, J BIOL CHEM, V271, P13497, DOI 10.1074/jbc.271.23.13497; Michalet S, 2000, J BIOL CHEM, V275, P25608, DOI 10.1074/jbc.M002362200; MIKHAILOV AM, 1990, FEBS LETT, V269, P255, DOI 10.1016/0014-5793(90)81167-M; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NEUMANN D, 1985, P NATL ACAD SCI USA, V82, P3490, DOI 10.1073/pnas.82.10.3490; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P3008, DOI 10.1073/pnas.83.9.3008; NEUMANN D, 1986, P NATL ACAD SCI USA, V83, P9250, DOI 10.1073/pnas.83.23.9250; NEUMANN D, 1989, P NATL ACAD SCI USA, V86, P7255, DOI 10.1073/pnas.86.18.7255; Osaka H, 2000, J BIOL CHEM, V275, P5478, DOI 10.1074/jbc.275.8.5478; Osaka H, 1999, J BIOL CHEM, V274, P9581, DOI 10.1074/jbc.274.14.9581; OSWALD RE, 1982, FEBS LETT, V139, P225, DOI 10.1016/0014-5793(82)80857-0; PEARSON WR, 1990, METHOD ENZYMOL, V183, P63; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Prince RJ, 1996, J BIOL CHEM, V271, P25770, DOI 10.1074/jbc.271.42.25770; RALSTON S, 1987, BIOCHEMISTRY-US, V26, P3261, DOI 10.1021/bi00386a004; Samson AO, 2001, BIOCHEMISTRY-US, V40, P5464, DOI 10.1021/bi0022689; Scherf T, 1997, P NATL ACAD SCI USA, V94, P6059, DOI 10.1073/pnas.94.12.6059; Scherf T, 2001, P NATL ACAD SCI USA, V98, P6629, DOI 10.1073/pnas.111164298; Sine SM, 1997, J BIOL CHEM, V272, P23521, DOI 10.1074/jbc.272.38.23521; Smit AB, 2001, NATURE, V411, P261, DOI 10.1038/35077000; TZARTOS SJ, 1984, J BIOL CHEM, V259, P1512; UNGER R, 1989, PROTEINS, V5, P355, DOI 10.1002/prot.340050410; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WILSON PT, 1988, BIOCHEMISTRY-US, V27, P6667, DOI 10.1021/bi00418a004; WILSON PT, 1988, MOL PHARMACOL, V34, P643; WILSON PT, 1985, P NATL ACAD SCI USA, V82, P8790, DOI 10.1073/pnas.82.24.8790; Zeng HY, 2001, J BIOL CHEM, V276, P22930, DOI 10.1074/jbc.M102300200	53	111	113	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					265	275		10.1016/S0896-6273(01)00461-5	http://dx.doi.org/10.1016/S0896-6273(01)00461-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683996	Bronze			2022-12-24	WOS:000171893700011
J	Nystuen, A; Legare, ME; Shultz, LD; Frankel, WN				Nystuen, A; Legare, ME; Shultz, LD; Frankel, WN			A null mutation in inositol polyphosphate 4-phosphatase type I causes selective neuronal loss in weeble mutant mice	NEURON			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; SIGNALING REACTIONS; PROTEIN; METABOLISM; EXPRESSION; ANTIGEN; CELLS; MOUSE; GENE; AKT	Weeble mutant mice have severe locomotor instability and significant neuronal loss in the cerebellum and in the hippocampal CA1 field. Genetic mapping was used to localize the mutation to the gene encoding inositol polyphosphate 4-phosphatase type I (Inpp4a), where a single nucleotide deletion results in a likely null allele. The substrates of INPP4A are intermediates in a pathway affecting intracellular Ca2+ release but are also involved in cell cycle regulation through binding the Akt protooncogene; dysfunction in either may account for the neuronal loss of weeble mice. Although other mutations in phosphoinositide enzymes are associated with synaptic defects without neuronal loss, weeble shows that Inpp4a is critical for the survival of a subset of neurons during postnatal development in mice.	Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Frankel, WN (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	wnf@jax.org			NATIONAL CANCER INSTITUTE [R01CA020408, P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS031348, R01NS031348] Funding Source: NIH RePORTER; NCI NIH HHS [CA34196, CA20408] Funding Source: Medline; NINDS NIH HHS [NS31348] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acharya JK, 1998, NEURON, V20, P1219, DOI 10.1016/S0896-6273(00)80502-4; Altman J., 1996, RELATION ITS EVOLUTI; ALUBAIDI MR, 1992, P NATL ACAD SCI USA, V89, P1194, DOI 10.1073/pnas.89.4.1194; ATTREE O, 1992, NATURE, V358, P239, DOI 10.1038/358239a0; BANSAL VS, 1987, J BIOL CHEM, V262, P9444; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BERRIDGE MJ, 1993, NATURE, V365, P388, DOI 10.1038/365388a0; Carpenter CL, 1996, CURR OPIN CELL BIOL, V8, P153, DOI 10.1016/S0955-0674(96)80060-3; Chi HB, 2000, MOL CELL BIOL, V20, P6496, DOI 10.1128/MCB.20.17.6496-6507.2000; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Feddersen RM, 1997, MOL CELL NEUROSCI, V9, P42, DOI 10.1006/mcne.1997.0601; Franke TF, 1997, SCIENCE, V275, P665, DOI 10.1126/science.275.5300.665; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Janne PA, 1998, J CLIN INVEST, V101, P2042, DOI 10.1172/JCI2414; KAUSHIK N, 1994, MAMM GENOME, V5, P688, DOI 10.1007/BF00426074; LEE EYHP, 1994, GENE DEV, V8, P2008, DOI 10.1101/gad.8.17.2008; MAEDA N, 1989, DEV BIOL, V133, P67, DOI 10.1016/0012-1606(89)90297-2; Majerus PW, 1996, GENE DEV, V10, P1051, DOI 10.1101/gad.10.9.1051; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Matsumoto M, 1996, NATURE, V379, P168, DOI 10.1038/379168a0; NORRIS FA, 1995, J BIOL CHEM, V270, P16128, DOI 10.1074/jbc.270.27.16128; Norris FA, 1997, J BIOL CHEM, V272, P23859, DOI 10.1074/jbc.272.38.23859; SCHWARTZKROIN PA, 1981, DEV BRAIN RES, V2, P469, DOI 10.1016/0165-3806(81)90017-1; SERESS L, 1988, DEV BRAIN RES, V44, P197, DOI 10.1016/0165-3806(88)90218-0; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; Street VA, 1997, J NEUROSCI, V17, P635; Vyas P, 2000, P NATL ACAD SCI USA, V97, P13696, DOI 10.1073/pnas.250476397; Zhang XL, 1998, SEMIN CELL DEV BIOL, V9, P153, DOI 10.1006/scdb.1997.0220	31	70	73	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					203	212		10.1016/S0896-6273(01)00468-8	http://dx.doi.org/10.1016/S0896-6273(01)00468-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683991	Bronze			2022-12-24	WOS:000171893700006
J	Ji, D; Lape, R; Dani, JA				Ji, D; Lape, R; Dani, JA			Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity	NEURON			English	Article							ACETYLCHOLINE-RECEPTOR ACTIVATION; LONG-TERM POTENTIATION; RAT HIPPOCAMPUS; CHANNEL DOMAIN; DENTATE GYRUS; ACH RECEPTORS; INTERNEURONS; NEURONS; BRAIN; TRANSMISSION	This study reveals mechanisms in the mouse hippocampus that may underlie nicotinic influences on attention, memory, and cognition. Induction of synaptic plasticity, arising via generally accepted mechanisms, is modulated by nicotinic acetylcholine receptors. Properly timed nicotinic activity at pyramidal neurons boosted the induction of long-term potentiation via presynaptic and postsynaptic pathways. On the other hand, nicotinic activity on interneurons inhibited nearby pyramidal neurons and thereby prevented or diminished the induction of synaptic potentiation. The synaptic modulation was dependent on the location and timing of the nicotinic activity. Loss of these synaptic mechanisms may contribute to the cognitive deficits experienced during Alzheimer's diseases, which is associated with a loss of cholinergic projections and with a decrease in the number of nicotinic receptors.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Dani, JA (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza, Houston, TX 77030 USA.		Lape, Remigijus/C-6175-2008	Lape, Remigijus/0000-0002-6604-0828	NIDA NIH HHS [DA09411, DA12661] Funding Source: Medline; NINDS NIH HHS [NS21229] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R23NS021229, R37NS021229, R01NS021229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009411, P01DA012661] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Alkondon M, 2000, J NEUROSCI, V20, P66, DOI 10.1523/JNEUROSCI.20-01-00066.2000; Alkondon M, 1997, J PHARMACOL EXP THER, V283, P1396; Alkondon M, 1998, BRAIN RES, V810, P257, DOI 10.1016/S0006-8993(98)00880-4; Alkondon M, 1996, J PHARMACOL EXP THER, V278, P1460; ALKONDON M, 1993, J PHARMACOL EXP THER, V265, P1455; Aramakis VB, 1998, J NEUROSCI, V18, P8485; BERTRAND D, 1992, P NATL ACAD SCI USA, V89, P1261, DOI 10.1073/pnas.89.4.1261; Brazhnik ES, 1997, EXP BRAIN RES, V114, P442, DOI 10.1007/PL00005653; BRIONI JD, 1993, BEHAV NEURAL BIOL, V59, P57, DOI 10.1016/0163-1047(93)91159-K; BUCCAFUSCO JJ, 1995, PSYCHOPHARMACOLOGY, V120, P256, DOI 10.1007/BF02311172; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Coggan JS, 1997, J NEUROSCI, V17, P5798; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; FROTSCHER M, 1985, J COMP NEUROL, V239, P237, DOI 10.1002/cne.902390210; Fujii S, 1999, BRAIN RES, V846, P137, DOI 10.1016/S0006-8993(99)01982-4; Girod R, 2000, NEUROPHARMACOLOGY, V39, P2715, DOI 10.1016/S0028-3908(00)00145-3; Gray R, 1996, NATURE, V383, P713, DOI 10.1038/383713a0; GRIGORYAN GA, 1994, PHARMACOL BIOCHEM BE, V49, P511, DOI 10.1016/0091-3057(94)90063-9; Hamid S, 1997, NEUROSCI RES, V29, P81, DOI 10.1016/S0168-0102(97)00074-6; Hefft S, 1999, J PHYSIOL-LONDON, V515, P769, DOI 10.1111/j.1469-7793.1999.769ab.x; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Jones S, 1999, TRENDS NEUROSCI, V22, P555, DOI 10.1016/S0166-2236(99)01471-X; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Lena C, 1997, J NEUROSCI, V17, P576; Levin ED, 2000, EUR J PHARMACOL, V393, P141, DOI 10.1016/S0014-2999(99)00885-7; Levin ED, 1998, PSYCHOPHARMACOLOGY, V138, P217, DOI 10.1007/s002130050667; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Mansvelder HD, 2000, NEURON, V27, P349, DOI 10.1016/S0896-6273(00)00042-8; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Newhouse PA, 1997, DRUG AGING, V11, P206, DOI 10.2165/00002512-199711030-00005; OHNO M, 1993, PHARMACOL BIOCHEM BE, V45, P89, DOI 10.1016/0091-3057(93)90091-7; Orr-Urtreger A, 2000, J NEUROCHEM, V74, P2154, DOI 10.1046/j.1471-4159.2000.0742154.x; Papke RL, 1996, NEUROSCI LETT, V213, P201; Paterson D, 2000, PROG NEUROBIOL, V61, P75, DOI 10.1016/S0301-0082(99)00045-3; Radcliffe KA, 1998, J NEUROSCI, V18, P7075; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; SEGUELA P, 1993, J NEUROSCI, V13, P596; STALEY KJ, 1992, J NEUROPHYSIOL, V68, P197, DOI 10.1152/jn.1992.68.1.197; Umbriaco D, 1995, HIPPOCAMPUS, V5, P605, DOI 10.1002/hipo.450050611; WADA E, 1989, J COMP NEUROL, V284, P314, DOI 10.1002/cne.902840212; Wang XJ, 1996, J NEUROSCI, V16, P6402; Wonnacott S, 1997, TRENDS NEUROSCI, V20, P92, DOI 10.1016/S0166-2236(96)10073-4; WOOLF NJ, 1991, PROG NEUROBIOL, V37, P475, DOI 10.1016/0301-0082(91)90006-M	50	354	365	2	14	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					131	141		10.1016/S0896-6273(01)00332-4	http://dx.doi.org/10.1016/S0896-6273(01)00332-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498056	Bronze			2022-12-24	WOS:000170101100016
J	Vissel, B; Krupp, JJ; Heinemann, SE; Westbrook, GL				Vissel, B; Krupp, JJ; Heinemann, SE; Westbrook, GL			A use-dependent tyrosine dephosphorylation of NMDA receptors is independent of ion flux	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; AMPA RECEPTOR; POSTSYNAPTIC DENSITY; SYNAPTIC TRANSMISSION; HIPPOCAMPAL-NEURONS; CHANNEL ACTIVITY; NR1 SUBUNIT; SH2 DOMAINS; PROTEIN; KINASE	Tyrosine phosphorylation can upregulate NMDA receptor activity during pathological and physiological alterations of synaptic strength. Here we describe downregulation of recombinant NR1/2A receptors by tyrosine dephosphorylation that requires agonist binding, but is independent of ion flux. The tyrosine residues involved in this new form of NMDA receptor modulation likely form a 'ring' adjacent to the last transmembrane domain. The downregulation was due to a reduction in the number of functional channels, and was blocked by co-expressing a dominant-negative mu2-subunit of the clathrin-adaptor protein AP-2. Our results provide a mechanism by which synaptic NMDA receptors can be modulated in a use-dependent manner even when the postsynaptic membrane is not sufficiently depolarized to relieve channel block by magnesium ions.	Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA; Salk Inst Biol Studies, La Jolla, CA 92037 USA	Oregon Health & Science University; Salk Institute	Krupp, JJ (corresponding author), Karolinska Inst, NOVUM, AstraZeneca R&D Sodertalje, Halsovagen 7, S-14157 Huddinge, Sweden.	johannes.krupp@astrazeneca.com		Vissel, Bryce/0000-0001-8860-8050	NIMH NIH HHS [MH46613] Funding Source: Medline; NINDS NIH HHS [NS28709] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH046613, R01MH046613] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028709] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chen SJ, 1996, J NEUROCHEM, V67, P194; Colledge M, 1998, CURR OPIN NEUROBIOL, V8, P357, DOI 10.1016/S0959-4388(98)80061-5; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dunah AW, 1998, J NEUROCHEM, V71, P1926; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fadool DA, 1998, J NEUROSCI, V18, P6126; Gurd JW, 1997, J NEUROCHEM, V69, P623; Hayashi T, 1999, NATURE, V397, P72, DOI 10.1038/16269; HOLLMANN M, 1993, NEURON, V10, P943, DOI 10.1016/0896-6273(93)90209-A; Holmes TC, 1996, SCIENCE, V274, P2089, DOI 10.1126/science.274.5295.2089; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; ISHII T, 1993, J BIOL CHEM, V268, P2836; Jones SM, 1998, SCIENCE, V279, P573, DOI 10.1126/science.279.5350.573; Kobayashi S, 1997, J BIOL CHEM, V272, P16262, DOI 10.1074/jbc.272.26.16262; Kohr G, 1996, J PHYSIOL-LONDON, V492, P445; Kreitzer G, 2000, NAT CELL BIOL, V2, P125, DOI 10.1038/35000081; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; LEGENDRE P, 1993, J NEUROSCI, V13, P674; Lin SY, 1999, MOL BRAIN RES, V70, P18, DOI 10.1016/S0169-328X(99)00122-9; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; MOON IS, 1994, P NATL ACAD SCI USA, V91, P3954, DOI 10.1073/pnas.91.9.3954; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Osten P, 2000, NEURON, V27, P313, DOI 10.1016/S0896-6273(00)00039-8; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSENMUND C, 1993, NEURON, V10, P805, DOI 10.1016/0896-6273(93)90197-Y; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; STERN P, 1994, J PHYSIOL-LONDON, V476, P391, DOI 10.1113/jphysiol.1994.sp020140; SWOPE SL, 1994, J BIOL CHEM, V269, P29817; Swope SL, 1999, ADV SEC MESS PHOSPH, V33, P49; Takagi N, 1999, J CEREBR BLOOD F MET, V19, P880, DOI 10.1097/00004647-199908000-00007; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; TONG G, 1994, J NEUROPHYSIOL, V72, P754, DOI 10.1152/jn.1994.72.2.754; Wang H, 1999, J NEUROSCI, V19, pU1; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Wang YT, 1996, P NATL ACAD SCI USA, V93, P1721, DOI 10.1073/pnas.93.4.1721; Wang YZ, 1997, NATURE, V389, P502, DOI 10.1038/39062; Xiong ZG, 1999, J NEUROSCI, V19; Yu XM, 1998, NATURE, V396, P469, DOI 10.1038/24877; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zheng F, 1998, NAT NEUROSCI, V1, P185, DOI 10.1038/634; ZHOU SY, 1995, TRENDS BIOCHEM SCI, V20, P470	50	196	201	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					587	596		10.1038/88404	http://dx.doi.org/10.1038/88404			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369939				2022-12-24	WOS:000169061800011
J	Perrone, JA; Thiele, A				Perrone, JA; Thiele, A			Speed skills: measuring the visual speed analyzing properties of primate MT neurons	NATURE NEUROSCIENCE			English	Article							RECEPTIVE-FIELD PROPERTIES; AREA MT; MACAQUE MONKEY; DIRECTION SELECTIVITY; MOTION ANALYSIS; TEMPORAL AREA; SELF-MOTION; VELOCITY; CORTEX; MODEL	Knowing the direction and speed of moving objects is often critical for survival. However, it is poorly understood how cortical neurons process the speed of image movement. Here we tested Mi neurons using moving sine-wave gratings of different spatial and temporal frequencies, and mapped out the neurons' spatiotemporal frequency response profiles, The maps typically had oriented ridges of peak sensitivity as expected for speed-tuned neurons. The preferred speed estimate, derived from the orientation of the maps, corresponded well to the preferred speed when moving bars were presented. Thus, our data demonstrate that MT neurons are truly sensitive to the object speed. These findings indicate that MT is not only a key structure in the analysis of direction of motion and depth perception, but also in the analysis of object speed.	Univ Waikato, Dept Psychol, Hamilton, New Zealand; Salk Inst Biol Studies, La Jolla, CA 92037 USA	University of Waikato; Salk Institute	Perrone, JA (corresponding author), Univ Waikato, Dept Psychol, Private Bag 3105, Hamilton, New Zealand.			Thiele, Alexander/0000-0003-4894-0213				ADELSON EH, 1982, NATURE, V300, P523, DOI 10.1038/300523a0; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; BRACEWELL RN, 1978, FOURIER TRANSFORM IT; BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; Del Viva MM, 1998, VISION RES, V38, P3633, DOI 10.1016/S0042-6989(98)00022-4; DOBKINS KR, 1994, J NEUROSCI, V14, P4854; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; FAHLE M, 1981, PROC R SOC SER B-BIO, V213, P451, DOI 10.1098/rspb.1981.0075; FELLEMAN DJ, 1984, J NEUROPHYSIOL, V52, P488, DOI 10.1152/jn.1984.52.3.488; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; Gibson JJ, 1950, PERCEPTION VISUAL WO; KOENDERINK JJ, 1975, OPT ACTA, V22, P773, DOI 10.1080/713819112; LAGAE L, 1993, J NEUROPHYSIOL, V69, P19, DOI 10.1152/jn.1993.69.1.19; Lisberger SG, 1999, J NEUROSCI, V19, P2224; LONGUETHIGGINS HC, 1980, PROC R SOC SER B-BIO, V208, P385, DOI 10.1098/rspb.1980.0057; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MOVSHON JA, 1975, J PHYSIOL-LONDON, V249, P445, DOI 10.1113/jphysiol.1975.sp011025; NAKAAMA K, 1984, VISION RES, V25, P625; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NEWSOME WT, 1985, J NEUROSCI, V5, P825; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; Perrone JA, 1998, J NEUROSCI, V18, P5958; PERRONE JA, 1994, VISION RES, V34, P2917, DOI 10.1016/0042-6989(94)90060-4; PERRONE JA, 1992, J OPT SOC AM A, V9, P177, DOI 10.1364/JOSAA.9.000177; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; STONER GR, 1992, NATURE, V358, P412, DOI 10.1038/358412a0; TANAKA K, 1989, J NEUROPHYSIOL, V62, P626, DOI 10.1152/jn.1989.62.3.626; Thiele A, 1999, EUR J NEUROSCI, V11, P2044, DOI 10.1046/j.1460-9568.1999.00630.x; Thiele A, 1999, J NEUROSCI, V19, P6571; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Watson A.B, 1983, MOTION PERCEPTION RE, P1; WATSON AB, 1986, J OPT SOC AM A, V3, P300, DOI 10.1364/JOSAA.3.000300; WATSON AB, 1986, BEHAV RES METH INSTR, V18, P587, DOI 10.3758/BF03201433; [No title captured]	35	179	180	1	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					526	532		10.1038/87480	http://dx.doi.org/10.1038/87480			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319562				2022-12-24	WOS:000168412600017
J	Phelps, EA; O'Connor, KJ; Gatenby, JC; Gore, JC; Grillon, C; Davis, M				Phelps, EA; O'Connor, KJ; Gatenby, JC; Gore, JC; Grillon, C; Davis, M			Activation of the left amygdala to a cognitive representation of fear	NATURE NEUROSCIENCE			English	Article							POTENTIATED STARTLE; NEURONS; HUMANS; BRAIN; ANTICIPATION; RESPONSES; REFLEX; STRESS; CORTEX; FMRI	We examined the neural substrates involved when subjects encountered an event linked verbally, but not experientially, to an aversive outcome. This instructed fear task models a primary way humans learn about the emotional nature of events. Subjects were told that one stimulus (threat) represents an aversive event (a shock may be given), whereas another (safe) represents safety (no shock will be given). Using functional magnetic resonance imaging (fMRI), activation of the left amygdala was observed in response to threat versus safe conditions, which correlated with the expression of the fear response as measured by skin conductance. Additional activation observed in the insular cortex is proposed to be involved in conveying a cortical representation of fear to the amygdala. These results suggest that the neural substrates that support conditioned fear across species have a similar but somewhat different role in more abstract representations of fear in humans.	NYU, Dept Psychol, New York, NY 10003 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Yale Univ, Sch Med, Dept Radiol, New Haven, CT 06520 USA; NIMH, Bethesda, MD 20892 USA; Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA	New York University; Massachusetts Institute of Technology (MIT); Yale University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Emory University	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl,8th Floor, New York, NY 10003 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH050812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033332] Funding Source: NIH RePORTER; NIMH NIH HHS [MH50812] Funding Source: Medline; NINDS NIH HHS [NS33332] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Angrilli A, 1996, BRAIN, V119, P1991, DOI 10.1093/brain/119.6.1991; BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Collins DR, 1999, J NEUROSCI, V19, P836; Constable RT, 1998, MAGN RESON IMAGING, V16, P289, DOI 10.1016/S0730-725X(97)00278-6; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; DEANE GE, 1961, J EXP PSYCHOL, V61, P489, DOI 10.1037/h0049220; FUNAYAMA ES, IN PRESS J COGN NEUR; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; Grillon C, 1997, PSYCHOPHYSIOLOGY, V34, P511, DOI 10.1111/j.1469-8986.1997.tb01737.x; Kapp BS, 1984, NEUROPSYCHOLOGY MEMO, P473; LABAR KS, 1995, J NEUROSCI, V15, P6846; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LeDoux J. E., 1996, EMOTIONAL BRAIN; MAEDA H, 1993, CAN J PHYSIOL PHARM, V71, P374, DOI 10.1139/y93-057; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; PASCOE JP, 1985, BRAIN RES BULL, V14, P331, DOI 10.1016/0361-9230(85)90194-7; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; ROMANSKI LM, 1992, J NEUROSCI, V12, P4501; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; Shi CJ, 1999, J NEUROSCI, V19, P420, DOI 10.1523/JNEUROSCI.19-01-00420.1999; Talairach J., 1988, COPLANAR STEREOTAXIC	28	674	683	4	54	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					437	441		10.1038/86110	http://dx.doi.org/10.1038/86110			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276236				2022-12-24	WOS:000168762200026
J	Yang, ZH; Sehgal, A				Yang, ZH; Sehgal, A			Role of molecular oscillations in generating behavioral rhythms in Drosophila	NEURON			English	Article							CIRCADIAN CLOCK; PERIOD PROTEIN; GENE-PRODUCT; DOUBLE-TIME; EXPRESSION; LIGHT; MUTATION; RNA; MELANOGASTER; FEEDBACK	Circadian oscillations of clock gene products are thought to provide time-of-day signals that drive overt rhythms. In Drosophila, RNA and protein levels of the period and timeless genes oscillate and the proteins autoregulate their transcription. To test the relevance of these oscillations, we expressed period and timeless under control of constitutively active promoters. Constitutive expression of either RNA supported protein cycling and behavioral rhythms in the respective null mutant, although constitutive timeless was less effective than constitutive period. Constitutive expression of both genes restored behavioral rhythms that showed deficits in photic resetting and drove cyclic expression of the clock-controlled RNA, vrille. Overexpression of either period or timeless, but especially timeless, attenuated behavioral rhythmicity and protein cycling in lateral neurons. We propose that the two proteins must cycle to drive rhythmic expression of downstream genes.	Univ Penn, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Philadelphia, PA 19104 USA	Howard Hughes Medical Institute; University of Pennsylvania	Sehgal, A (corresponding author), Univ Penn, Sch Med, Dept Neurosci, Howard Hughes Med Inst, Philadelphia, PA 19104 USA.							ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; BAYLIES MK, 1987, NATURE, V326, P390, DOI 10.1038/326390a0; Blau J, 1999, CELL, V99, P661, DOI 10.1016/S0092-8674(00)81554-8; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen YF, 1998, J BIOL RHYTHM, V13, P364, DOI 10.1177/074873098129000192; Cheng YZ, 1998, J NEUROSCI, V18, P741; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Emery P, 2000, NEURON, V26, P493, DOI 10.1016/S0896-6273(00)81181-2; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; FRISCH B, 1994, NEURON, V12, P555, DOI 10.1016/0896-6273(94)90212-7; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; HARDIN PE, 1999, HDB BEHAV STATE CONT, P61; HunterEnsor M, 1996, CELL, V84, P677, DOI 10.1016/S0092-8674(00)81046-6; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kaneko M, 2000, J NEUROBIOL, V43, P207, DOI 10.1002/(SICI)1097-4695(20000605)43:3<207::AID-NEU1>3.0.CO;2-0; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KONOPKA RJ, 1994, J BIOL RHYTHM, V9, P189, DOI 10.1177/074873049400900303; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Naidoo N, 1999, SCIENCE, V285, P1737, DOI 10.1126/science.285.5434.1737; Ousley A, 1998, GENETICS, V148, P815; Park JH, 2000, P NATL ACAD SCI USA, V97, P3608, DOI 10.1073/pnas.070036197; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; PRICE JL, 1995, EMBO J, V14, P4044, DOI 10.1002/j.1460-2075.1995.tb00075.x; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rothenfluh A, 2000, NEURON, V26, P505, DOI 10.1016/S0896-6273(00)81182-4; Rutila JE, 1996, NEURON, V17, P921, DOI 10.1016/S0896-6273(00)80223-8; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; SEHGAL A, 1994, SCIENCE, V263, P1603, DOI 10.1126/science.8128246; SMITH RF, 1982, MOL GEN GENET, V185, P30, DOI 10.1007/BF00333786; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky R, 1997, EMBO J, V16, P5006, DOI 10.1093/emboj/16.16.5006; VOSSHALL LB, 1995, NEURON, V15, P345, DOI 10.1016/0896-6273(95)90039-X; VOSSHALL LB, 1994, SCIENCE, V263, P1606, DOI 10.1126/science.8128247; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yang ZH, 1998, NEURON, V21, P215, DOI 10.1016/S0896-6273(00)80528-0; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZERR DM, 1990, J NEUROSCI, V10, P2749	45	205	207	1	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					453	467		10.1016/S0896-6273(01)00218-5	http://dx.doi.org/10.1016/S0896-6273(01)00218-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239435	Bronze			2022-12-24	WOS:000167141700018
J	Rosenbaum, T; Gordon, SE				Rosenbaum, T; Gordon, SE			Dissecting intersubunit contacts in cyclic nucleotide-gated ion channels	NEURON			English	Article							ACTIVATION; MODULATION; MOVEMENT; RESIDUE; DOMAINS; SITE	In cyclic nucleotide-gated (CNG) ion channels, binding of cGMP or cAMP drives a conformational change that leads to opening of an ion-conducting pore. One region implicated in the coupling of ligand binding to opening of the pore is the C linker region. Here, we used crosslinking of endogenous cysteines to study interregion proximity. We demonstrate that an individual amino acid-C481-in the C linker region of each of two neighboring subunits can form a disulfide bond. Further, using tandem dimers, we show that a disulfide bond between C35 in the N-terminal region and C481 in the C linker region can form either within a subunit or between subunits. From our data on proximity between individual amino acids and previous studies, a picture emerges of the C linker as a potential dimerization interface.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Gordon, SE (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA.	seg@u.washington.edu		Rosenbaum, Tamara/0000-0002-4791-3195	NATIONAL EYE INSTITUTE [R01EY013007, P30EY001730] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY13007, EY01730] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Armstrong N, 1999, PROTEIN SCI, V8, P1475, DOI 10.1110/ps.8.7.1475; Bonigk W, 1999, J NEUROSCI, V19, P5332; Broillet MC, 2000, J BIOL CHEM, V275, P15135, DOI 10.1074/jbc.275.20.15135; Brown RL, 2000, BIOCHEMISTRY-US, V39, P432, DOI 10.1021/bi9920735; Brown RL, 1998, BIOPHYS J, V75, P825, DOI 10.1016/S0006-3495(98)77571-X; GORDON SE, 1992, NEURON, V9, P739, DOI 10.1016/0896-6273(92)90036-D; GORDON SE, 1995, P NATL ACAD SCI USA, V92, P10222, DOI 10.1073/pnas.92.22.10222; Gordon SE, 1997, NEURON, V19, P431, DOI 10.1016/S0896-6273(00)80951-4; GORDON SE, 1995, NEURON, V14, P177; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; JAN LY, 1992, CELL, V69, P715, DOI 10.1016/0092-8674(92)90280-P; JAN LY, 1990, NATURE, V345, P672, DOI 10.1038/345672a0; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Johnson JP, 2001, NATURE, V412, P917, DOI 10.1038/35091089; KOBASHI K, 1968, BIOCHIM BIOPHYS ACTA, V158, P239, DOI 10.1016/0304-4165(68)90136-0; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; LIU MY, 1994, SCIENCE, V266, P1348, DOI 10.1126/science.266.5189.1348; Matulef K, 1999, BIOPHYS J, V76, pA337; Molokanova E, 1997, J NEUROSCI, V17, P9068; Rho SH, 2000, FEBS LETT, V478, P246, DOI 10.1016/S0014-5793(00)01863-9; Richards MJ, 2000, BIOCHEMISTRY-US, V39, P14003, DOI 10.1021/bi001639i; Ruiz M, 1999, J GEN PHYSIOL, V113, P873, DOI 10.1085/jgp.113.6.873; Tibbs GR, 1997, NATURE, V386, P612, DOI 10.1038/386612a0; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3	26	35	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					703	713		10.1016/S0896-6273(02)00599-8	http://dx.doi.org/10.1016/S0896-6273(02)00599-8			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879648	Bronze			2022-12-24	WOS:000174286200007
J	Chang, KT; Berg, DK				Chang, KT; Berg, DK			Voltage-gated channels block nicotinic regulation of CREB phosphorylation and gene expression in neurons	NEURON			English	Article							ACETYLCHOLINE-RECEPTORS; TYROSINE-HYDROXYLASE; ALPHA-BUNGAROTOXIN; CALCIUM CHANNELS; OKADAIC ACID; C-FOS; PROTEIN; CA2+; TRANSCRIPTION; CIRCUITS	Synaptic activation of the transcription factor CREB and downstream gene expression usually depend on calcium influx aided by voltage-gated calcium channels. We find that nicotinic signaling, in contrast, activates CREB and gene expression in ciliary ganglion neurons both in culture and in situ only if voltage-gated channels are silent. The nicotinic response requires calcium influx and release from internal stores and acts through CaMK and MAPK pathways to sustain activated CREB. Voltage-gated channels mobilize CaMK to activate CREB initially, but they also enable calcineurin and PP1 to terminate the activation before transcription is affected. L-type voltage-gated channels dominate the outcome and block the effects of nicotinic signaling on transcription. This demonstrates a novel aspect of activity-dependent gene regulation.	Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Berg, DK (corresponding author), Univ Calif San Diego, Div Biol, Neurobiol Sect, La Jolla, CA 92093 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012601, R01NS035469] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35469, NS12601] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alberini CM, 1999, J EXP BIOL, V202, P2887; ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Bansal A, 2000, J NEUROSCI, V20, P7672; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; Blumenthal EM, 1999, J NEUROPHYSIOL, V81, P111, DOI 10.1152/jn.1999.81.1.111; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; Broide RS, 1999, MOL NEUROBIOL, V20, P1, DOI 10.1007/BF02741361; Brosenitsch TA, 2001, J NEUROSCI, V21, P2571, DOI 10.1523/JNEUROSCI.21-08-02571.2001; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; CHALAZONITIS A, 1980, J PHYSIOL-LONDON, V300, P525, DOI 10.1113/jphysiol.1980.sp013177; Chang KT, 1999, J NEUROSCI, V19, P3701; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; CORRIVEAU RA, 1993, J NEUROSCI, V13, P2662, DOI 10.1523/JNEUROSCI.13-06-02662.1993; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Dani JA, 1996, NEURON, V16, P905, DOI 10.1016/S0896-6273(00)80112-9; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; FAUCONBIGUET N, 1989, NEUROSCI LETT, V104, P189; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1994, J NEUROBIOL, V25, P294, DOI 10.1002/neu.480250309; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Greenberg ME, 2001, SYNAPSES, P357; Gueorguiev VD, 2000, J NEUROCHEM, V75, P1997, DOI 10.1046/j.1471-4159.2000.0751997.x; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Josselyn SA, 2001, J NEUROSCI, V21, P2404, DOI 10.1523/JNEUROSCI.21-07-02404.2001; Lein ES, 2000, J NEUROSCI, V20, P1470; Lena C, 1997, CURR OPIN NEUROBIOL, V7, P674, DOI 10.1016/S0959-4388(97)80088-8; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu YW, 1999, J GASTROINTEST SURG, V3, P82, DOI 10.1016/S1091-255X(99)80013-4; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Mermelstein PG, 2000, J NEUROSCI, V20, P266, DOI 10.1523/JNEUROSCI.20-01-00266.2000; Milner LD, 1999, J NEUROSCI, V19, P3007; Nagao M, 1995, MUTAT RES-FUND MOL M, V333, P173, DOI 10.1016/0027-5107(95)00143-3; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PELTOHUIKKO M, 1995, J NEUROSCI, V15, P1854, DOI 10.1523/JNEUROSCI.15-03-01854.1995; Rajadhyaksha A, 1999, J NEUROSCI, V19, P6348; Salminen O, 1999, J NEUROSCI, V19, P8145; SARGENT PB, 1993, ANNU REV NEUROSCI, V16, P403, DOI 10.1146/annurev.ne.16.030193.002155; Shoop RD, 2001, J NEUROSCI, V21, P771, DOI 10.1523/JNEUROSCI.21-03-00771.2001; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4; VIJAYARAGHAVAN S, 1992, NEURON, V8, P353, DOI 10.1016/0896-6273(92)90301-S; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Zhang ZW, 1996, NEURON, V17, P1231, DOI 10.1016/S0896-6273(00)80253-6	51	134	136	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					855	865		10.1016/S0896-6273(01)00516-5	http://dx.doi.org/10.1016/S0896-6273(01)00516-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738031	Bronze			2022-12-24	WOS:000172700700012
J	Lu, T; Liang, L; Wang, XQ				Lu, T; Liang, L; Wang, XQ			Temporal and rate representations of time-varying signals in the auditory cortex of awake primates	NATURE NEUROSCIENCE			English	Article							COMMON MARMOSET; DISCHARGE PATTERNS; PITCH PERCEPTION; COMPLEX TONES; RESPONSES; AMPLITUDE; DISCRIMINATION; CAT; TRANSFORMATION; NEURONS	Because auditory cortical neurons have limited stimulus-synchronized responses, cortical representations of more rapidly occurring but still perceivable stimuli remain unclear. Here we show that there are two largely distinct populations of neurons in the auditory cortex of awake primates: one with stimulus-synchronized discharges that, with a temporal code, explicitly represented slowly occurring sound sequences and the other with non-stimulus-synchronized discharges that, with a rate code, implicitly represented rapidly occurring events. Furthermore, neurons of both populations displayed selectivity in their discharge rates to temporal features within a short time-window. Our results suggest that the combination of temporal and rate codes in the auditory cortex provides a possible neural basis for the wide perceptual range of temporal information.	Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, Baltimore, MD 21205 USA; First Med Univ, Pear River Hosp, Hearing Ctr, Guangzhou 510282, GuangDong Prov, Peoples R China	Johns Hopkins University	Wang, XQ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Lab Auditory Neurophysiol, 720 Rutland Ave,Ross 424, Baltimore, MD 21205 USA.	xwang@bme.jhu.edu			NIDCD NIH HHS [DC03180, R01 DC003180] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; AITKIN L, 1993, PROG NEUROBIOL, V41, P345, DOI 10.1016/0301-0082(93)90004-C; AITKIN LM, 1986, J COMP NEUROL, V252, P175, DOI 10.1002/cne.902520204; Akeroyd MA, 1997, J ACOUST SOC AM, V101, P430, DOI 10.1121/1.417988; Bieser A, 1996, EXP BRAIN RES, V108, P273; BROWN CH, 1986, J ACOUST SOC AM, V79, P1058, DOI 10.1121/1.393378; Cheung SW, 2001, HEARING RES, V156, P115, DOI 10.1016/S0378-5955(01)00272-6; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DOUPE AJ, 1991, P NATL ACAD SCI USA, V88, P11339, DOI 10.1073/pnas.88.24.11339; EGGERMONT JJ, 1991, HEARING RES, V56, P153, DOI 10.1016/0378-5955(91)90165-6; Esser KH, 1997, P NATL ACAD SCI USA, V94, P14019, DOI 10.1073/pnas.94.25.14019; Fay RR, 1996, AUDIT NEUROSCI, V2, P377; Fitzpatrick DC, 1999, J ACOUST SOC AM, V106, P3460, DOI 10.1121/1.428199; FLANAGAN JL, 1960, J ACOUST SOC AM, V32, P1308, DOI 10.1121/1.1907900; GAESE BH, 1995, EUR J NEUROSCI, V7, P438, DOI 10.1111/j.1460-9568.1995.tb00340.x; GOLDSTEIN MH, 1959, J ACOUST SOC AM, V31, P356, DOI 10.1121/1.1907724; GREEN DM, 1973, J ACOUST SOC AM, V54, P373, DOI 10.1121/1.1913587; HEFFNER HE, 1986, J NEUROPHYSIOL, V56, P683, DOI 10.1152/jn.1986.56.3.683; Heil P, 1997, J NEUROPHYSIOL, V77, P2616, DOI 10.1152/jn.1997.77.5.2616; HIRSH IJ, 1959, J ACOUST SOC AM, V31, P759, DOI 10.1121/1.1907782; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Krumbholz K, 2000, J ACOUST SOC AM, V108, P1170, DOI 10.1121/1.1287843; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; Lu T, 2000, J NEUROPHYSIOL, V84, P236, DOI 10.1152/jn.2000.84.1.236; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; Mardia K. V., 2000, DIRECTIONAL STAT; MARGOLIASH D, 1983, J NEUROSCI, V3, P1039; MILLER GA, 1948, J ACOUST SOC AM, V20, P171, DOI 10.1121/1.1906360; MOODY DB, 1994, J ACOUST SOC AM, V95, P3499, DOI 10.1121/1.409967; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1419, DOI 10.1121/1.410286; PATTERSON RD, 1994, J ACOUST SOC AM, V96, P1409, DOI 10.1121/1.410285; PHILLIPS DP, 1989, J ACOUST SOC AM, V85, P2537, DOI 10.1121/1.397748; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; RESNICK SB, 1975, J ACOUST SOC AM, V57, P1493, DOI 10.1121/1.380590; RIBAUPIERRE FD, 1972, BRAIN RES, V48, P205, DOI 10.1016/0006-8993(72)90179-5; RONKEN DA, 1970, J ACOUST SOC AM, V47, P1091, DOI 10.1121/1.1912010; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; SCHOUTEN JF, 1962, J ACOUST SOC AM, V34, P517, DOI 10.1121/1.1918160; Schulze H, 1997, J COMP PHYSIOL A, V181, P651, DOI 10.1007/s003590050147; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; WANG XQ, 1995, J NEUROPHYSIOL, V73, P1600, DOI 10.1152/jn.1995.73.4.1600; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; WHITFIELD IC, 1980, J ACOUST SOC AM, V67, P644, DOI 10.1121/1.383889; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834	50	356	359	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1131	1138		10.1038/nn737	http://dx.doi.org/10.1038/nn737			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11593234				2022-12-24	WOS:000171970900017
J	Rossi, S; Cappa, SF; Babiloni, C; Pasqualetti, P; Miniussi, C; Carducci, F; Babiloni, F; Rossini, PM				Rossi, S; Cappa, SF; Babiloni, C; Pasqualetti, P; Miniussi, C; Carducci, F; Babiloni, F; Rossini, PM			Prefontal cortex in long-term memory: an "interference" approach using magnetic stimulation	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; EPISODIC MEMORY; WORKING-MEMORY; RECOGNITION MEMORY; FUNCTIONAL NEUROANATOMY; COGNITIVE NEUROSCIENCE; FALSE RECOGNITION; RETRIEVAL; FMRI	Neuroimaging has consistently shown engagement of the prefrontal cortex during episodic memory tasks, but the functional relevance of this metabolic/hemodynamic activation in memory processing is still to be determined. We used repetitive transcranial magnetic stimulation (rTMS) to transiently interfere with either left or right prefrontal brain activity during the encoding or retrieval of pictures showing complex scenes. We found that the right dorsolateral prefrontal cortex (DLPFC) was crucial for the retrieval of the encoded pictorial information, whereas the left DLPFC was involved in encoding operations. This 'interference' approach allowed us to establish whether a cortical area activated by a memory task actually contributes to behavioral performance.	IRCCS S Giovanni di Dio, I-25125 Brescia, Italy; Policlin Le Scotte, UO Neurofisiopatol, Dipartimento Neurosci, Sez Neurol, I-53100 Siena, Italy; Univ Salute Vita S Raffaele, Ctr Neurosci Cognit, I-20132 Milan, Italy; Univ Roma La Sapienza, Dipartimento Fisiol Umana & Farmacol, I-00185 Rome, Italy; AFaR, Dipartimento Neurosci, Fatebenefratelli Isola Tiberina, I-00186 Rome, Italy	IRCCS Fatebenefratelli; University of Siena; Vita-Salute San Raffaele University; Sapienza University Rome	Rossi, S (corresponding author), IRCCS S Giovanni di Dio, Via Pilastroni 4, I-25125 Brescia, Italy.		Babiloni, Claudio/AAC-5324-2022; Miniussi, Carlo/E-7602-2010; Cappa, Stefano/B-1874-2014; Pasqualetti, Patrizio/D-4496-2013; Miniussi, Carlo/P-5610-2019; Rossini, Paolo M./D-4994-2013; Rossi, Simone/AAC-6067-2022; Babiloni, Fabio/E-5169-2015	Babiloni, Claudio/0000-0002-5245-9839; Miniussi, Carlo/0000-0002-5436-4745; Cappa, Stefano/0000-0003-1003-3925; Pasqualetti, Patrizio/0000-0001-5560-1979; Miniussi, Carlo/0000-0002-5436-4745; Rossini, Paolo M./0000-0003-2665-534X; Rossi, Simone/0000-0001-6697-9459; Babiloni, Fabio/0000-0002-4962-176X; carducci, filippo/0000-0003-4795-0970	Telethon [E.C0985] Funding Source: Medline	Telethon(Fondazione Telethon)		AMASSIAN VE, 1990, ELECTROEN CLIN NEURO, V77, P390, DOI 10.1016/0168-5597(90)90061-H; Brandt SA, 1998, EXP BRAIN RES, V118, P197, DOI 10.1007/s002210050272; Buckner RL, 1998, NEUROIMAGE, V7, P151, DOI 10.1006/nimg.1998.0327; Cabeza Roberto, 2000, Current Opinion in Neurology, V13, P415, DOI 10.1097/00019052-200008000-00008; Callicott JH, 1999, CEREB CORTEX, V9, P20, DOI 10.1093/cercor/9.1.20; Curran T, 1997, NEUROPSYCHOLOGIA, V35, P1035, DOI 10.1016/S0028-3932(97)00029-8; Desgranges B, 1998, NEUROIMAGE, V8, P198, DOI 10.1006/nimg.1998.0359; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Fletcher PC, 1997, TRENDS NEUROSCI, V20, P213, DOI 10.1016/S0166-2236(96)01013-2; Flitman SS, 1998, NEUROLOGY, V50, P175, DOI 10.1212/WNL.50.1.175; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Haxby JV, 2000, NEUROIMAGE, V11, P380, DOI 10.1006/nimg.2000.0592; ILLMONIEMI RJ, 1997, NEUROREPORT, V8, P3537; Jahanshahi M, 1998, BRAIN, V121, P1533, DOI 10.1093/brain/121.8.1533; JANOWSKY JS, 1989, BEHAV NEUROSCI, V103, P548, DOI 10.1037/0735-7044.103.3.548; KAMMAN R, 1970, WORKBOOK GEN PSYCHOL, P228; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Lepage M, 2000, P NATL ACAD SCI USA, V97, P506, DOI 10.1073/pnas.97.1.506; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; MILNER B, 1964, FRONTAL AGRANULAR CO; Mottaghy FM, 2000, NEUROSCI LETT, V280, P167, DOI 10.1016/S0304-3940(00)00798-9; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; Nyberg L, 1995, NEUROREPORT, V7, P249, DOI 10.1097/00001756-199512000-00060; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oliveri M, 2000, BRAIN, V123, P1939, DOI 10.1093/brain/123.9.1939; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; PascualLeone A, 1996, EXP BRAIN RES, V107, P479; Paus T, 1997, J NEUROSCI, V17, P3178; Rossi S, 2000, CEREB CORTEX, V10, P802, DOI 10.1093/cercor/10.8.802; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Rossini PM, 1998, ELECTROEN CLIN NEURO, V106, P180, DOI 10.1016/S0013-4694(97)00097-7; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Rugg MD, 1999, NEUROIMAGE, V10, P520, DOI 10.1006/nimg.1999.0488; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, NEURON, V17, P267, DOI 10.1016/S0896-6273(00)80158-0; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Swick D, 1999, NEUROPSYCHOLOGY, V13, P155, DOI 10.1037/0894-4105.13.2.155; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Walsh V, 2000, NAT REV NEUROSCI, V1, P73, DOI 10.1038/35036239; Wheeler M A, 1995, J Int Neuropsychol Soc, V1, P525	44	207	212	0	28	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					948	952		10.1038/nn0901-948	http://dx.doi.org/10.1038/nn0901-948			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	467JL	11528428	Green Published			2022-12-24	WOS:000170698600023
J	Miller, CT; Dibble, E; Hauser, MD				Miller, CT; Dibble, E; Hauser, MD			Amodal completion of acoustic signals by a nonhuman primate	NATURE NEUROSCIENCE			English	Article							AUDITORY-CORTEX; PERCEPTION		Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, Cambridge, MA 02138 USA	Harvard University	Miller, CT (corresponding author), Harvard Univ, Dept Psychol, Primate Cognit Neurosci Lab, 33 Kirkland St, Cambridge, MA 02138 USA.							Bregman A.S., 1990, AUDITORY SCENE ANAL; CLEVELAND J, 1982, Z TIERPSYCHOL, V58, P231; Ghazanfar AA, 2001, J COMP PHYSIOL A, V187, P27, DOI 10.1007/s003590000173; HEFFNER HE, 1984, SCIENCE, V226, P75, DOI 10.1126/science.6474192; PALMER SF, 1999, VISON SCI PHOTONS PH; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; REGOLIN L, 1995, PERCEPT PSYCHOPHYS, V57, P971, DOI 10.3758/BF03205456; Samuel A, 1996, LANG COGNITIVE PROC, V11, P647, DOI 10.1080/016909696387051; Shams L, 2000, NATURE, V408, P788, DOI 10.1038/35048669; Wang XQ, 1995, J NEUROPHYSIOL, V74, P2685, DOI 10.1152/jn.1995.74.6.2685; WARREN RM, 1970, SCIENCE, V167, P392, DOI 10.1126/science.167.3917.392; WEISS D, IN PRESS J COMP PSYC	12	65	66	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					783	784		10.1038/90481	http://dx.doi.org/10.1038/90481			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477422				2022-12-24	WOS:000170137300009
J	Boyle, MET; Berglund, EO; Murai, KK; Weber, L; Peles, E; Ranscht, B				Boyle, MET; Berglund, EO; Murai, KK; Weber, L; Peles, E; Ranscht, B			Contactin orchestrates assembly of the septate-like junctions at the paranode in myelinated peripheral nerve	NEURON			English	Article							CELL-ADHESION MOLECULE; SODIUM-CHANNELS; POTASSIUM CHANNELS; AXOGLIAL JUNCTIONS; AXONAL MEMBRANE; MOUSE; CONDUCTION; NODE; GLYCOPROTEIN; SHIVERER	Rapid nerve impulse conduction depends on specialized membrane domains in myelinated nerve, the node of Ranvier, the paranode, and the myelinated internodal region. We report that GPI-linked contactin enables the formation of the paranodal septate-like axo-glial junctions in myelinated peripheral nerve. Contactin clusters at the paranodal axolemma during Schwann cell myelination. Ablation of contactin in mutant mice disrupts junctional attachment at the paranode and reduces nerve conduction velocity 3-fold. The mutation impedes intracellular transport and surface expression of Caspr and leaves NF155 on apposing paranodal myelin disengaged. The contactin mutation does not affect sodium channel clustering at the nodes of Ranvier but alters the location of the Shaker-type Kv1.1 and Kv1.2 potassium channels. Thus, contactin is a crucial part in the machinery that controls junctional attachment at the paranode and ultimately the physiology of myelinated nerve.	Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego; Weizmann Institute of Science	Ranscht, B (corresponding author), Burnham Inst, Neurobiol Program, La Jolla, CA 92037 USA.	ranscht@burnham.org		Peles, Elior/0000-0002-3325-0597	NATIONAL CANCER INSTITUTE [P30CA030199] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038297] Funding Source: NIH RePORTER; NCI NIH HHS [CA30199] Funding Source: Medline; NEI NIH HHS [F32 EY 06792] Funding Source: Medline; NINDS NIH HHS [NS38297] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRETT EF, 1981, J PHYSL, V323, P117; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; BOSTOCK H, 1978, J PHYSIOL-LONDON, V280, P273, DOI 10.1113/jphysiol.1978.sp012384; BRILL MH, 1977, J NEUROL NEUROSUR PS, V40, P769, DOI 10.1136/jnnp.40.8.769; BRUMMENDORF T, 1989, NEURON, V2, P1351, DOI 10.1016/0896-6273(89)90073-1; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHIU SY, 1984, PROC R SOC SER B-BIO, V220, P415, DOI 10.1098/rspb.1984.0010; CHIU SY, 1980, NATURE, V284, P170, DOI 10.1038/284170a0; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Deerinck TJ, 1997, J NEUROSCI, V17, P5080; DREYER F, 1987, J PHYSIOL-LONDON, V386, P455, DOI 10.1113/jphysiol.1987.sp016544; Dupree JL, 1999, J NEUROCYTOL, V28, P271, DOI 10.1023/A:1007049310758; Dupree JL, 1999, J CELL BIOL, V147, P1145, DOI 10.1083/jcb.147.6.1145; Dupree JL, 1998, J NEUROSCI, V18, P1642; DURBEC P, 1992, J CELL BIOL, V117, P877, DOI 10.1083/jcb.117.4.877; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; ELLISMAN MH, 1984, NODE RANVIER, P153; Faivre-Sarrailh C, 2000, J CELL BIOL, V149, P491, DOI 10.1083/jcb.149.2.491; Friedrich Jr VL, 1981, NEUROANATOMICAL TRAC, P345; FUNCH PG, 1984, SCIENCE, V225, P538, DOI 10.1126/science.6204382; GENNARINI G, 1989, J CELL BIOL, V109, P775, DOI 10.1083/jcb.109.2.775; GENNARINI G, 1991, NEURON, V6, P595, DOI 10.1016/0896-6273(91)90062-5; INOUE Y, 1981, BRAIN RES, V219, P85, DOI 10.1016/0006-8993(81)90269-9; Kaplan MR, 1997, NATURE, V386, P724, DOI 10.1038/386724a0; Lambert S, 1997, J NEUROSCI, V17, P7025; LITTLE GJ, 1994, J ANAT, V184, P387; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Peles E, 2000, CURR OPIN NEUROBIOL, V10, P558, DOI 10.1016/S0959-4388(00)00122-7; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; Peles E, 1997, EMBO J, V16, P978, DOI 10.1093/emboj/16.5.978; PESHEVA P, 1993, NEURON, V10, P69, DOI 10.1016/0896-6273(93)90243-K; RANSCHT B, 1988, J CELL BIOL, V107, P1561, DOI 10.1083/jcb.107.4.1561; Rasband M, 1998, J NEUROSCI, V18, P36; Rasband MN, 1999, J NEUROSCI, V19, P7516, DOI 10.1523/JNEUROSCI.19-17-07516.1999; RATHJEN FG, 1987, J CELL BIOL, V104, P343, DOI 10.1083/jcb.104.2.343; ROACH A, 1985, CELL, V42, P149, DOI 10.1016/S0092-8674(85)80110-0; ROSENBLUTH J, 1987, J NEUROCYTOL, V16, P497, DOI 10.1007/BF01668504; ROSENBLUTH J, 1981, BRAIN RES, V208, P283, DOI 10.1016/0006-8993(81)90558-8; ROSENBLUTH J, 1980, J COMP NEUROL, V193, P729, DOI 10.1002/cne.901930310; ROSENBLUTH J, 1984, NODE RANVIER, P31; Rosenbluth Jack, 1995, P613; Salzer JL, 1997, NEURON, V18, P843, DOI 10.1016/S0896-6273(00)80323-2; SMITH RS, 1970, AM J PHYSIOL, V219, P1256, DOI 10.1152/ajplegacy.1970.219.5.1256; Tait S, 2000, J CELL BIOL, V150, P657, DOI 10.1083/jcb.150.3.657; Trapp BD, 2000, J CELL BIOL, V150, pF97, DOI 10.1083/jcb.150.3.F97; Vabnick I, 1996, J NEUROSCI, V16, P4914; Vabnick I, 1999, J NEUROSCI, V19, P747; Volkmer H, 1998, J CELL BIOL, V142, P1083, DOI 10.1083/jcb.142.4.1083; Wang H, 1995, NEURON, V15, P1337, DOI 10.1016/0896-6273(95)90012-8; WANG H, 1993, NATURE, V365, P75, DOI 10.1038/365075a0; WILEY CA, 1980, J CELL BIOL, V84, P261, DOI 10.1083/jcb.84.2.261; Zhou L, 1998, J NEUROSCI, V18, P7200	54	393	402	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					385	397		10.1016/S0896-6273(01)00296-3	http://dx.doi.org/10.1016/S0896-6273(01)00296-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395001	Bronze			2022-12-24	WOS:000168962000012
J	Hubner, CA; Stein, V; Hermans-Borgmeyer, I; Meyer, T; Ballanyi, K; Jentsch, TJ				Hubner, CA; Stein, V; Hermans-Borgmeyer, I; Meyer, T; Ballanyi, K; Jentsch, TJ			Disruption of KCC2 reveals an essential role of K-Cl cotransport already in early synaptic inhibition	NEURON			English	Article							SPINAL-CORD PREPARATION; RESPIRATORY RHYTHM; NA+-K+-2CL(-) COTRANSPORTER; HYPOKALEMIC ALKALOSIS; BARTTERS-SYNDROME; CHLORIDE CHANNEL; RAT-BRAIN; GABA; NEURONS; EXPRESSION	Synaptic inhibition by GABA, and glycine receptors, which are ligand-gated anion channels, depends on the electrochemical potential for chloride. Several potassium-chloride cotransporters can lower the intracellular chloride concentration [Cl-](i), including the neuronal isoform KCC2. We show that KCC2 knockout mice died immediately after birth due to severe motor deficits that also abolished respiration. Sciatic nerve recordings revealed abnormal spontaneous electrical activity and altered spinal cord responses to peripheral electrical stimuli. In the spinal cord of wild-type animals, the KCC2 protein was found at inhibitory synapses. Patch-clamp measurements of embryonic day 18.5 spinal cord motoneurons demonstrated an excitatory GABA and glycine action in the absence, but not in the presence, of KCC2, revealing a crucial role of KCC2 for synaptic inhibition.	Univ Hamburg, Zentrum Mol Neurobiol Hamburg, D-20246 Hamburg, Germany; Univ Gottingen, Zentrum Physiol & Pathophysiol, D-37073 Gottingen, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen	Jentsch, TJ (corresponding author), Univ Hamburg, Zentrum Mol Neurobiol Hamburg, Martinistr 52, D-20246 Hamburg, Germany.		Stein, Valentin/A-8025-2008; Hübner, Christian/A-2950-2017	Stein, Valentin/0000-0003-1222-4928; Hübner, Christian/0000-0002-1030-4943; Jentsch, Thomas/0000-0002-3509-2553				Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; BISCOE TJ, 1986, J PHYSIOL-LONDON, V379, P275, DOI 10.1113/jphysiol.1986.sp016253; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; BUCKLE PJ, 1981, N-S ARCH PHARMACOL, V315, P211, DOI 10.1007/BF00499837; CHERUBINI E, 1991, TRENDS NEUROSCI, V14, P515, DOI 10.1016/0166-2236(91)90003-D; Clayton GH, 1998, DEV BRAIN RES, V109, P281, DOI 10.1016/S0165-3806(98)00078-9; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; FELDMAN JL, 1989, ANN NY ACAD SCI, V563, P114, DOI 10.1111/j.1749-6632.1989.tb42194.x; Flint AC, 1998, NEURON, V20, P43, DOI 10.1016/S0896-6273(00)80433-X; GAO BX, 1995, J NEUROPHYSIOL, V74, P113, DOI 10.1152/jn.1995.74.1.113; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Haas M, 1998, J BIOENERG BIOMEMBR, V30, P161, DOI 10.1023/A:1020521308985; KIRSCH J, 1995, J NEUROSCI, V15, P418; Kneussel M, 2000, J PHYSIOL-LONDON, V525, P1, DOI 10.1111/j.1469-7793.2000.t01-4-00001.x; KYROZIS A, 1995, J NEUROSCI METH, V57, P27, DOI 10.1016/0165-0270(94)00116-X; Lloyd DPC, 1943, J NEUROPHYSIOL, V6, P317, DOI 10.1152/jn.1943.6.4.317; LoTurco JJ, 1995, NEURON, V15, P1287, DOI 10.1016/0896-6273(95)90008-X; Mount DB, 1999, J BIOL CHEM, V274, P16355, DOI 10.1074/jbc.274.23.16355; Obrietan K, 1997, J NEUROSCI, V17, P4785; ONIMARU H, 1987, BRAIN RES, V403, P380, DOI 10.1016/0006-8993(87)90080-1; Pace AJ, 2000, J CLIN INVEST, V105, P441, DOI 10.1172/JCI8553; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; PRICHARD JW, 1969, J PHARMACOL EXP THER, V166, P170; Randall J, 1997, AM J PHYSIOL-CELL PH, V273, pC1267, DOI 10.1152/ajpcell.1997.273.4.C1267; Rivera C, 1999, NATURE, V397, P251, DOI 10.1038/16697; SCHNEIDER SP, 1992, J NEUROPHYSIOL, V68, P397, DOI 10.1152/jn.1992.68.2.397; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH RL, 1995, J NEUROSCI, V15, P4057; Staley K, 1996, NEURON, V17, P543, DOI 10.1016/S0896-6273(00)80186-5; Sun DD, 1999, J NEUROPHYSIOL, V81, P1939, DOI 10.1152/jn.1999.81.4.1939; Sung KW, 2000, J NEUROSCI, V20, P7531; SUZUE T, 1984, J PHYSIOL-LONDON, V354, P173, DOI 10.1113/jphysiol.1984.sp015370; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Vardi N, 2000, J NEUROSCI, V20, P7657; VOIPIO J, 2000, GABAERGIC EXCITATION, V125; Vu TQ, 2000, J NEUROSCI, V20, P1414; WENTWORTH LE, 1984, J COMP NEUROL, V222, P81, DOI 10.1002/cne.902220108; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942	44	436	442	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					515	524		10.1016/S0896-6273(01)00297-5	http://dx.doi.org/10.1016/S0896-6273(01)00297-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395011	Green Published, hybrid			2022-12-24	WOS:000168962000022
J	Puopolo, M; Hochstetler, SE; Gustincich, S; Wightman, RM; Raviola, E				Puopolo, M; Hochstetler, SE; Gustincich, S; Wightman, RM; Raviola, E			Extrasynaptic release of dopamine in a retinal neuron: Activity dependence and transmitter modulation	NEURON			English	Article							RAT RETINA; CHROMAFFIN CELLS; QUANTAL SIZE; GANGLION NEURONS; CAT RETINA; EXTRACELLULAR ELECTROPHYSIOLOGY; ACCUMULATING NEURONS; HIPPOCAMPAL-NEURONS; CALCIUM CHANNELS; SUBSTANTIA-NIGRA	Extrasynaptic release of dopamine is well documented, but its relation to the physiological activity of the neuron is unclear. Here we show that in absence of presynaptic active zones, solitary cell bodies of retinal dopaminergic neurons release by exocytosis packets of similar to 40,000 molecules of dopamine at irregular intervals and low frequency. The release is triggered by the action potentials that the neurons generate in a rhythmic fashion upon removal of all synaptic influences and therefore depends upon the electrical events at the neuronal surface. Furthermore, it is stimulated by kainate and abolished by GABA and quinpirole, an agonist at the D-2 dopamine receptor. Since the somatic receptors for these ligands are extrasynaptic, we suggest that the composition of the extracellular fluid directly modulates extrasynaptic release.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA	Harvard University; Harvard Medical School; University of North Carolina; University of North Carolina Chapel Hill	Raviola, E (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.			Gustincich, Stefano/0000-0002-2749-2514	NATIONAL EYE INSTITUTE [R01EY001344] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038879] Funding Source: NIH RePORTER; NEI NIH HHS [EY01344] Funding Source: Medline; NINDS NIH HHS [NS38879] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; BEAN BP, 1994, HDB MEMBRANE CHANNEL, P199; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Bjelke B, 1996, J CHEM NEUROANAT, V12, P37, DOI 10.1016/S0891-0618(96)00176-7; Brandstatter JH, 1996, EUR J NEUROSCI, V8, P823, DOI 10.1111/j.1460-9568.1996.tb01268.x; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Bunin MA, 1999, TRENDS NEUROSCI, V22, P377, DOI 10.1016/S0166-2236(99)01410-1; CARDOZO DL, 1995, J NEUROPHYSIOL, V74, P1137, DOI 10.1152/jn.1995.74.3.1137; CHERAMY A, 1981, NATURE, V289, P537, DOI 10.1038/289537a0; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; DAN Y, 1994, NEURON, V13, P909, DOI 10.1016/0896-6273(94)90256-9; Derouiche A, 1999, EUR J NEUROSCI, V11, P1391, DOI 10.1046/j.1460-9568.1999.00557.x; DEWAELE P, 1982, ARCH INT PHYSIOL BIO, V90, pB21; DUCHEN MR, 1992, MONITORING NEURONAL, P231; Feigenspan A, 1998, J NEUROSCI, V18, P6776; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Galli A, 1998, P NATL ACAD SCI USA, V95, P13260, DOI 10.1073/pnas.95.22.13260; Garaschuk O, 1997, J PHYSIOL-LONDON, V502, P13, DOI 10.1111/j.1469-7793.1997.013bl.x; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; GRACE AA, 1983, NEUROSCIENCE, V10, P317, DOI 10.1016/0306-4522(83)90136-7; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Gustincich S, 1999, J NEUROSCI, V19, P7812; Gustincich S, 1997, NEURON, V18, P723, DOI 10.1016/S0896-6273(00)80313-X; Hochstetler SE, 2000, ANAL CHEM, V72, P489, DOI 10.1021/ac991119x; HOCHSTETLER SE, 1998, ON LINE BIOPHYSICS T; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; Jaffe EH, 1998, J NEUROSCI, V18, P3548; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kim KT, 2000, J NEUROSCI, V20, part. no.; Koh DS, 1997, P NATL ACAD SCI USA, V94, P1506, DOI 10.1073/pnas.94.4.1506; KOLB H, 1990, J NEUROCYTOL, V19, P343, DOI 10.1007/BF01188404; KOLB H, 1991, J COMP NEUROL, V310, P267, DOI 10.1002/cne.903100210; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; Morishita W, 1999, J NEUROPHYSIOL, V82, P2556, DOI 10.1152/jn.1999.82.5.2556; Nguyen-Legros J., 1988, Progress in Retinal Research, V7, P113, DOI 10.1016/0278-4327(88)90007-7; Nirenberg MJ, 1996, J NEUROSCI, V16, P4135; Pothos E, 1996, J NEUROCHEM, V66, P629; Pothos EN, 1998, J NEUROSCI, V18, P4106; SANDELL JH, 1986, J NEUROSCI, V6, P3331; SIMMONS ML, 1995, NEURON, V14, P1265, DOI 10.1016/0896-6273(95)90273-2; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; TAUCHI M, 1990, J COMP NEUROL, V293, P178, DOI 10.1002/cne.902930203; Trifaro JM, 1997, NEUROCHEM RES, V22, P831, DOI 10.1023/A:1022087910902; Verkhratsky A, 1996, CELL CALCIUM, V19, P1, DOI 10.1016/S0143-4160(96)90009-3; Veruki ML, 1996, EUR J NEUROSCI, V8, P2286, DOI 10.1111/j.1460-9568.1996.tb01192.x; Veruki ML, 1997, EUR J NEUROSCI, V9, P1096, DOI 10.1111/j.1460-9568.1997.tb01461.x; WASSLE H, 1988, J NEUROSCI, V8, P3383; WIGHTMAN RM, 1995, BIOPHYS J, V68, P383, DOI 10.1016/S0006-3495(95)80199-2; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; WITKOVSKY P, 1991, PROG RETIN RES, V11, P247, DOI 10.1016/0278-4327(91)90031-V; WITKOVSKY P, 1993, P NATL ACAD SCI USA, V90, P6667; WULLE I, 1990, J COMP NEUROL, V296, P173, DOI 10.1002/cne.902960111; ZHOU Z, 1995, P NATL ACAD SCI USA, V92, P6938, DOI 10.1073/pnas.92.15.6938; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	58	110	112	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					211	225		10.1016/S0896-6273(01)00274-4	http://dx.doi.org/10.1016/S0896-6273(01)00274-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343656	Bronze			2022-12-24	WOS:000168412900022
J	Montgomery, JM; Pavlidis, P; Madison, DV				Montgomery, JM; Pavlidis, P; Madison, DV			Pair recordings reveal all-silent synaptic connections and the postsynaptic expression of long-term potentiation	NEURON			English	Article							EXTRASYNAPTIC GLUTAMATE SPILLOVER; HIPPOCAMPAL SLICE CULTURES; CA3 PYRAMIDAL CELLS; RAT HIPPOCAMPUS; TRANSPORTER CURRENTS; AMPA RECEPTORS; SYNAPSES; LTP; RELEASE; NEURONS	The activation of silent synapses is a proposed mechanism to account for rapid increases in synaptic efficacy such as long-term potentiation (LTP). Using simultaneous recordings from individual pre- and postsynaptic neurons in organotypic hippocampal slices, we show that two CA3 neurons can be connected entirely by silent synapses. Increasing release probability or application of cyclothiazide does not produce responses from these silent synapses. Direct measurement of NMDAR-mediated postsynaptic responses in all-silent synaptic connections before and after LTP induction show no change in failure rate, amplitude. or area. These data do not support hypotheses that synapse silent results from presynaptic factors or that LTP results from increases in presynaptic glutamate release. LTP is also associated with an increase in postsynaptic responsiveness to exogenous AMPA. We conclude that synapse silence, activation, and expression of LTP are postsynaptic.	Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA	Stanford University	Madison, DV (corresponding author), Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Stanford, CA 94305 USA.	madison@stanford.edu	Pavlidis, Paul/H-8406-2013; Madison, Daniel/F-9341-2017	Pavlidis, Paul/0000-0002-0426-5028; Madison, Daniel/0000-0002-0718-5373	NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER; NIMH NIH HHS [MH48108] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; CLARK KA, 1995, J PHYSIOL-LONDON, V482, P39, DOI 10.1113/jphysiol.1995.sp020498; CREAGER R, 1980, J PHYSIOL-LONDON, V299, P409, DOI 10.1113/jphysiol.1980.sp013133; DAVIES SN, 1989, NATURE, V338, P500, DOI 10.1038/338500a0; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; Debanne D, 1999, J NEUROSCI, V19, P10664, DOI 10.1523/JNEUROSCI.19-24-10664.1999; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; FABER DS, 1991, ANN NY ACAD SCI, V627, P151; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Hardingham NR, 1998, J PHYSIOL-LONDON, V507, P249, DOI 10.1111/j.1469-7793.1998.249bu.x; Isaac JTR, 1999, CAN J PHYSIOL PHARM, V77, P735, DOI 10.1139/cjpp-77-9-735; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; MCALLISTER KA, 2000, PNAS, V97, P6173; Miles R, 1996, CURR OPIN NEUROBIOL, V6, P387, DOI 10.1016/S0959-4388(96)80124-3; MILES R, 1987, NATURE, V329, P724, DOI 10.1038/329724a0; MILES R, 1986, J PHYSIOL-LONDON, V373, P397, DOI 10.1113/jphysiol.1986.sp016055; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PATNEAU DK, 1990, J NEUROSCI, V10, P2385; Pavlidis P, 1999, J NEUROPHYSIOL, V81, P2787, DOI 10.1152/jn.1999.81.6.2787; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Umemiya M, 1999, J PHYSIOL-LONDON, V521, P113, DOI 10.1111/j.1469-7793.1999.00113.x; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; YAMADA KA, 1993, J NEUROSCI, V13, P3904; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	43	136	140	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					691	701		10.1016/S0896-6273(01)00244-6	http://dx.doi.org/10.1016/S0896-6273(01)00244-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301028	Bronze			2022-12-24	WOS:000167868900018
J	Saari, JC; Nawrot, M; Kennedy, BN; Garwin, GG; Hurley, JB; Huang, J; Possin, DE; Crabb, JW				Saari, JC; Nawrot, M; Kennedy, BN; Garwin, GG; Hurley, JB; Huang, J; Possin, DE; Crabb, JW			Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation	NEURON			English	Article							PIGMENT EPITHELIAL-CELLS; PERFORMANCE LIQUID-CHROMATOGRAPHY; RETINITIS-PIGMENTOSA; BOVINE RETINA; CIS-RETINOLS; VITAMIN-A; GENE; MOUSE; RHODOPSIN; RESPONSES	Mutations in the human CRALBP gene cause retinal pathology and delayed dark adaptation. Biochemical studies have not identified the primary physiological function of CRALBP. To resolve this, we generated and characterized mice with a non-functional CRALBP gene (Rlbp1(-/-) mice). The photosensitivity of Rlbp1(-/-) mice is normal but rhodopsin regeneration, 11-cis-retinal production, and dark adaptation after illumination are delayed by >10-fold. All-trans-retinyl esters accumulate during the delay indicating that isomerization of all-trans- to 11-cis-retinol is impaired. No evidence of photoreceptor degeneration was observed in animals raised in cyclic light/dark conditions for up to 1 year. Albino Rlbp(-/-) mice are protected from light damage relative to the wild type. These findings support a role for CRALBP as an acceptor of 11-cis-retinol in the isomerization reaction of the visual cycle.	Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Cleveland Clin Fdn, Dept Ophthalm Res, Cole Eye Inst, Cleveland, OH 44195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Cleveland Clinic Foundation	Saari, JC (corresponding author), Univ Washington, Dept Ophthalmol, Box 356485, Seattle, WA 98195 USA.	jsaari@u.washington.edu; jbhhh@u.washington.edu; crabbj@ccf.org	kennedy, Breandan/H-5643-2019	kennedy, Breandan/0000-0001-7991-4689	NEI NIH HHS [R01 EY006641, EY02317, EY06641, EY01730, EY06603] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY001730, R01EY006641] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ANDREWS EJ, 1993, J AM VET MED ASSOC, V202, P230; Bayer AU, 1999, DOC OPHTHALMOL, V98, P233, DOI 10.1023/A:1002416918247; BOK D, 1990, EYE, V4, P326, DOI 10.1038/eye.1990.44; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Burstedt MSI, 1999, INVEST OPHTH VIS SCI, V40, P995; CARR RE, 1994, RETINA, P502; CHEN Y, 1994, TECHNIQUES PROTEIN C, V5, P371; Crabb JW, 1998, J BIOL CHEM, V273, P20712, DOI 10.1074/jbc.273.33.20712; Crouch RK, 1996, PHOTOCHEM PHOTOBIOL, V64, P613, DOI 10.1111/j.1751-1097.1996.tb03114.x; Danciger M, 2000, MAMM GENOME, V11, P422, DOI 10.1007/s003350010081; DEIGNER PS, 1989, SCIENCE, V244, P968, DOI 10.1126/science.2727688; DOWLING JE, 1960, NATURE, V188, P114, DOI 10.1038/188114a0; Driessen CAGG, 2000, MOL CELL BIOL, V20, P4275, DOI 10.1128/MCB.20.12.4275-4287.2000; Fain GL, 1996, TRENDS NEUROSCI, V19, P502, DOI 10.1016/S0166-2236(96)10056-4; Garwin GG, 2000, METHOD ENZYMOL, V316, P313; Gonzalez-Fernandez F, 1999, MOL VIS, V5, pU1; Grimm C, 2000, NAT GENET, V25, P63, DOI 10.1038/75614; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hetling JR, 1999, J PHYSIOL-LONDON, V516, P593, DOI 10.1111/j.1469-7793.1999.0593v.x; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hurley James B., 1994, Current Opinion in Neurobiology, V4, P481, DOI 10.1016/0959-4388(94)90047-7; INTRES R, 1994, J BIOL CHEM, V269, P25411; Kennedy B N, 1998, Mol Vis, V4, P14; Kennedy BN, 1999, RETINAL DEGENERATIVE DISEASES AND EXPERIMENTAL THERAPY, P43, DOI 10.1007/978-0-585-33172-0_5; LANDERS GM, 1990, METHOD ENZYMOL, V189, P70; Lewin AS, 1998, NAT MED, V4, P967, DOI 10.1038/nm0898-967; Lyubarsky AL, 2000, J NEUROSCI, V20, P2209; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Maw MA, 1997, NAT GENET, V17, P198, DOI 10.1038/ng1097-198; McBee JK, 2000, BIOCHEMISTRY-US, V39, P11370, DOI 10.1021/bi001061c; Morimura H, 1999, INVEST OPHTH VIS SCI, V40, P1000; Noell W K, 1966, Invest Ophthalmol, V5, P450; Palczewski K, 1999, BIOCHEMISTRY-US, V38, P12012, DOI 10.1021/bi990504d; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Rando RR, 1996, CHEM BIOL, V3, P255, DOI 10.1016/S1074-5521(96)90105-2; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; RIPPS H, 1978, INVEST OPHTH VIS SCI, V17, P735; RUSHTON WA, 1961, J PHYSIOL-LONDON, V156, P193, DOI 10.1113/jphysiol.1961.sp006668; SAARI JC, 1989, J BIOL CHEM, V264, P8636; SAARI JC, 1982, J BIOL CHEM, V257, P13329; SAARI JC, 1994, BIOCHEMISTRY-US, V33, P3106, DOI 10.1021/bi00176a045; SAARI JC, 1987, J BIOL CHEM, V262, P7618; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; SAARI JC, 1997, PR MED BIOL A, V8, P883; Saari John C., 1994, P351; Stecher H, 1999, BIOCHEMISTRY-US, V38, P13542, DOI 10.1021/bi9913294; Stecher H, 1999, J BIOL CHEM, V274, P8577, DOI 10.1074/jbc.274.13.8577; Sun H, 1997, P NATL ACAD SCI USA, V94, P9893, DOI 10.1073/pnas.94.18.9893; WALD G, 1968, SCIENCE, V162, P230, DOI 10.1126/science.162.3850.230; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285; Winston A, 1998, BIOCHEMISTRY-US, V37, P2044, DOI 10.1021/bi971908d; Xu J, 1997, NATURE, V389, P505, DOI 10.1038/39068; Yamamoto H, 1999, NAT GENET, V22, P188, DOI 10.1038/9707; Yamamoto S, 1997, NAT GENET, V15, P175, DOI 10.1038/ng0297-175; ZIMMERMAN WF, 1974, VISION RES, V14, P795, DOI 10.1016/0042-6989(74)90143-6	56	181	186	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					739	748		10.1016/S0896-6273(01)00248-3	http://dx.doi.org/10.1016/S0896-6273(01)00248-3			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301032	Bronze			2022-12-24	WOS:000167868900022
J	Ward, R; Danziger, S; Owen, V; Rafal, R				Ward, R; Danziger, S; Owen, V; Rafal, R			Deficits in spatial coding and feature binding following damage to spatiotopic maps in the human pulvinar	NATURE NEUROSCIENCE			English	Article							ILLUSORY CONJUNCTIONS; ATTENTION; PATIENT		Univ Wales, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales; Ben Gurion Univ Negev, IL-84105 Beer Sheva, Israel	Bangor University; Ben Gurion University	Ward, R (corresponding author), Univ Wales, Ctr Cognit Neurosci, Bangor LL57 2AS, Gwynedd, Wales.		Danziger, Shai/AAE-8799-2019					BENDER DB, 1981, J NEUROPHYSIOL, V46, P672, DOI 10.1152/jn.1981.46.3.672; COHEN A, 1989, J EXP PSYCHOL HUMAN, V15, P650, DOI 10.1037/0096-1523.15.4.650; COHEN A, 1991, PSYCHOL SCI, V2, P106, DOI 10.1111/j.1467-9280.1991.tb00109.x; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PRINZMETAL W, 1995, J EXP PSYCHOL HUMAN, V21, P1362, DOI 10.1037/0096-1523.21.6.1362; ROBINSON DL, 1989, NEUROBIOLOGY SACCADI, P337; Talairach J., 1988, COPLANAR STEREOTAXIC; TREISMAN A, 1982, COGNITIVE PSYCHOL, V14, P107, DOI 10.1016/0010-0285(82)90006-8; Treisman A, 1996, CURR OPIN NEUROBIOL, V6, P171, DOI 10.1016/S0959-4388(96)80070-5	11	94	96	0	8	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					99	100		10.1038/nn794	http://dx.doi.org/10.1038/nn794			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11780145				2022-12-24	WOS:000173558400009
J	Holthoff, K; Tsay, D; Yuste, R				Holthoff, K; Tsay, D; Yuste, R			Calcium dynamics of spines depend on their dendritic location	NEURON			English	Article							NEOCORTICAL PYRAMIDAL NEURONS; PROPAGATING ACTION-POTENTIALS; POSTSYNAPTIC DENSITY; HIPPOCAMPAL SPINES; SINGLE SPINES; CA2+; RELEASE; KINASE; COMPARTMENTALIZATION; COINCIDENCE	Dendritic spines are morphologically and functionally heterogeneous. To understand this diversity, we use two-photon imaging of layer 5 neocortical pyramidal cells and measure action potential-evoked [Ca2+](i) transients in spines. Spine calcium kinetics are controlled by (i) the diameter of the parent dendrite, (ii) the length of the spine neck, and (iii) the strength of spine calcium pumps. These factors produce different calcium dynamics in spines from basal, proximal apical, and distal apical dendrites, differences that are more pronounced without exogenous buffers. In proximal and distal apical dendrites, different calcium dynamics correlate with different susceptibility to synaptic depression, and modifying calcium kinetics in spines changes the expression of long-term depression. Thus, the spine location apparently determines its calcium dynamics and synaptic plasticity. Our results highlight the precision in design of neocortical neurons.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Holthoff, K (corresponding author), Univ Munich, Inst Phys, Biedersteiner Str 29, D-80802 Munich, Germany.				NATIONAL EYE INSTITUTE [R01EY011787, R01EY013237] Funding Source: NIH RePORTER; NEI NIH HHS [EY11787, EY13237] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLBRITTON NL, 1992, SCIENCE, V258, P1812, DOI 10.1126/science.1465619; Berg H. C., 1982, RANDOM WALKS BIOL; CAJAL R, 1891, REV CIENC MED BARCL, V22, P1; CAJAL R, 1888, REV TRIM HISTOL NORM, V1, P1; CAULLER LJ, 1994, J NEUROSCI, V14, P751; Conchello JA, 1998, J OPT SOC AM A, V15, P2609, DOI 10.1364/JOSAA.15.002609; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GRAY EG, 1959, NATURE, V183, P1592, DOI 10.1038/1831592a0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Helmchen F, 1997, BIOPHYS J, V72, P1458, DOI 10.1016/S0006-3495(97)78792-7; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; Hille B., 1992, IONIC CHANNELS EXCIT; JONES EG, 1969, J CELL SCI, V5, P509; KOCH C, 1993, J NEUROSCI, V13, P413; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; Korkotian E, 1998, EUR J NEUROSCI, V10, P2076, DOI 10.1046/j.1460-9568.1998.00219.x; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; LISMAN JE, 1988, P NATL ACAD SCI USA, V85, P5320, DOI 10.1073/pnas.85.14.5320; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Majewska A, 2000, J NEUROSCI, V20, P1722; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MILLER SG, 1985, J BIOL CHEM, V260, P9039; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Murthy VN, 2000, P NATL ACAD SCI USA, V97, P901, DOI 10.1073/pnas.97.2.901; NEHER E, 1992, J PHYSIOL-LONDON, V450, P273, DOI 10.1113/jphysiol.1992.sp019127; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Tank DW, 1995, J NEUROSCI, V15, P7940; WAGNER J, 1994, BIOPHYS J, V67, P447, DOI 10.1016/S0006-3495(94)80500-4; WICKENS J, 1988, PROG NEUROBIOL, V31, P507, DOI 10.1016/0301-0082(88)90013-5; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Yuste R, 2000, NAT NEUROSCI, V3, P653, DOI 10.1038/76609; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; YUSTE R, 1994, NEURON, V13, P23, DOI 10.1016/0896-6273(94)90457-X; Yuste R, 1999, J NEUROSCI, V19, P1976	49	94	94	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					425	437		10.1016/S0896-6273(02)00576-7	http://dx.doi.org/10.1016/S0896-6273(02)00576-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832229	Bronze			2022-12-24	WOS:000173643200012
J	Stellwagen, D; Shatz, CJ				Stellwagen, D; Shatz, CJ			An instructive role for retinal waves in the development of retinogeniculate connectivity	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; DEVELOPING MAMMALIAN RETINA; NEURONAL-ACTIVITY; OCULAR DOMINANCE; GANGLION-CELLS; RETINOTECTAL PROJECTION; PRENATAL DEVELOPMENT; BURSTING ACTIVITY; VISUAL-CORTEX; FERRET	A central hypothesis of neural development is that patterned activity drives the refinement of initially imprecise connections. We have examined this hypothesis directly by altering the frequency of spontaneous waves of activity that sweep across the mammalian retina prior to vision. Activity levels were increased in vivo using agents that elevate cAMP. When one eye is made more active, its layer within the LGN is larger despite the other eye having normal levels of activity. Remarkably, when the frequency of retinal waves is Increased in both eyes, normally sized layers form. Because relative, rather than absolute, levels of activity between the eyes regulate the amount of LGN territory devoted to each eye, we conclude that activity acts instructively to guide binocular segregation during development.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Shatz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	carla_shatz@hms.harvard.edu			NIGMS NIH HHS [GM0748] Funding Source: Medline; NIMH NIH HHS [MH48108] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH048108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; CHAPMAN B, 1986, NATURE, V324, P154, DOI 10.1038/324154a0; CLINE HT, 1991, TRENDS NEUROSCI, V14, P104, DOI 10.1016/0166-2236(91)90071-2; CONSTANTINEPATON M, 1990, ANNU REV NEUROSCI, V13, P129, DOI 10.1146/annurev.neuro.13.1.129; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; Crair MC, 1999, CURR OPIN NEUROBIOL, V9, P88, DOI 10.1016/S0959-4388(99)80011-7; Crair MC, 2001, J COMP NEUROL, V430, P235, DOI 10.1002/1096-9861(20010205)430:2<235::AID-CNE1028>3.0.CO;2-P; Cramer KS, 1997, DEV BRAIN RES, V98, P287, DOI 10.1016/S0165-3806(96)00188-5; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; DUBIN MW, 1986, J NEUROSCI, V6, P1021; EISELE LE, 1988, J NEUROBIOL, V19, P395, DOI 10.1002/neu.480190502; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1997, NEURON, V19, P293, DOI 10.1016/S0896-6273(00)80940-X; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Hahm JO, 1999, J COMP NEUROL, V411, P327, DOI 10.1002/(SICI)1096-9861(19990823)411:2<327::AID-CNE12>3.0.CO;2-#; HENDERSON Z, 1988, J NEUROSCI, V8, P1194; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LAM K, 1982, DEV BRAIN RES, V3, P487, DOI 10.1016/0165-3806(82)90014-1; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MEISTER M, 1991, SCIENCE, V252, P939, DOI 10.1126/science.2035024; MESULAM MM, 1978, J HISTOCHEM CYTOCHEM, V26, P106, DOI 10.1177/26.2.24068; Mooney R, 1996, NEURON, V17, P863, DOI 10.1016/S0896-6273(00)80218-4; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; POTTS RA, 1982, DEV BRAIN RES, V3, P481, DOI 10.1016/0165-3806(82)90013-X; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; SEAMON KB, 1986, ADV CYCLIC NUCL PROT, V20, P1; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; Shatz CJ, 1996, P NATL ACAD SCI USA, V93, P602, DOI 10.1073/pnas.93.2.602; SHATZ CJ, 1983, J NEUROSCI, V3, P482; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Stellwagen D, 1999, NEURON, V24, P673, DOI 10.1016/S0896-6273(00)81121-6; STRYKER MP, 1983, J NEUROSCI, V3, P1943; TSAI SC, 1987, P NATL ACAD SCI USA, V84, P5139, DOI 10.1073/pnas.84.15.5139; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Zhou ZJ, 1998, J NEUROSCI, V18, P4155	43	256	259	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					357	367		10.1016/S0896-6273(02)00577-9	http://dx.doi.org/10.1016/S0896-6273(02)00577-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832224	Bronze			2022-12-24	WOS:000173643200007
J	Kalidas, S; Smith, DP				Kalidas, S; Smith, DP			Novel genomic cDNA hybrids produce effective RNA interference in adult Drosophila	NEURON			English	Article							GENETIC INTERFERENCE; EXPRESSION; POTENT	Drosophila melanogaster has been a premier genetic model system for nearly 100 years, yet lacks a simple method to disrupt gene expression. Here, we show genomic cDNA fusions predicted to form double-stranded RNA (dsRNA) following splicing, effectively silencing expression of target genes in adult transgenic animals. We targeted three Drosophila genes: lush, white, and dGqalpha. In each case, target gene expression is dramatically reduced, and the white RNAi phenotype is indistinguishable from a deletion mutant. This technique efficiently targets genes expressed in neurons, a tissue refractory to RNAi in C. elegans. These results demonstrate a simple strategy to knock out gene function in specific cells in living adult Drosophila that can be applied to define the biological function of hundreds of orphan genes and open reading frames.	Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Smith, DP (corresponding author), Univ Texas, SW Med Ctr, Dept Pharmacol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	dean.smith@utsouthwestern.edu			NIDCD NIH HHS [DC02539] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002539] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BRAND AH, 1993, DEVELOPMENT, V118, P401; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fortier E, 2000, GENESIS, V26, P240, DOI 10.1002/(SICI)1526-968X(200004)26:4<240::AID-GENE40>3.0.CO;2-P; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Furner IJ, 1998, GENETICS, V149, P651; Galindo K, 2001, GENETICS, V159, P1059; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; Gonczy P, 2000, NATURE, V408, P331, DOI 10.1038/35042526; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; HAY BA, 1994, DEVELOPMENT, V120, P2121; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Kim MS, 1998, GENETICS, V150, P711; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; Mackenzie SM, 2000, GENETICA, V108, P239, DOI 10.1023/A:1004115718597; Martinek S, 2000, GENETICS, V156, P1717; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piccin A, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.12.e55; Pirrotta V, 1988, Biotechnology, V10, P437; Rong YS, 2001, GENETICS, V157, P1307; SCOTT K, 1995, NEURON, V15, P919, DOI 10.1016/0896-6273(95)90182-5; Smith NA, 2000, NATURE, V407, P319, DOI 10.1038/35030305; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; TALLURI S, 1995, P NATL ACAD SCI USA, V92, P11475, DOI 10.1073/pnas.92.25.11475; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	35	170	177	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					177	184		10.1016/S0896-6273(02)00560-3	http://dx.doi.org/10.1016/S0896-6273(02)00560-3			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804566	Bronze			2022-12-24	WOS:000173387700006
J	Whitford, KL; Marillat, V; Stein, E; Goodman, CS; Tessier-Lavigne, M; Chedotal, A; Ghosh, A				Whitford, KL; Marillat, V; Stein, E; Goodman, CS; Tessier-Lavigne, M; Chedotal, A; Ghosh, A			Regulation of cortical dendrite development by Slit-Robo interactions	NEURON			English	Article							REPULSIVE AXON GUIDANCE; EXTRACELLULAR PROTEIN; ADAPTER PROTEIN; OPPOSING ROLES; NERVOUS-SYSTEM; KINASE PAK1; GROWTH; ROUNDABOUT; DROSOPHILA; REPELLENT	Slit proteins have previously been shown to regulate axon guidance, branching, and neural migration. Here we report that, in addition to acting as a chemorepellant for cortical axons, Slit1 regulates dendritic development. Slit1 is expressed in the developing cortex, and exposure to Slit1 leads to increased dendritic growth and branching. Conversely, inhibition of Slit-Robo interactions by Robo-Fc fusion proteins or by a dominant-negative Robo attenuates dendritic branching. Stimulation of neurons transfected with a Met-Robo chimeric receptor with Hepatocyte growth factor leads to a robust induction of dendritic growth and branching, suggesting that Robo-mediated signaling is sufficient to induce dendritic remodeling. These experiments indicate that Slit-Robo interactions may exert a significant influence over the specification of cortical neuron morphology by regulating both axon guidance and dendritic patterning.	Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21205 USA; Hop La Pitie Salpetriere, INSERM, U106, F-75013 Paris, France; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Johns Hopkins University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Ghosh, A (corresponding author), Johns Hopkins Univ, Dept Neurosci, Sch Med, 725 N Wolfe St, Baltimore, MD 21205 USA.	aghosh@jhmi.edu	Stein, Elke/E-8107-2013; Chedotal, Alain/F-2750-2017	Stein, Elke/0000-0001-8965-5692; Chedotal, Alain/0000-0001-7577-3794	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039993] Funding Source: NIH RePORTER; NINDS NIH HHS [NS39993] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bokoch GM, 1996, J BIOL CHEM, V271, P25746, DOI 10.1074/jbc.271.42.25746; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Cabelli RJ, 1997, NEURON, V19, P63, DOI 10.1016/S0896-6273(00)80348-7; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gao FB, 1999, GENE DEV, V13, P2549, DOI 10.1101/gad.13.19.2549; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kramer SG, 2001, SCIENCE, V292, P737, DOI 10.1126/science.1058766; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Li Z, 2000, NAT NEUROSCI, V3, P217, DOI 10.1038/72920; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1997, NEURON, V18, P767, DOI 10.1016/S0896-6273(00)80316-5; Metin C, 1997, DEVELOPMENT, V124, P5063; Niclou SP, 2000, J NEUROSCI, V20, P4962; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; Richards LJ, 1997, J NEUROSCI, V17, P2445; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1992, J MOL BIOL, V227, P367, DOI 10.1016/0022-2836(92)90891-M; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	39	215	223	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2002	33	1					47	61		10.1016/S0896-6273(01)00566-9	http://dx.doi.org/10.1016/S0896-6273(01)00566-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779479	Bronze			2022-12-24	WOS:000173106200009
J	Zhang, LI; Bao, SW; Merzenich, MM				Zhang, LI; Bao, SW; Merzenich, MM			Persistent and specific influences of early acoustic environments on primary auditory cortex	NATURE NEUROSCIENCE			English	Article							CORTICAL PLASTICITY; NEURONAL-ACTIVITY; RECEPTIVE-FIELDS; VISUAL-CORTEX; REPRESENTATION; EXPERIENCE; SYSTEM; ADULT; RAT; DRIVEN	This study demonstrates that the adult form of 'tonotopic maps' of sound frequency in the rat primary auditory cortex (A1) arises from parallel developmental processes involving two cortical zones: the progressive differentiation and refinement of selectively tone-responsive receptive fields within an initially broadly-tuned posterior zone, and the progressive loss of tone-evoked, short-latency response over an initially large, very broadly tuned anterior zone. The formation of tonotopic maps in A1 was specifically influenced by a rat pup's early acoustic environments. Exposure to pulsed tones resulted in accelerated emergence and an expansion of A1 representations of those specific tone frequencies, as well as a deteriorated tonotopicity and broader-than-normal receptive fields. Thus, auditory experiences during early postnatal development are important in shaping the functional development of auditory cortical representations of specific acoustic environments.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Zhang, LI (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.	lizhang@phy.ucsf.edu			NINDS NIH HHS [NS-10414, NS-34835] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AHISSAR E, 1992, SCIENCE, V257, P1412, DOI 10.1126/science.1529342; BLATCHLEY BJ, 1987, DEV BRAIN RES, V32, P75, DOI 10.1016/0165-3806(87)90140-4; BRUGGE JF, 1988, HEARING RES, V34, P127, DOI 10.1016/0378-5955(88)90100-1; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CLOPTON BM, 1976, J NEUROPHYSIOL, V39, P1081, DOI 10.1152/jn.1976.39.5.1081; CONDON CD, 1991, BEHAV NEUROSCI, V105, P416, DOI 10.1037/0735-7044.105.3.416; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Eggermont JJ, 1996, AUDIT NEUROSCI, V2, P309; EGGERMONT JJ, 1991, HEARING RES, V57, P45, DOI 10.1016/0378-5955(91)90073-I; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Fox K, 1996, PROG BRAIN RES, V108, P219, DOI 10.1016/S0079-6123(08)62542-X; FRIAUF E, 1992, EUR J NEUROSCI, V4, P798, DOI 10.1111/j.1460-9568.1992.tb00190.x; FROST DO, 1990, ANN NY ACAD SCI, V608, P92, DOI 10.1111/j.1749-6632.1990.tb48893.x; Gao E, 1998, P NATL ACAD SCI USA, V95, P12663, DOI 10.1073/pnas.95.21.12663; Gao EQ, 2000, P NATL ACAD SCI USA, V97, P8081, DOI 10.1073/pnas.97.14.8081; HARRISON RV, 1993, ACTA OTO-LARYNGOL, V113, P296, DOI 10.3109/00016489309135812; HEIL P, 1992, J COMP NEUROL, V322, P548, DOI 10.1002/cne.903220409; HORIKAWA J, 1988, P JPN ACAD B-PHYS, V64, P260, DOI 10.2183/pjab.64.260; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kilgard MP, 1998, SCIENCE, V279, P1714, DOI 10.1126/science.279.5357.1714; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; KING AJ, 1988, NATURE, V332, P73, DOI 10.1038/332073a0; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; KUHL PK, 1992, SCIENCE, V255, P606, DOI 10.1126/science.1736364; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; Pantev C, 1998, NATURE, V392, P811, DOI 10.1038/33918; Penn AA, 1999, PEDIATR RES, V45, P447, DOI 10.1203/00006450-199904010-00001; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; POON PWF, 1992, BRAIN RES, V585, P391, DOI 10.1016/0006-8993(92)91243-8; PUEL JL, 1987, BRAIN RES, V15, P179; RAJAN R, 1993, J COMP NEUROL, V338, P17, DOI 10.1002/cne.903380104; Rauschecker JP, 1999, TRENDS NEUROSCI, V22, P74, DOI 10.1016/S0166-2236(98)01303-4; RECANZONE GH, 1993, J NEUROSCI, V13, P87; Romand R, 1997, PROG NEUROBIOL, V51, P1, DOI 10.1016/S0301-0082(96)00043-3; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; SANES DH, 1983, SCIENCE, V221, P1183, DOI 10.1126/science.6612332; SANES DH, 1985, J NEUROSCI, V5, P1152; SCHMIDT JT, 1993, J NEUROBIOL, V24, P384, DOI 10.1002/neu.480240310; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Stanton SG, 1996, AUDIT NEUROSCI, V2, P97; Tallal P, 1996, SCIENCE, V271, P81, DOI 10.1126/science.271.5245.81; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; ZILLES K, 1990, CEREBRAL CORTEX RAT, P77	49	333	341	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1123	1130		10.1038/nn745	http://dx.doi.org/10.1038/nn745			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687817				2022-12-24	WOS:000171970900016
J	Harris, KD; Hirase, H; Leinekugel, X; Henze, DA; Buzsaki, G				Harris, KD; Hirase, H; Leinekugel, X; Henze, DA; Buzsaki, G			Temporal interaction between single spikes and complex spike bursts in hippocampal pyramidal cells	NEURON			English	Article							SODIUM-CHANNEL INACTIVATION; RAT HIPPOCAMPUS; SYNAPTIC PLASTICITY; NEURONS INVITRO; CA1; SYNAPSES; POTENTIATION; GENERATION; INDUCTION; PATTERNS	Cortical pyramidal cells fire single spikes and complex spike bursts, However, neither the conditions necessary for triggering complex spikes, nor their computational function are well understood, CA1 pyramidal cell burst activity was examined in behaving rats. The fraction of bursts was not reliably higher in place field centers, but rather in places where discharge frequency was 6-7 Hz. Burst probability was lower and bursts were shorter after recent spiking activity than after prolonged periods of silence (100 ms-1 s). Burst initiation probability and burst length were correlated with extracellular spike amplitude and with intracellular action potential rising slope. We suggest that bursts may function as "conditional synchrony detectors," signaling strong afferent synchrony after neuronal silence, and that single spikes triggered by a weak input may suppress bursts evoked by a subsequent strong input.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu	Harris, Kenneth/B-3469-2009; Leinekugel, Xavier/F-4034-2014; Leinekugel, Xavier/ABD-8347-2021; Hirase, Hajime/A-3709-2012	Leinekugel, Xavier/0000-0003-2878-3791; Hirase, Hajime/0000-0003-3806-6905; Buzsaki, Gyorgy/0000-0002-3100-4800; Harris, Kenneth/0000-0002-5930-6456	NIMH NIH HHS [MH12403, MH54671] Funding Source: Medline; NINDS NIH HHS [NS34994] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDREASEN M, 1995, J PHYSIOL-LONDON, V483, P421, DOI 10.1113/jphysiol.1995.sp020595; Azouz R, 1996, J PHYSIOL-LONDON, V492, P211, DOI 10.1113/jphysiol.1996.sp021302; BAIR W, 1994, J NEUROSCI, V14, P2870; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BUZSAKI G, 1981, EXP BRAIN RES, V43, P429; CONNORS BW, 1982, J NEUROPHYSIOL, V48, P1302, DOI 10.1152/jn.1982.48.6.1302; Csicsvari J, 1998, NEURON, V21, P179, DOI 10.1016/S0896-6273(00)80525-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gray CM, 1996, SCIENCE, V274, P109, DOI 10.1126/science.274.5284.109; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HENZE DA, 2001, IN PRESS NEUROSCIENC; HUERTA PT, 1993, NATURE, V364, P723, DOI 10.1038/364723a0; Jack J.J.B., 1975, ELECT CURRENT FLOW E; Jung HY, 1997, J NEUROSCI, V17, P6639; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P243, DOI 10.1152/jn.1961.24.3.243; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Livingstone MS, 1996, COLD SPRING HARB SYM, V61, P27; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Metzner W, 1998, J NEUROSCI, V18, P2283; Mickus T, 1999, ANN NY ACAD SCI, V868, P97, DOI 10.1111/j.1749-6632.1999.tb11280.x; MILES R, 1987, J PHYSIOL-LONDON, V388, P611, DOI 10.1113/jphysiol.1987.sp016634; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; Otto T, 1991, Hippocampus, V1, P181, DOI 10.1002/hipo.450010206; Paulsen O, 2000, CURR OPIN NEUROBIOL, V10, P172, DOI 10.1016/S0959-4388(00)00076-3; Pike FG, 1999, J PHYSIOL-LONDON, V518, P571, DOI 10.1111/j.1469-7793.1999.0571p.x; Pinsky P F, 1994, J Comput Neurosci, V1, P39, DOI 10.1007/BF00962717; Quirk MC, 1999, J NEUROSCI METH, V94, P41, DOI 10.1016/S0165-0270(99)00124-7; Quirk MC, 2001, J NEUROSCI, V21, P240, DOI 10.1523/JNEUROSCI.21-01-00240.2001; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Reinagel P, 1999, J NEUROPHYSIOL, V81, P2558, DOI 10.1152/jn.1999.81.5.2558; Skaggs W., 1993, ADV NEURAL INFORM PR, V5, P1030; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Su HL, 2001, J NEUROSCI, V21, P4173, DOI 10.1523/JNEUROSCI.21-12-04173.2001; THACH WT, 1968, J NEUROPHYSIOL, V31, P785, DOI 10.1152/jn.1968.31.5.785; Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998; Thomson AM, 2000, TRENDS NEUROSCI, V23, P305, DOI 10.1016/S0166-2236(00)01580-0; TRAUB RD, 1994, J PHYSIOL-LONDON, V481, P79, DOI 10.1113/jphysiol.1994.sp020420; WONG RKS, 1981, J NEUROPHYSIOL, V45, P86, DOI 10.1152/jn.1981.45.1.86	46	276	283	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					141	149		10.1016/S0896-6273(01)00447-0	http://dx.doi.org/10.1016/S0896-6273(01)00447-0			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604145	Bronze			2022-12-24	WOS:000171525200015
J	Phillips, GR; Huang, JK; Wang, Y; Tanaka, H; Shapiro, L; Zhang, WD; Shan, WS; Arndt, K; Frank, M; Gordon, RE; Gawinowicz, MA; Zhao, YM; Colman, DR				Phillips, GR; Huang, JK; Wang, Y; Tanaka, H; Shapiro, L; Zhang, WD; Shan, WS; Arndt, K; Frank, M; Gordon, RE; Gawinowicz, MA; Zhao, YM; Colman, DR			The presynaptic particle web: Ultrastructure, composition, dissolution, and reconstitution	NEURON			English	Article							SYNAPTIC VESICLE ENDOCYTOSIS; ACTIVE ZONES; NEUROTRANSMITTER RELEASE; POSTSYNAPTIC DENSITY; PROTEIN INTERACTIONS; HIPPOCAMPAL-NEURONS; CENTRAL SYNAPSES; N-CADHERIN; MEMBRANE; TRANSPORT	We report the purification of a presynaptic "particle web" consisting of similar to 50 nm pyramidally shaped particles interconnected by similar to 100 nm spaced fibrils. This is the "presynaptic grid" described in early EM studies. It is completely soluble above pH 8, but reconstitutes after dialysis against pH 6. Interestingly, reconstituted particles orient and bind PSDs asymmetrically. Mass spectrometry of purified web components reveals major proteins involved in the exocytosis of synaptic vesicles and in membrane retrieval. Our data support the idea that the CNS synaptic junction is organized by transmembrane adhesion molecules interlinked in the synaptic cleft, connected via their intracytoplasmic domains to the presynaptic web on one side and to the postsynaptic density on the other. The CNS synaptic junction may therefore be conceptualized as a complicated macromolecular scaffold that isostatically bridges two closely aligned plasma membranes.	CUNY Mt Sinai Sch Med, Dept Neurol, Corinne Goldsmith Dickinson Ctr Mutiple Sclerosis, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Fishberg Res Ctr Neurobiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, Program Struct Biol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Pathol, New York, NY 10029 USA; Columbia Univ, Howard Hughes Med Inst, Prot Chem Core Facil, New York, NY 10032 USA; Kratos Analyt Inc, Chestnut Ridge, NY 10977 USA; Osaka Univ, Sch Med, Dept Pharmacol, Suita, Osaka 565, Japan; Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Columbia University; Howard Hughes Medical Institute; Osaka University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Colman, DR (corresponding author), CUNY Mt Sinai Sch Med, Dept Neurol, Corinne Goldsmith Dickinson Ctr Mutiple Sclerosis, 1 Gustave L Levy Pl, New York, NY 10029 USA.	david.colman@mssm.edu	Huang, Jeffrey K./AAH-2418-2021; Huang, Jeffrey/J-5248-2017	Huang, Jeffrey K./0000-0003-0996-9451; Huang, Jeffrey/0000-0003-0996-9451	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041687, R01NS037731, R01NS020147] Funding Source: NIH RePORTER; NINDS NIH HHS [NS37731, NS20147, NS10836, NS041687] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Adam JC, 2000, MOL BIOL CELL, V11, P3123, DOI 10.1091/mbc.11.9.3123; Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Allison DW, 2000, J NEUROSCI, V20, P4545, DOI 10.1523/JNEUROSCI.20-12-04545.2000; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Benson DL, 1998, J NEUROSCI, V18, P6892; Biederer T, 2000, J BIOL CHEM, V275, P39803, DOI 10.1074/jbc.C000656200; BLOOM FE, 1968, J ULTRA MOL STRUCT R, V22, P361, DOI 10.1016/S0022-5320(68)90027-0; BURRY RW, 1980, BRAIN RES, V184, P85, DOI 10.1016/0006-8993(80)90588-0; CasesLanghoff C, 1996, EUR J CELL BIOL, V69, P214; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; COHEN RS, 1977, J CELL BIOL, V74, P181, DOI 10.1083/jcb.74.1.181; COLMAN DR, 1997, NEURITES CADHERINS S; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; Fenyo D, 1998, ELECTROPHORESIS, V19, P998, DOI 10.1002/elps.1150190615; Forgac M, 2000, J EXP BIOL, V203, P71; Foster M., 1897, TXB PHYSL 3; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; Garner JA, 1996, J NEUROCHEM, V67, P845; HAINFELD JF, 1977, J SUPRAMOL STR CELL, V6, P301, DOI 10.1002/jss.400060303; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; Harlow ML, 2001, NATURE, V409, P479, DOI 10.1038/35054000; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; Huntley GW, 1999, J COMP NEUROL, V407, P453; ICHIMURA T, 1988, J NEUROCYTOL, V17, P3, DOI 10.1007/BF01735373; Kennedy MB, 1998, BRAIN RES REV, V26, P243, DOI 10.1016/S0165-0173(97)00043-X; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KENNEDY MB, 1983, P NATL ACAD SCI-BIOL, V80, P7357, DOI 10.1073/pnas.80.23.7357; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LANDIS DMD, 1988, NEURON, V1, P201, DOI 10.1016/0896-6273(88)90140-7; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; Peters A., 1991, FINE STRUCTURE NERVO; PFENNINGER K, 1972, J NEUROCYTOL, V1, P129, DOI 10.1007/BF01099180; PHEND KD, 1995, J HISTOCHEM CYTOCHEM, V43, P283, DOI 10.1177/43.3.7532656; Rao A, 2000, NAT NEUROSCI, V3, P747, DOI 10.1038/77636; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6; SCHELLER RH, 1995, NEURON, V14, P893; SCHLOSSMAN DM, 1984, J CELL BIOL, V99, P723, DOI 10.1083/jcb.99.2.723; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Soltys BJ, 1999, TRENDS BIOCHEM SCI, V24, P174, DOI 10.1016/S0968-0004(99)01390-0; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; TRILLER A, 1985, J NEUROCYTOL, V14, P177, DOI 10.1007/BF01258446; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Vincent V, 1997, J BIOL CHEM, V272, P7062, DOI 10.1074/jbc.272.11.7062; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wang XL, 1999, J CELL BIOL, V147, P151, DOI 10.1083/jcb.147.1.151; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zinsmaier KE, 2001, BIOCHEM PHARMACOL, V62, P1, DOI 10.1016/S0006-2952(01)00648-7	62	360	368	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					63	77		10.1016/S0896-6273(01)00450-0	http://dx.doi.org/10.1016/S0896-6273(01)00450-0			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604139	Bronze			2022-12-24	WOS:000171525200009
J	Tobaben, S; Thakur, P; Fernandez-Chacon, R; Sudhof, TC; Rettig, J; Stahl, B				Tobaben, S; Thakur, P; Fernandez-Chacon, R; Sudhof, TC; Rettig, J; Stahl, B			A trimeric protein complex functions as a synaptic chaperone machine	NEURON			English	Article							CYSTEINE-STRING PROTEIN; TETRATRICOPEPTIDE REPEAT; ESCHERICHIA-COLI; VESICLE CYCLE; PURIFICATION; INTERACTS; DNAJ; OVEREXPRESSION; MODULATION; EXOCYTOSIS	We identify a chaperone complex composed of (1) the synaptic vesicle cysteine string protein (CSP), thought to function in neurotransmitter release, (2) the ubiquitous heat-shock protein cognate Hsc70, and (3) the SGT protein containing three tandem tetratricopeptide repeats. These three proteins interact with each other to form a stable trimeric complex that is located on the synaptic vesicle surface, and is disrupted in CSP knockout mice. The CSP/SGT/Hsc70 complex functions as an ATP-dependent chaperone that reactivates a denatured substrate. SGT overexpression in cultured neurons inhibits neurotransmitter release, suggesting that the CSP/SGT/Hsc70 complex is important for maintenance of a normal synapse. Taken together, our results identify a novel trimeric complex that functions as a synapse-specific chaperone machine.	Max Planck Inst Expt Med, D-37075 Gottingen, Germany; Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; Univ Saarland, Inst Physiol, D-66421 Homburg, Germany; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Bas Neurosci, Howard Hughes Med Inst, Dallas, TX 75235 USA	Max Planck Society; Max Planck Society; Saarland University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Stahl, B (corresponding author), Max Planck Inst Expt Med, Hermann Rein Str 3, D-37075 Gottingen, Germany.	stahl@em.mpg.de	Rettig, Jens/K-5103-2013; IBIS, FISIOLOGIA/O-9485-2015; Fernandez-Chacon, Rafael/E-6303-2010	Rettig, Jens/0000-0001-6160-3954; Fernandez-Chacon, Rafael/0000-0002-9845-9885				Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N; BRAUN JEA, 1995, NEUROPHARMACOLOGY, V34, P1361, DOI 10.1016/0028-3908(95)00114-L; Braun JEA, 1996, J BIOL CHEM, V271, P25989, DOI 10.1074/jbc.271.42.25989; Bronk P, 2001, NEURON, V30, P475, DOI 10.1016/S0896-6273(01)00292-6; Buchner E, 1997, TRENDS NEUROSCI, V20, P223, DOI 10.1016/S0166-2236(96)10082-5; Callahan MA, 1998, J VIROL, V72, P5189, DOI 10.1128/JVI.72.6.5189-5197.1998; Chamberlain LH, 1998, BIOCHEM J, V335, P205, DOI 10.1042/bj3350205; Chamberlain LH, 1997, BIOCHEM J, V322, P853, DOI 10.1042/bj3220853; Chamberlain LH, 1996, J BIOL CHEM, V271, P19514, DOI 10.1074/jbc.271.32.19514; Cziepluch C, 1998, J VIROL, V72, P4149, DOI 10.1128/JVI.72.5.4149-4156.1998; Dawson-Scully K, 2000, J NEUROSCI, V20, P6039, DOI 10.1523/JNEUROSCI.20-16-06039.2000; Fink AL, 1999, PHYSIOL REV, V79, P425, DOI 10.1152/physrev.1999.79.2.425; Graham ME, 2000, J NEUROSCI, V20, P1281; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; GUNDERSEN CB, 1992, NEURON, V9, P527, DOI 10.1016/0896-6273(92)90190-O; GUNDERSEN CB, 1994, J BIOL CHEM, V269, P19197; Hendrick JP, 1995, FASEB J, V9, P1559, DOI 10.1096/fasebj.9.15.8529835; HOHFELD J, 1995, CELL, V83, P589; JAHN R, 1985, P NATL ACAD SCI USA, V82, P4137, DOI 10.1073/pnas.82.12.4137; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lao GF, 2000, NEURON, V25, P191, DOI 10.1016/S0896-6273(00)80882-X; Leveque C, 1998, J BIOL CHEM, V273, P13488, DOI 10.1074/jbc.273.22.13488; Liu FH, 1999, J BIOL CHEM, V274, P34425, DOI 10.1074/jbc.274.48.34425; Magga JM, 2000, NEURON, V28, P195, DOI 10.1016/S0896-6273(00)00096-9; MASTROGIACOMO A, 1994, SCIENCE, V263, P981, DOI 10.1126/science.7906056; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Nie ZP, 1999, J NEUROSCI, V19, P10270; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Ranjan R, 1998, J NEUROSCI, V18, P956; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; SASAKI T, 1990, J BIOL CHEM, V265, P2333; Scales SJ, 1999, NATURE, V401, P123, DOI 10.1038/43582; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; Stahl B, 1999, EUR J CELL BIOL, V78, P375, DOI 10.1016/S0171-9335(99)80079-X; Stahl B, 1996, EMBO J, V15, P1799, DOI 10.1002/j.1460-2075.1996.tb00529.x; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UNGEWICKELL E, 1995, NATURE, V378, P632, DOI 10.1038/378632a0; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WALCHSOLIMENA C, 1995, J CELL BIOL, V128, P637, DOI 10.1083/jcb.128.4.637; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	50	167	174	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					987	999		10.1016/S0896-6273(01)00427-5	http://dx.doi.org/10.1016/S0896-6273(01)00427-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580898	Green Published, Bronze			2022-12-24	WOS:000171281300013
J	Boettiger, CA; Doupe, AJ				Boettiger, CA; Doupe, AJ			Developmentally restricted synaptic plasticity in a songbird nucleus required for song learning	NEURON			English	Article							LONG-TERM POTENTIATION; ADULT ZEBRA FINCHES; ANTERIOR FOREBRAIN; VISUAL-CORTEX; HETEROSYNAPTIC DEPRESSION; HIPPOCAMPAL-NEURONS; NEURAL SELECTIVITY; PYRAMIDAL CELLS; NMDA RECEPTORS; MESSENGER-RNA	We provide evidence here of long-term synaptic plasticity in a songbird forebrain area required for song learning, the lateral magnocellular nucleus of the anterior neostriatum (LMAN). Pairing postsynaptic bursts in LMAN principal neurons with stimulation of recurrent collateral synapses had two effects: spike timing- and NMDA receptor-dependent LTP of the recurrent synapses, and LTD of thalamic afferent synapses that were stimulated out of phase with the postsynaptic bursting. Both types of plasticity were restricted to the sensory critical period for song learning, consistent with a role for each in sensory learning. The properties of the observed plasticity are appropriate to establish recurrent circuitry within LMAN that reflects the spatiotemporal pattern of thalamic afferent activity evoked by tutor song. Such circuit organization could represent a tutor song memory suitable for reinforcing particular vocal sequences during sensorimotor learning.	Univ Calif San Francisco, Dept Physiol, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Boettiger, CA (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.		Boettiger, Charlotte A/J-9094-2012	Boettiger, Charlotte A/0000-0003-1853-1574	NATIONAL INSTITUTE OF MENTAL HEALTH [F31MH011896, R01MH055937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; NIMH NIH HHS [MH11896, MH55937, F31 MH011896] Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AAMODT SM, 1992, J NEUROBIOL, V23, P997, DOI 10.1002/neu.480230806; ABBOTT LF, 1996, CEREB CORTEX, V6, P416; Basham ME, 1999, J NEUROBIOL, V39, P155, DOI 10.1002/(SICI)1097-4695(199905)39:2<155::AID-NEU1>3.3.CO;2-J; Basham ME, 1996, NEUROBIOL LEARN MEM, V66, P295, DOI 10.1006/nlme.1996.0071; Bell CC, 1997, NATURE, V387, P278, DOI 10.1038/387278a0; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boettiger CA, 1998, J NEUROPHYSIOL, V79, P2615, DOI 10.1152/jn.1998.79.5.2615; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Bottjer SW, 1997, BRAIN BEHAV EVOLUT, V50, P284, DOI 10.1159/000113342; Bottjer SW, 1998, J NEUROBIOL, V37, P642, DOI 10.1002/(SICI)1097-4695(199812)37:4<642::AID-NEU12>3.0.CO;2-G; BOTTJER SW, 1989, J COMP NEUROL, V279, P312, DOI 10.1002/cne.902790211; Brainard MS, 2000, NATURE, V404, P762, DOI 10.1038/35008083; Buonomano DV, 1999, J NEUROSCI, V19, P6748, DOI 10.1523/JNEUROSCI.19-16-06748.1999; CAREW TJ, 1998, MECH RELATIONSHIPS D; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Dittman JS, 1997, J NEUROSCI, V17, P9048; Doupe AJ, 1997, J NEUROSCI, V17, P1147; EALES LA, 1989, ANIM BEHAV, V37, P507, DOI 10.1016/0003-3472(89)90097-3; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; EALES LA, 1987, ANIM BEHAV, V35, P1356, DOI 10.1016/S0003-3472(87)80008-8; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; GERSTNER W, 1993, BIOL CYBERN, V69, P503, DOI 10.1007/BF00199450; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Hebb Donald O., 1949, ORG BEHAV; Hensch TK, 1998, J NEUROSCI, V18, P2108; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hinde R.A., 1969, BIRD VOCALIZATIONS, P64; Hua SE, 1999, BIOL CYBERN, V81, P211, DOI 10.1007/s004220050557; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; Iyengar S, 1999, J NEUROSCI, V19, P6037, DOI 10.1523/JNEUROSCI.19-14-06037.1999; JOHNSON F, 1992, J COMP NEUROL, V326, P442, DOI 10.1002/cne.903260309; Johnston D., 1995, FDN CELLULAR NEUROPH; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Livingston FS, 2000, NAT NEUROSCI, V3, P482, DOI 10.1038/74857; Livingston FS, 1997, J NEUROSCI, V17, P8997; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOONEY R, 1991, P NATL ACAD SCI USA, V88, P4075, DOI 10.1073/pnas.88.10.4075; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; NIXDORFBERGWEILER BE, 1995, NEUROREPORT, V6, P1729, DOI 10.1097/00001756-199509000-00006; NIXDORFBERGWEILER BE, 1995, J NEUROBIOL, V27, P204, DOI 10.1002/neu.480270207; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; Ohno-Shosaku T, 2000, NEUROSCI RES, V36, P67, DOI 10.1016/S0168-0102(99)00110-8; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; OKUHATA S, 1987, BRAIN RES BULL, V18, P35, DOI 10.1016/0361-9230(87)90031-1; Roberts PD, 1999, J COMPUT NEUROSCI, V7, P235, DOI 10.1023/A:1008910918445; Rosen MJ, 2000, J NEUROSCI, V20, P5437, DOI 10.1523/JNEUROSCI.20-14-05437.2000; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Singh TD, 2000, J NEUROBIOL, V44, P82, DOI 10.1002/1097-4695(200007)44:1<82::AID-NEU8>3.0.CO;2-W; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Solis MM, 1999, J NEUROSCI, V19, P4559; Solis MM, 2000, NEURON, V25, P109, DOI 10.1016/S0896-6273(00)80875-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stark LL, 1999, J NEUROSCI, V19, P9107, DOI 10.1523/JNEUROSCI.19-20-09107.1999; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Troyer TW, 2000, J NEUROPHYSIOL, V84, P1224, DOI 10.1152/jn.2000.84.3.1224; VATES GE, 1995, P NATL ACAD SCI USA, V92, P5139, DOI 10.1073/pnas.92.11.5139; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	73	56	60	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					809	818		10.1016/S0896-6273(01)00403-2	http://dx.doi.org/10.1016/S0896-6273(01)00403-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567618	Bronze			2022-12-24	WOS:000171013300013
J	Graus-Porta, D; Blaess, S; Senften, M; Littlewood-Evans, A; Damsky, C; Huang, Z; Orban, P; Klein, R; Schittny, JC; Muller, U				Graus-Porta, D; Blaess, S; Senften, M; Littlewood-Evans, A; Damsky, C; Huang, Z; Orban, P; Klein, R; Schittny, JC; Muller, U			beta 1-class integrins regulate the development of laminae and folia in the cerebral and cerebellar cortex	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; CAJAL-RETZIUS CELLS; NEURONAL MIGRATION; MUSCULAR-DYSTROPHY; ALPHA-6 INTEGRINS; NEURITE OUTGROWTH; MICE; EXPRESSION; GENE; NEOCORTEX	Mice that lack all beta1-class integrins in neurons and glia die prematurely after birth with severe brain malformations. Cortical hemispheres and cerebellar folia fuse, and cortical laminae are perturbed. These defects result from disorganization of the cortical marginal zone, where beta1-class integrins regulate glial endfeet anchorage, meningeal basement membrane remodeling, and formation of the Cajal-Retzius cell layer. Surprisingly, beta1-class integrins are not essential for neuron-glia interactions and neuronal migration during corticogenesis. The phenotype of the beta1-deficient mice resembles pathological changes observed in human cortical dysplasias, suggesting that defective integrin-mediated signal transduction contributes to the development of some of these diseases.	Friedrich Miescher Inst, CH-4058 Basel, Switzerland; Univ Bern, Inst Anat, CH-3000 Bern, Switzerland; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Stomatol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA; Hosp San Raffaele, Sci Res Inst, I-20132 Milan, Italy; European Mol Biol Lab, D-69117 Heidelberg, Germany	Friedrich Miescher Institute for Biomedical Research; University of Bern; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; European Molecular Biology Laboratory (EMBL)	Muller, U (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.	umuller@fmi.ch	Blaess, Sandra/K-8503-2015; Schittny, Johannes C/U-2956-2017; Klein, Ruediger/C-6147-2008	Schittny, Johannes C/0000-0003-4025-3961; Klein, Ruediger/0000-0002-3109-0163; Blaess, Sandra/0000-0002-1898-4891	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS019090] Funding Source: NIH RePORTER; NINDS NIH HHS [NS19090] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anton ES, 1999, NEURON, V22, P277, DOI 10.1016/S0896-6273(00)81089-2; BARTSCH S, 1992, J NEUROSCI, V12, P736; Bayer, 1997, RELATION ITS EVOLUTI; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Brunstrom JE, 1997, NEURON, V18, P505, DOI 10.1016/S0896-6273(00)81250-7; BURRI PH, 1974, ANAT REC, V180, P77, DOI 10.1002/ar.1091800109; CAMPBELL MJ, 1989, J COMP NEUROL, V282, P191, DOI 10.1002/cne.902820204; Cooper JA, 1999, CELL, V97, P671, DOI 10.1016/S0092-8674(00)80778-3; Costell M, 1999, J CELL BIOL, V147, P1109, DOI 10.1083/jcb.147.5.1109; De Arcangelis A, 1999, DEVELOPMENT, V126, P3957; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Farinas I, 1996, NEURON, V17, P1065, DOI 10.1016/S0896-6273(00)80240-8; FISHMAN RB, 1993, J NEUROSCI, V13, P3485; FRASCA JM, 1965, J CELL BIOL, V25, P157, DOI 10.1083/jcb.25.1.157; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Goslin, 1998, CULTURING NERVE CELL, P419; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; HAUSMANN B, 1985, J COMP NEUROL, V241, P50, DOI 10.1002/cne.902410105; Hemler M. E., 1999, GUIDEBOOK EXTRACELLU, P196; Herrup K, 1997, ANNU REV NEUROSCI, V20, P61, DOI 10.1146/annurev.neuro.20.1.61; HIRSCH E, 1994, DEV DYNAM, V201, P108, DOI 10.1002/aja.1002010203; HUSMANN K, 1992, J CELL BIOL, V116, P1475, DOI 10.1083/jcb.116.6.1475; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LIESI P, 1985, EMBO J, V4, P1163, DOI 10.1002/j.1460-2075.1985.tb03755.x; Mao XH, 1999, P NATL ACAD SCI USA, V96, P5037, DOI 10.1073/pnas.96.9.5037; Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8; Mayer U, 1997, NAT GENET, V17, P318, DOI 10.1038/ng1197-318; MILNER R, 1994, DEVELOPMENT, V120, P3497; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; NAGATA I, 1990, DEV BRAIN RES, V52, P63, DOI 10.1016/0165-3806(90)90222-K; OSHEA KS, 1990, J CELL BIOL, V110, P1275, DOI 10.1083/jcb.110.4.1275; Pinkstaff JK, 1999, J NEUROSCI, V19, P1541; RAKIC P, 1970, J COMP NEUROL, V139, P473, DOI 10.1002/cne.901390407; Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; SIEVERS J, 1994, J NEUROCYTOL, V23, P135, DOI 10.1007/BF01183867; STEPHENS LE, 1995, GENE DEV, V9, P1883, DOI 10.1101/gad.9.15.1883; Taverna D, 1998, J CELL BIOL, V143, P849, DOI 10.1083/jcb.143.3.849; TOMASELLI KJ, 1990, NEURON, V5, P651, DOI 10.1016/0896-6273(90)90219-6; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; WEISENHORN DMV, 1994, DEV BRAIN RES, V82, P293; Zhang ZQ, 1998, J NEUROSCI, V18, P6928; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	56	447	460	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					367	379		10.1016/S0896-6273(01)00374-9	http://dx.doi.org/10.1016/S0896-6273(01)00374-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516395	Bronze, Green Published			2022-12-24	WOS:000170601000007
J	Golby, AJ; Gabrieli, JDE; Chiao, JY; Eberhardt, JL				Golby, AJ; Gabrieli, JDE; Chiao, JY; Eberhardt, JL			Differential responses in the fusiform region to same-race and other-race faces	NATURE NEUROSCIENCE			English	Article							HUMAN EXTRASTRIATE CORTEX; HEMISPHERIC-SPECIALIZATION; FUNCTIONAL MRI; TEMPORAL-LOBE; OWN-RACE; RECOGNITION; EXPERTISE; AMYGDALA; MEMORY; ACTIVATION	Many studies have shown that people remember faces of their own race better than faces of other races. We investigated the neural substrates of same-race memory superiority using functional MRI (fMRI). European-American (EA) and African-American (AA) males underwent fMRI while they viewed photographs of AA males, EA males and objects under intentional encoding conditions. Recognition memory was superior for same-race versus other-race faces. Individually defined areas in the fusiform region that responded preferentially to faces had greater response to same-race versus other-race faces. Across both groups, memory differences between same-race and other-race faces correlated with activation in left fusiform cortex and right parahippocampal and hippocampal areas. These results suggest that differential activation in fusiform regions contributes to same-race memory superiority.	Stanford Univ, Dept Radiol, Stanford, CA 94305 USA; Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University; Stanford University	Eberhardt, JL (corresponding author), Stanford Univ, Dept Radiol, Jordan Hall,Bldg 420, Stanford, CA 94305 USA.		Gabrieli, John/AAJ-2869-2020		NIMH NIH HHS [MH59940] Funding Source: Medline; NINDS NIH HHS [F32 NS10925-01, F32 NS010925, F32 NS010925-02, F32 NS010925-01] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010925] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; ANTHONY T, 1992, PERS SOC PSYCHOL B, V18, P296, DOI 10.1177/0146167292183005; Benton A L, 1968, Trans Am Neurol Assoc, V93, P38; BRIGHAM JC, 1985, J SOC ISSUES, V41, P139, DOI 10.1111/j.1540-4560.1985.tb01133.x; BRIGHAM JC, 1978, J APPL SOC PSYCHOL, V8, P306, DOI 10.1111/j.1559-1816.1978.tb00786.x; BRUYER R, 1992, B PSYCHONOMIC SOC, V30, P501; Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016; Canli T, 2000, J NEUROSCI, V20; CARROO AW, 1986, PERCEPT MOTOR SKILL, V62, P135, DOI 10.2466/pms.1986.62.1.135; CHANCE JE, 1982, J PSYCHOL, V112, P29, DOI 10.1080/00223980.1982.9923531; Chance JE., 1996, PSYCHOL ISSUES EYEWI, P153; DERENZI E, 1966, NEUROLOGY, V16, P145, DOI 10.1212/WNL.16.2_Part_1.145; DIAMOND R, 1986, J EXP PSYCHOL GEN, V115, P107, DOI 10.1037/0096-3445.115.2.107; ELLINWOO.EH, 1969, PSYCHIAT QUART, V43, P622, DOI 10.1007/BF01564275; FALLSHORE M, 1995, J EXP PSYCHOL LEARN, V21, P1608, DOI 10.1037/0278-7393.21.6.1608; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Gauthier I, 1999, NAT NEUROSCI, V2, P568, DOI 10.1038/9224; Glover GH, 1998, MAGN RESON MED, V39, P361, DOI 10.1002/mrm.1910390305; GROSS CG, 1969, SCIENCE, V166, P1303, DOI 10.1126/science.166.3910.1303; Hart AJ, 2000, NEUROREPORT, V11, P2351, DOI 10.1097/00001756-200008030-00004; Haxby JV, 1996, P NATL ACAD SCI USA, V93, P922, DOI 10.1073/pnas.93.2.922; HAXBY JV, 1994, J NEUROSCI, V14, P6336; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KAPUR N, 1995, CORTEX, V31, P99, DOI 10.1016/S0010-9452(13)80108-6; Katanoda K, 2000, NEUROPSYCHOLOGIA, V38, P1616, DOI 10.1016/S0028-3932(00)00069-5; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KOSSLYN SM, 1989, J EXP PSYCHOL HUMAN, V15, P723, DOI 10.1037/0096-1523.15.4.723; Kuskowski MA, 1999, NEUROIMAGE, V9, P599, DOI 10.1006/nimg.1999.0442; Levin DT, 2000, J EXP PSYCHOL GEN, V129, P559, DOI 10.1037//0096-3445.129.4.559; Logothetis NK, 2000, SPATIAL VISION, V13, P165, DOI 10.1163/156856800741180; MacWhinney B, 1997, SPATIAL VISION, V11, P99, DOI 10.1163/156856897X00113; MALPASS RS, 1969, J PERS SOC PSYCHOL, V13, P330, DOI 10.1037/h0028434; MILNER B, 1968, NEUROPSYCHOLOGIA, V6, P191, DOI 10.1016/0028-3932(68)90019-5; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Phelps EA, 1997, CURR BIOL, V7, pR311, DOI 10.1016/S0960-9822(06)00146-1; Phelps EA, 2000, J COGNITIVE NEUROSCI, V12, P729, DOI 10.1162/089892900562552; Phinney, 1992, J ADOLESCENT RES, V7, P156, DOI [10.1177/074355489272003, DOI 10.1177/074355489272003]; PUCE A, 1995, J NEUROPHYSIOL, V74, P1192, DOI 10.1152/jn.1995.74.3.1192; PUCE A, 1996, NEUROPHYSIOLOGY, V74, P1192; RHODES G, 1989, BRIT J PSYCHOL, V80, P313, DOI 10.1111/j.2044-8295.1989.tb02323.x; ROLLS ET, 1992, PHILOS T R SOC B, V335, P11, DOI 10.1098/rstb.1992.0002; SEECK M, 1993, ANN NEUROL, V34, P369, DOI 10.1002/ana.410340311; SERGENT J, 1992, BRAIN, V115, P15, DOI 10.1093/brain/115.1.15; Warrington E.K., 1967, CORTEX, V3, P317; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; YARMEY AD, 1971, PSYCHON SCI, V24, P286; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474	49	351	358	3	51	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					845	850		10.1038/90565	http://dx.doi.org/10.1038/90565			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	457KY	11477432				2022-12-24	WOS:000170137300019
J	Sala, C; Piech, V; Wilson, NR; Passafaro, M; Liu, GS; Sheng, M				Sala, C; Piech, V; Wilson, NR; Passafaro, M; Liu, GS; Sheng, M			Regulation of dendritic spine morphology and synaptic function by Shank and Homer	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; POSTSYNAPTIC DENSITY PROTEINS; HIPPOCAMPAL-NEURONS; BINDING-PROTEIN; MULTIDOMAIN PROTEINS; EXCITATORY SYNAPSES; DENTATE GYRUS; SMALL GTPASES; FAMILY	The Shank family of proteins interacts with NMDA receptor and metabotropic glutamate receptor complexes in the postsynaptic density (PSD). Targeted to the PSD by a PDZ-dependent mechanism, Shank promotes the maturation of dendritic spines and the enlargement of spine heads via its ability to recruit Homer to postsynaptic sites. Shank and Homer cooperate to induce accumulation of IP3 receptors in dendritic spines and formation of putative multisynapse spines. In addition, postsynaptic expression of Shank enhances presynaptic function, as measured by increased minifrequency and FM4-64 uptake. These data suggest a central role for the Shank scaffold in the structural and functional organization of the dendritic spine and synaptic junction.	Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; MIT, Dept Brain & Cognit Sci, RIKEN MIT Neurosci Res Ctr, Ctr Learning & Memory, Cambridge, MA 02139 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); RIKEN	Sheng, M (corresponding author), Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA.		Sala, Carlo/A-2493-2009	Sala, Carlo/0000-0003-0662-9523; Sheng, Morgan/0000-0002-8703-5366				BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; CALVERLEY RKS, 1990, BRAIN RES REV, V15, P215, DOI 10.1016/0165-0173(90)90002-6; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; DESMOND NL, 1988, BRAIN RES, V453, P308, DOI 10.1016/0006-8993(88)90171-0; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Ehlers MD, 1999, CURR BIOL, V9, pR848, DOI 10.1016/S0960-9822(00)80043-3; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Harris KM, 1999, P NATL ACAD SCI USA, V96, P12213, DOI 10.1073/pnas.96.22.12213; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HORNER CH, 1993, PROG NEUROBIOL, V41, P281, DOI 10.1016/0301-0082(93)90002-A; HOSOKAWA T, 1995, J NEUROSCI, V15, P5560; Kennedy MB, 1997, TRENDS NEUROSCI, V20, P264, DOI 10.1016/S0166-2236(96)01033-8; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Korkotian E, 1999, P NATL ACAD SCI USA, V96, P12068, DOI 10.1073/pnas.96.21.12068; Kreienkamp HJ, 2000, J BIOL CHEM, V275, P32387, DOI 10.1074/jbc.C000490200; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, HIPPOCAMPUS, V10, P555, DOI 10.1002/1098-1063(2000)10:5<555::AID-HIPO5>3.0.CO;2-Z; Muller D, 2000, HIPPOCAMPUS, V10, P596, DOI 10.1002/1098-1063(2000)10:5<596::AID-HIPO10>3.3.CO;2-P; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1997, HIPPOCAMPUS, V7, P489, DOI 10.1002/(SICI)1098-1063(1997)7:5<489::AID-HIPO5>3.0.CO;2-C; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; Sheng M, 2000, J CELL SCI, V113, P1851; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Shiraishi Y, 1999, J NEUROSCI, V19, P8389; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Tobaben S, 2000, J BIOL CHEM, V275, P36204, DOI 10.1074/jbc.M006448200; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Valtschanoff JG, 2001, J NEUROSCI, V21, P1211; Weed SA, 1998, J CELL SCI, V111, P2433; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8; Yao I, 1999, J BIOL CHEM, V274, P27463, DOI 10.1074/jbc.274.39.27463; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2; Zitzer H, 1999, J BIOL CHEM, V274, P18153, DOI 10.1074/jbc.274.26.18153; Zitzer H, 1999, J BIOL CHEM, V274, P32997, DOI 10.1074/jbc.274.46.32997	50	538	556	1	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					115	130		10.1016/S0896-6273(01)00339-7	http://dx.doi.org/10.1016/S0896-6273(01)00339-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498055	Bronze			2022-12-24	WOS:000170101100015
J	Todorovic, SM; Jevtovic-Todorovic, V; Meyenburg, A; Mennerick, S; Perez-Reyes, E; Romano, C; Olney, JW; Zorumski, CF				Todorovic, SM; Jevtovic-Todorovic, V; Meyenburg, A; Mennerick, S; Perez-Reyes, E; Romano, C; Olney, JW; Zorumski, CF			Redox modulation of T-type calcium channels in rat peripheral nociceptors	NEURON			English	Article							SENSORY NEURONS; PHARMACOLOGICAL PROPERTIES; CA-2+ CURRENT; GENE FAMILY; RECEPTORS; PAIN; HYPERALGESIA; INHIBITION; EXPRESSION; RESPONSES	Although T-type calcium channels were first described in sensory neurons, their function in sensory processing remains unclear. In isolated rat sensory neurons, we show that redox agents modulate T currents but not other voltage- and ligand-gated channels thought to mediate pain sensitivity. Similarly, redox agents modulate currents through Ca(v)3.2 recombinant channels. When injected into peripheral receptive fields, reducing agents, including the endogenous amino acid L-cysteine, induce thermal hyperalgesia. This hyperalgesia is blocked by the oxidizing agent 5,5'-dithio-bis-(2-nitrobenzoic acid) (DTNB) and the T channel antagonist mibefradil. DTNB alone and in combination with mibefradil induces thermal analgesia. Likewise, L-cysteine induces mechanical DTNB-sensitive hyperalgesia in peripheral receptive fields. These data strongly suggest a role for T channels in peripheral nociception. Redox sites on T channels in peripheral nociceptors could be important targets for agents that modify pain perception.	Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA; Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Virginia	Todorovic, SM (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.		Mennerick, Steven/O-2806-2017	Mennerick, Steven/0000-0003-0868-0664				AIZENMAN E, 1989, NEURON, V2, P1257, DOI 10.1016/0896-6273(89)90310-3; AUGHLIN TM, 1998, PAIN, V80, P37; Campbell DL, 1996, J GEN PHYSIOL, V108, P277, DOI 10.1085/jgp.108.4.277; CARBONE E, 1984, NATURE, V310, P501, DOI 10.1038/310501a0; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; CODERRE TJ, 1993, PAIN, V52, P259, DOI 10.1016/0304-3959(93)90161-H; Cook SP, 1997, NEUROPHARMACOLOGY, V36, P1303, DOI 10.1016/S0028-3908(97)00132-9; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; De Waard M, 1996, Ion Channels, V4, P41; Dolphin AC, 1999, J PHYSIOL-LONDON, V519, P35, DOI 10.1111/j.1469-7793.1999.0035o.x; Ertel S I, 1997, Expert Opin Investig Drugs, V6, P569, DOI 10.1517/13543784.6.5.569; Ertel SI, 1997, CARDIOVASC DRUG THER, V11, P723, DOI 10.1023/A:1007706022381; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HERRINGTON J, 1992, J NEUROPHYSIOL, V68, P213, DOI 10.1152/jn.1992.68.1.213; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; JACKSON DL, 1995, EUR J PHARMACOL, V284, P321, DOI 10.1016/0014-2999(95)00449-U; Jevtovic-Todorovic V, 1998, BRAIN RES, V781, P202, DOI 10.1016/S0006-8993(97)01247-X; Lawand NB, 1997, EUR J PHARMACOL, V324, P169, DOI 10.1016/S0014-2999(97)00072-1; Lee JH, 1999, J NEUROSCI, V19, P1912; LEVINE JD, 1993, J NEUROSCI, V13, P2273, DOI 10.1523/JNEUROSCI.13-06-02273.1993; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; Miller RJ, 1998, ANNU REV PHARMACOL, V38, P201, DOI 10.1146/annurev.pharmtox.38.1.201; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Reichling DB, 2000, NEURON, V26, P555, DOI 10.1016/S0896-6273(00)81191-5; SCROGGS RS, 1992, J PHYSIOL-LONDON, V445, P639, DOI 10.1113/jphysiol.1992.sp018944; Sluka KA, 1997, PAIN, V71, P165, DOI 10.1016/S0304-3959(97)03371-X; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Suliman ME, 1997, NEPHROL DIAL TRANSPL, V12, P2332, DOI 10.1093/ndt/12.11.2332; Talley EM, 1999, J NEUROSCI, V19, P1895; TANG LH, 1993, J PHYSIOL-LONDON, V465, P303, DOI 10.1113/jphysiol.1993.sp019678; TODOROVIC S, 1992, BRAIN RES, V585, P212, DOI 10.1016/0006-8993(92)91209-W; Todorovic SM, 1998, J NEUROPHYSIOL, V79, P240, DOI 10.1152/jn.1998.79.1.240; Todorovic SM, 2000, MOL PHARMACOL, V58, P98, DOI 10.1124/mol.58.1.98; WHITE G, 1989, P NATL ACAD SCI USA, V86, P6802, DOI 10.1073/pnas.86.17.6802; Zhou ST, 1996, NEUROREPORT, V7, P895, DOI 10.1097/00001756-199603220-00012	40	194	199	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					75	85		10.1016/S0896-6273(01)00338-5	http://dx.doi.org/10.1016/S0896-6273(01)00338-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498052	Bronze			2022-12-24	WOS:000170101100012
J	Hardingham, GE; Arnold, FJL; Bading, H				Hardingham, GE; Arnold, FJL; Bading, H			A calcium microdomain near NMDA receptors: on switch for ERK-dependent synapse-to-nucleus communication	NATURE NEUROSCIENCE			English	Article							DENDRITIC SPINES; GENE-EXPRESSION; PHOSPHORYLATION; NEURONS		MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Hardingham, Giles/0000-0002-7629-5314				BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; Deisseroth K, 1996, NEURON, V16, P89, DOI 10.1016/S0896-6273(00)80026-4; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Shibasaki F, 1996, NATURE, V382, P370, DOI 10.1038/382370a0; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Wu GY, 2001, P NATL ACAD SCI USA, V98, P2808, DOI 10.1073/pnas.051634198; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0	14	226	237	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					565	566		10.1038/88380	http://dx.doi.org/10.1038/88380			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369935				2022-12-24	WOS:000169061800007
J	Bae, K; Jin, XW; Maywood, ES; Hastings, MH; Reppert, SM; Weaver, DR				Bae, K; Jin, XW; Maywood, ES; Hastings, MH; Reppert, SM; Weaver, DR			Differential functions of mPer1, mPer2, and mPer3 in the SCN circadian clock	NEURON			English	Article							MAMMALIAN PERIOD GENES; SUPRACHIASMATIC NUCLEUS; MOLECULAR ANALYSIS; FEEDBACK LOOPS; MOUSE SCN; LIGHT; PHOSPHORYLATION; PROTEINS; EXPRESSION; INDUCTION	The role of mPer1 and mPer2 in regulating circadian rhythms was assessed by disrupting these genes. Mice homozygous for the targeted allele of either mPer1 or mPer2 had severely disrupted locomotor activity rhythms during extended exposure to constant darkness. Clock gene RNA rhythms were blunted in the suprachiasmatic nucleus of mPer2 mutant mice, but not of mPER1-deficient mice. Peak mPER and mCRY1 protein levels were reduced in both lines. Behavioral rhythms of mPer1/mPer3 and mPer2/mPer3 double-mutant mice resembled rhythms of mice with disruption of mPer1 or mPer2 alone, respectively, confirming the placement of mPer3 outside the core circadian clockwork. In contrast, mPer1/mPer2 double-mutant mice were immediately arrhythmic. Thus, mPER1 influences rhythmicity primarily through interaction with other clock proteins, while mPER2 positively regulates rhythmic gene expression, and there is partial compensation between products of these two genes.	Massachusetts Gen Hosp, Lab Dev Chronobiol, MassGen Hosp Children, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; MRC, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge; MRC Laboratory Molecular Biology	Weaver, DR (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA.	david.weaver@umassmed.edu	Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X; Hastings, Michael Harvey/0000-0001-8576-6651; Weaver, David/0000-0001-7941-6719	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD014427, R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER; NICHD NIH HHS [HD14427] Funding Source: Medline; NINDS NIH HHS [NS39303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama M, 1999, J NEUROSCI, V19, P1115; Albrecht U, 2001, J BIOL RHYTHM, V16, P100, DOI 10.1177/074873001129001791; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Bae K, 1998, MOL CELL BIOL, V18, P6142, DOI 10.1128/MCB.18.10.6142; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Camacho F, 2001, FEBS LETT, V489, P159, DOI 10.1016/S0014-5793(00)02434-0; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings M H, 1999, J Neurosci, V19, pRC11; Hida A, 2000, GENOMICS, V65, P224, DOI 10.1006/geno.2000.6166; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Horikawa K, 2000, J NEUROSCI, V20, P5867, DOI 10.1523/JNEUROSCI.20-15-05867.2000; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vielhaber E, 2000, MOL CELL BIOL, V20, P4888, DOI 10.1128/MCB.20.13.4888-4899.2000; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wakamatsu H, 2001, NEUROREPORT, V12, P127, DOI 10.1097/00001756-200101220-00033; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yagita K, 2000, GENE DEV, V14, P1353; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	44	654	691	4	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					525	536		10.1016/S0896-6273(01)00302-6	http://dx.doi.org/10.1016/S0896-6273(01)00302-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395012	Bronze			2022-12-24	WOS:000168962000023
J	Tropepe, V; Hitoshi, S; Sirard, C; Mak, TW; Rossant, J; van der Kooy, D				Tropepe, V; Hitoshi, S; Sirard, C; Mak, TW; Rossant, J; van der Kooy, D			Direct neural fate specification from embryonic stem cells: A primitive mammalian neural stem cell stage acquired through a default mechanism	NEURON			English	Article							IN-VITRO DIFFERENTIATION; ES CELLS; SPEMANN ORGANIZER; SECRETED FACTOR; XENOPUS-LAEVIS; MOUSE EMBRYOS; CHICK-EMBRYO; INDUCTION; GENE; EXPRESSION	Little is known about how neural stem cells are formed initially during development. We investigated whether a default mechanism of neural specification could regulate acquisition of neural stem cell identity directly from embryonic stem (ES) cells. ES cells cultured in defined, low-density conditions readily acquire a neural identity. We characterize a novel primitive neural stem cell as a component of neural lineage specification that is negatively regulated by TGF beta -related signaling. Primitive neural stem cells have distinct growth factor requirements, express neural precursor markers, generate neurons and glia in vitro, and have neural and non-neural lineage potential in vivo. These results are consistent with a default mechanism for neural fate specification and support a model whereby definitive neural stem cell formation is preceded by a primitive neural stem cell stage during neural lineage commitment.	Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Med Biophys, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto	van der Kooy, D (corresponding author), Univ Toronto, Dept Anat & Cell Biol, 100 Coll St, Toronto, ON M5S 1A8, Canada.							Acampora D, 1998, DEVELOPMENT, V125, P5091; ARCECI RJ, 1993, MOL CELL BIOL, V13, P2235, DOI 10.1128/MCB.13.4.2235; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BEDDINGTON RSP, 1992, DEVELOPMENT, P157; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; Belo JA, 1997, MECH DEVELOP, V68, P45, DOI 10.1016/S0925-4773(97)00125-1; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Elefanty AG, 1997, BLOOD, V90, P1435, DOI 10.1182/blood.V90.4.1435.1435_1435_1447; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fainsod A, 1997, MECH DEVELOP, V63, P39, DOI 10.1016/S0925-4773(97)00673-4; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; FRAICHARD A, 1995, J CELL SCI, V108, P3181; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GeorgeWeinstein M, 1996, DEV BIOL, V173, P279, DOI 10.1006/dbio.1996.0023; Glinka A, 1997, NATURE, V389, P517, DOI 10.1038/39092; GODSAVE SF, 1989, DEV BIOL, V134, P486, DOI 10.1016/0012-1606(89)90122-X; Grinblat Y, 1998, DEVELOPMENT, V125, P4403; GRUNZ H, 1989, CELL DIFFER DEV, V28, P211, DOI 10.1016/0922-3371(89)90006-3; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HemmatiBrivanlou A, 1997, ANNU REV NEUROSCI, V20, P43, DOI 10.1146/annurev.neuro.20.1.43; HEMMATIBRIVANLOU A, 1994, CELL, V77, P273, DOI 10.1016/0092-8674(94)90319-0; Hoodless PA, 1997, DEV GENES EVOL, V207, P19, DOI 10.1007/s004270050088; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; KISHIMOTO T, 1994, CELL, V76, P253, DOI 10.1016/0092-8674(94)90333-6; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Li JX, 2000, GENE DEV, V14, P464; Martens DJ, 2000, J NEUROSCI, V20, P1085, DOI 10.1523/JNEUROSCI.20-03-01085.2000; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; Mehler MF, 1997, TRENDS NEUROSCI, V20, P357, DOI 10.1016/S0166-2236(96)01045-4; Mokry J, 1998, Acta Medica (Hradec Kralove), V41, P73; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Nagy A., 1993, Gene targeting: a practical approach., P147; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; O'Shea KS, 1999, ANAT RECORD, V257, P32, DOI 10.1002/(SICI)1097-0185(19990215)257:1<32::AID-AR6>3.0.CO;2-2; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Oliver G, 1995, DEVELOPMENT, V121, P4045; Oppenheimer JM, 1936, P SOC EXP BIOL MED, V34, P461; Pearce JJH, 1999, DEV BIOL, V209, P98, DOI 10.1006/dbio.1999.9240; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; SATO SM, 1989, DEV BIOL, V134, P263, DOI 10.1016/0012-1606(89)90096-1; Seaberg R. M., 1999, Society for Neuroscience Abstracts, V25, P527; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Sirard C, 1998, GENE DEV, V12, P107, DOI 10.1101/gad.12.1.107; SMITH WC, 1993, NATURE, V361, P547, DOI 10.1038/361547a0; SOLTER D, 1978, P NATL ACAD SCI USA, V75, P5565, DOI 10.1073/pnas.75.11.5565; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Stanford WL, 1998, BLOOD, V92, P4622, DOI 10.1182/blood.V92.12.4622.424k23_4622_4631; Streit A, 1998, DEVELOPMENT, V125, P507; STRUBING C, 1995, MECH DEVELOP, V53, P275, DOI 10.1016/0925-4773(95)00446-8; TOHYAMA T, 1992, LAB INVEST, V66, P303; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; van der Kooy D, 2000, SCIENCE, V287, P1439, DOI 10.1126/science.287.5457.1439; Waddington CH, 1933, ROUX ARCH DEV BIOL, V128, P522, DOI 10.1007/BF00649863; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wilson PA, 1997, DEVELOPMENT, V124, P3177; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Wrana JL, 2000, CELL, V100, P189, DOI 10.1016/S0092-8674(00)81556-1; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	70	567	617	0	34	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					65	78		10.1016/S0896-6273(01)00263-X	http://dx.doi.org/10.1016/S0896-6273(01)00263-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343645	Bronze			2022-12-24	WOS:000168412900011
J	Kefalov, VJ; Crouch, RK; Cornwall, MC				Kefalov, VJ; Crouch, RK; Cornwall, MC			Role of noncovalent binding of 11-cis-retinal to opsin in dark adaptation of rod and cone photoreceptors	NEURON			English	Article							VISUAL-PIGMENT; RETINAL CONES; LIGHT ADAPTATION; OUTER SEGMENTS; SALAMANDER; RHODOPSIN; ACTIVATION; TRANSDUCTION; MECHANISMS; OCCUPANCY	Regeneration of visual pigments of vertebrate rod and cone photoreceptors occurs by the initial noncovalent binding of 11-cis-retinal to opsin, followed by the formation of a covalent bond between the ligand and the protein. Here, we show that the noncovalent interaction between 11-cis-retinal and opsin affects the rate of dark adaptation. In rods, 11-cis-retinal produces a transient activation of the phototransduction cascade that precedes sensitivity recovery, thus slowing dark adaptation. In cones, 11-cis-retinal immediately deactivates phototransduction, Thus, the initial binding of the same ligand to two very similar G protein receptors, the rod and cone opsins, activates one and deactivates the other, contributing to the remarkable difference in the rates of rod and cone dark adaptation.	Boston Univ, Sch Med, Dept Physiol, Boston, MA 02118 USA; Med Univ S Carolina, Dept Ophthalmol, Charleston, SC 29425 USA	Boston University; Medical University of South Carolina	Kefalov, VJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.			Kefalov, Vladimir/0000-0002-1659-008X; Cornwall, M./0000-0002-0847-939X	NEI NIH HHS [EY01157, EY04939] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY004939, R01EY001157] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P589; BAYLOR DA, 1980, J PHYSIOL-LONDON, V309, P591, DOI 10.1113/jphysiol.1980.sp013529; BENNETT N, 1980, EUR J BIOCHEM, V111, P99; BOWNDS D, 1967, NATURE, V216, P1178, DOI 10.1038/2161178a0; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; CORNWALL MC, 1995, J GEN PHYSIOL, V106, P543, DOI 10.1085/jgp.106.3.543; Cornwall MC, 2000, METHOD ENZYMOL, V316, P224; CORNWALL MC, 1990, J GEN PHYSIOL, V96, P345, DOI 10.1085/jgp.96.2.345; DAEMEN FJM, 1978, NATURE, V276, P847, DOI 10.1038/276847a0; DAEMEN FJM, 1974, EXP EYE RES, V18, P97, DOI 10.1016/0014-4835(74)90047-5; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; DOUKAS AG, 1978, BIOCHEMISTRY-US, V17, P2430, DOI 10.1021/bi00605a028; Hecht S, 1937, J GEN PHYSIOL, V20, P831, DOI 10.1085/jgp.20.6.831; HODGKIN AL, 1988, J PHYSIOL-LONDON, V403, P439, DOI 10.1113/jphysiol.1988.sp017258; HODGKIN AL, 1985, J PHYSIOL-LONDON, V358, P447, DOI 10.1113/jphysiol.1985.sp015561; IMAI H, 1995, BIOCHEMISTRY-US, V34, P10525, DOI 10.1021/bi00033a026; Imai H, 1997, BIOCHEMISTRY-US, V36, P12773, DOI 10.1021/bi970809x; JIN J, 1993, NEURON, V11, P513, DOI 10.1016/0896-6273(93)90155-K; JONES GJ, 1989, P NATL ACAD SCI USA, V86, P9606, DOI 10.1073/pnas.86.23.9606; JONES GJ, 1993, J GEN PHYSIOL, V102, P483, DOI 10.1085/jgp.102.3.483; JONES GJ, 1995, J PHYSIOL-LONDON, V487, P441, DOI 10.1113/jphysiol.1995.sp020891; Kefalov VJ, 1999, J GEN PHYSIOL, V113, P491, DOI 10.1085/jgp.113.3.491; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; MATSUMOTO H, 1975, NATURE, V258, P523, DOI 10.1038/258523a0; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; NAKATANI K, 1995, J PHYSIOL-LONDON, V484, P69, DOI 10.1113/jphysiol.1995.sp020648; OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932; PEPPERBERG DR, 1978, J GEN PHYSIOL, V71, P369, DOI 10.1085/jgp.71.4.369; PERRY RJ, 1991, J PHYSIOL-LONDON, V433, P561, DOI 10.1113/jphysiol.1991.sp018444; PERRY RJ, 1991, J PHYSIOL-LONDON, V436, P771; Press W. H., 1992, ART SCI COMPUTING; Rieke F, 2000, NEURON, V26, P181, DOI 10.1016/S0896-6273(00)81148-4; ROBINSON PR, 1992, NEURON, V9, P719, DOI 10.1016/0896-6273(92)90034-B; Tan Q, 1998, J AM CHEM SOC, V120, P12357, DOI 10.1021/ja9827752; WALD G, 1955, J GEN PHYSIOL, V38, P623, DOI 10.1085/jgp.38.5.623; Xu L, 1998, Mol Vis, V4, P10; YAU KW, 1984, NATURE, V311, P661, DOI 10.1038/311661a0; YOSHIKAMI S, 1982, METHOD ENZYMOL, V81, P447	39	53	59	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					749	755		10.1016/S0896-6273(01)00249-5	http://dx.doi.org/10.1016/S0896-6273(01)00249-5			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301033	Bronze			2022-12-24	WOS:000167868900023
J	Mansour, M; Nagarajan, N; Nehring, RB; Clements, JD; Rosenmund, C				Mansour, M; Nagarajan, N; Nehring, RB; Clements, JD; Rosenmund, C			Heteromeric AMPA receptors assemble with a preferred subunit stoichiometry and spatial arrangement	NEURON			English	Article							GLUTAMATE BINDING-SITE; INWARD RECTIFICATION; CALCIUM PERMEABILITY; HIPPOCAMPAL-NEURONS; KAINATE RECEPTORS; CA2+ PERMEABILITY; CHANNELS; DESENSITIZATION; CONDUCTANCE; MECHANISMS	AMPA receptors are thought to be a tetrameric assembly of the subunits GluR1-4. We have examined whether two coexpressed subunits (GluR1/2) combine at random to form channels, or preferentially assemble with a specific stoichiometry and spatial configuration. The subunits carried markers controlling ion permeation and desensitization, and these properties were monitored as a function of relative expression level and subunit composition. Homomeric receptors assembled stochastically while heteromeric receptors preferentially formed with a stoichiometry of two GluR1 and two GluR2 subunits, and with identical subunits positioned on opposite sides of the channel pore. This structure will predominate if GluR1 binds to GluR2 more rapidly during receptor assembly than other subunit combinations. The practical outcome of selective heteromeric assembly is a more homogenous receptor population in vivo.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37070 Gottingen, Germany; Australian Natl Univ, Div Biochem & Mol Biol, Canberra, ACT 0200, Australia	Max Planck Society; Australian National University	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37070 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CLEMENTS JD, 1991, NEURON, V7, P605, DOI 10.1016/0896-6273(91)90373-8; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; GEIGER JRP, 1995, NEURON, V15, P193, DOI 10.1016/0896-6273(95)90076-4; Hall RA, 1997, J NEUROCHEM, V68, P625; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; IINO M, 1994, NEUROSCI LETT, V173, P14, DOI 10.1016/0304-3940(94)90139-2; JONAS P, 1995, NEURON, V15, P987, DOI 10.1016/0896-6273(95)90087-X; JONAS P, 1994, NEURON, V12, P1281, DOI 10.1016/0896-6273(94)90444-8; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; NEHER E, 1977, ANNU REV BIOPHYS BIO, V6, P345, DOI 10.1146/annurev.bb.06.060177.002021; RAMAN IM, 1994, J NEUROSCI, V14, P4998; Robert A, 2001, J NEUROSCI, V21, P5574, DOI 10.1523/JNEUROSCI.21-15-05574.2001; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Seeburg PH, 1998, BRAIN RES REV, V26, P217, DOI 10.1016/S0165-0173(97)00062-3; Smith TC, 2000, J NEUROSCI, V20, P2073; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Takamori S, 2000, NATURE, V407, P189, DOI 10.1038/35025070; Thalhammer A, 1999, NEUROSCI LETT, V277, P161, DOI 10.1016/S0304-3940(99)00885-X; TRAYNELIS SF, 1993, NEURON, V11, P279, DOI 10.1016/0896-6273(93)90184-S; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Washburn MS, 1997, J NEUROSCI, V17, P9393; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; YAMADA KA, 1993, J NEUROSCI, V13, P3904	39	172	179	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					841	853		10.1016/S0896-6273(01)00520-7	http://dx.doi.org/10.1016/S0896-6273(01)00520-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738030	Green Published, Bronze			2022-12-24	WOS:000172700700011
J	Rattner, A; Smallwood, PM; Williams, J; Cooke, C; Savchenko, A; Lyubarsky, A; Pugh, EN; Nathans, J				Rattner, A; Smallwood, PM; Williams, J; Cooke, C; Savchenko, A; Lyubarsky, A; Pugh, EN; Nathans, J			A photoreceptor-specific cadherin is essential for the structural integrity of the outer segment and for photoreceptor survival	NEURON			English	Article							DISK MEMBRANE MORPHOGENESIS; FIBRILLARY ACIDIC PROTEIN; RETINAL DEGENERATION; ACTIVATION STEPS; MULLER CELLS; MYOSIN VIIA; KINESIN-II; MOUSE; ROD; LOCALIZATION	A cadherin family member, prCAD, was identified in retina cDNA by subtractive hybridization and high throughput sequencing. prCAD is expressed only in retinal photoreceptors, and the prCAD protein is localized to the base of the outer segment of both rods and cones. In prCAD(-/-) mice, outer segments are disorganized and fragmented, and there is progressive death of photoreceptor cells. prCAD is unlikely to be involved in protein trafficking between inner and outer segments, since phototransduction proteins appear to be correctly localized and the light responses of both rods and cones are only modestly compromised in prCAD(-/-) mice. These experiments imply a highly specialized cell biological function for prCAD and suggest that localized adhesion activity is essential for outer segment integrity.	Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Ophthalmol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Microscope Facil, Baltimore, MD 21205 USA; Univ Penn, Sch Med, Dept Ophthalmol, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania	Nathans, J (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	jnathans@jhmi.edu		Rattner, Amir/0000-0001-9542-6212; Nathans, Jeremy/0000-0001-8106-5460	NATIONAL EYE INSTITUTE [R01EY002660] Funding Source: NIH RePORTER	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Angst BD, 2001, J CELL SCI, V114, P629; ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Beech PL, 1996, J CELL SCI, V109, P889; CEPEK KL, 1994, NATURE, V372, P190, DOI 10.1038/372190a0; CHANG GQ, 1993, NEURON, V11, P595, DOI 10.1016/0896-6273(93)90072-Y; Clarke G, 2000, NAT GENET, V25, P67, DOI 10.1038/75621; deRaad S, 1996, OPHTHALMIC RES, V28, P99, DOI 10.1159/000267881; Goodyear R, 1999, J NEUROSCI, V19, P3761; Hagstrom SA, 1999, INVEST OPHTH VIS SCI, V40, P2795; HARLOW E, 1988, ANTIBODIES PRACTICAL; Haverkamp S, 2000, J COMP NEUROL, V424, P1; Hong DH, 2001, J BIOL CHEM, V276, P12091, DOI 10.1074/jbc.M009351200; Hong DH, 2000, P NATL ACAD SCI USA, V97, P3649, DOI 10.1073/pnas.060037497; Honjo M, 2000, INVEST OPHTH VIS SCI, V41, P546; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; LAMB TD, 1992, J PHYSIOL-LONDON, V449, P719, DOI 10.1113/jphysiol.1992.sp019111; Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5; Li TS, 1996, P NATL ACAD SCI USA, V93, P14176, DOI 10.1073/pnas.93.24.14176; Liu XR, 1999, J NEUROSCI, V19, P6267; Liu XR, 1997, CELL MOTIL CYTOSKEL, V37, P240, DOI 10.1002/(SICI)1097-0169(1997)37:3<240::AID-CM6>3.3.CO;2-2; LOLLEY RN, 1994, INVEST OPHTH VIS SCI, V35, P358; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; Molday RS, 1998, INVEST OPHTH VIS SCI, V39, P2493; MURESAN V, 1993, J CELL SCI, V104, P1229; Muresan V, 1997, EXP EYE RES, V64, P895, DOI 10.1006/exer.1996.0261; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777; Pennesi ME, 1998, INVEST OPHTH VIS SCI, V39, P2148; PORTERACAILLIAU C, 1994, P NATL ACAD SCI USA, V91, P974, DOI 10.1073/pnas.91.3.974; Pugh EN, 1998, PHOTOSTASIS AND RELATED PHENOMENA, P93, DOI 10.1007/978-1-4899-1549-8_7; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; SANYAL S, 1980, J COMP NEUROL, V194, P193, DOI 10.1002/cne.901940110; SEMPLEROWLAND SL, 1991, J COMP NEUROL, V305, P582, DOI 10.1002/cne.903050405; Senzaki K, 1999, CELL, V99, P635, DOI 10.1016/S0092-8674(00)81552-4; Smith NP, 1997, VISION RES, V37, P2943, DOI 10.1016/S0042-6989(97)00094-1; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307; SUNG CH, 1994, J NEUROSCI, V14, P5818; Tepass U, 2000, NAT REV MOL CELL BIO, V1, P91, DOI 10.1038/35040042; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TRAVIS GH, 1992, NEURON, V9, P113, DOI 10.1016/0896-6273(92)90226-4; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724; Wilkinson DG, 1992, SITU HYBRIDIZATION P; WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202; Wohrn JCP, 1998, J COMP NEUROL, V396, P20; Wyszecki G, 1982, COLOR SCI, Vsecond; Yagi T, 2000, GENE DEV, V14, P1169; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303	53	99	107	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					775	786		10.1016/S0896-6273(01)00531-1	http://dx.doi.org/10.1016/S0896-6273(01)00531-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738025	Bronze			2022-12-24	WOS:000172700700006
J	Zilberberg, N; Ilan, N; Goldstein, SAN				Zilberberg, N; Ilan, N; Goldstein, SAN			KCNKO: Opening and closing the 2-P-domain potassium leak channel entails "C-type" gating of the outer pore	NEURON			English	Article							PIG VENTRICULAR MYOCYTES; RECTIFIER K+ CHANNEL; SLOW INACTIVATION; MYELINATED NERVE; EXTRACELLULAR K+; MODULATION; REGION; TASK-1; ION; SELECTIVITY	Essential to nerve and muscle function, little is known about how potassium leak channels operate. KCNKO opens and closes in a kinase-dependent fashion. Here, the transition is shown to correspond to changes in the outer aspect of the ion conduction pore. Voltage-gated potassium (VGK) channels open and close via an internal gate; however, they also have an outer pore gate that produces "C-type" inactivation. While KCNKO does not inactivate, KCNKO and VGK channels respond in like manner to outer pore blockers, potassium, mutations, and chemical modifiers. Structural relatedness is confirmed: VGK residues that come close during C-type gating predict KCNKO sites that crosslink (after mutation to cysteine) to yield channels controlled by reduction and oxidization. We conclude that similar outer pore gates mediate KCNKO opening and closing and VGK channel C-type inactivation despite their divergent structures and physiological roles.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 333 Cedar St, New Haven, CT 06536 USA.		Zilberberg, Noam/F-2005-2012; Goldstein, Steven A./E-9817-2015	Zilberberg, Noam/0000-0002-7848-2391; Goldstein, Steven A./0000-0001-5207-5061				Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; BACKX PH, 1993, CIRC RES, V72, P890, DOI 10.1161/01.RES.72.4.890; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Bockenhauer D, 2001, NAT NEUROSCI, V4, P486, DOI 10.1038/87434; Bowlby MR, 1997, J GEN PHYSIOL, V110, P601, DOI 10.1085/jgp.110.5.601; BOYLE WA, 1992, J GEN PHYSIOL, V100, P1041, DOI 10.1085/jgp.100.6.1041; Buckler KJ, 2000, J PHYSIOL-LONDON, V525, P135, DOI 10.1111/j.1469-7793.2000.00135.x; CHOL KL, 1991, P NATL ACAD SCI USA, V88, P5092; Colquhoun David, 1995, P483; Craven KB, 2001, BIOPHYS J, V80, p631A; Czirjak G, 2000, MOL ENDOCRINOL, V14, P863, DOI 10.1210/me.14.6.863; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; DEMO SD, 1991, NEURON, V7, P743, DOI 10.1016/0896-6273(91)90277-7; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Fadool DA, 1997, J NEUROPHYSIOL, V78, P1563, DOI 10.1152/jn.1997.78.3.1563; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstein SAN, 1999, P NATL ACAD SCI USA, V96, P318; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; GRISSMER S, 1989, BIOPHYS J, V55, P203, DOI 10.1016/S0006-3495(89)82793-6; Heath BM, 2000, J PHYSIOL-LONDON, V522, P391, DOI 10.1111/j.1469-7793.2000.t01-2-00391.x; Hille B, 1975, Membranes, V3, P255; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HODGKIN AL, 1952, J PHYSIOL-LONDON, V116, P424, DOI 10.1113/jphysiol.1952.sp004716; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; KOH DS, 1992, J MEMBRANE BIOL, V130, P149; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Loots E, 2000, J GEN PHYSIOL, V116, P623, DOI 10.1085/jgp.116.5.623; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; Lopes CMB, 2001, J BIOL CHEM, V276, P24449, DOI 10.1074/jbc.C100184200; Lopes CMB, 2000, J BIOL CHEM, V275, P16969, DOI 10.1074/jbc.M001948200; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Miller AG, 1996, NEURON, V16, P853, DOI 10.1016/S0896-6273(00)80105-1; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Ortega-Saenz P, 2000, J GEN PHYSIOL, V116, P181, DOI 10.1085/jgp.116.2.181; PARDO LA, 1992, P NATL ACAD SCI USA, V89, P2466, DOI 10.1073/pnas.89.6.2466; RETTIG J, 1994, NATURE, V369, P289, DOI 10.1038/369289a0; SCHMIDT H, 1966, PFLUG ARCH GES PHYS, V287, P311, DOI 10.1007/BF00363245; Sesti F, 2001, BIOPHYS J, V80, p446A; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; WU JV, 1993, J NEUROSCI, V13, P5153, DOI 10.1523/JNEUROSCI.13-12-05153.1993; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; YUE DT, 1988, PFLUG ARCH EUR J PHY, V413, P127, DOI 10.1007/BF00582522; ZAGOTTA WN, 1990, SCIENCE, V250, P568, DOI 10.1126/science.2122520; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721	64	66	66	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					635	648		10.1016/S0896-6273(01)00503-7	http://dx.doi.org/10.1016/S0896-6273(01)00503-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719204	Bronze			2022-12-24	WOS:000172363900010
J	Wadiche, JI; Jahr, CE				Wadiche, JI; Jahr, CE			Multivesicular release at climbing fiber-Purkinje cell synapses	NEURON			English	Article							FROG NEUROMUSCULAR-JUNCTION; GLUTAMATE-RECEPTOR CHANNELS; RAT CEREBELLAR SLICES; BERGMANN GLIAL-CELLS; TRANSMITTER RELEASE; TIME-COURSE; SYNAPTIC CURRENTS; EXTRASYNAPTIC GLUTAMATE; HIPPOCAMPAL SYNAPSES; EXCITATORY SYNAPSES	Synapses driven by action potentials are thought to release transmitter in an all-or-none fashion; either one synaptic vesicle undergoes exocytosis, or there is no release. We have estimated the glutamate concentration transient at climbing fiber synapses on Purkinje cells by measuring the inhibition of excitatory postsynaptic currents (EPSCs) produced by a low-affinity competitive antagonist of AMPA receptors, gamma -DGG. The results, together with simulations using a kinetic model of the AMPA receptor, suggest that the peak glutamate concentration at this synapse is dependent on release probability but is not affected by pooling of transmitter released from neighboring synapses. We propose that the mechanism responsible for the elevated glutamate concentration at this synapse is the simultaneous release of multiple vesicles per site.	Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Jahr, CE (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474,3181 SW Sam Jackson Pk Rd, Portland, OR 97201 USA.			Wadiche, Jacques/0000-0001-8180-2061	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS040056, R01NS040056, F32NS011095] Funding Source: NIH RePORTER; NINDS NIH HHS [NS40056, NS11095] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; ALVAREZLEEFMANS FJ, 1979, J PHYSIOL-LONDON, V294, P387, DOI 10.1113/jphysiol.1979.sp012936; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BARRETT EF, 1972, J PHYSIOL-LONDON, V227, P691, DOI 10.1113/jphysiol.1972.sp010054; Bergles DE, 1997, P NATL ACAD SCI USA, V94, P14821, DOI 10.1073/pnas.94.26.14821; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Clark BA, 1997, J PHYSIOL-LONDON, V502, P335, DOI 10.1111/j.1469-7793.1997.335bk.x; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647; DATYNER NB, 1980, J PHYSIOL-LONDON, V303, P299, DOI 10.1113/jphysiol.1980.sp013286; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P574, DOI 10.1113/jphysiol.1954.sp005130; Diamond JS, 1997, J NEUROSCI, V17, P4672; DIAMOND JS, 1995, NEURON, V15, P1097, DOI 10.1016/0896-6273(95)90098-5; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dobrunz LE, 1997, NEURON, V18, P995, DOI 10.1016/S0896-6273(00)80338-4; Dzubay JA, 1999, J NEUROSCI, V19, P5265; Eliasof S, 1996, P NATL ACAD SCI USA, V93, P4153, DOI 10.1073/pnas.93.9.4153; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hanse E, 2001, J PHYSIOL-LONDON, V531, P481, DOI 10.1111/j.1469-7793.2001.0481i.x; Hashimoto K, 1998, J PHYSIOL-LONDON, V506, P391, DOI 10.1111/j.1469-7793.1998.391bw.x; Hausser M, 1997, J PHYSIOL-LONDON, V501, P77; HESTRIN S, 1993, NEURON, V11, P1083, DOI 10.1016/0896-6273(93)90221-C; HEUSER JE, 1979, J CELL BIOL, V81, P275, DOI 10.1083/jcb.81.2.275; ISAACSON JS, 1995, NEURON, V15, P875, DOI 10.1016/0896-6273(95)90178-7; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; KORN H, 1994, ADV SEC MESS PHOSPH, V29, P301; Lehre KP, 1998, J NEUROSCI, V18, P8751, DOI 10.1523/jneurosci.18-21-08751.1998; LESTER RAJ, 1990, NATURE, V346, P565, DOI 10.1038/346565a0; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIVSEY CT, 1993, J NEUROSCI, V13, P5324, DOI 10.1523/JNEUROSCI.13-12-05324.1993; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MAGLEBY KL, 1972, J PHYSIOL-LONDON, V223, P151, DOI 10.1113/jphysiol.1972.sp009839; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Palay S. L., 1974, CEREBELLAR CORTEX CY; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Prange O, 1999, J NEUROPHYSIOL, V81, P1810, DOI 10.1152/jn.1999.81.4.1810; REDMAN S, 1990, PHYSIOL REV, V70, P165, DOI 10.1152/physrev.1990.70.1.165; Renger JJ, 2001, NEURON, V29, P469, DOI 10.1016/S0896-6273(01)00219-7; Rusakov DA, 1998, TRENDS NEUROSCI, V21, P469, DOI 10.1016/S0166-2236(98)01309-5; Schikorski T, 2001, NAT NEUROSCI, V4, P391, DOI 10.1038/86042; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; SORRA KE, 1993, J NEUROSCI, V13, P3736; SPACEK J, 1985, ANAT EMBRYOL, V171, P235, DOI 10.1007/BF00341418; TONG G, 1994, NEURON, V12, P51, DOI 10.1016/0896-6273(94)90151-1; VANDERKLOOT W, 1988, J PHYSIOL-LONDON, V402, P595, DOI 10.1113/jphysiol.1988.sp017224; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; WATKINS JC, 1991, CAN J PHYSIOL PHARM, V69, P1064, DOI 10.1139/y91-158; Xu-Friedman MA, 2001, J NEUROSCI, V21, P6666, DOI 10.1523/JNEUROSCI.21-17-06666.2001; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	63	289	292	0	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					301	313		10.1016/S0896-6273(01)00488-3	http://dx.doi.org/10.1016/S0896-6273(01)00488-3			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683999	Bronze			2022-12-24	WOS:000171893700014
J	Patterson, SL; Pittenger, C; Morozov, A; Martin, KC; Scanlin, H; Drake, C; Kandel, ER				Patterson, SL; Pittenger, C; Morozov, A; Martin, KC; Scanlin, H; Drake, C; Kandel, ER			Some forms of cAMP-mediated long-lasting potentiation are associated with release of BDNF and nuclear translocation of phospho-MAP kinase	NEURON			English	Article							ACTIVATED PROTEIN-KINASE; NERVE GROWTH-FACTOR; INDUCED SYNAPTIC POTENTIATION; CULTURED HIPPOCAMPAL-NEURONS; ACTIVITY-DEPENDENT RELEASE; TERM POTENTIATION; NEUROTROPHIC FACTOR; LATE-PHASE; RAT HIPPOCAMPUS; MEMORY STORAGE	Long-lasting forms of synaptic plasticity like the late phase of LTP (L-LTP) typically require an elevation of cAMP, the recruitment of the cAMP-dependent protein kinase (PKA), and ultimately the activation of transcription and translation; some forms also require brain-derived neurotrophic factor (BDNF). Both cAMP and BDNF can activate mitogen-activated protein kinase (MAPK/ERK), which also plays a role in LTP. However, little is known about the mechanisms whereby cAMP, BDNF, and MAPK interact. We find that increases in cAMP can rapidly activate the BDNF receptor TrkB and induce BDNF-dependent long-lasting potentiation at the Schaffer collateral-CA1 synapse in hippocampus. Surprisingly, in these BDNF-dependent forms of potentiation, which are also MAPK dependent, TrkB activation is not critical for the activation of MAPK but instead appears to modulate the subcellular distribution and nuclear translocation of the activated MAPK.	Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, New York, NY 10032 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Cornell Univ, Weill Med Coll, Dept Neurol, Div Neurobiol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Neurosci, New York, NY 10021 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Cornell University; Cornell University	Kandel, ER (corresponding author), Columbia Univ Coll Phys & Surg, Howard Hughes Med Inst, New York, NY 10032 USA.		Pittenger, Christopher/G-8402-2012	Pittenger, Christopher/0000-0003-2117-9321	NIGMS NIH HHS [GM08464-05/06] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Aloyz R, 1999, LEARN MEMORY, V6, P216; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000; Binder DK, 1999, J NEUROSCI, V19, P4616; BIOCHI A, 1995, EUR J NEUROSCI, V7, P1220; Blitzer RD, 1995, NEURON, V15, P1403, DOI 10.1016/0896-6273(95)90018-7; Blochl A, 1996, MOL CELL NEUROSCI, V7, P173, DOI 10.1006/mcne.1996.0014; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Boulanger L, 1999, SCIENCE, V284, P1982, DOI 10.1126/science.284.5422.1982; BRAMHAM CR, 1990, NEUROSCIENCE, V39, P405, DOI 10.1016/0306-4522(90)90277-B; Cavus I, 1996, J NEUROPHYSIOL, V76, P3038, DOI 10.1152/jn.1996.76.5.3038; CHAVEZNORIEGA LE, 1992, BRAIN RES, V574, P85, DOI 10.1016/0006-8993(92)90803-H; Chen GQ, 1999, J NEUROSCI, V19, P7983; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Drake CT, 1999, J NEUROSCI, V19, P8009; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; English JD, 1996, J BIOL CHEM, V271, P24329, DOI 10.1074/jbc.271.40.24329; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Friedman WJ, 1998, NEUROSCIENCE, V84, P101, DOI 10.1016/S0306-4522(97)00526-5; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; Goodman LJ, 1996, MOL CELL NEUROSCI, V7, P222, DOI 10.1006/mcne.1996.0017; Gottschalk W, 1998, J NEUROSCI, V18, P6830; GROVER LM, 1995, SYNAPSE, V19, P121, DOI 10.1002/syn.890190208; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; GUITON M, 1994, J BIOL CHEM, V269, P30370; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; HEIDEMANN SR, 1985, J CELL BIOL, V100, P916, DOI 10.1083/jcb.100.3.916; HRKENHAM M, 1988, NIDA RES MONOGR, V82, P33; Huang Y Y, 1994, Learn Mem, V1, P74; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jankowsky JL, 1999, MOL CELL NEUROSCI, V14, P273, DOI 10.1006/mcne.1999.0792; Jarvis CR, 1997, J NEUROPHYSIOL, V78, P2363, DOI 10.1152/jn.1997.78.5.2363; KANDEL E, 1995, SCIENCE, V268, P825, DOI 10.1126/science.7754367; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; KANG HJ, 1995, J PHYSIOLOGY-PARIS, V89, P11, DOI 10.1016/0928-4257(96)80547-X; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Korte M, 1998, NEUROPHARMACOLOGY, V37, P553, DOI 10.1016/S0028-3908(98)00035-5; LENORMAND P, 1993, ADV SEC MESS PHOSPH, V28, P237; Lenormand P, 1998, J CELL BIOL, V142, P625, DOI 10.1083/jcb.142.3.625; LESSMANN V, 1994, NEUROREPORT, V6, P21; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; Martin KC, 1997, NEURON, V18, P899, DOI 10.1016/S0896-6273(00)80330-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Peters A., 1991, FINE STRUCTURE NERVO; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Roberson ED, 1999, J NEUROSCI, V19, P4337; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SCHLESSINGER J, 1992, NEURON, V9, P383, DOI 10.1016/0896-6273(92)90177-F; SHELTON DL, 1995, J NEUROSCI, V15, P477, DOI 10.1523/jneurosci.15-01-00477.1995; Suen PC, 1997, P NATL ACAD SCI USA, V94, P8191, DOI 10.1073/pnas.94.15.8191; Sweatt JD, 2001, J NEUROCHEM, V76, P1, DOI 10.1046/j.1471-4159.2001.00054.x; TIMMUSK T, 1993, EUR J NEUROSCI, V5, P605, DOI 10.1111/j.1460-9568.1993.tb00526.x; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wang SJ, 1999, J NEUROSCI, V19, P570; Widmann C, 1999, PHYSIOL REV, V79, P143, DOI 10.1152/physrev.1999.79.1.143; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Wong ST, 1999, NEURON, V23, P787, DOI 10.1016/S0896-6273(01)80036-2; YAO H, 1995, J BIOL CHEM, V270, P20748, DOI 10.1074/jbc.270.35.20748	73	261	267	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					123	140		10.1016/S0896-6273(01)00443-3	http://dx.doi.org/10.1016/S0896-6273(01)00443-3			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604144	Bronze			2022-12-24	WOS:000171525200014
J	Wenk, MR; Pellegrini, L; Klenchin, VA; Di Paolo, G; Chang, SH; Daniell, L; Arioka, M; Martin, TF; De Camilli, P				Wenk, MR; Pellegrini, L; Klenchin, VA; Di Paolo, G; Chang, SH; Daniell, L; Arioka, M; Martin, TF; De Camilli, P			PIP kinase 1 gamma is the major PI(4,5)P-2 synthesizing enzyme at the synapse	NEURON			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; I PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASES; STIMULATION-DEPENDENT DEPHOSPHORYLATION; TERMINAL-SPECIFIC PHOSPHOPROTEIN; PLECKSTRIN HOMOLOGY DOMAIN; NERVE-TERMINALS; PLASMA-MEMBRANE; NEUROTRANSMITTER RELEASE; VESICLE EXOCYTOSIS; COATED VESICLES	Disruption of the presynaptically enriched polyphosphoinositide phosphatase synaptojanin 1 leads to an increase of clathrin-coated intermediates and of polymerized actin at endocytic zones of nerve terminals. These changes correlate with elevated levels of PI(4,5)P-2 in neurons. We report that phosphatidylinositol phosphate kinase type I gamma (PIPKI gamma), a major brain PI(4)P 5-kinase, is concentrated at synapses. Synaptojanin 1 and PIPKI gamma antagonize each other in the recruitment of clathrin coats to lipid membranes. Like synaptojanin 1 and other proteins involved in endocytosis, PIPKI gamma undergoes stimulation-dependent dephosphorylation. These results implicate PIPKI gamma in the synthesis of a PI(4,5)P-2 pool that acts as a positive regulator of clathrin coat recruitment and actin function at the synapse.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA; Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06511 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Howard Hughes Medical Institute; Yale University; Yale University; University of Wisconsin System; University of Wisconsin Madison; University of Tokyo	De Camilli, P (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06511 USA.		Wenk, Markus Rene/D-1441-2014; Chang, Sunghoe/J-2784-2012	chang, sunghoe/0000-0002-3446-7288				Anderson RA, 1999, J BIOL CHEM, V274, P9907, DOI 10.1074/jbc.274.15.9907; Barylko B, 2001, J BIOL CHEM, V276, P7705, DOI 10.1074/jbc.C000861200; Bauerfeind R, 1997, J BIOL CHEM, V272, P30984, DOI 10.1074/jbc.272.49.30984; BAUMERT M, 1989, EMBO J, V8, P379, DOI 10.1002/j.1460-2075.1989.tb03388.x; BERNSTEIN BW, 1989, NEURON, V3, P257, DOI 10.1016/0896-6273(89)90039-1; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Brodin L, 2000, CURR OPIN NEUROBIOL, V10, P312, DOI 10.1016/S0959-4388(00)00097-0; BRODIN L, 1999, BIOCHIMIE, V81, P49; Chen H, 1999, J BIOL CHEM, V274, P3257, DOI 10.1074/jbc.274.6.3257; Chung SH, 1998, J BIOL CHEM, V273, P10240, DOI 10.1074/jbc.273.17.10240; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Cremona O, 2001, J CELL SCI, V114, P1041; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Domin J, 2000, J BIOL CHEM, V275, P11943, DOI 10.1074/jbc.275.16.11943; Dunaevsky A, 2000, J NEUROSCI, V20, P6007, DOI 10.1523/JNEUROSCI.20-16-06007.2000; EBERHARD DA, 1990, BIOCHEM J, V268, P15, DOI 10.1042/bj2680015; Ford MGJ, 2001, SCIENCE, V291, P1051, DOI 10.1126/science.291.5506.1051; Fruman DA, 1998, ANNU REV BIOCHEM, V67, P481, DOI 10.1146/annurev.biochem.67.1.481; Gad H, 2000, NEURON, V27, P301, DOI 10.1016/S0896-6273(00)00038-6; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gaidarov I, 1999, J CELL BIOL, V146, P755, DOI 10.1083/jcb.146.4.755; Gaidarov I, 2001, MOL CELL, V7, P443, DOI 10.1016/S1097-2765(01)00191-5; GELL MI, 1996, SCIENCE, V272, P533; Haffner C, 1997, FEBS LETT, V419, P175, DOI 10.1016/S0014-5793(97)01451-8; Hao WH, 1997, J BIOL CHEM, V272, P6393, DOI 10.1074/jbc.272.10.6393; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hawthorne J N, 1977, Adv Exp Med Biol, V83, P419; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HOKIN LE, 1985, ANNU REV BIOCHEM, V54, P205, DOI 10.1146/annurev.biochem.54.1.205; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Hyman J, 2000, J CELL BIOL, V149, P537, DOI 10.1083/jcb.149.3.537; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Itoh T, 2000, J BIOL CHEM, V275, P19389, DOI 10.1074/jbc.M000426200; Itoh T, 2001, SCIENCE, V291, P1047, DOI 10.1126/science.291.5506.1047; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kirk CJ., 1990, PEPTIDE HORMONE ACTI, P151; LIU JP, 1994, SCIENCE, V265, P970, DOI 10.1126/science.8052858; LOLJENS JC, 1996, J BIOL CHEM, V271, P32937; Majerus PW, 1999, J BIOL CHEM, V274, P10669, DOI 10.1074/jbc.274.16.10669; Martin TFJ, 1998, ANNU REV CELL DEV BI, V14, P231, DOI 10.1146/annurev.cellbio.14.1.231; Martin TFJ, 1997, CURR OPIN NEUROBIOL, V7, P331, DOI 10.1016/S0959-4388(97)80060-8; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MCPHERSON PS, 1994, J BIOL CHEM, V269, P30132; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Mikoshiba K, 1999, CHEM PHYS LIPIDS, V98, P59, DOI 10.1016/S0009-3084(99)00018-3; MINOGUE S, 2001, J BIOL CHEM, V13, P13; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Nemoto Y, 2000, J BIOL CHEM, V275, P34293, DOI 10.1074/jbc.M003923200; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; Park SJ, 2001, J BIOL CHEM, V276, P4781, DOI 10.1074/jbc.M010177200; Prior I A, 1999, Mol Cell Biol Res Commun, V1, P162, DOI 10.1006/mcbr.1999.0126; Rameh LE, 1997, NATURE, V390, P192, DOI 10.1038/36621; Rapoport I, 1997, EMBO J, V16, P2240, DOI 10.1093/emboj/16.9.2240; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Rupnik M, 2000, P NATL ACAD SCI USA, V97, P5627, DOI 10.1073/pnas.090359097; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Sechi AS, 2000, J CELL SCI, V113, P3685; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Slepnev VI, 1998, SCIENCE, V281, P821, DOI 10.1126/science.281.5378.821; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; SUHOF TC, 2000, SYNAPSE, P177; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1996, J CELL BIOL, V133, P1237, DOI 10.1083/jcb.133.6.1237; TAKEI K, 1992, J NEUROSCI, V12, P489; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; Tolias KF, 1999, CHEM PHYS LIPIDS, V98, P69, DOI 10.1016/S0009-3084(99)00019-5; Tolias KF, 1998, J BIOL CHEM, V273, P18040, DOI 10.1074/jbc.273.29.18040; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wiedemann C, 1998, J NEUROSCI, V18, P5594; Wiedemann C, 1996, EMBO J, V15, P2094, DOI 10.1002/j.1460-2075.1996.tb00563.x; Woscholski R, 1997, J BIOL CHEM, V272, P9625; Zhang XL, 1997, J BIOL CHEM, V272, P17756, DOI 10.1074/jbc.272.28.17756; Zheng J, 1996, J MOL BIOL, V255, P14, DOI 10.1006/jmbi.1996.0002	78	184	187	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					79	88		10.1016/S0896-6273(01)00456-1	http://dx.doi.org/10.1016/S0896-6273(01)00456-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604140	Bronze			2022-12-24	WOS:000171525200010
J	Sharpe, IA; Gehrmann, J; Loughnan, ML; Thomas, L; Adams, DA; Atkins, A; Palant, E; Craik, DJ; Adams, DJ; Alewood, PF; Lewis, RJ				Sharpe, IA; Gehrmann, J; Loughnan, ML; Thomas, L; Adams, DA; Atkins, A; Palant, E; Craik, DJ; Adams, DJ; Alewood, PF; Lewis, RJ			Two new classes of conopeptides inhibit the alpha 1-adrenoceptor and noradrenaline transporter	NATURE NEUROSCIENCE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; 1.1 ANGSTROM RESOLUTION; CONUS-GEOGRAPHUS VENOM; ALPHA-CONOTOXIN; CRYSTAL-STRUCTURE; SODIUM-CHANNELS; VAS-DEFERENS; NOREPINEPHRINE TRANSPORTER; PEPTIDE; ANTAGONIST	Cone snails use venom containing a cocktail of peptides ('conopeptides') to capture their prey. Many of these peptides also target mammalian receptors, often with exquisite selectivity. Here we report the discovery of two new classes of conopeptides. One class targets alpha (1)-adrenoceptors (rho -TIA from the fish-hunting Conus tulipa), and the second class targets the neuronal noradrenaline transporter (chi -MrIA and chi -MrIB from the mollusk-hunting C. marmoreus). rho -TIA and chi -MrIA selectively modulate these important membrane-bound proteins. Both peptides act as reversible non-competitive inhibitors and provide alternative avenues for the identification of inhibitor drugs.	Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Dept Physiol & Pharmacol, Brisbane, Qld 4072, Australia; Xenome Ltd, Brisbane, Qld 4068, Australia	University of Queensland; University of Queensland	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.		Loughnan, Marion/B-4508-2009; Craik, David/B-1695-2010; Adams, David/J-9125-2014; Adams, David John/K-3578-2019; Lewis, Richard J/E-8674-2013; Lewis, Richard/T-8763-2019	Craik, David/0000-0003-0007-6796; Adams, David/0000-0002-7030-2288; Adams, David John/0000-0002-7030-2288; Lewis, Richard J/0000-0003-3470-923X; Lewis, Richard/0000-0003-3470-923X; Alewood, Paul/0000-0001-7454-6522; Atkins, Annette/0000-0003-2558-7058				Adams DJ, 1999, DRUG DEVELOP RES, V46, P219; Balaji RA, 2000, J BIOL CHEM, V275, P39516, DOI 10.1074/jbc.M006354200; Bruss M, 1997, MOL BRAIN RES, V52, P257, DOI 10.1016/S0169-328X(97)00267-2; Craig AG, 1998, BIOCHEMISTRY-US, V37, P16019, DOI 10.1021/bi981690a; Craig AG, 1999, J BIOL CHEM, V274, P13752, DOI 10.1074/jbc.274.20.13752; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; CUSACK B, 1994, PSYCHOPHARMACOLOGY, V114, P559, DOI 10.1007/BF02244985; England LJ, 1998, SCIENCE, V281, P575, DOI 10.1126/science.281.5376.575; FAINZILBER M, 1994, BIOCHEMISTRY-US, V33, P9523, DOI 10.1021/bi00198a018; FAINZILBER M, 1994, J BIOL CHEM, V269, P2574; Furst S, 1999, BRAIN RES BULL, V48, P129, DOI 10.1016/S0361-9230(98)00159-2; GRAY WR, 1981, J BIOL CHEM, V256, P4734; HOPKINS C, 1995, J BIOL CHEM, V270, P22361, DOI 10.1074/jbc.270.38.22361; Hu SH, 1996, STRUCTURE, V4, P417, DOI 10.1016/S0969-2126(96)00047-0; Hu SH, 1997, BIOCHEMISTRY-US, V36, P11323, DOI 10.1021/bi9713052; Hu SH, 1998, BIOCHEMISTRY-US, V37, P11425, DOI 10.1021/bi9806549; HWA J, 1995, J BIOL CHEM, V270, P23189, DOI 10.1074/jbc.270.39.23189; Kenakin T., 1997, PHARMACOLOGIC ANAL D, Vsecond edition, P137, DOI DOI 10.1097/00007691-198803000-00029; Loughnan M, 1998, J BIOL CHEM, V273, P15667, DOI 10.1074/jbc.273.25.15667; Massot O, 1996, MOL PHARMACOL, V50, P752; MCGRATH JC, 1978, J PHYSIOL-LONDON, V283, P23, DOI 10.1113/jphysiol.1978.sp012486; MCINTOSH JM, 1995, J BIOL CHEM, V270, P16796, DOI 10.1074/jbc.270.28.16796; McIntosh JM, 2000, J BIOL CHEM, V275, P32391, DOI 10.1074/jbc.M003619200; MENA EE, 1990, NEUROSCI LETT, V118, P241, DOI 10.1016/0304-3940(90)90637-O; MINNEMAN KP, 1983, MOL PHARMACOL, V23, P359; Nielsen KJ, 1999, BIOCHEMISTRY-US, V38, P6741, DOI 10.1021/bi982980u; NORTHOVER BJ, 1983, BRIT J PHARMACOL, V80, P85, DOI 10.1111/j.1476-5381.1983.tb11053.x; Olivera BM, 2001, TOXICON, V39, P7, DOI 10.1016/S0041-0101(00)00157-4; OLIVERA BM, 1984, BIOCHEMISTRY-US, V23, P5087, DOI 10.1021/bi00317a001; OLIVERA BM, 1990, SCIENCE, V249, P257, DOI 10.1126/science.2165278; Percy E, 1999, BRIT J PHARMACOL, V128, P774, DOI 10.1038/sj.bjp.0702831; PEREZ O, 1994, BRIT J PHARMACOL, V111, P717, DOI 10.1111/j.1476-5381.1994.tb14796.x; PRZYWARA DA, 1989, CIRC RES, V65, P185, DOI 10.1161/01.RES.65.1.185; Shon KJ, 1997, BIOCHEMISTRY-US, V36, P9581, DOI 10.1021/bi970235w; Shon KJ, 1998, J BIOL CHEM, V273, P33, DOI 10.1074/jbc.273.1.33; SNEDDON P, 1984, J PHYSIOL-LONDON, V347, P561, DOI 10.1113/jphysiol.1984.sp015083; TRENDELENBURG U, 1970, J PHARMACOL EXP THER, V172, P91	38	203	211	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					902	907		10.1038/nn0901-902	http://dx.doi.org/10.1038/nn0901-902			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528421				2022-12-24	WOS:000170698600016
J	Wilson, RI; Kunos, G; Nicoll, RA				Wilson, RI; Kunos, G; Nicoll, RA			Presynaptic specificity of endocannabinoid signaling in the hippocampus	NEURON			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; CALCIUM-CHANNEL INVOLVEMENT; CANNABINOID CB1 RECEPTORS; BETA-GAMMA-SUBUNITS; RAT HIPPOCAMPUS; N-TYPE; SYNAPTIC TRANSMISSION; GABA RELEASE; AREA CA1; MESENTERIC VASODILATION	Endocannabinoids are retrograde messengers released by neurons to modulate the strength of their synaptic inputs. Endocannabinoids are thought to mediate the suppression of GABA release that follows depolarization of a hippocampal CA1 pyramidal neuron-termed "depolarization-induced suppression of inhibition" (DSI). Here, we report that DSI is absent in mice which lack cannabinoid receptor-1 (CB1). Pharmacological and kinetic evidence suggests that CB1 activation inhibits presynaptic Ca2+ channels through direct G protein inhibition. Paired recordings show that endocannabinoids selectively inhibit a subclass of synapses distinguished by their fast kinetics and large unitary conductance. Furthermore, cannabinoid-sensitive inputs are unusual among central nervous system synapses in that they use N- but not P/Q-type Ca2+ channels for neurotransmitter release. These results indicate that endocannabinoids are highly selective, rapid modulators of hippocampal inhibition.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; NIAAA, Lab Physiol Studies, NIH, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Nicoll, RA (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.		Wilson, Rachel/E-2227-2012	Wilson, Rachel/0000-0001-8573-9266	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000350, ZIAAA000350] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; Ameri A, 1999, PROG NEUROBIOL, V58, P315, DOI 10.1016/S0301-0082(98)00087-2; Banks MI, 2000, NEURON, V25, P449, DOI 10.1016/S0896-6273(00)80907-1; Banks MI, 1998, J NEUROSCI, V18, P1305; Breivogel CS, 2001, MOL PHARMACOL, V60, P155, DOI 10.1124/mol.60.1.155; BUHL EH, 1995, EUR J NEUROSCI, V7, P1989, DOI 10.1111/j.1460-9568.1995.tb00721.x; Currie KPM, 1997, J NEUROSCI, V17, P4570; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; DOZE VA, 1995, J NEUROPHYSIOL, V74, P43, DOI 10.1152/jn.1995.74.1.43; Du J, 1996, J NEUROSCI, V16, P506; EVANS DM, 1994, J PHARMACOL EXP THER, V268, P1271; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gray C M, 1994, J Comput Neurosci, V1, P11, DOI 10.1007/BF00962716; Hajos N, 2000, EUR J NEUROSCI, V12, P3239, DOI 10.1046/j.1460-9568.2000.00217.x; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Hescheler J, 1993, Curr Opin Neurobiol, V3, P360, DOI 10.1016/0959-4388(93)90129-M; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hoffman AF, 2000, J NEUROSCI, V20, P2470; HOWLETT AC, 1984, MOL PHARMACOL, V26, P532; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Jarai Z, 1999, P NATL ACAD SCI USA, V96, P14136, DOI 10.1073/pnas.96.24.14136; Katona I, 2000, NEUROSCIENCE, V100, P797, DOI 10.1016/S0306-4522(00)00286-4; Katona I, 1999, J NEUROSCI, V19, P4544; KAWAGUCHI Y, 1987, BRAIN RES, V416, P369, DOI 10.1016/0006-8993(87)90921-8; Kreitzer AC, 2001, NEURON, V29, P717, DOI 10.1016/S0896-6273(01)00246-X; Lenz RA, 1998, J PHYSIOL-LONDON, V512, P61, DOI 10.1111/j.1469-7793.1998.061bf.x; Maccaferri G, 2000, J PHYSIOL-LONDON, V524, P91, DOI 10.1111/j.1469-7793.2000.t01-3-00091.x; MACKIE K, 1992, P NATL ACAD SCI USA, V89, P3825, DOI 10.1073/pnas.89.9.3825; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Morishita W, 1997, J PHYSIOL-LONDON, V505, P307, DOI 10.1111/j.1469-7793.1997.307bb.x; Morishita W, 1998, J NEUROSCI, V18, P4870; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; OHNOSHOSAKU T, 1994, NEUROSCI LETT, V181, P145, DOI 10.1016/0304-3940(94)90580-0; Parra P, 1998, NEURON, V20, P983, DOI 10.1016/S0896-6273(00)80479-1; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1992, J NEUROSCI, V12, P4122; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; SIK A, 1995, J NEUROSCI, V15, P6651; SOLTESZ I, 1995, NEURON, V14, P1273, DOI 10.1016/0896-6273(95)90274-0; TAKAHASHI T, 1993, NATURE, V366, P156, DOI 10.1038/366156a0; Toth K, 2000, J PHYSIOL-LONDON, V525, P41, DOI 10.1111/j.1469-7793.2000.00041.x; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; USOWICZ MM, 1992, NEURON, V9, P1185, DOI 10.1016/0896-6273(92)90076-P; Vida I, 1998, J PHYSIOL-LONDON, V506, P755, DOI 10.1111/j.1469-7793.1998.755bv.x; Wagner JA, 1999, HYPERTENSION, V33, P429, DOI 10.1161/01.HYP.33.1.429; Wagner JJ, 1996, J PHYSIOL-LONDON, V495, P107, DOI 10.1113/jphysiol.1996.sp021577; WILLIAMS S, 1994, J NEUROPHYSIOL, V71, P2217, DOI 10.1152/jn.1994.71.6.2217; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; WU LG, 1994, NEURON, V12, P1139, DOI 10.1016/0896-6273(94)90321-2; Zhang JF, 1996, NEURON, V17, P991, DOI 10.1016/S0896-6273(00)80229-9; Zimmer A, 1999, P NATL ACAD SCI USA, V96, P5780, DOI 10.1073/pnas.96.10.5780	55	405	419	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					453	462		10.1016/S0896-6273(01)00372-5	http://dx.doi.org/10.1016/S0896-6273(01)00372-5			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516401	Bronze			2022-12-24	WOS:000170601000013
J	Patel, AD; Balaban, E				Patel, AD; Balaban, E			Human pitch perception is reflected in the timing of stimulus-related cortical activity	NATURE NEUROSCIENCE			English	Article							STEADY-STATE RESPONSES; HUMAN AUDITORY-CORTEX; FREQUENCY-FOLLOWING RESPONSES; AMPLITUDE-MODULATED TONES; COMPLEX TONES; VIRTUAL PITCH; BRAIN; MODEL; PHASE	'Pitch' refers to a sound's subjective highness or lowness, as distinct from 'frequency,' which refers to a sound's physical structure. In speech, music and other natural contexts, complex tones are often perceived with a single pitch. Using whole-head magnetoencephalography (MEG) and stimuli that dissociate pitch from frequency, we studied cortical dynamics in normal individuals who extracted different pitches from the same tone complexes. Whereas all subjects showed similar spatial distributions in the magnitude of their brain responses to the stimuli, subjects who heard different pitches exhibited contrasting temporal patterns of brain activity in their right but not their left hemispheres. These data demonstrate a specific relationship between pitch perception and the timing (phase) of dynamic patterns of cortical activity.	Inst Neurosci, San Diego, CA 92121 USA		Patel, AD (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.		Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433				Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; COHEN MA, 1995, J ACOUST SOC AM, V98, P862, DOI 10.1121/1.413512; GALBRAITH GC, 1994, ELECTROEN CLIN NEURO, V92, P321, DOI 10.1016/0168-5597(94)90100-7; GOLDSTEIN JL, 1973, J ACOUST SOC AM, V54, P1496, DOI 10.1121/1.1914448; GREENBERG S, 1987, HEARING RES, V25, P91, DOI 10.1016/0378-5955(87)90083-9; GREENBERG S, **NON-TRADITIONAL**; Griffiths TD, 1998, NAT NEUROSCI, V1, P422, DOI 10.1038/1637; Griffiths TD, 2001, NAT NEUROSCI, V4, P633, DOI 10.1038/88459; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; John MS, 2000, HEARING RES, V141, P57, DOI 10.1016/S0378-5955(99)00209-9; Johnsrude IS, 2000, BRAIN, V123, P155, DOI 10.1093/brain/123.1.155; LICKLIDER JCR, 1951, EXPERIENTIA, V7, P128, DOI 10.1007/BF02156143; LYON R, 1996, AUDITORY COMPUTATION, P221, DOI DOI 10.1007/978-1-4612-4070-9_6; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; MEDDIS R, 1991, J ACOUST SOC AM, V89, P2866, DOI 10.1121/1.400725; Pantev C, 1996, HEARING RES, V100, P164, DOI 10.1016/0378-5955(96)00124-4; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; Patel AD, 2000, NATURE, V404, P80, DOI 10.1038/35003577; Ross B, 2000, J ACOUST SOC AM, V108, P679, DOI 10.1121/1.429600; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Shamma S, 2000, J ACOUST SOC AM, V107, P2631, DOI 10.1121/1.428649; Tallal P, 1998, EXP BRAIN RES, V123, P210, DOI 10.1007/s002210050563; TERHARDT E, 1974, J ACOUST SOC AM, V55, P1061, DOI 10.1121/1.1914648; Wetzel W, 1998, NEUROSCI LETT, V252, P115, DOI 10.1016/S0304-3940(98)00561-8; ZATORRE RJ, 1988, J ACOUST SOC AM, V84, P566, DOI 10.1121/1.396834; [No title captured]; [No title captured]; [No title captured]	29	47	47	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					839	844		10.1038/90557	http://dx.doi.org/10.1038/90557			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477431				2022-12-24	WOS:000170137300018
J	Patton, BL; Cunningham, JM; Thyboll, J; Kortesmaa, J; Westerblad, H; Edstrom, L; Tryggvason, K; Sanes, JR				Patton, BL; Cunningham, JM; Thyboll, J; Kortesmaa, J; Westerblad, H; Edstrom, L; Tryggvason, K; Sanes, JR			Properly formed but improperly localized synaptic specializations in the absence of laminin alpha 4	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; ACTIVE ZONES; S-LAMININ; MUSCLE; DIFFERENTIATION; EXPRESSION; ISOFORMS; CHAINS; ROLES; CLEFT	Precise apposition of pre- to postsynaptic specializations is required for optimal function of chemical synapses, but little is known about how it is achieved. At the skeletal neuromuscular junction, active zones (transmitter release sites) in the nerve terminal lie directly opposite junctional folds in the postsynaptic membrane. Few active zones or junctional folds form in mice lacking the laminin beta2 chain, which is normally concentrated in the synaptic cleft. beta2 and the broadly expressed gamma1 chain form heterotrimers with alpha chains, three of which, alpha2, alpha4 and alpha5, are present in the synaptic cleft. Thus, alpha2 beta2 gamma1, alpha4 beta2 gamma1 and alpha5 beta2 gamma1 heterotrimers are all lost in beta2 mutants. In mice lacking laminin alpha4, active zones and junctional folds form in normal numbers, but are not precisely apposed to each other. Thus, formation and localization of synaptic specializations are regulated separately, and alpha4 beta2 gamma1 (called laminin-9) is critical in the latter process.	Washington Univ, Med Ctr, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Oregon Hlth Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; Karolinska Inst, Dept Clin Neurosci, S-17177 Stockholm, Sweden	Washington University (WUSTL); Oregon Health & Science University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Patton, BL (corresponding author), Washington Univ, Med Ctr, Dept Anat & Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.			Westerblad, Hakan/0000-0002-8180-3029				BLOCH RJ, 1988, AM J PHYSIOL, V254, pC345, DOI 10.1152/ajpcell.1988.254.3.C345; Burgess RW, 1999, NEURON, V23, P33, DOI 10.1016/S0896-6273(00)80751-5; Cho SI, 1998, J NEUROBIOL, V37, P339, DOI 10.1002/(SICI)1097-4695(19981115)37:3<339::AID-NEU1>3.3.CO;2-0; COHEN MW, 1991, J NEUROSCI, V11, P1032; Cohen MW, 2000, J NEUROSCI, V20, P4912; Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R; GILBERT JJ, 1973, J NEUROPATH EXP NEUR, V32, P345, DOI 10.1097/00005072-197307000-00001; Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6; Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; JOHSNSSON C, 2000, AM J PHYSIOL-REG I, V278, pR598; LAW PK, 1983, EXP NEUROL, V80, P361, DOI 10.1016/0014-4886(83)90289-3; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; MARTIN PT, 1995, SCIENCE, V269, P413, DOI 10.1126/science.7618109; MATTHEWSBELLINGER JA, 1983, J NEUROSCI, V3, P644; MERISH L, 1996, AM LIT HIST, V8, P1; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Patton BL, 1999, NEUROMUSCULAR DISORD, V9, P423, DOI 10.1016/S0960-8966(99)00033-4; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PORTER BE, 1995, NEURON, V14, P549, DOI 10.1016/0896-6273(95)90311-9; Prokop A, 1996, NEURON, V17, P617, DOI 10.1016/S0896-6273(00)80195-6; Reese T, 2000, NMR BIOMED, V13, P361, DOI 10.1002/1099-1492(200010)13:6<361::AID-NBM654>3.0.CO;2-C; Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; SANES JR, 1990, J CELL BIOL, V111, P1685, DOI 10.1083/jcb.111.4.1685; SANES JR, 1978, J CELL BIOL, V78, P176, DOI 10.1083/jcb.78.1.176; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Son YJ, 1999, EUR J NEUROSCI, V11, P3457, DOI 10.1046/j.1460-9568.1999.00766.x; Son YJ, 2000, J BIOL CHEM, V275, P451, DOI 10.1074/jbc.275.1.451; Sunderland WJ, 2000, J NEUROSCI, V20, P1009, DOI 10.1523/JNEUROSCI.20-03-01009.2000; Uteshev VV, 2000, BIOPHYS J, V79, P2825, DOI 10.1016/S0006-3495(00)76521-0; Wood SJ, 1997, J PHYSIOL-LONDON, V500, P165, DOI 10.1113/jphysiol.1997.sp022007; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983	35	155	158	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					597	604		10.1038/88414	http://dx.doi.org/10.1038/88414			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369940				2022-12-24	WOS:000169061800012
J	Magdaleno, S; Keshvara, L; Curran, T				Magdaleno, S; Keshvara, L; Curran, T			Rescue of ataxia and preplate splitting by ectopic expression of reelin in reeler mice	NEURON			English	Article							MOUSE-BRAIN DEVELOPMENT; APOE RECEPTOR 2; CORTICAL DEVELOPMENT; CEREBRAL-CORTEX; EXTRACELLULAR-MATRIX; NEURONAL MIGRATION; MUTANT MICE; TYROSINE PHOSPHORYLATION; LAMINAR ORGANIZATION; SIGNALING PATHWAY	The gene mutated in reeler (reelin) encodes a protein secreted by neurons in the developing brain that controls laminar positioning of migrating cells in the CNS by an unknown mechanism. To investigate Reelin function, we used the nestin promoter to express Reelin ectopically in the ventricular zone and other brain regions in transgenic mice. In the presence of the endogenous protein, ectopic Reelin did not alter cell migration in the neocortex or the cerebellum. However, in the reeler background, ectopic Reelin induced tyrosine phosphorylation of Dab-1 in the ventricular zone and rescued some, but not all, of the neuroanatomic and behavioral abnormalities characteristic of reeler. These results indicate that Reelin does not function simply as a positional signal. Rather, it appears to participate in multiple events critical for neuronal migration and cell positioning.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fos1@aol.com	Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/F-5234-2018; Curran, Tom/C-1164-2008	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551	NINDS NIH HHS [R01 NS36558] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Caviness V S Jr, 1982, Brain Res, V256, P293; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; CAVINESS VS, 1973, J COMP NEUROL, V148, P141, DOI 10.1002/cne.901480202; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DArcangelo G, 1996, MOL BRAIN RES, V39, P234, DOI 10.1016/0169-328X(96)00046-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; de Bergeyck V, 1998, J NEUROSCI METH, V82, P17, DOI 10.1016/S0165-0270(98)00024-7; DERER P, 1979, NEUROSCI LETT, V13, P195, DOI 10.1016/0304-3940(79)90041-7; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; FALCONER DS, 1951, J GENET, V50, P192, DOI 10.1007/BF02996215; Frotscher M, 1997, CELL TISSUE RES, V290, P315, DOI 10.1007/s004410050936; Gilmore EC, 2000, CURR BIOL, V10, pR162, DOI 10.1016/S0960-9822(00)00332-8; Gilmore EC, 1998, J NEUROSCI, V18, P6370; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; Homayouni R, 1999, J NEUROSCI, V19, P7507, DOI 10.1523/JNEUROSCI.19-17-07507.1999; Howe S, 1999, STAND MAG, V1, P19; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Kwon YT, 1998, J COMP NEUROL, V395, P510, DOI 10.1002/(SICI)1096-9861(19980615)395:4<510::AID-CNE7>3.0.CO;2-4; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; MARINPADILLA M, 1978, ANAT EMBRYOL, V152, P109, DOI 10.1007/BF00315920; MIKOSHIBA K, 1984, DEV NEUROSCI-BASEL, V6, P101; Miyata T, 1997, J NEUROSCI, V17, P3599; Miyata T, 1996, J COMP NEUROL, V372, P215; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Pearlman AL, 1998, CURR OPIN NEUROBIOL, V8, P45, DOI 10.1016/S0959-4388(98)80007-X; PEARLMAN AL, 1986, PROG BRAIN RES, V108, P117; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005; Rice DS, 1999, GENE DEV, V13, P2758, DOI 10.1101/gad.13.21.2758; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Searle S.R., 1987, LINEAR MODELS UNBALA; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; TERASHIMA T, 1986, J COMP NEUROL, V252, P264, DOI 10.1002/cne.902520209; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; WASSEF M, 1985, DEV BIOL, V111, P129, DOI 10.1016/0012-1606(85)90441-5; ZIMMERMAN L, 1994, NEURON, V12, P11, DOI 10.1016/0896-6273(94)90148-1	48	139	145	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					573	586		10.1016/S0896-6273(02)00582-2	http://dx.doi.org/10.1016/S0896-6273(02)00582-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856531	Bronze			2022-12-24	WOS:000173911100010
J	Britto, J; Tannahill, D; Keynes, R				Britto, J; Tannahill, D; Keynes, R			A critical role for sonic hedgehog signaling in the early expansion of the developing brain	NATURE NEUROSCIENCE			English	Article							MOTOR-NEURON INDUCTION; DEVELOPING CHICK; NERVOUS-SYSTEM; FEEDBACK LOOP; EXPRESSION; PROLIFERATION; GROWTH; MIDBRAIN; CELLS; FGF4	The mechanisms that coordinate the three-dimensional shape of the vertebrate brain during development are largely unknown. We have found that sonic hedgehog (Shh) is crucial in driving the rapid, extensive expansion of the early vesicles of the developing midbrain and forebrain. Transient displacement of the notochord from the midbrain floor plate resulted in abnormal folding and overall collapse of the vesicles, accompanied by reduced cell proliferation and increased cell death in the midbrain. Simultaneously, expression of Shh decreased locally in the notochord and floor plate, whereas overt patterning and differentiation proceeded normally. Normal midbrain expansion was restored by implantation of Shh-secreting cells in a dose-dependent manner; conversely, expansion was retarded following antagonism of the Shh signaling pathway by cyclopamine. Our results indicate that Shh signaling from the ventral midline is essential for regulating brain morphogenesis during early development.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Keynes, R (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.	rjk10@cus.cam.ac.uk		Tannahill, David/0000-0002-3811-6864				Agarwala S, 2001, SCIENCE, V291, P2147, DOI 10.1126/science.1058624; Ahlgren SC, 1999, CURR BIOL, V9, P1304, DOI 10.1016/S0960-9822(00)80052-4; ALTABA AR, 1995, DEV BIOL, V170, P299; ALVARADOMALLART RM, 1993, J NEUROBIOL, V24, P1341, DOI 10.1002/neu.480241007; Borycki AG, 1999, DEVELOPMENT, V126, P4053; BROWN M, 2001, DEV BRAIN; BURDA DJ, 1968, ANAT REC, V161, P419, DOI 10.1002/ar.1091610403; Carl M, 1999, DEVELOPMENT, V126, P5659; Charrier JB, 2001, DEVELOPMENT, V128, P4011; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; DESMOND ME, 1986, J EMBRYOL EXP MORPH, V97, P25; DESMOND ME, 1977, DEV BIOL, V57, P188, DOI 10.1016/0012-1606(77)90364-5; Duprez D, 1998, DEVELOPMENT, V125, P495; ECHELARD Y, 1993, CELL, V75, P1417, DOI 10.1016/0092-8674(93)90627-3; Epstein DJ, 1999, DEVELOPMENT, V126, P281; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Jensen AM, 1997, DEVELOPMENT, V124, P363; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KALLEN B, 1965, PROGR BRAIN RES, V14, P263; Lee SMK, 1997, DEVELOPMENT, V124, P959; Liu AM, 2001, ANNU REV NEUROSCI, V24, P869, DOI 10.1146/annurev.neuro.24.1.869; Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346; MARTI E, 1995, DEVELOPMENT, V121, P2537; Miao NN, 1997, J NEUROSCI, V17, P5891; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; NISWANDER L, 1994, NATURE, V371, P609, DOI 10.1038/371609a0; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Sanz-Ezquerro JJ, 2000, DEVELOPMENT, V127, P4811; Shamim H, 1999, MECH DEVELOP, V85, P189, DOI 10.1016/S0925-4773(99)00093-3; Shamim H, 1999, DEVELOPMENT, V126, P945; Sun X, 2000, NAT GENET, V25, P83, DOI 10.1038/75644; Teillet MA, 1998, DEVELOPMENT, V125, P2019; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061; Wallace VA, 1999, DEVELOPMENT, V126, P2901; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Watanabe Y, 2000, DEVELOPMENT, V127, P1131; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; WILSON DB, 1974, BRAIN RES, V69, P41, DOI 10.1016/0006-8993(74)90368-0; WILSON DB, 1978, J COMP NEUROL, V180, P501, DOI 10.1002/cne.901800307; YAMADA T, 1993, CELL, V73, P673, DOI 10.1016/0092-8674(93)90248-O; Zuniga A, 1999, NATURE, V401, P598, DOI 10.1038/44157	47	98	105	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					103	110		10.1038/nn797	http://dx.doi.org/10.1038/nn797			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788837				2022-12-24	WOS:000173558400011
J	Glowatzki, E; Fuchs, PA				Glowatzki, E; Fuchs, PA			Transmitter release at the hair cell ribbon synapse	NATURE NEUROSCIENCE			English	Article							EXCITATORY POSTSYNAPTIC CURRENTS; GUINEA-PIG COCHLEA; AUDITORY-NERVE; MOUSE COCHLEA; TRANSMISSION; FIBERS; POTENTIALS; ENDOCYTOSIS; EXOCYTOSIS; RECEPTORS	Neurotransmitters are released continuously at ribbon synapses in the retina and cochlea. Notably, a single ribbon synapse of inner hair cells provides the entire input to each cochlear afferent fiber. We investigated hair cell transmitter release in the postnatal rat cochlea by recording excitatory postsynaptic currents (EPSCs) from afferent boutons directly abutting the ribbon synapse. EPSCs were carried by rapidly gating AMPA receptors. EPSCs were clustered in time, indicating the possibility of coordinate release. Amplitude distributions of spontaneous EPSCs were highly skewed, peaking at 0.4 nS and ranging up to 20 times larger. Hair cell depolarization increased EPSC frequency up to 150 Hz without altering the amplitude distribution. We propose that the ribbon synapse operates by multivesicular release, possibly to achieve high-frequency transmission.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Baltimore, MD 21205 USA	Johns Hopkins University	Glowatzki, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Ctr Hearing & Balance, Traylor 521,720 Rutland Ave, Baltimore, MD 21205 USA.			Glowatzki, Elisabeth/0000-0003-3135-658X	PHS HHS [00276] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Auger C, 1998, J NEUROSCI, V18, P4532; Auger C, 2000, J PHYSIOL-LONDON, V526, P3, DOI 10.1111/j.1469-7793.2000.t01-3-00003.x; BEKKERS JM, 1990, P NATL ACAD SCI USA, V87, P5359, DOI 10.1073/pnas.87.14.5359; Beutner D, 2001, NEURON, V29, P681, DOI 10.1016/S0896-6273(01)00243-4; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; ECHTELER SM, 1992, P NATL ACAD SCI USA, V89, P6324, DOI 10.1073/pnas.89.14.6324; EMMERLING MR, 1990, J ELECTRON MICR TECH, V15, P123, DOI 10.1002/jemt.1060150205; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; FURUKAWA T, 1978, J PHYSIOL-LONDON, V276, P211, DOI 10.1113/jphysiol.1978.sp012229; GEISLER CD, 1998, FROM SOUND SYNAPSE, P177; Glowatzki E, 2000, SCIENCE, V288, P2366, DOI 10.1126/science.288.5475.2366; Isaacson JS, 1996, J NEUROPHYSIOL, V76, P1566, DOI 10.1152/jn.1996.76.3.1566; JOHNSON DH, 1980, J ACOUST SOC AM, V68, P1115, DOI 10.1121/1.384982; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; LIBERMAN MC, 1982, SCIENCE, V216, P1239, DOI 10.1126/science.7079757; LIBERMAN MC, 1980, HEARING RES, V3, P45, DOI 10.1016/0378-5955(80)90007-6; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Locke R, 1999, ANN NY ACAD SCI, V871, P35, DOI 10.1111/j.1749-6632.1999.tb09174.x; MAPLE BR, 1994, VISION RES, V34, P2357, DOI 10.1016/0042-6989(94)90281-X; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; Muller M, 1996, HEARING RES, V94, P148, DOI 10.1016/0378-5955(95)00230-8; NAKAGAWA T, 1991, J NEUROPHYSIOL, V65, P715, DOI 10.1152/jn.1991.65.3.715; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; Ottersen OP, 1998, PROG NEUROBIOL, V54, P127, DOI 10.1016/S0301-0082(97)00054-3; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; Puel JL, 1995, PROG NEUROBIOL, V47, P449, DOI 10.1016/0301-0082(95)00028-3; ROSSI ML, 1994, J PHYSIOL-LONDON, V478, P17, DOI 10.1113/jphysiol.1994.sp020227; Ruel J, 1999, J PHYSIOL-LONDON, V518, P667, DOI 10.1111/j.1469-7793.1999.0667p.x; Sahara Y, 2001, J PHYSIOL-LONDON, V536, P189, DOI 10.1111/j.1469-7793.2001.00189.x; SIEGEL JH, 1992, HEARING RES, V59, P85, DOI 10.1016/0378-5955(92)90105-V; SOBKOWICZ HM, 1982, J NEUROSCI, V2, P942; Spassova M, 2001, J PHYSIOL-LONDON, V535, P689, DOI 10.1111/j.1469-7793.2001.00689.x; Trussell LO, 1999, ANNU REV PHYSIOL, V61, P477, DOI 10.1146/annurev.physiol.61.1.477; UZIEL A, 1981, AUDIOLOGY, V20, P89; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Gersdorff H, 2001, NEURON, V29, P7, DOI 10.1016/S0896-6273(01)00175-1; ZHANG S, 1994, J PHYSIOL-LONDON, V480, P123, DOI 10.1113/jphysiol.1994.sp020346	41	407	421	0	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					147	154		10.1038/nn796	http://dx.doi.org/10.1038/nn796			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802170				2022-12-24	WOS:000173558400017
J	Morgan, D; Grant, KA; Gage, HD; Mach, RH; Kaplan, JR; Prioleau, O; Nader, SH; Buchheimer, N; Ehrenkaufer, RL; Nader, MA				Morgan, D; Grant, KA; Gage, HD; Mach, RH; Kaplan, JR; Prioleau, O; Nader, SH; Buchheimer, N; Ehrenkaufer, RL; Nader, MA			Social dominance in monkeys: dopamine D-2 receptors and cocaine self-administration	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; INDIVIDUAL VULNERABILITY; BINDING CHARACTERISTICS; HOUSING CONDITIONS; RHESUS-MONKEYS; D-AMPHETAMINE; DRUG-ABUSE; RATS; BEHAVIOR; ADDICTION	Disruption of the dopaminergic system has been implicated in the etiology of many pathological conditions, including drug addiction. Here we used positron emission tomography (PET) imaging to study brain dopaminergic function in individually housed and in socially housed cynomolgus macaques (n = 20). Whereas the monkeys did not differ during individual housing, social housing increased the amount or availability of dopamine D-2 receptors in dominant monkeys and produced no change in subordinate monkeys. These neurobiological changes had an important behavioral influence as demonstrated by the finding that cocaine functioned as a reinforcer in subordinate but not dominant monkeys. These data demonstrate that alterations in an organism's environment can produce profound biological changes that have important behavioral associations, including vulnerability to cocaine addiction.	Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Pathol Comparat Med, Winston Salem, NC 27157 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Anthropol, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Nader, MA (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.		Morgan, Drake/A-6373-2008; Morgan, Drake/F-6664-2012		NIDA NIH HHS [DA-10584] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA010584, R01DA010584] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BLANC G, 1980, NATURE, V284, P265, DOI 10.1038/284265a0; Blum K, 1996, AM SCI, V84, P132; BOWLING SL, 1993, NEUROPHARMACOLOGY, V32, P885, DOI 10.1016/0028-3908(93)90144-R; BOYLE AE, 1991, PHARMACOL BIOCHEM BE, V39, P269, DOI 10.1016/0091-3057(91)90178-5; BOZARTH MA, 1989, PHARMACOL BIOCHEM BE, V33, P903, DOI 10.1016/0091-3057(89)90490-5; Caine SB, 2000, PSYCHOPHARMACOLOGY, V148, P41, DOI 10.1007/s002130050023; Calabresi P, 1997, NEUROSCIENCE, V78, P39; CROWLEY TJ, 1992, DRUG ALCOHOL DEPEN, V29, P205, DOI 10.1016/0376-8716(92)90094-S; CROWLEY TJ, 1974, ARCH GEN PSYCHIAT, V31, P829; Grant KA, 1998, SYNAPSE, V29, P80, DOI 10.1002/(SICI)1098-2396(199805)29:1<80::AID-SYN7>3.0.CO;2-7; Hall FS, 1998, PHARMACOL BIOCHEM BE, V59, P859, DOI 10.1016/S0091-3057(97)00510-8; Hurd YL, 1999, ANN NY ACAD SCI, V877, P499, DOI 10.1111/j.1749-6632.1999.tb09285.x; Khroyan TV, 2000, J PHARMACOL EXP THER, V294, P680; Laruelle M, 2000, J CEREBR BLOOD F MET, V20, P423, DOI 10.1097/00004647-200003000-00001; LeSage MG, 1999, NEUROSCI BIOBEHAV R, V23, P717, DOI 10.1016/S0149-7634(99)00015-9; Leshner AI, 2000, AM J MED GENET, V96, P590, DOI 10.1002/1096-8628(20001009)96:5<590::AID-AJMG2>3.0.CO;2-2; LOGAN J, 1990, J CEREBR BLOOD F MET, V10, P740, DOI 10.1038/jcbfm.1990.127; Lucas LR, 1998, EUR J NEUROSCI, V10, P3153, DOI 10.1046/j.1460-9568.1998.00321.x; Mach RH, 1996, SYNAPSE, V24, P322, DOI 10.1002/(SICI)1098-2396(199612)24:4<322::AID-SYN2>3.0.CO;2-F; Mach RH, 1997, PHARMACOL BIOCHEM BE, V57, P477, DOI 10.1016/S0091-3057(96)00449-2; Marinelli M, 2000, J NEUROSCI, V20, P8876; MARTIN SP, 1990, PHARMACOL BIOCHEM BE, V37, P493, DOI 10.1016/0091-3057(90)90018-D; MICZEK KA, 1983, PSYCHOPHARMACOLOGY, V81, P183, DOI 10.1007/BF00427259; Morgan D, 2000, AM J PRIMATOL, V52, P115, DOI 10.1002/1098-2345(200011)52:3<115::AID-AJP1>3.0.CO;2-Z; Nader MA, 1999, PSYCHOPHARMACOLOGY, V147, P143, DOI 10.1007/s002130051154; NADER MA, 1991, PSYCHOPHARMACOLOGY, V105, P169, DOI 10.1007/BF02244304; Nader MA, 1999, NEUROPSYCHOPHARMACOL, V21, P589, DOI 10.1016/S0893-133X(98)00101-8; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V115, P407, DOI 10.1007/BF02245084; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; Piazza PV, 2000, J NEUROSCI, V20, P4226; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; RILKE O, 1995, PHARMACOL BIOCHEM BE, V52, P23, DOI 10.1016/0091-3057(95)00093-C; SCHENK S, 1987, NEUROSCI LETT, V81, P227, DOI 10.1016/0304-3940(87)91003-2; Schultz W, 2000, CEREB CORTEX, V10, P272, DOI 10.1093/cercor/10.3.272; Verhoeff NPLG, 1999, PSYCHOPHARMACOLOGY, V147, P217, DOI 10.1007/s002130051163; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Volkow ND, 1999, AM J PSYCHIAT, V156, P1440; VOLKOW ND, 1993, SYNAPSE, V14, P169, DOI 10.1002/syn.890140210; VOLKOW ND, 1990, AM J PSYCHIAT, V147, P719; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141	42	447	458	0	20	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					169	174		10.1038/nn798	http://dx.doi.org/10.1038/nn798			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802171				2022-12-24	WOS:000173558400020
J	Luo, M; Katz, LC				Luo, M; Katz, LC			Response correlation maps of neurons in the mammalian olfactory bulb	NEURON			English	Article							MITRAL TUFTED CELLS; CAT STRIATE CORTEX; ODOR STIMULATION; MITRAL/TUFTED CELLS; RECEPTIVE-FIELDS; GLOMERULAR LAYER; ORGANIZATION; SALAMANDER; REPRESENTATIONS; COMBINATORIAL	To define the relationship between glomerular activation patterns and neuronal olfactory responses in the main olfactory bulb, intracellular recordings were combined with optical imaging of intrinsic signals. Response correlation maps (RCMs) were constructed by correlating the fluctuations in membrane potential and firing rate during odorant presentations with patterns of glomerular activation. The RCMs indicated that mitral/tufted cells were excited by activation of a focal region surrounding their principal glomerulus and generally inhibited by activation of more distant regions. However, the structure of the RCMs and the relative contribution of excitatory and inhibitory glomerular input evolved and even changed sign during and after odorant application. These data suggest a dynamic center-surround organization of mitral/tufted cell receptive fields.	Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University	Luo, M (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.			Luo, Minmin/0000-0003-3535-6624				BAIER H, 1994, J NEUROSCI, V14, P219; Belluscio L, 2001, J NEUROSCI, V21, P2113, DOI 10.1523/JNEUROSCI.21-06-02113.2001; BUONVISO N, 1991, J COMP NEUROL, V307, P57, DOI 10.1002/cne.903070106; Buonviso N, 1996, J NEUROPHYSIOL, V76, P2393, DOI 10.1152/jn.1996.76.4.2393; BUONVISO N, 1992, J NEUROPHYSIOL, V68, P417, DOI 10.1152/jn.1992.68.2.417; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chalansonnet M, 1998, CHEM SENSES, V23, P1; Christensen TA, 2000, NAT NEUROSCI, V3, P927, DOI 10.1038/78840; CINELLI AR, 1995, J NEUROPHYSIOL, V73, P2053, DOI 10.1152/jn.1995.73.5.2053; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; DEANGELIS GC, 1995, TRENDS NEUROSCI, V18, P451, DOI 10.1016/0166-2236(95)94496-R; Delaney K, 2001, EUR J NEUROSCI, V13, P1658, DOI 10.1046/j.1460-9568.2001.01545.x; DEMONASTERIO FM, 1979, BRAIN RES, V166, P39, DOI 10.1016/0006-8993(79)90647-4; DOVING KB, 1966, J PHYSIOL-LONDON, V186, P97; EZEH PI, 1993, J NEUROPHYSIOL, V70, P263, DOI 10.1152/jn.1993.70.1.263; Friedrich RW, 1998, J NEUROSCI, V18, P9977; Friedrich RW, 1997, NEURON, V18, P737, DOI 10.1016/S0896-6273(00)80314-1; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; HAMILTON KA, 1989, J NEUROPHYSIOL, V62, P609, DOI 10.1152/jn.1989.62.3.609; Hopfield JJ, 1999, P NATL ACAD SCI USA, V96, P12506, DOI 10.1073/pnas.96.22.12506; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; IMAMURA K, 1992, J NEUROPHYSIOL, V68, P1986, DOI 10.1152/jn.1992.68.6.1986; JAHR CE, 1980, SCIENCE, V207, P1473, DOI 10.1126/science.7361098; Jenison RL, 2001, J NEUROSCI, V21, P4408, DOI 10.1523/JNEUROSCI.21-12-04408.2001; JIANG T, 1992, J NEUROPHYSIOL, V68, P726, DOI 10.1152/jn.1992.68.3.726; Johnson BA, 2000, J COMP NEUROL, V426, P330, DOI 10.1002/1096-9861(20001016)426:2<330::AID-CNE12>3.0.CO;2-5; Johnson BA, 1998, J COMP NEUROL, V393, P457, DOI 10.1002/(SICI)1096-9861(19980420)393:4<457::AID-CNE5>3.0.CO;2-#; Johnson BA, 2000, J COMP NEUROL, V422, P496, DOI 10.1002/1096-9861(20000710)422:4<496::AID-CNE2>3.0.CO;2-4; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; Kashiwadani H, 1999, J NEUROPHYSIOL, V82, P1786, DOI 10.1152/jn.1999.82.4.1786; KATOH K, 1993, J NEUROPHYSIOL, V70, P2161, DOI 10.1152/jn.1993.70.5.2161; KATZ LC, 1994, J NEUROSCI METH, V54, P205, DOI 10.1016/0165-0270(94)90194-5; KAUER JS, 1988, NATURE, V331, P166, DOI 10.1038/331166a0; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P717, DOI 10.1113/jphysiol.1974.sp010773; King JR, 2000, J NEUROSCI, V20, P2391; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Laurent G, 1997, CURR OPIN NEUROBIOL, V7, P547, DOI 10.1016/S0959-4388(97)80035-9; Ma MH, 2000, P NATL ACAD SCI USA, V97, P12869, DOI 10.1073/pnas.220301797; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; MCLEAN J, 1994, VISUAL NEUROSCI, V11, P271, DOI 10.1017/S0952523800001632; Meister M, 2001, J NEUROSCI, V21, P1351; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORI K, 1982, J NEUROSCI, V2, P497; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Mori Kensaku, 1994, Seminars in Cell Biology, V5, P65, DOI 10.1006/scel.1994.1009; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; NOWYCKY MC, 1981, J NEUROPHYSIOL, V46, P639, DOI 10.1152/jn.1981.46.3.639; RALL W, 1966, EXP NEUROL, V14, P44, DOI 10.1016/0014-4886(66)90023-9; RESSLER KJ, 1993, CELL, V73, P597, DOI 10.1016/0092-8674(93)90145-G; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; VASSAR R, 1994, CELL, V79, P981, DOI 10.1016/0092-8674(94)90029-9; WELLIS DP, 1990, J NEUROPHYSIOL, V64, P932, DOI 10.1152/jn.1990.64.3.932; WELLIS DP, 1989, J NEUROPHYSIOL, V61, P1161, DOI 10.1152/jn.1989.61.6.1161; WIESEL TN, 1966, J NEUROPHYSIOL, V29, P1115, DOI 10.1152/jn.1966.29.6.1115; WILSON DA, 1987, BRAIN RES, V417, P175, DOI 10.1016/0006-8993(87)90196-X; Wilson DA, 2001, CHEM SENSES, V26, P577, DOI 10.1093/chemse/26.5.577; Wilson DA, 2000, J NEUROPHYSIOL, V84, P3036, DOI 10.1152/jn.2000.84.6.3036; Xu FQ, 2000, J COMP NEUROL, V422, P489, DOI 10.1002/1096-9861(20000710)422:4<489::AID-CNE1>3.0.CO;2-#; Yang XJ, 1998, P NATL ACAD SCI USA, V95, P7715, DOI 10.1073/pnas.95.13.7715; YOKOI M, 1995, P NATL ACAD SCI USA, V92, P3371, DOI 10.1073/pnas.92.8.3371; Yoshihara Y, 2001, SCIENCE, V291, P835, DOI 10.1126/science.1058773	68	139	142	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1165	1179		10.1016/S0896-6273(01)00537-2	http://dx.doi.org/10.1016/S0896-6273(01)00537-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754845	Bronze			2022-12-24	WOS:000172886800020
J	Thomas, MJ; Beurrier, C; Bonci, A; Malenka, RC				Thomas, MJ; Beurrier, C; Bonci, A; Malenka, RC			Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine	NATURE NEUROSCIENCE			English	Article							AMPHETAMINE ADMINISTRATION ALTERS; MEDIAL PREFRONTAL CORTEX; IBOTENIC ACID LESIONS; EXTRACELLULAR DOPAMINE; SYNAPTIC PLASTICITY; SHELL; EXPRESSION; RAT; POTENTIATION; TRANSMISSION	A compelling model of experience-dependent plasticity is the long-lasting sensitization to the locomotor stimulatory effects of drugs of abuse. Adaptations in the nucleus accumbens (NAc), a component of the mesolimbic dopamine system, are thought to contribute to this behavioral change. Here we examine excitatory synaptic transmission in NAc slices prepared from animals displaying sensitization 10-14 days after repeated in vivo cocaine exposure. The ratio of AMPA (alpha -amino-3-hydroxy-5-methyl-4- isoxazole propionic acid) receptor- to NMDA (N-methyl-D-aspartate) receptor-mediated excitatory postsynaptic currents (EPSCs) was decreased at synapses made by prefrontal cortical afferents onto medium spiny neurons in the shell of the NAc. The amplitude of miniature EPSCs at these synapses also was decreased, as was the magnitude of long-term depression. These data suggest that chronic in vivo administration of cocaine elicits a long-lasting depression of excitatory synaptic transmission in the NAc, a change that may contribute to behavioral sensitization and addiction.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Univ Calif San Francisco, Dept Neurol, Ernest Gallo Clin & Res Ctr, San Francisco, CA 94110 USA	Stanford University; University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.		Thomas, Mark John/HHC-7509-2022; Jansen, Heiko T./A-5770-2008	Thomas, Mark John/0000-0001-5721-5350; Jansen, Heiko T./0000-0003-0178-396X	NIDA NIH HHS [F32 DA005945] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA005945] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andersen P, 1996, J PHYSIOLOGY-PARIS, V90, P349, DOI 10.1016/S0928-4257(97)87917-X; Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; CAINE SB, 1995, BRAIN RES, V692, P47; Carlezon WA, 1996, J NEUROSCI, V16, P3112; CARLEZON WA, 1995, PSYCHOPHARMACOLOGY, V122, P194, DOI 10.1007/BF02246095; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Churchill L, 1999, J NEUROCHEM, V72, P2397, DOI 10.1046/j.1471-4159.1999.0722397.x; GODA Y, 1994, P NATL ACAD SCI USA, V91, P12942, DOI 10.1073/pnas.91.26.12942; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li Y, 1997, BEHAV BRAIN RES, V84, P285, DOI 10.1016/S0166-4328(96)00158-1; Lu WX, 1997, SYNAPSE, V26, P269, DOI 10.1002/(SICI)1098-2396(199707)26:3<269::AID-SYN8>3.0.CO;2-5; Lu WX, 1999, SYNAPSE, V32, P119, DOI 10.1002/(SICI)1098-2396(199905)32:2<119::AID-SYN5>3.0.CO;2-F; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; MCGINTY JF, 1999, ADV VENTRAL STRIATUM, V877; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; McKinzie DL, 1999, ANN NY ACAD SCI, V877, P788, DOI 10.1111/j.1749-6632.1999.tb09323.x; Moser EI, 1998, SCIENCE, V281, P2038, DOI 10.1126/science.281.5385.2038; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nicola SM, 1996, J NEUROSCI, V16, P1591; Oliet SHR, 1996, SCIENCE, V271, P1294, DOI 10.1126/science.271.5253.1294; Parkinson JA, 1999, J NEUROSCI, V19, P2401; PENNARTZ CMA, 1994, PROG NEUROBIOL, V42, P719, DOI 10.1016/0301-0082(94)90025-6; PIERCE RC, 1995, J PHARMACOL EXP THER, V275, P1019; Pierce RC, 1998, NEUROSCIENCE, V82, P1103; Pierce RC, 1996, J NEUROSCI, V16, P1550; Pontieri FE, 1995, P NATL ACAD SCI USA, V92, P12304, DOI 10.1073/pnas.92.26.12304; PONTIERI FE, 1994, NEUROREPORT, V5, P2561, DOI 10.1097/00001756-199412000-00039; Rioult-Pedotti MS, 2000, SCIENCE, V290, P533, DOI 10.1126/science.290.5491.533; Robinson TE, 1999, EUR J NEUROSCI, V11, P1598, DOI 10.1046/j.1460-9568.1999.00576.x; Robinson TE, 1997, J NEUROSCI, V17, P8491; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; SCHENK S, 1994, BRAIN RES, V659, P17, DOI 10.1016/0006-8993(94)90858-3; Segal D. S., 1983, STIMULANTS NEUROCHEM, P131; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Vanderschuren LJMJ, 2000, PSYCHOPHARMACOLOGY, V151, P99, DOI 10.1007/s002130000493; WHITE FJ, 1995, J PHARMACOL EXP THER, V273, P445; Wise RA, 1998, DRUG ALCOHOL DEPEN, V51, P13, DOI 10.1016/S0376-8716(98)00063-5; Wolf ME, 1998, PROG NEUROBIOL, V54, P679, DOI 10.1016/S0301-0082(97)00090-7; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhang XF, 1998, J NEUROSCI, V18, P488; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13	47	491	501	0	42	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1217	1223		10.1038/nn757	http://dx.doi.org/10.1038/nn757			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11694884				2022-12-24	WOS:000172525000018
J	Beaumont, V; Zhong, N; Fletcher, R; Froemke, RC; Zucker, RS				Beaumont, V; Zhong, N; Fletcher, R; Froemke, RC; Zucker, RS			Phosphorylation and local presynaptic protein synthesis in calcium- and calcineurin-dependent induction of crayfish long-term facilitation	NEURON			English	Article							LATE-PHASE LTP; NEUROMUSCULAR-JUNCTION; NERVE-TERMINALS; SYNAPTIC TRANSMISSION; TRANSMITTER RELEASE; GLUTAMATE RECEPTORS; HIPPOCAMPAL SLICES; MOTOR SYNAPSES; REQUIRING CAMP; VISUAL-CORTEX	Long-term facilitation at the crayfish opener muscle is elicited by prolonged high frequency stimulation, and arises from an increase in functional active zones, resulting in increased transmitter release. LTF induction depends critically upon presynaptic calcium accumulation and calcineurin (PP2B) activity. The protein synthesis dependence of this synaptic strengthening was investigated. LTF occurred without transcription, but the translation inhibitors cycloheximide and anisomycin, or local presynaptic injection of mRNA cap analog m(7)GpppG, impaired LTF expression. Both MAP kinase and phosphatidylinositol 3-OH kinase (PI3K) activation are implicated in this rapamycin-sensitive synaptic potentiation. This study defines an important role for protein synthesis in the expression of activity-dependent plasticity, and provides mechanistic insight for the induction of this process at presynaptic sites.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Beaumont, V (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Beaumont, Vahri/0000-0002-6488-2175; Zhong, Ning/0000-0002-3696-5301; Froemke, Robert/0000-0002-1230-6811				Alvarez J, 2000, PROG NEUROBIOL, V62, P1, DOI 10.1016/S0301-0082(99)00062-3; Amaldi F, 1997, Prog Mol Subcell Biol, V18, P1; ATWOOD HL, 1975, BRAIN RES, V100, P198, DOI 10.1016/0006-8993(75)90260-7; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bradley J, 1999, BRAIN RES, V815, P140, DOI 10.1016/S0006-8993(98)01112-3; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Crispino M, 1997, J NEUROSCI, V17, P7694; Crow T, 1999, J NEUROPHYSIOL, V82, P495, DOI 10.1152/jn.1999.82.1.495; DELANEY K, 1991, J NEUROSCI, V11, P2631; DELANEY KR, 1989, J NEUROSCI, V9, P3558; Dufner A, 1999, EXP CELL RES, V253, P100, DOI 10.1006/excr.1999.4683; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Gray NK, 1998, ANNU REV CELL DEV BI, V14, P399, DOI 10.1146/annurev.cellbio.14.1.399; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hodgkiss JP, 1995, BRAIN RES, V705, P241, DOI 10.1016/0006-8993(95)01168-4; Huang YY, 2000, J NEUROSCI, V20, P6317, DOI 10.1523/JNEUROSCI.20-17-06317.2000; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Khan A, 2001, J NEUROSCI, V21, P382, DOI 10.1523/JNEUROSCI.21-02-00382.2001; Lazarovici P, 1996, ADV EXP MED BIOL, V391, P367; LNENICKA GA, 1985, J NEUROBIOL, V16, P97, DOI 10.1002/neu.480160203; Lu YF, 1999, J NEUROSCI, V19, P10250; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Martin R, 1998, J CELL SCI, V111, P3157; Merlin LR, 1998, J NEUROPHYSIOL, V80, P989, DOI 10.1152/jn.1998.80.2.989; MING XF, 1994, NATURE, V371, P426, DOI 10.1038/371426a0; MULKEY RM, 1991, NATURE, V350, P153, DOI 10.1038/350153a0; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; MULLER D, 1995, NEURON, V14, P599, DOI 10.1016/0896-6273(95)90316-X; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nguyen PV, 1997, LEARN MEMORY, V4, P230, DOI 10.1101/lm.4.2.230; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Parnas I, 1996, EUR J NEUROSCI, V8, P116, DOI 10.1111/j.1460-9568.1996.tb01172.x; Raught B, 1999, INT J BIOCHEM CELL B, V31, P43, DOI 10.1016/S1357-2725(98)00131-9; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Roberts LA, 1998, MOL BRAIN RES, V56, P38, DOI 10.1016/S0169-328X(98)00026-6; Schilhab TSS, 1996, NEUROSCIENCE, V73, P999, DOI 10.1016/0306-4522(96)00068-1; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sotelo JR, 1999, NEUROSCIENCE, V90, P705, DOI 10.1016/S0306-4522(98)00587-9; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; TORII N, 1995, NEUROSCI LETT, V185, P1, DOI 10.1016/0304-3940(94)11210-A; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WOJTOWICZ JM, 1988, J NEUROSCI, V8, P4667; WOJTOWICZ JM, 1988, NEUROSCI LETT, V90, P152, DOI 10.1016/0304-3940(88)90803-8; WOJTOWICZ JM, 1986, J NEUROPHYSIOL, V55, P484, DOI 10.1152/jn.1986.55.3.484; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; Xie KW, 1997, J NEUROSCI, V17, P2947; Yang SN, 1999, J NEUROPHYSIOL, V81, P781, DOI 10.1152/jn.1999.81.2.781; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	59	75	76	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					489	501		10.1016/S0896-6273(01)00483-4	http://dx.doi.org/10.1016/S0896-6273(01)00483-4			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709159	Bronze			2022-12-24	WOS:000172119100014
J	Luthi, A; Schwyzer, L; Mateos, JM; Gahwiler, BH; McKinney, RA				Luthi, A; Schwyzer, L; Mateos, JM; Gahwiler, BH; McKinney, RA			NMDA receptor activation limits the number of synaptic connections during hippocampal development	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; NEONATAL HIPPOCAMPUS; EXCITATORY SYNAPSES; AMPA RECEPTORS; IN-VITRO; MATURATION; CA1; OSCILLATIONS; INDUCTION	Activity-dependent synaptic plasticity triggered by N-methyl-D-aspartate (NMDA) receptor activation is a fundamental property of many glutamatergic synapses and may be critical for the shaping and refinement of the structural and functional properties of neuronal circuits during early postnatal development. Using a combined morphological and electrophysiological approach, we showed that chronic blockade of NMDA receptors in hippocampal slice cultures during the first two weeks of postnatal development leads to a substantial increase in synapse number and results in a more complex dendritic arborization of CA1 pyramidal cells. Thus, the development of excitatory circuitry in the hippocampus is determined by two opposing processes: NMDA receptor-independent synapse formation and NMDA receptor-dependent attenuation of synaptogenesis.	Univ Zurich, Brain Res Inst, CH-8057 Zurich, Switzerland	University of Zurich	McKinney, RA (corresponding author), Univ Zurich, Brain Res Inst, Winterthurerstr 190, CH-8057 Zurich, Switzerland.			Mateos, Jose Maria/0000-0002-3675-6198				BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Cline H., 1999, DENDRITES, P35; Colonnese MT, 2001, J NEUROSCI, V21, P1557, DOI 10.1523/JNEUROSCI.21-05-01557.2001; Constantine-Paton M, 1998, CURR OPIN NEUROBIOL, V8, P139, DOI 10.1016/S0959-4388(98)80017-2; Debanne D, 1997, J NEUROPHYSIOL, V77, P2851, DOI 10.1152/jn.1997.77.5.2851; Debanne D, 1996, P NATL ACAD SCI USA, V93, P11225, DOI 10.1073/pnas.93.20.11225; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Gahwiler BH, 1998, CULTURING NERVE CELL, P461; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; Gomperts SN, 2000, J NEUROSCI, V20, P2229; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HESS G, 1987, NEUROSCI LETT, V77, P187, DOI 10.1016/0304-3940(87)90584-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Katz LC, 1999, CELL, V99, P673, DOI 10.1016/S0092-8674(00)81665-7; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McKinney RA, 1997, NAT MED, V3, P990, DOI 10.1038/nm0997-990; McKinney RA, 1999, P NATL ACAD SCI USA, V96, P11631, DOI 10.1073/pnas.96.20.11631; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; RABACCHI S, 1992, SCIENCE, V256, P1823, DOI 10.1126/science.1352066; ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026; Rohrbough J, 1999, J NEUROSCI, V19, P8528; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zou DJ, 1999, J NEUROSCI, V19, P8909, DOI 10.1523/JNEUROSCI.19-20-08909.1999	36	110	115	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1102	1107		10.1038/nn744	http://dx.doi.org/10.1038/nn744			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687815				2022-12-24	WOS:000171970900013
J	Hao, JC; Yu, TW; Fujisawa, K; Culotti, JG; Gengyo-Ando, K; Mitani, S; Moulder, G; Barstead, R; Tessier-Lavigne, M; Bargmann, CI				Hao, JC; Yu, TW; Fujisawa, K; Culotti, JG; Gengyo-Ando, K; Mitani, S; Moulder, G; Barstead, R; Tessier-Lavigne, M; Bargmann, CI			C-elegans slit acts in midline, dorsal-ventral, and anterior-posterior guidance via the SAX-3/Robo receptor	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; AXON GUIDANCE; TRANSMEMBRANE PROTEIN; NEURONAL MIGRATION; VERTEBRATE SLIT; SEMAPHORIN-III; CELL LINEAGE; NETRIN CUES; GENES; MORPHOGENESIS	Robo receptors interact with ligands of the Slit family. The nematode C. elegans has one Robo receptor (SAX-3) and one Slit protein (SLT-1), which direct ventral axon guidance and guidance at the midline. In larvae, slt-1 expression in dorsal muscles repels axons to promote ventral guidance. SLT-1 acts through the SAX-3 receptor, in parallel with the ventral attractant UNC-6 (Netrin). Removing both UNC-6 and SLT-1 eliminates all ventral guidance information for some axons, revealing an underlying longitudinal guidance pathway. In the embryo, slt-1 is expressed at high levels in anterior epidermis. Embryonic expression of SLT-1 provides anterior-posterior guidance information to migrating CAN neurons. Surprisingly, slt-1 mutants do not exhibit the nerve ring and epithelial defects of sax-3 mutants, suggesting that SAX-3 has both Slit-dependent and Slit-independent functions in development.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, Program Neurosci, San Francisco, CA 94143 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Tokyo Womens Med Univ, Sch Med, Dept Physiol, Tokyo 1628666, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo 1628666, Japan; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Tokyo Women's Medical University; Japan Science & Technology Agency (JST); Oklahoma Medical Research Foundation	Bargmann, CI (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA.	cori@itsa.ucsf.edu	Gengyo-Ando, Keiko/AAC-4504-2019; Yu, Timothy W./AAF-5738-2019; Gengyo-Ando, Keiko/B-2753-2012; Culotti, Joseph/G-6467-2013	Yu, Timothy W./0000-0003-2988-7701; Bargmann, Cornelia/0000-0002-8484-0618; Culotti, Joseph/0000-0001-6325-4612				Ba-Charvet KTN, 2001, J NEUROSCI, V21, P4281; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Battye R, 2001, J NEUROSCI, V21, P4290, DOI 10.1523/JNEUROSCI.21-12-04290.2001; BRENNER S, 1974, GENETICS, V77, P71; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Chin-Sang ID, 1999, CELL, V99, P781, DOI 10.1016/S0092-8674(00)81675-X; Dernburg AF, 1998, CELL, V94, P387, DOI 10.1016/S0092-8674(00)81481-6; Erskine L, 2000, J NEUROSCI, V20, P4975; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Forrester WC, 1999, NATURE, V400, P881, DOI 10.1038/23722; Forrester WC, 1998, GENETICS, V148, P151; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; George SE, 1998, CELL, V92, P633, DOI 10.1016/S0092-8674(00)81131-9; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; HUANG LS, 1994, MOL BIOL CELL, V5, P395, DOI 10.1091/mbc.5.4.395; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Piper M, 2000, MECH DEVELOP, V94, P213, DOI 10.1016/S0925-4773(00)00313-0; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; WilliamsMasson EM, 1997, DEVELOPMENT, V124, P2889; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1999, DEVELOPMENT, V126, P3679; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; [No title captured]	50	180	194	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					25	38		10.1016/S0896-6273(01)00448-2	http://dx.doi.org/10.1016/S0896-6273(01)00448-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604136	Bronze			2022-12-24	WOS:000171525200006
J	Klyachko, VA; Ahern, GP; Jackson, MB				Klyachko, VA; Ahern, GP; Jackson, MB			CGMP-mediated facilitation in nerve terminals by enhancement of the spike afterhyperpolarization	NEURON			English	Article							LONG-TERM POTENTIATION; NITRIC-OXIDE; INTRACELLULAR CALCIUM; TRANSMITTER RELEASE; POTASSIUM CHANNELS; CYCLIC-GMP; INDUCTION; DEPOLARIZATION; ARBORIZATION; VASOPRESSIN	cGMP has long been suspected to play a role in synaptic plasticity, but the inaccessibility of nerve terminals to electrical recording has impeded tests of this hypothesis. In posterior pituitary nerve terminals, nitric oxide enhanced Ca2+-activated K+ channel activity by activating guanylate cyclase and PKG. This enhancement occured only at depolarized potentials, so the spike threshold remained unaltered but the afterhyperpolarization became larger. During spike trains, the enhanced afterhyperpolarization promoted Na+ channel recovery from inactivation, thus reducing action potential failures and allowing more Ca2+ to enter. Activating guanylate cyclase, either with applied nitric oxide, or with physiological stimulation to activate nitric oxide synthase, increased action potential firing. Thus, the cGMP/nitric oxide cascade generates a shortterm, use-dependent enhancement of release.	Univ Wisconsin, Dept Physiol & Biophys, PhD Program, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Physiol & Biophys, PhD Program, 1300 Univ Ave, Madison, WI 53706 USA.	mjackson@physiology.wisc.edu	Klyachko, Vitaly/E-9431-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030016, R01NS030016] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 30016] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahern GP, 1999, J PHYSIOL-LONDON, V520, P165, DOI 10.1111/j.1469-7793.1999.00165.x; Ahern GP, 2000, J BIOL CHEM, V275, P28810, DOI 10.1074/jbc.M003090200; Arancio O, 1996, CELL, V87, P1025, DOI 10.1016/S0092-8674(00)81797-3; ARANCIO O, 1995, NATURE, V376, P74, DOI 10.1038/376074a0; BIELEFELDT K, 1993, J NEUROPHYSIOL, V70, P284, DOI 10.1152/jn.1993.70.1.284; BIELEFELDT K, 1994, J PHYSIOL-LONDON, V475, P241, DOI 10.1113/jphysiol.1994.sp020065; BIELEFELDT K, 1992, J PHYSIOL-LONDON, V458, P41, DOI 10.1113/jphysiol.1992.sp019405; BOLOTINA VM, 1994, NATURE, V368, P850, DOI 10.1038/368850a0; BOURQUE CW, 1990, J PHYSIOL-LONDON, V421, P247, DOI 10.1113/jphysiol.1990.sp017943; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; BRETHES D, 1987, P NATL ACAD SCI USA, V84, P1439, DOI 10.1073/pnas.84.5.1439; Broillet MC, 1997, NEURON, V18, P951, DOI 10.1016/S0896-6273(00)80334-7; Calabresi P, 1999, J NEUROSCI, V19, P2489; CHARLTON MP, 1978, J GEN PHYSIOL, V72, P487, DOI 10.1085/jgp.72.4.487; Chen CH, 1998, NEUROSCI LETT, V248, P127, DOI 10.1016/S0304-3940(98)00316-4; DERRICK BE, 1991, BRAIN RES BULL, V27, P219, DOI 10.1016/0361-9230(91)90071-Q; DEVENTE J, 1992, ACTA HISTOCHEM, V92, P13, DOI 10.1016/S0065-1281(11)80138-8; GAINER H, 1986, NEUROENDOCRINOLOGY, V43, P557, DOI 10.1159/000124582; GARTHWAITE J, 1995, ANNU REV PHYSIOL, V57, P683, DOI 10.1146/annurev.ph.57.030195.003343; GOLDSTEIN SS, 1974, BIOPHYS J, V14, P731, DOI 10.1016/S0006-3495(74)85947-3; GRAHAM B, 1994, J NEUROPHYSIOL, V71, P538, DOI 10.1152/jn.1994.71.2.538; Hindley S, 1997, J NEUROSCI RES, V47, P427; Holscher C, 1997, TRENDS NEUROSCI, V20, P298, DOI 10.1016/S0166-2236(97)01065-5; Hsu SF, 1996, J PHYSIOL-LONDON, V494, P539, DOI 10.1113/jphysiol.1996.sp021512; Hsu SF, 1999, J NEUROSCI METH, V90, P67, DOI 10.1016/S0165-0270(99)00071-0; JACKSON MB, 1993, J NEUROPHYSIOL, V69, P692, DOI 10.1152/jn.1993.69.3.692; JACKSON MB, 1991, P NATL ACAD SCI USA, V88, P380, DOI 10.1073/pnas.88.2.380; JACKSON MB, 1995, J PHYSIOL-LONDON, V483, P597, DOI 10.1113/jphysiol.1995.sp020609; KHARITONOV VG, 1995, J BIOL CHEM, V270, P28158; Lei SB, 2000, NAT NEUROSCI, V3, P559, DOI 10.1038/75729; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; MEFFERT MK, 1994, NEURON, V12, P1235, DOI 10.1016/0896-6273(94)90440-5; MURPHY KPSJ, 1994, NEUROPHARMACOLOGY, V33, P1375, DOI 10.1016/0028-3908(94)90039-6; Muschol M, 2000, J NEUROSCI, V20, P6773, DOI 10.1523/JNEUROSCI.20-18-06773.2000; Obaid AL, 1996, J GEN PHYSIOL, V107, P353, DOI 10.1085/jgp.107.3.353; OGILVIE P, 1995, FASEB J, V9, P799, DOI 10.1096/fasebj.9.9.7541381; PACKER L, 1996, NITRIC OXIDE, V268; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; RENAUD LP, 1991, PROG NEUROBIOL, V36, P131, DOI 10.1016/0301-0082(91)90020-2; Rudy B, 1999, ANN NY ACAD SCI, V868, P304, DOI 10.1111/j.1749-6632.1999.tb11295.x; SCHUMAN EM, 1991, SCIENCE, V254, P1503, DOI 10.1126/science.1720572; SCHUMAN EM, 1994, P NATL ACAD SCI USA, V91, P11958, DOI 10.1073/pnas.91.25.11958; SEGEV I, 1990, J NEUROPHYSIOL, V63, P987, DOI 10.1152/jn.1990.63.5.987; SHIBUKI K, 1991, NATURE, V349, P326, DOI 10.1038/349326a0; Son H, 1996, CELL, V87, P1015, DOI 10.1016/S0092-8674(00)81796-1; STAMLER JS, 1992, P NATL ACAD SCI USA, V89, P444, DOI 10.1073/pnas.89.1.444; STUENKEL EL, 1990, BRAIN RES, V529, P96, DOI 10.1016/0006-8993(90)90815-S; STUENKEL EL, 1994, J PHYSIOL-LONDON, V481, P251, DOI 10.1113/jphysiol.1994.sp020436; Swayze RD, 2001, J BIOL CHEM, V276, P19729, DOI 10.1074/jbc.M005711200; VALE MR, 1982, J NEUROCHEM, V39, P569, DOI 10.1111/j.1471-4159.1982.tb03983.x; WANG G, 1992, J PHYSIOL-LONDON, V457, P47, DOI 10.1113/jphysiol.1992.sp019364; White RE, 1999, ADV SEC MESS PHOSPH, V33, P251; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; ZHANG SLJ, 1993, SCIENCE, V259, P531, DOI 10.1126/science.8380942; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; ZUCKER RS, 1974, J PHYSIOL-LONDON, V241, P111, DOI 10.1113/jphysiol.1974.sp010643	57	62	67	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					1015	1025		10.1016/S0896-6273(01)00449-4	http://dx.doi.org/10.1016/S0896-6273(01)00449-4			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580900	Bronze			2022-12-24	WOS:000171281300015
J	Voets, T; Toonen, RF; Brian, EC; de Wit, H; Moser, T; Rettig, J; Sudhof, TC; Neher, E; Verhage, M				Voets, T; Toonen, RF; Brian, EC; de Wit, H; Moser, T; Rettig, J; Sudhof, TC; Neher, E; Verhage, M			Munc18-1 promotes large dense-core vesicle docking	NEURON			English	Article							MOUSE ADRENAL SLICES; CHROMAFFIN CELLS; NEUROTRANSMITTER RELEASE; MEMBRANE-FUSION; REGULATED EXOCYTOSIS; TRANSMITTER RELEASE; PC12 CELLS; COMPLEX; SECRETION; PROTEINS	Secretory vesicles dock at the plasma membrane before Ca2+ triggers their exocytosis. Exocytosis requires the assembly of SNARE complexes formed by the vesicle protein Synaptobrevin and the membrane proteins Syntaxin-1 and SNAP-25. We analyzed the role of Munc18-1, a cytosolic binding partner of Syntaxin-1, in large dense-core vesicle (LDCV) secretion. Calcium-dependent LDCV exocytosis was reduced 10-fold in mouse chromaffin cells lacking Munc18-1, but the kinetic properties of the remaining release, including single fusion events, were not different from controls. Concomitantly, mutant cells displayed a 10-fold reduction in morphologically docked LDCVs. Moreover, acute overexpression of Munc18-1 in bovine chromaffin cells increased the amount of releasable vesicles and accelerated vesicle supply. We conclude that Munc18-1 functions upstream of SNARE complex formation and promotes LDCV docking.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Gottingen, Sch Med, Dept Otolaryngol, D-37073 Gottingen, Germany; Univ Utrecht, Med Ctr, Mol Neurosci Rudolf Magnus Inst, NL-3584 CG Utrecht, Netherlands; Univ Texas, SW Med Ctr, Dept Mol Genet, Dallas, TX 75235 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Howard Hughes Med Inst, Dallas, TX 75235 USA	Max Planck Society; University of Gottingen; Utrecht University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Voets, T (corresponding author), Katholieke Univ Leuven, Fysiol Lab, Campus Gasthuisberg O&N, B-3000 Louvain, Belgium.	thomas.voets@med.kuleuven.ac.be	Rettig, Jens/K-5103-2013; Voets, Thomas/AAD-4389-2019; Voets, Thomas/E-2466-2012; Neher, Erwin/A-2109-2013; Moser, Tobias/L-5068-2014	Rettig, Jens/0000-0001-6160-3954; Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Moser, Tobias/0000-0001-7145-0533; verhage, matthijs/0000-0002-6085-7503				Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Ashery U, 1999, EUR J CELL BIOL, V78, P525, DOI 10.1016/S0171-9335(99)80017-X; Augustine GJ, 1999, J PHYSIOL-LONDON, V520, P33, DOI 10.1111/j.1469-7793.1999.00033.x; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Brose N, 2000, CURR OPIN NEUROBIOL, V10, P303, DOI 10.1016/S0959-4388(00)00105-7; Brunger AT, 2000, CURR OPIN NEUROBIOL, V10, P293, DOI 10.1016/S0959-4388(00)00098-2; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Dresbach T, 1998, J NEUROSCI, V18, P2923; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; EDELMANN L, 1995, EMBO J, V14, P224, DOI 10.1002/j.1460-2075.1995.tb06995.x; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GORGAS K, 1977, HISTOCHEMISTRY, V50, P17, DOI 10.1007/BF00492782; Grabowski R, 1997, FEBS LETT, V411, P169, DOI 10.1016/S0014-5793(97)00720-5; Graham ME, 1997, J NEUROCHEM, V69, P2369; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Jahn R, 2000, NEURON, V27, P201, DOI 10.1016/S0896-6273(00)00029-5; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Morgan A, 1997, SEMIN CELL DEV BIOL, V8, P141, DOI 10.1006/scdb.1996.0133; Moser T, 1997, J NEUROSCI, V17, P2314; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Nichols BJ, 1998, EUR J CELL BIOL, V77, P263, DOI 10.1016/S0171-9335(98)80084-8; Niemann Heiner, 1994, Trends in Cell Biology, V4, P179, DOI 10.1016/0962-8924(94)90203-8; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Okamoto M, 1997, J BIOL CHEM, V272, P31459, DOI 10.1074/jbc.272.50.31459; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Reim K, 2001, CELL, V104, P71, DOI 10.1016/S0092-8674(01)00192-1; Robinson LJ, 1998, CURR OPIN CELL BIOL, V10, P483, DOI 10.1016/S0955-0674(98)80063-X; ROSENTHAL RN, 1977, BRIT J PHARMACOL, V60, P59, DOI 10.1111/j.1476-5381.1977.tb16747.x; Sassa T, 1999, J NEUROSCI, V19, P4772; Schulte A, 1996, ANAL CHEM, V68, P3054, DOI 10.1021/ac960210n; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SLOTKIN TA, 1980, BIOGENIC AMINES DEV, P29; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Tokumaru H, 2001, CELL, V104, P421, DOI 10.1016/S0092-8674(01)00229-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Voets T, 2000, NEURON, V28, P537, DOI 10.1016/S0896-6273(00)00131-8; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; Watanabe T, 1999, J BIOCHEM-TOKYO, V125, P685, DOI 10.1093/oxfordjournals.jbchem.a022337; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	58	284	296	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 30	2001	31	4					581	591		10.1016/S0896-6273(01)00391-9	http://dx.doi.org/10.1016/S0896-6273(01)00391-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545717	Bronze			2022-12-24	WOS:000170759200012
J	Hormuzdi, SG; Pais, I; LeBeau, FEN; Towers, SK; Rozov, A; Buhl, EH; Whittington, MA; Monyer, H				Hormuzdi, SG; Pais, I; LeBeau, FEN; Towers, SK; Rozov, A; Buhl, EH; Whittington, MA; Monyer, H			Impaired electrical signaling disrupts gamma frequency oscillations in connexin 36-deficient mice	NEURON			English	Article							HIPPOCAMPUS IN-VITRO; GAP-JUNCTIONS; NETWORK OSCILLATIONS; NERVOUS-SYSTEM; BRAIN NEURONS; RAT; EXPRESSION; CX36; SYNCHRONIZATION; RECOMBINATION	Neural processing occurs in parallel in distant cortical areas even for simple perceptual tasks. Associated cognitive binding is believed to occur through the interareal synchronization of rhythmic activity in the gamma (30-80 Hz) range. Such oscillations arise as an emergent property of the neuronal network and require conventional chemical neurotransmission. To test the potential role of gap junction-mediated electrical signaling in this network property, we generated mice lacking connexin 36, the major neuronal connexin. Here we show that the loss of this protein disrupts gamma frequency network oscillations in vitro but leaves high frequency (150 Hz) rhythms, which may involve gap junctions between principal cells (Schmitz et al., 2001), unaffected. Thus, specific connexins differentially deployed throughout cortical networks are likely to regulate different functional aspects of neuronal information processing in the mature brain.	Univ Hosp Neurol, Dept Clin Neurobiol, Heidelberg, Germany; Univ Leeds, Sch Biomed Sci, Leeds LS2 9NQ, W Yorkshire, England; Max Planck Inst Med Res, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg; University of Leeds; Max Planck Society	Monyer, H (corresponding author), Univ Hosp Neurol, Dept Clin Neurobiol, Neuenheimer Feld 364, Heidelberg, Germany.	monyer@urz.unl-hd.de	Rozov, Andrei/C-1997-2015	LeBeau, Fiona/0000-0003-1453-4022; Whittington, Miles Adrian/0000-0002-0247-1362; Monyer, Hannah/0000-0002-9332-5749				Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BRAGIN A, 1995, J NEUROSCI, V15, P47; BRONSON SK, 1994, J BIOL CHEM, V269, P27155; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Cape EG, 2000, J NEUROSCI, V20, P8452, DOI 10.1523/JNEUROSCI.20-22-08452.2000; CAPECCHI MR, 1989, TRENDS GENET, V5, P70, DOI 10.1016/0168-9525(89)90029-2; Condorelli DF, 1998, EUR J NEUROSCI, V10, P1202, DOI 10.1046/j.1460-9568.1998.00163.x; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Gulisano M, 2000, NEUROREPORT, V11, P3823, DOI 10.1097/00001756-200011270-00045; Jones MS, 1999, J NEUROPHYSIOL, V82, P1599, DOI 10.1152/jn.1999.82.3.1599; Kandler Karl, 1995, Current Opinion in Neurobiology, V5, P98, DOI 10.1016/0959-4388(95)80093-X; Karbowski J, 2000, NEURAL COMPUT, V12, P1573, DOI 10.1162/089976600300015277; Parenti R, 2000, NEUROREPORT, V11, P1497, DOI 10.1097/00001756-200005150-00027; SCHMITZ D, 2001, IN PRESS NEURON; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; Siapas AG, 1998, NEURON, V21, P1123, DOI 10.1016/S0896-6273(00)80629-7; Singer W, 1999, CURR OPIN NEUROBIOL, V9, P189, DOI 10.1016/S0959-4388(99)80026-9; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Traub RD, 1999, J NEUROSCI, V19, P1088; Traub RD, 1999, NEUROSCIENCE, V92, P407, DOI 10.1016/S0306-4522(98)00755-6; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; White JA, 1998, J COMPUT NEUROSCI, V5, P5, DOI 10.1023/A:1008841325921; Whittington MA, 2001, J NEUROSCI, V21, P1727, DOI 10.1523/JNEUROSCI.21-05-01727.2001; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; WISDEN W, 1994, IN SITU HYBRIDIZATIO, P9; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417	34	409	416	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					487	495		10.1016/S0896-6273(01)00387-7	http://dx.doi.org/10.1016/S0896-6273(01)00387-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516404	Bronze			2022-12-24	WOS:000170601000016
J	Ayalon, G; Stern-Bach, Y				Ayalon, G; Stern-Bach, Y			Functional assembly of AMPA and kainate receptors is mediated by several discrete protein-protein interactions	NEURON			English	Article							LIGAND-BINDING PROPERTIES; GLUTAMATE-RECEPTOR; SUBUNIT STOICHIOMETRY; INWARD RECTIFICATION; TETRAMERIC STRUCTURE; CHANNEL; DESENSITIZATION; SITE; CYCLOTHIAZIDE; PERSPECTIVE	Functional heterogeneity of ionotropic glutamate receptors arises not only from the existence of many subunits and isoforms, but also from combinatorial assembly creating channels with distinct properties. This heteromerization is subtype restricted and thought to be determined exclusively by the proximal extracellular N-terminal domain of the subunits. However, using functional assays for heteromer formation, we show that, besides the N-terminal domain, the membrane sector and the C-terminal part of S2 are critical determinants for the formation of functional channels. Our results are compatible with a model where the N-terminal domain only mediates the initial subunit associations into dimers, whereas for the assembly of the full functional tetramer, compatibility of the other regions is required.	Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Dept Anat & Cell Biol, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem	Stern-Bach, Y (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Dept Anat & Cell Biol, IL-91120 Jerusalem, Israel.	yaelb@cc.huji.ac.il						Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BEHE P, 1995, P ROY SOC B-BIOL SCI, V262, P205, DOI 10.1098/rspb.1995.0197; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; BROSE N, 1994, J BIOL CHEM, V269, P16780; Dingledine R, 1999, PHARMACOL REV, V51, P7; DONEVAN SD, 1995, P NATL ACAD SCI USA, V92, P9298, DOI 10.1073/pnas.92.20.9298; Eertmoed AL, 1999, J NEUROSCI, V19, P6298; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; FerrerMontiel AV, 1996, P NATL ACAD SCI USA, V93, P2741, DOI 10.1073/pnas.93.7.2741; Green WN, 1999, J GEN PHYSIOL, V113, P163, DOI 10.1085/jgp.113.2.163; HERB A, 1992, NEURON, V8, P775, DOI 10.1016/0896-6273(92)90098-X; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; HUGHES TE, 1994, J MOL NEUROSCI, V5, P211, DOI 10.1007/BF02736722; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Keller SH, 1999, J GEN PHYSIOL, V113, P171, DOI 10.1085/jgp.113.2.171; KOH DS, 1995, J PHYSL, V15, P305; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Kuusinen A, 1999, J BIOL CHEM, V274, P28937, DOI 10.1074/jbc.274.41.28937; Kuusinen A, 1995, EMBO J, V14, P6327, DOI 10.1002/j.1460-2075.1995.tb00323.x; Laube B, 1998, J NEUROSCI, V18, P2954; Leuschner WD, 1999, J BIOL CHEM, V274, P16907, DOI 10.1074/jbc.274.24.16907; Liu DT, 1998, NEURON, V21, P235, DOI 10.1016/S0896-6273(00)80530-9; Mano I, 1998, NEUROREPORT, V9, P327, DOI 10.1097/00001756-199801260-00027; MOSBACHER J, 1994, SCIENCE, V266, P1059, DOI 10.1126/science.7973663; OHARA PJ, 1993, NEURON, V11, P41, DOI 10.1016/0896-6273(93)90269-W; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; Papazian DM, 1999, NEURON, V23, P7, DOI 10.1016/S0896-6273(00)80746-1; PARTIN KM, 1993, NEURON, V11, P1069, DOI 10.1016/0896-6273(93)90220-L; PARTIN KM, 1994, MOL PHARMACOL, V46, P129; Premkumar LS, 1997, J GEN PHYSIOL, V110, P485, DOI 10.1085/jgp.110.5.485; PUCHALSKI RB, 1994, NEURON, V13, P131, DOI 10.1016/0896-6273(94)90464-2; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; Seeburg PH, 1996, J NEUROCHEM, V66, P1; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; SOMMER B, 1990, SCIENCE, V249, P1580, DOI 10.1126/science.1699275; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Swanson GT, 1997, J NEUROSCI, V17, P58, DOI 10.1523/JNEUROSCI.17-01-00058.1997; Tu LW, 1999, BIOPHYS J, V76, P2004, DOI 10.1016/S0006-3495(99)77358-3; UCHINO S, 1992, FEBS LETT, V308, P253, DOI 10.1016/0014-5793(92)81286-U; Washburn MS, 1997, J NEUROSCI, V17, P9393; WATKINS JC, 1981, ANNU REV PHARMACOL, V21, P165, DOI 10.1146/annurev.pa.21.040181.001121; Wells GB, 2001, J BIOL CHEM, V276, P3031, DOI 10.1074/jbc.M006668200; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; YAMADA KA, 1993, J NEUROSCI, V13, P3904	48	196	203	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2001	31	1					103	113		10.1016/S0896-6273(01)00333-6	http://dx.doi.org/10.1016/S0896-6273(01)00333-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498054	Bronze			2022-12-24	WOS:000170101100014
J	Frens, MA; Mathoera, AL; van der Steen, J				Frens, MA; Mathoera, AL; van der Steen, J			Floccular complex spike response to transparent retinal slip	NEURON			English	Article							EYE-MOVEMENTS; DEPRESSION; RABBIT; LABYRINTHECTOMY; ORGANIZATION; REFLEXES; NUCLEUS; INPUT	The flocculus of the rabbit is involved in the plasticity of compensatory eye movements. It is generally assumed that the climbing fiber input to floccular Purkinje cells encodes "retinal slip," which in turn would be a measure for the oculomotor performance error. To test this, we used transparent motion stimuli, creating a retinal slip signal that broke up this relation. We recorded the ensuing oculomotor behavior and complex spike activity of floccular Purkinje cells. Complex spike modulation in response to transparent stimulation was identical to that of a single optokinetic pattern, despite considerably different retinal slip. These results suggest that the climbing fiber code may be effectively related to the eye movement performance error, rather than to retinal slip.	Erasmus Univ, Dept Physiol, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam	Frens, MA (corresponding author), Erasmus Univ, Dept Physiol, POB 1738, NL-3000 DR Rotterdam, Netherlands.	frens@fys.fgg.eur.nl	van der Steen, Johannes/F-6767-2011	van der Steen, Johannes/0000-0002-3989-3075				BARMACK NH, 1985, J NEUROPHYSIOL, V53, P481, DOI 10.1152/jn.1985.53.2.481; BARMACK NH, 1980, BRAIN RES, V196, P520, DOI 10.1016/0006-8993(80)90418-7; COLLEWIJN H, 1969, VISION RES, V9, P117, DOI 10.1016/0042-6989(69)90035-2; COLLEWIJN H, 1976, EXP NEUROL, V52, P146, DOI 10.1016/0014-4886(76)90207-7; DEZEEUW CI, 1993, J COMP NEUROL, V327, P63, DOI 10.1002/cne.903270106; EPPING WJM, 1987, J NEUROPHYSIOL, V57, P1464, DOI 10.1152/jn.1987.57.5.1464; Frens MA, 2000, PROG BRAIN RES, V124, P247; GRAF W, 1988, J NEUROPHYSIOL, V60, P2091, DOI 10.1152/jn.1988.60.6.2091; Ilg UJ, 1996, EUR J NEUROSCI, V8, P92, DOI 10.1111/j.1460-9568.1996.tb01170.x; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; ITO M, 1993, REV NEUROL, V149, P692; LINDEN DJ, 1994, NEURON, V12, P457, DOI 10.1016/0896-6273(94)90205-4; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Mathoera AL, 1999, EXP BRAIN RES, V125, P87, DOI 10.1007/s002210050662; Raymond JL, 1998, J NEUROSCI, V18, P9112; Simpson JI, 1996, BEHAV BRAIN SCI, V19, P384, DOI 10.1017/S0140525X00081486; SIMPSON JI, 1999, SOC NEUR ABS; SOODAK RE, 1988, J NEUROPHYSIOL, V60, P2037, DOI 10.1152/jn.1988.60.6.2037; VANDERSTEEN J, 1994, J NEUROPHYSIOL, V72, P31, DOI 10.1152/jn.1994.72.1.31; VANDERSTEEN J, 1984, EXP BRAIN RES, V56, P263, DOI 10.1007/BF00236282; VANNEERVEN J, 1989, ARCH ITAL BIOL, V127, P243; WURTZ RH, 1971, SCIENCE, V171, P82, DOI 10.1126/science.171.3966.82	22	28	28	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					795	801		10.1016/S0896-6273(01)00321-X	http://dx.doi.org/10.1016/S0896-6273(01)00321-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430812	Bronze			2022-12-24	WOS:000169508900019
J	Bazhenov, M; Stopfer, M; Rabinovich, M; Abarbanel, HDI; Sejnowski, TJ; Laurent, G				Bazhenov, M; Stopfer, M; Rabinovich, M; Abarbanel, HDI; Sejnowski, TJ; Laurent, G			Model of cellular and network mechanisms for odor-evoked temporal patterning in the locust antennal lobe	NEURON			English	Article							OSCILLATING NEURAL ASSEMBLIES; OLFACTORY-BULB; REPRESENTATION; STIMULATION; COMPUTATION; INFORMATION; RESPONSES; PHEROMONE; NEURONS; MEMORY	Locust antennal lobe (AL) projection neurons (PNs) respond to olfactory stimuli with sequences of depolarizing and hyperpolarizing epochs, each lasting hundreds of milliseconds. A computer simulation of an AL network was used to test the hypothesis that slow inhibitory connections between local neurons (LNs) and PNs are responsible for temporal patterning. Activation of slow inhibitory receptors on PNs by the same GABAergic synapses that underlie fast oscillatory synchronization of PNs was sufficient to shape slow response modulations. This slow stimulus- and neuron-specific patterning of AL activity was resistant to blockade of fast inhibition. Fast and slow inhibitory mechanisms at synapses between LNs and PNs can thus form dynamical PN assemblies whose elements synchronize transiently and oscillate collectively, as observed not only in the locust AL, but also in the vertebrate olfactory bulb.	Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA; CALTECH, Div Biol, Pasadena, CA 91125 USA; Univ Calif San Diego, Inst Nonlinear Sci, La Jolla, CA 92093 USA; Univ Calif San Diego, Scripps Inst Oceanog, Dept Phys, La Jolla, CA 92093 USA; Univ Calif San Diego, Scripps Inst Oceanog, Marine Phys Lab, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; Salk Institute; California Institute of Technology; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Bazhenov, M (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Computat Neurobiol Lab, La Jolla, CA 92037 USA.		Laurent, Gilles/A-4583-2012; Sejnowski, Terrence/AAV-5558-2021; Abarbanel, Henry Don Isaac/AAX-3192-2021	Laurent, Gilles/0000-0002-2296-114X; Stopfer, Mark/0000-0001-9200-1884; Rabinovich, Mikhail I./0000-0003-4499-5348	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Bazhenov M, 1998, J NEUROPHYSIOL, V79, P2730, DOI 10.1152/jn.1998.79.5.2730; Bazhenov M, 2001, NEURON, V30, P553, DOI 10.1016/S0896-6273(01)00284-7; BURROWS M, 1982, J COMP PHYSIOL, V145, P447, DOI 10.1007/BF00612810; CHAPUT M, 1980, J PHYSIOL-PARIS, V76, P551; CHRISTENSEN TA, 1987, J COMP PHYSIOL A, V160, P553, DOI 10.1007/BF00611929; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; DUTAR P, 1988, NATURE, V332, P156, DOI 10.1038/332156a0; Enright W. H., 1995, SURVEY EXPLICIT RUNG; Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889; Golomb D, 2000, NEURAL COMPUT, V12, P1095, DOI 10.1162/089976600300015529; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; HUGUENARD JR, 1991, J NEUROPHYSIOL, V66, P1305; KAUER JS, 1974, J PHYSIOL-LONDON, V243, P695, DOI 10.1113/jphysiol.1974.sp010772; KAUER JS, 1977, J PHYSIOL-LONDON, V272, P495, DOI 10.1113/jphysiol.1977.sp012056; KERSZBERG M, 1995, BIOL CYBERN, V72, P487, DOI 10.1007/BF00199891; LAURENT G, 1993, J NEUROPHYSIOL, V69, P1484, DOI 10.1152/jn.1993.69.5.1484; LAURENT G, 1994, J NEUROSCI, V14, P2993; LAURENT G, 1994, SCIENCE, V265, P1872, DOI 10.1126/science.265.5180.1872; Laurent G, 1996, J NEUROSCI, V16, P3837; Laurent G, 1996, TRENDS NEUROSCI, V19, P489, DOI 10.1016/S0166-2236(96)10054-0; LAURENT G, 2001, IN PRESS ANN REV NEU; Linster C, 1996, NEURAL COMPUT, V8, P94, DOI 10.1162/neco.1996.8.1.94; LINSTER C, 1994, ADV NEURAL INFORMATI, V6, P527; MacLeod K, 1996, SCIENCE, V274, P976, DOI 10.1126/science.274.5289.976; MacLeod K, 1998, NATURE, V395, P693, DOI 10.1038/27201; MEREDITH M, 1986, J NEUROPHYSIOL, V56, P572, DOI 10.1152/jn.1986.56.3.572; MEREDITH M, 1992, BRAIN RES BULL, V29, P111, DOI 10.1016/0361-9230(92)90014-O; Sloper J., 1978, PHILOS T R SOC LON B, V285, P124; Stopfer M, 1997, NATURE, V390, P70, DOI 10.1038/36335; Stopfer M, 1999, NATURE, V402, P664, DOI 10.1038/45244; Traub R.D., 1991, NEURONAL NETWORKS HI; Wehr M, 1999, J NEUROSCI, V19, P381, DOI 10.1523/JNEUROSCI.19-01-00381.1999; Wehr M, 1996, NATURE, V384, P162, DOI 10.1038/384162a0	35	101	102	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					569	581		10.1016/S0896-6273(01)00286-0	http://dx.doi.org/10.1016/S0896-6273(01)00286-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395015	Green Accepted, Bronze			2022-12-24	WOS:000168962000026
J	Montmayeur, JP; Liberles, SD; Matsunami, H; Buck, LB				Montmayeur, JP; Liberles, SD; Matsunami, H; Buck, LB			A candidate taste receptor gene near a sweet taste locus	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; METABOTROPIC GLUTAMATE-RECEPTOR; CROSS-ADAPTATION; MULTIGENE FAMILY; INBRED STRAINS; MICE; TRANSDUCTION; MOUSE; RESPONSES; SACCHARIN	The mechanisms underlying sweet taste in mammals have been elusive. Although numerous studies have implicated G proteins in sweet taste detection, the expected G protein-coupled receptors have not been found. Here we describe a candidate taste receptor gene, T1r3, that is located at or near the mouse Sac locus, a genetic locus that controls the detection of certain sweet tastants. T1R3 differs in amino acid sequence in mouse strains with different Sac phenotypes ('tasters' versus 'nontasters'). In addition, a perfect correlation exists between two different T1r3 alleles and Sac phenotypes in recombinant inbred mouse strains. The T1r3 gene is expressed in a subset of taste cells in circumvallate, foliate and fungiform taste papillae. In circumvallate and foliate papillae, most T1r3-expressing cells also express a gene encoding a related receptor, T1R2 raising the possibility that these cells recognize more than one ligand, or that the two receptors function as heterodimers.	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buck, LB (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	lbuck@hms.harvard.edu	Montmayeur, Jean-Pierre R/A-5723-2009	Montmayeur, Jean-Pierre/0000-0002-0942-1114; Liberles, Stephen/0000-0002-2177-9741				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Bachmanov AA, 1997, MAMM GENOME, V8, P545, DOI 10.1007/s003359900500; Bai M, 1999, INT J MOL MED, V4, P115; BELKNAP JK, 1992, BEHAV GENET, V22, P81, DOI 10.1007/BF01066794; Berghard A, 1996, J NEUROSCI, V16, P909; Bernhardt SJ, 1996, J PHYSIOL-LONDON, V490, P325, DOI 10.1113/jphysiol.1996.sp021147; Blizard DA, 1999, CHEM SENSES, V24, P373, DOI 10.1093/chemse/24.4.373; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; CAPELESS CG, 1995, CHEM SENSES, V20, P291, DOI 10.1093/chemse/20.3.291; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; DANCIGER M, 1990, GENOMICS, V6, P428, DOI 10.1016/0888-7543(90)90472-7; EICHER EM, 1993, MAMM GENOME, V4, P226, DOI 10.1007/BF00417568; FAURION A, 1980, CHEM SENSES, V5, P107, DOI 10.1093/chemse/5.2.107; Frank ME, 1999, PHYSIOL BEHAV, V67, P287, DOI 10.1016/S0031-9384(99)00071-2; Froloff N, 1998, CHEM SENSES, V23, P197, DOI 10.1093/chemse/23.2.197; Froloff N, 1996, CHEM SENSES, V21, P425, DOI 10.1093/chemse/21.4.425; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; Gilbertson TA, 2000, CURR OPIN NEUROBIOL, V10, P519, DOI 10.1016/S0959-4388(00)00118-5; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; GLASER D, 1995, CHEM SENSES, V20, P573, DOI 10.1093/chemse/20.5.573; GREENFIELD AJ, 1992, MOUSE GENOME, V90, P94; Herness MS, 1999, ANNU REV PHYSIOL, V61, P873, DOI 10.1146/annurev.physiol.61.1.873; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ishimoto H, 2000, SCIENCE, V289, P116, DOI 10.1126/science.289.5476.116; Kinnamon SC, 2000, NEURON, V25, P507, DOI 10.1016/S0896-6273(00)81054-5; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Li X, 2001, MAMM GENOME, V12, P13, DOI 10.1007/s003350010236; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1989, GENET RES, V53, P95, DOI 10.1017/S0016672300027968; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; NIMOMIYA Y, 1997, AM J PHYSIOL, V272, pR1002; Ninomiya Y, 1999, J NEUROPHYSIOL, V81, P3087, DOI 10.1152/jn.1999.81.6.3087; Nofre C, 1996, CHEM SENSES, V21, P747, DOI 10.1093/chemse/21.6.747; PELZ WE, 1973, PHYSIOL BEHAV, V10, P263, DOI 10.1016/0031-9384(73)90308-9; RAMIREZ I, 1976, PHYSIOL BEHAV, V16, P163, DOI 10.1016/0031-9384(76)90300-0; Reed DR, 2000, APPETITE, V35, P189, DOI 10.1006/appe.2000.0347; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; SCHIFFMAN SS, 1981, PHARMACOL BIOCHEM BE, V15, P377, DOI 10.1016/0091-3057(81)90266-5; TAKAHASHI K, 1993, J BIOL CHEM, V268, P19341; TONOSAKI K, 1989, COMP BIOCHEM PHYS A, V92, P181, DOI 10.1016/0300-9629(89)90149-7; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	50	361	396	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					492	498		10.1038/87440	http://dx.doi.org/10.1038/87440			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319557				2022-12-24	WOS:000168412600012
J	Sugita, S; Han, WP; Butz, S; Liu, XR; Fernandez-Chacon, R; Lao, Y; Sudhof, TC				Sugita, S; Han, WP; Butz, S; Liu, XR; Fernandez-Chacon, R; Lao, Y; Sudhof, TC			Synaptotagmin VII as a plasma membrane Ca2+ sensor in exocytosis	NEURON			English	Article							PROTEIN-KINASE-C; SYNAPTIC VESICLE; CA2+-DEPENDENT EXOCYTOSIS; NEUROTRANSMITTER RELEASE; REGULATED EXOCYTOSIS; HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; CALCIUM SENSOR; PC12 CELLS; BINDING	Synaptotagmins I and II are Ca2+ binding proteins of synaptic vesicles essential for fast Ca2+-triggered neurotransmitter release. However, central synapses and neuroendocrine cells lacking these synaptotagmins still exhibit Ca2+-evoked exocytosis. We now propose that synaptotagmin VII functions as a plasma membrane Ca2+ sensor in synaptic exocytosis complementary to vesicular synaptotagmins. We show that alternatively spliced forms of synaptotagmin VII are expressed in a developmentally regulated pattern in brain and are concentrated in presynaptic active zones of central synapses. In neuroendocrine PC12 cells, the C(2)A and C2B domains of synaptotagmin VII are potent inhibitors of Ca2+-dependent exocytosis, but only when they bind Ca2+, Our data suggest that in synaptic vesicle exocytosis, distinct synaptotagmins function as independent Ca2+ sensors on the two fusion partners, the plasma membrane (synaptotagmin VII) versus synaptic vesicles (synaptotagmins I and II).	Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Sudhof, TC (corresponding author), Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, 6000 Harry Hines Blvd,NA4-118, Dallas, TX 75390 USA.	thomas.sudhof@utsouthwestern.edu	Fernandez-Chacon, Rafael/E-6303-2010; IBIS, FISIOLOGIA/O-9485-2015	Sugita, Shuzo/0000-0002-9182-873X; Fernandez-Chacon, Rafael/0000-0002-9845-9885				Avery J, 2000, J CELL BIOL, V148, P317, DOI 10.1083/jcb.148.2.317; Babity JM, 1997, P NATL ACAD SCI USA, V94, P2638, DOI 10.1073/pnas.94.6.2638; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; CHAMBERLAIN LH, 1995, J CELL BIOL, V130, P1063, DOI 10.1083/jcb.130.5.1063; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Chen YA, 1999, J BIOL CHEM, V274, P26469, DOI 10.1074/jbc.274.37.26469; Craxton M, 1999, FEBS LETT, V460, P417, DOI 10.1016/S0014-5793(99)01382-4; CRAXTON M, 1995, FEBS LETT, V361, P196, DOI 10.1016/0014-5793(95)00176-A; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; GEPPERT M, 1991, J BIOL CHEM, V266, P13548; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; HILBUSH BS, 1994, P NATL ACAD SCI USA, V91, P8195, DOI 10.1073/pnas.91.17.8195; HOOPER JE, 1984, J BIOL CHEM, V259, P148; HUDSON AW, 1995, P NATL ACAD SCI USA, V92, P5895, DOI 10.1073/pnas.92.13.5895; JOHNSTON PA, 1989, J BIOL CHEM, V264, P1268; JONES DH, 1974, BIOCHIM BIOPHYS ACTA, V356, P276, DOI 10.1016/0005-2736(74)90268-5; Kee Y, 1996, J NEUROSCI, V16, P1975; KELLY RB, 1995, CURR BIOL, V5, P257, DOI 10.1016/S0960-9822(95)00054-6; Klenchin VA, 1998, METHODS, V16, P204, DOI 10.1006/meth.1998.0668; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; LI C, 1995, J BIOL CHEM, V270, P24898, DOI 10.1074/jbc.270.42.24898; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; MIZUTA M, 1994, J BIOL CHEM, V269, P11675; NEHER E, 1994, NATURE, V372, P316, DOI 10.1038/372316a0; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Pyle JL, 2000, NEURON, V28, P221, DOI 10.1016/S0896-6273(00)00098-2; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SHOJIKASAI Y, 1992, SCIENCE, V256, P1820, DOI 10.1126/science.256.5065.1820; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1999, J BIOL CHEM, V274, P18893, DOI 10.1074/jbc.274.27.18893; Sugita S, 2000, BIOCHEMISTRY-US, V39, P2940, DOI 10.1021/bi9920984; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Thompson CC, 1996, J NEUROSCI, V16, P7832; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094; von Poser C, 2000, J BIOL CHEM, V275, P30916, DOI 10.1074/jbc.M005559200; von Poser C, 2001, EUR J CELL BIOL, V80, P41; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	63	179	184	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					459	473		10.1016/S0896-6273(01)00290-2	http://dx.doi.org/10.1016/S0896-6273(01)00290-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395007	Bronze			2022-12-24	WOS:000168962000018
J	Bhave, G; Karim, F; Carlton, SM; Gereau, RW				Bhave, G; Karim, F; Carlton, SM; Gereau, RW			Peripheral group I metabotropic glutamate receptors modulate nociception in mice	NATURE NEUROSCIENCE			English	Article							RAT SPINAL-CORD; FORMALIN TEST; PAIN RESPONSE; HYPERALGESIA; AXONS; NEURONS; RELEASE; NMDA; LOCALIZATION; INFLAMMATION	The metabotropic glutamate receptors (mGluRs) are found throughout the central nervous system, where they modulate neuronal excitability and synaptic transmission. Here we report the presence of phospholipase C-coupled group I mGluRs (mGluR1 and mGluR5) outside the central nervous system on peripheral unmyelinated sensory afferents. Given their localization on predominantly nociceptive afferents, we investigated whether these receptors modulate nociceptive signaling, and found that agonist-induced activation of peripheral group I mGluRs leads to increased sensitivity to noxious heat, a phenomenon termed thermal hyperalgesia. Furthermore, group I mGluR antagonists not only prevent, but also attenuate established formalin-induced pain. Taken together, these results suggest that peripheral mGluRs mediate a component of hyperalgesia and may be therapeutically targeted to prevent and treat inflammatory pain.	Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA; Inst Marine Biomed, Dept Anat & Neurosci, Galveston, TX 77555 USA	Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston	Gereau, RW (corresponding author), Baylor Coll Med, Div Neurosci, 1 Baylor Plaza,Room S636, Houston, TX 77030 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS027910, R01NS027910, P01NS011255] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60230] Funding Source: Medline; NINDS NIH HHS [NS27910, NS11255] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABBOTT FV, 1995, PAIN, V60, P91, DOI 10.1016/0304-3959(94)00095-V; Annoura H, 1996, BIOORG MED CHEM LETT, V6, P763, DOI 10.1016/0960-894X(96)00104-7; BAKER SR, 1995, BIOORG MED CHEM LETT, V5, P223; Carlton SM, 1998, NEUROSCIENCE, V83, P601, DOI 10.1016/S0306-4522(97)00406-5; Carlton SM, 1998, BRAIN RES, V790, P160, DOI 10.1016/S0006-8993(97)01471-6; CARLTON SM, 1995, NEUROSCI LETT, V197, P25, DOI 10.1016/0304-3940(95)11889-5; Clark BP, 1997, BIOORG MED CHEM LETT, V7, P2777, DOI 10.1016/S0960-894X(97)10071-3; CODERRE TJ, 1990, BRAIN RES, V535, P155, DOI 10.1016/0006-8993(90)91835-5; Coggeshall RE, 1997, BRAIN RES, V764, P126, DOI 10.1016/S0006-8993(97)00446-0; Coggeshall RE, 1998, J COMP NEUROL, V391, P78; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contractor A, 1998, P NATL ACAD SCI USA, V95, P8969, DOI 10.1073/pnas.95.15.8969; Crawford JH, 2000, NEUROPHARMACOLOGY, V39, P621, DOI 10.1016/S0028-3908(99)00167-7; Davidson EM, 1997, NEUROREPORT, V8, P941, DOI 10.1097/00001756-199703030-00025; de Groot J, 2000, NEUROREPORT, V11, P497, DOI 10.1097/00001756-200002280-00014; Fisher K, 1998, PAIN, V77, P59, DOI 10.1016/S0304-3959(98)00082-7; Fisher K, 1998, NEUROREPORT, V9, P1169, DOI 10.1097/00001756-199804200-00038; Fisher K, 1996, NEUROREPORT, V7, P2743, DOI 10.1097/00001756-199611040-00067; Fisher K, 1996, PAIN, V68, P255, DOI 10.1016/S0304-3959(96)03212-5; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; GEREAU RW, 1995, J NEUROPHYSIOL, V74, P122, DOI 10.1152/jn.1995.74.1.122; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; JACKSON DL, 1995, EUR J PHARMACOL, V284, P321, DOI 10.1016/0014-2999(95)00449-U; Jia H, 1999, J COMP NEUROL, V410, P627; Lawand NB, 2000, PAIN, V86, P69, DOI 10.1016/S0304-3959(99)00311-5; Litschig S, 1999, MOL PHARMACOL, V55, P453; McCall WD, 1996, NEUROSCI LETT, V208, P45, DOI 10.1016/0304-3940(96)12552-0; McNearney T, 2000, J RHEUMATOL, V27, P739; NEUGEBAUER V, 1994, EUR J NEUROSCI, V6, P1179, DOI 10.1111/j.1460-9568.1994.tb00616.x; Neugebauer V, 1999, J NEUROPHYSIOL, V82, P272, DOI 10.1152/jn.1999.82.1.272; Omote K, 1998, BRAIN RES, V787, P161, DOI 10.1016/S0006-8993(97)01568-0; Peng YB, 1999, J NEUROPHYSIOL, V82, P1164, DOI 10.1152/jn.1999.82.3.1164; Puig S, 1996, PAIN, V64, P345, DOI 10.1016/0304-3959(95)00121-2; SCHOEPP DD, 1994, J NEUROCHEM, V63, P769; TAYLOR BK, 1995, J NEUROSCI, V15, P7575; TJOLSEN A, 1992, PAIN, V51, P5, DOI 10.1016/0304-3959(92)90003-T; Valerio A, 1997, NEUROREPORT, V8, P2695, DOI 10.1097/00001756-199708180-00012; Valerio A, 1997, NEUROSCI RES, V28, P49, DOI 10.1016/S0168-0102(97)01175-9; VIDNYANSZKY Z, 1994, NEUROREPORT, V6, P209, DOI 10.1097/00001756-199412300-00053; Walker K, 2001, NEUROPHARMACOLOGY, V40, P10, DOI 10.1016/S0028-3908(00)00114-3; Young MR, 1997, BRAIN RES, V777, P161; Zhou ST, 1996, NEUROREPORT, V7, P895, DOI 10.1097/00001756-199603220-00012	42	233	239	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					417	423		10.1038/86075	http://dx.doi.org/10.1038/86075			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276233				2022-12-24	WOS:000168762200023
J	Critchley, HD; Mathias, CJ; Dolan, RJ				Critchley, HD; Mathias, CJ; Dolan, RJ			Neural activity in the human brain relating to uncertainty and arousal during anticipation	NEURON			English	Article							ANTERIOR CINGULATE CORTEX; PREFRONTAL CORTEX; ORBITOFRONTAL CORTEX; WORKING-MEMORY; ELECTRODERMAL ACTIVITY; HUMAN AMYGDALA; RESPONSES; PERFORMANCE; NEURONS; DAMAGE	We used functional magnetic resonance neuroimaging to measure brain activity during delay between reward-related decisions and their outcomes, and the modulation of this delay activity by uncertainty and arousal. Feedback, indicating financial gain or loss, was given following a fixed delay. Anticipatory arousal was indexed by galvanic skin conductance. Delay-period activity was associated with bilateral activation in orbital and medial prefrontal, temporal, and right parietal cortices. During delay, activity in anterior cingulate and orbitofrontal cortices was modulated by outcome uncertainty, whereas anterior cingulate, dorsolateral prefrontal, and parietal cortices activity was modulated by degree of anticipatory arousal. A distinct region of anterior cingulate was commonly activated by both uncertainty and arousal. Our findings highlight distinct contributions of cognitive uncertainty and autonomic arousal to anticipatory neural activity in prefrontal cortex.	UCL, Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Natl Hosp Neurol & Neurosurg, Autonom Unit, London WC1N 3BG, England; St Marys Hosp, Imperial Coll Sch Med, Neurovasc Med Unit, London W2 1NY, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; Imperial College London	Critchley, HD (corresponding author), UCL, Inst Neurol, Wellcome Dept Cognit Neurol, 12 Queen Sq, London WC1N 3BG, England.	h.critchley@fil.ion.ucl.ac.uk	critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				Adolphs R, 1998, NATURE, V393, P470, DOI 10.1038/30982; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; Bechara A, 1999, J NEUROSCI, V19, P5473; Bechara A, 1996, CEREB CORTEX, V6, P215, DOI 10.1093/cercor/6.2.215; Bechara A, 1997, SCIENCE, V275, P1293, DOI 10.1126/science.275.5304.1293; Bouscein W., 1992, ELECTRODERMAL ACTIVI; Chua P, 1999, NEUROIMAGE, V9, P563, DOI 10.1006/nimg.1999.0407; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1659, DOI 10.1152/jn.1996.75.4.1659; Critchley HD, 1996, J NEUROPHYSIOL, V75, P1673, DOI 10.1152/jn.1996.75.4.1673; DAMASIO AR, 1991, FRONTAL LOBE FUNCTION AND DYSFUNCTION, P217; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; DAMASIO AR, 1994, DESCARTES ERROR; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Elliott R, 2000, CEREB CORTEX, V10, P308, DOI 10.1093/cercor/10.3.308; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; ESLINGER PJ, 1985, NEUROLOGY, V35, P1731, DOI 10.1212/WNL.35.12.1731; Fredrikson M, 1998, PSYCHOPHYSIOLOGY, V35, P179; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1973, J NEUROPHYSIOL, V36, P61, DOI 10.1152/jn.1973.36.1.61; GoldmanRakic PS, 1996, P NATL ACAD SCI USA, V93, P13435, DOI 10.1073/pnas.93.24.13435; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Mangina CA, 1996, INT J PSYCHOPHYSIOL, V22, P1, DOI 10.1016/0167-8760(96)00022-0; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Nobre AC, 1997, BRAIN, V120, P515, DOI 10.1093/brain/120.3.515; Paus T, 1998, NEUROREPORT, V9, pR37, DOI 10.1097/00001756-199806220-00001; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1994, J NEUROL NEUROSUR PS, V57, P1518, DOI 10.1136/jnnp.57.12.1518; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1970, DOI 10.1152/jn.1996.75.5.1970; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAVER JL, 1991, NEUROPSYCHOLOGIA, V29, P1241, DOI 10.1016/0028-3932(91)90037-9; SHALLICE T, 1991, BRAIN, V114, P727, DOI 10.1093/brain/114.2.727; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Talairach J., 1988, COPLANAR STEREOTAXIC; TRANEL D, 1994, PSYCHOPHYSIOLOGY, V31, P427, DOI 10.1111/j.1469-8986.1994.tb01046.x; TRANEL D, 2000, SER AFFECTIVE SCI, P192; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Tremblay L, 2000, J NEUROPHYSIOL, V83, P1864, DOI 10.1152/jn.2000.83.4.1864; VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; Zahn TP, 1999, NEUROPSYCHOLOGIA, V37, P1227, DOI 10.1016/S0028-3932(99)00020-2	53	502	505	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					537	545		10.1016/S0896-6273(01)00225-2	http://dx.doi.org/10.1016/S0896-6273(01)00225-2			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405DD	11239442	Bronze			2022-12-24	WOS:000167141700025
J	Bagri, A; Marin, O; Plump, AS; Mak, J; Pleasure, SJ; Rubenstein, JLR; Tessier-Lavigne, M				Bagri, A; Marin, O; Plump, AS; Mak, J; Pleasure, SJ; Rubenstein, JLR; Tessier-Lavigne, M			Slit proteins prevent midline crossing and determine the dorsoventral position of major axonal pathways in the mammalian forebrain	NEURON			English	Article							THALAMOCORTICAL AXONS; CEREBRAL-CORTEX; CORTICOTHALAMIC PROJECTIONS; INTERMEDIATE TARGET; NEURONAL MIGRATION; NERVOUS-SYSTEM; GUIDANCE; GROWTH; RAT; ROUNDABOUT	We report that Slit proteins, a family of secreted chemorepellents, are crucial for the proper development of several major forebrain tracts. Mice deficient in Slit2 and, even more so, mice deficient in both Slit1 and Slit2 show significant axon guidance errors in a variety of pathways, including corticofugal, callosal, and thalamocortical tracts. Analysis of multiple pathways suggests several generalizations regarding the functions of Slit proteins in the brain, which appear to contribute to (1) the maintenance of dorsal position by prevention of axonal growth into ventral regions, (2) the prevention of axonal extension toward and across the midline, and (3) the channeling of axons toward particular regions.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Langley Porter Psychiat Inst, Dept Psychiat, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tessier-Lavigne, M (corresponding author), Stanford Univ, Dept Biol Sci, 371 Serra Mall, Stanford, CA 94305 USA.	marctl@stanford.edu	Marin, Oscar/F-3856-2012	Marin, Oscar/0000-0001-6264-7027	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001046, R01MH049428, R01MH051561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012462] Funding Source: NIH RePORTER; NIDA NIH HHS [R01DA12462] Funding Source: Medline; NIMH NIH HHS [K02MH01046-01, R01MH51561-01A1, R01MH49428-01] Funding Source: Medline; NINDS NIH HHS [NS02208] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adams NC, 1997, EUR J NEUROSCI, V9, P204, DOI 10.1111/j.1460-9568.1997.tb01391.x; Auladell C, 2000, ANAT EMBRYOL, V201, P169, DOI 10.1007/PL00008238; Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Braisted JE, 2000, J NEUROSCI, V20, P5792, DOI 10.1523/JNEUROSCI.20-15-05792.2000; Braisted JE, 1999, DEV BIOL, V208, P430, DOI 10.1006/dbio.1999.9216; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; DECARLOS JA, 1992, J NEUROSCI, V12, P1194; Erskine L, 2000, J NEUROSCI, V20, P4975; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; JONES EG, 1996, CEREBRAL CORTEX, V5; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; LEE VMY, 1987, J NEUROSCI, V7, P3474; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Marillat V, 2002, J COMP NEUROL, V442, P130, DOI 10.1002/cne.10068; Marin O, 2000, J NEUROSCI, V20, P6063; MCCONNELL SK, 1989, SCIENCE, V245, P978, DOI 10.1126/science.2475909; Metin C, 1996, J NEUROSCI, V16, P3219; Metin C, 1997, DEVELOPMENT, V124, P5063; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; MITROFANIS J, 1993, J COMP NEUROL, V338, P575, DOI 10.1002/cne.903380407; Molnar Z, 1999, J COMP NEUROL, V413, P1, DOI 10.1002/(SICI)1096-9861(19991011)413:1<1::AID-CNE1>3.0.CO;2-5; MOLNAR Z, 1995, TRENDS NEUROSCI, V18, P389, DOI 10.1016/0166-2236(95)93935-Q; Molnar Z, 1998, J NEUROSCI, V18, P5723; Murray MJ, 1999, J NEUROSCI, V19, P7901; Nieuwenhuys R., 1985, CHEMOARCHITECTURE BR, VVolume 33; Parent JM, 1997, J NEUROSCI, V17, P3727; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Richards LJ, 1997, J NEUROSCI, V17, P2445; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; ROTHBERG JM, 1988, CELL, V55, P1047, DOI 10.1016/0092-8674(88)90249-8; Shu TZ, 2001, J NEUROSCI, V21, P2749, DOI 10.1523/JNEUROSCI.21-08-02749.2001; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Skaliora I, 2000, J NEUROSCI, V20, P3650, DOI 10.1523/JNEUROSCI.20-10-03650.2000; Tuttle R, 1999, DEVELOPMENT, V126, P1903; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan WL, 1999, DEV BIOL, V212, P290, DOI 10.1006/dbio.1999.9371; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	50	333	340	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					233	248		10.1016/S0896-6273(02)00561-5	http://dx.doi.org/10.1016/S0896-6273(02)00561-5			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804571	Bronze			2022-12-24	WOS:000173387700011
J	Chi, P; Greengard, P; Ryan, TA				Chi, P; Greengard, P; Ryan, TA			Synapsin dispersion and reclustering during synaptic activity	NATURE NEUROSCIENCE			English	Article							TERMINAL-SPECIFIC PHOSPHOPROTEIN; SQUID GIANT SYNAPSE; PROTEIN-KINASE-II; F-ACTIN; NEUROTRANSMITTER RELEASE; VESICLE PHOSPHOPROTEINS; NERVE-TERMINALS; GENE FAMILY; ASSOCIATION; SITES	Presynaptic modulation of synaptic transmission provides an important basis for control of synaptic function. The synapsins, a family of highly conserved proteins associated with synaptic vesicles, have long been implicated in the regulation of neurotransmitter release. However, direct physiological measurements of the molecular mechanisms have been lacking. Here we show that in living hippocampal terminals, green fluorescent protein (GFP)-labeled synapsin la dissociates from synaptic vesicles, disperses into axons during action potential (AP) firing, and reclusters to synapses after the cessation of synaptic activity. Using various mutated forms of synapsin la that prevent phosphorylation at specific sites, we performed simultaneous FM 4-64 measurements of vesicle pool mobilization along with synapsin dispersion kinetics. These studies indicate that the rate of synapsin dispersion is controlled by phosphorylation, which in turn controls the kinetics of vesicle pool turnover. Thus synapsin acts as a phosphorylation-state-dependent regulator of synaptic vesicle mobilization, and hence, neurotransmitter release.	Cornell Univ, Weill Med Coll, Dept Biochem, New York, NY 10021 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Cornell University; Rockefeller University	Ryan, TA (corresponding author), Cornell Univ, Weill Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10021 USA.	taryan@med.cornell.edu	Ryan, Timothy/AAO-8286-2020	Ryan, Timothy/0000-0003-2533-9548	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039327, R01MH039327] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM61925-01] Funding Source: Medline; NIMH NIH HHS [MH39327] Funding Source: Medline; NINDS NIH HHS [NS24692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAHLER M, 1987, NATURE, V326, P704, DOI 10.1038/326704a0; BAHLER M, 1989, J CELL BIOL, V108, P1841, DOI 10.1083/jcb.108.5.1841; BENFENATI F, 1989, J CELL BIOL, V108, P1863, DOI 10.1083/jcb.108.5.1863; BENFENATI F, 1989, J CELL BIOL, V108, P1851, DOI 10.1083/jcb.108.5.1851; BENFENATI F, 1993, J CELL BIOL, V123, P1845, DOI 10.1083/jcb.123.6.1845; BENFENATI F, 1989, CELL BIOL INT REP, V13, P1007, DOI 10.1016/0309-1651(89)90016-7; BENFENATI F, 1992, NEURON, V8, P377, DOI 10.1016/0896-6273(92)90303-U; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; CHILCOTE TJ, 1994, J NEUROCHEM, V63, P1568; CZERNIK AJ, 1987, P NATL ACAD SCI USA, V84, P7518, DOI 10.1073/pnas.84.21.7518; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; DECAMILLI P, 1983, J CELL BIOL, V96, P1355, DOI 10.1083/jcb.96.5.1355; Esser L, 1998, EMBO J, V17, P977, DOI 10.1093/emboj/17.4.977; Ferreira A, 1998, MOL MED, V4, P22, DOI 10.1007/BF03401726; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Greengard P., 1987, Advances in Experimental Medicine and Biology, V221, P135; Henkel AW, 1995, J NEUROSCI, V15, P8246; Hilfiker S, 1998, NAT NEUROSCI, V1, P29, DOI 10.1038/229; Hosaka M, 1999, J BIOL CHEM, V274, P16747, DOI 10.1074/jbc.274.24.16747; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Hosaka M, 1998, J BIOL CHEM, V273, P13371, DOI 10.1074/jbc.273.22.13371; Hosaka M, 1998, J BIOL CHEM, V273, P1425, DOI 10.1074/jbc.273.3.1425; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kao HT, 1998, P NATL ACAD SCI USA, V95, P4667, DOI 10.1073/pnas.95.8.4667; LI L, 1995, P NATL ACAD SCI USA, V92, P9235, DOI 10.1073/pnas.92.20.9235; LLINAS R, 1985, P NATL ACAD SCI USA, V82, P3035, DOI 10.1073/pnas.82.9.3035; LLINAS R, 1991, J PHYSIOL-LONDON, V436, P257, DOI 10.1113/jphysiol.1991.sp018549; MANDELL JW, 1992, J NEUROSCI, V12, P1736; MANDELL JW, 1990, NEURON, V5, P19, DOI 10.1016/0896-6273(90)90030-J; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Sankaranarayanan S, 2000, NAT CELL BIOL, V2, P197, DOI 10.1038/35008615; SCHIEBLER W, 1986, J BIOL CHEM, V261, P8383; SIHRA TS, 1989, P NATL ACAD SCI USA, V86, P8108, DOI 10.1073/pnas.86.20.8108; Stefani G, 1997, J PHYSIOL-LONDON, V504, P501, DOI 10.1111/j.1469-7793.1997.501bd.x; SUDHOF TC, 1989, SCIENCE, V245, P1474, DOI 10.1126/science.2506642; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; TARELLI FT, 1992, NEURON, V9, P1143, DOI 10.1016/0896-6273(92)90072-L; THIEL G, 1990, J BIOL CHEM, V265, P16527; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1	43	265	274	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1187	1193		10.1038/nn756	http://dx.doi.org/10.1038/nn756			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11685225				2022-12-24	WOS:000172525000014
J	Pan, ZH; Hu, HJ; Perring, P; Andrade, R				Pan, ZH; Hu, HJ; Perring, P; Andrade, R			T-type Ca2+ channels mediate neurotransmitter release in retinal bipolar cells	NEURON			English	Article							TIGER SALAMANDER RETINA; ADRENAL CHROMAFFIN CELLS; CALCIUM CHANNELS; TRANSMITTER RELEASE; SYNAPTIC TERMINALS; GOLDFISH RETINA; GANGLION-CELLS; AMACRINE CELLS; GENE FAMILY; RAT RETINA	Transmitter release in neurons is thought to be mediated exclusively by high-voltage-activated (HVA) Ca2+ channels. However, we now report that, in retinal bipolar cells, low-voltage-activated (LVA) Ca2+ channels also mediate neurotransmitter release. Bipolar cells are specialized neurons that release neurotransmitter in response to graded depolarizations. Here we show that these cells express T-type Ca2+ channel subunits and functional LVA Call currents sensitive to mibefradil. Activation of these currents results in Call influx into presynaptic terminals and exocytosis, which we detected as a capacitance increase in isolated terminals and the appearance of reciprocal currents in retinal slices. The involvement of T-type Call channels in bipolar cell transmitter release may contribute to retinal information processing.	Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA; Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA	Wayne State University; Wayne State University	Pan, ZH (corresponding author), Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA.			Hu, Huijuan/0000-0003-2306-2514	NATIONAL EYE INSTITUTE [R01EY012180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH043985, R29MH043985, R01MH049355] Funding Source: NIH RePORTER; NEI NIH HHS [EY12180] Funding Source: Medline; NIMH NIH HHS [MH 49355, MH 43985] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ASHMORE JF, 1983, J PHYSIOL-LONDON, V340, P569, DOI 10.1113/jphysiol.1983.sp014781; ASHMORE JF, 1980, J PHYSIOL-LONDON, V300, P115, DOI 10.1113/jphysiol.1980.sp013155; AUGUSTINE GJ, 1992, J PHYSIOL-LONDON, V450, P247, DOI 10.1113/jphysiol.1992.sp019126; Awatramani GB, 2000, J NEUROSCI, V20, P7087, DOI 10.1523/JNEUROSCI.20-18-07087.2000; Bieda MC, 2000, VISUAL NEUROSCI, V17, P243, DOI 10.1017/S0952523800172062; Borst JGG, 1996, NATURE, V383, P431, DOI 10.1038/383431a0; COHEN CJ, 1987, J PHYSIOL-LONDON, V387, P195, DOI 10.1113/jphysiol.1987.sp016570; COHEN CJ, 1988, P NATL ACAD SCI USA, V85, P2412, DOI 10.1073/pnas.85.7.2412; Cribbs LL, 1998, CIRC RES, V83, P103, DOI 10.1161/01.RES.83.1.103; de la Villa P, 1998, EUR J NEUROSCI, V10, P317, DOI 10.1046/j.1460-9568.1998.00051.x; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; DIXON DB, 1992, J PHYSIOL-LONDON, V449, P589, DOI 10.1113/jphysiol.1992.sp019103; Dong CJ, 1998, J NEUROPHYSIOL, V79, P2171, DOI 10.1152/jn.1998.79.4.2171; DOWLING JE, 1966, PROC R SOC SER B-BIO, V166, P80, DOI 10.1098/rspb.1966.0086; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Gillis Kevin D., 1995, P155; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; HEIDELBERGER R, 1992, J PHYSIOL-LONDON, V447, P235, DOI 10.1113/jphysiol.1992.sp019000; HORRIGAN FT, 1994, NEURON, V13, P1119, DOI 10.1016/0896-6273(94)90050-7; Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.physiol.58.1.329; Isaacson JS, 1998, NEURON, V20, P749, DOI 10.1016/S0896-6273(00)81013-2; Ivanov AI, 2000, J NEUROSCI, V20, P4930; KANEKO A, 1989, J PHYSIOL-LONDON, V410, P613, DOI 10.1113/jphysiol.1989.sp017551; Lambert RC, 1998, J NEUROSCI, V18, P8605; LASATER EM, 1988, J NEUROPHYSIOL, V60, P1460, DOI 10.1152/jn.1988.60.4.1460; Lee JH, 1999, J NEUROSCI, V19, P1912; LLINAS R, 1992, SCIENCE, V256, P677, DOI 10.1126/science.1350109; MAGUIRE G, 1989, P NATL ACAD SCI USA, V86, P10144, DOI 10.1073/pnas.86.24.10144; Margrie TW, 2001, P NATL ACAD SCI USA, V98, P319, DOI 10.1073/pnas.011523098; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McDonough SI, 1998, MOL PHARMACOL, V54, P1080, DOI 10.1124/mol.54.6.1080; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; MISHRA SK, 1994, CIRC RES, V75, P144, DOI 10.1161/01.RES.75.1.144; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neves G, 1999, J PHYSIOL-LONDON, V515, P181, DOI 10.1111/j.1469-7793.1999.181ad.x; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; PAN ZH, 1995, J NEUROSCI, V15, P2668; Pan ZH, 2001, VISUAL NEUROSCI, V18, P279, DOI 10.1017/S095252380118212X; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Plant TD, 1998, J NEUROSCI, V18, P9573; Protti DA, 1998, J NEUROSCI, V18, P3715; Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5; RICHARD S, 1991, NEUROSCI LETT, V132, P229, DOI 10.1016/0304-3940(91)90308-G; Rieke F, 1996, J PHYSIOL-LONDON, V493, P1; Sabatini BL, 2000, NATURE, V408, P589, DOI 10.1038/35046076; SAITO T, 1983, J GEN PHYSIOL, V81, P589, DOI 10.1085/jgp.81.4.589; SIMON EJ, 1975, NATURE, V256, P661, DOI 10.1038/256661a0; TACHIBANA M, 1991, J NEUROSCI, V11, P2199; TACHIBANA M, 1993, J NEUROSCI, V13, P2898; Talley EM, 1999, J NEUROSCI, V19, P1895; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; TSIEN RW, 1988, TRENDS NEUROSCI, V11, P431, DOI 10.1016/0166-2236(88)90194-4; TURNER TJ, 1995, MOL PHARMACOL, V47, P348; von Gersdorff H, 1999, ANNU REV PHYSIOL, V61, P725, DOI 10.1146/annurev.physiol.61.1.725; von Gersdorff H, 1998, NEURON, V21, P1177, DOI 10.1016/S0896-6273(00)80634-0; VONGERSDORFF H, 1994, NATURE, V367, P735, DOI 10.1038/367735a0; vonGersdorff H, 1997, J NEUROSCI, V17, P1919; WERBLIN FS, 1978, J PHYSIOL-LONDON, V280, P449, DOI 10.1113/jphysiol.1978.sp012394; WERBLIN FS, 1969, J NEUROPHYSIOL, V32, P339, DOI 10.1152/jn.1969.32.3.339; Wu LG, 1998, P NATL ACAD SCI USA, V95, P4720, DOI 10.1073/pnas.95.8.4720; Zhuang H, 2000, DIABETES, V49, P59, DOI 10.2337/diabetes.49.1.59	63	95	97	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					89	98		10.1016/S0896-6273(01)00454-8	http://dx.doi.org/10.1016/S0896-6273(01)00454-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604141	Bronze			2022-12-24	WOS:000171525200011
J	Winberg, ML; Tamagnone, L; Bai, JW; Comoglio, PM; Montell, D; Goodman, CS				Winberg, ML; Tamagnone, L; Bai, JW; Comoglio, PM; Montell, D; Goodman, CS			The transmembrane protein off-track associates with plexins and functions downstream of semaphorin signaling during axon guidance	NEURON			English	Article							TYROSINE KINASE FAMILY; ACTIVE RAC; EPH RECEPTORS; CELL-ADHESION; DROSOPHILA; SLIT; IMMUNOGLOBULIN; REPELLENT; MOLECULE; ENCODES	The Plexin family of transmembrane proteins appears to function as repulsive receptors for most if not all Semaphorins. Here, we use genetic and biochemical analysis in Drosophila to show that the transmembrane protein Off-track (OTK) associates with Plexin A, the receptor for Sema 1a, and that OTK is a component of the repulsive signaling response to Semaphorin ligands. In vitro, OTK associates with Plexins. In vivo, mutations in the otk gene lead to phenotypes resembling those of loss-of-function mutations of either Sema1a or PlexA. The otk gene displays strong genetic interactions with Sema1a and PlexA, suggesting that OTK and Plexin A function downstream of Sema 1a.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Turin, Sch Med, Canc Res Inst, Dept Mol Oncol, I-10060 Turin, Italy; Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Turin; Johns Hopkins University	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.	goodman@uclink4.berkeley.edu	Tamagnone, Luca/J-8948-2018; Comoglio, Paolo/G-6323-2011	Tamagnone, Luca/0000-0002-2884-7946; Comoglio, Paolo/0000-0002-7056-5328	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021294, R37HD021294] Funding Source: NIH RePORTER; NICHD NIH HHS [HD21294] Funding Source: Medline; Telethon [E.1129] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon)		ARTAVANISTSAKONAS S, 1995, SCIENCE, V268, P225, DOI 10.1126/science.7716513; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bruckner K, 1998, CURR OPIN NEUROBIOL, V8, P375, DOI 10.1016/S0959-4388(98)80064-0; CALLAHAN CA, 1995, NATURE, V376, P171, DOI 10.1038/376171a0; CHOU YH, 1991, P NATL ACAD SCI USA, V88, P4897, DOI 10.1073/pnas.88.11.4897; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Driessens MHE, 2001, CURR BIOL, V11, P339, DOI 10.1016/S0960-9822(01)00092-6; Frisen J, 1999, EMBO J, V18, P5159, DOI 10.1093/emboj/18.19.5159; Hu HL, 2001, NEURON, V32, P39, DOI 10.1016/S0896-6273(01)00453-6; Katso RM, 1999, MOL CELL BIOL, V19, P6427; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kopczynski CC, 1996, SCIENCE, V271, P1867, DOI 10.1126/science.271.5257.1867; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Maestrini E, 1996, P NATL ACAD SCI USA, V93, P674, DOI 10.1073/pnas.93.2.674; MOSSIE K, 1995, ONCOGENE, V11, P2179; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Park SK, 1996, J BIOCHEM, V119, P235; PULIDO D, 1992, EMBO J, V11, P391, DOI 10.1002/j.1460-2075.1992.tb05067.x; Rohm B, 2000, FEBS LETT, V486, P68, DOI 10.1016/S0014-5793(00)02240-7; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; Suga H, 1997, FEBS LETT, V412, P540, DOI 10.1016/S0014-5793(97)00639-X; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; van Kesteren RE, 1998, EMBO J, V17, P2534, DOI 10.1093/emboj/17.9.2534; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Vikis HG, 2000, P NATL ACAD SCI USA, V97, P12457, DOI 10.1073/pnas.220421797; VOELKER RA, 1984, GENETICS, V107, P279; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Yu HH, 1998, NEURON, V20, P207, DOI 10.1016/S0896-6273(00)80450-X; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	40	127	131	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					53	62		10.1016/S0896-6273(01)00446-9	http://dx.doi.org/10.1016/S0896-6273(01)00446-9			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604138	Bronze			2022-12-24	WOS:000171525200008
J	Marrs, GS; Green, SH; Dailey, ME				Marrs, GS; Green, SH; Dailey, ME			Rapid formation and remodeling of postsynaptic densities in developing dendrites	NATURE NEUROSCIENCE			English	Article							SYNAPSE FORMATION; SLICE CULTURES; PLASTICITY; SPINE; RAT; ACTIN; FILOPODIA; CORTEX; AREA; CA1	The dynamics of postsynaptic density (PSD) formation and remodeling were investigated in live developing hippocampal tissue slices. Time lapse imaging of transfected neurons expressing GFP-tagged PSD95, a prominent PSD protein, revealed that up to 40% of PSDs in developing dendrites are structurally dynamic; they rapidly (<15 min) appear or disappear, but also grow, shrink and move within shafts and spines. New spines containing Ms were formed by conversion of dynamic filopodia-like spine precursors in which PSDs appeared de novo, or by direct extension of spines or spine precursors carrying preformed PSDs from the shaft. Ms are therefore highly dynamic structures that can undergo rapid structural alteration within dendrite shafts, spines and spine precursors, permitting rapid formation and remodeling of synaptic connections in developing CNS tissues.	Univ Iowa, Dept Biol Sci, Iowa City, IA 52242 USA; Univ Iowa, Program Neurosci, Med Labs 1178, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Dailey, ME (corresponding author), Univ Iowa, Dept Biol Sci, 335 Biol Bldg, Iowa City, IA 52242 USA.	michael-e-dailey@uiowa.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002961] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC002961, DC02961] Funding Source: Medline; NINDS NIH HHS [R29 NS037159, NS37159] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Arnold DB, 1999, NEURON, V23, P149, DOI 10.1016/S0896-6273(00)80761-8; BLUE ME, 1983, J NEUROCYTOL, V12, P599, DOI 10.1007/BF01181526; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; COTMAN C, 1973, BRAIN RES, V63, P205, DOI 10.1016/0006-8993(73)90089-9; Dailey ME, 1996, J NEUROSCI, V16, P2983; DAILEY ME, 1999, IMAGING NEURONS LAB; DECAMILLI P, 1983, J CELL BIOL, V96, P1337, DOI 10.1083/jcb.96.5.1337; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; El-Hussein AE, 2000, SCIENCE, V290, P1364; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; FROTSCHER M, 1995, PROG NEUROBIOL, V45, P143, DOI 10.1016/0301-0082(94)00040-O; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harris KM., 1989, HIPPOCAMPUS NEW VIST, P33; HINDS JW, 1976, J COMP NEUROL, V169, P41, DOI 10.1002/cne.901690104; Jontes JD, 2000, NEURON, V27, P11, DOI 10.1016/S0896-6273(00)00003-9; Kennedy MB, 2000, SCIENCE, V290, P750, DOI 10.1126/science.290.5492.750; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Korkotian E, 1999, NEUROREPORT, V10, P2875, DOI 10.1097/00001756-199909090-00032; Krucker T, 2000, P NATL ACAD SCI USA, V97, P6856, DOI 10.1073/pnas.100139797; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LO DC, 1994, NEURON, V13, P1263, DOI 10.1016/0896-6273(94)90412-X; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; MOREST DK, 1969, Z ANAT ENTWICKLUNGS, V128, P271, DOI 10.1007/BF00522528; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Okabe S, 1999, NAT NEUROSCI, V2, P804, DOI 10.1038/12175; Parnass Z, 2000, HIPPOCAMPUS, V10, P561, DOI 10.1002/1098-1063(2000)10:5<561::AID-HIPO6>3.3.CO;2-O; Passafaro M, 1999, NAT NEUROSCI, V2, P1063, DOI 10.1038/15990; POKORNY J, 1981, BRAIN RES BULL, V7, P121, DOI 10.1016/0361-9230(81)90076-9; PURPURA DP, 1975, ADV NEUROL, V12, P91; Rao A, 2000, HIPPOCAMPUS, V10, P527, DOI 10.1002/1098-1063(2000)10:5<527::AID-HIPO3>3.0.CO;2-B; Rao A, 1998, J NEUROSCI, V18, P1217; SAITO Y, 1992, NEUROSCI LETT, V147, P81, DOI 10.1016/0304-3940(92)90779-7; SMITH SJ, 1991, NERVE GROWTH CONE, P19; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; STEWARD O, 1988, MOL NEUROBIOL, V2, P227, DOI 10.1007/BF02935634; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987; Wong WT, 2000, CURR OPIN NEUROBIOL, V10, P118, DOI 10.1016/S0959-4388(99)00059-8; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	49	228	233	2	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1006	1013		10.1038/nn717	http://dx.doi.org/10.1038/nn717			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11574832				2022-12-24	WOS:000171325800014
J	Watson, FL; Heerssen, HM; Bhattacharyya, A; Klesse, L; Lin, MZ; Segal, RA				Watson, FL; Heerssen, HM; Bhattacharyya, A; Klesse, L; Lin, MZ; Segal, RA			Neurotrophins use the Erk5 pathway to mediate a retrograde survival response	NATURE NEUROSCIENCE			English	Article							TRANSCRIPTION FACTOR; SYMPATHETIC NEURONS; CELL-SURVIVAL; CREB PHOSPHORYLATION; SIGNALING PATHWAY; NERVOUS-SYSTEM; GROWTH-FACTOR; NGF; KINASE; RAS	Growth factors synthesized and released by target tissues promote survival and differentiation of innervating neurons. This retrograde signal begins when growth factors bind receptors at nerve terminals. Activated receptors are then endocytosed and transported through the axon to the cell body. Here we show that the mitogen-activated protein kinase (MAPK) signaling pathways used by neurotrophins during retrograde signaling differ from those used following direct stimulation of the cell soma. During retrograde signaling, endocytosed neurotrophin receptors (Trks) activate the extracellular signal-related protein kinase S (Erk5) pathway, leading to nuclear translocation of Erk5, phosphorylation of CREB, and enhanced neuronal survival. In contrast, Erk1/2, which mediates nuclear responses following direct cell body stimulation, does not transmit a retrograde signal. Thus, the Erk5 pathway has a unique function in retrograde signaling. Differential activation of distinct MAPK pathways may enable an individual growth factor to relay information that specifies the location and the nature of stimulation.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Boston Children's Hospital	Segal, RA (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	rosalind_segal@dfci.harvard.edu		Bhattacharyya, Anita/0000-0002-0360-7145; Klesse, Laura/0000-0003-1323-7720; Lin, Michael/0000-0002-0492-1961	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035148] Funding Source: NIH RePORTER; NINDS NIH HHS [NS35148] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Altar CA, 1998, TRENDS NEUROSCI, V21, P433, DOI 10.1016/S0166-2236(98)01273-9; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; Delcroix JD, 1999, J NEUROSCI, V19, part. no.; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fukuhara S, 2000, J BIOL CHEM, V275, P21730, DOI 10.1074/jbc.M002410200; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Klesse LJ, 1998, J NEUROSCI, V18, P10420; Kohara K, 2001, SCIENCE, V291, P2419, DOI 10.1126/science.1057415; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; Lom B, 1999, J NEUROSCI, V19, P9928; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; Snider WD, 1996, MOL CELL NEUROSCI, V7, P433, DOI 10.1006/mcne.1996.0031; VANDERBLIEK AM, 1993, J CELL BIOL, V122, P553, DOI 10.1083/jcb.122.3.553; Walton M, 1999, J NEUROCHEM, V73, P1836; Watson FL, 1999, J NEUROSCI, V19, P7889; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	38	355	366	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					981	988		10.1038/nn720	http://dx.doi.org/10.1038/nn720			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11544482				2022-12-24	WOS:000171325800011
J	Miyata, T; Kawaguchi, A; Okano, H; Ogawa, M				Miyata, T; Kawaguchi, A; Okano, H; Ogawa, M			Asymmetric inheritance of radial glial fibers by cortical neurons	NEURON			English	Article							MURINE CEREBRAL WALL; CENTRAL-NERVOUS-SYSTEM; CELL-CYCLE; STEM-CELLS; CORTEX; NEOCORTEX; LINEAGE; NEUROGENESIS; GENERATION; MIGRATION	Recent studies demonstrated the neuronogenic role of radial glial cells (RGCs) in the rodent. To reveal the fate of radial glial processes, we intensively monitored divisions of RGCs in Dil-labeled slices from the embryonic day 14 mouse cortex. During RGC division, each pia-connected fiber becomes thin but is neither lost nor divided; it is inherited asymmetrically by one daughter cell. In divisions that produce a neuron and a progenitor, the neuron inherits the pial fiber, also grows a thick ventricular process for several hours, and is therefore indistinguishable from the progenitor RGC. The ventricular process in the radial glial-like neuron ("radial neuron") then collapses, leading to ascent of the neuron by using the "recycled" radial fiber.	RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan; Osaka Univ, Grad Sch Med, Div Ophthalmol, Suita, Osaka 5650871, Japan; Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo 1050011, Japan	RIKEN; Osaka University; Keio University; Japan Science & Technology Agency (JST)	Miyata, T (corresponding author), RIKEN, Brain Sci Inst, Lab Cell Culture Dev, Wako, Saitama 3510198, Japan.		MIYATA, TAKAKI/I-7066-2014; Okano, Hideyuki/I-7584-2019; Kawaguchi, Ayano/I-7286-2014	Kawaguchi, Ayano/0000-0002-0339-3992				Alvarez-Buylla A, 2001, NAT REV NEUROSCI, V2, P287, DOI 10.1038/35067582; Barres BA, 1999, CELL, V97, P667, DOI 10.1016/S0092-8674(00)80777-1; Bentivoglio M, 1999, BRAIN RES BULL, V49, P305, DOI 10.1016/S0361-9230(99)00065-9; BERRY M, 1964, NATURE, V203, P591, DOI 10.1038/203591b0; BRITTIS PA, 1995, EXP NEUROL, V134, P1, DOI 10.1006/exnr.1995.1031; Cai L, 1997, J NEUROSCI, V17, P2079; CAMERON RS, 1991, GLIA, V4, P124, DOI 10.1002/glia.440040204; Caviness V S Jr, 1982, Brain Res, V256, P293; Chanas-Sacre G, 2000, J NEUROSCI RES, V61, P357, DOI 10.1002/1097-4547(20000815)61:4<357::AID-JNR1>3.0.CO;2-7; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; FUJITA S, 1963, J COMP NEUROL, V120, P37, DOI 10.1002/cne.901200104; GADISSEUX JF, 1992, J COMP NEUROL, V322, P246, DOI 10.1002/cne.903220210; GLOSTER A, 1994, J NEUROSCI, V14, P7319; Hartfuss E, 2001, DEV BIOL, V229, P15, DOI 10.1006/dbio.2000.9962; HINDS JW, 1971, Z ZELLFORSCH MIK ANA, V115, P226, DOI 10.1007/BF00391127; Hopwood D., 1990, THEORY PRACTICE HIST, V3rd, P21; HunterSchaedle KE, 1997, J NEUROBIOL, V33, P459, DOI 10.1002/(SICI)1097-4695(199710)33:4<459::AID-NEU9>3.0.CO;2-9; Kamei Y, 1998, GLIA, V23, P191, DOI 10.1002/(SICI)1098-1136(199807)23:3<191::AID-GLIA2>3.0.CO;2-8; Kaneko Y, 2000, DEV NEUROSCI-BASEL, V22, P139, DOI 10.1159/000017435; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; LOTURCO JJ, 1991, SCIENCE, V252, P563, DOI 10.1126/science.1850552; LUSKIN MB, 1988, NEURON, V1, P635, DOI 10.1016/0896-6273(88)90163-8; Malatesta P, 2000, DEVELOPMENT, V127, P5253; MCCONNELL SK, 1988, J NEUROSCI, V8, P945; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MENEZES JRL, 1994, J NEUROSCI, V14, P5399; Misson JP, 1991, CEREB CORTEX, V1, P221, DOI 10.1093/cercor/1.3.221; MISSON JP, 1991, GLIA, V4, P138, DOI 10.1002/glia.440040205; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Miyata T, 1997, J NEUROSCI, V17, P3599; MOREST DK, 1970, Z ANAT ENTWICKLUNGS, V130, P265, DOI 10.1007/BF00520999; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Okano HJ, 1997, J NEUROSCI, V17, P3024; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Qian XM, 1997, NEURON, V18, P81, DOI 10.1016/S0896-6273(01)80048-9; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Ramirez-Weber FA, 1999, CELL, V97, P599, DOI 10.1016/S0092-8674(00)80771-0; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; SEYMOUR RM, 1975, J COMP NEUROL, V160, P105, DOI 10.1002/cne.901600107; Takahashi T, 1996, J NEUROSCI, V16, P5762; Takahashi T, 1999, EXP NEUROL, V156, P407, DOI 10.1006/exnr.1999.7023; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Takahashi T, 1996, J NEUROSCI, V16, P6183; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; WOODHAMS PL, 1981, ANAT EMBRYOL, V163, P331, DOI 10.1007/BF00315709	52	682	691	0	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 13	2001	31	5					727	741		10.1016/S0896-6273(01)00420-2	http://dx.doi.org/10.1016/S0896-6273(01)00420-2			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567613	Bronze			2022-12-24	WOS:000171013300008
J	Hutcheson, DM; Everitt, BJ; Robbins, TW; Dickinson, A				Hutcheson, DM; Everitt, BJ; Robbins, TW; Dickinson, A			The role of withdrawal in heroin addiction: enhances reward or promotes avoidance?	NATURE NEUROSCIENCE			English	Article							OPPONENT-PROCESS THEORY; MOTIVATION; DEPENDENCE; RATS; COCAINE; REINFORCEMENT; DYNAMICS	The compulsive nature of heroin abuse has been attributed to the fact that drug self-administration enables an addict to escape from and avoid the severe withdrawal symptoms resulting from opiate dependence. However, studies of incentive learning under natural motivational states suggest an alternative hypothesis, that withdrawal from heroin functions as a motivational state that enhances the incentive value of the drug, thereby enabling it to function as a much more effective reward for self-administration. In support of this hypothesis, we show here that previous experience with heroin in withdrawal is necessary for subsequent heroin-seeking behavior to be enhanced when dependent rats once again experience withdrawal.	Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England	University of Cambridge	Hutcheson, DM (corresponding author), Univ Cambridge, Dept Expt Psychol, Downing St, Cambridge CB2 3EB, England.		Robbins, Trevor W/A-7551-2008	Robbins, Trevor/0000-0003-0642-5977; Everitt, Barry/0000-0003-4431-6536	MRC [G9537855] Funding Source: UKRI; Medical Research Council [G9537855] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ahmed SH, 2000, NEUROPSYCHOPHARMACOL, V22, P413, DOI 10.1016/S0893-133X(99)00133-5; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; BALLEINE B, 1992, J EXP PSYCHOL ANIM B, V18, P236, DOI 10.1037/0097-7403.18.3.236; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Balleine BW, 2000, J NEUROSCI, V20, P8954; BOZARTH MA, 1984, SCIENCE, V224, P516, DOI 10.1126/science.6324347; DICKINSON A, 1994, ANIM LEARN BEHAV, V22, P1, DOI 10.3758/BF03199951; GOLDBERG SR, 1971, J PHARMACOL EXP THER, V179, P268; HAND TH, 1988, BRAIN RES, V474, P364, DOI 10.1016/0006-8993(88)90452-0; KHANTZIAN EJ, 1985, AM J PSYCHIAT, V142, P1259; KOOB GF, 1989, NEUROSCI BIOBEHAV R, V13, P135, DOI 10.1016/S0149-7634(89)80022-3; Koob GF, 1996, NEURON, V16, P893, DOI 10.1016/S0896-6273(00)80109-9; MALDONADO R, 1995, BRIT J PHARMACOL, V114, P1031, DOI 10.1111/j.1476-5381.1995.tb13309.x; Mucha R F, 1986, NIDA Res Monogr, V75, P567; Nader K, 1997, ANNU REV PSYCHOL, V48, P85, DOI 10.1146/annurev.psych.48.1.85; Olmstead MC, 2000, PSYCHOPHARMACOLOGY, V152, P123, DOI 10.1007/s002130000498; Olmstead MC, 2001, BEHAV NEUROSCI, V115, P394, DOI 10.1037/0735-7044.115.2.394; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; SOLOMON RL, 1974, PSYCHOL REV, V81, P119, DOI 10.1037/h0036128; SOLOMON RL, 1980, AM PSYCHOL, V35, P691, DOI 10.1037/0003-066X.35.8.691; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; WIKLER A, 1973, ARCH GEN PSYCHIAT, V28, P611; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	23	160	168	1	25	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					943	947		10.1038/nn0901-943	http://dx.doi.org/10.1038/nn0901-943			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	467JL	11528427				2022-12-24	WOS:000170698600022
J	Letinic, K; Rakic, P				Letinic, K; Rakic, P			Telencephalic origin of human thalamic GABAergic neurons	NATURE NEUROSCIENCE			English	Article							MEDIAL GANGLIONIC EMINENCE; DEVELOPING HUMAN BRAIN; INTERNEURON PRECURSORS; DLX GENES; MIGRATION; FOREBRAIN; NEOCORTEX; SYSTEM; ZONE; EXPRESSION	In non-primate mammalian species, telencephalic and diencephalic neurons originate from their respective local proliferative zones. Using vital dye labeling in organotypic slice cultures, we show that in human brain, a contingent of neurons from the ganglionic eminence of the telencephalon migrate to the dorsal thalamic association nuclei of the diencephalon. These neurons rely on homotypic-neurophilic guidance during their migration, are GABAergic, and express DIx1/2 homeodomain-containing proteins. Similar experiments in a non-human primate and in rodent embryos did not reveal a similar migratory pathway. Migration assays demonstrated that the human dorsal thalamus attracts telencephalic cells, an effect not observed in the mouse, in which such migration is inhibited by chemorepulsive cues. These data suggest that modifications in the pattern of migratory guidance cues in the forebrain may underlie the appearance of a new migratory pathway and thus contribute to the evolutionary expansion of the thalamic association nuclei in the human.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Rakic, P (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.							Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; BARBEAU D, 1995, P NATL ACAD SCI USA, V92, P2785, DOI 10.1073/pnas.92.7.2785; Barton RA, 2000, NATURE, V405, P1055, DOI 10.1038/35016580; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; HARRIS RM, 1987, NEUROSCIENCE, V21, P229, DOI 10.1016/0306-4522(87)90335-6; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; Haydar TF, 1999, BRAIN RES PROTOC, V4, P425, DOI 10.1016/S1385-299X(99)00033-1; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Letinic K, 1997, J COMP NEUROL, V384, P373; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; MONTERO VM, 1986, EXP BRAIN RES, V62, P215; ORourke NA, 1997, DEVELOPMENT, V124, P997; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; PORTEUS MH, 1994, J NEUROSCI, V14, P6370; Rakic P, 2000, NEURON, V27, P409, DOI 10.1016/S0896-6273(00)00047-7; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1969, Z ANAT ENTWICKLUNGS, V129, P53, DOI 10.1007/BF00521955; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; SIDMAN RL, 1973, BRAIN RES, V62, P1, DOI 10.1016/0006-8993(73)90617-3; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	29	131	132	0	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					931	936		10.1038/nn0901-931	http://dx.doi.org/10.1038/nn0901-931			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528425				2022-12-24	WOS:000170698600020
J	Taubenfeld, SM; Milekic, MH; Monti, B; Alberini, CM				Taubenfeld, SM; Milekic, MH; Monti, B; Alberini, CM			The consolidation of new but not reactivated memory requires hippocampal C/EBP beta	NATURE NEUROSCIENCE			English	Article							ELEMENT-BINDING PROTEIN; RETROGRADE-AMNESIA; AMYGDALA; CREB; GENES; RECONSOLIDATION; TRANSCRIPTION; NEUROBIOLOGY; NEUROSCIENCE; INVOLVEMENT	Long-term memory formation consists of multiple phases. A new memory is initially labile and sensitive to disruption by a variety of interfering events or agents. To become stable, this new memory undergoes a process known as consolidation, which, in the case of declarative memories, occurs within the medial temporal lobes and requires gene expression. When recalled, memories re-enter a new phase of vulnerability and seem to require a reconsolidation process in order to be maintained. Here we show that consolidation but not reconsolidation of inhibitory avoidance memory requires the expression of the transcription factor CCAAT enhancer binding protein beta (C/EBP beta) in the hippocampus. Furthermore, in the same region, de novo protein synthesis is not essential for memory reconsolidation. C/EBP beta is an evolutionarily conserved genetic marker that has a selective role in the consolidation of new but not reactivated memories in the hippocampus.	CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, New York, NY 10029 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Brown University	Alberini, CM (corresponding author), CUNY Mt Sinai Sch Med, Dept Physiol & Biophys, 1 Gustave L Levy Pl,Box 1218, New York, NY 10029 USA.	cristina.alberini@inka.mssm.edu	Monti, Barbara/AAG-1258-2021	Monti, Barbara/0000-0003-0330-482X				Alberini CM, 1999, J EXP BIOL, V202, P2887; ALBERINI CM, 1994, CELL, V76, P1099, DOI 10.1016/0092-8674(94)90386-7; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; Bourtchouladze R, 1998, LEARN MEMORY, V5, P365; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Dudai Y, 1996, NEURON, V17, P367, DOI 10.1016/S0896-6273(00)80168-3; Gerlai R, 2000, REV NEUROSCIENCE, V11, P15; Guzowski JF, 1997, P NATL ACAD SCI USA, V94, P2693, DOI 10.1073/pnas.94.6.2693; Guzowski JF, 2000, J NEUROSCI, V20, P3993; HOOPER ML, 1994, NEUROSCIENCE, V63, P917, DOI 10.1016/0306-4522(94)90559-2; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; JUDGE ME, 1982, PHYSIOL BEHAV, V28, P585, DOI 10.1016/0031-9384(82)90034-8; Lamprecht R, 1997, J NEUROSCI, V17, P8443; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; MACTUTUS CF, 1979, SCIENCE, V204, P1319, DOI 10.1126/science.572083; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ogawa S, 1998, CHEM SENSES, V23, P249, DOI 10.1093/chemse/23.2.249; Pall M, 1997, EMBO J, V16, P5273, DOI 10.1093/emboj/16.17.5273; Quevedo J, 1999, LEARN MEMORY, V6, P600, DOI 10.1101/lm.6.6.600; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9; Swank MW, 2000, NEUROREPORT, V11, P1625, DOI 10.1097/00001756-200006050-00006; Taubenfeld SM, 1999, NAT NEUROSCI, V2, P309, DOI 10.1038/7217; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tischmeyer W, 1999, CELL MOL LIFE SCI, V55, P564, DOI 10.1007/s000180050315; Widnell KL, 1996, J PHARMACOL EXP THER, V276, P306; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000; Yin JCP, 1996, CURR OPIN NEUROBIOL, V6, P264, DOI 10.1016/S0959-4388(96)80082-1; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	37	344	350	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					813	818		10.1038/90520	http://dx.doi.org/10.1038/90520			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	457KY	11477427				2022-12-24	WOS:000170137300014
J	Sutton, MA; Masters, SE; Bagnall, MW; Carew, TJ				Sutton, MA; Masters, SE; Bagnall, MW; Carew, TJ			Molecular mechanisms underlying a unique intermediate phase of memory in Aplysia	NEURON			English	Article							LONG-TERM FACILITATION; SIPHON-WITHDRAWAL REFLEX; DEPENDENT PROTEIN-KINASE; PRE-SYNAPTIC FACILITATION; SENSORY NEURONS; GILL-WITHDRAWAL; PRESYNAPTIC FACILITATION; BEHAVIORAL SENSITIZATION; MACROMOLECULAR-SYNTHESIS; TRANSMITTER RELEASE	Short- and long-term synaptic facilitation induced by serotonin at Aplysia sensory-motor (SN-MN) synapses has been widely used as a cellular model of short- and long-term memory for sensitization. In recent years, a distinct intermediate phase of synaptic facilitation (ITF) has been described at SN-MN synapses. Here, we identify a novel intermediate phase of behavioral memory (ITM) for sensitization in Aplysia and demonstrate that it shares the temporal and mechanistic features of ITF in the intact CNS: (1) it declines completely prior to the onset of LTM, (2) its induction requires protein but not RNA synthesis, and (3) its expression requires the persistent activation of protein kinase A. Thus, in Aplysia, the same temporal and molecular characteristics that distinguish ITF from other phases of synaptic plasticity distinguish ITM from other phases of behavioral memory.	Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Yale Univ, Interdepartmental Neurosci Program, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	University of California System; University of California Irvine; Yale University; Yale University	Carew, TJ (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92697 USA.		Sutton, Michael/C-6264-2011	Bagnall, Martha/0000-0003-2102-6165; Sutton, Michael/0000-0002-0692-6459	NIMH NIH HHS [R01 MH-14-1083] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Antonov I, 1999, J NEUROSCI, V19, P10438; BACSKAI BJ, 1993, SCIENCE, V260, P222, DOI 10.1126/science.7682336; Bao JX, 1998, J NEUROSCI, V18, P458; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bernabeu R, 1997, P NATL ACAD SCI USA, V94, P7041, DOI 10.1073/pnas.94.13.7041; BRAHA O, 1990, P NATL ACAD SCI USA, V87, P2040, DOI 10.1073/pnas.87.5.2040; BUONOMANO DV, 1990, SCIENCE, V249, P420, DOI 10.1126/science.2165631; CAREW TJ, 1983, SCIENCE, V219, P397, DOI 10.1126/science.6681571; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; CASTELLUCCI VF, 1982, J NEUROSCI, V2, P1673; CASTELLUCCI VF, 1980, P NATL ACAD SCI-BIOL, V77, P7492, DOI 10.1073/pnas.77.12.7492; CASTELLUCCI VF, 1989, J NEUROBIOL, V20, P1, DOI 10.1002/neu.480200102; CLARK GA, 1993, P NATL ACAD SCI USA, V90, P11411, DOI 10.1073/pnas.90.23.11411; Cleary LJ, 1998, J NEUROSCI, V18, P5988; CLEARY LJ, 1993, J NEUROPHYSIOL, V70, P1767, DOI 10.1152/jn.1993.70.5.1767; Crow T, 1999, J NEUROPHYSIOL, V82, P495, DOI 10.1152/jn.1999.82.1.495; CROW T, 1997, NEUROBIOL LEARN MEM, V68, P340; DASH PK, 1990, NATURE, V345, P718, DOI 10.1038/345718a0; EMPTAGE NJ, 1993, SCIENCE, V262, P253, DOI 10.1126/science.8211146; FISCHER TM, 1993, J NEUROSCI, V13, P1302; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; FRIEDER B, 1978, BEHAV BIOL, V22, P178, DOI 10.1016/S0091-6773(78)92200-9; FRIEDER B, 1982, PHYSIOL BEHAV, V29, P1071, DOI 10.1016/0031-9384(82)90300-6; FROST WN, 1985, P NATL ACAD SCI USA, V82, P8266, DOI 10.1073/pnas.82.23.8266; FROST WN, 1995, J NEUROPHYSIOL, V73, P2413, DOI 10.1152/jn.1995.73.6.2413; Gerber B, 2000, LEARN MEMORY, V7, P151, DOI 10.1101/lm.7.3.151; GHIRARDI M, 1995, NEURON, V14, P413, DOI 10.1016/0896-6273(95)90297-X; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GIBBS ME, 1977, BIOBEHAV REV, V1, P113, DOI 10.1016/0147-7552(77)90017-1; GIBBS ME, 1979, NEUROSCI LETT, V13, P279, DOI 10.1016/0304-3940(79)91507-6; HAWKINS RD, 1983, SCIENCE, V219, P400, DOI 10.1126/science.6294833; HAWKINS RD, 1981, J NEUROPHYSIOL, V45, P304, DOI 10.1152/jn.1981.45.2.304; HICKIE C, 1995, J NEUROPHYSIOL, V74, P307, DOI 10.1152/jn.1995.74.1.307; HUANG YY, 1994, CELL, V79, P69, DOI 10.1016/0092-8674(94)90401-4; Izquierdo I, 1998, NATURE, V393, P635, DOI 10.1038/31371; KAMIN LJ, 1957, J COMP PHYSIOL PSYCH, V50, P457, DOI 10.1037/h0044226; KAMIN LJ, 1963, J COMP PHYSIOL PSYCH, V56, P719; Levenson J, 1999, J NEUROSCI, V19, P8094; Levenson J, 2000, P NATL ACAD SCI USA, V97, P12858, DOI 10.1073/pnas.220256497; MACKEY SL, 1989, J NEUROSCI, V9, P4227; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mauelshagen J, 1996, J NEUROSCI, V16, P7099; MERCER AR, 1982, J COMP PHYSIOL, V145, P363, DOI 10.1007/BF00619340; MERCER AR, 1991, SCIENCE, V254, P1811, DOI 10.1126/science.1662413; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Muller U, 1998, NEURON, V21, P1423, DOI 10.1016/S0896-6273(00)80660-1; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; PINSKER HM, 1973, SCIENCE, V182, P1039, DOI 10.1126/science.182.4116.1039; RIEGE WH, 1971, SCIENCE, V172, P966, DOI 10.1126/science.172.3986.966; ROSENZWEIG MR, 1993, BEHAV BRAIN RES, V57, P193, DOI 10.1016/0166-4328(93)90135-D; SANDERS GD, 1971, NATURE, V232, P203, DOI 10.1038/232203a0; Sherff CM, 1999, SCIENCE, V285, P1911, DOI 10.1126/science.285.5435.1911; Stopfer M, 1996, J NEUROSCI, V16, P4923; Sutton MA, 2000, NEURON, V26, P219, DOI 10.1016/S0896-6273(00)81152-6; TALLARICO PT, 1973, J RES MUSIC EDUC, V21, P153, DOI 10.2307/3344591; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1990, COLD SH Q B, V55, P203; WALTERS ET, 1983, J NEUROPHYSIOL, V50, P1543, DOI 10.1152/jn.1983.50.6.1543; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; WRIGHT WG, 1995, J NEUROSCI, V15, P790; Xia SZ, 1998, PHARMACOL BIOCHEM BE, V60, P809, DOI 10.1016/S0091-3057(98)00060-4; Yanow SK, 1998, J NEUROCHEM, V70, P572; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5; Zhang F, 1997, SCIENCE, V275, P1318, DOI 10.1126/science.275.5304.1318	68	141	142	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUL 19	2001	31	1					143	154		10.1016/S0896-6273(01)00342-7	http://dx.doi.org/10.1016/S0896-6273(01)00342-7			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498057				2022-12-24	WOS:000170101100017
J	Cho, KW				Cho, KW			Chronic 'jet lag' produces temporal lobe atrophy and spatial cognitive deficits	NATURE NEUROSCIENCE			English	Article							MEMORY IMPAIRMENT; PERFORMANCE		Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol	Cho, KW (corresponding author), Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	kei.cho@bris.ac.uk		Cho, Kwangwook/0000-0001-6724-7073				Abrahams S, 1999, BRAIN COGNITION, V41, P39, DOI 10.1006/brcg.1999.1095; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Cho K, 2000, J NEUROSCI, V20, part. no.; Deacon S, 1996, PHYSIOL BEHAV, V59, P665, DOI 10.1016/0031-9384(95)02147-7; Lupien SJ, 1997, J CLIN ENDOCR METAB, V82, P2070, DOI 10.1210/jc.82.7.2070; Lupien SJ, 1998, NAT NEUROSCI, V1, P69, DOI 10.1038/271; Newcomer JW, 1999, ARCH GEN PSYCHIAT, V56, P527, DOI 10.1001/archpsyc.56.6.527; Nunn JA, 1999, BRAIN, V122, P47, DOI 10.1093/brain/122.1.47; Porter NM, 1998, NAT NEUROSCI, V1, P3, DOI 10.1038/196; Sapolsky RM, 1992, STRESS AGING BRAIN M; SQUIRE LR, 1990, J NEUROSCI, V10, P3106; WINGET CM, 1984, AVIAT SPACE ENVIR MD, V55, P1085	12	221	226	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					567	568		10.1038/88384	http://dx.doi.org/10.1038/88384			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369936				2022-12-24	WOS:000169061800008
J	Giraud, AL; Price, CJ; Graham, JM; Truy, E; Frackowiak, RSJ				Giraud, AL; Price, CJ; Graham, JM; Truy, E; Frackowiak, RSJ			Cross-modal plasticity underpins language recovery after cochlear implantation	NEURON			English	Article							AUDITORY-CORTEX; CEREBRAL-CORTEX; VISUAL AREAS; SPEECH; ACTIVATION; HUMANS; COMPENSATION; RECRUITMENT; ATTENTION; MOVEMENTS	Postlingually deaf subjects learn the meaning of sounds after cochlear implantation by forming new associations between sounds and their sources. Implants generate coarse frequency responses, preventing place-coding fine enough to discriminate sounds with similar temporal characteristics, e.g., buck/duck. This limitation imposes a dependency on visual cues, e.g., lipreading. We hypothesized that cross-modal facilitation results from engagement of the visual cortex by purely auditory tasks. In four functional neuroimaging experiments, we show recruitment of early visual cortex (V1/V2) when cochlear implant users listen to sounds with eyes closed. Activity in visual cortex evolved in a stimulus-specific manner as a function of time from implantation reflecting experience-dependent adaptations in the postimplant phase.	Goethe Univ Frankfurt, Dept Physiol, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Dept Neurol, D-60590 Frankfurt, Germany; Wellcome Dept Cognit Neurol, London WC1N 3BG, England; Royal Natl Throat Nose & Ear Hosp, Cochlear Implant Programme, London WC1X 8DA, England; Hop Edouard Herriot, F-69003 Lyon, France	Goethe University Frankfurt; Goethe University Frankfurt; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; CHU Lyon	Giraud, AL (corresponding author), Goethe Univ Frankfurt, Dept Physiol, D-60590 Frankfurt, Germany.	giraud@em.uni-frankfurt.de	Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013; truy, eric/J-9097-2017	Frackowiak, Richard/0000-0002-3151-822X; truy, eric/0000-0002-1769-8623; Price, Catherine/0000-0001-7448-4835	Wellcome Trust [051067] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bavelier D, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-17-j0001.2000; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Campbell R, 1998, SCAND AUDIOL, V27, P80, DOI 10.1080/010503998420694; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Fuster JM, 2000, NATURE, V405, P347, DOI 10.1038/35012613; Giraud AL, 2000, BRAIN, V123, P1391, DOI 10.1093/brain/123.7.1391; Grant KW, 1998, J ACOUST SOC AM, V103, P2677, DOI 10.1121/1.422788; Klinke R, 1999, SCIENCE, V285, P1729, DOI 10.1126/science.285.5434.1729; Lee DS, 2001, NATURE, V409, P149, DOI 10.1038/35051653; MacSweeney M, 2000, NEUROREPORT, V11, P1729, DOI 10.1097/00001756-200006050-00026; McIntosh AR, 1998, J NEUROPHYSIOL, V80, P2790, DOI 10.1152/jn.1998.80.5.2790; MIDDELWEERD MJ, 1987, J ACOUST SOC AM, V82, P2145, DOI 10.1121/1.395659; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; Nishimura H, 2000, NEUROREPORT, V11, P811, DOI 10.1097/00001756-200003200-00031; Puce A, 1998, J NEUROSCI, V18, P2188; Rauschecker JP, 1998, AUDIOL NEURO-OTOL, V3, P86, DOI 10.1159/000013784; RAUSCHECKER JP, 1993, J NEUROSCI, V13, P4538; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; SAMS M, 1991, NEUROSCI LETT, V127, P141, DOI 10.1016/0304-3940(91)90914-F; SELTZER B, 1994, J COMP NEUROL, V343, P445, DOI 10.1002/cne.903430308; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; Tyler RS, 1997, OTOLARYNG HEAD NECK, V117, P180, DOI 10.1016/S0194-5998(97)70172-4; Tyler RS, 1997, J ACOUST SOC AM, V102, P508, DOI 10.1121/1.419724; Watanabe T, 1998, P NATL ACAD SCI USA, V95, P11489, DOI 10.1073/pnas.95.19.11489; Weeks R, 2000, J NEUROSCI, V20, P2664	27	148	151	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					657	663		10.1016/S0896-6273(01)00318-X	http://dx.doi.org/10.1016/S0896-6273(01)00318-X			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430800	Bronze			2022-12-24	WOS:000169508900007
J	Horenstein, J; Wagner, DA; Czajkowski, C; Akabas, MH				Horenstein, J; Wagner, DA; Czajkowski, C; Akabas, MH			Protein mobility and GABA-induced conformational changes in GABA(A) receptor pore-lining M2 segment	NATURE NEUROSCIENCE			English	Article							GATED ION-CHANNEL; ZN2+ BINDING-SITE; ACETYLCHOLINE-RECEPTOR; BETA-SUBUNIT; POINT MUTATIONS; ALPHA-SUBUNIT; A RECEPTORS; IDENTIFICATION; STOICHIOMETRY; AFFINITY	Protein movements underlying ligand-gated ion channel activation are poorly understood. Here we used disulfide bond trapping to examine the proximity and mobility of cysteines substituted for aligned GABA(A) receptor alpha (1) and beta (1) M2 segment channel-lining residues in resting and activated receptors. With or without GABA, disulfide bonds formed at alpha (1)N275C/beta (1)E270C (20') and alpha (1)S272C/beta (1)H267C (17'), near the extracellular end, suggesting that this end is more mobile and/or flexible than the rest of the segment. Near the middle of M2, at alpha (1)T261C/beta (1)T256C (6'), a disulfide bond formed only in the presence of GABA and locked the channels open. Channel activation must involve an asymmetric rotation of two adjacent subunits toward each other. This would move aligned engineered cysteines on different subunits into proximity and allow disulfide bond formation without blocking conduction. Asymmetric rotation of M2 segments is probably a common gating mechanism in other ligand-gated ion channels.	Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; Columbia Univ, Dept Physiol, New York, NY 10032 USA; Univ Wisconsin, Dept Physiol, Madison, WI 53706 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; University of Wisconsin System; University of Wisconsin Madison	Akabas, MH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Physiol & Biophys, 1300 Morris Pk Ave, Bronx, NY 10461 USA.			Akabas, Myles/0000-0001-8781-7846	NIGMS NIH HHS [GM61925] Funding Source: Medline; NINDS NIH HHS [NS30808, NS34727] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030808, R01NS034727] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amato A, 1999, J PHYSIOL-LONDON, V517, P35, DOI 10.1111/j.1469-7793.1999.0035z.x; AMIN J, 1993, NATURE, V366, P565, DOI 10.1038/366565a0; Boileau AJ, 1999, J NEUROSCI, V19, P4847; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; Chang YC, 1996, J NEUROSCI, V16, P5415; CHARNET P, 1990, NEURON, V2, P87; Connolly CN, 1996, J BIOL CHEM, V271, P89, DOI 10.1074/jbc.271.1.89; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Gage PW, 1998, IMMUNOL CELL BIOL, V76, P436, DOI 10.1046/j.1440-1711.1998.00763.x; GURLEY D, 1995, RECEPTOR CHANNEL, V3, P13; HAMILTON SL, 1979, BIOCHEMISTRY-US, V18, P155, DOI 10.1021/bi00568a024; HIGAKI JN, 1992, TRENDS BIOCHEM SCI, V17, P100, DOI 10.1016/0968-0004(92)90245-5; Horenstein J, 1998, MOL PHARMACOL, V53, P870; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; Karlin A, 1995, NEURON, V15, P1231, DOI 10.1016/0896-6273(95)90004-7; Krasowski MD, 1999, CELL MOL LIFE SCI, V55, P1278, DOI 10.1007/s000180050371; Krovetz HS, 1997, BIOPHYS J, V72, P117, DOI 10.1016/S0006-3495(97)78651-X; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Pan ZH, 2000, NEUROSCIENCE, V98, P333, DOI 10.1016/S0306-4522(00)00114-7; RABOW LE, 1995, SYNAPSE, V21, P189, DOI 10.1002/syn.890210302; Sieghart W, 1999, NEUROCHEM INT, V34, P379, DOI 10.1016/S0197-0186(99)00045-5; SIGEL E, 1992, EMBO J, V11, P2017, DOI 10.1002/j.1460-2075.1992.tb05258.x; SIGEL E, 1990, NEURON, V5, P703, DOI 10.1016/0896-6273(90)90224-4; SMITH GB, 1994, J BIOL CHEM, V269, P20380; Tretter V, 1997, J NEUROSCI, V17, P2728; TWYMAN RE, 1992, J PHYSIOL-LONDON, V445, P97, DOI 10.1113/jphysiol.1992.sp018914; UNWIN N, 1995, NATURE, V373, P37, DOI 10.1038/373037a0; UNWIN N, 1993, J MOL BIOL, V229, P1101, DOI 10.1006/jmbi.1993.1107; WHITE BH, 1992, J BIOL CHEM, V267, P15770; Wilson GG, 1998, NEURON, V20, P1269, DOI 10.1016/S0896-6273(00)80506-1; Wooltorton JRA, 1997, J PHYSIOL-LONDON, V505, P633, DOI 10.1111/j.1469-7793.1997.633ba.x; Wu JH, 1996, P NATL ACAD SCI USA, V93, P14498, DOI 10.1073/pnas.93.25.14498; Xu M, 1995, BIOPHYS J, V69, P1858, DOI 10.1016/S0006-3495(95)80056-1; Xu M, 1996, J GEN PHYSIOL, V107, P195, DOI 10.1085/jgp.107.2.195; YU HB, 1995, BIOCHEMISTRY-US, V34, P14963, DOI 10.1021/bi00046a002; Zhang H, 1998, BIOCHEMISTRY-US, V37, P7952, DOI 10.1021/bi980143m	37	132	136	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					477	485		10.1038/87425	http://dx.doi.org/10.1038/87425			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319555				2022-12-24	WOS:000168412600010
J	Fu, AKY; Fu, WY; Cheung, J; Tsim, KWK; Ip, FCF; Wang, JH; Ip, NY				Fu, AKY; Fu, WY; Cheung, J; Tsim, KWK; Ip, FCF; Wang, JH; Ip, NY			Cdk5 is involved in neuregulin-induced AChR expression at the neuromuscular junction	NATURE NEUROSCIENCE			English	Article							CYCLIN-DEPENDENT KINASE-5; RECEPTOR EPSILON-SUBUNIT; DIRECTED PROTEIN-KINASE; MUSCLE-SPECIFIC KINASE; NEURITE OUTGROWTH; GENE-EXPRESSION; REGULATORY SUBUNIT; SKELETAL-MUSCLE; C-JUN; ARIA	Here we describe an important involvement of Cdk5/p35 in regulating the gene expression of acetylcholine receptor (AChR) at the neuromuscular synapse. Cdk5 and p35 were prominently expressed in embryonic muscle, and concentrated at the neuromuscular junction in adulthood. Neuregulin increased the p35-associated Cdk5 kinase activity in the membrane fraction of cultured C2C12 myotubes. Co-immunoprecipitation studies revealed the association between Cdk5, p35 and ErbB receptors in muscle and cultured myotubes. Inhibition of Cdk5 activity not only blocked the NRG-induced AChR transcription, but also attenuated ErbB activation in cultured myotubes. In light of our finding that overexpression of p35 alone led to an increase in AChR promoter activity in muscle, Cdk5 activation is sufficient to mediate the up-regulation of AChR gene expression. Taken together, these results reveal the unexpected involvement of Cdk5/p35 in neuregulin signaling at the neuromuscular synapse.	Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Biotechnol Res Inst, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; Hong Kong Univ Sci & Technol, Dept Biol, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Ip, NY (corresponding author), Hong Kong Univ Sci & Technol, Mol Neurosci Ctr, Biotechnol Res Inst, Dept Biochem, Clear Water Bay, Hong Kong, Hong Kong, Peoples R China.			Fu, Kit Yu/0000-0003-4085-6201; Tsim, Karl/0000-0003-4808-1674; Ip, Nancy Yuk-Yu/0000-0002-2763-8907				CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; Chae T, 1997, NEURON, V18, P29, DOI 10.1016/S0896-6273(01)80044-1; Ching YP, 2000, GENE, V242, P285, DOI 10.1016/S0378-1119(99)00499-0; CHU GC, 1995, NEURON, V14, P329, DOI 10.1016/0896-6273(95)90289-9; CORFAS G, 1993, J NEUROSCI, V13, P2118; Feinmesser RL, 1999, J BIOL CHEM, V274, P16168, DOI 10.1074/jbc.274.23.16168; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; Fu AKY, 1999, EUR J NEUROSCI, V11, P373, DOI 10.1046/j.1460-9568.1999.00443.x; Fu AKY, 1999, MOL CELL NEUROSCI, V14, P241, DOI 10.1006/mcne.1999.0784; Garcia RAG, 2000, P NATL ACAD SCI USA, V97, P3596, DOI 10.1073/pnas.070042497; Gramolini AO, 1999, P NATL ACAD SCI USA, V96, P3223, DOI 10.1073/pnas.96.6.3223; Huang YZ, 2000, NEURON, V26, P443, DOI 10.1016/S0896-6273(00)81176-9; Ip FCF, 2000, MOL CELL NEUROSCI, V16, P661, DOI 10.1006/mcne.2000.0892; IP FCF, 1995, J NEUROCHEM, V65, P2393; Kiyokawa N, 1997, ONCOGENE, V15, P2633, DOI 10.1038/sj.onc.1201442; Kwon YT, 2000, RES PRO CEL, V30, P241; Lazaro JB, 1997, J CELL SCI, V110, P1251; LEW J, 1992, J BIOL CHEM, V267, P25922; LEW J, 1995, TRENDS BIOCHEM SCI, V20, P33, DOI 10.1016/S0968-0004(00)88948-3; LEW J, 1994, NATURE, V371, P423, DOI 10.1038/371423a0; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; MINDEN A, 1995, CELL, V81, P1147, DOI 10.1016/S0092-8674(05)80019-4; MOSCOSO LM, 1995, DEV BIOL, V172, P158, DOI 10.1006/dbio.1995.0012; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Ojala J, 1997, ANTISENSE NUCLEIC A, V7, P31, DOI 10.1089/oli.1.1997.7.31; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Philpott A, 1997, GENE DEV, V11, P1409, DOI 10.1101/gad.11.11.1409; Pigino G, 1997, J CELL SCI, V110, P257; Rieff HI, 1999, J NEUROSCI, V19, P10757, DOI 10.1523/JNEUROSCI.19-24-10757.1999; Sheng M, 1997, BIOESSAYS, V19, P847, DOI 10.1002/bies.950191004; Si JT, 1996, J BIOL CHEM, V271, P19752, DOI 10.1074/jbc.271.33.19752; Si JT, 1997, J BIOL CHEM, V272, P10367; Si JT, 1999, MOL BRAIN RES, V67, P18, DOI 10.1016/S0169-328X(99)00028-5; Si JT, 1999, J NEUROSCI, V19, P8498; TANG DM, 1995, J BIOL CHEM, V270, P26897, DOI 10.1074/jbc.270.45.26897; Tansey MG, 1996, J CELL BIOL, V134, P465, DOI 10.1083/jcb.134.2.465; Tomizawa K, 1996, NEUROSCIENCE, V74, P519, DOI 10.1016/0306-4522(96)00136-4; TSAI LH, 1994, NATURE, V371, P419, DOI 10.1038/371419a0; Yang JF, 1997, FEBS LETT, V403, P163, DOI 10.1016/S0014-5793(97)00044-6; Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7; Zukerberg LR, 2000, NEURON, V26, P633, DOI 10.1016/S0896-6273(00)81200-3	44	144	161	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					374	381		10.1038/86019	http://dx.doi.org/10.1038/86019			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276227				2022-12-24	WOS:000168762200017
J	Krukowski, AE; Miller, KD				Krukowski, AE; Miller, KD			Thalamocortical NMDA conductances and intracortical inhibition can explain cortical temporal tuning	NATURE NEUROSCIENCE			English	Article							CAT VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CELL RECEPTIVE-FIELDS; D-ASPARTATE RECEPTORS; SUSPECTED INTERNEURONS; AXONAL PROPERTIES; EFFERENT NEURONS; AWAKE RABBIT; POSTSYNAPTIC POTENTIALS; DIRECTION SELECTIVITY	Cells in cerebral cortex fail to respond to fast-moving stimuli that evoke strong responses in the thalamic nuclei innervating the cortex. The reason for this behavior has remained a mystery. We study an experimentally motivated model of the thalamic input-recipient layer of cat primary visual cortex that accounts for many aspects of cortical orientation tuning. In this circuit, inhibition dominates over excitation, but temporal modulations of excitation and inhibition occur out of phase with one another, allowing excitation to transiently drive cells. We show that this circuit provides a natural explanation of cortical low-pass temporal frequency tuning, provided N-methyl-D-aspartate (NMDA) receptors are present in thalamocortical synapses in proportions measured experimentally. This suggests a new and unanticipated role for NMDA conductances in shaping the temporal response properties of cortical cells, and suggests that common cortical circuit mechanisms underlie both spatial and temporal response tuning.	Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Biophys Grad Program, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Krukowski, AE (corresponding author), Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA.				NEI NIH HHS [R01EY001] Funding Source: Medline	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; Allison JD, 1996, VISUAL NEUROSCI, V13, P559, DOI 10.1017/S0952523800008233; Angulo MC, 1999, J NEUROPHYSIOL, V82, P1295, DOI 10.1152/jn.1999.82.3.1295; ARMSTRONGJAMES M, 1993, J NEUROSCI, V13, P2149; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Catalano SM, 1997, J NEUROSCI, V17, P8376; Chance FS, 1998, J NEUROSCI, V18, P4785; CRAIR MC, 1995, NATURE, V375, P325, DOI 10.1038/375325a0; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; CZEPITA D, 1994, J NEUROPHYSIOL, V72, P1220, DOI 10.1152/jn.1994.72.3.1220; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; Feldman HI, 1999, PHARMACOEPIDEM DR S, V8, P1; FERSTER D, 1988, J NEUROSCI, V8, P1172; FERSTER D, 1992, J NEUROSCI, V12, P1262; FOX K, 1992, J NEUROSCI, V12, P2672; FOX K, 1989, J NEUROSCI, V9, P2443; GARYBOBO E, 1995, NEUROSCI LETT, V189, P147, DOI 10.1016/0304-3940(95)11477-E; Gil Z, 1996, J NEUROPHYSIOL, V76, P2547, DOI 10.1152/jn.1996.76.4.2547; HAGIHARA K, 1988, EXP BRAIN RES, V69, P407; HAMAMOTO J, 1994, EXP BRAIN RES, V98, P191; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HOLUB RA, 1981, J NEUROPHYSIOL, V46, P1244, DOI 10.1152/jn.1981.46.6.1244; IKEDA H, 1975, EXP BRAIN RES, V22, P363; JAHR CE, 1990, J NEUROSCI, V10, P3178; Kasamatsu T, 1998, NEUROSCIENCE, V82, P687; Ling DSF, 1995, J NEUROPHYSIOL, V74, P2329, DOI 10.1152/jn.1995.74.6.2329; MAEX R, 1992, NEURAL COMPUT, V4, P932, DOI 10.1162/neco.1992.4.6.932; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; MILLER KD, 1989, P NATL ACAD SCI USA, V86, P5183, DOI 10.1073/pnas.86.13.5183; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; O'Keefe LP, 1998, J NEUROPHYSIOL, V80, P594, DOI 10.1152/jn.1998.80.2.594; Pinto DJ, 2000, J NEUROPHYSIOL, V83, P1158, DOI 10.1152/jn.2000.83.3.1158; QUINN PJ, 1980, CRC CR REV BIOCH MOL, V8, P1, DOI 10.3109/10409238009105466; SALT TE, 1995, NEUROSCIENCE, V64, P433, DOI 10.1016/0306-4522(94)00357-B; SAUL AB, 1990, J NEUROPHYSIOL, V64, P206, DOI 10.1152/jn.1990.64.1.206; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; SCLAR G, 1987, EXP BRAIN RES, V66, P589, DOI 10.1007/BF00270692; SIMONS DJ, 1985, J NEUROPHYSIOL, V54, P615, DOI 10.1152/jn.1985.54.3.615; SUAREZ H, 1995, J NEUROSCI, V15, P6700; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; SWADLOW HA, 1989, J NEUROPHYSIOL, V62, P288, DOI 10.1152/jn.1989.62.1.288; SWADLOW HA, 1991, J NEUROPHYSIOL, V66, P1392, DOI 10.1152/jn.1991.66.4.1392; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thomson AM, 1999, NEUROSCIENCE, V92, P1193, DOI 10.1016/S0306-4522(99)00021-4; Troyer TW, 1998, J NEUROSCI, V18, P5908; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719	50	54	54	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					424	430		10.1038/86084	http://dx.doi.org/10.1038/86084			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276234				2022-12-24	WOS:000168762200024
J	Pardal, R; Lopez-Barneo, J				Pardal, R; Lopez-Barneo, J			Low glucose-sensing cells in the carotid body	NATURE NEUROSCIENCE			English	Article							CHEMORECEPTOR CELLS; GLOMUS CELLS; K+ CURRENT; HYPOGLYCEMIA; HYPOXIA; PLAY		Univ Sevilla, Dept Fisiol, Lab Invest Biomed, E-41013 Seville, Spain; Univ Sevilla, Hosp Univ Virgen Rocio, E-41013 Seville, Spain	University of Sevilla; University of Sevilla; Virgen del Rocio University Hospital	Lopez-Barneo, J (corresponding author), Univ Sevilla, Dept Fisiol, Lab Invest Biomed, E-41013 Seville, Spain.		IBIS, FISIOPATOLOGIA/O-9510-2015; Pardal, Ricardo/C-4370-2015; IBIS, NEUROBIOLOGIA/O-9922-2015	Pardal, Ricardo/0000-0003-1085-0714; 				ALVAREZBUYLLA R, 1994, BRAIN RES, V654, P167, DOI 10.1016/0006-8993(94)91585-7; ALVAREZBUYLLA R, 1988, RESP PHYSIOL, V72, P347, DOI 10.1016/0034-5687(88)90093-X; AUER RN, 1986, STROKE, V17, P699, DOI 10.1161/01.STR.17.4.699; CANE P, 1986, DIABETES, V35, P268, DOI 10.2337/diabetes.35.3.268; DONOVAN CM, 1994, P NATL ACAD SCI USA, V91, P2863, DOI 10.1073/pnas.91.7.2863; GERICH JE, 1988, DIABETES METAB REV, V4, P93, DOI 10.1002/dmr.5610040202; HAVENER AL, 1997, DIABETES, V46, P1521; LOPEZBARNEO J, 1988, SCIENCE, V241, P580, DOI 10.1126/science.2456613; MARTIN RL, 1994, TRENDS NEUROSCI, V17, P251, DOI 10.1016/0166-2236(94)90008-6; Perez-Garcia MT, 2000, J NEUROSCI, V20, P5689, DOI 10.1523/JNEUROSCI.20-15-05689.2000; ZINKER BA, 1994, AM J PHYSIOL, V266, pE921, DOI 10.1152/ajpendo.1994.266.6.E921	15	159	166	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					197	198		10.1038/nn812	http://dx.doi.org/10.1038/nn812			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850631				2022-12-24	WOS:000174146000007
J	Adams, WJ; Banks, MS; van Ee, R				Adams, WJ; Banks, MS; van Ee, R			Adaptation to three-dimensional distortions in human vision	NATURE NEUROSCIENCE			English	Article							STEREOSCOPIC SLANT PERCEPTION		Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; Univ Calif Berkeley, Vis Sci Program, Berkeley, CA 94720 USA; Univ Glasgow, Dept Psychol, Glasgow G12 8QB, Lanark, Scotland; Helmholtz Inst, NL-3584 CC Utrecht, Netherlands	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Glasgow	Banks, MS (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.		van Ee, Raymond/C-4881-2013					Backus BT, 1999, PERCEPTION, V28, P217, DOI 10.1068/p2753; Backus BT, 1999, VISION RES, V39, P1143, DOI 10.1016/S0042-6989(98)00139-4; BURIAN HM, 1945, AM J OPHTHALMOL, V28, P735, DOI 10.1016/S0002-9394(45)90820-8; Burian HM, 1943, ARCH OPHTHALMOL-CHIC, V30, P645; Clark J.J., 1990, DATA FUSION SENSORY; EPSTEIN W, 1974, J EXP PSYCHOL, V102, P585, DOI 10.1037/h0036086; EPSTEIN W, 1972, PERCEPT PSYCHOPHYS, V12, P315, DOI 10.3758/BF03207212; EPSTEIN W, 1970, AM J PSYCHOL, V83, P322, DOI 10.2307/1420409; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; MILES PW, 1948, AM J OPHTHALMOL, V36, P687; MORRISON LC, 1972, BRIT J PHYSIOL OPT, V27, P84; Ogle K. N., 1950, RES BINOCULAR VISION; REMOLE A, 1991, CLIN EXPT OPTOM, V74, P71; Rock I., 1966, NATURE PERCEPTUAL AD	14	70	70	0	13	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1063	1064		10.1038/nn729	http://dx.doi.org/10.1038/nn729			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11584290				2022-12-24	WOS:000171970900007
J	Cheng, K; Waggoner, RA; Tanaka, K				Cheng, K; Waggoner, RA; Tanaka, K			Human ocular dominance columns as revealed by high-field functional magnetic resonance imaging	NEURON			English	Article							CYTOCHROME-OXIDASE PATCHES; PRIMARY VISUAL-CORTEX; HUMAN STRIATE CORTEX; CEREBRAL-BLOOD-FLOW; OXYGEN-CONSUMPTION; RECEPTIVE-FIELDS; BOLD CONTRAST; MONKEY; MACAQUE; MRI	We mapped ocular dominance columns (ODCs) in normal human subjects using high-field (4 T) functional magnetic resonance imaging (fMRI) with a segmented echo planar imaging technique and an in-plane resolution of 0.47 x 0.47 mm(2). The differential responses to left or right eye stimulation could be reliably resolved in anatomically well-defined sections of V1. The orientation and width (similar to1 mm) of mapped ODC stripes conformed to those previously revealed in postmortem brains stained with cytochrome oxidase. In addition, we showed that mapped ODC patterns could be largely reproduced in different experiments conducted within the same experimental session or over different sessions. Our results demonstrate that high-field fMRI can be used for studying the functions of human brains at columnar spatial resolution.	RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, CREST, Wako, Saitama 3510198, Japan	RIKEN; Japan Science & Technology Agency (JST)	Cheng, K (corresponding author), RIKEN, Brain Sci Inst, Lab Cognit Brain Mapping, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kcheng@mailman.riken.go.jp	Waggoner, Allen/F-2654-2010; Cheng, Kang/A-6448-2016; Tanaka, Keiji/N-5917-2015	Waggoner, Allen/0000-0002-4921-7521; Tanaka, Keiji/0000-0002-1910-3427				BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BLASDEL GG, 1992, J NEUROSCI, V12, P3115, DOI 10.1523/JNEUROSCI.12-08-03115.1992; Buxton RB, 1997, J CEREBR BLOOD F MET, V17, P64, DOI 10.1097/00004647-199701000-00009; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Davis TL, 1998, P NATL ACAD SCI USA, V95, P1834, DOI 10.1073/pnas.95.4.1834; Dechent P, 2000, NEUROREPORT, V11, P3247, DOI 10.1097/00001756-200009280-00039; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; ERNST T, 1994, MAGN RESON MED, V32, P146, DOI 10.1002/mrm.1910320122; FLORENCE SL, 1992, VISUAL NEUROSCI, V8, P449, DOI 10.1017/S0952523800004958; Fransson P, 1998, MAGNET RESON MED, V39, P912, DOI 10.1002/mrm.1910390608; Gati JS, 1997, MAGNET RESON MED, V38, P296, DOI 10.1002/mrm.1910380220; Grinvald A, 2000, NAT NEUROSCI, V3, P105, DOI 10.1038/72045; HITCHCOCK PF, 1980, BRAIN RES, V182, P176; Hoge RD, 1999, P NATL ACAD SCI USA, V96, P9403, DOI 10.1073/pnas.96.16.9403; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P255, DOI 10.1098/rstb.1984.0022; Horton JC, 1998, J NEUROSCI, V18, P5433, DOI 10.1523/JNEUROSCI.18-14-05433.1998; HORTON JC, 1984, PHILOS T ROY SOC B, V304, P199, DOI 10.1098/rstb.1984.0021; HORTON JC, 1990, ARCH OPHTHALMOL-CHIC, V108, P1025, DOI 10.1001/archopht.1990.01070090127054; HU XP, 1994, MAGN RESON MED, V31, P495, DOI 10.1002/mrm.1910310505; Hu XP, 1997, MAGNET RESON MED, V37, P877, DOI 10.1002/mrm.1910370612; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUBEL DH, 1972, J COMP NEUROL, V146, P421, DOI 10.1002/cne.901460402; Jones M, 2001, NEUROIMAGE, V13, P1002, DOI 10.1006/nimg.2001.0808; KENNEDY C, 1976, P NATL ACAD SCI USA, V73, P4230, DOI 10.1073/pnas.73.11.4230; Kim DS, 2000, NAT NEUROSCI, V3, P164, DOI 10.1038/72109; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; Kim SG, 1999, MAGN RESON MED, V41, P1152, DOI 10.1002/(SICI)1522-2594(199906)41:6<1152::AID-MRM11>3.0.CO;2-T; LEUBA G, 1994, ANAT EMBRYOL, V190, P351; Lindauer U, 2001, NEUROIMAGE, V13, P988, DOI 10.1006/nimg.2000.0709; Luh WM, 2000, MAGNET RESON MED, V44, P137, DOI 10.1002/1522-2594(200007)44:1<137::AID-MRM20>3.0.CO;2-R; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Malonek D, 1996, SCIENCE, V272, P551, DOI 10.1126/science.272.5261.551; Malonek D, 1997, P NATL ACAD SCI USA, V94, P14826, DOI 10.1073/pnas.94.26.14826; Menon RS, 1997, J NEUROPHYSIOL, V77, P2780, DOI 10.1152/jn.1997.77.5.2780; MENON RS, 1993, MAGNET RESON MED, V30, P380, DOI 10.1002/mrm.1910300317; MENON RS, 1995, MAGNET RESON MED, V33, P453, DOI 10.1002/mrm.1910330323; Menon RS, 1999, MAGNET RESON MED, V41, P230, DOI 10.1002/(SICI)1522-2594(199902)41:2<230::AID-MRM3>3.0.CO;2-O; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Ogawa S, 1998, ANNU REV BIOPH BIOM, V27, P447, DOI 10.1146/annurev.biophys.27.1.447; Ono M, 1990, ATLAS CEREBRAL SULCI; PONCELET BP, 1992, RADIOLOGY, V185, P645, DOI 10.1148/radiology.185.3.1438740; Schwarzbauer C, 1999, MAGNET RESON MED, V41, P537, DOI 10.1002/(SICI)1522-2594(199903)41:3<537::AID-MRM16>3.0.CO;2-V; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; TOOTELL RBH, 1988, J NEUROSCI, V8, P1500; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; TURNER R, 1991, MAGNET RESON MED, V22, P159, DOI 10.1002/mrm.1910220117; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; Wiser AK, 1997, VISUAL NEUROSCI, V14, P241, DOI 10.1017/S095252380001138X; Yacoub E, 2001, MAGN RESON MED, V45, P588, DOI 10.1002/mrm.1080; Yacoub E, 1999, MAGNET RESON MED, V41, P1088, DOI 10.1002/(SICI)1522-2594(199906)41:6<1088::AID-MRM3>3.0.CO;2-Q; Yoshioka T, 1996, CEREB CORTEX, V6, P297, DOI 10.1093/cercor/6.2.297	58	274	279	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 25	2001	32	2					359	374		10.1016/S0896-6273(01)00477-9	http://dx.doi.org/10.1016/S0896-6273(01)00477-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684004	Bronze			2022-12-24	WOS:000171893700019
J	Helmchen, F; Fee, MS; Tank, DW; Denk, W				Helmchen, F; Fee, MS; Tank, DW; Denk, W			A miniature head-mounted two-photon microscope: High-resolution brain imaging in freely moving animals	NEURON			English	Article							DENDRITIC CALCIUM DYNAMICS; NEOCORTICAL PYRAMIDAL NEURONS; GREEN FLUORESCENT PROTEINS; CORTEX IN-VIVO; ACTION-POTENTIALS; BEHAVING ANIMALS; RAT; INTEGRATION; HIPPOCAMPAL; INDICATOR	Two-photon microscopy has enabled anatomical and functional fluorescence imaging in the intact brain of rats. Here, we extend two-photon imaging from anesthetized, head-stabilized to awake, freely moving animals by using a miniaturized head-mounted microscope. Excitation light is conducted to the microscope in a single-mode optical fiber, and images are scanned using vibrations of the fiber tip. Microscope performance was first characterized in the neocortex of anesthetized rats. We readily obtained images of vasculature filled with fluorescently labeled blood and of layer 2/3 pyramidal neurons filled with a calcium indicator. Capillary blood flow and dendritic calcium transients were measured with high time resolution using line scans. In awake, freely moving rats, stable imaging was possible except during sudden head movements.	Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA; Max Planck Inst Med Res, Dept Biomed Opt, D-69120 Heidelberg, Germany	Alcatel-Lucent; Lucent Technologies; AT&T; Max Planck Society	Denk, W (corresponding author), Lucent Technol, Bell Labs, Biol Computat Res Dept, Murray Hill, NJ 07974 USA.		denk, winfried/I-6627-2012; Helmchen, Fritjof/A-6255-2008	Helmchen, Fritjof/0000-0002-8867-9569; Fee, Michale/0000-0001-7539-1745				Agrawal G.P., 2000, NONLINEAR FIBER OPTI, V4th; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BIRGE RR, 1986, ACCOUNTS CHEM RES, V19, P138, DOI 10.1021/ar00125a003; BORST A, 1992, P NATL ACAD SCI USA, V89, P4139, DOI 10.1073/pnas.89.9.4139; Bussau LJ, 1998, J ANAT, V192, P187, DOI 10.1046/j.1469-7580.1998.19220187.x; Buzsaki G, 1998, J NEUROPHYSIOL, V79, P1587, DOI 10.1152/jn.1998.79.3.1587; Davis MD, 2000, J NEUROSCI METH, V99, P9, DOI 10.1016/S0165-0270(00)00209-0; deCharms RC, 1999, J NEUROSCI METH, V93, P27, DOI 10.1016/S0165-0270(99)00087-4; Delaney P. M., 1995, P515; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Denk W, 1996, CURR OPIN NEUROBIOL, V6, P372, DOI 10.1016/S0959-4388(96)80122-X; Denk Winfried, 1995, P445; Dickensheets DL, 1996, OPT LETT, V21, P764, DOI 10.1364/OL.21.000764; DIRNAGL U, 1992, J MICROSC-OXFORD, V165, P147, DOI 10.1111/j.1365-2818.1992.tb04312.x; Eilers J, 1997, CURR OPIN NEUROBIOL, V7, P385, DOI 10.1016/S0959-4388(97)80067-0; Fee MS, 2000, NEURON, V27, P461, DOI 10.1016/S0896-6273(00)00057-X; FORK RL, 1984, OPT LETT, V9, P150, DOI 10.1364/OL.9.000150; GOSNELL TR, 1991, SELECTED PAPERS ULTR; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Hofmann U, 1999, P SOC PHOTO-OPT INS, V3878, P29, DOI 10.1117/12.361269; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; Kuner T, 2000, NEURON, V27, P447, DOI 10.1016/S0896-6273(00)00056-8; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; LISSAJOUS JA, 1855, CR HEBD ACAD SCI, V41, P814; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; OMalley DM, 1996, NEURON, V17, P1145, DOI 10.1016/S0896-6273(00)80246-9; Papworth GD, 1998, J ANAT, V192, P489, DOI 10.1046/j.1469-7580.1998.19240489.x; Pare D, 1998, NEUROSCIENCE, V84, P377, DOI 10.1016/S0306-4522(97)00530-7; Rector DM, 1997, J NEUROSCI METH, V78, P85, DOI 10.1016/S0165-0270(97)00137-4; RECTOR DM, 1993, NEUROSCIENCE, V54, P633, DOI 10.1016/0306-4522(93)90234-7; Regehr Wade G., 1994, Current Opinion in Neurobiology, V4, P373, DOI 10.1016/0959-4388(94)90099-X; Sabharwal YS, 1999, APPL OPTICS, V38, P7133, DOI 10.1364/AO.38.007133; Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848; SOBEL EC, 1994, SCIENCE, V263, P823, DOI 10.1126/science.263.5148.823; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TREACY EB, 1969, IEEE J QUANTUM ELECT, VQE 5, P454, DOI 10.1109/JQE.1969.1076303; Yuste R, 1996, NEURON, V16, P701, DOI 10.1016/S0896-6273(00)80091-4; YUSTE R, 1999, IMAGING NEURONS LAB	42	455	487	6	67	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					903	912		10.1016/S0896-6273(01)00421-4	http://dx.doi.org/10.1016/S0896-6273(01)00421-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580892	Bronze			2022-12-24	WOS:000171281300007
J	White, BH; Osterwalder, TP; Yoon, KS; Joiner, WJ; Whim, MD; Kaczmarek, LK; Keshishian, H				White, BH; Osterwalder, TP; Yoon, KS; Joiner, WJ; Whim, MD; Kaczmarek, LK; Keshishian, H			Targeted attenuation of electrical activity in Drosophila using a genetically modified K+ channel	NEURON			English	Article							SHAKER POTASSIUM CHANNEL; SYNAPSE FORMATION; EXPRESSION; GENE; NEURONS; OVEREXPRESSION; MUTATIONS; CURRENTS; EXCITABILITY; PLASTICITY	We describe here a general technique for the graded inhibition of cellular excitability in vivo. Inhibition is accomplished by expressing a genetically modified Shaker K+ channel (termed the EKO channel) in targeted cells. Unlike native K+ channels, the EKO channel strongly shunts depolarizing current: activating at potentials near E-K and not inactivating. Selective targeting of the channel to neurons, muscles, and photoreceptors in Drosophila using the Gal4-UAS system results in physiological and behavioral effects consistent with attenuated excitability in the targeted cells, often with loss of neuronal function at higher transgene dosages. By permitting the incremental reduction of electrical activity, the EKO technique can be used to address a wide range of questions regarding neuronal function.	Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University	White, BH (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, POB 208066, New Haven, CT 06520 USA.	benjamin.white@yale.edu						Aamodt S M, 1999, Adv Neurol, V79, P133; Allen MJ, 1999, J NEUROSCI, V19, P9374; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chang TN, 1996, J NEUROSCI, V16, P5715; Ehrengruber MU, 1997, P NATL ACAD SCI USA, V94, P7070, DOI 10.1073/pnas.94.13.7070; Gelbart WM, 1999, NUCLEIC ACIDS RES, V27, P85, DOI 10.1093/nar/27.1.85; GERMROTH PG, 1995, MICROSC RES TECHNIQ, V30, P513, DOI 10.1002/jemt.1070300608; GORCZYCA MG, 1994, DEVELOPMENT, V120, P2143; HAUGLAND FN, 1990, J NEUROSCI, V10, P1357; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; JAN LY, 1976, J PHYSIOL-LONDON, V262, P189, DOI 10.1113/jphysiol.1976.sp011592; Jarecki J, 1995, J NEUROSCI, V15, P8177; Johns DC, 1999, J NEUROSCI, V19, P1691; JONES SM, 1994, J NEUROSCI, V14, P2789; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kandler K, 1998, J NEUROSCI, V18, P1419; KESHISHIAN H, 1994, FASEB J, V8, P731, DOI 10.1096/fasebj.8.10.8050672; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Lnenicka GA, 2000, J NEUROBIOL, V43, P186, DOI 10.1002/(SICI)1097-4695(200005)43:2<186::AID-NEU8>3.3.CO;2-E; MCCORMACK K, 1994, NEURON, V12, P301, DOI 10.1016/0896-6273(94)90273-9; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Nadeau H, 2000, J NEUROPHYSIOL, V84, P1062, DOI 10.1152/jn.2000.84.2.1062; PAPAZIAN DM, 1991, NATURE, V349, P305, DOI 10.1038/349305a0; Paradis S, 2001, NEURON, V30, P737, DOI 10.1016/S0896-6273(01)00326-9; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Phelan P, 1996, J NEUROSCI, V16, P1101; Rogero O, 1997, J NEUROSCI, V17, P5108; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SALKOFF LB, 1983, J PHYSIOL-LONDON, V337, P687, DOI 10.1113/jphysiol.1983.sp014649; Seecof R L, 1971, Curr Top Microbiol Immunol, V55, P71; SEECOF RL, 1971, EXP CELL RES, V69, P161, DOI 10.1016/0014-4827(71)90321-1; Sutherland ML, 1999, P NATL ACAD SCI USA, V96, P2451, DOI 10.1073/pnas.96.5.2451; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; THOMAS JB, 1984, J NEUROSCI, V4, P530; TIMPE LC, 1988, NEURON, V1, P659, DOI 10.1016/0896-6273(88)90165-1; Whim MD, 1998, J NEUROSCI, V18, P9171; Whim MD, 1998, NEUROSCI LETT, V258, P143, DOI 10.1016/S0304-3940(98)00850-7; WU CF, 1990, J NEUROBIOL, V21, P499, DOI 10.1002/neu.480210310; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; Yuste R, 1999, J NEUROBIOL, V41, P1, DOI 10.1002/(SICI)1097-4695(199910)41:1<1::AID-NEU1>3.0.CO;2-2; ZHAO B, 1994, NEURON, V13, P1205, DOI 10.1016/0896-6273(94)90058-2	47	103	103	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					699	711		10.1016/S0896-6273(01)00415-9	http://dx.doi.org/10.1016/S0896-6273(01)00415-9			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567611	Bronze			2022-12-24	WOS:000171013300006
J	Bodegard, A; Geyer, S; Grefkes, C; Zilles, K; Roland, PE				Bodegard, A; Geyer, S; Grefkes, C; Zilles, K; Roland, PE			Hierarchical processing of tactile shape in the human brain	NEURON			English	Article							POST-CENTRAL GYRUS; SOMATOSENSORY CORTEX; POSTCENTRAL-GYRUS; CEREBRAL-CORTEX; CONSCIOUS MONKEY; RECEPTIVE-FIELD; PARIETAL CORTEX; HAND AREA; NEURONS; PET	It is not known exactly which cortical areas compute somatosensory representations of shape. This was investigated using positron emission tomography and cytoarchitectonic mapping. Volunteers discriminated shapes by passive or active touch, brush velocity, edge length, curvature, and roughness. Discrimination of shape by active touch, as opposed to passive touch, activated the right anterior lobe of cerebellum only. Areas 3b and 1 were activated by all stimuli. Area 2 was activated with preference for surface curvature changes and shape stimuli. The anterior part of the supramarginal gyrus (ASM) and the cortex lining the intraparietal sulcus (IPA) were activated by active and passive shape discrimination but not by other mechanical stimuli. We suggest, based on these findings, that somatosensory representations of shape are computed by areas 3b, 1, 2, IPA, and ASM in this hierarchical fashion.	Karolinska Inst, Dept Neurosci, Div Human Brain Res, S-17177 Stockholm, Sweden; Univ Dusseldorf, C&O Vogt Brain Res Inst, D-40001 Dusseldorf, Germany; Univ Dusseldorf, Dept Neuroanat, D-40001 Dusseldorf, Germany; Res Ctr Julich, Inst Med, D-52425 Julich, Germany	Karolinska Institutet; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich	Roland, PE (corresponding author), Karolinska Inst, Dept Neurosci, Div Human Brain Res, S-17177 Stockholm, Sweden.	per.roland@neuro.ki.se	Grefkes, Christian/H-3972-2013; Zilles, Karl/J-9704-2013; Zilles, Karl/Y-3784-2019	Grefkes, Christian/0000-0002-1656-720X; Zilles, Karl/0000-0001-9296-9959; Zilles, Karl/0000-0002-4705-4175				Amunts K, 1999, J COMP NEUROL, V412, P319, DOI 10.1002/(SICI)1096-9861(19990920)412:2<319::AID-CNE10>3.0.CO;2-7; Anton JL, 1996, NEUROREPORT, V7, P2849, DOI 10.1097/00001756-199611250-00008; Binkofski F, 1999, EUR J NEUROSCI, V11, P3276, DOI 10.1046/j.1460-9568.1999.00753.x; Bodegard A, 2000, NEUROREPORT, V11, P187, DOI 10.1097/00001756-200001170-00037; Bodegard A, 2000, J NEUROSCI, V20; Boecker H, 1995, HUM BRAIN MAPP, V3, P236, DOI 10.1002/hbm.460030307; Brodman K., 1909, VERGLEICHENDE LOKALI; CARLSON M, 1981, BRAIN RES, V204, P424, DOI 10.1016/0006-8993(81)90602-8; CORKIN S, 1970, ARCH NEUROL-CHICAGO, V23, P41, DOI 10.1001/archneur.1970.00480250045007; COSTANZO RM, 1980, J NEUROPHYSIOL, V43, P1318, DOI 10.1152/jn.1980.43.5.1319; Debowy DJ, 2001, EXP BRAIN RES, V137, P269, DOI 10.1007/s002210000660; DELAY JPL, 1935, ASTEREOGNOSIES, P1; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; EVANS JP, 1935, P ASS RES NERV MENT, V15, P331; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; GARRAGHTY PE, 1990, BRAIN RES, V528, P165, DOI 10.1016/0006-8993(90)90213-U; Geyer S, 1999, NEUROIMAGE, V10, P63, DOI 10.1006/nimg.1999.0440; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Goodwin AW, 1997, J NEUROPHYSIOL, V78, P2881, DOI 10.1152/jn.1997.78.6.2881; GREFKES C, 2001, IN PRESS HUMAN PRIMA, V2; Hadjikhani N, 1998, J NEUROSCI, V18, P1072; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P539, DOI 10.1113/jphysiol.1978.sp012518; HYVARINEN J, 1978, J PHYSIOL-LONDON, V283, P523, DOI 10.1113/jphysiol.1978.sp012517; Iwamura Y, 1998, CURR OPIN NEUROBIOL, V8, P522, DOI 10.1016/S0959-4388(98)80041-X; IWAMURA Y, 1985, EXP BRAIN RES, V58, P412; IWAMURA Y, 1983, EXP BRAIN RES, V51, P327; IWAMURA Y, 1978, BRAIN RES, V150, P662, DOI 10.1016/0006-8993(78)90834-X; JOHANSSON RS, 1982, BRAIN RES, V244, P17, DOI 10.1016/0006-8993(82)90899-X; KATZ D, 1925, AUFBAU TASTWELT, P270; Kawashima R, 1998, EUR J NEUROSCI, V10, P2254, DOI 10.1046/j.1460-9568.1998.00237.x; LaMotte RH, 1996, J NEUROPHYSIOL, V76, P3787, DOI 10.1152/jn.1996.76.6.3787; Ledberg A, 2000, HUM BRAIN MAPP, V9, P143, DOI 10.1002/(SICI)1097-0193(200003)9:3<143::AID-HBM3>3.0.CO;2-2; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Matsumura M, 1996, NEUROREPORT, V7, P749, DOI 10.1097/00001756-199602290-00017; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P369, DOI 10.1146/annurev.ne.16.030193.002101; MEYER E, 1989, J NUCL MED, V30, P1069; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P201; MOUNTCASTLE VB, 1959, B JOHNS HOPKINS HOSP, V105, P173; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; Murata A, 2000, J NEUROPHYSIOL, V83, P2580, DOI 10.1152/jn.2000.83.5.2580; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PHILLIPS JR, 1988, P NATL ACAD SCI USA, V85, P1317, DOI 10.1073/pnas.85.4.1317; RANDOLPH M, 1974, BRAIN RES, V70, P55, DOI 10.1016/0006-8993(74)90211-X; Ro JY, 2000, EXP BRAIN RES, V135, P1, DOI 10.1007/s002210000496; ROLAND E, 1976, ARCH NEUROL-CHICAGO, V33, P543; ROLAND PE, 1994, TRENDS NEUROSCI, V17, P458, DOI 10.1016/0166-2236(94)90131-7; Roland PE, 1998, BRAIN RES REV, V26, P87, DOI 10.1016/S0165-0173(97)00058-1; ROLAND PE, 1989, EUR J NEUROSCI, V1, P3, DOI 10.1111/j.1460-9568.1989.tb00769.x; ROLAND PE, 1987, BRAIN RES REV, V12, P1, DOI 10.1016/0165-0173(87)90017-8; ROLAND PE, 1987, EXP BRAIN RES, V66, P303; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; ROLAND PE, 1975, BEHAV RES METH INSTR, V7, P333, DOI 10.3758/BF03201532; ROLAND PE, 1993, BRAIN ACTIVATION, P83; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Romo R, 1997, CEREB CORTEX, V7, P317, DOI 10.1093/cercor/7.4.317; Sakata H, 1997, TRENDS NEUROSCI, V20, P350, DOI 10.1016/S0166-2236(97)01067-9; Salinas E, 1998, J NEUROSCI, V18, P499; SCANNELL JW, 1993, CURR BIOL, V3, P191, DOI 10.1016/0960-9822(93)90331-H; Schleicher A, 1999, NEUROIMAGE, V9, P165, DOI 10.1006/nimg.1998.0385; Schormann T, 1998, HUM BRAIN MAPP, V6, P339, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<339::AID-HBM3>3.3.CO;2-H; SEITZ RJ, 1991, EUR J NEUROSCI, V3, P481, DOI 10.1111/j.1460-9568.1991.tb00835.x; SHINDY WW, 1994, CEREB CORTEX, V4, P443, DOI 10.1093/cercor/4.4.443; TAIRA M, 1990, EXP BRAIN RES, V83, P29; Talairach J, 1967, ATLAS ANATOMIE STERE; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; WHEAT HE, 1995, J NEUROSCI, V15, P5582; YOUNG MP, 1992, NATURE, V358, P152, DOI 10.1038/358152a0; Zhou YD, 1996, P NATL ACAD SCI USA, V93, P10533, DOI 10.1073/pnas.93.19.10533	69	192	193	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2001	31	2					317	328		10.1016/S0896-6273(01)00362-2	http://dx.doi.org/10.1016/S0896-6273(01)00362-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502261	Bronze			2022-12-24	WOS:000170277700015
J	McIntyre, J; Zago, M; Berthoz, A; Lacquaniti, F				McIntyre, J; Zago, M; Berthoz, A; Lacquaniti, F			Does the brain model Newton's laws?	NATURE NEUROSCIENCE			English	Article							COORDINATION; MOVEMENT; GRAVITY; BALL; TIME		European Lab Neurosci Act, CNRS, Lab Physiol Percept & Act, F-75005 Paris, France; Coll France, F-75005 Paris, France; IRCCS, Fdn Santa Lucia, Sez Fisiol Umana, European Lab Neurosci Act, I-00179 Rome, Italy; Univ Roma Tor Vergata, Ctr Biomed Spaziale, I-00173 Rome, Italy	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France; IRCCS Santa Lucia; University of Rome Tor Vergata	McIntyre, J (corresponding author), European Lab Neurosci Act, CNRS, Lab Physiol Percept & Act, 11 Pl Marcelin Berthelot, F-75005 Paris, France.		Zago, Myrka/B-3669-2012; Lacquaniti, Francesco/J-9842-2016; McIntyre, Joseph/K-6395-2015	Zago, Myrka/0000-0001-7100-7582; Lacquaniti, Francesco/0000-0003-0896-7315; McIntyre, Joseph/0000-0003-4974-4257				COLLEWIJN H, 1972, BRAIN RES, V36, P59, DOI 10.1016/0006-8993(72)90766-4; Gibson JJ., 1966, SENSES CONSIDERED PE; HUBBARD TL, 1995, PSYCHON B REV, V2, P322, DOI 10.3758/BF03210971; Lackner JR, 2000, EXP BRAIN RES, V130, P2, DOI 10.1007/s002210050002; LACQUANITI F, 1989, J NEUROSCI, V9, P134, DOI 10.1523/JNEUROSCI.09-01-00134.1989; Lacquaniti F., 1993, MULTISENSORY CONTROL, P379, DOI [10.1093/acprof:oso/9780198547853.003.0190, DOI 10.1093/ACPROF:OSO/9780198547853.003.0190]; Lee DN, 1999, P ROY SOC B-BIOL SCI, V266, P2029, DOI 10.1098/rspb.1999.0882; LEE DN, 1983, Q J EXP PSYCHOL-A, V35, P333, DOI 10.1080/14640748308402138; LEE DN, 1980, TUTORIALS MOTOR BEHA, P281; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Regan D, 1997, J SPORT SCI, V15, P533, DOI 10.1080/026404197366985; Rushton SK, 1999, NAT NEUROSCI, V2, P186, DOI 10.1038/5750; SAVELSBERGH GJP, 1992, EXP BRAIN RES, V89, P223; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z	15	275	280	0	33	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					693	694		10.1038/89477	http://dx.doi.org/10.1038/89477			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426224				2022-12-24	WOS:000169621300013
J	Livingstone, MS; Pack, CC; Born, RT				Livingstone, MS; Pack, CC; Born, RT			Two-dimensional substructure of MT receptive fields	NEURON			English	Article							VISUAL AREA MT; MOTION PERCEPTION; STRIATE CORTEX; RESPONSE PROPERTIES; SPATIAL SUMMATION; APPARENT MOTION; COMPLEX CELLS; SHORT-RANGE; MACAQUE; NEURONS	Neurons at progressively higher levels of the visual system have progressively larger, more complicated receptive fields, presumably constructed from simpler antecedent receptive fields. To study this hierarchical organization, we used sparse white noise to map receptive-field substructure (second order Wiener-like kernels) in an extrastriate motion processing area (MT) of alert monkeys. The maps revealed a clear substructure, on a spatial scale comparable to the receptive fields of the V1 inputs. There were both facilitatory and suppressive interactions that differed in spatial organization and time course. Directional interactions were remarkably precise over a very small spatial range, and reversed when successive stimuli reversed contrast-a neural correlate of "reverse phi" motion perception. The maps of some cells had an unexpected, curved shape, which challenges existing models for direction selectivity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Livingstone, MS (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.		Born, Richard/M-6454-2019	Born, Richard/0000-0003-4360-427X; Livingstone, Margaret/0000-0002-1950-0123	NATIONAL EYE INSTITUTE [R01EY011379, R01EY013135, P30EY012196] Funding Source: NIH RePORTER; NEI NIH HHS [EY11379, EY13135, P30-EY12196] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; ANSTIS SM, 1975, VISION RES, V15, P957, DOI 10.1016/0042-6989(75)90236-9; BARLOW HB, 1965, J PHYSIOL-LONDON, V178, P477, DOI 10.1113/jphysiol.1965.sp007638; Born RT, 2000, NEURON, V26, P725, DOI 10.1016/S0896-6273(00)81208-8; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Britten KH, 1999, J NEUROSCI, V19, P5074; CASCO C, 1989, PERCEPTION, V18, P285, DOI 10.1068/p180285; CAVANAGH P, 1984, J OPT SOC AM A, V1, P893, DOI 10.1364/JOSAA.1.000893; DEBOER E, 1968, IEEE T BIOMEDICAL EN, V153, P169; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; EGELHAAF M, 1992, VISUAL NEUROSCI, V8, P151, DOI 10.1017/S0952523800009317; EGGERMONT JJ, 1983, Q REV BIOPHYS, V16, P341, DOI 10.1017/S0033583500005126; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; Ferster David, 1994, Current Opinion in Neurobiology, V4, P563, DOI 10.1016/0959-4388(94)90058-2; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P427, DOI 10.1017/S095252380001124X; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; KOCH C, 1982, PHILOS T R SOC B, V298, P227, DOI 10.1098/rstb.1982.0084; KOCH C, 1987, SYNAPTIC FUNCTION, P637; Livingstone MS, 1998, NEURON, V20, P509, DOI 10.1016/S0896-6273(00)80991-5; LIVINGSTONE MS, 2000, SOC NEUR ABST, V26; LU ZL, 1995, VISION RES, V35, P2697, DOI 10.1016/0042-6989(95)00025-U; MEL BW, 1993, J NEUROPHYSIOL, V70, P1086, DOI 10.1152/jn.1993.70.3.1086; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1328, DOI 10.1152/jn.1986.55.6.1328; MIKAMI A, 1991, INT J NEUROSCI, V61, P101, DOI 10.3109/00207459108986278; Movshon A, 1985, PATTERN RECOGN, V54, P117; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Movshon JA, 1996, J NEUROSCI, V16, P7733; Pack CC, 2001, NATURE, V409, P1040, DOI 10.1038/35059085; Poggio T, 1976, Cold Spring Harb Symp Quant Biol, V40, P635; QIAN N, 1994, J NEUROSCI, V14, P7381; RAMACHANDRAN VS, 1978, NATURE, V275, P55, DOI 10.1038/275055a0; Shadlen M. N., 1993, Society for Neuroscience Abstracts, V19, P1282; Simoncelli EP, 1998, VISION RES, V38, P743, DOI 10.1016/S0042-6989(97)00183-1; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1981, J COMP NEUROL, V199, P293, DOI 10.1002/cne.901990302	37	76	76	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					781	793		10.1016/S0896-6273(01)00313-0	http://dx.doi.org/10.1016/S0896-6273(01)00313-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430811	Bronze			2022-12-24	WOS:000169508900018
J	Cameron, KA; Yashar, S; Wilson, CL; Fried, I				Cameron, KA; Yashar, S; Wilson, CL; Fried, I			Human hippocampal neurons predict how well word pairs will be remembered	NEURON			English	Article							MEDIAL TEMPORAL-LOBE; EPISODIC MEMORY; RECOGNITION MEMORY; ENTORHINAL CORTEX; SAMPLE PERFORMANCE; DELAYED-NONMATCH; BRAIN ACTIVITY; SINGLE-NEURON; IMPAIR MEMORY; AMYGDALA	What is the neuronal basis for whether an experience is recalled or forgotten? In contrast to recognition, recall is difficult to study in nonhuman primates and rarely is accessible at the single neuron level in humans. We recorded 128 medial temporal lobe (MTL) neurons in patients implanted with intracranial microelectrodes while they encoded and recalled word paired associates. Neurons in the amygdala, entorhinal cortex, and hippocampus showed altered activity during encoding (9%), recall (22%), and both task phases (23%). The responses of hippocampal neurons during encoding predicted whether or not subjects later remembered the pairs successfully. Entorhinal cortex neuronal activity during retrieval was correlated with recall success, These data provide support at the single neuron level for MTL contributions to encoding and retrieval, white also suggesting there may be differences in the revel of contribution of MTL regions to these memory processes.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Div Neurosurg, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cameron, KA (corresponding author), Univ Maryland, Dept Physiol, Baltimore, MD 21201 USA.	kmacd002@umaryland.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS002808, R01NS033221] Funding Source: NIH RePORTER; NINDS NIH HHS [NS33221, NS02808] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; Aguirre GK, 1997, J NEUROSCI, V17, P2512; Aguirre GK, 1996, CEREB CORTEX, V6, P823, DOI 10.1093/cercor/6.6.823; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BUNSEY M, 1993, BEHAV NEUROSCI, V107, P740, DOI 10.1037/0735-7044.107.5.740; Bunsey M, 1996, NATURE, V379, P255, DOI 10.1038/379255a0; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; CAHILL L, 1990, BEHAV NEUROSCI, V104, P532, DOI 10.1037/0735-7044.104.4.532; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Desimone R, 1996, P NATL ACAD SCI USA, V93, P13494, DOI 10.1073/pnas.93.24.13494; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; DRACHMAN DA, 1966, ARCH NEUROL-CHICAGO, V15, P52, DOI 10.1001/archneur.1966.00470130056005; EICHENBAUM H, 1994, BEHAV BRAIN SCI, V17, P449, DOI 10.1017/S0140525X00035391; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Fernandez G, 1998, J NEUROSCI, V18, P1841; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Haxby JV, 1996, NATURE, V380, P669; HEIT G, 1988, NATURE, V333, P773, DOI 10.1038/333773a0; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; JONES MK, 1974, NEUROPSYCHOLOGIA, V12, P21, DOI 10.1016/0028-3932(74)90023-2; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; KLINGBERG T, 1994, NEUROREPORT, V6, P57, DOI 10.1097/00001756-199412300-00016; Kreiman G, 2000, NAT NEUROSCI, V3, P946, DOI 10.1038/78868; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; Martin A, 1997, HIPPOCAMPUS, V7, P587, DOI 10.1002/(SICI)1098-1063(1997)7:6<587::AID-HIPO1>3.0.CO;2-C; McGaugh JL, 1996, P NATL ACAD SCI USA, V93, P13508, DOI 10.1073/pnas.93.24.13508; MILNER B, 1958, RES PUBL ASS RES MEN, V36, P247; MISHKIN M, 1982, PHILOS T R SOC B, V298, P85, DOI 10.1098/rstb.1982.0074; MISHKIN M, 1978, NATURE, V273, P297, DOI 10.1038/273297a0; MURRAY EA, 1993, J NEUROSCI, V13, P4549; Nyberg L, 1996, NATURE, V380, P715, DOI 10.1038/380715a0; OTTO T, 1992, HIPPOCAMPUS, V2, P323, DOI 10.1002/hipo.450020310; OTTO T, 1992, BEHAV NEUROSCI, V106, P762, DOI 10.1037/0735-7044.106.5.762; PAIVIO A, 1973, COGNITIVE PSYCHOL, V5, P176, DOI 10.1016/0010-0285(73)90032-7; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1993, EXP BRAIN RES, V93, P299; ROLLS ET, 1989, J NEUROSCI, V9, P1835; Rombouts SARB, 1997, HIPPOCAMPUS, V7, P594, DOI 10.1002/(SICI)1098-1063(1997)7:6<594::AID-HIPO2>3.3.CO;2-I; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schacter DL, 1996, P NATL ACAD SCI USA, V93, P321, DOI 10.1073/pnas.93.1.321; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Squire L. R., 1987, MEMORY BRAIN; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Squire LR, 1998, HIPPOCAMPUS, V8, P205, DOI 10.1002/(SICI)1098-1063(1998)8:3<205::AID-HIPO3>3.0.CO;2-I; Stark CEL, 2000, J NEUROSCI, V20, P7776; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Suzuki WA, 1999, NEURON, V24, P295, DOI 10.1016/S0896-6273(00)80844-2; SUZUKI WA, 1994, J NEUROSCI, V14, P1856, DOI 10.1523/JNEUROSCI.14-03-01856.1994; VANHOESEN GW, 1975, BRAIN RES, V95, P25, DOI 10.1016/0006-8993(75)90205-X; VANHOESEN GW, 1975, BRAIN RES, V95, P1, DOI 10.1016/0006-8993(75)90204-8; VANHOESEN GW, 1975, BRAIN RES, V95, P48; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; Wiebe SP, 1999, J NEUROSCI, V19, P10562; ZOLAMORGAN S, 1985, BEHAV NEUROSCI, V99, P22, DOI 10.1037/0735-7044.99.1.22; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P1922; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P898; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355	68	85	86	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					289	298		10.1016/S0896-6273(01)00280-X	http://dx.doi.org/10.1016/S0896-6273(01)00280-X			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343662	Bronze			2022-12-24	WOS:000168412900028
J	Ohno-Shosaku, T; Maejima, T; Kano, M				Ohno-Shosaku, T; Maejima, T; Kano, M			Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals	NEURON			English	Article							CULTURED HIPPOCAMPAL-NEURONS; MOUSE NEUROBLASTOMA-CELLS; LONG-TERM POTENTIATION; RAT-BRAIN; INDUCED SUPPRESSION; CB1 RECEPTORS; MOLECULAR CHARACTERIZATION; FUNCTIONAL EXPRESSION; 2-ARACHIDONOYLGLYCEROL; LOCALIZATION	Endogenous cannabinoids are considered to function as diffusible and short-lived modulators that may transmit signals retrogradely from postsynaptic to presynaptic neurons. To evaluate this possibility, we have made a paired whole-cell recording from cultured hippocampal neurons with inhibitory synaptic connections. In about 60% of pairs, a cannabinoid agonist greatly reduced the release of the inhibitory neurotransmitter GABA from presynaptic terminals. In most of such pairs but not in those insensitive to the agonist, depolarization of postsynaptic neurons and the resultant elevation of intracellular Ca2+ concentration caused transient suppression of inhibitory synaptic currents, which is mainly due to reduction of GABA release. This depolarization-induced suppression was completely blocked by selective cannabinoid antagonists. Our results reveal that endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals to cause the reduction of transmitter release.	Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan	Kanazawa University	Kano, M (corresponding author), Kanazawa Univ, Sch Med, Dept Physiol, Kanazawa, Ishikawa 9208640, Japan.		Ohno-Shosaku, Takako/C-3250-2015	Kano, Masanobu/0000-0002-0725-3292				Auclair N, 2000, J NEUROPHYSIOL, V83, P3287, DOI 10.1152/jn.2000.83.6.3287; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; Beltramo M, 2000, NEUROREPORT, V11, P1231, DOI 10.1097/00001756-200004270-00018; Bisogno T, 1999, J NEUROCHEM, V72, P2113, DOI 10.1046/j.1471-4159.1999.0722113.x; Bisogno T, 1997, BIOCHEM J, V322, P671, DOI 10.1042/bj3220671; Cadas H, 1996, J NEUROSCI, V16, P3934; Cadas H, 1997, J NEUROSCI, V17, P1226; CHEN QX, 1995, J PHYSIOL-LONDON, V482, P353, DOI 10.1113/jphysiol.1995.sp020522; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Egertova M, 2000, J COMP NEUROL, V422, P159, DOI 10.1002/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Felder CC, 1998, ANNU REV PHARMACOL, V38, P179, DOI 10.1146/annurev.pharmtox.38.1.179; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; Goparaju SK, 1998, FEBS LETT, V422, P69, DOI 10.1016/S0014-5793(97)01603-7; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hoffman AF, 2000, J NEUROSCI, V20, P2470; INOUE M, 1986, NATURE, V324, P156, DOI 10.1038/324156a0; Irving AJ, 2000, NEUROSCIENCE, V98, P253, DOI 10.1016/S0306-4522(00)00120-2; Jensen K, 1999, J NEUROPHYSIOL, V82, P42, DOI 10.1152/jn.1999.82.1.42; Katona I, 1999, J NEUROSCI, V19, P4544; Klein TW, 1998, IMMUNOL TODAY, V19, P373, DOI 10.1016/S0167-5699(98)01300-0; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R, 1998, EUR J PHARMACOL, V359, P1, DOI 10.1016/S0014-2999(98)00649-9; Misner DL, 1999, J NEUROSCI, V19, P6795, DOI 10.1523/JNEUROSCI.19-16-06795.1999; Morishita W, 1998, J NEUROSCI, V18, P4870; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Ohno-Shosaku T, 1998, PFLUG ARCH EUR J PHY, V435, P273; Ohno-Shosaku T, 2000, NEUROSCI RES, V36, P67, DOI 10.1016/S0168-0102(99)00110-8; Piomelli D, 1999, P NATL ACAD SCI USA, V96, P5802, DOI 10.1073/pnas.96.10.5802; Piomelli D, 2000, TRENDS PHARMACOL SCI, V21, P218, DOI 10.1016/S0165-6147(00)01482-6; PITLER TA, 1992, J NEUROSCI, V12, P4122; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tsou K, 1999, NEUROSCIENCE, V93, P969, DOI 10.1016/S0306-4522(99)00086-X; WILCOX KS, 1994, J NEUROSCI, V14, P1775, DOI 10.1523/JNEUROSCI.14-03-01775.1994; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076	45	638	657	2	22	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					729	738		10.1016/S0896-6273(01)00247-1	http://dx.doi.org/10.1016/S0896-6273(01)00247-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301031	Bronze			2022-12-24	WOS:000167868900021
J	Renger, JJ; Egles, C; Liu, GS				Renger, JJ; Egles, C; Liu, GS			A developmental switch in neurotransmitter flux enhances synaptic efficacy by affecting AMPA receptor activation	NEURON			English	Article							LONG-TERM POTENTIATION; CENTRAL-NERVOUS-SYSTEM; POSTSYNAPTICALLY SILENT SYNAPSES; HIPPOCAMPAL-NEURONS; GLUTAMATE RECEPTORS; TRANSPORTER CURRENTS; EXCITATORY SYNAPSES; NMDA RECEPTORS; VESICLE CYCLE; SPINAL-CORD	Formation of glutamatergic synapses entails development of "silent" immature contacts into mature functional synapses. To determine how this transformation occurs, we investigated the development of neurotransmission at single synapses in vitro. Maturation of presynaptic function, assayed with endocytotic markers, followed accumulation of synapsin 1. During this period, synaptic transmission was primarily mediated by activation of NMDA receptors, suggesting that most synapses were functionally silent. However, local glutamate application to silent synapses indicated that these synapses contained functional AMPA receptors, suggesting a possible presynaptic locus for silent transmission. Interference with presynaptic vesicle fusion by exposure to tetanus toxin reverted functional to silent transmission, implicating SNARE-mediated fusion as a determinant of the ratio of NMDA:AMPA receptor activation. This work reveals that functional maturation of synaptic transmission involves transformation of presynaptic silent secretion into mature synaptic transmitter release.	MIT, RIKEN, Neurosci Res Ctr,Ctr Learning & Memory, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); RIKEN; Massachusetts Institute of Technology (MIT)	Liu, GS (corresponding author), MIT, RIKEN, Neurosci Res Ctr,Ctr Learning & Memory, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	liu@mit.edu	babakinejad, babak/G-2674-2012	EGLES, Christophe/0000-0003-0982-7752				Atwood HL, 1999, LEARN MEMORY, V6, P542, DOI 10.1101/lm.6.6.542; Bardoni R, 1998, J NEUROSCI, V18, P6558; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Bernard V, 1997, J NEUROSCI, V17, P819; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; BETZ WJ, 1992, J NEUROSCI, V12, P363, DOI 10.1523/jneurosci.12-02-00363.1992; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; Calakos N, 1996, PHYSIOL REV, V76, P1; Clements JD, 1996, TRENDS NEUROSCI, V19, P163, DOI 10.1016/S0166-2236(96)10024-2; Cottrell JR, 2000, J NEUROPHYSIOL, V84, P1573, DOI 10.1152/jn.2000.84.3.1573; CRAIG AM, 1993, NEURON, V10, P1055, DOI 10.1016/0896-6273(93)90054-U; Diamond JS, 1997, J NEUROSCI, V17, P4672; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dube G. R., 1999, Society for Neuroscience Abstracts, V25, P992; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; ELFERINK LA, 1993, J CELL SCI, P75; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Forti L, 1997, NATURE, V388, P874, DOI 10.1038/42251; Friedman HV, 2000, NEURON, V27, P57, DOI 10.1016/S0896-6273(00)00009-X; Galarreta M, 1997, J NEUROSCI, V17, P7220; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Henkel AW, 1995, J NEUROSCI, V15, P8246; HESTRIN S, 1990, COLD SH Q B, V55, P87; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; Isaac JTR, 1997, NEURON, V18, P269, DOI 10.1016/S0896-6273(00)80267-6; Kirischuk S, 1999, P NATL ACAD SCI USA, V96, P7520, DOI 10.1073/pnas.96.13.7520; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; Kullmann DM, 1996, NEURON, V17, P461, DOI 10.1016/S0896-6273(00)80178-6; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Li P, 1998, NATURE, V393, P695, DOI 10.1038/31496; Liao DH, 1999, NAT NEUROSCI, V2, P37, DOI 10.1038/4540; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Linden DJ, 1998, J NEUROPHYSIOL, V79, P3151, DOI 10.1152/jn.1998.79.6.3151; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1999, NAT NEUROSCI, V2, P31; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; MONCK JR, 1994, NEURON, V12, P707, DOI 10.1016/0896-6273(94)90325-5; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; O'Brien RJ, 1998, NEURON, V21, P1067, DOI 10.1016/S0896-6273(00)80624-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Rao A, 1998, J NEUROSCI, V18, P1217; Renger JJ, 2000, J NEUROSCI, V20, P3980; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schikorski T, 1997, J NEUROSCI, V17, P5858; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stiles JR, 1996, P NATL ACAD SCI USA, V93, P5747, DOI 10.1073/pnas.93.12.5747; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Uteshev VV, 1996, BIOPHYS J, V71, P1256, DOI 10.1016/S0006-3495(96)79325-6; VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312; WALL PD, 1977, PHILOS T R SOC B, V278, P361, DOI 10.1098/rstb.1977.0048; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Xie XP, 1997, P NATL ACAD SCI USA, V94, P6983, DOI 10.1073/pnas.94.13.6983	67	185	191	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					469	484		10.1016/S0896-6273(01)00219-7	http://dx.doi.org/10.1016/S0896-6273(01)00219-7			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239436	Bronze			2022-12-24	WOS:000167141700019
J	Tsui-Pierchala, B; Milbrandt, J; Johnson, EM				Tsui-Pierchala, B; Milbrandt, J; Johnson, EM			NGF utilizes c-Ret via a novel GFL-independent, inter-RTK signaling mechanism to maintain the trophic status of mature sympathetic neurons	NEURON			English	Article							NERVE GROWTH-FACTOR; PROTEIN-COUPLED RECEPTORS; NEUROTROPHIC FACTOR; GDNF-FAMILY; CELL-LINE; TYROSINE KINASE; EGF RECEPTOR; PHOSPHORYLATION; NEURTURIN; SURVIVAL	During postnatal development, sympathetic neurons lose their dependence upon NGF for survival but continue to require NGF for soma and process growth and for development of a mature neurotransmitter phenotype. Although c-Ret is expressed in sympathetic neurons during this period, its function in these transitional processes is unclear. The level of Ret phosphorylation markedly increased with postnatal age in SCG neurons in vitro and in vivo. Postnatal Ret phosphorylation did not require either GFLs or GFRalpha coreceptors. Instead, NGF promoted age-dependent Ret phosphorylation with delayed kinetics both in vitro and in vivo. Functionally, maximal NGF-dependent trophism of mature sympathetic neurons required Ret, but not GFRalpha coreceptors. Therefore, NGF promotes phosphorylation of the heterologous RTK Ret resulting in augmented growth, metabolism, and gene expression.	Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Johnson, EM (corresponding author), Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA.			Milbrandt, Jeffrey/0000-0002-5477-7689	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007129, R01NS038651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG012947] Funding Source: NIH RePORTER; NIA NIH HHS [AG12947] Funding Source: Medline; NINDS NIH HHS [5T32-NS07129, NS38651-01] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn S, 2000, ANNU REV PHYSIOL, V62, P803, DOI 10.1146/annurev.physiol.62.1.803; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; ANGELETTI PU, 1971, BRAIN RES, V27, P343, DOI 10.1016/0006-8993(71)90259-9; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Baloh RH, 1998, NEURON, V21, P1291, DOI 10.1016/S0896-6273(00)80649-2; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BERG MM, 1992, J BIOL CHEM, V267, P13; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; Creedon DJ, 1997, P NATL ACAD SCI USA, V94, P7018, DOI 10.1073/pnas.94.13.7018; de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001; Easton RM, 1997, J NEUROSCI, V17, P9656; Enomoto H, 2001, DEVELOPMENT, V128, P3963; Francis NJ, 1999, ANNU REV NEUROSCI, V22, P541, DOI 10.1146/annurev.neuro.22.1.541; GOEDERT M, 1978, BRAIN RES, V148, P264, DOI 10.1016/0006-8993(78)90401-8; GORIN PD, 1980, BRAIN RES, V198, P27, DOI 10.1016/0006-8993(80)90341-8; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Jing SQ, 1997, J BIOL CHEM, V272, P33111, DOI 10.1074/jbc.272.52.33111; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Kato M, 2000, MOL BIOL CELL, V11, P93, DOI 10.1091/mbc.11.1.93; Klein RD, 1997, NATURE, V387, P717, DOI 10.1038/42722; Kobayashi M, 2000, NEUROREPORT, V11, P2541, DOI 10.1097/00001756-200008030-00039; Kotzbauer PT, 1996, NATURE, V384, P467, DOI 10.1038/384467a0; LAZARUS KJ, 1976, BRAIN RES, V113, P159, DOI 10.1016/0006-8993(76)90013-5; Lee FS, 2001, P NATL ACAD SCI USA, V98, P3555, DOI 10.1073/pnas.061020198; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liu PS, 1999, BIOCHEM BIOPH RES CO, V261, P695, DOI 10.1006/bbrc.1999.1082; LO LC, 1995, NEURON, V15, P527, DOI 10.1016/0896-6273(95)90142-6; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Masure S, 1999, EUR J BIOCHEM, V266, P892, DOI 10.1046/j.1432-1327.1999.00925.x; Milbrandt J, 1998, NEURON, V20, P245, DOI 10.1016/S0896-6273(00)80453-5; Molliver DC, 1997, NEURON, V19, P849, DOI 10.1016/S0896-6273(00)80966-6; NAKAMURA T, 1994, J PATHOL, V172, P255, DOI 10.1002/path.1711720305; OHMICHI M, 1992, BIOCHEMISTRY-US, V31, P4034, DOI 10.1021/bi00131a019; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Paratcha G, 2001, NEURON, V29, P171, DOI 10.1016/S0896-6273(01)00188-X; Prenzel N, 1999, NATURE, V402, P884, DOI 10.1038/47260; REICHARDT LF, 1987, MOL CELLULAR APPROAC, P220; Rosenblad C, 2000, MOL CELL NEUROSCI, V15, P199, DOI 10.1006/mcne.1999.0817; RUIT KG, 1990, J NEUROSCI, V10, P2412; SANTORO M, 1990, ONCOGENE, V5, P1595; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SCHOTZINGER RJ, 1988, NATURE, V335, P637, DOI 10.1038/335637a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; TAHIRA T, 1990, ONCOGENE, V5, P97; Tansey MG, 2000, NEURON, V25, P611, DOI 10.1016/S0896-6273(00)81064-8; TAPLEY P, 1992, ONCOGENE, V7, P371; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Yamauchi T, 1997, NATURE, V390, P91, DOI 10.1038/36369	53	95	97	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					261	273		10.1016/S0896-6273(01)00585-2	http://dx.doi.org/10.1016/S0896-6273(01)00585-2			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804573	Bronze			2022-12-24	WOS:000173387700013
J	Coyle, JE; Qamar, S; Rajashankar, KR; Nikolov, DB				Coyle, JE; Qamar, S; Rajashankar, KR; Nikolov, DB			Structure of GABARAP in two conformations: Implications for GABA(A) receptor localization and tubulin binding	NEURON			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MICROTUBULE-ASSOCIATED PROTEINS; MEMBRANE-TRANSPORT MODULATOR; GEPHYRIN; NSF; STOICHIOMETRY; SUBUNIT; IDENTIFICATION; AUTOPHAGY; DOMAINS	GABARAP recognizes and binds the gamma2 subunit of the GABA(A) receptor, interacts with microtubules and the N-ethyl maleimide sensitive factor, and is proposed to function in GABA(A) receptor trafficking and postsynaptic localization. We have determined the crystal structure of human GABARAP at 1.6 Angstrom resolution. The structure comprises an N-terminal helical subdomain and a ubiquitin-like C-terminal domain. Structure-based mutational analysis demonstrates that the N-terminal subdomain is responsible for tubulin binding while the C-terminal domain contains the binding site for the GABA(A). A second GABARAP crystal form was determined at 1.9 Angstrom resolution and documents that GABARAP can self-associate in a head-to-tail manner. The structural details of this oligomerization reveal how GABARAP can both promote tubulin polymerization and facilitate GABA(A) receptor clustering.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA; Brookhaven Natl Lab, Upton, NY 11973 USA	Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Brookhaven National Laboratory	Nikolov, DB (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	dimitar@ximpact3.ski.mskcc.org						Amos LA, 2000, CURR OPIN STRUC BIOL, V10, P236, DOI 10.1016/S0959-440X(00)00070-1; BACKUS KH, 1993, NEUROREPORT, V5, P285, DOI 10.1097/00001756-199312000-00026; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumann SW, 2001, J BIOL CHEM, V276, P36275, DOI 10.1074/jbc.M105240200; BRANDT R, 1993, J BIOL CHEM, V268, P3414; BRUNNETT B, 1993, SURVEYS MATH IND, V3, P1; Chang YC, 1996, J NEUROSCI, V16, P5415; Chen L, 2000, P NATL ACAD SCI USA, V97, P11557, DOI 10.1073/pnas.190133497; Colledge M, 1998, P NATL ACAD SCI USA, V95, P3341, DOI 10.1073/pnas.95.7.3341; Deka J, 1998, EUR J BIOCHEM, V253, P591, DOI 10.1046/j.1432-1327.1998.2530591.x; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Feng GP, 1998, SCIENCE, V282, P1321, DOI 10.1126/science.282.5392.1321; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Huang WP, 2000, J BIOL CHEM, V275, P5845, DOI 10.1074/jbc.275.8.5845; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; JANIN J, 1990, J BIOL CHEM, V265, P16027; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KHAN ZU, 1994, J NEUROCHEM, V63, P1466; Kim J, 2001, J CELL BIOL, V152, P51, DOI 10.1083/jcb.152.1.51; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; KIRSCH J, 1991, J BIOL CHEM, V266, P22242; KIRSCH J, 1993, NATURE, V366, P745, DOI 10.1038/366745a0; KIRSCH J, 1995, J NEUROSCI, V15, P4148; KISHIDA T, 1995, CANCER RES, V55, P4544; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Lang T, 1998, EMBO J, V17, P3597, DOI 10.1093/emboj/17.13.3597; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; Maimone MM, 1999, MOL CELL NEUROSCI, V14, P340, DOI 10.1006/mcne.1999.0779; MANN SS, 1994, J BIOL CHEM, V269, P11492; MARYA PK, 1994, J CELL SCI, V107, P339; McDonald PH, 1999, J BIOL CHEM, V274, P10677, DOI 10.1074/jbc.274.16.10677; MELKI R, 1991, BIOCHEMISTRY-US, V30, P11536, DOI 10.1021/bi00113a008; MEYER G, 1995, NEURON, V15, P563, DOI 10.1016/0896-6273(95)90145-0; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; Okazaki N, 2000, MOL BRAIN RES, V85, P1, DOI 10.1016/S0169-328X(00)00218-7; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Otwinowski Z., 1993, DATA COLLECTION PROC, P556; Paz Y, 2000, J BIOL CHEM, V275, P25445, DOI 10.1074/jbc.C000307200; PHILLIPS WD, 1991, J CELL BIOL, V115, P1713, DOI 10.1083/jcb.115.6.1713; QUIRK K, 1994, MOL PHARMACOL, V45, P1061; Ramarao MK, 2001, J BIOL CHEM, V276, P7475, DOI 10.1074/jbc.M009888200; Ramarao MK, 1998, P NATL ACAD SCI USA, V95, P4007, DOI 10.1073/pnas.95.7.4007; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; SCHIFF PB, 1979, NATURE, V277, P665, DOI 10.1038/277665a0; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SERRANO L, 1984, P NATL ACAD SCI-BIOL, V81, P5989, DOI 10.1073/pnas.81.19.5989; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Tanida I, 2001, J BIOL CHEM, V276, P1701, DOI 10.1074/jbc.C000752200; Tretter V, 1997, J NEUROSCI, V17, P2728; Unwin N, 1998, J STRUCT BIOL, V121, P181, DOI 10.1006/jsbi.1997.3949; Wang HB, 2000, J NEUROCHEM, V75, P644, DOI 10.1046/j.1471-4159.2000.0750644.x; Wang HB, 1999, NATURE, V397, P69, DOI 10.1038/16264; YOON Y, 1995, BIOCHEMISTRY-US, V34, P6373, DOI 10.1021/bi00019a016; YOUNG L, 1994, PROTEIN SCI, V3, P717; Zhou B, 1997, J CLIN INVEST, V100, P3070, DOI 10.1172/JCI119862	67	117	121	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2002	33	1					63	74		10.1016/S0896-6273(01)00558-X	http://dx.doi.org/10.1016/S0896-6273(01)00558-X			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779480	Bronze			2022-12-24	WOS:000173106200010
J	Villarreal, DM; Do, V; Haddad, E; Derrick, BE				Villarreal, DM; Do, V; Haddad, E; Derrick, BE			NMDA receptor antagonists sustain LTP and spatial memory: active processes mediate LTP decay	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; FREELY MOVING RATS; DENTATE GYRUS; ANESTHETIZED RATS; PERFORANT PATH; LATE-PHASE; DEPRESSION; HIPPOCAMPUS; DEPOTENTIATION; STIMULATION	Although long-term potentiation (LTP) is long-lasting, it is not permanent and decays within weeks after its induction. Little is known about the processes underlying this decay. Here we assessed the contribution of synaptic activity to LTP decay by determining the effect of the competitive NMDA receptor antagonist CPP on the decay of perforant path-dentate LTR CPP blocked decay over a one-week period when administered daily following the induction of LTP, and blocked decay of the late, protein-synthesis-dependent phase of LTP when administered two days after LTP induction. CPP administered for a five-day period following spatial memory training enhanced subsequent memory retention. These data suggest that LTP is normally a persistent process that is actively reversed by NMDA receptor activation, and that both the early and late phases of LTP are dynamic processes regulated by NMDA receptors. These data also support the view that LTP is involved in maintaining spatial memory.	Univ Texas, Dept Biol, San Antonio, TX 78249 USA; Univ Texas, Cajal Neurosci Res Ctr, Div Life Sci, San Antonio, TX 78249 USA	University of Texas System; University of Texas System	Derrick, BE (corresponding author), Univ Texas, Dept Biol, 6900 N Loop 1604 W, San Antonio, TX 78249 USA.		Derrick, Brian/P-3005-2014	Derrick, Brian/0000-0001-6940-6509	NIDA NIH HHS [DA01983] Funding Source: Medline	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		ABRAHAM WC, 1988, BRAIN RES, V462, P40, DOI 10.1016/0006-8993(88)90582-3; ABRAHAM WC, 1983, NATURE, V305, P717, DOI 10.1038/305717a0; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BARNES CA, 1985, BEHAV NEUROSCI, V99, P1040, DOI 10.1037/0735-7044.99.6.1040; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barnes CA, 1996, EUR J NEUROSCI, V8, P565, DOI 10.1111/j.1460-9568.1996.tb01241.x; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; CHRISTIE BR, 1992, SYNAPSE, V10, P1, DOI 10.1002/syn.890100102; CHRISTIE BR, 1992, NEURON, V9, P79, DOI 10.1016/0896-6273(92)90222-Y; DESMOND NL, 1991, BRAIN RES, V552, P93, DOI 10.1016/0006-8993(91)90664-H; DESMOND NL, 1983, BRAIN RES, V265, P21, DOI 10.1016/0006-8993(83)91329-X; Doyere V, 1997, J NEUROPHYSIOL, V77, P571, DOI 10.1152/jn.1997.77.2.571; EBBINGHAUS H, 1913, MEMORY CONTRIBUTIONS; KRUG M, 1984, BRAIN RES BULL, V13, P39, DOI 10.1016/0361-9230(84)90005-4; Kulla A, 1999, EUR J NEUROSCI, V11, P3864, DOI 10.1046/j.1460-9568.1999.00807.x; LAMBERT JD, 1990, J NEUROPHYSIOL, V4, P119; LAROCHE S, 1989, NEUROSCIENCE, V28, P375, DOI 10.1016/0306-4522(89)90184-X; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; MARTENS R, 1975, SPORTWISSENSCHAFT, V5, P9; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Morris RGM, 1991, LONG TERM POTENTIATI, P267; Nguyen PV, 1996, J NEUROSCI, V16, P3189; Norris CM, 1999, NEUROBIOL LEARN MEM, V71, P194, DOI 10.1006/nlme.1998.3864; OLTON DS, 1977, LEARN MOTIV, V8, P289, DOI 10.1016/0023-9690(77)90054-6; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; PAXINOS G, 1982, STEREOTAXIC ATLAS RA; Shors TJ, 1997, BEHAV BRAIN SCI, V20, P597, DOI 10.1017/S0140525X97001593; STAUBLI U, 1987, BRAIN RES, V435, P227, DOI 10.1016/0006-8993(87)91605-2; Strack S, 1997, J NEUROCHEM, V68, P2119; Thorndike EL, 1927, AM J PSYCHOL, V39, P212, DOI 10.2307/1415413; Xiao MY, 1996, EUR J NEUROSCI, V8, P1916, DOI 10.1111/j.1460-9568.1996.tb01335.x; Xu L, 1998, NATURE, V394, P891, DOI 10.1038/29783	37	137	143	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					48	52		10.1038/nn776	http://dx.doi.org/10.1038/nn776			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740500				2022-12-24	WOS:000173031800014
J	Anderson, JC; Martin, KAC				Anderson, JC; Martin, KAC			Does bouton morphology optimize axon length?	NATURE NEUROSCIENCE			English	Article							CAT STRIATE CORTEX; DENDRITIC SPINES; PLASTICITY; NEURONS; LAYER-4		Univ Zurich, Inst Neuroinformat, CH-8057 Zurich, Switzerland; ETH Zurich, CH-8057 Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Anderson, JC (corresponding author), Univ Zurich, Inst Neuroinformat, Winterthurerstr 190, CH-8057 Zurich, Switzerland.							Braitenberg V, 1991, ANATOMY CORTEX; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; GRAY EG, 1982, TRENDS NEUROSCI, V5, P5, DOI 10.1016/0166-2236(82)90005-4; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MARTIN KAC, 1984, J PHYSIOL-LONDON, V353, P463, DOI 10.1113/jphysiol.1984.sp015347; MCGUIRE BA, 1984, J NEUROSCI, V4, P3021; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; SWINDALE NV, 1981, TRENDS NEUROSCI, V4, P240, DOI 10.1016/0166-2236(81)90075-8; Tarczy-Hornoch K, 1999, CEREB CORTEX, V9, P833, DOI 10.1093/cercor/9.8.833; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574	14	31	31	1	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1166	1167		10.1038/nn772	http://dx.doi.org/10.1038/nn772			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713473				2022-12-24	WOS:000172525000008
J	Gooley, JJ; Lu, J; Chou, TC; Scammell, TE; Saper, CB				Gooley, JJ; Lu, J; Chou, TC; Scammell, TE; Saper, CB			Melanopsin in cells of origin of the retinohypothalamic tract	NATURE NEUROSCIENCE			English	Article							CIRCADIAN-RHYTHMS; SPECTRAL SENSITIVITY; PHOTORECEPTORS; CONE; MICE		Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Program Neurosci, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Saper, CB (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NHLBI NIH HHS [HL07901, HL60292] Funding Source: Medline; NIMH NIH HHS [MH62589] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL060292] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062589] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Miyamoto Y, 1998, P NATL ACAD SCI USA, V95, P6097, DOI 10.1073/pnas.95.11.6097; MOORE RY, 1995, J COMP NEUROL, V352, P351, DOI 10.1002/cne.903520304; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; TAKAHASHI JS, 1984, NATURE, V308, P186, DOI 10.1038/308186a0; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797	7	392	408	0	61	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1165	1165		10.1038/nn768	http://dx.doi.org/10.1038/nn768			1	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713469				2022-12-24	WOS:000172525000007
J	Tang, SJ; Meulemans, D; Vazquez, L; Colaco, N; Schuman, E				Tang, SJ; Meulemans, D; Vazquez, L; Colaco, N; Schuman, E			A role for a rat homolog of staufen in the transport of RNA to neuronal dendrites	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; MENTAL-RETARDATION PROTEIN; LONG-TERM POTENTIATION; MESSENGER-RNA; HIPPOCAMPAL-NEURONS; ASYMMETRIC PROTEIN; MAMMALIAN STAUFEN; BINDING PROTEIN; LOCALIZATION; MICROTUBULES	RNAs are present in dendrites and may be used for local protein synthesis in response to synaptic activity. To begin to understand dendritic RNA targeting, we cloned a rat homolog of staufen, a Drosophila gene that participates in mRNA targeting during development. In hippocampal neurons, rat staufen protein displays a microtubule-dependent somatodendritic distribution pattern that overlaps with dendritic RNAs. To determine whether r-staufen is required for dendritic RNA targeting, we constructed a mutant version containing the RNA binding domains (stau-RBD) but lacking the C-terminal portion potentially involved in dendritic targeting. Stau-RBD expression was restricted to the cell bodies and proximal dendrites. Expression of stau-RBD significantly decreased, while overexpression of wild-type r-staufen increased, the amount of dendritic mRNA. Taken together, these results suggest that the rat staufen protein plays an important role in the delivery of RNA to dendrites.	CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, E (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, 216-76, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011	MEDEIROS, DANIEL/0000-0002-8182-6028				ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; Broadus J, 1997, CURR BIOL, V7, P827, DOI 10.1016/S0960-9822(06)00370-8; BURGIN KE, 1990, J NEUROSCI, V10, P1788; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Cohen AS, 1998, HIPPOCAMPUS, V8, P160, DOI 10.1002/(SICI)1098-1063(1998)8:2<160::AID-HIPO8>3.3.CO;2-J; Cohen AS, 1996, J NEUROPHYSIOL, V76, P953, DOI 10.1152/jn.1996.76.2.953; DESGROSEILLERS L, 2001, J NEUROCHEM, V76, P155; Duchaine T, 2000, MOL CELL BIOL, V20, P5592, DOI 10.1128/MCB.20.15.5592-5601.2000; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Feng Y, 1997, J NEUROSCI, V17, P1539; FERRANDON D, 1994, CELL, V79, P1221, DOI 10.1016/0092-8674(94)90013-2; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GOEDERT M, 1991, TRENDS NEUROSCI, V14, P193, DOI 10.1016/0166-2236(91)90105-4; Goslin K., 1990, CULTURING NERVE CELL; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; KLEIMAN R, 1993, MOL BRAIN RES, V20, P305, DOI 10.1016/0169-328X(93)90057-V; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; Knowles RB, 1996, J NEUROSCI, V16, P7812; KOHMANN M, 1999, MOL BIOL CELL, V10, P2945; Li P, 1997, CELL, V90, P437, DOI 10.1016/S0092-8674(00)80504-8; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Ouyang Y, 1999, J NEUROSCI, V19, P7823; POKRYWKA NJ, 1991, DEVELOPMENT, V113, P55; Raymond CR, 2000, J NEUROSCI, V20, P969, DOI 10.1523/JNEUROSCI.20-03-00969.2000; Righi M, 2000, J NEUROSCI, V20, P3165, DOI 10.1523/JNEUROSCI.20-09-03165.2000; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; Shen CP, 1998, GENE DEV, V12, P1837, DOI 10.1101/gad.12.12.1837; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; STJOHNSTON D, 1992, P NATL ACAD SCI USA, V89, P10979, DOI 10.1073/pnas.89.22.10979; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; Tongiorgi E, 1997, J NEUROSCI, V17, P9492; VERKERK AJMH, 1993, HUM MOL GENET, V2, P1348, DOI 10.1093/hmg/2.8.1348; Weiler IJ, 1999, AM J MED GENET, V83, P248, DOI 10.1002/(SICI)1096-8628(19990402)83:4<248::AID-AJMG3>3.0.CO;2-1; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wickham L, 1999, MOL CELL BIOL, V19, P2220; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3; YISRAELI JK, 1990, DEVELOPMENT, V108, P289	49	182	187	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					463	475		10.1016/S0896-6273(01)00493-7	http://dx.doi.org/10.1016/S0896-6273(01)00493-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709157	Bronze			2022-12-24	WOS:000172119100012
J	Elhamdani, A; Palfrey, HC; Artalejo, CR				Elhamdani, A; Palfrey, HC; Artalejo, CR			Quantal size is dependent on stimulation frequency and calcium entry in calf chromaffin cells	NEURON			English	Article							SYNAPTIC VESICLE MEMBRANE; DENSE-CORE VESICLES; RAPID ENDOCYTOSIS; TRANSMITTER RELEASE; FUSION PORE; EXOCYTOSIS; SECRETION; CATECHOLAMINES; KISS; GRANULES	To what extent the quantal hypothesis of transmitter release applies to dense-core vesicle (DCV) secretion is unknown. We determined the characteristics of individual secretory events in calf chromaffin cells using catecholamine amperometry combined with different patterns of stimulation. Raising the frequency of action potential trains from 0.25-10 Hz in 2 mM [Ca2+](o) or [Ca2+](o) from 0.25-7 mM at 7 Hz elevated the amount released per event (quantal size). With increased stimulation, quantal size rose continuously, not abruptly, suggesting that release efficiency from a single population of DCVs rather than recruitment of different-sized vesicles contributed to the effect. These results suggest that catecholamine secretion does not conform to the quantal model. Inhibition of rapid endocytosis damped secretion in successive episodes, implying an essential role for this process in the recycling of vesicles needed for continuous secretion.	Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA	Wayne State University; University of Chicago	Artalejo, CR (corresponding author), Wayne State Univ, Sch Med, Dept Pharmacol, Detroit, MI 48201 USA.	cartalej@med.wayne.edu			NIDDK NIH HHS [DK 58921] Funding Source: Medline; NIGMS NIH HHS [GM-56396] Funding Source: Medline; NIMH NIH HHS [MH47181] Funding Source: Medline; PHS HHS [IBN-9985874] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058921] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056396] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH047181] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; Angleson JK, 1999, NAT NEUROSCI, V2, P440, DOI 10.1038/8107; Artalejo CR, 1998, CURR BIOL, V8, pR62, DOI 10.1016/S0960-9822(98)70036-3; Artalejo CR, 1997, EMBO J, V16, P1565, DOI 10.1093/emboj/16.7.1565; Artalejo CR, 1996, NEURON, V16, P195, DOI 10.1016/S0896-6273(00)80036-7; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Borges R, 1997, J BIOL CHEM, V272, P8325, DOI 10.1074/jbc.272.13.8325; BRECKENRIDGE LJ, 1987, NATURE, V328, P814, DOI 10.1038/328814a0; Bruns D, 2000, NEURON, V28, P205, DOI 10.1016/S0896-6273(00)00097-0; BRUNS D, 1995, NATURE, V377, P62, DOI 10.1038/377062a0; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; COUPLAND RE, 1968, NATURE, V217, P384, DOI 10.1038/217384a0; De Camilli P, 2001, SYNAPSES, P217; DETOLEDO GA, 1993, NATURE, V363, P554, DOI 10.1038/363554a0; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Elhamdani A, 2000, J NEUROSCI, V20, P2495; Elhamdani A, 1998, J NEUROSCI, V18, P6230; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Folkow B, 1997, NEWS PHYSIOL SCI, V12, P32; GRYNSZPANWINOGR.O, 1975, HDB PHYSIOLOGY     7, V6, P295; HARTMANN J, 1995, FEBS LETT, V363, P217, DOI 10.1016/0014-5793(95)00318-4; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; HEUSER J, 1989, CELL BIOL INT REP, V13, P1063, DOI 10.1016/0309-1651(89)90020-9; HEUSER JE, 1973, J CELL BIOL, V57, P315, DOI 10.1083/jcb.57.2.315; JANKOWSKI JA, 1993, J BIOL CHEM, V268, P14694; Katz B, 1969, SHERRINGTON LECT, VX; Kawasaki F, 2000, NAT NEUROSCI, V3, P859, DOI 10.1038/78753; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Mansvelder HD, 1998, J NEUROSCI, V18, P81; Marszalek PE, 1997, BIOPHYS J, V73, P1169, DOI 10.1016/S0006-3495(97)78149-9; MARTIN AR, 1966, PHYSIOL REV, V46, P51, DOI 10.1152/physrev.1966.46.1.51; Monck JR, 1996, CURR OPIN CELL BIOL, V8, P524, DOI 10.1016/S0955-0674(96)80031-7; Palfrey HC, 1998, NEUROSCIENCE, V83, P969, DOI 10.1016/S0306-4522(97)00453-3; PARSONS TD, 1995, NEURON, V15, P1085, DOI 10.1016/0896-6273(95)90097-7; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; Rahamimoff R, 1997, NEURON, V18, P17, DOI 10.1016/S0896-6273(01)80043-X; Regehr WG, 2001, SYNAPSES, P135; Scepek S, 1998, EMBO J, V17, P4340, DOI 10.1093/emboj/17.15.4340; Shupliakov O, 1997, SCIENCE, V276, P259, DOI 10.1126/science.276.5310.259; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; Stjarne L, 2000, J AUTONOM NERV SYST, V81, P236, DOI 10.1016/S0165-1838(00)00119-3; THOMAS P, 1994, J CELL BIOL, V124, P667, DOI 10.1083/jcb.124.5.667; Travis ER, 1998, ANNU REV BIOPH BIOM, V27, P77, DOI 10.1146/annurev.biophys.27.1.77; UVNAS B, 1985, ACTA PHYSIOL SCAND, V123, P249, DOI 10.1111/j.1748-1716.1985.tb07585.x; VANDERKLOOT W, 1991, PROG NEUROBIOL, V36, P93, DOI 10.1016/0301-0082(91)90019-W; WIGHTMAN RM, 1995, BIOPHYS J, V68, P383, DOI 10.1016/S0006-3495(95)80199-2; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zimmerberg J, 2001, TRENDS CELL BIOL, V11, P233, DOI 10.1016/S0962-8924(01)02003-7	52	141	143	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					819	830		10.1016/S0896-6273(01)00418-4	http://dx.doi.org/10.1016/S0896-6273(01)00418-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567619	Bronze			2022-12-24	WOS:000171013300014
J	Kay, JN; Finger-Baier, KC; Roeser, T; Staub, W; Baier, H				Kay, JN; Finger-Baier, KC; Roeser, T; Staub, W; Baier, H			Retinal ganglion cell genesis requires lakritz, a zebrafish atonal homolog	NEURON			English	Article							PRONEURAL GENE; BEHAVIORAL SCREEN; DANIO-RERIO; DIFFERENTIATION; NEUROGENESIS; HEDGEHOG; MATH1; SPECIFICATION; INITIATION; MECHANISMS	Mutation of the zebrafish lakritz (lak) locus completely eliminates the earliest-born retinal cells, the ganglion cells (RGCs). Instead, excess amacrine, bipolar, and Muller glial cells are generated in the mutant. The extra amacrines are found at ectopic locations in the ganglion cell layer. Cone photoreceptors appear unaffected by the mutation. Molecular analysis reveals that lak encodes Ath5, the zebrafish eye-specific ortholog of the Drosophila basic helix-loop-helix transcription factor Atonal. A combined birth-dating and cell marker analysis demonstrates that lak/ath5 is essential for RGC determination during the first wave of neurogenesis in the retina. Our results suggest that this wave is skipped in the mutant, leading to an accumulation of progenitors for inner nuclear layer cells.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Program Neurosci, San Francisco, CA USA; Univ Calif San Francisco, Genet Program, San Francisco, CA USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Baier, H (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.		Kay, Jeremy/G-9309-2011		NEI NIH HHS [R01 EY 12406] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012406] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Borod ER, 1998, DEV BIOL, V197, P187, DOI 10.1006/dbio.1998.8888; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Brown NL, 1998, DEVELOPMENT, V125, P4821; Connaughton VP, 1999, VISUAL NEUROSCI, V16, P483, DOI 10.1017/S0952523899163090; Dominguez M, 1999, DEVELOPMENT, V126, P2345; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; Easter SS, 1996, DEV BIOL, V180, P646; Gan L, 1999, DEV BIOL, V210, P469, DOI 10.1006/dbio.1999.9280; Geisler R, 1999, NAT GENET, V23, P86, DOI 10.1038/12692; HEBERLEIN U, 1995, CELL, V81, P987, DOI 10.1016/S0092-8674(05)80003-0; Hitchcock PF, 1996, J NEUROBIOL, V29, P399; Hu M, 1999, DEV BIOL, V207, P309, DOI 10.1006/dbio.1998.9031; JARMAN AP, 1993, CELL, V73, P1307, DOI 10.1016/0092-8674(93)90358-W; JARMAN AP, 1994, NATURE, V369, P398, DOI 10.1038/369398a0; JOHNSON AD, 1994, GENE, V147, P223, DOI 10.1016/0378-1119(94)90070-1; Kammandel B, 1999, DEV BIOL, V205, P79, DOI 10.1006/dbio.1998.9128; Kanekar S, 1997, NEURON, V19, P981, DOI 10.1016/S0896-6273(00)80391-8; Kelsh RN, 1996, DEVELOPMENT, V123, P369; Kim CH, 1996, NEUROSCI LETT, V216, P109, DOI 10.1016/0304-3940(96)13021-4; LARISON KD, 1990, DEVELOPMENT, V109, P567; Link BA, 2000, DEVELOPMENT, V127, P2177; Liu W, 2000, DEVELOPMENT, V127, P3237; Liu W, 2001, P NATL ACAD SCI USA, V98, P1649, DOI 10.1073/pnas.98.4.1649; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Malicki J, 2000, TRENDS NEUROSCI, V23, P531, DOI 10.1016/S0166-2236(00)01655-6; MARUSICH MF, 1994, J NEUROBIOL, V25, P143, DOI 10.1002/neu.480250206; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Matter-Sadzinski L, 2001, DEVELOPMENT, V128, P217; McCabe KL, 1999, DEVELOPMENT, V126, P5713; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; NEUMAN D, 1989, ETR&D-EDUC TECH RES, V37, P39, DOI 10.1007/BF02299055; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; PLAZA S, 1995, MOL CELL BIOL, V15, P892; Schmitt EA, 1999, J COMP NEUROL, V404, P515; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Xiang MQ, 1998, DEV BIOL, V197, P155, DOI 10.1006/dbio.1998.8868	43	312	316	0	10	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JUN	2001	30	3					725	736		10.1016/S0896-6273(01)00312-9	http://dx.doi.org/10.1016/S0896-6273(01)00312-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430806	Bronze			2022-12-24	WOS:000169508900013
J	Li, CSR; Padoa-Schioppa, C; Bizzi, E				Li, CSR; Padoa-Schioppa, C; Bizzi, E			Neuronal correlates of motor performance and motor learning in the primary motor cortex of monkeys adapting to an external force field	NEURON			English	Article							SIMILAR HAND PATHS; REACHING MOVEMENTS; CORTICAL REPRESENTATION; SYSTEMATIC CHANGES; PLASTICITY; DIRECTION; MUSCLE; AMPUTATION; REORGANIZATION; TRANSFORMATION	The primary motor cortex (M1) is known to control motor performance. Recent findings have also implicated M1 in motor learning, as neurons in this area show learning-related plasticity. In the present study, we analyzed the neuronal activity recorded in M1 in a force field adaptation task. Our goal was to investigate the neuronal reorganization across behavioral epochs (before, during, and after adaptation). Here we report two main findings. First, memory cells were present in two classes. With respect to the changes of preferred direction (Pd), these two classes complemented each other after readaptation. Second, for the entire neuronal population, the shift of Pd matched the shift observed for muscles. These results provide a framework whereby the activity of distinct neuronal subpopulations combines to subserve both functions of motor performance and motor learning.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Bizzi, E (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.		Li, Chiang-Shan Ray/J-2813-2016	Li, Chiang-Shan Ray/0000-0002-9393-1212; Padoa-Schioppa, Camillo/0000-0002-7519-8790	OMHHE CDC HHS [MN481185] Funding Source: Medline	OMHHE CDC HHS		AOSAKI T, 1994, J NEUROSCI, V14, P3969; BelhajSaif A, 1996, EXP BRAIN RES, V111, P405; Borsook D, 1998, NEUROREPORT, V9, P1013, DOI 10.1097/00001756-199804200-00011; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; CHENEY PD, 1980, J NEUROPHYSIOL, V44, P773, DOI 10.1152/jn.1980.44.4.773; Classen J, 1998, J NEUROPHYSIOL, V79, P1117, DOI 10.1152/jn.1998.79.2.1117; CRUTCHER MD, 1990, J NEUROPHYSIOL, V64, P151, DOI 10.1152/jn.1990.64.1.151; DeVore D.L., 1990, PROBABILITY STAT ENG, Vthird; DILORENZO DJ, 1999, THESIS MIT CAMBRIDGE; Dinse HR, 1997, ADV NEUROL, V73, P159; Donoghue JP, 1995, CURR OPIN NEUROBIOL, V5, P749, DOI 10.1016/0959-4388(95)80102-2; Dorris MC, 2000, J NEUROSCI, V20; ELBERT T, 1995, SCIENCE, V270, P305, DOI 10.1126/science.270.5234.305; EVARTS EV, 1968, J NEUROPHYSIOL, V31, P14, DOI 10.1152/jn.1968.31.1.14; Faggin BM, 1997, P NATL ACAD SCI USA, V94, P9428, DOI 10.1073/pnas.94.17.9428; Fisher NI, 1995, STAT ANAL CIRCULAR D; Florence SL, 1995, J NEUROSCI, V15, P8083; FROMM C, 1983, PFLUG ARCH EUR J PHY, V398, P318, DOI 10.1007/BF00657241; Gandolfo F, 2000, P NATL ACAD SCI USA, V97, P2259, DOI 10.1073/pnas.040567097; GEORGOPOULOS AP, 1992, SCIENCE, V256, P1692, DOI 10.1126/science.256.5064.1692; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; HIKOSAKA O, 2000, NEW COGNITIVE NEUROS, P553; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Huntley GW, 1997, CEREB CORTEX, V7, P143, DOI 10.1093/cercor/7.2.143; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1989, J NEUROSCI, V9, P2080; KARNI A, 1995, NATURE, V377, P155; Laubach M, 2000, NATURE, V405, P567, DOI 10.1038/35014604; Manger PR, 1996, P ROY SOC B-BIOL SCI, V263, P933, DOI 10.1098/rspb.1996.0138; MITZ AR, 1991, J NEUROSCI, V11, P1855; Moran DW, 1999, J NEUROPHYSIOL, V82, P2676, DOI 10.1152/jn.1999.82.5.2676; Nakamura K, 1998, J NEUROPHYSIOL, V80, P2671, DOI 10.1152/jn.1998.80.5.2671; Nudo RJ, 1996, J NEUROSCI, V16, P785; PASCUALLEONE A, 1994, SCIENCE, V263, P1287, DOI 10.1126/science.8122113; RECANZONE GH, 1993, J NEUROSCI, V13, P87; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Scott SH, 1997, J NEUROPHYSIOL, V77, P826, DOI 10.1152/jn.1997.77.2.826; SCOTT SH, 1995, J NEUROPHYSIOL, V73, P2563, DOI 10.1152/jn.1995.73.6.2563; Sergio LE, 1997, J NEUROPHYSIOL, V78, P1170, DOI 10.1152/jn.1997.78.2.1170; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; THACH WT, 1978, J NEUROPHYSIOL, V41, P654, DOI 10.1152/jn.1978.41.3.654; Thoroughman KA, 1999, J NEUROSCI, V19, P8573; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Xerri C, 1998, J NEUROPHYSIOL, V79, P2119, DOI 10.1152/jn.1998.79.4.2119; Zhang J, 1997, J NEUROSCI, V17, P2227	46	302	305	1	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					593	607		10.1016/S0896-6273(01)00301-4	http://dx.doi.org/10.1016/S0896-6273(01)00301-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395017	Green Submitted, Bronze			2022-12-24	WOS:000168962000028
J	Bar, M; Tootell, RBH; Schacter, DL; Greve, DN; Fischl, B; Mendola, JD; Rosen, BR; Dale, AM				Bar, M; Tootell, RBH; Schacter, DL; Greve, DN; Fischl, B; Mendola, JD; Rosen, BR; Dale, AM			Cortical mechanisms specific to explicit visual object recognition	NEURON			English	Article							HUMAN EXTRASTRIATE CORTEX; AREA	The cortical mechanisms associated with conscious object recognition were studied using functional magnetic resonance imaging (fMRI). Participants were required to recognize pictures of masked objects that were presented very briefly, randomly and repeatedly. This design yielded a gradual accomplishment of successful recognition. Cortical activity in a ventrotemporal visual region was linearly correlated with perception of object identity. Therefore, although object recognition is rapid, awareness of an object's identity is not a discrete phenomenon but rather associated with gradually increasing cortical activity. Furthermore, the focus of the activity in the temporal cortex shifted anteriorly as subjects reported an increased knowledge regarding identity. The results presented here provide new insights into the processes underlying explicit object recognition, as well as the analysis that takes place immediately before and after recognition is possible.	Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University	Bar, M (corresponding author), Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA.	bar@nmr.mgh.harvard.edu	Dale, Anders M/A-5180-2010	Schacter, Daniel/0000-0002-2460-6061; Bar, Moshe/0000-0003-3362-3709	NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR013609] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY007980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR13609] Funding Source: Medline; NEI NIH HHS [EY07980] Funding Source: Medline; NIMH NIH HHS [R01 MH60941] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bar M, 1999, P NATL ACAD SCI USA, V96, P1790, DOI 10.1073/pnas.96.4.1790; Bar M, 1998, PSYCHOL SCI, V9, P464, DOI 10.1111/1467-9280.00086; BEHRMANN M, 1992, NATURE, V359, P636, DOI 10.1038/359636a0; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Farah MJ, 1999, TRENDS COGN SCI, V3, P179, DOI 10.1016/S1364-6613(99)01309-1; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; Josephs O, 1997, HUM BRAIN MAPP, V5, P243, DOI 10.1002/(SICI)1097-0193(1997)5:4<243::AID-HBM7>3.0.CO;2-3; Kanwisher N, 1997, J COGNITIVE NEUROSCI, V9, P133, DOI 10.1162/jocn.1997.9.1.133; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kosslyn SM, 1995, HUM BRAIN MAPP, V3, P107, DOI 10.1002/hbm.460030207; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; Martin A, 1996, NATURE, V379, P649, DOI 10.1038/379649a0; McCarthy G, 1997, J COGNITIVE NEUROSCI, V9, P605, DOI 10.1162/jocn.1997.9.5.605; Pasupathy A, 1999, J NEUROPHYSIOL, V82, P2490, DOI 10.1152/jn.1999.82.5.2490; SHERIDAN J, 1993, COGNITIVE NEUROPSYCH, V10, P143, DOI 10.1080/02643299308253459; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Tootell RBH, 1997, J NEUROSCI, V17, P7060; ULLMAN S, 1995, CEREB CORTEX, V5, P1, DOI 10.1093/cercor/5.1.1	24	344	353	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					529	535		10.1016/S0896-6273(01)00224-0	http://dx.doi.org/10.1016/S0896-6273(01)00224-0			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	405DD	11239441	Bronze			2022-12-24	WOS:000167141700024
J	von Gall, C; Garabette, ML; Kell, CA; Frenzel, S; Dehghani, F; Schumm-Draeger, PM; Weaver, DR; Korf, HW; Hastings, MH; Stehle, JH				von Gall, C; Garabette, ML; Kell, CA; Frenzel, S; Dehghani, F; Schumm-Draeger, PM; Weaver, DR; Korf, HW; Hastings, MH; Stehle, JH			Rhythmic gene expression in pituitary depends on heterologous sensitization by the neurohormone melatonin	NATURE NEUROSCIENCE			English	Article							PARS TUBERALIS; PHOTOPERIODIC REGULATION; CIRCADIAN CLOCK; PINEAL-GLAND; MOUSE SCN; MPER1; ADENOSINE; HAMSTER; CLONING; LIGHT	In mammals, many daily cycles are driven by a central circadian clock, which is based on the cell-autonomous rhythmic expression of clock genes. It is not clear, however, how peripheral cells are able to interpret the rhythmic signals disseminated from this central oscillator. Here we show that cycling expression of the clock gene Period1 in rodent pituitary cells depends on the heterologous sensitization of the adenosine A(2b) receptor, which occurs through the nocturnal activation of melatonin mt1 receptors. Eliminating the impact of the neurohormone melatonin simultaneously suppresses the expression of Period1 and evokes an increase in the release of pituitary prolactin. Our findings expose a mechanism by which two convergent signals interact within a temporal dimension to establish high-amplitude, precise and robust cycles of gene expression.	Goethe Univ Frankfurt, Inst Anat 2, D-60590 Frankfurt, Germany; Goethe Univ Frankfurt, Inst Internal Med, D-60590 Frankfurt, Germany; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01655 USA; MRC Ctr, Mol Biol Lab, Div Neurobiol, Cambridge CB2 2QH, England	Goethe University Frankfurt; Goethe University Frankfurt; University of Cambridge; University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology	Stehle, JH (corresponding author), Goethe Univ Frankfurt, Inst Anat 2, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	stehle@em.uni-frankfurt.de	Jansen, Heiko T./A-5770-2008; Korf, Horst/ACX-9860-2022; Von+Gall, Charlotte/AAJ-2160-2021	Jansen, Heiko T./0000-0003-0178-396X; Korf, Horst/0000-0002-5051-0303; Von+Gall, Charlotte/0000-0002-5088-3118; Hastings, Michael Harvey/0000-0001-8576-6651; Weaver, David/0000-0001-7941-6719	NATIONAL INSTITUTE ON AGING [P01AG009975] Funding Source: NIH RePORTER; NIA NIH HHS [AG09975] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; CARLSON LL, 1989, ENDOCRINOLOGY, V125, P2670, DOI 10.1210/endo-125-5-2670; Hastings MH, 2001, J BIOL RHYTHM, V16, P424, DOI 10.1177/074873001129002015; HAZLERIGG DG, 1993, ENDOCRINOLOGY, V132, P285, DOI 10.1210/en.132.1.285; Hazlerigg DG, 2001, J ENDOCRINOL, V170, P493, DOI 10.1677/joe.0.1700493; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Korf H.-W., 1998, Advances in Anatomy Embryology and Cell Biology, V146, P1; Li XM, 2000, AM J PHYSIOL-REG I, V278, pR924, DOI 10.1152/ajpregu.2000.278.4.R924; LINCOLN GA, 1995, J NEUROENDOCRINOL, V7, P637, DOI 10.1111/j.1365-2826.1995.tb00802.x; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Maronde E, 1999, J NEUROSCI, V19, P3326; MARQUARDT DL, 1994, J IMMUNOL, V152, P4508; McNulty S, 1996, J NEUROENDOCRINOL, V8, P635; Messager S, 2001, NEUROREPORT, V12, P579, DOI 10.1097/00001756-200103050-00029; Messager S, 1999, P NATL ACAD SCI USA, V96, P9938, DOI 10.1073/pnas.96.17.9938; Morgan PJ, 2000, J NEUROENDOCRINOL, V12, P287; Pfeffer M, 1998, EUR J NEUROSCI, V10, P2896, DOI 10.1111/j.1460-9568.1998.00309.x; Porkka-Heiskanen T, 1997, SCIENCE, V276, P1265, DOI 10.1126/science.276.5316.1265; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; STEHLE JH, 1995, J PINEAL RES, V18, P179, DOI 10.1111/j.1600-079X.1995.tb00158.x; STEHLE JH, 1993, NATURE, V365, P314, DOI 10.1038/365314a0; STEHLE JH, 1992, MOL ENDOCRINOL, V6, P384, DOI 10.1210/me.6.3.384; Stirland JA, 2001, J NEUROENDOCRINOL, V13, P147, DOI 10.1046/j.1365-2826.2001.00611.x; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takekida S, 2000, EUR J NEUROSCI, V12, P4557, DOI 10.1046/j.0953-816X.2000.01324.x; von Gall C, 1998, J NEUROSCI, V18, P10389; von Gall C, 2000, EUR J NEUROSCI, V12, P964, DOI 10.1046/j.1460-9568.2000.00990.x; von Gall C, 2000, NEUROREPORT, V11, P1803, DOI 10.1097/00001756-200006260-00002; von Gall C, 2001, J NEUROENDOCRINOL, V13, P313, DOI 10.1046/j.1365-2826.2001.00643.x; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682	36	214	217	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					234	238		10.1038/nn806	http://dx.doi.org/10.1038/nn806			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836530				2022-12-24	WOS:000174146000013
J	Weiskrantz, L; Cowey, A; Hodinott-Hill, I				Weiskrantz, L; Cowey, A; Hodinott-Hill, I			Prime-sight in a blindsight subject	NATURE NEUROSCIENCE			English	Article									Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Weiskrantz, L (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	larry.weiskrantz@psy.ox.ac.uk						COWEY A, 1991, TRENDS NEUROSCI, V29, P65; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; James W., 1891, PRINCIPLES PSYCHOL, V2; Johnson H, 2000, EXP BRAIN RES, V132, P269, DOI 10.1007/s002210000384; Julesz, 1971, FDN CYCLOPEAN PERCEP; KANSKI JJ, 1999, CLIN OPHTHALMOLOGY S; Shepherd AJ, 2001, BRAIN, V124, P2310, DOI 10.1093/brain/124.11.2310; Stoerig P, 1997, BRAIN, V120, P535, DOI 10.1093/brain/120.3.535; Weiskrantz L, 1950, Q J EXP PSYCHOL, V2, P170, DOI 10.1080/17470215008416594; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709; Weiskrantz L., 1998, BLINDSIGHT CASE STUD; Weiskrantz L., 1997, CONSCIOUSNESS LOST F; WEISKRANTZ L, HDB NEUROPSYCHOLOGY, V4	13	35	35	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					101	102		10.1038/nn793	http://dx.doi.org/10.1038/nn793			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11788836				2022-12-24	WOS:000173558400010
J	Rosenmund, C; Sigler, A; Augustin, I; Reim, K; Brose, N; Rhee, JS				Rosenmund, C; Sigler, A; Augustin, I; Reim, K; Brose, N; Rhee, JS			Differential control of vesicle priming and short-term plasticity by Munc13 isoforms	NEURON			English	Article							READILY RELEASABLE POOL; PROTEIN-KINASE-C; SYNAPTIC PLASTICITY; TRANSMITTER RELEASE; CHROMAFFIN CELLS; HIPPOCAMPAL SYNAPSES; PYRAMIDAL NEURONS; TRANSMISSION; PROBABILITY; MODULATION	Presynaptic short-term plasticity is an important adaptive mechanism regulating synaptic transmitter release at varying action potential frequencies. However, the underlying molecular mechanisms are unknown. We examined genetically defined and functionally unique axonal subpopulations of synapses in excitatory hippocampal neurons that utilize either Munc13-1 or Munc13-2 as synaptic vesicle priming factor. In contrast to Munc13-1-dependent synapses, Munc-13-2-driven synapses show pronounced and transient augmentation of synaptic amplitudes following high-frequency stimulation. This augmentation is caused by a Ca2+-dependent increase in release probability and releasable vesicle pool size, and requires phospholipase C activity. Thus, differential expression of Munc13 isoforms at individual synapses represents a general mechanism that controls short-term plasticity and contributes to the heterogeneity of synaptic Information coding.	Max Planck Inst Biophys Chem, Abt Membranbiophys, D-37077 Gottingen, Germany; Max Planck Inst Expt Med, AG Mol Neurobiol, Abt Neurogenet, D-37075 Gottingen, Germany	Max Planck Society; Max Planck Society	Rosenmund, C (corresponding author), Max Planck Inst Biophys Chem, Abt Membranbiophys, Fassberg 11, D-37077 Gottingen, Germany.		Rosenmund, Christian/AAC-3596-2020	Rosenmund, Christian/0000-0002-3905-2444				Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Asztely F, 2000, EUR J NEUROSCI, V12, P662, DOI 10.1046/j.1460-9568.2000.00956.x; Augustin I, 1999, BIOCHEM J, V337, P363, DOI 10.1042/0264-6021:3370363; Augustin I, 2001, J NEUROSCI, V21, P10, DOI 10.1523/JNEUROSCI.21-01-00010.2001; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; BEKKERS JM, 1991, P NATL ACAD SCI USA, V88, P7834, DOI 10.1073/pnas.88.17.7834; Betz A, 2001, NEURON, V30, P183, DOI 10.1016/S0896-6273(01)00272-0; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Craig AM, 2001, NAT NEUROSCI, V4, P569, DOI 10.1038/88388; DAVIS GW, 1994, TRENDS NEUROSCI, V17, P9, DOI 10.1016/0166-2236(94)90028-0; Gillis KD, 1996, NEURON, V16, P1209, DOI 10.1016/S0896-6273(00)80147-6; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Malgaroli A, 1999, NAT NEUROSCI, V2, P3, DOI 10.1038/4503; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Pouzat C, 1997, J NEUROSCI, V17, P9104; Reyes A, 1999, J NEUROSCI, V19, P3827; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; Rhee JS, 2002, CELL, V108, P121, DOI 10.1016/S0092-8674(01)00635-3; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Schikorski T, 1997, J NEUROSCI, V17, P5858; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; Stevens CF, 1999, NEURON, V22, P139, DOI 10.1016/S0896-6273(00)80685-6; Thomson AM, 1997, J PHYSIOL-LONDON, V502, P131, DOI 10.1111/j.1469-7793.1997.131bl.x; Wadiche JI, 2001, NEURON, V32, P301, DOI 10.1016/S0896-6273(01)00488-3; Walmsley B, 1998, TRENDS NEUROSCI, V21, P81, DOI 10.1016/S0166-2236(97)01170-3; Wang LY, 1998, NATURE, V394, P384, DOI 10.1038/28645; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	37	242	246	1	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					411	424		10.1016/S0896-6273(02)00568-8	http://dx.doi.org/10.1016/S0896-6273(02)00568-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832228	Bronze, Green Published			2022-12-24	WOS:000173643200011
J	Hummel, T; Attix, S; Gunning, D; Zipursky, SL				Hummel, T; Attix, S; Gunning, D; Zipursky, SL			Temporal control of glial cell migration in the Drosophila eye requires gilgamesh, hedgehog, and eye specification genes	NEURON			English	Article							GROWTH CONE GUIDANCE; CASEIN-KINASE-I; OLIGODENDROCYTE PRECURSORS ORIGINATE; CENTRAL-NERVOUS-SYSTEM; AXON GUIDANCE; EMBRYONIC CNS; OPTIC-NERVE; TRACT FORMATION; MIDLINE GLIA; SPINAL-CORD	In the Drosophila visual system, photoreceptor neurons (R cells) extend axons towards glial cells located at the posterior edge of the eye disc. In gilgamesh (gish) mutants, glial cells invade anterior regions of the eye disc prior to R cell differentiation and R cell axons extend anteriorly along these cells. gish encodes casein kinase Igamma. gish, sine oculis, eyeless, and hedgehog (hh) act in the posterior region of the eye disc to prevent precocious glial cell migration. Targeted expression of Hh in this region rescues the gish phenotype, though the glial cells do not require the canonical Hh signaling pathway to respond. We propose that the spatiotemporal control of glial cell migration plays a critical role in determining the directionality of R cell axon outgrowth.	Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Howard Hughes Med Inst, Dept Biol Chem, 5-748 MRL,675 Charles Young Dr S, Los Angeles, CA 90095 USA.			Zipursky, Stephen/0000-0001-5630-7181				Auld V, 1999, CELL MOL LIFE SCI, V55, P1377, DOI 10.1007/s000180050378; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Bertuzzi S, 1999, GENE DEV, V13, P3092, DOI 10.1101/gad.13.23.3092; Booth GE, 2000, DEVELOPMENT, V127, P237; CameronCurry P, 1995, NEURON, V15, P1299, DOI 10.1016/0896-6273(95)90009-8; CHOI KW, 1994, NEURON, V12, P423, DOI 10.1016/0896-6273(94)90282-8; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Dominguez M, 1997, GENE DEV, V11, P3254, DOI 10.1101/gad.11.23.3254; FFRENCHCONSTANT C, 1988, J NEUROCYTOL, V17, P13, DOI 10.1007/BF01735374; Fitch MT, 1997, CELL TISSUE RES, V290, P379, DOI 10.1007/s004410050944; Giesen K, 1997, DEVELOPMENT, V124, P2307; Goodman C. S., 1993, DEV DROSOPHILA MELAN; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; HALTER DA, 1995, DEVELOPMENT, V121, P317; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hidalgo A, 2000, DEVELOPMENT, V127, P393; Hummel T, 1999, DEV BIOL, V209, P381, DOI 10.1006/dbio.1999.9235; Jacobs JR, 2000, PROG NEUROBIOL, V62, P475, DOI 10.1016/S0301-0082(00)00016-2; JACOBS JR, 1989, J NEUROSCI, V9, P2402; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kinrade EFV, 2001, DEVELOPMENT, V128, P207; Klambt C, 1996, DEV GENET, V18, P40, DOI 10.1002/(SICI)1520-6408(1996)18:1&lt;40::AID-DVG5&gt;3.0.CO;2-1; KLAMBT C, 1991, CELL, V64, P801, DOI 10.1016/0092-8674(91)90509-W; KLAMBT C, 1991, GLIA, V4, P205, DOI 10.1002/glia.440040212; Lu Q, 2001, CELL, V105, P69, DOI 10.1016/S0092-8674(01)00297-5; Newsome TP, 2000, DEVELOPMENT, V127, P851; NOLL E, 1993, DEVELOPMENT, V118, P563; Ono K, 1997, NEURON, V19, P283, DOI 10.1016/S0896-6273(00)80939-3; Ono K, 1997, J NEUROSCI RES, V48, P212; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; Peters JM, 1999, NATURE, V401, P345, DOI 10.1038/43830; Pignoni F, 1997, DEVELOPMENT, V124, P271; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Powell EM, 1997, CELL TISSUE RES, V290, P385, DOI 10.1007/s004410050945; Powell EM, 1999, GLIA, V26, P73, DOI 10.1002/(SICI)1098-1136(199903)26:1<73::AID-GLIA8>3.0.CO;2-S; Rangarajan R, 1999, DEVELOPMENT, V126, P3285; READY DF, 1989, TRENDS NEUROSCI, V12, P102, DOI 10.1016/0166-2236(89)90166-5; READY DF, 1976, DEV BIOL, V53, P217, DOI 10.1016/0012-1606(76)90225-6; Rogister B, 1999, MOL CELL NEUROSCI, V14, P287, DOI 10.1006/mcne.1999.0790; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Sakanaka C, 1999, P NATL ACAD SCI USA, V96, P12548, DOI 10.1073/pnas.96.22.12548; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Sela-Donenfeld D, 1999, DEVELOPMENT, V126, P4749; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Stowers RS, 1999, GENETICS, V152, P1631; Stuermer CAO, 2000, PROG NEUROBIOL, V62, P197, DOI 10.1016/S0301-0082(00)00012-5; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Tix S, 1997, CELL TISSUE RES, V289, P397, DOI 10.1007/s004410050886; TOWER J, 1993, GENETICS, V133, P347; WANG PC, 1992, MOL BIOL CELL, V3, P275, DOI 10.1091/mbc.3.3.275; WINBERG ML, 1992, DEVELOPMENT, V115, P903; WOLFF T, 1991, DEVELOPMENT, V113, P841; Zhang JR, 1996, BIOCHEMISTRY-US, V35, P16319, DOI 10.1021/bi9614444; ZHANG P, 1993, GENETICS, V133, P361	56	85	86	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 17	2002	33	2					193	203		10.1016/S0896-6273(01)00581-5	http://dx.doi.org/10.1016/S0896-6273(01)00581-5			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804568	Bronze			2022-12-24	WOS:000173387700008
J	Ojemann, GA; Schoenfield-McNeill, J; Corina, DP				Ojemann, GA; Schoenfield-McNeill, J; Corina, DP			Anatomic subdivisions in human temporal cortical neuronal activity related to recent verbal memory	NATURE NEUROSCIENCE			English	Article							SHORT-TERM-MEMORY; HIPPOCAMPAL-FORMATION; CORTEX; STIMULATION; RETRIEVAL; LOBE; EXPERIENCE; PRIMATE; BRAIN; WORDS	We identified functional anatomical subdivisions of human lateral and basal temporal cortex related to recent verbal memory for object names, text and auditory words. Extracellular neuronal activity was recorded during memory encoding compared to identification, during encoding, storage or recall retrieval stages of the memory task, during recognition memory, and during implicit memory as measured by repetition priming. Changes in frequency of activity during encoding were recorded from most neurons. In lateral temporal cortex, these encoding changes in the dominant hemisphere were more likely to be polymodal, whereas those in nondominant hemisphere were unimodal. There was substantial separation of neurons with changes in other aspects of memory, defining additional subdivisions. Inferior lateral and basal cortex were related to memory stages, and superior-posterior lateral cortex was related to implicit and recognition memory.	Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ojemann, GA (corresponding author), Univ Washington, Dept Neurol Surg, Box 356470, Seattle, WA 98195 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036527] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 36527] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; BROWN MW, 1987, BRAIN RES, V409, P158, DOI 10.1016/0006-8993(87)90753-0; BUCKNER RL, 1995, J NEUROSCI, V15, P12; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Buckner RL, 1996, J NEUROSCI, V16, P6219; CALVIN WH, 1973, ELECTROEN CLIN NEURO, V34, P337, DOI 10.1016/0013-4694(73)90086-2; Cameron KA, 2001, NEURON, V30, P289, DOI 10.1016/S0896-6273(01)00280-X; Darley, 1967, BRAIN MECH UNDERLY, P122; Desimone Robert, 1995, P475; Dhond RP, 2001, J NEUROSCI, V21, P3564, DOI 10.1523/JNEUROSCI.21-10-03564.2001; Dodrill, 1987, ADV EPILEPTOL, V16, P327; Dodrill CB, 1997, BRAIN COGNITION, V33, P210, DOI 10.1006/brcg.1997.0893; Dolan RJ, 1997, NATURE, V388, P582, DOI 10.1038/41561; EICHBAUM H, 2001, CONDITIONING CONSCIO; FUSTER JM, 1982, J NEUROSCI, V2, P361; Fuster JM, 1995, MEMORY CEREBRAL CORT; HAGLUND MM, 1994, J NEUROSCI, V14, P1507, DOI 10.1523/JNEUROSCI.14-03-01507.1994; HALGREN E, 1978, ELECTROEN CLIN NEURO, V45, P585, DOI 10.1016/0013-4694(78)90159-1; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Martin A, 1997, HIPPOCAMPUS, V7, P587, DOI 10.1002/(SICI)1098-1063(1997)7:6<587::AID-HIPO1>3.0.CO;2-C; MILLER EK, 1993, J NEUROSCI, V13, P1460; Milner B, 1972, Clin Neurosurg, V19, P421; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; OJEMANN GA, 1985, J NEUROSURG, V62, P101, DOI 10.3171/jns.1985.62.1.0101; Ojemann GA, 1999, J NEUROSCI, V19, P5674; Ojemann GA, 1998, NEUROSCIENTIST, V4, P285, DOI 10.1177/107385849800400417; Ojemann GA, 1998, BRAIN LANG, V64, P317, DOI 10.1006/brln.1998.1982; OJEMANN GA, 1978, BRAIN LANG, V5, P331, DOI 10.1016/0093-934X(78)90030-5; OJEMANN GA, 1988, BRAIN, V111, P1383, DOI 10.1093/brain/111.6.1383; OJEMANN GA, 1995, OPERATIVE NEUROSURGI, P1317; PERRINE K, 1994, NEUROLOGY, V44, P1845, DOI 10.1212/WNL.44.10.1845; RICHES IP, 1991, J NEUROSCI, V11, P1763; Schwartz TH, 1996, COGNITIVE BRAIN RES, V4, P263, DOI 10.1016/S0926-6410(96)00062-6; SHIMAMURA AP, 1989, HDB NEUROPSYCHOLOGY, V3, P35; Squire LR, 2001, NAT NEUROSCI, V4, P867; WEBER PB, 1995, NEUROREPORT, V6, P685, DOI 10.1097/00001756-199503000-00025	38	83	85	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					64	71		10.1038/nn785	http://dx.doi.org/10.1038/nn785			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753418				2022-12-24	WOS:000173031800017
J	Washbourne, P; Thompson, PM; Carta, M; Costa, ET; Mathews, JR; Lopez-Bendito, G; Molnar, Z; Becher, MW; Valenzuela, CF; Partridge, LD; Wilson, MC				Washbourne, P; Thompson, PM; Carta, M; Costa, ET; Mathews, JR; Lopez-Bendito, G; Molnar, Z; Becher, MW; Valenzuela, CF; Partridge, LD; Wilson, MC			Genetic ablation of the t-SNARE SNAP-25 distinguishes mechanisms of neuroexocytosis	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; FROG NEUROMUSCULAR-JUNCTION; TRANSMITTER RELEASE; SYNAPTIC VESICLES; TETANUS TOXIN; NEUROTRANSMITTER SECRETION; CLOSTRIDIAL NEUROTOXINS; MEMBRANE-FUSION; GROWTH CONES; EXOCYTOSIS	Axon outgrowth during development and neurotransmitter release depends on exocytotic mechanisms, although what protein machinery is common to or differentiates these processes remains unclear. Here we show that the neural t-SNARE (target-membrane-associated-soluble N-ethylmaleimide fusion protein attachment protein (SNAP) receptor) SNAP-25 is not required for nerve growth or stimulus-independent neurotransmitter release, but is essential for evoked synaptic transmission at neuromuscular junctions and central synapses. These results demonstrate that the development of neurotransmission requires the recruitment of a specialized SNARE core complex to meet the demands of regulated exocytosis.	Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA; Univ New Mexico, Hlth Sci Ctr, Dept Pathol, Albuquerque, NM 87131 USA; Univ Oxford, Dept Human Anat & Genet, Oxford OX1 3QX, England	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of Oxford	Wilson, MC (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurosci, Albuquerque, NM 87131 USA.		Carta, Mauro/AAV-3451-2021; Molnar, Zoltan/J-7281-2012; Lopez-Bendito, Guillermina/E-4028-2014	Carta, Mauro/0000-0003-0706-9687; Molnar, Zoltan/0000-0002-6852-6004; Carta, Mario/0000-0003-1225-2742; Lopez-Bendito, Guillermina/0000-0002-8965-6836; Partridge, Linda/0000-0001-9615-0094	NIMH NIH HHS [R01 MH048989, MH 4-8989] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AITKEN PG, 1995, J NEUROSCI METH, V59, P139, DOI 10.1016/0165-0270(94)00204-T; BARK IC, 1993, J MOL BIOL, V233, P67, DOI 10.1006/jmbi.1993.1485; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; Brunger AT, 2000, CURR OPIN NEUROBIOL, V10, P293, DOI 10.1016/S0959-4388(00)00098-2; Capogna M, 1997, J NEUROSCI, V17, P7190; CAPOGNA M, 1996, J NEUROPHYSIOL, V76, P149; CECCARELLI B, 1980, J CELL BIOL, V87, P297, DOI 10.1083/jcb.87.1.297; CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; Chen D, 1999, BRAIN RES, V831, P11, DOI 10.1016/S0006-8993(99)01371-2; Coco S, 1999, J NEUROSCI, V19, P9803; Costa ET, 2000, ALCOHOL CLIN EXP RES, V24, P220, DOI 10.1097/00000374-200002000-00013; Deitcher DL, 1998, J NEUROSCI, V18, P2028; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HESS DT, 1992, J NEUROSCI, V12, P4634; HEUSER JE, 1981, J CELL BIOL, V88, P564, DOI 10.1083/jcb.88.3.564; Hua SY, 1998, J NEUROPHYSIOL, V80, P3233, DOI 10.1152/jn.1998.80.6.3233; Katz B., 1969, RELEASE NEURAL TRANS; Lane SR, 1997, J NEUROCHEM, V69, P1864; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Mehta PP, 1996, P NATL ACAD SCI USA, V93, P10471, DOI 10.1073/pnas.93.19.10471; Morihara T, 1999, NEUROSCIENCE, V91, P695, DOI 10.1016/S0306-4522(98)00671-X; OSENSAND A, 1993, NATURE, V364, P445, DOI 10.1038/364445a0; OsenSand A, 1996, J COMP NEUROL, V367, P222, DOI 10.1002/(SICI)1096-9861(19960401)367:2<222::AID-CNE5>3.0.CO;2-7; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; Ravichandran V, 1996, J BIOL CHEM, V271, P13300, DOI 10.1074/jbc.271.23.13300; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; Verderio C, 1999, J NEUROSCI, V19, P6723, DOI 10.1523/JNEUROSCI.19-16-06723.1999; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Washbourne P, 2001, BIOCHEM J, V357, P625, DOI 10.1042/0264-6021:3570625; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2; YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507	48	387	399	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					19	26		10.1038/nn783	http://dx.doi.org/10.1038/nn783			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753414				2022-12-24	WOS:000173031800010
J	Finn, AK; Whistler, JL				Finn, AK; Whistler, JL			Endocytosis of the mu opioid receptor reduces tolerance and a cellular hallmark of opiate withdrawal	NEURON			English	Article							RAT-BRAIN; GABA RELEASE; MORPHINE; KINASE; DESENSITIZATION; INTERNALIZATION; DISSOCIATION; DEPENDENCE; ACTIVATION; CELLS	Morphine is unusual in its failure to promote robust desensitization and endocytosis of the mu opioid receptor (MOR), processes that for many receptors contribute directly to tolerance. This apparent paradox has led us to revise the idea that receptor desensitization and endocytosis are solely responsible for tolerance and withdrawal to morphine, and instead test the hypothesis that these side effects occur due to abnormally prolonged MOR signaling. We report here that MOR mutations that facilitate endocytosis reduce the development of cellular tolerance and cAMP superactivation, a cellular hallmark of withdrawal. Moreover, mutant receptors with reduced endocytosis produce exacerbated superactivation. These data demonstrate a critical role for receptor endocytosis in the development of adverse side effects associated with prolonged opiate use.	Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California Berkeley	Whistler, JL (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA 94608 USA.							Abbadie C, 2000, J COMP NEUROL, V419, P244, DOI 10.1002/(SICI)1096-9861(20000403)419:2<244::AID-CNE8>3.0.CO;2-R; ARDEN JR, 1995, J NEUROCHEM, V65, P1636; AvidorReiss T, 1996, J BIOL CHEM, V271, P21309, DOI 10.1074/jbc.271.35.21309; AVIDORREISS T, 1995, J BIOL CHEM, V270, P29732; Blake AD, 1997, J BIOL CHEM, V272, P782, DOI 10.1074/jbc.272.2.782; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bonci A, 1997, J NEUROSCI, V17, P796; BURROUGHS WS, 1956, B J ADDICT, V53; Chieng B, 1998, J NEUROSCI, V18, P7033; Daaka Y, 1998, J BIOL CHEM, V273, P685, DOI 10.1074/jbc.273.2.685; De Quincey Thomas., 1976, CONFESSIONS ENGLISH; Evans CJ, 1993, BIOL BASIS SUBSTANCE, P31; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Keith DE, 1998, MOL PHARMACOL, V53, P377, DOI 10.1124/mol.53.3.377; Keith DE, 1996, J BIOL CHEM, V271, P19021, DOI 10.1074/jbc.271.32.19021; Liu JG, 2001, MOL PHARMACOL, V60, P53, DOI 10.1124/mol.60.1.53; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Nestler EJ, 1996, NEURON, V16, P897, DOI 10.1016/S0896-6273(00)80110-5; Pierce KL, 2001, ONCOGENE, V20, P1532, DOI 10.1038/sj.onc.1204184; SHARMA SK, 1975, P NATL ACAD SCI USA, V72, P3092, DOI 10.1073/pnas.72.8.3092; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2000, J NEUROSCI, V20, P4555, DOI 10.1523/JNEUROSCI.20-12-04555.2000; SNYDER SH, 1996, DRUGS BRAIN; Sternini C, 1996, P NATL ACAD SCI USA, V93, P9241, DOI 10.1073/pnas.93.17.9241; Trapaidze N, 2000, MOL BRAIN RES, V76, P220, DOI 10.1016/S0169-328X(00)00002-4; Tsao PI, 2000, J BIOL CHEM, V275, P11130, DOI 10.1074/jbc.275.15.11130; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Whistler JL, 1999, J BIOL CHEM, V274, P24575, DOI 10.1074/jbc.274.35.24575; Williams JT, 2001, PHYSIOL REV, V81, P299, DOI 10.1152/physrev.2001.81.1.299; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157	33	223	237	1	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					829	839		10.1016/S0896-6273(01)00517-7	http://dx.doi.org/10.1016/S0896-6273(01)00517-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738029	Bronze			2022-12-24	WOS:000172700700010
J	Howe, CL; Valletta, JS; Rusnak, AS; Mobley, WC				Howe, CL; Valletta, JS; Rusnak, AS; Mobley, WC			NGF signaling from clathrin-coated vesicles: Evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway	NEURON			English	Article							NERVE GROWTH-FACTOR; RECEPTOR-MEDIATED ENDOCYTOSIS; SYMPATHETIC NEURONS; RETROGRADE TRANSPORT; TRKA; INSULIN; KINASE; INTERNALIZATION; PHOSPHORYLATION; CULTURES	The target-derived neurotrophic factor "nerve growth factor" (NGF) signals through TrkA to promote the survival, differentiation, and maintenance of neurons. How the NGF signal in axon terminals is conveyed to the cell body is unknown. The "signaling endosome hypothesis" envisions that NGF-TrkA complexes are internalized at the axon terminal and retrogradely transported to the cell body. Following NGF treatment, we found that clathrin-coated vesicles contained NGF bound to TrkA together with activated signaling proteins of the Ras-MAP kinase pathway. Evidence that these vesicles could signal was their ability in vitro to activate Elk, a downstream target of Erk1/2. Our results point to the existence of a population of signaling endosomes derived from clathrin-coated membranes in NGF-treated cells.	Stanford Univ, Med Ctr, Dept Neurol, Stanford, CA 94305 USA	Stanford University	Howe, CL (corresponding author), Mayo Clin & Mayo Fdn, Dept Neurol, 200 1st St SW, Rochester, MN 55905 USA.		Howe, Charles/B-4945-2009	Howe, Charles/0000-0002-3889-8739	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024054] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24054] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Beattie EC, 2000, J NEUROSCI, V20, P7325; Beattie EC, 1996, COLD SPRING HARB SYM, V61, P389; Bhattacharyya A, 1997, J NEUROSCI, V17, P7007; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Casaccia-Bonnefil P, 1999, ADV EXP MED BIOL, V468, P275; Cavanaugh JE, 2001, J NEUROSCI, V21, P434, DOI 10.1523/JNEUROSCI.21-02-00434.2001; Ceresa BP, 1998, MOL CELL BIOL, V18, P3862, DOI 10.1128/MCB.18.7.3862; Chan JR, 1998, P NATL ACAD SCI USA, V95, P10459, DOI 10.1073/pnas.95.18.10459; Chow JC, 1998, J BIOL CHEM, V273, P4672, DOI 10.1074/jbc.273.8.4672; DAVIES PJA, 1984, DIABETES CARE, V7, P35; EHLERS MD, 1995, J CELL BIOL, V130, P149, DOI 10.1083/jcb.130.1.149; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; GILAD GM, 1986, INT J DEV NEUROSCI, V4, P401, DOI 10.1016/0736-5748(86)90022-5; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Grimes ML, 1996, J NEUROSCI, V16, P7950; HENDRY IA, 1993, NEUROTROPHIC FACTORS, P51; JOHANSON SO, 1995, BRAIN RES, V690, P55, DOI 10.1016/0006-8993(95)00587-G; Kuruvilla R, 2000, NEURON, V27, P499, DOI 10.1016/S0896-6273(00)00061-1; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Leof EB, 2000, TRENDS CELL BIOL, V10, P343, DOI 10.1016/S0962-8924(00)01795-5; MAYCOX PR, 1992, J CELL BIOL, V118, P1379, DOI 10.1083/jcb.118.6.1379; MOBLEY WC, 1985, SCIENCE, V229, P284, DOI 10.1126/science.2861660; PEELER JS, 1993, J CELL BIOL, V120, P47, DOI 10.1083/jcb.120.1.47; Reynolds AJ, 2001, NEUROSCIENCE, V105, P761, DOI 10.1016/S0306-4522(01)00235-4; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; Senger DL, 1997, J CELL BIOL, V138, P411, DOI 10.1083/jcb.138.2.411; SOFER A, 1995, J BIOL CHEM, V270, P12117, DOI 10.1074/jbc.270.20.12117; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Tsui-Pierchala BA, 1999, J NEUROSCI, V19, P8207; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Watson FL, 1999, J NEUROSCI, V19, P7889; Watson FL, 2001, NAT NEUROSCI, V4, P981, DOI 10.1038/nn720; WEI L, 1990, J NEUROCHEM, V54, P1661, DOI 10.1111/j.1471-4159.1990.tb01219.x; Wood TL, 2000, J MAMMARY GLAND BIOL, V5, P1, DOI 10.1023/A:1009580913795; York RD, 2000, MOL CELL BIOL, V20, P8069, DOI 10.1128/MCB.20.21.8069-8083.2000; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	37	271	280	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					801	814		10.1016/S0896-6273(01)00526-8	http://dx.doi.org/10.1016/S0896-6273(01)00526-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738027	Bronze			2022-12-24	WOS:000172700700008
J	Haruta, M; Kosaka, M; Kanegae, Y; Saito, I; Inoue, T; Kageyama, R; Nishida, A; Honda, Y; Takahashi, M				Haruta, M; Kosaka, M; Kanegae, Y; Saito, I; Inoue, T; Kageyama, R; Nishida, A; Honda, Y; Takahashi, M			Induction of photoreceptor-specific phenotypes in adult mammalian iris tissue	NATURE NEUROSCIENCE			English	Article							NEURAL STEM-CELLS; RAT RETINA; PROGENITOR CELLS; DIFFERENTIATION; INTEGRATION; EXPRESSION; ADENOVIRUS; PROTEIN; GENE; EYE		Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan; Japan Sci & Technol Corp, TOREST, Okayama Technol Ctr, Okayama 7011221, Japan; Univ Tokyo, Inst Med Sci, Mol Genet Lab, Minato Ku, Tokyo 1088639, Japan; Kyoto Univ, Inst Virus Res, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; Kyoto University	Takahashi, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan.		KOSAKA, Mitsuko/B-1603-2011	KOSAKA, Mitsuko/0000-0001-6146-5184				Ahmad I, 2000, BIOCHEM BIOPH RES CO, V270, P517, DOI 10.1006/bbrc.2000.2473; BARNSTABLE CJ, 1980, NATURE, V286, P231, DOI 10.1038/286231a0; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; Hojo M, 2000, DEVELOPMENT, V127, P2515; KANEGAE Y, 1994, JPN J MED SCI BIOL, V47, P157, DOI 10.7883/yoken1952.47.157; McGinnis JF, 1999, J NEUROSCI RES, V55, P252, DOI 10.1002/(SICI)1097-4547(19990115)55:2<252::AID-JNR13>3.0.CO;2-N; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nishida A, 2000, INVEST OPHTH VIS SCI, V41, P4268; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; WATANABE T, 1990, NEURON, V4, P461, DOI 10.1016/0896-6273(90)90058-N; Young MJ, 2000, MOL CELL NEUROSCI, V16, P197, DOI 10.1006/mcne.2000.0869	15	127	137	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1163	1164		10.1038/nn762	http://dx.doi.org/10.1038/nn762			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704762	Green Submitted			2022-12-24	WOS:000172525000006
J	Lauri, SE; Bortolotto, ZA; Bleakman, D; Ornstein, PL; Lodge, D; Isaac, JTR; Collingridge, GL				Lauri, SE; Bortolotto, ZA; Bleakman, D; Ornstein, PL; Lodge, D; Isaac, JTR; Collingridge, GL			A critical role of a facilitatory presynaptic kainate receptor in mossy fiber LTP	NEURON			English	Article							LONG-TERM POTENTIATION; HIPPOCAMPAL CA3 NEURONS; SYNAPTIC ACTIVATION; RAT HIPPOCAMPUS; BINDING-SITES; GLUR5 SUBTYPE; 2 FORMS; PLASTICITY; SYNAPSES; INDUCTION	The mechanisms involved in mossy fiber LTP in the hippocampus are not well established. In the present study, we show that the kainate receptor antagonist LY382884 (10 muM) is selective for presynaptic kainate receptors in the CA3 region of the hippocampus. At a concentration at which it blocks mossy fiber LTP, LY382884 selectively blocks the synaptic activation of a presynaptic kainate receptor that facilitates AMPA receptor-mediated synaptic transmission. Following the induction of mossy fiber LTP, there is a complete loss of the presynaptic kainate receptor-mediated facilitation of synaptic transmission. These results identify a central role for the presynaptic kainate receptor in the induction of mossy fiber LTP. In addition, these results suggest that the pathway by which kainate receptors facilitate glutamate release is utilized for the expression of mossy fiber LTP.	Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA	University of Bristol; Eli Lilly	Collingridge, GL (corresponding author), Univ Bristol, Sch Med, Dept Anat, MRC,Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.		Ornstein, Paul/E-4212-2016; Collingridge, Graham L/C-4605-2015; collingridge, graham/AAI-8362-2020; Lauri, Sari/AAD-6417-2021	Ornstein, Paul/0000-0002-4335-1877; Collingridge, Graham L/0000-0002-9572-5359; Lauri, Sari/0000-0002-5895-1357				Anderson WW, 2001, J NEUROSCI METH, V108, P71, DOI 10.1016/S0165-0270(01)00374-0; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; Bleisch TJ, 1997, BIOORG MED CHEM LETT, V7, P1161, DOI 10.1016/S0960-894X(97)00185-6; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bortolotto ZA, 2000, NATURE, V406, P957, DOI 10.1038/35023077; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; CASTILLO PE, 1994, NEURON, V12, P261, DOI 10.1016/0896-6273(94)90269-0; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; DAVIES CH, 1993, NEUROPHARMACOLOGY, V32, P1071, DOI 10.1016/0028-3908(93)90073-C; FREKING M, 2001, J NEUROSCI, V21, P2958; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; JAFFE D, 1990, J NEUROPHYSIOL, V64, P948, DOI 10.1152/jn.1990.64.3.948; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KATSUKI H, 1991, NEUROSCI RES, V12, P393, DOI 10.1016/0168-0102(91)90070-F; KEHL SJ, 1984, NEUROSCIENCE, V11, P111, DOI 10.1016/0306-4522(84)90217-3; Kidd FL, 1999, NATURE, V400, P569, DOI 10.1038/23040; Kidd FL, 2001, J NEUROPHYSIOL, V86, P1139, DOI 10.1152/jn.2001.86.3.1139; LAURI SE, 2001, IN PRESS NEUROPHARMA, V47; Mellor J, 2001, NAT NEUROSCI, V4, P125, DOI 10.1038/83941; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Nicoll RA, 2000, NATURE, V406, P957, DOI 10.1038/35023075; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; REPRESA A, 1987, NEUROSCIENCE, V20, P739, DOI 10.1016/0306-4522(87)90237-5; Robinson I. K., 1991, HDB SYNCHROTRON RAD, V3, P221; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Urban NN, 1996, J NEUROSCI, V16, P4293; Vignes M, 1997, NEUROPHARMACOLOGY, V36, P1477, DOI 10.1016/S0028-3908(97)00158-5; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WESTBROOK GL, 1983, BRAIN RES, V273, P97, DOI 10.1016/0006-8993(83)91098-3; WILLIAMS S, 1989, NEURON, V3, P583, DOI 10.1016/0896-6273(89)90268-7; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180; ZALUTSKY RA, 1990, SCIENCE, V248, P1619, DOI 10.1126/science.2114039	42	156	161	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					697	709		10.1016/S0896-6273(01)00511-6	http://dx.doi.org/10.1016/S0896-6273(01)00511-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719209	Bronze			2022-12-24	WOS:000172363900015
J	Miller, LM; Escabi, MA; Read, HL; Schreiner, CE				Miller, LM; Escabi, MA; Read, HL; Schreiner, CE			Functional convergence of response properties in the auditory thalamocortical system	NEURON			English	Article							CROSS-CORRELATION ANALYSIS; RECEPTIVE-FIELDS; MEDIAL GENICULATE; ORIENTATION SELECTIVITY; SOMATOSENSORY CORTEX; SYNAPTIC INTEGRATION; SIMPLE CELLS; CAT; ORGANIZATION; PLASTICITY	One of the brain's fundamental tasks is to construct and transform representations of an animal's environment, yet few studies describe how individual neurons accomplish this. Our results from correlated pairs in the auditory thalamocortical system show that cortical excitatory receptive field regions can be directly inherited from thalamus, constructed from smaller inputs, and assembled by the cooperative activity of neuronal ensembles. The prevalence of functional thalamocortical connectivity is strictly governed by tonotopy, but connection strength is not. Finally, spectral and temporal modulation preferences in cortex may differ dramatically from the thalamic input. Our observations reveal a radical reconstruction of response properties from auditory thalamus to cortex, and illustrate how some properties are propagated with great fidelity while others are significantly transformed or generated intracortically.	Univ Calif San Francisco, Med Ctr, UCSF UCB Bioengn Grp, San Francisco, CA 94143 USA; Univ Connecticut, Storrs, CT 06269 USA	University of California System; University of California San Francisco; University of Connecticut	Miller, LM (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall 1650, Berkeley, CA 94720 USA.	lmiller@socrates.berkeley.edu		Schreiner, Christoph/0000-0002-4571-4328; Escabi, Monty/0000-0001-7271-1061	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS034835] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002260] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02260, R01 DC002260, R01 DC002260-06] Funding Source: Medline; NINDS NIH HHS [NS34835] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Adrian ED, 1941, J PHYSIOL-LONDON, V100, P159, DOI 10.1113/jphysiol.1941.sp003932; AERTSEN AMHJ, 1980, BIOL CYBERN, V38, P223, DOI 10.1007/BF00337015; Ahissar E, 2000, NATURE, V406, P302, DOI 10.1038/35018568; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Arai T, 1998, INT CONF ACOUST SPEE, P933, DOI 10.1109/ICASSP.1998.675419; BRANDNER S, 1990, J NEUROSCI, V10, P50; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Cetas JS, 1999, BRAIN RES, V830, P203, DOI 10.1016/S0006-8993(99)01355-4; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; CLAREY JC, 1994, MAMMALIAN AUDITORY P, P232; Cotillon N, 2000, HEARING RES, V142, P113, DOI 10.1016/S0378-5955(00)00016-2; CREUTZFELDT O, 1980, EXP BRAIN RES, V39, P87; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DEVENECIA RK, 1994, DEV BRAIN RES, V81, P135, DOI 10.1016/0165-3806(94)90077-9; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P1053, DOI 10.1121/1.408467; EGGERMONT JJ, 1992, HEARING RES, V61, P1, DOI 10.1016/0378-5955(92)90029-M; Fanselow EE, 1999, J NEUROSCI, V19, P7603, DOI 10.1523/JNEUROSCI.19-17-07603.1999; Feldman DE, 1999, J NEUROBIOL, V41, P92, DOI 10.1002/(SICI)1097-4695(199910)41:1<92::AID-NEU12>3.0.CO;2-U; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Fishman YI, 1998, BRAIN RES, V786, P18, DOI 10.1016/S0006-8993(97)01423-6; Hirsch JA, 1998, J NEUROSCI, V18, P9517; Huang CL, 2000, J COMP NEUROL, V427, P302, DOI 10.1002/1096-9861(20001113)427:2<302::AID-CNE10>3.0.CO;2-J; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Johnson MJ, 1996, J NEUROPHYSIOL, V75, P1444, DOI 10.1152/jn.1996.75.4.1444; Jones EG, 1998, SCIENCE, V282, P1121, DOI 10.1126/science.282.5391.1121; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Klein DJ, 2000, J COMPUT NEUROSCI, V9, P85, DOI 10.1023/A:1008990412183; Kowalski N, 1996, J NEUROPHYSIOL, V76, P3503, DOI 10.1152/jn.1996.76.5.3503; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Langner G, 1997, J COMP PHYSIOL A, V181, P665, DOI 10.1007/s003590050148; LEVICK WR, 1972, INVEST OPHTH VISUAL, V11, P302; LEWICKI MS, 1994, NEURAL COMPUT, V6, P1005, DOI 10.1162/neco.1994.6.5.1005; MIDDLEBROOKS JC, 1983, J NEUROSCI, V3, P203; Miller LM, 2000, J NEUROSCI, V20, P7011, DOI 10.1523/JNEUROSCI.20-18-07011.2000; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; Nicolelis MAL, 1998, REV NEUROSCIENCE, V9, P213; PANTEV C, 1989, SCIENCE, V246, P486, DOI 10.1126/science.2814476; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Rajan R, 1998, AUDIOL NEURO-OTOL, V3, P123, DOI 10.1159/000013786; RECANZONE GH, 1993, J NEUROSCI, V13, P87; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Scharf B., 1970, F MODERN AUDITORY TH, V1, P159; Schreiner C.E., 1994, AUDIT NEUROSCI, V1, P39; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Schreiner CE, 1997, NATURE, V388, P383, DOI 10.1038/41106; SCHROEDER CE, 1995, J NEUROPHYSIOL, V74, P722, DOI 10.1152/jn.1995.74.2.722; SWADLOW HA, 1995, J NEUROPHYSIOL, V73, P1584, DOI 10.1152/jn.1995.73.4.1584; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; WEINBERGER NM, 1995, ANNU REV NEUROSCI, V18, P129; Worgotter F, 2000, TRENDS NEUROSCI, V23, P497, DOI 10.1016/S0166-2236(00)01632-5; Zhang YF, 1997, J NEUROPHYSIOL, V78, P3489, DOI 10.1152/jn.1997.78.6.3489	56	169	172	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	OCT 11	2001	32	1					151	160		10.1016/S0896-6273(01)00445-7	http://dx.doi.org/10.1016/S0896-6273(01)00445-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604146	Bronze			2022-12-24	WOS:000171525200016
J	Kakei, S; Hoffman, DS; Strick, PL				Kakei, S; Hoffman, DS; Strick, PL			Direction of action is represented in the ventral premotor cortex	NATURE NEUROSCIENCE			English	Article							PRIMARY MOTOR CORTEX; MOVEMENT-RELATED ACTIVITY; STEP-TRACKING MOVEMENTS; POST-ARCUATE AREA; MACAQUE MONKEYS; INFERIOR AREA-6; FUNCTIONAL-ORGANIZATION; PERIARCUATE NEURONS; 3-DIMENSIONAL SPACE; AFFERENT PROPERTIES	The ventral premotor area (PMv) is a major source of input to the primary motor cortex (M1). To examine the potential hierarchical processing between these motor areas, we recorded the activity of PMv neurons in a monkey trained to perform wrist movements in different directions with the wrist in three different postures. The task dissociated three major variables of wrist movement: muscle activity, direction of joint movement and direction of movement in space. Many PMv neurons were directionally tuned. Nearly all of these neurons (61/65, 94%) were 'extrinsic-like'; they seemed to encode the direction of movement in space independent of forearm posture. These results are strikingly different from results from M1 of the same animal, and suggest that intracortical processing between PMv and M1 may contribute to a sensorimotor transformation between extrinsic and intrinsic coordinate frames.	Univ Pittsburgh, Sch Med, Vet Affairs Med Ctr, Res Serv, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Ctr Neural Basis Cognit, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Strick, PL (corresponding author), Univ Pittsburgh, Sch Med, Vet Affairs Med Ctr, Res Serv, W1640 Biomed Sci Tower,200 Lothrop St, Pittsburgh, PA 15261 USA.	strickp@pitt.edu		Kakei, Shinji/0000-0001-5111-5789				ALEXANDER GE, 1990, J NEUROPHYSIOL, V64, P133, DOI 10.1152/jn.1990.64.1.133; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P28; Crammond DJ, 1996, EXP BRAIN RES, V108, P45; DUM RP, 1991, LIFE SCI R, V50, P383; FOGARTY TJ, 1996, ADV VASC SURG, V4, P1; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; GODSCHALK M, 1981, EXP BRAIN RES, V44, P113; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HOFFMAN DS, 1986, J NEUROSCI, V6, P3309; Hoffman DS, 1999, J NEUROPHYSIOL, V81, P319, DOI 10.1152/jn.1999.81.1.319; Kakei S, 1999, SCIENCE, V285, P2136, DOI 10.1126/science.285.5436.2136; KALASKA JF, 1992, SCIENCE, V255, P1517, DOI 10.1126/science.1549781; KUBOTA K, 1978, J PHYSIOL-PARIS, V74, P297; KURATA K, 1986, J NEUROSCI, V6, P403; KURATA K, 1989, EXP BRAIN RES, V77, P245, DOI 10.1007/BF00274982; KURATA K, 1993, J NEUROPHYSIOL, V69, P187, DOI 10.1152/jn.1993.69.1.187; KURATA K, 1991, NEUROSCI RES, V12, P263, DOI 10.1016/0168-0102(91)90116-G; LU MT, 1994, J COMP NEUROL, V341, P375, DOI 10.1002/cne.903410308; Luppino G, 1999, EXP BRAIN RES, V128, P181, DOI 10.1007/s002210050833; MATELLI M, 1986, J COMP NEUROL, V251, P281, DOI 10.1002/cne.902510302; MATSUMURA M, 1979, NEUROSCI LETT, V11, P241, DOI 10.1016/0304-3940(79)90001-6; MOLL L, 1977, SCIENCE, V198, P317, DOI 10.1126/science.410103; MUAKKASSA KF, 1979, BRAIN RES, V177, P176, DOI 10.1016/0006-8993(79)90928-4; Murata A, 1997, J NEUROPHYSIOL, V78, P2226, DOI 10.1152/jn.1997.78.4.2226; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P147, DOI 10.1016/0166-4328(81)90053-X; RIZZOLATTI G, 1981, BEHAV BRAIN RES, V2, P125, DOI 10.1016/0166-4328(81)90052-8; SCHWARTZ AB, 1988, J NEUROSCI, V8, P2913; Shen LM, 1997, J NEUROPHYSIOL, V77, P1171, DOI 10.1152/jn.1997.77.3.1171; SOECHTING JF, 1992, ANNU REV NEUROSCI, V15, P167, DOI 10.1146/annurev.ne.15.030192.001123; WEINRICH M, 1982, J NEUROSCI, V2, P1329; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582	35	256	256	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1020	1025		10.1038/nn726	http://dx.doi.org/10.1038/nn726			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11547338				2022-12-24	WOS:000171325800016
J	Yamamoto, S; Kitazawa, S				Yamamoto, S; Kitazawa, S			Sensation at the tips of invisible tools	NATURE NEUROSCIENCE			English	Article									Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; Japan Sci & Technol Corp, PRESTO, Kawaguchi 3320012, Japan; Univ Tsukuba, Doctoral Program Med Sci, Tsukuba, Ibaraki 3058575, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); University of Tsukuba	Yamamoto, S (corresponding author), Natl Inst Adv Ind Sci & Technol, Neurosci Res Inst, 1-1-1 Umezono, Tsukuba, Ibaraki 3058568, Japan.		Yamamoto, Shinya/S-3134-2016	Yamamoto, Shinya/0000-0002-0505-8848				Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Iriki A, 1996, NEUROREPORT, V7, P2325; Paillard J., 1993, USE TOOLS HUMAN NONH, P36; RAMACHANDRAN VS, 1995, NATURE, V377, P489, DOI 10.1038/377489a0; RIGGIO L, 1986, ACTA PSYCHOL, V62, P89, DOI 10.1016/0001-6918(86)90006-5; Yamamoto S, 2001, NAT NEUROSCI, V4, P759, DOI 10.1038/89559	7	114	117	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					979	980		10.1038/nn721	http://dx.doi.org/10.1038/nn721			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11544483				2022-12-24	WOS:000171325800010
J	La Spada, AR; Fu, YH; Sopher, BL; Libby, RT; Wang, XJ; Li, LY; Einum, DD; Huang, J; Possin, DE; Smith, AC; Martinez, RA; Koszdin, KL; Treuting, PM; Ware, CB; Hurley, JB; Ptacek, LJ; Chen, SM				La Spada, AR; Fu, YH; Sopher, BL; Libby, RT; Wang, XJ; Li, LY; Einum, DD; Huang, J; Possin, DE; Smith, AC; Martinez, RA; Koszdin, KL; Treuting, PM; Ware, CB; Hurley, JB; Ptacek, LJ; Chen, SM			Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7	NEURON			English	Article							DOMINANT CEREBELLAR-ATAXIA; TRANSCRIPTION FACTOR NRL; NUCLEAR-LOCALIZATION; TRANSGENIC MICE; HOMEOBOX GENE; RETINAL DEGENERATION; HUNTINGTONS-DISEASE; LEUCINE-ZIPPER; PROTEIN; PHOTORECEPTOR	Spinocerebellar ataxia type 7 (SCA7) is an autosomal dominant disorder caused by a CAG repeat expansion. To determine the mechanism of neurotoxicity, we produced transgenic mice and observed a cone-rod dystrophy. Nuclear inclusions were present, suggesting that the disease pathway involves the nucleus. When yeast two-hybrid assays indicated that cone-rod homeobox protein (CRX) interacts with ataxin-7, we performed further studies to assess this interaction. We found that ataxin-7 and CRX colocalize and coimmunoprecipitate. We observed that polyglutamine-expanded ataxin-7 can dramatically suppress CRX transactivation. In SCA7 transgenic mice, electrophoretic mobility shift assays indicated reduced CRX binding activity, while RT-PCR analysis detected reductions in CRX-regulated genes. Our results suggest that CRX transcription interference accounts for the retinal degeneration in SCA7 and thus may provide an explanation for how cell-type specificity is achieved in this polyglutamine repeat disease.	Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Comparat Med, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Med Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Utah, Dept Anat & Neurobiol, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; Univ Washington, Med Ctr, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Washington University (WUSTL); Washington University (WUSTL); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	La Spada, AR (corresponding author), Univ Washington, Med Ctr, Dept Lab Med, Seattle, WA 98195 USA.		Alcaraz, Raul/L-7592-2014; La Spada, Albert/AAG-8809-2020; Treuting, Piper M./AAB-2721-2019	Alcaraz, Raul/0000-0002-0942-3638; Treuting, Piper M./0000-0002-1812-1519	NATIONAL EYE INSTITUTE [P30EY002687, R01EY012543, P30EY001730] Funding Source: NIH RePORTER; NEI NIH HHS [EY06641, EY12543, R01 EY012543, EY01730, EY02687] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Borchelt DR, 1996, GENET ANAL-BIOMOL E, V13, P159, DOI 10.1016/S1050-3862(96)00167-2; Chen SM, 1996, J BIOL CHEM, V271, P28549, DOI 10.1074/jbc.271.45.28549; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; David G, 1997, NAT GENET, V17, P65, DOI 10.1038/ng0997-65; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; ENEVOLDSON TP, 1994, BRAIN, V117, P445, DOI 10.1093/brain/117.3.445; Fernandez-Funez P, 2000, NATURE, V408, P101, DOI 10.1038/35040584; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Gibson UEM, 1996, GENOME RES, V6, P995, DOI 10.1101/gr.6.10.995; GOUW LG, 1994, NEUROLOGY, V44, P1441, DOI 10.1212/WNL.44.8.1441; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Huynh DP, 2000, NAT GENET, V26, P44, DOI 10.1038/79162; Kaytor MD, 1999, HUM MOL GENET, V8, P1657, DOI 10.1093/hmg/8.9.1657; Kleiman FE, 1999, SCIENCE, V285, P1576, DOI 10.1126/science.285.5433.1576; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Kumar R, 1996, J BIOL CHEM, V271, P29612, DOI 10.1074/jbc.271.47.29612; Lin X, 2000, NAT NEUROSCI, V3, P157, DOI 10.1038/72101; Lindenberg KS, 2000, BRAIN PATHOL, V10, P385; LIVAK KJ, 1995, PCR METH APPL, V4, P357; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Lyubarsky AL, 1999, J NEUROSCI, V19, P442, DOI 10.1523/JNEUROSCI.19-01-00442.1999; MARTIN JJ, 1994, ACTA NEUROPATHOL, V88, P277; Mauger C, 1999, MOL BRAIN RES, V74, P35, DOI 10.1016/S0169-328X(99)00256-9; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Mitton KP, 2000, J BIOL CHEM, V275, P29794, DOI 10.1074/jbc.M003658200; Moore D.D., 1987, CURRENT PROTOCOLS MO; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Paulson HL, 2000, P NATL ACAD SCI USA, V97, P12957, DOI 10.1073/pnas.210395797; PITTLER SJ, 1991, P NATL ACAD SCI USA, V88, P8322, DOI 10.1073/pnas.88.19.8322; Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; SIEBERT PD, 1992, NATURE, V359, P557, DOI 10.1038/359557a0; SOPHER BL, 1992, J BIOL CHEM, V267, P6178; Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7; TO KW, 1993, OPHTHALMOLOGY, V100, P15; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Yvert G, 2000, HUM MOL GENET, V9, P2491, DOI 10.1093/hmg/9.17.2491; Zack DJ, 2000, NEURON, V26, P285, DOI 10.1016/S0896-6273(00)81160-5; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	46	175	179	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	SEP 27	2001	31	6					913	927		10.1016/S0896-6273(01)00422-6	http://dx.doi.org/10.1016/S0896-6273(01)00422-6			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580893	Bronze			2022-12-24	WOS:000171281300008
J	Wagner, AD; Pare-Blagoev, EJ; Clark, J; Poldrack, RA				Wagner, AD; Pare-Blagoev, EJ; Clark, J; Poldrack, RA			Recovering meaning: Left prefrontal cortex guides controlled semantic retrieval	NEURON			English	Article							POSITRON-EMISSION-TOMOGRAPHY; SURFACE-BASED ANALYSIS; VERBAL WORKING-MEMORY; FRONTAL-CORTEX; FUNCTIONAL MRI; REPETITION; SPECIALIZATION; ACTIVATION; GENERATION; KNOWLEDGE	Prefrontal cortex plays a central role in mnemonic control, with left inferior prefrontal cortex (LIPC) mediating control of semantic knowledge. One prominent theory posits that LIPC does not mediate semantic retrieval per se, but rather subserves the selection of task-relevant knowledge from amidst competing knowledge. The present event-related fMRl study provides evidence for an alternative hypothesis: LIPC guides controlled semantic retrieval irrespective of whether retrieval requires selection against competing representations. With selection demands held constant, LIPC activation increased with semantic retrieval demands and with the level of control required during retrieval. LIPC mediates a top-down bias signal that is recruited to the extent that the recovery of meaning demands controlled retrieval. Selection may reflect a specific instantiation of this mechanism.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA; Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University	Wagner, AD (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.	awagner@psyche.mit.edu		Wagner, Anthony/0000-0003-0624-4543				Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Awh E, 1996, PSYCHOL SCI, V7, P25, DOI 10.1111/j.1467-9280.1996.tb00662.x; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; Bokde ALW, 2001, NEURON, V30, P609, DOI 10.1016/S0896-6273(01)00288-4; Buckner RL, 1996, PSYCHON B REV, V3, P149, DOI 10.3758/BF03212413; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen JD, 1996, PHILOS T R SOC B, V351, P1515, DOI 10.1098/rstb.1996.0138; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; DAVACHI L, 2001, IN PRESS J COGN NEUR; DEMB JB, 1995, J NEUROSCI, V15, P5870; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fiez JA, 1996, J NEUROSCI, V16, P808; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; FUSTER JM, 1997, PREFRONTAL CORTEX; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GoldmanRakic PS, 1995, ANN NY ACAD SCI, V769, P71, DOI 10.1111/j.1749-6632.1995.tb38132.x; Jonides J, 1998, P NATL ACAD SCI USA, V95, P8410, DOI 10.1073/pnas.95.14.8410; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Koutstaal W, 2001, NEUROPSYCHOLOGIA, V39, P184, DOI 10.1016/S0028-3932(00)00087-7; Kucera H., 1967, COMPUTATIONAL ANAL P; MARTIN A, 1995, SCIENCE, V270, P102, DOI 10.1126/science.270.5233.102; MARTIN A, 2001, IN PRESS CURR OPIN N; MILLER EK, 2001, IN PRESS ANN REV NEU; Norman D. A., 1986, CONSCIOUSNESS SELF R, VIV, P1, DOI 10.1007/978-1-4757-0629-1_1; Owen AM, 1997, EUR J NEUROSCI, V9, P1329, DOI 10.1111/j.1460-9568.1997.tb01487.x; Passingham RE, 2000, EXP BRAIN RES, V133, P103, DOI 10.1007/s002210000405; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Petrides M, 1996, PHILOS T ROY SOC B, V351, P1455, DOI 10.1098/rstb.1996.0130; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Postman L., 1970, NORMS WORD ASS; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shimamura Arthur P., 1995, P803; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Swick D, 1998, COGNITIVE BRAIN RES, V7, P143, DOI 10.1016/S0926-6410(98)00019-6; Thompson-Schill SL, 1999, NEURON, V23, P513, DOI 10.1016/S0896-6273(00)80804-1; Thompson-Schill SL, 1998, P NATL ACAD SCI USA, V95, P15855, DOI 10.1073/pnas.95.26.15855; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Vandenberghe R, 1996, NATURE, V383, P254, DOI 10.1038/383254a0; Wagner AD, 2000, J COGNITIVE NEUROSCI, V12, P52, DOI 10.1162/089892900564064; Wagner AD, 1998, NEUROREPORT, V9, P3711, DOI 10.1097/00001756-199811160-00026; Wagner AD, 1997, J COGNITIVE NEUROSCI, V9, P714, DOI 10.1162/jocn.1997.9.6.714; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wagner AD, 2000, CEREB CORTEX, V10, P1176, DOI 10.1093/cercor/10.12.1176; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WAGNER AD, 2001, NEUROPSYCHOLOGY MEMO	58	707	715	1	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 2	2001	31	2					329	338		10.1016/S0896-6273(01)00359-2	http://dx.doi.org/10.1016/S0896-6273(01)00359-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	459XX	11502262	Bronze			2022-12-24	WOS:000170277700016
J	Tsunoda, K; Yamane, Y; Nishizaki, M; Tanifuji, M				Tsunoda, K; Yamane, Y; Nishizaki, M; Tanifuji, M			Complex objects are represented in macaque inferotemporal cortex by the combination of feature columns	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; VENTRAL VISUAL PATHWAY; FUNCTIONAL ARCHITECTURE; MONKEY; NEURONS; ORGANIZATION; SELECTIVITY; RECOGNITION; RESPONSES; FACES	Intrinsic signal imaging from inferotemporal (IT) cortex, a visual area essential for object perception and recognition, revealed that visually presented objects activated patches in a distributed manner. When visual features of these objects were partially removed, the simplified stimuli activated only a subset of the patches elicited by the originals. This result, in conjunction with extracellular recording, suggests that an object is represented by a combination of cortical columns, each of which represents a visual feature (feature column). Simplification of an object occasionally caused the appearance of columns that were not active when viewing the more complex form. Thus, not all the columns related to a particular feature were necessarily activated by the original objects. Taken together, these results suggest that objects may be represented not only by simply combining feature columns but also by using a variety of combinations of active and inactive columns for individual features.	RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Integrat Neural Syst, Wako, Saitama 3510198, Japan; Hokkaido Univ, Grad Sch Sci, Div Biol Sci, Sapporo, Hokkaido 0600810, Japan	RIKEN; Hokkaido University	Tanifuji, M (corresponding author), RIKEN, Inst Phys & Chem Res, Brain Sci Inst, Lab Integrat Neural Syst, Hirosawa 2-1, Wako, Saitama 3510198, Japan.		Tanifuji, Manabu/H-1744-2019	Tanifuji, Manabu/0000-0001-7754-7774; yamane, yukako/0000-0002-3348-1942				BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; DESIMONE R, 1984, J NEUROSCI, V4, P2051; Edelman S, 1998, PSYCHOBIOLOGY, V26, P309; Erickson CA, 1999, J NEUROSCI, V19, P10404; FUJITA I, 1992, NATURE, V360, P343, DOI 10.1038/360343a0; Ghose GM, 1997, J NEUROPHYSIOL, V77, P2191, DOI 10.1152/jn.1997.77.4.2191; GOCHIN PM, 1991, EXP BRAIN RES, V84, P505; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HASSELMO ME, 1989, EXP BRAIN RES, V75, P417; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; KOBATAKE E, 1994, J NEUROPHYSIOL, V71, P856, DOI 10.1152/jn.1994.71.3.856; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; MARR D, 1978, PROC R SOC SER B-BIO, V200, P269, DOI 10.1098/rspb.1978.0020; PERRETT DI, 1982, EXP BRAIN RES, V47, P329; ROE AW, 1995, J NEUROSCI, V15, P3689; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shtoyerman E, 2000, J NEUROSCI, V20, P8111; TANAKA K, 1991, J NEUROPHYSIOL, V66, P170, DOI 10.1152/jn.1991.66.1.170; TSO DY, 1990, SCIENCE, V249, P417, DOI 10.1126/science.2165630; Uchida N, 2000, NAT NEUROSCI, V3, P1035, DOI 10.1038/79857; Ullman S, 1999, NEURAL NETWORKS, V12, P1021, DOI 10.1016/S0893-6080(99)00048-9; Wang G, 1998, NEUROSCI RES, V32, P33, DOI 10.1016/S0168-0102(98)00062-5; Wang G, 1996, SCIENCE, V272, P1665, DOI 10.1126/science.272.5268.1665; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; YAMANE S, 1988, EXP BRAIN RES, V73, P209, DOI 10.1007/BF00279674	28	271	277	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					832	838		10.1038/90547	http://dx.doi.org/10.1038/90547			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477430				2022-12-24	WOS:000170137300017
J	Breiter, HC; Aharon, I; Kahneman, D; Dale, A; Shizgal, P				Breiter, HC; Aharon, I; Kahneman, D; Dale, A; Shizgal, P			Functional imaging of neural responses to expectancy and experience of monetary gains and losses	NEURON			English	Article							MIDBRAIN DOPAMINE NEURONS; ORBITOFRONTAL CORTEX; BASOLATERAL AMYGDALA; NUCLEUS-ACCUMBENS; SELF-STIMULATION; HUMAN BRAIN; FACIAL EXPRESSIONS; VENTRAL STRIATUM; REWARD; BEHAVIOR	Neural responses accompanying anticipation and experience of monetary gains and losses were monitored by functional magnetic resonance imaging. Trials comprised an initial "prospect" (expectancy) phase, when a set of three monetary amounts was displayed, and a subsequent "outcome" phase, when one of these amounts was awarded. Hemodynamic responses in the sublenticular extended amygdala (SLEA) and orbital gyrus tracked the expected values of the prospects, and responses to the highest value set of outcomes increased monotonically with monetary value in the nucleus accumbens, SLEA, and hypothalamus. Responses to prospects and outcomes were generally, but not always, seen in the same regions. The overlap of the observed activations with those seen previously in response to tactile stimuli, gustatory stimuli, and euphoria-inducing drugs is consistent with a contribution of common circuitry to the processing of diverse rewards.	Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Ctr, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Radiol, MGH NMR Ctr, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Concordia Univ, Ctr Studies Behav Neurobiol, Montreal, PQ H3G 1M8, Canada; Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Concordia University - Canada; Princeton University	Breiter, HC (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Ctr, Charlestown, MA 02129 USA.	hbreiter@partners.org	Dale, Anders M/A-5180-2010; Shizgal, Peter/V-5602-2019; Shizgal, Peter/H-9823-2013	Shizgal, Peter/0000-0003-4265-0792; 	NCRR NIH HHS [R01-RR13609, P41-RR14075] Funding Source: Medline; NINDS NIH HHS [R01-NS39581] Funding Source: Medline; PHS HHS [09467, 00265] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075, R01RR013609] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039581] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arvanitogiannis A, 1996, PHYSIOL BEHAV, V59, P795, DOI 10.1016/0031-9384(95)02157-4; Arvanitogiannis A, 2000, BEHAV BRAIN RES, V107, P123, DOI 10.1016/S0166-4328(99)00120-5; BECERRA L, 2000, AM PAIN SOC ATL GA; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; BLACKBURN JR, 1992, PROG NEUROBIOL, V39, P247, DOI 10.1016/0301-0082(92)90018-A; BORDI F, 1992, J NEUROSCI, V12, P2493; BORSOOK D, 2000, AM PAIN SOC ATL GA; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Breiter H.C., 1996, NEUROIMAGE, V3, pS220, DOI 10.1016/S1053-8119(96)80222-9; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BREITER HC, 1998, INT SOC MAGN RES MED; BREITER HC, 2000, AM PAIN SOC ATL GA; Brown VJ, 1996, BRAIN RES BULL, V39, P163, DOI 10.1016/0361-9230(95)02088-8; BUSH G, 1996, 2 INT C FUNCT MAPP H; Carlezon WA, 1996, J NEUROSCI, V16, P3112; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Dale AM, 1997, HUM BRAIN MAPP, V5, P329, DOI 10.1002/(SICI)1097-0193(1997)5:5<329::AID-HBM1>3.0.CO;2-5; Damasio A.R., 1994, DESCARTES ERROR EMOT; DAVIDSON RJ, 1995, CURR OPIN NEUROBIOL, V5, P217, DOI 10.1016/0959-4388(95)80029-8; Davidson RJ, 1998, COGNITION EMOTION, V12, P307, DOI 10.1080/026999398379628; DAVIS M, 1992, P255; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVERITT B J, 1992, P401; EVERITT BJ, 1991, NEUROSCIENCE, V42, P1, DOI 10.1016/0306-4522(91)90145-E; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Flores C, 1997, BEHAV BRAIN RES, V87, P239, DOI 10.1016/S0166-4328(97)02288-2; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; Guarraci FA, 1999, BEHAV BRAIN RES, V99, P169, DOI 10.1016/S0166-4328(98)00102-8; Hauber W, 2000, J NEUROSCI, V20, P6282, DOI 10.1523/JNEUROSCI.20-16-06282.2000; Heimer L, 1997, NEUROSCIENCE, V76, P957, DOI 10.1016/S0306-4522(96)00405-8; Hoaglin D.C., 1983, UNDERSTANDING ROBUST; Hollerman JR, 1998, J NEUROPHYSIOL, V80, P947, DOI 10.1152/jn.1998.80.2.947; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; IGLEWICZ B, 1983, UNDERSTANDING ROBUST, P404; JIANG A, 1995, HUM BRAIN MAPP, V3, P1; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; KAPP B S, 1992, P229; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; LEDOUX J E, 1992, P339; LeDoux J. E., 1996, EMOTIONAL BRAIN; LEDOUX JE, 1994, SCI AM, V270, P50, DOI 10.1038/scientificamerican0694-50; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; LINDVALL O, 1974, ACTA PHYSIOL SCAND, P1; LYNDBALTA E, 1994, NEUROSCIENCE, V59, P609, DOI 10.1016/0306-4522(94)90181-3; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Mellers BA, 1997, PSYCHOL SCI, V8, P423, DOI 10.1111/j.1467-9280.1997.tb00455.x; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; MORA F, 1977, BRAIN RES, V133, P267, DOI 10.1016/0006-8993(77)90763-6; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Nakahara D, 1999, NEUROSCIENCE, V90, P1013, DOI 10.1016/S0306-4522(98)00510-7; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; ONO T, 1981, NEUROSCI LETT, V21, P99, DOI 10.1016/0304-3940(81)90065-3; ONO T, 1986, J NEUROPHYSIOL, V56, P63, DOI 10.1152/jn.1986.56.1.63; PFAUS JG, 1990, BRAIN RES, V530, P345, DOI 10.1016/0006-8993(90)91309-5; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Reese TG, 1995, JMRI-J MAGN RESON IM, V5, P739, DOI 10.1002/jmri.1880050621; Regan D., 1989, HUMAN BRAIN ELECTROP; Richardson NR, 1996, J NEUROSCI, V16, P8160; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; ROLLS ET, 1976, BRAIN RES, V111, P53, DOI 10.1016/0006-8993(76)91048-9; ROLLS ET, 1999, BRAIN EMOTION; Schoenbaum G, 1998, NAT NEUROSCI, V1, P155, DOI 10.1038/407; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schoenbaum G, 2000, J NEUROSCI, V20, P5179; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; SCHULTZ W, 1990, J NEUROPHYSIOL, V63, P607, DOI 10.1152/jn.1990.63.3.607; SCHULTZ W, 1992, J NEUROSCI, V12, P4595, DOI 10.1523/jneurosci.12-12-04595.1992; SCHULTZ W, 1993, J NEUROSCI, V13, P900; SCHULTZ W, 1986, J NEUROPHYSIOL, V56, P1439, DOI 10.1152/jn.1986.56.5.1439; Scott T. R., 1995, Neurobiology (Budapest), V3, P281; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; SMALL DM, 2001, IN PRESS BRAIN; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; Tremblay L, 1999, NATURE, V398, P704, DOI 10.1038/19525; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILSON FAW, 1990, J NEUROSCI, V10, P1254; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	96	936	954	4	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					619	639		10.1016/S0896-6273(01)00303-8	http://dx.doi.org/10.1016/S0896-6273(01)00303-8			21	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	436XW	11395019	Bronze			2022-12-24	WOS:000168962000030
J	Miki, T; Liss, B; Minami, K; Shiuchi, T; Saraya, A; Kashima, Y; Horiuchi, M; Ashcroft, F; Minokoshi, Y; Roeper, J; Seino, S				Miki, T; Liss, B; Minami, K; Shiuchi, T; Saraya, A; Kashima, Y; Horiuchi, M; Ashcroft, F; Minokoshi, Y; Roeper, J; Seino, S			ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis	NATURE NEUROSCIENCE			English	Article							POTASSIUM CHANNELS; VENTROMEDIAL HYPOTHALAMUS; SULFONYLUREA RECEPTOR; BODY-WEIGHT; FOOD-INTAKE; GLUCAGON-SECRETION; HORMONE-RELEASE; SKELETAL-MUSCLE; RAT-BRAIN; NEURONS	Glucose-responsive (GR) neurons in the hypothalamus are thought to be critical in glucose homeostasis, but it is not known how they function in this context. Kir6.2 is the pore-forming subunit of K-ATP channels in many cell types, including pancreatic beta -cells and heart. Here we show the complete absence of both functional ATP-sensitive K+ (K-ATP) channels and glucose responsiveness in the neurons of the ventromedial hypothalamus (VMH) in Kir6.2(-/-) mice. Although pancreatic alpha -cells were functional in Kir6.2(-/-), the mice exhibited a severe defect in glucagon secretion in response to systemic hypoglycemia. In addition, they showed a complete loss of glucagon secretion, together with reduced food intake in response to neuroglycopenia. Thus, our results demonstrate that K-ATP channels are important in glucose sensing in VMH GR neurons, and are essential for the maintenance of glucose homeostasis.	Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; Univ Oxford, MRC, Anat Neuropharmacol Unit, Oxford OX1 3TH, England; Ehime Univ, Sch Med, Dept Biochem Med, Matsuyama, Ehime 7910295, Japan; Univ Oxford, Univ Lab Physiol, Oxford OX1 3TH, England	Chiba University; University of Oxford; Ehime University; University of Oxford	Seino, S (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan.		MIKI, Takashi/ABD-3995-2020; Shiuchi, Tetsuya/AAG-7620-2020	MIKI, Takashi/0000-0001-5741-1626; Shiuchi, Tetsuya/0000-0002-3027-5465; Roeper, Jochen/0000-0003-2145-8742; liss, Birgit/0000-0002-6733-9207; Minokoshi, Yasuhiko/0000-0002-7119-4805; Minami, Kohtaro/0000-0003-4698-6250				Aguilar-Bryan L, 1999, ENDOCR REV, V20, P101, DOI 10.1210/er.20.2.101; AMOROSO S, 1990, SCIENCE, V247, P852, DOI 10.1126/science.2305257; Ashcroft FM, 1998, TRENDS NEUROSCI, V21, P288, DOI 10.1016/S0166-2236(98)01225-9; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; ASHFORD MLJ, 1988, PFLUG ARCH EUR J PHY, V412, P297, DOI 10.1007/BF00582512; ASHFORD MLJ, 1990, PFLUG ARCH EUR J PHY, V415, P479, DOI 10.1007/BF00373626; ASHFORD MLJ, 1990, BRIT J PHARMACOL, V101, P531, DOI 10.1111/j.1476-5381.1990.tb14116.x; Bergen HT, 1996, BRAIN RES, V734, P332, DOI 10.1016/0006-8993(96)00887-6; BERNARDI H, 1993, P NATL ACAD SCI USA, V90, P1340, DOI 10.1073/pnas.90.4.1340; Bokvist K, 1999, PFLUG ARCH EUR J PHY, V438, P428, DOI 10.1007/s004240051058; Borg MA, 1999, DIABETES, V48, P584, DOI 10.2337/diabetes.48.3.584; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; BORG WP, 1994, J CLIN INVEST, V93, P1677, DOI 10.1172/JCI117150; BORG WP, 1995, DIABETES, V44, P180, DOI 10.2337/diabetes.44.2.180; Chutkow WA, 1999, J BIOL CHEM, V274, P13656, DOI 10.1074/jbc.274.19.13656; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; Dunn-Meynell AA, 1998, BRAIN RES, V814, P41, DOI 10.1016/S0006-8993(98)00956-1; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Karschin A, 1998, J PHYSIOL-LONDON, V509, P339, DOI 10.1111/j.1469-7793.1998.339bn.x; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; Lee K, 1999, J PHYSIOL-LONDON, V515, P439, DOI 10.1111/j.1469-7793.1999.439ac.x; LELOUP C, 1994, BRAIN RES, V638, P221, DOI 10.1016/0006-8993(94)90653-X; Levin BE, 1999, AM J PHYSIOL-REG I, V276, pR1223; Liss B, 1999, EMBO J, V18, P833, DOI 10.1093/emboj/18.4.833; Lynch RM, 2000, DIABETES, V49, P693, DOI 10.2337/diabetes.49.5.693; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Miki T, 1998, P NATL ACAD SCI USA, V95, P10402, DOI 10.1073/pnas.95.18.10402; MINAMI T, 1986, J PHYSIOL-LONDON, V380, P127, DOI 10.1113/jphysiol.1986.sp016276; MULLER EE, 1971, LIFE SCI, V10, P1057, DOI 10.1016/0024-3205(71)90180-9; OHNOSHOSAKU T, 1992, PFLUG ARCH EUR J PHY, V422, P260, DOI 10.1007/BF00376211; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; ROPER J, 1995, PFLUG ARCH EUR J PHY, V430, P44, DOI 10.1007/BF00373838; Sakura H, 1995, FEBS LETT, V377, P338, DOI 10.1016/0014-5793(95)01369-5; Salehi A, 1999, J PHYSIOL-LONDON, V514, P579, DOI 10.1111/j.1469-7793.1999.579ae.x; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Silver IA, 1998, J NEUROPHYSIOL, V79, P1733, DOI 10.1152/jn.1998.79.4.1733; Spanswick D, 1997, NATURE, V390, P521, DOI 10.1038/37379; SPRUCE AE, 1985, NATURE, V316, P736, DOI 10.1038/316736a0; STEFFENS AB, 1990, NEUROSCI BIOBEHAV R, V14, P305, DOI 10.1016/S0149-7634(05)80040-5; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Suzuki M, 1997, DIABETES, V46, P1440, DOI 10.2337/diabetes.46.9.1440; Taborsky GJ, 1998, DIABETES, V47, P995, DOI 10.2337/diabetes.47.7.995; TERZIC A, 1995, AM J PHYSIOL-CELL PH, V269, pC525, DOI 10.1152/ajpcell.1995.269.3.C525; Yang XJ, 1999, DIABETES, V48, P1763, DOI 10.2337/diabetes.48.9.1763; Zawar C, 1999, J PHYSIOL-LONDON, V514, P327	50	415	426	0	21	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					507	512		10.1038/87455	http://dx.doi.org/10.1038/87455			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319559				2022-12-24	WOS:000168412600014
J	Aizawa, H; Wakatsuki, S; Ishii, A; Moriyama, K; Sasaki, Y; Ohashi, K; Sekine-Aizawa, Y; Sehara-Fujisawa, A; Mizuno, K; Goshima, Y; Yahara, I				Aizawa, H; Wakatsuki, S; Ishii, A; Moriyama, K; Sasaki, Y; Ohashi, K; Sekine-Aizawa, Y; Sehara-Fujisawa, A; Mizuno, K; Goshima, Y; Yahara, I			Phosphorylation of cofilin by LIM-kinase is necessary for semaphorin 3A-induced growth cone collapse	NATURE NEUROSCIENCE			English	Article							ACTIN-DEPOLYMERIZING FACTOR; RETROGRADE AXOPLASMIC-TRANSPORT; ARP2/3 COMPLEX; PROTEIN; CYTOSKELETON; FILAMENTS; DYNAMICS; FAMILY; WASP; ADF/COFILIN	Semaphorin 3A is a chemorepulsive axonal guidance molecule that depolymerizes the actin cytoskeleton and collapses growth cones of dorsal root ganglia neurons. Here we investigate! the role of LIM-kinase 1, which phosphorylates an actin-depolymerizimg protein, cofilin, in semaphorin 3A-induced growth cone collapse. Semaphorin 3A induced phosphorylation and dephosphorylation of cofilin at growth cones sequentially. A synthetic cell-permeable peptide containing a cofilin phosphorylation site inhibited LIM-kinase in vitro and in vivo, and essentially suppressed semaphorin 3A-induced growth cone collapse. A dominant-negative LIM kinase, which could not be activated by PAK or ROCK, suppressed the collapsing activity of semaphorin 3A. Phosphorylation of cofilin by LIM-kinase may be a critical signaling event in growth cone collapse by semaphorin 3A.	Tokyo Metropolitan Inst Med Sci, Dept Cell Biol, Bunkyo Ku, Tokyo 1138613, Japan; Yokohama City Univ, Sch Med, Dept Pharmacol, Yokohama, Kanagawa 2360004, Japan; Tohoku Univ, Grad Sch Sci, Inst Biol, Sendai, Miyagi 9808578, Japan; RIKEN, Brain Sci Inst, Lab Proteolyt Neurosci, Wako, Saitama 3510198, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi 3320012, Japan	Tokyo Metropolitan Institute of Medical Science; Yokohama City University; Tohoku University; RIKEN; Japan Science & Technology Agency (JST)	Aizawa, H (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.	aizawa@rr.iij4u.or.jp	Mizuno, Kensaku/G-8631-2015; Ohashi, Kazumasa/U-7028-2019; Sasaki, Yukio/P-7662-2015	Ohashi, Kazumasa/0000-0001-7617-403X; Sasaki, Yukio/0000-0001-6143-7001				Abe H, 1996, J CELL BIOL, V132, P871, DOI 10.1083/jcb.132.5.871; AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Aizawa H, 1996, J CELL BIOL, V132, P335, DOI 10.1083/jcb.132.3.335; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bailly M, 1999, J CELL BIOL, V145, P331, DOI 10.1083/jcb.145.2.331; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; BAMBURG JR, 1987, J CELL BIOL, V105, P2817, DOI 10.1083/jcb.105.6.2817; Beckerle MC, 1998, CELL, V95, P741, DOI 10.1016/S0092-8674(00)81697-9; Byk T, 1996, J NEUROSCI, V16, P688; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Edwards DC, 1999, J BIOL CHEM, V274, P11352, DOI 10.1074/jbc.274.16.11352; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; Goshima Y, 1999, J NEUROBIOL, V39, P579, DOI 10.1002/(SICI)1097-4695(19990615)39:4<579::AID-NEU11>3.0.CO;2-9; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Goshima Y, 1997, J NEUROBIOL, V33, P316, DOI 10.1002/(SICI)1097-4695(199709)33:3<316::AID-NEU9>3.0.CO;2-4; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; IIDA K, 1993, GENE, V124, P115; Jin Z, 1997, J NEUROSCI, V17, P6256; Kuhn TB, 1999, J NEUROSCI, V19, P1965; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Machesky LM, 1999, NAT CELL BIOL, V1, pE29, DOI 10.1038/10020; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MINTURN JE, 1995, J NEUROSCI, V15, P6757; MOON AL, 1993, J CELL BIOL, V120, P421, DOI 10.1083/jcb.120.2.421; Moriyama K, 1999, EMBO J, V18, P6752, DOI 10.1093/emboj/18.23.6752; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; PANTALONI D, 1993, CELL, V75, P1007, DOI 10.1016/0092-8674(93)90544-Z; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Prochiantz A, 1996, CURR OPIN NEUROBIOL, V6, P629, DOI 10.1016/S0959-4388(96)80095-X; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rosenblatt J, 1998, NATURE, V393, P739, DOI 10.1038/31597; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tassabehji M, 1996, NAT GENET, V13, P272, DOI 10.1038/ng0796-272; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Vastrik I, 1999, CURR BIOL, V9, P991, DOI 10.1016/S0960-9822(99)80447-3; Welch MD, 1997, NATURE, V385, P265, DOI 10.1038/385265a0; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YONEZAWA N, 1990, J BIOL CHEM, V265, P8382	47	288	294	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					367	373		10.1038/86011	http://dx.doi.org/10.1038/86011			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276226				2022-12-24	WOS:000168762200016
J	Lee, A; Westenbroek, RE; Haeseleer, F; Palczewski, K; Scheuer, T; Catterall, WA				Lee, A; Westenbroek, RE; Haeseleer, F; Palczewski, K; Scheuer, T; Catterall, WA			Differential modulation of Ca(v)2.1 channels by calmodulin and Ca2+-binding protein 1	NATURE NEUROSCIENCE			English	Article							PRESYNAPTIC CALCIUM CURRENT; BETA-GAMMA-SUBUNITS; RAT BRAIN-STEM; CA2+ CHANNELS; N-TYPE; SUBCELLULAR-DISTRIBUTION; ALPHA(1A) SUBUNITS; FACILITATION; INACTIVATION; SYNTAXIN	Ca(v)2.1 channels, which mediate P/Q-type Ca2+ currents, undergo Ca2+/calmodulin (CaM) dependent inactivation and facilitation that can significantly alter synaptic efficacy. Here we report that the neuronal Ca2+-binding protein 1 (CaBP1) modulates Ca(v)2.1 channels in a manner that is markedly different from modulation by CaM. CaBP1 enhances inactivation, causes a depolarizing shift in the voltage dependence of activation, and does not support Ca2+-dependent facilitation of Ca(v)2.1 channels. These inhibitory effects of CaBP1 do not require Ca2+, but depend on the CaM-binding domain in the alpha(1) subunit of Ca(v)2.1 channels (alpha(1)2.1). CaBP1 binds to the CaM-binding domain, co-immunoprecipitates with alpha(1)2.1 from transfected cells and brain extracts, and colocalizes with alpha(1)2.1 in discrete microdomains of neurons in the hippocampus and cerebellum. Our results identify an interaction between Ca2+ channels and CaBP1 that may regulate Ca2+-dependent forms of synaptic plasticity by inhibiting Ca2+ influx into neurons.	Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Ophthalmol, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Chem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Catterall, WA (corresponding author), Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA.			Lee, Amy/0000-0001-8021-0443	NATIONAL EYE INSTITUTE [R01EY008061] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS010645, R01NS022625] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY08061, R01 EY008061] Funding Source: Medline; NINDS NIH HHS [F32 NS010645, R01 NS22625, R01 NS022625, F32 NS10645] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Borst JGG, 1998, J PHYSIOL-LONDON, V513, P149, DOI 10.1111/j.1469-7793.1998.149by.x; Burgoyne RD, 2001, BIOCHEM J, V353, P1; Catterall WA, 1998, CELL CALCIUM, V24, P307, DOI 10.1016/S0143-4160(98)90055-0; CHAO SH, 1984, MOL PHARMACOL, V26, P75; Chen XL, 2001, J PHYSIOL-LONDON, V532, P649, DOI 10.1111/j.1469-7793.2001.0649e.x; Cuttle MF, 1998, J PHYSIOL-LONDON, V512, P723, DOI 10.1111/j.1469-7793.1998.723bd.x; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; DeWaard M, 1997, NATURE, V385, P446, DOI 10.1038/385446a0; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Forsythe ID, 1998, NEURON, V20, P797, DOI 10.1016/S0896-6273(00)81017-X; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; GREENLEE DV, 1982, BIOCHEMISTRY-US, V21, P2759, DOI 10.1021/bi00540a028; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Haeseleer F, 2000, J BIOL CHEM, V275, P1247, DOI 10.1074/jbc.275.2.1247; Herlitze S, 1996, NATURE, V380, P258, DOI 10.1038/380258a0; Ikeda SR, 1996, NATURE, V380, P255, DOI 10.1038/380255a0; Lee A, 2000, J NEUROSCI, V20, P6830, DOI 10.1523/JNEUROSCI.20-18-06830.2000; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; MILLER RJ, 1987, SCIENCE, V235, P46, DOI 10.1126/science.2432656; Pate P, 2000, J BIOL CHEM, V275, P39786, DOI 10.1074/jbc.M007158200; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Rodney GG, 2000, BIOCHEMISTRY-US, V39, P7807, DOI 10.1021/bi0005660; Rudnicka-Nawrot M, 1998, BIOCHEMISTRY-US, V37, P248, DOI 10.1021/bi972306x; Sakurai T, 1996, J CELL BIOL, V134, P511, DOI 10.1083/jcb.134.2.511; Sallese M, 2000, FASEB J, V14, P2569, DOI 10.1096/fj.00-0072com; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Seidenbecher CI, 1998, J BIOL CHEM, V273, P21324, DOI 10.1074/jbc.273.33.21324; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Weiss JL, 2000, J BIOL CHEM, V275, P40082, DOI 10.1074/jbc.M008603200; WESTENBROEK RE, 1995, J NEUROSCI, V15, P6403; WHEELER DB, 1994, SCIENCE, V264, P107, DOI 10.1126/science.7832825; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; YAMAKI T, 1980, BIOCHEM BIOPH RES CO, V94, P727, DOI 10.1016/0006-291X(80)91293-0; Zhong HJ, 1999, NAT NEUROSCI, V2, P939, DOI 10.1038/14721; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	39	148	154	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					210	217		10.1038/nn805	http://dx.doi.org/10.1038/nn805			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865310	Green Accepted			2022-12-24	WOS:000174146000010
J	Christensen, M; Estevez, A; Yin, XY; Fox, R; Morrison, R; McDonnell, M; Gleason, C; Miller, DM; Strange, K				Christensen, M; Estevez, A; Yin, XY; Fox, R; Morrison, R; McDonnell, M; Gleason, C; Miller, DM; Strange, K			A primary culture system for functional analysis of C-elegans neurons and muscle cells	NEURON			English	Article							HEAVY-CHAIN ISOFORMS; DOUBLE-STRANDED-RNA; CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; HOMEODOMAIN PROTEIN; CALCIUM TRANSIENTS; DROSOPHILA; EXPRESSION; UNC-4; MYOSIN	C. elegans has provided important insights into neuromuscular system function and development. However, the animal's small size limits access to individual neurons and muscle cells for physiological, biochemical, and molecular study. We describe here primary culture methods that allow C. elegans embryonic cells to differentiate into neurons and muscle cells in vitro. Morphological, electrophysiological, and GFP reporter studies demonstrate that the differentiation and functional properties of cultured cells are similar to those observed in vivo. Enriched populations of cells expressing specific GFP reporters can be generated by fluorescence-activated cell sorting. Addition of double-stranded RNA to the culture medium induces dramatic knockdown of targeted gene expression. Primary nematode cell culture provides a new foundation for a wide variety of experimental opportunities heretofore unavailable in the field.	Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Cell Biol, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Physiol & Mol Biophys, Nashville, TN 37232 USA; Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Strange, K (corresponding author), Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA.	kevin.strange@mcmail.vanderbilt.edu			NCI NIH HHS [CA68485] Funding Source: Medline; NCRR NIH HHS [S10 RR15682] Funding Source: Medline; NICHD NIH HHS [T32 HD007502] Funding Source: Medline; NIDDK NIH HHS [P01 DK58212, R01 DK51610, R21 DK60829, DK20593] Funding Source: Medline; NINDS NIH HHS [R01 NS26511] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015682] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, P01DK058212, P30DK020593, R21DK060829, R01DK051610] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Bloom L., 1993, THESIS MIT CAMBRIDGE; Bosher JM, 2000, NAT CELL BIOL, V2, pE31, DOI 10.1038/35000102; BRENNER S, 1974, GENETICS, V77, P71; Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398; CAMARDO J, 1983, J NEUROSCI, V3, P2614; Caplen NJ, 2000, GENE, V252, P95, DOI 10.1016/S0378-1119(00)00224-9; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Christensen M, 2001, J BIOL CHEM, V276, P45024, DOI 10.1074/jbc.M107652200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Edgar LG, 1995, METHOD CELL BIOL, V48, P303; EPSTEIN HF, 1974, J MOL BIOL, V90, P291, DOI 10.1016/0022-2836(74)90374-X; Fei YJ, 2000, J BIOL CHEM, V275, P9563, DOI 10.1074/jbc.275.13.9563; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; GOSSETT LA, 1982, CELL, V30, P193, DOI 10.1016/0092-8674(82)90025-3; HAMELIN M, 1992, EMBO J, V11, P2885, DOI 10.1002/j.1460-2075.1992.tb05357.x; HUANG MX, 1994, NATURE, V367, P467, DOI 10.1038/367467a0; Kerr R, 2000, NEURON, V26, P583, DOI 10.1016/S0896-6273(00)81196-4; Khatchatouriants A, 2000, BIOPHYS J, V79, P2345, DOI 10.1016/S0006-3495(00)76480-0; Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Liu LX, 1999, GENOME RES, V9, P859, DOI 10.1101/gr.9.9.859; Lockery SR, 1998, METHOD ENZYMOL, V293, P201; MADURO M, 1995, GENETICS, V141, P977; Maduro MF, 2000, J NEUROGENET, V13, P191, DOI 10.3109/01677060009084494; Mellmann A, 2000, J HOSP INFECT, V44, P281, DOI 10.1053/jhin.1999.0704; Mello C, 1995, METHOD CELL BIOL, V48, P451; Merz DC, 2000, J NEUROBIOL, V44, P281, DOI 10.1002/1097-4695(200008)44:2&lt;281::AID-NEU16&gt;3.0.CO;2-4; MILLER DM, 1986, P NATL ACAD SCI USA, V83, P2305, DOI 10.1073/pnas.83.8.2305; MILLER DM, 1995, DEVELOPMENT, V121, P2877; MILLER DM, 1983, CELL, V34, P477, DOI 10.1016/0092-8674(83)90381-1; MILLER DM, 1992, NATURE, V355, P841, DOI 10.1038/355841a0; Miller DM, 1999, BIOTECHNIQUES, V26, P914, DOI 10.2144/99265rr01; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Pflugrad A, 1997, DEVELOPMENT, V124, P1699; Pierce-Shimomura JT, 2001, NATURE, V410, P694, DOI 10.1038/35070575; PRIESS JR, 1987, CELL, V48, P241, DOI 10.1016/0092-8674(87)90427-2; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Schmidt H, 2000, J NEUROBIOL, V44, P392, DOI 10.1002/1097-4695(20000915)44:4<392::AID-NEU3>3.0.CO;2-M; Schnabel R., 1997, C ELEGANS, P361; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Tavernarakis N, 1997, ANNU REV PHYSIOL, V59, P659, DOI 10.1146/annurev.physiol.59.1.659; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Ui-Tei K, 2000, FEBS LETT, V479, P79, DOI 10.1016/S0014-5793(00)01883-4; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Winnier AR, 1999, GENE DEV, V13, P2774, DOI 10.1101/gad.13.21.2774; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Zamore PD, 2001, NAT STRUCT BIOL, V8, P746, DOI 10.1038/nsb0901-746	55	167	174	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 14	2002	33	4					503	514		10.1016/S0896-6273(02)00591-3	http://dx.doi.org/10.1016/S0896-6273(02)00591-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856526	Bronze			2022-12-24	WOS:000173911100005
J	Pagnoni, G; Zink, CF; Montague, PR; Berns, GS				Pagnoni, G; Zink, CF; Montague, PR; Berns, GS			Activity in human ventral striatum locked to errors of reward prediction	NATURE NEUROSCIENCE			English	Article							RESPONSES; DOPAMINE; SYSTEMS		Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA; Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA	Emory University; Baylor College of Medicine	Pagnoni, G (corresponding author), Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.		anand, amit/A-7222-2009; Pagnoni, Giuseppe/F-3398-2015	Pagnoni, Giuseppe/0000-0002-8272-8091	NIDA NIH HHS [DA11723, DA00367] Funding Source: Medline; NIMH NIH HHS [MH61010] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061010] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011723] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Cohen MS, 1997, NEUROIMAGE, V6, P93, DOI 10.1006/nimg.1997.0278; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Duvernoy HM, 1999, HUMAN BRAIN; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; WARD BD, 2001, AFNI 3DDECONVOLVE DO	13	336	337	2	27	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					97	98		10.1038/nn802	http://dx.doi.org/10.1038/nn802			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802175				2022-12-24	WOS:000173558400008
J	Tao, X; West, AE; Chen, WG; Corfas, G; Greenberg, ME				Tao, X; West, AE; Chen, WG; Corfas, G; Greenberg, ME			A calcium-responsive transcription factor, CaRF, that regulates neuronal activity-dependent expression of BDNF	NEURON			English	Article							NEUROTROPHIC FACTOR; DENDRITIC GROWTH; MESSENGER-RNAS; CREB; RECEPTORS; IDENTIFICATION; STIMULATION; REQUIREMENT; PROMOTERS; SURVIVAL	Transcription of the brain-derived neurotrophic factor (BDNF) gene is regulated in a calcium- and neuron-selective manner; however, the mechanisms that underlie this selectivity are not known. We have characterized a new calcium-response element, CaRE1, that is required for activity-de pendent transcription of BDNF exon III and have cloned a transcription factor, CaRF, that activates transcription from BDNF promoter III in a CaRE1-dependent manner. The transcriptional activity of CaRF is regulated in a calcium- and neuron-selective manner, suggesting that CaRF may confer selectivity upon the activity-dependent induction of BDNF exon III expression.	Childrens Hosp, Div Neurosci, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Childrens Hosp, Div Neurosci, 300 Longwood Ave, Boston, MA 02115 USA.	michael.greenberg@tch.harvard.edu	Corfas, Gabriel/AAH-2378-2020	Corfas, Gabriel/0000-0001-5412-9473; Chen, Wen/0000-0003-0853-7526	NICHD NIH HHS [HD18655] Funding Source: Medline; NINDS NIH HHS [NS28829-07] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028829, R01NS028829] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Ahn S, 1999, NEURON, V23, P559, DOI 10.1016/S0896-6273(00)80808-9; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bito H, 1997, CURR OPIN NEUROBIOL, V7, P419, DOI 10.1016/S0959-4388(97)80072-4; CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444; CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9; Cruzalegui FH, 2000, CELL MOL LIFE SCI, V57, P402, DOI 10.1007/PL00000702; GHOSH A, 1994, SCIENCE, V263, P1618, DOI 10.1126/science.7907431; GREENBERG ME, 1986, SCIENCE, V234, P80, DOI 10.1126/science.3749894; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; LEIBROCK J, 1989, NATURE, V341, P149, DOI 10.1038/341149a0; Liang FQ, 1998, NEUROSCI LETT, V242, P89, DOI 10.1016/S0304-3940(98)00062-7; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Nedivi E, 1998, SCIENCE, V281, P1863, DOI 10.1126/science.281.5384.1863; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; PATTERSON SL, 1992, NEURON, V9, P1081, DOI 10.1016/0896-6273(92)90067-N; Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004; Ringstedt T, 1998, NEURON, V21, P305, DOI 10.1016/S0896-6273(00)80540-1; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; TIMMUSK T, 1994, NEUROSCIENCE, V60, P287, DOI 10.1016/0306-4522(94)90242-9; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; TRIEZENBERG SJ, 1995, CURR OPIN GENET DEV, V5, P190, DOI 10.1016/0959-437X(95)80007-7; Tu JC, 1998, NEURON, V21, P717, DOI 10.1016/S0896-6273(00)80589-9; WANG T, 1995, J NEUROSCI, V15, P4796; West AE, 2001, P NATL ACAD SCI USA, V98, P11024, DOI 10.1073/pnas.191352298; Xia ZG, 1996, J NEUROSCI, V16, P5425; YOUN HD, 1999, SCIENCE, V268, P709; ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x	39	257	268	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 31	2002	33	3					383	395		10.1016/S0896-6273(01)00561-X	http://dx.doi.org/10.1016/S0896-6273(01)00561-X			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832226	Bronze			2022-12-24	WOS:000173643200009
J	Morishita, W; Connor, JH; Xia, H; Quinlan, EM; Shenolikar, S; Malenka, RC				Morishita, W; Connor, JH; Xia, H; Quinlan, EM; Shenolikar, S; Malenka, RC			Regulation of synaptic strength by protein phosphatase 1	NEURON			English	Article							LONG-TERM DEPRESSION; VOLTAGE-DEPENDENT POTENTIATION; GLYCOGEN-TARGETING SUBUNIT; D-ASPARTATE RECEPTOR; GLUTAMATE RECEPTORS; CATALYTIC SUBUNIT; SKELETAL-MUSCLE; KINASE-II; DENDRITIC SPINES; AMPA RECEPTORS	We investigated the role of postsynaptic protein phosphatase 1 (PP1) in regulating synaptic strength by loading CA1 pyramidal cells either with peptides that disrupt PP1 binding to synaptic targeting proteins or with active PP1. The peptides blocked synaptically evoked LTD but had no effect on basal synaptic currents mediated by either AMPA or NMDA receptors. They did, however, cause an increase in synaptic strength following the induction of LTD. Similarly, PP1 had no effect on basal synaptic strength but enhanced LTD. In cultured neurons, synaptic activation of NMDA receptors increased the proportion of PP1 localized to synapses. These results suggest that PP1 does not significantly regulate basal synaptic strength. Appropriate NMDA receptor activation, however, allows PP1 to gain access to synaptic substrates and be recruited to synapses where its activity is necessary for sustaining LTD.	Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA; Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Univ Maryland, Dept Biol Neurobiol & Cognit Sci, College Pk, MD 20742 USA	Stanford University; Duke University; University System of Maryland; University of Maryland College Park	Malenka, RC (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Nancy Pritzker Lab, Palo Alto, CA 94304 USA.			Connor, John/0000-0002-8867-7256	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052054] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK52054] Funding Source: Medline; NIMH NIH HHS [MH00942] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Allen PB, 1997, P NATL ACAD SCI USA, V94, P9956, DOI 10.1073/pnas.94.18.9956; Banke TG, 2000, J NEUROSCI, V20, P89, DOI 10.1523/JNEUROSCI.20-01-00089.2000; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bear MF, 2001, SYNAPSES, P455; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Beullens M, 2000, BIOCHEM J, V352, P651, DOI 10.1042/0264-6021:3520651; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bolshakov VY, 2000, NAT NEUROSCI, V3, P1107, DOI 10.1038/80624; Carroll RC, 2001, NAT REV NEUROSCI, V2, P315, DOI 10.1038/35072500; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chung HJ, 2000, J NEUROSCI, V20, P7258; Colledge M, 2000, NEURON, V27, P107, DOI 10.1016/S0896-6273(00)00013-1; Connor JH, 2000, J BIOL CHEM, V275, P18670, DOI 10.1074/jbc.M909312199; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; DEGUZMAN A, 1988, METHOD ENZYMOL, V159, P356; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Endo S, 1996, BIOCHEMISTRY-US, V35, P5220, DOI 10.1021/bi952940f; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Fraser IDC, 1999, NEURON, V23, P423, DOI 10.1016/S0896-6273(00)80795-3; Hsieh-Wilson LC, 1999, BIOCHEMISTRY-US, V38, P4365, DOI 10.1021/bi982900m; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; JOHNSON BD, 1994, P NATL ACAD SCI USA, V91, P11492, DOI 10.1073/pnas.91.24.11492; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; Lai MM, 1999, J BIOL CHEM, V274, P25963, DOI 10.1074/jbc.274.37.25963; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; Liu J, 2000, J BIOL CHEM, V275, P26074, DOI 10.1074/jbc.M003843200; Liu J, 2000, BIOCHEM J, V346, P77, DOI 10.1042/0264-6021:3460077; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; MacMillan LB, 1999, J BIOL CHEM, V274, P35845, DOI 10.1074/jbc.274.50.35845; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; Matsuda S, 1999, J NEUROCHEM, V73, P1765, DOI 10.1046/j.1471-4159.1999.731765.x; McAvoy T, 1999, BIOCHEMISTRY-US, V38, P12943, DOI 10.1021/bi991227d; Moorhead G, 1998, FEBS LETT, V438, P141, DOI 10.1016/S0014-5793(98)01276-9; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; O'Dell T J, 1994, Learn Mem, V1, P129; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Oliver C.J., 1998, FRONT BIOSCI, V3, P961; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Price NE, 1999, CURR OPIN NEUROBIOL, V9, P336, DOI 10.1016/S0959-4388(99)80049-X; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; SCULPTOREANU A, 1993, NATURE, V364, P240, DOI 10.1038/364240a0; SELIG DK, 1995, NEURON, V15, P417, DOI 10.1016/0896-6273(95)90045-4; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shen K, 2000, NAT NEUROSCI, V3, P881, DOI 10.1038/78783; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Terry-Lorenzo RT, 2000, J BIOL CHEM, V275, P2439, DOI 10.1074/jbc.275.4.2439; Thiels E, 1998, NEUROSCIENCE, V86, P1023, DOI 10.1016/S0306-4522(98)00135-3; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Yan Z, 1999, NAT NEUROSCI, V2, P13, DOI 10.1038/4516	65	183	189	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1133	1148		10.1016/S0896-6273(01)00554-2	http://dx.doi.org/10.1016/S0896-6273(01)00554-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754843	Bronze			2022-12-24	WOS:000172886800018
J	Byrd, DT; Kawasaki, M; Walcoff, M; Hisamoto, N; Matsumoto, K; Jin, YS				Byrd, DT; Kawasaki, M; Walcoff, M; Hisamoto, N; Matsumoto, K; Jin, YS			UNC-16, a JNK-signaling scaffold protein, regulates vesicle transport in C-elegans	NEURON			English	Article							N-TERMINAL KINASE; NEMATODE CAENORHABDITIS-ELEGANS; GLUTAMIC-ACID DECARBOXYLASE; DYNEIN SUPERFAMILY PROTEINS; KINESIN HEAVY-CHAIN; SYNAPTIC TRANSMISSION; AXONAL-TRANSPORT; HOMEODOMAIN PROTEIN; ORGANELLE TRANSPORT; NERVOUS-SYSTEM	Transport of synaptic components is a regulated process. Loss-of-function mutations in the C. elegans unc-16 gene result in the mislocalization of synaptic vesicle and glutamate receptor markers. unc-16 encodes a homolog of mouse JSAP1/JIP3 and Drosophila Sunday Driver. Like JSAP1/JIP3, UNC-16 physically interacts with JNK. and JNK kinases. Deletion mutations in Caenorhabditis elegans JNK and JNK kinases result in similar mislocalization of synaptic vesicle markers and enhance weak unc-16 mutant phenotypes. unc-116 kinesin heavy chain mutants also mislocalize synaptic vesicle markers, as well as a functional UNC16::GFP. Intriguingly, unc-16 mutations partially suppress the vesicle retention defect in unc-104 KIF1A kinesin mutants. Cur results suggest that UNC-16 may regulate the localization of vesicular cargo by integrating JNK signaling and kinesin-1 transport.	Univ Calif Santa Cruz, Sinsheimer Labs, Dept MCD Biol, Santa Cruz, CA 95064 USA; Japan Sci & Technol Corp, CREST, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Nagoya Univ, Grad Sch Sci, Dept Mol Biol, Nagoya, Aichi 4648602, Japan; Univ Calif Santa Cruz, Howard Hughes Med Inst, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Japan Science & Technology Agency (JST); Nagoya University; Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Jin, YS (corresponding author), Univ Calif Santa Cruz, Sinsheimer Labs, Dept MCD Biol, Santa Cruz, CA 95064 USA.			Jin, Yishi/0000-0002-9371-9860	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008646] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM0864602] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akechi M, 2001, NEUROSCI RES, V39, P391, DOI 10.1016/S0168-0102(01)00194-8; Bamber BA, 1999, J NEUROSCI, V19, P5348; Bowman AB, 2000, CELL, V103, P583, DOI 10.1016/S0092-8674(00)00162-8; BRENNER S, 1974, GENETICS, V77, P71; Brownlees J, 2000, J CELL SCI, V113, P401; Crump JG, 2001, NEURON, V29, P115, DOI 10.1016/S0896-6273(01)00184-2; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Duerr JS, 1999, J NEUROSCI, V19, P72, DOI 10.1523/JNEUROSCI.19-01-00072.1999; Eastman C, 1999, J NEUROSCI, V19, P6225; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; HALL D H, 1991, Journal of Cell Biology, V115, p389A; HALL DH, 1991, CELL, V65, P837, DOI 10.1016/0092-8674(91)90391-B; Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hobert O, 1998, J NEUROSCI, V18, P2084; Ito M, 1999, MOL CELL BIOL, V19, P7539; Ito M, 2000, GENE, V255, P229, DOI 10.1016/S0378-1119(00)00335-8; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Jin YS, 1999, J NEUROSCI, V19, P539; JIN YS, 1994, NATURE, V372, P780, DOI 10.1038/372780a0; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kawasaki M, 1999, EMBO J, V18, P3604, DOI 10.1093/emboj/18.13.3604; Kelkar N, 2000, MOL CELL BIOL, V20, P1030, DOI 10.1128/MCB.20.3.1030-1043.2000; Koushika SP, 2000, CURR OPIN CELL BIOL, V12, P517, DOI 10.1016/S0955-0674(00)00125-3; LEE KD, 1995, J BIOL CHEM, V270, P5600, DOI 10.1074/jbc.270.10.5600; LEOPOLD PL, 1992, CELL MOTIL CYTOSKEL, V23, P19, DOI 10.1002/cm.970230104; Lindesmith L, 1997, J BIOL CHEM, V272, P22929, DOI 10.1074/jbc.272.36.22929; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; McDonald D, 2000, US FOR SERV RMRS-P, V2, P290; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nonet ML, 1997, J NEUROSCI, V17, P8061; Nonet ML, 1998, J NEUROSCI, V18, P70; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; Nonet ML, 1999, J NEUROSCI METH, V89, P33, DOI 10.1016/S0165-0270(99)00031-X; Nurrish S, 1999, NEURON, V24, P231, DOI 10.1016/S0896-6273(00)80835-1; OKADA Y, 1995, CELL, V81, P769, DOI 10.1016/0092-8674(95)90538-3; OTSUKA AJ, 1991, NEURON, V6, P113, DOI 10.1016/0896-6273(91)90126-K; Otto IM, 2000, CURR BIOL, V10, P345, DOI 10.1016/S0960-9822(00)00388-2; PATEL N, 1993, P NATL ACAD SCI USA, V90, P9181, DOI 10.1073/pnas.90.19.9181; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Sambrook J., 2002, MOL CLONING LAB MANU; SATOYOSHITAKE R, 1992, J BIOL CHEM, V267, P23930; Schaefer AM, 2001, CURR OPIN NEUROBIOL, V11, P127, DOI 10.1016/S0959-4388(00)00183-5; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; Stockinger W, 2000, J BIOL CHEM, V275, P25625, DOI 10.1074/jbc.M004119200; THOMAS JH, 1990, GENETICS, V124, P855; TRENT C, 1983, GENETICS, V104, P619; Verhey KJ, 2001, TRENDS BIOCHEM SCI, V26, P545, DOI 10.1016/S0968-0004(01)01931-4; Verhey KJ, 2001, J CELL BIOL, V152, P959, DOI 10.1083/jcb.152.5.959; WHITE JG, 1978, NATURE, V271, P764, DOI 10.1038/271764a0; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yonekawa Y, 1998, J CELL BIOL, V141, P431, DOI 10.1083/jcb.141.2.431; Zhai RG, 2001, NEURON, V29, P131, DOI 10.1016/S0896-6273(01)00185-4; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Zhen M, 1999, NATURE, V401, P371, DOI 10.1038/43886; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001	61	173	186	1	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					787	+		10.1016/S0896-6273(01)00532-3	http://dx.doi.org/10.1016/S0896-6273(01)00532-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738026	Bronze			2022-12-24	WOS:000172700700007
J	Roozendaal, B; Phillips, RG; Power, AE; Brooke, SM; Sapolsky, RM; McGaugh, JL				Roozendaal, B; Phillips, RG; Power, AE; Brooke, SM; Sapolsky, RM; McGaugh, JL			Memory retrieval impairment induced by hippocampal CA3 lesions is blocked by adrenocortical suppression	NATURE NEUROSCIENCE			English	Article							STRESS; AXIS		Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Stanford University	Roozendaal, B (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Irvine, CA 92697 USA.		Roozendaal, Benno/B-8403-2013		NATIONAL INSTITUTE OF MENTAL HEALTH [R56MH012526, R01MH053814, R37MH012526, R01MH012526] Funding Source: NIH RePORTER; NIMH NIH HHS [R01 MH53814, MH12526] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ARBEL I, 1994, BRAIN RES, V657, P227, DOI 10.1016/0006-8993(94)90972-5; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; FISCHETTE CT, 1980, BRAIN RES, V195, P105; HERMAN JP, 1989, J NEUROSCI, V9, P3072; JACOBSON L, 1991, ENDOCR REV, V12, P118, DOI 10.1210/edrv-12-2-118; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; McLaughlin J, 2000, P NATL ACAD SCI USA, V97, P12804, DOI 10.1073/pnas.210350097; Moser MB, 1998, J NEUROSCI, V18, P7535; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Roozendaal B, 1996, PSYCHONEUROENDOCRINO, V21, P681, DOI 10.1016/S0306-4530(96)00028-5; SAPOLSKY RM, 1986, J NEUROSCI, V6, P2240	12	102	108	0	4	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1169	1171		10.1038/nn766	http://dx.doi.org/10.1038/nn766			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11713467				2022-12-24	WOS:000172525000010
J	Yao, HS; Dan, Y				Yao, HS; Dan, Y			Stimulus timing-dependent plasticity in cortical processing of orientation	NEURON			English	Article							LONG-TERM POTENTIATION; UNDERLYING CONTRAST ADAPTATION; PRIMARY VISUAL-CORTEX; CAT STRIATE CORTEX; SYNAPTIC DEPRESSION; RESPONSE AMPLITUDE; PYRAMIDAL CELLS; SELECTIVITY; NEURONS; HIPPOCAMPUS	The relative timing of presynaptic and postsynaptic spikes plays a critical role in activity-induced synaptic modification. Here we examined whether plasticity of orientation selectivity in the visual cortex depends on stimulus timing. Repetitive pairing of visual stimuli at two orientations induced a shift in orientation tuning of cat cortical neurons, with the direction of the shift depending on the temporal order of the pair. Induction of a significant shift required that the interval between the pair fall within +/-40 ms, reminiscent of the temporal window for spike timing-dependent synaptic plasticity. Mirroring the plasticity found in cat visual cortex, similar conditioning also induced a shift in perceived orientation by human subjects, further suggesting functional relevance of this phenomenon. Thus, relative timing of visual stimuli can play a critical role in dynamic modulation of adult cortical function, perhaps through spike timing-dependent synaptic plasticity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dan, Y (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Dan, Yang/0000-0002-3818-877X				Abbott LF, 2000, NAT NEUROSCI, V3, P1178, DOI 10.1038/81453; Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Brenner N, 2000, NEURON, V26, P695, DOI 10.1016/S0896-6273(00)81205-2; Carandini M, 1997, SCIENCE, V276, P949, DOI 10.1126/science.276.5314.949; Chance FS, 1998, J NEUROSCI, V18, P4785; DEAN AF, 1981, J PHYSIOL-LONDON, V318, P413; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Deneve S, 1999, NAT NEUROSCI, V2, P740, DOI 10.1038/11205; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Dragoi V, 2000, NEURON, V28, P287, DOI 10.1016/S0896-6273(00)00103-3; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FREGNAC Y, 1992, J NEUROSCI, V12, P1280; FREGNAC Y, 1988, NATURE, V333, P367, DOI 10.1038/333367a0; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; McLean J, 1998, VISUAL NEUROSCI, V15, P177, DOI 10.1017/S0952523898151143; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; Muller JR, 1999, SCIENCE, V285, P1405, DOI 10.1126/science.285.5432.1405; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; RAO RPN, 2000, ADV NEURAL INFORMATI; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; Sanchez-Vives MV, 2000, J NEUROSCI, V20, P4267; SCHUETT S, 2000, SOC NEUR ABSTR, V26; SILLITO AM, 1975, J PHYSIOL-LONDON, V250, P305, DOI 10.1113/jphysiol.1975.sp011056; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; TOLHURST DJ, 1981, EXP BRAIN RES, V41, P414; Treue S, 2000, NAT NEUROSCI, V3, P270, DOI 10.1038/72985; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	42	172	175	0	11	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					315	323		10.1016/S0896-6273(01)00460-3	http://dx.doi.org/10.1016/S0896-6273(01)00460-3			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11684000	Bronze			2022-12-24	WOS:000171893700015
J	Gray, PA; Janczewski, WA; Mellen, N; McCrimmon, DR; Feldman, JL				Gray, PA; Janczewski, WA; Mellen, N; McCrimmon, DR; Feldman, JL			Normal breathing requires preBotzinger complex neurokinin-1 receptor-expressing neurons	NATURE NEUROSCIENCE			English	Article							RESPIRATORY RHYTHM; SPINAL NEURONS; GENERATION; HYPOVENTILATION	The normal breathing rhythm in mammals is hypothesized to be generated by neurokinin-1 receptor(NK1R)-expressing neurons in the preBotzinger complex (preBotc), a medullary region proposed to contain the kernel of the circuits generating respiration. If this hypothesis is correct, then complete destruction of preBotC NK1R neurons should severely perturb and perhaps even fatally arrest breathing. Here we show that specific and near complete bilateral (but not unilateral) destruction of preBotC NK1R neurons results in both an ataxic breathing pattern with markedly altered blood gases and pH, and pathological responses to challenges such as hyperoxia, hypoxia and anesthesia. Thus, these similar to 600 neurons seem necessary for the generation of normal breathing in rats.	Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Interdepartmental PhD Program Neurosci, Los Angeles, CA 90095 USA; Northwestern Univ, Sch Med, Dept Physiol, Chicago, IL 60611 USA; Northwestern Univ, Sch Med, NW Inst Neurosci, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; Northwestern University	Feldman, JL (corresponding author), Univ Calif Los Angeles, Dept Neurobiol, Box 951763, Los Angeles, CA 90095 USA.	feldman@ucla.edu	McCrimmon, Donald R/F-9271-2013; feldman, jack/AAO-7505-2021	feldman, jack/0000-0003-3692-9412; McCrimmon, Donald/0000-0001-5339-6043	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL040959] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL040959, HL40959, R01 HL040959-12] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ballanyi K, 1999, PROG NEUROBIOL, V59, P583, DOI 10.1016/S0301-0082(99)00009-X; Champagnat J, 1997, TRENDS NEUROSCI, V20, P119, DOI 10.1016/S0166-2236(96)10078-3; DOBBINS EG, 1994, J COMP NEUROL, V347, P64, DOI 10.1002/cne.903470106; Gdovin MJ, 1999, COMP BIOCHEM PHYS A, V124, P275, DOI 10.1016/S1095-6433(99)00116-6; Gozal D, 1998, PEDIATR PULM, V26, P273; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Guilleminault C, 1996, NEUROL CLIN, V14, P611, DOI 10.1016/S0733-8619(05)70276-0; Guilleminault C, 1996, Curr Opin Pulm Med, V2, P492; Guyenet PG, 2001, J NEUROPHYSIOL, V86, P438, DOI 10.1152/jn.2001.86.1.438; Habre W, 1997, PAEDIATR ANAESTH, V7, P251, DOI 10.1046/j.1460-9592.1997.d01-65.x; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; Mantyh PW, 1997, SCIENCE, V278, P275, DOI 10.1126/science.278.5336.275; MANTYH PW, 1995, SCIENCE, V268, P1629, DOI 10.1126/science.7539937; Maria BL, 1999, J CHILD NEUROL, V14, P583, DOI 10.1177/088307389901400906; McCrimmon DR, 2000, CLIN EXP PHARMACOL P, V27, P126, DOI 10.1046/j.1440-1681.2000.03193.x; NATTIE EE, 1975, AM REV RESPIR DIS, V112, P259; Rekling JC, 1998, ANNU REV PHYSIOL, V60, P385, DOI 10.1146/annurev.physiol.60.1.385; Remmers JE, 1999, LUNG BIOL HEALTH DIS, V135, P1; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SPECK DF, 1982, J NEUROSCI, V2, P744; Thalhofer S, 1997, RESPIRATION, V64, P2; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169	22	400	411	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					927	930		10.1038/nn0901-927	http://dx.doi.org/10.1038/nn0901-927			4	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528424	Green Accepted			2022-12-24	WOS:000170698600019
J	Brasnjo, G; Otis, TS				Brasnjo, G; Otis, TS			Neuronal glutamate transporters control activation of postsynaptic metabotropic glutamate receptors and influence cerebellar long-term depression	NEURON			English	Article							AMINO-ACID TRANSPORTER; EXCITATORY SYNAPTIC-TRANSMISSION; GATED CHLORIDE CHANNEL; PURKINJE-CELLS; RAT-BRAIN; INWARD CURRENT; PHARMACOLOGICAL CHARACTERIZATION; PARALLEL FIBER; RELEASE SITES; LOCALIZATION	Neuronal and glial isoforms of glutamate transporters show distinct distributions on membranes surrounding excitatory synapses, but specific roles for transporter subtypes remain unidentified. At parallel fiber (PF) synapses in cerebellum, neuronal glutamate transporters and metabotropic glutamate receptors (mGluRs) have overlapping postsynaptic distributions suggesting that postsynaptic transporters selectively regulate mGluR activation. We examined interactions between transporters and mGluRs by evoking mGluR-mediated excitatory postsynaptic currents (mGluR EPSCs) in slices of rat cerebellum. Selective inhibition of postsynaptic transporters enhanced mGluR EPSCs greater than 3-fold. Moreover, impairing glutamate uptake facilitated mGluR-dependent long-term depression at PF synapses. Our results demonstrate that uniquely positioned glutamate transporters strongly influence mGluR activation at cerebellar PF synapses. Postsynaptic glutamate uptake may serve as a general mechanism for regulating mGluR-initiated synaptic depression.	Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Brain Res Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Otis, TS (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurobiol, Los Angeles, CA 90095 USA.	otist@ucla.edu			NINDS NIH HHS [NS41651] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AIBA A, 1994, CELL, V79, P377, DOI 10.1016/0092-8674(94)90204-6; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Arriza JL, 1997, P NATL ACAD SCI USA, V94, P4155, DOI 10.1073/pnas.94.8.4155; Asztely F, 1997, NEURON, V18, P281, DOI 10.1016/S0896-6273(00)80268-8; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; BARBOUR B, 1988, NATURE, V335, P433, DOI 10.1038/335433a0; BATCHELOR AM, 1994, NEUROSCIENCE, V63, P911, DOI 10.1016/0306-4522(94)90558-4; Batchelor AM, 1997, NEUROPHARMACOLOGY, V36, P401, DOI 10.1016/S0028-3908(97)00014-2; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Carter AG, 2000, J NEUROSCI, V20, P4423, DOI 10.1523/JNEUROSCI.20-12-04423.2000; CHAUDHRY FA, 1995, NEURON, V15, P711, DOI 10.1016/0896-6273(95)90158-2; Congar P, 1997, J NEUROSCI, V17, P5366; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; Dehnes Y, 1998, J NEUROSCI, V18, P3606; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Eliasof S, 1998, J NEUROSCI, V18, P698; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FERKANY J, 1986, J NEUROSCI RES, V16, P491, DOI 10.1002/jnr.490160305; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; He Y, 2000, J COMP NEUROL, V418, P255; Heuss C, 1999, NAT NEUROSCI, V2, P1070, DOI 10.1038/15996; Higgs MH, 1999, J NEUROSCI, V19, P3691; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; Kataoka Y, 1997, J NEUROSCI, V17, P7017; Kinney GA, 1997, J NEUROPHYSIOL, V78, P1320, DOI 10.1152/jn.1997.78.3.1320; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; LEHRE KP, 1995, J NEUROSCI, V15, P1835; LINDEN DJ, 1991, NEURON, V7, P81, DOI 10.1016/0896-6273(91)90076-C; LINDEN DJ, 1994, J NEUROPHYSIOL, V71, P1992, DOI 10.1152/jn.1994.71.5.1992; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; MAKI R, 1994, J NEUROSCI, V14, P6754; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Normann C, 2000, J NEUROSCI, V20, P8290, DOI 10.1523/JNEUROSCI.20-22-08290.2000; Otani S, 1998, J PHYSIOL-LONDON, V511, P761, DOI 10.1111/j.1469-7793.1998.761bg.x; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Otis TS, 1996, J NEUROSCI, V16, P1634, DOI 10.1523/jneurosci.16-05-01634.1996; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Petralia RS, 1997, J CHEM NEUROANAT, V13, P77, DOI 10.1016/S0891-0618(97)00023-9; PINES G, 1992, NATURE, V360, P464, DOI 10.1038/360464a0; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; SHIGEMOTO R, 1994, NEURON, V12, P1245, DOI 10.1016/0896-6273(94)90441-3; Shimamoto K, 1998, MOL PHARMACOL, V53, P195, DOI 10.1124/mol.53.2.195; STAUB C, 1992, EUR J NEUROSCI, V4, P832, DOI 10.1111/j.1460-9568.1992.tb00193.x; STORCK T, 1992, P NATL ACAD SCI USA, V89, P10955, DOI 10.1073/pnas.89.22.10955; Takahashi M, 1996, J PHYSIOL-LONDON, V497, P523, DOI 10.1113/jphysiol.1996.sp021785; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TANAKA K, 1994, MOL BRAIN RES, V21, P167, DOI 10.1016/0169-328X(94)90390-5; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; Wadiche JI, 1998, J NEUROSCI, V18, P7650	58	171	176	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	AUG 30	2001	31	4					607	616		10.1016/S0896-6273(01)00377-4	http://dx.doi.org/10.1016/S0896-6273(01)00377-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545719	Bronze			2022-12-24	WOS:000170759200014
J	Pham, TA; Rubenstein, JLR; Silva, AJ; Storm, DR; Stryker, MP				Pham, TA; Rubenstein, JLR; Silva, AJ; Storm, DR; Stryker, MP			The CRE/CREB pathway is transiently expressed in thalamic circuit development and contributes to refinement of retinogeniculate axons	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; MEDIATED GENE-EXPRESSION; PRIMARY VISUAL-CORTEX; LONG-TERM-MEMORY; EXPERIENCE-DEPENDENT PLASTICITY; ELEMENT-BINDING PROTEIN; RETINAL GANGLION-CELLS; CLASS-I MHC; CRITICAL-PERIOD; POSTNATAL-DEVELOPMENT	The development of precise connections in the mammalian brain proceeds through refinement of initially diffuse patterns, a process that occurs largely within critical developmental windows. To elucidate the molecular pathways that orchestrate these early periods of circuit remodeling, we have examined the role of a calcium- and cAMP-regulated transcriptional pathway. We show that there is a window of CRE/CREB-mediated gene expression in the developing thalamus, which precedes neocortical expression. In the LGN, this wave of gene expression occurs prior to visual experience, but requires retinal function. Mutant mice with reduced CREB expression show loss of refinement of retinogeniculate projections. These results suggest an important role of the CRE/CREB transcriptional pathway in the coordination of experience-independent circuit remodeling during forebrain development.	Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Ophthalmol, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA; Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Pham, TA (corresponding author), Univ Washington, Sch Med, Dept Psychiat & Behav Sci, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA.	tonypham@u.washington.edu	Silva, Alcino/ABD-7684-2021	Silva, Alcino/0000-0002-1587-4558; Silva, Alcino/0000-0001-5525-0494; Stryker, Michael/0000-0003-1546-5831	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-200017] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonini A, 1999, J NEUROSCI, V19, P4388; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Barth AL, 2000, J NEUROSCI, V20, P4206; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; BLAKEMORE C, 1978, J PHYSIOL-LONDON, V283, P223, DOI 10.1113/jphysiol.1978.sp012498; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Corriveau RA, 1999, J NEUROSCI, V19, P7999, DOI 10.1523/jneurosci.19-18-07999.1999; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; FOX K, 1994, J NEUROSCI, V14, P7665; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Fox Kevin, 1994, Current Opinion in Neurobiology, V4, P112, DOI 10.1016/0959-4388(94)90040-X; GALLI L, 1988, SCIENCE, V242, P90, DOI 10.1126/science.3175637; GODEMENT P, 1984, J COMP NEUROL, V230, P552, DOI 10.1002/cne.902300406; GODEMENT P, 1987, J COMP NEUROL, V255, P97, DOI 10.1002/cne.902550108; Gordon JA, 1996, J NEUROSCI, V16, P3274; GUILLERY RW, 1972, J COMP NEUROL, V146, P407, DOI 10.1002/cne.901460306; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; HEUMANN D, 1980, EXP BRAIN RES, V38, P75; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Hubel DH, 1998, NEURON, V20, P401, DOI 10.1016/S0896-6273(00)80984-8; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kogan JH, 1997, CURR BIOL, V7, P1, DOI 10.1016/S0960-9822(06)00022-4; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Obrietan K, 1999, J BIOL CHEM, V274, P17748, DOI 10.1074/jbc.274.25.17748; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 1999, NEURON, V22, P63, DOI 10.1016/S0896-6273(00)80679-0; RAKIC P, 1981, SCIENCE, V214, P928, DOI 10.1126/science.7302569; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; ROBSON JA, 1978, SCIENCE, V201, P635, DOI 10.1126/science.675248; RUBENSTEIN JLR, 1994, SCIENCE, V266, P578, DOI 10.1126/science.7939711; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; RUPPERT S, 1992, EMBO J, V11, P1503, DOI 10.1002/j.1460-2075.1992.tb05195.x; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SRETAVAN DW, 1986, J NEUROSCI, V6, P234; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029; TSUMOTO T, 1987, NATURE, V327, P513, DOI 10.1038/327513a0; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; YIN JCP, 1994, CELL, V79, P49, DOI 10.1016/0092-8674(94)90399-9	57	73	74	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					409	420		10.1016/S0896-6273(01)00381-6	http://dx.doi.org/10.1016/S0896-6273(01)00381-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516398	Bronze			2022-12-24	WOS:000170601000010
J	Renden, R; Berwin, B; Davis, W; Ann, K; Chin, CT; Kreber, R; Ganetzky, B; Martin, TFJ; Broadie, K				Renden, R; Berwin, B; Davis, W; Ann, K; Chin, CT; Kreber, R; Ganetzky, B; Martin, TFJ; Broadie, K			Drosophila CAPS is an essential gene that regulates dense-core vesicle release and synaptic vesicle fusion	NEURON			English	Article							NEUROTRANSMITTER RELEASE; SNARE COMPLEX; SYNAPTOTAGMIN MUTANTS; SEC1 HOMOLOG; NEUROMUSCULAR-JUNCTIONS; CLOSTRIDIAL NEUROTOXINS; MOLECULAR-MECHANISMS; TRANSMITTER RELEASE; SECRETORY VESICLES; PEPTIDE SECRETION	Calcium-activated protein for secretion (CAPS) is proposed to play an essential role in Ca2+-regulated dense-core vesicle exocytosis in vertebrate neuroendocrine cells. Here we report the cloning, mutation, and characterization of the Drosophila ortholog (dCAPS). Null dCAPS mutants display locomotory deficits and complete embryonic lethality. The mutant NMJ reveals a 50% loss in evoked glutamatergic transmission, and an accumulation of synaptic vesicles at active zones. Importantly, dCAPS mutants display a highly specific 3-fold accumulation of dense-core vesicles in synaptic terminals, which was not observed in mutants that completely arrest synaptic vesicle exocytosis. Targeted transgenic CAPS expression in identified motoneurons fails to rescue dCAPS neurotransmission defects, demonstrating a cell nonautonomous role in synaptic vesicle fusion. We conclude that dCAPS is required for dense-core vesicle release and that a dCAPS-dependent mechanism modulates synaptic vesicle release at glutamatergic synapses.	Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	Utah System of Higher Education; University of Utah; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Broadie, K (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	broadie@biology.utah.edu	Oka, Yoshitaka/C-9670-2010; Renden, Robert/AAC-8294-2020	Oka, Yoshitaka/0000-0002-3482-3051; Renden, Robert/0000-0001-7905-4789; Berwin, Brent/0000-0001-9196-3256	NICHD NIH HHS [5T32HD07491] Funding Source: Medline; NIDDK NIH HHS [DK40428] Funding Source: Medline; NIGMS NIH HHS [GM54544] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054544] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANDERSON MS, 1988, J NEUROSCI, V8, P242; Ann K, 1997, J BIOL CHEM, V272, P19637, DOI 10.1074/jbc.272.32.19637; Aravamudan B, 1999, NAT NEUROSCI, V2, P965, DOI 10.1038/14764; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; Augustin I, 1999, NATURE, V400, P457, DOI 10.1038/22768; AVERY L, 1993, GENETICS, V134, P454; BAJJALIEH SM, 1995, J BIOL CHEM, V270, P1971, DOI 10.1074/jbc.270.5.1971; Banerjee A, 1996, J BIOL CHEM, V271, P20227, DOI 10.1074/jbc.271.34.20227; BATE M, 1990, DEVELOPMENT, V110, P791; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; Berwin B, 1998, NEURON, V21, P137, DOI 10.1016/S0896-6273(00)80521-8; Betz A, 1997, J BIOL CHEM, V272, P2520; BRAND AH, 1993, DEVELOPMENT, V118, P401; BROADIE K, 1994, P NATL ACAD SCI USA, V91, P10727, DOI 10.1073/pnas.91.22.10727; BROADIE K, 1995, NEURON, V15, P663, DOI 10.1016/0896-6273(95)90154-X; BROADIE KS, 1995, J PHYSIOLOGY-PARIS, V89, P59, DOI 10.1016/0928-4257(96)80552-3; BROADIE KS, 1993, J NEUROSCI, V13, P144; CAMPUZANO S, 1985, CELL, V40, P327, DOI 10.1016/0092-8674(85)90147-3; CANTERA R, 1992, CELL TISSUE RES, V269, P459, DOI 10.1007/BF00353901; CHIN CT, 1995, BIOCHEMISTRY-US, P26; Cooper RL, 1999, COMP BIOCHEM PHYS B, V122, P199, DOI 10.1016/S0305-0491(98)10160-8; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DECAMILLI P, 1991, TRENDS PHARMACOL SCI, V12, P446, DOI 10.1016/0165-6147(91)90631-2; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Dresbach T, 1998, J NEUROSCI, V18, P2923; Edwards RH, 1998, CURR BIOL, V8, pR883, DOI 10.1016/S0960-9822(07)00551-9; Elhamdani A, 1999, J NEUROSCI, V19, P7375, DOI 10.1523/JNEUROSCI.19-17-07375.1999; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Featherstone DE, 2000, NEURON, V27, P71, DOI 10.1016/S0896-6273(00)00010-6; Fergestad T, 1999, J NEUROSCI, V19, P5847, DOI 10.1523/JNEUROSCI.19-14-05847.1999; Gainer H, 1998, CELL MOL NEUROBIOL, V18, P211, DOI 10.1023/A:1022568904002; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; GORCZYCA M, 1993, J NEUROSCI, V13, P3692; Gramates LS, 1999, INT REV NEUROBIOL, V43, P93, DOI 10.1016/S0074-7742(08)60542-5; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hewes RS, 1998, J NEUROSCI, V18, P7138; HOTTA Y, 1969, NATURE, V222, P354, DOI 10.1038/222354a0; JAHN R, 1994, ANN NY ACAD SCI, V733, P245, DOI 10.1111/j.1749-6632.1994.tb17274.x; JAN YN, 1977, PROC R SOC SER B-BIO, V198, P87, DOI 10.1098/rspb.1977.0087; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; JOHNSONSCHLITZ D, 1987, GENETICS, V115, P701; JORGENSEN EM, 1995, NATURE, V378, P196, DOI 10.1038/378196a0; KAMMERER RA, 1995, J MOL BIOL, V250, P64, DOI 10.1006/jmbi.1995.0358; Kawasaki F, 1998, J NEUROSCI, V18, P10241; KELLY RB, 1993, CELL, V72, P43, DOI 10.1016/S0092-8674(05)80027-3; Lawrence PA, 1995, DEVELOPMENT, V121, P4303; Linial M, 1997, J NEUROCHEM, V69, P1781; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Littleton JT, 1999, INT REV NEUROBIOL, V43, P139, DOI 10.1016/S0074-7742(08)60544-9; LIVINGSTONE D, 1991, THESIS U CAMBRIDGE C; Loyet KM, 1998, J BIOL CHEM, V273, P8337, DOI 10.1074/jbc.273.14.8337; Martin TFJ, 1997, J BIOL CHEM, V272, P14447, DOI 10.1074/jbc.272.22.14447; MARUYAMA IN, 1991, P NATL ACAD SCI USA, V88, P5729, DOI 10.1073/pnas.88.13.5729; MAYER BJ, 1993, CELL, V73, P629, DOI 10.1016/0092-8674(93)90244-K; MCLEAN JR, 1990, GENETICS, V126, P1007; Miller KG, 1996, P NATL ACAD SCI USA, V93, P12593, DOI 10.1073/pnas.93.22.12593; Mizuta M, 1997, DIABETES, V46, P2002, DOI 10.2337/diabetes.46.12.2002; Nassel DR, 1999, PEPTIDES, V20, P141, DOI 10.1016/S0196-9781(98)00142-9; Nishikawa K, 1999, BRAIN RES, V837, P67, DOI 10.1016/S0006-8993(99)01676-5; OLMSTED JB, 1981, J BIOL CHEM, V256, P1955; PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0; PELLEGRINI LL, 1995, EMBO J, V14, P4705, DOI 10.1002/j.1460-2075.1995.tb00152.x; Reist NE, 1998, J NEUROSCI, V18, P7662; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; Schweizer FE, 1998, SCIENCE, V279, P1203, DOI 10.1126/science.279.5354.1203; SEWARD EP, 1995, J NEUROSCI, V15, P3390; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Stewart BA, 2000, P NATL ACAD SCI USA, V97, P13955, DOI 10.1073/pnas.250491397; SUDHOF TC, 1989, NEURON, V2, P1475, DOI 10.1016/0896-6273(89)90193-1; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THOMAS P, 1993, NEURON, V11, P93, DOI 10.1016/0896-6273(93)90274-U; Thureson-Klein A K, 1990, Int Rev Cytol, V121, P67, DOI 10.1016/S0074-7696(08)60659-2; Ungermann C, 1998, J CELL BIOL, V140, P61, DOI 10.1083/jcb.140.1.61; VERHAGE M, 1991, NEURON, V6, P517, DOI 10.1016/0896-6273(91)90054-4; WALENT JH, 1992, CELL, V70, P765, DOI 10.1016/0092-8674(92)90310-9; Wheeler MB, 1996, ENDOCRINOLOGY, V137, P1340, DOI 10.1210/en.137.4.1340; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967; ZHONG Y, 1995, NEURON, V14, P527, DOI 10.1016/0896-6273(95)90309-7	95	113	115	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					421	437		10.1016/S0896-6273(01)00382-8	http://dx.doi.org/10.1016/S0896-6273(01)00382-8			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516399	Bronze			2022-12-24	WOS:000170601000011
J	Repa, JC; Muller, J; Apergis, J; Desrochers, TM; Zhou, Y; LeDoux, JE				Repa, JC; Muller, J; Apergis, J; Desrochers, TM; Zhou, Y; LeDoux, JE			Two different lateral amygdala cell populations contribute to the initiation and storage of memory	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; BASOLATERAL AMYGDALA; CONDITIONED FEAR; MEDIAL GENICULATE; AUDITORY-CORTEX; RESPONSE PROPERTIES; CONSCIOUS CATS; SPIKE TRAINS; SINGLE UNITS; RATS	Single-cell activity was recorded in the dorsal subnucleus of the lateral amygdala (LAd) of freely behaving rats during Pavlovian fear conditioning, to determine the relationship between neuronal activity and behavioral learning. Neuronal responses elicited by the conditioned stimulus typically increased before behavioral fear was evident, supporting the hypothesis that neural changes in LAd account for the conditioning of behavior. Furthermore, two types of these rapidly modified cells were found. Some, located in the dorsal tip of LAd, exhibited short-latency responses (<20 ms) that were only transiently changed. A second class of cells, most commonly found in ventral regions of LAd, had longer latency responses, but maintained enhanced responding throughout training and even through extinction. These anatomically distinct cells in LAd may be differentially involved in the initiation of learning and long-term memory storage.	NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, New York, NY 10003 USA	New York University	Repa, JC (corresponding author), NYU, Ctr Neural Sci, WM Keck Fdn Lab Neurobiol, 4 Washington Pl,Room 809, New York, NY 10003 USA.		Desrochers, Theresa/A-2654-2011	Desrochers, Theresa/0000-0002-7223-0556	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH000956, R01MH046516, F31MH011659, R37MH038774] Funding Source: NIH RePORTER; NIMH NIH HHS [F31 MH11659, R01 MH46516, KO2 MH00956, R37 MH38774] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Amorapanth P, 1999, LEARN MEMORY, V6, P491, DOI 10.1101/lm.6.5.491; Armony JL, 1998, J NEUROSCI, V18, P2592; Bailey DJ, 1999, BEHAV NEUROSCI, V113, P276, DOI 10.1037/0735-7044.113.2.276; BORDI F, 1992, J NEUROSCI, V12, P2493; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; BOUTON ME, 1980, ANIM LEARN BEHAV, V8, P429, DOI 10.3758/BF03199629; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; Davis M, 1997, J NEUROPSYCH CLIN N, V9, P382; Doron NN, 1999, J COMP NEUROL, V412, P383; Doron NN, 2000, J COMP NEUROL, V425, P257; EDELINE JM, 1992, BEHAV NEUROSCI, V106, P81, DOI 10.1037/0735-7044.106.1.81; Estes WK, 1941, J EXP PSYCHOL, V29, P390, DOI 10.1037/h0062283; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0; Fitts PM., 1967, HUM PERFORM; FOX SE, 1981, EXP BRAIN RES, V41, P399; Gothard KM, 1996, J NEUROSCI, V16, P823; HELMSTETTER FJ, 1994, BEHAV NEUROSCI, V108, P1005, DOI 10.1037/0735-7044.108.5.1005; Hennevin E, 1998, BEHAV NEUROSCI, V112, P839, DOI 10.1037/0735-7044.112.4.839; Huang YY, 1998, NEURON, V21, P169, DOI 10.1016/S0896-6273(00)80524-3; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; Ledoux J E, 1989, J Cogn Neurosci, V1, P238, DOI 10.1162/jocn.1989.1.3.238; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee H, 1998, J NEUROSCI, V18, P8444; Maren S, 2000, EUR J NEUROSCI, V12, P4047, DOI 10.1046/j.1460-9568.2000.00281.x; Maren S, 1999, TRENDS NEUROSCI, V22, P561, DOI 10.1016/S0166-2236(99)01465-4; Maren S, 1996, BEHAV NEUROSCI, V110, P1365, DOI 10.1037/0735-7044.110.6.1365; MCECHRON MD, 1995, BRAIN RES, V682, P157, DOI 10.1016/0006-8993(95)00331-J; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; MCNAUGHTON BL, 1983, J NEUROSCI METH, V8, P391, DOI 10.1016/0165-0270(83)90097-3; Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683; Pare D, 1996, J NEUROSCI, V16, P3334; Pare D, 2000, J NEUROSCI, V20, P2701; Paxinos G., 1986, RAT BRAIN STEREOTAXI, V2nd; PEARCE JM, 1980, PSYCHOL REV, V87, P532, DOI 10.1037/0033-295X.87.6.532; Poremba A, 2001, J NEUROSCI, V21, P270, DOI 10.1523/JNEUROSCI.21-01-00270.2001; Quirk GJ, 1996, COLD SPRING HARB SYM, V61, P247; Quirk GJ, 1997, NEURON, V19, P613, DOI 10.1016/S0896-6273(00)80375-X; QUIRK GJ, 1995, NEURON, V15, P1029, DOI 10.1016/0896-6273(95)90092-6; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; ROMANSKI LM, 1993, BEHAV NEUROSCI, V107, P444, DOI 10.1037/0735-7044.107.3.444; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schafe GE, 2000, J NEUROSCI, V20, P8177; Weinberger N M, 1993, Curr Opin Neurobiol, V3, P570, DOI 10.1016/0959-4388(93)90058-7; Weisskopf MG, 1999, J NEUROSCI, V19, P10512; Wilensky AE, 2000, J NEUROSCI, V20, P7059, DOI 10.1523/JNEUROSCI.20-18-07059.2000	48	333	337	0	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					724	731		10.1038/89512	http://dx.doi.org/10.1038/89512			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426229				2022-12-24	WOS:000169621300018
J	Lucas, RJ; Douglas, RH; Foster, RG				Lucas, RJ; Douglas, RH; Foster, RG			Characterization of an ocular photopigment capable of driving pupillary constriction in mice	NATURE NEUROSCIENCE			English	Article							LIGHT REFLEX; CIRCADIAN PHOTORECEPTION; RETINAL DEGENERATION; SPECTRAL SENSITIVITY; BODY-TEMPERATURE; VISUAL PIGMENTS; GANGLION-CELLS; ROYAL-COLLEGE; SURGEONS RATS; NON-CONE	This work demonstrates that transgenic mice lacking both rod and cone photoreceptors (rd/rd cl) retain a pupillary light reflex (PLR) that does not rely on local iris photoreceptors. These data, combined with previous reports that rodless and coneless mice show circadian and pineal responses to light, suggest that multiple non-image-forming light responses use non-rod, non-cone ocular photoreceptors in mice. An action spectrum for the PLR in rd/rd cl mice demonstrates that over the range 420-625 nm, this response is driven by a single opsin/vitamin A-based photopigment with peak sensitivity around 479 nm (opsin photopigment/OP479). These data represent the first functional characterization of a non-rod, non-cone photoreceptive system in the mammalian CNS.	Charing Cross Hosp, Imperial Coll, Sch Med,Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, London W6 8RF, England; City Univ London, Dept Optometry & Visual Sci, Appl Vis Res Ctr, London EC1V 0HB, England	Imperial College London; City University London	Lucas, RJ (corresponding author), Charing Cross Hosp, Imperial Coll, Sch Med,Dept Integrat & Mol Neurosci, Div Neurosci & Psychol Med, Fulham Palace Rd, London W6 8RF, England.	r.j.lucas@ic.ac.uk		Lucas, Robert/0000-0002-1088-8029				ALPERN M, 1972, VISION RES, V12, P943, DOI 10.1016/0042-6989(72)90016-8; ALPERN M, 1962, J PHYSIOL-LONDON, V164, P478, DOI 10.1113/jphysiol.1962.sp007033; BADIA P, 1991, PHYSIOL BEHAV, V50, P583, DOI 10.1016/0031-9384(91)90549-4; BITO LZ, 1975, COMP BIOCHEM PHYSIOL, V50, P407, DOI 10.1016/0300-9629(75)90034-1; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; BOWMAKER JK, 1972, VISION RES, V12, P529, DOI 10.1016/0042-6989(72)90149-6; BRIDGES CDB, 1959, NATURE, V184, P1727, DOI 10.1038/1841727a0; CAJOCHEN C, 1992, SLEEP, V15, P337; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; CARTERDAWSON LD, 1978, INVEST OPHTH VIS SCI, V17, P489; CZEISLER CA, 1995, NEW ENGL J MED, V332, P6, DOI 10.1056/NEJM199501053320102; FOSTER RG, 1993, J BIOL RHYTHM, V8, pS17; FOSTER RG, 1985, NATURE, V313, P50, DOI 10.1038/313050a0; Foster RG, 1998, NEURON, V20, P829, DOI 10.1016/S0896-6273(00)80464-X; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GOTO M, 1990, NEUROSCI LETT, V108, P267, DOI 10.1016/0304-3940(90)90652-P; Iwakabe H, 1997, NEUROPHARMACOLOGY, V36, P135, DOI 10.1016/S0028-3908(96)00167-0; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; Keeler CE, 1927, AM J PHYSIOL, V81, P107, DOI 10.1152/ajplegacy.1927.81.1.107; KLEIN DC, 1972, SCIENCE, V177, P532, DOI 10.1126/science.177.4048.532; Knowles A., 1977, PHOTOBIOLOGY VISION; KOVALEVSKY G, 1995, EXP NEUROL, V133, P43, DOI 10.1006/exnr.1995.1006; LAU KC, 1992, J NEUROL SCI, V113, P70, DOI 10.1016/0022-510X(92)90267-O; Lockley SW, 1997, J CLIN ENDOCR METAB, V82, P3763, DOI 10.1210/jc.82.11.3763; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lythgoe J.N., 1979, ECOLOGY VISION; Mrosovsky N, 1999, J COMP PHYSIOL A, V184, P423, DOI 10.1007/s003590050341; NELSON DE, 1991, J PHYSIOL-LONDON, V439, P115, DOI 10.1113/jphysiol.1991.sp018660; NELSON RJ, 1981, COMP BIOCHEM PHYS A, V69, P145, DOI 10.1016/0300-9629(81)90651-4; OHBA N, 1972, VISION RES, V12, P953, DOI 10.1016/0042-6989(72)90017-X; PARTRIDGE JC, 1991, VISION RES, V31, P619, DOI 10.1016/0042-6989(91)90002-M; PICKARD GE, 1985, NEUROSCI LETT, V55, P211, DOI 10.1016/0304-3940(85)90022-9; PROVENCIO I, 1994, VISION RES, V34, P1799, DOI 10.1016/0042-6989(94)90304-2; Provencio I, 1998, J COMP NEUROL, V395, P417, DOI 10.1002/(SICI)1096-9861(19980615)395:4<417::AID-CNE1>3.0.CO;2-4; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; PROVENCIO I, 1995, BRAIN RES, V694, P183, DOI 10.1016/0006-8993(95)00694-L; Selby CP, 2000, P NATL ACAD SCI USA, V97, P14697, DOI 10.1073/pnas.260498597; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; Sun H, 1997, P NATL ACAD SCI USA, V94, P8860, DOI 10.1073/pnas.94.16.8860; TREJO LJ, 1982, VISION RES, V22, P1163, DOI 10.1016/0042-6989(82)90081-5; von Schantz M, 2000, INVEST OPHTH VIS SCI, V41, P1605; Whiteley SJO, 1996, EXP NEUROL, V140, P100, DOI 10.1006/exnr.1996.0120; Whiteley SJO, 1998, EXP EYE RES, V66, P719, DOI 10.1006/exer.1997.0479; Whiteley SJO, 1998, EXP NEUROL, V154, P560, DOI 10.1006/exnr.1998.6959; Wolken J., 1995, LIGHT DETECTORS PHOT; Yoshimura T, 1996, J COMP PHYSIOL A, V178, P797; YOUNG MJ, 1994, NEUROSCIENCE, V62, P481, DOI 10.1016/0306-4522(94)90381-6	48	466	476	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					621	626		10.1038/88443	http://dx.doi.org/10.1038/88443			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369943				2022-12-24	WOS:000169061800015
J	Szczypka, MS; Kwok, K; Brot, MD; Marck, BT; Matsumoto, AM; Donahue, BA; Palmiter, RD				Szczypka, MS; Kwok, K; Brot, MD; Marck, BT; Matsumoto, AM; Donahue, BA; Palmiter, RD			Dopamine production in the caudate putamen restores feeding in dopamine-deficient mice	NEURON			English	Article							NUCLEUS-ACCUMBENS; FOOD-INTAKE; BEHAVIOR; REWARD; REINFORCEMENT; SHELL; MECHANISMS; MOTOR; 6-HYDROXYDOPAMINE; TRANSMISSION	Dopamine-deficient (DD) mice cannot synthesize dopamine (DA) in dopaminergic neurons due to selective inactivation of the tyrosine hydroxylase gene in those neurons. These mice become hypoactive and hypophagic and die of starvation by 4 weeks of age. We used gene therapy to ascertain where DA replacement in the brain restores feeding and other behaviors in DD mice. Restoration of DA production within the caudate putamen restores feeding on regular chow and nest-building behavior, whereas restoration of DA production in the nucleus accumbens restores exploratory behavior. Replacement of DA to either region restores preference for sucrose or a palatable diet without fully rescuing coordination or initiation of movement. These data suggest that a fundamental difference exists between feeding for sustenance and the ability to prefer rewarding substances.	Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Dept Biochem, Seattle, WA 98195 USA; Univ Washington, Dept Orthodont, Seattle, WA 98195 USA; Vet Adm Med Ctr, Gerontol Res Educ & Clin Ctr, Seattle, WA 98108 USA; Dept Med, Seattle, WA 98108 USA; Cell Genesys Inc, Dept Preclin Biol, Foster City, CA 94404 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cell Genesys Inc	Palmiter, RD (corresponding author), Univ Washington, Howard Hughes Med Inst, Box 357370, Seattle, WA 98195 USA.	palmiter@u.washington.edu	Matsumoto, Alvin/AAH-6096-2020		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK035816] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-08121] Funding Source: Medline; NIDDK NIH HHS [5 P30 DK35816-14] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGMO A, 1995, PHARMACOL BIOCHEM BE, V52, P403, DOI 10.1016/0091-3057(95)00128-J; Aubert A, 1997, BRAIN BEHAV IMMUN, V11, P107, DOI 10.1006/brbi.1997.0485; Bassareo V, 1999, EUR J NEUROSCI, V11, P4389, DOI 10.1046/j.1460-9568.1999.00843.x; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bussey TJ, 1997, BEHAV NEUROSCI, V111, P908, DOI 10.1037/0735-7044.111.5.908; Cadoni C, 2000, EUR J PHARMACOL, V388, P69, DOI 10.1016/S0014-2999(99)00824-9; Chase TN, 1996, ADV NEUROL, V69, P497; Cote L, 1999, NEUROLOGY, V52, pS7; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; EPSTEIN AN, 1971, PROGRESS PHYSIOLOGIC, P263; FOURIEZOS G, 1976, BRAIN RES, V103, P377, DOI 10.1016/0006-8993(76)90809-X; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; GRAYBIEL AM, 1990, ADV NEUROL, V53, P17; Haber SN, 2000, J NEUROSCI, V20, P2369; JANKOVIC J, 1992, SOUTHERN MED J, V85, P351, DOI 10.1097/00007611-199204000-00005; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; Kim DS, 2000, J NEUROSCI, V20, P4405, DOI 10.1523/JNEUROSCI.20-12-04405.2000; KOOB GF, 1992, TRENDS PHARMACOL SCI, V13, P177, DOI 10.1016/0165-6147(92)90060-J; LINDVALL O, 1983, CHEM NEUROANATOMY, P229; MALDONADOIRIZARRY CS, 1995, J NEUROSCI, V15, P6779; Mandel RJ, 1998, J NEUROSCI, V18, P4271; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; McBride WJ, 1999, BEHAV BRAIN RES, V101, P129, DOI 10.1016/S0166-4328(99)00022-4; MCGEORGE AJ, 1989, NEUROSCIENCE, V29, P503, DOI 10.1016/0306-4522(89)90128-0; NEILL DB, 1974, PHARM BIOCH BEHAV, V3, P485; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Obeso JA, 1997, ADV NEUROL, V74, P3; Pecina S, 2000, BRAIN RES, V863, P71, DOI 10.1016/S0006-8993(00)02102-8; PHILLIPS AG, 1993, CAN J PHYSIOL PHARM, V71, P387, DOI 10.1139/y93-059; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V114, P477, DOI 10.1007/BF02249339; PHILLIPS GD, 1994, PSYCHOPHARMACOLOGY, V114, P345, DOI 10.1007/BF02244858; Richardson NR, 1996, J NEUROSCI, V16, P8160; Rios M, 1999, J NEUROSCI, V19, P3519; SALAMONE JD, 1994, PHARMACOL BIOCHEM BE, V49, P25, DOI 10.1016/0091-3057(94)90452-9; SALAMONE JD, 1992, PSYCHOPHARMACOLOGY, V107, P160, DOI 10.1007/BF02245133; SALAMONE JD, 1993, PHARMACOL BIOCHEM BE, V44, P605, DOI 10.1016/0091-3057(93)90174-R; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Sawchenko PE, 1998, J COMP NEUROL, V402, P435; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P131, DOI 10.1016/S0149-7634(87)80019-2; SELF DW, 1995, ANNU REV NEUROSCI, V18, P463, DOI 10.1146/annurev.neuro.18.1.463; Sherwin CM, 1997, LAB ANIM, V31, P125, DOI 10.1258/002367797780600134; Smith GP, 1995, PROG PSYCHOB PHYSIOL, V16, P83; Stratford TR, 1997, J NEUROSCI, V17, P4434; Szczypka MS, 1999, P NATL ACAD SCI USA, V96, P12138, DOI 10.1073/pnas.96.21.12138; Szczypka MS, 1999, NEURON, V22, P167, DOI 10.1016/S0896-6273(00)80688-1; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P95; WHITE NM, 1986, NEUROSCI BIOBEHAV R, V10, P15, DOI 10.1016/0149-7634(86)90030-8; WILSON C, 1995, J NEUROSCI, V15, P5169; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Zahm DS, 1999, ANN NY ACAD SCI, V877, P113, DOI 10.1111/j.1749-6632.1999.tb09264.x; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0; ZIGMOND MJ, 1972, SCIENCE, V177, P1211	55	267	271	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					819	828		10.1016/S0896-6273(01)00319-1	http://dx.doi.org/10.1016/S0896-6273(01)00319-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430814	Bronze			2022-12-24	WOS:000169508900021
J	Lan, JY; Skeberdis, VA; Jover, T; Grooms, SY; Lin, Y; Araneda, RC; Zheng, X; Bennett, MVL; Zukin, RS				Lan, JY; Skeberdis, VA; Jover, T; Grooms, SY; Lin, Y; Araneda, RC; Zheng, X; Bennett, MVL; Zukin, RS			Protein kinase C modulates NMDA receptor trafficking and gating	NATURE NEUROSCIENCE			English	Article							METHYL-D-ASPARTATE; LONG-TERM POTENTIATION; GLUTAMATE RECEPTORS; OPEN PROBABILITY; PYRAMIDAL CELLS; RAT HIPPOCAMPUS; XENOPUS OOCYTES; NR1 SUBUNIT; PHOSPHORYLATION; CHANNEL	Regulation of neuronal N-methyl-D-aspartate receptors (NMDARs) by protein kinases is critical in synaptic transmission. However, the molecular mechanisms underlying protein kinase C (PKC) potentiation of NMDARs are uncertain. Here we demonstrate that PKC increases NMDA channel opening rate and delivers new NMDA channels to the plasma membrane through regulated exocytosis. PKC induced a rapid delivery of functional NMDARs to the cell surface and increased surface NR1 immunofluorescence in Xenopus oocytes expressing NMDARs. PKC potentiation was inhibited by botulinum neurotoxin A and a dominant negative mutant of soluble NSF-associated protein (SNAP-25), suggesting that receptor trafficking occurs via SNARE-dependent exocytosis. In neurons, PKC induced a rapid delivery of functional NMDARs, assessed by electrophysiology, and an increase in NMDAR clusters on the surface of dendrites and dendritic spines, as indicated by immunofluorescence. Thus, PKC regulates NMDAR channel gating and trafficking in recombinant systems and in neurons, mechanisms that may be relevant to synaptic plasticity.	Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Bennett, MVL (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Araneda, Ricardo/AAN-1051-2020; Bennett, Michael/A-6958-2009	Araneda, Ricardo/0000-0001-8728-3063; Skeberdis, Vytenis Arvydas/0000-0001-7137-3187	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031282, R01NS020752] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 31282, NS 07512, NS 20752] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABELIOVICH A, 1993, CELL, V75, P1253, DOI 10.1016/0092-8674(93)90613-U; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; ANIKSZTEJN L, 1991, EUR J PHARMACOL, V205, P327, DOI 10.1016/0014-2999(91)90921-C; BANKER G, 1988, NATURE, V336, P185, DOI 10.1038/336185a0; BENNETT MK, 1993, P NATL ACAD SCI USA, V90, P2559, DOI 10.1073/pnas.90.7.2559; Carroll RC, 1998, J NEUROPHYSIOL, V80, P2797, DOI 10.1152/jn.1998.80.5.2797; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Chen FS, 1997, BIOCHEMISTRY-US, V36, P5719, DOI 10.1021/bi962331n; CHEN L, 1992, NATURE, V356, P521, DOI 10.1038/356521a0; CHEN L, 1991, NEURON, V7, P319, DOI 10.1016/0896-6273(91)90270-A; Chen NS, 1999, J NEUROSCI, V19, P6844, DOI 10.1523/JNEUROSCI.19-16-06844.1999; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Filippova N, 1999, J PHYSIOL-LONDON, V518, P385, DOI 10.1111/j.1469-7793.1999.0385p.x; Gazzaley AH, 1996, J NEUROSCI, V16, P6830; Genoud S, 1999, J NEUROCHEM, V72, P1699, DOI 10.1046/j.1471-4159.1999.721699.x; GERBER G, 1989, J NEUROSCI, V9, P3606; HOLLMANN M, 1994, NEURON, V13, P1331, DOI 10.1016/0896-6273(94)90419-7; Hrabetova S, 1996, J NEUROSCI, V16, P5324; HU GY, 1987, NATURE, V328, P426, DOI 10.1038/328426a0; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; JAHR CE, 1992, SCIENCE, V255, P470, DOI 10.1126/science.1346477; KELSO SR, 1992, J PHYSIOL-LONDON, V449, P705, DOI 10.1113/jphysiol.1992.sp019110; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; LIEBERMAN DN, 1994, NATURE, V369, P235, DOI 10.1038/369235a0; Lledo PM, 1998, SCIENCE, V279, P399, DOI 10.1126/science.279.5349.399; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MARKRAM H, 1990, NEUROSCI LETT, V113, P62, DOI 10.1016/0304-3940(90)90495-U; MORI H, 1993, NEUROREPORT, V4, P519, DOI 10.1097/00001756-199305000-00014; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Okabe S, 1999, J NEUROSCI, V19, P7781; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Pisani A, 1997, BRIT J PHARMACOL, V120, P1007, DOI 10.1038/sj.bjp.0700999; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; ROSENMUND C, 1995, J NEUROSCI, V15, P2788; ROSSETTO O, 1994, NATURE, V372, P415, DOI 10.1038/372415a0; Shimazaki Y, 1996, J BIOL CHEM, V271, P14548, DOI 10.1074/jbc.271.24.14548; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; Sweatt JD, 1998, J NEUROCHEM, V71, P1075; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Yamada Y, 1999, J BIOL CHEM, V274, P6647, DOI 10.1074/jbc.274.10.6647; Yao Y, 1999, CELL, V98, P475, DOI 10.1016/S0092-8674(00)81976-5; Yu SP, 1997, J PHYSIOL-LONDON, V499, P721, DOI 10.1113/jphysiol.1997.sp021964; Zampighi GA, 1999, J GEN PHYSIOL, V113, P507, DOI 10.1085/jgp.113.4.507; Zheng X, 1999, P NATL ACAD SCI USA, V96, P15262, DOI 10.1073/pnas.96.26.15262	50	333	345	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					382	390		10.1038/86028	http://dx.doi.org/10.1038/86028			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276228				2022-12-24	WOS:000168762200018
J	Hannan, AJ; Blakemore, C; Katsnelson, A; Vitalis, T; Huber, KM; Bear, M; Roder, J; Kim, D; Shin, HS; Kind, PC				Hannan, AJ; Blakemore, C; Katsnelson, A; Vitalis, T; Huber, KM; Bear, M; Roder, J; Kim, D; Shin, HS; Kind, PC			PLC-beta 1, activated via mGluRs, mediates activity-dependent differentiation in cerebral cortex	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; LONG-TERM POTENTIATION; MOUSE SOMATOSENSORY CORTEX; CAT VISUAL-CORTEX; CRITICAL PERIOD; MONOAMINE-OXIDASE; BARREL CORTEX; POSTNATAL-DEVELOPMENT; PATTERN-FORMATION; RAT	During development of the cerebral cortex, the invasion of thalamic axons and subsequent differentiation of cortical neurons are tightly coordinated. Here we provide evidence that glutamate neurotransmission triggers a critical signaling mechanism involving the activation of phospholipase C-beta1 (PLC-beta1) by metabotropic glutamate receptors (mGluRs). Homozygous null mutation of either PLC-beta1 or mGluR5 dramatically disrupts the cytoarchitectural differentiation of 'barrels' in the mouse somatosensory cortex, despite segregation in the pattern of thalamic innervation. Furthermore, group 1 mGluR-stimulated phosphoinositide hydrolysis is dramatically reduced in PLC-beta1(-/-) mice during barrel development. Our data indicate that PLC-beta1 activation via mGluR5 is critical for the coordinated development of the neocortex, and that presynaptic and postsynaptic components of cortical differentiation can be genetically dissociated.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Edinburgh, Dept Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland; Brown Univ, Dept Neurosci, Providence, RI 02912 USA; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Pohang Univ Sci & Technol, Dept Life Sci, Natl CRI Ctr Calcium & Learning, Pohang 790784, South Korea	University of Oxford; University of Edinburgh; Brown University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Pohang University of Science & Technology (POSTECH)	Kind, PC (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Roder, John/G-6468-2013; De Granzial, Nadine-Tania Vitalis/K-8485-2017; Huber, Kimberly/X-5534-2019; Kim, Daesoo/C-1625-2011	De Granzial, Nadine-Tania Vitalis/0000-0002-5531-3771; Kim, Daesoo/0000-0001-9915-1463; Kind, Peter/0000-0002-4256-9639; Hannan, Anthony/0000-0001-7532-8922; Blakemore, Colin/0000-0003-2659-7899				Abdel-Majid RM, 1998, NAT GENET, V19, P289, DOI 10.1038/980; AGMON A, 1995, J NEUROSCI, V15, P549; AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; BASHIR ZI, 1993, NATURE, V363, P347, DOI 10.1038/363347a0; BEAR MF, 1986, NATURE, V320, P172, DOI 10.1038/320172a0; Bevilacqua JA, 1995, J NEUROSCI, V15, P7916; Blue ME, 1997, J COMP NEUROL, V386, P16; Cases O, 1996, NEURON, V16, P297, DOI 10.1016/S0896-6273(00)80048-3; Cases O, 1998, J NEUROSCI, V18, P6914; CHIAIA NL, 1992, DEV BRAIN RES, V66, P244, DOI 10.1016/0165-3806(92)90086-C; DeCamilli P, 1996, SCIENCE, V271, P1533, DOI 10.1126/science.271.5255.1533; DIXON JF, 1994, P NATL ACAD SCI USA, V91, P8358, DOI 10.1073/pnas.91.18.8358; DUDEK SM, 1989, SCIENCE, V246, P673, DOI 10.1126/science.2573152; FABBRI M, 1994, J BIOL CHEM, V269, P26848; Fitzjohn SM, 1999, NEUROPHARMACOLOGY, V38, P1577, DOI 10.1016/S0028-3908(99)00123-9; Fox K, 1996, P NATL ACAD SCI USA, V93, P5584, DOI 10.1073/pnas.93.11.5584; Glazewski S, 2000, NAT NEUROSCI, V3, P911, DOI 10.1038/78820; GREENOUGH WT, 1988, DEV BRAIN RES, V43, P148, DOI 10.1016/0165-3806(88)90160-5; Hannan AJ, 1998, NEUROPHARMACOLOGY, V37, P593, DOI 10.1016/S0028-3908(98)00056-2; HENDERSON TA, 1992, DEV BRAIN RES, V66, P146, DOI 10.1016/0165-3806(92)90152-M; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059; Jia ZP, 1998, LEARN MEMORY, V5, P331; KATO N, 1993, P NATL ACAD SCI USA, V90, P3650, DOI 10.1073/pnas.90.8.3650; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KILLACKEY HP, 1979, J COMP NEUROL, V183, P285, DOI 10.1002/cne.901830206; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; KIND P, 1994, CEREB CORTEX, V4, P361, DOI 10.1093/cercor/4.4.361; Kind PC, 1997, J NEUROSCI, V17, P1471; Lebrand C, 1996, NEURON, V17, P823, DOI 10.1016/S0896-6273(00)80215-9; Lu YM, 1997, J NEUROSCI, V17, P5196; Munoz A, 1999, J COMP NEUROL, V409, P549; O'Leary D D, 1994, Curr Opin Neurobiol, V4, P535, DOI 10.1016/0959-4388(94)90054-X; OCONNOR JJ, 1995, J NEUROSCI, V15, P2013, DOI 10.1523/JNEUROSCI.15-03-02013.1995; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; REID SNM, 1995, J COMP NEUROL, V355, P470, DOI 10.1002/cne.903550311; Sabatini DD, 1996, BIOCELL, V20, P287; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; VANDERLO.H, 1973, SCIENCE, V179, P395, DOI 10.1126/science.179.4071.395; Vitalis T, 1998, J COMP NEUROL, V393, P169, DOI 10.1002/(SICI)1096-9861(19980406)393:2<169::AID-CNE3>3.0.CO;2-0; Walikonis RS, 2000, J NEUROSCI, V20, P4069; WELKER E, 1986, J NEUROSCI, V6, P3355; Welker E, 1996, SCIENCE, V271, P1864, DOI 10.1126/science.271.5257.1864; Westermann P, 1996, BIOCHEM J, V320, P651, DOI 10.1042/bj3200651; WOOLSEY TA, 1975, P NATL ACAD SCI USA, V72, P2165, DOI 10.1073/pnas.72.6.2165; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZHENG F, 1992, NEURON, V9, P163, DOI 10.1016/0896-6273(92)90231-2	50	174	181	0	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					282	288		10.1038/85132	http://dx.doi.org/10.1038/85132			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224545				2022-12-24	WOS:000167178300016
J	Goldberg, JL; Espinosa, JS; Xu, YF; Davidson, N; Kovacs, GTA; Barres, BA				Goldberg, JL; Espinosa, JS; Xu, YF; Davidson, N; Kovacs, GTA; Barres, BA			Retinal ganglion cells do not extend axons by default: Promotion by neurotrophic signaling and electrical activity	NEURON			English	Article							ADULT SENSORY NEURONS; BCL-2 TRANSGENIC MICE; GROWTH CONE MOTILITY; NEURITE OUTGROWTH; MICROELECTRODE ARRAYS; TROPHIC FACTORS; SEVERED AXONS; MAMMALIAN CNS; SPINAL-CORD; IN-VIVO	We investigate the signaling mechanisms that induce retinal ganglion cell (RGC) axon elongation by asking whether surviving neurons extend axons by default. We show that bcl-2 overexpression is sufficient to keep purified RGCs alive in the absence of any glial or trophic support. The bcl-2-expressing RGCs do not extend axons or dendrites unless signaled to do so by single peptide trophic factors. Axon growth stimulated by peptide trophic factors is remarkably slow but is profoundly potentiated by physiological levels of electrical activity spontaneously generated within embryonic explants or mimicked on a multielectrode silicon chip. These findings demonstrate that these surviving neurons do not constitutively extend axons and provide insight into the signals that may be necessary to promote CNS regeneration.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; Stanford Univ, CIS 202X, Dept Elect Engn, Stanford, CA 94305 USA	Stanford University; California Institute of Technology; Stanford University	Goldberg, JL (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Sherman Fairchild Sci Bldg D231,299 Campus Dr, Stanford, CA 94305 USA.	jlgoldbe@stanford.edu		Goldberg, Jeffrey/0000-0002-1390-7360	NATIONAL EYE INSTITUTE [U10EY011030] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007365] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY11030] Funding Source: Medline; NIGMS NIH HHS [2T32GM07365] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHESON A, 1995, NATURE, V374, P450, DOI 10.1038/374450a0; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; BAHR M, 1988, EXP BRAIN RES, V73, P393; BARDE Y-A, 1990, Progress in Growth Factor Research, V2, P237, DOI 10.1016/0955-2235(90)90021-B; BARDE YA, 1989, NEURON, V2, P1525, DOI 10.1016/0896-6273(89)90040-8; BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1993, NATURE, V361, P258, DOI 10.1038/361258a0; BARRES BA, 1993, DEVELOPMENT, V118, P283; BernsteinGoral H, 1997, EXP NEUROL, V148, P13, DOI 10.1006/exnr.1997.6640; BIXBY JL, 1988, J CELL BIOL, V107, P353, DOI 10.1083/jcb.107.1.353; Bonfanti L, 1996, J NEUROSCI, V16, P4186; Borkholder DA, 1997, J NEUROSCI METH, V77, P61, DOI 10.1016/S0165-0270(97)00112-X; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; CALOF AL, 1994, NEURON, V13, P117, DOI 10.1016/0896-6273(94)90463-4; CAMPENOT RB, 1994, J NEUROBIOL, V25, P599, DOI 10.1002/neu.480250603; Cantallops I, 2000, NAT NEUROSCI, V3, P1004, DOI 10.1038/79823; Cenni MC, 1996, EUR J NEUROSCI, V8, P1735, DOI 10.1111/j.1460-9568.1996.tb01317.x; Chen DF, 1997, NATURE, V385, P434, DOI 10.1038/385434a0; Chierzi S, 1999, J NEUROSCI, V19, P8367; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Cohen-Cory S, 1999, J NEUROSCI, V19, P9996; Cui Q, 1999, INVEST OPHTH VIS SCI, V40, P760; Deckwerth TL, 1996, NEURON, V17, P401, DOI 10.1016/S0896-6273(00)80173-7; Du J, 2000, J CELL BIOL, V150, P1423, DOI 10.1083/jcb.150.6.1423; DUSART I, 1994, J COMP NEUROL, V347, P211, DOI 10.1002/cne.903470206; EDGAR D, 1985, J CELL SCI, P107; Ehrengruber MU, 1998, METHOD ENZYMOL, V293, P483; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; FIELDS RD, 1990, J NEUROSCI, V10, P2950; FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670; Goldberg JL, 2000, ANNU REV NEUROSCI, V23, P579, DOI 10.1146/annurev.neuro.23.1.579; Gomez TM, 1999, NATURE, V397, P350, DOI 10.1038/16927; Gomez TM, 2001, SCIENCE, V291, P1983, DOI 10.1126/science.1056490; Gramowski A, 2000, NEUROTOXICOLOGY, V21, P331; GROSS GW, 1993, J NEUROSCI METH, V50, P131, DOI 10.1016/0165-0270(93)90001-8; Harada T, 2000, NEURON, V26, P533, DOI 10.1016/S0896-6273(00)81185-X; HARRIS WA, 1980, J COMP NEUROL, V194, P303, DOI 10.1002/cne.901940203; HOFER MM, 1988, NATURE, V331, P261, DOI 10.1038/331261a0; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jenkner M, 2001, BIOL CYBERN, V84, P239, DOI 10.1007/s004220000218; Jo SA, 1999, NEUROSCIENCE, V89, P579, DOI 10.1016/S0306-4522(98)00546-6; JOHNSON JE, 1986, J NEUROSCI, V6, P3031; LANDER AD, 1985, P NATL ACAD SCI USA, V82, P2183, DOI 10.1073/pnas.82.7.2183; LANDER AD, 1985, J CELL BIOL, V101, P898, DOI 10.1083/jcb.101.3.898; LETOURNEAU PC, 1978, DEV BIOL, V66, P183, DOI 10.1016/0012-1606(78)90283-X; LEVIMONTALCINI R, 1987, EMBO J, V6, P1145, DOI 10.1002/j.1460-2075.1987.tb02347.x; LINDSAY RM, 1985, DEV BIOL, V112, P319, DOI 10.1016/0012-1606(85)90402-6; LINDSAY RM, 1988, J NEUROSCI, V8, P2394; LIPTON SA, 1988, P NATL ACAD SCI USA, V85, P2388, DOI 10.1073/pnas.85.7.2388; LOCHTER A, 1993, J NEUROSCI, V13, P3986; Lodovichi C, 2001, EUR J NEUROSCI, V13, P833, DOI 10.1046/j.1460-9568.2001.01440.x; Maher MP, 1999, J NEUROSCI METH, V87, P45, DOI 10.1016/S0165-0270(98)00156-3; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; MARTINOU JC, 1994, NEURON, V13, P1017, DOI 10.1016/0896-6273(94)90266-6; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; Meyer-Franke A, 1998, NEURON, V21, P681, DOI 10.1016/S0896-6273(00)80586-3; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Mi HY, 1999, J NEUROSCI, V19, P1049; Michaelidis TM, 1996, NEURON, V17, P75, DOI 10.1016/S0896-6273(00)80282-2; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NEUGEBAUER KM, 1991, NATURE, V350, P68, DOI 10.1038/350068a0; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; RASHID NA, 1992, DEV BRAIN RES, V67, P301, DOI 10.1016/0165-3806(92)90231-K; Scholl M, 2000, J NEUROSCI METH, V104, P65, DOI 10.1016/S0165-0270(00)00325-3; Schwab ME, 1996, PHYSIOL REV, V76, P319, DOI 10.1152/physrev.1996.76.2.319; Service RFS, 1999, SCIENCE, V284, P578, DOI 10.1126/science.284.5414.578; Shen SL, 1999, NEURON, V23, P285, DOI 10.1016/S0896-6273(00)80780-1; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; Suter DM, 2000, J NEUROBIOL, V44, P97, DOI 10.1002/1097-4695(200008)44:2<97::AID-NEU2>3.0.CO;2-U; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang H, 1999, NATURE, V401, P765, DOI 10.1038/44521; Watson FL, 1999, J NEUROSCI, V19, P7889; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong WT, 1998, J NEUROSCI, V18, P8839	79	353	360	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB 28	2002	33	5					689	702		10.1016/S0896-6273(02)00602-5	http://dx.doi.org/10.1016/S0896-6273(02)00602-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	529EC	11879647	Bronze			2022-12-24	WOS:000174286200006
J	Behra, M; Cousin, X; Bertrand, C; Vonesch, JL; Biellmann, D; Chatonnet, A; Strahle, U				Behra, M; Cousin, X; Bertrand, C; Vonesch, JL; Biellmann, D; Chatonnet, A; Strahle, U			Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo	NATURE NEUROSCIENCE			English	Article							MONOCLONAL-ANTIBODIES; MUSCLE DEVELOPMENT; WILD-TYPE; EXPRESSION; CHOLINESTERASES; HINDBRAIN; IDENTIFICATION; MOTONEURONS; VERTEBRATE; OUTGROWTH	The neurotransmitter acetylcholine (ACh) has a crucial role in central and neuromuscular synapses of the cholinergic system. After release into the synaptic cleft, ACh is rapidly degraded by acetylcholinesterase (AChE). We have identified a mutation in the ache gene of the zebrafish, which abolishes ACh hydrolysis in homozygous animals completely. Embryos are initially motile but subsequently develop paralysis. Mutant embryos show defects in muscle fiber formation and innervation, and primary sensory neurons die prematurely. The neuromuscular phenotype in ache mutants is suppressed by a homozygous loss-of-function allele of the alpha-subunit of the nicotinic acetylcholine receptor (nAChR), indicating that the impairment of neuromuscular development is mediated by activation of nAChR in the mutant. Here we provide genetic evidence for non-classical functions of AChE in vertebrate development.	ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, F-67404 Illkirch Graffenstaden, France; INRA, Unite Differenciat Cellulaire & Croissance, F-34060 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; INRAE	Strahle, U (corresponding author), ULP, Inst Genet & Biol Mol & Cellulaire, CNRS, INSERM, BP 163,CU Strasbourg, F-67404 Illkirch Graffenstaden, France.		BERTRAND-GADAY, Christelle/ABA-8619-2021; Chatonnet, Arnaud/AAM-5569-2021; Straehle, Uwe/K-7054-2013; Chatonnet, Arnaud/E-2190-2017; Cousin, Xavier/E-2542-2013	BERTRAND-GADAY, Christelle/0000-0003-0461-2402; Chatonnet, Arnaud/0000-0002-4057-3896; Cousin, Xavier/0000-0002-8520-3610; Behra, Martine/0000-0001-8107-6565				Bertrand C, 2001, J BIOL CHEM, V276, P464, DOI 10.1074/jbc.M006308200; Buonanno A, 1999, CURR OPIN NEUROBIOL, V9, P110, DOI 10.1016/S0959-4388(99)80014-2; Coronas V, 2000, NEUROSCIENCE, V98, P213, DOI 10.1016/S0306-4522(00)00143-3; Cousin X, 1998, NUCLEIC ACIDS RES, V26, P226, DOI 10.1093/nar/26.1.226; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; Devoto SH, 1996, DEVELOPMENT, V122, P3371; EISEN JS, 1986, NATURE, V320, P269, DOI 10.1038/320269a0; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Feng GP, 1999, J CELL BIOL, V144, P1349, DOI 10.1083/jcb.144.6.1349; HANNEMAN E, 1989, J COMP NEUROL, V284, P350, DOI 10.1002/cne.902840303; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Koenigsberger C, 1997, J NEUROCHEM, V69, P1389; LASKOWSKI MB, 1977, EXP NEUROL, V57, P13, DOI 10.1016/0014-4886(77)90041-3; LAYER PG, 1995, PROG HISTOCHEM CYTOC, V29, P1; LAYER PG, 1990, BIOESSAYS, V12, P415, DOI 10.1002/bies.950120904; LEONARD JP, 1979, J CELL BIOL, V82, P811, DOI 10.1083/jcb.82.3.811; Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025; LINTON DM, 1990, DM-DIS MON, V36, P593; LIU DWC, 1992, J NEUROSCI, V12, P1859; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; MILLARD CB, 1995, J NEUROCHEM, V64, P1909, DOI 10.1046/j.1471-4159.1995.64051909.x; MILLER JB, 1989, J BIOL CHEM, V264, P13122; Muller F, 1999, DEVELOPMENT, V126, P2103; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; PARNETTI L, 1995, CLIN PHARMACOKINET, V29, P110, DOI 10.2165/00003088-199529020-00005; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Sambrock J, 2001, MOL CLONING LAB MANU, V3rd; Sepich DS, 1998, GENETICS, V148, P361; Silver A., 1974, BIOL CHOLINESTERASES; Simon S, 1999, J BIOL CHEM, V274, P27740, DOI 10.1074/jbc.274.39.27740; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Soreq H, 2001, NAT REV NEUROSCI, V2, P294, DOI 10.1038/35067589; Sternfeld M, 1998, J NEUROSCI, V18, P1240; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; TESSIERLAVIGNE M, 1994, CURR OPIN GENET DEV, V4, P596, DOI 10.1016/0959-437X(94)90078-H; Ticho BS, 1996, MECH DEVELOP, V59, P205, DOI 10.1016/0925-4773(96)00601-6; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WECKER L, 1986, FUND APPL TOXICOL, V6, P172, DOI 10.1016/0272-0590(86)90273-3; Weinberg ES, 1996, DEVELOPMENT, V122, P271; WESTERFIELD M, 1992, GENE DEV, V6, P591, DOI 10.1101/gad.6.4.591; WESTERFIELD M, 1990, NEURON, V4, P867, DOI 10.1016/0896-6273(90)90139-7; WESTERFIELD M, 1993, ZEBRA FISH BOOK; Williams JA, 2000, DEV BIOL, V226, P220, DOI 10.1006/dbio.2000.9860; Xie WH, 2000, J PHARMACOL EXP THER, V293, P896	50	280	289	4	30	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					111	118		10.1038/nn788	http://dx.doi.org/10.1038/nn788			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11753420				2022-12-24	WOS:000173558400012
J	Rodriguez, I; Del Punta, K; Rothman, A; Ishii, T; Mombaerts, P				Rodriguez, I; Del Punta, K; Rothman, A; Ishii, T; Mombaerts, P			Multiple new and isolated families within the mouse superfamily of V1r vomeronasal receptors	NATURE NEUROSCIENCE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; NEURONS; GENES; LOCALIZATION; ORGANIZATION; PROJECTIONS; EXPRESSION; SELECTION; PUBERTY	Seven-transmembrane-domain proteins encoded by the vomeronasal receptor V1r and V2r gene superfamilies, and expressed by vomeronasal sensory neurons, are believed to be pheromone receptors in rodents. Four V1r gene families have been described in the mouse (V1ra, V1rb, V1rc and V3r). Here we have screened near-complete mouse genomic databases to obtain a first global draft of the mouse V1r repertoire, including 104 new V1r genes. It comprises eight new and extremely isolated families in addition to the four families previously identified. Members of these new families were expressed in vomeronasal sensory neurons. The genome-wide view revealed great sequence diversity within the V1r superfamily. Phylogenetic analyses suggested an ancient original radiation, followed by the isolation, divergence and expansion of families by extensive gene duplications and frequent gene loss. The isolated nature of these gene families probably reflects a specialization of different receptor classes in the detection of specific types of chemicals.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Rodriguez, I (corresponding author), Univ Geneva, CMU, Dept Zool & Anim Biol, CH-1211 Geneva 4, Switzerland.	Ivan.Rodriguez@zoo.unige.ch; peter@rockefeller.edu		rodriguez, ivan/0000-0002-6468-0565				Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Berghard A, 1996, J NEUROSCI, V16, P909; Birkett MA, 2000, P NATL ACAD SCI USA, V97, P9329, DOI 10.1073/pnas.160241697; Cadavid LF, 1997, P NATL ACAD SCI USA, V94, P14536, DOI 10.1073/pnas.94.26.14536; Cao YX, 1998, P NATL ACAD SCI USA, V95, P11987, DOI 10.1073/pnas.95.20.11987; Del Punta K, 2000, GENOME RES, V10, P1958, DOI 10.1101/gr.10.12.1958; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Giorgi D, 2000, GENOME RES, V10, P1979, DOI 10.1101/gr.10.12.1979; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Gorodkin J, 1997, COMPUT APPL BIOSCI, V13, P583; HALPERN M, 1987, ANNU REV NEUROSCI, V10, P325, DOI 10.1146/annurev.ne.10.030187.001545; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; HILDEBRAND JG, 1995, P NATL ACAD SCI USA, V92, P67, DOI 10.1073/pnas.92.1.67; HIROTA S, 1992, MOL BRAIN RES, V15, P47, DOI 10.1016/0169-328X(92)90150-A; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; KARLSON P, 1959, NATURE, V183, P55, DOI 10.1038/183055a0; Keverne EB, 1999, SCIENCE, V286, P716, DOI 10.1126/science.286.5440.716; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Metz EC, 1996, MOL BIOL EVOL, V13, P397, DOI 10.1093/oxfordjournals.molbev.a025598; Naito T, 1998, P NATL ACAD SCI USA, V95, P5178, DOI 10.1073/pnas.95.9.5178; Norlin EM, 2001, MOL CELL NEUROSCI, V17, P872, DOI 10.1006/mcne.2001.0976; NOVOTNY M, 1986, SCIENCE, V231, P722, DOI 10.1126/science.3945805; NOVOTNY M, 1985, P NATL ACAD SCI USA, V82, P2059, DOI 10.1073/pnas.82.7.2059; Novotny MV, 1999, CHEM BIOL, V6, P377, DOI 10.1016/S1074-5521(99)80049-0; Otaki JM, 2001, J THEOR BIOL, V211, P77, DOI 10.1006/jtbi.2001.2272; Pantages E, 2000, NEURON, V28, P835, DOI 10.1016/S0896-6273(00)00157-4; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Saito H, 1998, MOL BRAIN RES, V60, P215, DOI 10.1016/S0169-328X(98)00183-1; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Speca DJ, 1999, NEURON, V23, P487, DOI 10.1016/S0896-6273(00)80802-8; STROTMANN J, 1994, CELL TISSUE RES, V278, P11, DOI 10.1007/s004410050189; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Wallace KJ, 2000, BEHAV NEUROSCI, V114, P912, DOI 10.1037//0735-7044.114.5.912; WANG D, 1993, BRAIN BEHAV EVOLUT, V41, P246, DOI 10.1159/000113846; WYSOCKI CJ, 1991, J STEROID BIOCHEM, V39, P661, DOI 10.1016/0960-0760(91)90265-7; Zhang XM, 2002, NAT NEUROSCI, V5, P124, DOI 10.1038/nn800; Zozulya S, 2001, GENOME BIOL, V2	43	154	167	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					134	140		10.1038/nn795	http://dx.doi.org/10.1038/nn795			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802169				2022-12-24	WOS:000173558400015
J	Suh, GSB; Poeck, B; Chouard, T; Oron, E; Segal, D; Chamovitz, DA; Zipursky, SL				Suh, GSB; Poeck, B; Chouard, T; Oron, E; Segal, D; Chamovitz, DA; Zipursky, SL			Drosophila JAB1/CSN5 acts in photoreceptor cells to induce glial cells	NEURON			English	Article							POLARITY GENE HEDGEHOG; COP9 SIGNALOSOME; AXON GUIDANCE; BITHORAX COMPLEX; NERVOUS-SYSTEM; VISUAL-SYSTEM; MELANOGASTER; PROTEIN; LIGHT; ARABIDOPSIS	Different classes of photoreceptor neurons (R cells) in the Drosophila compound eye form connections in different optic ganglia, The R1-R6 subclass connects to the first optic ganglion, the lamina, and relies upon glial cells as intermediate targets. Conversely, R cells promote glial cell development including migration of glial cells into the target region. Here, we show that the JAB1/CSN5 subunit of the COP9 signalosome complex is expressed in R cells, accumulates in the developing optic lobe neuropil, and through the analysis of a unique set of missense mutations, is required in R cells to induce lamina glial cell migration. In these CSN5 alleles, R1-R6 targeting is disrupted. Genetic analysis of protein null alleles further revealed that the COP9 signalosome is required at an earlier stage of development for R cell differentiation.	Univ Calif Los Angeles, Dept Biol Chem, Howard Hughes Med Inst, Sch Med, Los Angeles, CA 90095 USA; Univ Regensburg, Lehrstuhl Entwicklungsbiol, Inst Zool, D-93053 Regensburg, Germany; Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Regensburg; Tel Aviv University; Tel Aviv University	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, Howard Hughes Med Inst, Sch Med, Los Angeles, CA 90095 USA.		Chamovitz, Daniel/S-5021-2019	Chamovitz, Daniel/0000-0002-2815-2909; Segal, Daniel/0000-0002-6777-505X; Zipursky, Stephen/0000-0001-5630-7181				ASHBURNER M, 1989, DROSPHILA LAB MANUAL; Bech-Otschir D, 2001, EMBO J, V20, P1630, DOI 10.1093/emboj/20.7.1630; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; CAMPOS AR, 1985, J NEUROGENET, V2, P197, DOI 10.3109/01677068509100150; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Chamovitz DA, 2001, EMBO REP, V2, P96, DOI 10.1093/embo-reports/kve028; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Freilich S, 1999, CURR BIOL, V9, P1187, DOI 10.1016/S0960-9822(00)80023-8; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; HOMYK T, 1985, J NEUROGENET, V2, P309, DOI 10.3109/01677068509102326; HOPMANN R, 1995, GENETICS, V139, P815; Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2; Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6; Karniol B, 2000, CURR OPIN PLANT BIOL, V3, P387, DOI 10.1016/S1369-5266(00)00101-1; Kim TH, 2001, TRENDS PLANT SCI, V6, P379, DOI 10.1016/S1360-1385(01)02015-5; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; MA CY, 1993, CELL, V75, P927, DOI 10.1016/0092-8674(93)90536-Y; MEYEROWITZ EM, 1978, DEV BIOL, V62, P112, DOI 10.1016/0012-1606(78)90096-9; Naumann M, 1999, J BIOL CHEM, V274, P35297, DOI 10.1074/jbc.274.50.35297; Newsome TP, 2000, DEVELOPMENT, V127, P851; Newsome TP, 2000, CELL, V101, P283, DOI 10.1016/S0092-8674(00)80838-7; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; Osterlund MT, 1999, TRENDS CELL BIOL, V9, P113, DOI 10.1016/S0962-8924(99)01499-3; PALAZZOLO MJ, 1990, GENE, V88, P25, DOI 10.1016/0378-1119(90)90056-W; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Perez SE, 1996, J NEUROBIOL, V30, P359, DOI 10.1002/(SICI)1097-4695(199607)30:3<359::AID-NEU5>3.0.CO;2-3; PIERCE JC, 1992, METHOD ENZYMOL, V216, P549; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Power ME, 1943, J EXP ZOOL, V94, P33, DOI 10.1002/jez.1400940103; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; SALECKER I, 1995, J COMP NEUROL, V352, P33, DOI 10.1002/cne.903520104; Salecker I, 1998, CELL, V95, P587, DOI 10.1016/S0092-8674(00)81627-X; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Senti KA, 2000, DEVELOPMENT, V127, P2291; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Tio M, 1997, DEVELOPMENT, V124, P343; VANVACTOR DL, 1991, CELL, V67, P1145, DOI 10.1016/0092-8674(91)90291-6; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; XU T, 1993, DEVELOPMENT, V117, P1223; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7	47	79	81	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					35	46		10.1016/S0896-6273(01)00576-1	http://dx.doi.org/10.1016/S0896-6273(01)00576-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779478	Bronze			2022-12-24	WOS:000173106200008
J	Mao, BQ; Hamzei-Sichani, F; Aronov, D; Froemke, RC; Yuste, R				Mao, BQ; Hamzei-Sichani, F; Aronov, D; Froemke, RC; Yuste, R			Dynamics of spontaneous activity in neocortical slices	NEURON			English	Article							INTRINSIC ELECTROPHYSIOLOGICAL PROPERTIES; RAT VISUAL-CORTEX; PYRAMIDAL NEURONS; FUNCTIONAL ARCHITECTURE; CONNECTIONS; MORPHOLOGY; PATTERNS; CIRCUITS; LAYER-5	The flow of activity in the cortical microcircuitry is poorly understood. We use calcium imaging to reconstruct, with millisecond and single-cell resolution, the spontaneous activity of populations of neurons in unstimulated slices from mouse visual cortex. We find spontaneous activity correlated among networks of layer 5 pyramidal cells. Synchronous ensembles occupy overlapping territories, often share neurons, and are repeatedly activated. Sets of neurons are also sequentially activated numerous times. Network synchronization and sequential correlations are blocked by glutamatergic antagonists, even though spontaneous firing persists in many "autonomously active" neurons. This autonomous activity is periodic and depends on hyperpolarization-activated cationic (H) and persistent sodium (Na-p) currents. We conclude that the isolated neocortical microcircuit generates spontaneous activity, mediated by a combination of intrinsic and circuit mechanisms, and that this activity can be temporally precise.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Yuste, R (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	rmy5@columbia.edu		Froemke, Robert/0000-0002-1230-6811				Abeles M., 1991, CORTICONICS; Aksay E, 2001, NAT NEUROSCI, V4, P184, DOI 10.1038/84023; Barbour B, 2000, J NEUROSCI METH, V103, P199, DOI 10.1016/S0165-0270(00)00318-6; Braitenberg V., 1998, ANATOMY CORTEX; BURNS BD, 1979, PROC R SOC SER B-BIO, V206, P281, DOI 10.1098/rspb.1979.0105; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Creutzfeldt O., 1995, CORTEX CEREBRI; Crill WE, 1996, ANNU REV PHYSIOL, V58, P349, DOI 10.1146/annurev.physiol.58.1.349; de No RL, 1922, TRAB LAB BIOL U MADR, V20, P41; Douglas RJ, 1998, SYNAPTIC ORG BRAIN, P459; Fuster JM, 1995, MEMORY CEREBRAL CORT; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1986, SCIENCE, V233, P625, DOI 10.1126/science.3755256; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; KASPER EM, 1994, J COMP NEUROL, V339, P459, DOI 10.1002/cne.903390402; Kozloski J, 2001, SCIENCE, V293, P868, DOI 10.1126/science.293.5531.868; LLINAS R, 1993, P NATL ACAD SCI USA, V90, P2078, DOI 10.1073/pnas.90.5.2078; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lorente de No R., 1949, PHYSL NERVOUS SYSTEM, P228; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Markram H, 1997, CEREB CORTEX, V7, P523, DOI 10.1093/cercor/7.6.523; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; MASON A, 1990, J NEUROSCI, V10, P1415; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Peterlin ZA, 2000, P NATL ACAD SCI USA, V97, P3619, DOI 10.1073/pnas.97.7.3619; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Schwartz T, 1998, NEURON, V20, P1271; Smetters D, 1999, METHODS, V18, P215, DOI 10.1006/meth.1999.0774; Somogyi P, 1998, BRAIN RES REV, V26, P113, DOI 10.1016/S0165-0173(97)00061-1; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1991, NEURON, V6, P333, DOI 10.1016/0896-6273(91)90243-S; YUSTE R, 2000, IMAGING NEURONS LAB	39	217	225	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					883	898		10.1016/S0896-6273(01)00518-9	http://dx.doi.org/10.1016/S0896-6273(01)00518-9			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738033	Bronze			2022-12-24	WOS:000172700700014
J	Fell, J; Klaver, P; Lehnertz, K; Grunwald, T; Schaller, C; Elger, CE; Fernandez, G				Fell, J; Klaver, P; Lehnertz, K; Grunwald, T; Schaller, C; Elger, CE; Fernandez, G			Human memory formation is accompanied by rhinal-hippocampal coupling and decoupling	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; BRAIN ACTIVITY; SUBSEQUENT MEMORY; POTENTIALS; OSCILLATIONS; CORTEX; COHERENCE; ATTENTION; FREQUENCY; STIMULATION	In humans, distinct processes within the hippocampus and rhinal cortex support declarative memory formation. But do these medial temporal lobe (MTL) substructures directly cooperate in encoding new memories? Phase synchronization of gamma-band electroencephalogram (EEG) oscillations (around 40 Hz) is a general mechanism of transiently connecting neural assemblies. We recorded depth-EEG from within the MTL of epilepsy patients performing a memorization task. Successful as opposed to unsuccessful memory formation was accompanied by an initial elevation of rhinal-hippocampal gamma synchronization followed by a later desynchronization, suggesting that effective declarative memory formation is accompanied by a direct and temporarily limited cooperation between both MTL substructures.	Univ Bonn, Dept Epileptol, D-53105 Bonn, Germany; Univ Bonn, Dept Neurosurg, D-53105 Bonn, Germany	University of Bonn; University of Bonn	Fell, J (corresponding author), Univ Bonn, Dept Epileptol, Sigmund Freud Str 25, D-53105 Bonn, Germany.		Fernandez, Guillen/B-3771-2009; Klaver, Peter/M-9506-2019; Klaver, Peter/G-7988-2011	Fernandez, Guillen/0000-0002-5522-0604; Klaver, Peter/0000-0002-6541-9975; Klaver, Peter/0000-0002-6541-9975; Lehnertz, Klaus/0000-0002-5529-8559				Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; Baayen R. H., 1993, CELEX LEXICAL DATABA; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; BULLOCK TH, 1995, ELECTROEN CLIN NEURO, V95, P161, DOI 10.1016/0013-4694(95)93347-A; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Craik FIM, 1996, J EXP PSYCHOL GEN, V125, P159, DOI 10.1037/0096-3445.125.2.159; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; DESMEDT JE, 1994, NEUROSCI LETT, V168, P126, DOI 10.1016/0304-3940(94)90432-4; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Elger CE, 1997, NEUROPSYCHOLOGIA, V35, P657, DOI 10.1016/S0028-3932(96)00110-8; Engel AK, 2001, TRENDS COGN SCI, V5, P16, DOI 10.1016/S1364-6613(00)01568-0; Fernandez G, 1998, PSYCHOPHYSIOLOGY, V35, P709, DOI 10.1017/S0048577298970500; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Gabrieli JDE, 1998, ANNU REV PSYCHOL, V49, P87, DOI 10.1146/annurev.psych.49.1.87; Henke K, 1999, P NATL ACAD SCI USA, V96, P5884, DOI 10.1073/pnas.96.10.5884; Hermann BP, 1997, ARCH NEUROL-CHICAGO, V54, P369, DOI 10.1001/archneur.1997.00550160019010; Hirai N, 1999, NEUROSCIENCE, V90, P1149, DOI 10.1016/S0306-4522(98)00513-2; Huynh H, 1976, J EDUC STATIST, V1, P69, DOI DOI 10.3102/10769986001001069; JACKSON GD, 1996, MRI NEUROANATOMY; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; KLEE M, 1977, J NEUROPHYSIOL, V40, P647, DOI 10.1152/jn.1977.40.3.647; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; LaBerge D, 1997, CONSCIOUS COGN, V6, P149, DOI 10.1006/ccog.1997.0305; Lavenex P, 2000, HIPPOCAMPUS, V10, P420, DOI 10.1002/1098-1063(2000)10:4<420::AID-HIPO8>3.3.CO;2-X; Mardia KV, 1972, PROBABILITY MATH STA; MCCARTHY G, 1995, J NEUROSCI, V15, P1080; Menon V, 1996, ELECTROEN CLIN NEURO, V98, P89, DOI 10.1016/0013-4694(95)00206-5; Miltner WHR, 1999, NATURE, V397, P434, DOI 10.1038/17126; Morris H H 3rd, 1985, Electroencephalogr Clin Neurophysiol Suppl, V37, P3; Muller MM, 2000, INT J PSYCHOPHYSIOL, V38, P283, DOI 10.1016/s0167-8760(00)00171-9; Otten LJ, 2001, BRAIN, V124, P399, DOI 10.1093/brain/124.2.399; PALLER KA, 1992, ELECTROEN CLIN NEURO, V84, P269, DOI 10.1016/0168-5597(92)90008-Y; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Sauve K, 1999, CONSCIOUS COGN, V8, P213, DOI 10.1006/ccog.1999.0383; SCOVILLE WB, 1957, J NEUROL NEUROSUR PS, V20, P11, DOI 10.1136/jnnp.20.1.11; Singer W, 1999, NATURE, V397, P391, DOI 10.1038/17021; Steinmetz PN, 2000, NATURE, V404, P187, DOI 10.1038/35004588; Tallon-Baudry C, 1999, TRENDS COGN SCI, V3, P151, DOI 10.1016/S1364-6613(99)01299-1; Traub RD, 1999, J NEUROSCI, V19, P1088; Traub RD, 1996, NATURE, V383, P621, DOI 10.1038/383621a0; Van Roost D, 1998, NEUROSURGERY, V43, P819, DOI 10.1097/00006123-199810000-00058; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Whittington MA, 1997, P NATL ACAD SCI USA, V94, P12198, DOI 10.1073/pnas.94.22.12198; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; ZOLAMORGAN S, 1993, ANNU REV NEUROSCI, V16, P547, DOI 10.1146/annurev.ne.16.030193.002555	49	518	529	3	35	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1259	1264		10.1038/nn759	http://dx.doi.org/10.1038/nn759			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11694886				2022-12-24	WOS:000172525000024
J	Tian, N; Copenhagen, DR				Tian, N; Copenhagen, DR			Visual deprivation alters development of synaptic function in inner retina after eye opening	NEURON			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; EARLY POSTNATAL-DEVELOPMENT; GANGLION-CELLS; MONOCULAR DEPRIVATION; OSCILLATORY POTENTIALS; EVOKED-POTENTIALS; CRITICAL PERIOD; DEPRIVED CATS; RAT RETINA; CORTEX	Visual deprivation impedes refinement of neuronal function in higher visual centers of mammals. It is often assumed that visual deprivation has minimal effect, if any, on neuronal function in retina. Here we report that dark rearing reduces the light-evoked responsiveness of inner retinal neurons in young mice. We also find that 1 to 2 weeks after eye opening, there is a surge (>4-fold) in the frequency of spontaneous excitatory and inhibitory synaptic events in ganglion cells. Dark rearing reversibly suppresses this surge, but recovery takes >6 days. Frequency changes are not accompanied by amplitude changes, indicating that synaptic reorganization is likely to be presynaptic. These findings indicate there is a degree of activity-dependent plasticity in the mammalian retina that has not been previously described.	Univ Calif San Francisco, Sch Med, Dept Ophthalmol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sch Med, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tian, N (corresponding author), Yale Univ, Sch Med, Dept Ophthalmol & Visual Sci, 330 Cedar St, New Haven, CT 06520 USA.							BARO JA, 1990, INVEST OPHTH VIS SCI, V31, P1405; Beaver CJ, 2001, NAT NEUROSCI, V4, P159, DOI 10.1038/83985; BLANTON MG, 1991, J NEUROSCI, V11, P3907; BONAVENT.N, 1967, CR SOC BIOL, V161, P689; BOWEANDERS C, 1975, BRAIN RES, V87, P61, DOI 10.1016/0006-8993(75)90779-9; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; Davis GW, 1998, NATURE, V392, P82, DOI 10.1038/32176; DAW N, 1995, VISUAL DEV; ELAZAZI M, 1990, ACTA OPHTHALMOL, V68, P401; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; FISHER LJ, 1979, J EMBRYOL EXP MORPH, V54, P219; FOX K, 1991, NATURE, V350, P342, DOI 10.1038/350342a0; Fujikado T, 1996, CURR EYE RES, V15, P79, DOI 10.3109/02713689609017614; Gao BX, 1998, J NEUROPHYSIOL, V79, P2277, DOI 10.1152/jn.1998.79.5.2277; Gillespie DC, 2000, J NEUROSCI, V20, P9174; Gordon JA, 1996, J NEUROSCI, V16, P3274; GORFINKEL J, 1988, DOC OPHTHALMOL, V69, P237, DOI 10.1007/BF00154404; GREINER JV, 1981, EXP EYE RES, V33, P315, DOI 10.1016/S0014-4835(81)80055-3; Guire ES, 1999, J NEUROPHYSIOL, V81, P121, DOI 10.1152/jn.1999.81.1.121; HENDRICKSON A, 1976, VISION RES, V16, P517, DOI 10.1016/0042-6989(76)90033-X; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Hollrigel GS, 1997, J NEUROSCI, V17, P5119; Hwang TN, 1999, J NEUROSCI METH, V92, P65, DOI 10.1016/S0165-0270(99)00095-3; Issa NP, 1999, J NEUROSCI, V19, P6965, DOI 10.1523/JNEUROSCI.19-16-06965.1999; Kapur J, 1999, MOL PHARMACOL, V55, P444; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0; KRATZ KE, 1979, BRAIN RES, V172, P545, DOI 10.1016/0006-8993(79)90586-9; Matsui K, 1998, J NEUROSCI, V18, P4500; MOVSHON JA, 1976, J PHYSIOL-LONDON, V261, P125, DOI 10.1113/jphysiol.1976.sp011551; MOWER GD, 1981, BRAIN RES, V220, P255, DOI 10.1016/0006-8993(81)91216-6; MOWER GD, 1991, DEV BRAIN RES, V58, P151, DOI 10.1016/0165-3806(91)90001-Y; Pow DV, 2000, NEUROSCI LETT, V280, P21, DOI 10.1016/S0304-3940(99)00988-X; Prange O, 1999, J NEUROSCI, V19, P6427; Protti DA, 1997, J NEUROSCI, V17, P6075; Quinlan EM, 1999, NAT NEUROSCI, V2, P352, DOI 10.1038/7263; Redburn DA., 1987, PROGR RETINAL RES, V6, P16, DOI 10.1016/0278-4327(87)90020-4; REUTER JH, 1976, PFLUG ARCH EUR J PHY, V363, P7, DOI 10.1007/BF00587395; Robinson DW, 1998, SEMIN CELL DEV BIOL, V9, P301, DOI 10.1006/scdb.1998.0229; RORIG B, 1993, DEV BRAIN RES, V74, P98, DOI 10.1016/0165-3806(93)90088-R; RUSOFF AC, 1978, INVEST OPHTH VIS SCI, V17, P819; RUSOFF AC, 1977, J NEUROPHYSIOL, V40, P1188, DOI 10.1152/jn.1977.40.5.1188; SassoePognetto M, 1997, J COMP NEUROL, V381, P158, DOI 10.1002/(SICI)1096-9861(19970505)381:2<158::AID-CNE4>3.0.CO;2-2; Sernagor E, 1996, CURR BIOL, V6, P1503, DOI 10.1016/S0960-9822(96)00755-5; SEVERNS ML, 1994, DOC OPHTHALMOL, V86, P23, DOI 10.1007/BF01224625; SHERMAN SM, 1973, BRAIN RES, V60, P224, DOI 10.1016/0006-8993(73)90861-5; SOSULA L, 1971, J COMP NEUROL, V141, P427, DOI 10.1002/cne.901410403; STOCKTON RA, 1989, J GEN PHYSIOL, V93, P101, DOI 10.1085/jgp.93.1.101; SUTOR B, 1995, PERSPECT DEV NEUROBI, V2, P409; TAYLOR WR, 1995, J PHYSIOL-LONDON, V486, P207, DOI 10.1113/jphysiol.1995.sp020803; Tian N, 1998, J NEUROPHYSIOL, V80, P1327, DOI 10.1152/jn.1998.80.3.1327; TOOTLE JS, 1993, J NEUROPHYSIOL, V69, P1645, DOI 10.1152/jn.1993.69.5.1645; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; Wang GY, 2001, J NEUROSCI, V21, P4310, DOI 10.1523/JNEUROSCI.21-12-04310.2001; WASSLE H, 1988, TRENDS NEUROSCI, V11, P87, DOI 10.1016/0166-2236(88)90147-6; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; WINGATE RJT, 1994, J NEUROSCI, V14, P6621; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29	61	129	131	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					439	449		10.1016/S0896-6273(01)00470-6	http://dx.doi.org/10.1016/S0896-6273(01)00470-6			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709155	Bronze			2022-12-24	WOS:000172119100010
J	Yang, F; Feng, LY; Zheng, F; Johnson, SW; Du, J; Shen, LY; Wu, CP; Lu, B				Yang, F; Feng, LY; Zheng, F; Johnson, SW; Du, J; Shen, LY; Wu, CP; Lu, B			GDNF acutely modulates excitability and A-type K+ channels in midbrain dopaminergic neurons	NATURE NEUROSCIENCE			English	Article							VENTRAL MESENCEPHALIC NEURONS; MICE LACKING GDNF; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; ELECTROPHYSIOLOGICAL PROPERTIES; SYNAPTIC TRANSMISSION; TYROSINE KINASE; CATION CURRENT; IN-VIVO; RECEPTOR	Glial cell line-derived neurotrophic factor (GDNF) prevents lesion-induced death of midbrain dopaminergic neurons, but its function in normal brain remains uncertain. Here we show that GDNF acutely and reversibly potentiated the excitability of cultured midbrain neurons by inhibiting transient A-type K+ channels. The effects of GDNF were limited to large, tyrosine hydroxylase (TH)positive dopaminergic neurons, and were mediated by mitogen associated protein (MAP) kinase. Application of GDNF also elicited a MAP kinase-dependent enhancement of the excitability in dopaminergic neurons in midbrain slice. These results demonstrate an acute regulation of GDNF on ion channels and its underlying signaling mechanism, and reveal an unexpected role of GDNF in normal midbrain dopaminergic neurons.	NICHHD, Unit Synapse Dev & Plast, LCSN, NIH, Bethesda, MD 20892 USA; Oregon Hlth Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; Chinese Acad Sci, Inst Neurosci, Shanghai 200031, Peoples R China; NCI, Lab Carcinogenesis & Tumor Promot, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Oregon Health & Science University; Chinese Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lu, B (corresponding author), NICHHD, Unit Synapse Dev & Plast, LCSN, NIH, Bethesda, MD 20892 USA.		Lu, Bai/A-4018-2012; Du, Jing/A-9023-2012; Yang, Feng/C-9530-2011; Du, Jing/GWC-9642-2022	Du, Jing/0000-0003-3128-9997; Yang, Feng/0000-0003-1275-6641; Lu, Bai/0000-0001-5418-9759				Adams JP, 2000, J NEUROCHEM, V75, P2277, DOI 10.1046/j.1471-4159.2000.0752277.x; Airaksinen MS, 1999, MOL CELL NEUROSCI, V13, P313, DOI 10.1006/mcne.1999.0754; ANDERSEN P, 1987, J PHYSIOL-LONDON, V383, P509; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Beck KD, 1996, NEURON, V16, P665, DOI 10.1016/S0896-6273(00)80085-9; BECK KD, 1995, NATURE, V373, P339, DOI 10.1038/373339a0; BOWENKAMP KE, 1995, J COMP NEUROL, V355, P479, DOI 10.1002/cne.903550402; Cacalano G, 1998, NEURON, V21, P53, DOI 10.1016/S0896-6273(00)80514-0; Cass WA, 1996, J NEUROSCI, V16, P8132; Chung YH, 2000, BRAIN RES, V875, P164, DOI 10.1016/S0006-8993(00)02586-5; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Durbec P, 1996, NATURE, V381, P789, DOI 10.1038/381789a0; Feng L, 1999, NEUROSCIENCE, V93, P265, DOI 10.1016/S0306-4522(99)00129-3; Feng LY, 1999, MOL BRAIN RES, V66, P62, DOI 10.1016/S0169-328X(99)00015-7; Gao WQ, 1997, EXPERT OPIN THER PAT, V7, P325, DOI 10.1517/13543776.7.4.325; Gash DM, 1996, NATURE, V380, P252, DOI 10.1038/380252a0; Granholm AC, 2000, J NEUROSCI, V20, P3182, DOI 10.1523/JNEUROSCI.20-09-03182.2000; HERBERT MA, 1996, J PHARMACOL EXP THER, V279, P1181; HOFFER BJ, 1994, NEUROSCI LETT, V182, P107, DOI 10.1016/0304-3940(94)90218-6; HUDSON J, 1995, BRAIN RES BULL, V36, P425, DOI 10.1016/0361-9230(94)00224-O; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P227, DOI 10.1113/jphysiol.1984.sp015154; Jing SQ, 1996, CELL, V85, P1113, DOI 10.1016/S0092-8674(00)81311-2; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; Kafitz KW, 1999, NATURE, V401, P918, DOI 10.1038/44847; KIM HG, 1994, P NATL ACAD SCI USA, V91, P12341, DOI 10.1073/pnas.91.25.12341; LACEY MG, 1989, J NEUROSCI, V9, P1233; Li HS, 1999, NEURON, V24, P261, DOI 10.1016/S0896-6273(00)80838-7; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; LINDSAY RM, 1993, EXP NEUROL, V124, P103, DOI 10.1006/exnr.1993.1181; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCCORMICK DA, 1992, J NEUROPHYSIOL, V68, P1384, DOI 10.1152/jn.1992.68.4.1384; MERCURI NB, 1995, EUR J NEUROSCI, V7, P462, DOI 10.1111/j.1460-9568.1995.tb00342.x; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; MOUNT HTJ, 1995, P NATL ACAD SCI USA, V92, P9092, DOI 10.1073/pnas.92.20.9092; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Oppenheim RW, 2000, J NEUROSCI, V20, P5001; Plant TD, 1998, J NEUROSCI, V18, P9573; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SAUER H, 1995, P NATL ACAD SCI USA, V92, P8935, DOI 10.1073/pnas.92.19.8935; Serodio P, 1998, J NEUROPHYSIOL, V79, P1081, DOI 10.1152/jn.1998.79.2.1081; Soler RM, 1999, J NEUROSCI, V19, P9160; TOMAC A, 1995, NATURE, V373, P335, DOI 10.1038/373335a0; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; TRUPP M, 1995, J CELL BIOL, V130, P137, DOI 10.1083/jcb.130.1.137; Trupp M, 1996, NATURE, V381, P785, DOI 10.1038/381785a0; WANG C, IN PRESS NEURON; Washio H, 1999, NEUROSCI RES, V34, P91, DOI 10.1016/S0168-0102(99)00039-5; ZHANG L, 1995, J PHYSIOL-LONDON, V488, P661, DOI 10.1113/jphysiol.1995.sp020998	50	122	125	1	7	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1071	1078		10.1038/nn734	http://dx.doi.org/10.1038/nn734			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11593232				2022-12-24	WOS:000171970900009
J	Clandinin, TR; Lee, CH; Herman, T; Lee, RC; Yang, AY; Ovasapyan, S; Zipursky, SL				Clandinin, TR; Lee, CH; Herman, T; Lee, RC; Yang, AY; Ovasapyan, S; Zipursky, SL			Drosophila LAR regulates R1-R6 and R7 target specificity in the visual system	NEURON			English	Article							RECEPTOR TYROSINE PHOSPHATASES; MOTOR AXON GUIDANCE; NERVOUS-SYSTEM; IN-VIVO; PTP-MU; BRAKELESS; EMBRYO; RETINA; DLAR	Different classes of photoreceptor neurons (R cells) in the Drosophila compound eye connect to specific targets in the optic lobe. Using a behavioral screen, we identified LAR, a receptor tyrosine phosphatase, as being required for R cell target specificity. In LAR mutant mosaic eyes, R1-R6 cells target to the lamina correctly, but fail to choose the correct pattern of target neurons. Although mutant R7 axons initially project to the correct layer of the medulla, they retract into inappropriate layers. Using single cell mosaics, we demonstrate that LAR controls targeting of R1-R6 and R7 in a cell-autonomous fashion. The phenotypes of LAR mutant R cells are strikingly similar to those seen in N-cadherin mutants.	Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Sch Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Biol Chem, Sch Med, 5-748 MRL,675 Charles Young Dr S, Los Angeles, CA 90095 USA.		Lee, Chi-Hon/G-9190-2012	Lee, Chi-Hon/0000-0002-6138-711X; Zipursky, Stephen/0000-0001-5630-7181	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD008748, Z01HD008748] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08042] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Bateman J, 2001, CURR BIOL, V11, P1317, DOI 10.1016/S0960-9822(01)00420-1; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRAITENBERG V, 1967, EXP BRAIN RES, V3, P271; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Desai CJ, 1996, CELL, V84, P599, DOI 10.1016/S0092-8674(00)81035-1; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GERRESHEIM F, 1981, THESIS MUNICH U MUNI; GRIGLIATTI T, 1986, MUTAGENESIS DROSOPHI, P39; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; KIRSCHFELD K, 1967, EXP BRAIN RES, V3, P248; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kypta RM, 1996, J CELL BIOL, V134, P1519, DOI 10.1083/jcb.134.6.1519; LAUGHLIN SB, 1987, PROC R SOC SER B-BIO, V231, P437, DOI 10.1098/rspb.1987.0054; Lee CH, 2001, NEURON, V30, P437, DOI 10.1016/S0896-6273(01)00291-4; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Loureiro J, 1998, CURR BIOL, V8, P622, DOI 10.1016/S0960-9822(98)70249-0; Maurel-Zaffran C, 2001, NEURON, V32, P225, DOI 10.1016/S0896-6273(01)00471-8; Meinertzhagen Ian A., 1993, P1363; Newsome TP, 2000, DEVELOPMENT, V127, P851; O'Grady P, 1998, J CELL BIOL, V141, P1675, DOI 10.1083/jcb.141.7.1675; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; Rao Y, 2000, P NATL ACAD SCI USA, V97, P5966, DOI 10.1073/pnas.110135297; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Ren JM, 1998, DIABETES, V47, P493, DOI 10.2337/diabetes.47.3.493; Senti KA, 2000, DEVELOPMENT, V127, P2291; Stowers RS, 1999, GENETICS, V152, P1631; Sun Q, 2000, DEVELOPMENT, V127, P801; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Van Vactor D, 1998, CURR OPIN CELL BIOL, V10, P174, DOI 10.1016/S0955-0674(98)80139-7; Wills Z, 1999, NEURON, V22, P301, DOI 10.1016/S0896-6273(00)81091-0; Zabolotny JM, 2001, P NATL ACAD SCI USA, V98, P5187, DOI 10.1073/pnas.071050398	38	125	125	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 25	2001	32	2					237	248		10.1016/S0896-6273(01)00474-3	http://dx.doi.org/10.1016/S0896-6273(01)00474-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	487UG	11683994	Bronze			2022-12-24	WOS:000171893700009
J	Farid, H; Adelson, EH				Farid, H; Adelson, EH			Synchrony does not promote grouping in temporally structured displays	NATURE NEUROSCIENCE			English	Article							DISCRIMINATION; BINDING		Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA; Dartmouth Coll, Ctr Cognit Neurosci, Hanover, NH 03755 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Dartmouth College; Dartmouth College; Massachusetts Institute of Technology (MIT)	Farid, H (corresponding author), Dartmouth Coll, Dept Comp Sci, Hanover, NH 03755 USA.	farid@dartmouth.edu			NEI NIH HHS [EY12690-02] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012690] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adelson E. H., 1999, SCIENCE, V286, P2231; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; FAHLE M, 1993, P ROY SOC B-BIOL SCI, V254, P199, DOI 10.1098/rspb.1993.0146; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Kandil FI, 2001, EUR J NEUROSCI, V13, P2004, DOI 10.1046/j.0953-816x.2001.01573.x; Lee SH, 1999, SCIENCE, V284, P1165, DOI 10.1126/science.284.5417.1165; Shadlen MN, 1999, NEURON, V24, P67, DOI 10.1016/S0896-6273(00)80822-3; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; WATSON A. B, 1986, HDB PERCEPTION HUMAN	10	31	31	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					875	876		10.1038/nn0901-875	http://dx.doi.org/10.1038/nn0901-875			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528417				2022-12-24	WOS:000170698600012
J	Deans, MR; Gibson, JR; Sellitto, C; Connors, BW; Paul, DL				Deans, MR; Gibson, JR; Sellitto, C; Connors, BW; Paul, DL			Synchronous activity of inhibitory networks in neocortex requires electrical synapses containing Connexin36	NEURON			English	Article							GAP-JUNCTIONS; PLEXIFORM LAYER; FREEZE-FRACTURE; RAT NEOCORTEX; CHICK RETINA; NEURONS; CORTEX; INTERNEURONS; EXPRESSION; BRAIN	Inhibitory interneurons often generate synchronous activity as an emergent property of their interconnections. To determine the role of electrical synapses in such activity, we constructed mice expressing histochemical reporters in place of the gap junction protein Cx36. Localization of the reporter with somatostatin and parvalbumin suggested that Cx36 was expressed largely by Interneurons. Electrical synapses were common among cortical interneurons in controls but were nearly absent in knockouts. A metabotropic glutamate receptor agonist excited LTS interneurons, generating rhythmic inhibitory potentials in surrounding neurons of both wild-type and knockout animals. However, the synchrony of these rhythms was weaker and more spatially restricted in the knockout. We conclude that electrical synapses containing Cx36 are critical for the generation of widespread, synchronous inhibitory activity.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; Brown Univ, Dept Neurosci, Providence, RI 02912 USA	Harvard University; Harvard Medical School; Brown University	Paul, DL (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	dpaul@hms.harvard.edu	Connors, Barry/AAX-1975-2020	Connors, Barry/0000-0002-3739-3157	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM018974, R01GM037751, R01GM018974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS025983] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012500] Funding Source: NIH RePORTER; NIDA NIH HHS [DA12500] Funding Source: Medline; NIGMS NIH HHS [GM18974, GM37751] Funding Source: Medline; NINDS NIH HHS [NS25983] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGMON A, 1991, NEUROSCIENCE, V41, P365, DOI 10.1016/0306-4522(91)90333-J; Azouz R, 1997, CEREB CORTEX, V7, P534, DOI 10.1093/cercor/7.6.534; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; Belluardo N, 1999, J NEUROSCI RES, V57, P740, DOI 10.1002/(SICI)1097-4547(19990901)57:5<740::AID-JNR16>3.0.CO;2-Z; Benardo LS, 1997, J NEUROPHYSIOL, V77, P3134, DOI 10.1152/jn.1997.77.6.3134; Bennett MVL, 1997, J NEUROCYTOL, V26, P349, DOI 10.1023/A:1018560803261; BRAGIN A, 1995, J NEUROSCI, V15, P47; Brumberg JC, 1996, J NEUROPHYSIOL, V76, P130, DOI 10.1152/jn.1996.76.1.130; BUZSAKI G, 1995, CURR OPIN NEUROBIOL, V5, P504, DOI 10.1016/0959-4388(95)80012-3; Catsicas M, 1998, CURR BIOL, V8, P283, DOI 10.1016/S0960-9822(98)70110-1; Condorelli DF, 2000, BRAIN RES REV, V32, P72, DOI 10.1016/S0165-0173(99)00068-5; CONNORS BW, 1983, J NEUROSCI, V3, P773; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Jefferys JGR, 1996, TRENDS NEUROSCI, V19, P202, DOI 10.1016/S0166-2236(96)10023-0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; LYTTON WW, 1991, J NEUROPHYSIOL, V66, P1059, DOI 10.1152/jn.1991.66.3.1059; MICEVYCH PE, 1991, J COMP NEUROL, V305, P96, DOI 10.1002/cne.903050110; MICHELSON HB, 1994, J PHYSIOL-LONDON, V477, P35, DOI 10.1113/jphysiol.1994.sp020169; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Rash JE, 2000, P NATL ACAD SCI USA, V97, P7573, DOI 10.1073/pnas.97.13.7573; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; RAVIOLA E, 1982, J COMP NEUROL, V209, P233, DOI 10.1002/cne.902090303; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SHIOSAKA S, 1989, J COMP NEUROL, V281, P282, DOI 10.1002/cne.902810210; Sohl G, 1998, FEBS LETT, V428, P27, DOI 10.1016/S0014-5793(98)00479-7; Steriade M, 1997, CEREB CORTEX, V7, P583, DOI 10.1093/cercor/7.6.583; Swadlow HA, 1998, J NEUROPHYSIOL, V79, P567, DOI 10.1152/jn.1998.79.2.567; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Venance L, 2000, P NATL ACAD SCI USA, V97, P10260, DOI 10.1073/pnas.160037097; White TW, 1999, ANNU REV PHYSIOL, V61, P283, DOI 10.1146/annurev.physiol.61.1.283; WHITTINGTON MA, 1995, NATURE, V373, P612, DOI 10.1038/373612a0; Wong WT, 1998, J NEUROSCI, V18, P8839; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379	37	438	451	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 16	2001	31	3					477	485		10.1016/S0896-6273(01)00373-7	http://dx.doi.org/10.1016/S0896-6273(01)00373-7			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516403	Bronze			2022-12-24	WOS:000170601000015
J	Gomez, M; De Castro, E; Guarin, E; Sasakura, H; Kuhara, A; Mori, I; Bartfai, T; Bargmann, CI; Nef, P				Gomez, M; De Castro, E; Guarin, E; Sasakura, H; Kuhara, A; Mori, I; Bartfai, T; Bargmann, CI; Nef, P			Ca2+ signaling via the neuronal calcium sensor-1 regulates associative learning and memory in C-elegans	NEURON			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; BINDING PROTEINS; NERVOUS-SYSTEM; RAT-BRAIN; FREQUENIN; FAMILY; THERMOTAXIS; NCS-1; GENE; EXPRESSION	On a radial temperature gradient, C. elegans worms migrate, after conditioning with food, toward their cultivation temperature and move along this isotherm. This experience-dependent behavior is called isothermal tracking (IT). Here we show that the neuron-specific calcium sensor-1 (NCS-1) is essential for optimal IT. ncs-1 knockout animals show major defects in IT behavior, although their chemotactic, locomotor, and thermal avoidance behaviors are normal. The knockout phenotype can be rescued by reintroducing wildtype NCS-1 into the AIY interneuron, a key component of the thermotaxis network. A loss-of-function form of NCS-1 incapable of binding calcium does not restore IT, whereas NCS-1 overexpression enhances IT performance levels, accelerates learning (faster acquisition), and produces a memory with slower extinction. Thus, proper calcium signaling via NCS-1 defines a novel pathway essential for associative learning and memory.	F Hoffmann La Roche & Co Ltd, Dept Cent Nervous Syst, CH-4070 Basel, Switzerland; Univ Geneva, Dept Biochem, CH-1201 Geneva, Switzerland; Japan Sci & Technol Corp, PRESTO, Nagoya, Aichi 464, Japan; Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 464, Japan; Univ Calif San Francisco, Dept Anat, Howard Hughes Med Inst, San Francisco, CA 94143 USA	Roche Holding; University of Geneva; Japan Science & Technology Agency (JST); Nagoya University; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Nef, P (corresponding author), F Hoffmann La Roche & Co Ltd, Dept Cent Nervous Syst, CH-4070 Basel, Switzerland.		Kuhara, Atsushi/S-5855-2018	Kuhara, Atsushi/0000-0003-2994-8658; de Castro, Edouard/0000-0001-5436-7383; Bargmann, Cornelia/0000-0002-8484-0618				Bartlett SE, 2000, J NEUROSCI RES, V62, P216, DOI 10.1002/1097-4547(20001015)62:2<216::AID-JNR6>3.0.CO;2-A; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; COX JA, 1994, J BIOL CHEM, V269, P32807; DECASTRO E, 1995, BIOCHEM BIOPH RES CO, V216, P133, DOI 10.1006/bbrc.1995.2601; FONTANA G, 1993, J NEUROCHEM, V60, P843, DOI 10.1111/j.1471-4159.1993.tb03228.x; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Iacovelli L, 1999, FASEB J, V13, P1; Martone ME, 1999, CELL TISSUE RES, V295, P395, DOI 10.1007/s004410051246; MARUYAMA K, 1984, J BIOCHEM-TOKYO, V95, P511, DOI 10.1093/oxfordjournals.jbchem.a134633; McFerran BW, 1998, J BIOL CHEM, V273, P22768, DOI 10.1074/jbc.273.35.22768; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Mori I, 1999, ANNU REV GENET, V33, P399, DOI 10.1146/annurev.genet.33.1.399; NEF P, 1996, GUIDEBOOK CALCIUM BI, P94; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Plasterk RHA, 1995, METHOD CELL BIOL, V48, P59; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; PUTKEY JA, 1989, J BIOL CHEM, V264, P12370; RIVOSECCHI R, 1994, J PHYSIOL-LONDON, V474, P223, DOI 10.1113/jphysiol.1994.sp020015; Schaad NC, 1996, P NATL ACAD SCI USA, V93, P9253, DOI 10.1073/pnas.93.17.9253; Wittenburg N, 1999, P NATL ACAD SCI USA, V96, P10477, DOI 10.1073/pnas.96.18.10477; Yazejian B, 2000, NAT NEUROSCI, V3, P566, DOI 10.1038/75737; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	28	177	195	1	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					241	248		10.1016/S0896-6273(01)00276-8	http://dx.doi.org/10.1016/S0896-6273(01)00276-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343658	Bronze			2022-12-24	WOS:000168412900024
J	Amedi, A; Malach, R; Hendler, T; Peled, S; Zohary, E				Amedi, A; Malach, R; Hendler, T; Peled, S; Zohary, E			Visuo-haptic object-related activation in the ventral visual pathway	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; HUMAN OCCIPITAL LOBE; INFEROTEMPORAL CORTEX; SOMATOSENSORY CORTEX; CEREBRAL-CORTEX; MACAQUE MONKEY; PLASTICITY; AREAS; SHAPE; CONNECTIONS	The ventral pathway is involved in primate visual object recognition. In humans, a central stage in this pathway is an occipito-temporal region termed the lateral occipital complex (LOC), which is preferentially activated by visual objects compared to scrambled images or textures. However, objects have characteristic attributes (such as three-dimensional shape) that can be perceived both visually and haptically. Therefore, object-related brain areas may hold a representation of objects in both modalities. Using fMRI to map object-related brain regions, we found robust and consistent somatosensory activation in the occipito-temporal cortex. This region showed clear preference for objects compared to textures in both modalities. Most somatosensory object-selective voxels overlapped a part of the visual object-related region LOG. Thus, we suggest that neuronal populations in the occipito-temporal cortex may constitute a multimodal object-related network.	Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel; Hebrew Univ Jerusalem, Ctr Neural Computat, IL-91904 Jerusalem, Israel; Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Tel Aviv Sourasky Med Ctr, Wohl Inst Adv Imaging, Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Zohary, E (corresponding author), Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, IL-91904 Jerusalem, Israel.		hendler, talma/C-7677-2012; Peled, Sharon/F-8590-2015; Peled, Sharon/ABD-7732-2021	Amedi, Amir/0000-0001-5042-2533				ANDERSEN RA, 1990, J COMP NEUROL, V296, P65, DOI 10.1002/cne.902960106; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; CAVADA C, 1989, J COMP NEUROL, V287, P422, DOI 10.1002/cne.902870403; Cohen LG, 1997, NATURE, V389, P180, DOI 10.1038/38278; DESIMONE R, 1984, J NEUROSCI, V4, P2051; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; DEYOE EA, 1988, TRENDS NEUROSCI, V11, P219, DOI 10.1016/0166-2236(88)90130-0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 1998, NEURON, V21, P191, DOI 10.1016/S0896-6273(00)80526-7; Grill-Spector K, 1998, HUM BRAIN MAPP, V6, P316, DOI 10.1002/(SICI)1097-0193(1998)6:4<316::AID-HBM9>3.0.CO;2-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; HAXBY JV, 1991, P NATL ACAD SCI USA, V88, P1621, DOI 10.1073/pnas.88.5.1621; HIKOSAKA K, 1988, J NEUROPHYSIOL, V60, P1615, DOI 10.1152/jn.1988.60.5.1615; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; KAAS JH, 1983, ANNU REV NEUROSCI, V6, P325, DOI 10.1146/annurev.ne.06.030183.001545; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; Kourtzi Z, 2000, J NEUROSCI, V20, P3310, DOI 10.1523/JNEUROSCI.20-09-03310.2000; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; MERIGAN WH, 1993, ANNU REV NEUROSCI, V16, P3180; NEAL JW, 1990, BRAIN RES, V532, P249, DOI 10.1016/0006-8993(90)91767-B; OSULLIVAN BT, 1994, EUR J NEUROSCI, V6, P137, DOI 10.1111/j.1460-9568.1994.tb00255.x; PONS TP, 1988, P NATL ACAD SCI USA, V85, P5279, DOI 10.1073/pnas.85.14.5279; Pons TP, 1998, NAT MED, V4, P561, DOI 10.1038/nm0598-561; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; Roland PE, 1998, P NATL ACAD SCI USA, V95, P3295, DOI 10.1073/pnas.95.6.3295; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Saleem KS, 2000, J NEUROSCI, V20, P5083; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SERANO SC, 1995, SCIENCE, V268, P889; Talairach J., 1988, COPLANAR STEREOTAXIC; Tanaka K, 1997, CURR OPIN NEUROBIOL, V7, P523, DOI 10.1016/S0959-4388(97)80032-3; TANAKA K, 1993, SCIENCE, V262, P685, DOI 10.1126/science.8235589; Tootell RBH, 1996, TRENDS NEUROSCI, V19, P481, DOI 10.1016/S0166-2236(96)10053-9	38	469	477	2	38	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					324	330		10.1038/85201	http://dx.doi.org/10.1038/85201			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224551				2022-12-24	WOS:000167178300022
J	Takahashi, T; Strittmatter, SM				Takahashi, T; Strittmatter, SM			PlexinA1 autoinhibition by the Plexin Sema domain	NEURON			English	Article							SEMAPHORIN-III; GROWTH; RECEPTOR; NEUROPILIN-2; FAMILY; RESPONSES; COLLAPSE; PROTEIN; SIGNALS; NERVES	Semaphorin 3A (Sema3A) binds to neuropilin-1 (NP1) and activates the transmembrane Plexin to transduce a repulsive axon guidance signal. Here, we show that Sema3 signals are transduced equally effectively by PlexinA1 or PlexinA2, but not by PlexinA3. Deletion analysis of the PlexinA1 ectodomain demonstrates that the sema domain prevents PlexinA1 activation in the basal state. Sema-deleted PlexinA1 is constitutively active, producing cell contraction, growth cone collapse, and inhibition of neurite outgrowth. The sema domain of PlexinA1 physically associates with the remainder of the PlexinA1 ectodomain and can reverse constitutive activation. Both the sema portion and the remainder of the ectodomain of PlexinA1 associate with NP1 in a Sema3A-independent fashion. Plexin Al is autoinhibited by its sema domain, and Sema3A/NP1 releases this inhibition.	Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University; Yale University	Strittmatter, SM (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	stephen.strittmatter@yale.edu	Strittmatter, Stephen/F-5739-2011	Strittmatter, Stephen/0000-0001-8188-3092				Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Chen H, 1997, NEURON, V19, P547, DOI 10.1016/S0896-6273(00)80371-2; Chen H, 2000, NEURON, V25, P43, DOI 10.1016/S0896-6273(00)80870-3; Comeau MR, 1998, IMMUNITY, V8, P473, DOI 10.1016/S1074-7613(00)80552-X; Fournier AE, 2000, J CELL BIOL, V149, P411, DOI 10.1083/jcb.149.2.411; Gagliardini V, 1999, MOL CELL NEUROSCI, V14, P301, DOI 10.1006/mcne.1999.0787; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Goodman CS, 1999, CELL, V97, P551, DOI 10.1016/S0092-8674(00)80766-7; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; IGARASHI M, 1993, SCIENCE, V259, P77, DOI 10.1126/science.8418498; Jin Z, 1997, J NEUROSCI, V17, P6256; Kameyama T, 1996, BIOCHEM BIOPH RES CO, V226, P396, DOI 10.1006/bbrc.1996.1367; Kitsukawa T, 1997, NEURON, V19, P995, DOI 10.1016/S0896-6273(00)80392-X; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kolodkin AL, 1996, TRENDS CELL BIOL, V6, P15, DOI 10.1016/0962-8924(96)81033-6; Koppel AM, 1997, NEURON, V19, P531, DOI 10.1016/S0896-6273(00)80369-4; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Michaely PA, 1999, J BIOL CHEM, V274, P21430, DOI 10.1074/jbc.274.30.21430; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1997, J NEUROSCI, V17, P9183; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035	33	168	177	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					429	439		10.1016/S0896-6273(01)00216-1	http://dx.doi.org/10.1016/S0896-6273(01)00216-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239433	Bronze			2022-12-24	WOS:000167141700016
J	Lembo, PMC; Grazzini, E; Groblewski, T; O'Donnell, D; Roy, MO; Zhang, J; Hoffert, C; Cao, J; Schmidt, R; Pelletier, M; Labarre, M; Gosselin, M; Fortin, Y; Banville, D; Shen, SH; Strom, P; Payza, K; Dray, A; Walker, P; Ahmad, S				Lembo, PMC; Grazzini, E; Groblewski, T; O'Donnell, D; Roy, MO; Zhang, J; Hoffert, C; Cao, J; Schmidt, R; Pelletier, M; Labarre, M; Gosselin, M; Fortin, Y; Banville, D; Shen, SH; Strom, P; Payza, K; Dray, A; Walker, P; Ahmad, S			Proenkephalin A gene products activate a new family of sensory neuron-specific GPCRs	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; BOVINE ADRENAL-MEDULLA; PEPTIDE-E; CHROMAFFIN CELLS; OPIOID PEPTIDE; SPINAL-CORD; RAT; ENKEPHALIN; NOCICEPTORS; EXPRESSION	Several peptide fragments are produced by proteolytic cleavage of the opioid peptide precursor proenkephalin A, and among these are a number of enkephalin fragments, in particular bovine adrenal medulla peptide 22 (BAM22). These peptide products have been implicated in diverse biological functions, including analgesia. We have cloned a newly identified family of 'orphan' G protein-coupled receptors (GPCRs) and demonstrate that BAM22 and a number of its fragments bind to and activate these receptors with nanomolar affinities. This family of GPCRs is uniquely localized in the human and rat small sensory neuron, and we called this family the sensory neuron-specific G protein-coupled receptors (SNSRs). Receptors of the SNSR family are distinct from the traditional opioid receptors in their insensitivity to the classical opioid antagonist naloxone and poor activation by opioid ligands. The unique localization of SNSRs and their activation by proenkephalin A peptide fragments indicate a possible function for SNSRs in sensory neuron regulation and in the modulation of nociception.	AstraZeneca R&D Montreal, St Laurent, PQ H4S 1Z9, Canada; Biotechnol Res Inst, Pharmaceut Sector, Montreal, PQ H4P 2R2, Canada; AstraZeneca R&D Sodertalje, S-15185 Sodertalje, Sweden	AstraZeneca; National Research Council Canada; AstraZeneca	Lembo, PMC (corresponding author), AstraZeneca R&D Montreal, 7171 Frederick Banting, St Laurent, PQ H4S 1Z9, Canada.		Zhang, Ji/L-5922-2019					AHMAD S, 1998, Patent No. 9932519; BAIRD A, 1984, P SOC EXP BIOL MED, V175, P304; BOARDER MR, 1987, J NEUROCHEM, V49, P1824, DOI 10.1111/j.1471-4159.1987.tb02443.x; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; BOERSMA GJC, 1994, J NEUROENDOCRINOL, V6, P47; Cao J, 1998, J BIOL CHEM, V273, P32281, DOI 10.1074/jbc.273.48.32281; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Che FY, 2001, P NATL ACAD SCI USA, V98, P9971, DOI 10.1073/pnas.161542198; Civelli O, 2001, TRENDS NEUROSCI, V24, P230, DOI 10.1016/S0166-2236(00)01763-X; Coward P, 1999, ANAL BIOCHEM, V270, P242, DOI 10.1006/abio.1999.4061; DAVIS TP, 1990, EUR J PHARMACOL, V191, P253, DOI 10.1016/0014-2999(90)94157-S; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; DORES RM, 1990, BRAIN BEHAV EVOLUT, V36, P80, DOI 10.1159/000115300; DRAY A, 1985, J PHARMACOL EXP THER, V235, P670; Goumon Y, 2000, J BIOL CHEM, V275, P38355, DOI 10.1074/jbc.M007557200; HARLAN RE, 1987, J COMP NEUROL, V258, P159, DOI 10.1002/cne.902580202; Henderson G, 1997, TRENDS PHARMACOL SCI, V18, P293, DOI 10.1016/S0165-6147(97)90645-3; HOLLT V, 1982, EUR J PHARMACOL, V85, P355, DOI 10.1016/0014-2999(82)90226-6; HOLLT V, 1982, LIFE SCI, V31, P1883, DOI 10.1016/0024-3205(82)90234-X; LOH YP, 1984, ANNU REV NEUROSCI, V7, P189, DOI 10.1146/annurev.ne.07.030184.001201; MANSOUR A, 1995, BRAIN RES, V700, P89, DOI 10.1016/0006-8993(95)00928-J; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; MIZUNO K, 1980, BIOCHEM BIOPH RES CO, V97, P1283, DOI 10.1016/S0006-291X(80)80005-2; PITTIUS CW, 1984, BRAIN RES, V304, P127, DOI 10.1016/0006-8993(84)90868-0; POHL M, 1994, J NEUROCHEM, V63, P1226; QUIRION R, 1983, PEPTIDES, V4, P445, DOI 10.1016/0196-9781(83)90047-5; RANG HP, 1994, TXB PAIN, P201; Rohrer DK, 1998, PHYSIOL REV, V78, P35, DOI 10.1152/physrev.1998.78.1.35; SANCHEZBLAZQUEZ P, 1984, NEUROPEPTIDES, V5, P181, DOI 10.1016/0143-4179(84)90057-X; SANCHEZBLAZQUEZ P, 1985, NEUROSCI LETT, V61, P267, DOI 10.1016/0304-3940(85)90475-6; Snider WD, 1998, NEURON, V20, P629, DOI 10.1016/S0896-6273(00)81003-X; Stadel JM, 1997, TRENDS PHARMACOL SCI, V18, P430, DOI 10.1016/S0165-6147(97)01117-6; SWAIN MG, 1994, AM J PHYSIOL, V266, pG201, DOI 10.1152/ajpgi.1994.266.2.G201; WEIHE E, 1992, ANN ANAT, V174, P89, DOI 10.1016/S0940-9602(11)80327-4; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3	35	291	336	0	14	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					201	209		10.1038/nn815	http://dx.doi.org/10.1038/nn815			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850634				2022-12-24	WOS:000174146000009
J	Meyer-Lindenberg, A; Miletich, RS; Kohn, PD; Esposito, G; Carson, RE; Quarantelli, M; Weinberger, DR; Berman, KF				Meyer-Lindenberg, A; Miletich, RS; Kohn, PD; Esposito, G; Carson, RE; Quarantelli, M; Weinberger, DR; Berman, KF			Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia	NATURE NEUROSCIENCE			English	Article							POSITRON EMISSION TOMOGRAPHY; DOPA DECARBOXYLASE ACTIVITY; VENTRAL TEGMENTAL AREA; CEREBRAL BLOOD-FLOW; CORTICAL REGULATION; WORKING-MEMORY; CORTEX; BRAIN; RECEPTORS; RELEASE	Both dopaminergic neurotransmission and prefrontal cortex (PFC) function are known to be abnormal in schizophrenia. To test the hypothesis that these phenomena are related, we measured presynaptic dopaminergic function simultaneously with regional cerebral blood flow during the Wisconsin Card Sorting Test (WCST) and a control task in unmedicated schizophrenic subjects and matched controls. We show that the dopaminergic uptake constant K-i in the striatum was significantly higher for patients than for controls. Patients had significantly less WCST-related activation in PFC. The two parameters were strongly linked in patients, but not controls. The tight within-patient coupling of these values, with decreased PFC activation predicting exaggerated striatal 6-fluorodopa uptake, supports the hypothesis that prefrontal cortex dysfunction may lead to dopaminergic transmission abnormalities.	NIMH, Unit Integrat Neuroimaging, NIH, Bethesda, MD 20892 USA; NINCDS, NIH, Bethesda, MD 20832 USA; NIH, PET Dept, Ctr Clin, Bethesda, MD 20832 USA; NIMH, Clin Brain Disorders Branch, NIH, Bethesda, MD 20832 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Meyer-Lindenberg, A (corresponding author), NIMH, Unit Integrat Neuroimaging, NIH, 10-4C101,9000 Rockville Pike, Bethesda, MD 20892 USA.		Carson, Richard E/H-3250-2011; Quarantelli, Mario/A-6154-2009; Meyer-Lindenberg, Andreas/H-1076-2011	Carson, Richard E/0000-0002-9338-7966; Quarantelli, Mario/0000-0001-7836-454X; Meyer-Lindenberg, Andreas/0000-0001-5619-1123	NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002652, Z01MH002716, ZIAMH002717, Z01MH002652, Z01MH002717, ZIAMH002716] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abi-Dargham A, 1998, AM J PSYCHIAT, V155, P761; Abi-Dargham A, 2000, P NATL ACAD SCI USA, V97, P8104, DOI 10.1073/pnas.97.14.8104; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Bennett MR, 1998, J PSYCHOPHARMACOL, V12, P289, DOI 10.1177/026988119801200310; BERMAN KF, 1995, NEUROPSYCHOLOGIA, V33, P1027, DOI 10.1016/0028-3932(95)00035-2; Bertolino A, 2000, NEUROPSYCHOPHARMACOL, V22, P125, DOI 10.1016/S0893-133X(99)00096-2; BROOKS DJ, 1990, ANN NEUROL, V28, P547, DOI 10.1002/ana.410280412; Carlsson A, 2001, ANNU REV PHARMACOL, V41, P237, DOI 10.1146/annurev.pharmtox.41.1.237; Carr DB, 2000, J NEUROSCI, V20, P3864, DOI 10.1523/JNEUROSCI.20-10-03864.2000; CHRISTIE MJ, 1985, BRAIN RES, V333, P169, DOI 10.1016/0006-8993(85)90140-4; CUMMING P, 1995, J NEUROCHEM, V65, P1381; DANIEL DG, 1991, J NEUROSCI, V11, P1907; DaoCastellana MH, 1997, SCHIZOPHR RES, V23, P167, DOI 10.1016/S0920-9964(96)00102-8; DEUTCH AY, 1992, J NEURAL TRANSM-GEN, P61; Elkashef AM, 2000, PSYCHIAT RES-NEUROIM, V100, P1, DOI 10.1016/S0925-4927(00)00064-0; GJEDDE A, 1991, P NATL ACAD SCI USA, V88, P2721, DOI 10.1073/pnas.88.7.2721; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; GRACE AA, 1993, J NEURAL TRANSM-GEN, V91, P111, DOI 10.1007/BF01245228; Hietala J, 1999, SCHIZOPHR RES, V35, P41, DOI 10.1016/S0920-9964(98)00113-3; HIETALA J, 1995, LANCET, V346, P1130, DOI 10.1016/S0140-6736(95)91801-9; Jackson ME, 2001, J NEUROCHEM, V78, P920, DOI 10.1046/j.1471-4159.2001.00499.x; JASKIW GE, 1990, BRAIN RES, V534, P321, DOI 10.1016/0006-8993(90)90149-6; Kegeles LS, 2000, BIOL PSYCHIAT, V48, P627, DOI 10.1016/S0006-3223(00)00976-8; Kraepelin E., 1919, CUTTING SHEPHERD; Laruelle M, 1999, J PSYCHOPHARMACOL, V13, P358, DOI 10.1177/026988119901300405; LEWIS DA, 1995, PSYCHOL MED, V25, P887, DOI 10.1017/S0033291700037375; Lindstrom LH, 1999, BIOL PSYCHIAT, V46, P681, DOI 10.1016/S0006-3223(99)00109-2; MILETICH RS, 1993, BRAIN RES, V626, P1, DOI 10.1016/0006-8993(93)90556-3; Muller U, 1998, J NEUROSCI, V18, P2720; MURASE S, 1993, NEUROSCI LETT, V157, P53, DOI 10.1016/0304-3940(93)90641-W; NAPIER TC, 1992, NEUROREPORT, V3, P609, DOI 10.1097/00001756-199207000-00016; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; PATLAK CS, 1983, J CEREBR BLOOD F MET, V3, P1, DOI 10.1038/jcbfm.1983.1; PYCOCK CJ, 1980, NATURE, V286, P74, DOI 10.1038/286074a0; REITH J, 1994, P NATL ACAD SCI USA, V91, P11651, DOI 10.1073/pnas.91.24.11651; Saunders RC, 1998, NATURE, V393, P169, DOI 10.1038/30245; Swerdlow NR, 1998, SCHIZOPHRENIA BULL, V24, P285, DOI 10.1093/oxfordjournals.schbul.a033326; Talairach J., 1988, COPLANAR STEREOTAXIC; WEINBERGER DR, 1986, ARCH GEN PSYCHIAT, V43, P114; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Weinberger DR, 1996, PHILOS T R SOC B, V351, P1495, DOI 10.1098/rstb.1996.0135; WEINBERGER DR, 1995, SCHIZOPHR RES, V16, P87, DOI 10.1016/0920-9964(95)00013-C; WEINBERGER DR, 1988, ARCH GEN PSYCHIAT, V45, P609; WONG DF, 1986, SCIENCE, V234, P1558, DOI 10.1126/science.2878495; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004	46	502	517	0	36	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					267	271		10.1038/nn804	http://dx.doi.org/10.1038/nn804			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11865311				2022-12-24	WOS:000174146000018
J	Ahmadi, S; Lippross, S; Neuhuber, WL; Zeilhofer, HU				Ahmadi, S; Lippross, S; Neuhuber, WL; Zeilhofer, HU			PGE(2) selectively blocks inhibitory glycinergic neurotransmission onto rat superficial dorsal horn neurons	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLOOXYGENASE-2 MESSENGER-RNA; SPINAL-CORD; PROSTAGLANDIN E-2; AMINO-ACIDS; PERIPHERAL INFLAMMATION; SYNAPTIC TRANSMISSION; PROSTANOID RECEPTORS; PAIN ALLODYNIA; DEFICIENT MICE	Despite the crucial role that prostaglandins (PGs) have in the sensitization of the central nervous system to pain, their cellular and molecular targets leading to increased pain perception have remained elusive. Here we investigated the effects of PGE(2) on fast synaptic transmission onto neurons in the rat spinal cord dorsal horn, the first site of synaptic integration in the pain pathway. We identified the inhibitory (strychnine-sensitive) glycine receptor as a specific target of PGE(2). PGE(2), but not PGF(2 alpha), PGD(2) or PGI(2), reduced inhibitory glycinergic synaptic transmission in low nanomolar concentrations, whereas GABA(A), AMPA and NMDA receptor-mediated transmission remained unaffected. Inhibition of glycine receptors occurred via a postsynaptic mechanism involving the activation of EP2 receptors, cholera-toxin-sensitive G-proteins and cAMP-dependent protein kinase. Via this mechanism, PGE(2) may facilitate the transmission of nociceptive input through the spinal cord dorsal horn to higher brain areas where pain becomes conscious.	Emil Fischer Zentrum, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; Univ Erlangen Nurnberg, Inst Anat, D-91054 Erlangen, Germany	University of Erlangen Nuremberg	Zeilhofer, HU (corresponding author), Emil Fischer Zentrum, Inst Expt & Klin Pharmakol & Toxikol, Fahrstr 17, D-91054 Erlangen, Germany.		Zeilhofer, Hanns Ulrich/A-4600-2008	Zeilhofer, Hanns Ulrich/0000-0001-6954-4629				ARENA JM, 1979, POISONING TOXICITY S; Baba H, 2001, J NEUROSCI, V21, P1750, DOI 10.1523/JNEUROSCI.21-05-01750.2001; Becker C.-M., 1992, HDB EXPT PHARM, V102, P539; Beiche F, 1998, J NEUROIMMUNOL, V89, P26, DOI 10.1016/S0165-5728(98)00061-7; Beiche F, 1996, FEBS LETT, V390, P165, DOI 10.1016/0014-5793(96)00604-7; BEYER C, 1985, LIFE SCI, V37, P875, DOI 10.1016/0024-3205(85)90523-5; Boie Y, 1997, EUR J PHARMACOL, V340, P227, DOI 10.1016/S0014-2999(97)01383-6; BRANDON EP, 1995, P NATL ACAD SCI USA, V92, P8851, DOI 10.1073/pnas.92.19.8851; Ceranik K, 1997, J NEUROSCI, V17, P5380; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Donaldson LF, 2001, PROSTAG OTH LIPID M, V63, P109, DOI 10.1016/S0090-6980(00)00101-5; Doubell TP, 1999, TXB PAIN, V4, P165; Eguchi N, 1999, P NATL ACAD SCI USA, V96, P726, DOI 10.1073/pnas.96.2.726; Fuxe K, 1991, VOLUME TRANSMISSION; Gosselin RE, 1976, CLIN TOXICOLOGY COMM; Guhring H, 2000, J NEUROSCI, V20, P6714, DOI 10.1523/JNEUROSCI.20-17-06714.2000; Ichitani Y, 1997, NEUROREPORT, V8, P2949, DOI 10.1097/00001756-199709080-00028; KASLOW HR, 1992, FASEB J, V6, P2684, DOI 10.1096/fasebj.6.9.1612292; Kawamura T, 1997, LIFE SCI, V61, P2111, DOI 10.1016/S0024-3205(97)00884-9; Kiriyama M, 1997, BRIT J PHARMACOL, V122, P217, DOI 10.1038/sj.bjp.0701367; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; KUMAZAWA T, 1993, BRAIN RES, V632, P321, DOI 10.1016/0006-8993(93)91169-S; Liebel JT, 1997, BRIT J PHARMACOL, V121, P425, DOI 10.1038/sj.bjp.0701149; MALMBERG AB, 1995, J NEUROSCI, V15, P2768; Malmberg AB, 1997, J NEUROSCI, V17, P7462; MATSUMURA K, 1992, BRAIN RES, V581, P292, DOI 10.1016/0006-8993(92)90720-T; MINAMI T, 1992, PAIN, V50, P223, DOI 10.1016/0304-3959(92)90166-9; Minami T, 1997, BRIT J PHARMACOL, V122, P605, DOI 10.1038/sj.bjp.0701421; Minami T, 1999, EUR J NEUROSCI, V11, P1849, DOI 10.1046/j.1460-9568.1999.00602.x; Nakamura K, 2000, J COMP NEUROL, V421, P543, DOI 10.1002/(SICI)1096-9861(20000612)421:4<543::AID-CNE6>3.0.CO;2-3; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; NISHIHARA I, 1995, NEUROSCI LETT, V196, P57, DOI 10.1016/0304-3940(95)11839-O; O'Banion MK, 1999, CRIT REV NEUROBIOL, V13, P45, DOI 10.1615/CritRevNeurobiol.v13.i1.30; Okuda-Ashitaka E, 1998, NATURE, V392, P286, DOI 10.1038/32660; PERPER JA, 1985, J FORENSIC SCI, V30, P1248; RIBEIRONETO FAP, 1985, METHOD ENZYMOL, V109, P566; Samad TA, 2001, NATURE, V410, P471, DOI 10.1038/35068566; Smart TG, 1997, CURR OPIN NEUROBIOL, V7, P358, DOI 10.1016/S0959-4388(97)80063-3; VAELLO ML, 1994, J BIOL CHEM, V269, P2002; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Vanegas HN, 2001, PROG NEUROBIOL, V64, P327, DOI 10.1016/S0301-0082(00)00063-0; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; Yaksh TL, 1999, P NATL ACAD SCI USA, V96, P7680, DOI 10.1073/pnas.96.14.7680; YAKSH TL, 1994, TXB PAIN, P165; Yang LC, 1996, PAIN, V67, P345, DOI 10.1016/0304-3959(96)03106-5; Zeilhofer HU, 2000, J NEUROSCI, V20, P4922; ZIEGLGANSBERGER W, 1971, EXP BRAIN RES, V13, P111	47	242	254	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					34	40		10.1038/nn778	http://dx.doi.org/10.1038/nn778			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740501				2022-12-24	WOS:000173031800012
J	Feng, RB; Rampon, C; Tang, YP; Shrom, D; Jin, J; Kim, M; Sopher, B; Martin, GM; Kim, SH; Langdon, RB; Sisodia, SS; Tsien, JZ				Feng, RB; Rampon, C; Tang, YP; Shrom, D; Jin, J; Kim, M; Sopher, B; Martin, GM; Kim, SH; Langdon, RB; Sisodia, SS; Tsien, JZ			Deficient neurogenesis in forebrain-specific presenilin-1 knockout mice is associated with reduced clearance of hippocampal memory traces	NEURON			English	Article							ELECTRON-MICROSCOPIC ANALYSIS; RAT DENTATE GYRUS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; ADULT-RAT; ENRICHED ENVIRONMENT; TRANSGENIC MICE; SPATIAL MEMORY; LONG-TERM; NEURONS	To examine the in vivo function of presenilin-1 (PS1), we selectively deleted the PS1 gene in excitatory neurons of the adult mouse forebrain. These conditional knockout mice were viable and grew normally, but they exhibited a pronounced deficiency in enrichment-induced neurogenesis in the dentate gyrus. This reduction in neurogenesis did not result in appreciable learning deficits, indicating that addition of new neurons is not required for memory formation. However, our postlearning enrichment experiments lead us to postulate that adult dentate neurogenesis may play a role in the periodic clearance of outdated hippocampal memory traces after cortical memory consolidation, thereby ensuring that the hippocampus is continuously available to process new memories. A chronic, abnormal clearance process in the hippocampus may conceivably lead to memory disorders in the mammalian brain.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Univ Washington, Dept Lab Med, Seattle, WA 98995 USA; Univ Washington, Dept Mol Med, Seattle, WA 98995 USA; Seton Hall Univ, New Jersey Neurosci Inst, Edison, NJ 08818 USA; Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; E China Normal Univ, Shanghai Inst Brain Funct Genom, Shanghai, Peoples R China	Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Seton Hall University; University of Chicago; East China Normal University	Tsien, JZ (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	jtsien@princeton.edu	Tang, Ya-Ping/A-1035-2011	Tang, Ya-Ping/0000-0002-0445-4072; rampon, claire/0000-0001-8551-8682				ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BAYER SA, 1980, J COMP NEUROL, V194, P845, DOI 10.1002/cne.901940409; Bayer TA, 1997, ACTA NEUROPATHOL, V94, P519, DOI 10.1007/s004010050745; Berezovska O, 2000, J NEUROCHEM, V75, P583, DOI 10.1046/j.1471-4159.2000.0750583.x; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; CLAIBORNE BJ, 1986, J COMP NEUROL, V246, P435, DOI 10.1002/cne.902460403; Cohen N. J., 1993, MEMORY AMNESIA HIPPO; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; DALRYMPLEALFORD JC, 1984, BEHAV NEUROSCI, V98, P23, DOI 10.1037/0735-7044.98.1.23; DAVIS M, 1987, PSYCHOL LEARN MOTIV, V21, P263; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Donoviel DB, 1999, GENE DEV, V13, P2801, DOI 10.1101/gad.13.21.2801; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; GAARSKJAER FB, 1986, BRAIN RES REV, V11, P335, DOI 10.1016/0165-0173(86)90004-4; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Gould E, 1999, TRENDS COGN SCI, V3, P186, DOI 10.1016/S1364-6613(99)01310-8; Gould E, 1999, P NATL ACAD SCI USA, V96, P5263, DOI 10.1073/pnas.96.9.5263; Greenough WT, 1999, NAT NEUROSCI, V2, P203, DOI 10.1038/6300; GREENOUGH WT, 1990, SYMP MED H, V23, P159; Haass C, 1997, NEURON, V18, P687, DOI 10.1016/S0896-6273(00)80309-8; Handler M, 2000, DEVELOPMENT, V127, P2593; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Holst BD, 1998, P NATL ACAD SCI USA, V95, P2597, DOI 10.1073/pnas.95.5.2597; ISHIZUKA N, 1990, J COMP NEUROL, V295, P580, DOI 10.1002/cne.902950407; KAPLAN MS, 1977, SCIENCE, V197, P1092, DOI 10.1126/science.887941; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; KIM JJ, 1992, BEHAV NEUROSCI, V106, P591, DOI 10.1037/0735-7044.106.4.591; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kim TW, 1997, CURR OPIN NEUROBIOL, V7, P683, DOI 10.1016/S0959-4388(97)80089-X; Kisby GE, 1999, DRUG METAB REV, V31, P589, DOI 10.1081/DMR-100101937; KORDOWER JH, 1992, DEV BRAIN RES, V68, P9, DOI 10.1016/0165-3806(92)90242-O; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; Lee MK, 1996, J NEUROSCI, V16, P7513, DOI 10.1523/jneurosci.16-23-07513.1996; Lendon CL, 1997, JAMA-J AM MED ASSOC, V277, P825, DOI 10.1001/jama.277.10.825; Liu JL, 1998, J NEUROSCI, V18, P7768; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Mehl A, 2000, NEUROTOXICOLOGY, V21, P165; Naruse S, 1998, NEURON, V21, P1213, DOI 10.1016/S0896-6273(00)80637-6; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nowakowski R, 2000, SCIENCE, V288, p771a, DOI DOI 10.1126/SCIENCE.288.5467.771A; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Rampon C, 2000, P NATL ACAD SCI USA, V97, P12880, DOI 10.1073/pnas.97.23.12880; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; Rampon C, 2000, HIPPOCAMPUS, V10, P605, DOI 10.1002/1098-1063(2000)10:5<605::AID-HIPO11>3.0.CO;2-3; Repa JC, 2001, NAT NEUROSCI, V4, P724, DOI 10.1038/89512; ROSENZWE.MR, 1966, AM PSYCHOL, V21, P321, DOI 10.1037/h0023555; Selkoe DJ, 2000, CURR OPIN NEUROBIOL, V10, P50, DOI 10.1016/S0959-4388(99)00054-9; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Squire L. R., 1987, MEMORY BRAIN; St George-Hyslop PH, 2000, SCI AM, V283, P76, DOI 10.1038/scientificamerican1200-76; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Tang YP, 2001, NEUROPHARMACOLOGY, V41, P779, DOI 10.1016/S0028-3908(01)00122-8; Traub R.D., 1991, NEURONAL NETWORKS HI; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wong PC, 1997, NATURE, V387, P288, DOI 10.1038/387288a0; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2	68	371	389	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 6	2001	32	5					911	926		10.1016/S0896-6273(01)00523-2	http://dx.doi.org/10.1016/S0896-6273(01)00523-2			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738035	Bronze			2022-12-24	WOS:000172700700016
J	Polo-Parada, L; Bose, CM; Landmesser, LT				Polo-Parada, L; Bose, CM; Landmesser, LT			Alterations in transmission, vesicle dynamics, and transmitter release machinery at NCAM-deficient neuromuscular junctions	NEURON			English	Article							MOTOR-NERVE TERMINALS; CELL-ADHESION MOLECULE; PROTEIN-KINASE-C; PRESYNAPTIC ACTIVE ZONES; LIGHT-CHAIN KINASE; SYNAPTIC PLASTICITY; ACETYLCHOLINE-RELEASE; CYTOSOLIC CA2+; LONG-TERM; IN-VITRO	Although functional neuromuscular junctions (NMJs) form in NCAM-deficient mice, they exhibit multiple alterations in presynaptic organization and function. Profound depression and unusual periodic total transmission failures with repetitive stimulation point to a defect in vesicle mobilization/cycling, and these defects were mimicked in (+/+) NMJs by inhibitors of myosin light chain kinase, known to affect vesicle mobilization. Two separate release mechanisms, utilizing different endocytic machinery and Ca2+ channels, were shown to coexist in (-/-) terminals, with the mature process targeted to presynaptic membrane opposed to muscle, and an abnormally retained immature process targeted to the remainder of the presynaptic terminal and axon. Thus, NCAM plays a critical and heretofore unsuspected role in the molecular organization of the presynaptic NMJ.	Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA	Case Western Reserve University	Landmesser, LT (corresponding author), Case Western Reserve Univ, Sch Med, Dept Neurosci, Cleveland, OH 44106 USA.			Polo-Parada, Luis/0000-0002-5221-6060	NINDS NIH HHS [NS 23678, NS 19640] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023678, R01NS019640] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Betz A, 1998, NEURON, V21, P123, DOI 10.1016/S0896-6273(00)80520-6; Cabaniols JP, 1999, MOL BIOL CELL, V10, P4033, DOI 10.1091/mbc.10.12.4033; CHOW I, 1985, J NEUROSCI, V5, P1076; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; CREMER H, 1994, NATURE, V367, P455, DOI 10.1038/367455a0; Cremer H, 1998, P NATL ACAD SCI USA, V95, P13242, DOI 10.1073/pnas.95.22.13242; DAHM LM, 1991, J NEUROSCI, V11, P238; Dai ZS, 1996, MOL CELL NEUROSCI, V7, P443, DOI 10.1006/mcne.1996.0032; David G, 2000, J NEUROSCI, V20, P7290; Day NC, 1997, J NEUROSCI, V17, P6226; Delgado R, 2000, NEURON, V28, P941, DOI 10.1016/S0896-6273(00)00165-3; Dityatev A, 2000, NEURON, V26, P207, DOI 10.1016/S0896-6273(00)81151-4; DODGE FA, 1967, J PHYSIOL-LONDON, V193, P419, DOI 10.1113/jphysiol.1967.sp008367; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; Fykse EM, 1998, J NEUROCHEM, V71, P1661; Garner CC, 2000, CURR OPIN NEUROBIOL, V10, P321, DOI 10.1016/S0959-4388(00)00093-3; GERSDORFF HV, 1999, ANNU REV PHYSIOL, V61, P725; GHIRARDI M, 1992, NEURON, V9, P479, DOI 10.1016/0896-6273(92)90185-G; GLAVINOVIC MI, 1979, J PHYSIOL-LONDON, V290, P467, DOI 10.1113/jphysiol.1979.sp012784; HONG SJ, 1995, J PHYSIOL-LONDON, V482, P283, DOI 10.1113/jphysiol.1995.sp020517; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Katz E, 1996, J PHYSIOL-LONDON, V497, P687, DOI 10.1113/jphysiol.1996.sp021800; Kolkova K, 2000, J NEUROSCI, V20, P2238; Kuromi H, 2000, NEURON, V27, P133, DOI 10.1016/S0896-6273(00)00015-5; LUPA MT, 1989, J NEUROSCI, V9, P3937; MAYFORD M, 1992, SCIENCE, V256, P638, DOI 10.1126/science.1585176; MOCHIDA S, 1994, NEURON, V13, P1131, DOI 10.1016/0896-6273(94)90051-5; Moscoso LM, 1998, J NEUROSCI, V18, P1465; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; NIELANDER HB, 1995, J NEUROCHEM, V65, P1712; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; PREKERIS R, 1997, NEURON, V18, P599; Rafuse VF, 2000, J NEUROSCI, V20, P6529, DOI 10.1523/JNEUROSCI.20-17-06529.2000; Reid B, 1999, J NEUROSCI, V19, P2511; RIBCHESTER RR, 1994, P ROY SOC B-BIOL SCI, V255, P61, DOI 10.1098/rspb.1994.0009; Richards DA, 2000, NEURON, V27, P551, DOI 10.1016/S0896-6273(00)00065-9; Risinger C, 1999, J NEUROCHEM, V72, P614, DOI 10.1046/j.1471-4159.1999.0720614.x; Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773; Ryan TA, 1999, J NEUROSCI, V19, P1317; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; SAITOH M, 1987, J BIOL CHEM, V262, P7796; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2001, CURR OPIN NEUROBIOL, V11, P127, DOI 10.1016/S0959-4388(00)00183-5; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schnell E, 2001, J NEUROPHYSIOL, V85, P1498, DOI 10.1152/jn.2001.85.4.1498; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Slepnev VI, 2000, NAT REV NEUROSCI, V1, P161, DOI 10.1038/35044540; Smith C, 1998, NEURON, V20, P1243, DOI 10.1016/S0896-6273(00)80504-8; Stevens CF, 1998, NEURON, V21, P885, DOI 10.1016/S0896-6273(00)80603-0; SUN YA, 1987, P NATL ACAD SCI USA, V84, P2540, DOI 10.1073/pnas.84.8.2540; TIAN LJ, 1994, J PHYSIOL-LONDON, V476, P517, DOI 10.1113/jphysiol.1994.sp020151; Traub LM, 1996, J CELL BIOL, V135, P1801, DOI 10.1083/jcb.135.6.1801; UCHITEL OD, 1992, P NATL ACAD SCI USA, V89, P3330, DOI 10.1073/pnas.89.8.3330; Verona M, 2000, J NEUROCHEM, V74, P209, DOI 10.1046/j.1471-4159.2000.0740209.x; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Yawo H, 1999, J PHYSIOL-LONDON, V515, P169, DOI 10.1111/j.1469-7793.1999.169ad.x; Zakharenko S, 1999, J CELL BIOL, V144, P507, DOI 10.1083/jcb.144.3.507; ZHU H, 1995, J NEUROSCI, V15, P4173	64	129	130	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					815	+		10.1016/S0896-6273(01)00521-9	http://dx.doi.org/10.1016/S0896-6273(01)00521-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738028	Bronze			2022-12-24	WOS:000172700700009
J	Atzori, M; Lei, S; Evans, DIP; Kanold, PO; Phillips-Tansey, E; McIntyre, O; McBain, CJ				Atzori, M; Lei, S; Evans, DIP; Kanold, PO; Phillips-Tansey, E; McIntyre, O; McBain, CJ			Differential synaptic processing separates stationary from transient inputs to the auditory cortex	NATURE NEUROSCIENCE			English	Article							PYRAMIDAL NEURONS; ORGANIZATION; CONNECTIONS; DEPRESSION; RECEPTORS; KAINATE; BLOCK	Sound features are blended together en route to the central nervous system before being discriminated for further processing by the cortical synaptic network. The mechanisms underlying this synaptic processing, however, are largely unexplored. Intracortical processing of the auditory signal was investigated by simultaneously recording from pairs of connected principal neurons in layer II/III in slices from A1 auditory cortex. Physiological patterns of stimulation in the presynaptic cell. revealed two populations of postsynaptic events that differed in mean amplitude, failure rate, kinetics and short-term plasticity. In contrast, transmission between layer II/III pyramidal neurons in barrel cortex were uniformly of large amplitude and high success (release) probability (P-r). These unique features of auditory cortical transmission may provide two distinct mechanisms for discerning and separating transient from stationary features of the auditory signal at an early stage of cortical processing.	NICHHD, LCMN, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21205 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Johns Hopkins University	McBain, CJ (corresponding author), NICHHD, LCMN, NIH, Rm 5A72,Bldg 49,Convent Dr, Bethesda, MD 20892 USA.	chrismcb@codon.nih.gov		Kanold, Patrick/0000-0002-7529-5435				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BLASCHKE M, 1993, P NATL ACAD SCI USA, V90, P6528, DOI 10.1073/pnas.90.14.6528; BRACKLEY PTH, 1993, J PHARMACOL EXP THER, V266, P1573; Clarey JC, 1992, MAMMALIAN AUDITORY P, P232, DOI [10.1007/978-1-4612-2838-7_5, DOI 10.1007/978-1-4612-2838-7_5]; CLARKE S, 1993, ANAT EMBRYOL, V188, P117; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Dingledine R, 1999, PHARMACOL REV, V51, P7; FABER DS, 1991, BIOPHYS J, V60, P1288, DOI 10.1016/S0006-3495(91)82162-2; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Giraud AL, 2000, J NEUROPHYSIOL, V84, P1588, DOI 10.1152/jn.2000.84.3.1588; HERLITZE S, 1993, NEURON, V10, P1131, DOI 10.1016/0896-6273(93)90061-U; Kaas JH, 1999, NAT NEUROSCI, V2, P1045, DOI 10.1038/15967; Kilgard MP, 1998, NAT NEUROSCI, V1, P727, DOI 10.1038/3729; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Metherate R, 1999, DEV BRAIN RES, V115, P131, DOI 10.1016/S0165-3806(99)00058-9; PHILLIPS DP, 1989, HEARING RES, V37, P269, DOI 10.1016/0378-5955(89)90027-0; ROUILLER E, 1981, HEARING RES, V5, P81, DOI 10.1016/0378-5955(81)90028-9; Schreiner CE, 2000, ANNU REV NEUROSCI, V23, P501, DOI 10.1146/annurev.neuro.23.1.501; Shen JX, 1999, HEARING RES, V137, P174, DOI 10.1016/S0378-5955(99)00149-5; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Washburn MS, 1996, J PHARMACOL EXP THER, V278, P669; WINER JA, 1984, J COMP NEUROL, V229, P476, DOI 10.1002/cne.902290404; WINER JA, 1985, J COMP NEUROL, V238, P10, DOI 10.1002/cne.902380103; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	27	101	101	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1230	1237		10.1038/nn760	http://dx.doi.org/10.1038/nn760			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11694887				2022-12-24	WOS:000172525000020
J	Petersen, RS; Panzeri, S; Diamond, ME				Petersen, RS; Panzeri, S; Diamond, ME			Population coding of stimulus location in rat somatosensory cortex	NEURON			English	Article							BARREL CORTEX; NEURONS; INFORMATION; ORGANIZATION; RESPONSES; DYNAMICS; PATTERNS; SYNCHRONIZATION; VARIABILITY; DISCHARGE	This study explores the nature of population coding in sensory cortex by applying information theoretic analyses to neuron pairs recorded simultaneously from rat barrel cortex. We quantified the roles of individual spikes and spike patterns in encoding whisker stimulus location. 82%-85% of the total information was contained in the timing of individual spikes: first spike time was particularly crucial. Spike patterns within neurons accounted for the remaining 15%-18%. Neuron pairs located in the same barrel column coded redundantly, whereas pairs in neighboring barrel columns coded independently. The barrel cortical population code for stimulus location appears to be the time of single neurons' first poststimulus spikes-a fast, robust coding mechanism that does not rely on "synergy" in crossneuronal spike patterns.	Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, I-34014 Trieste, Italy; Newcastle Univ, Dept Psychol, Neural Syst Grp, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	International School for Advanced Studies (SISSA); Newcastle University - UK	Petersen, RS (corresponding author), Scuola Int Super Studi Avanzati, Cognit Neurosci Sector, Via Beirut 2-4, I-34014 Trieste, Italy.	petersen@sissa.it	Panzeri, Stefano/L-5977-2013	Panzeri, Stefano/0000-0003-1700-8909; DIAMOND, Mathew Ernest/0000-0003-2286-4566; Petersen, Rasmus/0000-0002-5607-977X	Telethon [984] Funding Source: Medline; Fondazione Telethon Funding Source: Custom	Telethon(Fondazione Telethon); Fondazione Telethon(Fondazione Telethon)		Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; ARMSTRONGJAMES M, 1987, J COMP NEUROL, V263, P265, DOI 10.1002/cne.902630209; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; BIALEK W, 1991, SCIENCE, V252, P1854, DOI 10.1126/science.2063199; Brenner N, 2000, NEURAL COMPUT, V12, P1531, DOI 10.1162/089976600300015259; Buonomano DV, 1999, NEURAL COMPUT, V11, P103, DOI 10.1162/089976699300016836; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DeWeese M, 1996, NETWORK-COMP NEURAL, V7, P325, DOI 10.1088/0954-898X/7/2/013; Fairhall AL, 2001, NATURE, V412, P787, DOI 10.1038/35090500; Furukawa S, 2000, J NEUROSCI, V20, P1216, DOI 10.1523/JNEUROSCI.20-03-01216.2000; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Ghazanfar AA, 2000, J NEUROSCI, V20, P3761, DOI 10.1523/JNEUROSCI.20-10-03761.2000; Golomb D, 1997, NEURAL COMPUT, V9, P649, DOI 10.1162/neco.1997.9.3.649; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Jenison RL, 2001, NEUROCOMPUTING, V38, P239, DOI 10.1016/S0925-2312(01)00355-1; Jung MW, 2000, J NEUROSCI, V20, P6166, DOI 10.1523/JNEUROSCI.20-16-06166.2000; Kleinfeld D, 1999, SOMATOSENS MOT RES, V16, P69, DOI 10.1080/08990229970528; KYRIAZI HT, 1993, J NEUROSCI, V13, P1601; Kyriazi HT, 1996, J NEUROPHYSIOL, V75, P547, DOI 10.1152/jn.1996.75.2.547; Lebedev MA, 2000, CEREB CORTEX, V10, P23, DOI 10.1093/cercor/10.1.23; Lee D, 1998, J NEUROSCI, V18, P1161; LU SM, 1993, SOMATOSENS MOT RES, V10, P1, DOI 10.3109/08990229309028819; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Oram MW, 1998, TRENDS NEUROSCI, V21, P259, DOI 10.1016/S0166-2236(97)01216-2; Panzeri S, 1999, P ROY SOC B-BIOL SCI, V266, P1001, DOI 10.1098/rspb.1999.0736; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Panzeri S, 2001, NEURAL COMPUT, V13, P1311, DOI 10.1162/08997660152002870; Panzeri S, 2001, NEURON, V29, P769, DOI 10.1016/S0896-6273(01)00251-3; Petersen RS, 2000, J NEUROSCI, V20, P6135, DOI 10.1523/JNEUROSCI.20-16-06135.2000; Reich DS, 2001, J NEUROPHYSIOL, V85, P1039, DOI 10.1152/jn.2001.85.3.1039; Reich DS, 2000, J NEUROSCI, V20, P1964; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Rolls ET, 1997, EXP BRAIN RES, V114, P149, DOI 10.1007/PL00005615; Schultz SR, 2001, PHYS REV LETT, V86, P5823, DOI 10.1103/PhysRevLett.86.5823; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; SIMONS DJ, 1984, J COMP NEUROL, V230, P119, DOI 10.1002/cne.902300111; Snippe HP, 1996, NEURAL COMPUT, V8, P511, DOI 10.1162/neco.1996.8.3.511; Swadlow HA, 2000, J NEUROPHYSIOL, V83, P2802, DOI 10.1152/jn.2000.83.5.2802; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; VAITSCHANOFF JG, 1993, NEUROSCI LETT, V157, P157; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; Vickers NJ, 2001, NATURE, V410, P466, DOI 10.1038/35068559; Villa AEP, 1999, P NATL ACAD SCI USA, V96, P1106, DOI 10.1073/pnas.96.3.1106; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WELKER C, 1971, BRAIN RES, V26, P259, DOI 10.1016/S0006-8993(71)80004-5; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	52	181	181	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					503	514		10.1016/S0896-6273(01)00481-0	http://dx.doi.org/10.1016/S0896-6273(01)00481-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709160	Bronze			2022-12-24	WOS:000172119100015
J	Wang, CY; Yang, F; He, XP; Chow, A; Du, J; Russell, JT; Lu, B				Wang, CY; Yang, F; He, XP; Chow, A; Du, J; Russell, JT; Lu, B			Ca2+ binding protein frequenin mediates GDNF-induced potentiation of Ca2+ channels and transmitter release	NEURON			English	Article							DEVELOPING NEUROMUSCULAR SYNAPSES; LONG-TERM POTENTIATION; BDNF KNOCKOUT MICE; NEUROTROPHIC FACTOR; NEUROTRANSMITTER RELEASE; SYNAPTIC TRANSMISSION; CALCIUM CHANNELS; DOPAMINERGIC-NEURONS; MOTOR-NEURONS; HIPPOCAMPUS	Molecular mechanisms underlying long-term neurotrophic regulation of synaptic transmission and plasticity are unknown. We report here that long-term treatment of neuromuscular synapses with glial cell line-derived neurotrophic factor (GDNF) potentiates spontaneous and evoked transmitter release, in ways very similar to presynaptic expression of the Ca2+ binding protein frequenin. GDNF enhances the expression of frequenin in motoneurons, and inhibition of frequenin expression or activity prevents the synaptic action of GDNF. GDNF also facilitates Ca2+ influx into the nerve terminals during evoked transmission by enhancing Ca2+ currents. The effect of GDNF on Ca2+ currents is blocked by inhibition of frequenin expression, occluded by overexpression of frequenin, and is selective to N-type Ca2+ channels. These results identify an important molecular target that mediates the long-term, synaptic action of a neurotrophic factor.	NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA; George Washington Univ, Grad Program Genet, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); George Washington University	Lu, B (corresponding author), NICHHD, Lab Cellular & Synapt Neurophysiol, NIH, Bethesda, MD 20892 USA.		Lu, Bai/A-4018-2012; Du, Jing/A-9023-2012; Yang, Feng/C-9530-2011; Du, Jing/GWC-9642-2022	Du, Jing/0000-0003-3128-9997; Lu, Bai/0000-0001-5418-9759; Yang, Feng/0000-0003-1275-6641	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [ZIAHD001206, Z01HD001206] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ALDER J, 1992, NEURON, V9, P759, DOI 10.1016/0896-6273(92)90038-F; Baloh RH, 2000, CURR OPIN NEUROBIOL, V10, P103, DOI 10.1016/S0959-4388(99)00048-3; Boulanger L, 1999, NAT NEUROSCI, V2, P346, DOI 10.1038/7258; Bourque MJ, 2000, EUR J NEUROSCI, V12, P3172, DOI 10.1046/j.1460-9568.2000.00219.x; CABELLI RJ, 1995, SCIENCE, V267, P1662, DOI 10.1126/science.7886458; Chang SH, 1999, P NATL ACAD SCI USA, V96, P4095, DOI 10.1073/pnas.96.7.4095; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gervasi C, 2000, J COMP NEUROL, V423, P512; Gomez M, 2001, NEURON, V30, P241, DOI 10.1016/S0896-6273(01)00276-8; Gonzalez M, 1999, NEURON, V24, P567, DOI 10.1016/S0896-6273(00)81113-7; Gottschalk W, 1998, J NEUROSCI, V18, P6830; Gottschalk WA, 1999, LEARN MEMORY, V6, P243; He XP, 2000, J CELL BIOL, V149, P783, DOI 10.1083/jcb.149.4.783; HENDERSON CE, 1994, SCIENCE, V266, P1062, DOI 10.1126/science.7973664; Hendricks KB, 1999, NAT CELL BIOL, V1, P234, DOI 10.1038/12058; Jones LP, 1999, BIOPHYS J, V76, P2530, DOI 10.1016/S0006-3495(99)77407-2; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; Koester HJ, 2000, J PHYSIOL-LONDON, V529, P625, DOI 10.1111/j.1469-7793.2000.00625.x; KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856; Lee A, 1999, NATURE, V399, P155, DOI 10.1038/20194; LIN LFH, 1993, SCIENCE, V260, P1130, DOI 10.1126/science.8493557; Liou JC, 1997, J NEUROSCI, V17, P2459; LLINAS RR, 1982, SCI AM, V247, P56, DOI 10.1038/scientificamerican1082-56; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Lu B, 1999, J NEUROSCI RES, V58, P76, DOI 10.1002/(SICI)1097-4547(19991001)58:1<76::AID-JNR8>3.0.CO;2-0; MAFFEI L, 1992, J NEUROSCI, V12, P4651; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Ming GL, 2001, NEURON, V29, P441, DOI 10.1016/S0896-6273(01)00217-3; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; Nick TA, 2000, NAT NEUROSCI, V3, P142, DOI 10.1038/72082; OLAFSSON P, 1995, P NATL ACAD SCI USA, V92, P8001, DOI 10.1073/pnas.92.17.8001; OPPENHEIM RW, 1995, NATURE, V373, P344, DOI 10.1038/373344a0; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Paterlini M, 2000, NEUROSCIENCE, V99, P205, DOI 10.1016/S0306-4522(00)00201-3; Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PONGS O, 1993, NEURON, V11, P15, DOI 10.1016/0896-6273(93)90267-U; Pozzo-Miller LD, 1999, J NEUROSCI, V19, P4972; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; STOOP R, 1995, SCIENCE, V267, P695, DOI 10.1126/science.7839148; Treanor JJS, 1996, NATURE, V382, P80, DOI 10.1038/382080a0; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WANG T, 1995, J NEUROSCI, V15, P4796; Wang XH, 1997, NEURON, V19, P825, DOI 10.1016/S0896-6273(00)80964-2; Wiedemann C, 1998, J NEUROSCI, V18, P5594; Xie KW, 1997, J NEUROSCI, V17, P2947; XIE ZP, 1986, P NATL ACAD SCI USA, V83, P7069, DOI 10.1073/pnas.83.18.7069; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; YAN Q, 1995, NATURE, V373, P341, DOI 10.1038/373341a0; Yang F, 2001, NAT NEUROSCI, V4, P19, DOI 10.1038/82858; Yazejian B, 1997, J NEUROSCI, V17, P2990; Zhao MD, 1996, BIOPHYS J, V70, P896, DOI 10.1016/S0006-3495(96)79633-9; Zhao YG, 1997, J COMP NEUROL, V377, P351, DOI 10.1002/(SICI)1096-9861(19970120)377:3<351::AID-CNE4>3.0.CO;2-1; ZUCKER RS, 1989, ANNU REV NEUROSCI, V12, P13, DOI 10.1146/annurev.neuro.12.1.13; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	58	96	101	4	9	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	OCT 11	2001	32	1					99	112		10.1016/S0896-6273(01)00434-2	http://dx.doi.org/10.1016/S0896-6273(01)00434-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	481NF	11604142	Bronze			2022-12-24	WOS:000171525200012
J	Fletcher, PC; Anderson, JM; Shanks, DR; Honey, R; Carpenter, TA; Donovan, T; Papadakis, N; Bullmore, ET				Fletcher, PC; Anderson, JM; Shanks, DR; Honey, R; Carpenter, TA; Donovan, T; Papadakis, N; Bullmore, ET			Responses of human frontal cortex to surprising events are predicted by formal associative learning theory	NATURE NEUROSCIENCE			English	Article							ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; CONFLICT; FMRI; INHIBITION; ACTIVATION; SELECTION; MEMORIES	Learning depends on surprise and is not engendered by predictable occurrences. In this functional magnetic resonance imaging (fMRI) study of causal associative learning, we show that dorsolateral prefrontal cortex (DLPFC) is associated specifically with the adjustment of inferential learning on the basis of unpredictability. At the outset, when all associations were unpredictable, DLPFC activation was maximal. This response attenuated with learning but, subsequently, activation here was evoked by surprise violations of the learned association. Furthermore, the magnitude of DLPFC response to a surprise event was sensitive to the relationship that had been learned and was predictive of subsequent behavioral change. In short, the physiological response properties of right DLPFC satisfied specific predictions made by associative learning theory.	Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Cambridge CB2 2QQ, England; UCL, Dept Psychol, London WC1E 6BT, England; Univ Western Australia, Ctr Clin Res Neuropsychiat, Perth, WA 6009, Australia; Univ Cambridge, Addenbrookes Hosp, Wolfson Brain Imaging Ctr, Cambridge CB2 2QQ, England; Univ Sheffield, Sheffield S3 7RH, S Yorkshire, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London; University of Western Australia; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Sheffield	Fletcher, PC (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Brain Mapping Unit, Box 189,Hills Rd, Cambridge CB2 2QQ, England.	pcf22@cam.ac.uk	Donovan, Tim/AAF-3563-2019; Shanks, David/A-1510-2015; Bullmore, Ed/C-1706-2012; Fletcher, Paul/F-5380-2011	Shanks, David/0000-0002-4600-6323; Bullmore, Ed/0000-0002-8955-8283; Fletcher, Paul/0000-0001-8257-1517; Donovan, Tim/0000-0003-4112-861X				Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Brewer JB, 1998, SCIENCE, V281, P1185, DOI 10.1126/science.281.5380.1185; Buckner RL, 1998, HUM BRAIN MAPP, V6, P373, DOI 10.1002/(SICI)1097-0193(1998)6:5/6<373::AID-HBM8>3.3.CO;2-G; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Casey BJ, 2000, P NATL ACAD SCI USA, V97, P8728, DOI 10.1073/pnas.97.15.8728; Dickinson A, 2001, Q J EXP PSYCHOL-B, V54, P3, DOI 10.1080/02724990042000010; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fletcher PC, 2000, NEUROIMAGE, V12, P404, DOI 10.1006/nimg.2000.0633; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; Matute H, 1996, J EXP PSYCHOL LEARN, V22, P182, DOI 10.1037/0278-7393.22.1.182; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Nelson HE., 1982, NATL ADULT READING T; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; RAICHLE ME, 1994, CEREB CORTEX, V4, P8, DOI 10.1093/cercor/4.1.8; Rescorla R., 1972, CLASSICAL CONDITION, DOI DOI 10.1101/GR.110528.110; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Shanks D.R, 1995, PSYCHOL ASS LEARNING; Sussman G., 1975, COMPUTATIONAL MODEL; Talairach J., 1988, COPLANAR STEREOTAXIC; Waelti P, 2001, NATURE, V412, P43, DOI 10.1038/35083500; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WASSERMAN EA, 1993, J EXP PSYCHOL LEARN, V19, P174, DOI 10.1037/0278-7393.19.1.174; Zeki S, 1998, BRAIN, V121, P1669, DOI 10.1093/brain/121.9.1669; [No title captured]	34	168	170	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					1043	1048		10.1038/nn733	http://dx.doi.org/10.1038/nn733			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	478CR	11559855				2022-12-24	WOS:000171325800020
J	Chiamulera, C; Epping-Jordan, MP; Zocchi, A; Marcon, C; Cottiny, C; Tacconi, S; Corsi, M; Orzi, F; Conquet, F				Chiamulera, C; Epping-Jordan, MP; Zocchi, A; Marcon, C; Cottiny, C; Tacconi, S; Corsi, M; Orzi, F; Conquet, F			Reinforcing and locomotor stimulant effects of cocaine are absent in mGluR5 null mutant mice	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; AMPHETAMINE; DOPAMINE; NEUROADAPTATIONS; SENSITIZATION; ADDICTION		GlaxoSmithKline R&D, Inst Biol Cellulaire & Morphol, CH-1005 Lausanne, Switzerland; GlaxoSmithKline Labs, Dept Biol, I-37100 Verona, Italy; Neuromed Inst, I-86077 Pozzilli, Italy; Univ Roma La Sapienza, Dept Neurol Sci, I-00185 Rome, Italy	GlaxoSmithKline; GlaxoSmithKline; IRCCS Neuromed; Sapienza University Rome	Conquet, F (corresponding author), GlaxoSmithKline R&D, Inst Biol Cellulaire & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.		Chiamulera, Cristiano/C-4917-2015	Chiamulera, Cristiano/0000-0001-5076-8518; Orzi, Francesco/0000-0003-1048-4662; tacconi, stefano/0000-0003-2705-2989				Caine SB, 1999, PSYCHOPHARMACOLOGY, V147, P22, DOI 10.1007/s002130051134; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Ghasemzadeh MB, 1999, J NEUROCHEM, V72, P157, DOI 10.1046/j.1471-4159.1999.0720157.x; Kim JH, 1998, J PHARMACOL EXP THER, V284, P317; Koob GF, 1998, NEURON, V21, P467, DOI 10.1016/S0896-6273(00)80557-7; Miner LL, 1995, NEUROREPORT, V6, P2314, DOI 10.1097/00001756-199511270-00011; PARSONS LH, 1993, J NEUROCHEM, V61, P1611, DOI 10.1111/j.1471-4159.1993.tb09794.x; Pierce RC, 1996, J NEUROSCI, V16, P1550; SMITH JA, 1995, BRAIN RES, V683, P264, DOI 10.1016/0006-8993(95)00383-2; Swanson CJ, 2000, J PHARMACOL EXP THER, V292, P406; Tallaksen-Greene SJ, 1998, BRAIN RES, V780, P210, DOI 10.1016/S0006-8993(97)01141-4; Vezina P, 1999, NEUROSCI BIOBEHAV R, V23, P577, DOI 10.1016/S0149-7634(98)00055-4; White FJ, 1998, DRUG ALCOHOL DEPEN, V51, P141, DOI 10.1016/S0376-8716(98)00072-6; Zocchi A, 1998, NEUROSCIENCE, V82, P521	14	455	497	1	24	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					873	874		10.1038/nn0901-873	http://dx.doi.org/10.1038/nn0901-873			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528416				2022-12-24	WOS:000170698600011
J	Hu, HY				Hu, HY			Cell-surface heparan sulfate is involved in the repulsive guidance activities of Slit2 protein	NATURE NEUROSCIENCE			English	Article							GROWTH-ASSOCIATED MOLECULE; LONG-RANGE GUIDANCE; AXON GUIDANCE; NEURONAL MIGRATION; FIBROBLAST-GROWTH; ROBO RECEPTORS; HB-GAM; PROTEOGLYCAN GLYPICAN-1; MAMMALIAN HOMOLOGS; VERTEBRATE SLIT	Slit proteins are a family of secreted guidance proteins that can repel neuronal migration and axon growth via interaction with their cellular roundabout receptors (Robos). Here it was shown that Slit2-Robo-1 interactions were enhanced by cell-surface heparan sulfate. Removal of heparan sulfate decreased the affinity of Slit for Robe by about threefold. In addition, removal of cell-surface heparan sulfate by heparinase III abolished the chemorepulsive response to Slit2 normally shown by both the migrating neurons and growing axons. These results indicate essential roles for cell-surface heparan sulfate in the repulsive activities of Slit2.	Metrohlth Med Ctr, Rammelkamp Ctr Educ & Res, Cleveland, OH 44109 USA	MetroHealth System	Hu, HY (corresponding author), Metrohlth Med Ctr, Rammelkamp Ctr Educ & Res, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.	hhu@metrohealth.org			NINDS NIH HHS [NS38877] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038877] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Battye R, 1999, DEVELOPMENT, V126, P2475; Bellaiche Y, 1998, NATURE, V394, P85, DOI 10.1038/27932; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Binari RC, 1997, DEVELOPMENT, V124, P2623; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Chen JH, 2001, J NEUROSCI, V21, P1548, DOI 10.1523/JNEUROSCI.21-05-01548.2001; Erskine L, 2000, J NEUROSCI, V20, P4975; Hacker U, 1997, DEVELOPMENT, V124, P3565; Haerry TE, 1997, DEVELOPMENT, V124, P3055; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hu HY, 1999, NEURON, V23, P703, DOI 10.1016/S0896-6273(01)80029-5; Hu HY, 1996, NEURON, V16, P933, DOI 10.1016/S0896-6273(00)80116-6; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; KARTHIKEYAN L, 1994, J CELL SCI, V107, P3213; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kinnunen A, 1998, EUR J NEUROSCI, V10, P635, DOI 10.1046/j.1460-9568.1998.00082.x; Kinnunen A, 1999, EUR J NEUROSCI, V11, P491, DOI 10.1046/j.1460-9568.1999.00457.x; Kinnunen T, 1996, J BIOL CHEM, V271, P2243, DOI 10.1074/jbc.271.4.2243; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; Liang Y, 1999, J BIOL CHEM, V274, P17885, DOI 10.1074/jbc.274.25.17885; Lin XH, 1999, NATURE, V400, P281, DOI 10.1038/22343; Lin XH, 1999, DEVELOPMENT, V126, P3715; Litwack ED, 1998, DEV DYNAM, V211, P72, DOI 10.1002/(SICI)1097-0177(199801)211:1<72::AID-AJA7>3.3.CO;2-8; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Nakayama M, 1998, GENOMICS, V51, P27, DOI 10.1006/geno.1998.5341; Niclou SP, 2000, J NEUROSCI, V20, P4962; NUGENT MA, 1992, BIOCHEMISTRY-US, V31, P8876, DOI 10.1021/bi00152a026; PINI A, 1993, SCIENCE, V261, P95, DOI 10.1126/science.8316861; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Ringstedt T, 2000, J NEUROSCI, V20, P4983; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; Saunders S, 1997, DEV BIOL, V190, P78, DOI 10.1006/dbio.1997.8690; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; SERAFINI T, 1994, CELL, V78, P409, DOI 10.1016/0092-8674(94)90420-0; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	50	173	181	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					695	701		10.1038/89482	http://dx.doi.org/10.1038/89482			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426225				2022-12-24	WOS:000169621300014
J	Zakharenko, SS; Zablow, L; Siegelbaum, SA				Zakharenko, SS; Zablow, L; Siegelbaum, SA			Visualization of changes in presynaptic function during long-term synaptic plasticity	NATURE NEUROSCIENCE			English	Article							INDIVIDUAL HIPPOCAMPAL SYNAPSES; RAT HIPPOCAMPUS; NERVE-TERMINALS; AMPA RECEPTORS; AREA CA1; POTENTIATION; LTP; TRANSMISSION; BOUTONS; DEPRESSION	Controversy exists regarding the site of modification of synaptic transmission during long-term plasticity in the mammalian hippocampus. Here we used a fluorescent marker of presynaptic activity, FM 1-43, to directly image changes in presynaptic function during both short-term and long-term forms of plasticity at presynaptic boutons of CA3-CA1 excitatory synapses in acute hippocampal slices. We demonstrated enhanced presynaptic function during long-term potentiation (LTP) induced either chemically (with tetraethylammonium), or by high-frequency (200-Hz) electrical stimulation. Both of these forms of LTP required activation of L-type voltage-gated calcium channels and NMDA receptors in the postsynaptic CA1 neuron. These results thus implied that a long-lasting increase in the efficacy of synaptic transmission is likely to depend, at least in part, on enhanced transmitter release from the presynaptic neuron.	Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, New York, NY 10032 USA; Columbia Univ, Howard Hughes Med Inst, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute; Columbia University; Howard Hughes Medical Institute	Siegelbaum, SA (corresponding author), Columbia Univ, Howard Hughes Med Inst, Ctr Neurobiol & Behav, 722 W 168th St, New York, NY 10032 USA.		Zakharenko, Stanislav/D-3287-2013	Zakharenko, Stanislav/0000-0001-8115-202X				ANIKSZTEJN L, 1991, NATURE, V349, P67, DOI 10.1038/349067a0; Bear MF, 1999, P NATL ACAD SCI USA, V96, P9457, DOI 10.1073/pnas.96.17.9457; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BOLSHAKOV VY, 1995, SCIENCE, V269, P1730, DOI 10.1126/science.7569903; Bozdagi O, 2000, NEURON, V28, P245, DOI 10.1016/S0896-6273(00)00100-8; Carroll RC, 1999, NAT NEUROSCI, V2, P454, DOI 10.1038/8123; Choi S, 2000, NAT NEUROSCI, V3, P330, DOI 10.1038/73895; Cunha RA, 2000, NEUROPHARMACOLOGY, V39, P1156, DOI 10.1016/S0028-3908(99)00237-3; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DUNWIDDIE TV, 1981, N-S ARCH PHARMACOL, V316, P326, DOI 10.1007/BF00501365; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; GROVER LM, 1990, NATURE, V347, P477, DOI 10.1038/347477a0; HANSE E, 1994, J NEUROSCI, V14, P5028; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hawkins RD, 1998, PROG BRAIN RES, V118, P155; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Hiscock JJ, 2000, J NEUROSCI METH, V95, P1, DOI 10.1016/S0165-0270(99)00163-6; Huang YY, 1996, LEARN MEMORY, V3, P74, DOI 10.1101/lm.3.2-3.74; HUANG YY, 1993, J NEUROSCI, V13, P568; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KULLMANN DM, 1995, NEURON, V15, P997, DOI 10.1016/0896-6273(95)90089-6; LAMBERT NA, 1991, NEUROSCI LETT, V122, P50, DOI 10.1016/0304-3940(91)90190-5; LIU GS, 1995, NATURE, V375, P404, DOI 10.1038/375404a0; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Ma L, 1999, NAT NEUROSCI, V2, P24, DOI 10.1038/4525; Mainen ZF, 1999, METHODS, V18, P231, DOI 10.1006/meth.1999.0776; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1998, J NEUROSCI, V18, P6814; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; Nicoll RA, 1999, ANN NY ACAD SCI, V868, P515, DOI 10.1111/j.1749-6632.1999.tb11320.x; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; RYAN TA, 1993, NEURON, V11, P713, DOI 10.1016/0896-6273(93)90081-2; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; STEVENS CF, 1995, P NATL ACAD SCI USA, V92, P846, DOI 10.1073/pnas.92.3.846; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; STEVENS CF, 1994, NATURE, V371, P704, DOI 10.1038/371704a0; Stricker C, 1999, J PHYSIOL-LONDON, V520, P513, DOI 10.1111/j.1469-7793.1999.00513.x; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; YOON KW, 1991, J NEUROSCI, V11, P1375	49	241	242	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					711	717		10.1038/89498	http://dx.doi.org/10.1038/89498			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426227				2022-12-24	WOS:000169621300016
J	Zeltser, LM; Larsen, CW; Lumsden, A				Zeltser, LM; Larsen, CW; Lumsden, A			A new developmental compartment in the forebrain regulated by Lunatic fringe	NATURE NEUROSCIENCE			English	Article							DROSOPHILA EYE; ORGANIZATION; DORSAL		Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England	University of London; King's College London	Lumsden, A (corresponding author), Kings Coll London, MRC, Ctr Dev Neurobiol, London SE1 1UL, England.	andrew.lumsden@kcl.ac.uk	Lumsden, Andrew/C-5146-2009; Larsen, camilla/C-5346-2009	larsen, camilla/0000-0003-1138-3476				Cho KO, 1998, NATURE, V396, P272, DOI 10.1038/24394; Dominguez M, 1998, NATURE, V396, P276, DOI 10.1038/24402; FIGDOR MC, 1993, NATURE, V363, P630, DOI 10.1038/363630a0; IRVINE KD, IN PRESS ANN REV CEL; KUHLENBECK HARTWIG, 1930, ANAT ANZ, V70, P122; Papayannopoulos V, 1998, SCIENCE, V281, P2031, DOI 10.1126/science.281.5385.2031; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; Rhinn M, 2001, CURR OPIN NEUROBIOL, V11, P34, DOI 10.1016/S0959-4388(00)00171-9	9	88	88	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					683	684		10.1038/89455	http://dx.doi.org/10.1038/89455			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426219				2022-12-24	WOS:000169621300008
J	Aakalu, G; Smith, WB; Nguyen, N; Jiang, CG; Schuman, EM				Aakalu, G; Smith, WB; Nguyen, N; Jiang, CG; Schuman, EM			Dynamic visualization of local protein synthesis in hippocampal neurons	NEURON			English	Article							LONG-TERM POTENTIATION; MESSENGER-RNA; TETANIC STIMULATION; NEUROTROPHIC FACTOR; KINASE-II; LOCALIZATION; REQUIREMENT; DENDRITES; REGION; ALPHA	Using pharmacological approaches, several recent studies suggest that local protein synthesis is required for synaptic plasticity. Convincing demonstrations of bona fide dendritic protein synthesis in mammalian neurons are rare, however. We developed a protein synthesis reporter in which the coding sequence of green fluorescent protein is flanked by the 5' and 3' untranslated regions from CAMKII-alpha, conferring both dendritic mRNA localization and translational regulation. In cultured hippocampal neurons, we show that BDNF, a growth factor involved in synaptic plasticity, stimulates protein synthesis of the reporter in intact, mechanically, or "optically" isolated dendrites. The stimulation of protein synthesis is blocked by anisomycin and not observed in untreated neurons. In addition, dendrites appear to possess translational hot spots, regions near synapses where protein synthesis consistently occurs over time.	CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute	Schuman, EM (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol 216 76, Pasadena, CA 91125 USA.	schumane@its.caltech.edu	Schuman, Erin M/D-6204-2011					Brown EJ, 1996, CELL, V86, P517, DOI 10.1016/S0092-8674(00)80125-7; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; CUBITT AB, 1995, TRENDS BIOCHEM SCI, V20, P448, DOI 10.1016/S0968-0004(00)89099-4; FEIG S, 1993, J NEUROSCI, V13, P1010; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Goslin K., 1990, CULTURING NERVE CELL; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Kacharmina JE, 2000, P NATL ACAD SCI USA, V97, P11545, DOI 10.1073/pnas.97.21.11545; Kang HJ, 1997, NEURON, V19, P653, DOI 10.1016/S0896-6273(00)80378-5; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Koenig E, 2000, J NEUROSCI, V20, P8390, DOI 10.1523/JNEUROSCI.20-22-08390.2000; LERNER EA, 1981, P NATL ACAD SCI-BIOL, V78, P2737, DOI 10.1073/pnas.78.5.2737; LEVINE ES, 1995, P NATL ACAD SCI USA, V92, P8074, DOI 10.1073/pnas.92.17.8074; Levine ES, 1998, P NATL ACAD SCI USA, V95, P10235, DOI 10.1073/pnas.95.17.10235; Li YX, 1998, J NEUROSCI, V18, P10231; Li YX, 1998, P NATL ACAD SCI USA, V95, P10884, DOI 10.1073/pnas.95.18.10884; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; OTANI S, 1989, NEUROSCIENCE, V28, P519, DOI 10.1016/0306-4522(89)90001-8; Ouyang Y, 1997, J NEUROSCI, V17, P5416; Ouyang Y, 1999, J NEUROSCI, V19, P7823; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; RAO A, 1991, J NEUROSCI, V11, P2881; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Schuman EM, 1999, CURR OPIN NEUROBIOL, V9, P105, DOI 10.1016/S0959-4388(99)80013-0; Schuman EM, 1999, NEURON, V23, P645, DOI 10.1016/S0896-6273(01)80023-4; SRINIVASAN Y, 1990, J NEUROSCI, V10, P985; STANTON PK, 1984, J NEUROSCI, V4, P3080; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Torre ER, 1996, J NEUROSCI, V16, P5967; TORRE ER, 1992, J NEUROSCI, V12, P762; WEILER I J, 1991, Molecular and Cellular Neuroscience, V2, P305, DOI 10.1016/1044-7431(91)90060-2; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; WELSL DG, 2000, CURR OPIN NEUROBIOL, V10, P132; WEY CL, 1981, BIOPHYS J, V33, P225, DOI 10.1016/S0006-3495(81)84883-7; Wu L, 1998, NEURON, V21, P1129, DOI 10.1016/S0896-6273(00)80630-3	43	452	470	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					489	502		10.1016/S0896-6273(01)00295-1	http://dx.doi.org/10.1016/S0896-6273(01)00295-1			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395009	Bronze			2022-12-24	WOS:000168962000020
J	Jiang, L; Xu, J; Nedergaard, M; Kang, J				Jiang, L; Xu, J; Nedergaard, M; Kang, J			A Kainate receptor increases the efficacy of GABAergic synapses	NEURON			English	Article							INHIBITORY SYNAPTIC TRANSMISSION; METABOTROPIC GLUTAMATE RECEPTORS; RAT HIPPOCAMPAL-FORMATION; EXCITATORY AMINO-ACIDS; CA3 PYRAMIDAL NEURONS; MOSSY FIBER SYNAPSES; PRESYNAPTIC INHIBITION; DENDRITIC INHIBITION; AMPA RECEPTORS; SPINAL-CORD	Brain functions are based on the dynamic interaction of excitatory and inhibitory inputs. Spillover of glutamate from excitatory synapses may diffuse to and modulate nearby inhibitory synapses. By recording unitary inhibitory postsynaptic currents (uIPSCs) from cell pairs in CA1 of the hippocampus, we demonstrated that low concentrations of Kainate receptor (KAR) agonists increased the success rate (P-s) of ulPSCs, whereas high concentrations of KAR agonists depressed GABAergic synapses. Ambient glutamate released by basal activities or stimulation of the stratum radiatum increases the efficacy of GABAergic synapses by activating presynaptic KARs, which facilitate Ca2+-dependent GABA release. The results suggest that glutamate released from excitatory synapses may also function as an intermediary between excitatory and inhibitory synapses to protect overexcitation of local circuits.	New York Med Coll, Dept Cell Biol & Anat, Valhalla, NY 10595 USA	New York Medical College	Kang, J (corresponding author), New York Med Coll, Dept Cell Biol & Anat, Basic Sci Bldg,Room 220, Valhalla, NY 10595 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037349] Funding Source: NIH RePORTER; NINDS NIH HHS [IR29NS37349] Funding Source: Medline; PHS HHS [R0135011, R0139997] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALGER BE, 1982, J PHYSIOL-LONDON, V328, P105, DOI 10.1113/jphysiol.1982.sp014255; Araque A, 1998, J NEUROSCI, V18, P6822; Bergles DE, 1997, NEURON, V19, P1297, DOI 10.1016/S0896-6273(00)80420-1; Bergles DE, 1998, J NEUROSCI, V18, P7709; BETTLER B, 1995, NEUROPHARMACOLOGY, V34, P123, DOI 10.1016/0028-3908(94)00141-E; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; BUHL EH, 1994, NATURE, V368, P823, DOI 10.1038/368823a0; Bureau I, 1999, J NEUROSCI, V19, P653; CAPOGNA M, 1995, J NEUROSCI, V15, P1249; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Commons KG, 1996, BRAIN RES, V724, P1, DOI 10.1016/0006-8993(96)00236-3; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; Debanne D, 1997, NATURE, V389, P286, DOI 10.1038/38502; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; Ding RG, 1998, BRAIN RES, V800, P105, DOI 10.1016/S0006-8993(98)00507-1; Dirig DM, 1997, J NEUROSCI, V17, P4406; FLEIDERVISH IA, 1995, J NEUROPHYSIOL, V73, P2591, DOI 10.1152/jn.1995.73.6.2591; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HERTZ L, 1979, PROG NEUROBIOL, V13, P277, DOI 10.1016/0301-0082(79)90018-2; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Jeftinija SD, 1996, J NEUROCHEM, V66, P676; Jiang L, 2000, J PHYSIOL-LONDON, V523, P425, DOI 10.1111/j.1469-7793.2000.t01-1-00425.x; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; KANDEL ER, 1961, J NEUROPHYSIOL, V24, P225, DOI 10.1152/jn.1961.24.3.225; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Liu QY, 1998, J PHYSIOL-LONDON, V510, P721, DOI 10.1111/j.1469-7793.1998.721bj.x; MAJOR G, 1994, J NEUROSCI, V14, P4613; MCBAIN CJ, 1992, BRAIN RES, V592, P255, DOI 10.1016/0006-8993(92)91683-6; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; MILNER TA, 1992, HIPPOCAMPUS, V2, P107, DOI 10.1002/hipo.450020204; MILNER TA, 1989, J NEUROSCI, V9, P3410; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; NICHOLLS D, 1990, TRENDS PHARMACOL SCI, V11, P462, DOI 10.1016/0165-6147(90)90129-V; PARSONS CG, 1994, NEUROPHARMACOLOGY, V33, P589, DOI 10.1016/0028-3908(94)90163-5; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PEARCE RA, 1993, NEURON, V10, P189, DOI 10.1016/0896-6273(93)90310-N; Qian J, 1999, J NEUROPHYSIOL, V81, P288, DOI 10.1152/jn.1999.81.1.288; Qian J, 1997, BRIT J PHARMACOL, V122, P511, DOI 10.1038/sj.bjp.0701400; Qian J, 1999, J PHYSIOL-LONDON, V519, P427, DOI 10.1111/j.1469-7793.1999.0427m.x; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; THOMPSON SM, 1994, PROG NEUROBIOL, V42, P575, DOI 10.1016/0301-0082(94)90044-2; Vignes M, 1997, NATURE, V388, P179, DOI 10.1038/40639; WATKINS J, 1994, TRENDS PHARMACOL SCI, V15, P333, DOI 10.1016/0165-6147(94)90028-0; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Xiang ZX, 1998, SCIENCE, V281, P985, DOI 10.1126/science.281.5379.985; YU WF, 1995, BRAIN RES, V692, P190, DOI 10.1016/0006-8993(95)00665-D; Zuiderwijk M, 1996, EUR J PHARMACOL, V307, P275, DOI 10.1016/0014-2999(96)00284-1	65	105	109	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					503	513		10.1016/S0896-6273(01)00298-7	http://dx.doi.org/10.1016/S0896-6273(01)00298-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395010	Bronze			2022-12-24	WOS:000168962000021
J	Small, SA; Nava, AS; Perera, GM; DeLaPaz, R; Mayeux, R; Stern, Y				Small, SA; Nava, AS; Perera, GM; DeLaPaz, R; Mayeux, R; Stern, Y			Circuit mechanisms underlying memory encoding and retrieval in the long axis of the hippocampal formation	NATURE NEUROSCIENCE			English	Article							MEDIAL TEMPORAL-LOBE; FUNCTIONAL-DIFFERENTIATION; CORTICAL AFFERENTS; TERM POTENTIATION; ENTORHINAL CORTEX; ORGANIZATION; MONKEY; REPRESENTATION; ACTIVATIONS; FMRI	Circuits within the hippocampal formation are active during memory processing. Here we used functional magnetic resonance imaging (fMRI) to examine multiple sites across the long axis of the hippocampal formation while subjects performed different phases of an associative memory task, learning to associate faces with names. Viewing faces and hearing names in isolation resulted in separate hippocampal activation patterns. Pairing faces with names resulted a spatially redistributed activation pattern, rather than a simple summation of the activation patterns resulting from viewing faces and hearing names in isolation. Recalling names when cued with faces reactivated a pattern similar to that found during paired training. Finally, the activation patterns representing faces and names were found to be experience dependent, emerging with repeated exposure. Interpreted in the context of hippocampal anatomy and physiology, these findings reveal hippocampal circuit mechanisms that underlie memory encoding and retrieval.	Columbia Univ Coll Phys & Surg, Taub Inst Alzheimers Dis & Aging Brain, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Radiol, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University	Small, SA (corresponding author), Columbia Univ Coll Phys & Surg, Taub Inst Alzheimers Dis & Aging Brain, 630 W 168th St, New York, NY 10032 USA.		Mayeux, Richard/E-9788-2013	Mayeux, Richard/0000-0001-6519-9696; Stern, Yaakov/0000-0001-7542-3241	NATIONAL INSTITUTE ON AGING [P50AG008702] Funding Source: NIH RePORTER; NIA NIH HHS [AG08702, AG00946] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; Amaral DG, 1990, HUMAN NERVOUS SYSTEM, P711; ANDERSEN P, 1971, EXP BRAIN RES, V13, P222; Colombo M, 1998, J NEUROPHYSIOL, V80, P1002, DOI 10.1152/jn.1998.80.2.1002; DEBSKI EA, 1990, J NEUROBIOL, V21, P18, DOI 10.1002/neu.480210103; Duvernoy H, 1998, HUMAN HIPPOCAMPUS; EICHENBAUM H, 1989, BEHAV NEUROSCI, V103, P1207, DOI 10.1037/0735-7044.103.6.1207; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; GUSTAFSSON B, 1987, J NEUROSCI, V7, P774; Henke K, 1997, HIPPOCAMPUS, V7, P249, DOI 10.1002/(SICI)1098-1063(1997)7:3<249::AID-HIPO1>3.0.CO;2-G; INSAUSTI R, 1987, J COMP NEUROL, V264, P356, DOI 10.1002/cne.902640306; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Kohonen T, 1977, ASS MEMORY SYSTEM TH; Lepage M, 1998, HIPPOCAMPUS, V8, P313, DOI 10.1002/(SICI)1098-1063(1998)8:4<313::AID-HIPO1>3.0.CO;2-I; MARR D, 1971, PHILOS T ROY SOC B, V262, P23, DOI 10.1098/rstb.1971.0078; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; Moser MB, 1998, J NEUROSCI, V18, P7535; PARE D, 1994, HIPPOCAMPUS, V4, P403, DOI 10.1002/hipo.450040403; Pavlidis P, 2000, J NEUROSCI, V20, P4497, DOI 10.1523/JNEUROSCI.20-12-04497.2000; RempelClower NL, 1996, J NEUROSCI, V16, P5233; Saykin AJ, 1999, BRAIN, V122, P1963, DOI 10.1093/brain/122.10.1963; Schacter DL, 1999, HIPPOCAMPUS, V9, P7, DOI 10.1002/(SICI)1098-1063(1999)9:1<7::AID-HIPO2>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; SQUIRE LR, 1992, PSYCHOL REV, V99, P582; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; VarghaKhadem F, 1997, SCIENCE, V277, P376, DOI 10.1126/science.277.5324.376; VarghaKhadem F, 1997, SCIENCE, V277, P1117; WITTER MP, 1989, PROG NEUROBIOL, V33, P161, DOI 10.1016/0301-0082(89)90009-9; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P153, DOI 10.1097/00004728-199801000-00028	33	127	133	0	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					442	449		10.1038/86115	http://dx.doi.org/10.1038/86115			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276237	Green Published			2022-12-24	WOS:000168762200027
J	Steward, O; Worley, PF				Steward, O; Worley, PF			Selective targeting of newly synthesized Arc mRNA to active synapses requires NMDA receptor activation	NEURON			English	Article							LOCAL PROTEIN-SYNTHESIS; LONG-TERM POTENTIATION; IMMEDIATE-EARLY GENE; MESSENGER-RNA; DENDRITES; PATHWAY	Newly synthesized Are mRNA is selectively targeted to synapses that have experienced particular patterns of activity. Here, we demonstrate that the targeting requires NMDA receptor activation. Are expression was induced by an electroconvulsive seizure, and the newly synthesized mRNA was then targeted to synaptic sites by activating the perforant path projections to the dentate gyrus. When micropipette electrodes containing NMDA receptor antagonists (MK801 or APV) were positioned in the dentate gyrus during the stimulation period, newly synthesized Are mRNA was transported into dendrites but did not localize in the activated lamina; instead, the mRNA remained diffusely distributed. AMPA receptor antagonists (CNQX) blocked targeting of Are mRNA in a small region, and mGluR antagonists (MCPG) did not affect localization. These results demonstrate that NMDA receptor activation is required for the targeting of Are mRNA to active synapses.	Univ Calif Irvine, Coll Med, Reeve Irvine Res Ctr, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Dept Anat & Neurobiol, Irvine, CA 92697 USA; Univ Calif Irvine, Coll Med, Dept Neurobiol & Behav, Irvine, CA 92697 USA; Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Johns Hopkins University	Steward, O (corresponding author), Univ Calif Irvine, Coll Med, Reeve Irvine Res Ctr, Irvine, CA 92697 USA.			Steward, Oswald/0000-0001-7069-8756	NIMH NIH HHS [MH53603] Funding Source: Medline; NINDS NIH HHS [NS12333] Funding Source: Medline	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BLISS T V P, 1988, P3; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; LEVY WB, 1979, BRAIN RES, V175, P233, DOI 10.1016/0006-8993(79)91003-5; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Nguyen PV, 1996, J NEUROSCI, V16, P3189; STEWARD O, 1990, BRAIN RES, V516, P292, DOI 10.1016/0006-8993(90)90930-A; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; STEWARD O, 1993, 7 NOV NORD FDN S MEM, P281; Wallace CS, 1998, J NEUROSCI, V18, P26	12	345	357	0	15	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					227	240		10.1016/S0896-6273(01)00275-6	http://dx.doi.org/10.1016/S0896-6273(01)00275-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343657	Bronze			2022-12-24	WOS:000168412900023
J	King, M; Su, W; Chang, A; Zuckerman, A; Pasternak, GW				King, M; Su, W; Chang, A; Zuckerman, A; Pasternak, GW			Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs	NATURE NEUROSCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; ANTISENSE OLIGODEOXYNUCLEOTIDES; MORPHINE ANALGESIA; D-PENICILLAMINE(2,5) ENKEPHALIN; ORPHANIN FQ/NOCICEPTIN; ENDOTHELIAL-CELLS; RECEPTOR MECHANISMS; BLOOD; BARRIER; EXPRESSION	Many peptides and transmitters found within the brain also have peripheral sites of action. We now demonstrate that the brain releases functionally active neurotransmitters/neuromodulators directly from the brain into the blood through a saturable P-glycoprotein (Pgp) transport system. Downregulating Pgp1 expression with antisense reduced the brain-to-blood transport of morphine, beta -endorphin and other opioids. Lowering Pgp expression significantly enhanced systemic morphine analgesia and prevented tolerance, but diminished the analgesic activity of centrally administered morphine, implying that supraspinal analgesia resulted from a combination of central and peripheral mechanisms activated by morphine transported from the brain to the blood. Similarly, mice with a disruption of the Mdr1a gene were more sensitive to systemic morphine and less sensitive to morphine given centrally. This ability of the Pgp transport system to pump functionally active compounds from the brain to periphery defines a potentially important mechanism for the central nervous system to modulate peripheral systems.	Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, New York, NY 10021 USA; Cornell Univ, Grad Sch Med Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Pasternak, GW (corresponding author), Mem Sloan Kettering Canc Ctr, Cotzias Lab Neurooncol, 1275 York Ave, New York, NY 10021 USA.				NCI NIH HHS [CA08748] Funding Source: Medline; NIDA NIH HHS [DA02615, DA07242, T32DA07274, DA00220] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007274, R01DA002615, R37DA007242, R01DA007242, R56DA002615] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Aquilante CL, 1999, LIFE SCI, V66, pL47; BANKS WA, 1987, LIFE SCI, V41, P1319, DOI 10.1016/0024-3205(87)90606-0; Banks WA, 1996, LIFE SCI, V59, P1923, DOI 10.1016/S0024-3205(96)00380-3; BANKS WA, 1993, J NEUROSCI RES, V35, P690, DOI 10.1002/jnr.490350611; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; BODNAR RJ, 1989, CANCER RES, V49, P6280; Chen CP, 1999, PHARM RES-DORDR, V16, P296, DOI 10.1023/A:1018892811980; Chen CP, 1998, J PHARMACOL EXP THER, V287, P545; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Egleton RD, 1999, J PHARM SCI-US, V88, P392, DOI 10.1021/js980410+; Gao ZQ, 1998, ANTICANCER RES, V18, P3073; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135; HEGMANN EJ, 1992, CANCER RES, V52, P6969; Jonker JW, 1999, BRIT J PHARMACOL, V127, P43, DOI 10.1038/sj.bjp.0702497; King MA, 1997, NEUROSCI LETT, V223, P113, DOI 10.1016/S0304-3940(97)13414-0; Kolesnikov Y, 1999, J PHARMACOL EXP THER, V290, P247; Kolesnikov YA, 1999, EUR J PHARMACOL, V374, pR1, DOI 10.1016/S0014-2999(99)00318-0; Kolesnikov YA, 1996, J PHARMACOL EXP THER, V279, P502; Kolesnikov YA, 1997, P NATL ACAD SCI USA, V94, P8220, DOI 10.1073/pnas.94.15.8220; Letrent SP, 1999, DRUG METAB DISPOS, V27, P827; LING GSF, 1983, EUR J PHARMACOL, V86, P487; LING GSF, 1985, J PHARMACOL EXP THER, V232, P149; Mathis JP, 1997, BIOCHEM BIOPH RES CO, V230, P462, DOI 10.1006/bbrc.1996.5867; Motomura S, 1998, BLOOD, V91, P3163, DOI 10.1182/blood.V91.9.3163.3163_3163_3171; PAN YX, 1994, REGUL PEPTIDES, V54, P217, DOI 10.1016/0167-0115(94)90468-5; Pan YX, 1996, FEBS LETT, V395, P207; PAN YX, 1995, MOL PHARMACOL, V47, P1180; Pardridge WM, 1997, J NEUROCHEM, V68, P1278; Regina A, 1998, J NEUROCHEM, V71, P705; ROERIG SC, 1984, BRAIN RES, V308, P360, DOI 10.1016/0006-8993(84)91078-3; Rohde DS, 1997, NEUROSCIENCE, V80, P599, DOI 10.1016/S0306-4522(97)00096-1; Romero LI, 1996, AM J PHYSIOL-REG I, V270, pR518, DOI 10.1152/ajpregu.1996.270.3.R518; RONINSON IB, 1991, MOL CELLULAR BIOL MU, P189; Rossi GC, 1996, NEUROSCI LETT, V216, P1; ROSSI GC, 1993, BRAIN RES, V624, P171, DOI 10.1016/0006-8993(93)90075-X; Rossi GC, 1997, J PHARMACOL EXP THER, V282, P858; ROSSI GC, 1994, BRAIN RES, V665, P85, DOI 10.1016/0006-8993(94)91155-X; SCHINKEL AH, 1995, EUR J CANCER, V31A, P1295, DOI 10.1016/0959-8049(95)00130-B; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; SCHINKEL AH, 1996, J CLIN INVEST, V97, P25617; STANDIFER KM, 1994, NEURON, V12, P805, DOI 10.1016/0896-6273(94)90333-6; Standifer KM, 1996, MOL PHARMACOL, V50, P293; STANDIFER KM, 1995, J NEUROCHEM, V65, P1981; TALLARIDA RJ, 1987, MANUAL PHARM CALCULA; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Thompson SJ, 2000, ANESTHESIOLOGY, V92, P1392, DOI 10.1097/00000542-200005000-00030; Wang LW, 1998, J PHYSIOL-LONDON, V511, P33, DOI 10.1111/j.1469-7793.1998.033bi.x; Xie RJ, 1999, BRIT J PHARMACOL, V128, P563, DOI 10.1038/sj.bjp.0702804	50	158	165	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					268	274		10.1038/85115	http://dx.doi.org/10.1038/85115			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224543				2022-12-24	WOS:000167178300014
J	Wang, SL; Sdrulla, A; Johnson, JE; Yokota, Y; Barres, BA				Wang, SL; Sdrulla, A; Johnson, JE; Yokota, Y; Barres, BA			A role for the helix-loop-helix protein Id2 in the control of oligodendrocyte development	NEURON			English	Article							RETINAL GANGLION-CELLS; RAT OPTIC-NERVE; RETINOBLASTOMA PROTEIN; PRECURSOR CELLS; TRANSCRIPTION FACTORS; INTRINSIC TIMER; DIFFERENTIATION; NEUROGENESIS; SURVIVAL; LINEAGE	Compared to neurons, the intracellular mechanisms that control glial differentiation are still poorly understood. We show here that oligodendrocyte lineage cells express the helix-loop-helix proteins Mash1 and ld2. Although Mash1 has been found to regulate neuronal development, we found that in the absence of Mash1 oligodendrocyte differentiation occurs normally. In contrast, we found that overexpression of ld2 powerfully inhibits oligodendrocyte differentiation, that ld2 normally translocates out of the nucleus at the onset of differentiation, and that absence of ld2 induces premature oligodendrocyte differentiation in vitro. These findings demonstrate that ld2 is a component of the intracellular mechanism that times oligodendrocyte differentiation and point to the existence of an as yet unidentified MyoD-like bHLH protein necessary for oligodendrocyte differentiation.	Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; Univ Texas, SW Med Ctr, Ctr Basic Neurosci, Dallas, TX 75390 USA; Fukui Med Univ, Dept Biochem, Fukui 9101193, Japan	Stanford University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Fukui	Barres, BA (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Sherman Fairchild Sci Bldg D231,299 Campus Dr, Stanford, CA 94305 USA.		Sdrulla, Andrei/AAU-7664-2021; Johnson, Jane/F-8881-2010		NATIONAL EYE INSTITUTE [R29EY010257, R01EY010257] Funding Source: NIH RePORTER; NEI NIH HHS [EY10257] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		BARRES BA, 1988, NEURON, V1, P791, DOI 10.1016/0896-6273(88)90127-4; BARRES BA, 1994, NEURON, V12, P935, DOI 10.1016/0896-6273(94)90305-0; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; BARRES BA, 1993, DEVELOPMENT, V118, P283; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; CasacciaBonnefil P, 1997, GENE DEV, V11, P2335, DOI 10.1101/gad.11.18.2335; Deed RW, 1996, J BIOL CHEM, V271, P23603, DOI 10.1074/jbc.271.39.23603; Durand B, 2000, BIOESSAYS, V22, P64; Durand B, 1998, CURR BIOL, V8, P431, DOI 10.1016/S0960-9822(98)70177-0; Durand B, 1997, EMBO J, V16, P306, DOI 10.1093/emboj/16.2.306; Gao FB, 1997, CURR BIOL, V7, P152, DOI 10.1016/S0960-9822(06)00060-1; Granderath S, 1999, CURR OPIN NEUROBIOL, V9, P531, DOI 10.1016/S0959-4388(99)00008-2; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; Hara E, 1997, EMBO J, V16, P332, DOI 10.1093/emboj/16.2.332; IAVARONE A, 1994, GENE DEV, V8, P1270, DOI 10.1101/gad.8.11.1270; JAN YN, 1993, CELL, V75, P827, DOI 10.1016/0092-8674(93)90525-U; JOHNSON JE, 1990, NATURE, V346, P858, DOI 10.1038/346858a0; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kondo T, 2000, EMBO J, V19, P1998, DOI 10.1093/emboj/19.9.1998; Kondo T, 2000, DEVELOPMENT, V127, P2989; Lasorella A, 2000, NATURE, V407, P592, DOI 10.1038/35036504; Lasorella A, 1996, MOL CELL BIOL, V16, P2570; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; LO LC, 1991, GENE DEV, V5, P1524, DOI 10.1101/gad.5.9.1524; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Melnikova IN, 1999, EXP CELL RES, V247, P94, DOI 10.1006/excr.1998.4330; MEYERFRANKE A, 1995, NEURON, V15, P805, DOI 10.1016/0896-6273(95)90172-8; Norton JD, 2000, J CELL SCI, V113, P3897; Shi JY, 1998, J NEUROSCI, V18, P4627; TEMPLE S, 1986, CELL, V44, P773, DOI 10.1016/0092-8674(86)90843-3; Toma JG, 2000, J NEUROSCI, V20, P7648; Tzeng SF, 1997, MOL BRAIN RES, V46, P136, DOI 10.1016/S0169-328X(96)00294-X; Tzeng SF, 1998, GLIA, V24, P372, DOI 10.1002/(SICI)1098-1136(199812)24:4<372::AID-GLIA2>3.0.CO;2-B; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	39	199	209	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					603	614		10.1016/S0896-6273(01)00237-9	http://dx.doi.org/10.1016/S0896-6273(01)00237-9			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301021	Bronze			2022-12-24	WOS:000167868900011
J	Geschwind, DH; Ou, J; Easterday, MC; Dougherty, JD; Jackson, RL; Chen, ZG; Antoine, H; Terskikh, A; Weissman, IL; Nelson, SF; Kornblum, HI				Geschwind, DH; Ou, J; Easterday, MC; Dougherty, JD; Jackson, RL; Chen, ZG; Antoine, H; Terskikh, A; Weissman, IL; Nelson, SF; Kornblum, HI			A genetic analysis of neural progenitor differentiation	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; EPIDERMAL GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; FYN TYROSINE KINASE; SIGNALING PATHWAY; CYCLE KINETICS; GERMINAL ZONE; MESSENGER-RNA; EXPRESSION; BRAIN	Genetic mechanisms regulating CNS progenitor function and differentiation are not well understood. We have used microarrays derived from a representational difference analysis (RDA) subtraction in a heterogeneous stem cell culture system to systematically study the gene expression patterns of CNS progenitors. This analysis identified both known and novel genes enriched in progenitor cultures. In situ hybridization in a subset of clones demonstrated that many of these genes were expressed preferentially in germinal zones, some showing distinct ventricular or subventricular zone labeling. Several genes were also enriched in hematopoietic stem cells, suggesting an overlap of gene expression in neural and hematopoietic progenitors. This combination of methods demonstrates the power of using custom microarrays derived from RDA-subtracted libraries for both gene discovery and gene expression analysis in the central nervous system.	Univ Calif Los Angeles, Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Mental Retardat Res Ctr, Los Angeles, CA 90095 USA; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Stanford University; Stanford University	Geschwind, DH (corresponding author), Univ Calif Los Angeles, Sch Med, Neurogenet Program, Los Angeles, CA 90095 USA.	dhg@ucla.edu	Nelson, Stanley F/D-4771-2009; Terskikh, Alexey/U-8407-2019	Nelson, Stanley F/0000-0002-2082-3114; Antoine, Heath/0000-0002-1914-3576; Dougherty, Joseph/0000-0002-6385-3997	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH060233, R56MH060233, R01MH060233, R21MH062800] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS028383, P50NS028383] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60233, MH062800] Funding Source: Medline; NINDS NIH HHS [NS28383] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AnandApte B, 1997, STEM CELLS, V15, P259, DOI 10.1002/stem.150259; Arar C, 1999, BIOCHEM J, V343, P225, DOI 10.1042/0264-6021:3430225; Bjornson CRR, 1999, SCIENCE, V283, P534, DOI 10.1126/science.283.5401.534; Cameron HA, 1998, CURR OPIN NEUROBIOL, V8, P677, DOI 10.1016/S0959-4388(98)80099-8; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cheung VG, 1998, NAT GENET, V18, P225, DOI 10.1038/ng0398-225; Ciccolini F, 1998, J NEUROSCI, V18, P7869; Collet JF, 1997, FEBS LETT, V408, P281, DOI 10.1016/S0014-5793(97)00438-9; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; DEHAY C, 1993, NATURE, V366, P464, DOI 10.1038/366464a0; delaPompa J, 1997, DEVELOPMENT, V124, P1139; DeRisi J, 1996, NAT GENET, V14, P457; Doetsch F, 1997, J NEUROSCI, V17, P5046; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; FERRI RT, 1995, DEVELOPMENT, V121, P1151; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Gao YJ, 2000, NATURE, V404, P897, DOI 10.1038/35009138; Geschwind D. H., 1998, Society for Neuroscience Abstracts, V24, P1003; Geschwind DH, 2000, P NATL ACAD SCI USA, V97, P10676, DOI 10.1073/pnas.97.20.10676; Geschwind DH, 1998, DEV GENET, V23, P215, DOI 10.1002/(SICI)1520-6408(1998)23:3<215::AID-DVG7>3.0.CO;2-X; Gritti A, 1996, J NEUROSCI, V16, P1091; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621; HUBANK M, 1994, NUCLEIC ACIDS RES, V22, P5640, DOI 10.1093/nar/22.25.5640; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kornack DR, 1998, P NATL ACAD SCI USA, V95, P1242, DOI 10.1073/pnas.95.3.1242; Kornack DR, 1999, P NATL ACAD SCI USA, V96, P5768, DOI 10.1073/pnas.96.10.5768; KORNBLUM HI, 1994, MOL BRAIN RES, V21, P107, DOI 10.1016/0169-328X(94)90383-2; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Kurooka K, 2000, J BIOL CHEM, V275, P17211, DOI 10.1074/jbc.M000909200; Learish RD, 2000, DEV BRAIN RES, V122, P97; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCCONNELL SK, 1995, J NEUROSCI, V15, P6987; Meyyappan M, 1998, MOL CELL BIOL, V18, P3163, DOI 10.1128/MCB.18.6.3163; MORRISON RS, 1981, P NATL ACAD SCI-BIOL, V78, P7205, DOI 10.1073/pnas.78.11.7205; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Osterhout DJ, 1999, J CELL BIOL, V145, P1209, DOI 10.1083/jcb.145.6.1209; Parent JM, 1997, J NEUROSCI, V17, P3727; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; Polleux F, 1997, J NEUROSCI, V17, P7763; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Reznikov K, 1997, DEV DYNAM, V210, P328, DOI 10.1002/(SICI)1097-0177(199711)210:3<328::AID-AJA12>3.0.CO;2-6; Ross ME, 1996, J NEUROSCI, V16, P210; Roth LWA, 1999, DEVELOPMENT, V126, P1365; Schena M, 1996, P NATL ACAD SCI USA, V93, P10614, DOI 10.1073/pnas.93.20.10614; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; SOMMER I, 1981, DEV BIOL, V83, P311, DOI 10.1016/0012-1606(81)90477-2; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Takeuchi T, 2000, J NEUROCHEM, V74, P1489, DOI 10.1046/j.1471-4159.2000.0741489.x; TEMPLE S, 1989, NATURE, V340, P471, DOI 10.1038/340471a0; Tropepe V, 2000, SCIENCE, V287, P2032, DOI 10.1126/science.287.5460.2032; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; Weiss S, 1996, J NEUROSCI, V16, P7599; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Welford SM, 1998, NUCLEIC ACIDS RES, V26, P3059, DOI 10.1093/nar/26.12.3059; WILLIAMS BP, 1991, NEURON, V7, P685, DOI 10.1016/0896-6273(91)90381-9; Zhang KZ, 1998, AM J PATHOL, V153, P439, DOI 10.1016/S0002-9440(10)65587-3	67	198	213	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					325	339		10.1016/S0896-6273(01)00209-4	http://dx.doi.org/10.1016/S0896-6273(01)00209-4			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239426	Bronze			2022-12-24	WOS:000167141700009
J	Casado, M; Isope, P; Ascher, P				Casado, M; Isope, P; Ascher, P			Involvement of presynaptic N-methyl-D-aspartate receptors in cerebellar long-term depression	NEURON			English	Article							PURKINJE-CELL SYNAPSE; RAT HIPPOCAMPUS; DENDRITIC SPINES; CALCIUM-RELEASE; NMDA RECEPTORS; ACID RECEPTOR; AREA CA1; GLUTAMATE; POTENTIATION; STIMULATION	At the cerebellar synapses between parallel fibers (PFs) and Purkinje cells (PCs), long-term depression (LTD) of the excitatory synaptic current has been assumed to be Independent of the N-methyl-D-aspartate (NMDA) receptor activation because PCs lack NMDA receptors. However, we now report that LTD is suppressed by NMDA receptor antagonists that act on presynaptic NMDA receptors of the PFs. This effect is still observed when the input Is restricted to a single fiber. Therefore, LTD does not require the spatial integration of multiple inputs. In contrast, it involves a temporal integration, since reliable LTD induction requires the PFs to fire two action potentials in close succession. This implies that LTD will selectively depress the response to a burst of presynaptic action potentials.	Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Casado, M (corresponding author), Ecole Normale Super, Neurobiol Lab, CNRS, UMR 8544, 46 Rue Ulm, F-75005 Paris, France.			Casado, Mariano/0000-0001-8049-8096; Isope, Philippe/0000-0002-0630-5935				Atluri PP, 1996, J NEUROSCI, V16, P5661; Barbour B, 2000, J NEUROSCI METH, V103, P199, DOI 10.1016/S0165-0270(00)00318-6; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; BARBOUR B, 1994, NEURON, V12, P1331, DOI 10.1016/0896-6273(94)90448-0; Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; Boxall AR, 1996, EUR J NEUROSCI, V8, P2209, DOI 10.1111/j.1460-9568.1996.tb00743.x; Brasnjo G, 2001, NEURON, V31, P607, DOI 10.1016/S0896-6273(01)00377-4; Casado M, 2000, P NATL ACAD SCI USA, V97, P11593, DOI 10.1073/pnas.200354297; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CREPEL F, 1991, J PHYSIOL-LONDON, V432, P123, DOI 10.1113/jphysiol.1991.sp018380; D'Angelo E, 2001, J NEUROSCI, V21, P759, DOI 10.1523/JNEUROSCI.21-03-00759.2001; Dehnes Y, 1998, J NEUROSCI, V18, P3606; DUDEK SM, 1992, P NATL ACAD SCI USA, V89, P4363, DOI 10.1073/pnas.89.10.4363; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; Dzubay JA, 1996, J NEUROSCI, V16, P4129; FARRANT M, 1991, P ROY SOC B-BIOL SCI, V244, P179, DOI 10.1098/rspb.1991.0067; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; FUJII S, 1991, BRAIN RES, V555, P112, DOI 10.1016/0006-8993(91)90867-U; Furuta A, 1997, NEUROSCIENCE, V81, P1031, DOI 10.1016/S0306-4522(97)00252-2; Hamann M, 1996, EUR J NEUROSCI, V8, P1510, DOI 10.1111/j.1460-9568.1996.tb01613.x; Hartell NA, 1996, NEURON, V16, P601, DOI 10.1016/S0896-6273(00)80079-3; HERRON CE, 1986, NATURE, V322, P265, DOI 10.1038/322265a0; ITO M, 1982, J PHYSIOL-LONDON, V324, P113, DOI 10.1113/jphysiol.1982.sp014103; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; KONNERTH A, 1992, P NATL ACAD SCI USA, V89, P7051, DOI 10.1073/pnas.89.15.7051; LevRam V, 1997, NEURON, V18, P1025, DOI 10.1016/S0896-6273(00)80340-2; LINDEN DJ, 1992, EUR J NEUROSCI, V4, P10, DOI 10.1111/j.1460-9568.1992.tb00104.x; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MULKEY RM, 1992, NEURON, V9, P967, DOI 10.1016/0896-6273(92)90248-C; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; Pananceau M, 1997, BRAIN RES, V752, P255, DOI 10.1016/S0006-8993(96)01471-0; ROSEMUND C, 1992, J NEUROPHYSIOL, V68, P1901, DOI 10.1152/jn.1992.68.5.1901; Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x; Salin PA, 1996, NEURON, V16, P797, DOI 10.1016/S0896-6273(00)80099-9; SALT TE, 1986, NATURE, V322, P263, DOI 10.1038/322263a0; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	41	136	139	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					123	130		10.1016/S0896-6273(01)00568-2	http://dx.doi.org/10.1016/S0896-6273(01)00568-2			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779485	Bronze			2022-12-24	WOS:000173106200015
J	Zemelman, BV; Lee, GA; Ng, M; Miesenbock, G				Zemelman, BV; Lee, GA; Ng, M; Miesenbock, G			Selective photostimulation of genetically ChARGed neurons	NEURON			English	Article							VISUAL TRANSDUCTION; DROSOPHILA PHOTORECEPTORS; PHOTOTRANSDUCTION CASCADE; SIGNALING COMPLEX; BOVINE RHODOPSIN; XENOPUS-OOCYTES; BINDING PROTEIN; CA2+ CHANNEL; COMPOUND EYE; GENE	To permit direct functional analyses of neural circuits, we have developed a method for stimulating groups of genetically designated neurons optically. Coexpression of the Drosophila photoreceptor genes encoding arrestin-2, rhodopsin (formed by liganding opsin with retinal), and the alpha subunit of the cognate heterotrimeric G protein-an explosive combination we term "chARGe" - sensitizes generalist vertebrate neurons to light. Illumination of a mixed population of neurons elicits action potentials selectively and cell-autonomously in its genetically chARGed members. In contrast to bath-applied photostimulants or caged neurotransmitters, which act indiscriminately throughout the illuminated volume, chARGe localizes the responsiveness to light. Distributed activity may thus be fed directly into a circumscribed population of neurons in Intact tissue, irrespective of the spatial arrangement of its elements.	Mem Sloan Kettering Canc Ctr, Lab Neural Syst, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Miesenbock, G (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Neural Syst, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.			Miesenboeck, Gero/0000-0003-2940-3228; Zemelman, Boris/0000-0003-2463-4887				[Anonymous], [No title captured]; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; Bohm A, 1997, CURR OPIN BIOTECH, V8, P480, DOI 10.1016/S0958-1669(97)80072-9; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; BYK T, 1993, P NATL ACAD SCI USA, V90, P1907, DOI 10.1073/pnas.90.5.1907; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Colicos MA, 2001, CELL, V107, P605, DOI 10.1016/S0092-8674(01)00579-7; Crick F, 1999, PHILOS T ROY SOC B, V354, P2021, DOI 10.1098/rstb.1999.0541; DALVA MB, 1994, SCIENCE, V265, P255, DOI 10.1126/science.7912852; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; FARBER IC, 1983, SCIENCE, V222, P1025, DOI 10.1126/science.6648515; FROMHERZ P, 1995, PHYS REV LETT, V75, P1670, DOI 10.1103/PhysRevLett.75.1670; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; HARDIE RC, 1991, P ROY SOC B-BIOL SCI, V245, P203, DOI 10.1098/rspb.1991.0110; HARDIE RC, 1992, NEURON, V8, P643, DOI 10.1016/0896-6273(92)90086-S; Hardie RC, 2001, NATURE, V413, P186, DOI 10.1038/35093002; HARDIE RC, 1983, PROGR SENSORY PHYSL, P1; HILLMAN P, 1983, PHYSIOL REV, V63, P668, DOI 10.1152/physrev.1983.63.2.668; Huber A, 1996, EMBO J, V15, P7036, DOI 10.1002/j.1460-2075.1996.tb01095.x; HYDE DR, 1990, P NATL ACAD SCI USA, V87, P1008, DOI 10.1073/pnas.87.3.1008; INOUE H, 1985, BIOCHEM BIOPH RES CO, V132, P513, DOI 10.1016/0006-291X(85)91163-5; Julesz B., 1971, FDN CYCLOPEAN PERCEP; KHORANA HG, 1988, P NATL ACAD SCI USA, V85, P7917, DOI 10.1073/pnas.85.21.7917; KISELEV A, 1994, SCIENCE, V266, P1369, DOI 10.1126/science.7973725; Kiselev A, 1997, BIOCHEMISTRY-US, V36, P2188, DOI 10.1021/bi9621268; KNOX BE, 1993, J PHYSIOL-LONDON, V466, P157; Kovacs G., 1994, ENABLING TECHNOLOGIE, P121; LEE YJ, 1990, NEURON, V5, P889, DOI 10.1016/0896-6273(90)90349-K; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; LLINAS RR, 1988, SCIENCE, V242, P1654, DOI 10.1126/science.3059497; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; MONTELL C, 1989, NEURON, V2, P1313, DOI 10.1016/0896-6273(89)90069-X; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Penfield W, 1950, CEREBRAL CORTEX MAN; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; PHILLIPS AM, 1992, NEURON, V8, P631, DOI 10.1016/0896-6273(92)90085-R; PINE J, 1980, J NEUROSCI METH, V2, P19, DOI 10.1016/0165-0270(80)90042-4; RANDO RR, 1992, PHOTOCHEM PHOTOBIOL, V56, P1145, DOI 10.1111/j.1751-1097.1992.tb09739.x; RANGANATHAN R, 1995, CELL, V81, P841, DOI 10.1016/0092-8674(95)90004-7; RANGANATHAN R, 1991, NATURE, V354, P230, DOI 10.1038/354230a0; REGEHR WG, 1989, J NEUROSCI METH, V30, P91, DOI 10.1016/0165-0270(89)90055-1; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schulz S, 1999, J BIOL CHEM, V274, P37605, DOI 10.1074/jbc.274.53.37605; Scott K, 1997, TRENDS BIOCHEM SCI, V22, P350, DOI 10.1016/S0968-0004(97)01100-6; Scott K, 1998, NATURE, V395, P805, DOI 10.1038/27448; SHIEH BH, 1989, NATURE, V338, P67, DOI 10.1038/338067a0; SHIEH BH, 1995, NEURON, V14, P201, DOI 10.1016/0896-6273(95)90255-4; STRYER L, 1991, J BIOL CHEM, V266, P10711; Tsunoda S, 1997, NATURE, V388, P243, DOI 10.1038/40805; VOGT K, 1984, NATURWISSENSCHAFTEN, V71, P211, DOI 10.1007/BF00490436; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YARFITZ S, 1991, NEURON, V7, P429, DOI 10.1016/0896-6273(91)90295-B; Yuste R, 2000, METHOD ENZYMOL, V327, P522, DOI 10.1016/S0076-6879(00)27300-X; Zemelman BV, 2001, CURR OPIN NEUROBIOL, V11, P409, DOI 10.1016/S0959-4388(00)00227-0; ZUKER CS, 1988, CELL, V53, P475, DOI 10.1016/0092-8674(88)90167-5; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	62	316	368	0	66	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					15	22		10.1016/S0896-6273(01)00574-8	http://dx.doi.org/10.1016/S0896-6273(01)00574-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779476	Bronze			2022-12-24	WOS:000173106200006
J	Newman, AJ; Bavelier, D; Corina, D; Jezzard, P; Neville, HJ				Newman, AJ; Bavelier, D; Corina, D; Jezzard, P; Neville, HJ			A critical period for right hemisphere recruitment in American Sign Language processing	NATURE NEUROSCIENCE			English	Article							2ND LANGUAGE; MATURATIONAL CONSTRAINTS; CEREBRAL ORGANIZATION; BILINGUAL BRAIN; ACQUISITION; ENGLISH; AGE; COMPREHENSION; VARIABILITY; EXPERIENCE	Signed languages such as American Sign Language (ASL) are natural languages that are formally similar to spoken languages, and thus present an opportunity to examine the effects of language structure and modality on the neural organization for language. Native learners of spoken languages show predominantly left-lateralized patterns of neural activation for language processing, whereas native learners of ASL show extensive right hemisphere (RH) and LH activation. We demonstrate that the RH angular gyrus is active during ASL processing only in native signers (hearing, ASL-English bilinguals) but not in those who acquired ASL after puberty (hearing, native English speakers). This is the first demonstration of a 'sensitive' or 'critical' period for language in an RH structure. This has implications for language acquisition and for understanding age-related changes in neuroplasticity more generally.	Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA; Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; John Radcliffe Hosp, FMRIB Ctr, Oxford OX3 9DU, England	University of Oregon; University of Rochester; University of Washington; University of Washington Seattle; University of Oxford	Newman, AJ (corresponding author), Univ Oregon 1227, Dept Psychol, Eugene, OR 97403 USA.		; Newman, Aaron/A-6835-2011	Bavelier, Daphne/0000-0002-5904-1240; Newman, Aaron/0000-0001-5290-8342; Jezzard, Peter/0000-0001-7912-2251	NIDCD NIH HHS [R29 DCO3099, DC00128] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC003099] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BANDETTINI PA, 1993, MAGNET RESON MED, V30, P161, DOI 10.1002/mrm.1910300204; Bavelier D, 1998, NEUROREPORT, V9, P1537, DOI 10.1097/00001756-199805110-00054; Chee MWL, 1999, J NEUROSCI, V19, P3050; Corina D, 1998, APHASIA IN ATYPICAL POPULATIONS, P261; CURTIS S, 1977, GENIE PSYCHOL STUDY; Decety J, 1997, BRAIN, V120, P1763, DOI 10.1093/brain/120.10.1763; Dehaene S, 1997, NEUROREPORT, V8, P3809, DOI 10.1097/00001756-199712010-00030; DEMONET JF, 1992, BRAIN, V115, P1753, DOI 10.1093/brain/115.6.1753; Flege JE, 1999, J MEM LANG, V41, P78, DOI 10.1006/jmla.1999.2638; Friederici AD, 2000, BRAIN LANG, V74, P289, DOI 10.1006/brln.2000.2313; Grezes J, 1999, BRAIN, V122, P1875, DOI 10.1093/brain/122.10.1875; Hickok G, 1999, BRAIN LANG, V66, P233, DOI 10.1006/brln.1998.1995; Hickok G, 1998, TRENDS COGN SCI, V2, P465, DOI 10.1016/S1364-6613(98)01263-7; Hickok G, 1996, NATURE, V381, P699, DOI 10.1038/381699a0; JOHNSON JS, 1989, COGNITIVE PSYCHOL, V21, P60, DOI 10.1016/0010-0285(89)90003-0; Kim KHS, 1997, NATURE, V388, P171, DOI 10.1038/40623; Klein D, 1999, NEUROREPORT, V10, P2841, DOI 10.1097/00001756-199909090-00026; Klima E., 1979, SIGNS LANGUAGE; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Neville HJ, 1997, BRAIN LANG, V57, P285, DOI 10.1006/brln.1997.1739; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; NEWPORT EL, 1990, COGNITIVE SCI, V14, P11, DOI 10.1207/s15516709cog1401_2; OJEMANN GA, 1978, ARCH NEUROL-CHICAGO, V35, P409, DOI 10.1001/archneur.1978.00500310011002; OYAMA S, 1976, J PSYCHOLINGUIST RES, V5, P261, DOI 10.1007/BF01067377; Paradis M, 1998, APHASIA IN ATYPICAL POPULATIONS, P35; PENFIELD W, 1959, SPEECH MECHANISMS BR; Perani D, 1996, NEUROREPORT, V7, P2439, DOI 10.1097/00001756-199611040-00007; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; SODERFELDT B, 1994, BRAIN LANG, V46, P59, DOI 10.1006/brln.1994.1004; TURNER R, 1993, MAGNET RESON MED, V29, P277, DOI 10.1002/mrm.1910290221; WeberFox CM, 1996, J COGNITIVE NEUROSCI, V8, P231, DOI 10.1162/jocn.1996.8.3.231; WISE R, 1991, BRAIN, V114, P1803, DOI 10.1093/brain/114.4.1803; ZATORRE RJ, 1992, SCIENCE, V256, P846, DOI 10.1126/science.1589767; ZOLAMORGAN S, 1988, SPATIAL COGNITION BR	35	138	146	0	19	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					76	80		10.1038/nn775	http://dx.doi.org/10.1038/nn775			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	507MG	11753419				2022-12-24	WOS:000173031800019
J	Romanski, LM; Goldman-Rakic, PS				Romanski, LM; Goldman-Rakic, PS			An auditory domain in primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							MONKEY FRONTAL-CORTEX; CONNECTIONS; NEURONS; SULCUS; UNIT		Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA; Univ Rochester, Dept Neurobiol & Anat, Rochester, NY 14642 USA	Yale University; University of Rochester	Romanski, LM (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH038546, R01MH038546] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004845] Funding Source: NIH RePORTER; NIDCD NIH HHS [R01 DC004845, R01 DC004845-01] Funding Source: Medline; NIMH NIH HHS [MH-38546, R01 MH038546, R37 MH038546] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AZUMA M, 1984, BRAIN RES, V298, P343, DOI 10.1016/0006-8993(84)91434-3; BENEVENTO LA, 1977, EXP NEUROL, V57, P849, DOI 10.1016/0014-4886(77)90112-1; DEACON TW, 1992, BRAIN RES, V573, P8, DOI 10.1016/0006-8993(92)90109-M; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; GoldmanRakic PS, 1996, PHILOS T ROY SOC B, V351, P1445, DOI 10.1098/rstb.1996.0129; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; NEWMAN JD, 1976, EXP BRAIN RES, V25, P169; OScalaidhe SP, 1997, SCIENCE, V278, P1135, DOI 10.1126/science.278.5340.1135; Price CJ, 1998, TRENDS COGN SCI, V2, P281, DOI 10.1016/S1364-6613(98)01201-7; RAUSCHECKER JP, 1995, SCIENCE, V268, P111, DOI 10.1126/science.7701330; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Romanski LM, 1999, J COMP NEUROL, V403, P141, DOI 10.1002/(SICI)1096-9861(19990111)403:2<141::AID-CNE1>3.0.CO;2-V; TANILA H, 1993, BEHAV BRAIN RES, V53, P63, DOI 10.1016/S0166-4328(05)80266-9; VAADIA E, 1986, J NEUROPHYSIOL, V56, P934, DOI 10.1152/jn.1986.56.4.934; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836	15	257	264	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					15	16		10.1038/nn781	http://dx.doi.org/10.1038/nn781			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753413	Green Accepted			2022-12-24	WOS:000173031800008
J	Regalado, MP; Villarroel, A; Lerma, J				Regalado, MP; Villarroel, A; Lerma, J			Intersubunit cooperativity in the NMDA receptor	NEURON			English	Article							D-ASPARTATE RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; ACID-BINDING-PROTEINS; CALCIUM-DEPENDENT INACTIVATION; MOUSE-BRAIN NEURONS; GLUTAMATE RECEPTORS; INTRACELLULAR CALCIUM; KINETIC-ANALYSIS; XENOPUS-OOCYTES; GLYCINE SITE	Opening of the NMDA receptor channel requires simultaneous binding of glutamate and glycine. Although the binding sites for each agonist are in different subunits, the presence of one agonist influences the binding of the other. We have localized regions in the S1 binding domain of both subunits required for the transmission of allosteric signals from the glutamate binding NR2A subunit to the glycine binding NR1 subunit. Three-dimensional modeling indicates that these segments are not directly involved in ligand binding, but likely form solvent-accessible loops protruding out of the binding pocket, making them suitable to relay interactions between adjacent subunits. Thus, these segments mediate negative allosteric coupling between the two subunit types that form the NMDA receptor.	CSIC, Inst Cajal, E-28002 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC)	Lerma, J (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.		Villarroel, Alvaro/H-5580-2015; Lerma, Juan/G-7907-2015	Lerma, Juan/0000-0001-7838-5199				Anson LC, 1998, J NEUROSCI, V18, P581; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; BENVENISTE M, 1991, BIOPHYS J, V59, P560, DOI 10.1016/S0006-3495(91)82272-X; BENVENISTE M, 1990, J PHYSIOL-LONDON, V428, P333, DOI 10.1113/jphysiol.1990.sp018215; Berger AJ, 1998, J NEUROPHYSIOL, V80, P3336, DOI 10.1152/jn.1998.80.6.3336; Bergeron R, 1998, P NATL ACAD SCI USA, V95, P15730, DOI 10.1073/pnas.95.26.15730; Casado M, 1996, J PHYSIOL-LONDON, V490, P391, DOI 10.1113/jphysiol.1996.sp021153; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; COLQUHOUN D, 1985, J PHYSIOL-LONDON, V369, P501, DOI 10.1113/jphysiol.1985.sp015912; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fucile S, 2000, NEURON, V28, P571, DOI 10.1016/S0896-6273(00)00134-3; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hirai H, 1996, P NATL ACAD SCI USA, V93, P6031, DOI 10.1073/pnas.93.12.6031; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Honer M, 1998, J BIOL CHEM, V273, P11158, DOI 10.1074/jbc.273.18.11158; JOHNSON JW, 1992, J PHYSIOL-LONDON, V455, P339, DOI 10.1113/jphysiol.1992.sp019305; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Jones MV, 1998, J NEUROSCI, V18, P8590; KEMP JA, 1993, TRENDS PHARMACOL SCI, V14, P20, DOI 10.1016/0165-6147(93)90108-V; Kendrick SJ, 1996, J NEUROCHEM, V67, P608; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; Krupp JJ, 1998, NEURON, V20, P317, DOI 10.1016/S0896-6273(00)80459-6; Krupp JJ, 1996, MOL PHARMACOL, V50, P1680; KURYATOV A, 1994, NEURON, V12, P1291, DOI 10.1016/0896-6273(94)90445-6; KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0; KYROZIS A, 1995, J PHYSIOL-LONDON, V485, P373, DOI 10.1113/jphysiol.1995.sp020736; Laube B, 1997, NEURON, V18, P493, DOI 10.1016/S0896-6273(00)81249-0; LAURIE DJ, 1994, EUR J PHARM-MOLEC PH, V268, P335, DOI 10.1016/0922-4106(94)90058-2; LEGENDRE P, 1993, J NEUROSCI, V13, P674; LERMA J, 1990, P NATL ACAD SCI USA, V87, P2354, DOI 10.1073/pnas.87.6.2354; LERMA J, 1998, ION CHANNEL PHARM, P399; LESTER RAJ, 1993, J NEUROSCI, V13, P1088; LYNCH DR, 1994, MOL PHARMACOL, V45, P540; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; MAYER ML, 1995, EXCITATORY AMINO ACI, P89; MEDINA I, 1995, J PHYSIOL-LONDON, V482, P567, DOI 10.1113/jphysiol.1995.sp020540; Mendieta J, 2001, PROTEINS, V44, P460, DOI 10.1002/prot.1111; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Paas Y, 1998, TRENDS NEUROSCI, V21, P117, DOI 10.1016/S0166-2236(97)01184-3; PRIESTLEY T, 1994, MOL PHARMACOL, V46, P1191; SATHER W, 1990, NEURON, V4, P725, DOI 10.1016/0896-6273(90)90198-O; SATHER W, 1992, J PHYSIOL-LONDON, V450, P643, DOI 10.1113/jphysiol.1992.sp019148; SMITH KE, 1992, NEURON, V8, P927, DOI 10.1016/0896-6273(92)90207-T; STERNBACH Y, 1994, NEURON, V13, P1345, DOI 10.1016/0896-6273(94)90420-0; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; THOMSON AM, 1989, NATURE, V338, P422, DOI 10.1038/338422a0; Villarroel A, 1998, NEURON, V20, P329, DOI 10.1016/S0896-6273(00)80460-2; VILLARROEL A, 1997, TECHNICAL TIPS ONLIN; VYKLICKY L, 1993, J PHYSIOL-LONDON, V470, P575, DOI 10.1113/jphysiol.1993.sp019876; VYKLICKY L, 1990, J PHYSIOL-LONDON, V428, P313, DOI 10.1113/jphysiol.1990.sp018214; WAFFORD KA, 1995, MOL PHARMACOL, V47, P374; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; Zheng F, 2001, NAT NEUROSCI, V4, P894, DOI 10.1038/nn0901-894; ZILBERTER Y, 1991, MOL PHARMACOL, V40, P337; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	57	57	57	1	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1085	1096		10.1016/S0896-6273(01)00539-6	http://dx.doi.org/10.1016/S0896-6273(01)00539-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754839	Bronze			2022-12-24	WOS:000172886800014
J	Vanduffel, W; Fize, D; Mandeville, JB; Nelissen, K; Van Hecke, P; Rosen, BR; Tootell, RBH; Orban, GA				Vanduffel, W; Fize, D; Mandeville, JB; Nelissen, K; Van Hecke, P; Rosen, BR; Tootell, RBH; Orban, GA			Visual motion processing investigated using contrast agent-enhanced fMRI in awake behaving monkeys	NEURON			English	Article							SUPERPARAMAGNETIC IRON-OXIDE; CEREBRAL BLOOD-VOLUME; FRONTAL EYE FIELD; AREA MT; MACAQUE MONKEY; EXTRASTRIATE CORTEX; RESPONSE PROPERTIES; FUNCTIONAL-ANALYSIS; INTRAPARIETAL AREA; HUMAN BRAIN	To reduce the information gap between human neuroimaging and macaque physiology and anatomy, we mapped fMRI signals produced by moving and stationary stimuli (random dots or lines) in fixating monkeys. Functional sensitivity was increased by a factor of similar to5 relative to the BOLD technique by injecting a contrast agent (monocrystalline iron oxide nanoparticle [MION]). Areas identified as motion sensitive included V2, V3, MT/V5, vMST, FST, VIP, and FEF (with moving dots), as well as V4, TE, LIP, and PIP (with random lines). These regions sensitive for moving dots are largely in agreement with monkey single unit data and (except for V3A) with human fMRI results. Moving lines activate some regions that have not been previously implicated in motion processing. Overall, the results clarify the relationship between the motion pathway and the dorsal stream in primates.	Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Louvain, Belgium; UZ Gasthuisberg, Afdeling Radiol, B-3000 Louvain, Belgium; Massachusetts Gen Hosp, NMR Ctr, Charlestown, MA 02129 USA	KU Leuven; KU Leuven; University Hospital Leuven; Harvard University; Massachusetts General Hospital	Vanduffel, W (corresponding author), Katholieke Univ Leuven, Neuro & Psychofysiol Lab, Campus Gasthuisberg,Herestr 49, Louvain, Belgium.		Fize, Denis/F-4525-2011	Orban, Guy/0000-0002-8179-9584				ALBRIGHT TD, 1984, J NEUROPHYSIOL, V52, P1106, DOI 10.1152/jn.1984.52.6.1106; Andersen RA, 1997, NEURON, V18, P865, DOI 10.1016/S0896-6273(00)80326-8; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; BIZZI E, 1968, EXP BRAIN RES, V6, P69; Bizzi E, 1970, Exp Brain Res, V10, P150; Burman DD, 1997, J NEUROPHYSIOL, V77, P2252, DOI 10.1152/jn.1997.77.5.2252; COLBY CL, 1993, J NEUROPHYSIOL, V69, P902, DOI 10.1152/jn.1993.69.3.902; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; Disbrow EA, 2000, P NATL ACAD SCI USA, V97, P9718, DOI 10.1073/pnas.170205497; Dubowitz DJ, 1998, NEUROREPORT, V9, P2213, DOI 10.1097/00001756-199807130-00012; DUPONT P, 1994, J NEUROPHYSIOL, V72, P1420, DOI 10.1152/jn.1994.72.3.1420; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FUKUSHIMA K, 1999, ANN NY ACAD SCI, V87, P1248; Galletti C, 1996, EUR J NEUROSCI, V8, P30, DOI 10.1111/j.1460-9568.1996.tb01165.x; GASKA JP, 1988, VISION RES, V28, P1179, DOI 10.1016/0042-6989(88)90035-1; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; Goebel R, 1998, EUR J NEUROSCI, V10, P1563, DOI 10.1046/j.1460-9568.1998.00181.x; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P559; Hanes DP, 1998, J NEUROPHYSIOL, V79, P817, DOI 10.1152/jn.1998.79.2.817; Hayashi T, 1999, EUR J NEUROSCI, V11, P4451, DOI 10.1046/j.1460-9568.1999.00892.x; Holmes AP, 1997, NEUROIMAGE, V5, pS480; Joris P. X., 1997, Society for Neuroscience Abstracts, V23, P457; JOSEPHSON L, 1990, MAGN RESON IMAGING, V8, P637, DOI 10.1016/0730-725X(90)90143-P; LAGAE L, 1994, J NEUROPHYSIOL, V71, P1597, DOI 10.1152/jn.1994.71.5.1597; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Logothetis NK, 1999, NAT NEUROSCI, V2, P555, DOI 10.1038/9210; Mandeville JB, 1999, J CEREBR BLOOD F MET, V19, P679, DOI 10.1097/00004647-199906000-00012; Mandeville JB, 1998, MAGNET RESON MED, V39, P615, DOI 10.1002/mrm.1910390415; Mandeville JB, 1999, MAGNET RESON MED, V42, P591, DOI 10.1002/(SICI)1522-2594(199909)42:3<591::AID-MRM23>3.0.CO;2-8; MAUNSELL JHR, 1983, J NEUROSCI, V3, P2563; MAUNSELL JHR, 1987, ANNU REV NEUROSCI, V10, P363, DOI 10.1146/annurev.ne.10.030187.002051; MIKAMI A, 1986, J NEUROPHYSIOL, V55, P1308, DOI 10.1152/jn.1986.55.6.1308; ORAM MW, 1994, J COGNITIVE NEUROSCI, V6, P99, DOI 10.1162/jocn.1994.6.2.99; Orban G. A., 1996, FUNCTIONAL NEUROANAT, P23; ORBAN GA, 1986, J NEUROPHYSIOL, V56, P462, DOI 10.1152/jn.1986.56.2.462; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; PETERSEN SE, 1985, J NEUROPHYSIOL, V54, P867, DOI 10.1152/jn.1985.54.4.867; PETIT L, 1995, EUR J NEUROSCI, V7, P169, DOI 10.1111/j.1460-9568.1995.tb01031.x; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SCHAFFER BK, 1993, MAGN RESON IMAGING, V11, P411, DOI 10.1016/0730-725X(93)90074-N; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Siegel RM, 1997, CEREB CORTEX, V7, P327, DOI 10.1093/cercor/7.4.327; STANDAGE GP, 1983, BRAIN RES, V262, P288, DOI 10.1016/0006-8993(83)91020-X; Stefanacci L, 1998, NEURON, V20, P1051, DOI 10.1016/S0896-6273(00)80485-7; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; TANAKA K, 1993, J NEUROPHYSIOL, V69, P128, DOI 10.1152/jn.1993.69.1.128; TANAKA K, 1986, J NEUROSCI, V6, P134; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Tootell RBH, 1997, J NEUROSCI, V17, P7060; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Ungerleider L.G., 1982, ANAL VISUAL BEHAV; UNGERLEIDER LG, 1984, J COMP NEUROL, V223, P368, DOI 10.1002/cne.902230304; van Bruggen N, 1998, J CEREBR BLOOD F MET, V18, P1178, DOI 10.1097/00004647-199811000-00003; Vanduffel W., 1998, Society for Neuroscience Abstracts, V24, P11; WEISSLEDER R, 1990, RADIOLOGY, V175, P489, DOI 10.1148/radiology.175.2.2326474; ZEKI S, 1991, J NEUROSCI, V11, P641	61	350	355	0	19	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					565	577		10.1016/S0896-6273(01)00502-5	http://dx.doi.org/10.1016/S0896-6273(01)00502-5			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719199	Bronze			2022-12-24	WOS:000172363900005
J	Rice, DS; Nusinowitz, S; Azimi, AM; Martinez, A; Soriano, E; Curran, T				Rice, DS; Nusinowitz, S; Azimi, AM; Martinez, A; Soriano, E; Curran, T			The reelin pathway modulates the structure and function of retinal synaptic circuitry	NEURON			English	Article							INNER PLEXIFORM LAYER; MESSENGER-RNA EXPRESSION; MOUSE-BRAIN DEVELOPMENT; INTACT MACAQUE EYE; APOE RECEPTOR 2; TYROSINE PHOSPHORYLATION; HIPPOCAMPAL CONNECTIONS; EXTRACELLULAR-MATRIX; RETINITIS-PIGMENTOSA; LAMINAR ORGANIZATION	The formation of synaptic connections requires the coordination of specific guidance molecules and spontaneous neuronal activity. The visual system has provided a useful model for understanding the role of these cues in shaping the precise connections from the neural retina to the brain. Here, we demonstrate that two essential genes in the Reelin signaling pathway function during the patterning of synaptic connectivity in the retina. Physiological studies of mice deficient in either reelin or disabled-1 reveal an attenuation of rod-driven retinal responses. This defect is associated with a decrease in rod bipolar cell density and an abnormal distribution of processes in the inner plexiform layer. These results imply that, in addition to its essential role during neuronal migration, the Reelin pathway contributes to the formation of neuronal circuits in the central nervous system.	St Jude Childrens Res Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; Univ Calif Los Angeles, Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; Univ Barcelona, Dept Cell Biol & Neurosci, Res Ctr CERN, E-08028 Barcelona, Spain	St Jude Children's Research Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Barcelona	Curran, T (corresponding author), St Jude Childrens Res Hosp, Dept Dev Neurobiol, 332 N Lauderdale St, Memphis, TN 38105 USA.	fos1@aol.com	Curran, Tom/D-7515-2011; Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008; Curran, Tom/F-5234-2018	Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551; Martinez, Albert/0000-0003-0831-9916	NCI NIH HHS [P30 CA21765] Funding Source: Medline; NEI NIH HHS [F32 EY06972] Funding Source: Medline; NINDS NIH HHS [R01 NS36558] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY006972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036558] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alcantara S, 1998, J NEUROSCI, V18, P7779; Borrell V, 1999, J NEUROSCI, V19, P1345; CAVINESS VS, 1978, ANNU REV NEUROSCI, V1, P297, DOI 10.1146/annurev.ne.01.030178.001501; D'Arcangelo G, 1999, NEURON, V24, P471, DOI 10.1016/S0896-6273(00)80860-0; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DELONG GR, 1970, DEV BIOL, V22, P584, DOI 10.1016/0012-1606(70)90170-3; DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0; FAMIGLIETTI EV, 1975, BRAIN RES, V84, P293, DOI 10.1016/0006-8993(75)90983-X; Fatemi SH, 2000, MOL PSYCHIATR, V5, P654, DOI 10.1038/sj.mp.4000783; FISHER LJ, 1979, J COMP NEUROL, V187, P359, DOI 10.1002/cne.901870207; GOFFINET AM, 1984, BRAIN RES REV, V7, P261, DOI 10.1016/0165-0173(84)90013-4; Granit R, 1935, J PHYSIOL-LONDON, V85, P421, DOI 10.1113/jphysiol.1935.sp003329; Granit R., 1955, RECEPTORS SENSORY PE; Guidotti A, 2000, ARCH GEN PSYCHIAT, V57, P1061, DOI 10.1001/archpsyc.57.11.1061; Gunhan-Agar E, 2000, J NEUROSCI, V20, P306, DOI 10.1523/JNEUROSCI.20-01-00306.2000; Haverkamp S, 2000, J COMP NEUROL, V424, P1; HEYNEN H, 1985, VISION RES, V25, P697, DOI 10.1016/0042-6989(85)90176-2; HEYNEN H, 1985, VISION RES, V25, P709, DOI 10.1016/0042-6989(85)90177-4; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; HOFFARTH RM, 1995, J NEUROSCI, V15, P4838; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 2000, CURR BIOL, V10, P877, DOI 10.1016/S0960-9822(00)00608-4; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1997, NATURE, V389, P733, DOI 10.1038/39607; Keshvara L, 2001, J BIOL CHEM, V276, P16008, DOI 10.1074/jbc.M101422200; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOLB H, 1974, SCIENCE, V186, P47, DOI 10.1126/science.186.4158.47; Lewis GP, 1998, INVEST OPHTH VIS SCI, V39, P424; LI ZY, 1995, J NEUROSCI, V15, P5429; LILLIEN L, 1994, PERSPECT DEV NEUROBI, V2, P175; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; Peng YW, 2000, NAT NEUROSCI, V3, P1121, DOI 10.1038/80639; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; PITTLER SJ, 1993, P NATL ACAD SCI USA, V90, P9616, DOI 10.1073/pnas.90.20.9616; Rice DS, 2000, J COMP NEUROL, V424, P327, DOI 10.1002/1096-9861(20000821)424:2<327::AID-CNE10>3.0.CO;2-6; Rice DS, 1998, DEVELOPMENT, V125, P3719; Schiffmann SN, 1997, EUR J NEUROSCI, V9, P1055, DOI 10.1111/j.1460-9568.1997.tb01456.x; Sheldon M, 1997, NATURE, V389, P730, DOI 10.1038/39601; Sheppard AM, 1997, J COMP NEUROL, V378, P173, DOI 10.1002/(SICI)1096-9861(19970210)378:2<173::AID-CNE2>3.0.CO;2-0; STRETTOI E, 1992, J COMP NEUROL, V325, P152, DOI 10.1002/cne.903250203; STRETTOI E, 1990, J COMP NEUROL, V295, P449, DOI 10.1002/cne.902950309; Strettoi E, 2000, P NATL ACAD SCI USA, V97, P11020, DOI 10.1073/pnas.190291097; Sweet HO, 1996, MAMM GENOME, V7, P798, DOI 10.1007/s003359900240; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Wachtmeister L, 1998, PROG RETIN EYE RES, V17, P485, DOI 10.1016/S1350-9462(98)00006-8; WASSLE H, 1991, VISUAL NEUROSCI, V7, P99, DOI 10.1017/S095252380001097X; Williams RR, 2001, VISUAL NEUROSCI, V18, P233, DOI 10.1017/S0952523801182088; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; YOUNG RW, 1985, ANAT REC, V212, P199, DOI 10.1002/ar.1092120215	50	100	105	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					929	941		10.1016/S0896-6273(01)00436-6	http://dx.doi.org/10.1016/S0896-6273(01)00436-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580894	Bronze			2022-12-24	WOS:000171281300009
J	Novitch, BG; Chen, AI; Jessell, TM				Novitch, BG; Chen, AI; Jessell, TM			Coordinate regulation of motor neuron subtype identity and pan-neuronal properties by the bHLH repressor Olig2	NEURON			English	Article							PROGENITOR-CELL IDENTITY; COMMISSURAL INTERNEURONS; TRANSCRIPTION FACTOR; DETERMINATION GENES; PRONEURAL GENES; HOMEOBOX GENES; DEVELOPING CNS; SPINAL-CORD; EXPRESSION; SPECIFICATION	Within the developing vertebrate nervous system, the mechanisms that coordinate neuronal subtype identity with generic features of neuronal differentiation are poorly defined. We show here that a bHLH protein, Olig2, is expressed selectively by motor neuron progenitors and has a key role in specifying the subtype identity and pan-neuronal properties of developing motor neurons. The role of Olig2 in the specification of motor neuron subtype identity depends on regulatory interactions with progenitor homeodomain proteins, whereas its role in promoting pan-neuronal properties is associated with expression of another bHLH protein, Ngn2. Both aspects of Olig2 function appear to depend an its activity as a transcriptional repressor. Together, these studies show that Olig2 has a critical role in integrating diverse features of motor neuron differentiation in the developing spinal cord.	Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Neurobiol & Behav, 701 W 168th St, New York, NY 10032 USA.	tmj1@columbia.edu	Chen, Albert/E-7397-2014; Chen, Albert/AAH-9874-2020	Chen, Albert/0000-0001-5355-024X; Novitch, Bennett/0000-0002-2696-3708	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER; NIGMS NIH HHS [5T32GM08224] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTMAN J, 1984, ADV ANAT EMBRYOL CEL, V85, P1; Anderson D, 1997, MOL CELLULAR APPROAC, P26; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 1999, NATURE, V398, P622, DOI 10.1038/19315; Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3; Brunet JF, 1999, BIOESSAYS, V21, P313, DOI 10.1002/(SICI)1521-1878(199904)21:4<313::AID-BIES7>3.0.CO;2-C; Cai J, 2000, GENESIS, V27, P6, DOI 10.1002/1526-968X(200005)27:1<6::AID-GENE20>3.3.CO;2-F; Cepko CL, 1999, CURR OPIN NEUROBIOL, V9, P37, DOI 10.1016/S0959-4388(99)80005-1; Chien CT, 1996, P NATL ACAD SCI USA, V93, P13239, DOI 10.1073/pnas.93.23.13239; Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5; Dubreuil V, 2000, DEVELOPMENT, V127, P5191; Ericson J, 1997, CELL, V90, P169, DOI 10.1016/S0092-8674(00)80323-2; ERICSON J, 1992, SCIENCE, V256, P1555, DOI 10.1126/science.1350865; Farah MH, 2000, DEVELOPMENT, V127, P693; Fode C, 2000, GENE DEV, V14, P67; Gradwohl G, 1996, DEV BIOL, V180, P227, DOI 10.1006/dbio.1996.0297; Guillemot F, 1999, EXP CELL RES, V253, P357, DOI 10.1006/excr.1999.4717; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Helms AW, 1998, DEVELOPMENT, V125, P919; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jarman AP, 1998, MECH DEVELOP, V76, P117, DOI 10.1016/S0925-4773(98)00116-6; Jen Y, 1997, DEV DYNAM, V208, P92, DOI 10.1002/(SICI)1097-0177(199701)208:1<92::AID-AJA9>3.0.CO;2-X; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lo LC, 1999, NEURON, V22, P693, DOI 10.1016/S0896-6273(00)80729-1; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; Ma QF, 1997, J NEUROSCI, V17, P3644; Ma QF, 1996, CELL, V87, P43, DOI 10.1016/S0092-8674(00)81321-5; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Morrow EM, 1999, DEVELOPMENT, V126, P23; Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5; Pattyn A, 1997, DEVELOPMENT, V124, P4065; Perez SE, 1999, DEVELOPMENT, V126, P1715; Perron M, 1999, P NATL ACAD SCI USA, V96, P14996, DOI 10.1073/pnas.96.26.14996; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Roztocil T, 1997, DEVELOPMENT, V124, P3263; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Sander M, 2000, GENE DEV, V14, P2134, DOI 10.1101/gad.820400; Scardigli R, 2001, NEURON, V31, P203, DOI 10.1016/S0896-6273(01)00358-0; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Simmons AD, 2001, DEV BIOL, V229, P327, DOI 10.1006/dbio.2000.9984; Smith ST, 1996, DEVELOPMENT, V122, P3141; Sommer L, 1996, MOL CELL NEUROSCI, V8, P221, DOI 10.1006/mcne.1996.0060; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tanabe Y, 1998, CELL, V95, P67, DOI 10.1016/S0092-8674(00)81783-3; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Vallstedt A, 2001, NEURON, V31, P743, DOI 10.1016/S0896-6273(01)00412-3; WEINTRAUB H, 1991, GENE DEV, V5, P1377, DOI 10.1101/gad.5.8.1377; Zhou Q, 2001, NEURON, V31, P791, DOI 10.1016/S0896-6273(01)00414-7; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	54	478	491	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					773	789		10.1016/S0896-6273(01)00407-X	http://dx.doi.org/10.1016/S0896-6273(01)00407-X			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	472YV	11567616	Bronze			2022-12-24	WOS:000171013300011
J	Ranganath, C; D'Esposito, M				Ranganath, C; D'Esposito, M			Medial temporal lobe activity associated with active maintenance of novel information	NEURON			English	Article							SHORT-TERM-MEMORY; SPATIAL WORKING-MEMORY; RECOGNITION MEMORY; PERIRHINAL CORTEX; AMNESIC SUBJECTS; FUNCTIONAL MRI; FRONTAL-CORTEX; VISUAL MEMORY; PLACE MEMORY; TO-SAMPLE	Using event-related functional magnetic resonance imaging, we investigated the role of medial temporal regions during active maintenance of information over short delays or working memory. In experiment 1, we observed sustained bilateral hippocampal activation during maintenance of novel faces across a short delay period but not during face encoding or recognition. In contrast, we observed transient right parahippocampal activation during encoding and recognition but not during maintenance. We replicated these findings in experiment 2 and further determined that anterior hippocampal activation was greater during maintenance of novel than familiar faces. Our results reveal the importance of medial temporal lobe regions for the active maintenance of novel information in the absence of perceptual stimulation.	Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Ranganath, C (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	charan@socrates.berkeley.edu						Aggleton JP, 1999, BEHAV BRAIN SCI, V22, P425; AGGLETON JP, 1992, CORTEX, V28, P359, DOI 10.1016/S0010-9452(13)80146-3; Aguirre GK, 1998, NEUROIMAGE, V8, P360, DOI 10.1006/nimg.1998.0369; Aguirre GK, 2000, MED RAD DIA IMG, P369; Baddeley A., 2007, WORKING MEMORY THOUG; Baxter MG, 2001, HIPPOCAMPUS, V11, P61, DOI 10.1002/1098-1063(2001)11:1<61::AID-HIPO1021>3.3.CO;2-Q; Buffalo EA, 1998, HIPPOCAMPUS, V8, P330, DOI 10.1002/(SICI)1098-1063(1998)8:4<330::AID-HIPO3>3.0.CO;2-L; Cabeza R, 2001, P NATL ACAD SCI USA, V98, P4805, DOI 10.1073/pnas.081082698; CAHUSAC PMB, 1989, BEHAV BRAIN RES, V33, P229, DOI 10.1016/S0166-4328(89)80118-4; CAVE CB, 1992, HIPPOCAMPUS, V2, P151, DOI 10.1002/hipo.450020207; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; Cohen NJ, 1999, HIPPOCAMPUS, V9, P83, DOI 10.1002/(SICI)1098-1063(1999)9:1<83::AID-HIPO9>3.0.CO;2-7; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; Curtis CE, 2000, NEUROREPORT, V11, P2203, DOI 10.1097/00001756-200007140-00028; D'Esposito M, 1999, PSYCHOL BULL, V125, P155, DOI 10.1037/0033-2909.125.1.155; D'Esposito M, 2000, EXP BRAIN RES, V133, P3, DOI 10.1007/s002210000395; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Eldridge LL, 2000, NAT NEUROSCI, V3, P1149, DOI 10.1038/80671; Elliott R, 1999, J NEUROSCI, V19, P5066; Fried I, 1997, NEURON, V18, P753, DOI 10.1016/S0896-6273(00)80315-3; FRIEDMAN HR, 1988, J NEUROSCI, V8, P4693; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fuster J. M., 2015, PREFRONTAL CORTEX, V5th; FUSTER JM, 1982, J NEUROSCI, V2, P361; Fuster JM, 1995, MEMORY CEREBRAL CORT; Gabrieli JDE, 1997, SCIENCE, V276, P264, DOI 10.1126/science.276.5310.264; Haxby JV, 1995, HUM BRAIN MAPP, V3, P68, DOI 10.1002/hbm.460030204; Henson RNA, 1999, J NEUROSCI, V19, P3962; Holdstock JS, 1995, NEUROPSYCHOLOGIA, V33, P1583, DOI 10.1016/0028-3932(95)00145-X; Johnson Marcia K., 1994, P311; Josephs O, 1999, PHILOS T R SOC B, V354, P1215, DOI 10.1098/rstb.1999.0475; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kelley WM, 1998, NEURON, V20, P927, DOI 10.1016/S0896-6273(00)80474-2; Kimberg DY, 1997, CURR DIR PSYCHOL SCI, V6, P185, DOI 10.1111/1467-8721.ep10772959; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knight RT, 1996, NATURE, V383, P256, DOI 10.1038/383256a0; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; MILLER EK, 1993, J NEUROSCI, V13, P1460; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; MISHKIN M, 1975, J EXP PSYCHOL-ANIM B, V1, P326, DOI 10.1037/0097-7403.1.4.326; Mitchell KJ, 2000, COGNITIVE BRAIN RES, V10, P197, DOI 10.1016/S0926-6410(00)00029-X; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MURRAY EA, 1986, J NEUROSCI, V6, P1991; OReilly R., 1999, MODELS WORKING MEMOR, P375, DOI [10.1017/cbo9781139174909.014, DOI 10.1017/CBO9781139174909.014]; OWEN AM, 1995, NEUROPSYCHOLOGIA, V33, P1, DOI 10.1016/0028-3932(94)00098-A; Parker A, 1998, J COGNITIVE NEUROSCI, V10, P691, DOI 10.1162/089892998563103; Petrides M., 1989, HDB NEUROPSYCHOLOGY, P601; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Postle BR, 2000, BRAIN RES PROTOC, V5, P57, DOI 10.1016/S1385-299X(99)00053-7; Postle BR, 2000, PSYCHOBIOLOGY, V28, P132; SIDMAN M, 1968, NEUROPSYCHOLOGIA, V6, P245, DOI 10.1016/0028-3932(68)90023-7; SQUIRE LR, 1988, BEHAV NEUROSCI, V102, P210, DOI 10.1037/0735-7044.102.2.210; Stern CE, 1996, P NATL ACAD SCI USA, V93, P8660, DOI 10.1073/pnas.93.16.8660; Stern CE, 1999, HIPPOCAMPUS, V9, P45, DOI 10.1002/(SICI)1098-1063(1999)9:1<45::AID-HIPO5>3.3.CO;2-K; Suzuki WA, 1997, J NEUROPHYSIOL, V78, P1062, DOI 10.1152/jn.1997.78.2.1062; Sybirska E, 2000, J NEUROSCI, V20, P5827, DOI 10.1523/JNEUROSCI.20-15-05827.2000; Talairach J., 1988, COPLANAR STEREOTAXIC; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; WATANABE T, 1985, BRAIN RES, V325, P241, DOI 10.1016/0006-8993(85)90320-8; WICKELGREN WA, 1968, NEUROPSYCHOLOGIA, V6, P235, DOI 10.1016/0028-3932(68)90022-5; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023; Zarahn E, 1997, NEUROIMAGE, V5, P179, DOI 10.1006/nimg.1997.0263; Zarahn E, 1997, NEUROIMAGE, V6, P122, DOI 10.1006/nimg.1997.0279; ZOLAMORGAN S, 1985, BEHAV NEUROSCI, V99, P22, DOI 10.1037/0735-7044.99.1.22; ZOLAMORGAN S, 1989, J NEUROSCI, V9, P4355; ZOLAMORGAN S, 1993, J NEUROSCI, V13, P251	69	300	303	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 13	2001	31	5					865	873		10.1016/S0896-6273(01)00411-1	http://dx.doi.org/10.1016/S0896-6273(01)00411-1			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	472YV	11567623	Bronze			2022-12-24	WOS:000171013300018
J	Immke, DC; McCleskey, EW				Immke, DC; McCleskey, EW			Lactate enhances the acid-sensing Na+ channel on ischemia-sensing neurons	NATURE NEUROSCIENCE			English	Article							MYOCARDIAL-ISCHEMIA; EVOKED CURRENTS; SENSORY NEURONS; H+		Oregon Hlth Sci Univ, Vollum Inst, Portland, OR 97201 USA	Oregon Health & Science University	Immke, DC (corresponding author), Oregon Hlth Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA.							Armour JA, 1999, CARDIOVASC RES, V41, P41, DOI 10.1016/S0008-6363(98)00252-1; Askwith CC, 2000, NEURON, V26, P133, DOI 10.1016/S0896-6273(00)81144-7; Benson CJ, 1999, CIRC RES, V84, P921; COBBE SM, 1980, J MOL CELL CARDIOL, V12, P745, DOI 10.1016/0022-2828(80)90077-2; COHEN RD, 1983, DIABETES, V32, P181, DOI 10.2337/diab.32.2.181; Hong JL, 1997, J PHYSIOL-LONDON, V500, P319, DOI 10.1113/jphysiol.1997.sp022023; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Martell A. E., 1977, CRITICAL STABILITY C, V3; Pan HL, 1999, J PHYSIOL-LONDON, V518, P857, DOI 10.1111/j.1469-7793.1999.0857p.x; STAHL GL, 1992, AM J PHYSIOL, V262, pH748, DOI 10.1152/ajpheart.1992.262.3.H748; Sutherland SP, 2001, P NATL ACAD SCI USA, V98, P711, DOI 10.1073/pnas.011404498; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; YAN GX, 1992, CIRC RES, V71, P460, DOI 10.1161/01.RES.71.2.460	14	288	311	1	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					869	870		10.1038/nn0901-869	http://dx.doi.org/10.1038/nn0901-869			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528414				2022-12-24	WOS:000170698600009
J	Li, MX; Jia, M; Jiang, H; Dunlap, V; Nelson, PG				Li, MX; Jia, M; Jiang, H; Dunlap, V; Nelson, PG			Opposing actions of protein kinase A and C mediate Hebbian synaptic plasticity	NATURE NEUROSCIENCE			English	Article							NEUROMUSCULAR-JUNCTION; ACETYLCHOLINE-RECEPTOR; IN-VITRO; PHOSPHORYLATION; SITES		NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA; Henry Ford Hlth Sci Ctr, William T Gossett Neurol Labs, Detroit, MI 48202 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Henry Ford Health System; Henry Ford Hospital	Nelson, PG (corresponding author), NICHHD, Dev Neurobiol Lab, NIH, Bldg 49,Room 5A38, Bethesda, MD 20892 USA.	pgnelson@codon.nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000064] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; COGHLAN VM, 1993, MOL CELL BIOCHEM, V128, P309, DOI 10.1007/BF01076780; Hebb Donald O., 1949, ORG BEHAV; Jia M, 1999, J NEUROBIOL, V38, P369, DOI 10.1002/(SICI)1097-4695(19990215)38:3<369::AID-NEU6>3.0.CO;2-Q; Kano M, 1995, CELL, V83, P1223, DOI 10.1016/0092-8674(95)90147-7; Lanuza MA, 2000, J NEUROSCI RES, V61, P616, DOI 10.1002/1097-4547(20000915)61:6<616::AID-JNR5>3.0.CO;2-N; Lanuza MA, 2001, J NEUROSCI RES, V63, P330, DOI 10.1002/1097-4547(20010215)63:4<330::AID-JNR1027>3.0.CO;2-W; LU B, 1993, NATURE, V363, P76, DOI 10.1038/363076a0; Nimnual AS, 1998, BIOCHEMISTRY-US, V37, P14823, DOI 10.1021/bi9802824; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; YEE GH, 1987, J BIOL CHEM, V262, P16748	12	25	34	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					871	872		10.1038/nn0901-871	http://dx.doi.org/10.1038/nn0901-871			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	467JL	11528415				2022-12-24	WOS:000170698600010
J	Pak, DTS; Yang, SY; Rudolph-Correia, S; Kim, E; Sheng, M				Pak, DTS; Yang, SY; Rudolph-Correia, S; Kim, E; Sheng, M			Regulation of dendritic spine morphology by SPAR, a PSD-95-associated RapGAP	NEURON			English	Article							METHYL-D-ASPARTATE; POSTSYNAPTIC DENSITY FRACTION; GTPASE-ACTIVATING PROTEIN; NMDA RECEPTOR SUBUNITS; CENTRAL-NERVOUS-SYSTEM; ACTIN-BASED PLASTICITY; HIPPOCAMPAL-NEURONS; GUANYLATE KINASES; SYNAPTIC ACTIVITY; DENTATE GYRUS	The PSD-95/SAP90 family of scaffold proteins organizes the postsynaptic, density (PSD) and regulates NMDA receptor signaling at excitatory synapses. We report that SPAR, a Rap-specific GTPase-activating protein (RapGAP), interacts with the guanylate kinaselike domain of PSD-95 and forms a complex with PSD-95 and NMDA receptors in brain. In heterologous cells, SPAR reorganizes the actin cytoskeleton and recruits PSD-95 to F-actin. In hippocampal neurons, SPAR localizes to dendritic spines and causes enlargement of spine heads, many of which adopt an irregular appearance with putative multiple synapses. Dominant negative SPAR constructs cause narrowing and elongation of spines. The effects of SPAR on spine morphology depend on the RapGAP and actin-interacting domains, implicating Rap signaling in the regulation of postsynaptic structure.	Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Massachusetts Gen Hosp, Howard Hughes Med Inst, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Korea Advanced Institute of Science & Technology (KAIST)	Sheng, M (corresponding author), MIT, Ctr Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Kim, Eunjoon/C-1566-2011	Sheng, Morgan/0000-0002-8703-5366	NINDS NIH HHS [NS10886, NS35050] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035050] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AMARAL DG, 1981, J COMP NEUROL, V195, P51, DOI 10.1002/cne.901950106; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; BLACKSTONE CD, 1992, J NEUROCHEM, V58, P1118, DOI 10.1111/j.1471-4159.1992.tb09370.x; Boettner B, 2000, P NATL ACAD SCI USA, V97, P9064, DOI 10.1073/pnas.97.16.9064; Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Cabib E, 1998, ANNU REV BIOCHEM, V67, P307, DOI 10.1146/annurev.biochem.67.1.307; CARLIN RK, 1983, P NATL ACAD SCI-BIOL, V80, P3517, DOI 10.1073/pnas.80.11.3517; Caron E, 2000, CURR BIOL, V10, P974, DOI 10.1016/S0960-9822(00)00641-2; CHANG FLF, 1984, BRAIN RES, V309, P35, DOI 10.1016/0006-8993(84)91008-4; Chant T, 1999, ANNU REV CELL DEV BI, V15, P365, DOI 10.1146/annurev.cellbio.15.1.365; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; CRICK F, 1982, TRENDS NEUROSCI, V5, P44, DOI 10.1016/0166-2236(82)90020-0; Deguchi M, 1998, J BIOL CHEM, V273, P26269, DOI 10.1074/jbc.273.41.26269; DESMOND NL, 1988, BRAIN RES, V453, P308, DOI 10.1016/0006-8993(88)90171-0; Dunah AW, 1998, MOL PHARMACOL, V53, P429, DOI 10.1124/mol.53.3.429; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIFKOVA E, 1977, J NEUROCYTOL, V6, P211, DOI 10.1007/BF01261506; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gao QS, 1999, MOL CELL BIOL, V19, P733; Halpain S, 1998, J NEUROSCI, V18, P9835; Harris KM, 1999, CURR OPIN NEUROBIOL, V9, P343, DOI 10.1016/S0959-4388(99)80050-6; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; HATTORI M, 1995, MOL CELL BIOL, V15, P552, DOI 10.1128/MCB.15.1.552; Hayashi K, 1999, J NEUROSCI, V19, P3918; HORNER CH, 1993, PROG NEUROBIOL, V41, P281, DOI 10.1016/0301-0082(93)90002-A; Hsueh YP, 2000, NATURE, V404, P298, DOI 10.1038/35005118; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Janoueix-Lerosey I, 1998, EUR J BIOCHEM, V252, P290, DOI 10.1046/j.1432-1327.1998.2520290.x; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754; McKinney RA, 1999, NAT NEUROSCI, V2, P44, DOI 10.1038/4548; Nakayama AY, 2000, J NEUROSCI, V20, P5329, DOI 10.1523/JNEUROSCI.20-14-05329.2000; Niethammer M, 1996, J NEUROSCI, V16, P2157; NIETHAMMER M, 1999, METHOD ENZYMOL, P104; NIETOSAMPEDRO M, 1982, P NATL ACAD SCI-BIOL, V79, P5718, DOI 10.1073/pnas.79.18.5718; NODA M, 1993, FASEB J, V7, P834, DOI 10.1096/fasebj.7.10.8344483; Ohtsuka T, 1999, BIOCHEM BIOPH RES CO, V265, P38, DOI 10.1006/bbrc.1999.1619; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Reedquist KA, 2000, J CELL BIOL, V148, P1151, DOI 10.1083/jcb.148.6.1151; Sala C, 2000, J NEUROSCI, V20, P3529, DOI 10.1523/JNEUROSCI.20-10-03529.2000; SALA C, 2001, IN PRESS NEURON; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; SEGAL M, 1995, NEUROSCI LETT, V193, P73, DOI 10.1016/0304-3940(95)11665-J; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Sheng M, 2000, ANNU REV PHYSIOL, V62, P755, DOI 10.1146/annurev.physiol.62.1.755; Sorra KE, 1998, J COMP NEUROL, V398, P225; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Torti M, 1999, J CELL BIOCHEM, V75, P675, DOI 10.1002/(SICI)1097-4644(19991215)75:4<675::AID-JCB13>3.0.CO;2-M; Tsukamoto N, 1999, J BIOL CHEM, V274, P18463, DOI 10.1074/jbc.274.26.18463; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Wyszynski M, 1997, NATURE, V385, P439, DOI 10.1038/385439a0; Xia ZG, 1996, J NEUROSCI, V16, P5425; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4; Zwartkruis FJT, 1998, EMBO J, V17, P5905, DOI 10.1093/emboj/17.20.5905	67	302	325	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 2	2001	31	2					289	303		10.1016/S0896-6273(01)00355-5	http://dx.doi.org/10.1016/S0896-6273(01)00355-5			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502259	Bronze			2022-12-24	WOS:000170277700013
J	Dehaene, S; Naccache, L; Cohen, L; Le Bihan, D; Mangin, JF; Poline, JB; Riviere, D				Dehaene, S; Naccache, L; Cohen, L; Le Bihan, D; Mangin, JF; Poline, JB; Riviere, D			Cerebral mechanisms of word masking and unconscious repetition priming	NATURE NEUROSCIENCE			English	Article							PREFRONTAL CORTEX; VISUAL AWARENESS; NEUROPHYSIOLOGY; ACTIVATION; FREQUENCY; ATTENTION; WORKSPACE; AREA	We used functional magnetic resonance imaging (fMRI) and event-related potentials (ERPs) to visualize the cerebral processing of unseen masked words. Within the areas associated with conscious reading, masked words activated left extrastriate, fusiform and precentral areas. Furthermore, masked words reduced the amount of activation evoked by a subsequent conscious presentation of the same word. In the left fusiform gyrus, this repetition suppression phenomenon was independent of whether the prime and target shared the same case, indicating that case-independent information about letter strings was extracted unconsciously. In comparison to an unmasked situation, however, the activation evoked by masked words was drastically reduced and was undetectable in prefrontal and parietal areas, correlating with participants' inability to report the masked words.	Serv Hosp Frederic Joliot, CEA, DSV, IFR 49,INSERM,U334, F-91401 Orsay, France; Serv Hosp Frederic Joliot, CEA, DSV, IFR 49,Unite Neuroactivat Fonct, F-91401 Orsay, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Dehaene, S (corresponding author), Serv Hosp Frederic Joliot, CEA, DSV, IFR 49,INSERM,U334, 4 Pl Gen Leclerc, F-91401 Orsay, France.	dehaene@shfj.cea.fr	Mangin, Jean-Francois/AAI-8983-2020	naccache, lionel/0000-0002-2874-1009; cohen, laurent/0000-0002-5010-9085				Bar M, 1999, P NATL ACAD SCI USA, V96, P1790, DOI 10.1073/pnas.96.4.1790; Bar M, 2001, NEURON, V29, P529, DOI 10.1016/S0896-6273(01)00224-0; Bowers JS, 1998, J EXP PSYCHOL HUMAN, V24, P1705, DOI 10.1037/0096-1523.24.6.1705; Breitmeyer B.G., 1984, VISUAL MASKING INTEG; Buckner RL, 1998, NEURON, V20, P285, DOI 10.1016/S0896-6273(00)80456-0; Burock MA, 1998, NEUROREPORT, V9, P3735, DOI 10.1097/00001756-199811160-00030; CHEESMAN J, 1984, PERCEPT PSYCHOPHYS, V36, P387, DOI 10.3758/BF03202793; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; COMPTON PE, 1991, J COGNITIVE NEUROSCI, V3, P304, DOI 10.1162/jocn.1991.3.4.304; Deacon D, 2000, COGNITIVE BRAIN RES, V9, P137, DOI 10.1016/S0926-6410(99)00050-6; Dehaene S, 1998, P NATL ACAD SCI USA, V95, P14529, DOI 10.1073/pnas.95.24.14529; Dehaene S, 2001, COGNITION, V79, P1, DOI 10.1016/S0010-0277(00)00123-2; Dehaene S, 1998, NATURE, V395, P597, DOI 10.1038/26967; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Driver J, 2001, COGNITION, V79, P39, DOI 10.1016/S0010-0277(00)00124-4; Enns JT, 2000, TRENDS COGN SCI, V4, P345, DOI 10.1016/S1364-6613(00)01520-5; FERRAND L, 1994, Q J EXP PSYCHOL-A, V47, P365, DOI 10.1080/14640749408401116; Fiez JA, 1999, NEURON, V24, P205, DOI 10.1016/S0896-6273(00)80833-8; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; FORSTER KI, 1984, J EXP PSYCHOL LEARN, V10, P680, DOI 10.1037/0278-7393.10.4.680; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gauthier I, 2000, J COGNITIVE NEUROSCI, V12, P495, DOI 10.1162/089892900562165; Greenwald AG, 1996, SCIENCE, V273, P1699, DOI 10.1126/science.273.5282.1699; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Kiefer M, 2000, NEUROREPORT, V11, P2401, DOI 10.1097/00001756-200008030-00013; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; LUESCHOW A, 1994, CEREB CORTEX, V4, P523, DOI 10.1093/cercor/4.5.523; Lumer ED, 1999, P NATL ACAD SCI USA, V96, P1669, DOI 10.1073/pnas.96.4.1669; Macknik SL, 1998, NAT NEUROSCI, V1, P144, DOI 10.1038/393; MARSOLEK CJ, 1995, J EXP PSYCHOL HUMAN, V21, P375, DOI 10.1037/0096-1523.21.2.375; MARSOLEK CJ, 1992, J EXP PSYCHOL LEARN, V18, P492, DOI 10.1037/0278-7393.18.3.492; McIntosh AR, 1999, SCIENCE, V284, P1531, DOI 10.1126/science.284.5419.1531; NACCACHE L, IN PRESS CEREB CORTE; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; Portas CM, 2000, NEURON, V28, P991, DOI 10.1016/S0896-6273(00)00169-0; POSNER MI, 1994, P NATL ACAD SCI USA, V91, P7398, DOI 10.1073/pnas.91.16.7398; POSNER MI, 1993, PSYCHOL SCI, V4, P305, DOI 10.1111/j.1467-9280.1993.tb00569.x; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; ROLLS ET, 1994, P ROY SOC B-BIOL SCI, V257, P9, DOI 10.1098/rspb.1994.0087; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schnyer DM, 1997, NEUROPSYCHOLOGY, V11, P243, DOI 10.1037/0894-4105.11.2.243; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X	46	883	895	3	141	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					752	758		10.1038/89551	http://dx.doi.org/10.1038/89551			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	448HK	11426233				2022-12-24	WOS:000169621300022
J	Constantinidis, C; Franowicz, MN; Goldman-Rakic, PS				Constantinidis, C; Franowicz, MN; Goldman-Rakic, PS			The sensory nature of mnemonic representation in the primate prefrontal cortex	NATURE NEUROSCIENCE			English	Article							SPATIAL WORKING-MEMORY; NEURONAL-ACTIVITY; DELAYED-ALTERNATION; NEURAL ACTIVITY; FRONTAL-CORTEX; SINGLE NEURONS; UNIT-ACTIVITY; MONKEY; SYSTEM; AREA	A long-standing issue concerning the function of the primate dorsolateral prefrontal cortex is whether the activity of prefrontal neurons reflects the perceived sensory attributes of a remembered stimulus, or the decision to execute a motor response. To distinguish between these possibilities, we recorded neuronal activity from monkeys trained to make a saccade toward the brighter of two memoranda, under conditions of varied luminance. Our results indicated that during the delay period when sensory information was no longer available, neuronal discharge was modulated by the luminance of the stimulus appearing in the receptive field, and was directly correlated with psychophysical performance in the task. The findings suggest that although prefrontal cortex codes for a diversity of representations, including the decision for an impending response, a population of neurons maintains the dimensional attributes of remembered stimuli throughout the delay period, which allows for flexibility in the outcome of a mnemonic process.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.	patricia.goldman-rakic@yale.edu	Constantinidis, Christos/ABB-5760-2021	Constantinidis, Christos/0000-0001-7441-022X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH038546, R37MH038546, F31MH011812] Funding Source: NIH RePORTER; NIMH NIH HHS [MH38546, MH11812] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Adcock RA, 2000, P NATL ACAD SCI USA, V97, P3567, DOI 10.1073/pnas.060588897; Andersen RA, 1997, ANNU REV NEUROSCI, V20, P303, DOI 10.1146/annurev.neuro.20.1.303; Asaad WF, 2000, J NEUROPHYSIOL, V84, P451, DOI 10.1152/jn.2000.84.1.451; Asaad WF, 1998, NEURON, V21, P1399, DOI 10.1016/S0896-6273(00)80658-3; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; BOUSSAOUD D, 1993, EXP BRAIN RES, V95, P15, DOI 10.1007/BF00229650; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; BUTTERS N, 1969, SCIENCE, V165, P1271, DOI 10.1126/science.165.3899.1271; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Courtney SM, 1997, NATURE, V386, P608, DOI 10.1038/386608a0; Courtney SM, 1998, SCIENCE, V279, P1347, DOI 10.1126/science.279.5355.1347; FUNAHASHI S, 1990, J NEUROPHYSIOL, V63, P814, DOI 10.1152/jn.1990.63.4.814; FUNAHASHI S, 1993, NATURE, V365, P753, DOI 10.1038/365753a0; FUNAHASHI S, 1991, J NEUROPHYSIOL, V65, P1464, DOI 10.1152/jn.1991.65.6.1464; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; GOLDMANRAKIC PS, 1988, ANNU REV NEUROSCI, V11, P137, DOI 10.1146/annurev.neuro.11.1.137; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; Hikosaka K, 2000, CEREB CORTEX, V10, P263, DOI 10.1093/cercor/10.3.263; JONIDES J, 1993, NATURE, V363, P623, DOI 10.1038/363623a0; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; KUBOTA K, 1971, J NEUROPHYSIOL, V34, P337, DOI 10.1152/jn.1971.34.3.337; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; Levy R, 1999, J NEUROSCI, V19, P5149; Miller EK, 1996, J NEUROSCI, V16, P5154; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; NEWSOME WT, 1989, NATURE, V341, P52, DOI 10.1038/341052a0; NIKI H, 1976, BRAIN RES, V105, P79, DOI 10.1016/0006-8993(76)90924-0; Owen AM, 1998, P NATL ACAD SCI USA, V95, P7721, DOI 10.1073/pnas.95.13.7721; QUINTANA J, 1992, NEUROREPORT, V3, P721, DOI 10.1097/00001756-199208000-00018; Rainer G, 2000, NEURON, V27, P179, DOI 10.1016/S0896-6273(00)00019-2; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; Sawaguchi T, 1999, J NEUROPHYSIOL, V82, P2070, DOI 10.1152/jn.1999.82.5.2070; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Snyder LH, 1997, NATURE, V386, P167, DOI 10.1038/386167a0; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; WILSON FAW, 1993, SCIENCE, V260, P1955, DOI 10.1126/science.8316836; Wise SP, 1996, CRIT REV NEUROBIOL, V10, P317, DOI 10.1615/CritRevNeurobiol.v10.i3-4.30	48	166	169	0	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					311	316		10.1038/85179	http://dx.doi.org/10.1038/85179			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224549				2022-12-24	WOS:000167178300020
J	Jones, MW; Errington, ML; French, PJ; Fine, A; Bliss, TVP; Garel, S; Charnay, P; Bozon, B; Laroche, S; Davis, S				Jones, MW; Errington, ML; French, PJ; Fine, A; Bliss, TVP; Garel, S; Charnay, P; Bozon, B; Laroche, S; Davis, S			A requirement for the immediate early gene Zif268 in the expression of late LTP and long-term memories	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; PROTEIN-SYNTHESIS; DENTATE GYRUS; HIPPOCAMPAL-NEURONS; SYNTHESIS INHIBITOR; RAT HIPPOCAMPUS; SPATIAL MEMORY; GROWTH-FACTOR; IN-VIVO; POTENTIATION	The induction of long-term potentiation (LTP) in the dentate gyrus of the hippocampus is associated with a rapid and robust transcription of the immediate early gene Zif268. We used a mutant mouse with a targeted disruption of Zif268 to ask whether this gene, which encodes a zinc finger transcription factor, is required for the maintenance of late LTP and for the expression of long-term memory. We show that whereas mutant mice exhibit early LTP in the dentate gyrus, late LTP is absent when measured 24 and 48 hours after tetanus in the freely moving animal. In both spatial and non-spatial learning tasks, short-term memory remained intact, whereas performance was impaired in tests requiring long-term memory. Thus, Zif268 is essential for the transition from short- to long-term synaptic plasticity and for the expression of long-term memories.	Univ Paris Sud, CNRS, UMR 8620, Lab Neurobiol Apprentissage Memoire & Commun, F-91405 Orsay, France; Natl Inst Med Res, Div Neurophysiol, London NW7 1AA, England; Ecole Normale Super, INSERM, U368, F-75230 Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; MRC National Institute for Medical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Davis, S (corresponding author), Univ Paris Sud, CNRS, UMR 8620, Lab Neurobiol Apprentissage Memoire & Commun, F-91405 Orsay, France.		Fine, Alan/P-5936-2014; Garel, Sonia/P-4538-2017	Fine, Alan/0000-0002-4960-6973; Garel, Sonia/0000-0003-2984-3645; French, Pim/0000-0002-0668-9529; Charnay, Patrick/0000-0002-3847-6042; Jones, Matthew/0000-0001-5396-3108				ABRAHAM WC, 1991, MOL NEUROBIOL, V5, P297, DOI 10.1007/BF02935553; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Blum S, 1999, J NEUROSCI, V19, P3535; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; Davis S, 1998, CR ACAD SCI III-VIE, V321, P97, DOI 10.1016/S0764-4469(97)89808-3; Davis S, 1997, J NEUROSCI METH, V75, P75, DOI 10.1016/S0165-0270(97)00053-8; Davis S, 2000, J NEUROSCI, V20, P4563, DOI 10.1523/JNEUROSCI.20-12-04563.2000; FAZELI MS, 1993, J NEUROSCI, V13, P1346; FREY U, 1988, BRAIN RES, V452, P57, DOI 10.1016/0006-8993(88)90008-X; Frey U, 1996, J PHYSIOL-LONDON, V490, P703, DOI 10.1113/jphysiol.1996.sp021179; GARCIA J, 1955, SCIENCE, V122, P157; Gerlai R, 1998, BEHAV BRAIN RES, V95, P91, DOI 10.1016/S0166-4328(97)00214-3; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Impey S, 1999, NEURON, V23, P11, DOI 10.1016/S0896-6273(00)80747-3; Jones MR, 1999, J NEURO-OPHTHALMOL, V19, P1; Kato A, 1998, J BIOL CHEM, V273, P23969, DOI 10.1074/jbc.273.37.23969; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; KOGAN JH, 1996, CURR BIOL, V7, P1; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; LEMAIRE P, 1988, P NATL ACAD SCI USA, V85, P4691, DOI 10.1073/pnas.85.13.4691; LINK W, 1995, P NATL ACAD SCI USA, V92, P5734, DOI 10.1073/pnas.92.12.5734; LYFORD GL, 1995, NEURON, V14, P433, DOI 10.1016/0896-6273(95)90299-6; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; Meiri N, 1998, BRAIN RES, V789, P48, DOI 10.1016/S0006-8993(97)01528-X; MILBRANDT J, 1987, SCIENCE, V85, P7857; Miyashita Y, 1998, NEUROBIOL LEARN MEM, V70, P197, DOI 10.1006/nlme.1998.3848; NGUYEN PV, 1994, SCIENCE, V265, P1104, DOI 10.1126/science.8066450; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; OTANI S, 1989, NEUROSCI LETT, V106, P175, DOI 10.1016/0304-3940(89)90222-X; Rampon C, 2000, NAT NEUROSCI, V3, P238, DOI 10.1038/72945; RASMUSSEN M, 1989, PSYCHOBIOLOGY, V17, P335; RICHARDSON CL, 1992, BRAIN RES, V580, P147, DOI 10.1016/0006-8993(92)90938-6; ROSENBLUM K, 1993, BEHAV NEURAL BIOL, V59, P49, DOI 10.1016/0163-1047(93)91145-D; SAKAMOTO KM, 1991, ONCOGENE, V6, P867; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; SQUIRE LR, 1973, BRAIN RES, V56, P215, DOI 10.1016/0006-8993(73)90336-3; STRUPP BJ, 1984, J COMP PSYCHOL, V98, P257, DOI 10.1037/0735-7036.98.3.257; Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049; WALKER DL, 1994, BEHAV NEURAL BIOL, V62, P151, DOI 10.1016/S0163-1047(05)80036-6; WISDEN W, 1990, NEURON, V4, P603, DOI 10.1016/0896-6273(90)90118-Y; Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082; YIN JCP, 1995, CELL, V81, P107, DOI 10.1016/0092-8674(95)90375-5	47	676	700	1	58	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					289	296		10.1038/85138	http://dx.doi.org/10.1038/85138			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224546				2022-12-24	WOS:000167178300017
J	Kreitzer, AC; Regehr, WG				Kreitzer, AC; Regehr, WG			Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells	NEURON			English	Article							DEPOLARIZATION-INDUCED SUPPRESSION; METABOTROPIC GLUTAMATE-RECEPTOR; HIPPOCAMPAL PYRAMIDAL CELLS; CLIMBING FIBER; RAT-BRAIN; CEREBELLAR SYNAPSE; IN-VIVO; NEURONS; LOCALIZATION; CURRENTS	Brief depolarization of cerebellar Purkinje cells was found to inhibit parallel fiber and climbing fiber EPSCs for tens of seconds. This depolarization-induced suppression of excitation (DSE) is accompanied by altered paired-pulse plasticity, suggesting a presynaptic locus. Fluorometric imaging revealed that postsynaptic depolarization also reduces presynaptic calcium influx. The inhibition of both presynaptic calcium influx and EPSCs is eliminated by buffering postsynaptic calcium with BAPTA. The cannabinoid CB1 receptor antagonist AM251 prevents DSE, and the agonist WIN 55,212-2 occludes DSE. These findings suggest that Purkinje cells release endogenous cannabinoids in response to elevated calcium, thereby inhibiting presynaptic calcium entry and suppressing transmitter release. DSE may provide a way for cells to use their firing rate to dynamically regulate synaptic inputs. Together with previous studies, these findings suggest a widespread role for endogenous cannabinoids in retrograde synaptic inhibition.	Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Regehr, WG (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.				NINDS NIH HHS [R01-NS32405-01] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032405] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALGER BE, 1995, TRENDS NEUROSCI, V18, P333, DOI 10.1016/0166-2236(95)93923-L; Alger BE, 1996, J PHYSIOL-LONDON, V496, P197, DOI 10.1113/jphysiol.1996.sp021677; ANWYL R, 1991, BRAIN RES REV, V16, P265, DOI 10.1016/0165-0173(91)90010-6; Atluri PP, 1996, J NEUROSCI, V16, P5661; CALLAWAY JC, 1995, J NEUROSCI, V15, P2777; Chen CF, 1997, J NEUROSCI, V17, P8687; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dittman JS, 1998, J NEUROSCI, V18, P6147; Dittman JS, 1996, J NEUROSCI, V16, P1623; ECCLES JC, 1966, EXP BRAIN RES, V1, P17; ECCLES JC, 1966, J PHYSIOL-LONDON, V182, P268, DOI 10.1113/jphysiol.1966.sp007824; Egertova M, 1998, P ROY SOC B-BIOL SCI, V265, P2081, DOI 10.1098/rspb.1998.0543; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Fitzsimonds RM, 1998, PHYSIOL REV, V78, P143, DOI 10.1152/physrev.1998.78.1.143; Gatley SJ, 1996, EUR J PHARMACOL, V307, P331, DOI 10.1016/0014-2999(96)00279-8; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; HATT H, 1976, J PHYSIOL-LONDON, V259, P367, DOI 10.1113/jphysiol.1976.sp011471; HERKENHAM M, 1990, P NATL ACAD SCI USA, V87, P1932, DOI 10.1073/pnas.87.5.1932; HERRINGTON J, 1995, PULSE CONTROL V4 5 I; Ito M, 1984, CEREBELLUM NEURAL CO; Kombian SB, 1997, NEURON, V19, P903, DOI 10.1016/S0896-6273(00)80971-X; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; Kreitzer AC, 2000, NEURON, V27, P25, DOI 10.1016/S0896-6273(00)00006-4; LEVENES C, 1998, J PHYSL, V510, P876; LLANO I, 1994, NEURON, V12, P663, DOI 10.1016/0896-6273(94)90221-6; LLANO I, 1991, NEURON, V6, P565, DOI 10.1016/0896-6273(91)90059-9; LLANO I, 1991, J PHYSIOL-LONDON, V434, P183, DOI 10.1113/jphysiol.1991.sp018465; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; MATSUDA LA, 1993, J COMP NEUROL, V327, P535, DOI 10.1002/cne.903270406; MINTZ IM, 1995, NEURON, V15, P675, DOI 10.1016/0896-6273(95)90155-8; Morishita W, 1998, J NEUROSCI, V18, P4870; Ohno-Shosaku T, 2001, NEURON, V29, P729, DOI 10.1016/S0896-6273(01)00247-1; Palay S.L., 1974, CEREBELLAR CORTEX; Pekhletski R, 1996, J NEUROSCI, V16, P6364; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Pettit DAD, 1998, J NEUROSCI RES, V51, P391; PITLER TA, 1994, NEURON, V13, P1447; PITLER TA, 1992, J NEUROSCI, V12, P4122; REGEHR WG, 1994, NEURON, V12, P605, DOI 10.1016/0896-6273(94)90216-X; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Takahashi KA, 2000, J NEUROPHYSIOL, V83, P1167, DOI 10.1152/jn.2000.83.3.1167; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Twitchell W, 1997, J NEUROPHYSIOL, V78, P43, DOI 10.1152/jn.1997.78.1.43; VINCENT P, 1993, NEURON, V11, P885, DOI 10.1016/0896-6273(93)90118-B; Wilson RI, 2001, NATURE, V410, P588, DOI 10.1038/35069076; Zilberter Y, 2000, J PHYSIOL-LONDON, V528, P489, DOI 10.1111/j.1469-7793.2000.00489.x; Zilberter Y, 1999, NEURON, V24, P979, DOI 10.1016/S0896-6273(00)81044-2	50	652	670	3	26	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					717	727		10.1016/S0896-6273(01)00246-X	http://dx.doi.org/10.1016/S0896-6273(01)00246-X			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301030	Bronze			2022-12-24	WOS:000167868900020
J	Ming, GL; Henley, J; Tessier-Lavigne, M; Song, HJ; Poo, MM				Ming, GL; Henley, J; Tessier-Lavigne, M; Song, HJ; Poo, MM			Electrical activity modulates growth cone guidance by diffusible factors	NEURON			English	Article							NERVE GROWTH; NEURITE GROWTH; PROTEIN-KINASE; DIRECTION; ABSENCE; INHIBITION; CURRENTS	Brief periods of electrical stimulation of cultured Xenopus spinal neurons resulted in a marked alteration in the turning responses of the growth cone induced by gradients of attractive or repulsive guidance cues. Netrin-1-induced attraction was enhanced, and the repulsion induced by myelin-associated glycoprotein (MAG) or myelin membrane fragments was converted to attraction. The effect required the presence of extracellular Ca2+ during electrical stimulation and appeared to be mediated by an elevation of both cytoplasmic Ca2+ and cAMP. Thus, electrical activity may influence the axonal path finding of developing neurons, and intermittent electrical stimulation may be effective in promoting nerve regeneration after injury.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Song, HJ (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA.	hsong@ems.salk.edu; mpoo@uclink.berkeley.edu	Henley, John/D-7171-2011; Ming, Guo-li/J-7880-2013	Henley, John/0000-0003-1846-5941; Ming, Guo-li/0000-0002-2517-6075	NINDS NIH HHS [NS37831] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037831] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Al-Majed AA, 2000, J NEUROSCI, V20, P2602; BORGENS RB, 1987, SCIENCE, V238, P366, DOI 10.1126/science.3659920; BUTT E, 1990, FEBS LETT, V263, P47, DOI 10.1016/0014-5793(90)80702-K; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; COHAN CS, 1986, SCIENCE, V232, P1638, DOI 10.1126/science.3715470; Dantzker JL, 1998, J NEUROSCI, V18, P4145; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Hempel CM, 1996, NATURE, V384, P166, DOI 10.1038/384166a0; HINKLE L, 1981, J PHYSIOL-LONDON, V314, P121, DOI 10.1113/jphysiol.1981.sp013695; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; JAFFE LF, 1979, J EXP ZOOL, V209, P115, DOI 10.1002/jez.1402090114; KASE H, 1987, BIOCHEM BIOPH RES CO, V142, P436, DOI 10.1016/0006-291X(87)90293-2; Lin DM, 2000, NEURON, V26, P69, DOI 10.1016/S0896-6273(00)81139-3; MARSH G, 1946, J CELL COMPAR PHYSL, V27, P139, DOI 10.1002/jcp.1030270303; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Milner LD, 1999, J NEUROSCI, V19, P3007; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Ming GL, 1997, J NEUROSCI, V17, P7860; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9; PATEL N, 1982, J NEUROSCI, V2, P483; PATEL NB, 1984, J NEUROSCI, V4, P2939; POLITIS MJ, 1988, J TRAUMA, V28, P1548, DOI 10.1097/00005373-198811000-00005; ROTHERMEL JD, 1988, BIOCHEM J, V251, P757, DOI 10.1042/bj2510757; RYAN TA, 1995, NEURON, V14, P983, DOI 10.1016/0896-6273(95)90336-4; SCHWAB ME, 1993, ANNU REV NEUROSCI, V16, P565, DOI 10.1146/annurev.ne.16.030193.003025; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SISKEN BF, 1975, J EMBRYOL EXP MORPH, V33, P29; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Tabti N, 1998, CULTURING NERVE CELL, P237; TALPAIN E, 1995, BRIT J PHARMACOL, V114, P1459, DOI 10.1111/j.1476-5381.1995.tb13370.x; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Wang Q, 1998, J NEUROSCI, V18, P4973; Xia ZG, 1997, CURR OPIN NEUROBIOL, V7, P391, DOI 10.1016/S0959-4388(97)80068-2; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501; ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0	43	197	203	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	FEB	2001	29	2					441	452		10.1016/S0896-6273(01)00217-3	http://dx.doi.org/10.1016/S0896-6273(01)00217-3			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239434	Bronze			2022-12-24	WOS:000167141700017
J	Greer, JM; Capecchi, MR				Greer, JM; Capecchi, MR			Hoxb8 is required for normal grooming behavior in mice	NEURON			English	Article							PROTOONCOGENE INT-2; SERIAL ORDER; EXPRESSION; DISRUPTION; SEQUENCES; CHAINS; GENES; SITE; HIPPOCAMPAL; TRANSGENE	Repertoires of grooming behaviors critical to survival are exhibited by most animal species, including humans. Genes that influence this complex behavior are unknown. We report that mice with disruptions of Hoxb8 show, with 100% penetrance, excessive grooming leading to hair removal and lesions. Additionally, these mice excessively groom normal cagemates. We have been unable to detect any skin or PNS abnormalities In Hoxb8 mutants. These observations suggest that the excessive, pathological grooming exhibited by these mice results from CNS abnormalities. Consistent with this Interpretation, we demonstrate Hoxb8 expression in regions of the adult mouse CNS previously implicated in the control of grooming. The aberrant behavior observed in Hoxb8 mutants is not unlike that of humans suffering from the OC-spectrum disorder, trichotillomania. Interestingly, Hoxb8 is expressed in regions of the CNS known as the "OCD-circuit."	Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu						ALDRIDGE JW, 1993, PSYCHOL SCI, V4, P391, DOI 10.1111/j.1467-9280.1993.tb00587.x; ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; BERNTSON GG, 1988, ANN NY ACAD SCI, V525, P350, DOI 10.1111/j.1749-6632.1988.tb38619.x; BERRIDGE KC, 1987, BEHAV BRAIN RES, V23, P59, DOI 10.1016/0166-4328(87)90242-7; BERRIDGE KC, 1989, PSYCHOBIOLOGY, V17, P377; BERRIDGE KC, 1987, PSYCHOBIOLOGY, V15, P336; BERRIDGE KC, 1992, EXP BRAIN RES, V90, P275; BERRIDGE KC, 1989, BEHAV BRAIN RES, V33, P241, DOI 10.1016/S0166-4328(89)80119-6; CANNON RL, 1992, PSYCHOBIOLOGY, V20, P205; Capecchi MR, 1997, COLD SPRING HARB SYM, V62, P273, DOI 10.1101/SQB.1997.062.01.034; Chen F, 1997, DEV BIOL, V181, P186, DOI 10.1006/dbio.1996.8440; Chen F, 1999, P NATL ACAD SCI USA, V96, P541, DOI 10.1073/pnas.96.2.541; Cohen-Tannoudji M, 2000, MECH DEVELOP, V90, P29, DOI 10.1016/S0925-4773(99)00226-9; Cromwell HC, 1996, J NEUROSCI, V16, P3444; DESCHAMPS J, 1993, DEV BIOL, V156, P473, DOI 10.1006/dbio.1993.1093; FENTRESS JC, 1988, ANN NY ACAD SCI, V525, P18, DOI 10.1111/j.1749-6632.1988.tb38592.x; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Graybiel AM, 2000, NEURON, V28, P343, DOI 10.1016/S0896-6273(00)00113-6; Graybiel AM, 1997, SCHIZOPHRENIA BULL, V23, P459, DOI 10.1093/schbul/23.3.459; Guy LG, 1997, NUCLEIC ACIDS RES, V25, P4400, DOI 10.1093/nar/25.21.4400; Horwath E, 2000, PSYCHIAT CLIN N AM, V23, P493, DOI 10.1016/S0193-953X(05)70176-3; LEMOUELLIC H, 1992, CELL, V69, P251, DOI 10.1016/0092-8674(92)90406-3; MACLEAN PD, 1985, ARCH GEN PSYCHIAT, V42, P405; MACLEAN PD, 1985, PSYCHOL MED, V15, P219, DOI 10.1017/S0033291700023485; MACLEAN PD, 1978, BRAIN RES, V149, P175, DOI 10.1016/0006-8993(78)90597-8; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MANSOUR SL, 1993, DEVELOPMENT, V117, P13; MANSOUR SL, 1988, NATURE, V336, P348, DOI 10.1038/336348a0; McGrath MJ, 1999, BEHAV NEUROSCI, V113, P1249, DOI 10.1037/0735-7044.113.6.1249; ODENWALD WF, 1987, GENE DEV, V1, P482, DOI 10.1101/gad.1.5.482; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; Rauch SL, 1998, OBSESSIVE COMPULSIVE, P289; RICHMOND G, 1980, BEHAVIOUR, V75, P82, DOI 10.1163/156853980X00573; Robertson BJ, 1999, BRAIN RES, V838, P234, DOI 10.1016/S0006-8993(99)01743-6; SACHS BD, 1988, ANN NY ACAD SCI, V525, P1, DOI 10.1111/j.1749-6632.1988.tb38591.x; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Saxena S, 1998, BRIT J PSYCHIAT, V173, P26; STEIN DJ, 1992, COMPR PSYCHIAT, V33, P274, DOI 10.1016/0010-440X(92)90053-S; STROZIK E, 1981, LAB ANIM, V15, P309, DOI 10.1258/002367781780953040; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; THOREY IS, 1993, DEV BIOL, V160, P519, DOI 10.1006/dbio.1993.1326; van den Akker E, 1999, MECH DEVELOP, V89, P103, DOI 10.1016/S0925-4773(99)00212-9; WISE S, 1989, OBSESSIVE COMPULSIVE, P327	43	250	257	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 3	2002	33	1					23	34		10.1016/S0896-6273(01)00564-5	http://dx.doi.org/10.1016/S0896-6273(01)00564-5			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779477	Bronze			2022-12-24	WOS:000173106200007
J	Kayser, AS; Miller, KD				Kayser, AS; Miller, KD			Opponent inhibition: A developmental model of layer 4 of the neocortical circuit	NEURON			English	Article							CAT VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; LONG-TERM POTENTIATION; CELL RECEPTIVE-FIELDS; RAT BARREL CORTEX; ORIENTATION SELECTIVITY; OCULAR DOMINANCE; STRIATE CORTEX; SYNAPTIC TRANSMISSION; THALAMIC INPUT	We model the development of the functional circuit of layer 4 (the input-recipient layer) of cat primary visual cortex. The observed thalamocortical and intracortical circuitry codevelop under Hebb-like synaptic plasticity. Hebbian development yields opponent inhibition: Inhibition evoked by stimuli anticorrelated with those that excite a cell. Strong opponent inhibition enables recognition of stimulus orientation in a manner invariant to stimulus contrast. These principles may apply to cortex more generally: Hebb-like plasticity can guide layer 4 of any piece of cortex to create opposition between anticorrelated stimulus pairs, and this enables recognition of specific stimulus patterns in a manner invariant to stimulus magnitude. Properties that are invariant across a cortical column are predicted to be those shared by opponent stimulus pairs; this contrasts with the common idea that a column represents cells with similar response properties.	Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Sloan Swartz Ctr Theoret Neurobiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kayser, AS (corresponding author), Univ Calif San Francisco, Dept Physiol, Box 0444, San Francisco, CA 94143 USA.				NATIONAL EYE INSTITUTE [R01EY011001] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY11001] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153, DOI 10.1113/jphysiol.1984.sp015104; ALBUS K, 1975, EXP BRAIN RES, V24, P159, DOI 10.1007/BF00234061; Alonso JM, 2001, J NEUROSCI, V21, P4002, DOI 10.1523/JNEUROSCI.21-11-04002.2001; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; Bartsch AP, 2001, BIOL CYBERN, V84, P41, DOI 10.1007/s004220170003; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; CALLAWAY EM, 1992, J NEUROSCI, V12, P570; Callaway EM, 1998, ANNU REV NEUROSCI, V21, P47, DOI 10.1146/annurev.neuro.21.1.47; Chapman B, 2000, J NEUROSCI, V20, P1922; Chiu CY, 2001, J NEUROSCI, V21, P8906, DOI 10.1523/JNEUROSCI.21-22-08906.2001; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; deCharms RC, 1998, SCIENCE, V280, P1439, DOI 10.1126/science.280.5368.1439; Egger V, 1999, NAT NEUROSCI, V2, P1098, DOI 10.1038/16026; Erwin E, 1998, J NEUROSCI, V18, P9870; ERWIN E, 1995, NEURAL COMPUT, V7, P425, DOI 10.1162/neco.1995.7.3.425; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1986, J NEUROSCI, V6, P1284; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FERSTER D, 1992, J NEUROSCI, V12, P1262; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; Gillespie DC, 2001, NAT NEUROSCI, V4, P1014, DOI 10.1038/nn731; GOODHILL GJ, 1993, BIOL CYBERN, V69, P109, DOI 10.1007/BF00226194; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1974, J COMP NEUROL, V158, P295, DOI 10.1002/cne.901580305; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Issa NP, 2000, J NEUROSCI, V20, P8504, DOI 10.1523/JNEUROSCI.20-22-08504.2000; Kayser A, 2001, J NEUROPHYSIOL, V85, P2130, DOI 10.1152/jn.2001.85.5.2130; KAYSER AS, 1999, THESIS U CALIFORNIA; Komatsu Y, 1996, J NEUROSCI, V16, P6342; KOMATSU Y, 1994, J NEUROSCI, V14, P6488; KOMATSU Y, 1993, NEUROREPORT, V4, P907, DOI 10.1097/00001756-199307000-00017; Krukowski AE, 2001, NAT NEUROSCI, V4, P424, DOI 10.1038/86084; Lauritzen TZ, 2001, J NEUROPHYSIOL, V86, P1803, DOI 10.1152/jn.2001.86.4.1803; LEVINE MW, 1986, J PHYSIOL-LONDON, V375, P339, DOI 10.1113/jphysiol.1986.sp016120; LIU Z, 1992, VISION RES, V32, P1193, DOI 10.1016/0042-6989(92)90213-3; Lubke J, 2000, J NEUROSCI, V20, P5300, DOI 10.1523/JNEUROSCI.20-14-05300.2000; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Miller K. D., 1996, MODELS NEURAL NETWOR, P55, DOI [10.1007/978-1-4612-0723-8_2, DOI 10.1007/978-1-4612-0723-8_2]; MILLER KD, 1994, NEURAL COMPUT, V6, P100, DOI 10.1162/neco.1994.6.1.100; MILLER KD, 1994, J NEUROSCI, V14, P409; Miller KD, 1998, NEURAL COMPUT, V10, P529, DOI 10.1162/089976698300017647; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Olson SJ, 1998, NEURAL NETWORKS, V11, P189, DOI 10.1016/S0893-6080(98)00003-3; PALMER LA, 1981, J NEUROPHYSIOL, V46, P260, DOI 10.1152/jn.1981.46.2.260; POLLEN DA, 1981, SCIENCE, V212, P1409, DOI 10.1126/science.7233231; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; SCLAR G, 1982, EXP BRAIN RES, V46, P457; SCLAR G, 1987, EXP BRAIN RES, V66, P589, DOI 10.1007/BF00270692; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Sirosh J, 1997, NEURAL COMPUT, V9, P577, DOI 10.1162/neco.1997.9.3.577; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; Troyer TW, 1998, J NEUROSCI, V18, P5908; Turrigiano GG, 2000, CURR OPIN NEUROBIOL, V10, P358, DOI 10.1016/S0959-4388(00)00091-X; von der Malsburg C, 1973, Kybernetik, V14, P85; Weliky M, 1999, SCIENCE, V285, P599, DOI 10.1126/science.285.5427.599; Wolfe J, 1998, VISUAL NEUROSCI, V15, P653, DOI 10.1017/S0952523898154068; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29	68	23	23	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					131	142		10.1016/S0896-6273(01)00570-0	http://dx.doi.org/10.1016/S0896-6273(01)00570-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779486	Bronze			2022-12-24	WOS:000173106200016
J	Campbell, DS; Holt, CE				Campbell, DS; Holt, CE			Chemotropic responses of retinal growth cones mediated by rapid local protein synthesis and degradation	NEURON			English	Article							UBIQUITIN-PROTEASOME PATHWAY; ACTIN MESSENGER-RNA; AXON GUIDANCE; NEURONAL CONNECTIVITY; SYNAPTIC PLASTICITY; CELL-CYCLE; NETRIN-1; PROTEOLYSIS; MEMBRANE; SUBUNIT	Growth cones contain mRNAs, translation machinery, and, as we report here, protein degradation machinery. We show that isolated retinal growth cones immediately lose their ability to turn in a chemotropic gradient of netrin-1 or Sema3A when translation is inhibited. Translation inhibition also prevents Sema3A-induced collapse, while LPA-induced collapse is not affected. Inhibition of proteasome function blocks responses to netrin-1 and LPA but does not affect Sema3A responses. We further demonstrate in isolated growth cones that netrin-1 and Sema3A activate translation initiation factors and stimulate a marked rise in protein synthesis within minutes, while netrin-1 and LPA elicit similar rises in ubiquitin-protein conjugates. These results suggest that guidance molecules steer axon growth by triggering rapid local changes in protein levels in growth cones.	Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England	University of Cambridge	Holt, CE (corresponding author), Univ Cambridge, Dept Anat, Downing St, Cambridge CB2 3DY, England.			Holt, Christine Elizabeth/0000-0003-2829-121X; Campbell, Douglas/0000-0002-7371-9484				Aguilera M, 2000, GENETICS, V155, P1231; Bassell GJ, 1998, J NEUROSCI, V18, P251; BOCHNIG P, 1987, EUR J BIOCHEM, V168, P461, DOI 10.1111/j.1432-1033.1987.tb13439.x; BREHM P, 1987, DEV BIOL, V123, P222, DOI 10.1016/0012-1606(87)90444-1; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; CANO E, 1994, MOL CELL BIOL, V14, P7352, DOI 10.1128/MCB.14.11.7352; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Chain DG, 1999, MOL NEUROBIOL, V20, P125, DOI 10.1007/BF02742438; Chung CY, 2001, TRENDS BIOCHEM SCI, V26, P557, DOI 10.1016/S0968-0004(01)01934-X; COLAMARINO SA, 1995, CELL, V81, P621, DOI 10.1016/0092-8674(95)90083-7; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; DAVIS L, 1992, J NEUROSCI, V12, P4867; de la Torre JR, 1997, NEURON, V19, P1211, DOI 10.1016/S0896-6273(00)80413-4; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Everett RD, 2000, J VIROL, V74, P9994, DOI 10.1128/JVI.74.21.9994-10005.2000; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fraser CS, 1999, J BIOL CHEM, V274, P196, DOI 10.1074/jbc.274.1.196; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GUTHRIE PB, 1989, J NEUROSCI, V9, P3596; HARRIS WA, 1987, DEVELOPMENT, V101, P123; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; HOLLENBECK PJ, 1987, J CELL BIOL, V105, P2827, DOI 10.1083/jcb.105.6.2827; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Hu G, 1997, GENE DEV, V11, P2701, DOI 10.1101/gad.11.20.2701; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Ishizuka T, 1997, BIOCHEM BIOPH RES CO, V230, P386, DOI 10.1006/bbrc.1996.5967; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Karniol B, 2000, CURR OPIN PLANT BIOL, V3, P387, DOI 10.1016/S1369-5266(00)00101-1; KENNEDY TE, 1994, CELL, V78, P425, DOI 10.1016/0092-8674(94)90421-9; Kobayashi H, 1997, J NEUROSCI, V17, P8339; Liu YS, 1996, FREE RADICAL BIO MED, V21, P771, DOI 10.1016/0891-5849(96)00176-1; LOHOF AM, 1992, J NEUROSCI, V12, P1253; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Ming GI, 1999, NEURON, V23, P139, DOI 10.1016/S0896-6273(00)80760-6; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; MINICH WB, 1994, P NATL ACAD SCI USA, V91, P7668, DOI 10.1073/pnas.91.16.7668; Mohanty S, 2001, GENE DEV, V15, P1435, DOI 10.1101/gad.871101; Muckenthaler M, 1998, MOL CELL, V2, P383, DOI 10.1016/S1097-2765(00)80282-8; MURALIDHAR MG, 1993, NEURON, V11, P253, DOI 10.1016/0896-6273(93)90182-Q; OBRIG TG, 1971, J BIOL CHEM, V246, P174; OH CE, 1994, J NEUROSCI, V14, P3166; Ohta K, 1999, DEV BIOL, V211, P124, DOI 10.1006/dbio.1999.9312; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0; POPOV S, 1993, SCIENCE, V259, P244, DOI 10.1126/science.7678471; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Rechsteiner M, 1990, Semin Cell Biol, V1, P433; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Saito S, 1997, NEUROSCI LETT, V229, P73, DOI 10.1016/S0304-3940(97)00397-2; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Song HJ, 1999, CURR OPIN NEUROBIOL, V9, P355, DOI 10.1016/S0959-4388(99)80052-X; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; STEWARD O, 1982, J NEUROSCI, V2, P284; TENNYSON VM, 1970, J CELL BIOL, V44, P62, DOI 10.1083/jcb.44.1.62; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tokumoto M, 1999, GENE, V239, P301, DOI 10.1016/S0378-1119(99)00406-0; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Zakharenko S, 2000, NEUROSCIENCE, V97, P185, DOI 10.1016/S0306-4522(00)00022-1; Zhang HL, 2001, NEURON, V31, P261, DOI 10.1016/S0896-6273(01)00357-9; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zheng JQ, 2000, NATURE, V403, P89, DOI 10.1038/47501	74	595	605	0	23	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1013	1026		10.1016/S0896-6273(01)00551-7	http://dx.doi.org/10.1016/S0896-6273(01)00551-7			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754834	Bronze			2022-12-24	WOS:000172886800009
J	Barker, V; Middleton, G; Davey, F; Davies, AM				Barker, V; Middleton, G; Davey, F; Davies, AM			TNF alpha contributes to the death of NGF-dependent neurons during development	NATURE NEUROSCIENCE			English	Article							NERVE GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SYMPATHETIC NEURONS; CELL-DEATH; RECEPTOR GENE; EXPRESSION; RAT; ACTIVATION; SURVIVAL; INNERVATION	Many sympathetic and sensory neurons depend on a supply of nerve growth factor (NGF) from their targets during development, and neurons that fail to obtain sufficient NGF die by apoptosis. Here we show that tumor necrosis factor alpha (TNF alpha) is involved in bringing about the death of NGF-deprived neurons. Function-blocking antibodies against either TNF alpha or TNF receptor 1 (TNFR1) rescued many sympathetic and sensory neurons following NGF deprivation in vitro. Fewer sympathetic and sensory neurons died during the phase of naturally occurring neuronal death in TNF-deficient embryos, and neurons from these embryos survived in culture better than wild-type neurons. These neurons coexpress TNF alpha and TNFR1 during this stage of development, suggesting that TNFa acts by an autocrine loop.	Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Preclin Vet Sci, Edinburgh EH9 1QH, Midlothian, Scotland; Univ St Andrews, Sch Biomed Sci, St Andrews KY16 9AT, Fife, Scotland; Rinat Neurosci Corp, Palo Alto, CA 94304 USA	University of Edinburgh; University of St Andrews	Davies, AM (corresponding author), Univ Edinburgh, Royal Dick Sch Vet Studies, Dept Preclin Vet Sci, Summerhall Sq, Edinburgh EH9 1QH, Midlothian, Scotland.		Davies, Alun M/A-4334-2010	Davies, Alun M/0000-0001-5841-8176				Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carlson NG, 1998, J NEUROBIOL, V35, P29, DOI 10.1002/(SICI)1097-4695(199804)35:1<29::AID-NEU3>3.0.CO;2-D; CROWLEY C, 1994, CELL, V76, P1001, DOI 10.1016/0092-8674(94)90378-6; DAVIES A, 1984, J COMP NEUROL, V223, P124, DOI 10.1002/cne.902230110; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Dawson DA, 1996, NEUROSCI LETT, V218, P41, DOI 10.1016/S0304-3940(96)13116-5; Francis N, 1999, DEV BIOL, V210, P411, DOI 10.1006/dbio.1999.9269; Grell M, 1999, EMBO J, V18, P3034, DOI 10.1093/emboj/18.11.3034; HARPER S, 1990, DEVELOPMENT, V110, P515; Houzen H, 1997, J NEUROSCI RES, V50, P990, DOI 10.1002/(SICI)1097-4547(19971215)50:6<990::AID-JNR9>3.3.CO;2-8; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Knoblach SM, 1999, J NEUROIMMUNOL, V95, P115, DOI 10.1016/S0165-5728(98)00273-2; KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Raoul C, 1999, J CELL BIOL, V147, P1049, DOI 10.1083/jcb.147.5.1049; SMEYNE RJ, 1994, NATURE, V368, P246, DOI 10.1038/368246a0; Terrado J, 2000, EUR J NEUROSCI, V12, P3443, DOI 10.1046/j.1460-9568.2000.00240.x; WYATT S, 1995, J CELL BIOL, V130, P1435, DOI 10.1083/jcb.130.6.1435	23	93	94	2	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1194	1198		10.1038/nn755	http://dx.doi.org/10.1038/nn755			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11685224				2022-12-24	WOS:000172525000015
J	Finney, EM; Fine, I; Dobkins, KR				Finney, EM; Fine, I; Dobkins, KR			Visual stimuli activate auditory cortex in the deaf	NATURE NEUROSCIENCE			English	Article							SPATIAL ATTENTION; LANGUAGE; BLIND		Univ Calif San Diego, Psychol Dept 0109, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Dobkins, KR (corresponding author), Univ Calif San Diego, Psychol Dept 0109, La Jolla, CA 92093 USA.	kdobkins@ucsd.edu						Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Calvert GA, 1997, SCIENCE, V276, P593, DOI 10.1126/science.276.5312.593; Christman S, 1997, CEREBRAL ASYMMETRIES; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; Kujala T, 2000, TRENDS NEUROSCI, V23, P115, DOI 10.1016/S0166-2236(99)01504-0; Martinez A, 1999, NAT NEUROSCI, V2, P364, DOI 10.1038/7274; NEVILLE HJ, 1990, ANN NY ACAD SCI, V608, P71, DOI 10.1111/j.1749-6632.1990.tb48892.x; Nishimura H, 1999, NATURE, V397, P116, DOI 10.1038/16376; Petitto LA, 2000, P NATL ACAD SCI USA, V97, P13961, DOI 10.1073/pnas.97.25.13961; Rademacher J, 2001, NEUROIMAGE, V13, P669, DOI 10.1006/nimg.2000.0714; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Talairach J., 1988, COPLANAR STEREOTAXIC; Weeks R, 2000, J NEUROSCI, V20, P2664; Westbury CF, 1999, CEREB CORTEX, V9, P392, DOI 10.1093/cercor/9.4.392	15	411	426	1	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1171	1173		10.1038/nn763	http://dx.doi.org/10.1038/nn763			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704763				2022-12-24	WOS:000172525000011
J	Ekstrom, AD; Meltzer, J; McNaughton, BL; Barnes, CA				Ekstrom, AD; Meltzer, J; McNaughton, BL; Barnes, CA			NMDA receptor antagonism blocks experience-dependent expansion of hippocampal "place fields"	NEURON			English	Article							LONG-TERM POTENTIATION; PHASE-PRECESSION; SYNAPTIC ENHANCEMENT; PYRAMIDAL CELLS; UNIT-ACTIVITY; SPATIAL MAP; MEMORY; PLASTICITY; MK-801; CA1	In agreement with theories of sequence learning, hippocampal place representations expand asymmetrically during repeated route following. This behaviorally induced, experience-dependent expression of neuronal plasticity was blocked by the NMDA(R) antagonist CPP, suggesting that it may result from the temporal asymmetry and associative properties of LTP. NMDA(R) antagonism, however, had no effect on the range of the progressive shift of firing phase of hippocampal cells, relative to the theta rhythm, as the rat traverses the cell's "place field." Thus, when place fields normally expand with experience, the relationship between firing phase and position is altered, as predicted by models that account for "phase precession" on the basis of asymmetry of synaptic connection strengths. These effects of CPP mimic changes that occur during normal aging, suggesting mechanisms by which sequence learning deficits may arise in aged animals.	Univ Arizona, Dept Psychol, Tucson, AZ 85724 USA; Univ Arizona, Dept Neurol, Tucson, AZ 85724 USA; Univ Arizona, Dept Physiol, Tucson, AZ 85724 USA; Univ Arizona, Div Neural Syst Memory & Aging, Arizona Res Labs, Tucson, AZ 85724 USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona	Barnes, CA (corresponding author), Univ Arizona, Dept Psychol, Tucson, AZ 85724 USA.	carol@nsma.arizona.edu	Ekstrom, Arne/A-1329-2013	Ekstrom, Arne/0000-0002-6812-2368	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020331, R37NS020331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG012609, R37AG012609] Funding Source: NIH RePORTER; NIA NIH HHS [AG12609] Funding Source: Medline; NIMH NIH HHS [MH01565] Funding Source: Medline; NINDS NIH HHS [NS20331] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abbott LF, 1996, CEREB CORTEX, V6, P406, DOI 10.1093/cercor/6.3.406; AUGUST DA, 1997, THESIS U VIRGINIA CH; BANNERMAN DM, 1995, NATURE, V378, P182, DOI 10.1038/378182a0; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Barnes CA, 1997, NATURE, V388, P272, DOI 10.1038/40859; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Blum KI, 1996, NEURAL COMPUT, V8, P85, DOI 10.1162/neco.1996.8.1.85; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; CLINESCHMIDT BV, 1982, DRUG DEVELOP RES, V2, P135, DOI 10.1002/ddr.430020204; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; DEUPREE DL, 1993, NEUROBIOL AGING, V14, P249, DOI 10.1016/0197-4580(93)90009-Z; GAGE FH, 1989, NEUROBIOL AGING, V10, P347, DOI 10.1016/0197-4580(89)90047-X; GALLAGHER M, 1993, BEHAV NEUROSCI, V107, P618, DOI 10.1037/0735-7044.107.4.618; Gothard KM, 1996, J NEUROSCI, V16, P823; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hebb Donald O., 1949, ORG BEHAV; HUERTA PT, 1995, NEURON, V15, P1053, DOI 10.1016/0896-6273(95)90094-2; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Jevtovic-Todorovic V, 1998, BRAIN RES, V781, P202, DOI 10.1016/S0006-8993(97)01247-X; Kamondi A, 1998, HIPPOCAMPUS, V8, P244, DOI 10.1002/(SICI)1098-1063(1998)8:3<244::AID-HIPO7>3.0.CO;2-J; Kentros C, 1998, SCIENCE, V280, P2121, DOI 10.1126/science.280.5372.2121; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; MCFARLAND WL, 1975, J COMP PHYSIOL PSYCH, V88, P324, DOI 10.1037/h0076177; MCNAUGHTON BL, 1978, BRAIN RES, V157, P277, DOI 10.1016/0006-8993(78)90030-6; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Mehta MR, 1997, P NATL ACAD SCI USA, V94, P8918, DOI 10.1073/pnas.94.16.8918; MOORE CI, 1993, HIPPOCAMPUS, V3, P57, DOI 10.1002/hipo.450030106; MORIMOTO K, 1991, PHARMACOL BIOCHEM BE, V40, P893, DOI 10.1016/0091-3057(91)90103-9; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; Muller R U, 1991, Hippocampus, V1, P243, DOI 10.1002/hipo.450010306; MULLER RU, 1987, J NEUROSCI, V7, P1935; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; PAVLIDES C, 1988, BRAIN RES, V439, P383, DOI 10.1016/0006-8993(88)91499-0; PRESPICIUS C, 1994, INNS WORLD C NEURAL, V4, P164; RECCE ML, 1994, THESIS U COLL LONDON; Rosenzweig ES, 1997, HIPPOCAMPUS, V7, P549, DOI 10.1002/(SICI)1098-1063(1997)7:5<549::AID-HIPO10>3.0.CO;2-0; Shen JM, 1997, J NEUROSCI, V17, P6769; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; TRICKLEBANK MD, 1989, EUR J PHARMACOL, V167, P127, DOI 10.1016/0014-2999(89)90754-1; Tsodyks MV, 1996, HIPPOCAMPUS, V6, P271, DOI 10.1002/(SICI)1098-1063(1996)6:3<271::AID-HIPO5>3.3.CO;2-Q; Vanderwolf CH, 1975, HIPPOCAMPUS, V2, P101; Wallenstein GV, 1997, J NEUROPHYSIOL, V78, P393, DOI 10.1152/jn.1997.78.1.393; Wayner MJ, 2000, PHYSIOL BEHAV, V69, P505, DOI 10.1016/S0031-9384(00)00208-0; YAMAGUCHI Y, 1998, DYNAMIC BRAIN, V2, P781	48	185	189	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	AUG 30	2001	31	4					631	638		10.1016/S0896-6273(01)00401-9	http://dx.doi.org/10.1016/S0896-6273(01)00401-9			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545721	Bronze			2022-12-24	WOS:000170759200016
J	Solecki, DJ; Liu, XL; Tomoda, T; Fang, Y; Hatten, ME				Solecki, DJ; Liu, XL; Tomoda, T; Fang, Y; Hatten, ME			Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation	NEURON			English	Article							LOOP-HELIX FACTORS; BHLH GENE HES1; SONIC HEDGEHOG; NERVOUS-SYSTEM; CELL-PROLIFERATION; MOUSE-BRAIN; NEUROGENESIS; EXPRESSION; SPECIFICATION; PATHWAY	In the developing cerebellar cortex, granule neuron precursors (GNPs) proliferate and commence differentiation in a superficial zone, the external granule layer (EGL). The molecular basis of the transition from proliferating precursors to immature differentiating neurons remains unknown. Notch signaling is an evolutionarily conserved pathway regulating the differentiation of precursor cells of many lineages. Notch2 is specifically expressed in proliferating GNPs in the EGL. Treatment of GNPs with soluble Notch ligand Jagged1, or overexpression of activated Notch2 or its downstream target HES1, maintains precursor proliferation. The addition of GNP mitogens Jagged1 or Sonic Hedgehog (Shh) upregulates the expression of HES1, suggesting a role for HES1 in maintaining precursor proliferation.	Rockefeller Univ, Dev Neurobiol Lab, New York, NY 10021 USA	Rockefeller University	Hatten, ME (corresponding author), Rockefeller Univ, Dev Neurobiol Lab, 1230 York Ave, New York, NY 10021 USA.		Solecki, David/N-8080-2018		NCRR NIH HHS [P41 RR001192] Funding Source: Medline; PHS HHS [MS30532-05] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		AKAZAWA C, 1995, J BIOL CHEM, V270, P8730, DOI 10.1074/jbc.270.15.8730; Alder J, 1996, NEURON, V17, P389, DOI 10.1016/S0896-6273(00)80172-5; Altaba ARI, 1999, DEVELOPMENT, V126, P3205; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aruga J, 1998, J NEUROSCI, V18, P284; ARUGA J, 1994, J NEUROCHEM, V63, P1880; Bao ZZ, 1997, J NEUROSCI, V17, P1425; Baonza A, 2000, P NATL ACAD SCI USA, V97, P2609, DOI 10.1073/pnas.040576497; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Berry LW, 1997, DEVELOPMENT, V124, P925; Bhatt RS, 2000, GENE DEV, V14, P2216, DOI 10.1101/gad.821600; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; Cau E, 2000, DEVELOPMENT, V127, P2323; Chambers CB, 2001, DEVELOPMENT, V128, P689; Chitnis A, 1996, DEVELOPMENT, V122, P2295; Dahmane N, 1999, DEVELOPMENT, V126, P3089; delaPompa J, 1997, DEVELOPMENT, V124, P1139; FURLEY AJ, 1990, CELL, V61, P157, DOI 10.1016/0092-8674(90)90223-2; GAO WQ, 1991, NEURON, V6, P705, DOI 10.1016/0896-6273(91)90168-Y; HATTEN ME, 1995, ANNU REV NEUROSCI, V18, P385, DOI 10.1146/annurev.ne.18.030195.002125; HATTEN ME, 1985, J CELL BIOL, V100, P384, DOI 10.1083/jcb.100.2.384; Hays R, 1999, DEVELOPMENT, V126, P2891; Helms AW, 1998, DEVELOPMENT, V125, P919; Henrique D, 1997, CURR BIOL, V7, P661, DOI 10.1016/S0960-9822(06)00293-4; Ishibashi M, 1995, GENE DEV, V9, P3136, DOI 10.1101/gad.9.24.3136; Kageyama R, 1997, CURR OPIN GENET DEV, V7, P659, DOI 10.1016/S0959-437X(97)80014-7; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; Kinto N, 1997, FEBS LETT, V404, P319, DOI 10.1016/S0014-5793(97)00014-8; KUHAR SG, 1993, DEVELOPMENT, V117, P97; Lewis J, 1996, CURR OPIN NEUROBIOL, V6, P3, DOI 10.1016/S0959-4388(96)80002-X; Miyata T, 1999, GENE DEV, V13, P1647, DOI 10.1101/gad.13.13.1647; Miyazawa K, 2000, J NEUROSCI, V20, P5756, DOI 10.1523/JNEUROSCI.20-15-05756.2000; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Nagai T, 1997, DEV BIOL, V182, P299, DOI 10.1006/dbio.1996.8449; Nakagawa O, 2000, P NATL ACAD SCI USA, V97, P13655, DOI 10.1073/pnas.250485597; Nakamura Y, 2000, J NEUROSCI, V20, P283, DOI 10.1523/JNEUROSCI.20-01-00283.2000; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Ross ME, 1996, J NEUROSCI, V16, P210; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tanaka M, 1999, J NEUROBIOL, V41, P524, DOI 10.1002/(SICI)1097-4695(199912)41:4<524::AID-NEU8>3.3.CO;2-9; Tomita K, 1999, GENE DEV, V13, P1203, DOI 10.1101/gad.13.9.1203; Tomoda T, 1999, NEURON, V24, P833, DOI 10.1016/S0896-6273(00)81031-4; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yang XW, 1996, DEVELOPMENT, V122, P555; Zeng X, 2001, NATURE, V411, P716, DOI 10.1038/35079648	51	252	262	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 30	2001	31	4					557	568		10.1016/S0896-6273(01)00395-6	http://dx.doi.org/10.1016/S0896-6273(01)00395-6			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545715	Bronze			2022-12-24	WOS:000170759200010
J	Dunaevsky, A; Blaszeski, R; Yuste, R; Mason, C				Dunaevsky, A; Blaszeski, R; Yuste, R; Mason, C			Spine motility with synaptic contact	NATURE NEUROSCIENCE			English	Article							DENDRITIC FILOPODIA; PLASTICITY; SYNAPTOGENESIS; CA1		Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Anat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Cell Biol, New York, NY 10032 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Columbia University	Dunaevsky, A (corresponding author), Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Pathol, Room 14-509 P&S,630 W 168th St, New York, NY 10032 USA.				NATIONAL EYE INSTITUTE [R01EY013237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016951] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY13237] Funding Source: Medline; NINDS NIH HHS [NS10370, R01 NS16951] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 2000, NAT NEUROSCI, V3, P887, DOI 10.1038/78791; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; KORKOTIAN E, IN PRESS J NEUROSCI; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2000, J NEUROSCI, V20, P8262, DOI 10.1523/JNEUROSCI.20-22-08262.2000; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Wong WT, 2000, J NEUROSCI, V20, P5024; Wu GY, 2001, NAT NEUROSCI, V4, P151, DOI 10.1038/83976; Yamada K, 2000, J COMP NEUROL, V418, P106; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	15	74	74	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					685	686		10.1038/89460	http://dx.doi.org/10.1038/89460			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426220				2022-12-24	WOS:000169621300009
J	Beck, DM; Rees, G; Frith, CD; Lavie, N				Beck, DM; Rees, G; Frith, CD; Lavie, N			Neural correlates of change detection and change blindness	NATURE NEUROSCIENCE			English	Article							HUMAN BRAIN; ACTIVATION; ATTENTION; CORTEX; PERCEPTION; RIVALRY; FACE; MT	Functional magnetic resonance imaging (fMRI) of subjects attempting to detect a visual change occurring during a screen flicker was used to distinguish the neural correlates of change detection from those of change blindness. Change detection resulted in enhanced activity in the parietal and right dorsolateral prefrontal cortex as well as category-selective regions of the extrastriate visual cortex (for example, fusiform gyrus for changing faces). Although change blindness resulted in some extrastriate activity, the dorsal activations were clearly absent. These results demonstrate the importance of parietal and dorsolateral frontal activations for conscious detection of changes in properties coded in the ventral visual pathway, and thus suggest a key involvement of dorsal-ventral interactions in visual awareness.	UCL, Dept Psychol, London WC1E 6BT, England; UCL, Inst Cognit Neurosci, London WC1N 3AR, England; UCL, Inst Neurol, Wellcome Dept Cognit Neurol, London WC1N 3BG, England	University of London; University College London; University of London; University College London; University of London; University College London	Beck, DM (corresponding author), UCL, Dept Psychol, Gower St, London WC1E 6BT, England.	diane.beck@ucl.ac.uk	Beck, Diane M/F-7536-2010; Rees, Geraint/C-1493-2008; Frith, Chris D/A-2171-2009	Beck, Diane M/0000-0001-9802-5828; Rees, Geraint/0000-0002-9623-7007; Frith, Chris D/0000-0002-8665-0690	Wellcome Trust [067453] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		CORBETTA M, 1991, J NEUROSCI, V11, P2383; Coull JT, 1998, NEUROIMAGE, V8, P176, DOI 10.1006/nimg.1998.0354; Driver J, 1998, NAT NEUROSCI, V1, P17, DOI 10.1038/217; Epstein R, 1998, NATURE, V392, P598, DOI 10.1038/33402; Farah M.J., 1990, VISUAL AGNOSIA DISOR; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gitelman DR, 2000, NEUROIMAGE, V11, P58, DOI 10.1006/nimg.1999.0517; Grill-Spector K, 2000, NAT NEUROSCI, V3, P837, DOI 10.1038/77754; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Logothetis N, 1998, CURR OPIN NEUROBIOL, V8, P536; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; MACK A, 1998, INATTENTIONAL BUSINE; MILNER D, 1955, VISUAL BRAIN ASTION; NAVON D, 1979, PSYCHOL REV, V86, P214, DOI 10.1037/0033-295X.86.3.214; O'Regan JK, 1999, NATURE, V398, P34, DOI 10.1038/17953; OCraven KM, 1997, NEURON, V18, P591, DOI 10.1016/S0896-6273(00)80300-1; Rees G, 1999, SCIENCE, V286, P2504, DOI 10.1126/science.286.5449.2504; Rees G, 2000, BRAIN, V123, P1624, DOI 10.1093/brain/123.8.1624; Rees G, 1997, SCIENCE, V278, P1616, DOI 10.1126/science.278.5343.1616; Rensink RA, 1997, PSYCHOL SCI, V8, P368, DOI 10.1111/j.1467-9280.1997.tb00427.x; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Shulman GL, 2001, P NATL ACAD SCI USA, V98, P313, DOI 10.1073/pnas.021381198; Simons DJ, 1998, PSYCHON B REV, V5, P644, DOI 10.3758/BF03208840; Tempini MLG, 1998, BRAIN, V121, P2103, DOI 10.1093/brain/121.11.2103; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Treue S, 1996, NATURE, V382, P539, DOI 10.1038/382539a0; Turner R, 1998, EXP BRAIN RES, V123, P5, DOI 10.1007/s002210050538; Zeki S., 1993, VISION BRAIN	29	303	313	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					645	650		10.1038/88477	http://dx.doi.org/10.1038/88477			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	438PG	11369947				2022-12-24	WOS:000169061800019
J	Bockenhauer, D; Zilberberg, N; Goldstein, SAN				Bockenhauer, D; Zilberberg, N; Goldstein, SAN			KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel	NATURE NEUROSCIENCE			English	Article							DOMAIN K+ CHANNEL; 2 PORE DOMAINS; YEAST K+; FUNCTIONAL EXPRESSION; INWARD RECTIFICATION; TASK-1; PERMEABILITY; CURRENTS; SINGLE; FAMILY	Potassium leak channels are essential to neurophysiological function. Leaks suppress excitability through maintenance of resting membrane potential below the threshold for action potential firing. Conversely, voltage-dependent potassium channels permit excitation because they do not interfere with rise to threshold, and they actively promote recovery and rapid re-firing. Previously attributed to distinct transport pathways, we demonstrate here that phosphorylation of single, native hippocampal and cloned KCNK2 potassium channels produces reversible interconversion between leak and voltage-dependent phenotypes. The findings reveal a pathway for dynamic regulation of excitability.	Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, New Haven, CT 06536 USA; Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA	Yale University; Yale University	Goldstein, SAN (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Dept Pediat, 295 Congress Ave, New Haven, CT 06536 USA.	steve.goldstein@yale.edu	Bockenhauer, Detlef/AAF-6495-2020; Bockenhauer, Detlef/C-5951-2008; Zilberberg, Noam/F-2005-2012; Goldstein, Steven A./E-9817-2015	Bockenhauer, Detlef/0000-0001-5878-941X; Bockenhauer, Detlef/0000-0001-5878-941X; Goldstein, Steven A./0000-0001-5207-5061; Zilberberg, Noam/0000-0002-7848-2391				ADAMS DJ, 1980, ANNU REV NEUROSCI, V3, P141, DOI 10.1146/annurev.ne.03.030180.001041; Ahmed A, 1999, CELL, V99, P283, DOI 10.1016/S0092-8674(00)81659-1; BACKX PH, 1993, CIRC RES, V72, P890, DOI 10.1161/01.RES.72.4.890; BAKER M, 1987, J PHYSIOL-LONDON, V383, P45; BEAN BP, 1989, NATURE, V340, P153, DOI 10.1038/340153a0; Buckler KJ, 1997, J PHYSIOL-LONDON, V498, P649, DOI 10.1113/jphysiol.1997.sp021890; CHANG DC, 1986, BIOPHYS J, V50, P1095, DOI 10.1016/S0006-3495(86)83553-6; Colecraft HM, 2000, J GEN PHYSIOL, V115, P175, DOI 10.1085/jgp.115.2.175; Colquhoun David, 1995, P483; EVES EM, 1992, P NATL ACAD SCI USA, V89, P4373, DOI 10.1073/pnas.89.10.4373; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fink M, 1996, EMBO J, V15, P6854, DOI 10.1002/j.1460-2075.1996.tb01077.x; Goldman DE, 1943, J GEN PHYSIOL, V27, P37, DOI 10.1085/jgp.27.1.37; Goldstein SAN, 1998, J MOL MED-JMM, V76, P13, DOI 10.1007/s109-1998-8100-0; Goldstein SAN, 1996, P NATL ACAD SCI USA, V93, P13256, DOI 10.1073/pnas.93.23.13256; Goldstein SAN, 2001, NAT REV NEUROSCI, V2, P175, DOI 10.1038/35058574; Hille B, 1975, Membranes, V3, P255; HILLE B, 1973, J GEN PHYSIOL, V61, P669, DOI 10.1085/jgp.61.6.669; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; Ilan N, 2001, BIOPHYS J, V80, P241, DOI 10.1016/S0006-3495(01)76010-9; JONES SW, 1989, NEURON, V3, P153, DOI 10.1016/0896-6273(89)90028-7; KETCHUM KA, 1995, NATURE, V376, P690, DOI 10.1038/376690a0; Kim Y, 2000, J BIOL CHEM, V275, P9340, DOI 10.1074/jbc.275.13.9340; KUBO Y, 1993, NATURE, V364, P802, DOI 10.1038/364802a0; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Loukin SH, 1999, BIOPHYS J, V77, P3060, DOI 10.1016/S0006-3495(99)77137-7; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; Meadows HJ, 2000, PFLUG ARCH EUR J PHY, V439, P714, DOI 10.1007/s004240050997; Millar JA, 2000, P NATL ACAD SCI USA, V97, P3614, DOI 10.1073/pnas.050012597; Patel AJ, 1998, EMBO J, V17, P4283, DOI 10.1093/emboj/17.15.4283; SCHMIDT H, 1966, PFLUG ARCH GES PHYS, V287, P311, DOI 10.1007/BF00363245; SHEN KZ, 1992, J PHYSIOL-LONDON, V445, P581, DOI 10.1113/jphysiol.1992.sp018941; SIEGELBAUM SA, 1982, NATURE, V299, P413, DOI 10.1038/299413a0; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Talley EM, 2000, NEURON, V25, P399, DOI 10.1016/S0896-6273(00)80903-4; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; Vergani P, 1997, FEBS LETT, V405, P337, DOI 10.1016/S0014-5793(97)00211-1; Vergani P, 1998, EMBO J, V17, P7190, DOI 10.1093/emboj/17.24.7190; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Zhou Y, 1999, NEURON, V22, P809, DOI 10.1016/S0896-6273(00)80739-4; Zilberberg N, 2000, J GEN PHYSIOL, V116, P721, DOI 10.1085/jgp.116.5.721	46	132	139	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					486	491		10.1038/87434	http://dx.doi.org/10.1038/87434			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319556	Green Submitted			2022-12-24	WOS:000168412600011
J	Crist, RE; Li, W; Gilbert, CD				Crist, RE; Li, W; Gilbert, CD			Learning to see: experience and attention in primary visual cortex	NATURE NEUROSCIENCE			English	Article							STRIATE CORTEX; HORIZONTAL CONNECTIONS; MACAQUE MONKEY; ALERT MONKEYS; FUNCTIONAL ARCHITECTURE; VERNIER ACUITY; OWL MONKEYS; ORIENTATION; REPRESENTATION; DISCRIMINATION	The response properties of neurons in primary sensory cortices remain malleable throughout life. The existence of such plasticity, and the characteristics of a form of implicit learning known as perceptual learning, suggest that changes in primary sensory cortex may mediate learning. We explored whether modification of the functional properties of primary visual cortex (V1) accompanies perceptual learning. Basic receptive field properties, such as location, size and orientation selectivity, were unaffected by perceptual training, and visual topography (as measured by magnification factor) was indistinguishable between trained and untrained animals. On the other hand, the influence of contextual stimuli placed outside the receptive field showed a change consistent with the trained discrimination. Furthermore, this property showed task dependence, only being manifest when the animal was performing the trained discrimination.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Gilbert, CD (corresponding author), Rockefeller Univ, 1230 York Ave, New York, NY 10021 USA.		Li, Wu/AHA-4320-2022; Li, Wu/G-9415-2011	Li, Wu/0000-0002-2175-4579	NATIONAL EYE INSTITUTE [R01EY007968] Funding Source: NIH RePORTER; NEI NIH HHS [EY07968] Funding Source: Medline; NIGMS NIH HHS [GM07524] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Crist RE, 1997, J NEUROPHYSIOL, V78, P2889, DOI 10.1152/jn.1997.78.6.2889; DAS A, 1995, J NEUROPHYSIOL, V74, P779, DOI 10.1152/jn.1995.74.2.779; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; DOW BM, 1981, EXP BRAIN RES, V44, P213; FAHLE M, 1993, VISION RES, V33, P397, DOI 10.1016/0042-6989(93)90094-D; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1990, COLD SPRING HARB SYM, V55, P663; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; GILBERT CD, 1994, P NATL ACAD SCI USA, V91, P1195, DOI 10.1073/pnas.91.4.1195; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; HIRSCH JA, 1991, J NEUROSCI, V11, P1800; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; Ito M, 1999, NEURON, V22, P593, DOI 10.1016/S0896-6273(00)80713-8; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; Kapadia MK, 2000, J NEUROPHYSIOL, V84, P2048, DOI 10.1152/jn.2000.84.4.2048; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KAPADIA MK, 1994, J NEUROSCI, V14, P451; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; Levi DM, 1996, P NATL ACAD SCI USA, V93, P6830, DOI 10.1073/pnas.93.13.6830; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; MCKEE SP, 1978, PERCEPT PSYCHOPHYS, V24, P258, DOI 10.3758/BF03206097; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; RECANZONE GH, 1993, J NEUROSCI, V13, P87; RECANZONE GH, 1992, J NEUROPHYSIOL, V67, P1031, DOI 10.1152/jn.1992.67.5.1031; SNODDERLY DM, 1995, J NEUROPHYSIOL, V74, P2100, DOI 10.1152/jn.1995.74.5.2100; TSO DY, 1988, J NEUROSCI, V8, P1712; TSO DY, 1986, J NEUROSCI, V6, P1160; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VOGELS R, 1994, J NEUROPHYSIOL, V71, P1428, DOI 10.1152/jn.1994.71.4.1428; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; WEINBERGER NM, 1990, CONCEPTS NEUROSCIENC, V1, P91; WELIKY M, 1995, NEURON, V15, P541, DOI 10.1016/0896-6273(95)90143-4; WOLBARSHT ML, 1960, SCIENCE, V132, P1309, DOI 10.1126/science.132.3436.1309	36	267	273	0	12	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					519	525		10.1038/87470	http://dx.doi.org/10.1038/87470			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319561				2022-12-24	WOS:000168412600016
J	Lee, CH; Herman, T; Clandinin, TR; Lee, R; Zipursky, SL				Lee, CH; Herman, T; Clandinin, TR; Lee, R; Zipursky, SL			N-cadherin regulates target specificity in the Drosophila visual system	NEURON			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PHOTORECEPTOR AXON GUIDANCE; CHICK OPTIC TECTUM; IN-VIVO; CELL-ADHESION; PTP-MU; MULTIPLE CADHERINS; NEURAL CADHERIN; NERVOUS-SYSTEM; EXPRESSION	Using visual behavioral screens in Drosophila, we identified multiple alleles of N-cadherin. Removal of N-cadherin selectively from photoreceptor neurons (R cells) causes deficits in specific visual behaviors that correlate with disruptions in R cell connectivity. These defects include disruptions in the pattern of neuronal connections made by all three classes of R cells (R1-R6, R7, and R8). N-cadherin is expressed in both R cell axons and their targets. By inducing mitotic recombination in a subclass of eye progenitors, we generated mutant R7 axons surrounded by largely wildtype R cell axons and a wild-type target. R7 axons lacking N-cadherin mistarget to the R8 recipient layer. We consider the implications of these findings in the context of the proposed role for cadherins in target specificity.	Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Zipursky, SL (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Biol Chem, Howard Hughes Med Inst, 5-748 MRL,675 Charles Young Dr S, Los Angeles, CA 90095 USA.	zipursky@hhmi.ucla.edu	Lee, Chi-Hon/G-9190-2012	Zipursky, Stephen/0000-0001-5630-7181; Lee, Chi-Hon/0000-0002-6138-711X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008748, ZIAHD008748] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM08042] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; Benson DL, 1998, J NEUROSCI, V18, P6892; BENZER S, 1967, P NATL ACAD SCI USA, V58, P1112, DOI 10.1073/pnas.58.3.1112; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Burden-Gulley SM, 1999, J CELL BIOL, V144, P1323, DOI 10.1083/jcb.144.6.1323; Clandinin TR, 2000, NEURON, V28, P427, DOI 10.1016/S0896-6273(00)00122-7; Cooper MTD, 1999, NATURE, V397, P526, DOI 10.1038/17395; DETRICK RJ, 1990, NEURON, V4, P493, DOI 10.1016/0896-6273(90)90108-R; DICKSON B, 1995, TRENDS GENET, V11, P106, DOI 10.1016/S0168-9525(00)89011-3; Estes PS, 2000, J NEUROGENET, V13, P233, DOI 10.3109/01677060009084496; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; FISCHBACH KF, 1989, CELL TISSUE RES, V258, P441, DOI 10.1007/BF00218858; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929; Garrity PA, 1996, CELL, V85, P639, DOI 10.1016/S0092-8674(00)81231-3; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GERRESHEIM F, 1981, THESIS MUNICH U MUNI; Gregory G.E., 1980, P75; Grigliati T., 1986, DROSOPHILA PRACTICAL, P39; HARRIS WA, 1976, J PHYSIOL-LONDON, V256, P415; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HEISENBERG M, 1979, Z NATURFORSCH C, V34, P143; Inoue A, 1997, SCIENCE, V276, P1428, DOI 10.1126/science.276.5317.1428; Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; MARTIN KA, 1995, NEURON, V14, P229, DOI 10.1016/0896-6273(95)90281-3; Meinertzhagen Ian A., 1993, P1363; Miskevich F, 1998, MOL CELL NEUROSCI, V12, P240, DOI 10.1006/mcne.1998.0718; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Newsome TP, 2000, DEVELOPMENT, V127, P851; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; REINKE R, 1988, CELL, V55, P321, DOI 10.1016/0092-8674(88)90055-4; Riehl R, 1996, NEURON, V17, P837, DOI 10.1016/S0896-6273(00)80216-0; ROBINOW S, 1991, J NEUROBIOL, V22, P443, DOI 10.1002/neu.480220503; Serafini T, 1999, CELL, V98, P133, DOI 10.1016/S0092-8674(00)81008-9; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Shapiro L, 1999, NEURON, V23, P427, DOI 10.1016/S0896-6273(00)80796-5; Stowers RS, 1999, GENETICS, V152, P1631; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Tanaka H, 2000, NEURON, V25, P93, DOI 10.1016/S0896-6273(00)80874-0; Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Wohrn JCP, 1999, NEUROSCIENCE, V90, P985, DOI 10.1016/S0306-4522(98)00526-0; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yagi T, 2000, GENE DEV, V14, P1169; YAMAGATA M, 1995, J NEUROSCI, V15, P4556; ZIPURSKY SL, 1994, ANNU REV NEUROSCI, V17, P373, DOI 10.1146/annurev.neuro.17.1.373	52	218	220	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAY	2001	30	2					437	450		10.1016/S0896-6273(01)00291-4	http://dx.doi.org/10.1016/S0896-6273(01)00291-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395005	Bronze			2022-12-24	WOS:000168962000016
J	Chen, YA; Scales, SJ; Scheller, RH				Chen, YA; Scales, SJ; Scheller, RH			Sequential SNARE assembly underlies priming and triggering of exocytosis	NEURON			English	Article							MEMBRANE-FUSION; SYNAPTIC EXOCYTOSIS; COMPLEX-FORMATION; ALPHA-SNAP; T-SNARE; SYNAPTOTAGMIN; NEUROTOXINS; SPECIFICITY; RESOLUTION; SECRETION	Changes in SNARE conformations during MgATP-dependent priming of cracked PC12 cells were probed by their altered accessibility to various inhibitors. Dominant negative soluble syntaxin and, to a much lesser extent, VAMP coil domains inhibited exocytosis more efficiently after priming. Neurotoxins and an anti-SNAP25 antibody inhibited exocytosis less effectively after priming. We propose that SNAREs partially and reversibly assemble during priming, and that the syntaxin H3 domain is prevented from fully joining the complex until the arrival of the Ca2+ trigger. Furthermore, we find that mutation of hydrophobic residues of the SNAP25 C-terminal coil that contribute to SNARE core interactions affects the maximal rate of exocytosis, while mutation of charged residues on the surface of the complex affects the apparent affinity of the coil domain for the partially assembled complex.	Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Howard Hughes Med Inst, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Scheller, RH (corresponding author), Genentech Inc, 1 DNA Way, S San Francisco, CA 94080 USA.		Scales, Suzie J./H-4507-2019	Scales, Suzie J./0000-0003-2544-0283				CHAPMAN ER, 1994, J BIOL CHEM, V269, P27427; CHAPMAN ER, 1995, J BIOL CHEM, V270, P23667, DOI 10.1074/jbc.270.40.23667; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Geppert M, 1998, ANNU REV NEUROSCI, V21, P75, DOI 10.1146/annurev.neuro.21.1.75; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; HAY JC, 1995, NATURE, V374, P173, DOI 10.1038/374173a0; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hua SY, 1999, NAT NEUROSCI, V2, P1078, DOI 10.1038/16005; Kasai H, 1999, TRENDS NEUROSCI, V22, P88, DOI 10.1016/S0166-2236(98)01293-4; Lin RC, 1997, NEURON, V19, P1087, DOI 10.1016/S0896-6273(00)80399-2; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Scales SJ, 2000, NEURON, V26, P457, DOI 10.1016/S0896-6273(00)81177-0; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1999, EMBO J, V18, P3293, DOI 10.1093/emboj/18.12.3293; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247; Zhong PY, 1997, BIOCHEMISTRY-US, V36, P4317, DOI 10.1021/bi9625408	24	88	93	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					161	170		10.1016/S0896-6273(01)00270-7	http://dx.doi.org/10.1016/S0896-6273(01)00270-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343652	Bronze			2022-12-24	WOS:000168412900018
J	Beutner, D; Voets, T; Neher, E; Moser, T				Beutner, D; Voets, T; Neher, E; Moser, T			Calcium dependence of exocytosis and endocytosis at the Cochlear inner hair cell afferent synapse	NEURON			English	Article							ADRENAL CHROMAFFIN CELLS; RETINAL BIPOLAR NEURONS; PATCH-CLAMP TECHNIQUES; CAPACITANCE MEASUREMENTS; TRANSMITTER RELEASE; RIBBON SYNAPSE; ACTIVE ZONES; TIME-COURSE; CA2+; VESICLES	Release of neurotransmitter at the inner hair cell (IHC) afferent synapse is a fundamental step in translating sound into auditory nerve excitation. To study the Ca2+ dependence of the underlying vesicle fusion and subsequent endocytosis, we combined Ca2+ uncaging with membrane capacitance measurements in mouse IHCs. Rapid elevations in [Ca2+](i) above 8 muM caused a biphasic capacitance increase corresponding to the fusion of similar to 40,000 vesicles. The kinetics of exocytosis displayed a fifth-order Ca2+ dependence reaching maximal rates of >3 x 10(7) vesicle/s. Exocytosis was always followed by slow, compensatory endocytosis (tau approximate to 15 s). Higher [Ca2+](i) increased the contribution of a faster mode of endocytosis with a Ca2+-independent time constant of similar to 300 ms. These properties provide for rapid and sustained transmitter release from this large presynaptic terminal.	Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany; Univ Gottingen, Sch Med, Dept Otolaryngol, D-37073 Gottingen, Germany	Max Planck Society; University of Gottingen	Beutner, D (corresponding author), Max Planck Inst Biophys Chem, Dept Membrane Biophys, D-37077 Gottingen, Germany.		Voets, Thomas/E-2466-2012; Neher, Erwin/A-2109-2013; Voets, Thomas/AAD-4389-2019; Moser, Tobias/L-5068-2014	Voets, Thomas/0000-0001-5526-5821; Voets, Thomas/0000-0001-5526-5821; Moser, Tobias/0000-0001-7145-0533				ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; CHOW RH, 1994, P NATL ACAD SCI USA, V91, P12765, DOI 10.1073/pnas.91.26.12765; Engisch KL, 1998, J PHYSIOL-LONDON, V506, P591, DOI 10.1111/j.1469-7793.1998.591bv.x; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gomis A, 1999, J NEUROSCI, V19, P6309; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Heidelberger R, 1998, J GEN PHYSIOL, V111, P225, DOI 10.1085/jgp.111.2.225; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; HEINEMANN C, 1994, BIOPHYS J, V67, P2546, DOI 10.1016/S0006-3495(94)80744-1; Henkel AW, 1996, CURR OPIN NEUROBIOL, V6, P350, DOI 10.1016/S0959-4388(96)80119-X; KAPLAN JH, 1988, P NATL ACAD SCI USA, V85, P6571, DOI 10.1073/pnas.85.17.6571; Kiang N. Y., 1965, RES MONOGRAPH, V35; Klingauf J, 1998, NATURE, V394, P581, DOI 10.1038/29079; KONISHI M, 1991, J GEN PHYSIOL, V97, P271, DOI 10.1085/jgp.97.2.271; Lagnado L, 1996, NEURON, V17, P957, DOI 10.1016/S0896-6273(00)80226-3; Lenzi D, 1999, J NEUROSCI, V19, P119, DOI 10.1523/JNEUROSCI.19-01-00119.1999; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Matthews G, 2000, NATURE, V406, P835, DOI 10.1038/35022674; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Moser T, 2000, P NATL ACAD SCI USA, V97, P883, DOI 10.1073/pnas.97.2.883; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; PARSONS TD, 1994, NEURON, V13, P875, DOI 10.1016/0896-6273(94)90253-4; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; ROBERTS WM, 1990, J NEUROSCI, V10, P3664; Safieddine S, 1999, EUR J NEUROSCI, V11, P803, DOI 10.1046/j.1460-9568.1999.00487.x; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; SEWELL WF, 1996, COCHLEA, P503; Smith C, 1997, J CELL BIOL, V139, P885, DOI 10.1083/jcb.139.4.885; SMITH CA, 1961, J ULTRA MOL STRUCT R, V5, P184, DOI 10.1016/S0022-5320(61)90013-2; Voets T, 1999, NEURON, V23, P607, DOI 10.1016/S0896-6273(00)80812-0; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; VONGERSDORFF H, 1994, NATURE, V370, P652, DOI 10.1038/370652a0; Wu LG, 1996, NEURON, V17, P769, DOI 10.1016/S0896-6273(00)80208-1; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZHOU ZA, 1993, J PHYSIOL-LONDON, V469, P245, DOI 10.1113/jphysiol.1993.sp019813	36	255	259	0	16	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					681	690		10.1016/S0896-6273(01)00243-4	http://dx.doi.org/10.1016/S0896-6273(01)00243-4			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301027	Bronze, Green Published			2022-12-24	WOS:000167868900017
J	Hardingham, GE; Arnold, FJL; Bading, H				Hardingham, GE; Arnold, FJL; Bading, H			Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity	NATURE NEUROSCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; HIPPOCAMPAL-NEURONS; DIFFERENTIAL ACTIVATION; CYTOPLASMIC CALCIUM; PYRAMIDAL NEURONS; ACTION-POTENTIALS; TERNARY COMPLEX; TRANSCRIPTION; PHOSPHORYLATION; GROWTH	Information storage in the nervous system requires transcription triggered by synaptically evoked calcium signals. It has been suggested that translocation of calmodulin into the nucleus, initiated by submembranous calcium transients, relays synaptic signals to CREB. Here we show that in hippocampal neurons, signaling to CREB can be activated by nuclear calcium alone and does not require import of cytoplasmic proteins into the nucleus. The nucleus is particularly suited to integrate neuronal firing patterns, and specifies the transcriptional outputs through a burst frequency-to-nuclear calcium amplitude conversion. Calcium release from intracellular stores promotes calcium wave propagation into the nucleus, which is critical for CREB-mediated transcription by synaptic NMDA receptors. Pharmacological or genetic modulation of nuclear calcium may directly affect transcription-dependent memory and cognitive functions.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England	MRC Laboratory Molecular Biology	Bading, H (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.			Hardingham, Giles/0000-0002-7629-5314				Adams JP, 2000, ACTA NEUROBIOL EXP, V60, P377; Ahn S, 2000, ANNU REV PHYSIOL, V62, P803, DOI 10.1146/annurev.physiol.62.1.803; Bading H, 2000, EUR J BIOCHEM, V267, P5280, DOI 10.1046/j.1432-1327.2000.01565.x; BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; BONNI A, 1995, MOL CELL NEUROSCI, V6, P168, DOI 10.1006/mcne.1995.1015; Chawla S, 1998, SCIENCE, V281, P1505, DOI 10.1126/science.281.5382.1505; CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553, DOI 10.1152/jn.1995.73.6.2553; CRUZALEGUI FH, 1993, J BIOL CHEM, V268, P26171; Cruzalegui FH, 1999, EMBO J, V18, P1335, DOI 10.1093/emboj/18.5.1335; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; DEYO RA, 1989, SCIENCE, V243, P809, DOI 10.1126/science.2916127; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Fields RD, 1997, J NEUROSCI, V17, P7252; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; GINTY DD, 1993, SCIENCE, V260, P238, DOI 10.1126/science.8097062; GINTY DD, 1994, CELL, V77, P713, DOI 10.1016/0092-8674(94)90055-8; Goodman RH, 2000, GENE DEV, V14, P1553; HAGIWARA M, 1992, CELL, V70, P105, DOI 10.1016/0092-8674(92)90537-M; Hardingham GE, 1999, MICROSC RES TECHNIQ, V46, P348, DOI 10.1002/(SICI)1097-0029(19990915)46:6<348::AID-JEMT3>3.3.CO;2-1; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; Hu SC, 1999, NEURON, V22, P799, DOI 10.1016/S0896-6273(00)80738-2; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Johnson CM, 1997, J NEUROSCI, V17, P6189; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; LEREA LS, 1992, J NEUROSCI, V12, P2973, DOI 10.1523/JNEUROSCI.12-08-02973.1992; LEVERE TE, 1991, NEUROBIOL AGING, V13, P63; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Morich FJ, 1996, CLIN DRUG INVEST, V11, P185, DOI 10.2165/00044011-199611040-00001; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; Nakazawa H, 1999, J NEUROCHEM, V73, P1075, DOI 10.1046/j.1471-4159.1999.0731075.x; OLWIN BB, 1984, J BIOL CHEM, V259, P949; PRUSCHY M, 1994, J CELL BIOL, V127, P1527, DOI 10.1083/jcb.127.6.1527; SANDIN M, 1990, NEUROBIOL AGING, V11, P573, DOI 10.1016/0197-4580(90)90120-O; SCHILLER J, 1995, J PHYSIOL-LONDON, V487, P583, DOI 10.1113/jphysiol.1995.sp020902; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHENG M, 1988, MOL CELL BIOL, V8, P2787, DOI 10.1128/MCB.8.7.2787; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; TREISMAN R, 1994, CURR OPIN GENET DEV, V4, P96, DOI 10.1016/0959-437X(94)90097-3; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	50	416	423	0	11	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2001	4	3					261	267		10.1038/85109	http://dx.doi.org/10.1038/85109			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405UE	11224542				2022-12-24	WOS:000167178300013
J	Walker, MC; Ruiz, A; Kullmann, DM				Walker, MC; Ruiz, A; Kullmann, DM			Monosynaptic GABAergic signaling from dentate to CA3 with a pharmacological and physiological profile typical of mossy fiber synapses	NEURON			English	Article							LONG-TERM POTENTIATION; METABOTROPIC GLUTAMATE RECEPTORS; EXCITATORY GRANULE CELLS; TEMPORAL-LOBE EPILEPSY; RAT HIPPOCAMPUS; GUINEA-PIG; HETEROSYNAPTIC DEPRESSION; NEURONS; ACID; GABA	Mossy fibers are the sole excitatory projection from dentate gyrus granule cells to the hippocampus, where they release glutamate, dynorphin, and zinc. In addition, mossy fiber terminals show intense immunoreactivity for the inhibitory neurotransmitter GABA. Fast inhibitory transmission at mossy fiber synapses, however, has not previously been reported. Here, we show that electrical or chemical stimuli that recruit dentate granule cells elicit monosynaptic GABA, receptor-mediated synaptic signals in CA3 pyramidal neurons. These inhibitory signals satisfy the criteria that distinguish mossy fiber-CA3 synapses: high sensitivity to metabotropic glutamate receptor agonists, facilitation during repetitive stimulation, and NMDA receptor-independent long-term potentiation. GABAergic transmission from the dentate gyrus to CA3 has major implications not only for information flow into the hippocampus but also for developmental and pathological processes involving the hippocampus.	UCL, Inst Neurol, Dept Clin Neurol, London WC1N 3BG, England	University of London; University College London	Kullmann, DM (corresponding author), UCL, Inst Neurol, Dept Clin Neurol, Queen Sq, London WC1N 3BG, England.	d.kullmann@ion.ucl.ac.uk	Kullmann, Dimitri M/A-3162-2009; Walker, Matthew C/C-1577-2008	Kullmann, Dimitri M/0000-0001-6696-3545; Walker, Matthew C/0000-0002-0812-0352				Acsady L, 1998, J NEUROSCI, V18, P3386; AMARAL DG, 1990, PROG BRAIN RES, V83, P1; ASSAF SY, 1984, NATURE, V308, P734, DOI 10.1038/308734a0; BenAri Y, 1997, TRENDS NEUROSCI, V20, P523, DOI 10.1016/S0166-2236(97)01147-8; Bresink I, 1996, NEUROPHARMACOLOGY, V35, P503, DOI 10.1016/0028-3908(95)00192-1; Buhl EH, 1996, SCIENCE, V271, P369, DOI 10.1126/science.271.5247.369; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; Henze DA, 2000, NEUROSCIENCE, V98, P407, DOI 10.1016/S0306-4522(00)00146-9; HOWELL GA, 1984, NATURE, V308, P736, DOI 10.1038/308736a0; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395; LANTHORN TH, 1984, BRAIN RES, V290, P174, DOI 10.1016/0006-8993(84)90750-9; Lubke J, 1998, J NEUROPHYSIOL, V79, P1518, DOI 10.1152/jn.1998.79.3.1518; Maccaferri G, 1998, SCIENCE, V279, P1368, DOI 10.1126/science.279.5355.1368; MACONOCHIE DJ, 1994, NEURON, V12, P61, DOI 10.1016/0896-6273(94)90152-X; Makiura Y, 1999, EXP NEUROL, V159, P73, DOI 10.1006/exnr.1999.7138; MCGINTY JF, 1983, P NATL ACAD SCI-BIOL, V80, P589, DOI 10.1073/pnas.80.2.589; Min MY, 1999, P NATL ACAD SCI USA, V96, P9932, DOI 10.1073/pnas.96.17.9932; Min MY, 1998, NEURON, V21, P561, DOI 10.1016/S0896-6273(00)80566-8; NICOLL RA, 1995, NATURE, V377, P115, DOI 10.1038/377115a0; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; REGEHR WG, 1994, J NEUROSCI, V14, P523; Salin PA, 1996, P NATL ACAD SCI USA, V93, P13304, DOI 10.1073/pnas.93.23.13304; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; Scanziani M, 1998, P NATL ACAD SCI USA, V95, P12004, DOI 10.1073/pnas.95.20.12004; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Schwarzer C, 1997, NEUROSCIENCE, V80, P1001, DOI 10.1016/S0306-4522(97)00145-0; SCHWARZER C, 1995, NEUROSCIENCE, V69, P705, DOI 10.1016/0306-4522(95)00348-M; Semyanov A, 2000, NEURON, V25, P663, DOI 10.1016/S0896-6273(00)81068-5; Shew T, 2000, J NEUROPHYSIOL, V83, P3388, DOI 10.1152/jn.2000.83.6.3388; Shigemoto R, 1997, J NEUROSCI, V17, P7503, DOI 10.1523/jneurosci.17-19-07503.1997; Shigemoto R, 1996, NATURE, V381, P523, DOI 10.1038/381523a0; Sik A, 1997, EUR J NEUROSCI, V9, P573, DOI 10.1111/j.1460-9568.1997.tb01634.x; Sloviter R S, 1991, Hippocampus, V1, P41, DOI 10.1002/hipo.450010106; Sloviter RS, 1996, J COMP NEUROL, V373, P593; Sperk G, 1997, NEUROSCIENCE, V80, P987, DOI 10.1016/S0306-4522(97)00146-2; Spiridon M, 1998, J PHYSIOL-LONDON, V506, P363, DOI 10.1111/j.1469-7793.1998.363bw.x; Spruston N, 1997, J COMP NEUROL, V385, P427; TAUPIN P, 1994, BRAIN RES, V644, P313, DOI 10.1016/0006-8993(94)91695-0; Toth K, 2000, J NEUROSCI, V20, P8279, DOI 10.1523/JNEUROSCI.20-22-08279.2000; Vida I, 2000, P NATL ACAD SCI USA, V97, P1275, DOI 10.1073/pnas.97.3.1275; Vogt K, 2000, NEURON, V26, P187, DOI 10.1016/S0896-6273(00)81149-6; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; WEISSKOPF MG, 1994, SCIENCE, V265, P1878, DOI 10.1126/science.7916482; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WEISSKOPF MG, 1993, NATURE, V362, P423, DOI 10.1038/362423a0; WESTBROOK GL, 1987, NATURE, V328, P640, DOI 10.1038/328640a0; WILLIAMS SH, 1991, J NEUROPHYSIOL, V66, P1010, DOI 10.1152/jn.1991.66.3.1010; YAMAMOTO C, 1983, EXP BRAIN RES, V51, P128; Yeckel MF, 1999, NAT NEUROSCI, V2, P625, DOI 10.1038/10180	52	140	147	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	MAR	2001	29	3					703	715		10.1016/S0896-6273(01)00245-8	http://dx.doi.org/10.1016/S0896-6273(01)00245-8			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301029	Bronze			2022-12-24	WOS:000167868900019
J	Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N				Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N			G alpha(i) controls the gating of the G protein-activated K+ channel, GIRK	NEURON			English	Article							BETA-GAMMA-SUBUNITS; MUSCARINIC POTASSIUM CHANNEL; XENOPUS-OOCYTES; ATRIAL MYOCYTES; I-KACH; RECEPTORS; BINDING; CELLS; G(BETA-GAMMA); SPECIFICITY	GIRK (Kir3) channels are activated by neurotransmitters; coupled to G proteins, via a direct binding of Gbetagamma. The role of Galpha subunits in GIRK gating is elusive. Here we demonstrate that Galpha(i) is not only a donor of Gbetagamma but also regulates GIRK gating. When overexpressed in Xenopus oocytes, GIRK channels show excessive basal activity and poor activation by agonist or Gbetagamma. Coexpression of Galpha(i3) or Galpha(i1), restores the correct gating parameters. Galpha(i) acts neither as a pure Gbetagamma scavenger nor as an allosteric cofactor for Gbetagamma. It inhibits only the basal activity without interfering with Gbetagamma-induced response. Thus, GIRK is regulated, in distinct ways, by both arms of the G protein. Gal probably acts in its GDP bound form, alone or as a part of Galphabetagamma heterotrimer.	Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; Univ Texas, Houston Med Sch, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	Tel Aviv University; Sackler Faculty of Medicine; University of Texas System; University of Texas Health Science Center Houston	Dascal, N (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.		Dascal, Nathan/O-3915-2015; Dessauer, Carmen/N-6933-2018	Dascal, Nathan/0000-0002-5397-4146; Dessauer, Carmen/0000-0003-1210-4280	NIGMS NIH HHS [R01 GM060419-02, R01 GM060419, GM 56260-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060419, R01GM056260] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bender K, 1998, FEBS LETT, V439, P115, DOI 10.1016/S0014-5793(98)01350-7; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Dascal N, 1997, CELL SIGNAL, V9, P551, DOI 10.1016/S0898-6568(97)00095-8; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; He C, 1999, J BIOL CHEM, V274, P12517, DOI 10.1074/jbc.274.18.12517; HILLE B, 1994, TRENDS NEUROSCI, V17, P531, DOI 10.1016/0166-2236(94)90157-0; Huang CL, 1997, FEBS LETT, V405, P291, DOI 10.1016/S0014-5793(97)00197-X; HUANG CL, 1995, NEURON, V15, P1133, DOI 10.1016/0896-6273(95)90101-9; IVANINA T, 1994, BIOCHEMISTRY-US, V33, P8786, DOI 10.1021/bi00195a021; Ivanina T, 2000, J BIOL CHEM, V275, P39846, DOI 10.1074/jbc.M005881200; IvanovaNikolova TT, 1997, J GEN PHYSIOL, V109, P245, DOI 10.1085/jgp.109.2.245; Jelacic TM, 1999, J MEMBRANE BIOL, V169, P123, DOI 10.1007/s002329900524; Kim D, 1997, AM J PHYSIOL-HEART C, V272, pH195, DOI 10.1152/ajpheart.1997.272.1.H195; Kozasa T, 1996, NEUROSCI RES, V26, P289, DOI 10.1016/S0168-0102(96)01111-X; Krapivinsky G, 1998, J BIOL CHEM, V273, P16946, DOI 10.1074/jbc.273.27.16946; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; Leaney JL, 2000, P NATL ACAD SCI USA, V97, P5651, DOI 10.1073/pnas.080572297; Leaney JL, 2000, J BIOL CHEM, V275, P921, DOI 10.1074/jbc.275.2.921; Lei QB, 2000, P NATL ACAD SCI USA, V97, P9771, DOI 10.1073/pnas.97.17.9771; LESAGE F, 1995, J BIOL CHEM, V270, P28660, DOI 10.1074/jbc.270.48.28660; LIM NF, 1995, J GEN PHYSIOL, V105, P421, DOI 10.1085/jgp.105.3.421; Logothetis DE, 1999, J PHYSIOL-LONDON, V520, P630, DOI 10.1111/j.1469-7793.1999.00630.x; Lutz LB, 2000, J BIOL CHEM, V275, P41512, DOI 10.1074/jbc.M006757200; Nemec J, 1999, BIOPHYS J, V76, P246, DOI 10.1016/S0006-3495(99)77193-6; Petit-Jacques J, 1999, J GEN PHYSIOL, V114, P673, DOI 10.1085/jgp.114.5.673; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; ROSS EM, 1995, RECENT PROG HORM RES, V50, P207; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; SAKMANN B, 1983, NATURE, V303, P250, DOI 10.1038/303250a0; Sarvazyan NA, 1998, J BIOL CHEM, V273, P7934, DOI 10.1074/jbc.273.14.7934; Schreibmayer W, 1996, NATURE, V380, P624, DOI 10.1038/380624a0; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Singer-Lahat D, 2000, PFLUG ARCH EUR J PHY, V440, P627, DOI 10.1007/s004240000341; Sorota S, 1999, J PHYSIOL-LONDON, V514, P413, DOI 10.1111/j.1469-7793.1999.413ae.x; Sowell MO, 1997, P NATL ACAD SCI USA, V94, P7921, DOI 10.1073/pnas.94.15.7921; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Sunahara RK, 1996, ANNU REV PHARMACOL, V36, P461, DOI 10.1146/annurev.pa.36.040196.002333; Vorobiov D, 2000, J BIOL CHEM, V275, P4166, DOI 10.1074/jbc.275.6.4166; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; WICKMAN KD, 1994, NATURE, V368, P255, DOI 10.1038/368255a0; Yakubovich D, 2000, J PHYSIOL-LONDON, V524, P737, DOI 10.1111/j.1469-7793.2000.00737.x; Yamada M, 1998, PHARMACOL REV, V50, P723; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0	43	132	135	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 3	2002	33	1					87	99		10.1016/S0896-6273(01)00567-0	http://dx.doi.org/10.1016/S0896-6273(01)00567-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	508TT	11779482	Bronze			2022-12-24	WOS:000173106200012
J	Kros, CJ; Marcotti, W; van Netten, SM; Self, TJ; Libby, RT; Brown, SDM; Richardson, GP; Steel, KP				Kros, CJ; Marcotti, W; van Netten, SM; Self, TJ; Libby, RT; Brown, SDM; Richardson, GP; Steel, KP			Reduced climbing and increased slipping adaptation in cochlear hair cells of mice with Myo7a mutations	NATURE NEUROSCIENCE			English	Article							MYOSIN-VIIA; MECHANOELECTRICAL TRANSDUCTION; AMINOGLYCOSIDE ACCUMULATION; MEMBRANE; DEAFNESS; CADHERIN; CURRENTS; MODEL; CHANNELS; PROTEIN	Mutations in Myo7a cause hereditary deafness in mice and humans. We describe the effects of two mutations, Myo7a(6J) and Myo7a(4626SB). on mechano-electrical transduction in cochlear hair cells. Both mutations result in two major functional abnormalities that would interfere with sound transduction. The hair bundles need to be displaced beyond their physiological operating range for mechanotransducer channels to open. Transducer currents also adapt more strongly than normal to excitatory stimuli. We conclude that myosin VIIA participates in anchoring and holding membrane-bound elements to the actin core of the stereocilium. Myosin VIIA is therefore required for the normal gating of transducer channels.	Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England; Univ Bristol, Sch Med Sci, Dept Physiol, Bristol BS8 1TD, Avon, England; Univ Groningen, Dept Neurobiophys, NL-9747 AG Groningen, Netherlands; Univ Nottingham, MRC, Inst Hearing Res, Nottingham NG7 2RD, England; MRC, Mammalian Genet Unit, Didcot OX11 0RD, Oxon, England	University of Sussex; University of Bristol; University of Groningen; University of Nottingham; MRC Harwell	Kros, CJ (corresponding author), Univ Sussex, Sch Biol Sci, Brighton BN1 9QG, E Sussex, England.	c.j.kros@sussex.ac.uk	Libby, Richard/Q-6720-2019	Libby, Richard/0000-0003-2844-7632				ASSAD JA, 1989, P NATL ACAD SCI USA, V86, P2918, DOI 10.1073/pnas.86.8.2918; ASSAD JA, 1992, J NEUROSCI, V12, P3291; BARR E, 1994, GENE THER, V1, P51; Bolz H, 2001, NAT GENET, V27, P108, DOI 10.1038/83667; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; DENK W, 1992, J NEUROPHYSIOL, V68, P927, DOI 10.1152/jn.1992.68.3.927; Di Palma F, 2001, NAT GENET, V27, P103, DOI 10.1038/83660; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Garcia JA, 1998, J NEUROSCI, V18, P8637; Geleoc GSG, 1997, P ROY SOC B-BIOL SCI, V264, P611, DOI 10.1098/rspb.1997.0087; GIBSON F, 1995, NATURE, V374, P62, DOI 10.1038/374062a0; GILLESPIE PG, 1993, NEURON, V11, P581, DOI 10.1016/0896-6273(93)90071-X; Gillespie PG, 1997, NEURON, V19, P955, DOI 10.1016/S0896-6273(00)80387-6; GOODNO CC, 1982, P NATL ACAD SCI-BIOL, V79, P21, DOI 10.1073/pnas.79.1.21; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Holt JR, 2000, P NATL ACAD SCI USA, V97, P11730, DOI 10.1073/pnas.97.22.11730; HOWARD J, 1987, P NATL ACAD SCI USA, V84, P3064, DOI 10.1073/pnas.84.9.3064; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1994, NEURON, V12, P1, DOI 10.1016/0896-6273(94)90147-3; KROESE ABA, 1989, HEARING RES, V37, P203, DOI 10.1016/0378-5955(89)90023-3; Kros C. J., 1995, ACTIVE HEARING, P113; KROS CJ, 1992, P ROY SOC B-BIOL SCI, V249, P185, DOI 10.1098/rspb.1992.0102; Kussel-Andermann P, 2000, EMBO J, V19, P6020, DOI 10.1093/emboj/19.22.6020; Liu XZ, 1997, NAT GENET, V16, P188, DOI 10.1038/ng0697-188; Lord EM, 1929, AM NAT, V63, P435, DOI 10.1086/280276; Mangeat P, 1999, TRENDS CELL BIOL, V9, P187, DOI 10.1016/S0962-8924(99)01544-5; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Mburu Philomena, 1997, Genes and Function, V1, P191; OHMORI H, 1985, J PHYSIOL-LONDON, V359, P189, DOI 10.1113/jphysiol.1985.sp015581; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; RHODE WS, 1967, J ACOUST SOC AM, V42, P185, DOI 10.1121/1.1910547; Richardson GP, 1997, J NEUROSCI, V17, P9506; Richardson GP, 1999, ANN NY ACAD SCI, V884, P110; Ruggero MA, 1997, J ACOUST SOC AM, V101, P2151, DOI 10.1121/1.418265; RUSSELL IJ, 1987, HEARING RES, V31, P9, DOI 10.1016/0378-5955(87)90210-3; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Self T, 1998, DEVELOPMENT, V125, P557; SHEPHERD GMG, 1994, J NEUROSCI, V14, P6217; van Netten SM, 2000, P ROY SOC B-BIOL SCI, V267, P1915, DOI 10.1098/rspb.2000.1230; Verpy E, 2000, NAT GENET, V26, P51, DOI 10.1038/79171; Weil D, 1997, NAT GENET, V16, P191, DOI 10.1038/ng0697-191; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0; Wu YC, 1999, J NEUROPHYSIOL, V82, P2171, DOI 10.1152/jn.1999.82.5.2171; Yamoah EN, 1998, J NEUROSCI, V18, P610; Yamoah EN, 1996, NEURON, V17, P523, DOI 10.1016/S0896-6273(00)80184-1	47	193	200	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					41	47		10.1038/nn784	http://dx.doi.org/10.1038/nn784			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11753415				2022-12-24	WOS:000173031800013
J	DeVries, SH				DeVries, SH			Exocytosed protons feedback to suppress the Ca2+ current in mammalian cone photoreceptors	NEURON			English	Article							RETINAL BIPOLAR NEURONS; SYNAPTIC TRANSMISSION; SALAMANDER RETINA; INNER SEGMENTS; RECEPTOR DESENSITIZATION; GLUTAMATE-TRANSPORTER; EXTRACELLULAR PROTONS; TIGER SALAMANDER; HORIZONTAL CELLS; CALCIUM CHANNELS	A proton pump acidifies synaptic vesicles and provides the electrochemical gradient for transmitter uptake. Although external protons can modulate membrane voltage- and ligand-gated conductances, the fate of the protons released when vesicles fuse with the plasma membrane is unclear. In the dark, the glutamate-laden vesicles of cone photoreceptors fuse continuously with the plasma membrane. I now show that vesicular protons feed back to block the nearby calcium channels that mediate release. This local proton-mediated feedback is a novel mechanism through which neurons may regulate the release of transmitter.	Univ Texas, Houston Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	DeVries, SH (corresponding author), Northwestern Univ, Sch Med, Dept Ophthalmol, Tarry 5-715,300 E Super St, Chicago, IL 60611 USA.	s-devries@northwestern.edu			NATIONAL EYE INSTITUTE [R01EY012141] Funding Source: NIH RePORTER; NEI NIH HHS [EY12141] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADLER EM, 1991, J NEUROSCI, V11, P1496; AMES A, 1981, J NEUROCHEM, V37, P867, DOI 10.1111/j.1471-4159.1981.tb04473.x; ARSLAN P, 1985, J BIOL CHEM, V260, P2719; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARNES S, 1993, P NATL ACAD SCI USA, V90, P10081, DOI 10.1073/pnas.90.21.10081; BARNES S, 1991, J NEUROSCI, V11, P4015; Bellocchio EE, 2000, SCIENCE, V289, P957, DOI 10.1126/science.289.5481.957; Chen XH, 1996, J GEN PHYSIOL, V108, P363, DOI 10.1085/jgp.108.5.363; Choi DW, 1998, ANNU REV NEUROSCI, V21, P347, DOI 10.1146/annurev.neuro.21.1.347; COREY DP, 1984, J PHYSIOL-LONDON, V354, P557, DOI 10.1113/jphysiol.1984.sp015393; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Dmitriev AV, 2001, J NEUROSCI, V21, P2897, DOI 10.1523/JNEUROSCI.21-08-02897.2001; Eliasof S, 1998, J NEUROSCI, V18, P698; ELIASOF S, 1993, J NEUROSCI, V13, P402; Eliasof S, 1997, VISUAL NEUROSCI, V14, P13, DOI 10.1017/S0952523800008713; Hare WA, 1998, VISUAL NEUROSCI, V15, P263, DOI 10.1017/S0952523898152069; HEIDELBERGER R, 1994, NATURE, V371, P513, DOI 10.1038/371513a0; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; Ihle EC, 2000, MOL PHARMACOL, V58, P1204, DOI 10.1124/mol.58.6.1204; Kamermans M, 1999, VISION RES, V39, P2449, DOI 10.1016/S0042-6989(99)00043-7; KLOCKNER U, 1994, J GEN PHYSIOL, V103, P665, DOI 10.1085/jgp.103.4.665; Koulen P, 1999, P NATL ACAD SCI USA, V96, P9909, DOI 10.1073/pnas.96.17.9909; KRAFTE DS, 1988, J GEN PHYSIOL, V91, P641, DOI 10.1085/jgp.91.5.641; Krishek BJ, 1996, J PHYSIOL-LONDON, V492, P431, DOI 10.1113/jphysiol.1996.sp021319; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; LINSER PJ, 1984, DEV BRAIN RES, V13, P65, DOI 10.1016/0165-3806(84)90077-4; Liu YJ, 1997, ANNU REV NEUROSCI, V20, P125; MAYCOX PR, 1988, J BIOL CHEM, V263, P15423; Mennerick S, 1996, NEURON, V17, P1241, DOI 10.1016/S0896-6273(00)80254-8; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; MILLER AM, 1983, J PHYSIOL-LONDON, V334, P325, DOI 10.1113/jphysiol.1983.sp014497; Morgans CW, 1998, J NEUROSCI, V18, P2467; Pattnaik B, 2000, J NEUROSCI, V20, P6789, DOI 10.1523/JNEUROSCI.20-18-06789.2000; PICAUD SA, 1995, J NEUROPHYSIOL, V74, P1760, DOI 10.1152/jn.1995.74.4.1760; PRODHOM B, 1987, NATURE, V329, P243, DOI 10.1038/329243a0; RAVIOLA E, 1975, J CELL BIOL, V65, P192, DOI 10.1083/jcb.65.1.192; Rose B. D., 1989, CLIN PHYSL ACID BASE; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Taylor WR, 1998, VISUAL NEUROSCI, V15, P541; Thoreson WB, 1997, J NEUROPHYSIOL, V77, P2175, DOI 10.1152/jn.1997.77.4.2175; TRAYNELIS SF, 1991, J PHYSIOL-LONDON, V433, P727, DOI 10.1113/jphysiol.1991.sp018453; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8; WEST RW, 1976, J COMP NEUROL, V168, P355, DOI 10.1002/cne.901680304; WINEGAR BD, 1990, J PHYSIOL-LONDON, V425, P563, DOI 10.1113/jphysiol.1990.sp018118; WU SM, 1993, VISION RES, V33, P2611, DOI 10.1016/0042-6989(93)90219-M; YAGI T, 1994, J NEUROPHYSIOL, V71, P656, DOI 10.1152/jn.1994.71.2.656; YAMAMOTO F, 1992, EXP EYE RES, V54, P685, DOI 10.1016/0014-4835(92)90023-L; Zhou Q, 2000, J PHYSIOL-LONDON, V525, P195, DOI 10.1111/j.1469-7793.2000.t01-1-00195.x	49	215	221	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	DEC 26	2001	32	6					1107	1117		10.1016/S0896-6273(01)00535-9	http://dx.doi.org/10.1016/S0896-6273(01)00535-9			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754841	Bronze			2022-12-24	WOS:000172886800016
J	Ye, WL; Bouchard, M; Stone, D; Liu, XD; Vella, F; Lee, J; Nakamura, H; Ang, SL; Busslinger, M; Rosenthal, A				Ye, WL; Bouchard, M; Stone, D; Liu, XD; Vella, F; Lee, J; Nakamura, H; Ang, SL; Busslinger, M; Rosenthal, A			Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8	NATURE NEUROSCIENCE			English	Article							ANTERIOR NEURAL PLATE; ISTHMIC ORGANIZER; MOUSE-BRAIN; MID/HINDBRAIN ORGANIZER; MIDBRAIN DEVELOPMENT; INT-1 PROTOONCOGENE; VISCERAL ENDODERM; SEQUENTIAL ROLES; OTX2 EXPRESSION; CONTAINING GENE	Local expression of FGF8 at the mid/hindbrain boundary (MHB) governs the development of multiple neurons and support cells. Here we show that the paired-domain protein Pax2 is necessary and sufficient for the induction of FGF8 in part by regulating the expression of Pax5&8. A network of transcription and secreted factors, including En1, Otx2, Gbx2, Grg4 and Wnt1&4, that is established independently of Pax2, further refines the expression domain and level of FGF8 at the MHB through opposing effects on Pax2 activity. Our results indicate that the expression of local organizing factors is controlled by combinatorial interaction between inductive and modulatory factors.	Rinat Neurosci, Palo Alto, CA 94304 USA; Genentech Inc, Dept Mol Biol, S San Francisco, CA 94080 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria; Tohoku Univ, Inst Dev Aging & Canc, Dept Mol Neurobiol, Aoba Ku, Sendai, Miyagi 9808575, Japan; IGBMC, F-67404 Illkirch Graffenstaden, CU De Strasbour, France	Roche Holding; Genentech; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Tohoku University; Institut National de la Sante et de la Recherche Medicale (Inserm)	Rosenthal, A (corresponding author), Rinat Neurosci, 3155 Porter Dr, Palo Alto, CA 94304 USA.		Busslinger, Meinrad J./J-1249-2016	Busslinger, Meinrad J./0000-0002-9111-9351; Bouchard, Maxime/0000-0002-7619-9680; Ye, Weilan/0000-0002-6219-3982	Medical Research Council [MC_U117570533] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acampora D, 1998, DEVELOPMENT, V125, P5091; ANG SL, 1993, DEVELOPMENT, V118, P139; ANG SL, 1994, DEVELOPMENT, V120, P2979; Araki I, 1999, DEVELOPMENT, V126, P5127; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Bouchard M, 2000, DEVELOPMENT, V127, P3703; BOUILLET P, 1995, DEV DYNAM, V204, P372, DOI 10.1002/aja.1002040404; Broccoli V, 1999, NATURE, V401, P164, DOI 10.1038/43670; Crossley PH, 1996, NATURE, V380, P66, DOI 10.1038/380066a0; Danielian PS, 1996, NATURE, V383, P332, DOI 10.1038/383332a0; DRESSLER GR, 1990, DEVELOPMENT, V109, P787; Eberhard D, 2000, EMBO J, V19, P2292, DOI 10.1093/emboj/19.10.2292; Funahashi J, 1999, DEV GROWTH DIFFER, V41, P59; Gemel J, 1999, J BIOL CHEM, V274, P6020, DOI 10.1074/jbc.274.9.6020; Hidalgo-Sanchez M, 1999, MECH DEVELOP, V81, P175, DOI 10.1016/S0925-4773(98)00224-X; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Hynes M, 2000, NAT NEUROSCI, V3, P41, DOI 10.1038/71114; Irving C, 1999, DEVELOPMENT, V126, P3981; Katahira T, 2000, MECH DEVELOP, V91, P43, DOI 10.1016/S0925-4773(99)00262-2; Koop KE, 1996, MECH DEVELOP, V59, P73, DOI 10.1016/0925-4773(96)00582-5; Lee SMK, 1997, DEVELOPMENT, V124, P959; Liu AM, 1999, DEVELOPMENT, V126, P4827; Liu AM, 2001, DEVELOPMENT, V128, P181; MALLO M, 1993, MECH DEVELOP, V42, P67, DOI 10.1016/0925-4773(93)90099-J; MARIN F, 1994, DEV BIOL, V163, P19, DOI 10.1006/dbio.1994.1120; Martinez S, 1999, DEVELOPMENT, V126, P1189; MARTINEZ S, 1991, NEURON, V6, P971, DOI 10.1016/0896-6273(91)90237-T; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136; Millett S, 1999, NATURE, V401, P161, DOI 10.1038/43664; NAKAMURA H, 1986, CELL DIFFER DEV, V19, P187, DOI 10.1016/0045-6039(86)90095-3; NIEUWKOOP PD, 1989, DEV GROWTH DIFFER, V32, P149; Okafuji T, 1999, DEV BRAIN RES, V116, P41, DOI 10.1016/S0165-3806(99)00073-5; Pfeffer PL, 2000, DEVELOPMENT, V127, P1017; Rhinn M, 1999, DEVELOPMENT, V126, P4295; Rhinn M, 1998, DEVELOPMENT, V125, P845; Shamim H, 1999, DEVELOPMENT, V126, P945; Simeone A, 2000, TRENDS GENET, V16, P237, DOI 10.1016/S0168-9525(00)02000-X; Song DL, 2000, MECH DEVELOP, V90, P155, DOI 10.1016/S0925-4773(99)00242-7; Sugiyama S, 2000, DEV BIOL, V221, P168, DOI 10.1006/dbio.2000.9643; THOMAS KR, 1990, NATURE, V346, P847, DOI 10.1038/346847a0; Urbanek P, 1997, P NATL ACAD SCI USA, V94, P5703, DOI 10.1073/pnas.94.11.5703; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; WURST W, 1994, DEVELOPMENT, V120, P2065; Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3	47	101	101	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1175	1181		10.1038/nn761	http://dx.doi.org/10.1038/nn761			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704761				2022-12-24	WOS:000172525000012
J	Monuki, ES; Porter, FD; Walsh, CA				Monuki, ES; Porter, FD; Walsh, CA			Patterning of the dorsal telencephalon and cerebral cortex by a roof plate-Lhx2 pathway	NEURON			English	Article							CENTRAL-NERVOUS-SYSTEM; IN-SITU HYBRIDIZATION; PROMOTER DIRECTS EXPRESSION; REGULATORY GENES; TRANSGENIC MICE; NEURAL CREST; FOREBRAIN DEVELOPMENT; CORTICAL-NEURONS; SPINAL-CORD; DLX GENES	The organizing centers and molecules that pattern the cerebral cortex have been elusive. Here we show that cortical patterning involves regulation of the Lhx2 homeobox gene by the roof plate. Roof plate ablation results in reduced cortical size and Lhx2 expression defects that implicate roof plate signals in the bimodal regulation of Lhx2 in vivo. Bimodal Lhx2 regulation can be recapitulated in explants using two roof plate-derived signaling molecules, Bmp4 and Bmp2. Loss of Lhx2 function results in profound losses of cortical progenitors and neurons, but Lhx2 mutants continue to generate cortical neurons from dorsal sources that may include the roof plate region itself. These findings provide evidence for the roof plate as an organizing center of the developing cortex and for a roof plate-Lhx2 pathway in cortical patterning.	Beth Israel Deaconess Med Ctr, Div Neurogenet, Boston, MA 02115 USA; Childrens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; NICHHD, Heritable Disorders Branch, NIH, Bethesda, MD 20892 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Walsh, CA (corresponding author), Univ Calif Irvine, Coll Med, Dept Pathol, Irvine, CA 92697 USA.			Walsh, Christopher/0000-0002-0156-2238; Monuki, Edwin/0000-0001-5130-781X	NIMH NIH HHS [MH K08] Funding Source: Medline; NINDS NIH HHS [R01 NS32457] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032457] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Bachiller D, 2000, NATURE, V403, P658, DOI 10.1038/35001072; Bayer S.A., 1991, NEOCORTICAL DEV; Bertuzzi S, 1999, MECH DEVELOP, V81, P193, DOI 10.1016/S0925-4773(98)00233-0; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; BONCINELLI E, 1993, J NEUROBIOL, V24, P1356, DOI 10.1002/neu.480241008; Bulchand S, 2001, MECH DEVELOP, V100, P165, DOI 10.1016/S0925-4773(00)00515-3; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; DEBLOCK M, 1993, ANAL BIOCHEM, V215, P86, DOI 10.1006/abio.1993.1558; DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B; DICKINSON ME, 1994, DEVELOPMENT, V120, P1453; Donoghue MJ, 1999, CEREB CORTEX, V9, P586, DOI 10.1093/cercor/9.6.586; Dou CL, 1999, CEREB CORTEX, V9, P543, DOI 10.1093/cercor/9.6.543; Dymecki SM, 1998, DEV BIOL, V201, P57, DOI 10.1006/dbio.1998.8971; Furuta Y, 1997, DEVELOPMENT, V124, P2203; Golden JA, 1999, P NATL ACAD SCI USA, V96, P2439, DOI 10.1073/pnas.96.5.2439; GRAHAM A, 1994, NATURE, V372, P684, DOI 10.1038/372684a0; GRLESHAMMER U, 1998, DEV BIOL, V197, P234; Grove EA, 1998, DEVELOPMENT, V125, P2315; HAUPTMANN G, 1994, TRENDS GENET, V10, P266, DOI 10.1016/0168-9525(90)90008-T; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Kaufman M.H., 1992, ATLAS MOUSE DEV; Knecht AK, 1997, DEVELOPMENT, V124, P2477; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lee KJ, 1998, GENE DEV, V12, P3394, DOI 10.1101/gad.12.21.3394; Lee SMK, 2000, DEVELOPMENT, V127, P457; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; LIEM KF, 1995, CELL, V82, P969, DOI 10.1016/0092-8674(95)90276-7; Mabie PC, 1999, J NEUROSCI, V19, P7077, DOI 10.1523/JNEUROSCI.19-16-07077.1999; Marchant L, 1998, DEV BIOL, V198, P319, DOI 10.1006/dbio.1998.8902; MERCER EH, 1991, NEURON, V7, P703, DOI 10.1016/0896-6273(91)90274-4; MESSING A, 1992, NEURON, V8, P507, DOI 10.1016/0896-6273(92)90279-M; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; MISSON JP, 1988, DEV BRAIN RES, V44, P95, DOI 10.1016/0165-3806(88)90121-6; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; PALMITER RD, 1987, CELL, V50, P435, DOI 10.1016/0092-8674(87)90497-1; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Porter FD, 1997, DEVELOPMENT, V124, P2935; PUELLES L, 1993, TRENDS NEUROSCI, V16, P472, DOI 10.1016/0166-2236(93)90080-6; Retaux S, 1999, J NEUROSCI, V19, P783; Rincon-Limas DE, 1999, P NATL ACAD SCI USA, V96, P2165, DOI 10.1073/pnas.96.5.2165; ROBERSON MS, 1994, MOL CELL BIOL, V14, P2985, DOI 10.1128/MCB.14.5.2985; Rubenstein JLR, 1997, MOL CELLULAR APPROAC, P356; Shimamura K, 1995, DEVELOPMENT, V121, P3923; Solloway MJ, 1999, DEVELOPMENT, V126, P1753; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; Trousse F, 2001, J NEUROSCI, V21, P1292; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLIAMS JA, 1993, DEVELOPMENT, V117, P571; Wilson SW, 2000, NEURON, V28, P641, DOI 10.1016/S0896-6273(00)00171-9; XU Y, 1993, P NATL ACAD SCI USA, V90, P227, DOI 10.1073/pnas.90.1.227; Zhao YU, 1999, SCIENCE, V284, P1155, DOI 10.1126/science.284.5417.1155; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6	63	229	235	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 20	2001	32	4					591	604		10.1016/S0896-6273(01)00504-9	http://dx.doi.org/10.1016/S0896-6273(01)00504-9			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	495WT	11719201	Bronze			2022-12-24	WOS:000172363900007
J	Aharon, I; Etcoff, N; Ariely, D; Chabris, CF; O'Connor, E; Breiter, HC				Aharon, I; Etcoff, N; Ariely, D; Chabris, CF; O'Connor, E; Breiter, HC			Beautiful faces have variable reward value: fMRI and behavioral evidence	NEURON			English	Article							DIFFERENTIAL NEURAL RESPONSE; FACIAL ATTRACTIVENESS; SELF-STIMULATION; HUMAN BRAIN; INFANT PREFERENCES; PREFRONTAL CORTEX; DECISION-MAKING; HUMAN AMYGDALA; EXPRESSION; FOREBRAIN	The brain circuitry processing rewarding and aversive stimuli is hypothesized to be at the core of motivated behavior. In this study, discrete categories of beautiful faces are shown to have differing reward values and to differentially activate reward circuitry in human subjects. In particular, young heterosexual males rate pictures of beautiful males and females as attractive, but exert effort via a keypress procedure only to view pictures of attractive females. Functional magnetic resonance imaging at 3 T shows that passive viewing of beautiful female faces activates reward circuitry, in particular the nucleus accumbens. An extended set of subcortical and paralimbic reward regions also appear to follow aspects of the keypress rather than the rating procedures, suggesting that reward circuitry function does not include aesthetic assessment.	Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Ctr, Boston, MA 02129 USA; Harvard Univ, Sch Med, Boston, MA 02129 USA; Massachusetts Gen Hosp, MIT, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02129 USA; Harvard Univ, Sch Med, Charlestown, MA 02129 USA; Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; MIT, Cambridge, MA 02139 USA; Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Harvard University	Breiter, HC (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Motivat & Emot Neurosci Ctr, Boston, MA 02129 USA.				PHS HHS [09467, 00265] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ariely D, 2000, J EXP PSYCHOL GEN, V129, P508, DOI 10.1037//0096-3445.129.4.508; ARIELY D, 2001, 4158 MIT; Arvanitogiannis A, 1996, PHYSIOL BEHAV, V59, P795, DOI 10.1016/0031-9384(95)02157-4; Arvanitogiannis A, 2000, BEHAV BRAIN RES, V107, P123, DOI 10.1016/S0166-4328(99)00120-5; Bartels A, 2000, NEUROREPORT, V11, P3829, DOI 10.1097/00001756-200011270-00046; BECERRA L, 2001, IN PRESS NEURON; Bechara A, 1998, J NEUROSCI, V18, P428; Berns GS, 1997, SCIENCE, V276, P1272, DOI 10.1126/science.276.5316.1272; Berns GS, 2001, J NEUROSCI, V21, P2793, DOI 10.1523/JNEUROSCI.21-08-02793.2001; Berridge KC, 1996, NEUROSCI BIOBEHAV R, V20, P1, DOI 10.1016/0149-7634(95)00033-B; BERRIDGE KC, 2000, PSYCHOL LEARNING MOT, V40; Breiter H.C., 1996, NEUROIMAGE, V3, pS220, DOI 10.1016/S1053-8119(96)80222-9; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; BREITER HC, 1998, INT SOC MAGN RES MED; BREITER HC, 2000, AM PAIN SOC ATL US; Brown VJ, 1996, BRAIN RES BULL, V39, P163, DOI 10.1016/0361-9230(95)02088-8; BUSH G, 1996, 2 INT C FUNCT MAPP H; CABANAC M, 1979, Q REV BIOL, V54, P1, DOI 10.1086/410981; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; CUNNINGHAM MR, 1995, J PERS SOC PSYCHOL, V68, P261, DOI 10.1037/0022-3514.68.2.261; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Drevets WC, 2001, BIOL PSYCHIAT, V49, P81, DOI 10.1016/S0006-3223(00)01038-6; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; EVERITT B J, 1992, P401; Flores C, 1997, BEHAV BRAIN RES, V87, P239, DOI 10.1016/S0166-4328(97)02288-2; Francis S, 1999, NEUROREPORT, V10, P453, DOI 10.1097/00001756-199902250-00003; FRIEZE IH, 1991, J APPL SOC PSYCHOL, V21, P1039, DOI 10.1111/j.1559-1816.1991.tb00458.x; FRIEZE IH, 1990, J APPL SOC PSYCHOL, V20, P46, DOI 10.1111/j.1559-1816.1990.tb00377.x; Gallistel C. R., 1990, ORG LEARNING; GRAMMER K, 1994, J COMP PSYCHOL, V108, P233, DOI 10.1037/0735-7036.108.3.233; HAMERMESH DS, 1994, AM ECON REV, V84, P1174; Horvitz JC, 2000, NEUROSCIENCE, V96, P651, DOI 10.1016/S0306-4522(00)00019-1; JONES D, 1993, HUM NATURE-INT BIOS, V4, P271, DOI 10.1007/BF02692202; Kant Immanuel, 1960, OBSERVATIONS FEELING; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Knutson B, 2000, NEUROIMAGE, V12, P20, DOI 10.1006/nimg.2000.0593; KNUTSON B, 2001, J NEUROSCI, V15, P1; LANGLOIS JH, 1991, DEV PSYCHOL, V27, P79, DOI 10.1037/0012-1649.27.1.79; LANGLOIS JH, 1987, DEV PSYCHOL, V23, P363, DOI 10.1037/0012-1649.23.3.363; LOUILOT A, 1989, BRAIN BEHAV EVOLUT, V33, P157, DOI 10.1159/000115920; Makris N, 1999, NEUROIMAGE, V9, P18, DOI 10.1006/nimg.1998.0384; Marlowe CM, 1996, J APPL PSYCHOL, V81, P11, DOI 10.1037/0021-9010.81.1.11; Morris JS, 1996, NATURE, V383, P812, DOI 10.1038/383812a0; Nakahara D, 1999, NEUROSCIENCE, V90, P1013, DOI 10.1016/S0306-4522(98)00510-7; Nakamura K, 1998, NEUROREPORT, V9, P753, DOI 10.1097/00001756-199803090-00035; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Penton-Voak IS, 1999, NATURE, V399, P741, DOI 10.1038/21557; PERRETT DI, 1994, NATURE, V368, P239, DOI 10.1038/368239a0; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Perrett DI, 1999, EVOL HUM BEHAV, V20, P295, DOI 10.1016/S1090-5138(99)00014-8; Phillips ML, 1999, PSYCHIAT RES-NEUROIM, V92, P11, DOI 10.1016/S0925-4927(99)00031-1; ROBLEDO P, 1993, BEHAV BRAIN RES, V55, P159, DOI 10.1016/0166-4328(93)90112-4; Rogers RD, 1999, J NEUROSCI, V19, P9029, DOI 10.1523/JNEUROSCI.19-20-09029.1999; ROLLS ET, 1999, BRAIN EMOTION; RUSKIN J, 1997, LECT ART; Schoenbaum G, 1999, J NEUROSCI, V19, P1876; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P., 1999, WELL BEING FDN HEDON, P502; Slater A, 1998, INFANT BEHAV DEV, V21, P345, DOI 10.1016/S0163-6383(98)90011-X; Small DM, 2001, BRAIN, V124, P1720, DOI 10.1093/brain/124.9.1720; Stein EA, 1998, AM J PSYCHIAT, V155, P1009, DOI 10.1176/ajp.155.8.1009; Symons D., 1995, SEXUAL NATURE SEXUAL; Talairach J., 1988, COPLANAR STEREOTAXIC; Thomas KM, 2001, BIOL PSYCHIAT, V49, P309, DOI 10.1016/S0006-3223(00)01066-0; Thut G, 1997, NEUROREPORT, V8, P1225, DOI 10.1097/00001756-199703240-00033; WISE RA, 1978, SCIENCE, V201, P262, DOI 10.1126/science.566469; Wojciulik E, 1998, J NEUROPHYSIOL, V79, P1574, DOI 10.1152/jn.1998.79.3.1574; Wyvell CL, 2000, J NEUROSCI, V20, P8122; Zald DH, 1998, BRAIN, V121, P1143, DOI 10.1093/brain/121.6.1143	76	748	787	8	181	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					537	551		10.1016/S0896-6273(01)00491-3	http://dx.doi.org/10.1016/S0896-6273(01)00491-3			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	491QE	11709163	Bronze			2022-12-24	WOS:000172119100018
J	Matsuzaki, M; Ellis-Davies, GCR; Nemoto, T; Miyashita, Y; Iino, M; Kasai, H				Matsuzaki, M; Ellis-Davies, GCR; Nemoto, T; Miyashita, Y; Iino, M; Kasai, H			Dendritic spine geometry is critical for AMPA receptor expression in hippocampal CA1 pyramidal neurons	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; 2-PHOTON EXCITATION; GLUTAMATE RECEPTORS; SURFACE EXPRESSION; SILENT SYNAPSES; CROSS-SECTIONS; NMDA RECEPTORS; NONSATURATION; VARIABILITY	Dendritic spines serve as preferential sites of excitatory synaptic connections and are pleomorphic. To address the structure-function relationship of the dendritic spines, we used two-photon uncaging of glutamate to allow mapping of functional glutamate receptors at the level of the single synapse. Our analyses of the spines of CA1 pyramidal neurons reveal that AMPA (alpha -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid)-type glutamate receptors are abundant (up to 150/spine) in mushroom spines but sparsely distributed in thin spines and filopodia. The latter may be serving as the structural substrates of the silent synapses that have been proposed to play roles in development and plasticity of synaptic transmission. Our data indicate that distribution of functional AMPA receptors is tightly correlated with spine geometry and that receptor activity is independently regulated at the level of single spines.	Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan; Grad Univ Adv Studies, Okazaki, Aichi 4448585, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Bunkyo Ku, Tokyo 1130033, Japan; Med Coll Penn & Hahnemann Univ, Dept Physiol & Pharmacol, Philadelphia, PA 19102 USA	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Graduate University for Advanced Studies - Japan; Japan Science & Technology Agency (JST); University of Tokyo; Drexel University	Kasai, H (corresponding author), Natl Inst Physiol Sci, Dept Cell Physiol, Okazaki, Aichi 4448585, Japan.	hkasai@nips.ac.jp	Miyashita, Yasushi/B-7171-2019; Nemoto, Tomomi/B-4412-2012	Miyashita, Yasushi/0000-0003-3496-8637; Nemoto, Tomomi/0000-0001-6102-1495; Kasai, Haruo/0000-0003-2327-9027; Matsuzaki, Masanori/0000-0003-3872-4322	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053395] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM053395, GM53395] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arbib MA, 1995, HDB BRAIN THEORY NEU; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brown EB, 1999, BIOPHYS J, V76, P489, DOI 10.1016/S0006-3495(99)77217-6; Buchs PA, 1996, P NATL ACAD SCI USA, V93, P8040, DOI 10.1073/pnas.93.15.8040; Crank J., 1975, MATH DIFFUSION; DENK W, 1994, P NATL ACAD SCI USA, V91, P6629, DOI 10.1073/pnas.91.14.6629; Diamond JS, 1997, J NEUROSCI, V17, P4672; Durand GM, 1996, NATURE, V381, P71, DOI 10.1038/381071a0; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Furuta T, 1999, P NATL ACAD SCI USA, V96, P1193, DOI 10.1073/pnas.96.4.1193; Gomperts SN, 1998, NEURON, V21, P1443, DOI 10.1016/S0896-6273(00)80662-5; Halpain S, 2000, TRENDS NEUROSCI, V23, P141, DOI 10.1016/S0166-2236(00)01576-9; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hopt A, 2001, BIOPHYS J, V80, P2029, DOI 10.1016/S0006-3495(01)76173-5; JONAS P, 1992, J PHYSIOL-LONDON, V455, P143, DOI 10.1113/jphysiol.1992.sp019294; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lendvai B, 2000, NATURE, V404, P876, DOI 10.1038/35009107; Lissin DV, 1998, P NATL ACAD SCI USA, V95, P7097, DOI 10.1073/pnas.95.12.7097; Liu GS, 1999, NEURON, V22, P395, DOI 10.1016/S0896-6273(00)81099-5; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; McAllister AK, 2000, P NATL ACAD SCI USA, V97, P6173, DOI 10.1073/pnas.100126497; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Nemoto T, 2001, NAT CELL BIOL, V3, P253, DOI 10.1038/35060042; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Papageorgiou G, 2000, TETRAHEDRON, V56, P8197, DOI 10.1016/S0040-4020(00)00745-6; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pettit DL, 1997, NEURON, V19, P465, DOI 10.1016/S0896-6273(00)80361-X; Ramon y Cajal S, 1909, HISTOLOGIE SYSTEME N; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Segal M, 2000, TRENDS NEUROSCI, V23, P53, DOI 10.1016/S0166-2236(99)01499-X; Shen L, 2000, J NEUROSCI, V20, P7932; Shepherd GM, 1996, J NEUROPHYSIOL, V75, P2197, DOI 10.1152/jn.1996.75.6.2197; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIGWORTH FJ, 1980, J PHYSIOL-LONDON, V307, P97, DOI 10.1113/jphysiol.1980.sp013426; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; SPRUSTON N, 1995, J PHYSIOL-LONDON, V482, P325, DOI 10.1113/jphysiol.1995.sp020521; Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Tsubokawa H, 1996, J NEUROPHYSIOL, V76, P2896, DOI 10.1152/jn.1996.76.5.2896; Turrigiano GG, 2000, NEURON, V26, P5, DOI 10.1016/S0896-6273(00)81131-9; Wang SSH, 2000, P NATL ACAD SCI USA, V97, P8635, DOI 10.1073/pnas.130414597; Xu C, 1996, J OPT SOC AM B, V13, P481, DOI 10.1364/JOSAB.13.000481; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	50	1122	1146	1	75	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	NOV	2001	4	11					1086	1092		10.1038/nn736	http://dx.doi.org/10.1038/nn736			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	489AY	11687814	Green Accepted			2022-12-24	WOS:000171970900011
J	Jensen, K; Mody, I				Jensen, K; Mody, I			L-type Ca2+ channel-mediated short-term plasticity of GABAergic synapses	NATURE NEUROSCIENCE			English	Article							CEREBELLAR GRANULE CELLS; HIPPOCAMPAL-NEURONS; CALCIUM CHANNELS; GABA RELEASE; INTERNEURONS; RAT		Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Mody, I (corresponding author), Univ Calif Los Angeles, Dept Neurol, RNRC 3-131,710 Westwood Plaza, Los Angeles, CA 90095 USA.			Jensen, Kimmo/0000-0001-8895-6194	NINDS NIH HHS [NS 30549] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS030549, R01NS030549] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Atluri PP, 1998, J NEUROSCI, V18, P8214; Bartos M, 2001, J NEUROSCI, V21, P2687, DOI 10.1523/JNEUROSCI.21-08-02687.2001; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Holt EH, 1996, J BIOL CHEM, V271, P28105, DOI 10.1074/jbc.271.45.28105; Jensen K, 1999, J PHYSIOL-LONDON, V519, P71, DOI 10.1111/j.1469-7793.1999.0071o.x; Jensen K, 1999, J NEUROPHYSIOL, V81, P1225, DOI 10.1152/jn.1999.81.3.1225; KAMIYA H, 1994, NATURE, V371, P603, DOI 10.1038/371603a0; Kraushaar U, 2000, J NEUROSCI, V20, P5594, DOI 10.1523/JNEUROSCI.20-15-05594.2000; Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4; Penttonen M, 1998, EUR J NEUROSCI, V10, P718, DOI 10.1046/j.1460-9568.1998.00096.x; Poncer JC, 1997, NEURON, V18, P463, DOI 10.1016/S0896-6273(00)81246-5; Ryan TA, 1999, J NEUROSCI, V19, P1317; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; Whittington MA, 2000, INT J PSYCHOPHYSIOL, V38, P315, DOI 10.1016/S0167-8760(00)00173-2; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	15	43	45	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					975	976		10.1038/nn722	http://dx.doi.org/10.1038/nn722			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11547336				2022-12-24	WOS:000171325800008
J	Baylis, GC; Driver, J				Baylis, GC; Driver, J			Shape-coding in IT cells generalizes over contrast and mirror reversal, but not figure-ground reversal	NATURE NEUROSCIENCE			English	Article							SUPERIOR TEMPORAL SULCUS; SIDED EDGE ASSIGNMENT; INFEROTEMPORAL CORTEX; RECOGNITION; NEURONS; SEGMENTATION; VISION; MONKEY; OBJECTS; REPRESENTATION	We assessed how the visual shape preferences of neurons in the inferior temporal cortex of awake, behaving monkeys generalized across three different stimulus transformations. Stimulus-preferences of particular cells among different polygon displays were correlated across reversed contrast polarity or mirror reversal, but not across figure-ground reversal. This corresponds with psychological findings on human shape judgments. Our results imply that neurons in inferior temporal cortex respond to components of visual shape derived only after figure-ground assignment of contours, not to the contours themselves.	Univ Plymouth, Plymouth Inst Neurosci, Plymouth PL4 8AA, Devon, England; Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA; UCL, Inst Cognit Neurosci, London WC1N 3AR, England	University of Plymouth; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; University of London; University College London	Baylis, GC (corresponding author), Univ Plymouth, Plymouth Inst Neurosci, 12 Kirkby Pl, Plymouth PL4 8AA, Devon, England.	gordon@pion.ac.uk; j.driver@ucl.ac.uk	Driver, Jon/A-4779-2010	BAYLIS, Gordon/0000-0002-4223-9074	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS027296] Funding Source: NIH RePORTER; NINDS NIH HHS [R29 NS27296] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BAYLIS GC, 1987, J NEUROSCI, V7, P330; BAYLIS GC, 1985, BRAIN RES, V342, P91, DOI 10.1016/0006-8993(85)91356-3; BAYLIS GC, 1995, J EXP PSYCHOL HUMAN, V21, P1323, DOI 10.1037/0096-1523.21.6.1323; BAYLIS GC, 1995, CURR DIR PSYCHOL SCI, V4, P140, DOI 10.1111/1467-8721.ep10772580; Baylis GC, 2001, J EXP PSYCHOL HUMAN, V27, P633, DOI 10.1037//0096-1523.27.3.633; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; DESIMONE R, 1985, VISION RES, V25, P441, DOI 10.1016/0042-6989(85)90069-0; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Driver J, 1996, COGNITIVE PSYCHOL, V31, P248, DOI 10.1006/cogp.1996.0018; Driver J, 1995, CURR DIR PSYCHOL SCI, V4, P201, DOI 10.1111/1467-8721.ep10772645; Farah MJ, 1999, TRENDS COGN SCI, V3, P179, DOI 10.1016/S1364-6613(99)01309-1; FARAH MJ, 1990, VISUAL AGNOSIA; HOFFMAN DD, 1984, COGNITION, V18, P65, DOI 10.1016/0010-0277(84)90022-2; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; MALACH R, 1995, P NATL ACAD SCI USA, V92, P8135, DOI 10.1073/pnas.92.18.8135; NAKAYAMA K, 1989, PERCEPTION, V18, P55, DOI 10.1068/p180055; PALMER S, 1994, PSYCHON B REV, V1, P29, DOI 10.3758/BF03200760; PETERSON MA, 1994, CURR DIR PSYCHOL SCI, V3, P105, DOI 10.1111/1467-8721.ep10770552; PINKER S, 1984, COGNITION, V18, P1, DOI 10.1016/0010-0277(84)90021-0; Plaut D C, 1990, J Cogn Neurosci, V2, P320, DOI 10.1162/jocn.1990.2.4.320; Riesenhuber M, 2000, NAT NEUROSCI, V3, P1199, DOI 10.1038/81479; ROBINSON DA, 1963, IEEE T BIOMED ENG, V101, P131; Rollenhagen JE, 2000, SCIENCE, V287, P1506, DOI 10.1126/science.287.5457.1506; ROLLS ET, 1977, BRAIN RES, V130, P229, DOI 10.1016/0006-8993(77)90272-4; ROLLS ET, 1986, EXP BRAIN RES, V65, P38; RUBIN E, 1915, VISUELL WAHRGENOMMEE; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; SELZER B, 1978, BRAIN RES, V149, P1; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545	29	99	100	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	SEP	2001	4	9					937	942		10.1038/nn0901-937	http://dx.doi.org/10.1038/nn0901-937			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	467JL	11528426				2022-12-24	WOS:000170698600021
J	Maril, A; Wagner, AD; Schacter, DL				Maril, A; Wagner, AD; Schacter, DL			On the tip of the tongue: An event-related fMRI study of semantic retrieval failure and cognitive conflict	NEURON			English	Article							INFERIOR PREFRONTAL CORTEX; ANTERIOR CINGULATE CORTEX; POSITRON EMISSION TOMOGRAPHY; EPISODIC MEMORY RETRIEVAL; FUNCTIONAL MRI; RECOGNITION; ANATOMY; STROOP	The tip of the tongue (TOT) state refers to a temporary inaccessibility of information that one is sure exists in long-term memory and is on the verge of recovering. Using event-related fMRI, we assessed the neural correlates of this semantic retrieval failure to determine whether the anterior cingulate-lateral prefrontal neural circuit posited to mediate conflict resolution is engaged during metacognitive conflicts that arise during the TOT. Results revealed that, relative to successful retrieval or unsuccessful retrieval not accompanied by a TOT, retrieval failures accompanied by TOTs elicited a selective response in anterior cingulate-prefrontal cortices. During a TOT, cognitive control mechanisms may be recruited in attempts to resolve the conflict and retrieval failure that characterize this state.	Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Massachusetts Gen Hosp, Nucl Magnet Resonance Ctr, Charlestown, MA 02129 USA	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital	Maril, A (corresponding author), Harvard Univ, Dept Psychol, 33 Kirkland St, Cambridge, MA 02138 USA.			Wagner, Anthony/0000-0003-0624-4543; Schacter, Daniel/0000-0002-2460-6061	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG008441, R37AG008441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R03DC004466] Funding Source: NIH RePORTER; NIA NIH HHS [AG08441] Funding Source: Medline; NIDCD NIH HHS [DC04466] Funding Source: Medline; NIMH NIH HHS [MH60941] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Awh E, 1998, ATTENTIVE BRAIN, P353; Barch DM, 2000, J COGNITIVE NEUROSCI, V12, P298, DOI 10.1162/089892900562110; BROWN AS, 1991, PSYCHOL BULL, V109, P204, DOI 10.1037/0033-2909.109.2.204; BROWN R, 1966, J VERB LEARN VERB BE, V5, P325, DOI 10.1016/S0022-5371(66)80040-3; BURKE D, 1991, J MEM LANG, V30, P237; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cocosco C. A., 1997, NEUROIMAGE, V5, P425; COHEN G, 1986, BRIT J DEV PSYCHOL, V4, P187, DOI 10.1111/j.2044-835X.1986.tb01010.x; Cohen JD, 2000, NAT NEUROSCI, V3, P421, DOI 10.1038/74783; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; DEMB JB, 1995, J NEUROSCI, V15, P5870; Fiez JA, 1997, HUM BRAIN MAPP, V5, P79, DOI 10.1002/(SICI)1097-0193(1997)5:2<79::AID-HBM1>3.3.CO;2-M; Gabrieli JDE, 1996, PSYCHOL SCI, V7, P278, DOI 10.1111/j.1467-9280.1996.tb00374.x; Gehring WJ, 2000, NAT NEUROSCI, V3, P516, DOI 10.1038/74899; Henson RNA, 1999, J NEUROSCI, V19, P3962; Henson RNA, 1999, BRAIN, V122, P1367, DOI 10.1093/brain/122.7.1367; Henson RNA, 2000, J COGNITIVE NEUROSCI, V12, P913, DOI 10.1162/08989290051137468; James W, 1890, PRINCIPLES PSYCHOL, V1; JONES GV, 1987, COGNITION, V26, P115, DOI 10.1016/0010-0277(87)90027-8; KAPUR S, 1994, NEUROREPORT, V5, P2193, DOI 10.1097/00001756-199410270-00051; KORIAT A, 1974, MEM COGNITION, V2, P647, DOI 10.3758/BF03198134; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; McIntosh AR, 1997, HUM BRAIN MAPP, V5, P323, DOI 10.1002/(SICI)1097-0193(1997)5:4<323::AID-HBM20>3.0.CO;2-D; Miozzo M., 1997, J EXPT PSYCHOL LEARN, V23, P1; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Poldrack RA, 1999, NEUROIMAGE, V10, P15, DOI 10.1006/nimg.1999.0441; Price CJ, 1997, J COGNITIVE NEUROSCI, V9, P727, DOI 10.1162/jocn.1997.9.6.727; Reason J. T., 1984, EVERYDAY MEMORY ACTI, P53; RUBIN DC, 1975, J VERB LEARN VERB BE, V14, P392, DOI 10.1016/S0022-5371(75)80018-1; Rugg MD, 1996, BRAIN, V119, P2073, DOI 10.1093/brain/119.6.2073; Schacter D. L., 2001, 7 SINS MEMORY MIND F; Schacter DL, 1999, AM PSYCHOL, V54, P182, DOI 10.1037/0003-066X.54.3.182; Schacter DL, 1997, NEUROIMAGE, V6, P259, DOI 10.1006/nimg.1997.0305; Schwartz BL, 1999, PSYCHON B REV, V6, P379, DOI 10.3758/BF03210827; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Vigliocco G, 1997, PSYCHOL SCI, V8, P314, DOI 10.1111/j.1467-9280.1997.tb00444.x; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Wagner AD, 2001, NEURON, V31, P329, DOI 10.1016/S0896-6273(01)00359-2; Wagner AD, 1999, NEURON, V22, P19, DOI 10.1016/S0896-6273(00)80674-1; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188	45	101	105	0	24	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 30	2001	31	4					653	660		10.1016/S0896-6273(01)00396-8	http://dx.doi.org/10.1016/S0896-6273(01)00396-8			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	468LM	11545723	Bronze			2022-12-24	WOS:000170759200018
J	Tao, HZW; Zhang, LI; Engert, F; Poo, MM				Tao, HZW; Zhang, LI; Engert, F; Poo, MM			Emergence of input specificity of LTP during development of retinotectal connections in vivo	NEURON			English	Article							LONG-TERM POTENTIATION; DEPENDENT SYNAPTIC PLASTICITY; HIPPOCAMPAL PYRAMIDAL NEURONS; PROPAGATING ACTION-POTENTIALS; GATED CA2+ CHANNELS; DENDRITIC SPINES; NMDA RECEPTORS; CALCIUM INFLUX; NEURAL NETWORKS; SLICE CULTURES	Input specificity of activity-induced synaptic modification was examined in the developing Xenopus retinotectal connections. Early in development, long-term potentiation (LTP) induced by theta burst stimulation (TBS) at one retinal input spreads to other unstimulated converging inputs on the same tectal neuron. As the animal develops, LTP induced by the same TBS becomes input specific, a change that correlates with the increased complexity of tectal dendrites, and more restricted distribution of dendritic Ca2+ evoked by each retinal input. In contrast, LTP induced by 1 Hz correlated pre- and postsynaptic spiking is input specific throughout the same developmental period. Thus, input specificity of LTP emerges with neural development and depends on the pattern of synaptic activity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.		Tao, Huizhong W/HDM-9767-2022		NINDS NIH HHS [NS 36999] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036999] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALFORD S, 1993, J PHYSIOL-LONDON, V469, P693, DOI 10.1113/jphysiol.1993.sp019838; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BONHOEFFER T, 1989, P NATL ACAD SCI USA, V86, P8113, DOI 10.1073/pnas.86.20.8113; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; Cash S, 1996, SCIENCE, V272, P998, DOI 10.1126/science.272.5264.998; Chen CF, 2000, NEURON, V28, P955, DOI 10.1016/S0896-6273(00)00166-5; Debanne D, 1998, J PHYSIOL-LONDON, V507, P237, DOI 10.1111/j.1469-7793.1998.237bu.x; Emptage N, 1999, NEURON, V22, P115, DOI 10.1016/S0896-6273(00)80683-2; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; Fitzsimonds RM, 1997, NATURE, V388, P439, DOI 10.1038/41267; Flint AC, 1997, J NEUROSCI, V17, P2469; Goda Y, 1998, P NATL ACAD SCI USA, V95, P1283, DOI 10.1073/pnas.95.3.1283; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIRKWOOD A, 1995, NATURE, V375, P328, DOI 10.1038/375328a0; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335, DOI 10.1152/jn.1995.74.3.1335; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALINOW R, 1994, P NATL ACAD SCI USA, V91, P8170, DOI 10.1073/pnas.91.17.8170; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; McMahon LL, 1997, NEURON, V18, P295, DOI 10.1016/S0896-6273(00)80269-X; MIYAKAWA H, 1992, NEURON, V9, P1163, DOI 10.1016/0896-6273(92)90074-N; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Neveu D, 1996, J NEUROPHYSIOL, V75, P2157, DOI 10.1152/jn.1996.75.5.2157; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Nishiyama M, 2000, NATURE, V408, P584, DOI 10.1038/35046067; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; PETROZZINO JJ, 1995, NEURON, V14, P1223, DOI 10.1016/0896-6273(95)90269-4; Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; REGEHR WG, 1990, NATURE, V345, P807, DOI 10.1038/345807a0; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Tao HZW, 2000, J NEUROSCI, V20, P3233, DOI 10.1523/JNEUROSCI.20-09-03233.2000; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Wu GY, 1999, J NEUROSCI, V19, P4472; YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0; Yuste R, 1999, J NEUROSCI, V19, P1976; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665; Zhang LI, 2000, NAT NEUROSCI, V3, P708, DOI 10.1038/76665; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	54	55	57	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 30	2001	31	4					569	580		10.1016/S0896-6273(01)00393-2	http://dx.doi.org/10.1016/S0896-6273(01)00393-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	468LM	11545716	Bronze			2022-12-24	WOS:000170759200011
J	Personius, KE; Balice-Gordon, RJ				Personius, KE; Balice-Gordon, RJ			Loss of correlated motor neuron activity during synaptic competition at developing neuromuscular synapses	NEURON			English	Article							SOLEUS MUSCLE; NEONATAL RAT; MOTONEURON ACTIVITY; AXON WITHDRAWAL; SKELETAL-MUSCLE; SPINAL-CORD; UNIT SIZE; ELIMINATION; JUNCTIONS; STRENGTH	During late stages of neural development, synaptic circuitry is edited by neural activity. At neuromuscular synapses, the transition from multiple to single innervation is modulated by the relative pattern of activity among inputs competing for innervation of the same muscle fiber. While experimental perturbations of activity result in marked changes in the timing of neuromuscular synaptic competition, little is known about the patterns of activity present during normal development. Here, we report the temporal patterning of motor unit activity in the soleus muscle of awake, behaving neonatal mice, and that patterning is modulated by gap-junctional coupling. Our work suggests that neuromuscular synaptic competition is modulated by surprisingly low levels of activity and may be triggered by the disappearance of temporally correlated activity among inputs competing for innervation of the same muscle fiber.	Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA	University of Pennsylvania	Balice-Gordon, RJ (corresponding author), Univ Penn, Sch Med, Dept Neurosci, 215 Stemmler Hall, Philadelphia, PA 19104 USA.		PERSONIUS, KIRKWOOD/AAG-2294-2019	Balice-Gordon, Rita/0000-0002-9950-7965	NINDS NIH HHS [NS38517, NS10937] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038517] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BALICEGORDON RJ, 1994, NATURE, V372, P519, DOI 10.1038/372519a0; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Brocard F, 1999, DEV BRAIN RES, V117, P81, DOI 10.1016/S0165-3806(99)00101-7; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; BUFFELLI M, 2000, SOC NEUR ABSTR, V26, P1091; Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000; CALLAWAY EM, 1987, NATURE, V328, P422, DOI 10.1038/328422a0; Chang Q, 1999, J NEUROSCI, V19, P10813, DOI 10.1523/JNEUROSCI.19-24-10813.1999; Clarac F, 1998, BRAIN RES REV, V28, P35, DOI 10.1016/S0165-0173(98)00024-1; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; Costanzo EM, 2000, NAT NEUROSCI, V3, P694, DOI 10.1038/76649; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; Eken T, 1998, J NEUROPHYSIOL, V80, P365, DOI 10.1152/jn.1998.80.1.365; ELLAWAY PH, 1985, Q J EXP PHYSIOL CMS, V70, P219, DOI 10.1113/expphysiol.1985.sp002905; ELLAWAY PH, 1978, ELECTROEN CLIN NEURO, V45, P302, DOI 10.1016/0013-4694(78)90017-2; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FLADBY T, 1987, ACTA PHYSIOL SCAND, V129, P229, DOI 10.1111/j.1748-1716.1987.tb08063.x; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; JELLINCK PH, 1993, J STEROID BIOCHEM, V46, P209, DOI 10.1016/0960-0760(93)90296-9; Kopp DM, 2000, J NEUROSCI, V20, P8771; KUDO N, 1987, J PHYSIOL-LONDON, V389, P441, DOI 10.1113/jphysiol.1987.sp016665; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; LOGIGIAN EL, 1988, ANN NEUROL, V23, P242, DOI 10.1002/ana.410230306; Milner LD, 1999, J NEUROSCI, V19, P3007; NORDSTROM MA, 1992, J PHYSIOL-LONDON, V453, P547, DOI 10.1113/jphysiol.1992.sp019244; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; RIBCHESTER RR, 1993, J PHYSIOL-LONDON, V466, P421; RIBCHESTER RR, 1983, J PHYSIOL-LONDON, V344, P89, DOI 10.1113/jphysiol.1983.sp014926; RIDGE RMAP, 1984, J NEUROSCI, V4, P2614; SEARS TA, 1976, J PHYSIOL-LONDON, V263, P357, DOI 10.1113/jphysiol.1976.sp011635; SOILEAU LC, 1987, J NEUROSCI, V7, P4176; THOMPSON W, 1983, NATURE, V302, P614, DOI 10.1038/302614a0; THOMPSON WJ, 1985, CELL MOL NEUROBIOL, V5, P167, DOI 10.1007/BF00711091; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; WESTERGA J, 1994, DEV BRAIN RES, V80, P233, DOI 10.1016/0165-3806(94)90108-2; WESTERGA J, 1993, EXP BRAIN RES, V92, P479; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong WT, 1998, J NEUROSCI, V18, P8839; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	40	81	81	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					395	408		10.1016/S0896-6273(01)00369-5	http://dx.doi.org/10.1016/S0896-6273(01)00369-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516397	Bronze			2022-12-24	WOS:000170601000009
J	Parri, HR; Gould, TM; Crunelli, V				Parri, HR; Gould, TM; Crunelli, V			Spontaneous astrocytic Ca2+ oscillations in situ drive NMDAR-mediated neuronal excitation	NATURE NEUROSCIENCE			English	Article							CULTURED HIPPOCAMPAL-NEURONS; DEPENDENT GLUTAMATE RELEASE; GLIAL CALCIUM WAVES; SYNAPTIC TRANSMISSION; POSTNATAL-DEVELOPMENT; REGIONAL EXPRESSION; RAT-BRAIN; IN-SITU; RECEPTORS; CELLS	Astrocytes respond to chemical, electrical and mechanical stimuli with transient increases in intracellular calcium concentration ([Ca2+](i)). We now show that astrocytes in situ display intrinsic [Ca2+](i) oscillations that are not driven by neuronal activity. These spontaneous astrocytic oscillations can propagate as waves to neighboring astrocytes and trigger slowly decaying NMDA receptor-mediated inward currents in neurons located along the wave path. These findings show that astrocytes in situ can act as a primary source for generating neuronal activity in the mammalian central nervous system.	Cardiff Univ, Sch Biosci, Cardiff CF10 3US, S Glam, Wales	Cardiff University	Crunelli, V (corresponding author), Cardiff Univ, Sch Biosci, Museum Ave,POB 911, Cardiff CF10 3US, S Glam, Wales.	crunelli@cardiff.ac.uk	Crunelli, Vincenzo/A-7258-2010; Parri, Rheinallt/D-1748-2013	Crunelli, Vincenzo/0000-0001-7154-9752; Parri, Rheinallt/0000-0002-1412-2688				Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; Araque A, 1998, J NEUROSCI, V18, P6822; Araque A, 1998, EUR J NEUROSCI, V10, P2129, DOI 10.1046/j.1460-9568.1998.00221.x; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Carmignoto G, 2000, PROG NEUROBIOL, V62, P561, DOI 10.1016/S0301-0082(00)00029-0; Catalano SM, 1998, SCIENCE, V281, P559, DOI 10.1126/science.281.5376.559; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; CHARLES AC, 1994, DEV NEUROSCI-BASEL, V16, P196, DOI 10.1159/000112107; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; DANI JW, 1992, NEURON, V8, P429, DOI 10.1016/0896-6273(92)90271-E; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; FINKBEINER SM, 1993, GLIA, V9, P83, DOI 10.1002/glia.440090202; Giaume C, 1998, GLIA, V24, P50, DOI 10.1002/(SICI)1098-1136(199809)24:1<50::AID-GLIA6>3.0.CO;2-4; Golshani P, 1998, J NEUROPHYSIOL, V80, P143, DOI 10.1152/jn.1998.80.1.143; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; GU XN, 1995, NATURE, V375, P784, DOI 10.1038/375784a0; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; HASSINGER TD, 1995, J NEUROBIOL, V28, P159, DOI 10.1002/neu.480280204; Innocenti B, 2000, J NEUROSCI, V20, P1800; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LITTLE JDC, 1969, OPER RES, V17, P1, DOI 10.1287/opre.17.1.1; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; Misra C, 2000, J PHYSIOL-LONDON, V525, P299, DOI 10.1111/j.1469-7793.2000.t01-1-00299.x; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Newman EA, 1998, J NEUROSCI, V18, P4022; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parri HR, 1998, J NEUROSCI, V18, P854; Pasti L, 1997, J NEUROSCI, V17, P7817; PERKEL DJ, 1993, NEURON, V11, P817, DOI 10.1016/0896-6273(93)90111-4; PORTER JT, 1995, GLIA, V13, P101, DOI 10.1002/glia.440130204; Rajan I, 1998, J NEUROSCI, V18, P7836; Rakic Pasko, 1994, Current Opinion in Neurobiology, V4, P63, DOI 10.1016/0959-4388(94)90033-7; SCHNITZER J, 1981, J CELL BIOL, V90, P435, DOI 10.1083/jcb.90.2.435; SILVER J, 1982, J COMP NEUROL, V210, P10, DOI 10.1002/cne.902100103; SPREAFICO R, 1994, DEV BRAIN RES, V82, P231, DOI 10.1016/0165-3806(94)90166-X; TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359; Velazquez JLP, 1996, DEV BRAIN RES, V91, P164; Wenzel A, 1996, J NEUROCHEM, V66, P1240; Wyllie DJA, 1998, J PHYSIOL-LONDON, V510, P1, DOI 10.1111/j.1469-7793.1998.001bz.x; YUSTE R, 1992, SCIENCE, V257, P666, DOI 10.1126/science.1496379; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zantua JB, 1996, SOMATOSENS MOT RES, V13, P307, DOI 10.3109/08990229609052585	48	459	475	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					803	812		10.1038/90507	http://dx.doi.org/10.1038/90507			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477426				2022-12-24	WOS:000170137300013
J	Umilta, MA; Kohler, E; Gallese, V; Fogassi, L; Fadiga, L; Keysers, C; Rizzolatti, G				Umilta, MA; Kohler, E; Gallese, V; Fogassi, L; Fadiga, L; Keysers, C; Rizzolatti, G			I know what you are doing: A neurophysiological study	NEURON			English	Article							PREMOTOR CORTEX; FUNCTIONAL-ORGANIZATION; INFERIOR AREA-6; MACAQUE MONKEY; NEURONS; RECOGNITION; MOVEMENTS; DISTAL	In the ventral premotor cortex of the macaque monkey, there are neurons that discharge both during the execution of hand actions and during the observation of the same actions made by others (mirror neurons). In the present study, we show that a subset of mirror neurons becomes active during action presentation and also when the final part of the action, crucial in triggering the response in full vision, is hidden and can therefore only be inferred. This implies that the motor representation of an action performed by others can be internally generated in the observer's premotor cortex, even when a visual description of the action is lacking. The present findings support the hypothesis that mirror neuron activation could be at the basis of action recognition.	Univ Parma, Ist Fisiol Umana, I-43100 Parma, Italy; Dipartimento Psicol, I-43100 Parma, Italy	University of Parma	Rizzolatti, G (corresponding author), Univ Parma, Ist Fisiol Umana, Via Volturno 39, I-43100 Parma, Italy.	fisioum@symbolic.pr.it	Keysers, Christian/H-6251-2013; Fadiga, Luciano/AAC-7404-2022; Gallese, Vittorio/ABD-5097-2021; FOGASSI, Leonardo/K-3541-2018	Keysers, Christian/0000-0002-2845-5467; Gallese, Vittorio/0000-0003-4815-3607; Umilta', Maria Alessandra/0000-0003-0180-6818; FOGASSI, Leonardo/0000-0003-3348-039X; fadiga, luciano/0000-0001-5691-5080				ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; BACH M, 1983, J NEUROSCI METH, V9, P9, DOI 10.1016/0165-0270(83)90103-6; BAKER CI, 2001, IN PRESS EXP BRAIN R; CAREY DP, 1997, HANDB NEUR, V11, P111; Filion CM, 1996, J COMP PSYCHOL, V110, P386, DOI 10.1037/0735-7036.110.4.386; Fogassi L, 1996, J NEUROPHYSIOL, V76, P141, DOI 10.1152/jn.1996.76.1.141; Fogassi L, 2001, BRAIN, V124, P571, DOI 10.1093/brain/124.3.571; Fuster J.M., 1989, PREFRONTAL CORTEX; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; GENTILUCCI M, 1983, EXP BRAIN RES, V50, P464; GENTILUCCI M, 1988, EXP BRAIN RES, V71, P475, DOI 10.1007/BF00248741; Gibson JJ, 1979, ECOLOGICAL APPROACH; Goldman-Rakic P. S., 2011, COMPR PHYSIOL, DOI [10.1002/CPHY.CP010509, DOI 10.1002/CPHY.CP010509]; Graziano MSA, 1997, SCIENCE, V277, P239, DOI 10.1126/science.277.5323.239; Graziano MSA, 1997, J NEUROPHYSIOL, V77, P2268, DOI 10.1152/jn.1997.77.5.2268; HEPPREYMOND MC, 1994, CAN J PHYSIOL PHARM, V72, P571, DOI 10.1139/y94-081; KURATA K, 1986, J NEUROSCI, V6, P403; MATELLI M, 1985, BEHAV BRAIN RES, V18, P125, DOI 10.1016/0166-4328(85)90068-3; Michotte A. E, 1963, PERCEPTION CAUSALITY; Murata A, 1996, J NEUROPHYSIOL, V75, P2180, DOI 10.1152/jn.1996.75.5.2180; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; RIZZOLATTI G, 1990, EXP BRAIN RES, V82, P337; RIZZOLATTI G, 1981, BRAIN RES, V225, P421, DOI 10.1016/0006-8993(81)90847-7; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G., 2000, NEW COGNITIVE NEUROS, P539	25	745	770	0	96	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2001	31	1					155	165		10.1016/S0896-6273(01)00337-3	http://dx.doi.org/10.1016/S0896-6273(01)00337-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498058	Bronze			2022-12-24	WOS:000170101100018
J	Aston-Jones, G; Chen, S; Zhu, Y; Oshinsky, ML				Aston-Jones, G; Chen, S; Zhu, Y; Oshinsky, ML			A neural circuit for circadian regulation of arousal	NATURE NEUROSCIENCE			English	Article							NUCLEUS LOCUS-CERULEUS; SUPRACHIASMATIC NUCLEUS; EFFERENT PROJECTIONS; PSEUDORABIES VIRUS; COERULEUS; SLEEP; ACTIVATION; RAT; RETROGRADE; TRANSPORT	An unknown aspect of behavioral state regulation is how the circadian oscillator of the suprachiasmatic nucleus (SCN) regulates sleep and waking. In this report, we describe the necessary elements for a circuit that provides circadian regulation of arousal. Trans-synaptic retrograde tracing revealed a prominent indirect projection from the SCN to the noradrenergic nucleus locus coeruleus (LC), a brain arousal system. Double-labeling experiments revealed several possible links between the SCN and the LC, including the dorsomedial (DMH) and paraventricular hypothalamic nuclei (PVN), as well as medial and ventrolateral pre-optic areas. Lesion studies confirmed that the DMH is a substantial relay in this circuit. Next, neurophysiology experiments revealed circadian variations in LC impulse activity. Lesions of the DMH eliminated these circadian changes in LC activity, confirming the functionality of the SCN-DMH-LC circuit. These results reveal mechanisms for regulation of circadian and sleep-waking functions.	Univ Penn, Sch Med, Dept Psychiat, VAMC, Philadelphia, PA 19104 USA	University of Pennsylvania	Aston-Jones, G (corresponding author), Univ Penn, Sch Med, Dept Psychiat, VAMC, 151,Univ & Woodland Ave, Philadelphia, PA 19104 USA.	gaj@mail.med.upenn.edu		Oshinsky, Michael/0000-0002-0976-1047	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024698] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24698] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; AGHAJANIAN GK, 1975, BRAIN RES, V88, P221, DOI 10.1016/0006-8993(75)90386-8; Aston-Jones G, 2000, J NEUROSCI METH, V103, P51, DOI 10.1016/S0165-0270(00)00295-8; Aston-Jones G, 2000, PROG BRAIN RES, V126, P165; Aston-Jones Gary, 1995, P183; ASTONJONES G, 1986, SCIENCE, V234, P734, DOI 10.1126/science.3775363; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BERNARDIS LL, 1985, BRAIN RES BULL, V14, P537, DOI 10.1016/0361-9230(85)90103-0; Bernardis LL, 1998, P SOC EXP BIOL MED, V218, P284; BERRIDGE CW, 1991, J NEUROSCI, V11, P3135; Berridge CW, 2000, NEUROSCIENCE, V99, P495, DOI 10.1016/S0306-4522(00)00215-3; Berry MW, 1999, COMPUT SCI ENG, V1, P16, DOI 10.1109/MCISE.1999.774836; Billig I, 1999, BRAIN RES, V820, P31, DOI 10.1016/S0006-8993(98)01320-1; Buijs RM, 1996, PROG BRAIN RES, V111, P229, DOI 10.1016/S0079-6123(08)60411-2; Card JP, 1998, J VIROL, V72, P4434, DOI 10.1128/JVI.72.5.4434-4441.1998; CARD JP, 1993, J NEUROSCI, V13, P2515, DOI 10.1523/JNEUROSCI.13-06-02515.1993; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chen S, 1999, BRAIN RES, V838, P171, DOI 10.1016/S0006-8993(99)01680-7; Chen S, 1996, NEUROSCIENCE, V71, P443, DOI 10.1016/0306-4522(95)00437-8; DEVAUGES V, 1991, BEHAV BRAIN RES, V43, P93, DOI 10.1016/S0166-4328(05)80056-7; EDGAR DM, 1993, J NEUROSCI, V13, P1065; ENNIS M, 1988, J NEUROSCI, V8, P3644; FOOTE SL, 1983, PHYSIOL REV, V63, P844, DOI 10.1152/physrev.1983.63.3.844; Gillette MU, 1999, RECENT PROG HORM RES, V54, P33; Hagan JJ, 1999, P NATL ACAD SCI USA, V96, P10911, DOI 10.1073/pnas.96.19.10911; HOBSON JA, 1975, SCIENCE, V189, P55, DOI 10.1126/science.1094539; Horvath TL, 1999, J COMP NEUROL, V415, P145; Ivanov A, 2000, NEUROREPORT, V11, P1755, DOI 10.1097/00001756-200006050-00031; Jasmin L, 1997, J NEUROSCI, V17, P3751; Jodo E, 1998, NEUROSCIENCE, V83, P63, DOI 10.1016/S0306-4522(97)00372-2; Johnson M P, 1992, J Sleep Res, V1, P24; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; LUPPI PH, 1995, NEUROSCIENCE, V65, P119, DOI 10.1016/0306-4522(94)00481-J; MORIN LP, 1994, NEUROSCIENCE, V61, P391, DOI 10.1016/0306-4522(94)90240-2; ODonnell P, 1997, J NEUROSCI, V17, P2143; Peyron C, 1998, J NEUROSCI, V18, P9996; Robbins Trevor W., 1995, P363; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; SEMBA J, 1984, SLEEP, V7, P211, DOI 10.1093/sleep/7.3.211; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; STERIADE M, 1987, J NEUROPHYSIOL, V57, P260, DOI 10.1152/jn.1987.57.1.260; Swanson L. W., 1992, BRAIN MAPS STRUCTURE; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; WATTS AG, 1987, J COMP NEUROL, V258, P204, DOI 10.1002/cne.902580204; WEITZMAN ED, 1981, ANNU REV NEUROSCI, V4, P381, DOI 10.1146/annurev.ne.04.030181.002121; Wirz-Justice A, 1999, BIOL PSYCHIAT, V46, P445, DOI 10.1016/S0006-3223(99)00125-0	48	402	411	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JUL	2001	4	7					732	738		10.1038/89522	http://dx.doi.org/10.1038/89522			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	448HK	11426230				2022-12-24	WOS:000169621300019
J	Keat, J; Reinagel, P; Reid, RC; Meister, M				Keat, J; Reinagel, P; Reid, RC; Meister, M			Predicting every spike: A model for the responses of visual neurons	NEURON			English	Article							RETINAL GANGLION-CELLS; NONLINEAR CASCADE MODEL; INSECT SENSORY NEURON; SIGNAL TRANSMISSION; RECEPTIVE-FIELD; CATFISH RETINA; PRECISION; DYNAMICS; CORTEX; VARIABILITY	In the early visual system, neuronal responses can be extremely precise. Under a wide range of stimuli, cells in the retina and thalamus fire spikes very reproducibly, often with millisecond precision on subsequent stimulus repeats. Here we develop a mathematical description of the firing process that, given the recent visual input, accurately predicts the timing of individual spikes. The formalism is successful in matching the spike trains from retinal ganglion cells in salamander, rabbit, and cat, as well as from lateral geniculate nucleus neurons in cat. It adapts to many different response types, from very precise to highly variable. The accuracy of the model allows a compact description of how these neurons encode the visual stimulus.	Harvard Univ, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard Medical School	Meister, M (corresponding author), Harvard Univ, 16 Divin Ave, Cambridge, MA 02138 USA.	meister@biosun.harvard.edu	Reinagel, Pamela/ABI-7659-2020	Reinagel, Pamela/0000-0002-6338-2611; Meister, Markus/0000-0003-2136-6506	NATIONAL EYE INSTITUTE [R01EY010115, R01EY010020, P30EY012196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007009] Funding Source: NIH RePORTER; NEI NIH HHS [EY10115, EY10020, EY12196] Funding Source: Medline; NINDS NIH HHS [NS07009] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P107; Benardete EA, 1997, VISUAL NEUROSCI, V14, P187, DOI 10.1017/S0952523800008865; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berry MJ, 1998, J NEUROSCI, V18, P2200; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; Clifford CWG, 2000, VISUAL NEUROSCI, V17, P207, DOI 10.1017/S0952523800172037; Dan Y, 1996, J NEUROSCI, V16, P3351; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; ENROTHCUGELL C, 1966, J PHYSIOL-LONDON, V187, P517, DOI 10.1113/jphysiol.1966.sp008107; FOHLMEISTER JF, 1977, J GEN PHYSIOL, V69, P815, DOI 10.1085/jgp.69.6.815; FRENCH AS, 1989, BIOPHYS J, V55, P655, DOI 10.1016/S0006-3495(89)82863-2; FRENCH AS, 1991, ANN BIOMED ENG, V19, P473, DOI 10.1007/BF02584321; HOCHSTEIN S, 1976, J PHYSIOL-LONDON, V262, P265, DOI 10.1113/jphysiol.1976.sp011595; Humayun MS, 1999, VISION RES, V39, P2569, DOI 10.1016/S0042-6989(99)00052-8; HUNTER IW, 1986, BIOL CYBERN, V55, P135; Kara P, 2000, NEURON, V27, P635, DOI 10.1016/S0896-6273(00)00072-6; Kistler WM, 1997, NEURAL COMPUT, V9, P1015, DOI 10.1162/neco.1997.9.5.1015; KNIGHT BW, 1972, J GEN PHYSIOL, V59, P734, DOI 10.1085/jgp.59.6.734; KONDOH Y, 1991, J COMP PHYSIOL A, V169, P653; KORENBERG MJ, 1988, BIOL CYBERN, V58, P313, DOI 10.1007/BF00363940; LANKHEET MJM, 1989, VISION RES, V29, P505, DOI 10.1016/0042-6989(89)90037-0; Marmarelis P.Z., 1978, ANAL PHYSL SYSTEMS W; Meister M, 1999, NEURON, V22, P435, DOI 10.1016/S0896-6273(00)80700-X; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Press W. H., 1992, ART SCI COMPUTING; Reich DS, 1998, J NEUROSCI, V18, P10090; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Rieke F., 1997, SPIKES EXPLORING NEU; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; SAKAI HM, 1987, J NEUROPHYSIOL, V58, P1329, DOI 10.1152/jn.1987.58.6.1329; SAKAI HM, 1988, VISUAL NEUROSCI, V1, P287, DOI 10.1017/S0952523800001942; SAKAI HM, 1995, J GEN PHYSIOL, V105, P795, DOI 10.1085/jgp.105.6.795; SAKURANAGA M, 1985, J NEUROPHYSIOL, V53, P411, DOI 10.1152/jn.1985.53.2.411; SAKURANAGA M, 1987, J GEN PHYSIOL, V90, P229, DOI 10.1085/jgp.90.2.229; Shadlen Michael N., 1994, Current Opinion in Neurobiology, V4, P569, DOI 10.1016/0959-4388(94)90059-0; SMIMAKIS SM, 1997, NATURE, V386, P69; Usrey WM, 1999, J NEUROPHYSIOL, V82, P3527, DOI 10.1152/jn.1999.82.6.3527; VANSTEVENINCK RD, 1988, PROC R SOC SER B-BIO, V234, P379; VICTOR J, 1980, BIOPHYS J, V29, P459, DOI 10.1016/S0006-3495(80)85146-0; VICTOR JD, 1979, J GEN PHYSIOL, V74, P671, DOI 10.1085/jgp.74.6.671; VICTOR JD, 1987, J PHYSIOL-LONDON, V386, P219, DOI 10.1113/jphysiol.1987.sp016531; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310; Vinje WE, 2000, SCIENCE, V287, P1273, DOI 10.1126/science.287.5456.1273; Warland DK, 1997, J NEUROPHYSIOL, V78, P2336, DOI 10.1152/jn.1997.78.5.2336; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447	49	245	252	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUN	2001	30	3					803	817		10.1016/S0896-6273(01)00322-1	http://dx.doi.org/10.1016/S0896-6273(01)00322-1			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	446HY	11430813	Bronze			2022-12-24	WOS:000169508900020
J	Yang, X; Arber, S; William, C; Li, L; Tanabe, Y; Jessell, TM; Birchmeier, C; Burden, SJ				Yang, X; Arber, S; William, C; Li, L; Tanabe, Y; Jessell, TM; Birchmeier, C; Burden, SJ			Patterning of muscle acetylcholine receptor gene expression in the absence of motor innervation	NEURON			English	Article							NEUROMUSCULAR-JUNCTION FORMATION; TYROSINE KINASE MUSK; IN-VIVO; DROSOPHILA EMBRYO; MUTANT MICE; AGRIN; NEUREGULINS; SYNAPSES; CELLS; CLUSTERS	The patterning of skeletal muscle is thought to depend upon signals provided by motor neurons. We show that AChR gene expression and AChR clusters are concentrated in the central region of embryonic skeletal muscle in the absence of innervation. Neurally derived Ag rin is dispensable for this early phase of AChR expression, but MuSK, a receptor tyrosine kinase activated by Agrin, is required to establish this AChR prepattern. The zone of AChR expression in muscle lacking motor axons is wider than normal, indicating that neural signals refine this muscle-autonomous prepattern. Neuronal Neuregulin-1, however, is not involved in this refinement process, nor indeed in synapse-specific AChR gene expression. Our results demonstrate that AChR expression is patterned in the absence of innervation, raising the possibility that similarly prepatterned muscle-derived cues restrict axon growth and initiate synapse formation.	NYU, Sch Med, Skirball Inst, Mol Neurobiol Program, New York, NY 10011 USA; Columbia Univ, Dept Biochem & Mol Biophys, Howard Hughes Med Inst, New York, NY 10032 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	New York University; Columbia University; Howard Hughes Medical Institute; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Burden, SJ (corresponding author), NYU, Sch Med, Skirball Inst, Mol Neurobiol Program, New York, NY 10011 USA.		Tuluc, Petronel/C-2527-2011	Arber, Silvia/0000-0002-6261-250X; Burden, Steven/0000-0002-3550-6891	NINDS NIH HHS [R01 NS041311-02, NS27963, R01 NS041311, R01 NS036193, NS36193, R01 NS036193-02] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036193, R01NS027963, R01NS041311, R01NS036193] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880; Apel ED, 1997, NEURON, V18, P623, DOI 10.1016/S0896-6273(00)80303-7; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BRAITHWAITE AW, 1979, NATURE, V279, P549, DOI 10.1038/279549a0; BROADIE K, 1993, NATURE, V361, P350, DOI 10.1038/361350a0; Brown A, 2000, CELL, V102, P77, DOI 10.1016/S0092-8674(00)00012-X; Burden S, 1997, NEURON, V18, P847, DOI 10.1016/S0896-6273(00)80324-4; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; CARRAWAY KL, 1995, CURR OPIN NEUROBIOL, V5, P606, DOI 10.1016/0959-4388(95)80065-4; COHEN MW, 1994, J NEUROSCI, V14, P3293; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; DENNIS MJ, 1981, ANNU REV NEUROSCI, V4, P43, DOI 10.1146/annurev.ne.04.030181.000355; DOHMANN C, 1990, GENE DEV, V4, P2098; FALLS DL, 1993, CELL, V72, P801, DOI 10.1016/0092-8674(93)90407-H; FERNS M, 1992, NEURON, V8, P1079, DOI 10.1016/0896-6273(92)90129-2; FERNS MJ, 1993, NEURON, V11, P491, DOI 10.1016/0896-6273(93)90153-I; FISCHBACH GD, 1973, DEV BIOL, V31, P147, DOI 10.1016/0012-1606(73)90326-6; Fischbach GD, 1997, ANNU REV NEUROSCI, V20, P429, DOI 10.1146/annurev.neuro.20.1.429; FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143; Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gillespie SKH, 1996, NEURON, V16, P953, DOI 10.1016/S0896-6273(00)80118-X; Glass DJ, 1997, CURR OPIN NEUROBIOL, V7, P379, DOI 10.1016/S0959-4388(97)80066-9; GOLDMAN D, 1989, NEURON, V3, P219, DOI 10.1016/0896-6273(89)90035-4; HALL ZW, 1993, CELL, V72, P99, DOI 10.1016/S0092-8674(05)80031-5; HARRIS A J, 1981, Philosophical Transactions of the Royal Society of London B Biological Sciences, V293, P287, DOI 10.1098/rstb.1981.0078; Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654; Knirr S, 1999, DEVELOPMENT, V126, P4525; Landgraf M, 1999, CURR BIOL, V9, P589, DOI 10.1016/S0960-9822(99)80262-0; LAUFER R, 1989, MOL NEUROBIOL, V3, P1, DOI 10.1007/BF02935587; Lee KJ, 2000, NATURE, V403, P734, DOI 10.1038/35001507; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; MA EB, 1995, J NEUROBIOL, V26, P585, DOI 10.1002/neu.480260411; MARTINOU JC, 1991, P NATL ACAD SCI USA, V88, P7667; MCMAHAN UJ, 1990, COLD SPRING HARB SYM, V55, P407; Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Morris JK, 1999, NEURON, V23, P273, DOI 10.1016/S0896-6273(00)80779-5; Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593; Rimer M, 1998, MOL CELL NEUROSCI, V12, P1, DOI 10.1006/mcne.1998.0695; Sandrock AW, 1997, SCIENCE, V276, P599, DOI 10.1126/science.276.5312.599; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SIMON AM, 1992, DEVELOPMENT, V114, P545; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; SYTKOWSKI AJ, 1973, P NATL ACAD SCI USA, V70, P270, DOI 10.1073/pnas.70.1.270; Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1; WALLACE BG, 1991, PHILOS T ROY SOC B, V331, P273, DOI 10.1098/rstb.1991.0016; Watty A, 2000, P NATL ACAD SCI USA, V97, P4585, DOI 10.1073/pnas.080061997; WILKINSON DG, 1992, IN SITU HYBRIDIZATIO; WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Wolpowitz D, 2000, NEURON, V25, P79, DOI 10.1016/S0896-6273(00)80873-9; Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131	54	370	380	1	20	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					399	410		10.1016/S0896-6273(01)00287-2	http://dx.doi.org/10.1016/S0896-6273(01)00287-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	436XW	11395002	Bronze			2022-12-24	WOS:000168962000013
J	Litt, B; Esteller, R; Echauz, J; D'Alessandro, M; Shor, R; Henry, T; Pennell, P; Epstein, C; Bakay, R; Dichter, M; Vachtsevanos, G				Litt, B; Esteller, R; Echauz, J; D'Alessandro, M; Shor, R; Henry, T; Pennell, P; Epstein, C; Bakay, R; Dichter, M; Vachtsevanos, G			Epileptic seizures may begin hours in advance of clinical onset: A report of five patients	NEURON			English	Article							INDUCED INTERICTAL DISCHARGES; CAT HIPPOCAMPUS; SPIKING; PATTERNS; FOCI; EPILEPTOGENESIS; EXCITABILITY; STIMULATION; MECHANISMS; TRANSITION	Mechanisms underlying seizure generation are traditionally thought to act over seconds to minutes before clinical seizure onset. We analyzed continuous 3- to 14-day intracranial EEG recordings from five patients with mesial temporal lobe epilepsy obtained during evaluation for epilepsy surgery. We found localized quantitative EEG changes identifying prolonged bursts of complex epileptiform discharges that became more prevalent 7 hr before seizures and highly localized subclinical seizure-like activity that became more frequent 2 hr prior to seizure onset. Accumulated energy increased in the 50 min before seizure onset, compared to baseline. These observations, from a small number of patients, suggest that epileptic seizures may begin as a cascade of electrophysiological events that evolve over hours and that quantitative measures of preseizure electrical activity could possibly be used to predict seizures far in advance of clinical onset.	Hosp Univ Penn, Dept Neurol & Bioengn, Philadelphia, PA 19104 USA; Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA; Univ Puerto Rico, Dept Elect & Comp Engn, Mayaguez, PR 00681 USA; Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; Univ Simon Bolivar, Dept Tecnol Ind, Caracas, Edo Miranda, Venezuela	University of Pennsylvania; Pennsylvania Medicine; University System of Georgia; Georgia Institute of Technology; University of Puerto Rico; University of Puerto Rico Mayaguez; Emory University; Emory University; Simon Bolivar University	Litt, B (corresponding author), Hosp Univ Penn, Dept Neurol & Bioengn, 3 W Gates,3400 Spruce St, Philadelphia, PA 19104 USA.	littb@mail.med.upenn.edu	Henry, Thomas/X-1756-2019	Henry, Thomas/0000-0002-5708-903X	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062298] Funding Source: NIH RePORTER; NIMH NIH HHS [MH-62298RO1] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bailey CH, 1996, P NATL ACAD SCI USA, V93, P13445, DOI 10.1073/pnas.93.24.13445; Burgess DL, 1999, EPILEPSY RES, V36, P111, DOI 10.1016/S0920-1211(99)00045-5; DASILVA FHL, 1994, PROG BRAIN RES, V102, P359; DICHTER M, 1969, J NEUROPHYSIOL, V32, P649, DOI 10.1152/jn.1969.32.5.649; DICHTER M, 1969, J NEUROPHYSIOL, V32, P663, DOI 10.1152/jn.1969.32.5.663; DICHTER MA, 1987, SCIENCE, V237, P157, DOI 10.1126/science.3037700; DICHTER MA, 1972, BRAIN RES, V48, P173, DOI 10.1016/0006-8993(72)90177-1; Eder HG, 1997, EPILEPSY RES, V29, P17, DOI 10.1016/S0920-1211(97)00061-2; Engel Jr J., 1987, SURG TREATMENT EPILE, P553; Fanselow EE, 2000, J NEUROSCI, V20, P8160; FEINDEL WILLIAM WILDER PENFIELD, 1952, TRANS AMER NEUROL ASSOC, V77, P14; Franaszczuk PJ, 1999, BIOL CYBERN, V81, P3, DOI 10.1007/s004220050540; GLANZ J, 1994, SCIENCE, V265, P1174, DOI 10.1126/science.8066457; Gluckman BJ, 2001, J NEUROSCI, V21, P590, DOI 10.1523/JNEUROSCI.21-02-00590.2001; GOTMAN J, 1991, CAN J NEUROL SCI, V18, P573, DOI 10.1017/S031716710003273X; GOTMAN J, 1987, METHODS ANAL BRAIN E, P171; Haut SR, 1997, EPILEPSIA, V38, P937, DOI 10.1111/j.1528-1157.1997.tb01260.x; Heffernan MS, 1996, INTEGR PHYS BEH SCI, V31, P202, DOI 10.1007/BF02691450; Iaseemidis Leon D., 1996, Epilepsia, V37, P90; IASEMIDIS L, 1997, ANN NEUROL, V42, P429; IASEMIDIS L D, 1990, Brain Topography, V2, P187, DOI 10.1007/BF01140588; IASEMIDIS LD, 1994, EPILEPSY RES, V17, P81, DOI 10.1016/0920-1211(94)90081-7; Kafri T, 2000, MOL THER, V1, P516, DOI 10.1006/mthe.2000.0083; KATZ A, 1991, ELECTROEN CLIN NEURO, V79, P153, DOI 10.1016/0013-4694(91)90054-8; LANGE HH, 1983, ELECTROEN CLIN NEURO, V56, P543, DOI 10.1016/0013-4694(83)90022-6; Lehnertz K, 1998, PHYS REV LETT, V80, P5019, DOI 10.1103/PhysRevLett.80.5019; Liang FY, 1997, BRAIN RES, V778, P281, DOI 10.1016/S0006-8993(97)01049-4; LOTHMAN EW, 1994, BRAIN RES, V649, P71, DOI 10.1016/0006-8993(94)91050-2; Martinerie J, 1998, NAT MED, V4, P1173, DOI 10.1038/2667; Noebels J L, 1999, Adv Neurol, V79, P227; NOEBELS JL, 1990, BRAIN RES, V524, P225, DOI 10.1016/0006-8993(90)90695-8; NOEBELS JL, 1990, EPILEPSY RES, V7, P129, DOI 10.1016/0920-1211(90)90098-G; Osorio I, 1998, EPILEPSIA, V39, P615, DOI 10.1111/j.1528-1157.1998.tb01430.x; PENFIELD W, 1950, AMA ARCH NEUROL PSY, V64, P491, DOI 10.1001/archneurpsyc.1950.02310280003001; Penfield W., 1941, EPILEPSY CEREBRAL LO, DOI [10.1097/00007611-194202000-00031, DOI 10.1097/00007611-194202000-00031]; QIN DY, 1995, COMP MED SY, P151, DOI 10.1109/CBMS.1995.465436; Qu H, 1997, IEEE T BIO-MED ENG, V44, P115, DOI 10.1109/10.552241; Rajna P, 1997, SEIZURE-EUR J EPILEP, V6, P361, DOI 10.1016/S1059-1311(97)80035-0; RALSTON BL, 1958, ELECTROEN CLIN NEURO, V10, P217, DOI 10.1016/0013-4694(58)90029-4; RISINGER MW, 1989, NEUROLOGY, V39, P1288, DOI 10.1212/WNL.39.10.1288; ROGOWSKI Z, 1981, BIOL CYBERN, V42, P9, DOI 10.1007/BF00335153; Schiller Y, 1998, EPILEPSIA, V39, P380, DOI 10.1111/j.1528-1157.1998.tb01390.x; Schuh LA, 2000, EPILEPSIA, V41, P316, DOI 10.1111/j.1528-1157.2000.tb00161.x; Schwartzkroin PA, 1998, EPILEPSY RES, V32, P275, DOI 10.1016/S0920-1211(98)00058-8; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Sperling M, 1986, MECH EPILEPTOGENESIS, P17; SPERLING MR, 1990, ANN NEUROL, V28, P320, DOI 10.1002/ana.410280304; Stein AG, 2000, EPILEPSY RES, V39, P103, DOI 10.1016/S0920-1211(99)00107-2; TANG CM, 1990, P NATL ACAD SCI USA, V87, P6445, DOI 10.1073/pnas.87.16.6445; Vachtsevanos GJ, 1998, J INTELL FUZZY SYST, V6, P259; VANQUYEN ML, 2001, LANCET, V357, P183; VIGLIONE S, 1970, METHODOLOGY DETECTIN; Wang LL, 2000, MOL THER, V1, P154, DOI 10.1006/mthe.2000.0031; WARD S, 1998, Patent No. 5713923	54	420	437	4	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					51	64		10.1016/S0896-6273(01)00262-8	http://dx.doi.org/10.1016/S0896-6273(01)00262-8			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343644	Bronze			2022-12-24	WOS:000168412900010
J	Schikorski, T; Stevens, CF				Schikorski, T; Stevens, CF			Morphological correlates of functionally defined synaptic vesicle populations	NATURE NEUROSCIENCE			English	Article							SYNAPSES; RELEASE; BOUTONS; NEURONS; BRAIN	By combining photoconversion of FM1-43-stained vesicles and electron microscopy of hippocampal synapses, we find evidence that the population of morphologically docked synaptic vesicles corresponds to the release-ready neurotransmitter quanta. Furthermore, those synaptic vesicles that are participating in cycles of exo- and endocytosis tend to be closer to the active zone than vesicles that are being held in reserve.	Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute	Stevens, CF (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Schikorski, Thomas/0000-0003-3902-2461				Boyer C, 1998, J NEUROSCI, V18, P5294, DOI 10.1523/JNEUROSCI.18-14-05294.1998; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Fernandez-Chacon R, 1999, ANNU REV PHYSIOL, V61, P753, DOI 10.1146/annurev.physiol.61.1.753; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; Murthy VN, 1998, NATURE, V392, P497, DOI 10.1038/33152; Murthy VN, 1999, NAT NEUROSCI, V2, P503, DOI 10.1038/9149; Murthy VN, 1997, NEURON, V18, P599, DOI 10.1016/S0896-6273(00)80301-3; ROSENMUND C, 1996, NEURON, V16, P1; Ryan TA, 1996, J CELL BIOL, V134, P1219, DOI 10.1083/jcb.134.5.1219; Ryan TA, 1996, P NATL ACAD SCI USA, V93, P5567, DOI 10.1073/pnas.93.11.5567; Ryan TA, 1996, NEURON, V17, P125, DOI 10.1016/S0896-6273(00)80286-X; SANDELL JH, 1988, J HISTOCHEM CYTOCHEM, V36, P555, DOI 10.1177/36.5.3356898; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; SCHIKORSKI T, 1994, BRAIN BEHAV EVOLUT, V43, P306, DOI 10.1159/000113642; Schikorski T, 1997, J NEUROSCI, V17, P5858; Stevens CF, 2000, P NATL ACAD SCI USA, V97, P12828, DOI 10.1073/pnas.230438697; vonGersdorff H, 1996, NEURON, V16, P1221, DOI 10.1016/S0896-6273(00)80148-8	19	361	365	0	16	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					391	395		10.1038/86042	http://dx.doi.org/10.1038/86042			5	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276229				2022-12-24	WOS:000168762200019
J	Beaumont, V; Zhong, N; Froemke, RC; Ball, RW; Zucker, RS				Beaumont, V; Zhong, N; Froemke, RC; Ball, RW; Zucker, RS			Temporal synaptic tagging by I-h activation and actin: Involvement in long-term facilitation and cAMP-induced synaptic enhancement	NEURON			English	Article							CRAYFISH NEUROMUSCULAR-JUNCTION; NEUROTRANSMITTER RELEASE; POSTTETANIC POTENTIATION; GANGLION NEURONS; NERVE-TERMINALS; CATION CURRENT; CYCLIC-AMP; CALCIUM; CYTOSKELETON; ACCUMULATION	Presynaptic I-h channels become activated during a tetanus through membrane hyperpolarization resulting from Na+ accumulation and electrogenic Na+/K+ exchange. I-h activation is obligatory for inducing long-term facilitation (LTF), a long-lasting synaptic strengthening. cAMP-induced synaptic enhancement also requires I-h activation, and both processes are sensitive to actin depolymerization. Other mechanisms are responsible for expression of the responses. Once initiated, continued response to cAMP is I-h and actin independent. Moreover, LTF-induced activation of I-h renders subsequent cAMP enhancement insensitive to both I-h blockers and actin depolymerization. This actin-stabilized "temporal synaptic tagging" set by I-h activation is prolonged when I-h is activated concurrent with an elevation in presynaptic calcium concentration ([Ca2+](i)), permitting the further strengthening of synapses given appropriate additional stimuli.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Beaumont, V (corresponding author), MRC, Mol Biol Lab, Div Neurobiol, Hills Rd, Cambridge CB2 2QH, England.		Zucker, Robert S/J-9995-2012	Zucker, Robert S/0000-0003-1068-2343; Zhong, Ning/0000-0002-3696-5301; Froemke, Robert/0000-0002-1230-6811; Beaumont, Vahri/0000-0002-6488-2175				ATWOOD HL, 1975, BRAIN RES, V100, P198, DOI 10.1016/0006-8993(75)90260-7; Beaumont V, 2001, NEURON, V32, P489, DOI 10.1016/S0896-6273(01)00483-4; Beaumont V, 2000, NAT NEUROSCI, V3, P133, DOI 10.1038/72072; Bi GQ, 1997, J CELL BIOL, V138, P999, DOI 10.1083/jcb.138.5.999; CECCALDI PE, 1995, J CELL BIOL, V128, P905, DOI 10.1083/jcb.128.5.905; Cole JC, 2000, J PHYSIOL-LONDON, V525, P579, DOI 10.1111/j.1469-7793.2000.t01-2-00579.x; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; DELANEY KR, 1989, J NEUROSCI, V9, P3558; DIXON D, 1989, J NEUROSCI, V9, P4246; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Humeau Y, 2001, J NEUROSCI, V21, P4195, DOI 10.1523/JNEUROSCI.21-12-04195.2001; Janigro D, 1997, J MEMBRANE BIOL, V160, P101, DOI 10.1007/s002329900299; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kuromi H, 1998, NEURON, V20, P917, DOI 10.1016/S0896-6273(00)80473-0; LANDO L, 1994, J NEUROPHYSIOL, V72, P825, DOI 10.1152/jn.1994.72.2.825; LNENICKA GA, 1985, J NEUROBIOL, V16, P97, DOI 10.1002/neu.480160203; Morales M, 2000, NEURON, V27, P539, DOI 10.1016/S0896-6273(00)00064-7; MULKEY RM, 1992, J NEUROSCI, V12, P4327; PAPE HC, 1994, NEUROSCIENCE, V59, P363, DOI 10.1016/0306-4522(94)90602-5; Pape HC, 1996, ANNU REV PHYSIOL, V58, P299, DOI 10.1146/annurev.ph.58.030196.001503; Petrecca K, 2000, J NEUROSCI, V20, P8736; Raes A, 1998, BRIT J PHARMACOL, V125, P741, DOI 10.1038/sj.bjp.0702153; Sakaba T, 2001, P NATL ACAD SCI USA, V98, P331, DOI 10.1073/pnas.021541098; Spector I, 1999, MICROSC RES TECHNIQ, V47, P18, DOI 10.1002/(SICI)1097-0029(19991001)47:1<18::AID-JEMT3>3.0.CO;2-E; TRIFARO JM, 1993, TRENDS NEUROSCI, V16, P466, DOI 10.1016/0166-2236(93)90079-2; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang C, 1998, NEURON, V21, P155, DOI 10.1016/S0896-6273(00)80523-1; Wang XH, 1996, J PHYSIOL-LONDON, V491, P187, DOI 10.1113/jphysiol.1996.sp021206; WOJTOWICZ JM, 1994, J NEUROSCI, V14, P3688; WOJTOWICZ JM, 1988, J NEUROSCI, V8, P4667; WOJTOWICZ JM, 1988, NEUROSCI LETT, V90, P152, DOI 10.1016/0304-3940(88)90803-8; WOJTOWICZ JM, 1986, J NEUROPHYSIOL, V55, P484, DOI 10.1152/jn.1986.55.3.484; WOJTOWICZ JM, 1985, J NEUROPHYSIOL, V54, P220, DOI 10.1152/jn.1985.54.2.220; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	38	60	62	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					601	613		10.1016/S0896-6273(02)00581-0	http://dx.doi.org/10.1016/S0896-6273(02)00581-0			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856533	Bronze			2022-12-24	WOS:000173911100012
J	Zhang, XM; Firestein, S				Zhang, XM; Firestein, S			The olfactory receptor gene superfamily of the mouse	NATURE NEUROSCIENCE			English	Article							PROTEIN-COUPLED RECEPTORS; ODORANT RECEPTOR; SEQUENCE; CLUSTER; FAMILY; IDENTIFICATION; VERTEBRATES; EXPRESSION; NEURONS; ANOSMIA	Olfactory receptor (OR) genes are the largest gene superfamily in vertebrates. We have identified the mouse OR genes from the nearly complete Celera mouse genome by a comprehensive data mining strategy. We found 1,296 mouse OR genes (including similar to20% pseudogenes), which can be classified into 228 families. OR genes are distributed in 27 clusters on all mouse chromosomes except 12 and Y. One OR gene cluster matches a known locus mediating a specific anosmia, indicating the anosmia may be due directly to the loss of receptors. A large number of apparently functional 'fish-like' Class I OR genes in the mouse genome may have important roles in mammalian olfaction. Human ORs cover a similar 'receptor space' as the mouse ORs, suggesting that the human olfactory system has retained the ability to recognize a broad spectrum of chemicals even though humans have lost nearly two-thirds of the OR genes as compared to mice.	Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Firestein, S (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	sjf24@columbia.edu						Asai H, 1996, BIOCHEM BIOPH RES CO, V221, P240, DOI 10.1006/bbrc.1996.0580; Brosius J, 1999, TRENDS GENET, V15, P304, DOI 10.1016/S0168-9525(99)01783-7; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buck LB, 1996, ANNU REV NEUROSCI, V19, P517, DOI 10.1146/annurev.ne.19.030196.002505; Bulger M, 1999, P NATL ACAD SCI USA, V96, P5129, DOI 10.1073/pnas.96.9.5129; Carver EA, 1998, MAMM GENOME, V9, P349, DOI 10.1007/s003359900768; Conzelmann S, 2000, EUR J NEUROSCI, V12, P3926, DOI 10.1046/j.1460-9568.2000.00286.x; COPELAND NG, 1993, SCIENCE, V262, P57, DOI 10.1126/science.8211130; Ehlers A, 2000, GENOME RES, V10, P1968, DOI 10.1101/gr.10.12.1968; Freitag J, 1998, J COMP PHYSIOL A, V183, P635, DOI 10.1007/s003590050287; Freitag J, 1995, NEURON, V15, P1383, DOI 10.1016/0896-6273(95)90016-0; Gentles AJ, 1999, TRENDS GENET, V15, P47, DOI 10.1016/S0168-9525(98)01648-5; Gibson AD, 2000, ANNU REV NEUROSCI, V23, P417, DOI 10.1146/annurev.neuro.23.1.417; Glusman G, 2000, MAMM GENOME, V11, P1016, DOI 10.1007/s003350010196; Glusman G, 2001, GENOME RES, V11, P685, DOI 10.1101/gr.171001; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Glusman G, 1996, GENOMICS, V37, P147, DOI 10.1006/geno.1996.0536; GRIFF IC, 1995, CELL, V83, P407, DOI 10.1016/0092-8674(95)90118-3; Hoppe R, 2000, GENOMICS, V66, P284, DOI 10.1006/geno.2000.6205; Kajiya K, 2001, J NEUROSCI, V21, P6018, DOI 10.1523/JNEUROSCI.21-16-06018.2001; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Lane RP, 2001, P NATL ACAD SCI USA, V98, P7390, DOI 10.1073/pnas.131215398; Lapidot M, 2001, GENOMICS, V71, P296, DOI 10.1006/geno.2000.6431; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mezler M, 2001, J EXP BIOL, V204, P2987; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mombaerts P, 1999, ANNU REV NEUROSCI, V22, P487, DOI 10.1146/annurev.neuro.22.1.487; NGAI J, 1993, CELL, V72, P657, DOI 10.1016/0092-8674(93)90396-8; Pilpel Y, 1999, PROTEIN SCI, V8, P969, DOI 10.1110/ps.8.5.969; Raming K, 1998, RECEPTOR CHANNEL, V6, P141; Skoufos E, 1999, NUCLEIC ACIDS RES, V27, P343, DOI 10.1093/nar/27.1.343; Strotmann J, 1999, GENE, V236, P281, DOI 10.1016/S0378-1119(99)00275-9; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; Touhara K, 1999, P NATL ACAD SCI USA, V96, P4040, DOI 10.1073/pnas.96.7.4040; WANG HW, 1993, SCIENCE, V260, P998, DOI 10.1126/science.8493539; WYSOCKI CJ, 1977, BEHAV GENET, V7, P171, DOI 10.1007/BF01066005; Xie SY, 2000, MAMM GENOME, V11, P1070, DOI 10.1007/s003350010217; Younger RM, 2001, GENOME RES, V11, P519, DOI 10.1101/gr.GR-1603R; Zheng C, 2000, NEURON, V26, P81, DOI 10.1016/S0896-6273(00)81140-X; Zozulya S, 2001, GENOME BIOL, V2	40	627	736	2	56	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	FEB	2002	5	2					124	133		10.1038/nn800	http://dx.doi.org/10.1038/nn800			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	516NB	11802173				2022-12-24	WOS:000173558400014
J	Lyon, DC; Kaas, JH				Lyon, DC; Kaas, JH			Evidence for a modified V3 with dorsal and ventral halves in macaque monkeys	NEURON			English	Article							DORSOMEDIAL VISUAL AREA; CYTOCHROME-OXIDASE STRIPES; CORTICAL CONNECTIONS; STRIATE CORTEX; OWL MONKEY; EXTRASTRIATE CORTEX; AOTUS-TRIVIRGATUS; V2; ORGANIZATION; NEURONS	Through more than 30 years of research, the nature of the third visual area, V3, and even its existence have been in question. Here, we used injections of up to five distinguishable tracers into both dorsal and ventral portions of V1 of macaque monkeys (representing the lower and upper visual quadrant, respectively) to provide compelling evidence for a V3 that is smaller than V2. This V3 includes both dorsal and ventral halves mirroring dorsal and ventral V2 in retinotopic organization. Of the approximately ten areas with V1 connections, V3 appears to account for about 20%.	Vanderbilt Univ, Dept Psychol, Nashville, TN 37203 USA	Vanderbilt University	Kaas, JH (corresponding author), Vanderbilt Univ, Dept Psychol, 301 Wilson Hall,111 21st Ave S, Nashville, TN 37203 USA.			Lyon, David C./0000-0002-4367-5636	NEI NIH HHS [EY02686] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY002686] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ALLMAN JM, 1975, BRAIN RES, V100, P473, DOI 10.1016/0006-8993(75)90153-5; Beck PD, 1999, J COMP NEUROL, V406, P487; Beck PD, 1998, J COMP NEUROL, V400, P18, DOI 10.1002/(SICI)1096-9861(19981012)400:1<18::AID-CNE2>3.0.CO;2-W; BURKE DS, 1986, ARBOVIRUSES EPIDEMIO, V3, P63; BURKHALTER A, 1986, J NEUROSCI, V6, P2327; CRAGG BG, 1969, VISION RES, V9, P733, DOI 10.1016/0042-6989(69)90011-X; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; ERICSON H, 1988, J NEUROSCI METH, V24, P225, DOI 10.1016/0165-0270(88)90167-7; Felleman DJ, 1991, CEREB CORTEX, V1, P1, DOI 10.1093/cercor/1.1.1; Felleman DJ, 1997, J COMP NEUROL, V379, P21, DOI 10.1002/(SICI)1096-9861(19970303)379:1<21::AID-CNE3>3.0.CO;2-K; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; Gallyas F, 1979, Neurol Res, V1, P203; GATTASS R, 1988, J NEUROSCI, V8, P1831; Gegenfurtner KR, 1997, J NEUROPHYSIOL, V77, P1906, DOI 10.1152/jn.1997.77.4.1906; HORTON JC, 1981, NATURE, V292, P762, DOI 10.1038/292762a0; Kaas JH, 2001, PROG BRAIN RES, V134, P285; KEIZER K, 1983, EXP BRAIN RES, V51, P179; KRUBITZER LA, 1993, J COMP NEUROL, V334, P497, DOI 10.1002/cne.903340402; KUYPERS HGJ, 1980, EXP BRAIN RES, V40, P382; LEVITT JB, 1994, J NEUROPHYSIOL, V71, P2517, DOI 10.1152/jn.1994.71.6.2517; LIN CS, 1982, J COMP NEUROL, V211, P165, DOI 10.1002/cne.902110206; LIVINGSTONE MS, 1983, NATURE, V304, P531, DOI 10.1038/304531a0; Lyon DC, 2001, J NEUROSCI, V21, P249, DOI 10.1523/JNEUROSCI.21-01-00249.2001; MALACH R, 1994, CEREB CORTEX, V4, P151, DOI 10.1093/cercor/4.2.151; NEWSOME WT, 1986, J COMP NEUROL, V252, P139, DOI 10.1002/cne.902520202; Novikova L, 1997, J NEUROSCI METH, V74, P9, DOI 10.1016/S0165-0270(97)02227-9; Olavarria JF, 1997, CEREB CORTEX, V7, P395, DOI 10.1093/cercor/7.5.395; PERKEL DJ, 1986, J COMP NEUROL, V253, P374, DOI 10.1002/cne.902530307; ROSA MGP, 1995, J COMP NEUROL, V359, P272, DOI 10.1002/cne.903590207; Sakai ST, 2000, J COMP NEUROL, V417, P164; SCHMUED L, 1990, BRAIN RES, V526, P127, DOI 10.1016/0006-8993(90)90258-D; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SHIPP S, 1995, NEUROIMAGE, V2, P125, DOI 10.1006/nimg.1995.1015; Smith AT, 1998, J NEUROSCI, V18, P3816; Stepniewska I, 1996, J COMP NEUROL, V371, P129; TOOTELL RBH, 1983, SCIENCE, V220, P737, DOI 10.1126/science.6301017; TOOTELL RBH, 1982, SCIENCE, V218, P902, DOI 10.1126/science.7134981; Tootell RBH, 1997, J NEUROSCI, V17, P7060; UNGERLEIDER LG, 1986, J COMP NEUROL, V248, P147, DOI 10.1002/cne.902480202; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; VANESSEN DC, 1986, J COMP NEUROL, V244, P451, DOI 10.1002/cne.902440405; WELLER RE, 1983, J COMP NEUROL, V220, P253, DOI 10.1002/cne.902200302; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; ZEKI SM, 1969, BRAIN RES, V14, P271, DOI 10.1016/0006-8993(69)90110-3; ZEKI SM, 1978, J PHYSIOL-LONDON, V277, P273, DOI 10.1113/jphysiol.1978.sp012272	45	80	80	1	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	JAN 31	2002	33	3					453	461		10.1016/S0896-6273(02)00580-9	http://dx.doi.org/10.1016/S0896-6273(02)00580-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	518AG	11832231	Bronze			2022-12-24	WOS:000173643200014
J	Plump, AS; Erskine, L; Sabatier, C; Brose, K; Epstein, CJ; Goodman, CS; Mason, CA; Tessier-Lavigne, M				Plump, AS; Erskine, L; Sabatier, C; Brose, K; Epstein, CJ; Goodman, CS; Mason, CA; Tessier-Lavigne, M			Slit1 and Slit2 cooperate to prevent premature midline crossing of retinal axons in the mouse visual system	NEURON			English	Article							GANGLION-CELL AXONS; GROWTH CONE BEHAVIOR; OPTIC CHIASM; CHONDROITIN SULFATE; NEURONAL MIGRATION; UNCROSSED AXONS; EPHRINA LIGANDS; VERTEBRATE SLIT; NERVOUS-SYSTEM; GUIDANCE	During development, retinal ganglion cell (RGC) axons either cross or avoid the midline at the optic chiasm. In Drosophila, the Slit protein regulates midline axon crossing through repulsion. To determine the role of Slit proteins in RGC axon guidance, we disrupted Slit1 and Slit2, two of three known mouse Slit genes. Mice defective in either gene alone exhibited few RGC axon guidance defects, but in double mutant mice a large additional chiasm developed anterior to the true chiasm, many retinal axons projected into the contralateral optic nerve, and some extended ectopically-dorsal and lateral to the chiasm. Our results indicate that Slit proteins repel retinal axons in vivo and cooperate to establish a corridor through which the axons are channeled, thereby helping define the site in the ventral diencephalon where the optic chiasm forms.	Univ Calif San Francisco, Howard Hughes Med Inst, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Howard Hughes Med Inst, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Div Med Genet, San Francisco, CA 94143 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Pathol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Anat, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Ctr Neurobiol & Behav, Dept Cell Biol, New York, NY 10032 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tessier-Lavigne, M (corresponding author), Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA.	marctl@stanford.edu	Erskine, Lynda/AAE-9281-2020	Erskine, Lynda/0000-0001-6538-9406	NEI NIH HHS [EY 12736] Funding Source: Medline; NINDS NIH HHS [P0 NS 30532] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY012736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS030532] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ba-Charvet KTN, 1999, NEURON, V22, P463, DOI 10.1016/S0896-6273(00)80702-3; Bagri A, 2002, NEURON, V33, P233, DOI 10.1016/S0896-6273(02)00561-5; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Chan SO, 1999, J COMP NEUROL, V406, P251, DOI 10.1002/(SICI)1096-9861(19990405)406:2<251::AID-CNE8>3.0.CO;2-E; Chung KY, 2000, DEVELOPMENT, V127, P2673; COLELLO RJ, 1990, DEVELOPMENT, V108, P515; Deiner MS, 1999, J NEUROSCI, V19, P9900; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; Dutting D, 1999, DEV BIOL, V216, P297, DOI 10.1006/dbio.1999.9489; Erskine L, 2000, J NEUROSCI, V20, P4975; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; GODEMENT P, 1990, NEURON, V5, P173, DOI 10.1016/0896-6273(90)90307-2; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Holmes GP, 1998, MECH DEVELOP, V79, P57, DOI 10.1016/S0925-4773(98)00174-9; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Itoh A, 1998, MOL BRAIN RES, V62, P175, DOI 10.1016/S0169-328X(98)00224-1; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; LEE VMY, 1987, J NEUROSCI, V7, P3474; Lewandoski M, 1997, NAT GENET, V17, P223, DOI 10.1038/ng1097-223; Li HS, 1999, CELL, V96, P807, DOI 10.1016/S0092-8674(00)80591-7; MARCUS RC, 1995, J NEUROSCI, V15, P3716; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; O'Leary DDM, 1999, CELL, V96, P255, DOI 10.1016/S0092-8674(00)80565-6; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; SILVER J, 1987, J NEUROSCI, V7, P2264; SILVER J, 1984, J COMP NEUROL, V223, P238, DOI 10.1002/cne.902230207; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; SNOW DM, 1991, DEVELOPMENT, V113, P1473; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1990, J NEUROSCI, V10, P1995; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; Tuttle R, 1998, DEVELOPMENT, V125, P791; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Wu W, 1999, NATURE, V400, P331, DOI 10.1038/22477; Yuan SSF, 1999, DEV BIOL, V207, P62, DOI 10.1006/dbio.1998.9141; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	49	324	335	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					219	232		10.1016/S0896-6273(01)00586-4	http://dx.doi.org/10.1016/S0896-6273(01)00586-4			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804570	Bronze			2022-12-24	WOS:000173387700010
J	Andersen, SL; Arvanitogiannis, A; Pliakas, AM; LeBlanc, C; Carlezon, WA				Andersen, SL; Arvanitogiannis, A; Pliakas, AM; LeBlanc, C; Carlezon, WA			Altered responsiveness to cocaine in rats exposed to methylphenidate during development	NATURE NEUROSCIENCE			English	Article							EXPRESSION; DOPAMINE		Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; McLean Hosp, Belmont, MA 02478 USA	Harvard University; Harvard University; McLean Hospital	Andersen, SL (corresponding author), Harvard Univ, Sch Med, Dept Psychiat, 115 Mill St, Belmont, MA 02478 USA.	andersen@mclean.org			NIDA NIH HHS [DA12736] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012736] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDERSEN SL, IN PRESS BEHAV BRAIN; BALSKUBIK R, 1989, PSYCHOPHARMACOLOGY, V98, P203, DOI 10.1007/BF00444692; Biederman J, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.2.e20; Brandon CL, 2001, NEUROPSYCHOPHARMACOL, V25, P651, DOI 10.1016/S0893-133X(01)00281-0; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; COLE RL, 1995, NEURON, V14, P813, DOI 10.1016/0896-6273(95)90225-2; DICHIARA G, 1988, P NATL ACAD SCI USA, V85, P5274; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Nestler EJ, 2001, NAT REV NEUROSCI, V2, P119, DOI 10.1038/35053570; Pliakas AM, 2001, J NEUROSCI, V21, P7397, DOI 10.1523/JNEUROSCI.21-18-07397.2001; Robinson TE, 2000, ADDICTION, V95, pS91; ROSENGARTEN H, 1979, SCIENCE, V203, P1133, DOI 10.1126/science.570724; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; WARGIN W, 1983, J PHARMACOL EXP THER, V226, P382; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469	15	231	233	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					13	14		10.1038/nn777	http://dx.doi.org/10.1038/nn777			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11731802				2022-12-24	WOS:000173031800007
J	Chi, ZY; Margoliash, D				Chi, ZY; Margoliash, D			Temporal precision and temporal drift in brain and behavior of zebra finch song	NEURON			English	Article							SYNCHRONOUS ACTIVITY; MOVEMENT DIRECTION; CORTICAL-NEURONS; VISUAL-SYSTEM; NUCLEUS; REPRESENTATION; INFORMATION; DISCHARGE; PATTERNS; BIRDSONG	In the zebra finch forebrain nucleus robustus archistriatalis (RA), neurons burst during singing. We showed that the internal structure of spike bursts was regulated with a precision of circa 0.2 ms, and yielded alignment of acoustic features of song with a precision of circa I ms. In addition, interburst intervals and corresponding syllable durations displayed systematic variation within song (average elongation 0.3 ms/s song), and slower "drift" across songs. Systematic variation on even a coarser time scale might be difficult to detect in other systems, but could affect the analysis of temporal patterning. The close relationship between precise timing of individual spikes and stereotypic behavior suggests that song is represented in RA by a temporal code.	Univ Chicago, Dept Stat, Chicago, IL 60637 USA; Univ Chicago, Dept Organismal Biol & Anat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Chi, ZY (corresponding author), Univ Chicago, Dept Stat, Chicago, IL 60637 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059831, R01MH060276] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60276, MH59831] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Baker SN, 2000, J NEUROPHYSIOL, V84, P1770, DOI 10.1152/jn.2000.84.4.1770; CARR CE, 1986, J NEUROSCI, V6, P107; Date A, 1998, TEMPORAL RESOLUTION; Dave AS, 2000, SCIENCE, V290, P812, DOI 10.1126/science.290.5492.812; deCharms RC, 2000, ANNU REV NEUROSCI, V23, P613, DOI 10.1146/annurev.neuro.23.1.613; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; GEORGOPOULOS AP, 1986, SCIENCE, V233, P1416, DOI 10.1126/science.3749885; Hatsopoulos NG, 1998, P NATL ACAD SCI USA, V95, P15706, DOI 10.1073/pnas.95.26.15706; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Keat J, 2001, NEURON, V30, P803, DOI 10.1016/S0896-6273(01)00322-1; Laurent G, 1996, J NEUROSCI, V16, P3837; MOONEY R, 1992, J NEUROSCI, V12, P2464; Oram MW, 1999, J NEUROPHYSIOL, V81, P3021, DOI 10.1152/jn.1999.81.6.3021; Pauluis Q, 2000, NEURAL COMPUT, V12, P647, DOI 10.1162/089976600300015736; Searcy William A., 1996, P454; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.ne.18.030195.003011; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; Suthers RA, 1999, PHILOS T ROY SOC B, V354, P927, DOI 10.1098/rstb.1999.0444; Usrey WM, 1999, ANNU REV PHYSIOL, V61, P435, DOI 10.1146/annurev.physiol.61.1.435; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; WILD JM, 1993, J COMP NEUROL, V338, P225, DOI 10.1002/cne.903380207; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	23	112	115	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 6	2001	32	5					899	910		10.1016/S0896-6273(01)00524-4	http://dx.doi.org/10.1016/S0896-6273(01)00524-4			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	501RW	11738034	Bronze			2022-12-24	WOS:000172700700015
J	Thompson, PM; Cannon, TD; Narr, KL; van Erp, T; Poutanen, VP; Huttunen, M; Lonnqvist, J; Standertskjold-Nordenstam, CG; Kaprio, J; Khaledy, M; Dail, R; Zoumalan, CI; Toga, AW				Thompson, PM; Cannon, TD; Narr, KL; van Erp, T; Poutanen, VP; Huttunen, M; Lonnqvist, J; Standertskjold-Nordenstam, CG; Kaprio, J; Khaledy, M; Dail, R; Zoumalan, CI; Toga, AW			Genetic influences on brain structure	NATURE NEUROSCIENCE			English	Article							MONOZYGOTIC TWINS; COGNITIVE-ABILITIES; HERITABILITY; INTELLIGENCE; SCHIZOPHRENIA; CORTEX; SIZE; IQ; ABNORMALITIES; VARIABILITY	Here we report on detailed three-dimensional maps revealing how brain structure is influenced by individual genetic differences. A genetic continuum was detected in which brain structure was increasingly similar in subjects with increasing genetic affinity. Genetic factors significantly influenced cortical structure in Broca's and Wernicke's language areas, as well as frontal brain regions (r(MZ)(2) > 0.8, p < 0.05). Preliminary correlations were performed suggesting that frontal gray matter differences may be linked to Spearman's g, which measures successful test performance across multiple cognitive domains (p < 0.05). These genetic brain maps reveal how genes determine individual differences, and may shed light on the heritability of cognitive and linguistic skills, as well as genetic liability for diseases that affect the human cortex.	Univ Calif Los Angeles, Sch Med, Dept Neurol, Reed Neurol Res Ctr,Lab Neuroimaging, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Neurol, Reed Neurol Res Ctr,Brain Mapping Div, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Psychiat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Helsinki, Cent Hosp, Dept Radiol, Meilahti Clin, FIN-00290 Helsinki, Finland; Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; Univ Oulu, FIN-00014 Helsinki, Finland	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu	Thompson, PM (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Neurol, Reed Neurol Res Ctr,Lab Neuroimaging, Rm 4238,710 Westwood Plaza, Los Angeles, CA 90095 USA.		Kaprio, Jaakko/A-1820-2008; Thompson, Paul M/C-4194-2018	Kaprio, Jaakko/0000-0002-3716-2455; Thompson, Paul M/0000-0002-4720-8867	NCRR NIH HHS [P41 RR13642] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Alarcon M, 1998, BEHAV GENET, V28, P255, DOI 10.1023/A:1021667213066; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bartley AJ, 1997, BRAIN, V120, P257, DOI 10.1093/brain/120.2.257; Biondi A, 1998, AM J NEURORADIOL, V19, P1361; Cannon TD, 2000, AM J HUM GENET, V67, P369, DOI 10.1086/303006; CANNON TD, 1994, ARCH GEN PSYCHIAT, V51, P651; CHIPUER HM, 1990, INTELLIGENCE, V14, P11, DOI 10.1016/0160-2896(90)90011-H; Collins FS, 2001, JAMA-J AM MED ASSOC, V285, P540, DOI 10.1001/jama.285.5.540; Devlin B, 1997, NATURE, V388, P468, DOI 10.1038/41319; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Eley TC, 1997, CURR OPIN NEUROBIOL, V7, P279, DOI 10.1016/S0959-4388(97)80017-7; Falconer D. S., 1989, Introduction to quantitative genetics.; Feldman MW, 1997, SCIENCE, V278, P1383; Finkel D, 1998, DEV PSYCHOL, V34, P1400, DOI 10.1037/0012-1649.34.6.1400; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; Gayan J, 1999, EUR CHILD ADOLES PSY, V8, P52; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; HEDEKER D, 1994, J CONSULT CLIN PSYCH, V62, P757, DOI 10.1037/0022-006X.62.4.757; Hill L, 1999, NEUROREPORT, V10, P843, DOI 10.1097/00001756-199903170-00032; HUERTA MF, 1996, NEUROIMAGE, V4, P4; HUNTLEY RMC, 1966, GENETIC ENV FACTORS; KAPRIO J, 1990, BEHAV GENET, V20, P265, DOI 10.1007/BF01067794; Kreft I. G., 1998, INTRO MULTILEVEL MOD, DOI DOI 10.4135/9781849209366; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; LOEHLIN JC, 1989, AM PSYCHOL, V44, P1285, DOI 10.1037/0003-066X.44.10.1285; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560; Neale MC, 1992, METHODOLOGY GENETIC; OPPENHEIM JS, 1989, ANN NEUROL, V26, P100, DOI 10.1002/ana.410260117; Pennington BF, 2000, J COGNITIVE NEUROSCI, V12, P223, DOI 10.1162/089892900561850; Pfefferbaum A, 2000, NEUROBIOL AGING, V21, P63, DOI 10.1016/S0197-4580(00)00086-5; Plomin R, 1997, INTELLIGENCE, V24, P53, DOI 10.1016/S0160-2896(97)90013-1; PLOMIN R, 1989, BEHAV GENET, V19, P331, DOI 10.1007/BF01066162; RAJKOWSKA G, 1995, CEREB CORTEX, V5, P323, DOI 10.1093/cercor/5.4.323; Rutter M, 1999, J CHILD PSYCHOL PSYC, V40, P3, DOI 10.1111/1469-7610.00422; SMITH C, 1975, TXB HUMAN GENETICS; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; SUDDATH RL, 1990, NEW ENGL J MED, V322, P789, DOI 10.1056/NEJM199003223221201; SWAN GE, 1990, ARCH NEUROL-CHICAGO, V47, P259, DOI 10.1001/archneur.1990.00530030025010; Thompson PM, 2000, HUM BRAIN MAPP, V9, P81, DOI 10.1002/(SICI)1097-0193(200002)9:2<81::AID-HBM3>3.0.CO;2-8; Thompson PM, 2001, CEREB CORTEX, V11, P1, DOI 10.1093/cercor/11.1.1; THOMPSON PM, 2000, HDB MED IMAGE PROCES, P1066; TRAMO MJ, 1995, J COGNITIVE NEUROSCI, V7, P292, DOI 10.1162/jocn.1995.7.2.292; Tramo MJ, 1998, NEUROLOGY, V50, P1246, DOI 10.1212/WNL.50.5.1246; WEINBERGER DR, 1981, PSYCHIAT RES, V4, P65, DOI 10.1016/0165-1781(81)90009-3; Williams K, 1998, PHYS WORLD, V11, P18; Wright IC, 1995, NEUROIMAGE, V2, P244, DOI 10.1006/nimg.1995.1032; Zijdenbos Alex P., 1994, Critical Reviews in Biomedical Engineering, V22, P401	49	720	730	0	114	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1253	1258		10.1038/nn758	http://dx.doi.org/10.1038/nn758			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	498RV	11694885				2022-12-24	WOS:000172525000023
J	Poncer, JC; Malinow, R				Poncer, JC; Malinow, R			Postsynaptic conversion of silent synapses during LTP affects synaptic gain and transmission dynamics	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PAIRED-PULSE FACILITATION; NEOCORTICAL PYRAMIDAL NEURONS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; GLUTAMATE RELEASE; HIPPOCAMPAL SLICE; AMPA RECEPTORS; NMDA RECEPTORS; DENTATE GYRUS	Synaptic transmission relies on both the gain and the dynamics of synapses. Activity-dependent changes in synaptic gain are well-documented at excitatory synapses and may represent a substrate for information storage in the brain. Here we examine the mechanisms of changes in transmission dynamics at excitatory synapses. We show that paired-pulse ratios (PPRs) of AMPAR and NMDAR EPSCs onto dentate gyrus granule cells are often different; this difference is reduced during LTP, reflecting PPR changes of AMPAR but not NMDAR EPSCs. Presynaptic manipulations, however, produce parallel changes in AMPAR and NMDAR EPSCs. LTP at these synapses reflects a reduction in the proportion of silent synapses lacking functional AMPARs. Changes in PPR during LTP therefore reflect the initial difference between PPRs of silent and functional synapses. Functional conversion of silent synapses permits postsynaptic sampling from additional release sites and thereby affects the dynamics and gain of signals conveyed between neurons.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Inst Pasteur, INSERM, U261, F-75015 Paris, France	Cold Spring Harbor Laboratory; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Poncer, JC (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	jcponcer@biomedicale.univ-paris5.fr	Poncer, Jean Christophe/R-6362-2016	Poncer, Jean Christophe/0000-0001-5729-3009				Abbott LF, 1997, SCIENCE, V275, P220, DOI 10.1126/science.275.5297.221; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Buonomano DV, 1996, J NEUROPHYSIOL, V76, P631, DOI 10.1152/jn.1996.76.1.631; CHRISTIE BR, 1994, NEUROREPORT, V5, P385, DOI 10.1097/00001756-199401120-00003; CLARK KA, 1994, EXP BRAIN RES, V101, P272, DOI 10.1007/BF00228747; COLINO A, 1993, J NEUROPHYSIOL, V69, P1150, DOI 10.1152/jn.1993.69.4.1150; CONNORS BW, 1990, TRENDS NEUROSCI, V13, P99, DOI 10.1016/0166-2236(90)90185-D; DAVIS GW, 1994, TRENDS NEUROSCI, V17, P9, DOI 10.1016/0166-2236(94)90028-0; Debanne D, 1996, J PHYSIOL-LONDON, V491, P163, DOI 10.1113/jphysiol.1996.sp021204; FOX SE, 1975, EXP NEUROL, V49, P299, DOI 10.1016/0014-4886(75)90213-7; Gasparini S, 2000, P NATL ACAD SCI USA, V97, P9741, DOI 10.1073/pnas.170032297; Gerstner W, 1997, P NATL ACAD SCI USA, V94, P12740, DOI 10.1073/pnas.94.24.12740; HESSLER NA, 1993, NATURE, V366, P569, DOI 10.1038/366569a0; ISAAC JTR, 1995, NEURON, V15, P427, DOI 10.1016/0896-6273(95)90046-2; KATZ B, 1968, J PHYSIOL-LONDON, V195, P481, DOI 10.1113/jphysiol.1968.sp008469; Kleschevnikov AM, 1997, NEUROSCIENCE, V76, P829, DOI 10.1016/S0306-4522(96)00342-9; KULLMANN DM, 1994, NEURON, V12, P1111, DOI 10.1016/0896-6273(94)90318-2; LIAO DZ, 1995, NATURE, V375, P400, DOI 10.1038/375400a0; Lisman JE, 1997, TRENDS NEUROSCI, V20, P38, DOI 10.1016/S0166-2236(96)10070-9; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; Malinow R, 2000, CURR OPIN NEUROBIOL, V10, P352, DOI 10.1016/S0959-4388(00)00099-4; MALINOW R, 1991, SCIENCE, V252, P722, DOI 10.1126/science.1850871; MANABE T, 1993, J NEUROPHYSIOL, V70, P1451, DOI 10.1152/jn.1993.70.4.1451; Markram H, 1998, P NATL ACAD SCI USA, V95, P5323, DOI 10.1073/pnas.95.9.5323; Markram H, 1996, NATURE, V382, P807, DOI 10.1038/382807a0; MENNERICK S, 1995, J PHYSIOL-LONDON, V488, P85, DOI 10.1113/jphysiol.1995.sp020948; Min MY, 1998, P NATL ACAD SCI USA, V95, P4702, DOI 10.1073/pnas.95.8.4702; MULLER D, 1988, P NATL ACAD SCI USA, V85, P9346, DOI 10.1073/pnas.85.23.9346; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; PERKEL DJ, 1993, J PHYSIOL-LONDON, V471, P481, DOI 10.1113/jphysiol.1993.sp019911; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; PRINCE DA, 1992, P NATL ACAD SCI USA, V89, P8586, DOI 10.1073/pnas.89.18.8586; Racca C, 2000, J NEUROSCI, V20, P2512; RANCK JB, 1973, EXP NEUROL, V41, P462, DOI 10.1016/0014-4886(73)90290-2; Reyes A, 1998, NAT NEUROSCI, V1, P279, DOI 10.1038/1092; ROSENMUND C, 1993, SCIENCE, V262, P754, DOI 10.1126/science.7901909; Schikorski T, 1999, P NATL ACAD SCI USA, V96, P4107, DOI 10.1073/pnas.96.7.4107; Schulz PE, 1997, P NATL ACAD SCI USA, V94, P5888, DOI 10.1073/pnas.94.11.5888; SCHULZ PE, 1994, J NEUROSCI, V14, P5325; Schulz PE, 1997, J NEUROPHYSIOL, V78, P321, DOI 10.1152/jn.1997.78.1.321; Selig DK, 1999, J NEUROSCI, V19, P1236; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Volgushev M, 1997, EUR J NEUROSCI, V9, P1656, DOI 10.1111/j.1460-9568.1997.tb01523.x; Wang JH, 1997, J NEUROPHYSIOL, V78, P2707, DOI 10.1152/jn.1997.78.5.2707; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520	48	50	51	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	OCT	2001	4	10					989	996		10.1038/nn719	http://dx.doi.org/10.1038/nn719			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	478CR	11544481				2022-12-24	WOS:000171325800012
J	Saint-Amant, L; Drapeau, P				Saint-Amant, L; Drapeau, P			Synchronization of an embryonic network of identified spinal interneurons solely by electrical coupling	NEURON			English	Article							DEVELOPING NEURAL CIRCUITS; ZEBRAFISH EMBRYO; NEONATAL HIPPOCAMPUS; MOTONEURON ACTIVITY; LOCOMOTOR NETWORK; AXONAL OUTGROWTH; GAP-JUNCTIONS; IN-VIVO; NEURONS; CORD	There is a need to understand the mechanisms of neural synchronization during development because correlated rhythmic activity is thought to be critical for the establishment of proper connectivity. The relative importance of chemical and electrical synapses for synchronization of electrical activity during development is unclear. We examined the activity patterns of identified spinal neurons at the onset of motor activity in zebrafish embryos. Rhythmic activity appeared early and persisted upon blocking chemical neurotransmission but was abolished by inhibitors of gap junctions. Paired recordings revealed that active spinal neurons were electrically coupled and formed a simple network of motoneurons and a subset of interneurons. Thus, the earliest spinal central pattern generator consists of synchronously active, electrically coupled neurons.	McGill Univ, Montreal Gen Hosp, Inst Res, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biol, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; McGill University	Drapeau, P (corresponding author), McGill Univ, Montreal Gen Hosp, Inst Res, Neurosci Res Ctr, Montreal, PQ H3G 1A4, Canada.	pierre.drapeau@mcgill.ca						Ali DW, 2000, J NEUROPHYSIOL, V83, P181, DOI 10.1152/jn.2000.83.1.181; BARRY MAJ, 1987, DEV BRAIN RES, V36, P271, DOI 10.1016/0165-3806(87)90030-7; Beierlein M, 2000, NAT NEUROSCI, V3, P904, DOI 10.1038/78809; BERNHARDT RR, 1990, J COMP NEUROL, V302, P603, DOI 10.1002/cne.903020315; BRODIN L, 1985, BRAIN RES, V325, P302, DOI 10.1016/0006-8993(85)90328-2; Buss RR, 2001, J NEUROPHYSIOL, V86, P197, DOI 10.1152/jn.2001.86.1.197; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Chang Q, 2000, BRAIN RES REV, V32, P242, DOI 10.1016/S0165-0173(99)00085-5; Chub N, 1998, J NEUROSCI, V18, P294; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Drapeau P, 1999, J NEUROSCI METH, V88, P1, DOI 10.1016/S0165-0270(99)00008-4; Eisen JS, 1998, CURR OPIN NEUROBIOL, V8, P697, DOI 10.1016/S0959-4388(98)80110-4; EISEN JS, 1991, J NEUROSCI, V11, P311; ELMANIRA A, 1994, J NEUROPHYSIOL, V72, P1852, DOI 10.1152/jn.1994.72.4.1852; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 1999, NEURON, V22, P653, DOI 10.1016/S0896-6273(00)80724-2; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FISCHBACH GD, 1972, DEV BIOL, V28, P407, DOI 10.1016/0012-1606(72)90023-1; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Garaschuk O, 1998, J PHYSIOL-LONDON, V507, P219, DOI 10.1111/j.1469-7793.1998.219bu.x; GRILLNER S, 1991, ANNU REV NEUROSCI, V14, P169, DOI 10.1146/annurev.neuro.14.1.169; GRUNWALD DJ, 1988, DEV BIOL, V126, P115, DOI 10.1016/0012-1606(88)90245-X; HAMBURGER V, 1963, Q REV BIOL, V38, P342, DOI 10.1086/403941; Jontes JD, 2000, NAT NEUROSCI, V3, P231, DOI 10.1038/72936; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kristan WB, 2000, BRAIN RES BULL, V53, P561, DOI 10.1016/S0361-9230(00)00390-7; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; KUWADA JY, 1990, J COMP NEUROL, V302, P617, DOI 10.1002/cne.903020316; Leinekugel X, 1997, NEURON, V18, P243, DOI 10.1016/S0896-6273(00)80265-2; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; MENDELSON B, 1986, J COMP NEUROL, V251, P172, DOI 10.1002/cne.902510204; Milner LD, 1999, J NEUROSCI, V19, P3007; Myers P. Z., 1997, Journal of Computer-Assisted Microscopy, V9, P169; MYERS PZ, 1986, J NEUROSCI, V6, P2278; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Peinado A, 2000, J NEUROSCI, V20; PEINADO A, 1993, NEURON, V10, P103, DOI 10.1016/0896-6273(93)90246-N; POWELL SL, 1984, BRAIN RES, V294, P9, DOI 10.1016/0006-8993(84)91304-0; Rekling JC, 2000, J NEUROSCI, V20, part. no.; ROBERTS A, 1990, SCI PROG, V74, P31; Roerig B, 2000, BRAIN RES REV, V32, P86, DOI 10.1016/S0165-0173(99)00069-7; Rossignol Serge, 1994, Current Opinion in Neurobiology, V4, P894, DOI 10.1016/0959-4388(94)90139-2; Saint-Amant L, 2000, J NEUROSCI, V20, P3964; Saint-Amant L, 1998, J NEUROBIOL, V37, P622, DOI 10.1002/(SICI)1097-4695(199812)37:4<622::AID-NEU10>3.0.CO;2-S; ScrymgeourWedderburn JF, 1997, EUR J NEUROSCI, V9, P1473, DOI 10.1111/j.1460-9568.1997.tb01501.x; Selverston A., 1997, NEURONS NETWORKS MOT, P105; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; Soffe SR, 1996, J NEUROPHYSIOL, V75, P1815, DOI 10.1152/jn.1996.75.5.1815; Stein P. S. G., 1997, NEURONS NETWORKS MOT; Strata F, 1997, J NEUROSCI, V17, P1435; TAKENSKWAK BR, 1992, AM J PHYSIOL, V262, pC1531, DOI 10.1152/ajpcell.1992.262.6.C1531; Tanabe Y, 1996, SCIENCE, V274, P1115, DOI 10.1126/science.274.5290.1115; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; WONG ROL, 1995, NATURE, V374, P716, DOI 10.1038/374716a0; Wong WT, 1998, J NEUROSCI, V18, P8839	58	118	119	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	SEP 27	2001	31	6					1035	1046		10.1016/S0896-6273(01)00416-0	http://dx.doi.org/10.1016/S0896-6273(01)00416-0			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	477JW	11580902	Bronze			2022-12-24	WOS:000171281300017
J	Keller-Peck, CR; Walsh, MK; Gan, WB; Feng, GP; Sanes, JR; Lichtman, JW				Keller-Peck, CR; Walsh, MK; Gan, WB; Feng, GP; Sanes, JR; Lichtman, JW			Asynchronous synapse elimination in neonatal motor units: Studies using GFP transgenic mice	NEURON			English	Article							DEVELOPING NEUROMUSCULAR-JUNCTIONS; MOUSE SOLEUS MUSCLE; POLYNEURONAL INNERVATION; AXON WITHDRAWAL; STRIATED-MUSCLE; SKELETAL-MUSCLE; NERVOUS-SYSTEM; POSTNATAL LOSS; NEURONS; TERMINALS	In developing muscle, synapse elimination reduces the number of motor axons that innervate each postsynaptic cell. This loss of connections is thought to be a consequence of axon branch trimming. However, branch retraction has not been observed directly, and many questions remain, such as: do all motor axons retract branches, are eliminated branches withdrawn synchronously, and are withdrawing branches localized to particular regions? To address these questions, we used transgenic mice that express fluorescent proteins in small subsets of motor axons, providing a unique opportunity to reconstruct complete axonal arbors and identify all the postsynaptic targets. We found that, during early postnatal development, each motor axon loses terminal branches, but retracting branches withdraw asynchronously and without obvious spatial bias, suggesting that local interactions at each neuromuscular junction regulate synapse elimination.	Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Lichtman, JW (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.		Feng, Guoping/Y-2827-2019	Keller-Peck, Cynthia/0000-0001-8216-9632				BALICEGORDON RJ, 1988, J PHYSIOL-LONDON, V398, P211, DOI 10.1113/jphysiol.1988.sp017039; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Barber MJ, 1999, J NEUROSCI, V19, P9975; BENNETT MR, 1984, J NEUROSCI, V4, P2204; BENNETT MR, 1974, J PHYSIOL-LONDON, V241, P515, DOI 10.1113/jphysiol.1974.sp010670; BENNETT MR, 1983, J COMP NEUROL, V218, P351, DOI 10.1002/cne.902180311; Bernstein M, 1999, CURR OPIN NEUROBIOL, V9, P364, DOI 10.1016/S0959-4388(99)80053-1; BETZ WJ, 1979, J PHYSIOL-LONDON, V297, P463, DOI 10.1113/jphysiol.1979.sp013051; BIXBY JL, 1979, BRAIN RES, V169, P275, DOI 10.1016/0006-8993(79)91030-8; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387, DOI 10.1113/jphysiol.1976.sp011565; Bullock TH, 2000, BRAIN BEHAV EVOLUT, V55, P236, DOI 10.1159/000006657; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356; EDSTROM L, 1968, J NEUROL NEUROSUR PS, V31, P424, DOI 10.1136/jnnp.31.5.424; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; FLADBY T, 1987, ACTA PHYSIOL SCAND, V129, P239, DOI 10.1111/j.1748-1716.1987.tb08064.x; FLADBY T, 1988, ACTA PHYSIOL SCAND, V134, P561, DOI 10.1111/j.1365-201X.1988.tb10636.x; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Gan WB, 1999, J NEUROSCI METH, V93, P13, DOI 10.1016/S0165-0270(99)00096-5; GATESY SM, 1993, DEV DYNAM, V196, P174, DOI 10.1002/aja.1001960304; JANSEN JKS, 1990, PROG NEUROBIOL, V34, P39, DOI 10.1016/0301-0082(90)90025-C; Keller-Peck CR, 2001, J NEUROSCI, V21, P6136, DOI 10.1523/JNEUROSCI.21-16-06136.2001; Kopp DM, 2000, J NEUROSCI, V20, P8771; Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4; Lohof AM, 1996, REV NEUROSCIENCE, V7, P85; Nguyen QT, 1998, SCIENCE, V279, P1725, DOI 10.1126/science.279.5357.1725; ONTELL M, 1984, AM J ANAT, V171, P133, DOI 10.1002/aja.1001710202; ONTELL M, 1984, AM J ANAT, V171, P149, DOI 10.1002/aja.1001710203; PURVES D, 1980, SCIENCE, V210, P153, DOI 10.1126/science.7414326; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; THOMPSON W, 1977, NEUROSCIENCE, V2, P523, DOI 10.1016/0306-4522(77)90049-5; THOMPSON WJ, 1984, NATURE, V309, P709, DOI 10.1038/309709a0; VIDAL M, 1990, EMBO J, V9, P833, DOI 10.1002/j.1460-2075.1990.tb08180.x	34	125	126	0	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 16	2001	31	3					381	394		10.1016/S0896-6273(01)00383-X	http://dx.doi.org/10.1016/S0896-6273(01)00383-X			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	465QG	11516396	Bronze			2022-12-24	WOS:000170601000008
J	Zhang, HL; Eom, T; Oleynikov, Y; Shenoy, SM; Liebelt, DA; Dictenberg, JB; Singer, RH; Bassell, GJ				Zhang, HL; Eom, T; Oleynikov, Y; Shenoy, SM; Liebelt, DA; Dictenberg, JB; Singer, RH; Bassell, GJ			Neurotrophin-induced transport of a beta-actin mRNP complex increases beta-actin levels and stimulates growth cone motility	NEURON			English	Article							PROTEIN MESSENGER-RNA; DENDRITIC TARGETING ELEMENT; HIPPOCAMPAL-NEURONS; BINDING PROTEIN; INTRACELLULAR-LOCALIZATION; STAUFEN PROTEIN; XENOPUS OOCYTES; LIVING NEURONS; TRANSLOCATION; MICROTUBULES	Neurotrophin regulation of actin-dependent changes in growth cone motility may depend on the signaling of beta -actin mRNA transport. Formation of an RNP complex between the beta -actin mRNA zipcode sequence and Zip-code Binding Protein 1 (ZBP1) was required for its localization to growth cones. Antisense oligonucleotides to the zipcode inhibited formation of this RNP complex in vitro and the neurotrophin-induced localization of beta -actin mRNA and ZBP1 granules. Live cell imaging of neurons transfected with EGFP-ZBP1 revealed fast, bidirectional movements of granules in neurites that were inhibited by antisense treatment, as visualized by FRAP analysis. NT-3 stimulation of P-actin protein localization was dependent on the 3'UTR and inhibited by antisense treatment. Growth cones exhibited impaired motility in the presense of antisense. These results suggest a novel mechanism to influence growth cone dynamics involving the regulated transport of mRNA.	Yeshiva Univ Albert Einstein Coll Med, Rose F Kennedy Ctr Mental Retardat, Dept Neurosci, Bronx, NY 10461 USA; Yeshiva Univ Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Bassell, GJ (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Rose F Kennedy Ctr Mental Retardat, Dept Neurosci, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		shenoy, shailesh/AAD-4962-2020	Shenoy, Shailesh/0000-0002-5132-7236	NCI NIH HHS [CA09475-13] Funding Source: Medline; NIAMS NIH HHS [AR41480] Funding Source: Medline; NIGMS NIH HHS [R01 GM55599] Funding Source: Medline; NINDS NIH HHS [R01 NS39641, T32 NS07439] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007439, R01NS039641] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ainger K, 1997, J CELL BIOL, V138, P1077, DOI 10.1083/jcb.138.5.1077; AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Bassell G J, 2001, Results Probl Cell Differ, V34, P41; Bassell GJ, 1998, J NEUROSCI, V18, P251; BASSELL GJ, 1994, NEURON, V12, P571, DOI 10.1016/0896-6273(94)90213-5; BEHAR L, 1995, INT J DEV NEUROSCI, V13, P113, DOI 10.1016/0736-5748(95)00001-W; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Carson JH, 1997, CELL MOTIL CYTOSKEL, V38, P318, DOI 10.1002/(SICI)1097-0169(1997)38:4<318::AID-CM2>3.0.CO;2-#; Crino PB, 1996, NEURON, V17, P1173, DOI 10.1016/S0896-6273(00)80248-2; Deshler JO, 1998, CURR BIOL, V8, P489, DOI 10.1016/S0960-9822(98)70200-3; ELISHA Z, 1995, EMBO J, V14, P5109, DOI 10.1002/j.1460-2075.1995.tb00193.x; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; HANNAN AJ, 1995, MOL CELL NEUROSCI, V6, P397, DOI 10.1006/mcne.1995.1030; Havin L, 1998, GENE DEV, V12, P1593, DOI 10.1101/gad.12.11.1593; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Hoek KS, 1998, BIOCHEMISTRY-US, V37, P7021, DOI 10.1021/bi9800247; KAECH S, 1996, MOL BRAIN RES, V233, P66; Kiebler MA, 2000, NEURON, V25, P19, DOI 10.1016/S0896-6273(00)80868-5; Kiebler MA, 1999, J NEUROSCI, V19, P288, DOI 10.1523/JNEUROSCI.19-01-00288.1999; Kislauskis EH, 1997, J CELL BIOL, V136, P1263, DOI 10.1083/jcb.136.6.1263; KISLAUSKIS EH, 1994, J CELL BIOL, V127, P441, DOI 10.1083/jcb.127.2.441; KLEIMAN R, 1994, J NEUROSCI, V14, P1130, DOI 10.1523/JNEUROSCI.14-03-01130.1994; Knowles RB, 1997, P NATL ACAD SCI USA, V94, P14804, DOI 10.1073/pnas.94.26.14804; Knowles RB, 1996, J NEUROSCI, V16, P7812; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Kuhn TB, 2000, J NEUROBIOL, V44, P126, DOI 10.1002/1097-4695(200008)44:2<126::AID-NEU4>3.0.CO;2-Z; Kwon S, 1999, J CELL BIOL, V147, P247, DOI 10.1083/jcb.147.2.247; Latham VM, 2001, CURR BIOL, V11, P1010, DOI 10.1016/S0960-9822(01)00291-3; LITMAN P, 1993, NEURON, V10, P627, DOI 10.1016/0896-6273(93)90165-N; LITMAN P, 1994, NEURON, V13, P1463, DOI 10.1016/0896-6273(94)90432-4; LITMAN P, 1996, DEV BIOL, V176, P84; Long RM, 1997, SCIENCE, V277, P383, DOI 10.1126/science.277.5324.383; Mayford M, 1996, P NATL ACAD SCI USA, V93, P13250, DOI 10.1073/pnas.93.23.13250; Mori Y, 2000, NAT NEUROSCI, V3, P1079, DOI 10.1038/80591; Munro TP, 1999, J BIOL CHEM, V274, P34389, DOI 10.1074/jbc.274.48.34389; OKABE S, 1991, J NEUROSCI, V11, P1918; Paves H, 1997, CELL TISSUE RES, V290, P285, DOI 10.1007/s004410050933; Rehbein M, 2000, MOL BRAIN RES, V79, P192, DOI 10.1016/S0169-328X(00)00114-5; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; Ross AF, 1997, MOL CELL BIOL, V17, P2158, DOI 10.1128/MCB.17.4.2158; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Shestakova EA, 2001, P NATL ACAD SCI USA, V98, P7045, DOI 10.1073/pnas.121146098; SHUSTER CB, 1995, J CELL BIOL, V128, P837, DOI 10.1083/jcb.128.5.837; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; SUNDELL CL, 1991, SCIENCE, V253, P1275, DOI 10.1126/science.1891715; Tiedge H, 1999, SCIENCE, V283, P186, DOI 10.1126/science.283.5399.186; Tiedge H, 1996, J NEUROSCI, V16, P7171; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Zhang HL, 1999, J CELL BIOL, V147, P59, DOI 10.1083/jcb.147.1.59; Zhang JY, 1999, J EXP MED, V189, P1101, DOI 10.1084/jem.189.7.1101; Zhang QH, 1999, MECH DEVELOP, V88, P101, DOI 10.1016/S0925-4773(99)00162-8	55	302	314	1	8	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	AUG 2	2001	31	2					261	275		10.1016/S0896-6273(01)00357-9	http://dx.doi.org/10.1016/S0896-6273(01)00357-9			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	459XX	11502257	Bronze			2022-12-24	WOS:000170277700011
J	Roche, KW; Standley, S; McCallum, J; Ly, CD; Ehlers, MD; Wenthold, RJ				Roche, KW; Standley, S; McCallum, J; Ly, CD; Ehlers, MD; Wenthold, RJ			Molecular determinants of NMDA receptor internalization	NATURE NEUROSCIENCE			English	Article							AMPA RECEPTORS; GLUTAMATE RECEPTORS; K+ CHANNELS; EXPRESSION; SUBUNITS; DISTINCT; ENDOCYTOSIS; PSD-95; REDISTRIBUTION; PROTEINS	Although synaptic AMPA receptors have been shown to rapidly internalize, synaptic NMDA receptors are reported to be static. It is not certain whether NMDA receptor stability at synaptic sites is an inherent property of the receptor, or is due to stabilization by scaffolding proteins. In this study, we demonstrate that NMDA receptors are internalized in both heterologous cells and neurons, and we define an internalization motif, YEKL, on the distal C-terminus of NR2B. In addition, we show that the synaptic protein PSD-95 inhibits NR2B-mediated internalization, and that deletion of the PDZ-binding domain of NR2B increases internalization in neurons. This suggests an involvement for PSD-95 in NMDA receptor regulation and an explanation for NMDA receptor stability at synaptic sites.	Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Duke University	Roche, KW (corresponding author), Natl Inst Deafness & Other Commun Disorders, Neurochem Lab, NIH, Bldg 36,Room 5B25, Bethesda, MD 20892 USA.	rochek@nidcd.nih.gov	Roche, Katherine/W-9893-2019	Roche, Katherine/0000-0001-7282-6539	NINDS NIH HHS [R01-NS39402] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000003] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bonifacino JS, 1999, J CELL BIOL, V145, P923, DOI 10.1083/jcb.145.5.923; Carroll RC, 1999, P NATL ACAD SCI USA, V96, P14112, DOI 10.1073/pnas.96.24.14112; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Cohen NA, 1996, NEURON, V17, P759, DOI 10.1016/S0896-6273(00)80207-X; Craven SE, 2000, J BIOL CHEM, V275, P20045, DOI 10.1074/jbc.M910153199; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Garcia EP, 1998, NEURON, V21, P727, DOI 10.1016/S0896-6273(00)80590-5; Garner CC, 2000, TRENDS CELL BIOL, V10, P274, DOI 10.1016/S0962-8924(00)01783-9; Hawkins LM, 1999, J BIOL CHEM, V274, P27211, DOI 10.1074/jbc.274.38.27211; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hsueh YP, 1998, PROG BRAIN RES, V116, P123, DOI 10.1016/S0079-6123(08)60434-3; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Jugloff DGM, 2000, J BIOL CHEM, V275, P1357, DOI 10.1074/jbc.275.2.1357; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; KISTNER U, 1993, J BIOL CHEM, V268, P4580; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Lin JW, 2000, NAT NEUROSCI, V3, P1282, DOI 10.1038/81814; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Malenka RC, 1997, NEURON, V19, P473, DOI 10.1016/S0896-6273(00)80362-1; Mammen AL, 1997, J NEUROSCI, V17, P7351; Man HY, 2000, NEURON, V25, P649, DOI 10.1016/S0896-6273(00)81067-3; McIlhinney RAJ, 1998, NEUROPHARMACOLOGY, V37, P1355, DOI 10.1016/S0028-3908(98)00121-X; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Roche KW, 1999, J NEUROSCI, V19, P3926; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Rumbaugh G, 1999, J NEUROSCI, V19, P10603, DOI 10.1523/JNEUROSCI.19-24-10603.1999; Sans N, 2000, J NEUROSCI, V20, P1260, DOI 10.1523/JNEUROSCI.20-03-01260.2000; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Spacek J, 1997, J NEUROSCI, V17, P190, DOI 10.1523/JNEUROSCI.17-01-00190.1997; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Takagi N, 2000, J NEUROCHEM, V74, P169, DOI 10.1046/j.1471-4159.2000.0740169.x; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Tovar KR, 1999, J NEUROSCI, V19, P4180; Tsao P, 2000, CURR OPIN NEUROBIOL, V10, P365, DOI 10.1016/S0959-4388(00)00096-9; VICARIOABEJON C, 1997, CURRENT PROTOCOLS NE; Wang YT, 2000, NEURON, V25, P635, DOI 10.1016/S0896-6273(00)81066-1; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	50	403	420	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	AUG	2001	4	8					794	802		10.1038/90498	http://dx.doi.org/10.1038/90498			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	457KY	11477425				2022-12-24	WOS:000170137300012
J	Glatzel, M; Heppner, FL; Albers, KM; Aguzzi, A				Glatzel, M; Heppner, FL; Albers, KM; Aguzzi, A			Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion	NEURON			English	Article							PERIPHERAL NERVOUS-SYSTEM; FOLLICULAR DENDRITIC CELLS; SCRAPIE AGENT; MOUSE SCRAPIE; CHEMICAL SYMPATHECTOMY; LYMPHOID-TISSUES; IMMUNE-SYSTEM; SPINAL-CORD; IN-VIVO; PROTEIN	Transmissible spongiform encephalopathies are commonly propagated by extracerebral inoculation of the infectious agent. Indirect evidence suggests that entry into the central nervous system occurs via the peripheral nervous system. Here we have investigated the role of the sympathetic nervous system in prion neuroinvasion. Following intraperitoneal prion inoculation, chemical or immunological sympathectomy delayed or prevented scrapie. Prion titers in spinal cords were drastically reduced at early time points after inoculation. Instead, keratin 14-NGF transgenic mice, whose lymphoid organs are hyperinnervated by sympathetic nerves, showed reduction in scrapie incubation time and, unexpectedly, much higher titers of prion infectivity in spleens. We conclude that sympathetic innervation of lymphoid organs is rate limiting for prion neuroinvasion and that splenic sympathetic nerves may act as extracerebral prion reservoirs.	Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland; Univ Kentucky, Coll Med, Dept Pathol & Lab Med, Lexington, KY 40536 USA	University of Zurich; University Zurich Hospital; University of Kentucky	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Aguzzi, Adriano/A-3351-2008; Glatzel, Markus/G-3356-2011; Heppner, Frank/ABH-8393-2020; Glatzel, Markus/V-8844-2019	Glatzel, Markus/0000-0002-7720-8817; Heppner, Frank/0000-0001-9816-8917; Glatzel, Markus/0000-0002-7720-8817; Aguzzi, Adriano/0000-0002-0344-6708; Albers, Kathryn/0000-0003-4597-9323				Aguzzi A, 1997, NATURE, V389, P795, DOI 10.1038/39758; Aguzzi A, 2001, NAT REV MOL CELL BIO, V2, P118, DOI 10.1038/35052063; Baldauf E, 1997, J GEN VIROL, V78, P1187, DOI 10.1099/0022-1317-78-5-1187; Beekes M, 1996, J GEN VIROL, V77, P1925, DOI 10.1099/0022-1317-77-8-1925; Beekes M, 1998, J GEN VIROL, V79, P601, DOI 10.1099/0022-1317-79-3-601; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Carlson SL, 1997, BRAIN BEHAV IMMUN, V11, P307, DOI 10.1006/brbi.1997.0501; CARLSON SL, 1995, J NEUROSCI, V15, P5892; CLARKE MC, 1984, VET MICROBIOL, V9, P215, DOI 10.1016/0378-1135(84)90039-7; COLE S, 1985, NEUROPATH APPL NEURO, V11, P213, DOI 10.1111/j.1365-2990.1985.tb00019.x; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; Farquhar CF, 1996, J GEN VIROL, V77, P1941, DOI 10.1099/0022-1317-77-8-1941; FELTEN D L, 1988, Brain Behavior and Immunity, V2, P293, DOI 10.1016/0889-1591(88)90031-1; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fischer MB, 2000, NATURE, V408, P479, DOI 10.1038/35044100; Glatzel M, 2000, J GEN VIROL, V81, P2813, DOI 10.1099/0022-1317-81-11-2813; Glatzel M, 2000, MICROBES INFECT, V2, P613, DOI 10.1016/S1286-4579(00)00364-6; Glatzel W, 2000, P NATL ACAD SCI USA, V97, P442, DOI 10.1073/pnas.97.1.442; Hainfellner JA, 1999, ACTA NEUROPATHOL, V98, P458, DOI 10.1007/s004010051109; KIMBERLIN RH, 1983, J NEUROL SCI, V61, P315, DOI 10.1016/0022-510X(83)90165-X; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Kohm AP, 1999, J IMMUNOL, V162, P5299; KRUSZEWSKA B, 1995, J IMMUNOL, V155, P4613; Lasmezas CI, 1996, J VIROL, V70, P1292; MADDEN KS, 1994, J NEUROIMMUNOL, V49, P67, DOI 10.1016/0165-5728(94)90182-1; McBride PA, 1999, NEUROSCI LETT, V265, P135, DOI 10.1016/S0304-3940(99)00223-2; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Picklo MJ, 1997, J AUTONOM NERV SYST, V62, P111, DOI 10.1016/S0165-1838(96)00121-X; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Race R, 2000, J VIROL, V74, P828, DOI 10.1128/JVI.74.2.828-833.2000; TARABOULOS A, 1992, P NATL ACAD SCI USA, V89, P7620, DOI 10.1073/pnas.89.16.7620	38	181	186	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 19	2001	31	1					25	34		10.1016/S0896-6273(01)00331-2	http://dx.doi.org/10.1016/S0896-6273(01)00331-2			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	456UR	11498048	Green Accepted, Bronze			2022-12-24	WOS:000170101100008
J	Lampl, I; Anderson, JS; Gillespie, DC; Ferster, D				Lampl, I; Anderson, JS; Gillespie, DC; Ferster, D			Prediction of orientation selectivity from receptive field architecture in simple cells of cat visual cortex	NEURON			English	Article							LATERAL GENICULATE-NUCLEUS; CROSS-CORRELATION ANALYSIS; CORTICAL SIMPLE CELLS; STRIATE CORTEX; DIRECTION SELECTIVITY; AREA 17; SYNAPTIC INTEGRATION; SPATIAL SUMMATION; THALAMIC INPUT; MODEL	From the intracellularly recorded responses to small, rapidly flashed spots, we have quantitatively mapped the receptive fields of simple cells in the cat visual cortex. We then applied these maps to a feedforward model of orientation selectivity. Both the preferred orientation and the width of orientation tuning of the responses to oriented stimuli were well predicted by the model. Where tested, the tuning curve was well predicted at different spatial frequencies. The model was also successful in predicting certain features of the spatial frequency selectivity of the cells. It did not successfully predict the amplitude of the responses to drifting gratings. Our results show that the spatial organization of the receptive field can account for a large fraction of the orientation selectivity of simple cells.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA	Northwestern University	Lampl, I (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, 2153 N Campus Dr, Evanston, IL 60208 USA.			Anderson, Jeffrey/0000-0002-9669-3846; Lampl, Ilan/0000-0002-9380-0730	NEI NIH HHS [R01 EY04726, T32 EY07128] Funding Source: Medline; NATIONAL EYE INSTITUTE [T32EY007128, R01EY004726] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Adorjan P, 1999, VISUAL NEUROSCI, V16, P303, DOI 10.1017/S0952523899162114; ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; Alonso JM, 1996, NATURE, V383, P815, DOI 10.1038/383815a0; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BenYishai R, 1997, J COMPUT NEUROSCI, V4, P57, DOI 10.1023/A:1008816611284; Brainard D. H., 1997, SPATIAL VISION, V10, P443, DOI DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Carandini M, 1997, J NEUROSCI, V17, P8621; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Chung S, 1998, NEURON, V20, P1177, DOI 10.1016/S0896-6273(00)80498-5; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1118, DOI 10.1152/jn.1993.69.4.1118; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DOUGLAS RJ, 1991, J PHYSIOL-LONDON, V440, P735, DOI 10.1113/jphysiol.1991.sp018733; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1988, J NEUROSCI, V8, P1172; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Hansel D, 1996, J COMPUT NEUROSCI, V3, P7, DOI 10.1007/BF00158335; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; Hirsch JA, 1998, J NEUROSCI, V18, P9517; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Jagadeesh B, 1997, J NEUROPHYSIOL, V78, P2772, DOI 10.1152/jn.1997.78.5.2772; JAGADEESH B, 1993, SCIENCE, V262, P1901, DOI 10.1126/science.8266083; JONES JP, 1987, J NEUROPHYSIOL, V58, P1187, DOI 10.1152/jn.1987.58.6.1187; JONES JP, 1987, J NEUROPHYSIOL, V58, P1233, DOI 10.1152/jn.1987.58.6.1233; Lampl I, 1999, NEURON, V22, P361, DOI 10.1016/S0896-6273(00)81096-X; MCLEAN J, 1989, VISION RES, V29, P675, DOI 10.1016/0042-6989(89)90029-1; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P53, DOI 10.1113/jphysiol.1978.sp012488; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; REID RC, 1991, J NEUROPHYSIOL, V66, P505, DOI 10.1152/jn.1991.66.2.505; SAUL AB, 1992, J NEUROPHYSIOL, V68, P1190, DOI 10.1152/jn.1992.68.4.1190; SKOTTUN BC, 1987, J NEUROPHYSIOL, V57, P773, DOI 10.1152/jn.1987.57.3.773; SOMERS DC, 1995, J NEUROSCI, V15, P5448; SUAREZ H, 1995, J NEUROSCI, V15, P6700; TANAKA K, 1983, J NEUROPHYSIOL, V49, P1303, DOI 10.1152/jn.1983.49.6.1303; TOYAMA K, 1981, J NEUROPHYSIOL, V46, P191, DOI 10.1152/jn.1981.46.2.191; Troyer TW, 1998, J NEUROSCI, V18, P5908; Volgushev M, 2000, EUR J NEUROSCI, V12, P257, DOI 10.1046/j.1460-9568.2000.00909.x; Volgushev M, 1996, J PHYSIOL-LONDON, V496, P597, DOI 10.1113/jphysiol.1996.sp021711	42	70	72	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					263	274		10.1016/S0896-6273(01)00278-1	http://dx.doi.org/10.1016/S0896-6273(01)00278-1			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343660	Bronze			2022-12-24	WOS:000168412900026
J	Powell, EM; Mars, WM; Levitt, P				Powell, EM; Mars, WM; Levitt, P			Hepatocyte growth factor/scatter factor is a motogen for interneurons migrating from the ventral to dorsal telencephalon	NEURON			English	Article							RECEPTOR-DEFICIENT MICE; FACTOR SCATTER FACTOR; C-MET RECEPTOR; UROKINASE RECEPTOR; NEUROTROPHIC FACTOR; CEREBRAL-CORTEX; CELL-MIGRATION; PLASMINOGEN-ACTIVATOR; GANGLIONIC EMINENCE; LIVER-REGENERATION	Cortical interneurons arise from the proliferative tone of the ventral telencephalon, the ganglionic eminence, and migrate into the developing neocortex. The spatial patterns of migratory interneurons reflect the complementary expression of hepatocyte growth factor/scatter factor (HGF/SF) and its receptor, MET, in the forebrain. Scatter assays on forebrain explants demonstrate regionally specific motogenic activity due to HGF/SF. In addition, exogenous ligand disrupts normal cell migration. Mice lacking the urokinase-type plasminogen activator receptor (u-PAR), a key component of HGF/SF activation, exhibit deficient scatter activity in the forebrain, abnormal interneuron migration from the ganglionic eminence, and reduced interneurons in the frontal and parietal cortex. The data suggest that HGF/SF motogenic activity, which is essential for normal development of other organ systems, is a conserved mechanism that regulates trans-telencephalic migration of interneurons.	Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA; Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Powell, EM (corresponding author), Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA 15261 USA.	epowell+@pitt.edu	Powell, Elizabeth/C-3153-2013	Powell, Elizabeth/0000-0002-7529-9057	NIMH NIH HHS [MH12651, MH45507] Funding Source: Medline; NINDS NIH HHS [NS07391] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH045507, R37MH045507] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Achim CL, 1997, DEV BRAIN RES, V102, P299, DOI 10.1016/S0165-3806(97)00108-9; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Birchmeier C, 1998, TRENDS CELL BIOL, V8, P404, DOI 10.1016/S0962-8924(98)01359-2; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Blanquaert F, 2000, AM J PHYSIOL-ENDOC M, V278, pE509, DOI 10.1152/ajpendo.2000.278.3.E509; BLASI F, 1993, BIOESSAYS, V15, P105, DOI 10.1002/bies.950150206; Davey F, 2000, MOL CELL NEUROSCI, V15, P79, DOI 10.1006/mcne.1999.0803; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Dewerchin M, 1996, J CLIN INVEST, V97, P870, DOI 10.1172/JCI118489; Eagleson KL, 1999, CEREB CORTEX, V9, P562, DOI 10.1093/cercor/9.6.562; Ebens A, 1996, NEURON, V17, P1157, DOI 10.1016/S0896-6273(00)80247-0; Fiumelli H, 2000, J NEUROCHEM, V74, P1870, DOI 10.1046/j.1471-4159.2000.0741870.x; GHERARDI E, 1991, EUR J CANCER, V27, P403, DOI 10.1016/0277-5379(91)90370-S; Gyetko MR, 2000, J IMMUNOL, V165, P1513, DOI 10.4049/jimmunol.165.3.1513; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HONDA S, 1995, MOL BRAIN RES, V32, P197, DOI 10.1016/0169-328X(95)00075-4; Korhonen L, 2000, EUR J NEUROSCI, V12, P3453, DOI 10.1046/j.1460-9568.2000.00260.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lillien L, 1998, CURR BIOL, V8, pR872, DOI 10.1016/S0960-9822(07)00548-9; Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5; LIU FC, 1992, J NEUROSCI, V12, P674; Liu YH, 1999, AM J PHYSIOL-RENAL, V277, pF624, DOI 10.1152/ajprenal.1999.277.4.F624; Liu YH, 1999, KIDNEY INT, V55, P442, DOI 10.1046/j.1523-1755.1999.00267.x; Maina F, 1997, GENE DEV, V11, P3341, DOI 10.1101/gad.11.24.3341; Maina F, 1998, NEURON, V20, P835, DOI 10.1016/S0896-6273(00)80466-3; Mars WM, 1996, CANCER RES, V56, P2837; MARS WM, 1993, AM J PATHOL, V143, P949; MARS WM, 1995, HEPATOLOGY, V21, P1695, DOI 10.1016/0270-9139(95)90477-8; Matsumoto K, 1997, CIBA F SYMP, V212, P198; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; MILLER MW, 1986, DEV BRAIN RES, V28, P41, DOI 10.1016/0165-3806(86)90063-5; NAIDINI L, 1992, EMBO J, V11, P4825; Ossowski L, 2000, CURR OPIN CELL BIOL, V12, P613, DOI 10.1016/S0955-0674(00)00140-X; Parnavelas J G, 2000, Novartis Found Symp, V228, P129; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; ROGERS CJ, 1992, BRAIN RES BULL, V28, P587, DOI 10.1016/0361-9230(92)90107-9; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; Seeds NW, 1999, P NATL ACAD SCI USA, V96, P14118, DOI 10.1073/pnas.96.24.14118; Simon DI, 2000, J BIOL CHEM, V275, P10228, DOI 10.1074/jbc.275.14.10228; Stella MC, 1999, INT J BIOCHEM CELL B, V31, P1357, DOI 10.1016/S1357-2725(99)00089-8; STOKER M, 1987, NATURE, V327, P239, DOI 10.1038/327239a0; Streit ACE, 1997, CIBA F SYMP, V212, P155; Tamamaki N, 1997, J NEUROSCI, V17, P8313; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Thewke DP, 1999, BRAIN RES, V821, P356, DOI 10.1016/S0006-8993(99)01115-4; Thewke DP, 1996, J NEUROSCI, V16, P6933; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Waltz DA, 2000, AM J RESP CELL MOL, V22, P316, DOI 10.1165/ajrcmb.22.3.3713; Yamamoto Y, 1997, DEVELOPMENT, V124, P2903; Zhu Y, 1999, NEURON, V23, P473, DOI 10.1016/S0896-6273(00)80801-6	54	252	258	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	APR	2001	30	1					79	89		10.1016/S0896-6273(01)00264-1	http://dx.doi.org/10.1016/S0896-6273(01)00264-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343646	Bronze			2022-12-24	WOS:000168412900012
J	Tolias, AS; Moore, T; Smirnakis, SM; Tehovnik, EJ; Siapas, AG; Schiller, PH				Tolias, AS; Moore, T; Smirnakis, SM; Tehovnik, EJ; Siapas, AG; Schiller, PH			Eye movements modulate visual receptive fields of V4 neurons	NEURON			English	Article							SUPERIOR TEMPORAL SULCUS; RHESUS-MONKEY; AREA V4; PREFRONTAL CORTEX; PARIETAL CORTEX; ATTENTION; MACAQUE; SACCADES; REPRESENTATION; RESPONSES	The receptive field, defined as the spatiotemporal selectivity of neurons to sensory stimuli, is central to our understanding of the neuronal mechanisms of perception. However, despite the fact that eye movements are critical during normal vision, the influence of eye movements on the structure of receptive fields has never been characterized. Here, we map the receptive fields of macaque area V4 neurons during saccadic eye movements and find that receptive fields are remarkably dynamic. Specifically, before the initiation of a saccadic eye movement, receptive fields shrink and shift towards the saccade target. These spatiotemporal dynamics may enhance information processing of relevant stimuli during the scanning of a visual scene, thereby assisting the selection of saccade targets and accelerating the analysis of the visual scene during free viewing.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02114 USA; MIT, Ctr Learning & Memory, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Tolias, AS (corresponding author), Max Planck Inst Biol Cybernet, Spemannstr 38, Tubingen, Germany.							ANDERSEN RA, 1983, J NEUROSCI, V3, P532; BLATT GJ, 1990, J COMP NEUROL, V299, P421, DOI 10.1002/cne.902990404; BOCH RA, 1989, J NEUROPHYSIOL, V61, P1064, DOI 10.1152/jn.1989.61.5.1064; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; Cai RH, 1997, NATURE, V386, P601, DOI 10.1038/386601a0; CARMER SG, 1973, J AM STAT ASSOC, V68, P66, DOI 10.2307/2284140; Carpenter RHS, 1988, MOVEMENTS EYES; COMMENGES D, 1985, STAT MED, V4, P91, DOI 10.1002/sim.4780040113; Conner CE, 1997, J NEUROSCI, V17, P3201; Connor CE, 1996, J NEUROPHYSIOL, V75, P1306, DOI 10.1152/jn.1996.75.3.1306; DESIMONE R, 1979, BRAIN RES, V178, P363, DOI 10.1016/0006-8993(79)90699-1; DESIMONE R, 1987, J NEUROPHYSIOL, V57, P835, DOI 10.1152/jn.1987.57.3.835; DIMITROV G, 1976, VISION RES, V16, P411, DOI 10.1016/0042-6989(76)90205-4; DUBNER R, 1971, BRAIN RES, V35, P528, DOI 10.1016/0006-8993(71)90494-X; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; FISCHER B, 1981, EXP BRAIN RES, V44, P129; FISCHER B, 1981, EXP BRAIN RES, V41, P431; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HANES DP, 1995, EXP BRAIN RES, V103, P85; Hartline HK, 1940, AM J PHYSIOL, V130, P0690, DOI 10.1152/ajplegacy.1940.130.4.690; HENDERSON JM, 1989, PERCEPT PSYCHOPHYS, V45, P196, DOI 10.3758/BF03210697; Hikosaka K, 1998, BEHAV BRAIN RES, V96, P101, DOI 10.1016/S0166-4328(97)00202-7; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; LOGOTHETIS NK, 1990, VISION RES, V30, P1409, DOI 10.1016/0042-6989(90)90022-D; MACKEBEN M, 1993, VISION RES, V33, P85, DOI 10.1016/0042-6989(93)90061-Z; McAdams CJ, 1999, J NEUROSCI, V19, P431, DOI 10.1523/JNEUROSCI.19-01-00431.1999; Moore T, 1999, SCIENCE, V285, P1914, DOI 10.1126/science.285.5435.1914; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rainer G, 1998, P NATL ACAD SCI USA, V95, P15008, DOI 10.1073/pnas.95.25.15008; REMINGTON RW, 1992, PERCEPT PSYCHOPHYS, V51, P279, DOI 10.3758/BF03212254; ROBINSON DL, 1978, J NEUROPHYSIOL, V41, P910, DOI 10.1152/jn.1978.41.4.910; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SUZUKI H, 1983, EXP BRAIN RES, V53, P47; TANAKA M, 1986, EXP BRAIN RES, V65, P11; TEHOVNIK EJ, 1993, EXP BRAIN RES, V96, P430; Umeno MM, 1997, J NEUROPHYSIOL, V78, P1373, DOI 10.1152/jn.1997.78.3.1373; WALKER MF, 1995, J NEUROPHYSIOL, V73, P1988, DOI 10.1152/jn.1995.73.5.1988; WURTZ RH, 1969, J NEUROPHYSIOL, V32, P727, DOI 10.1152/jn.1969.32.5.727; WURTZ RH, 1976, J NEUROPHYSIOL, V39, P766, DOI 10.1152/jn.1976.39.4.766; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7; Zar, 2011, BIOSTAT ANAL	45	222	223	0	5	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAR	2001	29	3					757	767		10.1016/S0896-6273(01)00250-1	http://dx.doi.org/10.1016/S0896-6273(01)00250-1			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	418BA	11301034	Bronze			2022-12-24	WOS:000167868900024
J	Groh, JM; Trause, AS; Underhill, AM; Clark, KR; Inati, S				Groh, JM; Trause, AS; Underhill, AM; Clark, KR; Inati, S			Eye position influences auditory responses in primate inferior colliculus	NEURON			English	Article							POSTERIOR PARIETAL NEURONS; SUPERIOR COLLICULUS; SOUND-LOCALIZATION; NEURAL REPRESENTATION; EXTERNAL NUCLEUS; RECEPTIVE-FIELDS; BARN OWLS; VISUAL CALIBRATION; STIMULUS AZIMUTH; CORTEX NEURONS	We examined the frame of reference of auditory responses in the inferior colliculus in monkeys fixating visual stimuli at different locations. Eye position modulated the level of auditory responses in 33% of the neurons we encountered, but it did not appear to shift their spatial tuning. The effect of eye position on auditory responses was substantial-comparable in magnitude to that of sound location. The eye position signal appeared to interact with the auditory responses in at least a partly multiplicative fashion. We conclude that the representation of sound location in primate IC is distributed and that the frame of reference is intermediate between head- and eye-centered coordinates. The information contained in these neurons appears to be sufficient for later neural stages to calculate the positions of sounds with respect to the eyes.	Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, Hanover, NH 03755 USA	Dartmouth College	Groh, JM (corresponding author), Dartmouth Coll, Dept Psychol & Brain Sci, Ctr Cognit Neurosci, 6207 Moore Hall, Hanover, NH 03755 USA.		Clark, Kimberly/Z-6228-2019	Inati, Souheil/0000-0001-5596-9554; Groh, Jennifer/0000-0002-6435-3935				AITKIN L, 1990, HEARING RES, V50, P97, DOI 10.1016/0378-5955(90)90036-O; AITKIN LM, 1978, J NEUROPHYSIOL, V41, P837, DOI 10.1152/jn.1978.41.4.837; AITKIN LM, 1981, J COMP NEUROL, V196, P25, DOI 10.1002/cne.901960104; AITKIN LM, 1987, J NEUROPHYSIOL, V57, P1185, DOI 10.1152/jn.1987.57.4.1185; AITKIN LM, 1985, J NEUROPHYSIOL, V53, P43, DOI 10.1152/jn.1985.53.1.43; AITKIN LM, 1984, J NEUROPHYSIOL, V52, P1; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; BINNS KE, 1992, BRAIN RES, V589, P231, DOI 10.1016/0006-8993(92)91282-J; BOCK GR, 1974, EXP BRAIN RES, V21, P387; BRAINARD MS, 1995, J NEUROPHYSIOL, V73, P595, DOI 10.1152/jn.1995.73.2.595; BRAINARD MS, 1993, J NEUROSCI, V13, P4589; BRAINARD MS, 1993, BIOMED RES-TOKYO, V14, P35; Bremmer F, 1997, J NEUROPHYSIOL, V77, P962, DOI 10.1152/jn.1997.77.2.962; Bremmer F, 1997, J NEUROPHYSIOL, V77, P944, DOI 10.1152/jn.1997.77.2.944; Bremmer F, 1999, NEUROREPORT, V10, P873, DOI 10.1097/00001756-199903170-00037; CALFORD MB, 1986, J NEUROPHYSIOL, V55, P587, DOI 10.1152/jn.1986.55.3.587; Cohen YE, 2000, NEURON, V27, P647, DOI 10.1016/S0896-6273(00)00073-8; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; EHRET G, 1997, CENTRAL AUDITORY SYS; Feldman DE, 1996, SCIENCE, V271, P525, DOI 10.1126/science.271.5248.525; GROH JM, 1992, BIOL CYBERN, V67, P291, DOI 10.1007/BF02414885; Guo K, 1997, NEUROREPORT, V8, P1405, DOI 10.1097/00001756-199704140-00017; HARTLINE PH, 1995, EXP BRAIN RES, V104, P402; ITAYA SK, 1982, BRAIN RES, V233, P45, DOI 10.1016/0006-8993(82)90928-3; JAY MF, 1984, NATURE, V309, P345, DOI 10.1038/309345a0; JAY MF, 1987, J NEUROPHYSIOL, V57, P35, DOI 10.1152/jn.1987.57.1.35; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; KELLY JB, 1994, J NEUROPHYSIOL, V71, P1078, DOI 10.1152/jn.1994.71.3.1078; KNUDSEN EI, 1978, SCIENCE, V200, P795, DOI 10.1126/science.644324; KNUDSEN EI, 1991, SCIENCE, V253, P85, DOI 10.1126/science.2063209; KNUDSEN EI, 1985, SCIENCE, V230, P545, DOI 10.1126/science.4048948; MASCETTI GG, 1988, BRAIN RES, V442, P387, DOI 10.1016/0006-8993(88)91531-4; MCGURK H, 1976, NATURE, V264, P746, DOI 10.1038/264746a0; PALOFF AM, 1992, J HIRNFORSCH, V33, P597; PECK CK, 1995, EXP BRAIN RES, V103, P227; Populin LC, 1998, J NEUROSCI, V18, P4233; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; RUSSO GS, 1994, J NEUROPHYSIOL, V71, P1250, DOI 10.1152/jn.1994.71.3.1250; RYAN A, 1978, EXP BRAIN RES, V32, P389; RYAN A, 1977, J NEUROPHYSIOL, V40, P943, DOI 10.1152/jn.1977.40.4.943; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; SCHROEDER DM, 1976, BRAIN BEHAV EVOLUT, V13, P125, DOI 10.1159/000123805; SEMPLE MN, 1983, HEARING RES, V10, P203, DOI 10.1016/0378-5955(83)90054-0; SEMPLE MN, 1979, J NEUROPHYSIOL, V42, P1626, DOI 10.1152/jn.1979.42.6.1626; Stricanne B, 1996, J NEUROPHYSIOL, V76, P2071, DOI 10.1152/jn.1996.76.3.2071; Trotter Y, 1999, NATURE, V398, P239, DOI 10.1038/18444; VANOPSTAL AJ, 1995, J NEUROPHYSIOL, V74, P1593, DOI 10.1152/jn.1995.74.4.1593; VOLMAN SF, 1989, J NEUROSCI, V9, P3083; WAGNER H, 1987, J NEUROSCI, V7, P3105; WAGNER H, 1993, J NEUROSCI, V13, P371; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0; Zrull MC, 1997, EXP NEUROL, V145, P16, DOI 10.1006/exnr.1997.6439	55	135	135	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					509	518		10.1016/S0896-6273(01)00222-7	http://dx.doi.org/10.1016/S0896-6273(01)00222-7			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239439	Bronze			2022-12-24	WOS:000167141700022
J	Koulakov, AA; Chklovskii, DB				Koulakov, AA; Chklovskii, DB			Orientation preference patterns in mammalian visual cortex: A wire length minimization approach	NEURON			English	Article							OCULAR-DOMINANCE COLUMNS; MONKEY STRIATE CORTEX; RECEPTIVE-FIELD; FUNCTIONAL ARCHITECTURE; CORTICAL MAPS; CAT AREA-17; OWL MONKEY; ORGANIZATION; TOPOGRAPHY; NEURONS	In the visual cortex of many mammals, orientation preference changes smoothly along the cortical surface, with the exception of singularities such as pinwheels and fractures. The reason for the existence of these singularities has remained elusive, suggesting that they are developmental artifacts. We show that singularities reduce the length of intracortical neuronal connections for some connection rules. Therefore, pinwheels and fractures could be evolutionary adaptations keeping cortical volume to a minimum. Wire length minimization approach suggests that interspecies differences in orientation preference maps reflect differences in intracortical neuronal circuits, thus leading to experimentally testable predictions. We discuss application of our model to direction preference maps.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Salk Inst, La Jolla, CA 92037 USA	Cold Spring Harbor Laboratory; Salk Institute	Chklovskii, DB (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.							AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; ALLMAN JM, 1974, BRAIN RES, V76, P247, DOI 10.1016/0006-8993(74)90458-2; [Anonymous], 1999, TEXTURE NERVOUS SYST; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; BLASDEL GG, 1992, J NEUROSCI, V12, P3139, DOI 10.1523/JNEUROSCI.12-08-03139.1992; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Bosking WH, 1997, J NEUROSCI, V17, P2112; BRAITENBERG V, 1979, BIOL CYBERN, V33, P179, DOI 10.1007/BF00337296; Braitenberg V, 1998, CORTEX STAT GEOMETRY; Buzas P, 1998, BRAIN RES PROTOC, V3, P199, DOI 10.1016/S1385-299X(98)00041-5; CHERNIAK C, 1994, J NEUROSCI, V14, P2418; Chklovskii DB, 2000, PHYSICA A, V284, P318, DOI 10.1016/S0378-4371(00)00219-3; CHKLOVSKII DB, 1999, ADV NEURAL INFORMATI, V12, P103; COWAN JD, 1991, NEURAL INFORMATION P, V3, P26; COWEY A, 1979, Q J EXP PSYCHOL, V31, P1, DOI 10.1080/14640747908400703; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381, DOI 10.1152/jn.1997.77.6.3381; Crowley JC, 2000, SCIENCE, V290, P1321, DOI 10.1126/science.290.5495.1321; Crowley JC, 1999, NAT NEUROSCI, V2, P1125, DOI 10.1038/16051; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; ERWIN E, 1995, NEURAL COMPUT, V7, P425, DOI 10.1162/neco.1995.7.3.425; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Girman SV, 1999, J NEUROPHYSIOL, V82, P301, DOI 10.1152/jn.1999.82.1.301; Goodhill GJ, 2000, NETWORK-COMP NEURAL, V11, P153, DOI 10.1088/0954-898X/11/2/303; Hetherington PA, 1999, VISUAL NEUROSCI, V16, P637, DOI 10.1017/S0952523899164046; HUBEL DH, 1977, PROC R SOC SER B-BIO, V198, P1, DOI 10.1098/rspb.1977.0085; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Hubener M, 1997, J NEUROSCI, V17, P9270; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; Koulakov AA, 1998, PHYS REV B, V57, P2352, DOI 10.1103/PhysRevB.57.2352; Lee DK, 1999, NAT NEUROSCI, V2, P375, DOI 10.1038/7286; LEVAY S, 1976, BRAIN RES, V113, P1, DOI 10.1016/0006-8993(76)90002-0; MALONEK D, 1994, P ROY SOC B-BIOL SCI, V258, P109, DOI 10.1098/rspb.1994.0150; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; MITCHISON G, 1991, P ROY SOC B-BIOL SCI, V245, P151, DOI 10.1098/rspb.1991.0102; NELSON ME, 1990, TRENDS NEUROSCI, V13, P403, DOI 10.1016/0166-2236(90)90119-U; Obermayer K, 1997, NEURAL COMPUT, V9, P555, DOI 10.1162/neco.1997.9.3.555; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Rao SC, 1997, J COMP NEUROL, V387, P358; Roerig B, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0002.1999; SCHUMMERS J, 2000, SOC NEUR ANN M NEW O; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; Shmuel A, 2000, P NATL ACAD SCI USA, V97, P5568, DOI 10.1073/pnas.97.10.5568; Shmuel A, 1996, J NEUROSCI, V16, P6945; SWINDALE NV, 1982, PROC R SOC SER B-BIO, V215, P211, DOI 10.1098/rspb.1982.0038; Swindale NV, 1996, NETWORK-COMP NEURAL, V7, P161, DOI 10.1088/0954-898X/7/2/002; SWINDALE NV, 1987, J NEUROSCI, V7, P1414; Weliky M, 1996, NATURE, V379, P725, DOI 10.1038/379725a0; WHITE LE, 1999, SOC NEUR ANN M MIAM; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Yousef T, 1999, EUR J NEUROSCI, V11, P4291, DOI 10.1046/j.1460-9568.1999.00863.x	55	108	110	0	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB	2001	29	2					519	527		10.1016/S0896-6273(01)00223-9	http://dx.doi.org/10.1016/S0896-6273(01)00223-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	405DD	11239440	Green Published, Bronze			2022-12-24	WOS:000167141700023
J	Nadarajah, B; Alifragis, P; Wong, ROL; Parnavelas, JG				Nadarajah, B; Alifragis, P; Wong, ROL; Parnavelas, JG			Ventricle-directed migration in the developing cerebral cortex	NATURE NEUROSCIENCE			English	Article							TANGENTIAL CELL DISPERSION; CENTRAL-NERVOUS-SYSTEM; LOCAL CIRCUIT NEURONS; GANGLIONIC EMINENCE; BASAL FOREBRAIN; DLX GENES; NEOCORTEX; ZONE; SPECIFICATION; DEPENDENCE	It is believed that postmitotic neurons migrate away from their sites of origin in the germinal zones to populate distant targets. Contrary to this notion, we found, using time-lapse imaging of brain slices, populations of neurons positioned at various levels of the developing neocortex that migrate towards the cortical ventricular zone. After a pause in this proliferative zone, they migrate radially in the direction of the pial surface to take up positions in the cortical plate. Immunohistochemical analysis together with tracer labeling in brain slices showed that cells showing ventricle-directed migration in the developing cortex are GABAergic interneurons originating in the ganglionic eminence in the ventral telencephalon. We speculate that combinations of chemoattractant and chemorepellent molecules are involved in this ventricle-directed migration and that interneurons may seek the cortical ventricular zone to receive layer information.	UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of London; University College London; Washington University (WUSTL)	Parnavelas, JG (corresponding author), UCL, Dept Anat & Dev Biol, Gower St, London WC1E 6BT, England.	j.parnavelas@ucl.ac.uk		Alifragis, Pavlos/0000-0003-0844-2316				Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 2001, DEVELOPMENT, V128, P353; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; BERRY M, 1965, J ANAT, V99, P691; CAVANAGH ME, 1988, J COMP NEUROL, V268, P1, DOI 10.1002/cne.902680102; DeCarlos JA, 1996, J NEUROSCI, V16, P6146; Denaxa M, 2001, DEVELOPMENT, V128, P4635; EDMONDSON JC, 1987, J NEUROSCI, V7, P1928; GRAY GE, 1990, EXPERIENTIA, V46, P929, DOI 10.1007/BF01939386; Hatten ME, 1999, ANNU REV NEUROSCI, V22, P511, DOI 10.1146/annurev.neuro.22.1.511; KOMURO H, 1995, J NEUROSCI, V15, P1110; Lavdas AA, 1999, J NEUROSCI, V19, P7881; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; MCCONNELL SK, 1991, SCIENCE, V254, P282, DOI 10.1126/science.1925583; MILLER MW, 1985, DEV BRAIN RES, V23, P187, DOI 10.1016/0165-3806(85)90040-9; Mione MC, 1997, J NEUROSCI, V17, P2018; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Neyt C, 1997, J NEUROSCI, V17, P9194; OROURKE NA, 1992, SCIENCE, V258, P299, DOI 10.1126/science.1411527; ORourke NA, 1997, DEVELOPMENT, V124, P997; Parnavelas JG, 2000, TRENDS NEUROSCI, V23, P126, DOI 10.1016/S0166-2236(00)01553-8; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; RAKIC P, 1978, POSTGRAD MED J, V54, P25; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; RAKIC P, 1974, NATURE, V250, P31, DOI 10.1038/250031a0; REID CB, 1995, NEURON, V15, P299, DOI 10.1016/0896-6273(95)90035-7; Tamamaki N, 1997, J NEUROSCI, V17, P8313; TAN SS, 1993, NATURE, V362, P638, DOI 10.1038/362638a0; Tan SS, 1998, NEURON, V21, P295, DOI 10.1016/S0896-6273(00)80539-5; Wichterle H, 2001, DEVELOPMENT, V128, P3759	32	174	180	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					218	224		10.1038/nn813	http://dx.doi.org/10.1038/nn813			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11850632				2022-12-24	WOS:000174146000011
J	Rico, B; Xu, BJ; Reichardt, LF				Rico, B; Xu, BJ; Reichardt, LF			TrkB receptor signaling is required for establishment of GABAergic synapses in the cerebellum	NATURE NEUROSCIENCE			English	Article							NEUROTROPHIC FACTOR; TARGETED DISRUPTION; INHIBITORY SYNAPSES; GRANULE NEURONS; NERVOUS-SYSTEM; IN-VIVO; BRAIN; BDNF; RAT; EXPRESSION	Neurotrophins are essential to the normal development and maintenance of the nervous system. Neurotrophin signaling is mediated by Trk family tyrosine kinases such as TrkA, TrkB and TrkC, as well as by the pan-neurotrophin receptor p75NTR. Here we have deleted the trkB gene in cerebellar precursors by Wnt1-driven Cre-mediated recombination to study the function of the TrkB in the cerebellum. Despite the absence of TrkB, the mature cerebellum of mutant mice appears similar to that of wild type, with all types of cell present in normal numbers and positions. Granule and Purkinje cell dendrites appear normal and the former have typical numbers of excitatory synapses. By contrast, inhibitory interneurons are strongly affected: although present in normal numbers, they express reduced amounts of GABAergic markers and develop reduced numbers of GABAergic boutons and synaptic specializations. Thus, TrkB is essential to the development of GABAergic neurons and regulates synapse formation in addition to its role in the development of axon terminals.	Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Reichardt, LF (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Rico, Beatriz/0000-0002-0581-851X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS016033] Funding Source: NIH RePORTER; NINDS NIH HHS [P01 NS016033, P01 NS016033-23] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alsina B, 2001, NAT NEUROSCI, V4, P1093, DOI 10.1038/nn735; ALTMAN J, 1976, J COMP NEUROL, V165, P65, DOI 10.1002/cne.901650106; ALTMAN J, 1976, J COMP NEUROL, V165, P49, DOI 10.1002/cne.901650105; Balkowiec A, 1998, J PHYSIOL-LONDON, V510, P527, DOI 10.1111/j.1469-7793.1998.527bk.x; Bao SW, 1999, LEARN MEMORY, V6, P276; CALLAHAN CA, 1994, P NATL ACAD SCI USA, V91, P5972, DOI 10.1073/pnas.91.13.5972; Chai Y, 2000, DEVELOPMENT, V127, P1671; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Donovan MJ, 2000, DEVELOPMENT, V127, P4531; ESCLAPEZ M, 1994, J NEUROSCI, V14, P1834, DOI 10.1523/JNEUROSCI.14-03-01834.1994; Fukuda T, 1998, J COMP NEUROL, V399, P424, DOI 10.1002/(SICI)1096-9861(19980928)399:3<424::AID-CNE10>3.0.CO;2-8; GAO WQ, 1995, J NEUROSCI, V15, P2656; GREIF KF, 1991, NEUROCHEM RES, V16, P235, DOI 10.1007/BF00966086; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 1999, DEVELOPMENT, V126, P2191; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Ito M, 1984, CEREBELLUM NEURAL CO; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Lindholm D, 1997, PERSPECT DEV NEUROBI, V5, P83; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Martinez A, 1998, J NEUROSCI, V18, P7336; Marty S, 2000, J NEUROSCI, V20, P8087; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Minichiello L, 1996, GENE DEV, V10, P2849, DOI 10.1101/gad.10.22.2849; MIZUNO K, 1994, DEV BIOL, V165, P243, DOI 10.1006/dbio.1994.1250; Morara S, 1996, NEUROREPORT, V7, P2993, DOI 10.1097/00001756-199611250-00039; Nieto MA, 1996, METHOD CELL BIOL, V51, P219, DOI 10.1016/S0091-679X(08)60630-5; Palay S. L., 1974, CEREBELLAR CORTEX CY; Rabacchi SA, 1999, J NEUROBIOL, V40, P254, DOI 10.1002/(SICI)1097-4695(199908)40:2<254::AID-NEU11>3.0.CO;2-4; ROCAMORA N, 1993, MOL BRAIN RES, V17, P1, DOI 10.1016/0169-328X(93)90065-W; Rodriguez CI, 2000, NEURON, V27, P475, DOI 10.1016/S0896-6273(00)00059-3; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; SEGAL RA, 1992, NEURON, V9, P1041, DOI 10.1016/0896-6273(92)90064-K; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shimada A, 1998, J NEUROSCI, V18, P8559; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TOJO H, 1995, NEUROSCI LETT, V192, P169, DOI 10.1016/0304-3940(95)11637-C; VALVERDE F, 1993, NEUROSCI PROTOCOLS, V1, P1; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WIDMER HR, 1994, DEV BRAIN RES, V80, P279, DOI 10.1016/0165-3806(94)90114-7; Xu BJ, 2000, NEURON, V26, P233, DOI 10.1016/S0896-6273(00)81153-8; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yan Q, 1997, J COMP NEUROL, V378, P135	46	166	168	1	10	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAR	2002	5	3					225	233		10.1038/nn808	http://dx.doi.org/10.1038/nn808			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	526TP	11836532	Green Accepted			2022-12-24	WOS:000174146000012
J	Critchley, HD; Mathias, CJ; Dolan, RJ				Critchley, HD; Mathias, CJ; Dolan, RJ			Fear conditioning in humans: The influence of awareness and autonomic arousal on functional neuroanatomy	NEURON			English	Article							SKIN-CONDUCTANCE RESPONSES; FACIAL EXPRESSIONS; HUMAN AMYGDALA; STIMULI; ACTIVATION; MEMORY; ACQUISITION; KNOWLEDGE; SYSTEMS; DAMAGE	The degree to which perceptual awareness of threat stimuli and bodily states of arousal modulates neural activity associated with fear conditioning is unknown. We used functional magnetic neuroimaging (fMRI) to study healthy subjects and patients with peripheral autonomic denervation to examine how the expression of conditioning-related activity is modulated by stimulus awareness and autonomic arousal. In controls, enhanced amygdala activity was evident during conditioning to both "seen" (unmasked) and "unseen" (backward masked) stimuli, whereas insula activity was modulated by perceptual awareness of a threat stimulus. Absent peripheral autonomic arousal, in patients with autonomic denervation, was associated with decreased conditioning-related activity in insula and amygdala. The findings indicate that the expression of conditioning-related neural activity is modulated by both awareness and representations of bodily states of autonomic arousal.	Inst Neurol, Wellcome Dept Imaging Neurosci, London WC1N 3BG, England; UCl, Inst Cognit Neurosci, London WC1N 3BG, England; UCL, Natl Hosp Neurol & Neurosurg, Auton Unit, London, England; UCL, ION, London, England; St Marys Hosp, ICSM, Neurovasc Med Unit, London W2 1NY, England	University of London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London	Critchley, HD (corresponding author), Inst Neurol, Wellcome Dept Imaging Neurosci, 12 Queen Sq, London WC1N 3BG, England.		critchley, hugo d/G-9267-2011	critchley, hugo d/0000-0002-2445-9284; Dolan, Ray/0000-0001-9356-761X				BECHARA A, 1995, SCIENCE, V269, P1115, DOI 10.1126/science.7652558; Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6; Bunce SC, 1999, J PSYCHIATR RES, V33, P341, DOI 10.1016/S0022-3956(99)00003-5; Cahill L, 1999, NEURON, V23, P227, DOI 10.1016/S0896-6273(00)80774-6; CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0; Cahill L, 1998, TRENDS NEUROSCI, V21, P294, DOI 10.1016/S0166-2236(97)01214-9; Cahill L, 2000, PROG BRAIN RES, V126, P29; Canli T, 2000, J NEUROSCI, V20; Casey KL, 2001, J NEUROPHYSIOL, V85, P951, DOI 10.1152/jn.2001.85.2.951; CECHETTO DF, 1990, CENTRAL REGULATION A, P208; CLARK CV, 1988, DOC OPHTHALMOL, V70, P309, DOI 10.1007/BF00157061; Critchley HD, 2001, NAT NEUROSCI, V4, P207, DOI 10.1038/84048; Critchley HD, 2000, J PHYSIOL-LONDON, V523, P259, DOI 10.1111/j.1469-7793.2000.t01-1-00259.x; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2001, BRAIN, V124, P1003, DOI 10.1093/brain/124.5.1003; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; DAMASIO AR, 1990, BEHAV BRAIN RES, V41, P81, DOI 10.1016/0166-4328(90)90144-4; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; DAVIS M, 1992, P255; Dolan RS, 2000, NEUROIMAGE, V11, P203, DOI 10.1006/nimg.2000.0538; Ekman P., 1976, PICTURES FACIAL AFFE; ESTEVES F, 1994, PSYCHOPHYSIOLOGY, V31, P375, DOI 10.1111/j.1469-8986.1994.tb02446.x; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; Friston K. J., 1995, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; KAPP B S, 1992, P229; KAPP BS, 1981, AMYGDALOID COMPLEX, P355; LaBar KS, 1998, NEURON, V20, P937, DOI 10.1016/S0896-6273(00)80475-4; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; LEDOUX JE, 1992, COGNITIVE NEUROSCIEN, P1049; LOVIBOND PF, 2002, IN PRESS J EXPT PSYC; Magnifico F, 1998, CLIN AUTON RES, V8, P133, DOI 10.1007/BF02281117; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; MAREN S, 1994, BEHAV NEUROSCI, V108, P645, DOI 10.1037/0735-7044.108.3.645; Mathias CJ, 1999, AUTONOMIC FAILURE TX, V4, P169; MATHIAS CJ, 2000, NEUROLOGY CLIN PRACT, P2131; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Morris JS, 1997, P ROY SOC B-BIOL SCI, V264, P769, DOI 10.1098/rspb.1997.0109; OHMAN A, 1993, J ABNORM PSYCHOL, V102, P121; OPPENHEIMER SM, 1992, NEUROLOGY, V42, P1727, DOI 10.1212/WNL.42.9.1727; Phillips ML, 1997, NATURE, V389, P495, DOI 10.1038/39051; SHANKS DR, 1994, BEHAV BRAIN SCI, V17, P367, DOI 10.1017/S0140525X00035032; Talairach J., 1988, COPLANAR STEREOTAXIC; TRANEL D, 1989, NEUROPSYCHOLOGIA, V27, P381, DOI 10.1016/0028-3932(89)90046-8; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Whalen PJ, 1998, J NEUROSCI, V18, P411; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O; YOUNG SL, 1995, NEUROBIOL LEARN MEM, V63, P174, DOI 10.1006/nlme.1995.1018	49	336	337	2	37	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					653	663		10.1016/S0896-6273(02)00588-3	http://dx.doi.org/10.1016/S0896-6273(02)00588-3			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856537	Bronze			2022-12-24	WOS:000173911100016
J	Wang, J; Zugates, CT; Liang, IH; Lee, CHJ; Lee, TM				Wang, J; Zugates, CT; Liang, IH; Lee, CHJ; Lee, TM			Drosophila Dscam is required for divergent segregation of sister branches and suppresses ectopic bifurcation of axons	NEURON			English	Article							GROWTH CONE FORM; MUSHROOM BODIES; CNS MIDLINE; GUIDANCE; NEURONS; PATTERN; PROTEIN; BODY; MELANOGASTER; SEMAPHORINS	Axon bifurcation results in the formation of sister branches, and divergent segregation of the sister branches is essential for efficient innervation of multiple targets. From a genetic mosaic screen, we find that a lethal mutation in the Drosophila Down syndrome cell adhesion molecule (Dscam) specifically perturbs segregation of axonal branches in the mushroom bodies. Single axon analysis further reveals that Dscam mutant axons generate additional branches, which randomly segregate among the available targets. Moreover, when only one target remains, branching is suppressed in wild-type axons while Dscam mutant axons still form multiple branches at the original bifurcation point. Taken together, we conclude that Dscam controls axon branching and guidance such that a neuron can innervate multiple targets with minimal branching.	Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA; Univ Illinois, Dept Med, Hematol Oncol Sect, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Lee, TM (corresponding author), Univ Illinois, Dept Cell & Struct Biol, Urbana, IL 61801 USA.			Zugates, Christopher/0000-0003-1882-3665	NIGMS NIH HHS [T32 GM07283] Funding Source: Medline; NINDS NIH HHS [R01-NS42049] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042049] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Acebes A, 2000, TRENDS NEUROSCI, V23, P557, DOI 10.1016/S0166-2236(00)01646-5; Agarwala KL, 2001, BIOCHEM BIOPH RES CO, V281, P697, DOI 10.1006/bbrc.2001.4420; Agarwala KL, 2000, MOL BRAIN RES, V79, P118, DOI 10.1016/S0169-328X(00)00108-X; Bastmeyer M, 1996, J NEUROSCI, V16, P1450; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; Fashena D, 1999, J COMP NEUROL, V406, P415, DOI 10.1002/(SICI)1096-9861(19990412)406:3<415::AID-CNE9>3.0.CO;2-2; Gallo G, 1998, J NEUROSCI, V18, P5403, DOI 10.1523/JNEUROSCI.18-14-05403.1998; GOLIC KG, 1989, CELL, V59, P499, DOI 10.1016/0092-8674(89)90033-0; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; HEITZLER P, 1993, GENETICS, V135, P105; Hidalgo A, 1997, DEVELOPMENT, V124, P3253; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Ito K, 1997, DEVELOPMENT, V124, P761; ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q; Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Lawrence PA, 1999, DEVELOPMENT, V126, P2431; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; LEWIS EB, 1968, DROSOPHILA INFORM SE, V43, P193; Mason CA, 1997, J NEUROSCI, V17, P1086; Matheson SF, 1999, J NEUROBIOL, V38, P27, DOI 10.1002/(SICI)1097-4695(199901)38:1<27::AID-NEU3>3.3.CO;2-L; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; PIKE SH, 1992, DEVELOPMENT, V114, P825; SATO M, 1994, NEURON, V13, P791, DOI 10.1016/0896-6273(94)90246-1; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Scott EK, 2001, CURR BIOL, V11, P99, DOI 10.1016/S0960-9822(01)00020-3; SHAW G, 1977, EXP CELL RES, V104, P55, DOI 10.1016/0014-4827(77)90068-4; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Sugihara I, 1999, J COMP NEUROL, V414, P131; Tear G, 1996, NEURON, V16, P501, DOI 10.1016/S0896-6273(00)80070-7; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; TRUMAN JW, 1988, DEV BIOL, V125, P146; Wang F, 1998, CELL, V93, P47, DOI 10.1016/S0092-8674(00)81145-9; Wang KH, 1999, CELL, V96, P771, DOI 10.1016/S0092-8674(00)80588-7; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Yamakawa K, 1998, HUM MOL GENET, V7, P227, DOI 10.1093/hmg/7.2.227; YANG MY, 1995, NEURON, V15, P45	50	160	161	0	7	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	FEB 14	2002	33	4					559	571		10.1016/S0896-6273(02)00570-6	http://dx.doi.org/10.1016/S0896-6273(02)00570-6			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	522RQ	11856530	Bronze			2022-12-24	WOS:000173911100009
J	Hutson, LD; Chien, CB				Hutson, LD; Chien, CB			Pathfinding and error correction by retinal axons: The role of astray/robo2	NEURON			English	Article							GROWTH CONE MORPHOLOGY; TRANSIENT RETINOTECTAL PROJECTION; GANGLION-CELL AXONS; MOUSE OPTIC CHIASM; ZEBRAFISH EMBRYO; NITRIC-OXIDE; TIME-LAPSE; MULTIPLE ASPECTS; CNS MIDLINE; IN-VIVO	To address how the highly stereotyped retinotectal pathway develops in zebrafish, we used fixed-tissue and time-lapse imaging to analyze morphology and behavior of wild-type and mutant retinal growth cones. Wild-type growth cones increase in complexity and pause at the midline. Intriguingly, they make occasional ipsilateral projections and other path-finding errors, which are always eventually corrected. In the astray/robo2 mutant, growth cones are larger and more complex than wild-type. astray axons make midline errors not seen in wild-type, as well as errors both before and after the midline. astray errors are rarely corrected. The presumed Robo ligands Slit2 and Slit3 are expressed near the pathway in patterns consistent with their mediating pathfinding through Robo2. Thus, Robo2 does not control midline crossing of retinal axons, but rather shapes their pathway, by both preventing and correcting pathfinding errors.	Univ Utah, Med Ctr, Dept Neurobiol & Anat, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Chien, CB (corresponding author), Univ Utah, Med Ctr, Dept Neurobiol & Anat, 20 North 1900 East, Salt Lake City, UT 84132 USA.	chi-bin.chien@hsc.utah.edu			NEI NIH HHS [F32-EY07017, R01-EY12873] Funding Source: Medline; NATIONAL EYE INSTITUTE [F32EY007017, R01EY012873] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baier H, 1996, DEVELOPMENT, V123, P415; Battye R, 1999, DEVELOPMENT, V126, P2475; BERNHARDT RR, 1992, J COMP NEUROL, V326, P263, DOI 10.1002/cne.903260208; Birgbauer E, 2000, DEVELOPMENT, V127, P1231; BOVOLENTA P, 1987, J NEUROSCI, V7, P1447; Brand M, 1996, DEVELOPMENT, V123, P179; BRITTIS PA, 1992, SCIENCE, V255, P733, DOI 10.1126/science.1738848; BRITTIS PA, 1995, MOL CELL NEUROSCI, V6, P433, DOI 10.1006/mcne.1995.1032; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; BURRILL J D, 1989, Investigative Ophthalmology and Visual Science, V30, P226; BURRILL JD, 1994, J COMP NEUROL, V346, P583, DOI 10.1002/cne.903460410; CAUDY M, 1986, J NEUROSCI, V6, P364; CAUDY M, 1987, DEV BIOL, V119, P454, DOI 10.1016/0012-1606(87)90049-2; Challa AK, 2001, MECH DEVELOP, V101, P249, DOI 10.1016/S0925-4773(00)00570-0; Deiner MS, 1997, NEURON, V19, P575, DOI 10.1016/S0896-6273(00)80373-6; Ernst AF, 1998, PROG BRAIN RES, V118, P115; Ernst AF, 1999, J NEUROSCI, V19, P229, DOI 10.1523/JNEUROSCI.19-01-00229.1999; Erskine L, 2000, J NEUROSCI, V20, P4975; FAWCETT JW, 1984, P NATL ACAD SCI-BIOL, V81, P5589, DOI 10.1073/pnas.81.17.5589; Feldheim DA, 2000, NEURON, V25, P563, DOI 10.1016/S0896-6273(00)81060-0; Fricke C, 2001, SCIENCE, V292, P507, DOI 10.1126/science.1059496; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Halloran MC, 1999, DEV DYNAM, V214, P13, DOI 10.1002/(SICI)1097-0177(199901)214:1<13::AID-DVDY2>3.0.CO;2-3; HALLORAN MC, 1994, J NEUROSCI, V14, P2161; Hao JC, 2001, NEURON, V32, P25, DOI 10.1016/S0896-6273(01)00448-2; HOLT CE, 1989, J NEUROSCI, V9, P3123; KAETHNER RJ, 1992, J NEUROSCI, V12, P3257, DOI 10.1523/JNEUROSCI.12-08-03257.1992; Karlstrom RO, 1996, DEVELOPMENT, V123, P427; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6; KIM GJ, 1991, J NEUROBIOL, V22, P629, DOI 10.1002/neu.480220608; Knobel KM, 1999, DEVELOPMENT, V126, P4489; Lauderdale JD, 1997, MOL CELL NEUROSCI, V9, P293, DOI 10.1006/mcne.1997.0624; Lee JS, 2001, DEV DYNAM, V221, P216, DOI 10.1002/dvdy.1136; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Macdonald R, 1997, DEVELOPMENT, V124, P2397; Marcus RC, 2000, DEV BIOL, V221, P132, DOI 10.1006/dbio.2000.9660; Mason C, 2000, J NEUROBIOL, V44, P260, DOI 10.1002/1097-4695(200008)44:2<260::AID-NEU14>3.0.CO;2-H; Mason CA, 1997, J NEUROSCI, V17, P1086; McFarlane S, 1996, NEURON, V17, P245, DOI 10.1016/S0896-6273(00)80156-7; MCLOON SC, 1982, EXP BRAIN RES, V45, P277; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Murray MJ, 1999, J NEUROSCI, V19, P7901; MYERS PZ, 1993, J NEUROSCI, V13, P127; Nakagawa S, 2000, NEURON, V25, P599, DOI 10.1016/S0896-6273(00)81063-6; Niclou SP, 2000, J NEUROSCI, V20, P4962; OCONNOR TP, 1990, J NEUROSCI, V10, P3935, DOI 10.1523/JNEUROSCI.10-12-03935.1990; OLEARY DDM, 1983, DEV BRAIN RES, V10, P93, DOI 10.1016/0165-3806(83)90124-4; RAPER JA, 1990, EXP NEUROL, V109, P70, DOI 10.1016/S0014-4886(05)80009-3; RAPER JA, 1990, NEURON, V4, P21, DOI 10.1016/0896-6273(90)90440-Q; Ringstedt T, 2000, J NEUROSCI, V20, P4983; Rose TM, 1998, NUCLEIC ACIDS RES, V26, P1628, DOI 10.1093/nar/26.7.1628; SAKAGUCHI DS, 1985, J NEUROSCI, V5, P3228; Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549; Shirasaki R, 1998, SCIENCE, V279, P105, DOI 10.1126/science.279.5347.105; SRETAVAN DW, 1994, NEURON, V12, P957, DOI 10.1016/0896-6273(94)90307-7; SRETAVAN DW, 1993, NEURON, V10, P761, DOI 10.1016/0896-6273(93)90176-R; Stoeckli ET, 1998, CURR OPIN NEUROBIOL, V8, P73, DOI 10.1016/S0959-4388(98)80010-X; Strahle U, 1997, MECH DEVELOP, V62, P147, DOI 10.1016/S0925-4773(97)00657-6; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; STUERMER CAO, 1990, J NEUROSCI, V10, P3615; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Walz A, 1997, DEVELOPMENT, V124, P2421; WILSON SW, 1991, DEVELOPMENT, V112, P723; WIZENMANN A, 1993, DEVELOPMENT, V117, P725; WU HH, 1994, SCIENCE, V265, P1593, DOI 10.1126/science.7521541; Yeo SY, 2001, DEV BIOL, V230, P1, DOI 10.1006/dbio.2000.0105; Zallen JA, 1998, CELL, V92, P217, DOI 10.1016/S0092-8674(00)80916-2; Zoo YM, 2000, CELL, V102, P363, DOI 10.1016/S0092-8674(00)00041-6	71	139	139	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JAN 17	2002	33	2					205	217		10.1016/S0896-6273(01)00579-7	http://dx.doi.org/10.1016/S0896-6273(01)00579-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	513PU	11804569	Bronze			2022-12-24	WOS:000173387700009
J	Grosshans, DR; Clayton, DA; Coultrap, SJ; Browning, MD				Grosshans, DR; Clayton, DA; Coultrap, SJ; Browning, MD			LTP leads to rapid surface expression of NMDA but not AMPA receptors in adult rat CA1	NATURE NEUROSCIENCE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; TYROSINE PHOSPHORYLATION; GLUTAMATE RECEPTORS; DIFFERENTIAL DISTRIBUTION; SYNAPTIC-TRANSMISSION; SUBUNIT; NR1; TRAFFICKING; ACTIVATION	In the CA1 region of the rat hippocampus, long-term potentiation (LTP) requires the activation of NMDA receptors (NMDARs) and leads to an enhancement of AMPA receptor (AMPAR) function. In neonatal hippocampus, this increase in synaptic strength seems to be mediated by delivery of AMPARs to the synapse. Here we studied changes in surface expression of native AMPA and NMDA receptors following induction of LTP in the adult rat brain. In contrast to early postnatal rats, we find that LTP in the adult rat does not alter membrane association of AMPARs. Instead, LTP leads to rapid surface expression of NM DARs in a PKC- and Src-family-dependent manner. The present study suggests a developmental shift in the LTP-dependent trafficking of AMPA receptors. Moreover, our results indicate that insertion of NMDA receptors may be a key step in regulating synaptic plasticity.	Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Med Sci Training Program, Denver, CO 80262 USA; Univ Colorado, Hlth Sci Ctr, Program Neurosci, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Browning, MD (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, 4200 E 9th Ave Box C236, Denver, CO 80262 USA.	michael.browning@uchsc.edu			NATIONAL INSTITUTE ON AGING [P01AG004418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA009675] Funding Source: NIH RePORTER; NIAAA NIH HHS [R01 AA09675] Funding Source: Medline; NIA NIH HHS [AG04418-17] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aniksztejn L, 1995, J NEUROPHYSIOL, V74, P2349, DOI 10.1152/jn.1995.74.6.2349; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; Chazot PL, 1997, J NEUROCHEM, V68, P507; DAVID V, 1993, J BIOL CHEM, V268, P9585; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Gardoni F, 2001, J NEUROSCI, V21, P1501, DOI 10.1523/JNEUROSCI.21-05-01501.2001; Grosshans DR, 2001, J NEUROCHEM, V76, P737, DOI 10.1046/j.1471-4159.2001.00034.x; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hall RA, 1997, NEUROSCIENCE, V78, P361, DOI 10.1016/S0306-4522(96)00525-8; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Heynen AJ, 2000, NEURON, V28, P527, DOI 10.1016/S0896-6273(00)00130-6; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; LAU LF, 1995, J BIOL CHEM, V270, P20036, DOI 10.1074/jbc.270.34.20036; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Lu YM, 1998, SCIENCE, V279, P1363, DOI 10.1126/science.279.5355.1363; Mammen AL, 1997, J NEUROSCI, V17, P7351; MIYATANI S, 1989, SCIENCE, V245, P631, DOI 10.1126/science.2762814; Nayak A, 1998, NATURE, V394, P680, DOI 10.1038/29305; Nayak AS, 1996, P NATL ACAD SCI USA, V93, P15451, DOI 10.1073/pnas.93.26.15451; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; ODELL TJ, 1991, NATURE, V353, P558, DOI 10.1038/353558a0; Okabe S, 1999, J NEUROSCI, V19, P7781; PARFITT KD, 1993, J PHYSIOL-LONDON, V471, P245, DOI 10.1113/jphysiol.1993.sp019900; Petralia RS, 1997, J COMP NEUROL, V385, P456, DOI 10.1002/(SICI)1096-9861(19970901)385:3<456::AID-CNE9>3.0.CO;2-2; Petralia RS, 1999, NAT NEUROSCI, V2, P31, DOI 10.1038/4532; Pickard L, 2000, J NEUROSCI, V20, P7922; PORTER RM, 1993, J PATHOL, V170, P435, DOI 10.1002/path.1711700406; Racca C, 2000, J NEUROSCI, V20, P2512; Roche KW, 2001, NAT NEUROSCI, V4, P794, DOI 10.1038/90498; Rosenblum K, 1996, P NATL ACAD SCI USA, V93, P10457, DOI 10.1073/pnas.93.19.10457; Rosenblum K, 1997, J NEUROSCI, V17, P5129; Salter MW, 1998, BIOCHEM PHARMACOL, V56, P789, DOI 10.1016/S0006-2952(98)00124-5; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; SIEGEL SJ, 1994, P NATL ACAD SCI USA, V91, P564, DOI 10.1073/pnas.91.2.564; Snell LD, 1996, MOL BRAIN RES, V40, P71; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; STONE LM, 1994, J NEUROSCI, V14, P301; Vissel B, 2001, NAT NEUROSCI, V4, P587, DOI 10.1038/88404; Waters J, 2000, J NEUROSCI, V20, P7863; WENTHOLD RJ, 1992, J BIOL CHEM, V267, P501	47	281	293	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	JAN	2002	5	1					27	33		10.1038/nn779	http://dx.doi.org/10.1038/nn779			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	507MG	11740502				2022-12-24	WOS:000173031800011
J	Fernandez, I; Arac, D; Ubach, J; Gerber, SH; Shin, OH; Gao, Y; Anderson, RGW; Sudhof, TC; Rizo, J				Fernandez, I; Arac, D; Ubach, J; Gerber, SH; Shin, OH; Gao, Y; Anderson, RGW; Sudhof, TC; Rizo, J			Three-dimensional structure of the synaptotagmin 1 C2B-domain: Synaptotagmin 1 as a phospholipid binding machine	NEURON			English	Article							PROTEIN-KINASE-C; C2B DOMAIN; FUNCTIONAL DIVERSITY; TRANSMITTER RELEASE; CRYSTAL-STRUCTURE; CALCIUM SENSOR; SNARE COMPLEX; C-2 DOMAIN; CA2+; SENSITIVITY	Synaptotagmin 1 probably functions as a Ca2+ sensor in neurotransmitter release via its two C-2-domains, but no common Ca2+-dependent activity that could underlie a cooperative action between them has been described. The NMR structure of the C2B-domain now reveals a beta sandwich that exhibits striking similarities and differences with the C(2)A-domain. Whereas the bottom face of the C2B-domain has two additional a helices that may be involved in specialized Ca2+-independent functions, the top face binds two Ca2+ ions and is remarkably similar to the C(2)A-domain. Consistent with these results, but in contrast to previous studies, we find that the C2B-domain binds phospholipids in a Ca2+-dependent manner similarly to the C(2)A-domain. These results suggest a novel view of synaptotagmin function whereby the two C-2-domains cooperate in a common activity, Ca2+-dependent phospholipid binding, to trigger neurotransmitter release.	Univ Texas, SW Med Ctr, Dept Biochem, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Mol Genet, Ctr Basic Neurosci, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rizo, J (corresponding author), Univ Texas, SW Med Ctr, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.				NINDS NIH HHS [NS40944] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040944] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bai JH, 2000, J BIOL CHEM, V275, P25427, DOI 10.1074/jbc.M906729199; Bennett MR, 1999, PROG NEUROBIOL, V59, P243, DOI 10.1016/S0301-0082(99)00004-0; Blagoveshchenskaya AD, 1999, MOL BIOL CELL, V10, P3979, DOI 10.1091/mbc.10.11.3979; Bollmann JH, 2000, SCIENCE, V289, P953, DOI 10.1126/science.289.5481.953; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chapman ER, 1996, J BIOL CHEM, V271, P5844, DOI 10.1074/jbc.271.10.5844; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davis AF, 1999, NEURON, V24, P363, DOI 10.1016/S0896-6273(00)80850-8; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desai RC, 2000, J CELL BIOL, V150, P1125, DOI 10.1083/jcb.150.5.1125; Edwards AS, 1997, BIOCHEMISTRY-US, V36, P15615, DOI 10.1021/bi9718752; Essen LO, 1997, BIOCHEMISTRY-US, V36, P2753, DOI 10.1021/bi962466t; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; FUKUDA M, 1995, J BIOL CHEM, V270, P26523, DOI 10.1074/jbc.270.44.26523; Fukuda M, 2000, P NATL ACAD SCI USA, V97, P14715, DOI 10.1073/pnas.260491197; Garcia RA, 2000, P NATL ACAD SCI USA, V97, P5883, DOI 10.1073/pnas.100127197; Gerber SH, 2001, EMBO J, V20, P1605, DOI 10.1093/emboj/20.7.1605; GERBER SH, 2002, IN PRESS DIABETES; Jarousse N, 2001, J CELL BIOL, V154, P857, DOI 10.1083/jcb.200103040; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; KAY LE, 1993, J AM CHEM SOC, V115, P2055, DOI 10.1021/ja00058a072; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Littleton JT, 2001, J NEUROSCI, V21, P1421, DOI 10.1523/JNEUROSCI.21-05-01421.2001; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Nalefski EA, 2001, BIOCHEMISTRY-US, V40, P3089, DOI 10.1021/bi001968a; PERIN MS, 1990, NATURE, V345, P260, DOI 10.1038/345260a0; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Schivell AE, 1996, J BIOL CHEM, V271, P27770, DOI 10.1074/jbc.271.44.27770; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Shao XG, 1997, NEURON, V18, P133, DOI 10.1016/S0896-6273(01)80052-0; Shao XG, 1996, SCIENCE, V273, P248, DOI 10.1126/science.273.5272.248; Shao XG, 1998, BIOCHEMISTRY-US, V37, P16106, DOI 10.1021/bi981789h; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Sugita S, 1996, J BIOL CHEM, V271, P1262, DOI 10.1074/jbc.271.3.1262; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; SUTTON RB, 1995, CELL, V80, P929, DOI 10.1016/0092-8674(95)90296-1; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Ubach J, 1999, NAT CELL BIOL, V1, P106, DOI 10.1038/10076; Ubach J, 2001, BIOCHEMISTRY-US, V40, P5854, DOI 10.1021/bi010340c; Uellner R, 1997, EMBO J, V16, P7287, DOI 10.1093/emboj/16.24.7287; Verdaguer N, 1999, EMBO J, V18, P6329, DOI 10.1093/emboj/18.22.6329; Williams RL, 1996, STRUCTURE, V4, P1387, DOI 10.1016/S0969-2126(96)00146-3; ZHANG C, 1998, INT SER ON ADVANC FR, V2, P1; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1	57	303	307	0	12	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	DEC 26	2001	32	6					1057	1069		10.1016/S0896-6273(01)00548-7	http://dx.doi.org/10.1016/S0896-6273(01)00548-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	504ZT	11754837	Bronze			2022-12-24	WOS:000172886800012
J	Hirono, M; Yoshioka, T; Konishi, S				Hirono, M; Yoshioka, T; Konishi, S			GABA(B) receptor activation enhances mGIuR-mediated responses at cerebellar excitatory synapses	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; TERM SYNAPTIC DEPRESSION; PURKINJE-CELLS; PRESYNAPTIC INHIBITION; INWARD CURRENT; NEUROTRANSMITTER RELEASE; B RECEPTORS; A RECEPTORS; CROSS-TALK; NEURONS	Metabotropic gamma -aminobutyric acid type B (GABA(B)) and glutamate receptors (mGluRs) are postsynaptically co-expressed at cerebellar parallel fiber (PF)-Purkinje cell (PC) excitatory synapses, but their functional interactions are unclear. We found that mGluR1 agonist-induced currents and [Ca2+](i) increases in PCs were enhanced following co-activation of GABA(B) receptors. A GABA(B) antagonist and a G-protein uncoupler suppressed these effects. Low-concentration baclofen, a GABA(B) agonist, augmented mGluR1-mediated excitatory synaptic current produced by stimulating PFs. These results indicate that postsynaptic GABA(B) receptors functionally interact with mGluR1 and enhance mGluR1-mediated excitatory transmission at PF-PC synapses. The interaction between the two types of metabotropic receptors provides a likely mechanism for regulating cerebellar synaptic plasticity.	Mitsubishi Kagaku Inst Life Sci, Mol Neurobiol Lab, Machida, Tokyo 1948511, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Dept Mol Neurobiol, Tokyo 1698555, Japan; Waseda Univ, Sch Human Sci, Dept Mol Neurobiol, Tokorozawa, Saitama 3591192, Japan; JST, CREST, Machida, Tokyo 1948511, Japan	Mitsubishi Kagaku Institute of Life Sciences (MITILS); Waseda University; Waseda University; Japan Science & Technology Agency (JST)	Konishi, S (corresponding author), Mitsubishi Kagaku Inst Life Sci, Mol Neurobiol Lab, 11 Minamiooya, Machida, Tokyo 1948511, Japan.		Konishi, Shiro/ABA-5905-2020	Hirono, Moritoshi/0000-0001-6068-1045				Barnard EA, 1998, PHARMACOL REV, V50, P291; BATCHELOR AM, 1993, NEUROPHARMACOLOGY, V32, P11, DOI 10.1016/0028-3908(93)90124-L; Batchelor AM, 1997, NATURE, V385, P74, DOI 10.1038/385074a0; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BOWERY NG, 1993, ANNU REV PHARMACOL, V33, P109, DOI 10.1146/annurev.pa.33.040193.000545; CONQUET F, 1994, NATURE, V372, P237, DOI 10.1038/372237a0; DAVIES CH, 1991, NATURE, V349, P609, DOI 10.1038/349609a0; Dittman JS, 1996, J NEUROSCI, V16, P1623; Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x; GOODMAN RR, 1983, SCIENCE, V220, P967, DOI 10.1126/science.6302841; HAHNER L, 1991, FASEB J, V5, P2466, DOI 10.1096/fasebj.5.10.1648524; Hirono M, 1998, BIOCHEM BIOPH RES CO, V251, P753, DOI 10.1006/bbrc.1998.9465; Ichise T, 2000, SCIENCE, V288, P1832, DOI 10.1126/science.288.5472.1832; ITO M, 1989, ANNU REV NEUROSCI, V12, P85, DOI 10.1146/annurev.ne.12.030189.000505; Jaarsma D, 1995, J CHEM NEUROANAT, V9, P241, DOI 10.1016/0891-0618(95)00089-5; JIN WZ, 1994, J NEUROSCI, V14, P1920; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kawaguchi S, 2000, NEURON, V27, P339, DOI 10.1016/S0896-6273(00)00041-6; KERR DIB, 1995, PHARMACOL THERAPEUT, V67, P187, DOI 10.1016/0163-7258(95)00016-A; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Komatsu Y, 1996, J NEUROSCI, V16, P6342; Konishi S, 1997, ROLE ADENOSINE NERVO, P89; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; LINDEN DJ, 1994, J NEUROPHYSIOL, V71, P1992, DOI 10.1152/jn.1994.71.5.1992; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; MALEOS JM, 2000, J NEUROCHEM, V74, P1301; MARTINELLI GP, 1992, NEUROSCIENCE, V46, P23, DOI 10.1016/0306-4522(92)90005-M; MINTZ IM, 1993, NEURON, V10, P889, DOI 10.1016/0896-6273(93)90204-5; MIQUEL MC, 1994, DEV BRAIN RES, V80, P149, DOI 10.1016/0165-3806(94)90099-X; Mitoma H, 1999, NEUROSCIENCE, V88, P871, DOI 10.1016/S0306-4522(98)00260-7; Miyata M, 2000, NEURON, V28, P233, DOI 10.1016/S0896-6273(00)00099-4; MOTT DD, 1991, SCIENCE, V252, P1718, DOI 10.1126/science.1675489; NUSSER Z, 1994, NEUROSCIENCE, V61, P421, DOI 10.1016/0306-4522(94)90421-9; Rocheville M, 2000, SCIENCE, V288, P154, DOI 10.1126/science.288.5463.154; Selbie LA, 1998, TRENDS PHARMACOL SCI, V19, P87, DOI 10.1016/S0165-6147(97)01166-8; Sodickson DL, 1996, J NEUROSCI, V16, P6374; STAUB C, 1992, EUR J NEUROSCI, V4, P832, DOI 10.1111/j.1460-9568.1992.tb00193.x; TAKAHASHI M, 1995, J NEUROSCI, V15, P5693; Tempia F, 1998, J NEUROPHYSIOL, V80, P520, DOI 10.1152/jn.1998.80.2.520; THOMPSON SM, 1993, TRENDS NEUROSCI, V16, P222, DOI 10.1016/0166-2236(93)90160-N; TURGEON SM, 1993, NEUROSCIENCE, V55, P311, DOI 10.1016/0306-4522(93)90501-6; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792; Wu LG, 1997, TRENDS NEUROSCI, V20, P204, DOI 10.1016/S0166-2236(96)01015-6; Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4	50	122	124	1	6	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	DEC	2001	4	12					1207	1216		10.1038/nn764	http://dx.doi.org/10.1038/nn764			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	498RV	11704764				2022-12-24	WOS:000172525000017
J	Kerchner, GA; Wang, GD; Qiu, CS; Huettner, JE; Zhuo, M				Kerchner, GA; Wang, GD; Qiu, CS; Huettner, JE; Zhuo, M			Direct presynaptic regulation of GABA/glycine release by kainate receptors in the dorsal horn: An ionotropic mechanism	NEURON			English	Article							RAT SPINAL-CORD; SYNAPTIC TRANSMISSION; HIPPOCAMPAL INTERNEURONS; GABA RELEASE; GLUR6-DEFICIENT MICE; AMPA RECEPTORS; IN-VITRO; NEURONS; ACTIVATION; GLYCINE	In the spinal cord dorsal horn, excitatory sensory fibers terminate adjacent to interneuron terminals. Here, we show that kainate (KA) receptor activation triggered action potential-independent release of GABA and glycine from dorsal horn interneurons. This release was transient, because KA receptors desensitized, and it required Na+ entry and Ca2+ channel activation. KA modulated evoked inhibitory transmission in a dose-dependent, biphasic manner, with suppression being more prominent. In recordings from isolated neuron pairs, this suppression required GABA(B) receptor activation, suggesting that KA-triggered GABA release activated presynaptic GABA(B) autoreceptors. Finally, glutamate released from sensory fibers caused a KA and GABA(B) receptor-dependent suppression of inhibitory transmission in spinal slices. Thus, we show how presynaptic KA receptors are linked to changes in GABA/glycine release and highlight a novel role for these receptors in regulating sensory transmission.	Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhuo, M (corresponding author), Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA.		Huettner, James E/C-5219-2012; Zhuo, Min/A-2072-2008	Zhuo, Min/0000-0001-9062-3241	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030888, R01NS038680] Funding Source: NIH RePORTER; NINDS NIH HHS [NS38680, R01 NS030888, NS30888] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali AB, 2001, J NEUROSCI, V21, P2992, DOI 10.1523/JNEUROSCI.21-09-02992.2001; Bureau I, 1998, J PHYSIOL-LONDON, V509, P817, DOI 10.1111/j.1469-7793.1998.817bm.x; Bureau I, 1999, J NEUROSCI, V19, P653; BURGER PM, 1991, NEURON, V7, P287, DOI 10.1016/0896-6273(91)90267-4; Castillo PE, 1997, NATURE, V388, P182, DOI 10.1038/40645; Chergui K, 2000, J NEUROSCI, V20, P2175; Chery N, 2000, J NEUROPHYSIOL, V84, P1006, DOI 10.1152/jn.2000.84.2.1006; Chery N, 1999, J NEUROSCI, V19, P7342, DOI 10.1523/JNEUROSCI.19-17-07342.1999; Chittajallu R, 1999, TRENDS PHARMACOL SCI, V20, P26, DOI 10.1016/S0165-6147(98)01286-3; Chittajallu R, 1996, NATURE, V379, P78, DOI 10.1038/379078a0; CHRISTENSEN H, 1991, NEUROSCI LETT, V129, P217, DOI 10.1016/0304-3940(91)90465-6; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; Contractor A, 2001, NEURON, V29, P209, DOI 10.1016/S0896-6273(01)00191-X; Cossart R, 2001, NEURON, V29, P497, DOI 10.1016/S0896-6273(01)00221-5; Cossart R, 1998, NAT NEUROSCI, V1, P470, DOI 10.1038/2185; DAVIES J, 1979, J PHYSIOL-PARIS, V75, P641; Deisz RA, 1999, NEUROSCIENCE, V93, P1241, DOI 10.1016/S0306-4522(99)00203-1; ECCLES JC, 1963, J PHYSIOL-LONDON, V168, P500, DOI 10.1113/jphysiol.1963.sp007205; Frerking M, 1998, NAT NEUROSCI, V1, P479, DOI 10.1038/2194; Frerking M, 1999, P NATL ACAD SCI USA, V96, P12917, DOI 10.1073/pnas.96.22.12917; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Frerking M, 2001, J NEUROSCI, V21, P2958, DOI 10.1523/JNEUROSCI.21-09-02958.2001; Glitsch M, 1999, J NEUROSCI, V19, P511; HAMMOND DL, 1993, EUR J PHARMACOL, V234, P255, DOI 10.1016/0014-2999(93)90961-G; Hille B., 1992, IONIC CHANNELS EXCIT; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; HUETTNER JE, 1990, NEURON, V5, P255, DOI 10.1016/0896-6273(90)90163-A; Huettner JE, 1998, NEUROPHARMACOLOGY, V37, P1239, DOI 10.1016/S0028-3908(98)00082-3; Jonas P, 1998, SCIENCE, V281, P419, DOI 10.1126/science.281.5375.419; Jones KA, 1997, NEUROPHARMACOLOGY, V36, P853, DOI 10.1016/S0028-3908(97)00066-X; Kamiya H, 2000, J PHYSIOL-LONDON, V523, P653, DOI 10.1111/j.1469-7793.2000.t01-1-00653.x; Kerchner GA, 2001, J NEUROSCI, V21, P59, DOI 10.1523/JNEUROSCI.21-01-00059.2001; KOHLER M, 1993, NEURON, V10, P491, DOI 10.1016/0896-6273(93)90336-P; Li P, 1999, NATURE, V397, P161, DOI 10.1038/16469; Liu QS, 1999, J NEUROPHYSIOL, V82, P1059, DOI 10.1152/jn.1999.82.2.1059; Malcangio M, 1996, TRENDS PHARMACOL SCI, V17, P457; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; MENNERICK S, 1995, J NEUROPHYSIOL, V73, P320, DOI 10.1152/jn.1995.73.1.320; Mulle C, 2000, NEURON, V28, P475, DOI 10.1016/S0896-6273(00)00126-4; Mulle C, 1998, NATURE, V392, P601, DOI 10.1038/33408; Paternain AV, 2000, J NEUROSCI, V20, P196, DOI 10.1523/JNEUROSCI.20-01-00196.2000; RANSOM BR, 1977, J NEUROPHYSIOL, V40, P1163, DOI 10.1152/jn.1977.40.5.1163; RIBEIRODASILVA A, 1982, J COMP NEUROL, V209, P176, DOI 10.1002/cne.902090205; Rodriguez-Moreno A, 2000, P NATL ACAD SCI USA, V97, P1293, DOI 10.1073/pnas.97.3.1293; Rodriguez-Moreno A, 1998, NEURON, V20, P1211, DOI 10.1016/S0896-6273(00)80501-2; RodriguezMoreno A, 1997, NEURON, V19, P893, DOI 10.1016/S0896-6273(00)80970-8; Rosenmund C, 1996, NEURON, V16, P1197, DOI 10.1016/S0896-6273(00)80146-4; Satake S, 2000, NAT NEUROSCI, V3, P551, DOI 10.1038/75718; SAWYNOK J, 1987, PHARMACOL BIOCHEM BE, V26, P463, DOI 10.1016/0091-3057(87)90148-1; Schmitz D, 2000, NEURON, V27, P327, DOI 10.1016/S0896-6273(00)00040-4; Schmitz D, 2001, SCIENCE, V291, P1972, DOI 10.1126/science.1057105; Todd AJ, 1996, EUR J NEUROSCI, V8, P2492, DOI 10.1111/j.1460-9568.1996.tb01543.x; TOLLE TR, 1993, J NEUROSCI, V13, P5009, DOI 10.1523/JNEUROSCI.13-12-05009.1993; TSIEN RW, 1995, TRENDS NEUROSCI, V18, P52; Westenbroek RE, 1998, J NEUROSCI, V18, P6319; Wilding TJ, 1997, J NEUROSCI, V17, P2713; Wilding TJ, 2001, J PHYSIOL-LONDON, V532, P411, DOI 10.1111/j.1469-7793.2001.0411f.x; YAKSH TL, 1989, PAIN, V37, P111, DOI 10.1016/0304-3959(89)90160-7; YOSHIMURA M, 1995, J PHYSIOL-LONDON, V482, P29, DOI 10.1113/jphysiol.1995.sp020497	60	92	97	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	NOV 8	2001	32	3					477	488		10.1016/S0896-6273(01)00479-2	http://dx.doi.org/10.1016/S0896-6273(01)00479-2			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709158	Bronze			2022-12-24	WOS:000172119100013
J	Parnas, D; Haghighi, AP; Fetter, RD; Kim, SW; Goodman, CS				Parnas, D; Haghighi, AP; Fetter, RD; Kim, SW; Goodman, CS			Regulation of postsynaptic structure and protein localization by the Rho-type guanine nucleotide exchange factor dPix	NEURON			English	Article							GLUTAMATE RECEPTORS; FASCICLIN-II; DROSOPHILA REVEALS; GENETIC-ANALYSIS; SYNAPTIC GROWTH; PAK; ACTIN; EXPRESSION; KINASE; INTERACTS	Mutations in dpix were recovered from a large-scale screen in Drosophila for genes that control synaptic structure. dpix encodes dPix, a Rho-type guanine nucleotide exchange factor (RtGEF) homologous to mammalian Pix. Here we show that dPix plays a major role in regulating postsynaptic structure and protein localization at the Drosophila glutamatergic neuromuscular junction. dpix mutations lead to decreased synaptic levels of the PDZ protein Dig, the cell adhesion molecule Fas II, and the glutamate receptor subunit GluRIIA, and to a complete reduction of the serine/threonine kinase Pak and the subsynaptic reticulum. The electrophysiology of these mutant synapses is nearly normal. Many, but not all, dpix defects are mediated through dPak, a member of the family of Cdc42/Rac1-activated kinases. Thus, a Rho-type GEF and Rho-type effector kinase regulate postsynaptic structure.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Goodman, CS (corresponding author), Renovis Inc, 270 Littlefield Ave, San Francisco, CA 94080 USA.	goodman@uclink4.berkeley.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060711] Funding Source: NIH RePORTER; NIMH NIH HHS [MH60711] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Allison DW, 1998, J NEUROSCI, V18, P2423; Bagrodia S, 1999, TRENDS CELL BIOL, V9, P350, DOI 10.1016/S0962-8924(99)01618-9; Bagrodia S, 1998, J BIOL CHEM, V273, P23633, DOI 10.1074/jbc.273.37.23633; Bai CY, 2000, NUCLEIC ACIDS RES, V28, P1078, DOI 10.1093/nar/28.5.1078; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; Dai ZS, 2000, J CELL BIOL, V150, P1321, DOI 10.1083/jcb.150.6.1321; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; DiAntonio A, 1999, J NEUROSCI, V19, P3023; Fehon RG, 1997, GENETICS, V146, P245; Gardiol A, 1999, J NEUROSCI, V19, P168, DOI 10.1523/JNEUROSCI.19-01-00168.1999; Hing H, 1999, CELL, V97, P853, DOI 10.1016/S0092-8674(00)80798-9; Hirai H, 2000, EUR J NEUROSCI, V12, P563, DOI 10.1046/j.1460-9568.2000.00938.x; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Kins S, 2000, NAT NEUROSCI, V3, P22, DOI 10.1038/71096; KIRSCH J, 1995, J NEUROSCI, V15, P4148; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; LITTLETON JT, 1993, DEVELOPMENT, V118, P1077; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Obermeier A, 1998, EMBO J, V17, P4328, DOI 10.1093/emboj/17.15.4328; PATEL N, 1994, IMAGING NEURONAL SUB, P7; Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Saitoe M, 1997, DEV BIOL, V184, P48, DOI 10.1006/dbio.1996.8480; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; SCHUSTER CM, 1991, SCIENCE, V254, P112, DOI 10.1126/science.1681587; Sheng MHT, 2001, SYNAPSES, P315; Sigrist SJ, 2000, NATURE, V405, P1062, DOI 10.1038/35016598; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; Sone M, 2000, DEVELOPMENT, V127, P4157; Tejedor FJ, 1997, J NEUROSCI, V17, P152, DOI 10.1523/JNEUROSCI.17-01-00152.1997; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; TOWER J, 1993, GENETICS, V133, P347; Trinidad JC, 2000, J NEUROSCI, V20, P8762; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Werner LA, 1997, GENE, V187, P107, DOI 10.1016/S0378-1119(96)00732-9; Weston C, 2000, J CELL BIOL, V150, P205, DOI 10.1083/jcb.150.1.205; Winberg ML, 1998, CELL, V95, P903, DOI 10.1016/S0092-8674(00)81715-8; Zhang WD, 1999, J NEUROSCI, V19, P96, DOI 10.1523/JNEUROSCI.19-01-00096.1999; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	45	228	230	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	NOV 8	2001	32	3					415	424		10.1016/S0896-6273(01)00485-8	http://dx.doi.org/10.1016/S0896-6273(01)00485-8			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	491QE	11709153	Bronze			2022-12-24	WOS:000172119100008
J	Conti, L; Sipione, S; Magrassi, L; Bonfanti, L; Rigamonti, D; Pettirossi, V; Peschanski, M; Haddad, B; Pelicci, P; Milanesi, G; Pelicci, G; Cattaneo, E				Conti, L; Sipione, S; Magrassi, L; Bonfanti, L; Rigamonti, D; Pettirossi, V; Peschanski, M; Haddad, B; Pelicci, P; Milanesi, G; Pelicci, G; Cattaneo, E			Shc signaling in differentiating neural progenitor cells	NATURE NEUROSCIENCE			English	Article							CENTRAL-NERVOUS-SYSTEM; PHOSPHOTYROSINE-BINDING DOMAINS; ADAPTER PROTEIN; GROWTH-FACTOR; STEM-CELLS; KINASE ACTIVATION; MAMMALIAN BRAIN; SRC HOMOLOGY-2; SURVIVAL; PHOSPHORYLATION	Previously we found that the availability of ShcA adapter is maximal in neural stem cells but that it is absent in mature neurons. Here we report that ShcC, unlike ShcA, is not present in neural stem/progenitor cells, but is expressed after cessation of their division and becomes selectively enriched in mature neurons. Analyses of its activity in differentiating neural stem/progenitor cells revealed that ShcC positively affects their viability and neuronal maturation via recruitment of the PI3K-Akt-Bad pathway and persistent activation of the MAPK pathway. We suggest that the switch from ShcA to ShcC modifies the responsiveness of neural stem/progenitor cells to extracellular stimuli, generating proliferation (with ShcA) or survival/differentiation (with ShcC).	Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, I-20133 Milan, Italy; Univ Pavia, Policlin San Matteo, IRCCS, Dept Surg,Dept Neurosurg, I-27100 Pavia, Italy; CNR, Ist Genet Biol & Evoluzionist, I-27100 Pavia, Italy; Univ Turin, Dept Morfofisiol Vet, I-10095 Grugliasco, TO, Italy; European Inst Oncol, I-20141 Milan, Italy; Fac Med, INSERM, U421, F-94010 Creteil, France; Univ Milan, Dept Biol & Genet Med Sci, I-20133 Milan, Italy	University of Milan; IRCCS Fondazione San Matteo; University of Pavia; Consiglio Nazionale delle Ricerche (CNR); University of Turin; IRCCS European Institute of Oncology (IEO); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Milan	Cattaneo, E (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Dept Pharmacol Sci, Via Balzaretti 9, I-20133 Milan, Italy.	elena.cattaneo@unimi.it	Pelicci, Giuliana/AAA-8921-2022; Magrassi, Lorenzo/AAJ-3105-2020; Pelicci, Pier Giuseppe/AAL-6572-2020; Peschanski, Marc/N-5769-2017; Conti, Luciano/H-4184-2012	Pelicci, Giuliana/0000-0003-0986-8255; Conti, Luciano/0000-0002-2050-9846; CATTANEO, ELENA/0000-0002-0755-4917; Magrassi, Lorenzo/0000-0002-8308-2720	Telethon [A.128] Funding Source: Medline	Telethon(Fondazione Telethon)		Bonfanti L, 1997, NEUROSCIENCE, V81, P489, DOI 10.1016/S0306-4522(97)00090-0; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; CARAYON P, 1992, J IMMUNOL METHODS, V147, P225, DOI 10.1016/S0022-1759(12)80012-3; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Cattaneo E, 1998, TRENDS NEUROSCI, V21, P476, DOI 10.1016/S0166-2236(98)01282-X; Cattaneo E, 1996, MOL BRAIN RES, V42, P161, DOI 10.1016/S0169-328X(96)00159-3; CHO KO, 1992, NEURON, V9, P929, DOI 10.1016/0896-6273(92)90245-9; Conti L, 1997, P NATL ACAD SCI USA, V94, P8185, DOI 10.1073/pnas.94.15.8185; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Grignani F, 1998, CANCER RES, V58, P14; Hemmings BA, 1997, SCIENCE, V275, P628, DOI 10.1126/science.275.5300.628; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Klesse LJ, 1999, ONCOGENE, V18, P2055, DOI 10.1038/sj.onc.1202524; Lai KMV, 2000, GENE DEV, V14, P1132; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Nakamura T, 1998, J BIOL CHEM, V273, P6960, DOI 10.1074/jbc.273.12.6960; O'Bryan JP, 1998, J BIOL CHEM, V273, P20431, DOI 10.1074/jbc.273.32.20431; OBryan JP, 1996, P NATL ACAD SCI USA, V93, P2729, DOI 10.1073/pnas.93.7.2729; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pelicci G, 1996, ONCOGENE, V13, P633; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Sakai R, 2000, NEURON, V28, P819, DOI 10.1016/S0896-6273(00)00156-2; Segal RA, 1996, ANNU REV NEUROSCI, V19, P463, DOI 10.1146/annurev.ne.19.030196.002335; SHU SY, 1988, NEUROSCI LETT, V85, P169, DOI 10.1016/0304-3940(88)90346-1; YANG CZ, 1985, CHINESE J TRENDS NUC, V2, P1; YAO RJ, 1995, SCIENCE, V267, P2003, DOI 10.1126/science.7701324; York RD, 1998, NATURE, V392, P622, DOI 10.1038/33451; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	38	96	105	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					579	586		10.1038/88395	http://dx.doi.org/10.1038/88395			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369938				2022-12-24	WOS:000169061800010
J	Li, H; Chen, AQ; Xing, GQ; Wei, ML; Rogawski, MA				Li, H; Chen, AQ; Xing, GQ; Wei, ML; Rogawski, MA			Kainate receptor-mediated heterosynaptic facilitation in the amygdala	NATURE NEUROSCIENCE			English	Article							METABOTROPIC GLUTAMATE-RECEPTOR; PHASEOLUS-VULGARIS-LEUKOAGGLUTININ; EXCITATORY SYNAPTIC TRANSMISSION; RAT BASOLATERAL AMYGDALA; LONG-TERM POTENTIATION; IN-VITRO; PLASTICITY; HIPPOCAMPUS; GLUR5; NMDA	Prolonged low-frequency stimulation of excitatory afferents to basolateral amygdala neurons results in enduring enhancement of excitatory synaptic responses. The induction of this form of synaptic plasticity is eliminated by selective antagonists of GluR5 kainate receptors and can be mimicked by the GluR5 agonist ATPA. Kainate receptor-mediated synaptic facilitation generalizes to include inactive afferent synapses on the target neurons, and therefore contrasts with other types of activity-dependent enduring synaptic facilitation that are input-pathway specific. Such heterosynaptic spread of synaptic facilitation could account for adaptive and pathological expansion in the set of critical internal and external stimuli that trigger amygdala-dependent behavioral responses.	NINDS, Neuronal Excitabil Sect, NIH, Bethesda, MD 20892 USA; Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Uniformed Services University of the Health Sciences - USA	Rogawski, MA (corresponding author), NINDS, Neuronal Excitabil Sect, NIH, 10 Ctr Dr,Room 5N-250 MSC 1408, Bethesda, MD 20892 USA.		Rogawski, Michael A/B-6353-2009; Xing, Guoqiang/ABA-8450-2020	Rogawski, Michael A/0000-0002-3296-8193; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002877, Z01NS002732] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDERSEN P, 1977, NATURE, V266, P736, DOI 10.1038/266736a0; [Anonymous], [No title captured]; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Aroniadou-Anderjaska V, 2001, NEUROREPORT, V12, P635, DOI 10.1097/00001756-200103050-00041; BASHIR ZI, 1991, NATURE, V349, P156, DOI 10.1038/349156a0; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Bernard A, 1999, EUR J NEUROSCI, V11, P604, DOI 10.1046/j.1460-9568.1999.00479.x; BERNARD A, 1994, J NEUROCHEM, V62, P2057, DOI 10.1046/j.1471-4159.1994.62052057.x; Bleakman D, 1996, MOL PHARMACOL, V49, P581; BOLSER DC, 1995, J PHARMACOL EXP THER, V274, P1393; Bortolotto ZA, 1999, NATURE, V402, P297, DOI 10.1038/46290; Bureau I, 1999, J NEUROSCI, V19, P653; BURNASHEV N, 1995, J PHYSIOL-LONDON, V485, P403, DOI 10.1113/jphysiol.1995.sp020738; CHAPMAN PF, 2000, AMYGDALA FUNCTIONAL, P117; Clarke VRJ, 1997, NATURE, V389, P599, DOI 10.1038/39315; Contractor A, 2000, J NEUROSCI, V20, P8269, DOI 10.1523/JNEUROSCI.20-22-08269.2000; DAVIS M, 1994, TRENDS NEUROSCI, V17, P208, DOI 10.1016/0166-2236(94)90106-6; EGEBJERG J, 1993, P NATL ACAD SCI USA, V90, P755, DOI 10.1073/pnas.90.2.755; Engert F, 1997, NATURE, V388, P279, DOI 10.1038/40870; FARB CR, 1995, J COMP NEUROL, V362, P86, DOI 10.1002/cne.903620106; Fitzjohn SM, 1996, NEUROSCI LETT, V203, P211, DOI 10.1016/0304-3940(96)12301-6; Frerking M, 2000, CURR OPIN NEUROBIOL, V10, P342, DOI 10.1016/S0959-4388(00)00094-5; Hermans E, 1998, NEUROPHARMACOLOGY, V37, P1645, DOI 10.1016/S0028-3908(98)00132-4; HUME RI, 1991, SCIENCE, V253, P1028, DOI 10.1126/science.1653450; Jones KA, 1997, NEUROPHARMACOLOGY, V36, P853, DOI 10.1016/S0028-3908(97)00066-X; KIRKWOOD A, 1993, SCIENCE, V260, P1518, DOI 10.1126/science.8502997; LAURIDSEN J, 1985, J MED CHEM, V28, P668, DOI 10.1021/jm50001a022; Li H, 1998, NEUROPHARMACOLOGY, V37, P1279, DOI 10.1016/S0028-3908(98)00109-9; Li H, 1998, J NEUROSCI, V18, P1662; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Mainen ZF, 1999, NATURE, V399, P151, DOI 10.1038/20187; MALENKA RC, 1994, CELL, V78, P535, DOI 10.1016/0092-8674(94)90517-7; Maren S, 1996, MOL NEUROBIOL, V13, P1, DOI 10.1007/BF02740749; MASCAGNI F, 1993, NEUROSCIENCE, V57, P697, DOI 10.1016/0306-4522(93)90016-9; McDonald AJ, 1997, NEUROSCIENCE, V77, P445, DOI 10.1016/S0306-4522(96)00478-2; Nicoll RA, 2000, NATURE, V406, P957, DOI 10.1038/35023075; O'Neill MJ, 1998, NEUROPHARMACOLOGY, V37, P1211, DOI 10.1016/S0028-3908(98)00134-8; OCONNOR JJ, 1994, NATURE, V367, P557, DOI 10.1038/367557a0; Ouanounou A, 1996, NEUROSCIENCE, V75, P99, DOI 10.1016/0306-4522(96)00319-3; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; Savander V, 1997, NEUROSCIENCE, V77, P767, DOI 10.1016/S0306-4522(96)00513-1; Scanziani M, 1996, NATURE, V380, P446, DOI 10.1038/380446a0; SCHUMAN EM, 1994, SCIENCE, V263, P532, DOI 10.1126/science.8290963; SOMMER B, 1991, CELL, V67, P11, DOI 10.1016/0092-8674(91)90568-J; Stensbol TB, 1999, EUR J PHARMACOL, V380, P153, DOI 10.1016/S0014-2999(99)00512-9; Tuunanen J, 1996, EUR J NEUROSCI, V8, P2711, DOI 10.1111/j.1460-9568.1996.tb01566.x; vanderKolk BA, 1997, J CLIN PSYCHIAT, V58, P16; Vignes M, 1998, NEUROPHARMACOLOGY, V37, P1269, DOI 10.1016/S0028-3908(98)00148-8; WEISSKOPF MG, 1995, NATURE, V376, P256, DOI 10.1038/376256a0; WILDING TJ, 1995, MOL PHARMACOL, V47, P582	50	86	89	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					612	620		10.1038/88432	http://dx.doi.org/10.1038/88432			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369942				2022-12-24	WOS:000169061800014
J	Miall, RC; Reckess, GZ; Imamizu, H				Miall, RC; Reckess, GZ; Imamizu, H			The cerebellum coordinates eye and hand tracking movements	NATURE NEUROSCIENCE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; DELAYED VISUAL FEEDBACK; FUNCTIONAL-ANATOMY; MANUAL TRACKING; BRAIN ACTIVITY; MOTOR CONTROL; ACTIVATION; TASK; PURSUIT; MEMORY	The cerebellum is thought to help coordinate movement. We tested this using functional magnetic resonance imaging (fMRI) of the human brain during visually guided tracking tasks requiring varying degrees of eye-hand coordination. The cerebellum was more active during independent rather than coordinated eye and hand tracking. However, in three further tasks, we also found parametric increases in cerebellar blood oxygenation signal (BOLD) as eye-hand coordination increased. Thus, the cerebellar BOLD signal has a non-monotonic relationship to tracking performance, with high activity during both coordinated and independent conditions. These data provide the most direct evidence from functional imaging that the cerebellum supports motor coordination. Its activity is consistent with roles in coordinating and learning to coordinate eye and hand movement.	Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Dept Expt Psychol, Oxford OX1 3UD, England; JST, ERATO, Kawato Dynam Brain Project, Sora Ku, Kyoto 6190288, Japan	University of Oxford; Japan Science & Technology Agency (JST)	Miall, RC (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.		Miall, R. Chris/B-7449-2013; Imamizu, Hiroshi/AAK-6059-2020	Miall, R. Chris/0000-0003-3002-1251; Imamizu, Hiroshi/0000-0003-1024-0051				ABRAMS RA, 1990, J EXP PSYCHOL HUMAN, V16, P248, DOI 10.1037/0096-1523.16.2.248; Allen G, 1997, SCIENCE, V275, P1940, DOI 10.1126/science.275.5308.1940; Bastian AJ, 1996, J NEUROPHYSIOL, V76, P492, DOI 10.1152/jn.1996.76.1.492; Berman RA, 1999, HUM BRAIN MAPP, V8, P209, DOI 10.1002/(SICI)1097-0193(1999)8:4<209::AID-HBM5>3.0.CO;2-0; BIGUER B, 1984, EXP BRAIN RES, V55, P462; Clower DM, 1996, NATURE, V383, P618, DOI 10.1038/383618a0; Ferraina S, 1997, EUR J NEUROSCI, V9, P1090, DOI 10.1111/j.1460-9568.1997.tb01460.x; Flament D, 1996, HUM BRAIN MAPP, V4, P210, DOI 10.1002/hbm.460040302; Fletcher PC, 1996, BRAIN, V119, P1587, DOI 10.1093/brain/119.5.1587; Flourens P, 1968, HUMAN BRAIN SPINAL C, P657; Friston K.J., 1994, HUMAN BRAIN MAPPING, V1, P210; Ghaem O, 1997, NEUROREPORT, V8, P739, DOI 10.1097/00001756-199702100-00032; GRAFTON ST, 1992, BRAIN, V115, P565, DOI 10.1093/brain/115.2.565; Imamizu H, 2000, NATURE, V403, P192, DOI 10.1038/35003194; Ivry R, 1997, INT REV NEUROBIOL, V41, P555; Jenkins IH, 1997, J NEUROL SCI, V151, P195, DOI 10.1016/S0022-510X(97)00145-7; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jueptner M, 1996, EXP BRAIN RES, V112, P462; KOKEN PW, 1992, EXP BRAIN RES, V88, P657; Lewis RF, 1998, J NEUROPHYSIOL, V80, P1605, DOI 10.1152/jn.1998.80.3.1605; Marple-Horvat DE, 1998, J PHYSIOL-LONDON, V506, P489, DOI 10.1111/j.1469-7793.1998.489bw.x; Miall RC, 2000, EXP BRAIN RES, V135, P22, DOI 10.1007/s002210000491; Miall RC, 1998, NOVART FDN SYMP, V218, P272; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; MIALL RC, 1985, NEUROSCIENCE, V16, P511, DOI 10.1016/0306-4522(85)90189-7; MULLER F, 1994, EXP BRAIN RES, V101, P485; Nishitani N, 1999, J NEUROSCI, V19, P2647; PELISSON D, 1986, EXP BRAIN RES, V62, P303; Petit L, 1999, J NEUROPHYSIOL, V82, P463, DOI 10.1152/jn.1999.82.1.463; POULTON EC, 1974, TRACKIN SKILL MANUAL; ROLAND PE, 1995, CEREB CORTEX, V5, P79, DOI 10.1093/cercor/5.1.79; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Serrien DJ, 2000, NEUROPSYCHOLOGIA, V38, P558, DOI 10.1016/S0028-3932(99)00116-5; Shadmehr R, 1997, SCIENCE, V277, P821, DOI 10.1126/science.277.5327.821; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamada T, 1999, NEUROREPORT, V10, P325, DOI 10.1097/00001756-199902050-00022; Turner RS, 1998, J NEUROPHYSIOL, V80, P2162, DOI 10.1152/jn.1998.80.4.2162; VANDONKELAAR P, 1994, J NEUROPHYSIOL, V72, P1674, DOI 10.1152/jn.1994.72.4.1674; VANDONKELAAR P, 1994, EXP BRAIN RES, V99, P155, DOI 10.1007/BF00241420; VanMeter JW, 1995, NEUROIMAGE, V2, P273, DOI 10.1006/nimg.1995.1035; Vercher JL, 1996, J NEUROPHYSIOL, V76, P1133, DOI 10.1152/jn.1996.76.2.1133; VERCHER JL, 1988, EXP BRAIN RES, V73, P155, DOI 10.1007/BF00279669; VERCHER JL, 1992, EXP BRAIN RES, V90, P599; VERCHER JL, 1994, EXP BRAIN RES, V99, P507; Waldvogel D, 1999, J CEREBR BLOOD F MET, V19, P1209, DOI 10.1097/00004647-199911000-00004; Winstein CJ, 1997, J NEUROPHYSIOL, V77, P1581, DOI 10.1152/jn.1997.77.3.1581; Witney AG, 1999, J NEUROPHYSIOL, V82, P2039, DOI 10.1152/jn.1999.82.5.2039; Wolpert DM, 1998, NEURAL NETWORKS, V11, P1317, DOI 10.1016/S0893-6080(98)00066-5; Woods R.P., 1998, J COMPUT ASSIST TOMO, V22, P141	49	182	183	0	15	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	JUN	2001	4	6					638	644		10.1038/88465	http://dx.doi.org/10.1038/88465			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	438PG	11369946				2022-12-24	WOS:000169061800018
J	Anzai, A; Ohzawa, I; Freeman, RD				Anzai, A; Ohzawa, I; Freeman, RD			Joint-encoding of motion and depth by visual cortical neurons: neural basis of the Pulfrich effect	NATURE NEUROSCIENCE			English	Article							CATS STRIATE CORTEX; COMPLEX CELLS; STEREOSCOPIC DEPTH; RECEPTIVE-FIELDS; APPARENT MOTION; BINOCULAR DELAY; MACAQUE MONKEY; PERCEPTION; ORGANIZATION; STEREOPSIS	Motion and stereoscopic depth are fundamental parameters of the structural analysis of visual scenes. Because they are defined by a difference in object position, either over time or across the eyes, a common neural machinery may be used for encoding these attributes. To examine this idea, we analyzed responses of binocular complex cells in the cat striate cortex to stimuli of various intra- and interocular spatial and temporal shifts. We found that most neurons exhibit space-time-oriented response profiles in both monocular and binocular domains. This indicates that these neurons encode motion and depth jointly, and it explains phenomena such as the Pulfrich effect. We also found that the relationship between neuronal tuning of motion and depth conforms to that predicted by the use of motion parallax as a depth cue. These results demonstrate a joint-encoding of motion and depth at an early cortical stage.	Univ Calif Berkeley, Sch Optometry, Grp Vis Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Freeman, RD (corresponding author), Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA.			Ohzawa, Izumi/0000-0002-7123-7318	NEI NIH HHS [EY-03176, EY-01175] Funding Source: Medline; NATIONAL EYE INSTITUTE [P30EY003176, R01EY001175] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; BRADDICK O, 1974, VISION RES, V14, P519, DOI 10.1016/0042-6989(74)90041-8; Braddick OJ, 1978, VISUAL PSYCHOPHYSICS, P417; BRADLEY DC, 1995, NATURE, V373, P609, DOI 10.1038/373609a0; BURR DC, 1979, VISION RES, V19, P523, DOI 10.1016/0042-6989(79)90137-8; CARNEY T, 1993, VISION RES, V33, P1977, DOI 10.1016/0042-6989(93)90022-O; CARNEY T, 1989, VISION RES, V29, P155, DOI 10.1016/0042-6989(89)90121-1; CARNEY T, 1992, VISION RES, V32, P187, DOI 10.1016/0042-6989(92)90127-5; Cynader M., 1978, Frontiers in Visual Science, P373; DEANGELIS GC, 1993, J NEUROPHYSIOL, V69, P1091, DOI 10.1152/jn.1993.69.4.1091; DeAngelis GC, 1999, J NEUROSCI, V19, P4046; DeAngelis GC, 1998, NATURE, V394, P677, DOI 10.1038/29299; EMERSON RC, 1992, VISION RES, V32, P203, DOI 10.1016/0042-6989(92)90130-B; EMERSON RC, 1987, J NEUROPHYSIOL, V58, P33, DOI 10.1152/jn.1987.58.1.33; FALK DS, 1980, PERCEPT PSYCHOPHYS, V28, P19, DOI 10.3758/BF03204311; FELLEMAN DJ, 1987, J NEUROPHYSIOL, V57, P889, DOI 10.1152/jn.1987.57.4.889; GASKA JP, 1994, VISUAL NEUROSCI, V11, P805, DOI 10.1017/S0952523800003102; GEORGESON MA, 1989, VISION RES, V29, P1511, DOI 10.1016/0042-6989(89)90135-1; GEORGESON MA, 1992, VISION RES, V32, P193, DOI 10.1016/0042-6989(92)90128-6; Howard IP, 1995, BINOCULAR VISION STE; JULESZ B, 1969, NATURE, V222, P639, DOI 10.1038/222639a0; LEE DN, 1970, VISION RES, V10, P587, DOI 10.1016/0042-6989(70)90052-0; LIT A, 1949, AM J PSYCHOL, V62, P159, DOI 10.2307/1418457; MAUNSELL JH, 1983, J NEUROPHYSIOL, V49, P11458; MORGAN MJ, 1975, PERCEPTION, V4, P3, DOI 10.1068/p040003; MORGAN MJ, 1979, VISION RES, V19, P491, DOI 10.1016/0042-6989(79)90133-0; MORGAN MJ, 1995, NATURE, V378, P380, DOI 10.1038/378380a0; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P79, DOI 10.1113/jphysiol.1978.sp012489; NICKALLS RWD, 1986, VISION RES, V26, P367, DOI 10.1016/0042-6989(86)90035-0; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; PRESS WH, 1992, NEUMERICAL RECIPES C; Pulfrich C, 1922, NATURWISSENSCHAFTEN, V10, P553, DOI 10.1007/BF01571319; Qian N, 1997, VISION RES, V37, P1683, DOI 10.1016/S0042-6989(96)00164-2; ROGERS B, 1979, PERCEPTION, V8, P125, DOI 10.1068/p080125; ROSS J, 1974, NATURE, V248, P363, DOI 10.1038/248363a0; ROY JP, 1992, J NEUROSCI, V12, P2478; Sutter E.E., 1992, NONLINEAR VISION, P171, DOI [10.1201/9781351075060-6, DOI 10.1201/9781351075060-6]; SZULBORSKI RG, 1990, VISION RES, V30, P249, DOI 10.1016/0042-6989(90)90040-R; TYLER CW, 1974, NATURE, V250, P781, DOI 10.1038/250781a0; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WILSON JA, 1969, AM J PSYCHOL, V82, P350, DOI 10.2307/1420750; Ziegler LR, 1998, VISION RES, V38, P1199, DOI 10.1016/S0042-6989(97)00281-2	47	70	70	1	9	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	MAY	2001	4	5					513	518		10.1038/87462	http://dx.doi.org/10.1038/87462			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NN	11319560				2022-12-24	WOS:000168412600015
J	Sato, T; Murthy, A; Thompson, KG; Schall, JD				Sato, T; Murthy, A; Thompson, KG; Schall, JD			Search efficiency but not response interference affects visual selection in frontal eye field	NEURON			English	Article							SACCADE TARGET SELECTION; SUPERIOR COLLICULUS; NEURONAL-ACTIVITY; INTRACORTICAL MICROSTIMULATION; NEURAL MECHANISMS; PREFRONTAL CORTEX; SQUIRREL-MONKEYS; MENTAL PROCESSES; MACAQUE MONKEYS; CORTICAL AREAS	Two manipulations of a visual search task were used to test the hypothesis that the discrimination of a target from distracters by visually responsive neurons in the frontal eye field (FEF) marks the outcome and conclusion of visual processing instead of saccade preparation. First, search efficiency was reduced by increasing the similarity of the distracters to the target. Second, response interference was introduced by infrequently changing the location of the target in the array. Both manipulations increased reaction time, but only the change in search efficiency affected the time needed to select the target by visually responsive neurons. This result indicates that visually responsive neurons In FEF form an explicit representation of the location of the target in the image.	Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, Nashville, TN 37240 USA; NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA	Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Schall, JD (corresponding author), Vanderbilt Univ, Dept Psychol, Vanderbilt Vis Res Ctr, 111 21st Ave S,301 Wilson Hall, Nashville, TN 37240 USA.				NEI NIH HHS [R01-EY08890, P30-EY08126] Funding Source: Medline; NATIONAL EYE INSTITUTE [ZIAEY000389, R01EY008890, Z01EY000389, P30EY008126] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Basso MA, 1998, J NEUROSCI, V18, P7519; Bichot NP, 1999, NAT NEUROSCI, V2, P549, DOI 10.1038/9205; Bichot NP, 2001, J NEUROSCI, V21, P713, DOI 10.1523/JNEUROSCI.21-02-00713.2001; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; Carpenter RHS, 1991, EYE MOVEMENTS; CHELAZZI L, 1993, NATURE, V363, P345, DOI 10.1038/363345a0; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1101, DOI 10.1152/jn.1995.73.3.1101; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; COLES MGH, 1988, BIOL PSYCHOL, V26, P69, DOI 10.1016/0301-0511(88)90014-2; COLES MGH, 1995, OX PSYCH S, P86; CRIST CF, 1988, J NEUROSCI METH, V26, P117, DOI 10.1016/0165-0270(88)90160-4; Donders FC, 1868, ATTENTION PERFORM, V2, P92; Dorris MC, 1997, J NEUROSCI, V17, P8566; DUNCAN J, 1989, PSYCHOL REV, V96, P433, DOI 10.1037/0033-295X.96.3.433; DUNCANJOHNSON CC, 1982, BIOL PSYCHOL, V14, P1, DOI 10.1016/0301-0511(82)90016-3; ERIKSEN CW, 1979, PERCEPT PSYCHOPHYS, V25, P249, DOI 10.3758/BF03198804; GLIMCHER PW, 1992, NATURE, V355, P542, DOI 10.1038/355542a0; Gold JI, 2000, NATURE, V404, P390, DOI 10.1038/35006062; Gottlieb J, 1999, NAT NEUROSCI, V2, P906, DOI 10.1038/13209; GREEN DM, 1966, SIGNAL DETECTION THE; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; HIKOSAKA O, 1983, J NEUROPHYSIOL, V49, P1268; Hooge LTC, 1996, PERCEPT PSYCHOPHYS, V58, P969, DOI 10.3758/BF03206825; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; HUERTA MF, 1987, J COMP NEUROL, V265, P332, DOI 10.1002/cne.902650304; HUERTA MF, 1986, J COMP NEUROL, V253, P415, DOI 10.1002/cne.902530402; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Luce RD, 1986, RESPONSE TIMES THEIR; Luck SJ, 1997, J NEUROPHYSIOL, V77, P24, DOI 10.1152/jn.1997.77.1.24; MCCARTHY G, 1981, SCIENCE, V211, P77, DOI 10.1126/science.7444452; MCCLELLAND JL, 1979, PSYCHOL REV, V86, P287, DOI 10.1037/0033-295X.86.4.287; MEYER DE, 1988, BIOL PSYCHOL, V26, P3, DOI 10.1016/0301-0511(88)90013-0; MILLER J, 1992, J EXP PSYCHOL GEN, V121, P195, DOI 10.1037/0096-3445.121.2.195; MILLER J, 1982, J EXP PSYCHOL HUMAN, V8, P273, DOI 10.1037/0096-1523.8.2.273; MILLER JO, 1983, J EXP PSYCHOL HUMAN, V11, P221; MOTTER BC, 1994, J NEUROSCI, V14, P2178; MOTTER BC, 1993, J NEUROPHYSIOL, V70, P909, DOI 10.1152/jn.1993.70.3.909; Murthy A., 1999, Society for Neuroscience Abstracts, V25, P806; OSMAN A, 1992, J EXP PSYCHOL HUMAN, V18, P217, DOI 10.1037/0096-1523.18.1.217; PASHLER H, 1991, J EXP PSYCHOL HUMAN, V17, P1023, DOI 10.1037/0096-1523.17.4.1023; Rainer G, 1998, NATURE, V393, P577, DOI 10.1038/31235; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; SANDERS AF, 1990, ACTA PSYCHOL, V74, P123, DOI 10.1016/0001-6918(90)90004-Y; SAYER RJ, 1990, J NEUROSCI, V10, P826; SCHALL JD, 1993, NATURE, V366, P467, DOI 10.1038/366467a0; SCHALL JD, 1995, J NEUROSCI, V15, P6905; Schall JD, 1997, CEREBR CORT, V12, P527; SCHALL JD, 1995, J NEUROSCI, V15, P4464; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; STANTON GB, 1995, J COMP NEUROL, V353, P291, DOI 10.1002/cne.903530210; STERNBERG S, 1966, SCIENCE, V153, P652, DOI 10.1126/science.153.3736.652; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; Thompson K. G., 1998, Society for Neuroscience Abstracts, V24, P1146; Thompson KG, 1997, J NEUROPHYSIOL, V77, P1046, DOI 10.1152/jn.1997.77.2.1046; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Thompson KG, 2001, VISUAL ATTENTION AND CORTICAL CIRCUITS, P137; Viviani P, 1990, Rev Oculomot Res, V4, P353; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774	59	140	140	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	MAY	2001	30	2					583	591		10.1016/S0896-6273(01)00304-X	http://dx.doi.org/10.1016/S0896-6273(01)00304-X			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	436XW	11395016	Bronze			2022-12-24	WOS:000168962000027
J	Catania, KC				Catania, KC			Early development of a somatosensory fovea: a head start in the cortical space race?	NATURE NEUROSCIENCE			English	Article							OCULAR DOMINANCE COLUMNS; VISUAL-CORTEX; PLASTICITY; SYSTEM; INNERVATION; MONKEYS; MAMMALS; MICE; CAT		Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Catania, KC (corresponding author), Vanderbilt Univ, Dept Biol Sci, Box 1812,Stn B, Nashville, TN 37235 USA.				NIMH NIH HHS [MH 58909] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH058909] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AZZOPARDI P, 1993, NATURE, V361, P719, DOI 10.1038/361719a0; CATANIA KC, 1995, NATURE, V375, P453; Catarci T, 1997, J VISUAL LANG COMPUT, V8, P215, DOI 10.1006/jvlc.1997.0037; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; JENKINS WM, 1990, J NEUROPHYSIOL, V63, P82, DOI 10.1152/jn.1990.63.1.82; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.neuro.14.1.137; LEE KJ, 1975, BRAIN RES, V99, P349, DOI 10.1016/0006-8993(75)90035-9; Miyake T, 1996, J CRAN GENET DEV BIO, V16, P1; Purves Dale, 1994, Current Opinion in Neurobiology, V4, P120, DOI 10.1016/0959-4388(94)90041-8; RAPAPORT DH, 1984, NEUROSCIENCE, V11, P289, DOI 10.1016/0306-4522(84)90024-1; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; STRYKER MP, 1986, J NEUROSCI, V6, P2117; WELKER E, 1986, J NEUROSCI, V6, P3355; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Xerri C, 1999, CEREB CORTEX, V9, P264, DOI 10.1093/cercor/9.3.264	15	17	17	0	5	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1097-6256			NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					353	354		10.1038/85992	http://dx.doi.org/10.1038/85992			2	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276222				2022-12-24	WOS:000168762200012
J	Ernst, UA; Pawelzik, KR; Sahar-Pikielny, C; Tsodyks, MV				Ernst, UA; Pawelzik, KR; Sahar-Pikielny, C; Tsodyks, MV			Intracortical origin of visual maps	NATURE NEUROSCIENCE			English	Article							ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; RECEPTIVE-FIELDS; CAT; CONNECTIONS; MODEL; DYNAMICS; COLUMNS; ORGANIZATION; SPECIFICITY	Previous experiments indicate that the shape of maps of preferred orientation in the primary visual cortex does not depend on visual experience. We propose! a network model that demonstrates that the orientation and direction selectivity of individual units and the structure of the corresponding angle maps could emerge from local recurrent connections. Our model reproduces the structure of preferred orientation and direction maps, and explains the origin of their interrelationship. The model also provides an explanation for the correlation between position shifts of receptive fields and changes of preferred orientations of single neurons across the surface of the cortex.	Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; Univ Bremen, Inst Theoret Phys, D-28334 Bremen, Germany; Tel Aviv Univ, Sch Phys & Astron, IL-69978 Tel Aviv, Israel	Weizmann Institute of Science; University of Bremen; Tel Aviv University	Tsodyks, MV (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	misha@weizmann.ac.il	tsodyks, misha/J-4430-2013	Tsodyks, Misha/0000-0002-5661-4349				AHMED B, 1994, J COMP NEUROL, V341, P39, DOI 10.1002/cne.903410105; AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; Das A, 1997, NATURE, V387, P594, DOI 10.1038/42461; Ernst U, 1999, NEURAL COMPUT, V11, P375, DOI 10.1162/089976699300016692; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1997, EUR J NEUROSCI, V9, P1754; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; GRINVALD A, 1986, NATURE, V324, P361, DOI 10.1038/324361a0; GROSSBERG S, 1988, NEURAL NETWORKS, V1, P17, DOI 10.1016/0893-6080(88)90021-4; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; Lowel S, 1998, EUR J NEUROSCI, V10, P2629, DOI 10.1046/j.1460-9568.1998.t01-1-00274.x; MAFFEI L, 1990, P NATL ACAD SCI USA, V87, P2861, DOI 10.1073/pnas.87.7.2861; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; MALSBURG CV, 1973, KYBERNETIK, V14, P85, DOI 10.1007/BF00288907; McLaughlin D, 2000, P NATL ACAD SCI USA, V97, P8087, DOI 10.1073/pnas.110135097; MILLER KD, 1994, J NEUROSCI, V14, P409; OBERMAYER K, 1990, P NATL ACAD SCI USA, V87, P8345, DOI 10.1073/pnas.87.21.8345; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; REID RC, 1995, NATURE, V378, P281, DOI 10.1038/378281a0; ROJER AS, 1990, BIOL CYBERN, V62, P381, DOI 10.1007/BF00197644; Shmuel A, 1996, J NEUROSCI, V16, P6945; Shouval HZ, 2000, J NEUROSCI, V20, P1119, DOI 10.1523/JNEUROSCI.20-03-01119.2000; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sompolinsky H, 1997, CURR OPIN NEUROBIOL, V7, P514, DOI 10.1016/S0959-4388(97)80031-1; SWINDALE NV, 1982, PROC R SOC SER B-BIO, V215, P211, DOI 10.1098/rspb.1982.0038; SWINDALE NV, 1996, J NEUROSCI, V16, P6945; Tsodyks M, 1999, SCIENCE, V286, P1943, DOI 10.1126/science.286.5446.1943; Tsodyks M, 1995, INTERNATIONAL JOURNAL OF NEURAL SYSTEMS, SUPPLEMENTARY ISSUE, 1995, P81; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Wolf F, 1998, NATURE, V395, P73, DOI 10.1038/25736; Wolf F, 1996, NATURE, V382, P306, DOI 10.1038/382306a0	37	47	47	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1097-6256	1546-1726		NAT NEUROSCI	Nat. Neurosci.	APR	2001	4	4					431	436		10.1038/86089	http://dx.doi.org/10.1038/86089			6	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	433MB	11276235				2022-12-24	WOS:000168762200025
J	Krishnan, KS; Rikhy, R; Rao, S; Shivalkar, M; Mosko, M; Narayanan, R; Etter, P; Estes, PS; Ramaswami, M				Krishnan, KS; Rikhy, R; Rao, S; Shivalkar, M; Mosko, M; Narayanan, R; Etter, P; Estes, PS; Ramaswami, M			Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling	NEURON			English	Article							RECEPTOR-MEDIATED ENDOCYTOSIS; DROSOPHILA-MELANOGASTER; TUMOR-METASTASIS; NEUROMUSCULAR-JUNCTIONS; TRANSMITTER RELEASE; LETHAL INTERACTION; ENZYMATIC-ACTIVITY; TYROSINE-KINASE; NERVE-TERMINALS; MELANOMA-CELLS	Nucleoside diphosphate kinase (NDK), an enzyme encoded by the Drosophila abnormal wing discs (awd) or human nm23 tumor suppressor genes, generates nucleoside triphosphates from respective diphosphates. We demonstrate that NDK regulates synaptic vesicle internalization at the stage where function of the dynamin GTPase is required, awd mutations lower the temperature at which behavioral paralysis, synaptic failure, and blocked membrane internalization occur at dynamin-deficient, shi(ts), mutant nerve terminals. Hypomorphic awd alleles display shi(ts)-like defects. NDK is present at synapses and its enzymatic activity is essential for normal presynaptic function. We suggest a model in which dynamin activity in nerve terminals is highly dependent on NDK-mediated supply of GTP. This connection between NDK and membrane internalization further strengthens an emerging hypothesis that endocytosis, probably of activated growth factor receptors, is an important tumor suppressor activity in vivo.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, ARL, Div Neurobiol, Tucson, AZ 85721 USA; Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India	University of Arizona; University of Arizona; Tata Institute of Fundamental Research (TIFR)	Ramaswami, M (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.		Rikhy, Richa/J-4481-2012	Rikhy, Richa/0000-0002-4262-0238; Ramaswami, Mani/0000-0001-7631-0468	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034889, K02NS002001] Funding Source: NIH RePORTER; NINDS NIH HHS [KO2-NS02001, NS34889] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALAWI AA, 1971, SCIENCE, V172, P1055, DOI 10.1126/science.172.3987.1055; BABA H, 1995, CANCER RES, V55, P1977; Baba T, 1995, COLD SPRING HARB SYM, V60, P235, DOI 10.1101/SQB.1995.060.01.027; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; BETZ WJ, 1992, SCIENCE, V255, P200, DOI 10.1126/science.1553547; BIGGS J, 1988, GENE DEV, V2, P1333, DOI 10.1101/gad.2.10.1333; BIGGS J, 1990, CELL, V63, P933, DOI 10.1016/0092-8674(90)90496-2; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DEAROLF CR, 1988, DEV BIOL, V129, P169, DOI 10.1016/0012-1606(88)90171-6; DEAROLF CR, 1988, DEV BIOL, V129, P159, DOI 10.1016/0012-1606(88)90170-4; DeCamilli P, 1996, NEURON, V16, P481, DOI 10.1016/S0896-6273(00)80068-9; ENGEL M, 1995, EUR J BIOCHEM, V234, P200, DOI 10.1111/j.1432-1033.1995.200_c.x; Engel M, 1998, J BIOL CHEM, V273, P20058, DOI 10.1074/jbc.273.32.20058; Estes PS, 1996, J NEUROSCI, V16, P5443; Fish KN, 2000, J CELL BIOL, V150, P145, DOI 10.1083/jcb.150.1.145; Floyd S, 1998, TRENDS CELL BIOL, V8, P299, DOI 10.1016/S0962-8924(98)01316-6; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Fukuda M, 1996, INT J CANCER, V65, P531, DOI 10.1002/(SICI)1097-0215(19960208)65:4<531::AID-IJC23>3.0.CO;2-B; Futter CE, 1996, J CELL BIOL, V132, P1011, DOI 10.1083/jcb.132.6.1011; GonzalezGaitan M, 1997, CELL, V88, P767, DOI 10.1016/S0092-8674(00)81923-6; Grant D, 1998, GENETICS, V149, P1019; JONGEWARD GD, 1995, GENETICS, V139, P1553; KANTOR JD, 1993, CANCER RES, V53, P1971; KELLY LE, 1974, P NATL ACAD SCI USA, V71, P4906, DOI 10.1073/pnas.71.12.4906; KIM YT, 1990, J NEUROGENET, V7, P1, DOI 10.3109/01677069009084149; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Koenig JH, 1999, J NEUROPHYSIOL, V81, P1495, DOI 10.1152/jn.1999.81.4.1495; KOENIG JH, 1989, J NEUROSCI, V9, P3844; KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; KRAMER H, 1991, NATURE, V352, P207, DOI 10.1038/352207a0; Krishnan KS, 1996, J NEUROGENET, V10, P221, DOI 10.3109/01677069609083464; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEONE A, 1993, ONCOGENE, V8, P2325; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; MacDonald NJ, 1996, J BIOL CHEM, V271, P25107, DOI 10.1074/jbc.271.41.25107; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; McNiven MA, 2000, TRENDS BIOCHEM SCI, V25, P115, DOI 10.1016/S0968-0004(99)01538-8; PALLANCK L, 1995, NATURE, V376, P25, DOI 10.1038/376025a0; PARHAR RS, 1995, INT J CANCER, V60, P204; Petersen SA, 1997, NEURON, V19, P1237, DOI 10.1016/S0896-6273(00)80415-8; POODRY CA, 1990, DEV BIOL, V138, P464, DOI 10.1016/0012-1606(90)90212-2; POODRY CA, 1979, J CELL BIOL, V81, P520, DOI 10.1083/jcb.81.3.520; RAMASWAMI M, 1993, J NEUROGENET, V9, P73, DOI 10.3109/01677069309083451; RAMASWAMI M, 1994, NEURON, V13, P363, DOI 10.1016/0896-6273(94)90353-0; RANDAZZO PA, 1992, SCIENCE, V257, P862, DOI 10.1126/science.1323875; RICHTER MF, 1995, J BIOL CHEM, V270, P13512, DOI 10.1074/jbc.270.22.13512; Roos J, 1998, J BIOL CHEM, V273, P19108, DOI 10.1074/jbc.273.30.19108; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; ROSENGARD AM, 1989, NATURE, V342, P177, DOI 10.1038/342177a0; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 2000, TRAFFIC, V1, P385, DOI 10.1034/j.1600-0854.2000.010503.x; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; SHPETNER HS, 1992, NATURE, V355, P733, DOI 10.1038/355733a0; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; SIMON MA, 1991, CELL, V67, P701, DOI 10.1016/0092-8674(91)90065-7; STEEG PS, 1988, CANCER RES, V48, P6550; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Stimson DT, 1998, J NEUROSCI, V18, P9638; STURTEVANT AH, 1956, GENETICS, V41, P118; TAKEI K, 1995, NATURE, V374, P186, DOI 10.1038/374186a0; TENG DHF, 1991, NATURE, V353, P437, DOI 10.1038/353437a0; TIMMONS L, 1995, J BIOL CHEM, V270, P23021, DOI 10.1074/jbc.270.39.23021; TIMMONS L, 1993, DEV BIOL, V158, P364, DOI 10.1006/dbio.1993.1195; van der Bliek AM, 1999, TRENDS CELL BIOL, V9, P96, DOI 10.1016/S0962-8924(98)01490-1; VANDEGOOR J, 1995, P NATL ACAD SCI USA, V92, P5739, DOI 10.1073/pnas.92.12.5739; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wagner PD, 1997, P NATL ACAD SCI USA, V94, P9000, DOI 10.1073/pnas.94.17.9000; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Warnock Dale E., 1996, Bioessays, V18, P885, DOI 10.1002/bies.950181107; Whistler JL, 1999, J BIOL CHEM, V274, P24575, DOI 10.1074/jbc.274.35.24575; WU CF, 1977, J GEN PHYSIOL, V69, P705, DOI 10.1085/jgp.69.6.705; Xu J, 1996, DEV BIOL, V177, P544, DOI 10.1006/dbio.1996.0184; YOON CH, 1995, SCIENCE, V269, P1102, DOI 10.1126/science.7652556; Zhu JH, 1999, P NATL ACAD SCI USA, V96, P14911, DOI 10.1073/pnas.96.26.14911; Zuker CS, 1996, P NATL ACAD SCI USA, V93, P571, DOI 10.1073/pnas.93.2.571	83	133	134	0	13	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					197	210		10.1016/S0896-6273(01)00273-2	http://dx.doi.org/10.1016/S0896-6273(01)00273-2			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343655	Bronze			2022-12-24	WOS:000168412900021
J	Whim, MD; Moss, GWJ				Whim, MD; Moss, GWJ			A novel technique that measures peptide secretion on a millisecond timescale reveals rapid changes in release	NEURON			English	Article							MOUSE PITUITARY-CELLS; NEUROPEPTIDE-Y; SODIUM-CHANNEL; ATT-20 CELLS; NERVE-TERMINALS; CALCIUM; EXPRESSION; EXOCYTOSIS; FMRFAMIDE; VESICLES	Neuropeptides are ubiquitous transmitters that have been implicated in a wide variety of physiological and pathological conditions, and it is important to understand the processes that control their secretion. We have developed a technique that measures neuropeptide secretion with high temporal resolution. This method involves placing an electrophysiological "tag" in a neuropeptide prohormone. The tagged prohormone is subsequently expressed together with an ionotropic receptor that binds the tag. Because the neuropeptide of interest and the tag enter the same population of dense core granules, neuropeptide secretion gives rise to fast, synaptic-like currents. Using this method, we show that peptide secretion can be modulated on a millisecond time scale. This technique could be readily adapted to measure the secretion of any neuropeptide.	UCL, Dept Pharmacol, London WC1E 6BT, England	University of London; University College London	Whim, MD (corresponding author), UCL, Dept Pharmacol, Gower St, London WC1E 6BT, England.	m.whim@ucl.ac.uk						Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; BEAN AJ, 1994, FASEB J, V8, P630, DOI 10.1096/fasebj.8.9.8005390; Blomqvist AG, 1997, TRENDS NEUROSCI, V20, P294, DOI 10.1016/S0166-2236(96)01057-0; Burke NV, 1997, NEURON, V19, P1095, DOI 10.1016/S0896-6273(00)80400-6; CARMELIET P, 1989, ENDOCRINOLOGY, V124, P2218, DOI 10.1210/endo-124-5-2218; Chavez RA, 1997, CURR BIOL, V7, P349, DOI 10.1016/S0960-9822(06)00158-8; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Cottrell GA, 1997, J EXP BIOL, V200, P2377; DICKERSON IM, 1987, J BIOL CHEM, V262, P13646; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433, DOI 10.1113/jphysiol.1979.sp012781; FISHER JM, 1988, CELL, V54, P813, DOI 10.1016/S0092-8674(88)91131-2; GREEN KA, 1994, PFLUG ARCH EUR J PHY, V428, P232, DOI 10.1007/BF00724502; HALBAN PA, 1994, BIOCHEM J, V299, P1; Hille B., 1991, IONIC CHANNELS EXCIT; Hokfelt T, 2000, NEUROPHARMACOLOGY, V39, P1337, DOI 10.1016/S0028-3908(00)00010-1; Hollins B, 1997, J NEUROPHYSIOL, V78, P3069, DOI 10.1152/jn.1997.78.6.3069; JUNG LJ, 1993, J CELL BIOL, V121, P11, DOI 10.1083/jcb.121.1.11; KORN SJ, 1991, J PHYSIOL-LONDON, V439, P423, DOI 10.1113/jphysiol.1991.sp018674; KUPFERMANN I, 1991, PHYSIOL REV, V71, P683, DOI 10.1152/physrev.1991.71.3.683; Kuzhikandathil EV, 1999, J NEUROSCI, V19, P1698; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; LIM NF, 1990, NATURE, V344, P449, DOI 10.1038/344449a0; LINGUEGLIA E, 1995, NATURE, V378, P730, DOI 10.1038/378730a0; Lysakowski A, 1999, J COMP NEUROL, V403, P378, DOI 10.1002/(SICI)1096-9861(19990118)403:3<378::AID-CNE7>3.0.CO;2-X; MATSUUCHI L, 1988, J CELL BIOL, V106, P239, DOI 10.1083/jcb.106.2.239; McNicholas CM, 1997, J GEN PHYSIOL, V109, P681, DOI 10.1085/jgp.109.6.681; MINTH CD, 1984, P NATL ACAD SCI-BIOL, V81, P4577, DOI 10.1073/pnas.81.14.4577; Mochida S, 1996, NEURON, V17, P781, DOI 10.1016/S0896-6273(00)80209-3; Nelson LS, 1998, SCIENCE, V281, P1686, DOI 10.1126/science.281.5383.1686; Paquet L, 1996, J NEUROSCI, V16, P964; PENG YY, 1991, J NEUROSCI, V11, P85; Perone MJ, 1998, MOL CELL ENDOCRINOL, V142, P191, DOI 10.1016/S0303-7207(98)00104-X; Perry SJ, 1997, FEBS LETT, V409, P426, DOI 10.1016/S0014-5793(97)00557-7; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PRICE DA, 1977, SCIENCE, V197, P670, DOI 10.1126/science.877582; THOMAS P, 1990, NEURON, V5, P723, DOI 10.1016/0896-6273(90)90226-6; VARNDELL IM, 1984, ENDOCRINOLOGY, V114, P1460, DOI 10.1210/endo-114-4-1460; WAHLESTEDT C, 1993, ANNU REV PHARMACOL, V33, P309, DOI 10.1146/annurev.pa.33.040193.001521; Whim MD, 1997, J NEUROSCI, V17, P2338; WHIM MD, 1989, P NATL ACAD SCI USA, V86, P9034, DOI 10.1073/pnas.86.22.9034; WONG BS, 1982, BIOPHYS J, V39, P313, DOI 10.1016/S0006-3495(82)84522-0; WULFF BS, 1993, J BIOL CHEM, V268, P13327; Xia ZG, 1996, J NEUROSCI, V16, P5425; YANG HYT, 1985, P NATL ACAD SCI USA, V82, P7757, DOI 10.1073/pnas.82.22.7757; Zucker RS, 1999, CURR OPIN NEUROBIOL, V9, P305, DOI 10.1016/S0959-4388(99)80045-2	48	27	27	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0896-6273			NEURON	Neuron	APR	2001	30	1					37	50		10.1016/S0896-6273(01)00261-6	http://dx.doi.org/10.1016/S0896-6273(01)00261-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	427NR	11343643	Bronze			2022-12-24	WOS:000168412900009
